Citrus Sinensis ID: 041135
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 727 | 2.2.26 [Sep-21-2011] | |||||||
| Q9SX31 | 708 | Proline-rich receptor-lik | yes | no | 0.599 | 0.615 | 0.648 | 1e-175 | |
| Q9C660 | 762 | Proline-rich receptor-lik | no | no | 0.574 | 0.548 | 0.676 | 1e-171 | |
| Q9CAL8 | 710 | Proline-rich receptor-lik | no | no | 0.503 | 0.515 | 0.607 | 1e-144 | |
| Q9ZUE0 | 720 | Proline-rich receptor-lik | no | no | 0.762 | 0.769 | 0.461 | 1e-143 | |
| Q9LV48 | 652 | Proline-rich receptor-lik | no | no | 0.463 | 0.516 | 0.637 | 1e-136 | |
| Q9LK03 | 717 | Proline-rich receptor-lik | no | no | 0.591 | 0.599 | 0.501 | 1e-129 | |
| Q9ZNQ8 | 633 | Proline-rich receptor-lik | no | no | 0.460 | 0.529 | 0.613 | 1e-127 | |
| Q9C821 | 509 | Proline-rich receptor-lik | no | no | 0.610 | 0.872 | 0.485 | 1e-126 | |
| Q9SGY7 | 718 | Putative proline-rich rec | no | no | 0.550 | 0.557 | 0.508 | 1e-126 | |
| Q1PEM5 | 513 | Proline-rich receptor-lik | no | no | 0.537 | 0.762 | 0.490 | 1e-125 |
| >sp|Q9SX31|PERK9_ARATH Proline-rich receptor-like protein kinase PERK9 OS=Arabidopsis thaliana GN=PERK9 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 616 bits (1589), Expect = e-175, Method: Compositional matrix adjust.
Identities = 290/447 (64%), Positives = 363/447 (81%), Gaps = 11/447 (2%)
Query: 272 SPRNAGVLGTGGAVAIGIAVGFLVLSLLVMAVWFAHKRKKKRAGEHIGYTLPSPYASSQK 331
S N+G+ GTG V I +AV +V +L + VW KR+K+ + G PSP +S+ +
Sbjct: 270 STNNSGI-GTGAVVGISVAVALVVFTLFGIFVWCLRKREKRLSAVSGGDVTPSPMSSTAR 328
Query: 332 SDSVFLRPHSPAPLVGNGSNSGFSRSPSESGVLGNSRSWFTYDELIQATNGFSAHNVLGE 391
SDS F R S AP VG SG S+SG LGNS++ F+Y+EL++ATNGFS N+LGE
Sbjct: 329 SDSAFFRMQSSAP-VGASKRSG--SYQSQSGGLGNSKALFSYEELVKATNGFSQENLLGE 385
Query: 392 GGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERE 451
GGFGCVYKG+L DGR VAVKQLKIGG QG+REF+AEVE +SR+HHRHLVS+VG+CIS
Sbjct: 386 GGFGCVYKGILPDGRVVAVKQLKIGGGQGDREFKAEVETLSRIHHRHLVSIVGHCISGDR 445
Query: 452 RLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSS 511
RLL+Y+YV N+ L++HLH E + V+DWATRVK+AAGAARG+AYLHEDCHPRIIHRDIKSS
Sbjct: 446 RLLIYDYVSNNDLYFHLHGE-KSVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSS 504
Query: 512 NILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSF 571
NILL+ +F+ARV+DFGLA++AL D NTH++TRV+GTFGYMAPEYA+SGKLTEKSDV+SF
Sbjct: 505 NILLEDNFDARVSDFGLARLAL--DCNTHITTRVIGTFGYMAPEYASSGKLTEKSDVFSF 562
Query: 572 GVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMF 631
GVVLLELITGRKPVD SQPLGDESLVEWARPL++ A+E E+F++L D +L NYV+SEMF
Sbjct: 563 GVVLLELITGRKPVDTSQPLGDESLVEWARPLISHAIETEEFDSLADPKLGGNYVESEMF 622
Query: 632 WMIEAAAACVRHSATKRPRMSQVVRALDTLDGASDLTNGVKPGQSGIFSSAQHSAQIRMF 691
MIEAA ACVRH ATKRPRM Q+VRA ++L A DLTNG++ G+S +F+SAQ SA+IR+F
Sbjct: 623 RMIEAAGACVRHLATKRPRMGQIVRAFESL-AAEDLTNGMRLGESEVFNSAQQSAEIRLF 681
Query: 692 QRLAFGGSQDYSSDFYNQSQTSWRSRE 718
+R+AF GSQ+YS+DF+ S +S+ SR+
Sbjct: 682 RRMAF-GSQNYSTDFF--SHSSYNSRD 705
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9C660|PEK10_ARATH Proline-rich receptor-like protein kinase PERK10 OS=Arabidopsis thaliana GN=PERK10 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 603 bits (1554), Expect = e-171, Method: Compositional matrix adjust.
Identities = 286/423 (67%), Positives = 344/423 (81%), Gaps = 5/423 (1%)
Query: 284 AVAIGIAVGFLVLSLLVMAVWFAHKRKKKRAGEHIGYTLPSPYASSQ-KSDSVFLRPHSP 342
V + I V ++L+L+ + V KRKK+ + GY +P+P SS +SDS L+ S
Sbjct: 330 VVGVSIGVALVLLTLIGVVVCCLKKRKKRLSTIGGGYVMPTPMESSSPRSDSALLKTQSS 389
Query: 343 APLVGNGSNSGFSRSPSESGVLGNSRSWFTYDELIQATNGFSAHNVLGEGGFGCVYKGVL 402
APLVGN S++ S SE G G SR F+Y+EL+ ATNGFS N+LGEGGFG VYKGVL
Sbjct: 390 APLVGNRSSNRTYLSQSEPGGFGQSRELFSYEELVIATNGFSDENLLGEGGFGRVYKGVL 449
Query: 403 ADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPND 462
D R VAVKQLKIGG QG+REF+AEV+ ISRVHHR+L+S+VGYCISE RLL+Y+YVPN+
Sbjct: 450 PDERVVAVKQLKIGGGQGDREFKAEVDTISRVHHRNLLSMVGYCISENRRLLIYDYVPNN 509
Query: 463 TLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEAR 522
L++HLHA G P +DWATRVK+AAGAARG+AYLHEDCHPRIIHRDIKSSNILL+++F A
Sbjct: 510 NLYFHLHAAGTPGLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLENNFHAL 569
Query: 523 VADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGR 582
V+DFGLAK+A LD NTH++TRVMGTFGYMAPEYA+SGKLTEKSDV+SFGVVLLELITGR
Sbjct: 570 VSDFGLAKLA--LDCNTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGR 627
Query: 583 KPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVR 642
KPVDASQPLGDESLVEWARPLL+ A E E+F AL D +L +NYV EMF MIEAAAAC+R
Sbjct: 628 KPVDASQPLGDESLVEWARPLLSNATETEEFTALADPKLGRNYVGVEMFRMIEAAAACIR 687
Query: 643 HSATKRPRMSQVVRALDTLDGASDLTNGVKPGQSGIFSSAQHSAQIRMFQRLAFGGSQDY 702
HSATKRPRMSQ+VRA D+L DLTNG++ G+S I +SAQ SA+IR+F+R+AF GSQ+Y
Sbjct: 688 HSATKRPRMSQIVRAFDSL-AEEDLTNGMRLGESEIINSAQQSAEIRLFRRMAF-GSQNY 745
Query: 703 SSD 705
S+D
Sbjct: 746 STD 748
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 513 bits (1322), Expect = e-144, Method: Compositional matrix adjust.
Identities = 243/400 (60%), Positives = 293/400 (73%), Gaps = 34/400 (8%)
Query: 319 GYTLPSPYASSQKSDSVFLRPHSPAPLVGNGSNSGFSRSPSESGVLGNSRSWFTYDELIQ 378
GYT AP +S V+G+ ++ FTY+EL
Sbjct: 321 GYTRSG-----------------SAP---------------DSAVMGSGQTHFTYEELTD 348
Query: 379 ATNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRH 438
T GFS HN+LGEGGFGCVYKG L DG+ VAVKQLK+G QG+REF+AEVEIISRVHHRH
Sbjct: 349 ITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLKVGSGQGDREFKAEVEIISRVHHRH 408
Query: 439 LVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHED 498
LVSLVGYCI++ ERLL+YEYVPN TL +HLH +GRPV++WA RV++A G+A+G+AYLHED
Sbjct: 409 LVSLVGYCIADSERLLIYEYVPNQTLEHHLHGKGRPVLEWARRVRIAIGSAKGLAYLHED 468
Query: 499 CHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYAT 558
CHP+IIHRDIKS+NILLD FEA+VADFGLAK L + THVSTRVMGTFGY+APEYA
Sbjct: 469 CHPKIIHRDIKSANILLDDEFEAQVADFGLAK--LNDSTQTHVSTRVMGTFGYLAPEYAQ 526
Query: 559 SGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVD 618
SGKLT++SDV+SFGVVLLELITGRKPVD QPLG+ESLVEWARPLL +A+E DF LVD
Sbjct: 527 SGKLTDRSDVFSFGVVLLELITGRKPVDQYQPLGEESLVEWARPLLHKAIETGDFSELVD 586
Query: 619 SRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDGASDLTNGVKPGQSGI 678
RLEK+YV++E+F MIE AAACVRHS KRPRM QVVRALD+ D++NG K GQS
Sbjct: 587 RRLEKHYVENEVFRMIETAAACVRHSGPKRPRMVQVVRALDSEGDMGDISNGNKVGQSSA 646
Query: 679 FSSAQHSAQIRMFQRLAFGGSQDYSSDFYNQSQTSWRSRE 718
+ S Q++ F+++AFG S Y+ + SR+
Sbjct: 647 YDSGQYNNDTMKFRKMAFGFDDSSDSGMYSGDYSVQDSRK 686
|
Regulates negatively root hairs elongation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUE0|PEK12_ARATH Proline-rich receptor-like protein kinase PERK12 OS=Arabidopsis thaliana GN=PERK12 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 508 bits (1309), Expect = e-143, Method: Compositional matrix adjust.
Identities = 297/644 (46%), Positives = 384/644 (59%), Gaps = 90/644 (13%)
Query: 123 PTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPT 182
P + ++PPP+ +P SSP P P P S P ++ PP S PT
Sbjct: 116 PNESNDNNPPPSQDLQSPPPSSPSPNVGPTNPESPPLQSPPAPPASDPTNSPPASPLDPT 175
Query: 183 STPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPST---------SSPPAVSPPA 233
+ PPP+ S PA++ P + PS SS P VSP
Sbjct: 176 N-----------------PPPIQPSGPATSPPANPNAPPSPFPTVPPKTPSSGPVVSPSL 218
Query: 234 PPSNSSTRGSPSTPPLPSVPTEKPTAKSTNGTAVSANASPRNAGVLGTGGAVAIGIAVGF 293
S ++G+P TP + T V G AVA GF
Sbjct: 219 ---TSPSKGTP-TPNQGNGDGGGGGGGYQGKTMV--------------GMAVA-----GF 255
Query: 294 LVLSLLVMAVWFAHKRKKKRAGEHIGYT--LPSPYASSQKSDSVFLRPHSPAPLVGNGSN 351
+++L+ V F +RKKKR + ++ LP P S KSD FL P +G N
Sbjct: 256 AIMALI--GVVFLVRRKKKRNIDSYNHSQYLPHPNFSV-KSDG-FLYGQDPGKGYSSGPN 311
Query: 352 SGFSRSPSE----------------------------SGVLGNSRSWFTYDELIQATNGF 383
+ + S +LG+ ++ F+Y+EL + T GF
Sbjct: 312 GSMYNNSQQQQSSMGNSYGTAGGGYPHHQMQSSGTPDSAILGSGQTHFSYEELAEITQGF 371
Query: 384 SAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLV 443
+ N+LGEGGFGCVYKG L DG+ VAVKQLK G QG+REF+AEVEIISRVHHRHLVSLV
Sbjct: 372 ARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAGSGQGDREFKAEVEIISRVHHRHLVSLV 431
Query: 444 GYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRI 503
GYCIS++ RLL+YEYV N TL +HLH +G PV++W+ RV++A G+A+G+AYLHEDCHP+I
Sbjct: 432 GYCISDQHRLLIYEYVSNQTLEHHLHGKGLPVLEWSKRVRIAIGSAKGLAYLHEDCHPKI 491
Query: 504 IHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLT 563
IHRDIKS+NILLD +EA+VADFGLA+ L + THVSTRVMGTFGY+APEYA+SGKLT
Sbjct: 492 IHRDIKSANILLDDEYEAQVADFGLAR--LNDTTQTHVSTRVMGTFGYLAPEYASSGKLT 549
Query: 564 EKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRLEK 623
++SDV+SFGVVLLEL+TGRKPVD +QPLG+ESLVEWARPLL +A+E D L+D+RLEK
Sbjct: 550 DRSDVFSFGVVLLELVTGRKPVDQTQPLGEESLVEWARPLLLKAIETGDLSELIDTRLEK 609
Query: 624 NYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDGASDLTNGVKPGQSGIFSSAQ 683
YV+ E+F MIE AAACVRHS KRPRM QVVRALD + D++NG+K GQS + S Q
Sbjct: 610 RYVEHEVFRMIETAAACVRHSGPKRPRMVQVVRALDCDGDSGDISNGIKIGQSTTYDSGQ 669
Query: 684 HSAQIRMFQRLAFGGSQD-----YSSDFYNQSQTSWRSREYEDR 722
++ I F+++AFGG YS ++ +S + + E E R
Sbjct: 670 YNEDIMKFRKMAFGGDNSVESGLYSGNYSAKSSSDFSGNESETR 713
|
Regulates the auxin-related MAX (More Axillary Growth) pathway during the shoot branching. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 485 bits (1249), Expect = e-136, Method: Compositional matrix adjust.
Identities = 225/353 (63%), Positives = 275/353 (77%), Gaps = 16/353 (4%)
Query: 363 VLGNSRSWFTYDELIQATNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGER 422
VLG S+S FTY+EL +ATNGFS N+LG+GGFG V+KG+L G+EVAVKQLK G QGER
Sbjct: 260 VLGFSKSTFTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGER 319
Query: 423 EFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRV 482
EF+AEVEIISRVHHRHLVSL+GYC++ +RLLVYE+VPN+ L +HLH +GRP M+W+TR+
Sbjct: 320 EFQAEVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHGKGRPTMEWSTRL 379
Query: 483 KVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVS 542
K+A G+A+G++YLHEDC+P+IIHRDIK+SNIL+D FEA+VADFGLAKIA D+NTHVS
Sbjct: 380 KIALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIA--SDTNTHVS 437
Query: 543 TRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARP 602
TRVMGTFGY+APEYA SGKLTEKSDV+SFGVVLLELITGR+PVDA+ D+SLV+WARP
Sbjct: 438 TRVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARP 497
Query: 603 LLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLD 662
LL A E DFE L DS++ Y EM M+ AAACVRHSA +RPRMSQ+VRAL+
Sbjct: 498 LLNRASEEGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQIVRALEGNV 557
Query: 663 GASDLTNGVKPGQSGIFSSAQHSAQIRMFQRLAFGGSQDYSSDFYNQSQTSWR 715
SDL G++PG S ++SS +GGS DY + YN +R
Sbjct: 558 SLSDLNEGMRPGHSNVYSS--------------YGGSTDYDTSQYNDDMIKFR 596
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 463 bits (1192), Expect = e-129, Method: Compositional matrix adjust.
Identities = 238/475 (50%), Positives = 311/475 (65%), Gaps = 45/475 (9%)
Query: 279 LGTGGAVAIGIAVGFLVLSLLVMAVWFAHKRKKKRAGE-------HIGYTLPSPYASSQK 331
L G V I I GF++L L + ++F K+K++R E + Y +S++
Sbjct: 223 LSKGAMVGIAIGGGFVLLVALAL-IFFLCKKKRRRDNEAPPAPIDGVPYGGQQQQNASRR 281
Query: 332 SDSVFLRP--------------HSPAPLVGNGSNSGFSR-------SPSESGVLGNSRSW 370
SD V + H + +S +S SP + LG +
Sbjct: 282 SDHVVMSVPPPKSPSSAPPRPPHFMSSGSSGDYDSNYSDQSVLPPPSPGLALGLGIYQGT 341
Query: 371 FTYDELIQATNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEI 430
F Y+EL +ATNGFS N+LG+GGFG V+KG+L +G+EVAVKQLK G SQGEREF+AEV I
Sbjct: 342 FNYEELSRATNGFSEANLLGQGGFGYVFKGMLRNGKEVAVKQLKEGSSQGEREFQAEVGI 401
Query: 431 ISRVHHRHLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAAR 490
ISRVHHRHLV+LVGYCI++ +RLLVYE+VPN+TL +HLH +GRP M+W++R+K+A G+A+
Sbjct: 402 ISRVHHRHLVALVGYCIADAQRLLVYEFVPNNTLEFHLHGKGRPTMEWSSRLKIAVGSAK 461
Query: 491 GIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFG 550
G++YLHE+C+P+IIHRDIK+SNIL+D FEA+VADFGLAKIA D+NTHVSTRVMGTFG
Sbjct: 462 GLSYLHENCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIA--SDTNTHVSTRVMGTFG 519
Query: 551 YMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEH 610
Y+APEYA+SGKLTEKSDV+SFGVVLLELITGR+P+D + D SLV+WARPLL + E
Sbjct: 520 YLAPEYASSGKLTEKSDVFSFGVVLLELITGRRPIDVNNVHADNSLVDWARPLLNQVSEL 579
Query: 611 EDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDGASDLTNG 670
+FE +VD +L Y EM M+ AAACVR +A +RPRM QV R L+ SDL G
Sbjct: 580 GNFEVVVDKKLNNEYDKEEMARMVACAAACVRSTAPRRPRMDQVARVLEGNISPSDLNQG 639
Query: 671 VKPGQSGIFSSAQHSAQIRMFQRLAFGGSQDYSSDFYNQSQTSWRSREYEDRSSY 725
+ PG S ++ S+ GGS DY S N+ +R E + Y
Sbjct: 640 ITPGHSNVYGSS--------------GGSTDYDSSQDNEGMNKFRKVGLETQDLY 680
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZNQ8|PERK4_ARATH Proline-rich receptor-like protein kinase PERK4 OS=Arabidopsis thaliana GN=PERK4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 455 bits (1170), Expect = e-127, Method: Compositional matrix adjust.
Identities = 216/352 (61%), Positives = 266/352 (75%), Gaps = 17/352 (4%)
Query: 364 LGNSRSWFTYDELIQATNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGERE 423
LG ++S FTY EL AT GF+ N+LG+GGFG V+KGVL G+EVAVK LK G QGERE
Sbjct: 265 LGFNKSTFTYQELAAATGGFTDANLLGQGGFGYVHKGVLPSGKEVAVKSLKAGSGQGERE 324
Query: 424 FRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVK 483
F+AEV+IISRVHHR+LVSLVGYCI++ +R+LVYE+VPN TL YHLH + PVM+++TR++
Sbjct: 325 FQAEVDIISRVHHRYLVSLVGYCIADGQRMLVYEFVPNKTLEYHLHGKNLPVMEFSTRLR 384
Query: 484 VAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVST 543
+A GAA+G+AYLHEDCHPRIIHRDIKS+NILLD +F+A VADFGLAK L D+NTHVST
Sbjct: 385 IALGAAKGLAYLHEDCHPRIIHRDIKSANILLDFNFDAMVADFGLAK--LTSDNNTHVST 442
Query: 544 RVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPL 603
RVMGTFGY+APEYA+SGKLTEKSDV+S+GV+LLELITG++PVD S + D++LV+WARPL
Sbjct: 443 RVMGTFGYLAPEYASSGKLTEKSDVFSYGVMLLELITGKRPVDNSITM-DDTLVDWARPL 501
Query: 604 LAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663
+A ALE +F L D+RLE NY EM M+ AAA +RHS KRP+MSQ+VRAL+
Sbjct: 502 MARALEDGNFNELADARLEGNYNPQEMARMVTCAAASIRHSGRKRPKMSQIVRALEGEVS 561
Query: 664 ASDLTNGVKPGQSGIFSSAQHSAQIRMFQRLAFGGSQDYSSDFYNQSQTSWR 715
L GVKPG S ++ S G S DYS YN +R
Sbjct: 562 LDALNEGVKPGHSNVYGS--------------LGASSDYSQTSYNADMKKFR 599
|
Required during abscisic acid (ABA)-mediated activation of Ca(2+) channels. Regulates ABA signaling pathways. Modulates the expression of genes related to cell elongation and ABA signaling during root growth. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C821|PEK15_ARATH Proline-rich receptor-like protein kinase PERK15 OS=Arabidopsis thaliana GN=PERK15 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 452 bits (1164), Expect = e-126, Method: Compositional matrix adjust.
Identities = 239/492 (48%), Positives = 323/492 (65%), Gaps = 48/492 (9%)
Query: 214 SPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTPPLPSVPTEKPTAKSTNGTAVSANASP 273
SPP P PST+ A SP PS S G S P P T + +
Sbjct: 11 SPPAPEFPSTTPDTATSP--APSQPSIIGPSSLAPFPE-------------TTTNIDGGS 55
Query: 274 RNAGVLGTGGAVAIGIAVGFLVLSLLVMAVWFAHKRKKKRAGEHIGYTLPSPYASSQKSD 333
RN + G V +G F++L + + ++ K++K + +S D
Sbjct: 56 RNVALTGLITGVVLGAT--FVLLGVCIFVCFYKRKKRKLKK------KKKEDIEASINRD 107
Query: 334 SVFLRPHSPAPLVGNGSNSGFSRSPSESGVLGNSRSWFTYDELIQATNGFSAHNVLGEGG 393
S L P + SN+ S SE G ++ FTY++L +AT+ FS N+LG+GG
Sbjct: 108 S--LDPK-------DDSNNLQQWSSSEIG-----QNLFTYEDLSKATSNFSNTNLLGQGG 153
Query: 394 FGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERL 453
FG V++GVL DG VA+KQLK G QGEREF+AE++ ISRVHHRHLVSL+GYCI+ +RL
Sbjct: 154 FGYVHRGVLVDGTLVAIKQLKSGSGQGEREFQAEIQTISRVHHRHLVSLLGYCITGAQRL 213
Query: 454 LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNI 513
LVYE+VPN TL +HLH + RPVM+W+ R+K+A GAA+G+AYLHEDC+P+ IHRD+K++NI
Sbjct: 214 LVYEFVPNKTLEFHLHEKERPVMEWSKRMKIALGAAKGLAYLHEDCNPKTIHRDVKAANI 273
Query: 514 LLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGV 573
L+D S+EA++ADFGLA+ + LD++THVSTR+MGTFGY+APEYA+SGKLTEKSDV+S GV
Sbjct: 274 LIDDSYEAKLADFGLARSS--LDTDTHVSTRIMGTFGYLAPEYASSGKLTEKSDVFSIGV 331
Query: 574 VLLELITGRKPVDASQPLG-DESLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFW 632
VLLELITGR+PVD SQP D+S+V+WA+PL+ +AL +F+ LVD RLE ++ +EM
Sbjct: 332 VLLELITGRRPVDKSQPFADDDSIVDWAKPLMIQALNDGNFDGLVDPRLENDFDINEMTR 391
Query: 633 MIEAAAACVRHSATKRPRMSQVVRALDTLDGASDLTNGVKPGQSGI--------FSSAQH 684
M+ AAA VRHSA +RP+MSQ+VRA + DLT G PGQS I +SS Q+
Sbjct: 392 MVACAAASVRHSAKRRPKMSQIVRAFEGNISIDDLTEGAAPGQSTIYSLDGSSDYSSTQY 451
Query: 685 SAQIRMFQRLAF 696
++ F+++AF
Sbjct: 452 KEDLKKFKKMAF 463
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SGY7|PEK11_ARATH Putative proline-rich receptor-like protein kinase PERK11 OS=Arabidopsis thaliana GN=PERK11 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 451 bits (1161), Expect = e-126, Method: Compositional matrix adjust.
Identities = 247/486 (50%), Positives = 307/486 (63%), Gaps = 86/486 (17%)
Query: 284 AVAIGIAVGFLVLSLLVMAVWFAHKRKKK-----RAGEHIGYTLPSPYASSQKSDSVFLR 338
+ IGIA G LV+ L + V+F +++KK R+ ++ LP P S ++
Sbjct: 263 VIGIGIA-GVLVI-LFIAGVFFVRRKQKKGSSSPRSNQY----LP-PANVSVNTEGFIHY 315
Query: 339 PHSPAPLVGNGSNSGFSRSPS--------------ESGVLGNSRSWFTYDELIQATNGFS 384
P GNG++S + SP +S V+G S+ FTY+EL Q T GF
Sbjct: 316 RQKP----GNGNSSAQNSSPDTNSLGNPKHGRGTPDSAVIGTSKIHFTYEELSQITEGFC 371
Query: 385 AHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVG 444
V+GEGGFGCVYKG+L +G+ VA+KQLK ++G REF+AEVEIISRVHHRHLVSLVG
Sbjct: 372 KSFVVGEGGFGCVYKGILFEGKPVAIKQLKSVSAEGYREFKAEVEIISRVHHRHLVSLVG 431
Query: 445 YCISERERLLVYEYVPNDTLHYHLHA---------------------------EGRPVMD 477
YCISE+ R L+YE+VPN+TL YHLH +
Sbjct: 432 YCISEQHRFLIYEFVPNNTLDYHLHGKNLPVLEWSRRVRIAIGAAKGLAYLHED------ 485
Query: 478 WATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDS 537
CHP+IIHRDIKSSNILLD FEA+VADFGLA+ L +
Sbjct: 486 ---------------------CHPKIIHRDIKSSNILLDDEFEAQVADFGLAR--LNDTA 522
Query: 538 NTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLV 597
+H+STRVMGTFGY+APEYA+SGKLT++SDV+SFGVVLLELITGRKPVD SQPLG+ESLV
Sbjct: 523 QSHISTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDTSQPLGEESLV 582
Query: 598 EWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657
EWARP L EA+E D +VD RLE +YV+SE++ MIE AA+CVRHSA KRPRM QVVRA
Sbjct: 583 EWARPRLIEAIEKGDISEVVDPRLENDYVESEVYKMIETAASCVRHSALKRPRMVQVVRA 642
Query: 658 LDTLDGASDLTNGVKPGQSGIFSSAQHSAQIRMFQRLAFGGSQDYSSDFYNQSQTSWRSR 717
LDT D SDLTNGVK GQS ++ S Q+S +IR+F+R + S ++ Y SQ S
Sbjct: 643 LDTRDDLSDLTNGVKVGQSRVYDSGQYSNEIRIFRRASEDSSDLGTNTGYYPSQDYATSH 702
Query: 718 EYEDRS 723
EYE S
Sbjct: 703 EYESES 708
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q1PEM5|PERK3_ARATH Proline-rich receptor-like protein kinase PERK3 OS=Arabidopsis thaliana GN=PERK3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 449 bits (1156), Expect = e-125, Method: Compositional matrix adjust.
Identities = 238/485 (49%), Positives = 302/485 (62%), Gaps = 94/485 (19%)
Query: 214 SPPPPSVPSTSSPP--------AVSPPAPPSNSSTRGSPSTPPLPSVPTEKPTAKSTNGT 265
+PPPP+ PS P ++SPP+P S
Sbjct: 90 NPPPPASPSGQEPTTPTMTPGFSLSPPSP-SR---------------------------- 120
Query: 266 AVSANASPRNAGVLGTGGAVAIGIAVGFLVLSLLVMAVWFAHKRKKKRAGEHIGYTLPSP 325
L TG V I I G VL+L ++F K+K+ R + LP+P
Sbjct: 121 -------------LSTGAVVGISIGGGVFVLTL----IFFLCKKKRPRDDK----ALPAP 159
Query: 326 YASSQKSDSVFLRPHSPAPLVGNGSNSGFSRSPSESGVLGNSRSWFTYDELIQATNGFSA 385
VLG +S FTY EL +ATN FS
Sbjct: 160 IGL----------------------------------VLGIHQSTFTYGELARATNKFSE 185
Query: 386 HNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGY 445
N+LGEGGFG VYKG+L +G EVAVKQLK+G +QGE+EF+AEV IIS++HHR+LVSLVGY
Sbjct: 186 ANLLGEGGFGFVYKGILNNGNEVAVKQLKVGSAQGEKEFQAEVNIISQIHHRNLVSLVGY 245
Query: 446 CISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIH 505
CI+ +RLLVYE+VPN+TL +HLH +GRP M+W+ R+K+A +++G++YLHE+C+P+IIH
Sbjct: 246 CIAGAQRLLVYEFVPNNTLEFHLHGKGRPTMEWSLRLKIAVSSSKGLSYLHENCNPKIIH 305
Query: 506 RDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEK 565
RDIK++NIL+D FEA+VADFGLAKIA LD+NTHVSTRVMGTFGY+APEYA SGKLTEK
Sbjct: 306 RDIKAANILIDFKFEAKVADFGLAKIA--LDTNTHVSTRVMGTFGYLAPEYAASGKLTEK 363
Query: 566 SDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRLEKNY 625
SDVYSFGVVLLELITGR+PVDA+ D+SLV+WARPLL +ALE +FE L D +L Y
Sbjct: 364 SDVYSFGVVLLELITGRRPVDANNVYADDSLVDWARPLLVQALEESNFEGLADIKLNNEY 423
Query: 626 VDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDGASDLTNGVKPGQSGIFSSAQHS 685
EM M+ AAACVR++A +RPRM QVVR L+ SDL G+ PG S S +
Sbjct: 424 DREEMARMVACAAACVRYTARRRPRMDQVVRVLEGNISPSDLNQGITPGHSNTVSVRLDA 483
Query: 686 AQIRM 690
+R+
Sbjct: 484 RAVRV 488
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 727 | ||||||
| 224079900 | 686 | predicted protein [Populus trichocarpa] | 0.658 | 0.698 | 0.809 | 0.0 | |
| 255585933 | 752 | ATP binding protein, putative [Ricinus c | 0.674 | 0.651 | 0.773 | 0.0 | |
| 356567172 | 756 | PREDICTED: proline-rich receptor-like pr | 0.662 | 0.637 | 0.764 | 0.0 | |
| 356523696 | 724 | PREDICTED: proline-rich receptor-like pr | 0.674 | 0.676 | 0.712 | 0.0 | |
| 225451941 | 717 | PREDICTED: proline-rich receptor-like pr | 0.634 | 0.642 | 0.775 | 0.0 | |
| 298204391 | 436 | unnamed protein product [Vitis vinifera] | 0.577 | 0.963 | 0.809 | 0.0 | |
| 449447470 | 786 | PREDICTED: proline-rich receptor-like pr | 0.639 | 0.591 | 0.703 | 0.0 | |
| 449482277 | 661 | PREDICTED: proline-rich receptor-like pr | 0.639 | 0.703 | 0.703 | 0.0 | |
| 225423802 | 726 | PREDICTED: proline-rich receptor-like pr | 0.599 | 0.600 | 0.728 | 0.0 | |
| 307136482 | 786 | ATP binding protein [Cucumis melo subsp. | 0.635 | 0.587 | 0.713 | 0.0 |
| >gi|224079900|ref|XP_002305965.1| predicted protein [Populus trichocarpa] gi|222848929|gb|EEE86476.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 825 bits (2131), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 390/482 (80%), Positives = 434/482 (90%), Gaps = 3/482 (0%)
Query: 237 NSSTRGSPSTPPLPSVPTEKPTAKSTNGTAVSANASPRNAGVLGTGGAVAIGIAVGFLVL 296
NSS GSP TPP P++PTEKPTA++TNGT VS N S G L GGAV IGI GF+ L
Sbjct: 208 NSSVTGSP-TPPFPAIPTEKPTARATNGTDVSTNTSSTGPGGLNNGGAVTIGIVAGFVAL 266
Query: 297 SLLVMAVWFAHKRKKKRAGEHIGYTLPSPYASSQKSDSVFLRPHSPAPLVGNGSNSGFSR 356
SLLV+AVWFA KRK++R GE++GYT+PSP+ASSQ SDSVFL+P+ PAPLVG+ S S F
Sbjct: 267 SLLVVAVWFAQKRKRRR-GENVGYTIPSPFASSQNSDSVFLKPYPPAPLVGSPSGSDFMY 325
Query: 357 SPSESGVLGNSRSWFTYDELIQATNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIG 416
SPSE+GV+ NSR WFTY+EL+QATNGFSA N LGEGGFGCVYKGVL DGR+VAVKQLKIG
Sbjct: 326 SPSEAGVVNNSRQWFTYEELVQATNGFSAQNRLGEGGFGCVYKGVLVDGRDVAVKQLKIG 385
Query: 417 GSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVM 476
GSQGEREFRAEVEIISRVHHRHLVSLVGYCISE +RLLVY+Y+PNDTL++HLH EGRP M
Sbjct: 386 GSQGEREFRAEVEIISRVHHRHLVSLVGYCISEHQRLLVYDYLPNDTLYHHLHGEGRPFM 445
Query: 477 DWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536
DWATRV+VAAGAARGIAYLHEDCHPRIIHRDIKSSNILLD +FEA+V+DFGLAKIALELD
Sbjct: 446 DWATRVRVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDENFEAQVSDFGLAKIALELD 505
Query: 537 SNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESL 596
SNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYS+GVVLLELITGRKPVDASQPLGDESL
Sbjct: 506 SNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSYGVVLLELITGRKPVDASQPLGDESL 565
Query: 597 VEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVR 656
VEWARPLL +A+E+EDFEAL DS LEKNYV SEMF MIEAAAACVRHSA KRPRMSQVVR
Sbjct: 566 VEWARPLLTDAIENEDFEALADSGLEKNYVPSEMFRMIEAAAACVRHSAAKRPRMSQVVR 625
Query: 657 ALDTLDGASDLTNGVKPGQSGIFSSAQHSAQIRMFQRLAFGGSQDYSSDFYNQSQTSWRS 716
ALD LD +SDL+NG+KPGQS IF S QHSAQIRMFQRLAF GSQ+YSS+F++++Q+SWRS
Sbjct: 626 ALDLLDESSDLSNGMKPGQSEIFDSRQHSAQIRMFQRLAF-GSQEYSSEFFDRTQSSWRS 684
Query: 717 RE 718
R+
Sbjct: 685 RD 686
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255585933|ref|XP_002533638.1| ATP binding protein, putative [Ricinus communis] gi|223526467|gb|EEF28741.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 810 bits (2092), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 380/491 (77%), Positives = 424/491 (86%), Gaps = 1/491 (0%)
Query: 237 NSSTRGSPSTPPLPSVPTEKPTAKSTNGTAVSANASPRNAGVLGTGGAVAIGIAVGFLVL 296
NSST G+ PLPS+PTEKPTA++TNGT VS N + AG L TG AVAIGI VGF VL
Sbjct: 263 NSSTTGNSPLSPLPSIPTEKPTARATNGTDVSVNTASAGAGGLNTGSAVAIGIVVGFAVL 322
Query: 297 SLLVMAVWFAHKRKKKRAGEHIGYTLPSPYASSQKSDSVFLRPHSPAPLVGNGSNSGFSR 356
SLLVMAVWF KRK++ +IGYT+PSP+ASSQ S+++F+RP S PL G+ S S F
Sbjct: 323 SLLVMAVWFVKKRKRRHDISNIGYTMPSPFASSQNSEALFIRPQSQGPLGGSPSGSDFIY 382
Query: 357 SPSESGVLGNSRSWFTYDELIQATNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIG 416
S SE G + NS+SWFT+ EL+QATNGFS N+LGEGGFGCVYKG+L DGREVAVKQLKIG
Sbjct: 383 SSSEPGGVNNSKSWFTFGELVQATNGFSKENLLGEGGFGCVYKGLLVDGREVAVKQLKIG 442
Query: 417 GSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVM 476
GSQGEREF+AEVEIISR+HHRHLVSLVGYCISE +RLLVY+YVPNDTLHYHLHA G PVM
Sbjct: 443 GSQGEREFKAEVEIISRIHHRHLVSLVGYCISENQRLLVYDYVPNDTLHYHLHAYGMPVM 502
Query: 477 DWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536
DWA RVK+A GAARGIAYLHEDCHPRIIHRDIKSSNILLD +FEARV+DFGLAK+ALELD
Sbjct: 503 DWAIRVKIAVGAARGIAYLHEDCHPRIIHRDIKSSNILLDHNFEARVSDFGLAKLALELD 562
Query: 537 SNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESL 596
SNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLE+ITGRKPVDASQPLGDESL
Sbjct: 563 SNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLEVITGRKPVDASQPLGDESL 622
Query: 597 VEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVR 656
VEWARPLL EAL+ EDFEAL D RLEK YV EMF MIEAAAACVRHSA KRPRMSQV R
Sbjct: 623 VEWARPLLNEALDSEDFEALADPRLEKKYVAREMFRMIEAAAACVRHSAVKRPRMSQVAR 682
Query: 657 ALDTLDGASDLTNGVKPGQSGIFSSAQHSAQIRMFQRLAFGGSQDYSSDFYNQSQTSWRS 716
AL++LD SDL+NG+KPGQS IF S +HSAQIRMFQRLAF GSQDY+SD+ + SQ+SWRS
Sbjct: 683 ALESLDELSDLSNGIKPGQSEIFDSREHSAQIRMFQRLAF-GSQDYTSDYLDNSQSSWRS 741
Query: 717 REYEDRSSYMP 727
E+ RS+++P
Sbjct: 742 LEHGSRSNFIP 752
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356567172|ref|XP_003551795.1| PREDICTED: proline-rich receptor-like protein kinase PERK8-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 775 bits (2002), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 374/489 (76%), Positives = 423/489 (86%), Gaps = 7/489 (1%)
Query: 234 PPSNSSTRGSPSTPPLPSVPTEKPTAKSTN-GT-AVSANASPRNAGVLGTGGAVAIGIAV 291
PP+N + G P LPS+PTEKPTA+ TN GT ++S+N +P ++G L TGG+VAIGI V
Sbjct: 258 PPTNKTVVGGPKVS-LPSLPTEKPTARPTNDGTNSMSSNNTPSHSGGLSTGGSVAIGIVV 316
Query: 292 GFLVLSLLVMAVWFAHKRKKKRAGEHIGYTLPSPYASSQKSDSVFLRPHSPAPLVGNGSN 351
GF+VLSLLVMAVWFA K+KKK G Y PSP+ SS S ++FLRP SPA +G+GS
Sbjct: 317 GFIVLSLLVMAVWFAQKKKKKGTGSRGSYAAPSPFTSSHNSGTLFLRPQSPANFLGSGSG 376
Query: 352 SGFSRSPSESGVLGNSRSWFTYDELIQATNGFSAHNVLGEGGFGCVYKGVLADGREVAVK 411
S F SPSE G + +SRSWFTY+ELIQATNGFSA N+LGEGGFGCVYKG+L DGREVAVK
Sbjct: 377 SDFVYSPSEPGGVSSSRSWFTYEELIQATNGFSAQNLLGEGGFGCVYKGLLIDGREVAVK 436
Query: 412 QLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPNDTLHYHLHAE 471
QLKIGG QGEREFRAEVEIISRVHHRHLVSLVGYCISE +RLLVY+YVPNDTLHYHLH E
Sbjct: 437 QLKIGGGQGEREFRAEVEIISRVHHRHLVSLVGYCISEHQRLLVYDYVPNDTLHYHLHGE 496
Query: 472 GRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKI 531
RPV+DW TRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLD ++EA+V+DFGLAK+
Sbjct: 497 NRPVLDWPTRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDLNYEAQVSDFGLAKL 556
Query: 532 ALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPL 591
A LDSNTHV+TRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQP+
Sbjct: 557 A--LDSNTHVTTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPI 614
Query: 592 GDESLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRM 651
GDESLVEWARPLL EAL++EDFE LVD RL KNY +EMF MIEAAAACVRHS+ KRPRM
Sbjct: 615 GDESLVEWARPLLTEALDNEDFEILVDPRLGKNYDRNEMFRMIEAAAACVRHSSVKRPRM 674
Query: 652 SQVVRALDTLDGASDLTNGVKPGQSGIFSSAQHSAQIRMFQRLAFGGSQDYSSDFYNQSQ 711
SQVVRALD+LD +DL NG+KPGQS +F SAQ SAQIRMF+R+AF GSQD SS F+N+SQ
Sbjct: 675 SQVVRALDSLDEFTDLNNGMKPGQSSVFDSAQQSAQIRMFRRMAF-GSQD-SSGFFNESQ 732
Query: 712 TSWRSREYE 720
+SWRSR+++
Sbjct: 733 SSWRSRDHD 741
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356523696|ref|XP_003530471.1| PREDICTED: proline-rich receptor-like protein kinase PERK8-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 743 bits (1917), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 371/521 (71%), Positives = 422/521 (80%), Gaps = 31/521 (5%)
Query: 218 PSVPSTSSPPAVSPPAPPSNSSTRGSPSTPPLPSVPTEKPTAKSTN-GT-AVSANASPRN 275
PS S SSPPA + P PP+N++ P T LPS+PTEKPTA+ TN GT ++S+N +P +
Sbjct: 212 PSDTSGSSPPA-TLPDPPTNTTAAQGP-TVSLPSLPTEKPTARPTNDGTNSMSSNNTPSH 269
Query: 276 AGVLGTGGAVAIGI-----------AVGFLVLSLLVMAVWFAHKRKKKRAGEHIGYTLPS 324
+G L TGG+VAIGI AVWF K+KKK G GY S
Sbjct: 270 SGGLSTGGSVAIGIVVGFTVLSLVM------------AVWFVQKKKKKGTGSRGGYAAAS 317
Query: 325 PYASSQKSDSVFLRPHSPAPLVGNGSNSGFSRSPSESGVLGNSRSWFTYDELIQATNGFS 384
P+ SS S ++FLR SPA +G+GS S F SPSE G + +SRSWFTY+ELIQATNGFS
Sbjct: 318 PFTSSHNSGTLFLRSQSPANFLGSGSGSDFVYSPSEPGGVSSSRSWFTYEELIQATNGFS 377
Query: 385 AHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVG 444
A N+LGEGGFGCVYKG+L DGREVAVKQLK+GG QGEREFRAEVEIISRVHHRHLVSLVG
Sbjct: 378 AQNLLGEGGFGCVYKGLLIDGREVAVKQLKVGGGQGEREFRAEVEIISRVHHRHLVSLVG 437
Query: 445 YCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRII 504
YCISE +RLLVY+YVPNDTLHYHLH E RPV+DW TRVKVAAGAARGIAYLHEDCHPRII
Sbjct: 438 YCISEHQRLLVYDYVPNDTLHYHLHGENRPVLDWPTRVKVAAGAARGIAYLHEDCHPRII 497
Query: 505 HRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTE 564
HRDIKSSNILLD ++EARV+DFGLAK+A LDSNTHV+TRVMGTFGYMAPEYATSGKLTE
Sbjct: 498 HRDIKSSNILLDLNYEARVSDFGLAKLA--LDSNTHVTTRVMGTFGYMAPEYATSGKLTE 555
Query: 565 KSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRLEKN 624
KSDVYSFGVVLLELITGRKPVDASQP+GDESLVEWARPLL EAL++EDFE LVD RL KN
Sbjct: 556 KSDVYSFGVVLLELITGRKPVDASQPIGDESLVEWARPLLTEALDNEDFEILVDPRLGKN 615
Query: 625 YVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDGASDLTNGVKPGQSGIFSSAQH 684
Y +EMF MIEAAAACVRHS+ KRPRMSQVVRALD+LD +DL NG+KPGQS +F SAQ
Sbjct: 616 YDRNEMFRMIEAAAACVRHSSVKRPRMSQVVRALDSLDEFTDLNNGMKPGQSSVFDSAQQ 675
Query: 685 SAQIRMFQRLAFGGSQDYSSDFYNQSQTSWRSREYEDRSSY 725
SAQIRMF+R+AF GSQD SS F+N+SQ+SWRSR++ + +
Sbjct: 676 SAQIRMFRRMAF-GSQD-SSSFFNESQSSWRSRDHNSNTMF 714
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225451941|ref|XP_002279468.1| PREDICTED: proline-rich receptor-like protein kinase PERK8 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 731 bits (1888), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 363/468 (77%), Positives = 415/468 (88%), Gaps = 7/468 (1%)
Query: 242 GSPSTPPLPSVPTEKPTAKSTNGTAVSANASPRNAGVLGTGGAVAIGIAVGFLVLSLLVM 301
G+P++ PLPS+P+EKPTA+ST T +AN++ + G + G V IGI VG LVLSLLVM
Sbjct: 242 GTPTSSPLPSIPSEKPTARST--TNTTANSTSADNGGIKAGTMVTIGIVVGLLVLSLLVM 299
Query: 302 AVWFAHKRKKKRAGEHIGYTLPSPYASSQKSDSVFLRPHSPAPL-VGNGSNSGFSRSPSE 360
A WF KRKKKRAG +IGYT+PSP+ASSQ SDSVFLRPHS + L +G+GS S F SP +
Sbjct: 300 AAWFVQKRKKKRAGLNIGYTMPSPFASSQNSDSVFLRPHSSSALPLGSGSGSDFVYSPPD 359
Query: 361 SGVLGNSRSWFTYDELIQATNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQG 420
V NSR WF+Y+EL++AT+GFS+ N+LGEGGFGCVYKG LADGREVAVKQLKIGG QG
Sbjct: 360 P-VGSNSRPWFSYEELVEATDGFSSQNLLGEGGFGCVYKGFLADGREVAVKQLKIGGGQG 418
Query: 421 EREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWAT 480
EREF+AEVEIISRVHHRHLVSLVGYCISE +RLLVY++VPNDTLHYHLH EGRPVMDWAT
Sbjct: 419 EREFKAEVEIISRVHHRHLVSLVGYCISEHQRLLVYDFVPNDTLHYHLHGEGRPVMDWAT 478
Query: 481 RVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTH 540
RVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLD +FEA+V+DFGLAK+A LD+NTH
Sbjct: 479 RVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDMNFEAQVSDFGLAKLA--LDANTH 536
Query: 541 VSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWA 600
V+TRVMGTFGYMAPEYA+SGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWA
Sbjct: 537 VTTRVMGTFGYMAPEYASSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWA 596
Query: 601 RPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDT 660
RPLLA+AL+ +FE L+D RLEKN+V++EMF MIEAAAACVRHSA+KRPRMS VVRALD+
Sbjct: 597 RPLLAQALDSGNFEGLIDPRLEKNFVENEMFRMIEAAAACVRHSASKRPRMSLVVRALDS 656
Query: 661 LDGASDLTNGVKPGQSGIFSSAQHSAQIRMFQRLAFGGSQDYSSDFYN 708
+D SDLTNG+KPGQS +F SAQHSAQIRMFQR+AF GSQ+YSS+F+N
Sbjct: 657 MDELSDLTNGMKPGQSEVFDSAQHSAQIRMFQRMAF-GSQEYSSEFFN 703
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|298204391|emb|CBI16871.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 709 bits (1829), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 344/425 (80%), Positives = 385/425 (90%), Gaps = 5/425 (1%)
Query: 285 VAIGIAVGFLVLSLLVMAVWFAHKRKKKRAGEHIGYTLPSPYASSQKSDSVFLRPHSPAP 344
V IGI VG LVLSLLVMA WF KRKKKRAG +IGYT+PSP+ASSQ SDSVFLRPHS +
Sbjct: 2 VTIGIVVGLLVLSLLVMAAWFVQKRKKKRAGLNIGYTMPSPFASSQNSDSVFLRPHSSSA 61
Query: 345 L-VGNGSNSGFSRSPSESGVLGNSRSWFTYDELIQATNGFSAHNVLGEGGFGCVYKGVLA 403
L +G+GS S F SP + V NSR WF+Y+EL++AT+GFS+ N+LGEGGFGCVYKG LA
Sbjct: 62 LPLGSGSGSDFVYSPPDP-VGSNSRPWFSYEELVEATDGFSSQNLLGEGGFGCVYKGFLA 120
Query: 404 DGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPNDT 463
DGREVAVKQLKIGG QGEREF+AEVEIISRVHHRHLVSLVGYCISE +RLLVY++VPNDT
Sbjct: 121 DGREVAVKQLKIGGGQGEREFKAEVEIISRVHHRHLVSLVGYCISEHQRLLVYDFVPNDT 180
Query: 464 LHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARV 523
LHYHLH EGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLD +FEA+V
Sbjct: 181 LHYHLHGEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDMNFEAQV 240
Query: 524 ADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRK 583
+DFGLAK+A LD+NTHV+TRVMGTFGYMAPEYA+SGKLTEKSDVYSFGVVLLELITGRK
Sbjct: 241 SDFGLAKLA--LDANTHVTTRVMGTFGYMAPEYASSGKLTEKSDVYSFGVVLLELITGRK 298
Query: 584 PVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRH 643
PVDASQPLGDESLVEWARPLLA+AL+ +FE L+D RLEKN+V++EMF MIEAAAACVRH
Sbjct: 299 PVDASQPLGDESLVEWARPLLAQALDSGNFEGLIDPRLEKNFVENEMFRMIEAAAACVRH 358
Query: 644 SATKRPRMSQVVRALDTLDGASDLTNGVKPGQSGIFSSAQHSAQIRMFQRLAFGGSQDYS 703
SA+KRPRMS VVRALD++D SDLTNG+KPGQS +F SAQHSAQIRMFQR+AF GSQ+YS
Sbjct: 359 SASKRPRMSLVVRALDSMDELSDLTNGMKPGQSEVFDSAQHSAQIRMFQRMAF-GSQEYS 417
Query: 704 SDFYN 708
S+F+N
Sbjct: 418 SEFFN 422
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449447470|ref|XP_004141491.1| PREDICTED: proline-rich receptor-like protein kinase PERK10-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 666 bits (1718), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 344/489 (70%), Positives = 404/489 (82%), Gaps = 24/489 (4%)
Query: 232 PAPPSNSSTRGSPSTPPLPSVPTEKPTAKSTNGTAVSANASPRNAGVLGTGGAVAIGIAV 291
P P+NSS+ GSP TPP+ P E+P NGT +AN+S G TG +VA+G V
Sbjct: 271 PGSPTNSSS-GSPVTPPVSVTP-EQPIPP-INGTNTTANSSATGKGGFSTGTSVAVGSVV 327
Query: 292 GFLVLSLLVMAVWFAHKRKKKRAGEHIGYTLPSPYASSQKSDSVFLRPHSPAPLVGNGSN 351
G L +SL++M +WF KRK+++ ++I YT+ SP+ SSQ SDS+FLRPHS P++G+ ++
Sbjct: 328 GVLFVSLVIMVMWFVQKRKRRK--KNIPYTMASPF-SSQNSDSLFLRPHSSVPVLGSRTD 384
Query: 352 SGFSRSPSESGVLGNSRSWFTYDELIQATNGFSAHNVLGEGGFGCVYKGVLADGREVAVK 411
S F SPSE G +GNSRS F YD+L QAT+GFS++N+LGEGGFGCVYKG LADGR+VAVK
Sbjct: 385 SEFKYSPSEGGGVGNSRS-FAYDDLHQATDGFSSNNLLGEGGFGCVYKGTLADGRDVAVK 443
Query: 412 QLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPNDTLHYHLHAE 471
QLK+GG QGEREFRAEVEIISRVHHRHLVSLVGYCIS+ +RLLVY+YVPN+TLHYHLH E
Sbjct: 444 QLKVGGGQGEREFRAEVEIISRVHHRHLVSLVGYCISDYQRLLVYDYVPNNTLHYHLHGE 503
Query: 472 GRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKI 531
RPV+ W TRV++AAGAARGIAYLHEDCHPRIIHRDIKSSNILLD +FE++VADFGLAK+
Sbjct: 504 NRPVLAWGTRVRIAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDINFESQVADFGLAKL 563
Query: 532 ALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPL 591
A LDS+THV+TRVMGTFGYMAPEYATSGKLT+KSDV+SFGVVLLELITGRKPVD+SQPL
Sbjct: 564 A--LDSHTHVTTRVMGTFGYMAPEYATSGKLTDKSDVFSFGVVLLELITGRKPVDSSQPL 621
Query: 592 GDESLVEW--------------ARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAA 637
GDESLVEW ARPLLA+A+E E+F+ LVD RL+ NY+D EMF MIEAA
Sbjct: 622 GDESLVEWVSLSISTSFLLFNQARPLLAQAIEEENFDELVDPRLDNNYIDREMFRMIEAA 681
Query: 638 AACVRHSATKRPRMSQVVRALDTLDGASDLTNGVKPGQSGIFSSAQHSAQIRMFQRLAFG 697
AACVRHSA KRPRMSQVVRALD+LD SDL NGVKPGQSG+F SA+HSAQIRMFQR+AF
Sbjct: 682 AACVRHSAVKRPRMSQVVRALDSLDEMSDLANGVKPGQSGVFDSAEHSAQIRMFQRMAF- 740
Query: 698 GSQDYSSDF 706
GSQDYS +
Sbjct: 741 GSQDYSYGY 749
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449482277|ref|XP_004156235.1| PREDICTED: proline-rich receptor-like protein kinase PERK8-like, partial [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 665 bits (1717), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 344/489 (70%), Positives = 404/489 (82%), Gaps = 24/489 (4%)
Query: 232 PAPPSNSSTRGSPSTPPLPSVPTEKPTAKSTNGTAVSANASPRNAGVLGTGGAVAIGIAV 291
P P+NSS+ GSP TPP+ P E+P NGT +AN+S G TG +VA+G V
Sbjct: 146 PGSPTNSSS-GSPVTPPVSVTP-EQPIPP-INGTNTTANSSATGKGGFSTGTSVAVGSVV 202
Query: 292 GFLVLSLLVMAVWFAHKRKKKRAGEHIGYTLPSPYASSQKSDSVFLRPHSPAPLVGNGSN 351
G L +SL++M +WF KRK+++ ++I YT+ SP+ SSQ SDS+FLRPHS P++G+ ++
Sbjct: 203 GVLFVSLVIMVMWFVQKRKRRK--KNIPYTMASPF-SSQNSDSLFLRPHSSVPVLGSRTD 259
Query: 352 SGFSRSPSESGVLGNSRSWFTYDELIQATNGFSAHNVLGEGGFGCVYKGVLADGREVAVK 411
S F SPSE G +GNSRS F YD+L QAT+GFS++N+LGEGGFGCVYKG LADGR+VAVK
Sbjct: 260 SEFKYSPSEGGGVGNSRS-FAYDDLHQATDGFSSNNLLGEGGFGCVYKGTLADGRDVAVK 318
Query: 412 QLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPNDTLHYHLHAE 471
QLK+GG QGEREFRAEVEIISRVHHRHLVSLVGYCIS+ +RLLVY+YVPN+TLHYHLH E
Sbjct: 319 QLKVGGGQGEREFRAEVEIISRVHHRHLVSLVGYCISDYQRLLVYDYVPNNTLHYHLHGE 378
Query: 472 GRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKI 531
RPV+ W TRV++AAGAARGIAYLHEDCHPRIIHRDIKSSNILLD +FE++VADFGLAK+
Sbjct: 379 NRPVLAWGTRVRIAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDINFESQVADFGLAKL 438
Query: 532 ALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPL 591
A LDS+THV+TRVMGTFGYMAPEYATSGKLT+KSDV+SFGVVLLELITGRKPVD+SQPL
Sbjct: 439 A--LDSHTHVTTRVMGTFGYMAPEYATSGKLTDKSDVFSFGVVLLELITGRKPVDSSQPL 496
Query: 592 GDESLVEW--------------ARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAA 637
GDESLVEW ARPLLA+A+E E+F+ LVD RL+ NY+D EMF MIEAA
Sbjct: 497 GDESLVEWVSLSISTSFLLFNQARPLLAQAIEEENFDELVDPRLDNNYIDREMFRMIEAA 556
Query: 638 AACVRHSATKRPRMSQVVRALDTLDGASDLTNGVKPGQSGIFSSAQHSAQIRMFQRLAFG 697
AACVRHSA KRPRMSQVVRALD+LD SDL NGVKPGQSG+F SA+HSAQIRMFQR+AF
Sbjct: 557 AACVRHSAVKRPRMSQVVRALDSLDEMSDLANGVKPGQSGVFDSAEHSAQIRMFQRMAF- 615
Query: 698 GSQDYSSDF 706
GSQDYS +
Sbjct: 616 GSQDYSYGY 624
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225423802|ref|XP_002277905.1| PREDICTED: proline-rich receptor-like protein kinase PERK9 [Vitis vinifera] gi|297737910|emb|CBI27111.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 662 bits (1708), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 322/442 (72%), Positives = 380/442 (85%), Gaps = 6/442 (1%)
Query: 270 NASPRNA--GVLGTGGAVAIGIAVGFLVLSLLVMAVWFAHKRKKKRAGEHIGYTLPSPYA 327
N SP + G +GT G VAIG+ +G +VL L+ +A KRKKK +G + GY +P+
Sbjct: 287 NGSPNSTSKGGIGTVGTVAIGLVLGLVVLVLIGVAFLCLRKRKKKVSGLNGGYVMPATLG 346
Query: 328 SSQKSDSVFLRPHSPAPLVGNGSNSGFSRSPSESGVLGNSRSWFTYDELIQATNGFSAHN 387
SS +SDS F + S APL+G+GS S F SPSE G LGNSRSWFTY+EL++ATNGFS N
Sbjct: 347 SSPRSDSSFTKTLSSAPLIGSGSGSDFVYSPSEPGGLGNSRSWFTYEELVKATNGFSTQN 406
Query: 388 VLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCI 447
+LGEGGFG VYKG L DGRE+AVKQLKIGG+QGEREF+AEVEIISR+HHRHLVSLVGYCI
Sbjct: 407 LLGEGGFGSVYKGYLPDGREIAVKQLKIGGAQGEREFKAEVEIISRIHHRHLVSLVGYCI 466
Query: 448 SERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRD 507
SE +RLLVY+YVPN+TL++HLH EGRPVMDWATRVKVAAGAARGIAYLHEDCHPR+IHRD
Sbjct: 467 SESQRLLVYDYVPNNTLYFHLHGEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRVIHRD 526
Query: 508 IKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSD 567
IKSSNILL+ +FEA+V+DFGLAK+A LD++THV+TRVMGTFGYMAPEYA+SGKLTEKSD
Sbjct: 527 IKSSNILLNYNFEAQVSDFGLAKLA--LDADTHVTTRVMGTFGYMAPEYASSGKLTEKSD 584
Query: 568 VYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRLEKNYVD 627
V+SFGVVLLELITGRKPVDASQP+GDESLVEWARPLL+ ALE+E+FE L D RLEKNYV+
Sbjct: 585 VFSFGVVLLELITGRKPVDASQPVGDESLVEWARPLLSHALENEEFEGLTDPRLEKNYVE 644
Query: 628 SEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDGASDLTNGVKPGQSGIFSSAQHSAQ 687
SEMF M+EAAAACVRHSA KRPRM QVVRA D++ G SDL+NG++ G+S +F+SAQ S +
Sbjct: 645 SEMFRMLEAAAACVRHSAAKRPRMGQVVRAFDSM-GTSDLSNGMRVGESEVFNSAQQSEE 703
Query: 688 IRMFQRLAFGGSQDYSSDFYNQ 709
IR FQR+AF GSQDYS+DF++Q
Sbjct: 704 IRWFQRMAF-GSQDYSTDFFSQ 724
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|307136482|gb|ADN34283.1| ATP binding protein [Cucumis melo subsp. melo] | Back alignment and taxonomy information |
|---|
Score = 657 bits (1696), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 347/486 (71%), Positives = 402/486 (82%), Gaps = 24/486 (4%)
Query: 235 PSNSSTRGSPSTPPLPSVPTEKPTAKSTNGTAVSANASPRNAGVLGTGGAVAIGIAVGFL 294
P+NSS GSP TPP+ P E+P NGT +AN+S G TG +VA+G VG L
Sbjct: 274 PTNSSG-GSPVTPPISVTP-ERPIPP-INGTNTTANSSATGKGGFSTGTSVAVGSVVGVL 330
Query: 295 VLSLLVMAVWFAHKRKKKRAGEHIGYTLPSPYASSQKSDSVFLRPHSPAPLVGNGSNSGF 354
+LSL++MA+WF KRK+++ + I YT+ SP+ SSQ SDSVFLRPHS P++G+ ++S F
Sbjct: 331 LLSLVIMAMWFVQKRKRRK--KSIPYTMASPF-SSQNSDSVFLRPHSSVPVLGSRTDSEF 387
Query: 355 SRSPSESGVLGNSRSWFTYDELIQATNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLK 414
SPSE G +GNSRS F YD+L QATNGFS++N+LGEGGFGCVYKG LADGR+VAVKQLK
Sbjct: 388 KYSPSEGGGVGNSRS-FAYDDLHQATNGFSSNNLLGEGGFGCVYKGTLADGRDVAVKQLK 446
Query: 415 IGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRP 474
+GG QGEREFRAEVEIISRVHHRHLVSLVGYCIS+ +RLLVY+YVPN+TLHYHLH E P
Sbjct: 447 VGGGQGEREFRAEVEIISRVHHRHLVSLVGYCISDYQRLLVYDYVPNNTLHYHLHGENMP 506
Query: 475 VMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALE 534
V+ W TRV++AAGAARGIAYLHEDCHPRIIHRDIKSSNILLD +FEA+VADFGLAK+A
Sbjct: 507 VLAWGTRVRIAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDINFEAQVADFGLAKLA-- 564
Query: 535 LDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDE 594
LDS+THV+TRVMGTFGYMAPEYATSGKLT+KSDV+SFGVVLLELITGRKPVD+SQPLGDE
Sbjct: 565 LDSHTHVTTRVMGTFGYMAPEYATSGKLTDKSDVFSFGVVLLELITGRKPVDSSQPLGDE 624
Query: 595 SLVEW--------------ARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAAC 640
SLVEW ARPLLA+A+E E+F+ LVD RL+ NY+D EMF MIEAAAAC
Sbjct: 625 SLVEWVSLSISTSFLLFNQARPLLAQAIEDENFDELVDPRLDNNYIDREMFRMIEAAAAC 684
Query: 641 VRHSATKRPRMSQVVRALDTLDGASDLTNGVKPGQSGIFSSAQHSAQIRMFQRLAFGGSQ 700
VRHSA KRPRMSQVVRALD+LD SDL NGVKPGQSG+F SA+HSAQIRMFQR+AF GSQ
Sbjct: 685 VRHSAVKRPRMSQVVRALDSLDEMSDLANGVKPGQSGVFDSAEHSAQIRMFQRMAF-GSQ 743
Query: 701 DYSSDF 706
DYS +
Sbjct: 744 DYSYGY 749
|
Source: Cucumis melo subsp. melo Species: Cucumis melo Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 727 | ||||||
| TAIR|locus:2159873 | 681 | PERK8 "proline-rich extensin-l | 0.643 | 0.687 | 0.692 | 4.9e-172 | |
| TAIR|locus:2026925 | 708 | PERK9 "proline-rich extensin-l | 0.566 | 0.581 | 0.661 | 5e-147 | |
| TAIR|locus:2028756 | 762 | PERK10 "proline-rich extensin- | 0.573 | 0.547 | 0.672 | 2.8e-146 | |
| TAIR|locus:2028911 | 720 | PERK12 "proline-rich extensin- | 0.546 | 0.551 | 0.597 | 4.8e-131 | |
| TAIR|locus:2026846 | 710 | PERK13 "proline-rich extensin- | 0.546 | 0.559 | 0.622 | 2.2e-130 | |
| TAIR|locus:2019938 | 718 | PERK11 "proline-rich extensin- | 0.583 | 0.590 | 0.582 | 4.2e-127 | |
| UNIPROTKB|Q9ARH1 | 647 | Q9ARH1 "Receptor protein kinas | 0.539 | 0.605 | 0.580 | 3.1e-123 | |
| TAIR|locus:2091722 | 652 | PERK1 "proline-rich extensin-l | 0.541 | 0.604 | 0.565 | 3.2e-121 | |
| TAIR|locus:2139474 | 670 | PERK5 "proline-rich extensin-l | 0.500 | 0.543 | 0.593 | 1.2e-118 | |
| TAIR|locus:2046268 | 633 | PERK4 "proline-rich extensin-l | 0.526 | 0.605 | 0.567 | 5.5e-113 |
| TAIR|locus:2159873 PERK8 "proline-rich extensin-like receptor kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1672 (593.6 bits), Expect = 4.9e-172, P = 4.9e-172
Identities = 334/482 (69%), Positives = 385/482 (79%)
Query: 255 EKPTAKST-----NGTAVSANASPRNXXXXXXXXXXXXXXXXXXXXLSLLVMAVWFAHKR 309
EKP AK T NG ++SP LSL VM VWF KR
Sbjct: 205 EKPIAKPTGPASNNGNNTLPSSSP-GKSEVGTGGIVAIGVIVGLVFLSLFVMGVWFTRKR 263
Query: 310 KKKRAGEHIGYTLP-SPYASSQKSDSVFLRPHSPAP-LVGNGSNSGFSRSPSESGVLGNS 367
K+K G +GYT+P S Y+S Q SD V S AP + + S S + + S+SG++ N
Sbjct: 264 KRKDPGTFVGYTMPPSAYSSPQGSDVVLFNSRSSAPPKMRSHSGSDYMYASSDSGMVSNQ 323
Query: 368 RSWFTYDELIQATNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAE 427
RSWF+YDEL Q T+GFS N+LGEGGFGCVYKGVL+DGREVAVKQLKIGGSQGEREF+AE
Sbjct: 324 RSWFSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFKAE 383
Query: 428 VEIISRVHHRHLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAG 487
VEIISRVHHRHLV+LVGYCISE+ RLLVY+YVPN+TLHYHLHA GRPVM W TRV+VAAG
Sbjct: 384 VEIISRVHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHAPGRPVMTWETRVRVAAG 443
Query: 488 AARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMG 547
AARGIAYLHEDCHPRIIHRDIKSSNILLD+SFEA VADFGLAKIA ELD NTHVSTRVMG
Sbjct: 444 AARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVSTRVMG 503
Query: 548 TFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEA 607
TFGYMAPEYATSGKL+EK+DVYS+GV+LLELITGRKPVD SQPLGDESLVEWARPLL +A
Sbjct: 504 TFGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWARPLLGQA 563
Query: 608 LEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDGASDL 667
+E+E+F+ LVD RL KN++ EMF M+EAAAACVRHSA KRP+MSQVVRALDTL+ A+D+
Sbjct: 564 IENEEFDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVRALDTLEEATDI 623
Query: 668 TNGVKPGQSGIFSSAQHSAQIRMFQRLAFGGSQDYSSDFYNQSQT--SWRSREYEDRSSY 725
TNG++PGQS +F S Q SAQIRMFQR+AFG SQDYSSDF+++SQ+ SW SR D+S +
Sbjct: 624 TNGMRPGQSQVFDSRQQSAQIRMFQRMAFG-SQDYSSDFFDRSQSHSSWGSR---DQSRF 679
Query: 726 MP 727
+P
Sbjct: 680 VP 681
|
|
| TAIR|locus:2026925 PERK9 "proline-rich extensin-like receptor kinase 9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1436 (510.6 bits), Expect = 5.0e-147, P = 5.0e-147
Identities = 279/422 (66%), Positives = 349/422 (82%)
Query: 297 SLLVMAVWFAHKRKKKRAGEHIGYTLPSPYASSQKSDSVFLRPHSPAPLVGNGSNSGFSR 356
+L + VW KR+K+ + G PSP +S+ +SDS F R S AP VG SG +
Sbjct: 294 TLFGIFVWCLRKREKRLSAVSGGDVTPSPMSSTARSDSAFFRMQSSAP-VGASKRSGSYQ 352
Query: 357 SPSESGVLGNSRSWFTYDELIQATNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIG 416
S +SG LGNS++ F+Y+EL++ATNGFS N+LGEGGFGCVYKG+L DGR VAVKQLKIG
Sbjct: 353 S--QSGGLGNSKALFSYEELVKATNGFSQENLLGEGGFGCVYKGILPDGRVVAVKQLKIG 410
Query: 417 GSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVM 476
G QG+REF+AEVE +SR+HHRHLVS+VG+CIS RLL+Y+YV N+ L++HLH E + V+
Sbjct: 411 GGQGDREFKAEVETLSRIHHRHLVSIVGHCISGDRRLLIYDYVSNNDLYFHLHGE-KSVL 469
Query: 477 DWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536
DWATRVK+AAGAARG+AYLHEDCHPRIIHRDIKSSNILL+ +F+ARV+DFGLA++AL D
Sbjct: 470 DWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLEDNFDARVSDFGLARLAL--D 527
Query: 537 SNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESL 596
NTH++TRV+GTFGYMAPEYA+SGKLTEKSDV+SFGVVLLELITGRKPVD SQPLGDESL
Sbjct: 528 CNTHITTRVIGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDTSQPLGDESL 587
Query: 597 VEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVR 656
VEWARPL++ A+E E+F++L D +L NYV+SEMF MIEAA ACVRH ATKRPRM Q+VR
Sbjct: 588 VEWARPLISHAIETEEFDSLADPKLGGNYVESEMFRMIEAAGACVRHLATKRPRMGQIVR 647
Query: 657 ALDTLDGASDLTNGVKPGQSGIFSSAQHSAQIRMFQRLAFGGSQDYSSDFYNQSQTSWRS 716
A ++L A DLTNG++ G+S +F+SAQ SA+IR+F+R+AFG SQ+YS+DF++ S S+ S
Sbjct: 648 AFESL-AAEDLTNGMRLGESEVFNSAQQSAEIRLFRRMAFG-SQNYSTDFFSHS--SYNS 703
Query: 717 RE 718
R+
Sbjct: 704 RD 705
|
|
| TAIR|locus:2028756 PERK10 "proline-rich extensin-like receptor kinase 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1429 (508.1 bits), Expect = 2.8e-146, P = 2.8e-146
Identities = 285/424 (67%), Positives = 347/424 (81%)
Query: 296 LSLLVMAVWFAHKRKKKRAGEHIGYTLPSPY-ASSQKSDSVFLRPHSPAPLVGNGSNSGF 354
L+L+ + V KRKK+ + GY +P+P +SS +SDS L+ S APLVGN S++
Sbjct: 342 LTLIGVVVCCLKKRKKRLSTIGGGYVMPTPMESSSPRSDSALLKTQSSAPLVGNRSSNRT 401
Query: 355 SRSPSESGVLGNSRSWFTYDELIQATNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLK 414
S SE G G SR F+Y+EL+ ATNGFS N+LGEGGFG VYKGVL D R VAVKQLK
Sbjct: 402 YLSQSEPGGFGQSRELFSYEELVIATNGFSDENLLGEGGFGRVYKGVLPDERVVAVKQLK 461
Query: 415 IGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRP 474
IGG QG+REF+AEV+ ISRVHHR+L+S+VGYCISE RLL+Y+YVPN+ L++HLHA G P
Sbjct: 462 IGGGQGDREFKAEVDTISRVHHRNLLSMVGYCISENRRLLIYDYVPNNNLYFHLHAAGTP 521
Query: 475 VMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALE 534
+DWATRVK+AAGAARG+AYLHEDCHPRIIHRDIKSSNILL+++F A V+DFGLAK+AL
Sbjct: 522 GLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLENNFHALVSDFGLAKLAL- 580
Query: 535 LDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDE 594
D NTH++TRVMGTFGYMAPEYA+SGKLTEKSDV+SFGVVLLELITGRKPVDASQPLGDE
Sbjct: 581 -DCNTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDE 639
Query: 595 SLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQV 654
SLVEWARPLL+ A E E+F AL D +L +NYV EMF MIEAAAAC+RHSATKRPRMSQ+
Sbjct: 640 SLVEWARPLLSNATETEEFTALADPKLGRNYVGVEMFRMIEAAAACIRHSATKRPRMSQI 699
Query: 655 VRALDTLDGASDLTNGVKPGQSGIFSSAQHSAQIRMFQRLAFGGSQDYSSDFYNQSQTSW 714
VRA D+L DLTNG++ G+S I +SAQ SA+IR+F+R+AFG SQ+YS+D + ++ S+
Sbjct: 700 VRAFDSL-AEEDLTNGMRLGESEIINSAQQSAEIRLFRRMAFG-SQNYSTD--SLTRNSY 755
Query: 715 RSRE 718
S++
Sbjct: 756 ISKD 759
|
|
| TAIR|locus:2028911 PERK12 "proline-rich extensin-like receptor kinase 12" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1238 (440.9 bits), Expect = 4.8e-131, Sum P(2) = 4.8e-131
Identities = 240/402 (59%), Positives = 305/402 (75%)
Query: 324 SPYASSQKSDSVFLRPHSPAPLVGNGSNSGFSRSPSESGVLGNSRSWFTYDELIQATNGF 383
S Y +SQ+ S + A G + S +S +LG+ ++ F+Y+EL + T GF
Sbjct: 313 SMYNNSQQQQSSMGNSYGTAG-GGYPHHQMQSSGTPDSAILGSGQTHFSYEELAEITQGF 371
Query: 384 SAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLV 443
+ N+LGEGGFGCVYKG L DG+ VAVKQLK G QG+REF+AEVEIISRVHHRHLVSLV
Sbjct: 372 ARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAGSGQGDREFKAEVEIISRVHHRHLVSLV 431
Query: 444 GYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRI 503
GYCIS++ RLL+YEYV N TL +HLH +G PV++W+ RV++A G+A+G+AYLHEDCHP+I
Sbjct: 432 GYCISDQHRLLIYEYVSNQTLEHHLHGKGLPVLEWSKRVRIAIGSAKGLAYLHEDCHPKI 491
Query: 504 IHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLT 563
IHRDIKS+NILLD +EA+VADFGLA+ L + THVSTRVMGTFGY+APEYA+SGKLT
Sbjct: 492 IHRDIKSANILLDDEYEAQVADFGLAR--LNDTTQTHVSTRVMGTFGYLAPEYASSGKLT 549
Query: 564 EKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRLEK 623
++SDV+SFGVVLLEL+TGRKPVD +QPLG+ESLVEWARPLL +A+E D L+D+RLEK
Sbjct: 550 DRSDVFSFGVVLLELVTGRKPVDQTQPLGEESLVEWARPLLLKAIETGDLSELIDTRLEK 609
Query: 624 NYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDGAS-DLTNGVKPGQSGIFSSA 682
YV+ E+F MIE AAACVRHS KRPRM QVVRALD DG S D++NG+K GQS + S
Sbjct: 610 RYVEHEVFRMIETAAACVRHSGPKRPRMVQVVRALDC-DGDSGDISNGIKIGQSTTYDSG 668
Query: 683 QHSAQIRMFQRLAFGGSQDYSSDFYNQSQTSWRSREYEDRSS 724
Q++ I F+++AFGG S Y+ + ++ S ++ S
Sbjct: 669 QYNEDIMKFRKMAFGGDNSVESGLYSGNYSAKSSSDFSGNES 710
|
|
| TAIR|locus:2026846 PERK13 "proline-rich extensin-like receptor kinase 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1279 (455.3 bits), Expect = 2.2e-130, P = 2.2e-130
Identities = 254/408 (62%), Positives = 312/408 (76%)
Query: 319 GYTLPSPYASSQKSDSVFLRPHSPAPLVGNGSNSGFSRSPS--ESGVLGNSRSWFTYDEL 376
GY+ P Y S Q+S+S +S G G G++RS S +S V+G+ ++ FTY+EL
Sbjct: 294 GYSGPGGYNSQQQSNS----GNSFGSQRGGG---GYTRSGSAPDSAVMGSGQTHFTYEEL 346
Query: 377 IQATNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHH 436
T GFS HN+LGEGGFGCVYKG L DG+ VAVKQLK+G QG+REF+AEVEIISRVHH
Sbjct: 347 TDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLKVGSGQGDREFKAEVEIISRVHH 406
Query: 437 RHLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLH 496
RHLVSLVGYCI++ ERLL+YEYVPN TL +HLH +GRPV++WA RV++A G+A+G+AYLH
Sbjct: 407 RHLVSLVGYCIADSERLLIYEYVPNQTLEHHLHGKGRPVLEWARRVRIAIGSAKGLAYLH 466
Query: 497 EDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEY 556
EDCHP+IIHRDIKS+NILLD FEA+VADFGLAK L + THVSTRVMGTFGY+APEY
Sbjct: 467 EDCHPKIIHRDIKSANILLDDEFEAQVADFGLAK--LNDSTQTHVSTRVMGTFGYLAPEY 524
Query: 557 ATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEAL 616
A SGKLT++SDV+SFGVVLLELITGRKPVD QPLG+ESLVEWARPLL +A+E DF L
Sbjct: 525 AQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQPLGEESLVEWARPLLHKAIETGDFSEL 584
Query: 617 VDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDGASDLTNGVKPGQS 676
VD RLEK+YV++E+F MIE AAACVRHS KRPRM QVVRALD+ D++NG K GQS
Sbjct: 585 VDRRLEKHYVENEVFRMIETAAACVRHSGPKRPRMVQVVRALDSEGDMGDISNGNKVGQS 644
Query: 677 GIFSSAQHSAQIRMFQRLAFGGSQDYSSDFYNQSQTSWRSREYEDRSS 724
+ S Q++ F+++AFG S Y+ + SR+ + +S
Sbjct: 645 SAYDSGQYNNDTMKFRKMAFGFDDSSDSGMYSGDYSVQDSRKGSNGAS 692
|
|
| TAIR|locus:2019938 PERK11 "proline-rich extensin-like receptor kinase 11" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1248 (444.4 bits), Expect = 4.2e-127, P = 4.2e-127
Identities = 254/436 (58%), Positives = 315/436 (72%)
Query: 298 LLVMAVWFAHKRKKKRAGE-HIGYTLPSPYASSQKSDSVFLR--P---HSPA----PLVG 347
L + V+F +++KK + LP S + R P +S A P
Sbjct: 275 LFIAGVFFVRRKQKKGSSSPRSNQYLPPANVSVNTEGFIHYRQKPGNGNSSAQNSSPDTN 334
Query: 348 NGSNSGFSRSPSESGVLGNSRSWFTYDELIQATNGFSAHNVLGEGGFGCVYKGVLADGRE 407
+ N R +S V+G S+ FTY+EL Q T GF V+GEGGFGCVYKG+L +G+
Sbjct: 335 SLGNPKHGRGTPDSAVIGTSKIHFTYEELSQITEGFCKSFVVGEGGFGCVYKGILFEGKP 394
Query: 408 VAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPNDTLHYH 467
VA+KQLK ++G REF+AEVEIISRVHHRHLVSLVGYCISE+ R L+YE+VPN+TL YH
Sbjct: 395 VAIKQLKSVSAEGYREFKAEVEIISRVHHRHLVSLVGYCISEQHRFLIYEFVPNNTLDYH 454
Query: 468 LHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFG 527
LH + PV++W+ RV++A GAA+G+AYLHEDCHP+IIHRDIKSSNILLD FEA+VADFG
Sbjct: 455 LHGKNLPVLEWSRRVRIAIGAAKGLAYLHEDCHPKIIHRDIKSSNILLDDEFEAQVADFG 514
Query: 528 LAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDA 587
LA+ L + +H+STRVMGTFGY+APEYA+SGKLT++SDV+SFGVVLLELITGRKPVD
Sbjct: 515 LAR--LNDTAQSHISTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDT 572
Query: 588 SQPLGDESLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATK 647
SQPLG+ESLVEWARP L EA+E D +VD RLE +YV+SE++ MIE AA+CVRHSA K
Sbjct: 573 SQPLGEESLVEWARPRLIEAIEKGDISEVVDPRLENDYVESEVYKMIETAASCVRHSALK 632
Query: 648 RPRMSQVVRALDTLDGASDLTNGVKPGQSGIFSSAQHSAQIRMFQRLAFGGSQDYSSDFY 707
RPRM QVVRALDT D SDLTNGVK GQS ++ S Q+S +IR+F+R + S ++ Y
Sbjct: 633 RPRMVQVVRALDTRDDLSDLTNGVKVGQSRVYDSGQYSNEIRIFRRASEDSSDLGTNTGY 692
Query: 708 NQSQTSWRSREYEDRS 723
SQ S EYE S
Sbjct: 693 YPSQDYATSHEYESES 708
|
|
| UNIPROTKB|Q9ARH1 Q9ARH1 "Receptor protein kinase PERK1" [Brassica napus (taxid:3708)] | Back alignment and assigned GO terms |
|---|
Score = 1194 (425.4 bits), Expect = 3.1e-123, Sum P(2) = 3.1e-123
Identities = 244/420 (58%), Positives = 300/420 (71%)
Query: 316 EHIGYTLPSPYASSQKSDSVFLRPHSPAPLVGNGSNSGFSRSP-----SESGVLGNSRSW 370
+H+ +LP P + P P P + + S +S P S VLG S+S
Sbjct: 205 DHVVTSLPPPPKAPSPPRQP--PPPPPPPFMSSSGGSDYSDRPVLPPPSPGLVLGFSKST 262
Query: 371 FTYDELIQATNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEI 430
FTY+EL +ATNGFS N+LG+GGFG V+KGVL G+EVAVKQLK+G QGEREF+AEVEI
Sbjct: 263 FTYEELARATNGFSEANLLGQGGFGYVHKGVLPSGKEVAVKQLKVGSGQGEREFQAEVEI 322
Query: 431 ISRVHHRHLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAAR 490
ISRVHHRHLVSLVGYCI+ +RLLVYE+VPN+ L HLH EGRP M+W+TR+K+A G+A+
Sbjct: 323 ISRVHHRHLVSLVGYCIAGAKRLLVYEFVPNNNLELHLHGEGRPTMEWSTRLKIALGSAK 382
Query: 491 GIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFG 550
G++YLHEDC+P+IIHRDIK+SNIL+D FEA+VADFGLAKIA D+NTHVSTRVMGTFG
Sbjct: 383 GLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIAS--DTNTHVSTRVMGTFG 440
Query: 551 YMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEH 610
Y+APEYA SGKLTEKSDV+SFGVVLLELITGR+PVDA+ D+SLV+WARPLL A E
Sbjct: 441 YLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPLLNRASEQ 500
Query: 611 EDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDGASDLTNG 670
DFE L D+++ Y EM M+ AAACVRHSA +RPRMSQ+VRAL+ SDL G
Sbjct: 501 GDFEGLADAKMNNGYDREEMARMVACAAACVRHSARRRPRMSQIVRALEGNVSLSDLNEG 560
Query: 671 VKPGQSGIFSSAQHSAQIRMFQRLAFGGSQDYSSDFYNQSQTSWR-----SREYEDRSSY 725
++PGQS ++SS +GGS DY S YN+ +R ++EY Y
Sbjct: 561 MRPGQSNVYSS--------------YGGSTDYDSSQYNEDMKKFRKMALGTQEYNATGEY 606
|
|
| TAIR|locus:2091722 PERK1 "proline-rich extensin-like receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1168 (416.2 bits), Expect = 3.2e-121, Sum P(2) = 3.2e-121
Identities = 236/417 (56%), Positives = 296/417 (70%)
Query: 304 WFAHKRKKKRAGEHIGYTLPSPYASSQKSDSVFLRPHSPAPLVGNGSNSGFSR-----SP 358
++ + + + H+ +LP P S P P + + S +S P
Sbjct: 198 YWQQQNASRPSDNHVVTSLPPPKPPSPPRKPP--PPPPPPAFMSSSGGSDYSDLPVLPPP 255
Query: 359 SESGVLGNSRSWFTYDELIQATNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGS 418
S VLG S+S FTY+EL +ATNGFS N+LG+GGFG V+KG+L G+EVAVKQLK G
Sbjct: 256 SPGLVLGFSKSTFTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSG 315
Query: 419 QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDW 478
QGEREF+AEVEIISRVHHRHLVSL+GYC++ +RLLVYE+VPN+ L +HLH +GRP M+W
Sbjct: 316 QGEREFQAEVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHGKGRPTMEW 375
Query: 479 ATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSN 538
+TR+K+A G+A+G++YLHEDC+P+IIHRDIK+SNIL+D FEA+VADFGLAKIA D+N
Sbjct: 376 STRLKIALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIAS--DTN 433
Query: 539 THVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVE 598
THVSTRVMGTFGY+APEYA SGKLTEKSDV+SFGVVLLELITGR+PVDA+ D+SLV+
Sbjct: 434 THVSTRVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVD 493
Query: 599 WARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRAL 658
WARPLL A E DFE L DS++ Y EM M+ AAACVRHSA +RPRMSQ+VRAL
Sbjct: 494 WARPLLNRASEEGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQIVRAL 553
Query: 659 DTLDGASDLTNGVKPGQSGIFSSAQHSAQIRMFQRLAFGGSQDYSSDFYNQSQTSWR 715
+ SDL G++PG S ++SS +GGS DY + YN +R
Sbjct: 554 EGNVSLSDLNEGMRPGHSNVYSS--------------YGGSTDYDTSQYNDDMIKFR 596
|
|
| TAIR|locus:2139474 PERK5 "proline-rich extensin-like receptor kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1118 (398.6 bits), Expect = 1.2e-118, Sum P(3) = 1.2e-118
Identities = 228/384 (59%), Positives = 288/384 (75%)
Query: 339 PHSPAPLVGNGSN-SGFSRSPS-ESGVLGNSRSWFTYDELIQATNGFSAHNVLGEGGFGC 396
PHS A SN +G + PS ++ LG+++S FTYDEL AT GF+ N+LG+GGFG
Sbjct: 272 PHSDA------SNLTGRTAIPSPQAATLGHNQSTFTYDELSIATEGFAQSNLLGQGGFGY 325
Query: 397 VYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456
V+KGVL G+EVAVK LK+G QGEREF+AEV+IISRVHHRHLVSLVGYCIS +RLLVY
Sbjct: 326 VHKGVLPSGKEVAVKSLKLGSGQGEREFQAEVDIISRVHHRHLVSLVGYCISGGQRLLVY 385
Query: 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLD 516
E++PN+TL +HLH +GRPV+DW TRVK+A G+ARG+AYLHEDCHPRIIHRDIK++NILLD
Sbjct: 386 EFIPNNTLEFHLHGKGRPVLDWPTRVKIALGSARGLAYLHEDCHPRIIHRDIKAANILLD 445
Query: 517 SSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLL 576
SFE +VADFGLAK L D+ THVSTRVMGTFGY+APEYA+SGKL++KSDV+SFGV+LL
Sbjct: 446 FSFETKVADFGLAK--LSQDNYTHVSTRVMGTFGYLAPEYASSGKLSDKSDVFSFGVMLL 503
Query: 577 ELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEA 636
ELITGR P+D + + D SLV+WARPL +A + D+ L D RLE NY EM M
Sbjct: 504 ELITGRPPLDLTGEMED-SLVDWARPLCLKAAQDGDYNQLADPRLELNYSHQEMVQMASC 562
Query: 637 AAACVRHSATKRPRMSQVVRALDTLDGASDLTNGVKPGQS-----GIFSS----AQHSAQ 687
AAA +RHSA +RP+MSQ+VRAL+ DL+ G +PGQS G SS + ++A
Sbjct: 563 AAAAIRHSARRRPKMSQIVRALEGDMSMDDLSEGTRPGQSTYLSPGSVSSEYDASSYTAD 622
Query: 688 IRMFQRLAFGGSQDYSSDFYNQSQ 711
++ F++LA + SS++ S+
Sbjct: 623 MKKFKKLALENKEYQSSEYGGTSE 646
|
|
| TAIR|locus:2046268 PERK4 "proline-rich extensin-like receptor kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1094 (390.2 bits), Expect = 5.5e-113, Sum P(2) = 5.5e-113
Identities = 230/405 (56%), Positives = 292/405 (72%)
Query: 339 PHSPAPLVGNGSN--SGFSRS----PSESGVLGNSRSWFTYDELIQATNGFSAHNVLGEG 392
P P G S+ SG SR PS + LG ++S FTY EL AT GF+ N+LG+G
Sbjct: 234 PPPRMPTSGEDSSMYSGPSRPVLPPPSPALALGFNKSTFTYQELAAATGGFTDANLLGQG 293
Query: 393 GFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERER 452
GFG V+KGVL G+EVAVK LK G QGEREF+AEV+IISRVHHR+LVSLVGYCI++ +R
Sbjct: 294 GFGYVHKGVLPSGKEVAVKSLKAGSGQGEREFQAEVDIISRVHHRYLVSLVGYCIADGQR 353
Query: 453 LLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSN 512
+LVYE+VPN TL YHLH + PVM+++TR+++A GAA+G+AYLHEDCHPRIIHRDIKS+N
Sbjct: 354 MLVYEFVPNKTLEYHLHGKNLPVMEFSTRLRIALGAAKGLAYLHEDCHPRIIHRDIKSAN 413
Query: 513 ILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFG 572
ILLD +F+A VADFGLAK L D+NTHVSTRVMGTFGY+APEYA+SGKLTEKSDV+S+G
Sbjct: 414 ILLDFNFDAMVADFGLAK--LTSDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSYG 471
Query: 573 VVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFW 632
V+LLELITG++PVD S + D++LV+WARPL+A ALE +F L D+RLE NY EM
Sbjct: 472 VMLLELITGKRPVDNSITM-DDTLVDWARPLMARALEDGNFNELADARLEGNYNPQEMAR 530
Query: 633 MIEAAAACVRHSATKRPRMSQVVRALDTLDGASDLTNGVKPGQSGIFSS---------AQ 683
M+ AAA +RHS KRP+MSQ+VRAL+ L GVKPG S ++ S
Sbjct: 531 MVTCAAASIRHSGRKRPKMSQIVRALEGEVSLDALNEGVKPGHSNVYGSLGASSDYSQTS 590
Query: 684 HSAQIRMFQRLAFGGSQDYS-SDFYNQSQTSWRSREYEDRSSYMP 727
++A ++ F+++A SQ++ SD S SR+ +S P
Sbjct: 591 YNADMKKFRQIALS-SQEFPVSDCEGTSSND--SRDMGTKSPTPP 632
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 727 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-60 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-56 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-55 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 6e-55 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-54 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-54 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 5e-53 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 7e-45 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-40 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-35 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 9e-34 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-33 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-33 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-33 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-32 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-32 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-31 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-31 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-31 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-30 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-30 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-30 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-28 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-28 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-27 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-27 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 7e-27 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 8e-27 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-26 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-26 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-26 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-26 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-26 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-26 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 9e-26 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 9e-26 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-25 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-25 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-25 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-25 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 4e-25 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-25 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-25 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 9e-25 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 1e-24 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-24 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-24 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 5e-24 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 8e-24 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 8e-24 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 8e-24 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 9e-24 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 1e-23 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-23 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-23 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-23 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 5e-23 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 6e-23 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 9e-23 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-22 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-22 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-22 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-22 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 2e-22 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 2e-22 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 2e-22 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-22 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-22 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 3e-22 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-22 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-22 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-22 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-22 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-22 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-21 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-21 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-21 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-21 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-21 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-21 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-21 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-21 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-21 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-21 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-21 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-21 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-21 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-21 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-21 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 8e-21 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-20 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-20 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-20 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-20 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-20 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 7e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-20 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 8e-20 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 8e-20 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-19 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-19 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-19 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-19 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-19 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 3e-19 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 4e-19 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-19 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-19 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-19 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-19 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-19 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 7e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 8e-19 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 9e-19 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-18 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-18 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-18 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-18 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-18 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 3e-18 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-18 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-18 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-18 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 4e-18 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-18 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-18 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-18 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-18 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 6e-18 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 7e-18 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 8e-18 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-17 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-17 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-17 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-17 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-17 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-17 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 2e-17 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 4e-17 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-17 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-17 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-17 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 5e-17 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-17 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 5e-17 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 6e-17 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-17 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 6e-17 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-17 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 7e-17 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-17 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 8e-17 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 9e-17 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 1e-16 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-16 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-16 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-16 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 2e-16 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-16 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-16 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 3e-16 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-16 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-16 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 6e-16 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 8e-16 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-15 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-15 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-15 | |
| pfam09770 | 804 | pfam09770, PAT1, Topoisomerase II-associated prote | 2e-15 | |
| PRK07003 | 830 | PRK07003, PRK07003, DNA polymerase III subunits ga | 2e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-15 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-15 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-15 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 4e-15 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-15 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-15 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-15 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-15 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-15 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-15 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 6e-15 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 7e-15 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 7e-15 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 9e-15 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 9e-15 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 9e-15 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 1e-14 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-14 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-14 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-14 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-14 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-14 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-14 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-14 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-14 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-14 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-14 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-14 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 2e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-14 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-14 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 3e-14 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 4e-14 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 4e-14 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-14 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 6e-14 | |
| PRK07003 | 830 | PRK07003, PRK07003, DNA polymerase III subunits ga | 6e-14 | |
| pfam09770 | 804 | pfam09770, PAT1, Topoisomerase II-associated prote | 7e-14 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 8e-14 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 8e-14 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 8e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 9e-14 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-13 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-13 | |
| pfam09770 | 804 | pfam09770, PAT1, Topoisomerase II-associated prote | 2e-13 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 2e-13 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 2e-13 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-13 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-13 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-13 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-13 | |
| PRK07003 | 830 | PRK07003, PRK07003, DNA polymerase III subunits ga | 3e-13 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 3e-13 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-13 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-13 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 4e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-13 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-13 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-13 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 5e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-13 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 7e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 8e-13 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 8e-13 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 9e-13 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 1e-12 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 1e-12 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 2e-12 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-12 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-12 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-12 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 3e-12 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-12 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-12 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 4e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-12 | |
| pfam03154 | 979 | pfam03154, Atrophin-1, Atrophin-1 family | 4e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-12 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 6e-12 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 6e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-12 | |
| pfam09770 | 804 | pfam09770, PAT1, Topoisomerase II-associated prote | 7e-12 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 7e-12 | |
| pfam07223 | 357 | pfam07223, DUF1421, Protein of unknown function (D | 7e-12 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 8e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 8e-12 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 8e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 8e-12 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 9e-12 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 1e-11 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 1e-11 | |
| pfam09770 | 804 | pfam09770, PAT1, Topoisomerase II-associated prote | 1e-11 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 1e-11 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 1e-11 | |
| pfam03154 | 979 | pfam03154, Atrophin-1, Atrophin-1 family | 1e-11 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-11 | |
| PRK14086 | 617 | PRK14086, dnaA, chromosomal replication initiation | 1e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-11 | |
| pfam03154 | 979 | pfam03154, Atrophin-1, Atrophin-1 family | 2e-11 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-11 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-11 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 2e-11 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 3e-11 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 3e-11 | |
| pfam03154 | 979 | pfam03154, Atrophin-1, Atrophin-1 family | 3e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-11 | |
| pfam05109 | 830 | pfam05109, Herpes_BLLF1, Herpes virus major outer | 3e-11 | |
| PRK07003 | 830 | PRK07003, PRK07003, DNA polymerase III subunits ga | 4e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-11 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-11 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 6e-11 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 7e-11 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 7e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 7e-11 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 7e-11 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 7e-11 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 8e-11 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 8e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 9e-11 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 1e-10 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 1e-10 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 1e-10 | |
| PRK14086 | 617 | PRK14086, dnaA, chromosomal replication initiation | 1e-10 | |
| pfam05109 | 830 | pfam05109, Herpes_BLLF1, Herpes virus major outer | 1e-10 | |
| PHA03378 | 991 | PHA03378, PHA03378, EBNA-3B; Provisional | 1e-10 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-10 | |
| PTZ00436 | 357 | PTZ00436, PTZ00436, 60S ribosomal protein L19-like | 1e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-10 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 2e-10 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 2e-10 | |
| PTZ00436 | 357 | PTZ00436, PTZ00436, 60S ribosomal protein L19-like | 2e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-10 | |
| PLN03209 | 576 | PLN03209, PLN03209, translocon at the inner envelo | 2e-10 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-10 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 3e-10 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 3e-10 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 3e-10 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 3e-10 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 3e-10 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-10 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 4e-10 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 4e-10 | |
| pfam05109 | 830 | pfam05109, Herpes_BLLF1, Herpes virus major outer | 4e-10 | |
| PHA03378 | 991 | PHA03378, PHA03378, EBNA-3B; Provisional | 4e-10 | |
| PTZ00436 | 357 | PTZ00436, PTZ00436, 60S ribosomal protein L19-like | 4e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-10 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-10 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 5e-10 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 5e-10 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 5e-10 | |
| pfam05109 | 830 | pfam05109, Herpes_BLLF1, Herpes virus major outer | 6e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 6e-10 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 7e-10 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 7e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 8e-10 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 9e-10 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 9e-10 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 9e-10 | |
| PTZ00436 | 357 | PTZ00436, PTZ00436, 60S ribosomal protein L19-like | 9e-10 | |
| PRK14086 | 617 | PRK14086, dnaA, chromosomal replication initiation | 1e-09 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 1e-09 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 1e-09 | |
| PTZ00436 | 357 | PTZ00436, PTZ00436, 60S ribosomal protein L19-like | 1e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-09 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 2e-09 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 2e-09 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 2e-09 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 2e-09 | |
| PHA03378 | 991 | PHA03378, PHA03378, EBNA-3B; Provisional | 2e-09 | |
| PTZ00436 | 357 | PTZ00436, PTZ00436, 60S ribosomal protein L19-like | 2e-09 | |
| pfam03153 | 332 | pfam03153, TFIIA, Transcription factor IIA, alpha/ | 2e-09 | |
| pfam03153 | 332 | pfam03153, TFIIA, Transcription factor IIA, alpha/ | 2e-09 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 2e-09 | |
| PRK03427 | 333 | PRK03427, PRK03427, cell division protein ZipA; Pr | 2e-09 | |
| PTZ00449 | 943 | PTZ00449, PTZ00449, 104 kDa microneme/rhoptry anti | 3e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-09 | |
| PLN03209 | 576 | PLN03209, PLN03209, translocon at the inner envelo | 4e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-09 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 5e-09 | |
| PTZ00449 | 943 | PTZ00449, PTZ00449, 104 kDa microneme/rhoptry anti | 5e-09 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 5e-09 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-09 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 6e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 6e-09 | |
| PRK14086 | 617 | PRK14086, dnaA, chromosomal replication initiation | 7e-09 | |
| PRK03427 | 333 | PRK03427, PRK03427, cell division protein ZipA; Pr | 7e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 7e-09 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 7e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 8e-09 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 1e-08 | |
| PRK07003 | 830 | PRK07003, PRK07003, DNA polymerase III subunits ga | 1e-08 | |
| pfam03154 | 979 | pfam03154, Atrophin-1, Atrophin-1 family | 1e-08 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 1e-08 | |
| pfam03153 | 332 | pfam03153, TFIIA, Transcription factor IIA, alpha/ | 1e-08 | |
| pfam03153 | 332 | pfam03153, TFIIA, Transcription factor IIA, alpha/ | 1e-08 | |
| PRK03427 | 333 | PRK03427, PRK03427, cell division protein ZipA; Pr | 1e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-08 | |
| PRK14954 | 620 | PRK14954, PRK14954, DNA polymerase III subunits ga | 1e-08 | |
| PHA03269 | 566 | PHA03269, PHA03269, envelope glycoprotein C; Provi | 1e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-08 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 2e-08 | |
| pfam07223 | 357 | pfam07223, DUF1421, Protein of unknown function (D | 2e-08 | |
| PLN03209 | 576 | PLN03209, PLN03209, translocon at the inner envelo | 2e-08 | |
| pfam03153 | 332 | pfam03153, TFIIA, Transcription factor IIA, alpha/ | 2e-08 | |
| PRK03427 | 333 | PRK03427, PRK03427, cell division protein ZipA; Pr | 2e-08 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 2e-08 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 2e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-08 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 3e-08 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 3e-08 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 3e-08 | |
| PRK10263 | 1355 | PRK10263, PRK10263, DNA translocase FtsK; Provisio | 3e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-08 | |
| PRK14949 | 944 | PRK14949, PRK14949, DNA polymerase III subunits ga | 3e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-08 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 4e-08 | |
| PHA03378 | 991 | PHA03378, PHA03378, EBNA-3B; Provisional | 4e-08 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 4e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-08 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 5e-08 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 5e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 6e-08 | |
| PRK11633 | 226 | PRK11633, PRK11633, cell division protein DedD; Pr | 6e-08 | |
| PHA03269 | 566 | PHA03269, PHA03269, envelope glycoprotein C; Provi | 7e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 7e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 8e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 8e-08 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 8e-08 | |
| PHA03378 | 991 | PHA03378, PHA03378, EBNA-3B; Provisional | 9e-08 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 9e-08 | |
| PHA03132 | 580 | PHA03132, PHA03132, thymidine kinase; Provisional | 9e-08 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 1e-07 | |
| pfam05109 | 830 | pfam05109, Herpes_BLLF1, Herpes virus major outer | 1e-07 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 1e-07 | |
| PRK03427 | 333 | PRK03427, PRK03427, cell division protein ZipA; Pr | 1e-07 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 1e-07 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 1e-07 | |
| PRK14954 | 620 | PRK14954, PRK14954, DNA polymerase III subunits ga | 1e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-07 | |
| pfam03326 | 500 | pfam03326, Herpes_TAF50, Herpesvirus transcription | 1e-07 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-07 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 2e-07 | |
| PTZ00436 | 357 | PTZ00436, PTZ00436, 60S ribosomal protein L19-like | 2e-07 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 2e-07 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 2e-07 | |
| PRK10263 | 1355 | PRK10263, PRK10263, DNA translocase FtsK; Provisio | 2e-07 | |
| PRK11633 | 226 | PRK11633, PRK11633, cell division protein DedD; Pr | 2e-07 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 2e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-07 | |
| pfam03154 | 979 | pfam03154, Atrophin-1, Atrophin-1 family | 3e-07 | |
| PTZ00436 | 357 | PTZ00436, PTZ00436, 60S ribosomal protein L19-like | 3e-07 | |
| pfam03153 | 332 | pfam03153, TFIIA, Transcription factor IIA, alpha/ | 3e-07 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 3e-07 | |
| PHA03269 | 566 | PHA03269, PHA03269, envelope glycoprotein C; Provi | 3e-07 | |
| PRK11633 | 226 | PRK11633, PRK11633, cell division protein DedD; Pr | 3e-07 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 3e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-07 | |
| pfam06070 | 777 | pfam06070, Herpes_UL32, Herpesvirus large structur | 3e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-07 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 4e-07 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 4e-07 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 4e-07 | |
| PRK03427 | 333 | PRK03427, PRK03427, cell division protein ZipA; Pr | 4e-07 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 4e-07 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 4e-07 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 4e-07 | |
| PHA03269 | 566 | PHA03269, PHA03269, envelope glycoprotein C; Provi | 4e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-07 | |
| COG0810 | 244 | COG0810, TonB, Periplasmic protein TonB, links inn | 4e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-07 | |
| pfam07223 | 357 | pfam07223, DUF1421, Protein of unknown function (D | 5e-07 | |
| PRK03427 | 333 | PRK03427, PRK03427, cell division protein ZipA; Pr | 5e-07 | |
| PRK10263 | 1355 | PRK10263, PRK10263, DNA translocase FtsK; Provisio | 5e-07 | |
| PTZ00249 | 516 | PTZ00249, PTZ00249, variable surface protein Vir28 | 5e-07 | |
| PHA03369 | 663 | PHA03369, PHA03369, capsid maturational protease; | 5e-07 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 6e-07 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 6e-07 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 6e-07 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 6e-07 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 6e-07 | |
| pfam06070 | 777 | pfam06070, Herpes_UL32, Herpesvirus large structur | 6e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 6e-07 | |
| pfam03999 | 619 | pfam03999, MAP65_ASE1, Microtubule associated prot | 6e-07 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 7e-07 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 7e-07 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 7e-07 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 7e-07 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 7e-07 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 7e-07 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 8e-07 | |
| PRK03427 | 333 | PRK03427, PRK03427, cell division protein ZipA; Pr | 9e-07 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 1e-06 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 1e-06 | |
| pfam03154 | 979 | pfam03154, Atrophin-1, Atrophin-1 family | 1e-06 | |
| PTZ00449 | 943 | PTZ00449, PTZ00449, 104 kDa microneme/rhoptry anti | 1e-06 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 1e-06 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 1e-06 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 1e-06 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 1e-06 | |
| pfam03326 | 500 | pfam03326, Herpes_TAF50, Herpesvirus transcription | 1e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-06 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 2e-06 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 2e-06 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 2e-06 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 2e-06 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 2e-06 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 2e-06 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 2e-06 | |
| PRK03427 | 333 | PRK03427, PRK03427, cell division protein ZipA; Pr | 2e-06 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 2e-06 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 2e-06 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 2e-06 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 2e-06 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 2e-06 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 2e-06 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 2e-06 | |
| PRK10263 | 1355 | PRK10263, PRK10263, DNA translocase FtsK; Provisio | 2e-06 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 2e-06 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 2e-06 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 2e-06 | |
| PRK00708 | 209 | PRK00708, PRK00708, sec-independent translocase; P | 2e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-06 | |
| PTZ00144 | 418 | PTZ00144, PTZ00144, dihydrolipoamide succinyltrans | 2e-06 | |
| pfam03276 | 582 | pfam03276, Gag_spuma, Spumavirus gag protein | 2e-06 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 3e-06 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 3e-06 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 3e-06 | |
| PRK14954 | 620 | PRK14954, PRK14954, DNA polymerase III subunits ga | 3e-06 | |
| pfam11725 | 1771 | pfam11725, AvrE, Pathogenicity factor | 3e-06 | |
| PRK10819 | 246 | PRK10819, PRK10819, transport protein TonB; Provis | 3e-06 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 4e-06 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 4e-06 | |
| PRK03427 | 333 | PRK03427, PRK03427, cell division protein ZipA; Pr | 4e-06 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 4e-06 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 4e-06 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 4e-06 | |
| PHA03321 | 694 | PHA03321, PHA03321, tegument protein VP11/12; Prov | 4e-06 | |
| PTZ00395 | 1560 | PTZ00395, PTZ00395, Sec24-related protein; Provisi | 4e-06 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 5e-06 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 5e-06 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 5e-06 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 5e-06 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 5e-06 | |
| PTZ00144 | 418 | PTZ00144, PTZ00144, dihydrolipoamide succinyltrans | 5e-06 | |
| PRK14959 | 624 | PRK14959, PRK14959, DNA polymerase III subunits ga | 5e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 5e-06 | |
| pfam07223 | 357 | pfam07223, DUF1421, Protein of unknown function (D | 6e-06 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 6e-06 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 6e-06 | |
| PRK14949 | 944 | PRK14949, PRK14949, DNA polymerase III subunits ga | 6e-06 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 6e-06 | |
| PHA03132 | 580 | PHA03132, PHA03132, thymidine kinase; Provisional | 6e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 6e-06 | |
| PRK09111 | 598 | PRK09111, PRK09111, DNA polymerase III subunits ga | 6e-06 | |
| pfam12737 | 418 | pfam12737, Mating_C, C-terminal domain of homeodom | 6e-06 | |
| PHA03378 | 991 | PHA03378, PHA03378, EBNA-3B; Provisional | 7e-06 | |
| PTZ00436 | 357 | PTZ00436, PTZ00436, 60S ribosomal protein L19-like | 7e-06 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 7e-06 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 7e-06 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 7e-06 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 7e-06 | |
| PHA03269 | 566 | PHA03269, PHA03269, envelope glycoprotein C; Provi | 7e-06 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 7e-06 | |
| pfam09606 | 768 | pfam09606, Med15, ARC105 or Med15 subunit of Media | 7e-06 | |
| pfam04388 | 667 | pfam04388, Hamartin, Hamartin protein | 7e-06 | |
| PRK12727 | 559 | PRK12727, PRK12727, flagellar biosynthesis regulat | 7e-06 | |
| PRK10811 | 1068 | PRK10811, rne, ribonuclease E; Reviewed | 7e-06 | |
| PHA03269 | 566 | PHA03269, PHA03269, envelope glycoprotein C; Provi | 8e-06 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 8e-06 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 9e-06 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 9e-06 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 9e-06 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 9e-06 | |
| pfam12737 | 418 | pfam12737, Mating_C, C-terminal domain of homeodom | 9e-06 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 1e-05 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 1e-05 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 1e-05 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 1e-05 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 1e-05 | |
| PRK14949 | 944 | PRK14949, PRK14949, DNA polymerase III subunits ga | 1e-05 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 1e-05 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 1e-05 | |
| PRK10819 | 246 | PRK10819, PRK10819, transport protein TonB; Provis | 1e-05 | |
| COG3456 | 430 | COG3456, COG3456, Predicted component of the type | 1e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-05 | |
| PRK11901 | 327 | PRK11901, PRK11901, hypothetical protein; Reviewed | 1e-05 | |
| PRK11901 | 327 | PRK11901, PRK11901, hypothetical protein; Reviewed | 1e-05 | |
| pfam13388 | 422 | pfam13388, DUF4106, Protein of unknown function (D | 1e-05 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 2e-05 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 2e-05 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 2e-05 | |
| PLN03209 | 576 | PLN03209, PLN03209, translocon at the inner envelo | 2e-05 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 2e-05 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 2e-05 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 2e-05 | |
| PHA03269 | 566 | PHA03269, PHA03269, envelope glycoprotein C; Provi | 2e-05 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 2e-05 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 2e-05 | |
| PRK14959 | 624 | PRK14959, PRK14959, DNA polymerase III subunits ga | 2e-05 | |
| PHA03379 | 935 | PHA03379, PHA03379, EBNA-3A; Provisional | 2e-05 | |
| COG5373 | 931 | COG5373, COG5373, Predicted membrane protein [Func | 2e-05 | |
| pfam08580 | 626 | pfam08580, KAR9, Yeast cortical protein KAR9 | 2e-05 | |
| PRK14963 | 504 | PRK14963, PRK14963, DNA polymerase III subunits ga | 2e-05 | |
| pfam04484 | 313 | pfam04484, DUF566, Family of unknown function (DUF | 2e-05 | |
| PRK12799 | 421 | PRK12799, motB, flagellar motor protein MotB; Revi | 2e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-05 | |
| pfam05044 | 908 | pfam05044, Prox1, Homeobox prospero-like protein ( | 2e-05 | |
| PLN02258 | 590 | PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygen | 2e-05 | |
| pfam02993 | 238 | pfam02993, MCPVI, Minor capsid protein VI | 2e-05 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 3e-05 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 3e-05 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 3e-05 | |
| PRK14954 | 620 | PRK14954, PRK14954, DNA polymerase III subunits ga | 3e-05 | |
| COG0810 | 244 | COG0810, TonB, Periplasmic protein TonB, links inn | 3e-05 | |
| PRK10819 | 246 | PRK10819, PRK10819, transport protein TonB; Provis | 3e-05 | |
| pfam08580 | 626 | pfam08580, KAR9, Yeast cortical protein KAR9 | 3e-05 | |
| PHA03291 | 401 | PHA03291, PHA03291, envelope glycoprotein I; Provi | 3e-05 | |
| PHA03419 | 200 | PHA03419, PHA03419, E4 protein; Provisional | 3e-05 | |
| PHA03325 | 418 | PHA03325, PHA03325, nuclear-egress-membrane-like p | 3e-05 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 4e-05 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 4e-05 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 4e-05 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 4e-05 | |
| COG0810 | 244 | COG0810, TonB, Periplasmic protein TonB, links inn | 4e-05 | |
| PHA02682 | 280 | PHA02682, PHA02682, ORF080 virion core protein; Pr | 4e-05 | |
| pfam05518 | 753 | pfam05518, Totivirus_coat, Totivirus coat protein | 4e-05 | |
| PHA03377 | 1000 | PHA03377, PHA03377, EBNA-3C; Provisional | 4e-05 | |
| PLN02217 | 670 | PLN02217, PLN02217, probable pectinesterase/pectin | 4e-05 | |
| PLN02217 | 670 | PLN02217, PLN02217, probable pectinesterase/pectin | 4e-05 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 5e-05 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 5e-05 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 5e-05 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 5e-05 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 5e-05 | |
| PRK09111 | 598 | PRK09111, PRK09111, DNA polymerase III subunits ga | 5e-05 | |
| PRK09111 | 598 | PRK09111, PRK09111, DNA polymerase III subunits ga | 5e-05 | |
| pfam12737 | 418 | pfam12737, Mating_C, C-terminal domain of homeodom | 5e-05 | |
| PRK11901 | 327 | PRK11901, PRK11901, hypothetical protein; Reviewed | 5e-05 | |
| pfam13388 | 422 | pfam13388, DUF4106, Protein of unknown function (D | 5e-05 | |
| pfam03251 | 458 | pfam03251, Tymo_45kd_70kd, Tymovirus 45/70Kd prote | 5e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 5e-05 | |
| pfam13254 | 414 | pfam13254, DUF4045, Domain of unknown function (DU | 5e-05 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 6e-05 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 6e-05 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 6e-05 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 6e-05 | |
| PRK11633 | 226 | PRK11633, PRK11633, cell division protein DedD; Pr | 6e-05 | |
| PHA03132 | 580 | PHA03132, PHA03132, thymidine kinase; Provisional | 6e-05 | |
| PHA03369 | 663 | PHA03369, PHA03369, capsid maturational protease; | 6e-05 | |
| PRK12799 | 421 | PRK12799, motB, flagellar motor protein MotB; Revi | 6e-05 | |
| PHA03291 | 401 | PHA03291, PHA03291, envelope glycoprotein I; Provi | 6e-05 | |
| smart00818 | 165 | smart00818, Amelogenin, Amelogenins, cell adhesion | 6e-05 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 7e-05 | |
| PRK14954 | 620 | PRK14954, PRK14954, DNA polymerase III subunits ga | 7e-05 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 7e-05 | |
| PRK14959 | 624 | PRK14959, PRK14959, DNA polymerase III subunits ga | 7e-05 | |
| pfam05539 | 408 | pfam05539, Pneumo_att_G, Pneumovirinae attachment | 7e-05 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 8e-05 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 8e-05 | |
| COG5373 | 931 | COG5373, COG5373, Predicted membrane protein [Func | 8e-05 | |
| COG5373 | 931 | COG5373, COG5373, Predicted membrane protein [Func | 8e-05 | |
| PHA03325 | 418 | PHA03325, PHA03325, nuclear-egress-membrane-like p | 8e-05 | |
| PLN02983 | 274 | PLN02983, PLN02983, biotin carboxyl carrier protei | 8e-05 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 9e-05 | |
| PRK14949 | 944 | PRK14949, PRK14949, DNA polymerase III subunits ga | 9e-05 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 9e-05 | |
| TIGR01645 | 612 | TIGR01645, half-pint, poly-U binding splicing fact | 9e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 9e-05 | |
| TIGR00601 | 378 | TIGR00601, rad23, UV excision repair protein Rad23 | 9e-05 | |
| PRK01297 | 475 | PRK01297, PRK01297, ATP-dependent RNA helicase Rhl | 9e-05 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 1e-04 | |
| PRK14086 | 617 | PRK14086, dnaA, chromosomal replication initiation | 1e-04 | |
| pfam05109 | 830 | pfam05109, Herpes_BLLF1, Herpes virus major outer | 1e-04 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 1e-04 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 1e-04 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 1e-04 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 1e-04 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 1e-04 | |
| PHA03132 | 580 | PHA03132, PHA03132, thymidine kinase; Provisional | 1e-04 | |
| PTZ00144 | 418 | PTZ00144, PTZ00144, dihydrolipoamide succinyltrans | 1e-04 | |
| PRK14959 | 624 | PRK14959, PRK14959, DNA polymerase III subunits ga | 1e-04 | |
| PRK10811 | 1068 | PRK10811, rne, ribonuclease E; Reviewed | 1e-04 | |
| PHA03379 | 935 | PHA03379, PHA03379, EBNA-3A; Provisional | 1e-04 | |
| PHA03379 | 935 | PHA03379, PHA03379, EBNA-3A; Provisional | 1e-04 | |
| pfam05539 | 408 | pfam05539, Pneumo_att_G, Pneumovirinae attachment | 1e-04 | |
| PRK01297 | 475 | PRK01297, PRK01297, ATP-dependent RNA helicase Rhl | 1e-04 | |
| COG3889 | 872 | COG3889, COG3889, Predicted solute binding protein | 1e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-04 | |
| pfam10152 | 147 | pfam10152, DUF2360, Predicted coiled-coil domain-c | 1e-04 | |
| PTZ00441 | 576 | PTZ00441, PTZ00441, sporozoite surface protein 2 ( | 1e-04 | |
| PRK08691 | 709 | PRK08691, PRK08691, DNA polymerase III subunits ga | 1e-04 | |
| PRK11892 | 464 | PRK11892, PRK11892, pyruvate dehydrogenase subunit | 1e-04 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 2e-04 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 2e-04 | |
| PHA03378 | 991 | PHA03378, PHA03378, EBNA-3B; Provisional | 2e-04 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 2e-04 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 2e-04 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 2e-04 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 2e-04 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 2e-04 | |
| PTZ00144 | 418 | PTZ00144, PTZ00144, dihydrolipoamide succinyltrans | 2e-04 | |
| PTZ00395 | 1560 | PTZ00395, PTZ00395, Sec24-related protein; Provisi | 2e-04 | |
| pfam09606 | 768 | pfam09606, Med15, ARC105 or Med15 subunit of Media | 2e-04 | |
| PRK12727 | 559 | PRK12727, PRK12727, flagellar biosynthesis regulat | 2e-04 | |
| PRK10811 | 1068 | PRK10811, rne, ribonuclease E; Reviewed | 2e-04 | |
| PRK11901 | 327 | PRK11901, PRK11901, hypothetical protein; Reviewed | 2e-04 | |
| pfam13388 | 422 | pfam13388, DUF4106, Protein of unknown function (D | 2e-04 | |
| PHA03379 | 935 | PHA03379, PHA03379, EBNA-3A; Provisional | 2e-04 | |
| PRK12799 | 421 | PRK12799, motB, flagellar motor protein MotB; Revi | 2e-04 | |
| PRK12799 | 421 | PRK12799, motB, flagellar motor protein MotB; Revi | 2e-04 | |
| PLN02258 | 590 | PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygen | 2e-04 | |
| pfam02993 | 238 | pfam02993, MCPVI, Minor capsid protein VI | 2e-04 | |
| PHA03291 | 401 | PHA03291, PHA03291, envelope glycoprotein I; Provi | 2e-04 | |
| PHA03377 | 1000 | PHA03377, PHA03377, EBNA-3C; Provisional | 2e-04 | |
| PLN02217 | 670 | PLN02217, PLN02217, probable pectinesterase/pectin | 2e-04 | |
| TIGR01645 | 612 | TIGR01645, half-pint, poly-U binding splicing fact | 2e-04 | |
| TIGR00601 | 378 | TIGR00601, rad23, UV excision repair protein Rad23 | 2e-04 | |
| PRK08691 | 709 | PRK08691, PRK08691, DNA polymerase III subunits ga | 2e-04 | |
| PRK00404 | 141 | PRK00404, tatB, sec-independent translocase; Provi | 2e-04 | |
| pfam10428 | 419 | pfam10428, SOG2, RAM signalling pathway protein | 2e-04 | |
| pfam10428 | 419 | pfam10428, SOG2, RAM signalling pathway protein | 2e-04 | |
| COG5099 | 777 | COG5099, COG5099, RNA-binding protein of the Puf f | 2e-04 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 3e-04 | |
| PLN03209 | 576 | PLN03209, PLN03209, translocon at the inner envelo | 3e-04 | |
| pfam03153 | 332 | pfam03153, TFIIA, Transcription factor IIA, alpha/ | 3e-04 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 3e-04 | |
| PRK14954 | 620 | PRK14954, PRK14954, DNA polymerase III subunits ga | 3e-04 | |
| PRK14954 | 620 | PRK14954, PRK14954, DNA polymerase III subunits ga | 3e-04 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 3e-04 | |
| COG3456 | 430 | COG3456, COG3456, Predicted component of the type | 3e-04 | |
| PHA03325 | 418 | PHA03325, PHA03325, nuclear-egress-membrane-like p | 3e-04 | |
| pfam05518 | 753 | pfam05518, Totivirus_coat, Totivirus coat protein | 3e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-04 | |
| PRK14666 | 694 | PRK14666, uvrC, excinuclease ABC subunit C; Provis | 3e-04 | |
| PRK13042 | 291 | PRK13042, PRK13042, superantigen-like protein; Rev | 3e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-04 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 4e-04 | |
| PRK11633 | 226 | PRK11633, PRK11633, cell division protein DedD; Pr | 4e-04 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 4e-04 | |
| PRK00708 | 209 | PRK00708, PRK00708, sec-independent translocase; P | 4e-04 | |
| pfam05518 | 753 | pfam05518, Totivirus_coat, Totivirus coat protein | 4e-04 | |
| TIGR00601 | 378 | TIGR00601, rad23, UV excision repair protein Rad23 | 4e-04 | |
| TIGR00601 | 378 | TIGR00601, rad23, UV excision repair protein Rad23 | 4e-04 | |
| PRK00404 | 141 | PRK00404, tatB, sec-independent translocase; Provi | 4e-04 | |
| PRK06975 | 656 | PRK06975, PRK06975, bifunctional uroporphyrinogen- | 4e-04 | |
| PHA03201 | 318 | PHA03201, PHA03201, uracil DNA glycosylase; Provis | 4e-04 | |
| pfam12868 | 135 | pfam12868, DUF3824, Domain of unknwon function (DU | 4e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 4e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-04 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 5e-04 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 5e-04 | |
| pfam06070 | 777 | pfam06070, Herpes_UL32, Herpesvirus large structur | 5e-04 | |
| PHA03369 | 663 | PHA03369, PHA03369, capsid maturational protease; | 5e-04 | |
| pfam03276 | 582 | pfam03276, Gag_spuma, Spumavirus gag protein | 5e-04 | |
| PRK09111 | 598 | PRK09111, PRK09111, DNA polymerase III subunits ga | 5e-04 | |
| PRK12799 | 421 | PRK12799, motB, flagellar motor protein MotB; Revi | 5e-04 | |
| pfam05518 | 753 | pfam05518, Totivirus_coat, Totivirus coat protein | 5e-04 | |
| pfam13254 | 414 | pfam13254, DUF4045, Domain of unknown function (DU | 5e-04 | |
| TIGR00601 | 378 | TIGR00601, rad23, UV excision repair protein Rad23 | 5e-04 | |
| TIGR00601 | 378 | TIGR00601, rad23, UV excision repair protein Rad23 | 5e-04 | |
| PRK13042 | 291 | PRK13042, PRK13042, superantigen-like protein; Rev | 5e-04 | |
| PHA01929 | 306 | PHA01929, PHA01929, putative scaffolding protein | 5e-04 | |
| pfam08601 | 344 | pfam08601, PAP1, Transcription factor PAP1 | 5e-04 | |
| PTZ00449 | 943 | PTZ00449, PTZ00449, 104 kDa microneme/rhoptry anti | 6e-04 | |
| pfam03326 | 500 | pfam03326, Herpes_TAF50, Herpesvirus transcription | 6e-04 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 6e-04 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 6e-04 | |
| COG3456 | 430 | COG3456, COG3456, Predicted component of the type | 6e-04 | |
| pfam08580 | 626 | pfam08580, KAR9, Yeast cortical protein KAR9 | 6e-04 | |
| PHA03291 | 401 | PHA03291, PHA03291, envelope glycoprotein I; Provi | 6e-04 | |
| PHA02682 | 280 | PHA02682, PHA02682, ORF080 virion core protein; Pr | 6e-04 | |
| PHA03377 | 1000 | PHA03377, PHA03377, EBNA-3C; Provisional | 6e-04 | |
| PLN02983 | 274 | PLN02983, PLN02983, biotin carboxyl carrier protei | 6e-04 | |
| pfam10428 | 419 | pfam10428, SOG2, RAM signalling pathway protein | 6e-04 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 7e-04 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 7e-04 | |
| PRK09111 | 598 | PRK09111, PRK09111, DNA polymerase III subunits ga | 7e-04 | |
| PRK10811 | 1068 | PRK10811, rne, ribonuclease E; Reviewed | 7e-04 | |
| PHA03325 | 418 | PHA03325, PHA03325, nuclear-egress-membrane-like p | 7e-04 | |
| pfam05539 | 408 | pfam05539, Pneumo_att_G, Pneumovirinae attachment | 7e-04 | |
| TIGR00601 | 378 | TIGR00601, rad23, UV excision repair protein Rad23 | 7e-04 | |
| pfam10428 | 419 | pfam10428, SOG2, RAM signalling pathway protein | 7e-04 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 8e-04 | |
| PHA03132 | 580 | PHA03132, PHA03132, thymidine kinase; Provisional | 8e-04 | |
| COG0810 | 244 | COG0810, TonB, Periplasmic protein TonB, links inn | 8e-04 | |
| PRK11901 | 327 | PRK11901, PRK11901, hypothetical protein; Reviewed | 8e-04 | |
| TIGR00601 | 378 | TIGR00601, rad23, UV excision repair protein Rad23 | 8e-04 | |
| TIGR02927 | 579 | TIGR02927, SucB_Actino, 2-oxoglutarate dehydrogena | 8e-04 | |
| PRK11633 | 226 | PRK11633, PRK11633, cell division protein DedD; Pr | 9e-04 | |
| PRK06975 | 656 | PRK06975, PRK06975, bifunctional uroporphyrinogen- | 9e-04 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 9e-04 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 0.001 | |
| PTZ00436 | 357 | PTZ00436, PTZ00436, 60S ribosomal protein L19-like | 0.001 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 0.001 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 0.001 | |
| PRK14954 | 620 | PRK14954, PRK14954, DNA polymerase III subunits ga | 0.001 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 0.001 | |
| PRK11633 | 226 | PRK11633, PRK11633, cell division protein DedD; Pr | 0.001 | |
| pfam03326 | 500 | pfam03326, Herpes_TAF50, Herpesvirus transcription | 0.001 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 0.001 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 0.001 | |
| PTZ00144 | 418 | PTZ00144, PTZ00144, dihydrolipoamide succinyltrans | 0.001 | |
| pfam03276 | 582 | pfam03276, Gag_spuma, Spumavirus gag protein | 0.001 | |
| pfam03276 | 582 | pfam03276, Gag_spuma, Spumavirus gag protein | 0.001 | |
| pfam11725 | 1771 | pfam11725, AvrE, Pathogenicity factor | 0.001 | |
| PRK14959 | 624 | PRK14959, PRK14959, DNA polymerase III subunits ga | 0.001 | |
| PRK14959 | 624 | PRK14959, PRK14959, DNA polymerase III subunits ga | 0.001 | |
| PRK14959 | 624 | PRK14959, PRK14959, DNA polymerase III subunits ga | 0.001 | |
| PRK14959 | 624 | PRK14959, PRK14959, DNA polymerase III subunits ga | 0.001 | |
| PRK09111 | 598 | PRK09111, PRK09111, DNA polymerase III subunits ga | 0.001 | |
| PRK09111 | 598 | PRK09111, PRK09111, DNA polymerase III subunits ga | 0.001 | |
| PRK12799 | 421 | PRK12799, motB, flagellar motor protein MotB; Revi | 0.001 | |
| PLN02258 | 590 | PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygen | 0.001 | |
| PLN02258 | 590 | PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygen | 0.001 | |
| pfam02993 | 238 | pfam02993, MCPVI, Minor capsid protein VI | 0.001 | |
| pfam03251 | 458 | pfam03251, Tymo_45kd_70kd, Tymovirus 45/70Kd prote | 0.001 | |
| TIGR00601 | 378 | TIGR00601, rad23, UV excision repair protein Rad23 | 0.001 | |
| PRK08691 | 709 | PRK08691, PRK08691, DNA polymerase III subunits ga | 0.001 | |
| TIGR02927 | 579 | TIGR02927, SucB_Actino, 2-oxoglutarate dehydrogena | 0.001 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 0.001 | |
| pfam06583 | 295 | pfam06583, Neogenin_C, Neogenin C-terminus | 0.001 | |
| PRK12373 | 400 | PRK12373, PRK12373, NADH dehydrogenase subunit E; | 0.001 | |
| TIGR02813 | 2582 | TIGR02813, omega_3_PfaA, polyketide-type polyunsat | 0.001 | |
| TIGR02813 | 2582 | TIGR02813, omega_3_PfaA, polyketide-type polyunsat | 0.001 | |
| pfam11702 | 509 | pfam11702, DUF3295, Protein of unknown function (D | 0.001 | |
| pfam10667 | 245 | pfam10667, DUF2486, Protein of unknown function (D | 0.001 | |
| COG2948 | 360 | COG2948, VirB10, Type IV secretory pathway, VirB10 | 0.001 | |
| pfam01034 | 207 | pfam01034, Syndecan, Syndecan domain | 0.001 | |
| pfam06075 | 564 | pfam06075, DUF936, Plant protein of unknown functi | 0.001 | |
| pfam09507 | 427 | pfam09507, CDC27, DNA polymerase subunit Cdc27 | 0.001 | |
| pfam10243 | 506 | pfam10243, MIP-T3, Microtubule-binding protein MIP | 0.001 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 0.002 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 0.002 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 0.002 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 0.002 | |
| pfam05109 | 830 | pfam05109, Herpes_BLLF1, Herpes virus major outer | 0.002 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 0.002 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 0.002 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 0.002 | |
| PRK10263 | 1355 | PRK10263, PRK10263, DNA translocase FtsK; Provisio | 0.002 | |
| PRK10263 | 1355 | PRK10263, PRK10263, DNA translocase FtsK; Provisio | 0.002 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 0.002 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 0.002 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 0.002 | |
| PRK11633 | 226 | PRK11633, PRK11633, cell division protein DedD; Pr | 0.002 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 0.002 | |
| PTZ00249 | 516 | PTZ00249, PTZ00249, variable surface protein Vir28 | 0.002 | |
| pfam03999 | 619 | pfam03999, MAP65_ASE1, Microtubule associated prot | 0.002 | |
| PRK00708 | 209 | PRK00708, PRK00708, sec-independent translocase; P | 0.002 | |
| PTZ00144 | 418 | PTZ00144, PTZ00144, dihydrolipoamide succinyltrans | 0.002 | |
| PTZ00144 | 418 | PTZ00144, PTZ00144, dihydrolipoamide succinyltrans | 0.002 | |
| pfam11725 | 1771 | pfam11725, AvrE, Pathogenicity factor | 0.002 | |
| PRK14959 | 624 | PRK14959, PRK14959, DNA polymerase III subunits ga | 0.002 | |
| PRK09111 | 598 | PRK09111, PRK09111, DNA polymerase III subunits ga | 0.002 | |
| pfam04388 | 667 | pfam04388, Hamartin, Hamartin protein | 0.002 | |
| pfam04484 | 313 | pfam04484, DUF566, Family of unknown function (DUF | 0.002 | |
| pfam05518 | 753 | pfam05518, Totivirus_coat, Totivirus coat protein | 0.002 | |
| PLN02983 | 274 | PLN02983, PLN02983, biotin carboxyl carrier protei | 0.002 | |
| TIGR01645 | 612 | TIGR01645, half-pint, poly-U binding splicing fact | 0.002 | |
| PRK01297 | 475 | PRK01297, PRK01297, ATP-dependent RNA helicase Rhl | 0.002 | |
| PRK01297 | 475 | PRK01297, PRK01297, ATP-dependent RNA helicase Rhl | 0.002 | |
| pfam10152 | 147 | pfam10152, DUF2360, Predicted coiled-coil domain-c | 0.002 | |
| PTZ00441 | 576 | PTZ00441, PTZ00441, sporozoite surface protein 2 ( | 0.002 | |
| PRK06975 | 656 | PRK06975, PRK06975, bifunctional uroporphyrinogen- | 0.002 | |
| PHA03201 | 318 | PHA03201, PHA03201, uracil DNA glycosylase; Provis | 0.002 | |
| COG2948 | 360 | COG2948, VirB10, Type IV secretory pathway, VirB10 | 0.002 | |
| PLN02328 | 808 | PLN02328, PLN02328, lysine-specific histone demeth | 0.002 | |
| pfam11711 | 377 | pfam11711, Tim54, Inner membrane protein import co | 0.002 | |
| PRK12438 | 991 | PRK12438, PRK12438, hypothetical protein; Provisio | 0.002 | |
| pfam05110 | 1154 | pfam05110, AF-4, AF-4 proto-oncoprotein | 0.002 | |
| pfam12526 | 115 | pfam12526, DUF3729, Protein of unknown function (D | 0.002 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 0.002 | |
| PRK13335 | 356 | PRK13335, PRK13335, superantigen-like protein; Rev | 0.002 | |
| PRK13335 | 356 | PRK13335, PRK13335, superantigen-like protein; Rev | 0.002 | |
| PRK12495 | 226 | PRK12495, PRK12495, hypothetical protein; Provisio | 0.002 | |
| PTZ00108 | 1388 | PTZ00108, PTZ00108, DNA topoisomerase 2-like prote | 0.002 | |
| pfam05109 | 830 | pfam05109, Herpes_BLLF1, Herpes virus major outer | 0.003 | |
| pfam03153 | 332 | pfam03153, TFIIA, Transcription factor IIA, alpha/ | 0.003 | |
| PRK10263 | 1355 | PRK10263, PRK10263, DNA translocase FtsK; Provisio | 0.003 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 0.003 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 0.003 | |
| pfam04484 | 313 | pfam04484, DUF566, Family of unknown function (DUF | 0.003 | |
| PHA02682 | 280 | PHA02682, PHA02682, ORF080 virion core protein; Pr | 0.003 | |
| PLN02217 | 670 | PLN02217, PLN02217, probable pectinesterase/pectin | 0.003 | |
| PLN02217 | 670 | PLN02217, PLN02217, probable pectinesterase/pectin | 0.003 | |
| smart00818 | 165 | smart00818, Amelogenin, Amelogenins, cell adhesion | 0.003 | |
| PLN02983 | 274 | PLN02983, PLN02983, biotin carboxyl carrier protei | 0.003 | |
| TIGR00601 | 378 | TIGR00601, rad23, UV excision repair protein Rad23 | 0.003 | |
| PRK00404 | 141 | PRK00404, tatB, sec-independent translocase; Provi | 0.003 | |
| PRK00404 | 141 | PRK00404, tatB, sec-independent translocase; Provi | 0.003 | |
| pfam10428 | 419 | pfam10428, SOG2, RAM signalling pathway protein | 0.003 | |
| pfam10428 | 419 | pfam10428, SOG2, RAM signalling pathway protein | 0.003 | |
| COG5099 | 777 | COG5099, COG5099, RNA-binding protein of the Puf f | 0.003 | |
| PRK14666 | 694 | PRK14666, uvrC, excinuclease ABC subunit C; Provis | 0.003 | |
| PRK13042 | 291 | PRK13042, PRK13042, superantigen-like protein; Rev | 0.003 | |
| COG3147 | 226 | COG3147, DedD, Uncharacterized protein conserved i | 0.003 | |
| COG3147 | 226 | COG3147, DedD, Uncharacterized protein conserved i | 0.003 | |
| COG3147 | 226 | COG3147, DedD, Uncharacterized protein conserved i | 0.003 | |
| PRK10118 | 408 | PRK10118, PRK10118, flagellar hook-length control | 0.003 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.003 | |
| TIGR02442 | 633 | TIGR02442, Cob-chelat-sub, cobaltochelatase subuni | 0.003 | |
| PRK12757 | 256 | PRK12757, PRK12757, cell division protein FtsN; Pr | 0.003 | |
| pfam10349 | 111 | pfam10349, WWbp, WW-domain ligand protein | 0.003 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 0.004 | |
| PHA03369 | 663 | PHA03369, PHA03369, capsid maturational protease; | 0.004 | |
| PTZ00144 | 418 | PTZ00144, PTZ00144, dihydrolipoamide succinyltrans | 0.004 | |
| PTZ00144 | 418 | PTZ00144, PTZ00144, dihydrolipoamide succinyltrans | 0.004 | |
| PRK10819 | 246 | PRK10819, PRK10819, transport protein TonB; Provis | 0.004 | |
| PRK09111 | 598 | PRK09111, PRK09111, DNA polymerase III subunits ga | 0.004 | |
| PRK09111 | 598 | PRK09111, PRK09111, DNA polymerase III subunits ga | 0.004 | |
| pfam09606 | 768 | pfam09606, Med15, ARC105 or Med15 subunit of Media | 0.004 | |
| PRK11901 | 327 | PRK11901, PRK11901, hypothetical protein; Reviewed | 0.004 | |
| PRK14963 | 504 | PRK14963, PRK14963, DNA polymerase III subunits ga | 0.004 | |
| PLN02258 | 590 | PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygen | 0.004 | |
| PLN02258 | 590 | PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygen | 0.004 | |
| PHA03325 | 418 | PHA03325, PHA03325, nuclear-egress-membrane-like p | 0.004 | |
| PRK11892 | 464 | PRK11892, PRK11892, pyruvate dehydrogenase subunit | 0.004 | |
| pfam06075 | 564 | pfam06075, DUF936, Plant protein of unknown functi | 0.004 | |
| pfam10243 | 506 | pfam10243, MIP-T3, Microtubule-binding protein MIP | 0.004 | |
| pfam10243 | 506 | pfam10243, MIP-T3, Microtubule-binding protein MIP | 0.004 | |
| pfam11711 | 377 | pfam11711, Tim54, Inner membrane protein import co | 0.004 | |
| pfam07415 | 489 | pfam07415, Herpes_LMP2, Gammaherpesvirus latent me | 0.004 | |
| PRK11855 | 547 | PRK11855, PRK11855, dihydrolipoamide acetyltransfe | 0.004 | |
| TIGR01628 | 562 | TIGR01628, PABP-1234, polyadenylate binding protei | 0.004 | |
| COG1426 | 284 | COG1426, COG1426, Predicted transcriptional regula | 0.004 | |
| COG1426 | 284 | COG1426, COG1426, Predicted transcriptional regula | 0.004 | |
| pfam09786 | 559 | pfam09786, CytochromB561_N, Cytochrome B561, N ter | 0.004 | |
| pfam11719 | 397 | pfam11719, Drc1-Sld2, DNA replication and checkpoi | 0.004 | |
| PRK08119 | 382 | PRK08119, PRK08119, flagellar motor switch protein | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 200 bits (512), Expect = 5e-60
Identities = 81/231 (35%), Positives = 117/231 (50%), Gaps = 26/231 (11%)
Query: 389 LGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGERE-FRAEVEIISRVHHRHLVSLVGYC 446
LGEGGFG VY G++VA+K +K S E E+EI+ +++H ++V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 447 ISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHR 506
E LV EY +L L E + +++ G+ YLH + IIHR
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK-ENEGKLSEDEILRILLQILEGLEYLHS--NG-IIHR 116
Query: 507 DIKSSNILLDS-SFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPE-YATSGKLTE 564
D+K NILLDS + + ++ADFGL+K+ L S+ + ++GT YMAPE G +E
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKL---LTSDKSLLKTIVGTPAYMAPEVLLGKGYYSE 173
Query: 565 KSDVYSFGVVLLELITGRKPVDASQPLGD--ESLVEW---ARPLLAEALEH 610
KSD++S GV+L EL L D +++ RP E LEH
Sbjct: 174 KSDIWSLGVILYEL----------PELKDLIRKMLQKDPEKRPSAKEILEH 214
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 191 bits (488), Expect = 5e-56
Identities = 72/211 (34%), Positives = 101/211 (47%), Gaps = 11/211 (5%)
Query: 383 FSAHNVLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGERE-FRAEVEIISRVHHRHLV 440
+ LGEG FG VY G+ VA+K +K + +RE E++I+ ++ H ++V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 441 SLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCH 500
L E + LV EY L L GR D A + YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEA--RFYLRQILSALEYLHSK-- 116
Query: 501 PRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSG 560
I+HRD+K NILLD ++ADFGLA+ +LD ++T V GT YMAPE
Sbjct: 117 -GIVHRDLKPENILLDEDGHVKLADFGLAR---QLDPGEKLTTFV-GTPEYMAPEVLLGK 171
Query: 561 KLTEKSDVYSFGVVLLELITGRKPVDASQPL 591
+ D++S GV+L EL+TG+ P L
Sbjct: 172 GYGKAVDIWSLGVILYELLTGKPPFPGDDQL 202
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 189 bits (482), Expect = 5e-55
Identities = 84/291 (28%), Positives = 129/291 (44%), Gaps = 47/291 (16%)
Query: 387 NVLGEGGFGCVYKGVLADG----REVAVKQLKIGGSQGER-EFRAEVEIISRVHHRHLVS 441
LGEG FG VYKG L EVAVK LK S+ ER +F E ++ ++ H ++V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 442 LVGYCISERERLLVYEYVPNDTLHYHL-------HAEGRPVMDWATRVKVAAGAARGIAY 494
L+G C E LV EY+ L +L + + + + A A+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 495 LHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD-----SNTHVSTRVMGTF 549
L + +HRD+ + N L+ +++DFGL++ + D + + R
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR----- 172
Query: 550 GYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALE 609
+MAPE G T KSDV+SFGV+L E+ T + P S E + E L
Sbjct: 173 -WMAPESLKDGIFTSKSDVWSFGVLLWEIFT-----LGATPYPGLSNEE-----VLEYLR 221
Query: 610 HEDFEALVDSRLEK-NYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659
RL K Y E++ ++ +C + RP S++V L+
Sbjct: 222 K-------GYRLPKPEYCPDELYELML---SCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 189 bits (481), Expect = 6e-55
Identities = 84/247 (34%), Positives = 119/247 (48%), Gaps = 18/247 (7%)
Query: 388 VLGEGGFGCVYKGV-LADGREVAVKQLKIGG--SQGEREFRAEVEIISRVHHRHLVSLVG 444
LG G FG VYK G+ VAVK LK S+ ++ R E+ I+ R+ H ++V L+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 445 YCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRII 504
+ LV EY L +L G + K+A RG+ YLH + II
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSRGGP--LSEDEAKKIALQILRGLEYLHSN---GII 120
Query: 505 HRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPE-YATSGKLT 563
HRD+K NILLD + ++ADFGLAK L+ S++ ++T V GT YMAPE
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKLLK--SSSSLTTFV-GTPWYMAPEVLLGGNGYG 177
Query: 564 EKSDVYSFGVVLLELITGRKPVDASQPLGDESLV------EWARPLLAEALEHEDFEALV 617
K DV+S GV+L EL+TG+ P L L+ + E+ + L+
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLI 237
Query: 618 DSRLEKN 624
L K+
Sbjct: 238 KKCLNKD 244
|
Length = 260 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 186 bits (475), Expect = 4e-54
Identities = 86/278 (30%), Positives = 125/278 (44%), Gaps = 32/278 (11%)
Query: 388 VLGEGGFGCVYKGVLADG-----REVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVS 441
LGEG FG VYKG L EVAVK LK S Q EF E I+ ++ H ++V
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 442 LVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHP 501
L+G C E ++V EY+P L +L + + + A ARG+ YL
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK--- 122
Query: 502 RIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGK 561
IHRD+ + N L+ + +++DFGL++ + D ++ +MAPE GK
Sbjct: 123 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWMAPESLKEGK 180
Query: 562 LTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRL 621
T KSDV+SFGV+L E+ T +P S E + E L+ RL
Sbjct: 181 FTSKSDVWSFGVLLWEIFT-----LGEEPYPGMSNAE-----VLEYLKK-------GYRL 223
Query: 622 EK-NYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRAL 658
K E++ ++ C RP S++V L
Sbjct: 224 PKPPNCPPELYKLML---QCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 186 bits (474), Expect = 6e-54
Identities = 86/278 (30%), Positives = 127/278 (45%), Gaps = 33/278 (11%)
Query: 388 VLGEGGFGCVYKGVL-----ADGREVAVKQLKIGGSQGER-EFRAEVEIISRVHHRHLVS 441
LGEG FG VYKG L EVAVK LK S+ + EF E I+ ++ H ++V
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 442 LVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHP 501
L+G C E +V EY+ L +L RP + + + A ARG+ YL
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYLRKN-RPKLSLSDLLSFALQIARGMEYLESK--- 121
Query: 502 RIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGK 561
IHRD+ + N L+ + +++DFGL++ + D ++ +MAPE GK
Sbjct: 122 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL--PIRWMAPESLKEGK 179
Query: 562 LTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRL 621
T KSDV+SFGV+L E+ T QP S E + E L++ RL
Sbjct: 180 FTSKSDVWSFGVLLWEIFT-----LGEQPYPGMSNEE-----VLEYLKN-------GYRL 222
Query: 622 EK-NYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRAL 658
+ E++ ++ C RP S++V L
Sbjct: 223 PQPPNCPPELYDLML---QCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 183 bits (467), Expect = 5e-53
Identities = 86/278 (30%), Positives = 126/278 (45%), Gaps = 32/278 (11%)
Query: 388 VLGEGGFGCVYKGVL-----ADGREVAVKQLKIGGSQGER-EFRAEVEIISRVHHRHLVS 441
LGEG FG VYKG L +VAVK LK G S+ ER EF E I+ ++ H ++V
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 442 LVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHP 501
L+G C +V EY+P L L G + +++A A+G+ YL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKL-TLKDLLQMALQIAKGMEYLESK--- 121
Query: 502 RIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGK 561
+HRD+ + N L+ + +++DFGL++ + D +MAPE GK
Sbjct: 122 NFVHRDLAARNCLVTENLVVKISDFGLSR-DIYEDDYYRKRGGGKLPIKWMAPESLKDGK 180
Query: 562 LTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRL 621
T KSDV+SFGV+L E+ T QP S E + E LE RL
Sbjct: 181 FTSKSDVWSFGVLLWEIFTL-----GEQPYPGMSNEE-----VLELLED-------GYRL 223
Query: 622 EKN-YVDSEMFWMIEAAAACVRHSATKRPRMSQVVRAL 658
+ E++ ++ C + RP S++V L
Sbjct: 224 PRPENCPDELYELM---LQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 7e-45
Identities = 67/207 (32%), Positives = 104/207 (50%), Gaps = 19/207 (9%)
Query: 387 NVLGEGGFGCVYKGVLAD-GREVAVKQLKIGGSQGE--REFRAEVEIISRVHHRHLVSLV 443
+LG G FG VY + D G +AVK +++ G E E+ I+S + H ++V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 444 GYCISERER-LLVY-EYVPNDTLHYHLHAEGR---PVM-DWATRVKVAAGAARGIAYLHE 497
G E + L ++ EYV +L L G+ PV+ + ++ G+AYLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQI------LEGLAYLHS 119
Query: 498 DCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYA 557
+ I+HRDIK +NIL+DS ++ADFG AK L + V GT +MAPE
Sbjct: 120 N---GIVHRDIKGANILVDSDGVVKLADFGCAKR-LGDIETGEGTGSVRGTPYWMAPEVI 175
Query: 558 TSGKLTEKSDVYSFGVVLLELITGRKP 584
+ +D++S G ++E+ TG+ P
Sbjct: 176 RGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 148 bits (377), Expect = 2e-40
Identities = 64/214 (29%), Positives = 108/214 (50%), Gaps = 25/214 (11%)
Query: 387 NVLGEGGFGCVYKGV-LADGREVAVKQLKIGG-SQGEREF-RAEVEIISRVHHRHLVSLV 443
+G+G FG VY +DG+ +K++ + S+ ERE EV+I+ +++H +++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 444 GYCISERERLL-VYEYVPNDTLHYHLHA---EGRP-----VMDWATRVKVAAGAARGIAY 494
E+ +L V EY L + EG+P ++DW ++ + Y
Sbjct: 66 E-SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQL------CLALKY 118
Query: 495 LHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAP 554
LH +I+HRDIK NI L S+ ++ DFG++K+ L S ++ V+GT Y++P
Sbjct: 119 LHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKV---LSSTVDLAKTVVGTPYYLSP 172
Query: 555 EYATSGKLTEKSDVYSFGVVLLELITGRKPVDAS 588
E + KSD++S G VL EL T + P +
Sbjct: 173 ELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 3e-35
Identities = 62/199 (31%), Positives = 105/199 (52%), Gaps = 11/199 (5%)
Query: 388 VLGEGGFGCVYKG-VLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYC 446
+G+GGFG VYK G+EVA+K +K+ + + + E++I+ + H ++V G
Sbjct: 7 KIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYG-S 65
Query: 447 ISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIH 505
+++ L +V E+ +L L + + + + V +G+ YLH + IIH
Sbjct: 66 YLKKDELWIVMEFCSGGSLKDLLKSTNQT-LTESQIAYVCKELLKGLEYLHSN---GIIH 121
Query: 506 RDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEK 565
RDIK++NILL S E ++ DFGL+ S+T ++GT +MAPE K
Sbjct: 122 RDIKAANILLTSDGEVKLIDFGLSAQL----SDTKARNTMVGTPYWMAPEVINGKPYDYK 177
Query: 566 SDVYSFGVVLLELITGRKP 584
+D++S G+ +EL G+ P
Sbjct: 178 ADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 9e-34
Identities = 73/206 (35%), Positives = 98/206 (47%), Gaps = 16/206 (7%)
Query: 389 LGEGGFGCVYKGV--LADGREVAVKQLK---IGGSQGEREFRAEVEIISRVHHRHLVSLV 443
LG+G FG V V G+ A+K LK I + E I+SR++H +V L
Sbjct: 1 LGKGSFGKVLL-VRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH 59
Query: 444 GYCISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPR 502
Y E+L LV EY P L HL EGR + A AA + YLH
Sbjct: 60 -YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFY--AAEIVLALEYLHSL---G 113
Query: 503 IIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKL 562
II+RD+K NILLD+ ++ DFGLAK + +T GT Y+APE
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKEL--SSEGSRTNTFC-GTPEYLAPEVLLGKGY 170
Query: 563 TEKSDVYSFGVVLLELITGRKPVDAS 588
+ D +S GV+L E++TG+ P A
Sbjct: 171 GKAVDWWSLGVLLYEMLTGKPPFYAE 196
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 4e-33
Identities = 71/212 (33%), Positives = 114/212 (53%), Gaps = 17/212 (8%)
Query: 383 FSAHNVLGEGGFGCVYKGVL-ADGREVAVKQLKIGG-SQGER-EFRAEVEIISRVHHRHL 439
F N +G+G FG V+K V AD R A+KQ+ + ++ ER E E +++++ ++
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 440 VSLVGYCISERERLLVYEYVPNDTLHYHLHAE-GRPVMD---WATRVKVAAGAARGIAYL 495
+ + + + +V EY N LH L + GRP+ + W + G+A+L
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW----RFFIQILLGLAHL 117
Query: 496 HEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPE 555
H +I+HRDIKS N+ LD+ ++ D G+AK+ L NT+ + ++GT Y++PE
Sbjct: 118 HSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKL---LSDNTNFANTIVGTPYYLSPE 171
Query: 556 YATSGKLTEKSDVYSFGVVLLELITGRKPVDA 587
EKSDV++ GVVL E TG+ P DA
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGKHPFDA 203
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 5e-33
Identities = 65/197 (32%), Positives = 103/197 (52%), Gaps = 7/197 (3%)
Query: 389 LGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCIS 448
LG G FG V++G+ + VAVK LK G+ ++F AE +I+ ++ H L+ L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLK-PGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 449 ERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDI 508
E +V E + +L +L + + +AA A G+AYL + IHRD+
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNY---IHRDL 129
Query: 509 KSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDV 568
+ N+L+ + +VADFGLA++ E + + APE A + + KSDV
Sbjct: 130 AARNVLVGENNICKVADFGLARVIKEDIYEAREGAKF--PIKWTAPEAALYNRFSIKSDV 187
Query: 569 YSFGVVLLELIT-GRKP 584
+SFG++L E++T GR P
Sbjct: 188 WSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 5e-33
Identities = 76/286 (26%), Positives = 134/286 (46%), Gaps = 43/286 (15%)
Query: 388 VLGEGGFGCVYKGV-LADGR----EVAVKQLK-IGGSQGEREFRAEVEIISRVHHRHLVS 441
VLG G FG VYKGV + +G VA+K L+ + +E E +++ V H H+V
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 442 LVGYCISERERLLVYEYVPNDTL--HYHLHAE---GRPVMDWATRVKVAAGAARGIAYLH 496
L+G C+S + L+ + +P L + H + + +++W ++ A+G++YL
Sbjct: 74 LLGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMSYLE 126
Query: 497 EDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEY 556
E R++HRD+ + N+L+ + ++ DFGLAK+ L++D + + +MA E
Sbjct: 127 EK---RLVHRDLAARNVLVKTPQHVKITDFGLAKL-LDVDEKEYHAEGGKVPIKWMALES 182
Query: 557 ATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFEA 615
T KSDV+S+GV + EL+T G KP + + L+E
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE----------------- 225
Query: 616 LVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661
RL + + + +M+ C A RP +++ +
Sbjct: 226 -KGERLPQPPICTIDVYMV--LVKCWMIDAESRPTFKELINEFSKM 268
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 64/206 (31%), Positives = 106/206 (51%), Gaps = 13/206 (6%)
Query: 383 FSAHNVLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGE--REFRAEVEIISRVHHRHL 439
+ +++G G FG VYKG+ L G VA+KQ+ + + E + E++++ + H ++
Sbjct: 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNI 61
Query: 440 VSLVGYCISERERLLVYEYVPNDTLHYHLHAEGR-PVMDWATRVKVAAGAARGIAYLHED 498
V +G + ++ EY N +L + G P A V +G+AYLHE
Sbjct: 62 VKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYV---YQVLQGLAYLHEQ 118
Query: 499 CHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYAT 558
+IHRDIK++NIL ++ADFG+ A +L+ + V+GT +MAPE
Sbjct: 119 ---GVIHRDIKAANILTTKDGVVKLADFGV---ATKLNDVSKDDASVVGTPYWMAPEVIE 172
Query: 559 SGKLTEKSDVYSFGVVLLELITGRKP 584
+ SD++S G ++EL+TG P
Sbjct: 173 MSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 2e-32
Identities = 69/202 (34%), Positives = 110/202 (54%), Gaps = 14/202 (6%)
Query: 383 FSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSL 442
F+ LG G FG V++G+ + VA+K LK +++F+ EV+ + R+ H+HL+SL
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 443 VGYCISERERLLVYEYVPNDTLHYHLH-AEGRPVMDWATRVKVAAGAARGIAYLHEDCHP 501
C ++ E + +L L EG+ V+ A+ + +A A G+AYL E
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQ-VLPVASLIDMACQVAEGMAYLEEQ--- 123
Query: 502 RIIHRDIKSSNILLDSSFEARVADFGLAKIALE---LDSNTHVSTRVMGTFGYMAPEYAT 558
IHRD+ + NIL+ +VADFGLA++ E L S+ + + + APE A+
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYK------WTAPEAAS 177
Query: 559 SGKLTEKSDVYSFGVVLLELIT 580
G + KSDV+SFG++L E+ T
Sbjct: 178 HGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 126 bits (316), Expect = 2e-31
Identities = 73/228 (32%), Positives = 106/228 (46%), Gaps = 17/228 (7%)
Query: 382 GFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGG---SQGEREFRAEVEIISRV-HHR 437
+ LGEG FG VY D + VA+K L S+ F E++I++ + H
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 438 HLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRP-VMDWATRVKVAAGAARGIAYLH 496
++V L + E LV EYV +L L GR + + + + A + YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 497 EDCHPRIIHRDIKSSNILLDS-SFEARVADFGLAKIALELDSNTHV---STRVMGTFGYM 552
IIHRDIK NILLD ++ DFGLAK+ + S + + + +GT GYM
Sbjct: 119 SK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 553 APEYATSGKL---TEKSDVYSFGVVLLELITGRKPVDASQPLGDESLV 597
APE L + SD++S G+ L EL+TG P + + S
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQT 223
|
Length = 384 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 68/200 (34%), Positives = 104/200 (52%), Gaps = 18/200 (9%)
Query: 389 LGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCIS 448
+G+G FG V G G++VAVK LK + + F AE +++ + H +LV L+G +
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQ-AFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 449 ERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDI 508
+V EY+ +L +L + GR V+ A ++ A G+ YL E +HRD+
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDL 128
Query: 509 KSSNILLDSSFEARVADFGLAKIA-LELDSNTHVSTRVMGTF--GYMAPEYATSGKLTEK 565
+ N+L+ A+V+DFGLAK A DS G + APE K + K
Sbjct: 129 AARNVLVSEDLVAKVSDFGLAKEASQGQDS---------GKLPVKWTAPEALREKKFSTK 179
Query: 566 SDVYSFGVVLLELIT-GRKP 584
SDV+SFG++L E+ + GR P
Sbjct: 180 SDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 68/204 (33%), Positives = 100/204 (49%), Gaps = 16/204 (7%)
Query: 387 NVLGEGGFGCVYKGVL-----ADGREVAVKQLKI-GGSQGEREFRAEVEIISRVHHRHLV 440
LGEG FG V G +VAVK L G Q +F E+EI+ + H ++V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 441 SLVGYCIS--ERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHED 498
G C R L+ EY+P+ +L +L R ++ + ++ +G+ YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQ-RHRDQINLKRLLLFSSQICKGMDYLGSQ 128
Query: 499 CHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVST--RVMGTFGYMAPEY 556
R IHRD+ + NIL++S +++DFGLAK+ L D + + F Y APE
Sbjct: 129 ---RYIHRDLAARNILVESEDLVKISDFGLAKV-LPEDKDYYYVKEPGESPIFWY-APEC 183
Query: 557 ATSGKLTEKSDVYSFGVVLLELIT 580
+ K + SDV+SFGV L EL T
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 79/272 (29%), Positives = 124/272 (45%), Gaps = 41/272 (15%)
Query: 388 VLGEGGFGCVYKGVL-ADGREVAVKQLKIGG-SQGEREFRAEVEIISRVHHRHLVSLVGY 445
VLG+G G VYK G+ A+K++ + G + ++ E++ + ++V G
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 446 CISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRV--KVAAGAARGIAYLHEDCHPRI 503
E E +V EY+ +L L + + + V +A +G+ YLH H I
Sbjct: 68 FYKEGEISIVLEYMDGGSLA-DLLKKVGKIPE---PVLAYIARQILKGLDYLHTKRH--I 121
Query: 504 IHRDIKSSNILLDSSFEARVADFGLAKIALE---LDSNTHVSTRVMGTFGYMAPEYATSG 560
IHRDIK SN+L++S E ++ADFG++K+ LE NT V GT YM+PE
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKV-LENTLDQCNTFV-----GTVTYMSPERIQGE 175
Query: 561 KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDS- 619
+ +D++S G+ LLE G+ P P G S E L+ +A+ D
Sbjct: 176 SYSYAADIWSLGLTLLECALGKFPF---LPPGQPSFFE----LM---------QAICDGP 219
Query: 620 --RLEKNYVDSEMFWMIEAAAACVRHSATKRP 649
L E + +AC++ KRP
Sbjct: 220 PPSLPAEEFSPE---FRDFISACLQKDPKKRP 248
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 71/209 (33%), Positives = 107/209 (51%), Gaps = 20/209 (9%)
Query: 387 NVLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGE--REFRAEVEIISRVHHRHLVSLV 443
N +G G FG VY V L G +AVK+++I + + +E E++++ + H +LV
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 444 GYCISERERLLVY-EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPR 502
G + RE++ ++ EY TL L GR ++D G+AYLH
Sbjct: 66 GVEV-HREKVYIFMEYCSGGTLEELLE-HGR-ILDEHVIRVYTLQLLEGLAYLHSH---G 119
Query: 503 IIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVM----GTFGYMAPEYAT 558
I+HRDIK +NI LD + ++ DFG A L +NT + GT YMAPE T
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVK---LKNNTTTMGEEVQSLAGTPAYMAPEVIT 176
Query: 559 SGKLTEK---SDVYSFGVVLLELITGRKP 584
GK +D++S G V+LE+ TG++P
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 6e-30
Identities = 70/198 (35%), Positives = 103/198 (52%), Gaps = 9/198 (4%)
Query: 389 LGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCIS 448
LG G FG V+ G +VAVK LK G+ F E +I+ ++ H LV L C S
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLK-PGTMSPEAFLQEAQIMKKLRHDKLVQLYAVC-S 71
Query: 449 ERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRD 507
E E + +V EY+ +L L + + V +AA A G+AYL IHRD
Sbjct: 72 EEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRD 128
Query: 508 IKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSD 567
+ + NIL+ + ++ADFGLA++ + + + + APE A G+ T KSD
Sbjct: 129 LAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKF--PIKWTAPEAANYGRFTIKSD 186
Query: 568 VYSFGVVLLELIT-GRKP 584
V+SFG++L E++T GR P
Sbjct: 187 VWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 5e-28
Identities = 78/211 (36%), Positives = 113/211 (53%), Gaps = 30/211 (14%)
Query: 389 LGEGGFGCVYKGV--LADGRE--VAVKQLKIGGSQ-GEREFRAEVEIISRVHHRHLVSLV 443
LG G FG V KGV + G+E VAVK LK G++EF E +++++ H +V L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 444 GYCISERERLLVYEYVPNDTLHYHLHAEGR-PVMD---WATRVKVAAGAARGIAYLHEDC 499
G C E +LV E P L +L PV D A +V A G+AYL E
Sbjct: 63 GVCKGE-PLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV------AMGMAYL-ESK 114
Query: 500 HPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFG-----YMAP 554
H +HRD+ + N+LL + +A+++DFG+++ AL S+ + +T T G + AP
Sbjct: 115 H--FVHRDLAARNVLLVNRHQAKISDFGMSR-ALGAGSDYYRAT----TAGRWPLKWYAP 167
Query: 555 EYATSGKLTEKSDVYSFGVVLLELIT-GRKP 584
E GK + KSDV+S+GV L E + G KP
Sbjct: 168 ECINYGKFSSKSDVWSYGVTLWEAFSYGAKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 67/221 (30%), Positives = 100/221 (45%), Gaps = 32/221 (14%)
Query: 388 VLGEGGFGCVYKGVLADGRE------VAVKQLKIGGSQGERE-FRAEVEIISRVHHRHLV 440
LGEG FG V+ G VAVK LK S R+ F E E+++ H ++V
Sbjct: 12 ELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIV 71
Query: 441 SLVGYCISERERLLVYEYVPNDTLHYHLHAEGR---------PVMDWATR---VKVAAGA 488
G C ++V+EY+ + L+ L + G M T +++A
Sbjct: 72 KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131
Query: 489 ARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGT 548
A G+ YL +HRD+ + N L+ ++ DFG+++ D T RV G
Sbjct: 132 ASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSR-----DVYTTDYYRVGGH 183
Query: 549 ----FGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKP 584
+M PE K T +SDV+SFGVVL E+ T G++P
Sbjct: 184 TMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 70/210 (33%), Positives = 112/210 (53%), Gaps = 23/210 (10%)
Query: 387 NVLGEGGFGCVYKGVLA-DGRE---VAVKQLKIGGSQGER-EFRAEVEIISRVHHRHLVS 441
V+G G FG V +G L G++ VA+K LK G S +R +F E I+ + H +++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 442 LVGYCISERERLLVYEYVPNDTLHYHL-HAEGRPVMDWATRVKVAAGAARGIAYLHEDCH 500
L G R +++ EY+ N +L L +G+ V + G A G+ YL E +
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRENDGK--FTVGQLVGMLRGIASGMKYLSEMNY 127
Query: 501 PRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTR-----VMGTFGYMAPE 555
+HRD+ + NIL++S+ +V+DFGL++ LE DS +T+ + T APE
Sbjct: 128 ---VHRDLAARNILVNSNLVCKVSDFGLSRR-LE-DSEATYTTKGGKIPIRWT----APE 178
Query: 556 YATSGKLTEKSDVYSFGVVLLELIT-GRKP 584
K T SDV+SFG+V+ E+++ G +P
Sbjct: 179 AIAYRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 45/216 (20%)
Query: 389 LGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGERE-F-----RAEVEIISRVHHRHLVS 441
+GEG +G VYK G VA+K++++ + E+E F R E++++ ++ H ++V
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRM---ENEKEGFPITAIR-EIKLLQKLRHPNIVR 62
Query: 442 LVGYCISERER--LLVYEYVPND--TLHYHLHAEGRPVMDWATRVKVAAGAAR------- 490
L S+ + +V+EY+ +D L VK +
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMDHDLTGLLDS------------PEVKFTESQIKCYMKQLL 110
Query: 491 -GIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTF 549
G+ YLH I+HRDIK SNIL+++ ++ADFGLA+ ++ + RV+ T
Sbjct: 111 EGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLAR-PYTKRNSADYTNRVI-TL 165
Query: 550 GYMAPEY---ATSGKLTEKSDVYSFGVVLLELITGR 582
Y PE AT + + D++S G +L EL G+
Sbjct: 166 WYRPPELLLGAT--RYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 7e-27
Identities = 70/201 (34%), Positives = 101/201 (50%), Gaps = 13/201 (6%)
Query: 389 LGEGGFGCVYK-GVLADGREVAVKQL---KIGGSQGEREFRAEVEIISRVHHRHLVSLVG 444
LG+GGFG V V A G+ A K+L ++ +GE+ E +I+ +V R +VSL
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 445 YCISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRI 503
Y ++ L LV + L YH++ G P A + AA G+ +LH+ RI
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RI 116
Query: 504 IHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLT 563
++RD+K N+LLD R++D GLA +EL + R GT GYMAPE
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLA---VELKGGKKIKGRA-GTPGYMAPEVLQGEVYD 172
Query: 564 EKSDVYSFGVVLLELITGRKP 584
D ++ G L E+I GR P
Sbjct: 173 FSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 8e-27
Identities = 68/203 (33%), Positives = 107/203 (52%), Gaps = 13/203 (6%)
Query: 389 LGEGGFGCVYKGVLAD-GREVAVKQLKIGGSQGE--REFRA---EVEIISRVHHRHLVSL 442
LG+G FG VY D GRE+AVKQ+ E +E A E++++ + H +V
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 443 VGYCISERERLLVY-EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHP 501
G C+ + E L ++ EY+P ++ L A G + + TR K G+ YLH +
Sbjct: 70 YG-CLRDDETLSIFMEYMPGGSVKDQLKAYG-ALTETVTR-KYTRQILEGVEYLHSN--- 123
Query: 502 RIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGK 561
I+HRDIK +NIL DS+ ++ DFG +K + S+ V GT +M+PE +
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG 183
Query: 562 LTEKSDVYSFGVVLLELITGRKP 584
K+DV+S G ++E++T + P
Sbjct: 184 YGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 1e-26
Identities = 60/199 (30%), Positives = 103/199 (51%), Gaps = 8/199 (4%)
Query: 389 LGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCIS 448
+G G FG V+ G + R+VA+K ++ G+ E +F E +++ ++ H LV L G C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIR-EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 449 ERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDI 508
LV+E++ + L +L A+ R T + + G+AYL +IHRD+
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDL 126
Query: 509 KSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDV 568
+ N L+ + +V+DFG+ + LD ST + +PE + K + KSDV
Sbjct: 127 AARNCLVGENQVVKVSDFGMTRFV--LDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDV 184
Query: 569 YSFGVVLLELIT-GRKPVD 586
+SFGV++ E+ + G+ P +
Sbjct: 185 WSFGVLMWEVFSEGKTPYE 203
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 75/203 (36%), Positives = 106/203 (52%), Gaps = 19/203 (9%)
Query: 389 LGEGGFG----CVYKGVLAD--GREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSL 442
LG+G FG C Y L D G VAVK+L+ ++ R+F E+EI+ + H ++V
Sbjct: 12 LGKGNFGSVELCRYDP-LQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 443 VGYCIS--ERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCH 500
G C S R LV EY+P +L +L + R +D + A+ +G+ YL
Sbjct: 71 KGVCYSAGRRNLRLVMEYLPYGSLRDYLQ-KHRERLDHRKLLLYASQICKGMEYLGSK-- 127
Query: 501 PRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMG---TFGYMAPEYA 557
R +HRD+ + NIL++S ++ DFGL K+ L D + R G F Y APE
Sbjct: 128 -RYVHRDLATRNILVESENRVKIGDFGLTKV-LPQDKEYYK-VREPGESPIFWY-APESL 183
Query: 558 TSGKLTEKSDVYSFGVVLLELIT 580
T K + SDV+SFGVVL EL T
Sbjct: 184 TESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 109 bits (276), Expect = 1e-26
Identities = 63/210 (30%), Positives = 93/210 (44%), Gaps = 33/210 (15%)
Query: 388 VLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYC 446
+GEG G VYK A G+EVA+K++++ E E+ I+ H ++V
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN-EILIMKDCKHPNIVDYYDSY 84
Query: 447 ISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVK----------VAAGAARGIAYLH 496
+ E +V EY +G + D T+ V +G+ YLH
Sbjct: 85 LVGDELWVVMEY-----------MDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH 133
Query: 497 EDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTR--VMGTFGYMAP 554
+IHRDIKS NILL ++ADFG A +L S R V+GT +MAP
Sbjct: 134 SQ---NVIHRDIKSDNILLSKDGSVKLADFGFAA---QL--TKEKSKRNSVVGTPYWMAP 185
Query: 555 EYATSGKLTEKSDVYSFGVVLLELITGRKP 584
E K D++S G++ +E+ G P
Sbjct: 186 EVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 65/215 (30%), Positives = 111/215 (51%), Gaps = 21/215 (9%)
Query: 382 GFSAHNVLGEGGFGCVYK-GVLADGREVAVKQLKIGG-SQGEREFRA-EVEIISRVHHRH 438
F LG+G +G VYK L+D + A+K++ +G SQ ERE E+ I++ V+H +
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 439 LVSLVGYCISERERLLVYEYVPNDTLHYHL---HAEGRPV---MDWATRVKVAAGAARGI 492
++S + + +V EY P L + + + + W +++ RG+
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL----RGL 116
Query: 493 AYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYM 552
LHE +I+HRD+KS+NILL ++ ++ D G++K+ + + T +GT YM
Sbjct: 117 QALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKT-----QIGTPHYM 168
Query: 553 APEYATSGKLTEKSDVYSFGVVLLELITGRKPVDA 587
APE + KSD++S G +L E+ T P +A
Sbjct: 169 APEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEA 203
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 3e-26
Identities = 83/310 (26%), Positives = 144/310 (46%), Gaps = 30/310 (9%)
Query: 367 SRSWFTYDELIQATNGFSAHNVLGEGGFGCVYKG-VLADGREVAVKQLKIGGSQGEREFR 425
S+S T ++++ + NV+ G G YKG + +G + VK++ S E
Sbjct: 680 SKS-ITINDILSSLK---EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIA 735
Query: 426 AEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVA 485
+ ++ H ++V L+G C SE+ L++EY+ L L + W R K+A
Sbjct: 736 D----MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIA 786
Query: 486 AGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRV 545
G A+ + +LH C P ++ ++ I++D E + L L T+
Sbjct: 787 IGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPH--------LRLSLPGLLCTDTKC 838
Query: 546 MGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLA 605
+ Y+APE + +TEKSD+Y FG++L+EL+TG+ P DA S+VEWAR +
Sbjct: 839 FISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYS 897
Query: 606 EALEHEDFEALVDSRLEKNYV--DSEMFWMIEAAAACVRHSATKRPRMSQVVRALD-TLD 662
+ H D +D + + +E+ ++ A C T RP + V++ L+
Sbjct: 898 DC--HLDM--WIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953
Query: 663 GASDLTNGVK 672
+S G+K
Sbjct: 954 SSSSCVTGLK 963
|
Length = 968 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 65/209 (31%), Positives = 92/209 (44%), Gaps = 17/209 (8%)
Query: 382 GFSAHNVLGEGGFGCVYKGVLADGREV-AVKQL---KIGGSQGEREFRAEVEIISRVHHR 437
F V+G+G FG V D +++ A+K + K R E I+ ++H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 438 HLVSLVGYCISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKV-AAGAARGIAYL 495
LV+L Y + E + LV + + L YHL + V +VK + YL
Sbjct: 61 FLVNLW-YSFQDEENMYLVVDLLLGGDLRYHL---SQKVKFSEEQVKFWICEIVLALEYL 116
Query: 496 HEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPE 555
H IIHRDIK NILLD + DF +A + D+ T T GT GYMAPE
Sbjct: 117 HSK---GIIHRDIKPDNILLDEQGHVHITDFNIATK-VTPDTLT---TSTSGTPGYMAPE 169
Query: 556 YATSGKLTEKSDVYSFGVVLLELITGRKP 584
+ D +S GV E + G++P
Sbjct: 170 VLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 9e-26
Identities = 80/322 (24%), Positives = 106/322 (32%), Gaps = 53/322 (16%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTP------------- 47
PP PP P PP SP P+ P PPP PPP P P
Sbjct: 2612 APPSPLPPD--THAPDPPPPSPSPAANEPDPHPPPTVPPPERPRDDPAPGRVSRPRRARR 2669
Query: 48 -------------PSPPTAPPPSSPAVNS-----PPPQPSSPPPPLDAPPPPEVDPSPPS 89
P A P + PPP P P L + P P+
Sbjct: 2670 LGRAAQASSPPQRPRRRAARPTVGSLTSLADPPPPPPTPEPAPHALVSATPLPPGPAAAR 2729
Query: 90 PAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPAN 149
A P A AP+PP P TP + P T + PPA P PA
Sbjct: 2730 QASPALPA-APAPPAVPAGPATPGGPARPARPPTTAGPPAPAPPAAPAAGPPRRLTRPAV 2788
Query: 150 VPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPP 209
+ S S P P P ++ P ++ PP ++P+ P+ PPP +Q PP PP
Sbjct: 2789 ASLSESRESLPSPWDPADPPAAVLAPAAALPPAASPAGPL--PPPTSAQPTAPPPPPGPP 2846
Query: 210 ASTLSP-----------------PPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTPPLPSV 252
+L P + P+ + P V A P+ S + S + PP
Sbjct: 2847 PPSLPLGGSVAPGGDVRRRPPSRSPAAKPAAPARPPVRRLARPAVSRSTESFALPPDQPE 2906
Query: 253 PTEKPTAKSTNGTAVSANASPR 274
+P A P+
Sbjct: 2907 RPPQPQAPPPPQPQPQPPPPPQ 2928
|
Length = 3151 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 9e-26
Identities = 68/277 (24%), Positives = 123/277 (44%), Gaps = 41/277 (14%)
Query: 388 VLGEGGFGCVYKGVL----ADGREVAVKQLKIG--GSQGEREFRAEVEIISRVHHRHLVS 441
VLG+G FG + L D V K++ + + R+ E+ I+S + H ++++
Sbjct: 7 VLGKGAFG---EATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIA 63
Query: 442 LVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHP 501
+ + + L+ EY TL+ + + + + + ++Y+H+
Sbjct: 64 YYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA--- 120
Query: 502 RIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGK 561
I+HRDIK+ NI L + ++ DFG++KI L S ++ V+GT YM+PE K
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISKI---LGSEYSMAETVVGTPYYMSPELCQGVK 177
Query: 562 LTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRL 621
KSD+++ G VL EL+T ++ DA+ PL LV +
Sbjct: 178 YNFKSDIWALGCVLYELLTLKRTFDATNPL-----------------------NLVVKIV 214
Query: 622 EKNYVDSEMFW---MIEAAAACVRHSATKRPRMSQVV 655
+ NY + +I + ++ KRP +V+
Sbjct: 215 QGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 57/196 (29%), Positives = 99/196 (50%), Gaps = 9/196 (4%)
Query: 389 LGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCIS 448
LG G FG V+ G +VA+K ++ G+ E +F E +++ ++ H +LV L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIR-EGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 449 ERERLLVYEYVPNDTLHYHLHA-EGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRD 507
+R +V EY+ N L +L +G+ +W + + + + YL + IHRD
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKGKLGTEWL--LDMCSDVCEAMEYLESNG---FIHRD 125
Query: 508 IKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSD 567
+ + N L+ +V+DFGLA+ L+ + T+ + PE + + KSD
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKF--PVKWAPPEVFDYSRFSSKSD 183
Query: 568 VYSFGVVLLELITGRK 583
V+SFGV++ E+ + K
Sbjct: 184 VWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 72/222 (32%), Positives = 113/222 (50%), Gaps = 27/222 (12%)
Query: 387 NVLGEGGFGCVYKG----VLADGRE---VAVKQLKIGGSQGER-EFRAEVEIISRVHHRH 438
N LG G FG VY+G +L G VAVK L+ G + E+ EF E ++S +H +
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 439 LVSLVGYCISERERLLVYEYVP-NDTLHYHLHAE----GRPVMDWATRVKVAAGAARGIA 493
+V L+G C+ + ++ E + D L Y A G P++ + + A+G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 494 YLHEDCHPRIIHRDIKSSNILL-----DSSFEARVADFGLAKIALELDSNTHVSTRVMGT 548
YL E H IHRD+ + N L+ D+ ++ DFGLA+ ++ + + G
Sbjct: 121 YL-EQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR---DIYKSDYYRKEGEGL 174
Query: 549 FG--YMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDA 587
+MAPE GK T +SDV+SFGV++ E++T G++P A
Sbjct: 175 LPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPA 216
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 67/208 (32%), Positives = 105/208 (50%), Gaps = 32/208 (15%)
Query: 389 LGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGEREF-----RAEVEIISRVHHRHLVSL 442
LGEG +G VYK G VA+K++++ E R E+ ++ + H ++V L
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRL--DNEEEGIPSTALR-EISLLKELKHPNIVKL 63
Query: 443 VGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAA-RGIAYLHEDCHP 501
+ +ER+ LV+EY D L +L P + +K RG+AY H H
Sbjct: 64 LDVIHTERKLYLVFEYCDMD-LKKYLDKRPGP-LS-PNLIKSIMYQLLRGLAYCHS--H- 117
Query: 502 RIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPE------ 555
RI+HRD+K NIL++ ++ADFGLA+ A + T+ + V+ T Y APE
Sbjct: 118 RILHRDLKPQNILINRDGVLKLADFGLAR-AFGIPLRTY-THEVV-TLWYRAPEILLGSK 174
Query: 556 -YATSGKLTEKSDVYSFGVVLLELITGR 582
Y+T+ D++S G + E+ITG+
Sbjct: 175 HYSTA------VDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 64/217 (29%), Positives = 99/217 (45%), Gaps = 24/217 (11%)
Query: 389 LGEGGFGCVYKGVLAD------GREVAVKQLKIGGSQGER-EFRAEVEIISRVHHRHLVS 441
LG+G FG VY+G+ VA+K + S ER EF E ++ + H+V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 442 LVGYCISERERLLVYEYVPNDTLHYHL--------HAEGRPVMDWATRVKVAAGAARGIA 493
L+G + + L+V E + L +L + G +++AA A G+A
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 494 YLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMA 553
YL + +HRD+ + N ++ ++ DFG+ + E D ++ +MA
Sbjct: 134 YLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLL-PVRWMA 189
Query: 554 PEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQP 590
PE G T KSDV+SFGVVL E+ T A QP
Sbjct: 190 PESLKDGVFTTKSDVWSFGVVLWEMATL-----AEQP 221
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 4e-25
Identities = 71/287 (24%), Positives = 96/287 (33%), Gaps = 11/287 (3%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASP-PPSPPTSTPPSPPTAPPPSSP 59
P +++ P V ++ + P PPP+ P P + A+P PP P + SP P+ P
Sbjct: 2683 PRRRAARPTVGSLTSLADPPPPPPTPEPAPHALVSATPLPPGPAAARQASPALPAAPAPP 2742
Query: 60 AVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPP--PQAVAPSPPPPANVPTTPSSSSP 117
AV + P P P P PP P+P PA P P P + + S SP
Sbjct: 2743 AVPAGPATPGGPARP-ARPPTTAGPPAPAPPAAPAAGPPRRLTRPAVASLSESRESLPSP 2801
Query: 118 PPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSS-SPPPP 176
P + +P+ PPP + T P P P S +P
Sbjct: 2802 WDPADPPAAVLAPAAALPPAASPAGPLPPPTSAQPTAPPPPPGPPPPSLPLGGSVAPGGD 2861
Query: 177 SSNPPTSTPSPPVLTPPPHP-----SQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSP 231
P S P P ++ A T+S P P P PP P
Sbjct: 2862 VRRRPPSRSPAAKPAAPARPPVRRLARPAVSRSTESFALPPDQPERPPQPQAPPPPQPQP 2921
Query: 232 PAPPSNSSTRGSPSTPPLPSVPTEKPTAKSTNGTAVSANASPRNAGV 278
PP P PP P P T + G A P +
Sbjct: 2922 QPPPPPQPQ-PPPPPPPRPQPPLAPTTDPAGAGEPSGAVPQPWLGAL 2967
|
Length = 3151 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 66/217 (30%), Positives = 114/217 (52%), Gaps = 20/217 (9%)
Query: 387 NVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQ---GEREFRA---EVEIISRVHHRHLV 440
VLG+G +G VY G+ G+ +AVKQ+++ S E+E+ EV+++ + H ++V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 441 SLVGYCISERERLLVYEYVPNDTLHYHLHAEG---RPVMDWATRVKVAAGAARGIAYLHE 497
+G C+ + + E+VP ++ L+ G PV T+ + G+AYLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQIL-----DGVAYLHN 120
Query: 498 DCHPRIIHRDIKSSNILLDSSFEARVADFGLAK-IALELDSNTH--VSTRVMGTFGYMAP 554
+C ++HRDIK +N++L + ++ DFG A+ +A TH + + GT +MAP
Sbjct: 121 NC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177
Query: 555 EYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPL 591
E KSD++S G + E+ TG+ P+ + L
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL 214
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 68/207 (32%), Positives = 110/207 (53%), Gaps = 24/207 (11%)
Query: 389 LGEGGFGCVYKGV-LADGREVAVKQLKIG--GSQGE---REFRAEVEIISRVHHRHLVSL 442
LG G FG VY+G+ L DG AVK++ + G G+ ++ E+ ++S++ H ++V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 443 VGYCISERERLLVY-EYVPNDTLHYHLHAEGR---PVMDWATRVKVAAGAARGIAYLHED 498
+G E + L ++ E VP +L L G PV+ TR + G+ YLH+
Sbjct: 68 LGTEREE-DNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL-----GLEYLHDR 121
Query: 499 CHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEY-A 557
+HRDIK +NIL+D++ ++ADFG+AK +E + G+ +MAPE A
Sbjct: 122 ---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF----AKSFKGSPYWMAPEVIA 174
Query: 558 TSGKLTEKSDVYSFGVVLLELITGRKP 584
G +D++S G +LE+ TG+ P
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 9e-25
Identities = 72/246 (29%), Positives = 117/246 (47%), Gaps = 16/246 (6%)
Query: 387 NVLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGER-EFRAEVEIISRVHHRHLVSLVG 444
LG G G V K + G+ +AVK +++ ++ + + E++I+ + + ++V G
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 445 YCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRII 504
+ + + EY+ +L L E + + K+A +G+ YLHE II
Sbjct: 67 AFYNNGDISICMEYMDGGSLDKIL-KEVQGRIPERILGKIAVAVLKGLTYLHEKHK--II 123
Query: 505 HRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTE 564
HRD+K SNIL++S + ++ DFG++ + + T V GT YMAPE +
Sbjct: 124 HRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV-----GTSSYMAPERIQGNDYSV 178
Query: 565 KSDVYSFGVVLLELITGRKPVDASQ--PLGDESL----VEWARPLLAEALEHEDFEALVD 618
KSD++S G+ L+EL TGR P P G L V P L DF+ V+
Sbjct: 179 KSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVN 238
Query: 619 SRLEKN 624
L K+
Sbjct: 239 LCLIKD 244
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-24
Identities = 80/301 (26%), Positives = 111/301 (36%), Gaps = 29/301 (9%)
Query: 1 PPPQSSPPA-VLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPP-PSS 58
P P+ +P A V A P P P + ++ P +P P + P P T P+ P PP +
Sbjct: 2706 PTPEPAPHALVSATPLPPGPAAARQASPALPAAPAPPAVPAGPATPGGPARPARPPTTAG 2765
Query: 59 PAVNSPPPQPSSPPPPLDAPPP----PEVDPSPPSPAQPPPQAVAPSPPPPANVPT-TPS 113
P +PP P++ PP P E S PSP P A P A P +P+
Sbjct: 2766 PPAPAPPAAPAAGPPRRLTRPAVASLSESRESLPSPWDPADPPAAVLAPAAALPPAASPA 2825
Query: 114 SSSPPP-ANVPTTPSSSSPPPANVRTT--------PSSSSPPPANVPATPSSSSPPPVN- 163
PPP + PT P PP PP + A P++ + PPV
Sbjct: 2826 GPLPPPTSAQPTAPPPPPGPPPPSLPLGGSVAPGGDVRRRPPSRSPAAKPAAPARPPVRR 2885
Query: 164 VPTPPSSSS------PPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPP 217
+ P S S PP PP PP P P P P PP P
Sbjct: 2886 LARPAVSRSTESFALPPDQPERPPQPQAPPPPQPQPQPPPPPQPQPPPPPPPRPQPPLAP 2945
Query: 218 PSVPSTSSPPAVSPPAPPSNSSTRGSPSTP------PLPSVPTEKPTAKSTNGTAVSANA 271
+ P+ + P+ + P P + G + P P PS + G ++S +
Sbjct: 2946 TTDPAGAGEPSGAVPQPWLGALVPGRVAVPRFRVPQPAPSREAPASSTPPLTGHSLSRVS 3005
Query: 272 S 272
S
Sbjct: 3006 S 3006
|
Length = 3151 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 73/208 (35%), Positives = 108/208 (51%), Gaps = 15/208 (7%)
Query: 383 FSAHNVLGEGGFG--CVYKGVLADGREVAVKQL---KIGGSQGEREFRAEVEIISRVHHR 437
F + VLG+GGFG C + V A G+ A K+L +I +GE E +I+ +V+ R
Sbjct: 2 FRHYRVLGKGGFGEVCACQ-VRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR 60
Query: 438 HLVSLVGYCISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLH 496
+VSL Y ++ L LV + L +H++ G P D V AA G+ LH
Sbjct: 61 FVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH 119
Query: 497 EDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEY 556
+ RI++RD+K NILLD R++D GL A+E+ + RV GT GYMAPE
Sbjct: 120 RE---RIVYRDLKPENILLDDYGHIRISDLGL---AVEIPEGETIRGRV-GTVGYMAPEV 172
Query: 557 ATSGKLTEKSDVYSFGVVLLELITGRKP 584
+ + T D + G ++ E+I G+ P
Sbjct: 173 VKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 4e-24
Identities = 75/200 (37%), Positives = 106/200 (53%), Gaps = 14/200 (7%)
Query: 389 LGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCIS 448
LG G FG V+ G +VAVK LK G+ F E +I+ ++ H LV L +S
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLK-PGTMSPESFLEEAQIMKKLRHDKLVQLYA-VVS 71
Query: 449 ERERLLVYEYVPNDTLHYHLH-AEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRD 507
E +V EY+ +L L EGR + V +AA A G+AY+ + IHRD
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKDGEGR-ALKLPNLVDMAAQVAAGMAYIERMNY---IHRD 127
Query: 508 IKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTF--GYMAPEYATSGKLTEK 565
++S+NIL+ ++ADFGLA+ L + + R F + APE A G+ T K
Sbjct: 128 LRSANILVGDGLVCKIADFGLAR----LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 566 SDVYSFGVVLLELIT-GRKP 584
SDV+SFG++L EL+T GR P
Sbjct: 184 SDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 62/199 (31%), Positives = 102/199 (51%), Gaps = 8/199 (4%)
Query: 389 LGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCIS 448
LG G FG V G +VA+K +K GS E EF E +++ ++ H LV L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 449 ERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDI 508
+R +V EY+ N L +L E + +++ G+AYL + IHRD+
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLR-EHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDL 126
Query: 509 KSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDV 568
+ N L+D +V+DFGL++ L+ + + V ++ + PE K + KSDV
Sbjct: 127 AARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKF--PVRWSPPEVLLYSKFSSKSDV 184
Query: 569 YSFGVVLLELIT-GRKPVD 586
++FGV++ E+ + G+ P +
Sbjct: 185 WAFGVLMWEVYSLGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 63/227 (27%), Positives = 97/227 (42%), Gaps = 35/227 (15%)
Query: 388 VLGEGGFGCVYKGVL-ADGREVAVKQLKIGGSQGERE------FRAEVEIISRV-HHRHL 439
++GEG F V +E A+K L Q +E E E+++R+ H +
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDK--RQLIKEKKVKYVKI-EKEVLTRLNGHPGI 64
Query: 440 VSLVGYCISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHED 498
+ L Y + E L V EY PN L ++ G AA + YLH
Sbjct: 65 IKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCT--RFYAAEILLALEYLHSK 121
Query: 499 CHPRIIHRDIKSSNILLDSSFEARVADFGLAKI-------------ALELDSNTHVSTR- 544
IIHRD+K NILLD ++ DFG AK+ A +DS + R
Sbjct: 122 ---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRR 178
Query: 545 ---VMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDAS 588
+GT Y++PE + SD+++ G ++ +++TG+ P S
Sbjct: 179 FASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGS 225
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 66/211 (31%), Positives = 104/211 (49%), Gaps = 25/211 (11%)
Query: 389 LGEGGFGCVYKGVLADGRE------VAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVS 441
LGEG FG VYKG L E VA+K LK + ++EFR E E++S + H ++V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 442 LVGYCISERERLLVYEYVPNDTLHYHL--------------HAEGRPVMDWATRVKVAAG 487
L+G C E+ +++EY+ + LH L + +D + + +A
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 488 AARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMG 547
A G+ YL +HRD+ + N L+ +++DFGL++ D S ++
Sbjct: 133 IAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL- 188
Query: 548 TFGYMAPEYATSGKLTEKSDVYSFGVVLLEL 578
+M PE GK T +SD++SFGVVL E+
Sbjct: 189 PVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 8e-24
Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 11/211 (5%)
Query: 384 SAHNVLGEGGFGCVYKGVLAD-GREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSL 442
+ + LG G +G VY+GV VAVK LK + E EF E ++ + H +LV L
Sbjct: 9 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQL 67
Query: 443 VGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPR 502
+G C E ++ E++ L +L R ++ + +A + + YL +
Sbjct: 68 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---N 124
Query: 503 IIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKL 562
IHRD+ + N L+ + +VADFGL+++ H + + APE K
Sbjct: 125 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKF 182
Query: 563 TEKSDVYSFGVVLLELIT-GRKP---VDASQ 589
+ KSDV++FGV+L E+ T G P +D SQ
Sbjct: 183 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 213
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 9e-24
Identities = 66/200 (33%), Positives = 105/200 (52%), Gaps = 14/200 (7%)
Query: 389 LGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCIS 448
LG G FG V+ G +VA+K LK GS F AE ++ ++ H LV L Y +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLK-QGSMSPEAFLAEANLMKQLQHPRLVRL--YAVV 70
Query: 449 ERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRD 507
+E + ++ EY+ N +L L + + +AA A G+A++ + IHRD
Sbjct: 71 TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY---IHRD 127
Query: 508 IKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTF--GYMAPEYATSGKLTEK 565
++++NIL+ + ++ADFGLA++ + + R F + APE G T K
Sbjct: 128 LRAANILVSETLCCKIADFGLARLI----EDNEYTAREGAKFPIKWTAPEAINYGTFTIK 183
Query: 566 SDVYSFGVVLLELIT-GRKP 584
SDV+SFG++L E++T GR P
Sbjct: 184 SDVWSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-23
Identities = 82/293 (27%), Positives = 104/293 (35%), Gaps = 28/293 (9%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
SSPP P + S PP PP P P S P PP P ++
Sbjct: 2673 AAQASSPPQRPRRRAARPTVGSLTSLADPPPPPPTPEPAPHALVSATPLPPG--PAAARQ 2730
Query: 61 VNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPA 120
+ P +PP P P P PA+PP A P+P PPA P PA
Sbjct: 2731 ASPALPAAPAPPAV---PAGPATPGGPARPARPPTTAGPPAPAPPAAPAAGPPRRLTRPA 2787
Query: 121 NVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSP-PPVNVPTPPSSSSPPPPSSN 179
+ S S P P ++ PA A P ++SP P+ PT ++PPPP
Sbjct: 2788 VASLSESRESLPSPWDPADPPAAVLAPA--AALPPAASPAGPLPPPTSAQPTAPPPPPGP 2845
Query: 180 PPTSTP-------------SPPVLTPPPHPSQSAPPPVTK------SPPASTLSPPPPSV 220
PP S P PP +P P+ A PPV + S + + PP
Sbjct: 2846 PPPSLPLGGSVAPGGDVRRRPPSRSPAAKPAAPARPPVRRLARPAVSRSTESFALPPDQP 2905
Query: 221 PSTSSPPAVSPPAPPSNSSTRGSPSTPPLPSVPTEKPTAKSTNGTAVSANASP 273
P A PP P P PP P P +P T A + S
Sbjct: 2906 ERPPQPQAPPPPQPQPQPPPPPQP-QPPPPPPPRPQPPLAPTTDPAGAGEPSG 2957
|
Length = 3151 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 72/208 (34%), Positives = 106/208 (50%), Gaps = 15/208 (7%)
Query: 383 FSAHNVLGEGGFG--CVYKGVLADGREVAVKQL---KIGGSQGEREFRAEVEIISRVHHR 437
F + VLG+GGFG C + V A G+ A K+L +I +GE E I+ +V+ R
Sbjct: 2 FRHYRVLGKGGFGEVCACQ-VRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSR 60
Query: 438 HLVSLVGYCISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLH 496
+VSL Y ++ L LV + L +H++ G P D + AA G+ L
Sbjct: 61 FVVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ 119
Query: 497 EDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEY 556
+ RI++RD+K NILLD R++D GL A+++ V RV GT GYMAPE
Sbjct: 120 RE---RIVYRDLKPENILLDDRGHIRISDLGL---AVQIPEGETVRGRV-GTVGYMAPEV 172
Query: 557 ATSGKLTEKSDVYSFGVVLLELITGRKP 584
+ K T D + G ++ E+I G+ P
Sbjct: 173 INNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 3e-23
Identities = 71/208 (34%), Positives = 108/208 (51%), Gaps = 15/208 (7%)
Query: 383 FSAHNVLGEGGFG--CVYKGVLADGREVAVKQL---KIGGSQGEREFRAEVEIISRVHHR 437
F + VLG+GGFG C + V A G+ A K+L +I +GE E +I+ +V+ R
Sbjct: 2 FRQYRVLGKGGFGEVCACQ-VRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSR 60
Query: 438 HLVSLVGYCISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLH 496
+VSL Y ++ L LV + L +H++ G + V AA G+ LH
Sbjct: 61 FVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH 119
Query: 497 EDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEY 556
++ RI++RD+K NILLD R++D GLA + + + RV GT GYMAPE
Sbjct: 120 QE---RIVYRDLKPENILLDDHGHIRISDLGLA---VHVPEGQTIKGRV-GTVGYMAPEV 172
Query: 557 ATSGKLTEKSDVYSFGVVLLELITGRKP 584
+ + T D ++ G +L E+I G+ P
Sbjct: 173 VKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 99.6 bits (249), Expect = 3e-23
Identities = 61/231 (26%), Positives = 104/231 (45%), Gaps = 50/231 (21%)
Query: 387 NVLGEGGFGCVYKGV--LADGREVAVKQLKIGG-SQGERE-FRAEVEIISRVHHRHLVSL 442
+G+G FG V K V +DG+ + K++ G ++ E++ +EV I+ + H ++V
Sbjct: 6 ETIGKGSFGTVRK-VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV-- 62
Query: 443 VGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIA---YLHED- 498
Y +R++ N TL+ VM++ +A + Y+ E+
Sbjct: 63 -RYY----DRIIDRS---NQTLYI--------VMEYCEGGDLAQLIQKCKKERKYIEEEF 106
Query: 499 --------------CH------PRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSN 538
CH ++HRD+K +NI LD++ ++ DFGLAKI L +
Sbjct: 107 IWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI---LGHD 163
Query: 539 THVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQ 589
+ + +GT YM+PE EKSD++S G ++ EL P A
Sbjct: 164 SSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN 214
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 5e-23
Identities = 58/198 (29%), Positives = 100/198 (50%), Gaps = 14/198 (7%)
Query: 389 LGEGGFGCVYKGVLADGREVAVKQLKIGGSQGERE-FRAEVEIISRVHHRHLVSLVGYCI 447
+G+G FG VYKGVL EVAVK + + F E EI+ + H ++V L+G C+
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 448 SERERLLVYEYVPNDTLHYHLHAEGR--PVMDWATRVKVAAGAARGIAYLHEDCHPRIIH 505
++ +V E VP +L L + V ++++ AA G+ YL IH
Sbjct: 63 QKQPIYIVMELVPGGSLLTFLRKKKNRLTVK---KLLQMSLDAAAGMEYLESKN---CIH 116
Query: 506 RDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTF--GYMAPEYATSGKLT 563
RD+ + N L+ + +++DFG+++ E + + + + + APE G+ T
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYT 173
Query: 564 EKSDVYSFGVVLLELITG 581
+SDV+S+G++L E +
Sbjct: 174 SESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 6e-23
Identities = 77/286 (26%), Positives = 123/286 (43%), Gaps = 49/286 (17%)
Query: 389 LGEGGFGCVYKG----VLADGREVAVKQLKIGGSQG-EREFRAEVEIISRVHHRHLVSLV 443
LG+G FG V +G VAVK LK +F E I+ + H +L+ L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 444 GYCISERERLLVYEYVPNDTLHYHLHAEGRP------VMDWATRVKVAAGAARGIAYLHE 497
G ++ ++V E P +L L + + D+A ++ A G+ YL
Sbjct: 63 GVVLTH-PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQI------ANGMRYLES 115
Query: 498 DCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVST---RVMGTFGYMAP 554
R IHRD+ + NILL S + ++ DFGL + AL + + +V +V F + AP
Sbjct: 116 K---RFIHRDLAARNILLASDDKVKIGDFGLMR-ALPQNEDHYVMEEHLKV--PFAWCAP 169
Query: 555 EYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDF 613
E + + SDV+ FGV L E+ T G +P WA ++ L+ D
Sbjct: 170 ESLRTRTFSHASDVWMFGVTLWEMFTYGEEP--------------WAGLSGSQILKKIDK 215
Query: 614 EALVDSRLEK-NYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRAL 658
E RLE+ +++ ++ C H+ RP + + L
Sbjct: 216 EG---ERLERPEACPQDIYNVML---QCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 9e-23
Identities = 64/204 (31%), Positives = 99/204 (48%), Gaps = 10/204 (4%)
Query: 387 NVLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGE-REFRAEVEIISRVHHRHLVSLVG 444
V+G G VY + L + +VA+K++ + Q E R EV+ +S+ +H ++V
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 445 YCISERERLLVYEYVPNDTLHYHL--HAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPR 502
+ E LV Y+ +L + + R +D A V +G+ YLH +
Sbjct: 67 SFVVGDELWLVMPYLSGGSL-LDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ-- 123
Query: 503 IIHRDIKSSNILLDSSFEARVADFGL-AKIALELDSNTHVSTRVMGTFGYMAPEYATSGK 561
IHRDIK+ NILL ++ADFG+ A +A D V +GT +MAPE
Sbjct: 124 -IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVH 182
Query: 562 -LTEKSDVYSFGVVLLELITGRKP 584
K+D++SFG+ +EL TG P
Sbjct: 183 GYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 1e-22
Identities = 71/203 (34%), Positives = 105/203 (51%), Gaps = 15/203 (7%)
Query: 387 NVLGEGGFGCVYKGVLADG----REVAVKQL-KIGGSQGEREFRAEVEIISRVHHRHLVS 441
V+G+G FGCVY G L D AVK L +I + +F E I+ H +++S
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 442 LVGYCI-SERERLLVYEYVPNDTLHYHLHAEGR--PVMDWATRVKVAAGAARGIAYLHED 498
L+G C+ SE L+V Y+ + L + +E V D + A+G+ YL
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDL---IGFGLQVAKGMEYLASK 117
Query: 499 CHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD-SNTHVSTRVMGTFGYMAPEYA 557
+ +HRD+ + N +LD SF +VADFGLA+ + + + H T +MA E
Sbjct: 118 ---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESL 174
Query: 558 TSGKLTEKSDVYSFGVVLLELIT 580
+ K T KSDV+SFGV+L EL+T
Sbjct: 175 QTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 1e-22
Identities = 62/198 (31%), Positives = 106/198 (53%), Gaps = 14/198 (7%)
Query: 388 VLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCI 447
++GEG FG V +G G++VAVK +K + + F E +++++HH++LV L+G I
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKNLVRLLG-VI 68
Query: 448 SERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRD 507
+V E + L L GR ++ ++ + A G+ YL +++HRD
Sbjct: 69 LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRD 125
Query: 508 IKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSD 567
+ + NIL+ A+V+DFGLA++ N+ + + + APE K + KSD
Sbjct: 126 LAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALKHKKFSSKSD 179
Query: 568 VYSFGVVLLELIT-GRKP 584
V+S+GV+L E+ + GR P
Sbjct: 180 VWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 1e-22
Identities = 78/289 (26%), Positives = 141/289 (48%), Gaps = 34/289 (11%)
Query: 381 NGFSAHNVLGEGGFGCVYKGVL-ADGRE---VAVKQLKIGGSQGER-EFRAEVEIISRVH 435
+ + V+G G FG V++G+L GR+ VA+K LK G ++ +R +F +E I+ +
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64
Query: 436 HRHLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYL 495
H +++ L G + +++ EY+ N L +L + V + G A G+ YL
Sbjct: 65 HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL-VGMLRGIAAGMKYL 123
Query: 496 HEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPE 555
+ + +HRD+ + NIL++S+ E +V+DFGL+++ + T+ ++ + APE
Sbjct: 124 SDMNY---VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPE 180
Query: 556 YATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFE 614
K T SDV+SFG+V+ E+++ G +P W + HE +
Sbjct: 181 AIAYRKFTSASDVWSFGIVMWEVMSFGERPY-------------W------DMSNHEVMK 221
Query: 615 ALVDSRLEKNYVD--SEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661
A+ D +D S ++ ++ C + +RPR +V LD L
Sbjct: 222 AINDGFRLPAPMDCPSAVYQLM---LQCWQQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 97.3 bits (243), Expect = 1e-22
Identities = 61/212 (28%), Positives = 99/212 (46%), Gaps = 38/212 (17%)
Query: 388 VLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYC 446
LGEG +G VYK + G+ VA+K + + E E+ I+ + ++V G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEII--KEISILKQCDSPYIVKYYGSY 67
Query: 447 ISERERLLVYEY-----------VPNDTLHYHLHAEGRPVMDWATRVKVAA---GAARGI 492
+ +V EY + N TL T ++AA +G+
Sbjct: 68 FKNTDLWIVMEYCGAGSVSDIMKITNKTL---------------TEEEIAAILYQTLKGL 112
Query: 493 AYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYM 552
YLH + + IHRDIK+ NILL+ +A++ADFG++ D+ +T V+GT +M
Sbjct: 113 EYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQL--TDTMAKRNT-VIGTPFWM 166
Query: 553 APEYATSGKLTEKSDVYSFGVVLLELITGRKP 584
APE K+D++S G+ +E+ G+ P
Sbjct: 167 APEVIQEIGYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-22
Identities = 76/304 (25%), Positives = 100/304 (32%), Gaps = 25/304 (8%)
Query: 2 PPQSSPPAVLAVPPPSP--------PLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTA 53
P +S PP A P P P +PP S P P P S P A
Sbjct: 2564 PDRSVPPPRPAPRPSEPAVTSRARRPDAPPQSARPRAPVDDRGDPRGPAPPSPLPPDTHA 2623
Query: 54 PPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTT-P 112
P P P+ + +P PPP PP D P P +A A+ P P
Sbjct: 2624 PDPPPPSPSPAANEPDPHPPPTVPPPERPRDDPAPGRVSRPRRARRLGRAAQASSPPQRP 2683
Query: 113 SSSSPPPANVPTTPSSSSPPPANV---RTTPSSSSPPPANVPATPSSSSPPPVNVPTPPS 169
+ P T + PPP S+ P PA +SP P PP+
Sbjct: 2684 RRRAARPTVGSLTSLADPPPPPPTPEPAPHALVSATPLPPGPAAARQASPALPAAPAPPA 2743
Query: 170 SSSPP--PPSSNPPTS--TPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSS 225
+ P P P T + P PP + PP P ++LS S+PS
Sbjct: 2744 VPAGPATPGGPARPARPPTTAGPPAPAPPAAPAAGPPRRLTRPAVASLSESRESLPSPWD 2803
Query: 226 PPAVSPPAPPSNSSTRGSPS-TPPLPSVPTEKPTAKSTNGTAVSANASPRNAGVLGTGGA 284
P ++ + S PLP + +PTA L GG+
Sbjct: 2804 PADPPAAVLAPAAALPPAASPAGPLPPPTSAQPTAPPP--------PPGPPPPSLPLGGS 2855
Query: 285 VAIG 288
VA G
Sbjct: 2856 VAPG 2859
|
Length = 3151 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-22
Identities = 86/316 (27%), Positives = 107/316 (33%), Gaps = 45/316 (14%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSP-------------PPSTTPPPTSPPPASPPPSPPTSTP 47
P P PA+L P P+ P PP PPA+PP +P S P
Sbjct: 2510 PAPSRLAPAILPDEPVGEPVHPRMLTWIRGLEELASDDAGDPPPPLPPAAPPAAPDRSVP 2569
Query: 48 PSPPTAPPPSSPAVNS------PPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPS 101
P P AP PS PAV S PPQ + P P+D P P P+ PP AP
Sbjct: 2570 PPRP-APRPSEPAVTSRARRPDAPPQSARPRAPVDDRGDP---RGPAPPSPLPPDTHAPD 2625
Query: 102 PPPPANVP--TTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSP 159
PPPP+ P P PP P P P R + A + P
Sbjct: 2626 PPPPSPSPAANEPDPHPPPTVPPPERPRDDPAPGRVSRPRRARRLGRAAQASSPPQRPRR 2685
Query: 160 PPVNVPTPP--SSSSPPPPSSNPPTSTPSPPVLTP---------------PPHPSQSAPP 202
S + PPPP PPT P+P L P P+ APP
Sbjct: 2686 RAARPTVGSLTSLADPPPP---PPTPEPAPHALVSATPLPPGPAAARQASPALPAAPAPP 2742
Query: 203 PVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTPPLPSVPTEKPTAKST 262
V P P P+T+ PPA +PPA P+ R + +
Sbjct: 2743 AVPAGPATPGGPARPARPPTTAGPPAPAPPAAPAAGPPRRLTRPAVASLSESRESLPSPW 2802
Query: 263 NGTAVSANASPRNAGV 278
+ A A +
Sbjct: 2803 DPADPPAAVLAPAAAL 2818
|
Length = 3151 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-22
Identities = 74/278 (26%), Positives = 96/278 (34%), Gaps = 14/278 (5%)
Query: 7 PPAVLAVPPPSPPLSPPPSTTPPPTSPPP----ASPPPSPPTSTPPSPPTAPPPSSPAVN 62
PP A PP +P S PP P S P A P +PP S P P
Sbjct: 2553 PPLPPAAPPAAPDRSVPPPRPAPRPSEPAVTSRARRPDAPPQSARPRAPVDDRGDPRGPA 2612
Query: 63 SPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANV 122
P P P P D PPPP P+ P PP P P P + P S P A
Sbjct: 2613 PPSPLPPDTHAP-D-PPPPSPSPAANEPDPHPPPT-VPPPERPRDDPAPGRVSRPRRARR 2669
Query: 123 PTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPT 182
+ +S PP R + + A P P P P S++P PP
Sbjct: 2670 LGRAAQASSPPQRPRRRAARPTVGSLTSLADPPPPPPTPEPAPHALVSATPLPPGPAAAR 2729
Query: 183 STPSPPVLTPPPHPSQSAP-------PPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPP 235
P P + P P A +P PP+ P+ P ++ PA
Sbjct: 2730 QASPALPAAPAPPAVPAGPATPGGPARPARPPTTAGPPAPAPPAAPAAGPPRRLTRPAVA 2789
Query: 236 SNSSTRGSPSTPPLPSVPTEKPTAKSTNGTAVSANASP 273
S S +R S +P P+ P A + ++ A P
Sbjct: 2790 SLSESRESLPSPWDPADPPAAVLAPAAALPPAASPAGP 2827
|
Length = 3151 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 2e-22
Identities = 65/216 (30%), Positives = 102/216 (47%), Gaps = 24/216 (11%)
Query: 389 LGEGGFGCVYKGVLA------DGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSL 442
LGEG FG V+ D VAVK LK ++F+ E E+++ + H+H+V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 443 VGYCISERERLLVYEYVPNDTLHYHLHAEGRPV-------------MDWATRVKVAAGAA 489
G C R L+V+EY+ + L+ L + G + + +A+ A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 490 RGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTF 549
G+ YL H +HRD+ + N L+ ++ DFG+++ D V R M
Sbjct: 133 SGMVYL-ASLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY-YRVGGRTMLPI 188
Query: 550 GYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKP 584
+M PE K T +SD++SFGVVL E+ T G++P
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 72/243 (29%), Positives = 115/243 (47%), Gaps = 44/243 (18%)
Query: 389 LGEGGFGCVY----------------KGVLADG-REVAVKQLKIGGSQGER-EFRAEVEI 430
LGEG FG V+ + AD VAVK L+ S R +F EV+I
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 431 ISRVHHRHLVSLVGYCISERERLLVYEYVPNDTLHYHLH---------AEGRPVMDWATR 481
+SR+ ++ L+G C + ++ EY+ N L+ L A + ++T
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132
Query: 482 VKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTH- 540
+ +A A G+ YL +HRD+ + N L+ ++ ++ADFG+++ L S+ +
Sbjct: 133 LYMATQIASGMRYLES---LNFVHRDLATRNCLVGKNYTIKIADFGMSR---NLYSSDYY 186
Query: 541 -VSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQP---LGDES 595
V R +MA E GK T KSDV++FGV L E++T R+ QP L D+
Sbjct: 187 RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCRE-----QPYEHLTDQQ 241
Query: 596 LVE 598
++E
Sbjct: 242 VIE 244
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-22
Identities = 77/312 (24%), Positives = 102/312 (32%), Gaps = 28/312 (8%)
Query: 1 PPPQSSPPAVLAVPPP---SPPLSPPPSTTPPPTSPPPASPPPSPPTST---PPSPPTAP 54
P PA V P +++PP A+ P ++ PP PP P
Sbjct: 2649 PERPRDDPAPGRVSRPRRARRLGRAAQASSPPQRPRRRAARPTVGSLTSLADPPPPPPTP 2708
Query: 55 PPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSS 114
P+ A+ S P P P A P P+PP+ P P+ P P +
Sbjct: 2709 EPAPHALVSATPLPPGPAAARQASPALPAAPAPPAVPAGPATPGGPARPARPPTTAGPPA 2768
Query: 115 SSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPP---VNVPTPPSSS 171
+PP A P PA + S S P PA P ++ P + P+
Sbjct: 2769 PAPP-AAPAAGPPRRLTRPAVASLSESRESLPSPWDPADPPAAVLAPAAALPPAASPAGP 2827
Query: 172 SPPPPSSNP----PTSTPSPPVLTP-------------PPHPSQSAPPPVTKSPPASTLS 214
PPP S+ P P P PP L PP S +A P PP L+
Sbjct: 2828 LPPPTSAQPTAPPPPPGPPPPSLPLGGSVAPGGDVRRRPPSRSPAAKPAAPARPPVRRLA 2887
Query: 215 PPPPSVPSTSSP-PAVSPPAPPSNSSTRGSPSTPPLPSVPTEKPTAKSTNGTAVSANASP 273
P S + S P P PP + P P P +P +
Sbjct: 2888 RPAVSRSTESFALPPDQPERPPQPQAPPPPQPQPQPPPPPQPQPPPPPPPRPQPPLAPTT 2947
Query: 274 RNAGVLGTGGAV 285
AG GAV
Sbjct: 2948 DPAGAGEPSGAV 2959
|
Length = 3151 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 4e-22
Identities = 75/300 (25%), Positives = 123/300 (41%), Gaps = 36/300 (12%)
Query: 381 NGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGE--REFRAEVEIISRVHHRH 438
+ LGEG G V K L + + + + ++ E+EI +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 439 LVSLVGYCISERERLL--VYEYVPNDTLHYHLHAEGRPVMDWATRV------KVAAGAAR 490
+V G + E + EY +L + + V R+ K+A +
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLD----SIYKKVKKRGGRIGEKVLGKIAESVLK 116
Query: 491 GIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFG 550
G++YLH +IIHRDIK SNILL + ++ DFG++ + + T GT
Sbjct: 117 GLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT-----GTSF 168
Query: 551 YMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPV--DASQPLGDESLVEW----ARPLL 604
YMAPE + SDV+S G+ LLE+ R P + PLG L+ + P L
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPEL 228
Query: 605 AEALEH-----EDFEALVDSRLEKNYVDSEMFW-MIEAAAACVRHSATKRPRMSQVVRAL 658
+ + E+F+ + LEK+ W M+E ++ K+ M++ V +
Sbjct: 229 KDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPW--IKAQMKKKVNMAKFVAQV 286
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 4e-22
Identities = 70/199 (35%), Positives = 104/199 (52%), Gaps = 12/199 (6%)
Query: 389 LGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCIS 448
LG+G FG V+ G VA+K LK G+ F E +++ ++ H LV L +S
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 71
Query: 449 ERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDI 508
E +V EY+ +L L E + V +AA A G+AY+ + +HRD+
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY---VHRDL 128
Query: 509 KSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTF--GYMAPEYATSGKLTEKS 566
+++NIL+ + +VADFGLA+ L + + R F + APE A G+ T KS
Sbjct: 129 RAANILVGENLVCKVADFGLAR----LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 567 DVYSFGVVLLELIT-GRKP 584
DV+SFG++L EL T GR P
Sbjct: 185 DVWSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 5e-22
Identities = 85/303 (28%), Positives = 139/303 (45%), Gaps = 51/303 (16%)
Query: 381 NGFSAHNVLGEGGFGCVYKG-VLADG--REVAVKQLKIGGSQGE-REFRAEVEIISRV-H 435
N +V+GEG FG V K + DG + A+K++K S+ + R+F E+E++ ++ H
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66
Query: 436 HRHLVSLVGYCISERERLLVYEYVPNDTLHYHLHA----EGRPVMDWATR---------- 481
H ++++L+G C L EY P+ L L E P A
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 482 VKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHV 541
+ AA ARG+ YL + + IHRD+ + NIL+ ++ A++ADFGL++ +V
Sbjct: 127 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYV 178
Query: 542 STRVMGTFG--YMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEW 599
+ MG +MA E T SDV+S+GV+L E+++ LG
Sbjct: 179 K-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS----------LGGTPYCGM 227
Query: 600 ARPLLAEALEHEDFEALVDSRLEKNY-VDSEMFWMIEAAAACVRHSATKRPRMSQVVRAL 658
L E L RLEK D E++ ++ C R +RP +Q++ +L
Sbjct: 228 TCAELYEKLP-------QGYRLEKPLNCDDEVYDLMR---QCWREKPYERPSFAQILVSL 277
Query: 659 DTL 661
+ +
Sbjct: 278 NRM 280
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 5e-22
Identities = 68/201 (33%), Positives = 96/201 (47%), Gaps = 14/201 (6%)
Query: 388 VLGEGGFGCV----YKGVLAD-GREVAVKQLKIG-GSQGEREFRAEVEIISRVHHRHLVS 441
VLGEG FG V Y G VAVK LK G Q ++ E+ I+ ++H ++V
Sbjct: 11 VLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVK 70
Query: 442 LVGYCISERER--LLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDC 499
G C + + L+ EYVP +L +L + ++ A + A G+AYLH
Sbjct: 71 YKGCCSEQGGKGLQLIMEYVPLGSLRDYL---PKHKLNLAQLLLFAQQICEGMAYLHSQ- 126
Query: 500 HPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATS 559
IHRD+ + N+LLD+ ++ DFGLAK E V + A E
Sbjct: 127 --HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKE 184
Query: 560 GKLTEKSDVYSFGVVLLELIT 580
K + SDV+SFGV L EL+T
Sbjct: 185 NKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 5e-22
Identities = 64/213 (30%), Positives = 99/213 (46%), Gaps = 24/213 (11%)
Query: 392 GGFGCVYKGVLA----DGREVAVKQLK----IGGSQGEREFRAEVEIISRVHHRHLVSLV 443
G +G V+ LA G A+K +K I +Q ++ E +I+S+ ++V L
Sbjct: 4 GAYGRVF---LAKKKSTGDIYAIKVIKKADMIRKNQVDQVL-TERDILSQAQSPYVVKLY 59
Query: 444 GYCISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPR 502
Y ++ L LV EY+P L L G +D A + YLH +
Sbjct: 60 -YSFQGKKNLYLVMEYLPGGDLASLLENVG--SLDEDVARIYIAEIVLALEYLHSN---G 113
Query: 503 IIHRDIKSSNILLDSSFEARVADFGLAKIALE-----LDSNTHVSTRVMGTFGYMAPEYA 557
IIHRD+K NIL+DS+ ++ DFGL+K+ L L+ + R++GT Y+APE
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173
Query: 558 TSGKLTEKSDVYSFGVVLLELITGRKPVDASQP 590
++ D +S G +L E + G P P
Sbjct: 174 LGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP 206
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 1e-21
Identities = 72/212 (33%), Positives = 113/212 (53%), Gaps = 23/212 (10%)
Query: 388 VLGEGGFGCVYKGVLADGRE-----VAVKQL-KIGGSQGEREFRAEVEIISRVHHRHLVS 441
VLG G FG VYKG+ E VA+K L + G + EF E I++ + H HLV
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 442 LVGYCISERERLLVYEYVPNDTLHYHLHAE-----GRPVMDWATRVKVAAGAARGIAYLH 496
L+G C+S +L V + +P+ L ++H + +++W ++ A+G+ YL
Sbjct: 74 LLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYLE 126
Query: 497 EDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEY 556
E R++HRD+ + N+L+ S ++ DFGLA++ LE D + + +MA E
Sbjct: 127 ER---RLVHRDLAARNVLVKSPNHVKITDFGLARL-LEGDEKEYNADGGKMPIKWMALEC 182
Query: 557 ATSGKLTEKSDVYSFGVVLLELIT-GRKPVDA 587
K T +SDV+S+GV + EL+T G KP D
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG 214
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 1e-21
Identities = 68/213 (31%), Positives = 107/213 (50%), Gaps = 15/213 (7%)
Query: 383 FSAHNVLGEGGFG--CVYKGVLADGREVAVKQL---KIGGSQGEREFRAEVEIISRVHHR 437
F + VLG+GGFG C + V A G+ A K+L +I +GE E +I+ +V+ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQ-VRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQ 60
Query: 438 HLVSLVGYCISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLH 496
+V+L Y ++ L LV + L +H++ G P + + AA G+ LH
Sbjct: 61 FVVNL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH 119
Query: 497 EDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEY 556
+ ++RD+K NILLD R++D GLA E +S + RV GT GYMAPE
Sbjct: 120 RE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES---IRGRV-GTVGYMAPEV 172
Query: 557 ATSGKLTEKSDVYSFGVVLLELITGRKPVDASQ 589
+ + T D + G ++ E+I G+ P +
Sbjct: 173 LNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 2e-21
Identities = 61/212 (28%), Positives = 108/212 (50%), Gaps = 22/212 (10%)
Query: 388 VLGEGGFGCVYKGVLA-DGREVAVKQLKI--GGSQGEREFRA-------EVEIISRVHHR 437
++G G FG VY G+ A G +AVKQ+++ + + R+ E+ ++ + H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 438 HLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHE 497
++V +G + + EYVP ++ L+ G + +G+ YLH
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYG--AFEETLVRNFVRQILKGLNYLHN 124
Query: 498 DCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDS-----NTHVSTRVMGTFGYM 552
IIHRDIK +NIL+D+ +++DFG++K LE +S N + + G+ +M
Sbjct: 125 R---GIIHRDIKGANILVDNKGGIKISDFGISK-KLEANSLSTKTNGARPS-LQGSVFWM 179
Query: 553 APEYATSGKLTEKSDVYSFGVVLLELITGRKP 584
APE T K+D++S G +++E++TG+ P
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 2e-21
Identities = 67/222 (30%), Positives = 102/222 (45%), Gaps = 27/222 (12%)
Query: 386 HNV-----LGEGGFGCVYKGVL------ADGREVAVKQLKIGGSQGEREFRAEVEIISRV 434
HN+ LGEG FG V+ D VAVK LK ++F E E+++ +
Sbjct: 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 64
Query: 435 HHRHLVSLVGYCISERERLLVYEYVP----NDTLHYH-----LHAEGRPVMDW--ATRVK 483
H H+V G C+ ++V+EY+ N L H L AEG + + +
Sbjct: 65 QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124
Query: 484 VAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVST 543
+A A G+ YL +HRD+ + N L+ + ++ DFG+++ D V
Sbjct: 125 IAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDY-YRVGG 180
Query: 544 RVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKP 584
M +M PE K T +SDV+S GVVL E+ T G++P
Sbjct: 181 HTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 3e-21
Identities = 61/209 (29%), Positives = 110/209 (52%), Gaps = 14/209 (6%)
Query: 388 VLGEGGFGCVYKGV-LADGREVAVKQLK-IGGSQGERE-----FRAEVEIISRVHHRHLV 440
LG G F Y+ + G +AVKQ+ + + E+E R E+ +++R++H H++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 441 SLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCH 500
++G + L E++ ++ + L G A + RG++YLHE+
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHEN-- 122
Query: 501 PRIIHRDIKSSNILLDSSFE-ARVADFGLA-KIALELDSNTHVSTRVMGTFGYMAPEYAT 558
+IIHRD+K +N+L+DS+ + R+ADFG A ++A + +++GT +MAPE
Sbjct: 123 -QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLR 181
Query: 559 SGKLTEKSDVYSFGVVLLELITGRKPVDA 587
+ DV+S G V++E+ T + P +A
Sbjct: 182 GEQYGRSCDVWSVGCVIIEMATAKPPWNA 210
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 4e-21
Identities = 63/203 (31%), Positives = 107/203 (52%), Gaps = 14/203 (6%)
Query: 389 LGEGGFGCVYKGVLADGR---EVAVKQLKIGGSQGER-EFRAEVEIISRVHHRHLVSLVG 444
LG G FGCV KGV + +VA+K LK + R E E EI+ ++ + ++V ++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 445 YCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRII 504
C +E +LV E L+ L + + + + V++ + G+ YL +
Sbjct: 63 VCEAE-ALMLVMEMASGGPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGK---NFV 117
Query: 505 HRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTF--GYMAPEYATSGKL 562
HRD+ + N+LL + A+++DFGL+K AL D + + R G + + APE K
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSK-ALGADDS-YYKARSAGKWPLKWYAPECINFRKF 175
Query: 563 TEKSDVYSFGVVLLELIT-GRKP 584
+ +SDV+S+G+ + E + G+KP
Sbjct: 176 SSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 4e-21
Identities = 72/239 (30%), Positives = 117/239 (48%), Gaps = 37/239 (15%)
Query: 389 LGEGGFG----CVYKGVLA---------DGRE--VAVKQLKIGGSQGER-EFRAEVEIIS 432
LGEG FG C +G+ DG+ VAVK L+ ++ R +F E++I+S
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 433 RVHHRHLVSLVGYCISERERLLVYEYVPNDTLHYHL----------HAEGRPVMDWATRV 482
R+ + +++ L+G C+S+ ++ EY+ N L+ L HA P + A +
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 483 KVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVS 542
+A A G+ YL +HRD+ + N L+ + + ++ADFG+++ D +
Sbjct: 133 YMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDY-YRIQ 188
Query: 543 TRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQP---LGDESLVE 598
R + +MA E GK T SDV++FGV L E+ T K QP L DE ++E
Sbjct: 189 GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCK----EQPYSLLSDEQVIE 243
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 4e-21
Identities = 92/304 (30%), Positives = 135/304 (44%), Gaps = 61/304 (20%)
Query: 389 LGEGGFGCVYKGVLADGRE-VAVKQLKIGGSQGEREFR---AEVEIISRVHHRHLVSLVG 444
+G G FG VY E VA+K++ G Q +++ EV + ++ H + + G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 445 YCISERERLLVYEYV---PNDTLHYHLHAEGRPVMDWATRVKVAA---GAARGIAYLHED 498
+ E LV EY +D L H +P+ + V++AA GA +G+AYLH
Sbjct: 83 CYLREHTAWLVMEYCLGSASDILEVH----KKPLQE----VEIAAICHGALQGLAYLHSH 134
Query: 499 CHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYAT 558
IHRDIK+ NILL ++ADFG A +L +N+ V GT +MAPE
Sbjct: 135 ER---IHRDIKAGNILLTEPGTVKLADFGSA--SLVSPANSFV-----GTPYWMAPEVIL 184
Query: 559 S---GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGD----ESLVEWAR---PLLAEAL 608
+ G+ K DV+S G+ +EL RKP PL + +L A+ P L+
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL-AERKP-----PLFNMNAMSALYHIAQNDSPTLSSND 238
Query: 609 EHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQV-----------VRA 657
+ F VDS L+K D ++ ++H R R V VR
Sbjct: 239 WSDYFRNFVDSCLQKIPQDR------PSSEELLKHRFVLRERPPTVIIDLIQRTKDAVRE 292
Query: 658 LDTL 661
LD L
Sbjct: 293 LDNL 296
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 5e-21
Identities = 63/199 (31%), Positives = 104/199 (52%), Gaps = 11/199 (5%)
Query: 389 LGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCIS 448
LG G FG V+ G + +VAVK LK G+ + F E ++ + H LV L
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 449 ERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDI 508
E ++ EY+ +L L ++ + + +A A G+AY+ + IHRD+
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNY---IHRDL 129
Query: 509 KSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTF--GYMAPEYATSGKLTEKS 566
+++N+L+ S ++ADFGLA++ ++ N + + R F + APE G T KS
Sbjct: 130 RAANVLVSESLMCKIADFGLARV---IEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKS 185
Query: 567 DVYSFGVVLLELIT-GRKP 584
DV+SFG++L E++T G+ P
Sbjct: 186 DVWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 93.8 bits (234), Expect = 5e-21
Identities = 68/221 (30%), Positives = 94/221 (42%), Gaps = 29/221 (13%)
Query: 383 FSAHNVLGEGGFGCV----YKGVLADGREVAVKQL---KIGGSQGEREFRAEVEIISRVH 435
F LG G FG V +KG G+ A+K L KI + E I+ +
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKG---SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR 59
Query: 436 HRHLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKV-AAGAARGIAY 494
H LV+L G + LV EYVP L HL GR A + AA + Y
Sbjct: 60 HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVA---RFYAAQVVLALEY 116
Query: 495 LHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVM---GTFGY 551
LH I++RD+K N+LLDS ++ DFG AK V R GT Y
Sbjct: 117 LH-SLD--IVYRDLKPENLLLDSDGYIKITDFGFAK---------RVKGRTYTLCGTPEY 164
Query: 552 MAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLG 592
+APE S + D ++ G+++ E++ G P P+
Sbjct: 165 LAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ 205
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 5e-21
Identities = 62/199 (31%), Positives = 103/199 (51%), Gaps = 14/199 (7%)
Query: 388 VLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCI 447
+G+G FG V G G +VAVK +K + + F AE +++++ H +LV L+G +
Sbjct: 13 TIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIV 69
Query: 448 SERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHR 506
E+ L +V EY+ +L +L + GR V+ +K + + YL + +HR
Sbjct: 70 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHR 126
Query: 507 DIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKS 566
D+ + N+L+ A+V+DFGL K A + + + APE K + KS
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKKFSTKS 180
Query: 567 DVYSFGVVLLELIT-GRKP 584
DV+SFG++L E+ + GR P
Sbjct: 181 DVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 6e-21
Identities = 60/213 (28%), Positives = 111/213 (52%), Gaps = 25/213 (11%)
Query: 388 VLGEGGFGCVYKGVLAD-GREVAVKQLKIGGSQGERE----------FRAEVEIISRVHH 436
++G+G +G VY + G +AVKQ+++ + R R+E+E + + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 437 RHLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGR---PVMDWATRVKVAAGAARGIA 493
++V +G+ +E + EYVP ++ L GR ++ + T + G+A
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL-----EGLA 122
Query: 494 YLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMA 553
YLH I+HRD+K+ N+L+D+ +++DFG++K + ++ N + + G+ +MA
Sbjct: 123 YLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQ-NMSMQGSVFWMA 178
Query: 554 PEYATSGK--LTEKSDVYSFGVVLLELITGRKP 584
PE S + K D++S G V+LE+ GR+P
Sbjct: 179 PEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 6e-21
Identities = 76/254 (29%), Positives = 121/254 (47%), Gaps = 31/254 (12%)
Query: 389 LGEGGFGCVYKGV-LADGREVAVKQLKIGG-SQGEREFRAEVEIISRVHHRHLVSLVGYC 446
LG G G V K + G +A K + IG S ++ E++I+ ++VS G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 447 ISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRV----KVAAGAARGIAYLHEDCHPR 502
++E + E++ +L ++ +G P+ V K+A G+ YL+ + H R
Sbjct: 73 LNENNICMCMEFMDCGSLD-RIYKKGGPI-----PVEILGKIAVAVVEGLTYLY-NVH-R 124
Query: 503 IIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKL 562
I+HRDIK SNIL++S + ++ DFG++ + ++T V GT YM+PE GK
Sbjct: 125 IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV-----GTSTYMSPERIQGGKY 179
Query: 563 TEKSDVYSFGVVLLELITGRKPVDASQPLGDESL------------VEWARPLLAEALEH 610
T KSDV+S G+ ++EL G+ P S D V+ P L +
Sbjct: 180 TVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFP 239
Query: 611 EDFEALVDSRLEKN 624
ED VD+ L K+
Sbjct: 240 EDLRDFVDACLLKD 253
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 6e-21
Identities = 61/202 (30%), Positives = 93/202 (46%), Gaps = 17/202 (8%)
Query: 388 VLGEGGFGCVYKG-VLADGREVAVKQLKIGGSQGEREFRA----EVEIISRVHHRHLVSL 442
V+GEG +G V K A G VA+K+ K S+ + + + EV+++ ++ H ++V+L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKE--SEDDEDVKKTALREVKVLRQLRHENIVNL 65
Query: 443 VGYCISERERLLVYEYVPNDTLHYHLHAEGRPV-MDWATRVKVAAGAARGIAYLHEDCHP 501
+ LV+EYV L E P + + IAY H
Sbjct: 66 KEAFRRKGRLYLVFEYVERTLLEL---LEASPGGLPPDAVRSYIWQLLQAIAYCHSH--- 119
Query: 502 RIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGK 561
IIHRDIK NIL+ S ++ DFG A+ AL + ++ V T Y APE
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFAR-ALRARPASPLTDYV-ATRWYRAPELLVGDT 177
Query: 562 LTEKS-DVYSFGVVLLELITGR 582
K DV++ G ++ EL+ G
Sbjct: 178 NYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 6e-21
Identities = 63/217 (29%), Positives = 100/217 (46%), Gaps = 25/217 (11%)
Query: 389 LGEGGFG------CVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSL 442
LGEG FG C D VAVK LK ++F+ E E+++ + H H+V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 443 VGYCISERERLLVYEYVPNDTLHYHLHAEGRPVM--------------DWATRVKVAAGA 488
G C ++V+EY+ + L+ L A G M + + +A+
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 489 ARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGT 548
A G+ YL +HRD+ + N L+ ++ ++ DFG+++ D V M
Sbjct: 133 ASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY-YRVGGHTMLP 188
Query: 549 FGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKP 584
+M PE K T +SDV+SFGV+L E+ T G++P
Sbjct: 189 IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.7 bits (231), Expect = 8e-21
Identities = 63/220 (28%), Positives = 100/220 (45%), Gaps = 43/220 (19%)
Query: 383 FSAHNVLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGEREFRA-EVEIISRVHHRHLV 440
F+ +G+G FG VYK + + VA+K + + ++ E E E++ +S+ ++
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 441 SLVGYCISERERL-LVYEYVPN----DTLHYHLHAEG------RPVMDWATRVKVAAGAA 489
G + +L ++ EY D L E R V+
Sbjct: 63 KYYG-SFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVL------------- 108
Query: 490 RGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDS-----NTHVSTR 544
G+ YLHE+ IHRDIK++NILL + ++ADFG ++ +L S NT V
Sbjct: 109 LGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFG---VSGQLTSTMSKRNTFV--- 159
Query: 545 VMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKP 584
GT +MAPE EK+D++S G+ +EL G P
Sbjct: 160 --GTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 1e-20
Identities = 65/223 (29%), Positives = 100/223 (44%), Gaps = 35/223 (15%)
Query: 388 VLGEGGFGCVYKGV------LADGREVAVKQLKIGGSQGE-REFRAEVEIISRVHHRHLV 440
LGEG FG V K A VAVK LK S E R+ +E ++ +V+H H++
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 441 SLVGYCISERERLLVYEYVPNDTLHYHLH----------------------AEGRPVMDW 478
L G C + LL+ EY +L L +
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 479 ATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSN 538
+ A +RG+ YL E +++HRD+ + N+L+ + +++DFGL++ E DS
Sbjct: 127 GDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183
Query: 539 THVST-RVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT 580
S R+ +MA E T +SDV+SFGV+L E++T
Sbjct: 184 VKRSKGRI--PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 61/208 (29%), Positives = 102/208 (49%), Gaps = 31/208 (14%)
Query: 389 LGEGGFGCVYK-GVLADGREVAVKQL---KIGGSQGEREFRAEVEIISRVHHRHLVSL-- 442
+GEG G V+K G VA+K++ ++ G + R E++ + H ++V L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALR-EIKALQACQHPYVVKLLD 66
Query: 443 ---VGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDC 499
G LV EY+P+D L L E RP+ + + +G+AY+H +
Sbjct: 67 VFPHGSGFV-----LVMEYMPSD-LSEVLRDEERPLPEAQVK-SYMRMLLKGVAYMHAN- 118
Query: 500 HPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSN--TH-VSTRVMGTFGYMAPE- 555
I+HRD+K +N+L+ + ++ADFGLA++ E + +H V+TR Y APE
Sbjct: 119 --GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATR-----WYRAPEL 171
Query: 556 -YATSGKLTEKSDVYSFGVVLLELITGR 582
Y + K D+++ G + EL+ G
Sbjct: 172 LYG-ARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 2e-20
Identities = 56/206 (27%), Positives = 104/206 (50%), Gaps = 13/206 (6%)
Query: 388 VLGEGGFGCVY--KGVLADGREVAVKQLKIGGSQGEREFRA--EVEIISRVHHRHLVSLV 443
V+G G FG V+ + AD + V +KQ+ + + A E +++ + H +++
Sbjct: 7 VVGRGAFGIVHLCRR-KADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYY 65
Query: 444 GYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRI 503
+ ++ ++V EY P TL ++ ++D T + + ++H I
Sbjct: 66 ENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LI 122
Query: 504 IHRDIKSSNILLDS-SFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKL 562
+HRD+K+ NILLD ++ DFG++KI L S + T V+GT Y++PE
Sbjct: 123 LHRDLKTQNILLDKHKMVVKIGDFGISKI---LSSKSKAYT-VVGTPCYISPELCEGKPY 178
Query: 563 TEKSDVYSFGVVLLELITGRKPVDAS 588
+KSD+++ G VL EL + ++ +A+
Sbjct: 179 NQKSDIWALGCVLYELASLKRAFEAA 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 4e-20
Identities = 68/214 (31%), Positives = 94/214 (43%), Gaps = 31/214 (14%)
Query: 389 LGEGGFGCVYK-GVLADGREVAVKQLK---IGGSQGEREFRAEVEIISRVHHRHLVSLVG 444
LG GGFG V V + R A+K +K I + + +E EI+ +H +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-- 58
Query: 445 YCISERERLLVY---EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHP 501
Y + +++ +Y EY L L G D T A YLH
Sbjct: 59 YR-TFKDKKYIYMLMEYCLGGELWTILRDRGL--FDEYTARFYIACVVLAFEYLHNR--- 112
Query: 502 RIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPE------ 555
II+RD+K N+LLDS+ ++ DFG AK L+ T T GT Y+APE
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAKK-LKSGQKTW--TFC-GTPEYVAPEIILNKG 168
Query: 556 YATSGKLTEKSDVYSFGVVLLELITGRKPVDASQ 589
Y S D +S G++L EL+TGR P
Sbjct: 169 YDFS------VDYWSLGILLYELLTGRPPFGEDD 196
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 4e-20
Identities = 70/199 (35%), Positives = 105/199 (52%), Gaps = 12/199 (6%)
Query: 389 LGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCIS 448
LG+G FG V+ G +VA+K LK G E F E +I+ ++ H LV L +S
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPE-AFLQEAQIMKKLRHDKLVPLYA-VVS 71
Query: 449 ERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDI 508
E +V E++ +L L + V +AA A G+AY+ + IHRD+
Sbjct: 72 EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNY---IHRDL 128
Query: 509 KSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTF--GYMAPEYATSGKLTEKS 566
+++NIL+ + ++ADFGLA+ L + + R F + APE A G+ T KS
Sbjct: 129 RAANILVGDNLVCKIADFGLAR----LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 567 DVYSFGVVLLELIT-GRKP 584
DV+SFG++L EL+T GR P
Sbjct: 185 DVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 7e-20
Identities = 86/306 (28%), Positives = 134/306 (43%), Gaps = 71/306 (23%)
Query: 389 LGEGGFGCVYKGVLADGRE---------VAVKQLKIGGSQGEREFR---AEVEIISRV-H 435
LGEG FG V V A+ VAVK LK E++ +E+E++ +
Sbjct: 20 LGEGAFGQV---VKAEAVGLDNPNETSTVAVKMLK--DDATEKDLSDLVSEMEMMKMIGK 74
Query: 436 HRHLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATR-------------- 481
H+++++L+G C E +V EY + L L A RP ++A+
Sbjct: 75 HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRAR-RPPGEYASPDDPRPPEETLTQKD 133
Query: 482 -VKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD---- 536
V A ARG+ +L + IHRD+ + N+L+ ++ADFGLA+ +D
Sbjct: 134 LVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRK 190
Query: 537 -SNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDE 594
+N + + +MAPE T +SDV+SFGV+L E+ T G P P+ E
Sbjct: 191 TTNGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY-PGIPV--E 241
Query: 595 SLVEWARPLLAEALEHEDFEALVDSRLEK-NYVDSEMFWMIEAAAACVRHSATKRPRMSQ 653
L + LL E R+EK E++ ++ C ++RP Q
Sbjct: 242 ELFK----LLKEG-----------YRMEKPQNCTQELYHLM---RDCWHEVPSQRPTFKQ 283
Query: 654 VVRALD 659
+V LD
Sbjct: 284 LVEDLD 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 7e-20
Identities = 67/208 (32%), Positives = 114/208 (54%), Gaps = 18/208 (8%)
Query: 388 VLGEGGFGCVYKGVL-ADGRE---VAVKQLKIGGSQGER-EFRAEVEIISRVHHRHLVSL 442
V+G G FG V +G L G+ VA+K LK G ++ +R +F +E I+ + H +++ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 443 VGYCISERERLLVYEYVPNDTLHYHLHA-EGR-PVMDWATRVKVAAGAARGIAYLHEDCH 500
G R +++ E++ N L L +G+ V+ V + G A G+ YL E +
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL---VGMLRGIAAGMKYLSEMNY 127
Query: 501 PRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMG---TFGYMAPEYA 557
+HRD+ + NIL++S+ +V+DFGL++ LE D++ T +G + APE
Sbjct: 128 ---VHRDLAARNILVNSNLVCKVSDFGLSRF-LEDDTSDPTYTSSLGGKIPIRWTAPEAI 183
Query: 558 TSGKLTEKSDVYSFGVVLLELIT-GRKP 584
K T SDV+S+G+V+ E+++ G +P
Sbjct: 184 AYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 8e-20
Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 25/216 (11%)
Query: 388 VLGEGGFGCVYKGVLA--DGR--EVAVKQLKIGG-SQGE-REFRAEVEIISRVHHRHLVS 441
+LGEG FG V +G L+ DG +VAVK +K+ + E EF +E + H +++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 442 LVGYCISERER------LLVYEYVPNDTLHYHLHA---EGRPV-MDWATRVKVAAGAARG 491
L+G C +++ ++ + LH L G P + T +K A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 492 IAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD--SNTHVSTRVMGTF 549
+ YL IHRD+ + N +L VADFGL+K D ++ +
Sbjct: 126 MEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV--- 179
Query: 550 GYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKP 584
++A E T KSDV++FGV + E+ T G+ P
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 8e-20
Identities = 69/279 (24%), Positives = 109/279 (39%), Gaps = 24/279 (8%)
Query: 22 PPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPP 81
P T PPP A S T T AP + + PP PSSP PP PPP
Sbjct: 65 FEPPTGPPPGPGTEAPANESRSTPTWSLSTLAPASPAREGSPTPPGPSSPDPPPPTPPPA 124
Query: 82 EVDPSPPSPAQPPPQAVAPSPPPPANV-PTTPSSSSPPPANVPTTPSSSSPPPANVRTTP 140
PSP + V PPPA P +S + ++ ++ ++ P + T
Sbjct: 125 SPPPSPAPDLSEMLRPVGSPGPPPAASPPAAGASPAAVASDAASSRQAALPLSSPEETAR 184
Query: 141 SSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTP-------- 192
+ SSPP P+TP +++ P + P S+S P+ P S +
Sbjct: 185 APSSPPAEPPPSTPPAAASPRPPRRSSPISASASSPAPAPGRSAADDAGASSSDSSSSES 244
Query: 193 -------------PPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSS 239
P + P + ++ + S P S+SSP SP PS+
Sbjct: 245 SGCGWGPENECPLPRPAPITLPTRIWEASGWNGPSSRPGPASSSSSPRERSPSPSPSSPG 304
Query: 240 TRGSPSTPPLPSVPTEKPTAKSTNGTAVSANASPRNAGV 278
+ +PS+P + + + +S++ + S++ S R A V
Sbjct: 305 SGPAPSSP--RASSSSSSSRESSSSSTSSSSESSRGAAV 341
|
Length = 1352 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 19/206 (9%)
Query: 387 NVLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGY 445
+G G +G VYK +A G VA+K +K+ + E+ ++ H ++V+ G
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 446 CISERERLLVYEYVP----NDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHP 501
+ + +V EY D + + R +G+AYLHE
Sbjct: 69 YLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCR-----ETLKGLAYLHET--- 120
Query: 502 RIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYA---T 558
IHRDIK +NILL + ++ADFG ++ +L + +GT +MAPE A
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFG---VSAQLTATIAKRKSFIGTPYWMAPEVAAVER 177
Query: 559 SGKLTEKSDVYSFGVVLLELITGRKP 584
G K D+++ G+ +EL + P
Sbjct: 178 KGGYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 77/275 (28%), Positives = 113/275 (41%), Gaps = 50/275 (18%)
Query: 388 VLGEGGFGCVYKGVLADGREV-AVKQLK---------IGGSQGEREFRAEVEIISRVHHR 437
VLG+G FG V L E+ AVK LK + + E+ A H
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-----KHP 56
Query: 438 HLVSLVGYCISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLH 496
L L C ++RL V EYV L +H+ GR D AA G+ +LH
Sbjct: 57 FLTQLHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGR--FDEPRARFYAAEIVLGLQFLH 113
Query: 497 EDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEY 556
E II+RD+K N+LLDS ++ADFG+ K + L T ++ GT Y+APE
Sbjct: 114 ER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGI-LGGVT--TSTFCGTPDYIAPEI 167
Query: 557 ATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEAL 616
+ D ++ GV+L E++ G+ P + +D + L
Sbjct: 168 LSYQPYGPAVDWWALGVLLYEMLAGQSPFEG-----------------------DDEDEL 204
Query: 617 VDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRM 651
S LE W+ + A + ++ TK P
Sbjct: 205 FQSILEDEVRYPR--WLSKEAKSILKSFLTKNPEK 237
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 2e-19
Identities = 64/202 (31%), Positives = 97/202 (48%), Gaps = 12/202 (5%)
Query: 389 LGEGGFGCVYKGVL-ADGREVAVKQL---KIGGSQGEREFRAEVEIISRVHHRHLVSLVG 444
LG+GGFG V + A G+ A K+L ++ +G E I+++VH R +VSL
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 445 YCISERERLLVYEYVPNDTLHYHLHA--EGRPVMDWATRVKVAAGAARGIAYLHEDCHPR 502
++ + LV + L YH++ E P A G+ +LH+ R
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---R 117
Query: 503 IIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKL 562
II+RD+K N+LLD+ R++D GL A+EL + GT G+MAPE +
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGL---AVELKDGQSKTKGYAGTPGFMAPELLQGEEY 174
Query: 563 TEKSDVYSFGVVLLELITGRKP 584
D ++ GV L E+I R P
Sbjct: 175 DFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 2e-19
Identities = 61/207 (29%), Positives = 106/207 (51%), Gaps = 33/207 (15%)
Query: 389 LGEGGFGCVYKGVLA----DGREVAVKQLKIGG-SQGER-EFRAEVEIISRVHHRHLVSL 442
+GEG FG K +L DG++ +K++ I S ER E R EV ++S + H ++V
Sbjct: 8 IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ- 63
Query: 443 VGYCISERER---LLVYEYVPNDTLHYHLHAEG------RPVMDWATRVKVAAGAARGIA 493
Y S E +V +Y L+ ++A+ ++DW ++ +A +
Sbjct: 64 --YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA------LK 115
Query: 494 YLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMA 553
++H+ +I+HRDIKS NI L ++ DFG+A++ L+S ++ +GT Y++
Sbjct: 116 HVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARV---LNSTVELARTCIGTPYYLS 169
Query: 554 PEYATSGKLTEKSDVYSFGVVLLELIT 580
PE + KSD+++ G VL E+ T
Sbjct: 170 PEICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 70/215 (32%), Positives = 100/215 (46%), Gaps = 22/215 (10%)
Query: 387 NVLGEGGFGCVYKGVLADGR------EVAVKQL-KIGGSQGEREFRAEVEIISRVHHRHL 439
LG G FG VY+G+ +VAVK L + Q E +F E I+S+ +H+++
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 440 VSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATR------VKVAAGAARGIA 493
V L+G R ++ E + L L E RP + + + A A+G
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLR-ENRPRPERPSSLTMKDLLFCARDVAKGCK 130
Query: 494 YLHEDCHPRIIHRDIKSSNILLDSSFEARVA---DFGLAKIALELDSNTHVSTRVMGTFG 550
YL E+ IHRDI + N LL RVA DFG+A+ + S R M
Sbjct: 131 YLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR-DIYRASYYRKGGRAMLPIK 186
Query: 551 YMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKP 584
+M PE G T K+DV+SFGV+L E+ + G P
Sbjct: 187 WMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP 221
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 3e-19
Identities = 66/281 (23%), Positives = 94/281 (33%), Gaps = 8/281 (2%)
Query: 2 PPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAV 61
P P + PP PP SPPPS P + P PP + P A P + +
Sbjct: 106 PTPPGPSSPDPPPPTPPPASPPPSPAPDLSEMLRPVGSPGPPPAASPPAAGASPAAVASD 165
Query: 62 NSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPP--- 118
+ Q + P + P P PP A +P PP ++ + +SS P
Sbjct: 166 AASSRQAALPLSSPEETARAPSSPPAEPPPSTPPAAASPRPPRRSSPISASASSPAPAPG 225
Query: 119 --PANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPP 176
A+ SS S + + P PA + + SS P P
Sbjct: 226 RSAADDAGASSSDSSSSESSGCGWGPENECPLPRPAPITLPTRIWEASGWNGPSSRPGPA 285
Query: 177 SSNPPTSTPSPPVLTPPPHPSQSAPPPVTK---SPPASTLSPPPPSVPSTSSPPAVSPPA 233
SS+ SP P + P S + S S +S AVSP
Sbjct: 286 SSSSSPRERSPSPSPSSPGSGPAPSSPRASSSSSSSRESSSSSTSSSSESSRGAAVSPGP 345
Query: 234 PPSNSSTRGSPSTPPLPSVPTEKPTAKSTNGTAVSANASPR 274
PS S + P P PS P ++P + ++ P
Sbjct: 346 SPSRSPSPSRPPPPADPSSPRKRPRPSRAPSSPAASAGRPT 386
|
Length = 1352 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 4e-19
Identities = 81/306 (26%), Positives = 101/306 (33%), Gaps = 24/306 (7%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSP------PTAP 54
P P AVLA PP + P PPPTS P +PPP P P P P
Sbjct: 2802 WDPADPPAAVLAPAAALPPAASPAGPLPPPTSAQPTAPPPPPGPPPPSLPLGGSVAPGGD 2861
Query: 55 PPSSPAVNSPPPQPSSPP-PPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPS 113
P SP +P++P PP+ P V S S A PP Q P P P
Sbjct: 2862 VRRRPPSRSPAAKPAAPARPPVRRLARPAVSRSTESFALPPDQPERPPQPQAPPPPQPQP 2921
Query: 114 SSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSP 173
PPP P P P P TT + + P+ P + P V P
Sbjct: 2922 QPPPPPQPQPPPPPPPRPQPPLAPTTDPAGAGEPSGAVPQPWLGALVPGRVAVPRFRVPQ 2981
Query: 174 PPPSSNPPTSTPSPPVLTPPPHPS----------QSAPPPVT-----KSPPASTLSPPPP 218
P PS P S+ P S ++ PPPV+ P + S
Sbjct: 2982 PAPSREAPASSTPPLTGHSLSRVSSWASSLALHEETDPPPVSLKQTLWPPDDTEDSDADS 3041
Query: 219 SVPSTSSPPAVSP--PAPPSNSSTRGSPSTPPLPSVPTEKPTAKSTNGTAVSANASPRNA 276
S S + P PP P P + + +SANA+
Sbjct: 3042 LFDSDSERSDLEALDPLPPEPHDPFAHEPDPATPEAGARESPSSQFGPPPLSANAALSRR 3101
Query: 277 GVLGTG 282
V TG
Sbjct: 3102 YVRSTG 3107
|
Length = 3151 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 4e-19
Identities = 68/212 (32%), Positives = 99/212 (46%), Gaps = 32/212 (15%)
Query: 388 VLGEGGFGCVYKGVLADGREV----AVKQLKIGGSQGEREFRAEVE----------IISR 433
VLG G FG K +LA+ ++ A+K LK +G+ R EVE +
Sbjct: 6 VLGRGHFG---KVLLAEYKKTGELYAIKALK----KGDIIARDEVESLMCEKRIFETANS 58
Query: 434 VHHRHLVSLVGYCISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGI 492
H LV+L C + + V EY L H+H + V V AA G+
Sbjct: 59 ERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTD---VFSEPRAVFYAACVVLGL 114
Query: 493 AYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYM 552
YLHE+ +I++RD+K N+LLD+ ++ADFGL K + T ST GT ++
Sbjct: 115 QYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT--ST-FCGTPEFL 168
Query: 553 APEYATSGKLTEKSDVYSFGVVLLELITGRKP 584
APE T T D + GV++ E++ G P
Sbjct: 169 APEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 5e-19
Identities = 72/235 (30%), Positives = 112/235 (47%), Gaps = 19/235 (8%)
Query: 389 LGEGGFG--CVYKGVLADGREVAVKQL---KIGGSQGEREFRAEVEIISRVHHRHLVSLV 443
LG+GGFG C + V G+ A K+L ++ GE+ E EI+ +V+ +V+L
Sbjct: 1 LGKGGFGEVCAVQ-VKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL- 58
Query: 444 GYCISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPR 502
Y + L LV + L YH++ G ++ + +A GI +LH
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MD 115
Query: 503 IIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKL 562
I++RD+K N+LLD R++D GL A+EL ++ R GT GYMAPE
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGL---AVELKDGKTITQRA-GTNGYMAPEILKEEPY 171
Query: 563 TEKSDVYSFGVVLLELITGRKPV-DASQPLGDESLVEWARPLLAEA-LEHEDFEA 615
+ D ++ G + E++ GR P D + + E L R L E EH++F
Sbjct: 172 SYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKR--RTLEDEVKFEHQNFTE 224
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 5e-19
Identities = 61/203 (30%), Positives = 105/203 (51%), Gaps = 13/203 (6%)
Query: 388 VLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYC 446
VLG+G +G VY L+ +A+K++ S+ + E+ + S + HR++V +G
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLG-S 73
Query: 447 ISERERLLVY-EYVPNDTLHYHLHAEGRPVMD-WATRVKVAAGAARGIAYLHEDCHPRII 504
SE ++ E VP +L L ++ P+ D T + G+ YLH++ +I+
Sbjct: 74 DSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIV 130
Query: 505 HRDIKSSNILLDS-SFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGK-- 561
HRDIK N+L+++ S +++DFG +K ++ T T GT YMAPE G
Sbjct: 131 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT---GTLQYMAPEVIDKGPRG 187
Query: 562 LTEKSDVYSFGVVLLELITGRKP 584
+D++S G ++E+ TG+ P
Sbjct: 188 YGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 5e-19
Identities = 67/203 (33%), Positives = 101/203 (49%), Gaps = 13/203 (6%)
Query: 388 VLGEGGFGCVYKGVLADGR----EVAVKQLKIGGSQGERE-FRAEVEIISRVHHRHLVSL 442
+GEG FG VY+GV VAVK K S RE F E I+ + H H+V L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 443 VGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPR 502
+G +E +V E P L +L + +D A+ + + + +AYL R
Sbjct: 73 IGVI-TENPVWIVMELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLESK---R 127
Query: 503 IIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKL 562
+HRDI + N+L+ S ++ DFGL++ LE D + + +++ +MAPE +
Sbjct: 128 FVHRDIAARNVLVSSPDCVKLGDFGLSR-YLE-DESYYKASKGKLPIKWMAPESINFRRF 185
Query: 563 TEKSDVYSFGVVLLE-LITGRKP 584
T SDV+ FGV + E L+ G KP
Sbjct: 186 TSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 6e-19
Identities = 64/214 (29%), Positives = 112/214 (52%), Gaps = 23/214 (10%)
Query: 388 VLGEGGFGCVYKGVLA-DGRE----VAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVS 441
VLG G FG VYKG+ DG VA+K L+ S + +E E +++ V ++
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 442 LVGYCISERERLLVYEYVPNDTLHYHLHAE-----GRPVMDWATRVKVAAGAARGIAYLH 496
L+G C++ +L V + +P L ++ + +++W ++ A+G++YL
Sbjct: 74 LLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYLE 126
Query: 497 EDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEY 556
E R++HRD+ + N+L+ S ++ DFGLA++ L++D + + +MA E
Sbjct: 127 E---VRLVHRDLAARNVLVKSPNHVKITDFGLARL-LDIDETEYHADGGKVPIKWMALES 182
Query: 557 ATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQ 589
+ T +SDV+S+GV + EL+T G KP D
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP 216
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 7e-19
Identities = 91/300 (30%), Positives = 141/300 (47%), Gaps = 46/300 (15%)
Query: 389 LGEGGFGCVYKGVLADGRE-VAVKQLKIGGSQGEREFR---AEVEIISRVHHRHLVSLVG 444
+G G FG VY + E VAVK++ G Q +++ EV+ + ++ H + + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 445 YCISERERLLVYEYV---PNDTLHYHLHAEGRPVMDWATRVKVAA---GAARGIAYLHED 498
+ E LV EY +D L H +P+ + V++AA GA +G+AYLH
Sbjct: 89 CYLKEHTAWLVMEYCLGSASDLLEVH----KKPLQE----VEIAAITHGALQGLAYLHSH 140
Query: 499 CHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYAT 558
+IHRDIK+ NILL + ++ADFG A + +S +GT +MAPE
Sbjct: 141 N---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS-------FVGTPYWMAPEVIL 190
Query: 559 S---GKLTEKSDVYSFGVVLLELITGRKP----VDASQPLGDESLVEWARPLLAEALEHE 611
+ G+ K DV+S G+ +EL RKP ++A L + + P L +
Sbjct: 191 AMDEGQYDGKVDVWSLGITCIEL-AERKPPLFNMNAMSAL--YHIAQNDSPTLQSNEWTD 247
Query: 612 DFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRAL--DTLDGASDLTN 669
F VD L+K + E A+A +RH +R R ++V+ L T D +L N
Sbjct: 248 SFRGFVDYCLQK--IPQER----PASAELLRHDFVRRDRPARVLIDLIQRTKDAVRELDN 301
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 87.2 bits (217), Expect = 8e-19
Identities = 60/216 (27%), Positives = 104/216 (48%), Gaps = 42/216 (19%)
Query: 389 LGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGERE---FRA--EVEIISRVHHRHLVSL 442
LGEG + VYK GR VA+K++K+G + ++ F A E++++ + H +++ L
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 443 VGYCISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAA------RGIAYL 495
+ + + LV+E++ D L + D + + A + RG+ YL
Sbjct: 68 LD-VFGHKSNINLVFEFMETD-----LEK---VIKDKSIVLTPADIKSYMLMTLRGLEYL 118
Query: 496 HEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPE 555
H + I+HRD+K +N+L+ S ++ADFGLA+ N ++ +V+ T Y APE
Sbjct: 119 HSN---WILHRDLKPNNLLIASDGVLKLADFGLARSF--GSPNRKMTHQVV-TRWYRAPE 172
Query: 556 -------YATSGKLTEKSDVYSFGVVLLELITGRKP 584
Y D++S G + EL+ R P
Sbjct: 173 LLFGARHYGVG------VDMWSVGCIFAELLL-RVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 9e-19
Identities = 62/232 (26%), Positives = 107/232 (46%), Gaps = 21/232 (9%)
Query: 371 FTYDELIQATNGFSAHNVLGEGGFGCVYKGVLAD-GREVAVKQLKIGGSQGE-REFRAEV 428
FT ++L +G G FG V K + G +AVK+++ + E + ++
Sbjct: 1 FTAEDLKDL-------GEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDL 53
Query: 429 EIISRVHH-RHLVSLVGYCISERERLLVYEYVPN--DTLHYHLHAEGRPVMDWATRVKVA 485
+++ R ++V G E + + E + D + +++ + V+ K+A
Sbjct: 54 DVVMRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIA 113
Query: 486 AGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRV 545
+ + YL E+ IIHRD+K SNILLD + ++ DFG I+ +L ++ TR
Sbjct: 114 VATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFG---ISGQL-VDSIAKTRD 167
Query: 546 MGTFGYMAPEYATSGKLTE---KSDVYSFGVVLLELITGRKPVDASQPLGDE 594
G YMAPE +SDV+S G+ L E+ TG+ P + D+
Sbjct: 168 AGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQ 219
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-18
Identities = 64/207 (30%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 389 LGEGGFGCVY----KGVLADGRE--VAVKQLKIGGSQGER-EFRAEVEIISRVHHRHLVS 441
LG+G FG VY KGV+ D E VA+K + S ER EF E ++ + H+V
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 442 LVGYCISERERLLVYEYVPNDTLHYHLHA-----EGRPVMDWAT---RVKVAAGAARGIA 493
L+G + L++ E + L +L + E PV + +++A A G+A
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 494 YLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMA 553
YL+ + + +HRD+ + N ++ F ++ DFG+ + E D ++ +M+
Sbjct: 134 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL-PVRWMS 189
Query: 554 PEYATSGKLTEKSDVYSFGVVLLELIT 580
PE G T SDV+SFGVVL E+ T
Sbjct: 190 PESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-18
Identities = 61/193 (31%), Positives = 102/193 (52%), Gaps = 11/193 (5%)
Query: 388 VLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGER-EFRAEVEIISRVHHRHLVSLVGYC 446
+LG+G FG V+KG L D VAVK K Q + +F +E I+ + H ++V L+G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 447 ISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLH-EDCHPRIIH 505
+ +V E VP L + + + VK A AA G+AYL ++C IH
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKK-KDELKTKQLVKFALDAAAGMAYLESKNC----IH 116
Query: 506 RDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGT-FGYMAPEYATSGKLTE 564
RD+ + N L+ + +++DFG+++ + D + S+ + + APE G+ +
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR---QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSS 173
Query: 565 KSDVYSFGVVLLE 577
+SDV+S+G++L E
Sbjct: 174 ESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 87.6 bits (218), Expect = 1e-18
Identities = 59/218 (27%), Positives = 104/218 (47%), Gaps = 33/218 (15%)
Query: 383 FSAHNVLGEGGFGCVYKGV-LADGREVAVKQLKIGG-----SQGEREFRAEVEIISRVHH 436
+ +G G +G V V GR+VA+K KI +R R E++++ + H
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIK--KISNVFDDLIDAKRILR-EIKLLRHLRH 58
Query: 437 RHLVSLVGYCISE-----RERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVK-VAAGAAR 490
+++ L+ + +V E + D LH + + +P+ D ++ R
Sbjct: 59 ENIIGLLDILRPPSPEDFNDVYIVTELMETD-LHKVIKS-PQPLTD--DHIQYFLYQILR 114
Query: 491 GIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNT-----HVSTRV 545
G+ YLH + +IHRD+K SNIL++S+ + ++ DFGLA+ + +V TR
Sbjct: 115 GLKYLHS-AN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRW 171
Query: 546 MGTFGYMAPE-YATSGKLTEKSDVYSFGVVLLELITGR 582
Y APE +S + T+ D++S G + EL+T +
Sbjct: 172 -----YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 1e-18
Identities = 56/217 (25%), Positives = 96/217 (44%), Gaps = 40/217 (18%)
Query: 390 GEGGFGCVYKGVL---ADGREVAVKQLKIGGSQGE-------REFRAEVEIISRVHHRHL 439
G G +G VYK DG+E A+K+ K Q RE + ++ + H ++
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACRE----IALLRELKHENV 64
Query: 440 VSLVGYCISERERL--LVYEYVPNDTLH---YHLHAEGRPVMDWATRVKVAA-GAARGIA 493
VSLV + ++ L+++Y +D +H A+ + + VK G+
Sbjct: 65 VSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPP--SMVKSLLWQILNGVH 122
Query: 494 YLHEDCHPRIIHRDIKSSNILLDSSFEAR----VADFGLAKI-----ALELDSNTHVSTR 544
YLH + ++HRD+K +NIL+ R + D GLA++ D +
Sbjct: 123 YLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD-----P 174
Query: 545 VMGTFGYMAPEYATSGK-LTEKSDVYSFGVVLLELIT 580
V+ T Y APE + T+ D+++ G + EL+T
Sbjct: 175 VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 64/215 (29%), Positives = 111/215 (51%), Gaps = 30/215 (13%)
Query: 387 NVLGEGGFGCVYKGVLA-DGREV--AVKQLKIGGSQGE-REFRAEVEIISRV-HHRHLVS 441
+V+GEG FG V + ++ DG ++ A+K LK S+ + R+F E+E++ ++ HH ++++
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 442 LVGYCISERERLLVYEYVPNDTLHYHLHA----EGRP----------VMDWATRVKVAAG 487
L+G C + + EY P L L E P + ++ A+
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 488 AARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMG 547
A G+ YL E + IHRD+ + N+L+ + +++ADFGL++ +V + MG
Sbjct: 128 VATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR-----GEEVYVK-KTMG 178
Query: 548 TFG--YMAPEYATSGKLTEKSDVYSFGVVLLELIT 580
+MA E T KSDV+SFGV+L E+++
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 3e-18
Identities = 44/216 (20%), Positives = 62/216 (28%), Gaps = 1/216 (0%)
Query: 9 AVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQP 68
V AV P+P + P P S P P P+ P AP P+ A
Sbjct: 583 QVEAVVGPAPG-AAGGEGPPAPASSGPPEEAARPAAPAAPAAPAAPAPAGAAAAPAEASA 641
Query: 69 SSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSS 128
+ P P+ P + PA P P+ ++P
Sbjct: 642 APAPGVAAPEHHPKHVAVPDASDGGDGWPAKAGGAAPAAPPPAPAPAAPAAPAGAAPAQP 701
Query: 129 SSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPP 188
+ P A + A +S+ P + P P PP + P PP
Sbjct: 702 APAPAATPPAGQADDPAAQPPQAAQGASAPSPAADDPVPLPPEPDDPPDPAGAPAQPPPP 761
Query: 189 VLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTS 224
P +APPP S PS+
Sbjct: 762 PAPAPAAAPAAAPPPSPPSEEEEMAEDDAPSMDDED 797
|
Length = 824 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 3e-18
Identities = 62/223 (27%), Positives = 113/223 (50%), Gaps = 23/223 (10%)
Query: 388 VLGEGGFGCVYKGV-LADGRE----VAVKQLK-IGGSQGEREFRAEVEIISRVHHRHLVS 441
+LG G FG V+KG+ + +G VA+K ++ G Q +E + + + H ++V
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 442 LVGYCISERERLLVYEYVPNDTLHYHLHA-----EGRPVMDWATRVKVAAGAARGIAYLH 496
L+G C +L V + P +L H+ + + +++W ++ A+G+ YL
Sbjct: 74 LLGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI------AKGMYYLE 126
Query: 497 EDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEY 556
E ++HR++ + NILL S ++ADFG+A + L D + + +MA E
Sbjct: 127 EHR---MVHRNLAARNILLKSDSIVQIADFGVADL-LYPDDKKYFYSEHKTPIKWMALES 182
Query: 557 ATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVE 598
G+ T +SDV+S+GV + E+++ G +P +P L+E
Sbjct: 183 ILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE 225
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 3e-18
Identities = 66/205 (32%), Positives = 105/205 (51%), Gaps = 25/205 (12%)
Query: 389 LGEGGFGCVYKGV-LADGREVAVKQLKIGGSQG--EREFRAEVEIISRVHHRHLVSLVGY 445
LGEG + VYKG G VA+K++ + +G R E+ ++ + H ++V L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR-EISLMKELKHENIVRLHDV 66
Query: 446 CISERERLLVYEYVPNDTLHY-HLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRII 504
+E + +LV+EY+ D Y H +D T +GIA+ HE+ R++
Sbjct: 67 IHTENKLMLVFEYMDKDLKKYMDTHGVRGA-LDPNTVKSFTYQLLKGIAFCHEN---RVL 122
Query: 505 HRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPE-------YA 557
HRD+K N+L++ E ++ADFGLA+ A + NT + V T Y AP+ Y+
Sbjct: 123 HRDLKPQNLLINKRGELKLADFGLAR-AFGIPVNTFSNEVV--TLWYRAPDVLLGSRTYS 179
Query: 558 TSGKLTEKSDVYSFGVVLLELITGR 582
TS D++S G ++ E+ITGR
Sbjct: 180 TS------IDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 3e-18
Identities = 67/205 (32%), Positives = 112/205 (54%), Gaps = 14/205 (6%)
Query: 388 VLGEGGFGCVYKGVLA--DGRE--VAVKQLKIGGSQGER-EFRAEVEIISRVHHRHLVSL 442
V+G G FG V G L RE VA+K LK G ++ +R +F +E I+ + H +++ L
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 443 VGYCISERERLLVYEYVPNDTLHYHLHA-EGRPVMDWATRVKVAAGAARGIAYLHEDCHP 501
G + ++V EY+ N +L L +G+ + V + G A G+ YL + +
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTV--IQLVGMLRGIASGMKYLSDMGY- 127
Query: 502 RIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGT-FGYMAPEYATSG 560
+HRD+ + NIL++S+ +V+DFGL+++ LE D +TR + APE
Sbjct: 128 --VHRDLAARNILVNSNLVCKVSDFGLSRV-LEDDPEAAYTTRGGKIPIRWTAPEAIAYR 184
Query: 561 KLTEKSDVYSFGVVLLELIT-GRKP 584
K T SDV+S+G+V+ E+++ G +P
Sbjct: 185 KFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 4e-18
Identities = 49/212 (23%), Positives = 74/212 (34%), Gaps = 8/212 (3%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPP-TSTPPSPPTAPPPSSP 59
P P ++ P P+ P + P + P A P+P + P+ +A P
Sbjct: 590 PAPGAAGGE--GPPAPASSGPPEEAARPAAPAAPAAPAAPAPAGAAAAPAEASAAPAPGV 647
Query: 60 AVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPP 119
A P+ + P D +PA PPP +P PA P+ +P P
Sbjct: 648 AAPEHHPKHVAVPDASDGGDGWPAKAGGAAPAAPPPAPAPAAPAAPAGAA--PAQPAPAP 705
Query: 120 ANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSN 179
A P + P + +S+P PA P P P + PPPP+
Sbjct: 706 AATPPAGQADDPAAQPPQAAQGASAPSPAADDPVPLPPEPDDPPDPAGAPAQPPPPPAPA 765
Query: 180 PPTSTPSPPVLTPPPHPSQSAPPPVTKSPPAS 211
P + + P PP PS+ +P
Sbjct: 766 PAAAPAAAP---PPSPPSEEEEMAEDDAPSMD 794
|
Length = 824 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 4e-18
Identities = 54/215 (25%), Positives = 102/215 (47%), Gaps = 20/215 (9%)
Query: 380 TNGFSAHNVLGEGGFGCVYKGV-LADGREVAVKQLKI---GGSQGEREFRAEVEIISRVH 435
F +G+G F VYK + L DGR VA+K+++I ++ ++ E++++ ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 436 HRHLVSLVGYCISERERLLVYEYVPNDTLHY---HLHAEGRPVMD---WATRVKVAAGAA 489
H +++ + I E +V E L H + R + + W V++
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC---- 116
Query: 490 RGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTF 549
+ ++H RI+HRDIK +N+ + ++ ++ D GL + S T + ++GT
Sbjct: 117 SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRF---FSSKTTAAHSLVGTP 170
Query: 550 GYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKP 584
YM+PE KSD++S G +L E+ + P
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 5e-18
Identities = 59/198 (29%), Positives = 98/198 (49%), Gaps = 10/198 (5%)
Query: 389 LGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCIS 448
LG G FG V+ G +VA+K + G+ E +F E +++ ++ H LV L G C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 449 ERERLLVYEYVPNDTL-HYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRD 507
++ +V E++ N L +Y +G+ D + + G+ YL + IHRD
Sbjct: 71 QKPLYIVTEFMENGCLLNYLRQRQGKLSKD--MLLSMCQDVCEGMEYLERN---SFIHRD 125
Query: 508 IKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSD 567
+ + N L+ S+ +V+DFG+ + LD S+ + PE K + KSD
Sbjct: 126 LAARNCLVSSTGVVKVSDFGMTRYV--LDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSD 183
Query: 568 VYSFGVVLLELIT-GRKP 584
V+SFGV++ E+ T G+ P
Sbjct: 184 VWSFGVLMWEVFTEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 5e-18
Identities = 64/202 (31%), Positives = 104/202 (51%), Gaps = 16/202 (7%)
Query: 389 LGEGGFG----CVY--KGVLADGREVAVKQLKIG-GSQGEREFRAEVEIISRVHHRHLVS 441
LGEG FG C Y +G G +VAVK LK G + + E+EI+ ++H ++V
Sbjct: 12 LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 442 LVGYCISERER--LLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDC 499
G C + L+ E++P+ +L +L + ++ ++K A +G+ YL
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYL-PRNKNKINLKQQLKYAVQICKGMDYLGSR- 128
Query: 500 HPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTH-VSTRVMGTFGYMAPEYAT 558
+ +HRD+ + N+L++S + ++ DFGL K A+E D + V + + APE
Sbjct: 129 --QYVHRDLAARNVLVESEHQVKIGDFGLTK-AIETDKEYYTVKDDLDSPVFWYAPECLI 185
Query: 559 SGKLTEKSDVYSFGVVLLELIT 580
K SDV+SFGV L EL+T
Sbjct: 186 QSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 6e-18
Identities = 71/216 (32%), Positives = 106/216 (49%), Gaps = 34/216 (15%)
Query: 387 NVLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGE------REFRAEVEIISRVHHRHL 439
+GEG +G VYK L GR VA+K++++ S+ RE A ++ + H ++
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREI-ALLKQLESFEHPNI 63
Query: 440 VSLVGYC-ISERER----LLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAY 494
V L+ C +R LV+E+V D L +L +P + T + RG+ +
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHVDQD-LATYLSKCPKPGLPPETIKDLMRQLLRGVDF 122
Query: 495 LHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAP 554
LH H RI+HRD+K NIL+ S + ++ADFGLA+I S T V+ T Y AP
Sbjct: 123 LH--SH-RIVHRDLKPQNILVTSDGQVKIADFGLARIY----SFEMALTSVVVTLWYRAP 175
Query: 555 E------YATSGKLTEKSDVYSFGVVLLELITGRKP 584
E YAT D++S G + EL R+P
Sbjct: 176 EVLLQSSYATP------VDMWSVGCIFAELFR-RRP 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 6e-18
Identities = 63/203 (31%), Positives = 102/203 (50%), Gaps = 16/203 (7%)
Query: 388 VLGEGGFGCVYKGVLADG-------REVAVKQLKIGGSQGERE-FRAEVEIISRV-HHRH 438
LG G FG V + A G +VAVK LK ERE +E++I+S + +H +
Sbjct: 42 TLGAGAFGKVVEAT-AYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHEN 100
Query: 439 LVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYL-HE 497
+V+L+G C L++ EY L L + + + + A+G+A+L +
Sbjct: 101 IVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK 160
Query: 498 DCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYA 557
+C IHRD+ + N+LL ++ DFGLA+ + DSN V +MAPE
Sbjct: 161 NC----IHRDLAARNVLLTHGKIVKICDFGLARDIMN-DSNYVVKGNARLPVKWMAPESI 215
Query: 558 TSGKLTEKSDVYSFGVVLLELIT 580
+ T +SDV+S+G++L E+ +
Sbjct: 216 FNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 6e-18
Identities = 66/215 (30%), Positives = 112/215 (52%), Gaps = 30/215 (13%)
Query: 387 NVLGEGGFGCVYKGVLA-DGREV--AVKQLKIGGSQGE-REFRAEVEIISRV-HHRHLVS 441
+V+GEG FG V K + DG + A+K++K S+ + R+F E+E++ ++ HH ++++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 442 LVGYCISERERLLVYEYVPNDTLHYHLHA----EGRPVM--------DWATR--VKVAAG 487
L+G C L EY P+ L L E P +++ + AA
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 488 AARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMG 547
ARG+ YL + + IHRD+ + NIL+ ++ A++ADFGL++ +V + MG
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVK-KTMG 171
Query: 548 TFG--YMAPEYATSGKLTEKSDVYSFGVVLLELIT 580
+MA E T SDV+S+GV+L E+++
Sbjct: 172 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 7e-18
Identities = 65/216 (30%), Positives = 114/216 (52%), Gaps = 23/216 (10%)
Query: 383 FSAHNVLGEGGFGCVYKGV-LADGRE----VAVKQLKIGGS-QGEREFRAEVEIISRVHH 436
F VLG G FG VYKG+ + +G + VA+K+L+ S + +E E +++ V +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 437 RHLVSLVGYCISERERLLVYEYVPNDTL--HYHLHAE---GRPVMDWATRVKVAAGAARG 491
H+ L+G C++ +L + + +P L + H + + +++W ++ A+G
Sbjct: 69 PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 121
Query: 492 IAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGY 551
+ YL E R++HRD+ + N+L+ + ++ DFGLAK+ L D + + +
Sbjct: 122 MNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKL-LGADEKEYHAEGGKVPIKW 177
Query: 552 MAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVD 586
MA E T +SDV+S+GV + EL+T G KP D
Sbjct: 178 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 8e-18
Identities = 67/207 (32%), Positives = 110/207 (53%), Gaps = 17/207 (8%)
Query: 388 VLGEGGFGCVYKGVLAD-GREVAVKQLKI--GGSQGEREFRA---EVEIISRVHHRHLVS 441
+LG G FG VY AD GRE+AVKQ+ + +E A E++++ + H +V
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 442 LVGYCI---SERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHED 498
G C+ E++ + EY+P ++ L A G + + TR + +G++YLH +
Sbjct: 69 YYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYG-ALTENVTR-RYTRQILQGVSYLHSN 125
Query: 499 CHPRIIHRDIKSSNILLDSSFEARVADFGLAK-IALELDSNTHVSTRVMGTFGYMAPEYA 557
I+HRDIK +NIL DS+ ++ DFG +K I S T + + V GT +M+PE
Sbjct: 126 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS-VTGTPYWMSPEVI 181
Query: 558 TSGKLTEKSDVYSFGVVLLELITGRKP 584
+ K+DV+S ++E++T + P
Sbjct: 182 SGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 1e-17
Identities = 59/192 (30%), Positives = 97/192 (50%), Gaps = 16/192 (8%)
Query: 405 GREVAVKQLKIGGSQGERE---FRAEVEIISRVHHRHLVSLVGYCISERERLL-VYEYVP 460
G EVA+K L+ + E + FR E + +R++H ++V+L+ + L V+EYVP
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 461 NDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILL---DS 517
TL L A+G + ++ +A H I+HRD+K NI++
Sbjct: 63 GRTLREVLAADG--ALPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTGV 117
Query: 518 SFEARVADFGLAKI---ALELDSNT-HVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGV 573
A+V DFG+ + + D T +T V+GT Y APE +T SD+Y++G+
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGL 177
Query: 574 VLLELITGRKPV 585
+ LE +TG++ V
Sbjct: 178 IFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 63/200 (31%), Positives = 108/200 (54%), Gaps = 14/200 (7%)
Query: 389 LGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCIS 448
LG G FG V+ +VAVK +K GS F AE ++ + H LV L + +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKL--HAVV 70
Query: 449 ERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRD 507
+E + ++ E++ +L L ++ + +A A G+A++ + + IHRD
Sbjct: 71 TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY---IHRD 127
Query: 508 IKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTF--GYMAPEYATSGKLTEK 565
++++NIL+ +S ++ADFGLA++ ++ N + + R F + APE G T K
Sbjct: 128 LRAANILVSASLVCKIADFGLARV---IEDNEYTA-REGAKFPIKWTAPEAINFGSFTIK 183
Query: 566 SDVYSFGVVLLELIT-GRKP 584
SDV+SFG++L+E++T GR P
Sbjct: 184 SDVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 1e-17
Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 13/205 (6%)
Query: 388 VLGEGGFGCVYKGVLAD-GREVAVKQLKIGGSQGE--REFRA---EVEIISRVHHRHLVS 441
+LG+G FG VY AD GRE+AVKQ++ E +E A E++++ + H +V
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 442 LVGYCISERERLL--VYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDC 499
G ER L E++P ++ L + G + + TR K G++YLH +
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG-ALTENVTR-KYTRQILEGVSYLHSN- 125
Query: 500 HPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATS 559
I+HRDIK +NIL DS ++ DFG +K + + V GT +M+PE +
Sbjct: 126 --MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG 183
Query: 560 GKLTEKSDVYSFGVVLLELITGRKP 584
K+D++S G ++E++T + P
Sbjct: 184 EGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 1e-17
Identities = 67/213 (31%), Positives = 102/213 (47%), Gaps = 26/213 (12%)
Query: 388 VLGEGGFGCVYKGVLADGRE----VAVKQLK---IGGSQGEREF-RAEVEIISRVHHRHL 439
VLG+GG+G V++ G + A+K LK I +Q + +AE I+ V H +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 440 VSLVGYCISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWA----TRVKVAAGAARGIAY 494
V L+ Y +L L+ EY+ L HL EG + D A + + +A +
Sbjct: 63 VDLI-YAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALE------H 115
Query: 495 LHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAP 554
LH II+RD+K NILLD+ ++ DFGL K ++ + TH GT YMAP
Sbjct: 116 LH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---FCGTIEYMAP 169
Query: 555 EYATSGKLTEKSDVYSFGVVLLELITGRKPVDA 587
E + D +S G ++ +++TG P A
Sbjct: 170 EILMRSGHGKAVDWWSLGALMYDMLTGAPPFTA 202
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 63/207 (30%), Positives = 98/207 (47%), Gaps = 19/207 (9%)
Query: 389 LGEGGFGCVYKGVLAD------GREVAVKQLKIGGSQGER-EFRAEVEIISRVHHRHLVS 441
LG+G FG VY+G D VAVK + S ER EF E ++ H+V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 442 LVGYCISERERLLVYEYVPNDTLHYHLHA--------EGRPVMDWATRVKVAAGAARGIA 493
L+G + L+V E + + L +L + GRP +++AA A G+A
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 494 YLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMA 553
YL+ + +HRD+ + N ++ F ++ DFG+ + E D ++ +MA
Sbjct: 134 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLL-PVRWMA 189
Query: 554 PEYATSGKLTEKSDVYSFGVVLLELIT 580
PE G T SD++SFGVVL E+ +
Sbjct: 190 PESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 57/209 (27%), Positives = 96/209 (45%), Gaps = 13/209 (6%)
Query: 389 LGEGGFGCVYKGVLAD-GREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCI 447
LG+G FG VYK + G A K ++I + +F E++I+S H ++V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 448 SERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRD 507
E + ++ E+ L + R + + R V + +LH ++IHRD
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLTEPQIRY-VCRQMLEALNFLHSH---KVIHRD 128
Query: 508 IKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTE--- 564
+K+ NILL + ++ADFG++ A + T + GT +MAPE +
Sbjct: 129 LKAGNILLTLDGDVKLADFGVS--AKNKSTLQKRDTFI-GTPYWMAPEVVACETFKDNPY 185
Query: 565 --KSDVYSFGVVLLELITGRKPVDASQPL 591
K+D++S G+ L+EL P P+
Sbjct: 186 DYKADIWSLGITLIELAQMEPPHHELNPM 214
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 1e-17
Identities = 68/246 (27%), Positives = 120/246 (48%), Gaps = 55/246 (22%)
Query: 383 FSAHNVLGEGGFGCVYKGVLAD-GREVAVKQLKIGGSQGERE------FRAEVEIISRVH 435
F +GEG +G VYK D G VA+K++++ E+E R E++I+ +++
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRL---DNEKEGFPITAIR-EIKILRQLN 64
Query: 436 HRHLVSLVGYCISERERL----------LVYEYVPNDTL-----------HYHLHAEGRP 474
HR++V+L +++ L LV+EY+ +D + H+ + +
Sbjct: 65 HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQ 124
Query: 475 VMDWATRVKVAAGAARGIAYLHEDCHPR-IIHRDIKSSNILLDSSFEARVADFGLAKIAL 533
+++ G+ Y CH + +HRDIK SNILL++ + ++ADFGLA++
Sbjct: 125 LLE-------------GLNY----CHKKNFLHRDIKCSNILLNNKGQIKLADFGLARL-Y 166
Query: 534 ELDSNTHVSTRVMGTFGYMAPEYATSG-KLTEKSDVYSFGVVLLELITGRKPV-DASQPL 591
+ + + +V+ T Y PE + DV+S G +L EL T +KP+ A+Q L
Sbjct: 167 NSEESRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPIFQANQEL 224
Query: 592 GDESLV 597
L+
Sbjct: 225 AQLELI 230
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 2e-17
Identities = 67/277 (24%), Positives = 92/277 (33%), Gaps = 11/277 (3%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPS--PPTAPPPSS 58
PP + PA +A S + P ++P T+ P+SPP PP STPP+ P P SS
Sbjct: 152 PPAAGASPAAVASDAASSRQAALPLSSPEETARAPSSPPAEPPPSTPPAAASPRPPRRSS 211
Query: 59 PAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPP---PQAVAPSPPPPANV----PTT 111
P S +P S S + P+ P P P
Sbjct: 212 PISASASSPAPAPGRSAADDAGASSSDSSSSESSGCGWGPENECPLPRPAPITLPTRIWE 271
Query: 112 PSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSS--SSPPPVNVPTPPS 169
S + P + SSSSP + +PSS PA SS SS + + S
Sbjct: 272 ASGWNGPSSRPGPASSSSSPRERSPSPSPSSPGSGPAPSSPRASSSSSSSRESSSSSTSS 331
Query: 170 SSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAV 229
SS ++ P +PS P P P + P+ S P S + A
Sbjct: 332 SSESSRGAAVSPGPSPSRSPSPSRPPPPADPSSPRKRPRPSRAPSSPAASAGRPTRRRAR 391
Query: 230 SPPAPPSNSSTRGSPSTPPLPSVPTEKPTAKSTNGTA 266
+ A + P A S A
Sbjct: 392 AAVAGRARRRDATGRFPAGRPRPSPLDAGAASGAFYA 428
|
Length = 1352 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 4e-17
Identities = 74/295 (25%), Positives = 92/295 (31%), Gaps = 40/295 (13%)
Query: 19 PLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPL--- 75
P +P P A P P PP P P PS A P +P P
Sbjct: 2475 PGAPVYRRPAEARFPFAAGAAPDPGGGGPPDPDAPPAPSRLAPAILPDEPVGEPVHPRML 2534
Query: 76 ---------------DAPPPPEVDPSPPSPAQP-PPQAVAPSPPPPANVPTTPSSSSPPP 119
D PPP P +P + PP AP P PA +PP
Sbjct: 2535 TWIRGLEELASDDAGDPPPPLPPAAPPAAPDRSVPPPRPAPRPSEPAVTSRARRPDAPPQ 2594
Query: 120 ANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSN 179
+ P P P P S PP + P P S P N P P + PPP
Sbjct: 2595 SARPRAPVDDRGDPR--GPAPPSPLPPDTHAPDPPPPSPSPAANEPDPHPPPTVPPPER- 2651
Query: 180 PPTSTPSPPVLTPPPHPSQSAPPPVTKSPP---------------ASTLSPPPPSVPSTS 224
P P+P ++ P + SPP S PPPP
Sbjct: 2652 -PRDDPAPGRVSRPRRARRLGRAAQASSPPQRPRRRAARPTVGSLTSLADPPPPPPTPEP 2710
Query: 225 SPPAVSP--PAPPSNSSTRGSPSTPPLPSVPTEKPTAKSTNGTAVSANASPRNAG 277
+P A+ P PP ++ R + P P P +T G P AG
Sbjct: 2711 APHALVSATPLPPGPAAARQASPALPAAPAPPAVPAGPATPGGPARPARPPTTAG 2765
|
Length = 3151 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 4e-17
Identities = 54/202 (26%), Positives = 98/202 (48%), Gaps = 20/202 (9%)
Query: 389 LGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGEREFRA--EVEIISRVHHRHLVSLVGY 445
+GEG +G VYK G VA+K++K+ A E++++ ++H +++ L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD- 65
Query: 446 CISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVK-VAAGAARGIAYLHEDCHPRI 503
+ L LV+E++ D + R + + + +K +G+A+ H I
Sbjct: 66 VFRHKGDLYLVFEFMDTDLYKL-IKDRQRGLPE--SLIKSYLYQLLQGLAFCHSH---GI 119
Query: 504 IHRDIKSSNILLDSSFEARVADFGLAKIA-LELDSNTH-VSTRVMGTFGYMAPE-YATSG 560
+HRD+K N+L+++ ++ADFGLA+ + TH V TR Y APE
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYRAPELLLGDK 174
Query: 561 KLTEKSDVYSFGVVLLELITGR 582
+ D++S G + EL++ R
Sbjct: 175 GYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 4e-17
Identities = 78/255 (30%), Positives = 120/255 (47%), Gaps = 32/255 (12%)
Query: 383 FSAHNVLGEGGFGCVYKGVLADGREV-AVKQLKIGGSQGEREFR---AEVEIISRVHHRH 438
F+ +G G FG VY EV A+K++ G Q +++ EV+ + R+ H +
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 439 LVSLVGYCISERERLLVYEYV---PNDTLHYHLHAEGRPVMDWATRVKVAA---GAARGI 492
+ G + E LV EY +D L H +P+ + V++AA GA +G+
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLLEVH----KKPLQE----VEIAAITHGALQGL 138
Query: 493 AYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYM 552
AYLH +IHRDIK+ NILL + ++ADFG A IA +S +GT +M
Sbjct: 139 AYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANS-------FVGTPYWM 188
Query: 553 APEYATS---GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGD-ESLVEWARPLLAEAL 608
APE + G+ K DV+S G+ +EL + P+ + + + P L
Sbjct: 189 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNE 248
Query: 609 EHEDFEALVDSRLEK 623
+ F VDS L+K
Sbjct: 249 WSDYFRNFVDSCLQK 263
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 4e-17
Identities = 68/232 (29%), Positives = 102/232 (43%), Gaps = 44/232 (18%)
Query: 379 ATNGFSAHNVLGEGGFGCVYKGVLAD-GREVAVKQLKIGGSQGEREFRAEVEIISRV-HH 436
T F V+GEG +G VYK G+ VA+K + I + E E + E I+ + +H
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSNH 62
Query: 437 RHLVSLVGYCISERERL------LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAA---- 486
++ + G I + LV E G V D ++
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMEL-----------CGGGSVTDLVKGLRKKGKRLK 111
Query: 487 ---------GAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDS 537
RG+AYLHE+ ++IHRDIK NILL + E ++ DFG++ +LDS
Sbjct: 112 EEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSA---QLDS 165
Query: 538 NTHVSTRVMGTFGYMAPEY-ATSGKLTE----KSDVYSFGVVLLELITGRKP 584
+GT +MAPE A + +SDV+S G+ +EL G+ P
Sbjct: 166 TLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 4e-17
Identities = 65/206 (31%), Positives = 107/206 (51%), Gaps = 15/206 (7%)
Query: 388 VLGEGGFGCVYKGVLAD-GREVAVKQLKIGGSQGE--REFRA---EVEIISRVHHRHLVS 441
+LG+G FG VY D GRE+A KQ++ E +E A E++++ + H +V
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 442 LVGYCI---SERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHED 498
G C+ +E+ + EY+P ++ L A G + + TR K G++YLH +
Sbjct: 69 YYG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYG-ALTESVTR-KYTRQILEGMSYLHSN 125
Query: 499 CHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYAT 558
I+HRDIK +NIL DS+ ++ DFG +K + + V GT +M+PE +
Sbjct: 126 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS 182
Query: 559 SGKLTEKSDVYSFGVVLLELITGRKP 584
K+DV+S G ++E++T + P
Sbjct: 183 GEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 4e-17
Identities = 62/212 (29%), Positives = 106/212 (50%), Gaps = 36/212 (16%)
Query: 389 LGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGERE------FRAEVEIISRVHHRHLVS 441
+GEG +G VYK G VA+K++++ + E E R E+ ++ ++H ++V
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRL---ETEDEGVPSTAIR-EISLLKELNHPNIVR 62
Query: 442 LVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHP 501
L+ SE + LV+E++ D L ++ + +D +GIAY CH
Sbjct: 63 LLDVVHSENKLYLVFEFLDLD-LKKYMDSSPLTGLDPPLIKSYLYQLLQGIAY----CHS 117
Query: 502 -RIIHRDIKSSNILLDSSFEARVADFGLAKI-ALELDSNTHVSTRVMGTFGYMAPE---- 555
R++HRD+K N+L+D ++ADFGLA+ + + + TH V+ T Y APE
Sbjct: 118 HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH---EVV-TLWYRAPEILLG 173
Query: 556 ---YATSGKLTEKSDVYSFGVVLLELITGRKP 584
Y+T D++S G + E++ R+P
Sbjct: 174 SRQYSTP------VDIWSIGCIFAEMVN-RRP 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 5e-17
Identities = 63/274 (22%), Positives = 93/274 (33%), Gaps = 14/274 (5%)
Query: 1 PPPQSSPPAVL---AVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPS 57
Q++ P PS P + PP +TPP + P SP +++ SP AP S
Sbjct: 168 SSRQAALPLSSPEETARAPSSPPAEPPPSTPPAAASPRPPRRSSPISASASSPAPAPGRS 227
Query: 58 SPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQ-----PPPQAVAPSPPPPANVPTTP 112
+ SS PE + P PA +A + P P +
Sbjct: 228 AADDAGASSSDSSSSESSGCGWGPENECPLPRPAPITLPTRIWEASGWNGPSSRPGPASS 287
Query: 113 SSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSS 172
SSS + P+ S S P + SSSS + ++ SSSS ++ S
Sbjct: 288 SSSPRERSPSPSPSSPGSGPAPSSPRASSSSSSSRESSSSSTSSSSESS-----RGAAVS 342
Query: 173 PPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPP 232
P P S P+ + PP P + P SP AS P + + A
Sbjct: 343 PGPSPSRSPSPSRPPPPADPSSPRKRPRPSRAPSSPAASAGRPTRRRARAAVAGRARRRD 402
Query: 233 APPSNSSTRGSPSTPPLPSVPTEKPTAKSTNGTA 266
A + R +P + A+ T
Sbjct: 403 ATGRFPAGR-PRPSPLDAGAASGAFYARYPLLTP 435
|
Length = 1352 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 5e-17
Identities = 74/268 (27%), Positives = 114/268 (42%), Gaps = 60/268 (22%)
Query: 389 LGEGGFGCVYKG-VLADGREVAVKQL-KIGGSQGEREFRAEVEIISRVHH-RHLVSLVGY 445
+G G G VYK G +AVKQ+ + G + + +++++ + H ++V GY
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGY 82
Query: 446 CISER-------------ERLL--VYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAAR 490
I++ ++LL + +P D L K+ +
Sbjct: 83 FITDSDVFICMELMSTCLDKLLKRIQGPIPEDILG-----------------KMTVAIVK 125
Query: 491 GIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALEL-DSNTHVSTRVMGTF 549
+ YL E H +IHRD+K SNILLD+S ++ DFG I+ L DS TR G
Sbjct: 126 ALHYLKEK-H-GVIHRDVKPSNILLDASGNVKLCDFG---ISGRLVDSKAK--TRSAGCA 178
Query: 550 GYMAPEYATSGKLTEK----SDVYSFGVVLLELITGRKPVDA--------SQPLGDESLV 597
YMAPE K +DV+S G+ L+EL TG+ P ++ L +E
Sbjct: 179 AYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEP-- 236
Query: 598 EWARPLLAEALEHEDFEALVDSRLEKNY 625
E DF + VD L K++
Sbjct: 237 --PSLPPNEGFSP-DFCSFVDLCLTKDH 261
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 5e-17
Identities = 63/203 (31%), Positives = 103/203 (50%), Gaps = 14/203 (6%)
Query: 389 LGEGGFGCVYKGVL---ADGREVAVKQLKIGGSQG--EREFRAEVEIISRVHHRHLVSLV 443
LG G FG V KG+ + VAVK LK + + E E ++ ++ + ++V ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 444 GYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRI 503
G C +E +LV E L+ L + + V + ++ + G+ YL E
Sbjct: 63 GICEAE-SWMLVMELAELGPLNKFL-QKNKHVTE-KNITELVHQVSMGMKYLEET---NF 116
Query: 504 IHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTH-VSTRVMGTFGYMAPEYATSGKL 562
+HRD+ + N+LL + A+++DFGL+K AL D N + T + APE K
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSK-ALGADENYYKAKTHGKWPVKWYAPECMNYYKF 175
Query: 563 TEKSDVYSFGVVLLELIT-GRKP 584
+ KSDV+SFGV++ E + G+KP
Sbjct: 176 SSKSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 6e-17
Identities = 40/214 (18%), Positives = 70/214 (32%), Gaps = 10/214 (4%)
Query: 46 TPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPP 105
P+ A P + PA + P ++P P P +P + A A AP+ P
Sbjct: 372 AGPATAAAAPVAQPAPAAAAPAAAAPAPAAPPAAPA---AAPAAAAAARAVAAAPARRSP 428
Query: 106 ANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVP 165
A + + + +P A P A ++++ P
Sbjct: 429 APEALAAARQASARGPGGAPAPAPAPAAAPAAAAR----PAAAGPRPVAAAAAAAP--AR 482
Query: 166 TPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPP-VTKSPPASTLSPPPPSVPSTS 224
P+++ P PP P +P P +AP V +S P + P + + +
Sbjct: 483 AAPAAAPAPADDDPPPWEELPPEFASPAPAQPDAAPAGWVAESIPDPATADPDDAFETLA 542
Query: 225 SPPAVSPPAPPSNSSTRGSPSTPPLPSVPTEKPT 258
PA +P + ++ PP S
Sbjct: 543 PAPAAAPAPRAAAATEPVVAPRPPRASASGLPDM 576
|
Length = 700 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 6e-17
Identities = 69/250 (27%), Positives = 116/250 (46%), Gaps = 46/250 (18%)
Query: 389 LGEGGFGCVYKGVLADGRE-----------------VAVKQLKIGGSQGER-EFRAEVEI 430
LGEG FG V+ + + ++ VAVK L+ ++ R +F EV+I
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 431 ISRVHHRHLVSLVGYCISERERLLVYEYVPNDTL-----HYHL---HAEGR--------- 473
+SR+ +++ L+G C+ E ++ EY+ N L +HL G
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 474 PVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIAL 533
P + +++ + VA A G+ YL +HRD+ + N L+ + ++ADFG+++ L
Sbjct: 133 PAISYSSLLHVALQIASGMKYLSS---LNFVHRDLATRNCLVGENLTIKIADFGMSR-NL 188
Query: 534 ELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLG- 592
+ R + +MA E GK T SDV++FGV L E++ + QP G
Sbjct: 189 YAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM----LCKEQPYGE 244
Query: 593 --DESLVEWA 600
DE ++E A
Sbjct: 245 LTDEQVIENA 254
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 6e-17
Identities = 64/208 (30%), Positives = 92/208 (44%), Gaps = 25/208 (12%)
Query: 392 GGFGCVYKGVLAD----GREVAVKQLK----IGGSQGEREFRAEVEIISRVHHRHLVSLV 443
G FG VY LA G A+K LK I +Q +AE I+ V+ +
Sbjct: 7 GAFGSVY---LAKKRSTGDYFAIKVLKKSDMIAKNQ-VTNVKAERAIMMIQGESPYVAKL 62
Query: 444 GYCISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPR 502
Y ++ L LV EY+ + G DWA + A G+ LH+
Sbjct: 63 YYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK--QYIAEVVLGVEDLHQR---G 117
Query: 503 IIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKL 562
IIHRDIK N+L+D + ++ DFGL++ LE + + +GT Y+APE
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-------NKKFVGTPDYLAPETILGVGD 170
Query: 563 TEKSDVYSFGVVLLELITGRKPVDASQP 590
+ SD +S G V+ E + G P A P
Sbjct: 171 DKMSDWWSLGCVIFEFLFGYPPFHAETP 198
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 6e-17
Identities = 65/219 (29%), Positives = 114/219 (52%), Gaps = 43/219 (19%)
Query: 387 NVLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGERE------FRAEVEIISRVHHRHL 439
N + EG +G VY+ G VA+K+LK+ + E+E R E+ I+ ++ H ++
Sbjct: 11 NRIEEGTYGVVYRARDKKTGEIVALKKLKM---EKEKEGFPITSLR-EINILLKLQHPNI 66
Query: 440 VSL----VGYCISERERL-LVYEYVPND--TLHYHLH-----AEGRPVMDWATRVKVAAG 487
V++ VG S +++ +V EYV +D +L + +E + +M
Sbjct: 67 VTVKEVVVG---SNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLM---------LQ 114
Query: 488 AARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMG 547
G+A+LH++ I+HRD+K+SN+LL++ ++ DFGLA+ E S T+++
Sbjct: 115 LLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAR---EYGSPLKPYTQLVV 168
Query: 548 TFGYMAPEYATSGKL-TEKSDVYSFGVVLLELITGRKPV 585
T Y APE K + D++S G + EL+T +KP+
Sbjct: 169 TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLT-KKPL 206
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 7e-17
Identities = 46/209 (22%), Positives = 70/209 (33%), Gaps = 11/209 (5%)
Query: 4 QSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNS 63
+ P A P P P + P +P PA+PP +P + + ++PA S
Sbjct: 371 GAGPATAAAAPVAQPA---PAAAAPAAAAPAPAAPPAAPAAAPAAAAAARAVAAAPARRS 427
Query: 64 PPPQP------SSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSP 117
P P+ +S P AP P + P+ A P A A ++ +
Sbjct: 428 PAPEALAAARQASARGPGGAPAPAPAPAAAPAAAARPAAAGPRPVAAAAAAAPARAAPAA 487
Query: 118 PPANVPT-TPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPP 176
PA P PP P+ PA A + + P
Sbjct: 488 APAPADDDPPPWEELPPEFASPAPAQPDAAPAGWVAESIPDPATADPDDAFETLAPAPAA 547
Query: 177 SSNPPTSTPSPPVLTP-PPHPSQSAPPPV 204
+ P + + PV+ P PP S S P +
Sbjct: 548 APAPRAAAATEPVVAPRPPRASASGLPDM 576
|
Length = 700 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 7e-17
Identities = 58/224 (25%), Positives = 101/224 (45%), Gaps = 41/224 (18%)
Query: 389 LGEGGFGCVYK----GVLADGRE--VAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVS 441
+G+G FG V++ G+L VAVK LK S + +F+ E +++ H ++V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 442 LVGYCISERERLLVYEYVPNDTLHYHLHA--------------------EGRPVMDWATR 481
L+G C + L++EY+ L+ L + +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 482 VKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLA-KIAL----ELD 536
+ +A A G+AYL E + +HRD+ + N L+ + ++ADFGL+ I +
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 537 SNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT 580
N + R +M PE + T +SDV+++GVVL E+ +
Sbjct: 190 ENDAIPIR------WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 8e-17
Identities = 75/251 (29%), Positives = 115/251 (45%), Gaps = 36/251 (14%)
Query: 389 LGEGGFGCVYKGVLADGREV-AVKQLKIGGSQGEREFR---AEVEIISRVHHRHLVSLVG 444
+G G FG VY EV A+K++ G Q +++ EV + ++ H + + G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 445 YCISERERLLVYEYV---PNDTLHYHLHAEGRPVMDWATRVKVAA---GAARGIAYLHED 498
+ E LV EY +D L H +P+ + V++AA GA +G+AYLH
Sbjct: 83 CYLREHTAWLVMEYCLGSASDLLEVH----KKPLQE----VEIAAVTHGALQGLAYLHSH 134
Query: 499 CHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYAT 558
+IHRD+K+ NILL ++ DFG A I + +GT +MAPE
Sbjct: 135 ---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX-------FVGTPYWMAPEVIL 184
Query: 559 S---GKLTEKSDVYSFGVVLLELITGRKPV---DASQPLGDESLVEWARPLLAEALEHED 612
+ G+ K DV+S G+ +EL + P+ +A L + + P L E
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL--YHIAQNESPALQSGHWSEY 242
Query: 613 FEALVDSRLEK 623
F VDS L+K
Sbjct: 243 FRNFVDSCLQK 253
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 9e-17
Identities = 44/196 (22%), Positives = 68/196 (34%), Gaps = 13/196 (6%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
P ++PPA A P + + + P SP P + + S P +PA
Sbjct: 396 APAPAAPPAAPAAAPAAAAAARAVAAAPARRSPAPEALAAARQASARGPGGAPAPAPAPA 455
Query: 61 VNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVA--PSPPPPANVPTTPSSSSP- 117
P ++ P P + P+ A P PPP +P +S +P
Sbjct: 456 ---AAPAAAARPAAAGPRPVAAAAAAAPARAAPAAAPAPADDDPPPWEELPPEFASPAPA 512
Query: 118 ---PPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPP 174
S P A+ + +P PA PA ++++ PV P PP +S+
Sbjct: 513 QPDAAPAGWVAESIPDPATADPDDAFETLAPAPAAAPAPRAAAATEPVVAPRPPRASA-- 570
Query: 175 PPSSNPPTSTPSPPVL 190
S P P L
Sbjct: 571 --SGLPDMFDGDWPAL 584
|
Length = 700 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 1e-16
Identities = 74/308 (24%), Positives = 96/308 (31%), Gaps = 41/308 (13%)
Query: 8 PAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPP------------ 55
P P + + P PP PP+P P P P
Sbjct: 2478 PVYRRPAEARFPFAAGAAPDPGGGGPPDPDAPPAPSRLAPAILPDEPVGEPVHPRMLTWI 2537
Query: 56 ------PSSPAVNSPPPQPSSPPPPL--DAPPPPEVDPSPPSPA--------QPPPQAVA 99
S A + PPP P + PP + PPP P P PA PPQ+
Sbjct: 2538 RGLEELASDDAGDPPPPLPPAAPPAAPDRSVPPPRPAPRPSEPAVTSRARRPDAPPQSAR 2597
Query: 100 PSPP--PPANVPTTPSSSSPPPANVPTTPSSSSPPPA-----NVRTTPSSSSPPPANVPA 152
P P + S PP P SP PA P + PA
Sbjct: 2598 PRAPVDDRGDPRGPAPPSPLPPDTHAPDPPPPSPSPAANEPDPHPPPTVPPPERPRDDPA 2657
Query: 153 TPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLT----PPPHPSQSAPPPVTKSP 208
S P + +S PP + P+ LT PPP P P P
Sbjct: 2658 PGRVSRPRRARRLGRAAQASSPPQRPRRRAARPTVGSLTSLADPPPPPPTPEPAPHALVS 2717
Query: 209 PASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTPPLPSVPTEKPTAKSTNGTAVS 268
+T PP P+ +SP + PAPP+ + +P P P+ P + A
Sbjct: 2718 --ATPLPPGPAAARQASPALPAAPAPPAVPAGPATPGGPARPARPPTTAGPPAPAPPAAP 2775
Query: 269 ANASPRNA 276
A PR
Sbjct: 2776 AAGPPRRL 2783
|
Length = 3151 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 63/218 (28%), Positives = 105/218 (48%), Gaps = 26/218 (11%)
Query: 389 LGEGGFGCVYKGVL-----ADGREVAVKQLK-IGGSQGEREFRAEVEIISRVHHRHLVSL 442
LGE FG +YKG L + VA+K LK I Q EF+ E +++ +HH ++V L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 443 VGYCISERERLLVYEYVPNDTLHYHL-----HAEG----------RPVMDWATRVKVAAG 487
+G E+ +++EY+ LH L H++ + +D + +A
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 488 AARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMG 547
A G+ YL +H+D+ + NIL+ +++D GL++ D V + +
Sbjct: 133 IAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADY-YRVQPKSLL 188
Query: 548 TFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKP 584
+M PE GK + SD++SFGVVL E+ + G +P
Sbjct: 189 PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 1e-16
Identities = 59/218 (27%), Positives = 97/218 (44%), Gaps = 52/218 (23%)
Query: 389 LGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGEREFRA--------EVEIISRV-HHRH 438
LG+G FG VY G VA+K++K ++F + EV+ + ++ H +
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMK-------KKFYSWEECMNLREVKSLRKLNEHPN 59
Query: 439 LVSLVGYCISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAAR------- 490
+V L E + L V+EY+ + +G+P + R
Sbjct: 60 IVKLKE-VFRENDELYFVFEYMEGNLYQLMKDRKGKPF---------SESVIRSIIYQIL 109
Query: 491 -GIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSN----THVSTRV 545
G+A++H+ H HRD+K N+L+ ++ADFGLA+ E+ S +VSTR
Sbjct: 110 QGLAHIHK--H-GFFHRDLKPENLLVSGPEVVKIADFGLAR---EIRSRPPYTDYVSTR- 162
Query: 546 MGTFGYMAPE-YATSGKLTEKSDVYSFGVVLLELITGR 582
Y APE S + D+++ G ++ EL T R
Sbjct: 163 ----WYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 63/226 (27%), Positives = 102/226 (45%), Gaps = 23/226 (10%)
Query: 388 VLGEGGFGCVY----KGVLADGRE--VAVKQL-KIGGSQGEREFRAEVEIISRVHHRHLV 440
LG G FG V+ KG+ +G E V VK L K + EFR E+++ ++ H+++V
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 441 SLVGYCISERERLLVYEYVPNDTLHYHLHA-------EGRPVMDWATRVKVAAGAARGIA 493
L+G C ++ EY L L A P + +V + A G+
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 494 YLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMA 553
+L R +HRD+ + N L+ S E +V+ L+K + + + ++A
Sbjct: 132 HLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI--PLRWLA 186
Query: 554 PEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVE 598
PE + KSDV+SFGV++ E+ T G P L DE ++
Sbjct: 187 PEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPF---YGLSDEEVLN 229
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-16
Identities = 63/271 (23%), Positives = 87/271 (32%), Gaps = 18/271 (6%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPP-TSTPPSPPTAPPPSSP 59
P SP A PP+ SP + +S A P SP T+ PS P A PP S
Sbjct: 138 LRPVGSPGPPPAASPPAAGASPAAVASDAASSRQAALPLSSPEETARAPSSPPAEPPPST 197
Query: 60 AVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPP-------------PA 106
+ P+P P+ A S A + + S P
Sbjct: 198 PPAAASPRPPRRSSPISASASSPAPAPGRSAADDAGASSSDSSSSESSGCGWGPENECPL 257
Query: 107 NVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPT 166
P + + SS P PA+ ++P SP P+ S S P + P
Sbjct: 258 PRPAPITLPTRIWEASGWNGPSSRPGPASSSSSPRERSPS----PSPSSPGSGPAPSSPR 313
Query: 167 PPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSP 226
SSSS SS+ TS+ S P S + S P P P S
Sbjct: 314 ASSSSSSSRESSSSSTSSSSESSRGAAVSPGPSPSRSPSPSRPPPPADPSSPRKRPRPSR 373
Query: 227 PAVSPPAPPSNSSTRGSPSTPPLPSVPTEKP 257
SP A + R + + + +
Sbjct: 374 APSSPAASAGRPTRRRARAAVAGRARRRDAT 404
|
Length = 1352 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 67/234 (28%), Positives = 102/234 (43%), Gaps = 65/234 (27%)
Query: 389 LGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGERE------FRAEVEIISRVHHRHLVS 441
LGEG FG VYK + GR VA+K++ + E++ R E++I+ ++ H ++V
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILM---HNEKDGFPITALR-EIKILKKLKHPNVVP 71
Query: 442 LVGYCISE-----RERLLVYEYVPNDTLHYHLHAEGRPVMDWA-----TRVKVAAGAAR- 490
L+ + R+R VY P Y H D + VK+ +
Sbjct: 72 LIDMAVERPDKSKRKRGSVYMVTP-----YMDH-------DLSGLLENPSVKLTESQIKC 119
Query: 491 -------GIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALE--------L 535
GI YLHE+ I+HRDIK++NIL+D+ ++ADFGLA+
Sbjct: 120 YMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGG 176
Query: 536 DSNTHVSTRVMGTFGYMAPE-------YATSGKLTEKSDVYSFGVVLLELITGR 582
T T ++ T Y PE Y T+ D++ G V E+ T R
Sbjct: 177 GGGTRKYTNLVVTRWYRPPELLLGERRYTTA------VDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-16
Identities = 40/114 (35%), Positives = 66/114 (57%), Gaps = 7/114 (6%)
Query: 483 KVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVS 542
K++ RG+ YL E H +I+HRD+K SNIL++S E ++ DFG++ ++ +N+ V
Sbjct: 103 KISIAVLRGLTYLREK-H-KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVG 160
Query: 543 TRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESL 596
TR YM+PE T +SD++S G+ L+E+ GR P+ E++
Sbjct: 161 TR-----SYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAM 209
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 3e-16
Identities = 48/215 (22%), Positives = 79/215 (36%), Gaps = 12/215 (5%)
Query: 15 PPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPP 74
P+ + P + P + P A+ P PP+ P A P ++ A + P+ P
Sbjct: 373 GPATAAAAPVAQPAPAAAAPAAAAPAPAA---PPAAPAAAPAAAAAARAVAAAPARRSPA 429
Query: 75 LDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPA 134
+A + P P A AP+ P A + P A P+ ++P A
Sbjct: 430 PEALAAARQASARGPGGAPAP-APAPAAAPAAAARPAAAGPRPVAAAAAAAPARAAPAAA 488
Query: 135 NVRTTPSSSSPPP-ANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPP 193
P+ PPP +P +S +P + + P +P T+ P T
Sbjct: 489 PA---PADDDPPPWEELPPEFASPAPAQPDAAPAGWVAESIP---DPATADPDDAFETLA 542
Query: 194 PHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPA 228
P P+ AP P + ++P PP ++ P
Sbjct: 543 PAPAA-APAPRAAAATEPVVAPRPPRASASGLPDM 576
|
Length = 700 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 3e-16
Identities = 65/237 (27%), Positives = 112/237 (47%), Gaps = 32/237 (13%)
Query: 389 LGEGGFG----CVYKGVLADGRE-------------VAVKQLKIGGSQGER-EFRAEVEI 430
LGEG FG C +G+ + VAVK L+ ++ R +F E++I
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 431 ISRVHHRHLVSLVGYCISERERLLVYEYVPNDTLHYHL---------HAEGRPVMDWATR 481
+SR+ +++ L+ CI+ ++ EY+ N L+ L + ++T
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 482 VKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHV 541
+ +A A G+ YL +HRD+ + N L+ ++ ++ADFG+++ D +
Sbjct: 133 IFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDY-YRI 188
Query: 542 STRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVE 598
R + +M+ E GK T SDV++FGV L E++T K SQ L DE ++E
Sbjct: 189 QGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ-LSDEQVIE 244
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 3e-16
Identities = 57/217 (26%), Positives = 103/217 (47%), Gaps = 27/217 (12%)
Query: 382 GFSAHNVLGEGGFGCVYKGVLADG-----REVAVKQLKIGGSQGERE-FRAEVEIISRVH 435
+ ++L EG FG ++ G+L D EV VK +K S+ + E ++ +
Sbjct: 7 RVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLS 66
Query: 436 HRHLVSLVGYCISERERLLV-YEYVPNDTLHYHL----HAEGRPVMDWATR--VKVAAGA 488
H++++ ++ CI + E V Y Y+ L L E +T+ V +A
Sbjct: 67 HQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQI 126
Query: 489 ARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD-----SNTHVST 543
A G++YLH+ +IH+DI + N ++D + ++ D L++ +D N +
Sbjct: 127 ACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPV 183
Query: 544 RVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT 580
+ +MA E + + + SDV+SFGV+L EL+T
Sbjct: 184 K------WMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 6e-16
Identities = 63/213 (29%), Positives = 97/213 (45%), Gaps = 35/213 (16%)
Query: 388 VLGEGGFGCVYKGVLADGREV-AVKQLKIGGSQGEREFRAEV-----EIISRVHHRHLVS 441
VLG+G FG V L E A+K LK +V ++ + R +++
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALK-----------KDVVLEDDDVECTMVERRVLA 50
Query: 442 LVG--------YCISERERLL--VYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARG 491
L +C + + L V EY+ L +H+ + GR D A AA G
Sbjct: 51 LAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGR--FDEARARFYAAEIICG 108
Query: 492 IAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGY 551
+ +LH+ II+RD+K N+LLD ++ADFG+ K + + + GT Y
Sbjct: 109 LQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA---STFCGTPDY 162
Query: 552 MAPEYATSGKLTEKSDVYSFGVVLLELITGRKP 584
+APE K E D +SFGV+L E++ G+ P
Sbjct: 163 IAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 8e-16
Identities = 61/214 (28%), Positives = 107/214 (50%), Gaps = 37/214 (17%)
Query: 388 VLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGE-REFRAEVEIISRVHHRHLVSLVGY 445
++G G +G VY+G + GR VA+K + + + + + EV ++S++ ++ Y
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 446 --CISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIA--------- 493
+ RL ++ EY AEG V T +K A + I+
Sbjct: 68 YGSYLKGPRLWIIMEY-----------AEGGSVR---TLMKAGPIAEKYISVIIREVLVA 113
Query: 494 --YLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGY 551
Y+H+ +IHRDIK++NIL+ ++ ++ DFG +A L+ N+ + +GT +
Sbjct: 114 LKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFG---VAALLNQNSSKRSTFVGTPYW 167
Query: 552 MAPEYATSGKLTE-KSDVYSFGVVLLELITGRKP 584
MAPE T GK + K+D++S G+ + E+ TG P
Sbjct: 168 MAPEVITEGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 1e-15
Identities = 61/226 (26%), Positives = 94/226 (41%), Gaps = 33/226 (14%)
Query: 389 LGEGGFGCVYKGVLADGREVA---VKQLKIGGSQGER-EFRAEVEIISRVHHRHLVSLVG 444
+G G FG V G G A VK+L+ + E+ F EV+ ++H +++ +G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 445 YCISERERLLVYEYVPNDTLHYHLHAE-GRPVMDWATRV--KVAAGAARGIAYLHEDCHP 501
CI LLV E+ P L +L + G V ++A A G+ +LH+
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA--- 119
Query: 502 RIIHRDIKSSNILLDSSFEARVADFGLA-----KIALELDSNTHVSTRVMGTFGYMAPEY 556
IH D+ N L + ++ D+GLA + V R ++APE
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR------WLAPEL 173
Query: 557 ATS-------GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDES 595
T+KS+++S GV + EL T A QP D S
Sbjct: 174 VEIRGQDLLPKDQTKKSNIWSLGVTMWELFT-----AADQPYPDLS 214
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 58/193 (30%), Positives = 94/193 (48%), Gaps = 11/193 (5%)
Query: 389 LGEGGFGCVYKGVL-ADGREVAVKQLK-IGGSQGEREFRAEVEIISRVHHRHLVSLVGYC 446
+G G FG V+ G L AD VAVK + + +F E I+ + H ++V L+G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 447 ISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHR 506
++ +V E V L EG P + +++ AA G+ YL IHR
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKH---CIHR 118
Query: 507 DIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTF--GYMAPEYATSGKLTE 564
D+ + N L+ +++DFG+++ E + + ST M + APE G+ +
Sbjct: 119 DLAARNCLVTEKNVLKISDFGMSR---EEEDGVYASTGGMKQIPVKWTAPEALNYGRYSS 175
Query: 565 KSDVYSFGVVLLE 577
+SDV+SFG++L E
Sbjct: 176 ESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 1e-15
Identities = 59/206 (28%), Positives = 100/206 (48%), Gaps = 14/206 (6%)
Query: 389 LGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLV-GYC 446
+G+G G VY + +A G+EVA+KQ+ + + E+ ++ H ++V+ + Y
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 447 ISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHR 506
+ + E +V EY+ +L MD V + + +LH + ++IHR
Sbjct: 87 VGD-ELWVVMEYLAGGSL---TDVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHR 139
Query: 507 DIKSSNILLDSSFEARVADFGL-AKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEK 565
DIKS NILL ++ DFG A+I E + ++GT +MAPE T K
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS----TMVGTPYWMAPEVVTRKAYGPK 195
Query: 566 SDVYSFGVVLLELITGRKPVDASQPL 591
D++S G++ +E++ G P PL
Sbjct: 196 VDIWSLGIMAIEMVEGEPPYLNENPL 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 16/200 (8%)
Query: 388 VLGEGGFGCVYKGVLAD-GREVAVKQLKIGGSQGEREFRA----EVEIISRVHHRHLVSL 442
++GEG +G V K + G+ VA+K K S+ ++ + E+ ++ ++ H +LV+L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIK--KFLESEDDKMVKKIAMREIRMLKQLRHENLVNL 65
Query: 443 VGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPR 502
+ ++ LV+E+V + L +D + K RGI + H
Sbjct: 66 IEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG--LDESRVRKYLFQILRGIEFCHSH---N 120
Query: 503 IIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSG-K 561
IIHRDIK NIL+ S ++ DFG A+ L + V T + T Y APE K
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFART---LAAPGEVYTDYVATRWYRAPELLVGDTK 177
Query: 562 LTEKSDVYSFGVVLLELITG 581
D+++ G ++ E++TG
Sbjct: 178 YGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|220392 pfam09770, PAT1, Topoisomerase II-associated protein PAT1 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-15
Identities = 46/202 (22%), Positives = 56/202 (27%), Gaps = 3/202 (1%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPS--PPTAPPPSS 58
PPQ+ P LS P P P P A P
Sbjct: 135 QPPQAPESQPQPQTPAQKMLSLEEVEAQLQQRQQAPQLPQPPQQVLPQGMPPRQAAFPQQ 194
Query: 59 PAVNSPPPQPSSPPPPLDAPPPPEVDPSPP-SPAQPPPQAVAPSPPPPANVPTTPSSSSP 117
PP P P + P + P+P +PAQPP P PPP P P S
Sbjct: 195 GPPEQPPGYPQPPQGHPEQVQPQQFLPAPSQAPAQPPLPPQLPQQPPPLQQPQFPGLSQQ 254
Query: 118 PPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPS 177
P P P PP P + P P ++ PP P P
Sbjct: 255 MPPPPPQPPQQQQQPPQPQAQPPPQNQPTPHPGLPQGQNAPLPPPQQPQLLPLVQQPQGQ 314
Query: 178 SNPPTSTPSPPVLTPPPHPSQS 199
P L+ + S
Sbjct: 315 QRGPQFREQLVQLSQQQREALS 336
|
Members of this family are necessary for accurate chromosome transmission during cell division. Length = 804 |
| >gnl|CDD|235906 PRK07003, PRK07003, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-15
Identities = 46/274 (16%), Positives = 74/274 (27%), Gaps = 29/274 (10%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
P AVP P + + P + P A ++
Sbjct: 368 PGGGVPARVAGAVPAPGARAAAAVGASAVPAVTAVTGAAGAALA------PKAAAAAAAT 421
Query: 61 VNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVP-TTPSSSSPPP 119
PP +PP D +P + P S+S P
Sbjct: 422 RAEAPPAAPAPPATADRGDDAADGDAPVPAKANARASADSRCDERDAQPPADSGSASAPA 481
Query: 120 ANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSN 179
++ P + P A + + ++ P A PA S P P P + P P ++
Sbjct: 482 SDAPPDAAFEPAPRAAAPSAATPAAVPDARAPAAASREDAPAAAAPPAPEARPPTPAAAA 541
Query: 180 PPTST-----------------PSPPVLTPPPHPSQSAPPPVTKSPPAS--TLSPPPPSV 220
P S +A P P A + P P
Sbjct: 542 PAARAGGAAAALDVLRNAGMRVSSDRGARAAAAAKPAAAPAAAPKPAAPRVAVQVPTPRA 601
Query: 221 PSTSSPPAVSPPAP-PSNSSTRGSPSTPPLPSVP 253
+ + + A + +RG+P PP +P
Sbjct: 602 RAATGDAPPNGAARAEQAAESRGAP--PPWEDIP 633
|
Length = 830 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 65/246 (26%), Positives = 116/246 (47%), Gaps = 15/246 (6%)
Query: 383 FSAHNVLGEGGFGCVYKGVLADGREV-AVKQLKIGGSQGERE-FRAEVEIISRVHHRHLV 440
F+ +G+G FG VYKG+ +EV A+K + + ++ E E + E+ ++S+ ++
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 441 SLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCH 500
G + + ++ EY+ + L ++ + +G+ YLH +
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSA---LDLLKPGPLEETYIATILREILKGLDYLHSE-- 120
Query: 501 PRIIHRDIKSSNILLDSSFEARVADFGLAK--IALELDSNTHVSTRVMGTFGYMAPEYAT 558
R IHRDIK++N+LL + ++ADFG+A ++ NT V GT +MAPE
Sbjct: 121 -RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-----GTPFWMAPEVIK 174
Query: 559 SGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVD 618
K+D++S G+ +EL G P P+ L+ P E + F+ V+
Sbjct: 175 QSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVE 234
Query: 619 SRLEKN 624
+ L K+
Sbjct: 235 ACLNKD 240
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 64/212 (30%), Positives = 99/212 (46%), Gaps = 20/212 (9%)
Query: 389 LGEGGFGCVYKGVLADGR---EVAVKQLKIG-GSQGERE-FRAEVEIISRVHHRHLVSLV 443
LGEG FG V +G L +VAVK +KI ++ E E F +E + H +++ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 444 GYCISERER------LLVYEYVPNDTLH-YHLHAE--GRPV-MDWATRVKVAAGAARGIA 493
G C+ E +++ ++ + LH + L++ P + VK A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 494 YLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMA 553
YL IHRD+ + N +L+ + VADFGL+K D M ++A
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM-PVKWIA 182
Query: 554 PEYATSGKLTEKSDVYSFGVVLLELIT-GRKP 584
E T KSDV+SFGV + E+ T G+ P
Sbjct: 183 IESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 3e-15
Identities = 67/232 (28%), Positives = 96/232 (41%), Gaps = 45/232 (19%)
Query: 388 VLGEGGFGCVYKGVLA----DGREVAVKQLK----IGGSQGEREFRAEVEIISRVHHRHL 439
V+G G FG V+ L G+ A+K L+ I +Q RAE +I++ +
Sbjct: 8 VIGRGAFGEVW---LVRDKDTGQVYAMKVLRKSDMIKRNQ-IAHVRAERDILADADSPWI 63
Query: 440 VSLVGYCISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHED 498
V L Y + E L LV EY+P L L + + A R +A + +H+
Sbjct: 64 VKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETA-RFYIAELVL-ALDSVHKL 120
Query: 499 CHPRIIHRDIKSSNILLDSSFEARVADFGLAK---------------IALELDSNTHVST 543
IHRDIK NIL+D+ ++ADFGL K L N V
Sbjct: 121 GF---IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR 177
Query: 544 R-----------VMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKP 584
R +GT Y+APE + D +S GV+L E++ G P
Sbjct: 178 RDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 4e-15
Identities = 41/202 (20%), Positives = 67/202 (33%), Gaps = 5/202 (2%)
Query: 77 APPPPEVDP-SPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPAN 135
P P + P+PA P A AP+P P P +++ V P+ SP P
Sbjct: 373 GPATAAAAPVAQPAPAAAAPAAAAPAPAAPPAAPAAAPAAAAAARAVAAAPARRSPAPEA 432
Query: 136 VRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPH 195
+ +S+ P PA + + P P ++ P ++ + P P P
Sbjct: 433 LAAARQASARGPGGAPAPAPAPAAAPAAAARPAAAGPRPVAAAAAAAPARAAPAAAPAPA 492
Query: 196 PSQSAP----PPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTPPLPS 251
P PP SP + P + S P + + + +P+ P P
Sbjct: 493 DDDPPPWEELPPEFASPAPAQPDAAPAGWVAESIPDPATADPDDAFETLAPAPAAAPAPR 552
Query: 252 VPTEKPTAKSTNGTAVSANASP 273
+ SA+ P
Sbjct: 553 AAAATEPVVAPRPPRASASGLP 574
|
Length = 700 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 4e-15
Identities = 70/270 (25%), Positives = 122/270 (45%), Gaps = 38/270 (14%)
Query: 387 NVLGEGGFGCVYKG-VLADGREVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVG 444
+LG G G VYK L R +AVK + + + + +++ +E+EI+ + +++ G
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYG 66
Query: 445 YCISERERLLVYEYVPNDTLHYHL----HAEGRPVMDWATRVKVAAGAARGIAYLHEDCH 500
E + E++ +L + H GR +A +G+ YL
Sbjct: 67 AFFVENRISICTEFMDGGSLDVYRKIPEHVLGR----------IAVAVVKGLTYLWS--- 113
Query: 501 PRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSG 560
+I+HRD+K SN+L+++ + ++ DFG++ + + T+V GT YMAPE +
Sbjct: 114 LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV-----GTNAYMAPERISGE 168
Query: 561 KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPL-LAEALEHEDFEALVDS 619
+ SDV+S G+ +EL GR P Q SL+ PL L + + ED L
Sbjct: 169 QYGIHSDVWSLGISFMELALGRFPYPQIQK-NQGSLM----PLQLLQCIVDEDPPVLPVG 223
Query: 620 RLEKNYVDSEMFWMIEAAAACVRHSATKRP 649
+ + +V C+R +RP
Sbjct: 224 QFSEKFVH--------FITQCMRKQPKERP 245
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 4e-15
Identities = 66/204 (32%), Positives = 102/204 (50%), Gaps = 16/204 (7%)
Query: 388 VLGEGGFGCVY---KGVLAD-GREVAVKQLKIGGSQGEREFRAEVE--IISRVHHRHLVS 441
VLG+G FG V+ K D G+ A+K LK + R ++E I++ V+H +V
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 442 LVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKV-AAGAARGIAYLHEDCH 500
L +E + L+ +++ L L E VM VK A A + +LH
Sbjct: 63 LHYAFQTEGKLYLILDFLRGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHS--- 116
Query: 501 PRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSG 560
II+RD+K NILLD ++ DFGL+K +++ + + GT YMAPE
Sbjct: 117 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY---SFCGTVEYMAPEVVNRR 173
Query: 561 KLTEKSDVYSFGVVLLELITGRKP 584
T+ +D +SFGV++ E++TG P
Sbjct: 174 GHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 4e-15
Identities = 61/215 (28%), Positives = 105/215 (48%), Gaps = 19/215 (8%)
Query: 383 FSAHNVLGEGGFGCVYKGVLADGRE---VAVKQLKIGGSQGERE-FRAEVEIISRVHHRH 438
F+ +G+G FG V+KG+ D R VA+K + + ++ E E + E+ ++S+ +
Sbjct: 6 FTKLERIGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 439 LVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHED 498
+ G + + ++ EY+ + L A AT +K +G+ YLH +
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK---EILKGLDYLHSE 120
Query: 499 CHPRIIHRDIKSSNILLDSSFEARVADFGLAK--IALELDSNTHVSTRVMGTFGYMAPEY 556
+ IHRDIK++N+LL + ++ADFG+A ++ NT V GT +MAPE
Sbjct: 121 ---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-----GTPFWMAPEV 172
Query: 557 ATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPL 591
K+D++S G+ +EL G P P+
Sbjct: 173 IQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM 207
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 4e-15
Identities = 62/213 (29%), Positives = 104/213 (48%), Gaps = 35/213 (16%)
Query: 389 LGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGERE------FRAEVEIISRVHHRHLVS 441
+GEG +G VYKG G+ VA+K++++ + E E R E+ ++ + H ++V
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRL---ESEEEGVPSTAIR-EISLLKELQHPNIVC 63
Query: 442 LVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHED--- 498
L + E L++E++ D Y MD A VK +YL++
Sbjct: 64 LQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMD-AELVK---------SYLYQILQG 113
Query: 499 ---CHP-RIIHRDIKSSNILLDSSFEARVADFGLAK-IALELDSNTHVSTRVMGTFGYMA 553
CH R++HRD+K N+L+D+ ++ADFGLA+ + + TH T Y A
Sbjct: 114 ILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV----TLWYRA 169
Query: 554 PEYAT-SGKLTEKSDVYSFGVVLLELITGRKPV 585
PE S + + D++S G + E+ T +KP+
Sbjct: 170 PEVLLGSPRYSTPVDIWSIGTIFAEMAT-KKPL 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 5e-15
Identities = 65/257 (25%), Positives = 121/257 (47%), Gaps = 21/257 (8%)
Query: 383 FSAHNVLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGEREFRAEVEIISRV-HHRHLV 440
F ++G G +G VYKG + G+ A+K + + G + E E + E+ ++ + HHR++
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIA 66
Query: 441 SLVGYCISER------ERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAY 494
+ G I + + LV E+ ++ + + + RG+++
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 126
Query: 495 LHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAP 554
LH+ ++IHRDIK N+LL + E ++ DFG ++ +LD +GT +MAP
Sbjct: 127 LHQH---KVIHRDIKGQNVLLTENAEVKLVDFG---VSAQLDRTVGRRNTFIGTPYWMAP 180
Query: 555 EYATSGKLTE-----KSDVYSFGVVLLELITGRKPVDASQPLGDESLVEW-ARPLLAEAL 608
E + + KSD++S G+ +E+ G P+ P+ L+ P L
Sbjct: 181 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKK 240
Query: 609 EHEDFEALVDSRLEKNY 625
+ F++ ++S L KN+
Sbjct: 241 WSKKFQSFIESCLVKNH 257
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 5e-15
Identities = 77/271 (28%), Positives = 115/271 (42%), Gaps = 42/271 (15%)
Query: 388 VLGEGGFGCVYKGVL-ADGREVAVKQLKIGGSQGEREFRA---EVEIISRVHHRHLVSLV 443
VLG+G FG V L GR AVK LK + + E I+S + ++ +
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 444 GYCISERERLL-VYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPR 502
C +RL V E+V L +H+ R D A AA + +LH+
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR--FDEARARFYAAEITSALMFLHDK---G 116
Query: 503 IIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKL 562
II+RD+K N+LLD ++ADFG+ K E N ++ GT Y+APE
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCK---EGIFNGKTTSTFCGTPDYIAPEILQEMLY 173
Query: 563 TEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHED--FEALVDSR 620
D ++ GV+L E++ G P +A E+ED FEA+++
Sbjct: 174 GPSVDWWAMGVLLYEMLCGHAPFEA---------------------ENEDDLFEAILND- 211
Query: 621 LEKNYVDSEMFWMIEAAAACVRHSATKRPRM 651
E Y W+ + A ++ TK P M
Sbjct: 212 -EVVYPT----WLSQDAVDILKAFMTKNPTM 237
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 6e-15
Identities = 44/202 (21%), Positives = 65/202 (32%), Gaps = 10/202 (4%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPP--PSPPTSTPPSPPTAPPPSS 58
P P ++ PA A P +PP +P + + A+ P SP + A
Sbjct: 385 PAPAAAAPAAAAPAPAAPPAAPAAAPAAAAAARAVAAAPARRSPAPEALAAARQASARGP 444
Query: 59 PAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPP 118
+P P P++ P P P + A P AP+ P P P
Sbjct: 445 GGAPAPAPAPAAAPAAAARPAAAGPRP-VAAAAAAAPARAAPAAAPAPADDDPPPWEELP 503
Query: 119 PANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSS 178
P +SP PA P+ PAT P P ++ +P ++
Sbjct: 504 PE-------FASPAPAQPDAAPAGWVAESIPDPATADPDDAFETLAPAPAAAPAPRAAAA 556
Query: 179 NPPTSTPSPPVLTPPPHPSQSA 200
P P PP + P
Sbjct: 557 TEPVVAPRPPRASASGLPDMFD 578
|
Length = 700 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 7e-15
Identities = 36/115 (31%), Positives = 51/115 (44%), Gaps = 1/115 (0%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
+S P A P + P PP S+ P+ P P P SP S+ P P++ +P
Sbjct: 166 TNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPSSPSDSSLPPAPSSFQSDTPP 225
Query: 61 VNSPPPQPSSPPPPLDAPPPPEVDPSPPSP-AQPPPQAVAPSPPPPANVPTTPSS 114
+ P SPPP APPPP V PP A+P P + + +P P + +
Sbjct: 226 PSPESPTNPSPPPGPAAPPPPPVQQVPPLSTAKPTPPSASATPAPIGGITLDDDA 280
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 7e-15
Identities = 61/218 (27%), Positives = 105/218 (48%), Gaps = 26/218 (11%)
Query: 389 LGEGGFGCVYKGVL---ADGRE---VAVKQLKIGGSQGERE-FRAEVEIISRVHHRHLVS 441
LGE FG VYKG L A G + VA+K LK RE F+ E + SR+ H ++V
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 442 LVGYCISERERLLVYEYVPNDTLHYHL-----HAEG---------RPVMDWATRVKVAAG 487
L+G E+ +++ Y + LH L H++ + ++ A V +
Sbjct: 73 LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132
Query: 488 AARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMG 547
A G+ +L ++H+D+ + N+L+ +++D GL + D + ++
Sbjct: 133 IAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLL- 188
Query: 548 TFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKP 584
+M+PE GK + SD++S+GVVL E+ + G +P
Sbjct: 189 PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 9e-15
Identities = 59/236 (25%), Positives = 84/236 (35%), Gaps = 20/236 (8%)
Query: 16 PSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPL 75
P+PP P + A+ PP PP + P+ APP + P PP
Sbjct: 255 PAPPPVVGEGADRAPETARGATGPPPPPEAAAPNGAAAPPDGVWGAALAGAPLALPAPPD 314
Query: 76 DAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPT----------TPSSSSPPPANVPTT 125
PP P D + V+P P P + P TP SS +
Sbjct: 315 PPPPAPAGDAEEEDDEDGAMEVVSPLPRPRQHYPLGFPKRRRPTWTPPSSLEDLSAGRHH 374
Query: 126 PSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTP 185
P +S P R+ +++P + PV P + +P P S+ PP +TP
Sbjct: 375 PKRASLPTRKRRSARHAATPFARGPGGDDQTRPAAPVPASVPTPAPTPVPASAPPPPATP 434
Query: 186 SPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVS------PPAPP 235
P + P PP + PPA P P P ++ A+ PP PP
Sbjct: 435 LP---SAEPGSDDGPAPPPERQPPAPATEPAPDD-PDDATRKALDALRERRPPEPP 486
|
Length = 3151 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 9e-15
Identities = 64/216 (29%), Positives = 103/216 (47%), Gaps = 28/216 (12%)
Query: 389 LGEGGFGCVYK----GVLADGRE----VAVKQLKIGGSQGE-REFRAEVEIISRV-HHRH 438
LGEG FG V + G+ + VAVK LK + + + +E+E++ + H++
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 439 LVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWA---TR-----------VKV 484
+++L+G C E ++ EY L L A P D+ T+ V
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 485 AAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTR 544
A ARG+ YL R IHRD+ + N+L+ ++ADFGLA+ ++D S
Sbjct: 140 AYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 545 VMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT 580
+ +MAPE T +SDV+SFG+++ E+ T
Sbjct: 197 RL-PVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 9e-15
Identities = 65/210 (30%), Positives = 95/210 (45%), Gaps = 23/210 (10%)
Query: 389 LGEGGFGCVYKGVLADGRE----VAVKQLKIGGSQGEREFR---AEVEIISRVHHRHLVS 441
+G+GG+G V+ LA ++ VA+K++K E R E +I++ LV
Sbjct: 9 VGQGGYGQVF---LAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVK 65
Query: 442 LVGYCISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCH 500
L+ Y + E L L EYVP L+ G D A R +A + LHE
Sbjct: 66 LL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHA-RFYMAEMFE-AVDALHE--- 119
Query: 501 PRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSG 560
IHRD+K N L+D+S ++ DFGL+K + + V+G+ YMAPE
Sbjct: 120 LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTY------ANSVVGSPDYMAPEVLRGK 173
Query: 561 KLTEKSDVYSFGVVLLELITGRKPVDASQP 590
D +S G +L E + G P S P
Sbjct: 174 GYDFTVDYWSLGCMLYEFLCGFPPFSGSTP 203
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 36/124 (29%), Positives = 47/124 (37%), Gaps = 1/124 (0%)
Query: 26 TTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDP 85
P P P + +T + PA SP PSS P P PPE
Sbjct: 146 EDPNPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPS 205
Query: 86 SPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSS-PPPANVRTTPSSSS 144
SP + PP + S PP + + + S PP P P PP + + TP S+S
Sbjct: 206 SPSDSSLPPAPSSFQSDTPPPSPESPTNPSPPPGPAAPPPPPVQQVPPLSTAKPTPPSAS 265
Query: 145 PPPA 148
PA
Sbjct: 266 ATPA 269
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 60/199 (30%), Positives = 102/199 (51%), Gaps = 15/199 (7%)
Query: 389 LGEGGFGCVYKG-VLADGREVAVKQLKIGGSQGE--REFRAEVEIISRVHHRHLVSLVGY 445
LGEG + V+KG VA+K++++ +G R EV ++ + H ++V+L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLHDI 71
Query: 446 CISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAA-GAARGIAYLHEDCHPRII 504
+ER LV+EY+ +D Y + M VK+ RG++Y H +I+
Sbjct: 72 IHTERCLTLVFEYLDSDLKQYLDNCGNLMSMH---NVKIFMFQLLRGLSYCH---KRKIL 125
Query: 505 HRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYAT-SGKLT 563
HRD+K N+L++ E ++ADFGLA+ A + + T+ + V T Y P+ S + +
Sbjct: 126 HRDLKPQNLLINEKGELKLADFGLAR-AKSVPTKTYSNEVV--TLWYRPPDVLLGSTEYS 182
Query: 564 EKSDVYSFGVVLLELITGR 582
D++ G +L E+ TGR
Sbjct: 183 TPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 59/226 (26%), Positives = 101/226 (44%), Gaps = 51/226 (22%)
Query: 383 FSAHNVLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGE------REFRAEVEIISRVH 435
+ + +GEG +G V G +VA+K KI S E R R E++I+ R
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIK--KI--SPFEHQTFCQRTLR-EIKILRRFK 61
Query: 436 HRHLVSLVGYCISE-----RERLLVYEYVP-------------NDTLHYHLHAEGRPVMD 477
H +++ ++ + +V E + ND + Y L+
Sbjct: 62 HENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQ------- 114
Query: 478 WATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDS 537
RG+ Y+H ++HRD+K SN+LL+++ + ++ DFGLA+IA
Sbjct: 115 ----------ILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHD 161
Query: 538 NTHVSTRVMGTFGYMAPEYATSGKLTEKS-DVYSFGVVLLELITGR 582
+T T + T Y APE + K K+ D++S G +L E+++ R
Sbjct: 162 HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 1e-14
Identities = 53/213 (24%), Positives = 104/213 (48%), Gaps = 26/213 (12%)
Query: 388 VLGEGGFGCVY--KGVLADGREVAVKQLKIGGS--QGEREFRAEVEIISRVHHRHLVSLV 443
+GEG FG +Y K +D +K++ + + + + EV +++++ H ++V+
Sbjct: 7 KIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65
Query: 444 GYCISERERLLVYEYVPNDTL-------HYHLHAEGRPVMDWATRVKVAAGAARGIAYLH 496
+V EY L L +E + ++ W ++ + G+ ++H
Sbjct: 66 ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQ-ILSWFVQI------SLGLKHIH 118
Query: 497 EDCHPRIIHRDIKSSNILLDSS-FEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPE 555
+ +I+HRDIKS NI L + A++ DFG+A+ L+ + ++ +GT Y++PE
Sbjct: 119 DR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQ---LNDSMELAYTCVGTPYYLSPE 172
Query: 556 YATSGKLTEKSDVYSFGVVLLELITGRKPVDAS 588
+ K+D++S G VL EL T + P + +
Sbjct: 173 ICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 69/203 (33%), Positives = 93/203 (45%), Gaps = 15/203 (7%)
Query: 388 VLGEGGFGCVYKGV-LADGREVAVKQLK---IGGSQGEREFRAEVEI-ISRVHHRHLVSL 442
V+G+G FG V ADG+ AVK L+ I + ++ AE + + V H LV L
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 443 VGYCISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHP 501
Y ++L V +YV L +HL E R + R AA A + YLH
Sbjct: 62 -HYSFQTADKLYFVLDYVNGGELFFHLQRE-RSFPEPRARF-YAAEIASALGYLHS---L 115
Query: 502 RIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGK 561
II+RD+K NILLDS + DFGL K +E T + GT Y+APE
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTT---STFCGTPEYLAPEVLRKQP 172
Query: 562 LTEKSDVYSFGVVLLELITGRKP 584
D + G VL E++ G P
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 63/205 (30%), Positives = 94/205 (45%), Gaps = 18/205 (8%)
Query: 388 VLGEGGFGCVYKGVLAD-GREVAVKQL---KIGGSQGEREFRAEVEIISRVHHRH--LVS 441
++G GGFG VY AD G+ A+K L +I QGE E ++S V +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 442 LVGYCISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCH 500
+ Y ++L + + + LHYHL G V A G+ ++H
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHNRF- 117
Query: 501 PRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSG 560
+++RD+K +NILLD R++D GLA D + +GT GYMAPE G
Sbjct: 118 --VVYRDLKPANILLDEHGHVRISDLGLA-----CDFSKKKPHASVGTHGYMAPEVLQKG 170
Query: 561 KLTEKS-DVYSFGVVLLELITGRKP 584
+ S D +S G +L +L+ G P
Sbjct: 171 TAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 19/210 (9%)
Query: 389 LGEGGFGCVYKGVLADGRE-VAVKQLKIGGS---QGEREFRAEVEIISRVHHRHLVSLVG 444
+G G FG V+ A+K + I + E+ E ++ V H ++ L
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL-- 66
Query: 445 YCISERERLL--VYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPR 502
+ +R L + EYVP L +L GR +T + A+ + YLH
Sbjct: 67 FWTEHDQRFLYMLMEYVPGGELFSYLRNSGR--FSNSTGLFYASEIVCALEYLHSK---E 121
Query: 503 IIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKL 562
I++RD+K NILLD ++ DFG AK +L T + GT Y+APE S
Sbjct: 122 IVYRDLKPENILLDKEGHIKLTDFGFAK---KLRDRTWT---LCGTPEYLAPEVIQSKGH 175
Query: 563 TEKSDVYSFGVVLLELITGRKPVDASQPLG 592
+ D ++ G+++ E++ G P P G
Sbjct: 176 NKAVDWWALGILIYEMLVGYPPFFDDNPFG 205
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 61/216 (28%), Positives = 103/216 (47%), Gaps = 28/216 (12%)
Query: 389 LGEGGFGCVY--------KGVLADGREVAVKQLKIGGSQGE-REFRAEVEIISRV-HHRH 438
LGEG FG V K + VAVK LK ++ + + +E+E++ + H++
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 439 LVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWA---TRV-----------KV 484
+++L+G C + ++ EY L +L A P M+++ RV
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 485 AAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTR 544
ARG+ YL + IHRD+ + N+L+ + ++ADFGLA+ +D +
Sbjct: 143 TYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 545 VMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT 580
+ +MAPE T +SDV+SFGV++ E+ T
Sbjct: 200 RL-PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 65/205 (31%), Positives = 96/205 (46%), Gaps = 18/205 (8%)
Query: 388 VLGEGGFGCVYKGVLAD-GREVAVKQL---KIGGSQGEREFRAEVEIISRVHHRH--LVS 441
++G GGFG VY AD G+ A+K L +I QGE E ++S V +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 442 LVGYCISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCH 500
+ Y ++L + + + LHYHL G V A AA G+ ++H
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG--VFSEAEMRFYAAEIILGLEHMHNRF- 117
Query: 501 PRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSG 560
+++RD+K +NILLD R++D GLA D + +GT GYMAPE G
Sbjct: 118 --VVYRDLKPANILLDEHGHVRISDLGLA-----CDFSKKKPHASVGTHGYMAPEVLQKG 170
Query: 561 KLTEKS-DVYSFGVVLLELITGRKP 584
+ S D +S G +L +L+ G P
Sbjct: 171 VAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 20/205 (9%)
Query: 389 LGEGGFGCVYKGVLADGRE-VAVKQLKI-GGSQG--EREFRAEVEIISRVHHRHLVSLVG 444
+GEG +G V+K + E VA+K++++ +G R E+ ++ + H+++V L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRLYD 66
Query: 445 YCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRII 504
S+++ LV+EY D Y G +D +G+A+ H ++
Sbjct: 67 VLHSDKKLTLVFEYCDQDLKKYFDSCNGD--IDPEIVKSFMFQLLKGLAFCHSH---NVL 121
Query: 505 HRDIKSSNILLDSSFEARVADFGLAK---IALELDSNTHVSTRVMGTFGYMAPEYATSGK 561
HRD+K N+L++ + E ++ADFGLA+ I + S V T Y P+ K
Sbjct: 122 HRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV------TLWYRPPDVLFGAK 175
Query: 562 LTEKS-DVYSFGVVLLELITGRKPV 585
L S D++S G + EL +P+
Sbjct: 176 LYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 74.4 bits (182), Expect = 2e-14
Identities = 53/210 (25%), Positives = 101/210 (48%), Gaps = 10/210 (4%)
Query: 383 FSAHNVLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVS 441
++ + +G+G G V+ + +A G+EVA+KQ+ + + E+ ++ + + ++V+
Sbjct: 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVN 80
Query: 442 LVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHP 501
+ + E +V EY+ +L MD A V + + +LH +
Sbjct: 81 FLDSFLVGDELFVVMEYLAGGSL---TDVVTETCMDEAQIAAVCRECLQALEFLHAN--- 134
Query: 502 RIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGK 561
++IHRDIKS N+LL ++ DFG ++ + ++GT +MAPE T
Sbjct: 135 QVIHRDIKSDNVLLGMDGSVKLTDFGFCA---QITPEQSKRSTMVGTPYWMAPEVVTRKA 191
Query: 562 LTEKSDVYSFGVVLLELITGRKPVDASQPL 591
K D++S G++ +E++ G P PL
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPPYLNENPL 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 64/212 (30%), Positives = 102/212 (48%), Gaps = 39/212 (18%)
Query: 388 VLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGEREFRA--EVEIISRVHHRHLVSLVG 444
LGEG + VYKG G+ VA+K++++ +G F A E ++ + H ++V+L
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA-PFTAIREASLLKDLKHANIVTLHD 70
Query: 445 YCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATR------VKV-AAGAARGIAYLHE 497
+++ LV+EY+ D Y MD V++ RG+AY H
Sbjct: 71 IIHTKKTLTLVFEYLDTDLKQY---------MDDCGGGLSMHNVRLFLFQLLRGLAYCH- 120
Query: 498 DCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAP--- 554
R++HRD+K N+L+ E ++ADFGLA+ A + S T+ + V T Y P
Sbjct: 121 --QRRVLHRDLKPQNLLISERGELKLADFGLAR-AKSVPSKTYSNEVV--TLWYRPPDVL 175
Query: 555 ----EYATSGKLTEKSDVYSFGVVLLELITGR 582
EY+TS D++ G + E+ TGR
Sbjct: 176 LGSTEYSTS------LDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 63/219 (28%), Positives = 104/219 (47%), Gaps = 34/219 (15%)
Query: 389 LGEGGFGCVYKGVLADG-----------REVAVKQLKIGGSQGE-REFRAEVEIISRV-H 435
LGEG FG V V+A+ +VAVK LK ++ + + +E+E++ +
Sbjct: 26 LGEGCFGQV---VMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 82
Query: 436 HRHLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATR-------------- 481
H+++++L+G C + ++ EY L +L A P M++
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 482 VKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHV 541
V A ARG+ YL + IHRD+ + N+L+ ++ADFGLA+ +D
Sbjct: 143 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 199
Query: 542 STRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT 580
+ + +MAPE T +SDV+SFGV+L E+ T
Sbjct: 200 TNGRL-PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 76.4 bits (189), Expect = 2e-14
Identities = 34/156 (21%), Positives = 53/156 (33%), Gaps = 8/156 (5%)
Query: 16 PSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPL 75
P+ PL P PP ++ P AS + + +PP AP P ++P P+ P P
Sbjct: 361 PAAPLPEPEV--PPQSAAPAASAQATAAPTAAVAPPQAPAVPPPPASAPQQAPAVPLPE- 417
Query: 76 DAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPA- 134
+ S P A+ +S+ A+V PS+ PA
Sbjct: 418 --TTSQLLAARQQLQRAQGATKAKKSEPAAASRARPVNSALERLASVRPAPSALEKAPAK 475
Query: 135 --NVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPP 168
R ++ ATP + + TP
Sbjct: 476 KEAYRWKATNPVEVKKEPVATPKALKKALEHEKTPE 511
|
Length = 647 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 2e-14
Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 12/205 (5%)
Query: 389 LGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCI 447
+G+G G VY + +A G+EVA++Q+ + + E+ ++ + ++V+ + +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 448 SERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRD 507
E +V EY+ +L MD V + + +LH + ++IHRD
Sbjct: 88 VGDELWVVMEYLAGGSL---TDVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHRD 141
Query: 508 IKSSNILLDSSFEARVADFGL-AKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKS 566
IKS NILL ++ DFG A+I E + ++GT +MAPE T K
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS----TMVGTPYWMAPEVVTRKAYGPKV 197
Query: 567 DVYSFGVVLLELITGRKPVDASQPL 591
D++S G++ +E+I G P PL
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENPL 222
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 74.5 bits (184), Expect = 2e-14
Identities = 68/213 (31%), Positives = 109/213 (51%), Gaps = 36/213 (16%)
Query: 389 LGEGGFGCVYKGVLADGRE-VAVKQLKIGGSQG-----EREFRAEVEIISRV-HHRHLVS 441
LG+G +G V+K + +E VA+K KI + +R FR E+ + + H ++V
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALK--KIFDAFRNATDAQRTFR-EIMFLQELGDHPNIVK 71
Query: 442 LVGYCISERER--LLVYEYVPNDTLHYHLHAEGRP--VMDWATRVKVAAGAARGIAYLHE 497
L+ +E ++ LV+EY+ D LHA R + D R + + + Y+H
Sbjct: 72 LLNVIKAENDKDIYLVFEYMETD-----LHAVIRANILEDVHKRY-IMYQLLKALKYIHS 125
Query: 498 DCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNT-------HVSTRVMGTFG 550
+IHRD+K SNILL+S ++ADFGLA+ EL+ N +V+TR
Sbjct: 126 G---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATR-----W 177
Query: 551 YMAPE-YATSGKLTEKSDVYSFGVVLLELITGR 582
Y APE S + T+ D++S G +L E++ G+
Sbjct: 178 YRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 3e-14
Identities = 65/245 (26%), Positives = 115/245 (46%), Gaps = 15/245 (6%)
Query: 383 FSAHNVLGEGGFGCVYKGVLADGRE---VAVKQLKIGGSQGERE-FRAEVEIISRVHHRH 438
F+ +G+G FG V+KG+ D R VA+K + + ++ E E + E+ ++S+ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 439 LVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHED 498
+ G + + + ++ EY+ + L E P +D + +G+ YLH +
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGP-LDETQIATILREILKGLDYLHSE 120
Query: 499 CHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYAT 558
+ IHRDIK++N+LL E ++ADFG+A +L +GT +MAPE
Sbjct: 121 ---KKIHRDIKAANVLLSEHGEVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVIK 174
Query: 559 SGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVD 618
K+D++S G+ +EL G P P+ L+ P E + + V+
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVE 234
Query: 619 SRLEK 623
+ L K
Sbjct: 235 ACLNK 239
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 3e-14
Identities = 30/131 (22%), Positives = 48/131 (36%), Gaps = 1/131 (0%)
Query: 11 LAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSS 70
LA P + + P+ P P A+P +P +P A P++ A P ++
Sbjct: 362 LAFKPAAAAEAAAPAEKKTPARPEAAAPAAAPVAQAAAAPAPAAAPAAAASAPAAPPAAA 421
Query: 71 PPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPAN-VPTTPSSS 129
PP P+ AP +P + A AP P +P PA ++
Sbjct: 422 PPAPVAAPAAAAPAAAPAAAPAAVALAPAPPAQAAPETVAIPVRVAPEPAVASAAPAPAA 481
Query: 130 SPPPANVRTTP 140
+P A + T
Sbjct: 482 APAAARLTPTE 492
|
Length = 618 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 4e-14
Identities = 49/206 (23%), Positives = 70/206 (33%), Gaps = 15/206 (7%)
Query: 54 PPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPS 113
P ++ P P S PP P P P+ P+ P A AP+ A P +
Sbjct: 591 APGAAGGEGPPAPASSGPPEEAARPAAPAA-PAAPAAPAPAGAAAAPAEASAAPAPGVAA 649
Query: 114 SSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSP 173
P S P A A + P P P+ ++P
Sbjct: 650 PEHHPKHVAVPDASDGGDG-----------WPAKAGGAAPAAPPPAPAPAAPAAPAGAAP 698
Query: 174 PPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPP--PSVPSTSSPPAVSP 231
P+ P + P+ P P Q+A SP A P P P P + P
Sbjct: 699 AQPAPAPAATPPAGQADDPAAQPPQAAQGASAPSPAADDPVPLPPEPDDPPDPAGAPAQP 758
Query: 232 PAPPSNSSTRGSPSTPPLPSVPTEKP 257
P PP+ + +P+ P PS P+E+
Sbjct: 759 PPPPAPA-PAAAPAAAPPPSPPSEEE 783
|
Length = 824 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 4e-14
Identities = 38/138 (27%), Positives = 49/138 (35%), Gaps = 14/138 (10%)
Query: 14 PPPSPPL-------SPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPP 66
P P PPL + + A P + P+ P S P P SP + P
Sbjct: 148 PNPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPSSP 207
Query: 67 QPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTP 126
SS PP AP + D PPSP P + P P P P P PT P
Sbjct: 208 SDSSLPP---APSSFQSDTPPPSPESPTNPSPPPGPAAPP--PPPVQQVPPLSTAKPTPP 262
Query: 127 SSSSP--PPANVRTTPSS 142
S+S+ P + +
Sbjct: 263 SASATPAPIGGITLDDDA 280
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 5e-14
Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 12/205 (5%)
Query: 389 LGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCI 447
+G+G G VY + +A G+EVA+KQ+ + + E+ ++ + ++V+ + +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 448 SERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRD 507
E +V EY+ +L MD V + + +LH + ++IHRD
Sbjct: 87 VGDELWVVMEYLAGGSL---TDVVTETCMDEGQIAAVCRECLQALDFLHSN---QVIHRD 140
Query: 508 IKSSNILLDSSFEARVADFGL-AKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKS 566
IKS NILL ++ DFG A+I E + ++GT +MAPE T K
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS----TMVGTPYWMAPEVVTRKAYGPKV 196
Query: 567 DVYSFGVVLLELITGRKPVDASQPL 591
D++S G++ +E++ G P PL
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENPL 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 6e-14
Identities = 40/193 (20%), Positives = 58/193 (30%), Gaps = 3/193 (1%)
Query: 68 PSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPS 127
P+ + PP P P A+P A +P PA + + A P +
Sbjct: 590 PAPGAAGGEGPPAPASSGPPEEAARPAAPAAPAAPAAPAPAGAAAAPAEASAAPAPGVAA 649
Query: 128 SSSPPPANVRTTPSSS---SPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTST 184
P S P A A + P P P+ ++P P+ P +
Sbjct: 650 PEHHPKHVAVPDASDGGDGWPAKAGGAAPAAPPPAPAPAAPAAPAGAAPAQPAPAPAATP 709
Query: 185 PSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSP 244
P+ P P Q+A SP A P PP P PP + +
Sbjct: 710 PAGQADDPAAQPPQAAQGASAPSPAADDPVPLPPEPDDPPDPAGAPAQPPPPPAPAPAAA 769
Query: 245 STPPLPSVPTEKP 257
P P +
Sbjct: 770 PAAAPPPSPPSEE 782
|
Length = 824 |
| >gnl|CDD|235906 PRK07003, PRK07003, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 6e-14
Identities = 43/253 (16%), Positives = 76/253 (30%), Gaps = 14/253 (5%)
Query: 32 SPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPA 91
P P + P A + ++ P + A P + + A
Sbjct: 366 GAPGGGVPARVAGAVPAPGARAAA--AVGASAVPAVTAVTGAAGAALAPKAAAAAAATRA 423
Query: 92 QPPPQAVAPSP---------PPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSS 142
+ PP A AP A VP ++ + + + + S
Sbjct: 424 EAPPAAPAPPATADRGDDAADGDAPVPAKANARASADSRCDERDAQPPADSGSASAPASD 483
Query: 143 SSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPP 202
+ P A PA +++ P + + + P + P PP P+ +AP
Sbjct: 484 APPDAAFEPAPRAAAPSAATPAAVPDARAPAAASREDAPAAAAPPAPEARPPTPAAAAPA 543
Query: 203 PVTKSPPAS--TLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTPPLPSVPTEKPTAK 260
A+ L V S A + P + + P+ P +V P A+
Sbjct: 544 ARAGGAAAALDVLRNAGMRVSSDRGARAAAAAKPAAAPAAAPKPAAPR-VAVQVPTPRAR 602
Query: 261 STNGTAVSANASP 273
+ G A A+
Sbjct: 603 AATGDAPPNGAAR 615
|
Length = 830 |
| >gnl|CDD|220392 pfam09770, PAT1, Topoisomerase II-associated protein PAT1 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 7e-14
Identities = 54/240 (22%), Positives = 62/240 (25%), Gaps = 11/240 (4%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPS---TTPPPTSPPPASPPPSPPTSTPPSPPTAPPPS 57
P S P P L P PS T P P PP +P P TP +
Sbjct: 100 FSPCQSGYEASTDPEYIPDLQPDPSLWGTAPKPEPQPPQAPESQPQPQTPAQKMLSLEEV 159
Query: 58 SPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSP 117
+ P P PP P P Q PP+ P PP P
Sbjct: 160 EAQLQQRQQAPQLPQPPQQVLPQGMPPRQAAFPQQGPPEQPPGYPQPPQGHPEQVQPQQF 219
Query: 118 PPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPS 177
PA S +P + PP S PP P PP PP
Sbjct: 220 LPAP------SQAPAQPPLPPQLPQQPPPLQQPQFPGLSQQMPP-PPPQPPQQQQQPPQP 272
Query: 178 SNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSN 237
P P P Q+AP P + P L P
Sbjct: 273 QAQPPPQNQPTPH-PGLPQGQNAPLPPPQQPQLLPLVQQPQGQQRGPQFREQLVQLSQQQ 331
|
Members of this family are necessary for accurate chromosome transmission during cell division. Length = 804 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 8e-14
Identities = 71/253 (28%), Positives = 119/253 (47%), Gaps = 26/253 (10%)
Query: 389 LGEGGFGCVYKGVLADGREVAVKQLKIGGSQGERE-FRAEVEIISRVHHRHLVSLVGYCI 447
LG+G FG VYK + +A ++ S+ E E + E++I++ H ++V L+
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 448 SERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRD 507
E ++ E+ + + RP+ + RV V + YLHE+ +IIHRD
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRV-VCKQTLEALNYLHEN---KIIHRD 128
Query: 508 IKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTR---VMGTFGYMAPEYATSGKLTE 564
+K+ NIL + ++ADFG++ NT R +GT +MAPE +
Sbjct: 129 LKAGNILFTLDGDIKLADFGVSA------KNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 182
Query: 565 -----KSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWAR---PLLAEALE-HEDFEA 615
K+DV+S G+ L+E+ P P+ L++ A+ P LA+ +F+
Sbjct: 183 RPYDYKADVWSLGITLIEMAQIEPPHHELNPM--RVLLKIAKSEPPTLAQPSRWSSEFKD 240
Query: 616 LVDSRLEKNYVDS 628
+ LEKN VD+
Sbjct: 241 FLKKCLEKN-VDA 252
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 8e-14
Identities = 54/214 (25%), Positives = 110/214 (51%), Gaps = 30/214 (14%)
Query: 388 VLGEGGFGCV----YKGVLADGREVAVKQLKIGGSQGEREFRA---EVEIISRVHHRHLV 440
V+G+G +G V ++ DG++ +K+L + + RE +A E +++S++ H ++V
Sbjct: 7 VVGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNAS-RRERKAAEQEAQLLSQLKHPNIV 62
Query: 441 SLVGYCISERERL-LVYEYVPNDTLHYHLHAEG------RPVMDWATRVKVAAGAARGIA 493
+ E L +V + L++ L + V++W ++ +A +
Sbjct: 63 AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMA------LQ 116
Query: 494 YLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMA 553
YLHE I+HRD+K+ N+ L + +V D G+A++ L++ +++ ++GT YM+
Sbjct: 117 YLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARV---LENQCDMASTLIGTPYYMS 170
Query: 554 PEYATSGKLTEKSDVYSFGVVLLELITGRKPVDA 587
PE ++ KSDV++ G + E+ T + +A
Sbjct: 171 PELFSNKPYNYKSDVWALGCCVYEMATLKHAFNA 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 8e-14
Identities = 60/230 (26%), Positives = 97/230 (42%), Gaps = 43/230 (18%)
Query: 389 LGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGER---EFRAEVEIISRVHHRHLVSLVG 444
+G+GG G VY R VA+K+++ S+ F E +I + + H +V +
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYS 69
Query: 445 YCISERERLLVY---EYVPNDTLHYHL------------HAEGRPVMDWATRVKVAAGAA 489
C S+ + VY Y+ TL L AE V + +
Sbjct: 70 IC-SDGD--PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSV---GAFLSIFHKIC 123
Query: 490 RGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAK-IALELD------------ 536
I Y+H ++HRD+K NILL E + D+G A LE +
Sbjct: 124 ATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180
Query: 537 --SNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKP 584
S+ + +++GT YMAPE +E +D+Y+ GV+L +++T P
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 9e-14
Identities = 63/204 (30%), Positives = 95/204 (46%), Gaps = 17/204 (8%)
Query: 388 VLGEGGFGCVYKGVL-ADGREVAVKQLKIGGSQGEREFR---AEVEIISRV-HHRHLVSL 442
+LG+G FG V+ L + A+K LK + + E ++S H L L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 443 VGYC-ISERERLL-VYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCH 500
YC +E L V EY+ L +H+ + + D AA G+ +LH
Sbjct: 62 --YCTFQTKENLFFVMEYLNGGDLMFHIQSCHK--FDLPRATFYAAEIICGLQFLHSK-- 115
Query: 501 PRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSG 560
I++RD+K NILLD+ ++ADFG+ K + D+ T GT Y+APE
Sbjct: 116 -GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT---CTFCGTPDYIAPEILLGQ 171
Query: 561 KLTEKSDVYSFGVVLLELITGRKP 584
K D +SFGV+L E++ G+ P
Sbjct: 172 KYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 67/225 (29%), Positives = 108/225 (48%), Gaps = 42/225 (18%)
Query: 389 LGEGGFGCVYKG--VLADGREVAVKQLKIGGSQGE--REFRAEVEIISRVHHRHLVSLVG 444
LGEG + VYKG L D VA+K++++ +G R EV ++ + H ++V+L
Sbjct: 14 LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 71
Query: 445 YCISERERLLVYEYVPNDTLHY--------HLHAEGRPVMDWATRVKV-AAGAARGIAYL 495
+E+ LV+EY+ D Y ++H VK+ RG+ Y
Sbjct: 72 IIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMH-----------NVKLFLFQLLRGLNY- 119
Query: 496 HEDCHPR-IIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAP 554
CH R ++HRD+K N+L++ E ++ADFGLA+ A + + T+ + V T Y P
Sbjct: 120 ---CHRRKVLHRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYSNEVV--TLWYRPP 173
Query: 555 EYAT-SGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVE 598
+ S + + D++ G + E+ TGR PL S VE
Sbjct: 174 DILLGSTDYSTQIDMWGVGCIFYEMSTGR-------PLFPGSTVE 211
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-13
Identities = 64/219 (29%), Positives = 103/219 (47%), Gaps = 34/219 (15%)
Query: 389 LGEGGFGCVYKGVLADG-----------REVAVKQLKIGGSQGE-REFRAEVEIISRV-H 435
LGEG FG V V+A+ VAVK LK + + + +E+E++ +
Sbjct: 20 LGEGCFGQV---VMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGK 76
Query: 436 HRHLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWA--------------TR 481
H+++++L+G C + ++ EY L +L A P MD++
Sbjct: 77 HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL 136
Query: 482 VKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHV 541
V A ARG+ YL + IHRD+ + N+L+ ++ADFGLA+ +D
Sbjct: 137 VSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT 193
Query: 542 STRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT 580
+ + +MAPE T +SDV+SFGV+L E+ T
Sbjct: 194 TNGRL-PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 67/216 (31%), Positives = 93/216 (43%), Gaps = 22/216 (10%)
Query: 388 VLGEGGFGCVY----KGVLADGREVAVKQLK----IGGSQGEREFRAEVEIISRVHHR-H 438
VLG G +G V+ G G+ A+K LK + ++ R E +++ V
Sbjct: 7 VLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPF 66
Query: 439 LVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHED 498
LV+L ++ + L+ +YV L HL+ RV +A I +
Sbjct: 67 LVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES-EVRVYIAE-----IVLALDH 120
Query: 499 CHPR-IIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYA 557
H II+RDIK NILLDS + DFGL+K L + GT YMAPE
Sbjct: 121 LHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA--EEEERAYSFCGTIEYMAPEVI 178
Query: 558 TSGKLTEKS--DVYSFGVVLLELITGRKP--VDASQ 589
G D +S GV+ EL+TG P VD Q
Sbjct: 179 RGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ 214
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 1e-13
Identities = 63/251 (25%), Positives = 112/251 (44%), Gaps = 29/251 (11%)
Query: 389 LGEGGFGCVY----KGVLADGREVAVKQLKIGGSQGEREFRAEVE--IISRVHHRHLVSL 442
LG+G FG VY K +A+ R +K++ +G +A E ++S++ H +V
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 443 VGYCISERERLLVYEYVPNDTLHYHL----HAEGR----PVMDWATRVKVAAGAARGIAY 494
+ ++ EY L L H V +W ++ + G+ Y
Sbjct: 68 HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL------GVHY 121
Query: 495 LHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAP 554
+H+ RI+HRD+K+ NI L ++ ++ DFG++++ L + ++T GT YM+P
Sbjct: 122 MHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRL---LMGSCDLATTFTGTPYYMSP 174
Query: 555 EYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDE-SLVEWARPLLAEALEHEDF 613
E KSD++S G +L E+ + L +VE P L E +
Sbjct: 175 EALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQ-L 233
Query: 614 EALVDSRLEKN 624
+++ S L K+
Sbjct: 234 NSIMQSMLNKD 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|220392 pfam09770, PAT1, Topoisomerase II-associated protein PAT1 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 2e-13
Identities = 55/260 (21%), Positives = 67/260 (25%), Gaps = 34/260 (13%)
Query: 3 PQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPP----------- 51
S+ P +P + P + ++ P ST P
Sbjct: 70 KLSAAVRYNQNAPGAPSVGPDSDLSQKTSTFSPCQSGY--EASTDPEYIPDLQPDPSLWG 127
Query: 52 TAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVD------PSPPSPAQPPPQAV-APSPPP 104
TAP P +P QP P EV+ P QPP Q + PP
Sbjct: 128 TAPKPEPQPPQAPESQPQPQTPAQKMLSLEEVEAQLQQRQQAPQLPQPPQQVLPQGMPPR 187
Query: 105 PANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNV 164
A P P P P P P P+ PA P P
Sbjct: 188 QAAFPQQ--GPPEQPPGYPQPPQGHPEQVQ-----PQQFLPAPSQAPAQPPLPPQLP-QQ 239
Query: 165 PTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPP------ASTLSPPPP 218
P P P S P P PP P Q+ PPP + P PPP
Sbjct: 240 PPPLQQPQFPGLSQQMPPPPPQPPQQQQQPPQPQAQPPPQNQPTPHPGLPQGQNAPLPPP 299
Query: 219 SVPSTSSPPAVSPPAPPSNS 238
P
Sbjct: 300 QQPQLLPLVQQPQGQQRGPQ 319
|
Members of this family are necessary for accurate chromosome transmission during cell division. Length = 804 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 2e-13
Identities = 32/142 (22%), Positives = 49/142 (34%)
Query: 35 PASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPP 94
PA+P P P + P A ++ A + P +P P P+ P+ P P
Sbjct: 361 PAAPLPEPEVPPQSAAPAASAQATAAPTAAVAPPQAPAVPPPPASAPQQAPAVPLPETTS 420
Query: 95 PQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATP 154
A A T S P A+ +S+ A+VR PS+ PA A
Sbjct: 421 QLLAARQQLQRAQGATKAKKSEPAAASRARPVNSALERLASVRPAPSALEKAPAKKEAYR 480
Query: 155 SSSSPPPVNVPTPPSSSSPPPP 176
++ P P ++
Sbjct: 481 WKATNPVEVKKEPVATPKALKK 502
|
Length = 647 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 2e-13
Identities = 27/110 (24%), Positives = 44/110 (40%), Gaps = 2/110 (1%)
Query: 2 PPQSSPPAVLAVPPPSPP--LSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSP 59
P+++ PA V + + P+ + PPA+ PP+P + + P A P ++P
Sbjct: 383 RPEAAAPAAAPVAQAAAAPAPAAAPAAAASAPAAPPAAAPPAPVAAPAAAAPAAAPAAAP 442
Query: 60 AVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVP 109
A + P P + P P V P P + P A AP+
Sbjct: 443 AAVALAPAPPAQAAPETVAIPVRVAPEPAVASAAPAPAAAPAAARLTPTE 492
|
Length = 618 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 59/213 (27%), Positives = 101/213 (47%), Gaps = 28/213 (13%)
Query: 389 LGEGGFGCVYKGVLA----DGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVG 444
+GEG G V +A GR+VAVK++ + Q EV I+ H ++V +
Sbjct: 27 IGEGSTGIV---CIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYS 83
Query: 445 YCISERERLLVYEYVPNDTL-----HYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDC 499
+ E +V E++ L H ++ E AT V + +++LH
Sbjct: 84 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEE-----QIAT---VCLAVLKALSFLHAQ- 134
Query: 500 HPRIIHRDIKSSNILLDSSFEARVADFGL-AKIALELDSNTHVSTRVMGTFGYMAPEYAT 558
+IHRDIKS +ILL S +++DFG A+++ E+ ++GT +MAPE +
Sbjct: 135 --GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRR----KSLVGTPYWMAPEVIS 188
Query: 559 SGKLTEKSDVYSFGVVLLELITGRKPVDASQPL 591
+ D++S G++++E++ G P PL
Sbjct: 189 RLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 55/209 (26%), Positives = 102/209 (48%), Gaps = 33/209 (15%)
Query: 389 LGEGGFGCVYKGV-LADGREVAVKQLKIGG-SQG--EREFRAEVEIISRVHHRHLVSLVG 444
+GEG +G VYK G VA+K++++ ++G R E+ ++ ++H ++V L+
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLD 66
Query: 445 YCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAAR--------GIAYLH 496
+E + LV+E++ D + MD + + + G+A+
Sbjct: 67 VIHTENKLYLVFEFLHQDLKKF---------MDASPLSGIPLPLIKSYLFQLLQGLAF-- 115
Query: 497 EDCHP-RIIHRDIKSSNILLDSSFEARVADFGLAK-IALELDSNTHVSTRVMGTFGYMAP 554
CH R++HRD+K N+L+++ ++ADFGLA+ + + + TH T Y AP
Sbjct: 116 --CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAP 169
Query: 555 EYATSGKL-TEKSDVYSFGVVLLELITGR 582
E K + D++S G + E++T R
Sbjct: 170 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 65/213 (30%), Positives = 108/213 (50%), Gaps = 23/213 (10%)
Query: 380 TNGFSAHNVLGEGGFG--CVYKGVLADGREVAVKQLKIGGSQ---GEREFRAEVEIISRV 434
TN + +G G FG C + L G+ VA+K++ S +R +R E++++ +
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLT-GQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKHL 66
Query: 435 HHRHLVSLVGYCISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIA 493
H +++SL IS E + V E + D LH L + RP+ + RG+
Sbjct: 67 RHENIISLSDIFISPLEDIYFVTELLGTD-LHRLLTS--RPLEKQFIQY-FLYQILRGLK 122
Query: 494 YLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMA 553
Y+H ++HRD+K SNIL++ + + ++ DFGLA+I + +VSTR Y A
Sbjct: 123 YVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQ-DPQMTGYVSTRY-----YRA 173
Query: 554 PEYA-TSGKLTEKSDVYSFGVVLLELITGRKPV 585
PE T K + D++S G + E++ G KP+
Sbjct: 174 PEIMLTWQKYDVEVDIWSAGCIFAEMLEG-KPL 205
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 70/220 (31%), Positives = 105/220 (47%), Gaps = 35/220 (15%)
Query: 383 FSAHNVLGEGGFGCVYKGVLADGR---EV-AVKQLK----IGGSQGEREFRAEVEIISRV 434
F+ VLG+G FG K +LA+ + E+ A+K LK I E E +++
Sbjct: 2 FNFLMVLGKGSFG---KVMLAERKGTDELYAIKILKKDVIIQDDDVECTM-VEKRVLALP 57
Query: 435 HHRHLVSLVGYCISERERL-LVYEYVPNDTLHYHLHAEGR---PVMDWATRVKVAAGAAR 490
++ + C +RL V EYV L YH+ G+ P V AA A
Sbjct: 58 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHA-----VFYAAEIAI 112
Query: 491 GIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVM-GTF 549
G+ +LH II+RD+K N++LD+ ++ADFG+ K + +TR GT
Sbjct: 113 GLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENI----FGGKTTRTFCGTP 165
Query: 550 GYMAPE---YATSGKLTEKSDVYSFGVVLLELITGRKPVD 586
Y+APE Y GK D ++FGV+L E++ G+ P D
Sbjct: 166 DYIAPEIIAYQPYGK---SVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 56/217 (25%), Positives = 101/217 (46%), Gaps = 29/217 (13%)
Query: 389 LGEGGFGCVYK------GVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSL 442
LG+G FG VYK G LA A K ++ + ++ E+EI++ +H ++V L
Sbjct: 20 LGDGAFGKVYKAKNKETGALA-----AAKVIETKSEEELEDYMVEIEILATCNHPYIVKL 74
Query: 443 VGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPR 502
+G + + ++ E+ P + + R + + +V + + YLH +
Sbjct: 75 LGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-ICRQMLEALQYLHSM---K 130
Query: 503 IIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTR---VMGTFGYMAPEYATS 559
IIHRD+K+ N+LL + ++ADFG++ N R +GT +MAPE
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVSA------KNVKTLQRRDSFIGTPYWMAPEVVMC 184
Query: 560 GKLTE-----KSDVYSFGVVLLELITGRKPVDASQPL 591
+ + K+D++S G+ L+E+ P P+
Sbjct: 185 ETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM 221
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|235906 PRK07003, PRK07003, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-13
Identities = 42/234 (17%), Positives = 69/234 (29%), Gaps = 34/234 (14%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
P+++ A PP +P P T P P + + + A
Sbjct: 410 LAPKAAAAAAATRAEA-PPAAPAPPATADRGDDAADGDAPVPAKANARASADSRCDERDA 468
Query: 61 VNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPS----SSS 116
+S P DAPP +P+P + A A + ++
Sbjct: 469 QPPADSGSASAPAS-DAPPDAAFEPAPRAAAPSAATPAAVPDARAPAAASREDAPAAAAP 527
Query: 117 PPPANVPTTPSSSSPP---------------------PANVRTTPSSSSPPPANVPATPS 155
P P P TP++++P +++ P A A
Sbjct: 528 PAPEARPPTPAAAAPAARAGGAAAALDVLRNAGMRVSSDRGARAAAAAKPAAAPAAAPKP 587
Query: 156 SSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPP 209
++ V VPTP + ++ N S+ APPP PP
Sbjct: 588 AAPRVAVQVPTPRARAATGDAPPNGAAR-------AEQAAESRGAPPPWEDIPP 634
|
Length = 830 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 3e-13
Identities = 33/130 (25%), Positives = 46/130 (35%), Gaps = 6/130 (4%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPA--SPPPSPPTSTPPSPPTAPPPSS 58
P + PA P+ + P P + P A S P +PP + PP+P AP ++
Sbjct: 374 APAEKKTPARPEAAAPAAAPVAQAAAAPAPAAAPAAAASAPAAPPAAAPPAPVAAPAAAA 433
Query: 59 P-AVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSP 117
P A + P + P A PE P A P A A P A + +
Sbjct: 434 PAAAPAAAPAAVALAPAPPAQAAPETVAIPVRVAPEPAVASAAPAPAAAPAAARLTPTEE 493
Query: 118 PP---ANVPT 124
A V
Sbjct: 494 GDVWHATVQQ 503
|
Length = 618 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 3e-13
Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 21/219 (9%)
Query: 383 FSAHNVLGEGGFGCVYKGVL----ADGREVAVKQLK--IGGSQGEREFRAEVEIISRVHH 436
F+ +LG+G FG V + L ++VAVK LK I S EF E + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 437 RHLVSLVGYCISERER------LLVYEYVPNDTLHYHLHA----EGRPVMDWATRVKVAA 486
+++ L+G + R + +++ ++ + LH L E + T V+
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 487 GAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVM 546
A G+ YL IHRD+ + N +L+ + VADFGL+K D +
Sbjct: 121 DIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 547 GTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKP 584
++A E T SDV++FGV + E++T G+ P
Sbjct: 178 -PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 3e-13
Identities = 58/225 (25%), Positives = 106/225 (47%), Gaps = 42/225 (18%)
Query: 383 FSAHNVLGEGGFGCVYKGV-LADGREVAVKQLKIGGS-----QGEREFRAEVEIISRVHH 436
+ +G G +G V + G++VA+K KI + +R R E++I+ H
Sbjct: 7 YKPIENIGSGAYGVVCSAIDTRSGKKVAIK--KIPHAFDVPTLAKRTLR-ELKILRHFKH 63
Query: 437 RHLVSLVGYCISERERL-----------LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVA 485
+++++ R+ L +V + + +D LH+ +H+ +P+ + R +
Sbjct: 64 DNIIAI-------RDILRPPGADFKDVYVVMDLMESD-LHHIIHS-DQPLTEEHIRYFLY 114
Query: 486 AGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRV 545
RG+ Y+H +IHRD+K SN+L++ E R+ DFG+A+ L S+
Sbjct: 115 Q-LLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR---GLSSSPTEHKYF 167
Query: 546 M----GTFGYMAPEYATS-GKLTEKSDVYSFGVVLLELITGRKPV 585
M T Y APE S + T D++S G + E++ GR+ +
Sbjct: 168 MTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 4e-13
Identities = 31/117 (26%), Positives = 43/117 (36%), Gaps = 1/117 (0%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
P ++P A A P +P + +P A P P P P A +
Sbjct: 393 APAAAAPSAAAAAPAAAPAPAAAAPAAAAAPAPAAAPQPAPAPAPAPAPPSPAGNAPAGG 452
Query: 61 VNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSP 117
SPPP + P AP + P+PA P A A +P PA P P+ +
Sbjct: 453 APSPPPAAAPSAQPAPAPAAAPEPTAAPAPAPPAAPAPAAAPAAPA-APAAPAGADD 508
|
Length = 824 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-13
Identities = 68/260 (26%), Positives = 122/260 (46%), Gaps = 25/260 (9%)
Query: 383 FSAHNVLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGEREFRAEVEIISRV-HHRHLV 440
F V+G G +G VYKG + G+ A+K + + + E E + E+ ++ + HHR++
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIKLEINMLKKYSHHRNIA 76
Query: 441 SLVGYCISER------ERLLVYEYVPNDTLHYHL-HAEGRPVM-DWATRVKVAAGAARGI 492
+ G I + + LV E+ ++ + + +G + DW + RG+
Sbjct: 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGL 134
Query: 493 AYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYM 552
A+LH ++IHRDIK N+LL + E ++ DFG ++ +LD +GT +M
Sbjct: 135 AHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFG---VSAQLDRTVGRRNTFIGTPYWM 188
Query: 553 APEYATSGKLTE-----KSDVYSFGVVLLELITGRKPVDASQPLGDESLVEW-ARPLLAE 606
APE + + +SD++S G+ +E+ G P+ P+ L+ P L
Sbjct: 189 APEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKS 248
Query: 607 ALEHEDFEALVDSRLEKNYV 626
+ F ++ L KNY+
Sbjct: 249 KKWSKKFIDFIEGCLVKNYL 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 4e-13
Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 24/211 (11%)
Query: 383 FSAHNVLGEGGFGCVYKGVLADGRE-VAVKQLKIGGSQGERE------FRAEVEIISRVH 435
F N +GEG +G VY+ E VA+K++++ ER+ R E+ ++ +
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRM---DNERDGIPISSLR-EITLLLNLR 64
Query: 436 HRHLVSLVGYCISER--ERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVK-VAAGAARGI 492
H ++V L + + LV EY D L L P + ++VK + RG+
Sbjct: 65 HPNIVELKEVVVGKHLDSIFLVMEYCEQD-LASLLDNMPTPFSE--SQVKCLMLQLLRGL 121
Query: 493 AYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYM 552
YLHE+ IIHRD+K SN+LL ++ADFGLA+ T + T Y
Sbjct: 122 QYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLART---YGLPAKPMTPKVVTLWYR 175
Query: 553 APEYAT-SGKLTEKSDVYSFGVVLLELITGR 582
APE T D+++ G +L EL+ +
Sbjct: 176 APELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 4e-13
Identities = 61/202 (30%), Positives = 96/202 (47%), Gaps = 13/202 (6%)
Query: 388 VLGEGGFGCVYKGVL-ADGREVAVKQLKIGGSQGEREFR---AEVEIISRVHHRHLVSLV 443
VLG+G FG V L G AVK LK + + E +++ ++ +
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 444 GYCISERERLL-VYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPR 502
+E L V E++ L +H+ +GR + AT AA G+ +LH
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFY--AAEIVCGLQFLHSK---G 116
Query: 503 IIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKL 562
II+RD+K N++LD ++ADFG+ K + D+ ++ GT Y+APE K
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR---ASTFCGTPDYIAPEILQGLKY 173
Query: 563 TEKSDVYSFGVVLLELITGRKP 584
T D +SFGV+L E++ G+ P
Sbjct: 174 TFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 4e-13
Identities = 66/224 (29%), Positives = 106/224 (47%), Gaps = 33/224 (14%)
Query: 382 GFSAHNVLGEGGFGCVYKGVLADG-------REVAVKQLKIGGSQGERE-----FRAEVE 429
++ LG G FGCVYK + +E+ V G + ER+ +EV
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 430 IISRVHHRHLVSLVGY--CISERERL-LVYEYVPNDTLHYH---LHAEGRPVMD---WAT 480
II + RH ++V Y E +RL +V + + L H L + + + W
Sbjct: 61 II-KEQLRH-PNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNI 118
Query: 481 RVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTH 540
V++ A R YLH++ RI+HRD+ +NI+L + + DFGLAK + +
Sbjct: 119 FVQMVL-ALR---YLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESK 169
Query: 541 VSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKP 584
+ T V+GT Y PE + EK+DV++FG +L ++ T + P
Sbjct: 170 L-TSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 4e-13
Identities = 61/205 (29%), Positives = 87/205 (42%), Gaps = 20/205 (9%)
Query: 388 VLGEGGFGCVYKGVL----ADGREVAVKQLK---IGGSQGEREFRAEVEIISRVHHRHLV 440
+LG+G FG K +L A G+ A+K LK I E ++ H L
Sbjct: 2 LLGKGTFG---KVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLT 58
Query: 441 SLVGYCISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDC 499
+L Y +RL V EY L +HL E R + R A + YLH
Sbjct: 59 AL-KYSFQTHDRLCFVMEYANGGELFFHLSRE-RVFSEDRARF-YGAEIVSALGYLHSC- 114
Query: 500 HPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATS 559
+++RD+K N++LD ++ DFGL K + D T GT Y+APE
Sbjct: 115 --DVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS-DGAT--MKTFCGTPEYLAPEVLED 169
Query: 560 GKLTEKSDVYSFGVVLLELITGRKP 584
D + GVV+ E++ GR P
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 5e-13
Identities = 21/147 (14%), Positives = 35/147 (23%), Gaps = 1/147 (0%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
P P+ P + +P + PP P P +P + P A
Sbjct: 366 PEPEVPPQSAAPAASAQATAAPTAAVAPPQAPAVPPPPASAPQQAPAVPLPETTSQLLAA 425
Query: 61 VNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPA 120
+ + P P + A +V P+P P +
Sbjct: 426 RQQLQRAQGATKAK-KSEPAAASRARPVNSALERLASVRPAPSALEKAPAKKEAYRWKAT 484
Query: 121 NVPTTPSSSSPPPANVRTTPSSSSPPP 147
N P ++ P
Sbjct: 485 NPVEVKKEPVATPKALKKALEHEKTPE 511
|
Length = 647 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 5e-13
Identities = 58/231 (25%), Positives = 95/231 (41%), Gaps = 46/231 (19%)
Query: 387 NVLGEGGFGCVYKGV-LADGREVAVKQLK-IGGSQGEREFRA-------------EVEII 431
LGEG +G V K G+ VA+K++K I S + R E++I+
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 432 SRVHHRHLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAA-- 489
+ + H +++ LV + LV + + L + V+D R+ +
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDI-----MASDL----KKVVDRKIRLTESQVKCIL 125
Query: 490 ----RGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAK-----------IALE 534
G+ LH+ +HRD+ +NI ++S ++ADFGLA+ E
Sbjct: 126 LQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDE 182
Query: 535 LDSNTHVSTRVMGTFGYMAPEYAT-SGKLTEKSDVYSFGVVLLELITGRKP 584
T + T Y APE + K D++S G + EL+TG KP
Sbjct: 183 TMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG-KP 232
|
Length = 335 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 7e-13
Identities = 57/210 (27%), Positives = 106/210 (50%), Gaps = 22/210 (10%)
Query: 388 VLGEGGFG--CVYKGVLADGREVAVKQLKIGGSQGERE-FRAEVEIISRVHHRHLVSLVG 444
V+GEG FG + + V +D ++ A+K++++ S E R E +++++ H ++V+
Sbjct: 7 VVGEGSFGRALLVQHVNSD-QKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKE 65
Query: 445 YCISERERLLVYEYVPN-DTLHYHLHAEGR-----PVMDWATRVKVAAGAARGIAYLHED 498
++ +V EY D + G+ ++ W ++ + G+ ++HE
Sbjct: 66 SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHIHEK 119
Query: 499 CHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYAT 558
R++HRDIKS NI L + + ++ DFG A++ L S + +GT Y+ PE
Sbjct: 120 ---RVLHRDIKSKNIFLTQNGKVKLGDFGSARL---LTSPGAYACTYVGTPYYVPPEIWE 173
Query: 559 SGKLTEKSDVYSFGVVLLELITGRKPVDAS 588
+ KSD++S G +L EL T + P A+
Sbjct: 174 NMPYNNKSDIWSLGCILYELCTLKHPFQAN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 8e-13
Identities = 51/151 (33%), Positives = 79/151 (52%), Gaps = 16/151 (10%)
Query: 483 KVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVS 542
K+A + + YLH +IHRD+K SN+L++ + + ++ DFG I+ L ++
Sbjct: 107 KIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFG---ISGYL-VDSVAK 160
Query: 543 TRVMGTFGYMAPEY---ATSGKLTE-KSDVYSFGVVLLELITGRKPVDA----SQPLGDE 594
T G YMAPE + K + KSDV+S G+ ++EL TGR P D+ Q L +
Sbjct: 161 TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQL--K 218
Query: 595 SLVEWARPLLAEALEHEDFEALVDSRLEKNY 625
+VE P L +F+ V+ L+KNY
Sbjct: 219 QVVEEPSPQLPAEKFSPEFQDFVNKCLKKNY 249
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 8e-13
Identities = 58/278 (20%), Positives = 115/278 (41%), Gaps = 49/278 (17%)
Query: 397 VYKGVLADGREVAVKQLK---IGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERL 453
+YKG+ + +EV ++ K G E++ + R+ +++ + G+ I + L
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 454 ----LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHE-DCHPRIIHRDI 508
L+ EY L L E + + T++ +A +G+ L++ P ++++
Sbjct: 95 PRLSLILEYCTRGYLREVLDKEKD--LSFKTKLDMAIDCCKGLYNLYKYTNKP---YKNL 149
Query: 509 KSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATS--GKLTEKS 566
S + L+ +++ ++ GL KI L +V+ V Y + + + T K
Sbjct: 150 TSVSFLVTENYKLKIICHGLEKI-LSSPPFKNVNFMV-----YFSYKMLNDIFSEYTIKD 203
Query: 567 DVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRLEKN-- 624
D+YS GVVL E+ TG+ P E+ + + D + KN
Sbjct: 204 DIYSLGVVLWEIFTGKIP-----------------------FENLTTKEIYDLIINKNNS 240
Query: 625 -YVDSEMFWMIEAAA-ACVRHSATKRPRMSQVVRALDT 660
+ + I+ AC H + KRP + +++ L
Sbjct: 241 LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSL 278
|
Length = 283 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 9e-13
Identities = 45/206 (21%), Positives = 70/206 (33%), Gaps = 11/206 (5%)
Query: 84 DPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSS 143
P + A P AP+ PA P++ PA P +++ V P+
Sbjct: 371 GAGPATAAAAPVAQPAPAAAAPAAAAPAPAAPPAAPAAAP----AAAAAARAVAAAPARR 426
Query: 144 SPPPANVPATPSSSSPPPVNVPTPPSSSSP-PPPSSNPPTSTPSPPVLTPPPHPSQSAPP 202
SP P + A +S+ P P P + + P ++ P + P P P+++AP
Sbjct: 427 SPAPEALAAARQASARGPGGAPAPAPAPAAAPAAAARPAAAGPRPVAAAAAAAPARAAPA 486
Query: 203 PVTKSPPASTLSPP----PPSVPSTSSPPAVSPPAPPSNSSTRGSPSTPPLPSVPTEKPT 258
PA PP PP S + + PA S + P + T P
Sbjct: 487 A--APAPADDDPPPWEELPPEFASPAPAQPDAAPAGWVAESIPDPATADPDDAFETLAPA 544
Query: 259 AKSTNGTAVSANASPRNAGVLGTGGA 284
+ +A P A A
Sbjct: 545 PAAAPAPRAAAATEPVVAPRPPRASA 570
|
Length = 700 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-12
Identities = 59/268 (22%), Positives = 87/268 (32%), Gaps = 12/268 (4%)
Query: 19 PLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAP 78
P P TP + S + + A + A +P + PPP
Sbjct: 19 EFFPRPPATPGDAADDLLSGSQ-GQLVSDSAELAAVTVVAGAAACDRFEPPTGPPPGPGT 77
Query: 79 PPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPA---N 135
P + A A + P PSS PPP P SP P
Sbjct: 78 EAPANESRSTPTWSLSTLAPASPAREGSPTPPGPSSPDPPPPTPPPASPPPSPAPDLSEM 137
Query: 136 VRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSP---PPPSSNPPTSTPSPPVLTP 192
+R S PP A+ PA +S + + + ++ P P ++ P+S P+ P +
Sbjct: 138 LRPVGSPGPPPAASPPAAGASPAAVASDAASSRQAALPLSSPEETARAPSSPPAEPPPST 197
Query: 193 PPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSP---PAPPSNSSTRGSPSTPPL 249
PP + PP + AS SP P S + S + S+ G + PL
Sbjct: 198 PPAAASPRPPRRSSPISASASSPAPAPGRSAADDAGASSSDSSSSESSGCGWGPENECPL 257
Query: 250 PSVPTEKPTAKSTNGTAVSANASPRNAG 277
P T + A N G
Sbjct: 258 PRPAPI--TLPTRIWEASGWNGPSSRPG 283
|
Length = 1352 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 1e-12
Identities = 36/159 (22%), Positives = 51/159 (32%), Gaps = 9/159 (5%)
Query: 48 PSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPAN 107
P+ P P P +P + P A PP+ PP PA P +P P
Sbjct: 361 PAAPLPEPEVPPQSAAPAASAQATAAPTAAVAPPQAPAVPPPPASAP----QQAPAVPLP 416
Query: 108 VPTTPSS--SSPPPANVPTTPSSSSPPPANVRTTPSSSSPPP-ANVPATPSSSSPPPVNV 164
T+ T + S P A R P +S+ A+V PS+ P
Sbjct: 417 ETTSQLLAARQQLQRAQGATKAKKSEPAAASRARPVNSALERLASVRPAPSALEKAPAKK 476
Query: 165 PTPPSSSSPPPPSSNPPTSTPS--PPVLTPPPHPSQSAP 201
++ P P +TP L P +A
Sbjct: 477 EAYRWKATNPVEVKKEPVATPKALKKALEHEKTPELAAK 515
|
Length = 647 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 34/136 (25%), Positives = 46/136 (33%), Gaps = 8/136 (5%)
Query: 65 PPQPSSPPP-PLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVP 123
P P P + + P + A A PP++ P PS SPP
Sbjct: 147 DPNPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPSS 206
Query: 124 TTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPT- 182
+ SS P P + S PP + + + S PP P PP PP S+ PT
Sbjct: 207 PSDSSLPPAP-----SSFQSDTPPPSPESPTNPSPPPGPAAPPPPPVQQVPPLSTAKPTP 261
Query: 183 -STPSPPVLTPPPHPS 197
S + P
Sbjct: 262 PSASATPAPIGGITLD 277
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-12
Identities = 65/215 (30%), Positives = 99/215 (46%), Gaps = 28/215 (13%)
Query: 389 LGEGGFGCVYKGVLAD-GREVAVKQL---------KIGGSQGEREFRAEVEIISRVHHRH 438
+G+G FG VY+ D R A+K L ++ + GER I+ R
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERN------ILVRTLLDE 54
Query: 439 LVSLVGYCIS---ERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYL 495
+VG S + + LV +Y+ L +HL EGR D A + +A + +L
Sbjct: 55 SPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRA-KFYIAE-LVLALEHL 112
Query: 496 HEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPE 555
H+ I++RD+K NILLD++ + DFGL+K L + T+ GT Y+APE
Sbjct: 113 HKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT---FCGTTEYLAPE 166
Query: 556 YATSGK-LTEKSDVYSFGVVLLELITGRKPVDASQ 589
K T+ D +S GV++ E+ G P A
Sbjct: 167 VLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED 201
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 65/229 (28%), Positives = 105/229 (45%), Gaps = 20/229 (8%)
Query: 389 LGEGGFGCVYKGVLADGREV-AVKQLKIGGSQGEREFR---AEVEIISRVHHRHLVSLVG 444
+G+G FG V + D + + A+K ++ E AE ++++V+ +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL-K 59
Query: 445 YCISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRI 503
+ E+L LV ++ L +HL EGR D + A + LH+ +
Sbjct: 60 FSFQSPEKLYLVLAFINGGELFHHLQREGR--FDLSRARFYTAELLCALENLHK---FNV 114
Query: 504 IHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLT 563
I+RD+K NILLD + DFGL K+ + + + GT Y+APE T
Sbjct: 115 IYRDLKPENILLDYQGHIALCDFGLCKLNM---KDDDKTNTFCGTPEYLAPELLLGHGYT 171
Query: 564 EKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHED 612
+ D ++ GV+L E++TG P DE++ E R +L E L D
Sbjct: 172 KAVDWWTLGVLLYEMLTGLP------PFYDENVNEMYRKILQEPLRFPD 214
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 2e-12
Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 12/207 (5%)
Query: 389 LGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCI 447
+G G +G VYK L G AVK +K+ + E+ ++ H ++V+ G +
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 448 SERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRD 507
S + + EY +L H G P+ + V +G+AYLH +HRD
Sbjct: 77 SREKLWICMEYCGGGSLQDIYHVTG-PLSELQI-AYVCRETLQGLAYLHSKGK---MHRD 131
Query: 508 IKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYAT---SGKLTE 564
IK +NILL + + ++ADFG +A ++ + +GT +MAPE A +G +
Sbjct: 132 IKGANILLTDNGDVKLADFG---VAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQ 188
Query: 565 KSDVYSFGVVLLELITGRKPVDASQPL 591
D+++ G+ +EL + P+ P+
Sbjct: 189 LCDIWAVGITAIELAELQPPMFDLHPM 215
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 49/144 (34%), Positives = 74/144 (51%), Gaps = 11/144 (7%)
Query: 446 CISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRII 504
C +RL V EYV L YH+ G+ V AA + G+ +LH II
Sbjct: 69 CFQTVDRLYFVMEYVNGGDLMYHIQQVGK--FKEPQAVFYAAEISVGLFFLHRR---GII 123
Query: 505 HRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVM-GTFGYMAPEYATSGKLT 563
+RD+K N++LDS ++ADFG+ K + +D V+TR GT Y+APE
Sbjct: 124 YRDLKLDNVMLDSEGHIKIADFGMCKEHM-VDG---VTTRTFCGTPDYIAPEIIAYQPYG 179
Query: 564 EKSDVYSFGVVLLELITGRKPVDA 587
+ D +++GV+L E++ G+ P D
Sbjct: 180 KSVDWWAYGVLLYEMLAGQPPFDG 203
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 3e-12
Identities = 25/126 (19%), Positives = 45/126 (35%), Gaps = 4/126 (3%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
+ A P + P + P + +P A + + PP+ P ++PA
Sbjct: 371 EAAAPAEKKTPARPEAAAPAAAPVAQAAAAPAPAAAPAAAASAPAAPPAAAPPAPVAAPA 430
Query: 61 VNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPA 120
+P P++ P + P P +P + A P A P P +++P A
Sbjct: 431 AAAPAAAPAAAPAAVALAPAPPAQAAPETVAIPVRVA----PEPAVASAAPAPAAAPAAA 486
Query: 121 NVPTTP 126
+ T
Sbjct: 487 RLTPTE 492
|
Length = 618 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 3e-12
Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 28/213 (13%)
Query: 389 LGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCI 447
+GEG G V G++VAVK++ + Q EV I+ HH ++V + +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 448 SERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVK--------VAAGAARGIAYLHEDC 499
E +V E++ EG + D T + V R ++YLH
Sbjct: 90 VGDELWVVMEFL-----------EGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQ- 137
Query: 500 HPRIIHRDIKSSNILLDSSFEARVADFGL-AKIALELDSNTHVSTRVMGTFGYMAPEYAT 558
+IHRDIKS +ILL S +++DFG A+++ E+ ++GT +MAPE +
Sbjct: 138 --GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR----KSLVGTPYWMAPEVIS 191
Query: 559 SGKLTEKSDVYSFGVVLLELITGRKPVDASQPL 591
+ D++S G++++E+I G P PL
Sbjct: 192 RLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL 224
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 3e-12
Identities = 63/205 (30%), Positives = 91/205 (44%), Gaps = 20/205 (9%)
Query: 388 VLGEGGFGCVYKGVL----ADGREVAVKQLK---IGGSQGEREFRAEVEIISRVHHRHLV 440
+LG+G FG K +L A G+ A+K LK I E ++ H L
Sbjct: 2 LLGKGTFG---KVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLT 58
Query: 441 SLVGYCISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDC 499
SL Y ++RL V EYV L +HL E R + TR A + YLH
Sbjct: 59 SL-KYSFQTKDRLCFVMEYVNGGELFFHLSRE-RVFSEDRTRF-YGAEIVSALDYLHSG- 114
Query: 500 HPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATS 559
+I++RD+K N++LD ++ DFGL K + ++ GT Y+APE
Sbjct: 115 --KIVYRDLKLENLMLDKDGHIKITDFGLCKEGI---TDAATMKTFCGTPEYLAPEVLED 169
Query: 560 GKLTEKSDVYSFGVVLLELITGRKP 584
D + GVV+ E++ GR P
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 69.1 bits (170), Expect = 4e-12
Identities = 29/155 (18%), Positives = 44/155 (28%), Gaps = 3/155 (1%)
Query: 63 SPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANV 122
+P P+P PP P + A P PPPPA+ P + P
Sbjct: 363 APLPEPEVPPQSA--APAASAQATAAPTAAVAPPQAPAVPPPPASAPQQAPAVPLPETTS 420
Query: 123 PTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPT 182
+ A T S P A+ +S+ +V PS+ P
Sbjct: 421 QLLAARQQLQRAQGATKAKKSEPAAASRARPVNSALERLASVRPAPSALEKAPAKKEAYR 480
Query: 183 STPSPPVLTPPPHPSQ-SAPPPVTKSPPASTLSPP 216
+ PV + A + L+
Sbjct: 481 WKATNPVEVKKEPVATPKALKKALEHEKTPELAAK 515
|
Length = 647 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 4e-12
Identities = 53/178 (29%), Positives = 93/178 (52%), Gaps = 11/178 (6%)
Query: 427 EVEIISRVHHRHLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAA 486
E++++ + ++V G S+ E + E++ +L L R + +V +A
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAV 112
Query: 487 GAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVM 546
RG+AYL E +I+HRD+K SNIL++S E ++ DFG++ ++ +N+ V TR
Sbjct: 113 --LRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-- 166
Query: 547 GTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLL 604
YM+PE + +SD++S G+ L+EL GR P+ P E + RP++
Sbjct: 167 ---SYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI--PPPDAKELEAIFGRPVV 219
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-12
Identities = 71/206 (34%), Positives = 96/206 (46%), Gaps = 21/206 (10%)
Query: 388 VLGEGGFGCVYKGVLA----DGREVAVKQLK---IGGSQGEREFRAEVEIISR-VHHRHL 439
V+G+G FG K +LA DG AVK L+ I + + AE ++ + + H L
Sbjct: 2 VIGKGSFG---KVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFL 58
Query: 440 VSLVGYCISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHED 498
V L Y E+L V +YV L +HL E R ++ R AA A I YLH
Sbjct: 59 VGL-HYSFQTAEKLYFVLDYVNGGELFFHLQRE-RCFLEPRARF-YAAEVASAIGYLHS- 114
Query: 499 CHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYAT 558
II+RD+K NILLDS + DFGL K +E + T + GT Y+APE
Sbjct: 115 --LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT---STFCGTPEYLAPEVLR 169
Query: 559 SGKLTEKSDVYSFGVVLLELITGRKP 584
D + G VL E++ G P
Sbjct: 170 KEPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 4e-12
Identities = 62/211 (29%), Positives = 95/211 (45%), Gaps = 25/211 (11%)
Query: 388 VLGEGGFGCVYKGVLADGREV-AVKQLK---------IGGSQGEREFRAEVEIISRVHHR 437
VLG+G FG V L EV A+K LK + + E+ A ++ H
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILA----LAA-KHP 56
Query: 438 HLVSLVGYCISERERLL-VYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLH 496
L +L C ++RL V EYV L + + + D AA + +LH
Sbjct: 57 FLTALHC-CFQTKDRLFFVMEYVNGGDLMFQIQRSRK--FDEPRSRFYAAEVTLALMFLH 113
Query: 497 EDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEY 556
+I+RD+K NILLD+ ++ADFG+ K E N +T GT Y+APE
Sbjct: 114 RH---GVIYRDLKLDNILLDAEGHCKLADFGMCK---EGILNGVTTTTFCGTPDYIAPEI 167
Query: 557 ATSGKLTEKSDVYSFGVVLLELITGRKPVDA 587
+ D ++ GV++ E++ G+ P +A
Sbjct: 168 LQELEYGPSVDWWALGVLMYEMMAGQPPFEA 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|217393 pfam03154, Atrophin-1, Atrophin-1 family | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 4e-12
Identities = 76/284 (26%), Positives = 101/284 (35%), Gaps = 11/284 (3%)
Query: 5 SSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPA-SPPPSPPTSTPPSPPTAPPPSSPAVNS 63
SS L P P + PP P++PPP S PP +P + AP P P+ S
Sbjct: 166 SSAQQQLLQPQGPPSIQVPPGAALAPSAPPPTPSAQAVPPQGSPIAAQPAPQPQQPSPLS 225
Query: 64 PPPQPSSPPPPLDAPPPPEV--DPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPAN 121
PS P L +P PP S SP P P + P P P + P
Sbjct: 226 LISAPSLHPQRLPSPHPPLQPQTASQQSPQPPAPSSRHPQSSHHGPGPPMPHALQQGPVF 285
Query: 122 VPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPP 181
+ PSS+ P P + + P P+ + P P P PP+ + P
Sbjct: 286 LQ-HPSSNPPQPFGLAQSQVPPLPLPSQAQPHSHTPPSQSALQPQQPPREQPLPPAPSMP 344
Query: 182 TSTPSPPVLTPPPHPSQSAPPPVTKSPPA-----STLSPPPPSVPSTSSPPAVSPPAPPS 236
P P P PP + P S L PPP P +S P P A P
Sbjct: 345 HIKPPPTTPIPQLPNQSHKHPPHLQGPSPFPQMPSNLPPPPALKPLSSLPTHHPPSAHP- 403
Query: 237 NSSTRGSPSTPPLPSVPTEKPTAKSTNGTAVSANASPRNAGVLG 280
+ P + PL SVP + P + A+ P + G
Sbjct: 404 -PPLQLMPQSQPLQSVPAQPPVLTQSQSLPPKASTHPHSGLHSG 446
|
Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1, that is thought to confer toxicity to the protein, possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders, including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein, CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity. Length = 979 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 5e-12
Identities = 64/212 (30%), Positives = 86/212 (40%), Gaps = 27/212 (12%)
Query: 383 FSAHNVLGEGGFG----CVYKGVLADGREVAVKQLK---IGGSQGEREFRAEVEIISRVH 435
F LG G FG +KG G A+K LK I + + E I+ +
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMELS 76
Query: 436 HRHLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYL 495
H +V+++ E + E+V L HL GR D A A YL
Sbjct: 77 HPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFY--HAELVLAFEYL 134
Query: 496 HEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVM---GTFGYM 552
H II+RD+K N+LLD+ +V DFG AK V R GT Y+
Sbjct: 135 HSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAK---------KVPDRTFTLCGTPEYL 182
Query: 553 APEYATSGKLTEKSDVYSFGVVLLELITGRKP 584
APE S + D ++ GV+L E I G P
Sbjct: 183 APEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 6e-12
Identities = 29/130 (22%), Positives = 47/130 (36%), Gaps = 7/130 (5%)
Query: 33 PPPASPPPSPPTSTPPSPPTAPPPS-SPAVNSPPPQPSSPPPPLDAPPPPE-VDPSPPSP 90
P A+ +P P+ P A P+ +P + + P A P +PP+P
Sbjct: 366 PAAAAEAAAPAEKKTPARPEAAAPAAAPVAQAAAAPAPAAAPAAAASAPAAPPAAAPPAP 425
Query: 91 AQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANV 150
P A + P A P++ + PA + P V P+ +S PA
Sbjct: 426 VAAPAAAAPAAAPAAA-----PAAVALAPAPPAQAAPETVAIPVRVAPEPAVASAAPAPA 480
Query: 151 PATPSSSSPP 160
A ++ P
Sbjct: 481 AAPAAARLTP 490
|
Length = 618 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 6e-12
Identities = 29/134 (21%), Positives = 48/134 (35%), Gaps = 7/134 (5%)
Query: 50 PPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVP 109
P A ++PA P +P + P A P + P+PA P A + PPA P
Sbjct: 366 PAAAAEAAAPAEKKTPARPEAAAP---AAAPVAQAAAAPAPAAAPAAAASAPAAPPAAAP 422
Query: 110 TTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPS 169
P ++ A ++ + P+ + A P +P P P+
Sbjct: 423 PAPVAAPAAAAPAAAPAAAPAAVALA----PAPPAQAAPETVAIPVRVAPEPAVASAAPA 478
Query: 170 SSSPPPPSSNPPTS 183
++ P + PT
Sbjct: 479 PAAAPAAARLTPTE 492
|
Length = 618 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 6e-12
Identities = 49/212 (23%), Positives = 102/212 (48%), Gaps = 20/212 (9%)
Query: 383 FSAHNVLGEGGFGCVYKGV-LADGREVAVKQLKI---GGSQGEREFRAEVEIISRVHHRH 438
F +G G F VY+ L D + VA+K+++I ++ ++ E++++ +++H +
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 439 LVSLVGYCISERERLLVYEYVPNDTLHY---HLHAEGRPVMD---WATRVKVAAGAARGI 492
++ + I + E +V E L + + R + + W V++ + +
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSA----V 119
Query: 493 AYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYM 552
++H R++HRDIK +N+ + ++ ++ D GL + S T + ++GT YM
Sbjct: 120 EHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRF---FSSKTTAAHSLVGTPYYM 173
Query: 553 APEYATSGKLTEKSDVYSFGVVLLELITGRKP 584
+PE KSD++S G +L E+ + P
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|220392 pfam09770, PAT1, Topoisomerase II-associated protein PAT1 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 7e-12
Identities = 51/255 (20%), Positives = 67/255 (26%), Gaps = 18/255 (7%)
Query: 32 SPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPP-PQP-----SSPPPPLDAPPP-PEVD 84
+P ++ SP + +S P QP + P P PP PE
Sbjct: 84 APSVGPDSDLSQKTSTFSPCQSGYEASTDPEYIPDLQPDPSLWGTAPKPEPQPPQAPESQ 143
Query: 85 PSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSS 144
P P +PAQ A + + P P P A
Sbjct: 144 PQPQTPAQKMLSL----EEVEAQLQQRQQAPQLPQPPQQVLPQGMPPRQAAFPQQGPPEQ 199
Query: 145 PPP-ANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPP 203
PP P P +P P + + PP P P P Q PPP
Sbjct: 200 PPGYPQPPQGHPEQVQPQQFLPAPSQAPAQPPLPPQLPQQPPPLQQPQFPGLSQQMPPPP 259
Query: 204 VT----KSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTPPLPSVPTEKPTA 259
+ P + PPP T P P P PL P +
Sbjct: 260 PQPPQQQQQPPQPQAQPPPQNQPTPHPGLPQGQNAPLPPPQ--QPQLLPLVQQPQGQQRG 317
Query: 260 KSTNGTAVSANASPR 274
V + R
Sbjct: 318 PQFREQLVQLSQQQR 332
|
Members of this family are necessary for accurate chromosome transmission during cell division. Length = 804 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 7e-12
Identities = 50/144 (34%), Positives = 73/144 (50%), Gaps = 11/144 (7%)
Query: 446 CISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRII 504
C +RL V EYV L Y + GR A V AA A G+ +LH II
Sbjct: 69 CFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHA--VFYAAEIAIGLFFLHSK---GII 123
Query: 505 HRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVM-GTFGYMAPEYATSGKLT 563
+RD+K N++LDS ++ADFG+ K + D V+T+ GT Y+APE
Sbjct: 124 YRDLKLDNVMLDSEGHIKIADFGMCKENM-WDG---VTTKTFCGTPDYIAPEIIAYQPYG 179
Query: 564 EKSDVYSFGVVLLELITGRKPVDA 587
+ D ++FGV+L E++ G+ P +
Sbjct: 180 KSVDWWAFGVLLYEMLAGQAPFEG 203
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|219339 pfam07223, DUF1421, Protein of unknown function (DUF1421) | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 7e-12
Identities = 49/233 (21%), Positives = 66/233 (28%), Gaps = 6/233 (2%)
Query: 14 PPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPP--SPPTAPPPSSPAVNSPPPQPSSP 71
PP ++ P A PP P S P + PPS + PPQ
Sbjct: 50 PPAPEQVAKHELADAPLQQVNAALPPAPAPQSPQPDQQQQSQAPPSHQYPSQLPPQQVQS 109
Query: 72 PPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSP 131
P P P P P PP Q P P PP +
Sbjct: 110 VPQQPTPQQEPYYPPPSQPQPPPAQQPQAQQPQPPPQVPQQQQYQSPPQQPQYQQNPPPQ 169
Query: 132 PPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTP----SP 187
+ + + P + P + P PP S +PP P
Sbjct: 170 AQSAPQVSGLYPEESPYQPQSYPPNEPLPSSMAMQPPYSGAPPSQQFYGPPQPSPYMYGG 229
Query: 188 PVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSST 240
P P PP ++ S PPPS + S + +P + ST
Sbjct: 230 PGGRPNSGFPSGQQPPPSQGQEGYGYSGPPPSKGNHGSVASYAPQGSSQSYST 282
|
This family represents a conserved region approximately 350 residues long within a number of plant proteins of unknown function. Length = 357 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 8e-12
Identities = 31/107 (28%), Positives = 42/107 (39%), Gaps = 2/107 (1%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
P + PA A P + P + P +P PA PPSP + P +PPP++
Sbjct: 405 APAAAPAPA--AAAPAAAAAPAPAAAPQPAPAPAPAPAPPSPAGNAPAGGAPSPPPAAAP 462
Query: 61 VNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPAN 107
P P P++ P P AP P P+ A P A A
Sbjct: 463 SAQPAPAPAAAPEPTAAPAPAPPAAPAPAAAPAAPAAPAAPAGADDA 509
|
Length = 824 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 8e-12
Identities = 58/209 (27%), Positives = 106/209 (50%), Gaps = 24/209 (11%)
Query: 389 LGEGGFGCVYKGVL--ADGREVAVKQLKIGGSQGEREFRA---EVEIISRVHHRHLVSLV 443
LG+G +G VYK VL G +A+K++++ E +F E++I+ + ++V
Sbjct: 9 LGKGNYGSVYK-VLHRPTGVTMAMKEIRL--ELDESKFNQIIMELDILHKAVSPYIVDFY 65
Query: 444 GYCISERERLLVYEYVPNDTLHYHLHAEGRPV--MDWATRVKVAAGAARGIAYLHEDCHP 501
G E + EY+ +L L+A G + ++ +G+ +L E+ +
Sbjct: 66 GAFFIEGAVYMCMEYMDAGSLD-KLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN- 123
Query: 502 RIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGK 561
IIHRD+K +N+L++ + + ++ DFG++ + + T++ G YMAPE SG
Sbjct: 124 -IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI-----GCQSYMAPERIKSGG 177
Query: 562 LTE------KSDVYSFGVVLLELITGRKP 584
+ +SDV+S G+ +LE+ GR P
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 8e-12
Identities = 63/224 (28%), Positives = 102/224 (45%), Gaps = 53/224 (23%)
Query: 389 LGEGGFGCVYKGVLAD-GREVAVKQL----------KIGGSQGEREFRAEVEIISRVHHR 437
+GEG +G V+K + G+ VA+K+ KI R E+ ++ ++ H
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIA-------LR-EIRMLKQLKHP 60
Query: 438 HLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHE 497
+LV+L+ +R+ LV+EY + L+ L R V + + K+ + + + H+
Sbjct: 61 NLVNLIEVFRRKRKLHLVFEYCDHTVLN-ELEKNPRGVPEHLIK-KIIWQTLQAVNFCHK 118
Query: 498 -DCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIAL--ELDSNTHVSTRVMGTFGYMAP 554
+C IHRD+K NIL+ + ++ DFG A+I D +V+TR Y AP
Sbjct: 119 HNC----IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WYRAP 169
Query: 555 E-------YATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPL 591
E Y DV++ G V EL+TG QPL
Sbjct: 170 ELLVGDTQYGPP------VDVWAIGCVFAELLTG-------QPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 8e-12
Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 20/208 (9%)
Query: 389 LGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGEREFRA--EVEIISRVH---HRHLVSL 442
+G G +G VYK G VA+K +++ ++ EV ++ R+ H ++V L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 443 VGYCISER-----ERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHE 497
+ C + R + LV+E+V D L +L P + T + RG+ +LH
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQD-LRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126
Query: 498 DCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYA 557
+C I+HRD+K NIL+ S + ++ADFGLA+I S T V+ T Y APE
Sbjct: 127 NC---IVHRDLKPENILVTSGGQVKLADFGLARIY----SCQMALTPVVVTLWYRAPEVL 179
Query: 558 TSGKLTEKSDVYSFGVVLLELITGRKPV 585
D++S G + E+ RKP+
Sbjct: 180 LQSTYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 9e-12
Identities = 32/118 (27%), Positives = 45/118 (38%), Gaps = 3/118 (2%)
Query: 6 SPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTP---PSPPTAPPPSSPAVN 62
+ A + P+ P P + PA+ P + P P+P AP P SPA N
Sbjct: 388 AGGAGAPAAAAPSAAAAAPAAAPAPAAAAPAAAAAPAPAAAPQPAPAPAPAPAPPSPAGN 447
Query: 63 SPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPA 120
+P SPPP P P+ P P+ P PA P P++ + P
Sbjct: 448 APAGGAPSPPPAAAPSAQPAPAPAAAPEPTAAPAPAPPAAPAPAAAPAAPAAPAAPAG 505
|
Length = 824 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-11
Identities = 67/330 (20%), Positives = 97/330 (29%), Gaps = 21/330 (6%)
Query: 34 PPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQP 93
PPA+P + S S+ ++ P P P +
Sbjct: 24 PPATPGDAADDLLSGSQGQLVSDSAELAAVTVVAGAAACDR----FEPPTGPPPGPGTEA 79
Query: 94 PPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPAT 153
P +P +T + +SP PT P SSP P PPP PA+
Sbjct: 80 PANESRSTPTWS---LSTLAPASPAREGSPTPPGPSSPDP-----------PPPTPPPAS 125
Query: 154 PSSSSPPPVNVPTPPS-SSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPAST 212
P S P ++ P S PPP +S P V + Q+A P SP +
Sbjct: 126 PPPSPAPDLSEMLRPVGSPGPPPAASPPAAGASPAAVASDAASSRQAALP--LSSPEETA 183
Query: 213 LSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTPPLPSVPTEKPTAKSTNGTAVSANAS 272
+P P S P + P S+ S S P + ++ S+++
Sbjct: 184 RAPSSPPAEPPPSTPPAAASPRPPRRSSPISASASSPAPAPGRSAADDAGASSSDSSSSE 243
Query: 273 PRNAGVLGTGGAVAIGIAVGFLVLSLLVMAVWFAHKRKKKRAGEHIGYTLPSPYASSQKS 332
G A L + + W + A SP S
Sbjct: 244 SSGCGWGPENECPLPRPAPITLPTRIWEASGWNGPSSRPGPASSSSSPRERSPSPSPSSP 303
Query: 333 DSVFLRPHSPAPLVGNGSNSGFSRSPSESG 362
S A + S S S S S
Sbjct: 304 GSGPAPSSPRASSSSSSSRESSSSSTSSSS 333
|
Length = 1352 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 1e-11
Identities = 28/123 (22%), Positives = 46/123 (37%)
Query: 3 PQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVN 62
+ A PS + P + P + P A+ P+P + P+P AP P+ P+
Sbjct: 386 GVAGGAGAPAAAAPSAAAAAPAAAPAPAAAAPAAAAAPAPAAAPQPAPAPAPAPAPPSPA 445
Query: 63 SPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANV 122
P +P PP A P + P+P + +P P PA + ++P
Sbjct: 446 GNAPAGGAPSPPPAAAPSAQPAPAPAAAPEPTAAPAPAPPAAPAPAAAPAAPAAPAAPAG 505
Query: 123 PTT 125
Sbjct: 506 ADD 508
|
Length = 824 |
| >gnl|CDD|220392 pfam09770, PAT1, Topoisomerase II-associated protein PAT1 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-11
Identities = 48/234 (20%), Positives = 61/234 (26%), Gaps = 12/234 (5%)
Query: 40 PSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVA 99
+P SP S + P D P P + + P P PPQA
Sbjct: 83 GAPSVGPDSDLSQKTSTFSPC-QSGYEASTDPEYIPDLQPDPSLWGTAPKPEPQPPQAP- 140
Query: 100 PSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSP 159
S P P S A + + P + P P A P P
Sbjct: 141 ESQPQPQTPAQKMLSLEEVEAQLQQRQQAPQLPQPPQQVLPQGMPPRQAAFPQQGPPEQP 200
Query: 160 ------PPVNVPTPPSSSSPPPPSSNPPT-STPSPPVLTPPPHPSQSAPPPVTKSPPAST 212
P + P PS P P PPP P + PP
Sbjct: 201 PGYPQPPQGHPEQVQPQQFLPAPSQAPAQPPLPPQLPQQPPPLQQPQFPGLSQQMPPPPP 260
Query: 213 LSPP--PPSVPSTSSPPAVSPPAPPSNSSTRGSPSTPPLPSVPTEKPTAKSTNG 264
P + PP + P P + PP P P P + G
Sbjct: 261 QPPQQQQQPPQPQAQPPPQNQPTPHPGLPQGQNAPLPP-PQQPQLLPLVQQPQG 313
|
Members of this family are necessary for accurate chromosome transmission during cell division. Length = 804 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 41/144 (28%), Positives = 56/144 (38%), Gaps = 17/144 (11%)
Query: 98 VAPSPPPP-----ANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPA 152
P+P PP + ++S P+S+SP + S P P P+
Sbjct: 146 EDPNPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPS 205
Query: 153 TPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPAST 212
+PS SS PP P+ S +PPP +P +P P PPP P Q PP T
Sbjct: 206 SPSDSSLPPA--PSSFQSDTPPPSPESPTNPSPPPGPAAPPPPPVQQVPPLST------- 256
Query: 213 LSPPPPSVPSTSSPPAVSPPAPPS 236
P+ PS S+ PA
Sbjct: 257 ---AKPTPPSASATPAPIGGITLD 277
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 36/134 (26%), Positives = 51/134 (38%), Gaps = 6/134 (4%)
Query: 76 DAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPAN 135
D P P +D + P A+ P+S+SP + S P P
Sbjct: 147 DPNPGPPLDEEDEDADVATTNSDNSFPGEDAD----PASASPSDPPSSSPGVPSFPSPPE 202
Query: 136 VRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPH 195
++PS SS PPA P++ S +PPP S P P + PP PP+ T P
Sbjct: 203 DPSSPSDSSLPPA--PSSFQSDTPPPSPESPTNPSPPPGPAAPPPPPVQQVPPLSTAKPT 260
Query: 196 PSQSAPPPVTKSPP 209
P ++ P
Sbjct: 261 PPSASATPAPIGGI 274
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|217393 pfam03154, Atrophin-1, Atrophin-1 family | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 1e-11
Identities = 74/275 (26%), Positives = 94/275 (34%), Gaps = 12/275 (4%)
Query: 2 PPQSSPPAVLAVPPPSPPLSPP-PSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
PP V P +PP P PP P + P S P +A P P
Sbjct: 273 PPMPHALQQGPVFLQHPSSNPPQPFGLAQSQVPPLPLPSQAQPHSHTPPSQSALQPQQPP 332
Query: 61 VNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPA 120
P P P+ P + PP + P + PP PSP P P + P +
Sbjct: 333 REQPLP-PAPSMPHIKPPPTTPIPQLPNQSHKHPPHLQGPSPFPQMPSNLPPPPALKPLS 391
Query: 121 NVPTT-PSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSN 179
++PT P S+ PPP + PA P S S PP P S PP S
Sbjct: 392 SLPTHHPPSAHPPPLQLMPQSQPLQSVPAQPPVLTQSQSLPPKASTHPHSGLHSGPPQS- 450
Query: 180 PPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSS 239
P P P P S P +PP ++ PP SS P P
Sbjct: 451 PFAQHPFTSGGLPAIGPPPSLPTSTPAAPPRASSGSQPPGSALPSSGGCAGPGPPLPPIQ 510
Query: 240 TRGSP--------STPPLPSVPTEKPTAKSTNGTA 266
+ P S PP P P+ +PT +T A
Sbjct: 511 IKEEPLDEAEEPESPPPPPRSPSPEPTVVNTPSHA 545
|
Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1, that is thought to confer toxicity to the protein, possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders, including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein, CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity. Length = 979 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 30/208 (14%)
Query: 389 LGEGGFGCVYKGVLADGRE-VAVKQLKIGGSQGEREFRA-------EVEIISRVHHRHLV 440
+GEG +G VYK E +A+K++++ E+E E+ ++ + H ++V
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRL-----EQEDEGVPSTAIREISLLKEMQHGNIV 64
Query: 441 SLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAG----AARGIAYLH 496
L SE+ LV+EY+ L H + P D+A ++ RGIAY H
Sbjct: 65 RLQDVVHSEKRLYLVFEYL---DLDLKKHMDSSP--DFAKNPRLIKTYLYQILRGIAYCH 119
Query: 497 EDCHPRIIHRDIKSSNILLDSSFEA-RVADFGLAKIALELDSNTHVSTRVMGTFGYMAPE 555
R++HRD+K N+L+D A ++ADFGLA+ A + T V T Y APE
Sbjct: 120 SH---RVLHRDLKPQNLLIDRRTNALKLADFGLAR-AFGIPVRTFTHEVV--TLWYRAPE 173
Query: 556 YATSGK-LTEKSDVYSFGVVLLELITGR 582
+ + D++S G + E++ +
Sbjct: 174 ILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 37/103 (35%), Positives = 57/103 (55%), Gaps = 6/103 (5%)
Query: 490 RGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTF 549
RG+ YLH I+HRDIK N+L++S+ ++ DFGLA++ E D + H++ V+ +
Sbjct: 114 RGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVE-EPDESKHMTQEVVTQY 169
Query: 550 GYMAPEYAT-SGKLTEKSDVYSFGVVLLELITGRKPVDASQPL 591
Y APE S T D++S G + EL+ R A P+
Sbjct: 170 -YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI 211
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 1e-11
Identities = 33/94 (35%), Positives = 53/94 (56%), Gaps = 10/94 (10%)
Query: 490 RGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTF 549
RG+ Y+H IIHRD+K SNI ++ E ++ DFGLA+ + + +V+TR
Sbjct: 129 RGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHT-DDEMTGYVATR----- 179
Query: 550 GYMAPEYATS-GKLTEKSDVYSFGVVLLELITGR 582
Y APE + + D++S G ++ EL+TG+
Sbjct: 180 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|237605 PRK14086, dnaA, chromosomal replication initiation protein; Provisional | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 1e-11
Identities = 45/217 (20%), Positives = 61/217 (28%), Gaps = 15/217 (6%)
Query: 51 PTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPT 110
P+A P+ P PP + P L P + A P + P P
Sbjct: 90 PSAGEPAPP----PPHARRTSEPELPRPGRRPYEGYGGPRADDRPPGLPRQDQLPTARPA 145
Query: 111 TPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSS 170
P+ P P + + PP A+P+S +P P +
Sbjct: 146 YPAYQQRP------EPGAWPRAADDYGWQQQRLGFPPRAPYASPASYAPEQERDREPYDA 199
Query: 171 SSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVS 230
P P P P P P + P PP P +
Sbjct: 200 GRPEYDQRRRDYDHPRPDW-DRPRRDRTDRPEPPPGAGHVHRGGPGPPERDDAPVVP-IR 257
Query: 231 PPAPPSNSSTRGSPSTPPLPSVPTEKPTAKSTNGTAV 267
P AP P+ P P PT + K T T V
Sbjct: 258 PSAP---GPLAAQPAPAPGPGEPTARLNPKYTFDTFV 291
|
Length = 617 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 1e-11
Identities = 37/89 (41%), Positives = 55/89 (61%), Gaps = 9/89 (10%)
Query: 502 RIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFG----YMAPEYA 557
+IHRDIKS+NILL S+ ++ DFG +K+ + T VS V TF Y+APE
Sbjct: 163 HMIHRDIKSANILLCSNGLVKLGDFGFSKMY----AAT-VSDDVGRTFCGTPYYVAPEIW 217
Query: 558 TSGKLTEKSDVYSFGVVLLELITGRKPVD 586
++K+D++S GV+L EL+T ++P D
Sbjct: 218 RRKPYSKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 51/212 (24%), Positives = 100/212 (47%), Gaps = 20/212 (9%)
Query: 383 FSAHNVLGEGGFGCVYKGV-LADGREVAVKQLKI---GGSQGEREFRAEVEIISRVHHRH 438
F +G G F VY+ L DG VA+K+++I ++ + E++++ +++H +
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 439 LVSLVGYCISERERLLVYEYVPNDTLHY---HLHAEGRPVMD---WATRVKVAAGAARGI 492
++ I + E +V E L H + R + + W V++ + +
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA----L 119
Query: 493 AYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYM 552
++H R++HRDIK +N+ + ++ ++ D GL + S T + ++GT YM
Sbjct: 120 EHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRF---FSSKTTAAHSLVGTPYYM 173
Query: 553 APEYATSGKLTEKSDVYSFGVVLLELITGRKP 584
+PE KSD++S G +L E+ + P
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|217393 pfam03154, Atrophin-1, Atrophin-1 family | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-11
Identities = 69/266 (25%), Positives = 88/266 (33%), Gaps = 23/266 (8%)
Query: 14 PPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTP----PSPPTAPPPSSPAVNSPPPQPS 69
P P PPL P ++ P P P+S P P P P +S PPQP
Sbjct: 238 PSPHPPLQPQTASQQSPQPPAPSSRHPQSSHHGPGPPMPHALQQGPVFLQHPSSNPPQPF 297
Query: 70 SPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSS 129
PP P + P PP Q+ PP P P+ S P PTTP
Sbjct: 298 GLAQS-QVPPLPLPSQAQPHSHTPPSQSALQPQQPPREQPLPPAPSMPHIKPPPTTPIPQ 356
Query: 130 SPPPAN-----------VRTTPSSSSPPPANVPATPSSSSPPPVNVPTP----PSSSSPP 174
P ++ PS+ PPPA P + + PP P P P S
Sbjct: 357 LPNQSHKHPPHLQGPSPFPQMPSNLPPPPALKPLSSLPTHHPPSAHPPPLQLMPQSQPLQ 416
Query: 175 PPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPAST---LSPPPPSVPSTSSPPAVSP 231
+ PP T S + S P + S P++ S P +P
Sbjct: 417 SVPAQPPVLTQSQSLPPKASTHPHSGLHSGPPQSPFAQHPFTSGGLPAIGPPPSLPTSTP 476
Query: 232 PAPPSNSSTRGSPSTPPLPSVPTEKP 257
APP SS P + S P
Sbjct: 477 AAPPRASSGSQPPGSALPSSGGCAGP 502
|
Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1, that is thought to confer toxicity to the protein, possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders, including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein, CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity. Length = 979 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 58/206 (28%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 388 VLGEGGFGCVYKGVLA--DGRE--VAVKQLKIGGSQGERE-FRAEVEIISRVHHRHLVSL 442
+LG G FG + +G L RE VA+ L+ G S +R F AE + + H ++V L
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 443 VGYCISERERLLVYEYVPNDTLHYHLHA-EGRPVMDWATRVKVAAGAARGIAYLHEDCHP 501
G ++V EY+ N L L EG+ V + + G A G+ YL E +
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVA--GQLMGMLPGLASGMKYLSEMGY- 128
Query: 502 RIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMG--TFGYMAPEYATS 559
+H+ + + +L++S +++ F L+ D + + T + G + APE
Sbjct: 129 --VHKGLAAHKVLVNSDLVCKISGFR----RLQEDKSEAIYTTMSGKSPVLWAAPEAIQY 182
Query: 560 GKLTEKSDVYSFGVVLLELIT-GRKP 584
+ SDV+SFG+V+ E+++ G +P
Sbjct: 183 HHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 77/252 (30%), Positives = 116/252 (46%), Gaps = 32/252 (12%)
Query: 342 PAPLVGNGSNSGFSRSPSESGVLGNSRSWFTYDELIQATNGFSAHNVLGEGGFGCVYKGV 401
P PL S+S S S S SG ++ + E + N +G G G VYK +
Sbjct: 44 PLPLPPPSSSSSSSSSSSASGSAPSAAKSLSELERV---------NRIGSGAGGTVYKVI 94
Query: 402 -LADGREVAVKQLKIGGSQGE---REFRAEVEIISRVHHRHLVSLVGYCISERERLLVYE 457
GR A+K I G+ + R+ E+EI+ V+H ++V E ++ E
Sbjct: 95 HRPTGRLYALKV--IYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152
Query: 458 YVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDS 517
++ +L EG + D VA GIAYLH I+HRDIK SN+L++S
Sbjct: 153 FMDGGSL------EGTHIADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINS 203
Query: 518 SFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATS----GKLTEKS-DVYSFG 572
+ ++ADFG+++I L +GT YM+PE + G + D++S G
Sbjct: 204 AKNVKIADFGVSRI---LAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLG 260
Query: 573 VVLLELITGRKP 584
V +LE GR P
Sbjct: 261 VSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 60/212 (28%), Positives = 107/212 (50%), Gaps = 18/212 (8%)
Query: 389 LGEGGFGCVYKG--VLADGREVAVKQLKIGGSQGE--REFRAEVEIISRVHHRHLVSLVG 444
LGEG + V+KG L + VA+K++++ +G R EV ++ + H ++V+L
Sbjct: 14 LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 71
Query: 445 YCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPR-I 503
+++ LV+EY+ D Y + +M RG+AY CH R +
Sbjct: 72 IVHTDKSLTLVFEYLDKDLKQYM--DDCGNIMSMHNVKIFLYQILRGLAY----CHRRKV 125
Query: 504 IHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYAT-SGKL 562
+HRD+K N+L++ E ++ADFGLA+ A + + T+ + V T Y P+ S +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLAR-AKSVPTKTYSNEVV--TLWYRPPDVLLGSSEY 182
Query: 563 TEKSDVYSFGVVLLELITGRKPVDASQPLGDE 594
+ + D++ G + E+ +GR P+ + DE
Sbjct: 183 STQIDMWGVGCIFFEMASGR-PLFPGSTVEDE 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 2e-11
Identities = 28/96 (29%), Positives = 37/96 (38%), Gaps = 6/96 (6%)
Query: 11 LAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSS 70
L VP P+P + P + P P P PA P++ P + A P V P
Sbjct: 359 LLVPVPAPQPAKPTAAAPSPVRPTPA------PSTRPKAAAAANIPPKEPVRETATPPPV 412
Query: 71 PPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPA 106
PP P+ P P + +P P P PPA
Sbjct: 413 PPRPVAPPVPHTPESAPKLTRAAIPVDEKPKYTPPA 448
|
Length = 585 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 3e-11
Identities = 29/130 (22%), Positives = 44/130 (33%), Gaps = 3/130 (2%)
Query: 9 AVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQP 68
+A +P + P + P + P + + P P +PA P P P
Sbjct: 385 LGVAGGAGAPAAAAPSAAAAAPAAAPAPAAAAPAAAAAPAPAAAPQPAPAPA---PAPAP 441
Query: 69 SSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSS 128
SP A P P+ AQP P A P A P P++ +P A +
Sbjct: 442 PSPAGNAPAGGAPSPPPAAAPSAQPAPAPAAAPEPTAAPAPAPPAAPAPAAAPAAPAAPA 501
Query: 129 SSPPPANVRT 138
+ + T
Sbjct: 502 APAGADDAAT 511
|
Length = 824 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 66.4 bits (163), Expect = 3e-11
Identities = 29/169 (17%), Positives = 51/169 (30%), Gaps = 9/169 (5%)
Query: 68 PSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPS 127
P++P P + PP + P AVAP P P + P +P T S
Sbjct: 361 PAAPLPEPEVPPQSAAPAASAQATAAPTAAVAPPQAPAVPPPPASAPQQAPAVPLPETTS 420
Query: 128 SSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSP 187
++ ++ S P + P +S+ S P S
Sbjct: 421 QLLAARQQLQRAQGATKAKK---------SEPAAASRARPVNSALERLASVRPAPSALEK 471
Query: 188 PVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPS 236
+ ++ P K P +T ++ +P + A +
Sbjct: 472 APAKKEAYRWKATNPVEVKKEPVATPKALKKALEHEKTPELAAKLAAEA 520
|
Length = 647 |
| >gnl|CDD|217393 pfam03154, Atrophin-1, Atrophin-1 family | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 3e-11
Identities = 74/305 (24%), Positives = 98/305 (32%), Gaps = 17/305 (5%)
Query: 2 PPQSSPPAVLAVPPPSPPLSPPPSTTP---PPTSPPPASPPPSPPTSTPPSPPTAPPPSS 58
PPQ SP A P P P + P P P P PP P + P P PSS
Sbjct: 204 PPQGSPIAAQPAPQPQQPSPLSLISAPSLHPQRLPSP--HPPLQPQTASQQSPQPPAPSS 261
Query: 59 PAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQP---PPQAVAPSPPPPANVPTTPSSS 115
S P P P P + +P QP V P P P P + +
Sbjct: 262 RHPQSSHHGPGPPMPHALQQGPVFLQHPSSNPPQPFGLAQSQVPPLPLPSQAQPHSHTPP 321
Query: 116 SPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTP---PSSSS 172
S P PPA P S PP + P+P S+
Sbjct: 322 SQSALQPQQPPREQPLPPAPSMPHIKPPPTTPIPQLPNQSHKHPPHLQGPSPFPQMPSNL 381
Query: 173 PPPPSSNPPTSTPS--PPVLTPPP----HPSQSAPPPVTKSPPASTLSPPPPSVPSTSSP 226
PPPP+ P +S P+ PP PPP SQ + P + PP +
Sbjct: 382 PPPPALKPLSSLPTHHPPSAHPPPLQLMPQSQPLQSVPAQPPVLTQSQSLPPKASTHPHS 441
Query: 227 PAVSPPAPPSNSSTRGSPSTPPLPSVPTEKPTAKSTNGTAVSANASPRNAGVLGTGGAVA 286
S P + + P P PT+ S+ + P + + +GG
Sbjct: 442 GLHSGPPQSPFAQHPFTSGGLPAIGPPPSLPTSTPAAPPRASSGSQPPGSALPSSGGCAG 501
Query: 287 IGIAV 291
G +
Sbjct: 502 PGPPL 506
|
Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1, that is thought to confer toxicity to the protein, possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders, including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein, CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity. Length = 979 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 3e-11
Identities = 60/198 (30%), Positives = 102/198 (51%), Gaps = 15/198 (7%)
Query: 389 LGEGGFGCVYKG-VLADGREVAVKQLKIGGSQGEREFRA--EVEIISRVHHRHLVSLVGY 445
LGEG + VYKG +G+ VA+K +++ +G F A E ++ + H ++V L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT-PFTAIREASLLKGLKHANIVLLHDI 71
Query: 446 CISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAA-GAARGIAYLHEDCHPRII 504
++ LV+EYV D Y + P VK+ RG++Y+H+ I+
Sbjct: 72 IHTKETLTLVFEYVHTDLCQY---MDKHPGGLHPENVKLFLFQLLRGLSYIHQR---YIL 125
Query: 505 HRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYAT-SGKLT 563
HRD+K N+L+ + E ++ADFGLA+ A + S+T+ + V T Y P+ S + +
Sbjct: 126 HRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVV--TLWYRPPDVLLGSTEYS 182
Query: 564 EKSDVYSFGVVLLELITG 581
D++ G + +E+I G
Sbjct: 183 TCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 63/209 (30%), Positives = 99/209 (47%), Gaps = 21/209 (10%)
Query: 389 LGEGGFGCVYKG--VLADGREVAVKQLKIGGSQGEREFRA--EVEIISRVH---HRHLVS 441
+GEG +G V+K + GR VA+K++++ + EV ++ + H ++V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 442 LVGYCISER-----ERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLH 496
L C R + LV+E+V D Y L P + T + RG+ +LH
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQDLTTY-LDKVPEPGVPTETIKDMMFQLLRGLDFLH 127
Query: 497 EDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEY 556
R++HRD+K NIL+ SS + ++ADFGLA+I S T V+ T Y APE
Sbjct: 128 SH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY----SFQMALTSVVVTLWYRAPEV 180
Query: 557 ATSGKLTEKSDVYSFGVVLLELITGRKPV 585
D++S G + E+ RKP+
Sbjct: 181 LLQSSYATPVDLWSVGCIFAEMFR-RKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 3e-11
Identities = 47/152 (30%), Positives = 72/152 (47%), Gaps = 8/152 (5%)
Query: 435 HHRHLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAY 494
+H LV L +E V EYV L +H+ + R + + R +A + + Y
Sbjct: 54 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARF-YSAEISLALNY 111
Query: 495 LHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAP 554
LHE II+RD+K N+LLDS ++ D+G+ K L T + GT Y+AP
Sbjct: 112 LHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAP 165
Query: 555 EYATSGKLTEKSDVYSFGVVLLELITGRKPVD 586
E D ++ GV++ E++ GR P D
Sbjct: 166 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|218439 pfam05109, Herpes_BLLF1, Herpes virus major outer envelope glycoprotein (BLLF1) | Back alignment and domain information |
|---|
Score = 66.7 bits (162), Expect = 3e-11
Identities = 53/227 (23%), Positives = 86/227 (37%), Gaps = 11/227 (4%)
Query: 40 PSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVA 99
P S P + P S PP P DP+ +P +
Sbjct: 426 PDTTKSVIFVYTLVH--VEPHKTTAVPTTPSLPPASTGPTVSTADPTSGTPTGTT-SSTL 482
Query: 100 PSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSP 159
P P + T+ + ++ P TTP+++SP TP+++SP P + T +++SP
Sbjct: 483 PEDTSPTSRTTSATPNATSPTPAVTTPNATSPTTQKTSDTPNATSPTPIVIGVTTTATSP 542
Query: 160 P-----PVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQ---SAPPPVTKSPPAS 211
P N +P + P ++N P T +P VLT Q + P + S
Sbjct: 543 PTGTTSVPNATSPQVTEESPVNNTNTPVVTSAPSVLTSAVTTGQHGTGSSPTSQQPGIPS 602
Query: 212 TLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTPPLPSVPTEKPT 258
+ P S ++++P S + T +PS P V T P
Sbjct: 603 SSHSTPRSNSTSTTPLLTSAHPTGGENITEETPSVPSTTHVSTLSPG 649
|
This family consists of the BLLF1 viral late glycoprotein, also termed gp350/220. It is the most abundantly expressed glycoprotein in the viral envelope of the Herpesviruses and is the major antigen responsible for stimulating the production of neutralising antibodies in vivo. Length = 830 |
| >gnl|CDD|235906 PRK07003, PRK07003, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 4e-11
Identities = 46/212 (21%), Positives = 74/212 (34%), Gaps = 17/212 (8%)
Query: 72 PPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSP 131
P P P+ + A P P A A + + VP + + A P +++
Sbjct: 360 PAVTGGGAPGGGVPARVAGAVPAPGARAAAAVGASAVPAVTAVTGAAGA--ALAPKAAAA 417
Query: 132 PPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLT 191
A P ++ PPA + P P +++ S PP +
Sbjct: 418 AAATRAEAPPAAPAPPA---TADRGDDAADGDAPVPAKANARASADSRCDERDAQPPADS 474
Query: 192 PPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGS---PSTPP 248
SAP +PP + P P + +++ PA P A +++R + PP
Sbjct: 475 GS----ASAPAS--DAPPDAAFEPAPRAAAPSAATPAAVPDARAPAAASREDAPAAAAPP 528
Query: 249 LPSVPTEKPTAKSTNGTAVSANAS---PRNAG 277
P P A + A A A+ RNAG
Sbjct: 529 APEARPPTPAAAAPAARAGGAAAALDVLRNAG 560
|
Length = 830 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 4e-11
Identities = 43/170 (25%), Positives = 71/170 (41%), Gaps = 21/170 (12%)
Query: 490 RGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTF 549
G+ YLH RIIHRD+K+ NI ++ + + D G A+ + + GT
Sbjct: 168 EGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPV----VAPAFLGLAGTV 220
Query: 550 GYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALE 609
APE K K+D++S G+VL E++ + P E V+ L + +
Sbjct: 221 ETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIIS 280
Query: 610 H-----EDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQV 654
E+F SRL + +++ A+ R T+ P +V
Sbjct: 281 TLKVHPEEFPRDPGSRLVRGFIEY---------ASLERQPYTRYPCFQRV 321
|
Length = 357 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 61/214 (28%), Positives = 94/214 (43%), Gaps = 20/214 (9%)
Query: 383 FSAHNVLGEGGFGCVYKGVLADGREV----AVKQLK----IGGSQGEREFRAEVEIISRV 434
F VLG G +G V+ G + A+K LK + ++ R E +++ +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 435 HHRHLVSLVGYCISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGA-ARGI 492
+ + Y +L L+ +Y+ L HL R V++ +G +
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK---EQEVQIYSGEIVLAL 118
Query: 493 AYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYM 552
+LH+ II+RDIK NILLDS+ + DFGL+K E + S GT YM
Sbjct: 119 EHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS--FCGTIEYM 173
Query: 553 APEYATSGKLTEKS--DVYSFGVVLLELITGRKP 584
AP+ G D +S GV++ EL+TG P
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (155), Expect = 6e-11
Identities = 48/177 (27%), Positives = 76/177 (42%), Gaps = 37/177 (20%)
Query: 434 VH-----HRHLVSLVGYCI-SERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAG 487
VH + + + L Y + + + +L+ +Y+ + L L EG+ + A K+
Sbjct: 61 VHQLMKDNPNFIKLY-YSVTTLKGHVLIMDYIKDGDLFDLLKKEGK--LSEAEVKKIIRQ 117
Query: 488 AARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARV--ADFGLAKIALELDSNTHVSTRV 545
+ LH+ H IIH DIK N+L D + R+ D+GL KI +
Sbjct: 118 LVEALNDLHK--H-NIIHNDIKLENVLYD-RAKDRIYLCDYGLCKII-------GTPSCY 166
Query: 546 MGTFGYMAPE------YATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESL 596
GT Y +PE Y S D ++ GV+ EL+TG+ P + DE L
Sbjct: 167 DGTLDYFSPEKIKGHNYDVS------FDWWAVGVLTYELLTGKHPFKEDE---DEEL 214
|
Length = 267 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 7e-11
Identities = 28/114 (24%), Positives = 39/114 (34%), Gaps = 5/114 (4%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
P ++ PA P + P + P PA P P S + P PS P
Sbjct: 399 PSAAAAAPAAAPAPAAAAPAAAAAPAPAAAPQPAPAPAPAPAPPSPAGNAPAGGAPSPPP 458
Query: 61 VNSPPPQP-----SSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVP 109
+P QP ++P P P P P+P + P AP+ A
Sbjct: 459 AAAPSAQPAPAPAAAPEPTAAPAPAPPAAPAPAAAPAAPAAPAAPAGADDAATL 512
|
Length = 824 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 7e-11
Identities = 32/143 (22%), Positives = 53/143 (37%), Gaps = 21/143 (14%)
Query: 68 PSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPS 127
++ P P PE +P A AP+ P A ++S P A P+
Sbjct: 371 EAAAPAEKKTPARPEAAAPAAAPVAQAAAAPAPAAAPAA-------AASAPAA----PPA 419
Query: 128 SSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSP 187
++ P P + P A PA +++P V + P + + P + P P P
Sbjct: 420 AAPPAPV---------AAPAAAAPAAAPAAAPAAVALAPAPPAQAAPETVAIPVRVAPEP 470
Query: 188 PVLTPPPHPS-QSAPPPVTKSPP 209
V + P P+ A +T +
Sbjct: 471 AVASAAPAPAAAPAAARLTPTEE 493
|
Length = 618 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 7e-11
Identities = 68/206 (33%), Positives = 95/206 (46%), Gaps = 21/206 (10%)
Query: 388 VLGEGGFGCVYKGVLA----DGREVAVKQLK---IGGSQGEREFRAEVEIISR-VHHRHL 439
V+G+G FG K +LA DG+ AVK L+ + + ++ AE ++ + V H L
Sbjct: 2 VIGKGSFG---KVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFL 58
Query: 440 VSLVGYCISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHED 498
V L Y E+L V ++V L +HL E R + R AA A + YLH
Sbjct: 59 VGL-HYSFQTTEKLYFVLDFVNGGELFFHLQRE-RSFPEPRARF-YAAEIASALGYLHS- 114
Query: 499 CHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYAT 558
I++RD+K NILLDS + DFGL K + T T GT Y+APE
Sbjct: 115 --INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTT---TTFCGTPEYLAPEVIR 169
Query: 559 SGKLTEKSDVYSFGVVLLELITGRKP 584
D + G VL E++ G P
Sbjct: 170 KQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 7e-11
Identities = 52/207 (25%), Positives = 97/207 (46%), Gaps = 16/207 (7%)
Query: 389 LGEGGFGCVYKGVLA----DGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVG 444
+GEG G V +A GR+VAVK + + Q EV I+ H+++V +
Sbjct: 29 IGEGSTGIV---CIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYK 85
Query: 445 YCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRII 504
+ E ++ E++ L + ++ R ++ V + + YLH +I
Sbjct: 86 SYLVGEELWVLMEFLQGGAL-TDIVSQTR--LNEEQIATVCESVLQALCYLHSQ---GVI 139
Query: 505 HRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTE 564
HRDIKS +ILL +++DFG ++ + ++GT +MAPE +
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCA---QISKDVPKRKSLVGTPYWMAPEVISRTPYGT 196
Query: 565 KSDVYSFGVVLLELITGRKPVDASQPL 591
+ D++S G++++E++ G P + P+
Sbjct: 197 EVDIWSLGIMVIEMVDGEPPYFSDSPV 223
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 65.7 bits (161), Expect = 7e-11
Identities = 16/82 (19%), Positives = 30/82 (36%)
Query: 17 SPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLD 76
P + P+ + ++P +P P +P APP ++ P P ++
Sbjct: 37 GPGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAP 96
Query: 77 APPPPEVDPSPPSPAQPPPQAV 98
A PP + P+ A +
Sbjct: 97 AAPPAAAAAAAPAAAAVEDEVT 118
|
Length = 1228 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 8e-11
Identities = 32/126 (25%), Positives = 49/126 (38%), Gaps = 5/126 (3%)
Query: 35 PASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPP 94
+ P + PS A P ++PA + P ++ P P AP P P+PA P
Sbjct: 386 GVAGGAGAPAAAAPSAAAAAPAAAPAPAAAAPAAAAAPAPAAAPQPAP----APAPAPAP 441
Query: 95 PQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATP 154
P +P A P ++ S PA P + PA + + PA PA P
Sbjct: 442 PSPAGNAPAGGAPSPPPAAAPSAQPAPAPAAAPEPTAAPAPAPPAAPAPAAAPA-APAAP 500
Query: 155 SSSSPP 160
++ +
Sbjct: 501 AAPAGA 506
|
Length = 824 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 8e-11
Identities = 42/133 (31%), Positives = 55/133 (41%), Gaps = 10/133 (7%)
Query: 110 TTPSSSSPPP-----ANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNV 164
P+ P A+V TT S +S P + +S S PP++ P PS SPP +
Sbjct: 146 EDPNPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPE-DP 204
Query: 165 PTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTS 224
+P SS PP PSS + P P + S PP PP PP S +
Sbjct: 205 SSPSDSSLPPAPSSFQSDTPPPSP----ESPTNPSPPPGPAAPPPPPVQQVPPLSTAKPT 260
Query: 225 SPPAVSPPAPPSN 237
P A + PAP
Sbjct: 261 PPSASATPAPIGG 273
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 9e-11
Identities = 47/159 (29%), Positives = 85/159 (53%), Gaps = 9/159 (5%)
Query: 427 EVEIISRVHHRHLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAA 486
E++++ + ++V G S+ E + E++ +L L GR +V +A
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 112
Query: 487 GAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVM 546
+G+ YL E +I+HRD+K SNIL++S E ++ DFG++ ++ +N+ V TR
Sbjct: 113 --IKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-- 166
Query: 547 GTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPV 585
YM+PE + +SD++S G+ L+E+ GR P+
Sbjct: 167 ---SYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-10
Identities = 48/238 (20%), Positives = 70/238 (29%), Gaps = 11/238 (4%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTS--TPPSPPTAPPPSS 58
P +P A + S + P P P P A +
Sbjct: 218 SSPAPAPGRSAADDAGASSSDSSSSESSGCGWGPENECPLPRPAPITLPTRIWEASGWNG 277
Query: 59 PAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPP 118
P+ P SS P P P S P+P+ P + + S ++ T+ SS S
Sbjct: 278 PSSRPGPASSSSSPRERSPSPSPSSPGSGPAPSSPRASSSSSSSRESSSSSTSSSSESSR 337
Query: 119 PANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSS 178
A V PS S P S PPPA+ + P S+ P +
Sbjct: 338 GAAVSPGPSPSRSPS-------PSRPPPPADPSSPRKRPRPSRAPSSPAASAGRPTRRRA 390
Query: 179 NPPTSTPSPPVLTPPPHPSQSAP--PPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAP 234
+ + P+ P + + + P PS P PP P
Sbjct: 391 RAAVAGRARRRDATGRFPAGRPRPSPLDAGAASGAFYARYPLLTPSGEPWPGSPPPPP 448
|
Length = 1352 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 64.1 bits (157), Expect = 1e-10
Identities = 27/166 (16%), Positives = 45/166 (27%), Gaps = 8/166 (4%)
Query: 97 AVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSS 156
+A P P P P S+ P A+ T + ++ P + P + P
Sbjct: 356 MLAFHPAAPLPEPEVPPQSAAPAASAQATAAPTAAVA------PPQAPAVPPPPASAPQQ 409
Query: 157 SSPPPVNVPTPPSSSSPPPPSSNPPTSTPSP--PVLTPPPHPSQSAPPPVTKSPPASTLS 214
+ P+ T ++ + P P SA + PA +
Sbjct: 410 APAVPLPETTSQLLAARQQLQRAQGATKAKKSEPAAASRARPVNSALERLASVRPAPSAL 469
Query: 215 PPPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTPPLPSVPTEKPTAK 260
P+ A +P L T + AK
Sbjct: 470 EKAPAKKEAYRWKATNPVEVKKEPVATPKALKKALEHEKTPELAAK 515
|
Length = 647 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 1e-10
Identities = 36/148 (24%), Positives = 57/148 (38%), Gaps = 20/148 (13%)
Query: 71 PPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSS 130
P +A P E +PA+P A A +P A P++ P A ++S+
Sbjct: 366 PAAAAEAAAPAE----KKTPARPEAAAPAAAPVAQAAAAPAPAA--APAA------AASA 413
Query: 131 PPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVL 190
P P+ + P A PA +++P V + P + + P + P P P V
Sbjct: 414 PAAPPAAAPPAPVAAPAAAAPAAAPAAAPAAVALAPAPPAQAAPETVAIPVRVAPEPAV- 472
Query: 191 TPPPHPSQSAPPPVTKSPPASTLSPPPP 218
SA P +P A+ L+P
Sbjct: 473 -------ASAAPAPAAAPAAARLTPTEE 493
|
Length = 618 |
| >gnl|CDD|237605 PRK14086, dnaA, chromosomal replication initiation protein; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 1e-10
Identities = 36/197 (18%), Positives = 49/197 (24%), Gaps = 9/197 (4%)
Query: 27 TPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPS 86
T P++ PA PPP ++ P P + PP
Sbjct: 87 TVDPSAGEPAPPPPHARRTSEPELPRPGRRPYEGY---GGPRADDRPPGLPRQDQLPTAR 143
Query: 87 PPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPS---SS 143
P PA P + PP +P+S +P R
Sbjct: 144 PAYPAYQQRPEPGAWPRAADDYGWQQQRLGFPPRAPYASPASYAPEQERDREPYDAGRPE 203
Query: 144 SPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPP 203
P P T PPP + + P PP P P
Sbjct: 204 YDQRRRDYDHPRPDWDRPRRDRTD--RPEPPPGAGHVHRGGPGPPERDDAPVVPIRPSAP 261
Query: 204 VT-KSPPASTLSPPPPS 219
+ PA P P+
Sbjct: 262 GPLAAQPAPAPGPGEPT 278
|
Length = 617 |
| >gnl|CDD|218439 pfam05109, Herpes_BLLF1, Herpes virus major outer envelope glycoprotein (BLLF1) | Back alignment and domain information |
|---|
Score = 64.8 bits (157), Expect = 1e-10
Identities = 67/275 (24%), Positives = 99/275 (36%), Gaps = 13/275 (4%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
PP + P A P P ST P TSP + +P ++P T P +SP
Sbjct: 456 PPASTGPTVSTADPTSGTPTGTTSSTLPEDTSPTSRTTSATPNATSPTPAVTTPNATSPT 515
Query: 61 VNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVP-TTPSSSSPPP 119
P++ P SPP+ P A +P + V T + P
Sbjct: 516 TQKTSDTPNATSPTPIVIGVTTTATSPPTGTTSVPNATSPQVTEESPVNNTNTPVVTSAP 575
Query: 120 ANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSN 179
+ + + ++ + T S P++ +TP S+S TP +S+ P N
Sbjct: 576 SVLTSAVTTGQHGTGSSPT--SQQPGIPSSSHSTPRSNS----TSTTPLLTSAHPTGGEN 629
Query: 180 PPTSTPSPPVLTPPPHPSQSAPPPVT---KSPPASTLSPPPPSVPSTSSPP---AVSPPA 233
TPS P T S P T P S+ S P V T P A SP A
Sbjct: 630 ITEETPSVPSTTHVSTLSPGPGPGTTSQVSGPGNSSTSRYPGEVHVTEGMPNPNATSPSA 689
Query: 234 PPSNSSTRGSPSTPPLPSVPTEKPTAKSTNGTAVS 268
P + + ++ + T K T+ ST + S
Sbjct: 690 PSGQKTAVPTVTSTGGKANSTTKETSGSTLMASTS 724
|
This family consists of the BLLF1 viral late glycoprotein, also termed gp350/220. It is the most abundantly expressed glycoprotein in the viral envelope of the Herpesviruses and is the major antigen responsible for stimulating the production of neutralising antibodies in vivo. Length = 830 |
| >gnl|CDD|223065 PHA03378, PHA03378, EBNA-3B; Provisional | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 1e-10
Identities = 67/246 (27%), Positives = 85/246 (34%), Gaps = 18/246 (7%)
Query: 2 PPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAV 61
P S + LA PS +P P P T PP + P TS P P P
Sbjct: 576 PLTSPTTSQLASSAPSYAQTPWPVPHPSQTPEPPTTQSHIPETSAPRQWPMPLRPIPMRP 635
Query: 62 NSPPPQPSSPP--PPLDAPPPPEVDPSPPSPAQPPPQAVAPSPP------PPANVPTT-- 111
P + P PP E+ P P+ Q PSP P P T
Sbjct: 636 LRMQPITFNVLVFPTPHQPPQVEITPYKPTWTQIGHIPYQPSPTGANTMLPIQWAPGTMQ 695
Query: 112 PSSSSPPPANVPTTPSSSSPPP--ANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPS 169
P +P P P P + P A R P +++P A PA + PP P
Sbjct: 696 PPPRAPTPMRPPAAPPGRAQRPAAATGRARPPAAAPGRARPPAAAPGRARPPAAAPGRAR 755
Query: 170 SSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAV 229
+ P + PP + P P PPP APP + P + PPP T +
Sbjct: 756 PPAAAPGRARPPAAAPGAPTPQPPPQ----APPAPQQRPRGAPTPQPPPQAGPT--SMQL 809
Query: 230 SPPAPP 235
P A P
Sbjct: 810 MPRAAP 815
|
Length = 991 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 73/262 (27%), Positives = 114/262 (43%), Gaps = 48/262 (18%)
Query: 392 GGFGCVYKGVLADGREV----AVKQLK----IGGSQGEREFRAEVEIISRVHHRHLVSLV 443
G +G VY L +E A+K++ I +Q ++ F E +I++ + +VS+
Sbjct: 12 GAYGAVY---LVRHKETRQRFAMKKINKQNLILRNQIQQVF-VERDILTFAENPFVVSM- 66
Query: 444 GYCISERERLL--VYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHP 501
+C E +R L V EYV L G +D A R+ A + YLH +
Sbjct: 67 -FCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMA-RMYFAE-TVLALEYLH---NY 120
Query: 502 RIIHRDIKSSNILLDSSFEARVADFGLAKIAL------------ELDSNTHVSTRVMGTF 549
I+HRD+K N+L+ S ++ DFGL+KI L E D+ + +V GT
Sbjct: 121 GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTP 180
Query: 550 GYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKP---------------VDASQPLGDE 594
Y+APE + D ++ G++L E + G P D P GDE
Sbjct: 181 EYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDE 240
Query: 595 SLVEWARPLLAEALEHEDFEAL 616
+L A+ L++ L E L
Sbjct: 241 ALPADAQDLISRLLRQNPLERL 262
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 63/211 (29%), Positives = 97/211 (45%), Gaps = 35/211 (16%)
Query: 389 LGEGGFGCVYKGVL---------ADGREVAVKQLKIGGSQGER--EFRAEVEIISRVHHR 437
LG+G F +YKGVL G+EV+V LK+ GS F ++S++ H+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSV-VLKVLGSDHRDSLAFFETASLMSQLSHK 61
Query: 438 HLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPV-MDWATRVKVAAGAARGIAYLH 496
HLV L G C+ + E ++V EYV L LH E V + W ++ VA A + YL
Sbjct: 62 HLVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLE 118
Query: 497 EDCHPRIIHRDIKSSNILL-------DSSFEARVADFGLAKIALELDSNTHVSTRVMGTF 549
+ +++H ++ NIL+ +++D G+ L RV
Sbjct: 119 DK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS------REERVERI- 168
Query: 550 GYMAPEY--ATSGKLTEKSDVYSFGVVLLEL 578
++APE LT +D +SFG LLE+
Sbjct: 169 PWIAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|185616 PTZ00436, PTZ00436, 60S ribosomal protein L19-like protein; Provisional | Back alignment and domain information |
|---|
Score = 63.4 bits (153), Expect = 1e-10
Identities = 40/152 (26%), Positives = 63/152 (41%), Gaps = 14/152 (9%)
Query: 24 PSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEV 83
PS + PA +P + P A P+ A P ++ PP A PP +
Sbjct: 211 PSGKKSAKAAAPAKAAAAPAKAAAPPAKAAAAPAKAAA---APAKAAAPPAKAAAPPAKA 267
Query: 84 DPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSS 143
P A PP +A AP P+ ++ PPA P+ ++ PA P+ +
Sbjct: 268 AAPPAKAAAPPAKAAAP-----------PAKAAAPPAKAAAAPAKAAAAPAKAAAAPAKA 316
Query: 144 SPPPANVPATPSSSSPPPVNVPTPPSSSSPPP 175
+ PPA A P+ ++ PP PP+ ++ P
Sbjct: 317 AAPPAKAAAPPAKAATPPAKAAAPPAKAAAAP 348
|
Length = 357 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 60/203 (29%), Positives = 102/203 (50%), Gaps = 23/203 (11%)
Query: 389 LGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGEREFRA--EVEIISRVHHRHLVSLVGY 445
LGEG + VYKG+ +G+ VA+K + + +G F A E ++ + H ++V L+
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEG-VPFTAIREASLLKGLKHANIV-LLHD 70
Query: 446 CISERERL-LVYEYVPNDTLHYHLHAEG----RPVMDWATRVKVAAGAARGIAYLHEDCH 500
I +E L V+EY+ D Y + G V + ++ RG+AY+H
Sbjct: 71 IIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQL------LRGLAYIH---G 121
Query: 501 PRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYAT-S 559
I+HRD+K N+L+ E ++ADFGLA+ A + S T+ S V T Y P+ +
Sbjct: 122 QHILHRDLKPQNLLISYLGELKLADFGLAR-AKSIPSQTYSSEVV--TLWYRPPDVLLGA 178
Query: 560 GKLTEKSDVYSFGVVLLELITGR 582
+ D++ G + +E++ G+
Sbjct: 179 TDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 2e-10
Identities = 37/143 (25%), Positives = 46/143 (32%), Gaps = 4/143 (2%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
P A + P +PPP+ P + P + P P + +PP A
Sbjct: 660 PDASDGGDGWPAKAGGAAPAAPPPAPAPAAPAAPAGAAPAQPAPAPAATPPAGQADDPAA 719
Query: 61 VNSPPPQPSSPPPP---LDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSP 117
Q +S P P P PPE D PP PA P Q P P PA P SP
Sbjct: 720 QPPQAAQGASAPSPAADDPVPLPPEPDD-PPDPAGAPAQPPPPPAPAPAAAPAAAPPPSP 778
Query: 118 PPANVPTTPSSSSPPPANVRTTP 140
P + R
Sbjct: 779 PSEEEEMAEDDAPSMDDEDRRDA 801
|
Length = 824 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 2e-10
Identities = 22/114 (19%), Positives = 39/114 (34%)
Query: 146 PPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVT 205
P A A + P +++P ++ P +P P +A PP
Sbjct: 366 PAAAAEAAAPAEKKTPARPEAAAPAAAPVAQAAAAPAPAAAPAAAASAPAAPPAAAPPAP 425
Query: 206 KSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTPPLPSVPTEKPTA 259
+ PA+ P+ + A +PPA + + P P+V + P
Sbjct: 426 VAAPAAAAPAAAPAAAPAAVALAPAPPAQAAPETVAIPVRVAPEPAVASAAPAP 479
|
Length = 618 |
| >gnl|CDD|185616 PTZ00436, PTZ00436, 60S ribosomal protein L19-like protein; Provisional | Back alignment and domain information |
|---|
Score = 62.7 bits (151), Expect = 2e-10
Identities = 43/162 (26%), Positives = 72/162 (44%), Gaps = 18/162 (11%)
Query: 45 STPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPP 104
+ PS + ++PA + P ++ PP A P + +P A PP +A AP
Sbjct: 208 AAAPSGKKSAKAAAPAKAAAAPAKAAAPPAKAAAAPAKAAAAPAKAAAPPAKAAAP---- 263
Query: 105 PANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNV 164
PA P+ ++ PPA P+ ++ PPA P+ ++ PA A P+ ++ PP
Sbjct: 264 PAKAAAPPAKAAAPPAKAAAPPAKAAAPPAKAAAAPAKAAAAPAKAAAAPAKAAAPPAKA 323
Query: 165 PTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTK 206
PP+ ++ PP + P P+++A PV K
Sbjct: 324 AAPPAKAATPPAKAAAP--------------PAKAAAAPVGK 351
|
Length = 357 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 62/205 (30%), Positives = 87/205 (42%), Gaps = 20/205 (9%)
Query: 388 VLGEGGFGCVYKGVL----ADGREVAVKQLK---IGGSQGEREFRAEVEIISRVHHRHLV 440
+LG+G FG K +L A GR A+K L+ I E ++ H L
Sbjct: 2 LLGKGTFG---KVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 58
Query: 441 SLVGYCISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDC 499
+L Y +RL V EY L +HL E R + R A + YLH
Sbjct: 59 AL-KYAFQTHDRLCFVMEYANGGELFFHLSRE-RVFTEERARF-YGAEIVSALEYLHSR- 114
Query: 500 HPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATS 559
+++RDIK N++LD ++ DFGL K E S+ GT Y+APE
Sbjct: 115 --DVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPEVLED 169
Query: 560 GKLTEKSDVYSFGVVLLELITGRKP 584
D + GVV+ E++ GR P
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 65/203 (32%), Positives = 95/203 (46%), Gaps = 15/203 (7%)
Query: 388 VLGEGGFGCVYKGV-LADGREVAVKQLK---IGGSQGEREFRAEVEIISR-VHHRHLVSL 442
V+G+G FG V A+ + AVK L+ I + E+ +E ++ + V H LV L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 443 VGYCISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHP 501
+ ++L V +Y+ L YHL E R ++ R AA A + YLH
Sbjct: 62 -HFSFQTADKLYFVLDYINGGELFYHLQRE-RCFLEPRARF-YAAEIASALGYLHS---L 115
Query: 502 RIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGK 561
I++RD+K NILLDS + DFGL K +E + T + GT Y+APE
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTT---STFCGTPEYLAPEVLHKQP 172
Query: 562 LTEKSDVYSFGVVLLELITGRKP 584
D + G VL E++ G P
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|178748 PLN03209, PLN03209, translocon at the inner envelope of chloroplast subunit 62; Provisional | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-10
Identities = 60/229 (26%), Positives = 87/229 (37%), Gaps = 29/229 (12%)
Query: 3 PQSSPPAVLAVPPPSPPLSPPP----STTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSS 58
P+ P + PSPP+ P + P P SP A PPTS P+PP++ P SS
Sbjct: 339 PKPVPTKPVTPEAPSPPIEEEPPQPKAVVPRPLSPYTAYEDLKPPTSPIPTPPSSSPASS 398
Query: 59 PAVN--SPPPQPSSPPPPLDAPPPPEVDPS---------------------PPSPAQPPP 95
+V+ + P +P P P A PEV+P+ P SP+ P
Sbjct: 399 KSVDAVAKPAEPDVVPSPGSASNVPEVEPAQVEAKKTRPLSPYARYEDLKPPTSPSPTAP 458
Query: 96 QAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPS 155
V+PS ++VP P ++ A P ++ P + PP + PA P
Sbjct: 459 TGVSPSVSSTSSVPAVPDTAPATAATDAAAPPPANMRPLSPYAVYDDLKPPTSPSPAAPV 518
Query: 156 SSSPPPVNVPTPPSSSSPPP--PSSNPPTSTPSPPVLTPPPHPSQSAPP 202
P +S PP + + P P L+P PP
Sbjct: 519 GKVAPSSTNEVVKVGNSAPPTALADEQHHAQPKPRPLSPYTMYEDLKPP 567
|
Length = 576 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 54/212 (25%), Positives = 93/212 (43%), Gaps = 26/212 (12%)
Query: 389 LGEGGFGCV-YKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCI 447
+GEG G V V + G+ VAVK++ + Q EV I+ H ++V + +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 448 SERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVK--------VAAGAARGIAYLHEDC 499
E +V E++ EG + D T + V + ++ LH
Sbjct: 88 VGDELWVVMEFL-----------EGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQ- 135
Query: 500 HPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATS 559
+IHRDIKS +ILL +++DFG ++ ++GT +MAPE +
Sbjct: 136 --GVIHRDIKSDSILLTHDGRVKLSDFGFCA---QVSKEVPRRKSLVGTPYWMAPELISR 190
Query: 560 GKLTEKSDVYSFGVVLLELITGRKPVDASQPL 591
+ D++S G++++E++ G P PL
Sbjct: 191 LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL 222
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 3e-10
Identities = 37/195 (18%), Positives = 56/195 (28%), Gaps = 4/195 (2%)
Query: 81 PEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTP 140
E P A AP+ P P++ + P A P+ ++ PA P
Sbjct: 584 VEAVVGPAPGAAGGEGPPAPASSGPPEEAARPAAPAAPAAPAAPAPAGAAAAPAEASAAP 643
Query: 141 SSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNP-PTSTPSPPVLTPPPHPSQS 199
+ P + P + P + P + P P P
Sbjct: 644 APGVAAPEHHPKHVAVPDASDGGDGWPAKAGGAAPAAPPPAPAPAAPAAPAGAAPAQPAP 703
Query: 200 APPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTPPLPSVPTEKPTA 259
AP + A + PP +S P PA P PP P+ +P
Sbjct: 704 APAATPPAGQADDPAAQPPQAAQGASAP---SPAADDPVPLPPEPDDPPDPAGAPAQPPP 760
Query: 260 KSTNGTAVSANASPR 274
A + A+P
Sbjct: 761 PPAPAPAAAPAAAPP 775
|
Length = 824 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 3e-10
Identities = 37/188 (19%), Positives = 60/188 (31%)
Query: 97 AVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSS 156
AV P A P+ +S P P++ + P A P+ ++ PA A P+
Sbjct: 586 AVVGPAPGAAGGEGPPAPASSGPPEEAARPAAPAAPAAPAAPAPAGAAAAPAEASAAPAP 645
Query: 157 SSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPP 216
P + P + P PPP P+ +AP + PA P
Sbjct: 646 GVAAPEHHPKHVAVPDASDGGDGWPAKAGGAAPAAPPPAPAPAAPAAPAGAAPAQPAPAP 705
Query: 217 PPSVPSTSSPPAVSPPAPPSNSSTRGSPSTPPLPSVPTEKPTAKSTNGTAVSANASPRNA 276
+ P+ + + P + ++ SP+ +P E G P A
Sbjct: 706 AATPPAGQADDPAAQPPQAAQGASAPSPAADDPVPLPPEPDDPPDPAGAPAQPPPPPAPA 765
Query: 277 GVLGTGGA 284
A
Sbjct: 766 PAAAPAAA 773
|
Length = 824 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 30/122 (24%), Positives = 45/122 (36%), Gaps = 5/122 (4%)
Query: 124 TTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTS 183
P+ P +++ + P + + + P S P PS S
Sbjct: 146 EDPNPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPS 205
Query: 184 TPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSS-----PPAVSPPAPPSNS 238
+PS L P P QS PP + P + PP P+ P P + + P PPS S
Sbjct: 206 SPSDSSLPPAPSSFQSDTPPPSPESPTNPSPPPGPAAPPPPPVQQVPPLSTAKPTPPSAS 265
Query: 239 ST 240
+T
Sbjct: 266 AT 267
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 3e-10
Identities = 24/100 (24%), Positives = 33/100 (33%), Gaps = 10/100 (10%)
Query: 7 PPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPP 66
P P+ P TP P++ P A+ + P P TA PP PP
Sbjct: 362 PVPAPQPAKPTAAAPSPVRPTPAPSTRPKAAAAANIPP-KEPVRETATPP------PVPP 414
Query: 67 QPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPA 106
+P +PP P P + + P PP
Sbjct: 415 RPVAPPVP---HTPESAPKLTRAAIPVDEKPKYTPPAPPK 451
|
Length = 585 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 3e-10
Identities = 21/81 (25%), Positives = 30/81 (37%), Gaps = 3/81 (3%)
Query: 23 PPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPE 82
P ST P + A+ S P + P + A P +P P++PP P A
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPP---AAAAPAAPPKPAAAAAAAA 94
Query: 83 VDPSPPSPAQPPPQAVAPSPP 103
+PP+ A A A
Sbjct: 95 APAAPPAAAAAAAPAAAAVED 115
|
Length = 1228 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 3e-10
Identities = 54/192 (28%), Positives = 77/192 (40%), Gaps = 29/192 (15%)
Query: 438 HLVSLVGYCISERERLLVYEYVPNDTLHYH----LHAEGRPVMDWATRVKVAAGAARGIA 493
++V L Y +SE LV ++ L H L+ V WA + VA A
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA----- 100
Query: 494 YLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMA 553
LH + I+ RD+ +NILLD ++ F + V Y A
Sbjct: 101 -LHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YCA 150
Query: 554 PEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLG---------DESLVEWARPLL 604
PE + TE D +S G +L EL+TG+ V+ P G E + E AR LL
Sbjct: 151 PEVGGISEETEACDWWSLGAILFELLTGKTLVE-CHPSGINTHTTLNIPEWVSEEARSLL 209
Query: 605 AEALEHEDFEAL 616
+ L+ E L
Sbjct: 210 QQLLQFNPTERL 221
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 48/148 (32%), Positives = 72/148 (48%), Gaps = 11/148 (7%)
Query: 442 LVGY--CISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHED 498
LVG C RL LV EYV L +H+ + R + + R AA + +LHE
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQ-RKLPEEHARF-YAAEICIALNFLHER 115
Query: 499 CHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYAT 558
II+RD+K N+LLD+ ++ D+G+ K L T + GT Y+APE
Sbjct: 116 ---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT---STFCGTPNYIAPEILR 169
Query: 559 SGKLTEKSDVYSFGVVLLELITGRKPVD 586
+ D ++ GV++ E++ GR P D
Sbjct: 170 GEEYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 60/216 (27%), Positives = 98/216 (45%), Gaps = 20/216 (9%)
Query: 383 FSAHNVLGEGGFGCVYKGVLADGR--EVAVKQLK----IGGSQGEREFRAEVEIISRVHH 436
F+ LG G FG V + VA+K+ + I Q + F +E +I++ ++H
Sbjct: 32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF-SERKILNYINH 90
Query: 437 RHLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLH 496
V+L G E LV E+V L R D V A I +
Sbjct: 91 PFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPND------VGCFYAAQIVLIF 144
Query: 497 EDCHP-RIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPE 555
E I++RD+K N+LLD ++ DFG AK+ +D+ T+ + GT Y+APE
Sbjct: 145 EYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV---VDTRTYT---LCGTPEYIAPE 198
Query: 556 YATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPL 591
+ + +D ++ G+ + E++ G P A++PL
Sbjct: 199 ILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL 234
|
Length = 340 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 46/148 (31%), Positives = 72/148 (48%), Gaps = 11/148 (7%)
Query: 442 LVGY--CISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHED 498
LVG C RL V E+V L +H+ + R + + R +A + + +LHE
Sbjct: 58 LVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQ-RKLPEEHARF-YSAEISLALNFLHER 115
Query: 499 CHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYAT 558
II+RD+K N+LLD+ ++ D+G+ K + T ST GT Y+APE
Sbjct: 116 ---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT--ST-FCGTPNYIAPEILR 169
Query: 559 SGKLTEKSDVYSFGVVLLELITGRKPVD 586
D ++ GV++ E++ GR P D
Sbjct: 170 GEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 19/211 (9%)
Query: 389 LGEGGFGCVYKGVLADG---REVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVG 444
+G G FG V G + G +V VK+L++ S Q + +F E + + H +L+ +G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 445 YCISERERLLVYEYVPNDTLHYHLHAEGRP---VMDWATRVKVAAGAARGIAYLHEDCHP 501
C LLV E+ P L +L + + D T ++A A G+ +LH++
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN--- 119
Query: 502 RIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYA--TS 559
IH D+ N LL + ++ D+GL+ + D ++ ++APE
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV-TPDQLWVPLRWIAPELVDEVH 178
Query: 560 GKL-----TEKSDVYSFGVVLLELIT-GRKP 584
G L T++S+V+S GV + EL G +P
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWELFELGSQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 4e-10
Identities = 38/175 (21%), Positives = 46/175 (26%), Gaps = 16/175 (9%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
+P P P S P+ P P P AP + A
Sbjct: 639 ASAAPAPGVAAPEHHPKHVAVPDASDGGDGWPAKAGGAAPAAPP--PAPAPAAPAAPAGA 696
Query: 61 VNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPA 120
P QP+ P A PP + AQPP A S P PA P P
Sbjct: 697 ---APAQPAPAPA---ATPPAG--QADDPAAQPPQAAQGASAPSPAADDPVPLPPEPDDP 748
Query: 121 NVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPP 175
P + PPP P+ + PS S S
Sbjct: 749 PDPAGAPAQPPPP------PAPAPAAAPAAAPPPSPPSEEEEMAEDDAPSMDDED 797
|
Length = 824 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 4e-10
Identities = 31/127 (24%), Positives = 47/127 (37%), Gaps = 4/127 (3%)
Query: 47 PPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPA 106
+ P ++ + ++P P AP +P P A AP+PP PA
Sbjct: 386 GVAGGAGAPAAAAPSAAAAAPAAAPAPAAAAPAAAAAPAPAAAPQPAPAPAPAPAPPSPA 445
Query: 107 NVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPT 166
+ SPPPA P+ + +P A T + +PP A PA P P
Sbjct: 446 GNAPAGGAPSPPPAAAPSAQPAPAPAAAPEPTAAPAPAPPAAPAPAAA----PAAPAAPA 501
Query: 167 PPSSSSP 173
P+ +
Sbjct: 502 APAGADD 508
|
Length = 824 |
| >gnl|CDD|218439 pfam05109, Herpes_BLLF1, Herpes virus major outer envelope glycoprotein (BLLF1) | Back alignment and domain information |
|---|
Score = 62.9 bits (152), Expect = 4e-10
Identities = 55/280 (19%), Positives = 94/280 (33%), Gaps = 15/280 (5%)
Query: 16 PSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPP--SSPAVNSPPPQPSSPPP 73
P+ P PP ST P ++ P S P+ TS+ T+P +S N+ P P+ P
Sbjct: 450 PTTPSLPPASTGPTVSTADPTSGTPTGTTSSTLPEDTSPTSRTTSATPNATSPTPAVTTP 509
Query: 74 PLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPP 133
+A P S A P V + P+ ++ P + SP
Sbjct: 510 --NATSPTTQKTSDTPNATSPTPIVIGVTT---TATSPPTGTTSVPNATSPQVTEESPVN 564
Query: 134 ANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPP 193
T + P+ + + ++ + PT P S P +++ S L
Sbjct: 565 ---NTNTPVVTSAPSVLTSAVTTGQHGTGSSPTSQQPGIPSSSHSTPRSNSTSTTPLLTS 621
Query: 194 PHPSQSAP-----PPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTPP 248
HP+ P V + STLSP P ++ + + P
Sbjct: 622 AHPTGGENITEETPSVPSTTHVSTLSPGPGPGTTSQVSGPGNSSTSRYPGEVHVTEGMPN 681
Query: 249 LPSVPTEKPTAKSTNGTAVSANASPRNAGVLGTGGAVAIG 288
+ P+ + T V++ N+ T G+ +
Sbjct: 682 PNATSPSAPSGQKTAVPTVTSTGGKANSTTKETSGSTLMA 721
|
This family consists of the BLLF1 viral late glycoprotein, also termed gp350/220. It is the most abundantly expressed glycoprotein in the viral envelope of the Herpesviruses and is the major antigen responsible for stimulating the production of neutralising antibodies in vivo. Length = 830 |
| >gnl|CDD|223065 PHA03378, PHA03378, EBNA-3B; Provisional | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 4e-10
Identities = 58/238 (24%), Positives = 84/238 (35%), Gaps = 13/238 (5%)
Query: 25 STTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVD 84
S P T P P+P P P +S +S P +P P P P
Sbjct: 550 SDEPASTEPVHDQLLPAPGLGPLQIQPLTSPTTSQLASSAPSYAQTPWPV----PHPSQT 605
Query: 85 PSPPSPAQPPPQAVAPS--PPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSS 142
P PP+ P+ AP P P +P P P NV P+ PP + +
Sbjct: 606 PEPPTTQSHIPETSAPRQWPMPLRPIPMRPLRMQPITFNVLVFPTPHQPPQVEITPYKPT 665
Query: 143 SSPPPAN----VPATPSSSSPP---PVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPH 195
+ P ++ P P + PP + +P P + PP P T
Sbjct: 666 WTQIGHIPYQPSPTGANTMLPIQWAPGTMQPPPRAPTPMRPPAAPPGRAQRPAAATGRAR 725
Query: 196 PSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTPPLPSVP 253
P +AP A + PP + P + PPA +P ++ G+P+ P P P
Sbjct: 726 PPAAAPGRARPPAAAPGRARPPAAAPGRARPPAAAPGRARPPAAAPGAPTPQPPPQAP 783
|
Length = 991 |
| >gnl|CDD|185616 PTZ00436, PTZ00436, 60S ribosomal protein L19-like protein; Provisional | Back alignment and domain information |
|---|
Score = 61.9 bits (149), Expect = 4e-10
Identities = 38/145 (26%), Positives = 65/145 (44%), Gaps = 5/145 (3%)
Query: 91 AQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANV 150
A P + PA P+ ++ PPA P+ ++ PA P+ ++ PPA
Sbjct: 208 AAAPSGKKSAKAAAPAKAAAAPAKAAAPPAKAAAAPAKAAAAPAKAAAPPAKAAAPPAKA 267
Query: 151 PATPSSSSPPPVNVPTPPS-SSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPP 209
A P+ ++ PP PP+ +++PP ++ P + P +APP +PP
Sbjct: 268 AAPPAKAAAPPAKAAAPPAKAAAPPAKAAAAPAKAAAAPAKAAAAPAKAAAPPAKAAAPP 327
Query: 210 ASTLSPPPPSVPSTSSPPAVSPPAP 234
A +PP + ++PPA + AP
Sbjct: 328 AKAATPPAKA----AAPPAKAAAAP 348
|
Length = 357 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 62/216 (28%), Positives = 96/216 (44%), Gaps = 20/216 (9%)
Query: 381 NGFSAHNVLGEGGFGCVYKGV-LADGREVAVKQLK---IGGSQGEREFRAEVEIISRVHH 436
F +++G G FG V A G A+K +K + + F E +I+S +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 437 RHLVSLVGYCISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYL 495
+ L Y +++ L LV EY P L L+ + + +A I +
Sbjct: 61 PWIPQLQ-YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAE-LVLAIHSV 118
Query: 496 HEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHV-STRVMGTFGYMAP 554
H+ + +HRDIK N+L+D + ++ADFG A L +N V S +GT Y+AP
Sbjct: 119 HQMGY---VHRDIKPENVLIDRTGHIKLADFGSAA---RLTANKMVNSKLPVGTPDYIAP 172
Query: 555 EYATSGKLTEKS------DVYSFGVVLLELITGRKP 584
E T+ K D +S GV+ E+I GR P
Sbjct: 173 EVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 4e-10
Identities = 75/293 (25%), Positives = 120/293 (40%), Gaps = 52/293 (17%)
Query: 389 LGEGGFGCVYKGVLADGREVA---VKQLKIGGSQGER-EFRAEVEIISRVHHRHLVSLVG 444
+G G FG V + VA VK+LK S E+ EF + + + H +++ +G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 445 YCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATR-------VKVAAGAARGIAYLHE 497
C+ LLV+EY L +L E W R ++A A G+ ++H+
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQE-----QWHRRNSQLLLLQRMACEIAAGVTHMHK 117
Query: 498 DCHPRIIHRDIKSSNILLDSSFEARVADFGLA-----KIALELDSNTHVSTRVMGTFGYM 552
+H D+ N L S +V D+G+ + +E + + V R ++
Sbjct: 118 H---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR------WL 168
Query: 553 APEYATS--GKL-----TEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLA 605
APE G L T+ S+V++ GV L EL +A+QP S R +L
Sbjct: 169 APELVGEFHGGLITAEQTKPSNVWALGVTLWELFE-----NAAQPYSHLS----DREVLN 219
Query: 606 EALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRAL 658
++ + + L +LE Y + W E C S KR +V R L
Sbjct: 220 HVIKDQQVK-LFKPQLELPYSER---WY-EVLQFCWL-SPEKRATAEEVHRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 5e-10
Identities = 29/110 (26%), Positives = 38/110 (34%), Gaps = 22/110 (20%)
Query: 24 PSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEV 83
P P P P A+P P PT P + P A ++ P + PP
Sbjct: 362 PVPAPQPAKPTAAAPSPVRPTPAPSTRPKAAAAANIP--PKEPVRETATPP--------- 410
Query: 84 DPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPP 133
P PP P PP P P + P ++ P V P + P P
Sbjct: 411 -PVPPRPVAPPV------PHTPESAPKLTRAAIP----VDEKPKYTPPAP 449
|
Length = 585 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 5e-10
Identities = 17/89 (19%), Positives = 25/89 (28%), Gaps = 4/89 (4%)
Query: 14 PPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPP 73
+ + + PA+ P+ P PP+ P PA + + PP
Sbjct: 41 TAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPAAPP 100
Query: 74 PLDAPPPPEVDPSPPSPAQP---PPQAVA 99
A P P AVA
Sbjct: 101 AAAAAAAPAAAAVEDE-VTPLRGAAAAVA 128
|
Length = 1228 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 5e-10
Identities = 16/82 (19%), Positives = 26/82 (31%)
Query: 28 PPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSP 87
P T+ P A+ + ++ P+ A + +PP + PP A
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPA 97
Query: 88 PSPAQPPPQAVAPSPPPPANVP 109
PA A A + P
Sbjct: 98 APPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|218439 pfam05109, Herpes_BLLF1, Herpes virus major outer envelope glycoprotein (BLLF1) | Back alignment and domain information |
|---|
Score = 62.1 bits (150), Expect = 6e-10
Identities = 61/289 (21%), Positives = 97/289 (33%), Gaps = 20/289 (6%)
Query: 2 PPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAV 61
+S V + P+T P + + + PTS P+ T + P
Sbjct: 428 TTKSVIFVYTLVHVEPHKTTAVPTTPSLPPASTGPTVSTADPTSGTPTGTT--SSTLPED 485
Query: 62 NSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPAN 121
SP + +S P +A P +P + + P S P A PT
Sbjct: 486 TSPTSRTTSATP--NATSPTPAVTTPNATS---PTTQKTSDTPNATSPTPIVIGVTT--T 538
Query: 122 VPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPP 181
+ P+ ++ P + SP +S+ + T S+P
Sbjct: 539 ATSPPTGTTSVPNATSPQVTEESPVNNTNTPVVTSAPSVLTSAVTTGQHG----TGSSPT 594
Query: 182 TSTPSPPVLT--PPPHPSQSAPPPVTKSPP--ASTLSPPPPSVPSTSSPPAVSPPAPP-- 235
+ P P + P S S P +T + P ++ PSVPST+ +SP P
Sbjct: 595 SQQPGIPSSSHSTPRSNSTSTTPLLTSAHPTGGENITEETPSVPSTTHVSTLSPGPGPGT 654
Query: 236 -SNSSTRGSPSTPPLPSVPTEKPTAKSTNGTAVSANASPRNAGVLGTGG 283
S S G+ ST P + N T+ SA + + A T
Sbjct: 655 TSQVSGPGNSSTSRYPGEVHVTEGMPNPNATSPSAPSGQKTAVPTVTST 703
|
This family consists of the BLLF1 viral late glycoprotein, also termed gp350/220. It is the most abundantly expressed glycoprotein in the viral envelope of the Herpesviruses and is the major antigen responsible for stimulating the production of neutralising antibodies in vivo. Length = 830 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 6e-10
Identities = 36/99 (36%), Positives = 55/99 (55%), Gaps = 12/99 (12%)
Query: 490 RGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDS--NTHVSTRVMG 547
RG+ Y+H ++HRD+K SN+LL+++ + ++ DFGLA+ E +V TR
Sbjct: 119 RGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTR--- 172
Query: 548 TFGYMAPE-YATSGKLTEKSDVYSFGVVLLELITGRKPV 585
Y APE + T DV+S G + EL+ GRKP+
Sbjct: 173 --WYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 7e-10
Identities = 26/141 (18%), Positives = 48/141 (34%), Gaps = 11/141 (7%)
Query: 94 PPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPAT 153
P A + P P P +++P A V ++ PA +++S P A P
Sbjct: 366 PAAAAEAAAPAEKKTPARPEAAAPAAAPVA----QAAAAPAPAAAPAAAASAPAA--PPA 419
Query: 154 PSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTL 213
+ +P P++++P + P + P P A P PA
Sbjct: 420 AAPPAPVA-----APAAAAPAAAPAAAPAAVALAPAPPAQAAPETVAIPVRVAPEPAVAS 474
Query: 214 SPPPPSVPSTSSPPAVSPPAP 234
+ P P+ ++ +
Sbjct: 475 AAPAPAAAPAAARLTPTEEGD 495
|
Length = 618 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 62.2 bits (152), Expect = 7e-10
Identities = 18/84 (21%), Positives = 32/84 (38%), Gaps = 2/84 (2%)
Query: 2 PPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAV 61
P ++ P A + +P + + P +PP + + PP P A ++
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAP- 96
Query: 62 NSPPPQPSSPPPPLDAPPPPEVDP 85
+ PP ++ P A EV P
Sbjct: 97 -AAPPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 8e-10
Identities = 51/207 (24%), Positives = 97/207 (46%), Gaps = 12/207 (5%)
Query: 389 LGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCI 447
+G G +G VYK + G A+K +K+ + + E+ ++ H ++V+ G +
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 448 SERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRD 507
+ + E+ +L H G P+ + + V+ +G+ YLH +HRD
Sbjct: 77 RRDKLWICMEFCGGGSLQDIYHVTG-PLSE-SQIAYVSRETLQGLYYLHSKGK---MHRD 131
Query: 508 IKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYAT---SGKLTE 564
IK +NILL + ++ADFG ++ ++ + +GT +MAPE A G +
Sbjct: 132 IKGANILLTDNGHVKLADFG---VSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQ 188
Query: 565 KSDVYSFGVVLLELITGRKPVDASQPL 591
D+++ G+ +EL + P+ P+
Sbjct: 189 LCDIWAVGITAIELAELQPPMFDLHPM 215
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 9e-10
Identities = 29/142 (20%), Positives = 42/142 (29%), Gaps = 4/142 (2%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
P P + A P + P + P A+P +P + PP P A
Sbjct: 450 PAPAPAAAPAAAARPAAAGPRPVAAAAAAA--PARAAPAAAPAPADDDPPPWEELPPEFA 507
Query: 61 VNSPPPQPSSPPPPLDA--PPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPP 118
+P ++P + P P DP P A AP+P A + P
Sbjct: 508 SPAPAQPDAAPAGWVAESIPDPATADPDDAFETLAPAPAAAPAPRAAAATEPVVAPRPPR 567
Query: 119 PANVPTTPSSSSPPPANVRTTP 140
+ PA P
Sbjct: 568 ASASGLPDMFDGDWPALAARLP 589
|
Length = 700 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 9e-10
Identities = 27/128 (21%), Positives = 45/128 (35%), Gaps = 1/128 (0%)
Query: 138 TTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPS 197
P+ P +++ + P + + PS P +S P +PP PS
Sbjct: 146 EDPNPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPS 205
Query: 198 QSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTP-PLPSVPTEK 256
+ + +P + PPPS S ++P PA P + P P+ P+
Sbjct: 206 SPSDSSLPPAPSSFQSDTPPPSPESPTNPSPPPGPAAPPPPPVQQVPPLSTAKPTPPSAS 265
Query: 257 PTAKSTNG 264
T G
Sbjct: 266 ATPAPIGG 273
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 61.8 bits (151), Expect = 9e-10
Identities = 25/85 (29%), Positives = 34/85 (40%), Gaps = 3/85 (3%)
Query: 39 PPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAV 98
P S T + A S+PA P +P P APP +PP PA A
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPA---AAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAA 94
Query: 99 APSPPPPANVPTTPSSSSPPPANVP 123
AP+ PP A P++++ P
Sbjct: 95 APAAPPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|185616 PTZ00436, PTZ00436, 60S ribosomal protein L19-like protein; Provisional | Back alignment and domain information |
|---|
Score = 60.7 bits (146), Expect = 9e-10
Identities = 40/147 (27%), Positives = 62/147 (42%), Gaps = 8/147 (5%)
Query: 16 PSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPL 75
PS S + + P + P + P+ A P + A PP ++ PP
Sbjct: 211 PSGKKSAKAAAPAKAAAAPAKAAAPPAKAAAAPAKAAAAPAKAAA----PPAKAAAPPAK 266
Query: 76 DAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPAN 135
A PP + P A PP +A A PPA P+ ++ PA P+ ++ PPA
Sbjct: 267 AAAPPAKAAAPPAKAAAPPAKAAA----PPAKAAAAPAKAAAAPAKAAAAPAKAAAPPAK 322
Query: 136 VRTTPSSSSPPPANVPATPSSSSPPPV 162
P+ ++ PPA A P+ ++ PV
Sbjct: 323 AAAPPAKAATPPAKAAAPPAKAAAAPV 349
|
Length = 357 |
| >gnl|CDD|237605 PRK14086, dnaA, chromosomal replication initiation protein; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 1e-09
Identities = 40/191 (20%), Positives = 44/191 (23%), Gaps = 12/191 (6%)
Query: 1 PPPQSSPPAVLAVPP--PSPPLSPPPSTTPPPTSPPPASPPPSP--PTSTPPSPPTAPPP 56
P P A P P P P P P P PT+ P P P
Sbjct: 94 EPAPPPPHARRTSEPELPRPGRRPYEGYGGPRADDRPPGLPRQDQLPTARPAYPAYQQRP 153
Query: 57 S-----SPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTT 111
A + Q PP P + P A P
Sbjct: 154 EPGAWPRAADDYGWQQQRLGFPPRAPYASPASYAPEQERDREPYDAGRPEYDQRRRDYDH 213
Query: 112 PSSSSPPPANVPTTPSSSSPPPAN--VRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPS 169
P P T PP A R P A V S+ P P P
Sbjct: 214 PRPDWDRP-RRDRTDRPEPPPGAGHVHRGGPGPPERDDAPVVPIRPSAPGPLAAQPAPAP 272
Query: 170 SSSPPPPSSNP 180
P NP
Sbjct: 273 GPGEPTARLNP 283
|
Length = 617 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 1e-09
Identities = 21/81 (25%), Positives = 27/81 (33%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
P ++P V P PS + PP P + P P P +PP P S
Sbjct: 370 KPTAAAPSPVRPTPAPSTRPKAAAAANIPPKEPVRETATPPPVPPRPVAPPVPHTPESAP 429
Query: 61 VNSPPPQPSSPPPPLDAPPPP 81
+ P P P PP
Sbjct: 430 KLTRAAIPVDEKPKYTPPAPP 450
|
Length = 585 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 1e-09
Identities = 29/95 (30%), Positives = 38/95 (40%), Gaps = 4/95 (4%)
Query: 117 PPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPP 176
P PA P P++++P P VR TP+ S+ P A A PV P P P
Sbjct: 362 PVPAPQPAKPTAAAPSP--VRPTPAPSTRPKAAAAANIPPK--EPVRETATPPPVPPRPV 417
Query: 177 SSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPAS 211
+ P + S P LT P P +PP
Sbjct: 418 APPVPHTPESAPKLTRAAIPVDEKPKYTPPAPPKE 452
|
Length = 585 |
| >gnl|CDD|185616 PTZ00436, PTZ00436, 60S ribosomal protein L19-like protein; Provisional | Back alignment and domain information |
|---|
Score = 60.3 bits (145), Expect = 1e-09
Identities = 34/132 (25%), Positives = 58/132 (43%), Gaps = 1/132 (0%)
Query: 86 SPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSP 145
+P A A + PA P+ ++ PA P+ ++ PPA P+ ++
Sbjct: 210 APSGKKSAKAAAPAKAAAAPAKAAAPPAKAAAAPAKAAAAPAKAAAPPAKAAAPPAKAAA 269
Query: 146 PPANVPATPSSSSPPPVNVPTPPS-SSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPV 204
PPA A P+ ++ PP PP+ +++ P ++ P + P P +APP
Sbjct: 270 PPAKAAAPPAKAAAPPAKAAAPPAKAAAAPAKAAAAPAKAAAAPAKAAAPPAKAAAPPAK 329
Query: 205 TKSPPASTLSPP 216
+PPA +PP
Sbjct: 330 AATPPAKAAAPP 341
|
Length = 357 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 62/205 (30%), Positives = 90/205 (43%), Gaps = 19/205 (9%)
Query: 388 VLGEGGFGCVYKGVL----ADGREVAVKQLK---IGGSQGEREFRAEVEIISRVHHRHLV 440
+LG+G FG K +L A GR A+K LK I E ++ H L
Sbjct: 2 LLGKGTFG---KVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 58
Query: 441 SLVGYCISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDC 499
+L Y +RL V EY L +HL E R + R A + YLH +
Sbjct: 59 AL-KYSFQTHDRLCFVMEYANGGELFFHLSRE-RVFSEDRARF-YGAEIVSALDYLHSE- 114
Query: 500 HPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATS 559
+++RD+K N++LD ++ DFGL K ++ D T + GT Y+APE
Sbjct: 115 -KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK-DGATMKT--FCGTPEYLAPEVLED 170
Query: 560 GKLTEKSDVYSFGVVLLELITGRKP 584
D + GVV+ E++ GR P
Sbjct: 171 NDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 2e-09
Identities = 27/124 (21%), Positives = 43/124 (34%)
Query: 56 PSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSS 115
+ +P S A P +P + A P P A P PA P PS +
Sbjct: 386 GVAGGAGAPAAAAPSAAAAAPAAAPAPAAAAPAAAAAPAPAAAPQPAPAPAPAPAPPSPA 445
Query: 116 SPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPP 175
PA +P ++ P A P+++ P A P ++ P P + ++P
Sbjct: 446 GNAPAGGAPSPPPAAAPSAQPAPAPAAAPEPTAAPAPAPPAAPAPAAAPAAPAAPAAPAG 505
Query: 176 PSSN 179
Sbjct: 506 ADDA 509
|
Length = 824 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 2e-09
Identities = 23/130 (17%), Positives = 48/130 (36%), Gaps = 3/130 (2%)
Query: 126 PSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTP 185
P++++ A + A A + ++ P P +++S P PP + P
Sbjct: 366 PAAAAEAAAPAEKKTPARPEAAAPAAAPVAQAAAAPAPAAAPAAAASAPAA---PPAAAP 422
Query: 186 SPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPS 245
PV P +AP + + P + + + P V+P ++++ + +
Sbjct: 423 PAPVAAPAAAAPAAAPAAAPAAVALAPAPPAQAAPETVAIPVRVAPEPAVASAAPAPAAA 482
Query: 246 TPPLPSVPTE 255
PTE
Sbjct: 483 PAAARLTPTE 492
|
Length = 618 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 2e-09
Identities = 25/132 (18%), Positives = 44/132 (33%), Gaps = 10/132 (7%)
Query: 104 PPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVN 163
P A + PA +++P ++ PA A +++S P
Sbjct: 366 PAAAAEAAAPAEKKTPARPEAAAPAAAPVAQ--------AAAAPAPAAAPAAAASAPAAP 417
Query: 164 VPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPST 223
P + P ++ P + + P + P T + P P P+V S
Sbjct: 418 PAAAPPAPVAAPAAAAPAAAPAAAPAAVALAPAPPAQAAPETVAIPVRV--APEPAVASA 475
Query: 224 SSPPAVSPPAPP 235
+ PA +P A
Sbjct: 476 APAPAAAPAAAR 487
|
Length = 618 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-09
Identities = 29/95 (30%), Positives = 40/95 (42%), Gaps = 10/95 (10%)
Query: 145 PPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPV 204
P PA PA P++++P PV PTP S+ P ++ P + P P PV
Sbjct: 362 PVPAPQPAKPTAAAPSPVR-PTPAPSTRPKAAAAANI---PPKEPVRETATPPPVPPRPV 417
Query: 205 TKSPPASTLSPPPPSVPSTSSP----PAVSPPAPP 235
PP P + + P P +PPAPP
Sbjct: 418 A--PPVPHTPESAPKLTRAAIPVDEKPKYTPPAPP 450
|
Length = 585 |
| >gnl|CDD|223065 PHA03378, PHA03378, EBNA-3B; Provisional | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 2e-09
Identities = 55/249 (22%), Positives = 82/249 (32%), Gaps = 17/249 (6%)
Query: 8 PAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQ 67
L + P + P + +++ P + P P T PP+ + P +S P P
Sbjct: 569 LGPLQIQPLTSPTTSQLASSAPSYAQTPWPVPHPSQTPEPPTTQSHIPETSAPRQWPMPL 628
Query: 68 PSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPS 127
P PL P P+P QPP + P P + P SP T +
Sbjct: 629 RPIPMRPLRMQPITFNVLVFPTPHQPPQVEITPYKPTWTQIGHIPYQPSP------TGAN 682
Query: 128 SSSPPPANVRTTPSSSSPPPANVPATPSSSSPP---PVNVPTPPSSSSPPPPSSNPPTST 184
+ P P + PPP P+ PP P P +++ P + P
Sbjct: 683 TMLPIQW----APGTMQPPPR----APTPMRPPAAPPGRAQRPAAATGRARPPAAAPGRA 734
Query: 185 PSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSP 244
P P +AP A + PP + P +P P RG+P
Sbjct: 735 RPPAAAPGRARPPAAAPGRARPPAAAPGRARPPAAAPGAPTPQPPPQAPPAPQQRPRGAP 794
Query: 245 STPPLPSVP 253
+ P P
Sbjct: 795 TPQPPPQAG 803
|
Length = 991 |
| >gnl|CDD|185616 PTZ00436, PTZ00436, 60S ribosomal protein L19-like protein; Provisional | Back alignment and domain information |
|---|
Score = 60.0 bits (144), Expect = 2e-09
Identities = 36/134 (26%), Positives = 60/134 (44%), Gaps = 5/134 (3%)
Query: 77 APPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANV 136
A P + +P A PP +A A PA P+ ++ PPA P+ ++ PPA
Sbjct: 219 AAAPAKAAAAPAKAAAPPAKAAAA----PAKAAAAPAKAAAPPAKAAAPPAKAAAPPAKA 274
Query: 137 RTTPSSSSPPPANVPATPSSSSPPPVNVPTPPS-SSSPPPPSSNPPTSTPSPPVLTPPPH 195
P+ ++ PPA A P+ ++ P P+ +++ P ++ PP +PP P
Sbjct: 275 AAPPAKAAAPPAKAAAPPAKAAAAPAKAAAAPAKAAAAPAKAAAPPAKAAAPPAKAATPP 334
Query: 196 PSQSAPPPVTKSPP 209
+APP + P
Sbjct: 335 AKAAAPPAKAAAAP 348
|
Length = 357 |
| >gnl|CDD|217392 pfam03153, TFIIA, Transcription factor IIA, alpha/beta subunit | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 24/158 (15%), Positives = 35/158 (22%), Gaps = 7/158 (4%)
Query: 45 STPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPP 104
S PP A P P + P P+ A PP P
Sbjct: 52 SPQAPPPVAQLPQPLPQPPPTQALQALP---AGDQQQHNTPTGSPAANPPATF--ALPAG 106
Query: 105 PANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNV 164
PA P VP + P + P+ + +S +
Sbjct: 107 PAGPTIQTEPGQLYPVQVP--VMVTQNPANSPLDQPAQQRALQQLQQRYGAPASGQLPSQ 164
Query: 165 PTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPP 202
+ P TP S++
Sbjct: 165 QQSAQKNDESQLQQQPNGETPPQQTDGAGDDESEALVR 202
|
Transcription initiation factor IIA (TFIIA) is a heterotrimer, the three subunits being known as alpha, beta, and gamma, in order of molecular weight. The N and C-terminal domains of the gamma subunit are represented in pfam02268 and pfam02751, respectively. This family represents the precursor that yields both the alpha and beta subunits. The TFIIA heterotrimer is an essential general transcription initiation factor for the expression of genes transcribed by RNA polymerase II. Together with TFIID, TFIIA binds to the promoter region; this is the first step in the formation of a pre-initiation complex (PIC). Binding of the rest of the transcription machinery follows this step. After initiation, the PIC does not completely dissociate from the promoter. Some components, including TFIIA, remain attached and re-initiate a subsequent round of transcription. Length = 332 |
| >gnl|CDD|217392 pfam03153, TFIIA, Transcription factor IIA, alpha/beta subunit | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 29/154 (18%), Positives = 43/154 (27%), Gaps = 4/154 (2%)
Query: 87 PPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPP 146
P P+ P VA P P P T + + P + + + P AN T + + P
Sbjct: 48 PWDPSPQAPPPVAQLPQPLPQPPPTQALQALPAGDQQQHNTPTGSPAANPPATFALPAGP 107
Query: 147 PANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNP-PTSTPSPPVLTPPPHPSQSAPPPVT 205
T V P + P S P + L S P
Sbjct: 108 AGPTIQTEPG---QLYPVQVPVMVTQNPANSPLDQPAQQRALQQLQQRYGAPASGQLPSQ 164
Query: 206 KSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSS 239
+ P+ +PP + A S
Sbjct: 165 QQSAQKNDESQLQQQPNGETPPQQTDGAGDDESE 198
|
Transcription initiation factor IIA (TFIIA) is a heterotrimer, the three subunits being known as alpha, beta, and gamma, in order of molecular weight. The N and C-terminal domains of the gamma subunit are represented in pfam02268 and pfam02751, respectively. This family represents the precursor that yields both the alpha and beta subunits. The TFIIA heterotrimer is an essential general transcription initiation factor for the expression of genes transcribed by RNA polymerase II. Together with TFIID, TFIIA binds to the promoter region; this is the first step in the formation of a pre-initiation complex (PIC). Binding of the rest of the transcription machinery follows this step. After initiation, the PIC does not completely dissociate from the promoter. Some components, including TFIIA, remain attached and re-initiate a subsequent round of transcription. Length = 332 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-09
Identities = 28/127 (22%), Positives = 45/127 (35%), Gaps = 8/127 (6%)
Query: 12 AVPPPSPPLSPPPSTTPPPTSPPPAS---PPPSPPTSTPPSPPTAPPPSSPAVNSPPPQP 68
A P P T P +P P++ PSP S+ + P+AP ++ +PP
Sbjct: 369 ASGGRGPKQHIKPVFTQPAAAPQPSAAAAASPSPSQSSAAAQPSAPQSATQPAGTPPTVS 428
Query: 69 SSPPPPLDAPP----PPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPT 124
PP + P P V P+ + P + S P P + N+
Sbjct: 429 VDPPAAVPVNPPSTAPQAVRPAQFKEEKKIPVSKVSSLGPSTLRPIQEKAEQ-ATGNIKE 487
Query: 125 TPSSSSP 131
P+ +
Sbjct: 488 APTGTQK 494
|
Length = 614 |
| >gnl|CDD|235124 PRK03427, PRK03427, cell division protein ZipA; Provisional | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 29/123 (23%), Positives = 34/123 (27%), Gaps = 3/123 (2%)
Query: 1 PPPQSSPPAVLAVPPPSP---PLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPS 57
+ PSP P S P P P + P+ P P
Sbjct: 71 VNHAPANAQEHEAARPSPQHQYQPPYASAQPRQPVQQPPEAQVPPQHAPRPAQPAPQPVQ 130
Query: 58 SPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSP 117
PA P QP P P P+ S P PAQ Q P P P+
Sbjct: 131 QPAYQPQPEQPLQQPVSPQVAPAPQPVHSAPQPAQQAFQPAEPVAAPQPEPVAEPAPVMD 190
Query: 118 PPA 120
P
Sbjct: 191 KPK 193
|
Length = 333 |
| >gnl|CDD|185628 PTZ00449, PTZ00449, 104 kDa microneme/rhoptry antigen; Provisional | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 3e-09
Identities = 59/252 (23%), Positives = 75/252 (29%), Gaps = 9/252 (3%)
Query: 8 PAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPP-PSSPAVNSPPP 66
PA P P LS P P P P P PT P P P + P
Sbjct: 563 PAKEHKPSKIPTLSKKPEFPKDPKHPKDPEEPKKPKRPRSAQRPTRPKSPKLPELLDIPK 622
Query: 67 QPSSPPPPLDA-PPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTT 125
P P P PPP PS P + P +P PP P P +
Sbjct: 623 SPKRPESPKSPKRPPPPQRPSSPERPEGPKIIKSPKPPKSPKPPFDPKFKEKFYDDYLDA 682
Query: 126 PSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPT--PPSSSSPPPPSSNPPTS 183
+ S V S S +P TP + P +P P P P +P
Sbjct: 683 AAKSKETKTTVVLDESFESILKETLPETPGTPFTTPRPLPPKLPRDEEFPFEPIGDPDAE 742
Query: 184 TPSPPVLTPPPHPSQS---APPPVTKSPPASTLSPPPPSVPSTSSPP--AVSPPAPPSNS 238
P PP ++ P T P + + + P A+ P PS
Sbjct: 743 QPDDIEFFTPPEEERTFFHETPADTPLPDILAEEFKEEDIHAETGEPDEAMKRPDSPSEH 802
Query: 239 STRGSPSTPPLP 250
+ P LP
Sbjct: 803 EDKPPGDHPSLP 814
|
Length = 943 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 36/98 (36%), Positives = 55/98 (56%), Gaps = 6/98 (6%)
Query: 490 RGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAK-IALELDSNTHVSTRVMGT 548
G+ Y+H ++HRD+K N+L+++ E ++ DFGLA+ + N T + T
Sbjct: 116 CGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVAT 172
Query: 549 FGYMAPEYATSGKLTEKS-DVYSFGVVLLELITGRKPV 585
Y APE S + K+ DV+S G +L EL+ GRKPV
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 3e-09
Identities = 60/213 (28%), Positives = 105/213 (49%), Gaps = 35/213 (16%)
Query: 387 NVLGEGGFGCVYKGVLADGRE-VAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGY 445
N++G G FG VY+ + D E VA+K++ Q + E+ I+ ++H +++ L Y
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKV----LQDPQYKNRELLIMKNLNHINIIFLKDY 127
Query: 446 ----CISERERLL----VYEYVPNDTLHYHLHAEGR-----PVMDWATRVKV-AAGAARG 491
C + E+ + V E++P T+H ++ R P+ VK+ + R
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLF----LVKLYSYQLCRA 182
Query: 492 IAYLHEDCHPRIIHRDIKSSNILLD-SSFEARVADFGLAKIALE-LDSNTHVSTRVMGTF 549
+AY+H I HRD+K N+L+D ++ ++ DFG AK L S +++ +R
Sbjct: 183 LAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF---- 235
Query: 550 GYMAPEYAT-SGKLTEKSDVYSFGVVLLELITG 581
Y APE + T D++S G ++ E+I G
Sbjct: 236 -YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|178748 PLN03209, PLN03209, translocon at the inner envelope of chloroplast subunit 62; Provisional | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 4e-09
Identities = 58/230 (25%), Positives = 87/230 (37%), Gaps = 23/230 (10%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
PP+ S A P P+ P++P + P PP P S + PP+SP
Sbjct: 328 VPPKESDAADGPKPVPTKPVTPEAPSPPIEEEPPQPKAVVPRPLSPYTAYEDLKPPTSPI 387
Query: 61 VNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPA 120
P PSS P VD + A+P V PSP +NVP +
Sbjct: 388 ----PTPPSSSP-----ASSKSVD----AVAKPAEPDVVPSPGSASNVPEVEPAQVEAKK 434
Query: 121 NVPTTPSSSSP---PPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSS---PP 174
P +P + PP T+PS ++P + + +SS P + +++ PP
Sbjct: 435 TRPLSPYARYEDLKPP----TSPSPTAPTGVSPSVSSTSSVPAVPDTAPATAATDAAAPP 490
Query: 175 PPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTS 224
P + P + L PP PS +AP + + S P T+
Sbjct: 491 PANMRPLSPYAVYDDLKPPTSPSPAAPVGKVAPSSTNEVVKVGNSAPPTA 540
|
Length = 576 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 4e-09
Identities = 35/93 (37%), Positives = 48/93 (51%), Gaps = 9/93 (9%)
Query: 491 GIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNT-HVSTRVMGTF 549
GI +LH IIHRD+K SNI++ S ++ DFGLA+ A T +V TR
Sbjct: 130 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---- 182
Query: 550 GYMAPEYATSGKLTEKSDVYSFGVVLLELITGR 582
Y APE E D++S G ++ E+I G
Sbjct: 183 -YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 5e-09
Identities = 28/126 (22%), Positives = 38/126 (30%), Gaps = 1/126 (0%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
P PA A P+ P+ P T P + P+ +AP P++
Sbjct: 678 PAAPPPAPAPAAPAAPAGAAPAQPAPAPAATPPAGQADDPAAQPPQAAQGASAPSPAADD 737
Query: 61 VNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQP-PPQAVAPSPPPPANVPTTPSSSSPPP 119
PP+P PP P AP P P+P A P +P S
Sbjct: 738 PVPLPPEPDDPPDPAGAPAQPPPPPAPAPAAAPAAAPPPSPPSEEEEMAEDDAPSMDDED 797
Query: 120 ANVPTT 125
Sbjct: 798 RRDAEE 803
|
Length = 824 |
| >gnl|CDD|185628 PTZ00449, PTZ00449, 104 kDa microneme/rhoptry antigen; Provisional | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 5e-09
Identities = 46/228 (20%), Positives = 62/228 (27%), Gaps = 11/228 (4%)
Query: 3 PQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPP-PSSPAV 61
P+ A P P P P SP P SP PP P++P P P +
Sbjct: 594 PKKPKRPRSAQRPTRPKSPKLPELLDIPKSPKRPESPKSPKRPPPPQRPSSPERPEGPKI 653
Query: 62 NSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPAN 121
P P SP PP D + A + + + P
Sbjct: 654 IKSPKPPKSPKPPFDPKFKEKFYDDYLDAAAKSKETKTTVVLDESFESILKETLPETPGT 713
Query: 122 VPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSS---PPPPSS 178
TTP P P + P + P + P + TPP P+
Sbjct: 714 PFTTP---RPLPPKLPRDEEFPFEPIGD----PDAEQPDDIEFFTPPEEERTFFHETPAD 766
Query: 179 NPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSP 226
P + H P K P + + P S P
Sbjct: 767 TPLPDILAEEFKEEDIHAETGEPDEAMKRPDSPSEHEDKPPGDHPSLP 814
|
Length = 943 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 5e-09
Identities = 20/120 (16%), Positives = 32/120 (26%), Gaps = 4/120 (3%)
Query: 6 SPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPP 65
+PPA A PP + P+ P +P P + + + A
Sbjct: 52 APPAAAAPAAAQPPPAAAPAAVSRPAAPAAEPAPWLVEHAKRLTAQREQLVARAAA---- 107
Query: 66 PQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTT 125
P P + + A+ A P P A + + V T
Sbjct: 108 PAAPEAQAPAAPAERAAAENAARRLARAAAAAPRPRVPADAAAAVADAVKARIERIVNDT 167
|
Length = 484 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 5e-09
Identities = 31/95 (32%), Positives = 49/95 (51%), Gaps = 5/95 (5%)
Query: 490 RGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTF 549
R + Y+H + HRD+K NIL ++ + ++ DFGLA++A T + T
Sbjct: 114 RALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 550 GYMAPEYATS--GKLTEKSDVYSFGVVLLELITGR 582
Y APE S K T D++S G + E++TG+
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 52/201 (25%), Positives = 81/201 (40%), Gaps = 13/201 (6%)
Query: 382 GFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVS 441
GFS G G + + E V +K G G E I+ ++H ++
Sbjct: 93 GFSILETFTPGAEGFAFACIDNKTCEHVV--IKAGQRGGTA---TEAHILRAINHPSIIQ 147
Query: 442 LVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHP 501
L G + L+ D Y + D + + R I YLHE+
Sbjct: 148 LKGTFTYNKFTCLILPRYKTDLYCYLAAKRNIAICDI---LAIERSVLRAIQYLHEN--- 201
Query: 502 RIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGK 561
RIIHRDIK+ NI ++ + + DFG A +++++N + GT APE
Sbjct: 202 RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGW--AGTIATNAPELLARDP 259
Query: 562 LTEKSDVYSFGVVLLELITGR 582
D++S G+VL E+ T
Sbjct: 260 YGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 6e-09
Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 18/209 (8%)
Query: 381 NGFSAHNVLGEGGFGCVYKGVLADGRE-VAVKQLKIGGSQGEREFRA----EVEIISRVH 435
N F V+GEG +G V K + +E VA+K+ K S+ E + E++++ +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFK--DSEENEEVKETTLRELKMLRTLK 58
Query: 436 HRHLVSLVGYCISERERLLVYEYVPNDTLHY-HLHAEGRPVMDWATRVKVAAGAARGIAY 494
++V L + LV+EYV + L G P KV + + I
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVP------PEKVRSYIYQLIKA 112
Query: 495 LHEDCHPR-IIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMA 553
+H CH I+HRDIK N+L+ + ++ DFG A+ E + + T + T Y +
Sbjct: 113 IHW-CHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY--TEYVATRWYRS 169
Query: 554 PEYATSGKLTEKSDVYSFGVVLLELITGR 582
PE + D++S G +L EL G+
Sbjct: 170 PELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|237605 PRK14086, dnaA, chromosomal replication initiation protein; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 7e-09
Identities = 43/194 (22%), Positives = 50/194 (25%), Gaps = 27/194 (13%)
Query: 12 AVPPPSPPLSPPPSTTPPPTSPPPA--------SPPPSPPTSTPPSPPTAP--PPSSPAV 61
A P PP P T P P P P P P P+ PA
Sbjct: 92 AGEPAPPP--PHARRTSEPELPRPGRRPYEGYGGPRADDRPPGLPRQDQLPTARPAYPA- 148
Query: 62 NSPPPQPSS-PPPPLDAPP------PPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSS 114
P+P + P D P P SPA P+ P A P
Sbjct: 149 YQQRPEPGAWPRAADDYGWQQQRLGFPPRAP-YASPASYAPEQERDREPYDAGRPEYDQR 207
Query: 115 SSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPP 174
P P + P PP A P + P P S P
Sbjct: 208 RRDYDHPRP----DWDRPRRDRTDRP--EPPPGAGHVHRGGPGPPERDDAPVVPIRPSAP 261
Query: 175 PPSSNPPTSTPSPP 188
P + P P P
Sbjct: 262 GPLAAQPAPAPGPG 275
|
Length = 617 |
| >gnl|CDD|235124 PRK03427, PRK03427, cell division protein ZipA; Provisional | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 7e-09
Identities = 26/102 (25%), Positives = 32/102 (31%), Gaps = 1/102 (0%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
PP S+ P PP + P + P +P P P P P P +PA
Sbjct: 94 PPYASAQPRQPVQQPPEAQVPPQHAPRPAQPAPQPVQQPAYQPQPEQPLQQPVSPQVAPA 153
Query: 61 VNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSP 102
P P P P P P A+P P P
Sbjct: 154 PQPVHSAPQ-PAQQAFQPAEPVAAPQPEPVAEPAPVMDKPKR 194
|
Length = 333 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 7e-09
Identities = 34/98 (34%), Positives = 49/98 (50%), Gaps = 12/98 (12%)
Query: 504 IHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATS---- 559
IHRD+K N+LLD S ++ADFG + ++ + T V GT Y++PE S
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTC-MKMDANGMVRCDTAV-GTPDYISPEVLKSQGGD 221
Query: 560 GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLV 597
G + D +S GV L E++ G P +SLV
Sbjct: 222 GYYGRECDWWSVGVFLYEMLVG------DTPFYADSLV 253
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 7e-09
Identities = 27/86 (31%), Positives = 31/86 (36%), Gaps = 5/86 (5%)
Query: 32 SPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPA 91
S + P PP +PP P PP P +PPP P PPP P +
Sbjct: 516 SASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPADSS 575
Query: 92 QPPPQAVAPSPPPPANVPTTPSSSSP 117
PP P P P PT SS
Sbjct: 576 PPP-----PIPEEPTPSPTKDSSPEE 596
|
Length = 620 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 8e-09
Identities = 35/98 (35%), Positives = 56/98 (57%), Gaps = 7/98 (7%)
Query: 489 ARGIAYL-HEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMG 547
A+G+ +L ++C IHRD+ + N+LL A++ DFGLA+ + DSN V
Sbjct: 222 AQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLAR-DIMNDSNYVVKGNARL 276
Query: 548 TFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKP 584
+MAPE T +SDV+S+G++L E+ + G+ P
Sbjct: 277 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 1e-08
Identities = 32/125 (25%), Positives = 53/125 (42%), Gaps = 14/125 (11%)
Query: 87 PPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPP 146
P+ A P A AP+ P ++ PA +++P PA P+ + P
Sbjct: 393 APAAAAPSAAAAAPAAAPAP--------AAAAPAAAAAPAPAAAPQPA---PAPAPAPAP 441
Query: 147 PANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTK 206
P+ P+ +P P P + +P P ++ PT+ P+P PP P+ +A P
Sbjct: 442 PSPAGNAPAGGAPSPPPAAAPSAQPAPAPAAAPEPTAAPAPA---PPAAPAPAAAPAAPA 498
Query: 207 SPPAS 211
+P A
Sbjct: 499 APAAP 503
|
Length = 824 |
| >gnl|CDD|235906 PRK07003, PRK07003, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 1e-08
Identities = 54/230 (23%), Positives = 73/230 (31%), Gaps = 37/230 (16%)
Query: 2 PPQSSPPAVLAVPPPSP-PLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
S A PP S P S PP + PA +P +TP + P A P++ +
Sbjct: 458 SADSRCDERDAQPPADSGSASAPASDAPPDAAFEPAPRAAAPSAATPAAVPDARAPAAAS 517
Query: 61 VNSPPPQPSSPPPPLDAPPPPEVDPS------------------------------PPSP 90
P + P P P P P+ P
Sbjct: 518 REDAPAAAAPPAPEARPPTPAAAAPAARAGGAAAALDVLRNAGMRVSSDRGARAAAAAKP 577
Query: 91 AQPPPQAVAPSPP-PPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPS--SSSPPP 147
A P A P+ P VPT + ++ A P ++ + A R P PP
Sbjct: 578 AAAPAAAPKPAAPRVAVQVPTPRARAATGDA--PPNGAARAEQAAESRGAPPPWEDIPPD 635
Query: 148 ANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNP-PTSTPSPPVLTPPPHP 196
VP + P + P S P P P P+PPV T P P
Sbjct: 636 DYVPLSADEGFGGPDDGFVPVFDSGPDDVRVAPKPADAPAPPVDTRPLPP 685
|
Length = 830 |
| >gnl|CDD|217393 pfam03154, Atrophin-1, Atrophin-1 family | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 1e-08
Identities = 65/226 (28%), Positives = 85/226 (37%), Gaps = 16/226 (7%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
P Q PPA PP +P P PP PSP P + P PPP+
Sbjct: 332 PREQPLPPAPSMPHIKPPPTTPIPQLPNQSHKHPPHLQGPSPFPQMPSNLP--PPPALKP 389
Query: 61 VNSPPPQ--PSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPP 118
++S P PS+ PPPL P + P PAQPP + S PP A S+ P
Sbjct: 390 LSSLPTHHPPSAHPPPLQLMPQSQ--PLQSVPAQPPVLTQSQSLPPKA-------STHPH 440
Query: 119 PANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSS 178
P S + PPP+ +TP++ P + PP S+ P
Sbjct: 441 SGLHSGPPQSPFAQHPFTSGGLPAIGPPPSLPTSTPAAP-PRASSGSQPPGSALPSSGGC 499
Query: 179 NPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTS 224
P P P + P A P + PP + SP P V + S
Sbjct: 500 AGP--GPPLPPIQIKEEPLDEAEEPESPPPPPRSPSPEPTVVNTPS 543
|
Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1, that is thought to confer toxicity to the protein, possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders, including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein, CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity. Length = 979 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 58.7 bits (143), Expect = 1e-08
Identities = 16/98 (16%), Positives = 28/98 (28%), Gaps = 9/98 (9%)
Query: 43 PTSTPPS---------PPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQP 93
P S PS P + P++ A + + P P P + A
Sbjct: 22 PNSVDPSWREFFADYGPGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPA 81
Query: 94 PPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSP 131
P A + A P++++ +P
Sbjct: 82 APPKPAAAAAAAAAPAAPPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|217392 pfam03153, TFIIA, Transcription factor IIA, alpha/beta subunit | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 28/151 (18%), Positives = 37/151 (24%), Gaps = 18/151 (11%)
Query: 23 PPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPE 82
P PPP + P P PPT + P P L
Sbjct: 51 PSPQAPPPVAQLPQPLPQPPPTQALQALPAGDQQQHNTPTGSPAANPPATFAL------- 103
Query: 83 VDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRT--TP 140
PA P + P V + P + P+ + P
Sbjct: 104 -------PAGPAGPTIQTEPGQLYPVQVPVMVTQNPANSPLDQPAQQRALQQLQQRYGAP 156
Query: 141 SSSSPPPANVPATPSSSSPPPV--NVPTPPS 169
+S P A + S N TPP
Sbjct: 157 ASGQLPSQQQSAQKNDESQLQQQPNGETPPQ 187
|
Transcription initiation factor IIA (TFIIA) is a heterotrimer, the three subunits being known as alpha, beta, and gamma, in order of molecular weight. The N and C-terminal domains of the gamma subunit are represented in pfam02268 and pfam02751, respectively. This family represents the precursor that yields both the alpha and beta subunits. The TFIIA heterotrimer is an essential general transcription initiation factor for the expression of genes transcribed by RNA polymerase II. Together with TFIID, TFIIA binds to the promoter region; this is the first step in the formation of a pre-initiation complex (PIC). Binding of the rest of the transcription machinery follows this step. After initiation, the PIC does not completely dissociate from the promoter. Some components, including TFIIA, remain attached and re-initiate a subsequent round of transcription. Length = 332 |
| >gnl|CDD|217392 pfam03153, TFIIA, Transcription factor IIA, alpha/beta subunit | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 28/181 (15%), Positives = 45/181 (24%), Gaps = 10/181 (5%)
Query: 68 PSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPS 127
P P P P P P P QA+ N PT +++PP
Sbjct: 48 PWDPSPQAPPPVAQLPQPLPQPPPTQALQALPAGDQQQHNTPTGSPAANPPATF----AL 103
Query: 128 SSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSP 187
+ P ++T P P P + P N P + P+
Sbjct: 104 PAGPAGPTIQTEPGQLYPVQ-----VPVMVTQNPANSPLDQPAQQRALQQLQQRYGAPAS 158
Query: 188 PVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTP 247
L +Q + P PP + + ++ +
Sbjct: 159 GQLPSQQQSAQKNDESQLQQQPNGET-PPQQTDGAGDDESEALVRLREADGTLEQRIKGA 217
Query: 248 P 248
Sbjct: 218 E 218
|
Transcription initiation factor IIA (TFIIA) is a heterotrimer, the three subunits being known as alpha, beta, and gamma, in order of molecular weight. The N and C-terminal domains of the gamma subunit are represented in pfam02268 and pfam02751, respectively. This family represents the precursor that yields both the alpha and beta subunits. The TFIIA heterotrimer is an essential general transcription initiation factor for the expression of genes transcribed by RNA polymerase II. Together with TFIID, TFIIA binds to the promoter region; this is the first step in the formation of a pre-initiation complex (PIC). Binding of the rest of the transcription machinery follows this step. After initiation, the PIC does not completely dissociate from the promoter. Some components, including TFIIA, remain attached and re-initiate a subsequent round of transcription. Length = 332 |
| >gnl|CDD|235124 PRK03427, PRK03427, cell division protein ZipA; Provisional | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 31/129 (24%), Positives = 42/129 (32%), Gaps = 2/129 (1%)
Query: 61 VNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPA 120
V+ P++ A P P+ PP + P Q V PP A VP + PA
Sbjct: 68 VHRVNHAPANAQEHEAARPSPQHQYQPPYASAQPRQPV--QQPPEAQVPPQHAPRPAQPA 125
Query: 121 NVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNP 180
P + P P P S PA P + P P ++ P P + P
Sbjct: 126 PQPVQQPAYQPQPEQPLQQPVSPQVAPAPQPVHSAPQPAQQAFQPAEPVAAPQPEPVAEP 185
Query: 181 PTSTPSPPV 189
P
Sbjct: 186 APVMDKPKR 194
|
Length = 333 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 42/144 (29%), Positives = 69/144 (47%), Gaps = 23/144 (15%)
Query: 490 RGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNT--HVSTRVMG 547
+G+ Y+H IIHRD+K N+ ++ E ++ DFGLA+ + DS +V TR
Sbjct: 129 KGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR---QTDSEMTGYVVTR--- 179
Query: 548 TFGYMAPEYATSG-KLTEKSDVYSFGVVLLELITGRKPVDASQPL--GDESLVEWARPLL 604
Y APE + T+ D++S G ++ E++TG+ PL G + L + +
Sbjct: 180 --WYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK-------PLFKGHDHLDQLMEIMK 230
Query: 605 AEALEHEDFEALVDSRLEKNYVDS 628
++F + S KNYV
Sbjct: 231 VTGTPSKEFVQKLQSEDAKNYVKK 254
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 60/213 (28%), Positives = 93/213 (43%), Gaps = 19/213 (8%)
Query: 383 FSAHNVLGEGGFGCVYKGVLADGREV----AVKQLK----IGGSQGEREFRAEVEIISRV 434
F VLG G +G V+ G + A+K L+ + ++ R E ++ V
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 435 HHRHLVSLVGYCISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAA-RGI 492
+ + Y +L L+ +YV + HL+ D V+ +G +
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSED---EVRFYSGEIILAL 118
Query: 493 AYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYM 552
+LH+ I++RDIK NILLDS + DFGL+K L + S GT YM
Sbjct: 119 EHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS--FCGTIEYM 173
Query: 553 APEYATSGKLTEKS-DVYSFGVVLLELITGRKP 584
APE K+ D +S G+++ EL+TG P
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|184918 PRK14954, PRK14954, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 1e-08
Identities = 28/88 (31%), Positives = 36/88 (40%), Gaps = 4/88 (4%)
Query: 16 PSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPL 75
++P P+ +P P P P P+ P AP + PA P P+S P P
Sbjct: 376 NDGGVAPSPAGSPDVKKKAPEPDLPQPDRHPGPAKPEAPG-ARPAEL---PSPASAPTPE 431
Query: 76 DAPPPPEVDPSPPSPAQPPPQAVAPSPP 103
PP P PPSP P+ VA P
Sbjct: 432 QQPPVARSAPLPPSPQASAPRNVASGKP 459
|
Length = 620 |
| >gnl|CDD|165527 PHA03269, PHA03269, envelope glycoprotein C; Provisional | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 1e-08
Identities = 31/128 (24%), Positives = 50/128 (39%)
Query: 100 PSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSP 159
+ P + T+ ++ P PA P +S +P PA T+ +S P A P +S
Sbjct: 23 NTNIPIPELHTSAATQKPDPAPAPHQAASRAPDPAVAPTSAASRKPDLAQAPTPAASEKF 82
Query: 160 PPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPS 219
P P +S +P P + + P P +Q+ P A++ P P +
Sbjct: 83 DPAPAPHQAASRAPDPAVAPQLAAAPKPDAAEAFTSAAQAHEAPADAGTSAASKKPDPAA 142
Query: 220 VPSTSSPP 227
S PP
Sbjct: 143 HTQHSPPP 150
|
Length = 566 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 21/208 (10%)
Query: 389 LGEGGFGCVYKGVLADGRE---VAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGY 445
+G G +G VYK DG++ A+KQ++ G+ E+ ++ + H +++SL
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIE--GTGISMSACREIALLRELKHPNVISLQKV 66
Query: 446 CISERER--LLVYEYVPNDTLH---YHL--HAEGRPVMDWATRVK-VAAGAARGIAYLHE 497
+S +R L+++Y +D H +H A +PV VK + GI YLH
Sbjct: 67 FLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 126
Query: 498 DCHPRIIHRDIKSSNILLDSSFEAR----VADFGLAKIALELDSNTHVSTRVMGTFGYMA 553
+ ++HRD+K +NIL+ R +AD G A++ V+ TF Y A
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 554 PEYATSGK-LTEKSDVYSFGVVLLELIT 580
PE + T+ D+++ G + EL+T
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 2e-08
Identities = 25/135 (18%), Positives = 51/135 (37%), Gaps = 7/135 (5%)
Query: 111 TPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSS 170
+ + PA + ++++P A P+ ++ PA A +++P P P P +
Sbjct: 386 GVAGGAGAPAAAAPSAAAAAPAAA-----PAPAAAAPAAAAAPAPAAAPQPAPAPAPAPA 440
Query: 171 SSPPP--PSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPA 228
P + S P + P P+ +A P T +P + + P P+ +
Sbjct: 441 PPSPAGNAPAGGAPSPPPAAAPSAQPAPAPAAAPEPTAAPAPAPPAAPAPAAAPAAPAAP 500
Query: 229 VSPPAPPSNSSTRGS 243
+P ++ R
Sbjct: 501 AAPAGADDAATLRER 515
|
Length = 824 |
| >gnl|CDD|219339 pfam07223, DUF1421, Protein of unknown function (DUF1421) | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 58/240 (24%), Positives = 74/240 (30%), Gaps = 11/240 (4%)
Query: 2 PPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSP--PPASPPPSPPTSTPPSPPTAPPPSSP 59
P SP +PP PS PP P P P PPS P PP P
Sbjct: 77 PAPQSPQPDQQQQSQAPPSHQYPSQLPPQQVQSVPQQPTPQQEPYYPPPSQPQPPPAQQP 136
Query: 60 AVNSPPPQPSSPPPPLDAPPPPEVDP---SPPSPAQPPPQAVAPSPPPPANVPTTPSSSS 116
P P P P PP + PP P + P + P +
Sbjct: 137 QAQQPQPPPQVPQQQQYQSPPQQPQYQQNPPPQAQSAPQVSGLYPEESPYQPQSYPPNEP 196
Query: 117 PPPANVPTTPSSSSPPPAN----VRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSS 172
P + P S +PP + +P P + S PP + S
Sbjct: 197 LPSSMAMQPPYSGAPPSQQFYGPPQPSPYMYGGPGGRPNSGFPSGQQPPPSQGQEGYGYS 256
Query: 173 PPPPSSNPPTSTPSPPVLTPPPHPSQSAP--PPVTKSPPASTLSPPPPSVPSTSSPPAVS 230
PPPS S S S + P P T P A +S P S + SP + +
Sbjct: 257 GPPPSKGNHGSVASYAPQGSSQSYSTAYPSLPAATVLPQALPMSSAPMSGGGSGSPQSGN 316
|
This family represents a conserved region approximately 350 residues long within a number of plant proteins of unknown function. Length = 357 |
| >gnl|CDD|178748 PLN03209, PLN03209, translocon at the inner envelope of chloroplast subunit 62; Provisional | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 2e-08
Identities = 56/222 (25%), Positives = 72/222 (32%), Gaps = 14/222 (6%)
Query: 68 PSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPS 127
PS PP ++ P P P P + PP P SP A P
Sbjct: 324 PSQRVPPKESDAADGPKPVPTKPVTPEAPSPPIEEEPPQPKAVVPRPLSPYTAYEDLKPP 383
Query: 128 SSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSP 187
+S P + S +S + A P+ P P T SP
Sbjct: 384 TS---PIPTPPSSSPASSKSVDAVAKPAEPDVVPSPGSASNVPEVEPAQVEAKKTRPLSP 440
Query: 188 ----PVLTPPPHPSQSAPPPV------TKSPPASTLSPPPPSVPSTSSPP-AVSPPAPPS 236
L PP PS +AP V T S PA + P + ++PP A P P
Sbjct: 441 YARYEDLKPPTSPSPTAPTGVSPSVSSTSSVPAVPDTAPATAATDAAAPPPANMRPLSPY 500
Query: 237 NSSTRGSPSTPPLPSVPTEKPTAKSTNGTAVSANASPRNAGV 278
P T P P+ P K STN N++P A
Sbjct: 501 AVYDDLKPPTSPSPAAPVGKVAPSSTNEVVKVGNSAPPTALA 542
|
Length = 576 |
| >gnl|CDD|217392 pfam03153, TFIIA, Transcription factor IIA, alpha/beta subunit | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 29/159 (18%), Positives = 48/159 (30%), Gaps = 4/159 (2%)
Query: 2 PPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPP--ASPPPSPPTSTPPSPPTAPPPSSP 59
P +PP V +P P P P + P +P SP + P + P+ P
Sbjct: 51 PSPQAPPPVAQLPQPLPQPPPTQALQALPAGDQQQHNTPTGSPAANPPATFALPAGPAGP 110
Query: 60 AVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPAN--VPTTPSSSSP 117
+ + P Q P+ P P Q Q + PA+ +P+ S+
Sbjct: 111 TIQTEPGQLYPVQVPVMVTQNPANSPLDQPAQQRALQQLQQRYGAPASGQLPSQQQSAQK 170
Query: 118 PPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSS 156
+ + PP S + +
Sbjct: 171 NDESQLQQQPNGETPPQQTDGAGDDESEALVRLREADGT 209
|
Transcription initiation factor IIA (TFIIA) is a heterotrimer, the three subunits being known as alpha, beta, and gamma, in order of molecular weight. The N and C-terminal domains of the gamma subunit are represented in pfam02268 and pfam02751, respectively. This family represents the precursor that yields both the alpha and beta subunits. The TFIIA heterotrimer is an essential general transcription initiation factor for the expression of genes transcribed by RNA polymerase II. Together with TFIID, TFIIA binds to the promoter region; this is the first step in the formation of a pre-initiation complex (PIC). Binding of the rest of the transcription machinery follows this step. After initiation, the PIC does not completely dissociate from the promoter. Some components, including TFIIA, remain attached and re-initiate a subsequent round of transcription. Length = 332 |
| >gnl|CDD|235124 PRK03427, PRK03427, cell division protein ZipA; Provisional | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 30/128 (23%), Positives = 43/128 (33%), Gaps = 3/128 (2%)
Query: 107 NVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPT 166
V P+++ A P+ PP A+ + PP A VP + P P
Sbjct: 70 RVNHAPANAQEHEAARPSPQHQYQPPYASAQPRQPVQQPPEAQVPPQHAPRPAQPAPQPV 129
Query: 167 PPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSP 226
+ P P P P P + P P P SAP P ++ + P P
Sbjct: 130 QQPAYQPQPE---QPLQQPVSPQVAPAPQPVHSAPQPAQQAFQPAEPVAAPQPEPVAEPA 186
Query: 227 PAVSPPAP 234
P + P
Sbjct: 187 PVMDKPKR 194
|
Length = 333 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 2e-08
Identities = 18/103 (17%), Positives = 33/103 (32%), Gaps = 2/103 (1%)
Query: 48 PSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPS--PPSPAQPPPQAVAPSPPPP 105
P AP + P + P S P P P P V+ + + + A P
Sbjct: 53 PPAAAAPAAAQPPPAAAPAAVSRPAAPAAEPAPWLVEHAKRLTAQREQLVARAAAPAAPE 112
Query: 106 ANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPA 148
A P P+ + +++ P ++++ A
Sbjct: 113 AQAPAAPAERAAAENAARRLARAAAAAPRPRVPADAAAAVADA 155
|
Length = 484 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 2e-08
Identities = 24/80 (30%), Positives = 29/80 (36%)
Query: 14 PPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPP 73
S PP P P P P P P + PP P PPP++ +S P
Sbjct: 515 GSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPADS 574
Query: 74 PLDAPPPPEVDPSPPSPAQP 93
P P E PSP + P
Sbjct: 575 SPPPPIPEEPTPSPTKDSSP 594
|
Length = 620 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 37/103 (35%), Positives = 55/103 (53%), Gaps = 15/103 (14%)
Query: 502 RIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRV-MGTFGYMAPEYATS- 559
+HRDIK N+LLD + R+ADFG L+++ + V + V +GT Y++PE +
Sbjct: 122 HYVHRDIKPDNVLLDMNGHIRLADFG---SCLKMNQDGTVQSSVAVGTPDYISPEILQAM 178
Query: 560 ----GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVE 598
GK + D +S GV + E++ G P A ESLVE
Sbjct: 179 EDGMGKYGPECDWWSLGVCMYEMLYGETPFYA------ESLVE 215
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 37/103 (35%), Positives = 54/103 (52%), Gaps = 15/103 (14%)
Query: 502 RIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRV-MGTFGYMAPEYATS- 559
+HRDIK N+LLD + R+ADFG L L ++ V + V +GT Y++PE +
Sbjct: 122 GYVHRDIKPDNVLLDKNGHIRLADFG---SCLRLLADGTVQSNVAVGTPDYISPEILQAM 178
Query: 560 ----GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVE 598
G+ + D +S GV + E++ G P A ESLVE
Sbjct: 179 EDGKGRYGPECDWWSLGVCMYEMLYGETPFYA------ESLVE 215
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 52/219 (23%), Positives = 98/219 (44%), Gaps = 27/219 (12%)
Query: 389 LGEGGFGCVYKGV---LADGR-----EVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLV 440
LG+G F ++KG+ + D EV +K L F ++S++ H+HLV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 441 SLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPV-MDWATRVKVAAGAARGIAYLHEDC 499
G C+ E ++V EYV +L +L + + W +++VA A + +L +
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDK- 119
Query: 500 HPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGT------FGYMA 553
+ H ++ + N+LL + + + K+ S+ +S V+ ++
Sbjct: 120 --GLTHGNVCAKNVLLIREEDRKTGNPPFIKL-----SDPGISITVLPKEILLERIPWVP 172
Query: 554 PEYATSGK-LTEKSDVYSFGVVLLELITG-RKPVDASQP 590
PE + + L+ +D +SFG L E+ +G KP+ A
Sbjct: 173 PECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 3e-08
Identities = 29/96 (30%), Positives = 36/96 (37%), Gaps = 9/96 (9%)
Query: 103 PPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPV 162
P PA P P++++P P PT S+ P A P P ATP P PV
Sbjct: 362 PVPAPQPAKPTAAAPSPVR-PTPAPSTRPKAAAAANIPPK---EPVRETATPPPVPPRPV 417
Query: 163 NVPTPPSSSSPPPPSSNPPTSTPSP--PVLTPPPHP 196
P P +P + P P TPP P
Sbjct: 418 APPVPH---TPESAPKLTRAAIPVDEKPKYTPPAPP 450
|
Length = 585 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 3e-08
Identities = 25/83 (30%), Positives = 31/83 (37%), Gaps = 3/83 (3%)
Query: 23 PPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPE 82
++ T PPP PP P + P PTA P PPP P++ +AP
Sbjct: 515 GSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTP---PPPPPTATQASSNAPAQIP 571
Query: 83 VDPSPPSPAQPPPQAVAPSPPPP 105
D SPP P P P
Sbjct: 572 ADSSPPPPIPEEPTPSPTKDSSP 594
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 3e-08
Identities = 32/87 (36%), Positives = 35/87 (40%), Gaps = 2/87 (2%)
Query: 4 QSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNS 63
S A P PP PP P PT P P +PP + PP PPTA SS A
Sbjct: 512 SQSGSASNTAKTPPPPQKSPPP--PAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQ 569
Query: 64 PPPQPSSPPPPLDAPPPPEVDPSPPSP 90
P S PPP + P P S P
Sbjct: 570 IPADSSPPPPIPEEPTPSPTKDSSPEE 596
|
Length = 620 |
| >gnl|CDD|236669 PRK10263, PRK10263, DNA translocase FtsK; Provisional | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 3e-08
Identities = 59/299 (19%), Positives = 86/299 (28%), Gaps = 37/299 (12%)
Query: 3 PQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPP-ASPPPSPPT---STPPSPPTAPPPSS 58
P + P AV A + P T P PP+ PT P P T P +
Sbjct: 315 PITEPVAVAAAATTATQSWAAPVEPVTQTPPVASVDVPPAQPTVAWQPVPGPQTGEPVIA 374
Query: 59 PAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPP 118
PA P Q P + P + P QP AP+ PA P + P
Sbjct: 375 PAPEGYPQQSQYAQPAVQYNEPLQ------QPVQPQQPYYAPAAEQPAQQPYYAPAPEQP 428
Query: 119 PANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSS 178
P+ P N + P S+ P + P
Sbjct: 429 AQQPYYAPAPEQPVAGN------AWQAEEQQSTFAPQSTYQTEQTYQQP----AAQEPLY 478
Query: 179 NPPTSTPSPPVLTPPPHPSQSAP--PPV--------TKSPPASTLSPPPPSVPSTSSPPA 228
P PV+ P P ++ P PP+ ++ L+ +P P
Sbjct: 479 QQPQPVEQQPVVEPEPVVEETKPARPPLYYFEEVEEKRAREREQLAAWYQPIPE----PV 534
Query: 229 VSPPAPPSNSSTRGSPSTPPLPSVPTEKPTAKSTNGTAVSANASPRNAG---VLGTGGA 284
P S+ + PP+ + P A ++ A+ A L G
Sbjct: 535 KEPEPIKSSLKAPSVAAVPPVEAAAAVSPLASGVKKATLATGAAATVAAPVFSLANSGG 593
|
Length = 1355 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 38/209 (18%)
Query: 389 LGEGGFGCVYKG-VLADGREVAVKQLKIGGSQGER--EFRAEVEIISRV-HHRHLVSLVG 444
+GEG F V K G+ A+K +K E+ R E++ + R+ H +++ L+
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLR-EIQALRRLSPHPNILRLIE 65
Query: 445 YCISERE--RL-LV--------YEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIA 493
+ +R+ RL LV YE + L E R V + ++ + +
Sbjct: 66 -VLFDRKTGRLALVFELMDMNLYELIKGR--KRPL-PEKR-VKSYMYQL------LKSLD 114
Query: 494 YLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAK-IALELDSNTHVSTRVMGTFGYM 552
++H I HRDIK NIL+ ++ADFG + I + ++STR Y
Sbjct: 115 HMH---RNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYISTR-----WYR 165
Query: 553 APE-YATSGKLTEKSDVYSFGVVLLELIT 580
APE T G K D+++ G V E+++
Sbjct: 166 APECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|237863 PRK14949, PRK14949, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 3e-08
Identities = 31/149 (20%), Positives = 48/149 (32%), Gaps = 11/149 (7%)
Query: 19 PLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAV-NSPPPQPSSPPPPLDA 77
P +PP P S P +SP S +++ P + +V + S+P PP
Sbjct: 645 PKTPPSRAPPASLSKPASSPDASQTSASFDLDPDFELATHQSVPEAALASGSAPAPPPVP 704
Query: 78 PP---PPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSS---SSP 131
P PP + + A P A +V +S T +
Sbjct: 705 DPYDRPPWEEAPEVASANDGPN-NAAEGNLSESVEDASNSELQAVEQQATHQPQVQAEAQ 763
Query: 132 PPANVRTTPSSSSPP---PANVPATPSSS 157
PA+ +SS N+ S S
Sbjct: 764 SPASTTALTQTSSEVQDTELNLVLLSSGS 792
|
Length = 944 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 58/208 (27%), Positives = 101/208 (48%), Gaps = 21/208 (10%)
Query: 389 LGEGGFGCVYKGVLADGR---EVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSL--V 443
+G G +G VYK DG+ E A+KQ++ G+ E+ ++ + H ++++L V
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIE--GTGISMSACREIALLRELKHPNVIALQKV 66
Query: 444 GYCISERERLLVYEYVPNDTLH---YHL--HAEGRPVMDWATRVK-VAAGAARGIAYLHE 497
S+R+ L+++Y +D H +H A +P+ + VK + GI YLH
Sbjct: 67 FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126
Query: 498 DCHPRIIHRDIKSSNILLDSSFEAR----VADFGLAKIALELDSNTHVSTRVMGTFGYMA 553
+ ++HRD+K +NIL+ R +AD G A++ V+ TF Y A
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 554 PEYATSGK-LTEKSDVYSFGVVLLELIT 580
PE + T+ D+++ G + EL+T
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 56.1 bits (136), Expect = 4e-08
Identities = 26/125 (20%), Positives = 43/125 (34%)
Query: 63 SPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANV 122
+ + P A P P+P + A A AP+ P P+ + P PA
Sbjct: 388 AGGAGAPAAAAPSAAAAAPAAAPAPAAAAPAAAAAPAPAAAPQPAPAPAPAPAPPSPAGN 447
Query: 123 PTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPT 182
+ SPPPA + + +P A P + +PP P ++ P +
Sbjct: 448 APAGGAPSPPPAAAPSAQPAPAPAAAPEPTAAPAPAPPAAPAPAAAPAAPAAPAAPAGAD 507
Query: 183 STPSP 187
+
Sbjct: 508 DAATL 512
|
Length = 824 |
| >gnl|CDD|223065 PHA03378, PHA03378, EBNA-3B; Provisional | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 4e-08
Identities = 56/205 (27%), Positives = 73/205 (35%), Gaps = 15/205 (7%)
Query: 14 PPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPP 73
P P PL P T P P PP T P PT P ++ P
Sbjct: 630 PIPMRPLRMQPITFNVLVFPTPHQPPQVEIT---PYKPTWTQIGHIPYQPSPTGANTMLP 686
Query: 74 PLDAPPPPEVDPSPPSPAQPPPQAVAPSPPP-PANVPTTPSSSSPPPANVPTTPSSSSPP 132
AP + P P+P +P P+ PP A P + + PPA P + P
Sbjct: 687 IQWAPGTMQPPPRAPTPMRP------PAAPPGRAQRPAAATGRARPPAAAPG--RARPPA 738
Query: 133 PANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTP 192
A R P +++P A PA + PP P P +P PP PP P
Sbjct: 739 AAPGRARPPAAAPGRARPPAAAPGRARPPAAAPGAP---TPQPPPQAPPAPQQRPRGAPT 795
Query: 193 PPHPSQSAPPPVTKSPPASTLSPPP 217
P P Q+ P + P A+ P
Sbjct: 796 PQPPPQAGPTSMQLMPRAAPGQQGP 820
|
Length = 991 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 4e-08
Identities = 24/68 (35%), Positives = 32/68 (47%), Gaps = 3/68 (4%)
Query: 53 APPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPS---PAQPPPQAVAPSPPPPANVP 109
AP P S A +P P + PPP APP P P+ P+ PA P A +PP + P
Sbjct: 381 APAPPSAAWGAPTPAAPAAPPPAAAPPVPPAAPARPAAARPAPAPAPPAAAAPPARSADP 440
Query: 110 TTPSSSSP 117
+S+
Sbjct: 441 AAAASAGD 448
|
Length = 576 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 4e-08
Identities = 49/196 (25%), Positives = 82/196 (41%), Gaps = 13/196 (6%)
Query: 394 FGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERL 453
F C G ++V VK + G + G E++I+ + HR +++L+ + R +
Sbjct: 109 FVCTKHGD-EQRKKVIVKAVTGGKTPG-----REIDILKTISHRAIINLIH---AYRWKS 159
Query: 454 LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNI 513
V +P + + + + + +AYLH IIHRD+K+ NI
Sbjct: 160 TVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENI 216
Query: 514 LLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGV 573
LD A + DFG A L+ +T GT +PE K+D++S G+
Sbjct: 217 FLDEPENAVLGDFG-AACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGL 275
Query: 574 VLLELITGRKPVDASQ 589
VL E+ + Q
Sbjct: 276 VLFEMSVKNVTLFGKQ 291
|
Length = 392 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 5e-08
Identities = 26/99 (26%), Positives = 34/99 (34%), Gaps = 12/99 (12%)
Query: 50 PPTAPPPSSPAVNSPPP-QPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANV 108
P AP P+ P +P P +P+ P P P PP A PP P
Sbjct: 362 PVPAPQPAKPTAAAPSPVRPT--PAPSTRPKAAAAANIPPKEPVRET---ATPPPVPPRP 416
Query: 109 PTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPP 147
P +P A P ++ P V P + P P
Sbjct: 417 VAPPVPHTPESA--PKLTRAAIP----VDEKPKYTPPAP 449
|
Length = 585 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 56.1 bits (136), Expect = 5e-08
Identities = 28/80 (35%), Positives = 34/80 (42%), Gaps = 2/80 (2%)
Query: 40 PSPPTSTPPSPPTAPPPSSPAVNSPPPQPS--SPPPPLDAPPPPEVDPSPPSPAQPPPQA 97
S + PP P PA P PQP+ +PPP PPP S +PAQ P +
Sbjct: 515 GSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPADS 574
Query: 98 VAPSPPPPANVPTTPSSSSP 117
P P P P+ SSP
Sbjct: 575 SPPPPIPEEPTPSPTKDSSP 594
|
Length = 620 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 6e-08
Identities = 33/91 (36%), Positives = 47/91 (51%), Gaps = 7/91 (7%)
Query: 491 GIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFG 550
GI +LH IIHRD+K SNI++ S ++ DFGLA+ A + T + T
Sbjct: 135 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA----CTNFMMTPYVVTRY 187
Query: 551 YMAPEYATSGKLTEKSDVYSFGVVLLELITG 581
Y APE E D++S G ++ EL+ G
Sbjct: 188 YRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|236940 PRK11633, PRK11633, cell division protein DedD; Provisional | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 6e-08
Identities = 28/102 (27%), Positives = 35/102 (34%), Gaps = 1/102 (0%)
Query: 16 PSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPL 75
P P P P T P PP + A P PA +PP P P P
Sbjct: 45 PKPGDRDEPDMMPAATQALPTQPPEGA-AEAVRAGDAAAPSLDPATVAPPNTPVEPEPAP 103
Query: 76 DAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSP 117
PP P+ P +P + AP P P P ++P
Sbjct: 104 VEPPKPKPVEKPKPKPKPQQKVEAPPAPKPEPKPVVEEKAAP 145
|
Length = 226 |
| >gnl|CDD|165527 PHA03269, PHA03269, envelope glycoprotein C; Provisional | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 7e-08
Identities = 34/122 (27%), Positives = 50/122 (40%), Gaps = 5/122 (4%)
Query: 97 AVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSS 156
+ A P PA P +S +P PA PT+ +S P A T +S PA P +S
Sbjct: 34 SAATQKPDPAPAPHQAASRAPDPAVAPTSAASRKPDLAQAPTPAASEKFDPAPAPHQAAS 93
Query: 157 SSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPP 216
+P P P +++P P ++ TS P + ++ P A T P
Sbjct: 94 RAPDPAVAPQ--LAAAPKPDAAEAFTSAAQA---HEAPADAGTSAASKKPDPAAHTQHSP 148
Query: 217 PP 218
PP
Sbjct: 149 PP 150
|
Length = 566 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 7e-08
Identities = 36/106 (33%), Positives = 58/106 (54%), Gaps = 12/106 (11%)
Query: 489 ARGIAYL-HEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMG 547
A+G+++L ++C IHRD+ + NILL ++ DFGLA+ + DSN V
Sbjct: 224 AKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLAR-DIRNDSNYVVKGNARL 278
Query: 548 TFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT------GRKPVDA 587
+MAPE + T +SDV+S+G++L E+ + PVD+
Sbjct: 279 PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS 324
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 8e-08
Identities = 55/219 (25%), Positives = 97/219 (44%), Gaps = 45/219 (20%)
Query: 389 LGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGERE------FRAEVEIISRVHHR-HLV 440
+GEG +G VYK G+ VA+K+ + + + E R E+ ++ + ++V
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTR---LEMDEEGIPPTALR-EISLLQMLSESIYIV 64
Query: 441 SLVGYCISERER-----LLVYEYVPNDTLHY---HLHAEGRPVMDWATRVKVAAGAARGI 492
L+ E + LV+EY+ +D + + GRP + T +G+
Sbjct: 65 RLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRP-LPAKTIKSFMYQLLKGV 123
Query: 493 AYLHEDCHPR-IIHRDIKSSNILLDSSFEA-RVADFGLAK-IALELDSNTHVSTRVMGTF 549
A+ CH ++HRD+K N+L+D ++AD GL + ++ + S TH + T
Sbjct: 124 AH----CHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH----EIVTL 175
Query: 550 GYMAPE-------YATSGKLTEKSDVYSFGVVLLELITG 581
Y APE Y+T D++S G + E+
Sbjct: 176 WYRAPEVLLGSTHYSTP------VDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 8e-08
Identities = 52/211 (24%), Positives = 96/211 (45%), Gaps = 24/211 (11%)
Query: 389 LGEGGFGCVYKGVLAD-GREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLV------- 440
LG G G V+ V +D + VAVK++ + Q + E++II R+ H ++V
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 441 -------SLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIA 493
VG +V EY+ +T ++ +G + A RG+
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYM--ETDLANVLEQGPLSEEHARLF--MYQLLRGLK 128
Query: 494 YLHEDCHPRIIHRDIKSSNILLDS-SFEARVADFGLAKIALELDSNTHVSTRVMGTFGYM 552
Y+H ++HRD+K +N+ +++ ++ DFGLA+I S+ + + T Y
Sbjct: 129 YIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYR 185
Query: 553 APEYATS-GKLTEKSDVYSFGVVLLELITGR 582
+P S T+ D+++ G + E++TG+
Sbjct: 186 SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 8e-08
Identities = 56/219 (25%), Positives = 104/219 (47%), Gaps = 37/219 (16%)
Query: 389 LGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGERE------FRAEVEIISRVHHRHLVS 441
+G+G FG V+K + VA+K++ + E+E R E++I+ + H ++V+
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMEN---EKEGFPITALR-EIKILQLLKHENVVN 75
Query: 442 LVGYCISE-----RER---LLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIA 493
L+ C ++ R + LV+E+ +D + + + KV G+
Sbjct: 76 LIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVK--FTLSEIKKVMKMLLNGLY 133
Query: 494 YLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAK--IALELDSNTHVSTRVMGTFGY 551
Y+H + +I+HRD+K++NIL+ ++ADFGLA+ + + RV+ T Y
Sbjct: 134 YIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV-TLWY 189
Query: 552 MAPEYATSGKLTEKS-----DVYSFGVVLLELITGRKPV 585
PE L E+ D++ G ++ E+ T R P+
Sbjct: 190 RPPELL----LGERDYGPPIDMWGAGCIMAEMWT-RSPI 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|223065 PHA03378, PHA03378, EBNA-3B; Provisional | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 9e-08
Identities = 63/262 (24%), Positives = 78/262 (29%), Gaps = 18/262 (6%)
Query: 2 PPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAV 61
PPQ + PS T T P P T PP AP P P
Sbjct: 654 PPQVEITPYKPTWTQIGHIPYQPSPTGANTMLPIQWAP-----GTMQPPPRAPTPMRP-- 706
Query: 62 NSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPAN 121
P P P A + P A+PP A + PP A P + PP A
Sbjct: 707 --PAAPPGRAQRPAAATGRARPPAAAPGRARPPAAAPGRARPPAA----APGRARPPAAA 760
Query: 122 VPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPP 181
++ P A P + P P P + PPP PT P P
Sbjct: 761 PGRARPPAAAPGAPTPQPPPQAPPAPQQRPRGAPTPQPPPQAGPTSMQLMPRAAPGQQGP 820
Query: 182 TSTPSPPVLTPPP---HPSQSAPPPVTKSPPAS-TLSPPPPSVPSTSSPPAVSPPA-PPS 236
T +LT PS P + + A T SP + P PP P
Sbjct: 821 TKQILRQLLTGGVKRGRPSLKKPAALERQAAAGPTPSPGSGTSDKIVQAPVFYPPVLQPI 880
Query: 237 NSSTRGSPSTPPLPSVPTEKPT 258
+ S T+ PT
Sbjct: 881 QVMRQLGSVRAAAASTVTQAPT 902
|
Length = 991 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 9e-08
Identities = 20/62 (32%), Positives = 26/62 (41%)
Query: 6 SPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPP 65
P A P P+ P +PPP+ PP PA P + P P P A PP+ A +
Sbjct: 384 PPSAAWGAPTPAAPAAPPPAAAPPVPPAAPARPAAARPAPAPAPPAAAAPPARSADPAAA 443
Query: 66 PQ 67
Sbjct: 444 AS 445
|
Length = 576 |
| >gnl|CDD|222997 PHA03132, PHA03132, thymidine kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 9e-08
Identities = 26/144 (18%), Positives = 34/144 (23%), Gaps = 17/144 (11%)
Query: 33 PPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQ 92
P TST + P P ++ P P+S PP P PP +
Sbjct: 57 PRETGSGGGVATSTIYTVPRPPRGPEQTLDKPDSLPASR------ELPPGPTPVPPGGFR 110
Query: 93 PPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPA 152
S P T+P V P S + S + P
Sbjct: 111 G------ASSPRLGADSTSPRFLYQVNFPVILAPIGESNSSS-----EELSEEEEHSRPP 159
Query: 153 TPSSSSPPPVNVPTPPSSSSPPPP 176
S P S
Sbjct: 160 PSESLKVKNGGKVYPKGFSKHKTH 183
|
Length = 580 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-07
Identities = 25/102 (24%), Positives = 38/102 (37%), Gaps = 10/102 (9%)
Query: 77 APPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANV 136
P P P P P P V P+P P + P ++++ PP +++PPP
Sbjct: 361 VPVPA---PQPAKPTAAAPSPVRPTPAP-STRPKAAAAANIPPK--EPVRETATPPPVPP 414
Query: 137 RTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSS 178
R P + P ++ P V P + P PP
Sbjct: 415 RPVAPPVPHTPESAPKLTRAAIP----VDEKPKYTPPAPPKE 452
|
Length = 585 |
| >gnl|CDD|218439 pfam05109, Herpes_BLLF1, Herpes virus major outer envelope glycoprotein (BLLF1) | Back alignment and domain information |
|---|
Score = 55.2 bits (132), Expect = 1e-07
Identities = 59/280 (21%), Positives = 97/280 (34%), Gaps = 28/280 (10%)
Query: 2 PPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAP-PPSSPA 60
P +SP + P + P + S TP TSP P + ++PP+ T+ +SP
Sbjct: 497 PNATSPTPAVTTPNATSPTTQKTSDTPNATSPTPIVIGVTTTATSPPTGTTSVPNATSPQ 556
Query: 61 VNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPA 120
V P ++ P + + P + P P++ +TP S+S
Sbjct: 557 VTEESPVNNTNTPVVTSAPSVLTSAVTTGQHGTGSSPTSQQPGIPSSSHSTPRSNS---- 612
Query: 121 NVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNV----PTPPSSSSPPPP 176
TTP +S P + P+ + S P P SS+S P
Sbjct: 613 -TSTTPLLTSAHPTGGENITEETPSVPSTTHVSTLSPGPGPGTTSQVSGPGNSSTSRYPG 671
Query: 177 SSNPPTSTPSPPVLTPP-PHPSQSAPPPVTKSP----------PASTLSPP--PP----- 218
+ P+P +P P ++A P VT + STL P
Sbjct: 672 EVHVTEGMPNPNATSPSAPSGQKTAVPTVTSTGGKANSTTKETSGSTLMASTSPHTNEGA 731
Query: 219 SVPSTSSPPAVSPPAPPSNSSTRGSPSTPPLPSVPTEKPT 258
+ + PP+ S R + ++PP+ + P
Sbjct: 732 FRTTPYNATTYLPPSTSSKLRPRWTFTSPPVTTKQATVPV 771
|
This family consists of the BLLF1 viral late glycoprotein, also termed gp350/220. It is the most abundantly expressed glycoprotein in the viral envelope of the Herpesviruses and is the major antigen responsible for stimulating the production of neutralising antibodies in vivo. Length = 830 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 25/114 (21%), Positives = 44/114 (38%), Gaps = 4/114 (3%)
Query: 89 SPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPA 148
S + P Q + P PA P ++++ P+ P+ S+++ P A T + +PP
Sbjct: 370 SGGRGPKQHIKPVFTQPAAAPQPSAAAAASPS--PSQSSAAAQPSAPQSATQPAGTPPTV 427
Query: 149 NVPATPSSSSPPPVNVP--TPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSA 200
+V + PP P P+ S+ P L P ++ A
Sbjct: 428 SVDPPAAVPVNPPSTAPQAVRPAQFKEEKKIPVSKVSSLGPSTLRPIQEKAEQA 481
|
Length = 614 |
| >gnl|CDD|235124 PRK03427, PRK03427, cell division protein ZipA; Provisional | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 28/129 (21%), Positives = 38/129 (29%), Gaps = 2/129 (1%)
Query: 135 NVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPP 194
V P+++ A P +P PP P PP + PP P P P P
Sbjct: 70 RVNHAPANAQEHEAARP-SPQHQYQPPYASAQPRQPVQQPPEAQVPPQHAPRPAQPAPQP 128
Query: 195 HPSQ-SAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTPPLPSVP 253
P P + P P S+P P+ P P+
Sbjct: 129 VQQPAYQPQPEQPLQQPVSPQVAPAPQPVHSAPQPAQQAFQPAEPVAAPQPEPVAEPAPV 188
Query: 254 TEKPTAKST 262
+KP K
Sbjct: 189 MDKPKRKEA 197
|
Length = 333 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 1e-07
Identities = 24/84 (28%), Positives = 28/84 (33%), Gaps = 2/84 (2%)
Query: 48 PSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPAN 107
S P SPPP +PP P P P PP P + AP+ P +
Sbjct: 515 GSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPADS 574
Query: 108 VPTTPSSSSPPPANVPTTPSSSSP 131
P P P PT SS
Sbjct: 575 SP--PPPIPEEPTPSPTKDSSPEE 596
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 1e-07
Identities = 24/78 (30%), Positives = 32/78 (41%), Gaps = 1/78 (1%)
Query: 2 PPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAV 61
+ P P PP PP P T+PPP PPP P + S A P+ +
Sbjct: 518 SNTAKTPPP-PQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPADSSP 576
Query: 62 NSPPPQPSSPPPPLDAPP 79
P P+ +P P D+ P
Sbjct: 577 PPPIPEEPTPSPTKDSSP 594
|
Length = 620 |
| >gnl|CDD|184918 PRK14954, PRK14954, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 1e-07
Identities = 32/132 (24%), Positives = 43/132 (32%), Gaps = 15/132 (11%)
Query: 117 PPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPP 176
P PA P + P P P PA P + P +P+P +S P P
Sbjct: 382 PSPAGSPDVKKKAPEPDL-----PQPDRHPG---PAKPEAPGARPAELPSP---ASAPTP 430
Query: 177 SSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPS 236
PP S P+ PP P SAP V P L + + + P S
Sbjct: 431 EQQPP-VARSAPL---PPSPQASAPRNVASGKPGVDLGSWQGKFMNFTRNGSRKQPVQAS 486
Query: 237 NSSTRGSPSTPP 248
+S +
Sbjct: 487 SSDAAQTGVFEG 498
|
Length = 620 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 31/86 (36%), Positives = 54/86 (62%), Gaps = 7/86 (8%)
Query: 502 RIIHRDIKSSNILLDSSFEARVADFGLAKI---ALELDSNTHVSTRVMGTFGYMAPEYAT 558
+++HRD+KS+NI L + ++ DFG +K ++ LD V++ GT Y+APE
Sbjct: 189 KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLD----VASSFCGTPYYLAPELWE 244
Query: 559 SGKLTEKSDVYSFGVVLLELITGRKP 584
+ ++K+D++S GV+L EL+T +P
Sbjct: 245 RKRYSKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|217495 pfam03326, Herpes_TAF50, Herpesvirus transcription activation factor (transactivator) | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-07
Identities = 48/223 (21%), Positives = 63/223 (28%), Gaps = 7/223 (3%)
Query: 18 PPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDA 77
PLS TP P+ P P SP P+S P + PA ++ P+ + PL
Sbjct: 208 SPLSQFHGFTPHPSLPQPQSPLKPSPSSARPQQSESFSDVWPA-STQSPREETSAEPLAP 266
Query: 78 PPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVR 137
P PS Q + P SS S P + + + P N
Sbjct: 267 ASPSSRRPSTAQEEQIACSSPQAEPEQGVQSYVPQSSDSRPSCFPAPSTTQPTFLPPNTN 326
Query: 138 TTPSSSSPPPANVPAT----PSSSSPPPVNVPTPPSSSSPPP--PSSNPPTSTPSPPVLT 191
P P S + V P S P SN P + +
Sbjct: 327 KKAKRDRRPQMVTPKQEGGAAVSQNHDGGTVRAPRGRPSGSGQSPPSNSPLLSSLADTPS 386
Query: 192 PPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAP 234
H S PP S P P +S P
Sbjct: 387 GAAHQPASLLPPAVVQQQLEDASDKQPPTPGSSLVPQPDEQEL 429
|
This family includes EBV BRLF1 and similar ORF 50 proteins from other herpesviruses. Length = 500 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 39/112 (34%), Positives = 58/112 (51%), Gaps = 15/112 (13%)
Query: 487 GAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAK--IALELDSNTHVSTR 544
GA G+ +LH + RIIHRD+K +NILL + ++ DFG++ + L NT V
Sbjct: 136 GALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV--- 189
Query: 545 VMGTFGYMAPEYATSGKLTEKS-----DVYSFGVVLLELITGRKPVDASQPL 591
GT +MAPE + + S DV+S G+ +EL G P+ P+
Sbjct: 190 --GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV 239
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 34/93 (36%), Positives = 51/93 (54%), Gaps = 6/93 (6%)
Query: 489 ARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAK-IALELDSNTHVSTRVMG 547
ARG+ +L + IHRD+ + NILL + ++ DFGLA+ I + D R+
Sbjct: 183 ARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL-- 237
Query: 548 TFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT 580
+MAPE T +SDV+SFGV+L E+ +
Sbjct: 238 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 54.1 bits (131), Expect = 2e-07
Identities = 16/68 (23%), Positives = 22/68 (32%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
S+P A A P+ P PP+ P P PA+ + P A + A
Sbjct: 52 AAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPAAPPAAAAAAAPAAA 111
Query: 61 VNSPPPQP 68
P
Sbjct: 112 AVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|185616 PTZ00436, PTZ00436, 60S ribosomal protein L19-like protein; Provisional | Back alignment and domain information |
|---|
Score = 53.4 bits (127), Expect = 2e-07
Identities = 30/124 (24%), Positives = 55/124 (44%), Gaps = 5/124 (4%)
Query: 126 PSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPS-SSSPPPPSSNPPTST 184
P+ ++ PA P+ ++ PA A P+ ++ PP PP+ +++PP ++ PP
Sbjct: 222 PAKAAAAPAKAAAPPAKAAAAPAKAAAAPAKAAAPPAKAAAPPAKAAAPPAKAAAPPAKA 281
Query: 185 PSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSP 244
+PP P +A P + PA + P ++PPA + P ++
Sbjct: 282 AAPPAKAAAPPAKAAAAPAKAAAAPAKAAAAP----AKAAAPPAKAAAPPAKAATPPAKA 337
Query: 245 STPP 248
+ PP
Sbjct: 338 AAPP 341
|
Length = 357 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-07
Identities = 29/102 (28%), Positives = 38/102 (37%), Gaps = 5/102 (4%)
Query: 36 ASPPPSPPTSTPPS---PPTAPPPSSPAVNSP-PPQPSSPPPPLDAPPPPEVDPSPPSPA 91
AS P P P AP PS+ A SP P Q S+ P + +PP+ +
Sbjct: 369 ASGGRGPKQHIKPVFTQPAAAPQPSAAAAASPSPSQSSAAAQPSAPQSATQPAGTPPTVS 428
Query: 92 QPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPP 133
PP AV P PP + +P + SS P
Sbjct: 429 VDPPAAV-PVNPPSTAPQAVRPAQFKEEKKIPVSKVSSLGPS 469
|
Length = 614 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 2e-07
Identities = 23/80 (28%), Positives = 31/80 (38%)
Query: 5 SSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSP 64
S +P P PP +P S P + +T PSPP A V +
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAE 420
Query: 65 PPQPSSPPPPLDAPPPPEVD 84
P +PS PP A PP ++
Sbjct: 421 PTEPSPTPPANAANAPPSLN 440
|
Length = 620 |
| >gnl|CDD|236669 PRK10263, PRK10263, DNA translocase FtsK; Provisional | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 2e-07
Identities = 56/252 (22%), Positives = 74/252 (29%), Gaps = 31/252 (12%)
Query: 2 PPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAV 61
P +PP PP+ P P P + P P P P A P +
Sbjct: 339 PVTQTPPVASVDVPPAQPTVAW-QPVPGPQTGEPVIAPA--PEGYPQQSQYAQP--AVQY 393
Query: 62 NSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPAN 121
N P QP P P AP + P P A P P P ++
Sbjct: 394 NEPLQQPVQPQQPYYAPAAEQPAQQPYYAPAPEQPAQQPYYAPAPEQPVAGNAWQAEEQQ 453
Query: 122 VPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPP 181
P S+ +T ++ P P PV P P + P + PP
Sbjct: 454 STFAPQSTYQTE---QTYQQPAAQEPLYQQ--PQPVEQQPVVEPEPVVEETKP---ARPP 505
Query: 182 -------------TSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPA 228
P P P + P P+ S A P +VP + A
Sbjct: 506 LYYFEEVEEKRAREREQLAAWYQPIPEPVK-EPEPIKSSLKA----PSVAAVPPVEAAAA 560
Query: 229 VSPPAPPSNSST 240
VSP A +T
Sbjct: 561 VSPLASGVKKAT 572
|
Length = 1355 |
| >gnl|CDD|236940 PRK11633, PRK11633, cell division protein DedD; Provisional | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 25/93 (26%), Positives = 32/93 (34%), Gaps = 4/93 (4%)
Query: 12 AVPPPSPPL--SPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPS 69
+P + L PP + A+P P T PP+ P P P V P P+P
Sbjct: 55 MMPAATQALPTQPPEGAAEAVRAGDAAAPSLDPATVAPPNTPVEPEP--APVEPPKPKPV 112
Query: 70 SPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSP 102
P P P P P P P +P
Sbjct: 113 EKPKPKPKPQQKVEAPPAPKPEPKPVVEEKAAP 145
|
Length = 226 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 20/86 (23%), Positives = 30/86 (34%), Gaps = 2/86 (2%)
Query: 4 QSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNS 63
++ PA P +P S TP + P + P PS ++PA +
Sbjct: 168 TTTDPATTPAPAAPVDTTPTNSQTPAVATAPAPAVDPQQNAVVAPSQANVDTAATPAPAA 227
Query: 64 PPPQPSSPPPPLDAPPP--PEVDPSP 87
P + P P D P DP+
Sbjct: 228 PATPDGAAPLPTDQAGVSTPAADPNA 253
|
Length = 331 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 33/94 (35%), Positives = 53/94 (56%), Gaps = 10/94 (10%)
Query: 490 RGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTF 549
RG+ Y+H IIHRD+K SN+ ++ E ++ DFGLA+ + + +V+TR
Sbjct: 131 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-EMTGYVATR----- 181
Query: 550 GYMAPEYATSG-KLTEKSDVYSFGVVLLELITGR 582
Y APE + + D++S G ++ EL+TGR
Sbjct: 182 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 38/103 (36%), Positives = 55/103 (53%), Gaps = 7/103 (6%)
Query: 489 ARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAK-IALELDSNTHVSTRVMG 547
ARG+ +L + IHRD+ + NILL + ++ DFGLA+ I + D S R+
Sbjct: 184 ARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL-- 238
Query: 548 TFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQ 589
+MAPE T +SDV+SFGV+L E+ + G P Q
Sbjct: 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 35/109 (32%), Positives = 56/109 (51%), Gaps = 11/109 (10%)
Query: 488 AARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMG 547
A G+ +LH + + IHRD+K +NILL + ++ DFG ++ +L S +G
Sbjct: 133 ALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFG---VSAQLTSTRLRRNTSVG 186
Query: 548 TFGYMAPEY-ATSGKL----TEKSDVYSFGVVLLELITGRKPVDASQPL 591
T +MAPE A +L + DV+S G+ +EL G P+ P+
Sbjct: 187 TPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM 235
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|217393 pfam03154, Atrophin-1, Atrophin-1 family | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-07
Identities = 71/256 (27%), Positives = 91/256 (35%), Gaps = 25/256 (9%)
Query: 21 SPPPSTTPPPTSPPPASPPPSPPTSTPPSPPT--APPPSSPAVNSPPPQPSSPP-----P 73
S PS P + + P PP+ PP ++ A ++PPP PS+
Sbjct: 149 SSSPSIPSPQDNESDSDSSAQQQLLQPQGPPSIQVPPGAALAPSAPPPTPSAQAVPPQGS 208
Query: 74 PLDAPPPPEVDPSPPSPAQPPPQA---VAPSPPPPANVPTTPSSSSPPPANVPTTPSSS- 129
P+ A P P+ P P PSP PP T S PPA P SS
Sbjct: 209 PIAAQPAPQPQQPSPLSLISAPSLHPQRLPSPHPPLQPQTASQQSPQPPAPSSRHPQSSH 268
Query: 130 ----SPPPANVRTTPSSSSPPPANVP----ATPSSSSPPPVNVPTPPSSSSPPPPSSNPP 181
P P ++ P P +N P S P P+ P S +PP S+ P
Sbjct: 269 HGPGPPMPHALQQGPVFLQHPSSNPPQPFGLAQSQVPPLPLPSQAQPHSHTPPSQSALQP 328
Query: 182 TSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTR 241
P L P P PPP T P L P P+ P P S+
Sbjct: 329 QQPPREQPLPPAPSMPHIKPPPTT---PIPQLPNQSHKHPPHLQGPS---PFPQMPSNLP 382
Query: 242 GSPSTPPLPSVPTEKP 257
P+ PL S+PT P
Sbjct: 383 PPPALKPLSSLPTHHP 398
|
Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1, that is thought to confer toxicity to the protein, possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders, including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein, CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity. Length = 979 |
| >gnl|CDD|185616 PTZ00436, PTZ00436, 60S ribosomal protein L19-like protein; Provisional | Back alignment and domain information |
|---|
Score = 53.0 bits (126), Expect = 3e-07
Identities = 38/140 (27%), Positives = 58/140 (41%), Gaps = 13/140 (9%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
P ++ PA A PP +P + P + P + +PP A + PA
Sbjct: 222 PAKAAAAPAKAAAPPAKAAAAPAKAAAAPAKAAAPPAKAAAPP---------AKAAAPPA 272
Query: 61 VNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPA 120
+ PP ++ PP A PP + +P A P +A A PA P+ ++ PPA
Sbjct: 273 KAAAPPAKAAAPPAKAAAPPAKAAAAPAKAAAAPAKAAA----APAKAAAPPAKAAAPPA 328
Query: 121 NVPTTPSSSSPPPANVRTTP 140
T P+ ++ PPA P
Sbjct: 329 KAATPPAKAAAPPAKAAAAP 348
|
Length = 357 |
| >gnl|CDD|217392 pfam03153, TFIIA, Transcription factor IIA, alpha/beta subunit | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 34/151 (22%), Positives = 51/151 (33%), Gaps = 16/151 (10%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPP----PTSPPPASPPPSPPTSTPPSPPTAPPP 56
PPP + P L PPP+ L P+ PT P A+PP + P+ PT
Sbjct: 56 PPPVAQLPQPLPQPPPTQALQALPAGDQQQHNTPTGSPAANPPATFALPAGPAGPTIQTE 115
Query: 57 SS-------PAVNSPPPQPSSPPPPLDAPPPPEVDPS--PPSPAQPPPQAVAPSPPPPAN 107
P + + P S P ++ P+ Q P Q + +
Sbjct: 116 PGQLYPVQVPVMVTQNPANSPLDQPAQQRALQQLQQRYGAPASGQLPSQQQSAQKNDESQ 175
Query: 108 VPTTPSSSSPPPANVPTTPSSSSPPPANVRT 138
+ P+ +PP T + A VR
Sbjct: 176 LQQQPNGETPPQ---QTDGAGDDESEALVRL 203
|
Transcription initiation factor IIA (TFIIA) is a heterotrimer, the three subunits being known as alpha, beta, and gamma, in order of molecular weight. The N and C-terminal domains of the gamma subunit are represented in pfam02268 and pfam02751, respectively. This family represents the precursor that yields both the alpha and beta subunits. The TFIIA heterotrimer is an essential general transcription initiation factor for the expression of genes transcribed by RNA polymerase II. Together with TFIID, TFIIA binds to the promoter region; this is the first step in the formation of a pre-initiation complex (PIC). Binding of the rest of the transcription machinery follows this step. After initiation, the PIC does not completely dissociate from the promoter. Some components, including TFIIA, remain attached and re-initiate a subsequent round of transcription. Length = 332 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 53.0 bits (128), Expect = 3e-07
Identities = 20/109 (18%), Positives = 30/109 (27%)
Query: 20 LSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPP 79
L+PP + P PPPA+ P + P+ AP A +
Sbjct: 51 LAPPAAAAPAAAQPPPAAAPAAVSRPAAPAAEPAPWLVEHAKRLTAQREQLVARAAAPAA 110
Query: 80 PPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSS 128
P P+ P+ A A P + A +
Sbjct: 111 PEAQAPAAPAERAAAENAARRLARAAAAAPRPRVPADAAAAVADAVKAR 159
|
Length = 484 |
| >gnl|CDD|165527 PHA03269, PHA03269, envelope glycoprotein C; Provisional | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 3e-07
Identities = 35/116 (30%), Positives = 48/116 (41%), Gaps = 5/116 (4%)
Query: 88 PSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPP 147
P PA P P A P PA PT+ +S P A PT +S PA +S +P P
Sbjct: 40 PDPA-PAPHQAASRAPDPAVAPTSAASRKPDLAQAPTPAASEKFDPAPAPHQAASRAPDP 98
Query: 148 ANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPP 203
A P ++ P T S++ ++ TS S P +Q +PPP
Sbjct: 99 AVAPQLAAAPKPDAAEAFT--SAAQAHEAPADAGTSAASKK--PDPAAHTQHSPPP 150
|
Length = 566 |
| >gnl|CDD|236940 PRK11633, PRK11633, cell division protein DedD; Provisional | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 3e-07
Identities = 29/113 (25%), Positives = 38/113 (33%), Gaps = 9/113 (7%)
Query: 19 PLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAP 78
PL P P P P A T P P ++ AV + S P AP
Sbjct: 42 PLVPKPGDRDEPDMMPAA---------TQALPTQPPEGAAEAVRAGDAAAPSLDPATVAP 92
Query: 79 PPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSP 131
P V+P P P P+ V P P + +P P P ++P
Sbjct: 93 PNTPVEPEPAPVEPPKPKPVEKPKPKPKPQQKVEAPPAPKPEPKPVVEEKAAP 145
|
Length = 226 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 3e-07
Identities = 29/101 (28%), Positives = 38/101 (37%), Gaps = 8/101 (7%)
Query: 17 SPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLD 76
S PL +T P T P A +P S P+ TAP P + PQ ++ P
Sbjct: 161 SVPLDTSTTTDPATTPAPAAPVDTTPTNSQTPAVATAPAP------AVDPQQNAVVAPSQ 214
Query: 77 APPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSP 117
A P+P A P AP P A V T + +
Sbjct: 215 ANVDTAATPAP--AAPATPDGAAPLPTDQAGVSTPAADPNA 253
|
Length = 331 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 58/221 (26%), Positives = 91/221 (41%), Gaps = 22/221 (9%)
Query: 388 VLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGERE----FRAEVEIISRVHHRHLVSLV 443
V+G G FG V R+V +L +R F E +I++ + +V L
Sbjct: 50 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109
Query: 444 GYCISERERLLVYEYVPND---TLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCH 500
+R +V EY+P L + + + V +A A + +
Sbjct: 110 YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGF------ 163
Query: 501 PRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATS- 559
IHRD+K N+LLD S ++ADFG + + + T V GT Y++PE S
Sbjct: 164 ---IHRDVKPDNMLLDKSGHLKLADFGTC-MKMNKEGMVRCDTAV-GTPDYISPEVLKSQ 218
Query: 560 ---GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLV 597
G + D +S GV L E++ G P A +G S +
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI 259
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|218881 pfam06070, Herpes_UL32, Herpesvirus large structural phosphoprotein UL32 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 3e-07
Identities = 36/245 (14%), Positives = 58/245 (23%), Gaps = 21/245 (8%)
Query: 15 PPSPPLSPPPSTTPPPTSPPPASP---------PPSPPTSTPPSPPTAP-PPSSPAVNSP 64
P + +PPP SPP + PS S P P +
Sbjct: 524 KELRPRIGFINKSPPPKSPPKSRRTLIVALSLASPSTAGSPRPKPSLGKFVIGTDPFAFA 583
Query: 65 PPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPT 124
+ V P + ++P + P N T SS N
Sbjct: 584 NTVRLTDNMRGGNGVGSSVKPKGSASSKPLTGPGSDLKPATLNGKTPSSSLVGAARNAGA 643
Query: 125 TPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPT-PPSSSSPPPPSSNPPTS 183
+ P T+P S T ++S+P N P ++ + ++
Sbjct: 644 SSKVKIPSGLGGFTSPISLLESALEDVLTSATSTPVKKNDPYLWDTNGEKAGGGTESAST 703
Query: 184 TPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGS 243
T + P P PP + S +
Sbjct: 704 TDVFQNF------AGLNKKTPVGGPFQ----PKPPLSRALDSASSPGGSGGKPGLDGVEG 753
Query: 244 PSTPP 248
Sbjct: 754 AKGKD 758
|
The large phosphorylated protein (UL32-like) of herpes viruses is the polypeptide most frequently reactive in immuno-blotting analyses with antisera when compared with other viral proteins. Length = 777 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 64/255 (25%), Positives = 98/255 (38%), Gaps = 68/255 (26%)
Query: 381 NGFSAHNVLGEGGFGCVYKGVLAD-GREVAVKQLKIGGSQGERE----FRAEVEIISRVH 435
+ F + V+G G FG V D G A+K+L+ E+E RAE +I++
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLR-KSEMLEKEQVAHVRAERDILAEAD 59
Query: 436 HRHLVSLVGYCISERERL-LVYEYVPN----------DTLHYHLHAEGRPVMDWATRVKV 484
+ +V L Y + L L+ EY+P DT + TR +
Sbjct: 60 NPWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTF-----------TEEETRFYI 107
Query: 485 AAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAK-------------- 530
A I +H+ IHRDIK N+LLD+ +++DFGL
Sbjct: 108 AE-TILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRIL 163
Query: 531 ------IALELDSNTHVSTR---------------VMGTFGYMAPEYATSGKLTEKSDVY 569
L+ S S R +GT Y+APE ++ D +
Sbjct: 164 SHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWW 223
Query: 570 SFGVVLLELITGRKP 584
S GV++ E++ G P
Sbjct: 224 SLGVIMYEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 4e-07
Identities = 23/78 (29%), Positives = 26/78 (33%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
P P + P A A P +T PP P A P P P S P A P
Sbjct: 383 PAPSTRPKAAAAANIPPKEPVRETATPPPVPPRPVAPPVPHTPESAPKLTRAAIPVDEKP 442
Query: 61 VNSPPPQPSSPPPPLDAP 78
+PP P L A
Sbjct: 443 KYTPPAPPKEEEKALIAD 460
|
Length = 585 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 4e-07
Identities = 26/112 (23%), Positives = 39/112 (34%), Gaps = 11/112 (9%)
Query: 75 LDAPPP--PEVDPSP----PSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSS 128
DA P+ P P+ A P A A SP P + S+++ P A T +
Sbjct: 367 DDASGGRGPKQHIKPVFTQPAAAPQPSAAAAASPSPSQS-----SAAAQPSAPQSATQPA 421
Query: 129 SSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNP 180
+PP +V + PP+ P + SS P + P
Sbjct: 422 GTPPTVSVDPPAAVPVNPPSTAPQAVRPAQFKEEKKIPVSKVSSLGPSTLRP 473
|
Length = 614 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 4e-07
Identities = 22/113 (19%), Positives = 34/113 (30%), Gaps = 7/113 (6%)
Query: 151 PATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPA 210
P + P P S++ S +S + P PP V+ PPA
Sbjct: 378 HIKPVFTQP----AAAPQPSAAAAASPSPSQSSAAAQPSAPQSATQPAGTPPTVSVDPPA 433
Query: 211 STLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTPPLPSVPTEKPTAKSTN 263
+ PP + P P S S P P ++ ++T
Sbjct: 434 AVPVNPPSTAPQAVRPAQFKEEKKIPVSKV---SSLGPSTLRPIQEKAEQATG 483
|
Length = 614 |
| >gnl|CDD|235124 PRK03427, PRK03427, cell division protein ZipA; Provisional | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 4e-07
Identities = 35/123 (28%), Positives = 39/123 (31%), Gaps = 3/123 (2%)
Query: 12 AVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSP 71
A + PS PP AS P P PP PP +P P PQP
Sbjct: 74 APANAQEHEAARPSPQHQY-QPPYASAQPRQPVQQPPEAQV-PPQHAPRPAQPAPQPVQQ 131
Query: 72 PPPLDAPPPPEVDPSPPSPAQPP-PQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSS 130
P P P P P A P P AP P A P P ++ P P
Sbjct: 132 PAYQPQPEQPLQQPVSPQVAPAPQPVHSAPQPAQQAFQPAEPVAAPQPEPVAEPAPVMDK 191
Query: 131 PPP 133
P
Sbjct: 192 PKR 194
|
Length = 333 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 53.0 bits (128), Expect = 4e-07
Identities = 20/79 (25%), Positives = 25/79 (31%)
Query: 11 LAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSS 70
L S + P P P P P P++ P PA SPP +
Sbjct: 360 LPSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPA 419
Query: 71 PPPPLDAPPPPEVDPSPPS 89
P PP +PPS
Sbjct: 420 EPTEPSPTPPANAANAPPS 438
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 53.0 bits (128), Expect = 4e-07
Identities = 22/76 (28%), Positives = 27/76 (35%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
+PP PPP P P P T P P PPP+ ++ +P P SSP
Sbjct: 518 SNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPADSSPP 577
Query: 61 VNSPPPQPSSPPPPLD 76
P SP
Sbjct: 578 PPIPEEPTPSPTKDSS 593
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 53.0 bits (128), Expect = 4e-07
Identities = 22/76 (28%), Positives = 28/76 (36%)
Query: 29 PPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPP 88
S + P+ PT P P P A + + PPP A PP V P
Sbjct: 363 AFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAEPT 422
Query: 89 SPAQPPPQAVAPSPPP 104
P+ PP A +PP
Sbjct: 423 EPSPTPPANAANAPPS 438
|
Length = 620 |
| >gnl|CDD|165527 PHA03269, PHA03269, envelope glycoprotein C; Provisional | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 4e-07
Identities = 30/110 (27%), Positives = 45/110 (40%), Gaps = 2/110 (1%)
Query: 77 APPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANV 136
AP P + P PA P A A P A PT +S PA P +S +P PA
Sbjct: 43 APAPHQAASRAPDPAVAPTSA-ASRKPDLAQAPTPAASEKFDPAPAPHQAASRAPDPAVA 101
Query: 137 RTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPS 186
++ P A + + + P + T ++S P P+++ S P
Sbjct: 102 PQLAAAPKPDAAEAFTSAAQAHEAPADAGT-SAASKKPDPAAHTQHSPPP 150
|
Length = 566 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 33/99 (33%), Positives = 49/99 (49%), Gaps = 6/99 (6%)
Query: 503 IIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATS--- 559
+IHRD+K N+LLD ++ADFG + ++ T V GT Y++PE S
Sbjct: 163 LIHRDVKPDNMLLDKHGHLKLADFGTC-MKMDETGMVRCDTAV-GTPDYISPEVLKSQGG 220
Query: 560 -GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLV 597
G + D +S GV L E++ G P A +G S +
Sbjct: 221 DGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKI 259
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|223880 COG0810, TonB, Periplasmic protein TonB, links inner and outer membranes [Cell envelope biogenesis, outer membrane] | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 35/122 (28%), Positives = 46/122 (37%), Gaps = 1/122 (0%)
Query: 11 LAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSS 70
LAV + + P+ P P PP P P P PT P P P+
Sbjct: 39 LAVFLLAAKVLEAPTEEPQPEPEPPEEQPKPPTEPETPPEPTPPKPKEKPKPEKKPKKPK 98
Query: 71 PPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSS 130
P P P P+V P P P +PP + A +P P PS++S A + S S
Sbjct: 99 PKPKPKPKPKPKVKP-QPKPKKPPSKTAAKAPAAPNQPARPPSAASASGAATGPSASYLS 157
Query: 131 PP 132
Sbjct: 158 GL 159
|
Length = 244 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 4e-07
Identities = 37/100 (37%), Positives = 52/100 (52%), Gaps = 13/100 (13%)
Query: 504 IHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATS---- 559
+HRDIK NIL+D + R+ADFG +E T S+ +GT Y++PE +
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFGSCLKLME--DGTVQSSVAVGTPDYISPEILQAMEDG 181
Query: 560 -GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVE 598
GK + D +S GV + E++ G P A ESLVE
Sbjct: 182 KGKYGPECDWWSLGVCMYEMLYGETPFYA------ESLVE 215
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|219339 pfam07223, DUF1421, Protein of unknown function (DUF1421) | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 5e-07
Identities = 62/238 (26%), Positives = 76/238 (31%), Gaps = 27/238 (11%)
Query: 35 PASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPP 94
PP+P AP A P P P SP P +Q P
Sbjct: 46 STKQPPAPEQVAKHELADAPLQQVNAALPPAPAPQSPQPD------------QQQQSQAP 93
Query: 95 PQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATP 154
P PS PP V + P +P PS PPPA + PP VP
Sbjct: 94 PSHQYPSQLPPQQVQSVPQQPTPQQEPYYPPPSQPQPPPAQ--QPQAQQPQPPPQVPQQQ 151
Query: 155 SSSSPPPVNVPT---PPSSSSPPPPSSNPPTSTPSPPVLTPP---PHPSQSAPPPVTKSP 208
SPP PP + S P S P +P P PP S + PP + +P
Sbjct: 152 QYQSPPQQPQYQQNPPPQAQSAPQVSGLYPEESPYQPQSYPPNEPLPSSMAMQPPYSGAP 211
Query: 209 PASTLSPPPPSVPSTSSPPAVSPPA-------PPSNSSTRGSPSTPPLPSVPTEKPTA 259
P+ PP P P P + PP + G + P PS A
Sbjct: 212 PSQQFYGPPQPSPYMYGGPGGRPNSGFPSGQQPPPSQGQEGYGYSGPPPSKGNHGSVA 269
|
This family represents a conserved region approximately 350 residues long within a number of plant proteins of unknown function. Length = 357 |
| >gnl|CDD|235124 PRK03427, PRK03427, cell division protein ZipA; Provisional | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 5e-07
Identities = 28/111 (25%), Positives = 34/111 (30%), Gaps = 8/111 (7%)
Query: 28 PPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPP----PQPSSPPPPLDAPPPPEV 83
+ P PP A V PP P +P P AP P +
Sbjct: 72 NHAPANAQEHEAARPSPQHQYQPPYASAQPRQPVQQPPEAQVPPQHAPRPAQPAPQPVQQ 131
Query: 84 DPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPA 134
P P QP Q V+P P P S+P PA P+ P
Sbjct: 132 PAYQPQPEQPLQQPVSPQVAPAPQ----PVHSAPQPAQQAFQPAEPVAAPQ 178
|
Length = 333 |
| >gnl|CDD|236669 PRK10263, PRK10263, DNA translocase FtsK; Provisional | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 5e-07
Identities = 38/189 (20%), Positives = 47/189 (24%), Gaps = 9/189 (4%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
Q + PAV P P+ P P P P +P P P P
Sbjct: 382 QQSQYAQPAVQYNEPLQQPVQPQQPYYAPAAEQPAQQPYYAPAPEQPAQQPYYAPAPEQP 441
Query: 61 VNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPA 120
V Q + + + PA P P P P P
Sbjct: 442 VAGNAWQAEEQQSTFAPQSTYQTEQTYQQPAAQEPLYQQPQPVEQ------QPVVEPEPV 495
Query: 121 NVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNP 180
T P+ PP A P PV P P SS P +
Sbjct: 496 VEETKPAR---PPLYYFEEVEEKRAREREQLAAWYQPIPEPVKEPEPIKSSLKAPSVAAV 552
Query: 181 PTSTPSPPV 189
P + V
Sbjct: 553 PPVEAAAAV 561
|
Length = 1355 |
| >gnl|CDD|140276 PTZ00249, PTZ00249, variable surface protein Vir28; Provisional | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 5e-07
Identities = 36/175 (20%), Positives = 53/175 (30%), Gaps = 12/175 (6%)
Query: 28 PPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSP 87
PP + S PP SSP + PP + PP P+ P+
Sbjct: 217 PPREEQKAVTAHAHRRISGEARPPKHISFSSPHAHGRPPVETRPPNPVSV-SSPQAHGRH 275
Query: 88 PSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPP 147
P PP PS A+ + +P + ++ + A + +SS P
Sbjct: 276 PGETHTPPLVTVPS--SKAHDRNPVQTPTPTSVSGYSSQAKGLEKQAGGESERTSSVPS- 332
Query: 148 ANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPP 202
P P+ V P S P S + T + P P P
Sbjct: 333 --------EQFPLPLPVLLPLGQSGPLESSESEETDEYAGPKGLPEPELELVELQ 379
|
Length = 516 |
| >gnl|CDD|223061 PHA03369, PHA03369, capsid maturational protease; Provisional | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 5e-07
Identities = 47/285 (16%), Positives = 74/285 (25%), Gaps = 18/285 (6%)
Query: 7 PPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPP-SPPTAPPPSSPAVNSP- 64
P+ + + P T P P P S P SP TA PP P
Sbjct: 355 APSRVLAAAAKVAVIAAPQTHTGPADRQRPQRPDGIPYSVPARSPMTAYPPVPQFCGDPG 414
Query: 65 PPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPAN--- 121
P +P P + P V P PP P P ++ + P
Sbjct: 415 LVSPYNPQSPGTSYGPEPVGPVPPQPTNPYVMPISMANMVYPGHPQEHGHERKRKRGGEL 474
Query: 122 ----------VPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSS 171
V + T S ++ + P S+
Sbjct: 475 KEELIETLKLVKKLKEEQESLAKELEATAHKSEIKKIAESEFKNAGAKTAAANIEPNCSA 534
Query: 172 SPPPPSSNPPTSTPSPPVLT---PPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPA 228
P++ + P P S ++TL+ T+ A
Sbjct: 535 DAAAPATKRARPETKTELEAVVRFPYQIRNMESPAFVHSFTSTTLAAAAGQGSDTAEALA 594
Query: 229 VSPPAPPSNSSTRGSPSTPPLPSVPTEKPTAKSTNGTAVSANASP 273
+ + +S + + + P P+VP T ST
Sbjct: 595 GAIETLLTQASAQPAGLSLPAPAVPVNASTPASTPPPLAPQEPPQ 639
|
Length = 663 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 6e-07
Identities = 29/135 (21%), Positives = 43/135 (31%), Gaps = 12/135 (8%)
Query: 134 ANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPP 193
+RTT P + + P P P P++++P P P+P T P
Sbjct: 339 FQLRTTSYGQLP--LELAVIEALLVPVPAPQPAKPTAAAPSP-------VRPTPAPSTRP 389
Query: 194 PHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSP-PAVSPPAPPSNSSTRGSPSTPPLPSV 252
+ + PP K P T +PPP + P P AP + P
Sbjct: 390 KAAAAANIPP--KEPVRETATPPPVPPRPVAPPVPHTPESAPKLTRAAIPVDEKPKYTPP 447
Query: 253 PTEKPTAKSTNGTAV 267
K K+
Sbjct: 448 APPKEEEKALIADGD 462
|
Length = 585 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 6e-07
Identities = 27/118 (22%), Positives = 40/118 (33%), Gaps = 11/118 (9%)
Query: 2 PPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPP-PSPPT-STPPSPPTAPPPSSP 59
P + P+ A PSP S S P++P A+ P +PPT S P P S
Sbjct: 386 PAAAPQPSAAAAASPSPSQS---SAAAQPSAPQSATQPAGTPPTVSVDPPAAVPVNPPST 442
Query: 60 AVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSP 117
A + P + + PS P Q + N+ P+ +
Sbjct: 443 APQAVRPAQFKEEKKIPVSKVSSLGPSTLRPIQEKAEQAT------GNIKEAPTGTQK 494
|
Length = 614 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 6e-07
Identities = 16/78 (20%), Positives = 23/78 (29%)
Query: 20 LSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPP 79
L + S P P P+ P + P + A +P P P+ PP+ P
Sbjct: 360 LPSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPA 419
Query: 80 PPEVDPSPPSPAQPPPQA 97
P P
Sbjct: 420 EPTEPSPTPPANAANAPP 437
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 6e-07
Identities = 26/80 (32%), Positives = 31/80 (38%), Gaps = 1/80 (1%)
Query: 17 SPPLSPPPSTTPPPTSPPPASPPPSP-PTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPL 75
S S T PPP PP P P P T +PP PPP P + P
Sbjct: 514 SGSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPAD 573
Query: 76 DAPPPPEVDPSPPSPAQPPP 95
+PPPP + PSP +
Sbjct: 574 SSPPPPIPEEPTPSPTKDSS 593
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 6e-07
Identities = 28/76 (36%), Positives = 34/76 (44%), Gaps = 2/76 (2%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
PPPQ SPP PP P + P TPPP PPP + S ++PPP P
Sbjct: 525 PPPQKSPPPPAPTPPLPQPTATAPPPTPPP--PPPTATQASSNAPAQIPADSSPPPPIPE 582
Query: 61 VNSPPPQPSSPPPPLD 76
+P P S P +D
Sbjct: 583 EPTPSPTKDSSPEEID 598
|
Length = 620 |
| >gnl|CDD|218881 pfam06070, Herpes_UL32, Herpesvirus large structural phosphoprotein UL32 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 6e-07
Identities = 47/277 (16%), Positives = 75/277 (27%), Gaps = 22/277 (7%)
Query: 18 PPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDA 77
P LSP P++ P ST + AV + L
Sbjct: 371 PGLSPSPNSGKEMPGILTTENLDLPLASTDSTEMDPEDKRGGAVKINNSGILAWG--LKT 428
Query: 78 PPPPEVDPSPPSPAQPPPQAVAPSPPP--PANVPTTPSSSSPPPANVPTTPSSSSPPPAN 135
P D + + V P P + S SPP + P+S
Sbjct: 429 PGLAVNDERSIAVSSDGITDVLDPPSPLRLHSSDKVIDSVSPPSKRRVSAPASRLDD--- 485
Query: 136 VRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPP-- 193
+ +++P + + +S S S SPP +PP
Sbjct: 486 AKRPEVTATPESSGSDSEGGASGREDETSSDAESVVSIKELRPRIGFINKSPPPKSPPKS 545
Query: 194 -----PHPSQSAP--PPVTKSPPA---STLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGS 243
S ++P + P+ + P + +T SS +
Sbjct: 546 RRTLIVALSLASPSTAGSPRPKPSLGKFVIGTDPFAFANTVRLTDNMRGGNGVGSSVKPK 605
Query: 244 PSTPPLPS---VPTEKPTAKSTNGTAVSANASPRNAG 277
S P KP + + S + RNAG
Sbjct: 606 GSASSKPLTGPGSDLKPATLNGKTPSSSLVGAARNAG 642
|
The large phosphorylated protein (UL32-like) of herpes viruses is the polypeptide most frequently reactive in immuno-blotting analyses with antisera when compared with other viral proteins. Length = 777 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 6e-07
Identities = 33/94 (35%), Positives = 53/94 (56%), Gaps = 10/94 (10%)
Query: 490 RGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTF 549
RG+ Y+H IIHRD+K SN+ ++ E R+ DFGLA+ A + + +V+TR
Sbjct: 129 RGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQADD-EMTGYVATR----- 179
Query: 550 GYMAPEYATSG-KLTEKSDVYSFGVVLLELITGR 582
Y APE + + D++S G ++ EL+ G+
Sbjct: 180 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|217835 pfam03999, MAP65_ASE1, Microtubule associated protein (MAP65/ASE1 family) | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 6e-07
Identities = 30/162 (18%), Positives = 43/162 (26%), Gaps = 8/162 (4%)
Query: 42 PPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQ------PPP 95
P ST S P+ P N PS P + S S + P
Sbjct: 460 PYGSTESSVPSTPSTRRNDRNITSNTPSLKRTPNLTKSSLSQEASLISKSTGNTHKHSTP 519
Query: 96 QAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPS 155
+ + P + + S S P + +P S P
Sbjct: 520 RR-LTTLPKLPAASRSSKGNLIRSGANGNASSDLSSPGSINSKSPEHSVPLVRVFDIHLR 578
Query: 156 SSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPS 197
+S+ TP ++ P S P V T P S
Sbjct: 579 ASTTKG-RHSTPSTNEKKKRLLKRSPLSPPKESVATTPRLNS 619
|
Length = 619 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 7e-07
Identities = 28/113 (24%), Positives = 37/113 (32%), Gaps = 14/113 (12%)
Query: 49 SPPTAPP-PSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPAN 107
S P P P++ P P A PSP + + S PA
Sbjct: 370 SGGRGPKQHIKPVFTQ----PAAAPQPSAAAAA---SPSPSQSSAAAQPSAPQSATQPA- 421
Query: 108 VPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPP 160
T P+ S PPA VP P S++P P+ + SS P
Sbjct: 422 -GTPPTVSVDPPAAVPVNPPSTAPQ----AVRPAQFKEEKKIPVSKVSSLGPS 469
|
Length = 614 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 7e-07
Identities = 21/86 (24%), Positives = 23/86 (26%), Gaps = 7/86 (8%)
Query: 85 PSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSS 144
PS A A P P P P + S PP S
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKA-------SP 413
Query: 145 PPPANVPATPSSSSPPPVNVPTPPSS 170
P P T S +PP PPS
Sbjct: 414 PIPVPAEPTEPSPTPPANAANAPPSL 439
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 7e-07
Identities = 26/81 (32%), Positives = 36/81 (44%), Gaps = 3/81 (3%)
Query: 16 PSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPL 75
PS +S + + P P +P P P P +P T ++P SPPP +SPP P+
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTP---SPPPAKASPPIPV 417
Query: 76 DAPPPPEVDPSPPSPAQPPPQ 96
A P P + A PP
Sbjct: 418 PAEPTEPSPTPPANAANAPPS 438
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 7e-07
Identities = 18/76 (23%), Positives = 28/76 (36%), Gaps = 1/76 (1%)
Query: 15 PPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPP 74
++ + P +P P+ PP S P + A PS P + PP P P
Sbjct: 363 AFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAEPT 422
Query: 75 LDAPPPPEVDPSPPSP 90
+ P P + + P
Sbjct: 423 -EPSPTPPANAANAPP 437
|
Length = 620 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 7e-07
Identities = 31/69 (44%), Positives = 36/69 (52%), Gaps = 2/69 (2%)
Query: 27 TPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPS 86
PPP P A+ P+P PP PP APP P + P P PP +APPPP VDP+
Sbjct: 42 APPPPPPSTAAAAPAPAAPPPPPPPAAPPA--PQPDDPNAAPPPPPADPNAPPPPPVDPN 99
Query: 87 PPSPAQPPP 95
P P P P
Sbjct: 100 APPPPAPEP 108
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 7e-07
Identities = 61/235 (25%), Positives = 102/235 (43%), Gaps = 39/235 (16%)
Query: 389 LGEGGFGCVYKGVLAD---------GREVAVKQ-LKIGGSQGERE----FRAEVEIISRV 434
LG G +Y G+L E +K LK+ R+ F ++ +V
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDP-SHRDISLAFFETASMMRQV 61
Query: 435 HHRHLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAY 494
H+H+V L G C+ + E ++V E+V L +H + + + KVA A ++Y
Sbjct: 62 SHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTT-PWKFKVAKQLASALSY 120
Query: 495 LHEDCHPRIIHRDIKSSNILL-----DSSFEA--RVADFGLAKIALELDSNTHVSTRVMG 547
L ED ++H ++ + NILL D +++D G I + + S R+
Sbjct: 121 L-ED--KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG---IPITVLSRQECVERI-- 172
Query: 548 TFGYMAPEYATSGK-LTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWAR 601
++APE K L+ +D +SFG L E+ + PL D++L E R
Sbjct: 173 --PWIAPECVEDSKNLSIAADKWSFGTTLWEIC-----YNGEIPLKDKTLAEKER 220
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 8e-07
Identities = 31/125 (24%), Positives = 42/125 (33%), Gaps = 11/125 (8%)
Query: 91 AQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANV 150
AQ + S P + P A P+ +++SP P+ S+P A
Sbjct: 360 AQLTQKGDDASGGRGPKQHIKPVFTQPAAAPQPSAAAAASPSPSQSSAAAQPSAPQSATQ 419
Query: 151 PATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPA 210
PA +PP V+V PP P ST V + P S
Sbjct: 420 PAG----TPPTVSVD-------PPAAVPVNPPSTAPQAVRPAQFKEEKKIPVSKVSSLGP 468
Query: 211 STLSP 215
STL P
Sbjct: 469 STLRP 473
|
Length = 614 |
| >gnl|CDD|235124 PRK03427, PRK03427, cell division protein ZipA; Provisional | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 9e-07
Identities = 35/136 (25%), Positives = 39/136 (28%), Gaps = 10/136 (7%)
Query: 46 TPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPP 105
P PQ PP A P V P + P AP P P
Sbjct: 68 VHRVNHAPANAQEHEAARPSPQHQYQPPYASAQPRQPVQQPPEAQVPPQH---APRPAQP 124
Query: 106 ANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVP 165
A P + P P P S PA P S+P PA P PV P
Sbjct: 125 APQPVQQPAYQPQPEQPLQQPVSPQVAPA---PQPVHSAPQPAQQAFQP----AEPVAAP 177
Query: 166 TPPSSSSPPPPSSNPP 181
P + P P P
Sbjct: 178 QPEPVAEPAPVMDKPK 193
|
Length = 333 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-06
Identities = 53/227 (23%), Positives = 68/227 (29%), Gaps = 63/227 (27%)
Query: 1 PPPQSSPPAVLAVPPP---------SPPLSPPPSTTPPPTSPPPA-------------SP 38
PPP+++ P A PP +P P P PPP A SP
Sbjct: 280 PPPEAAAPNGAAAPPDGVWGAALAGAPLALPAPPDPPPPAPAGDAEEEDDEDGAMEVVSP 339
Query: 39 PPSP-------------PTSTPPS-----------PPTAPPPSSPAVNSPPPQ-PSSPPP 73
P P PT TPPS P A P+ ++ P + P
Sbjct: 340 LPRPRQHYPLGFPKRRRPTWTPPSSLEDLSAGRHHPKRASLPTRKRRSARHAATPFARGP 399
Query: 74 PLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPP 133
D P P P A +PPPPA P P+ P + +PPP
Sbjct: 400 GGDDQTRPAAPVPASVPTPAPTPVPASAPPPPAT---------PLPSAEPGSDDGPAPPP 450
Query: 134 ANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNP 180
P PA PA + P PP ++
Sbjct: 451 E-------RQPPAPATEPAPDDPDDATRKALDALRERRPPEPPGADL 490
|
Length = 3151 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 1e-06
Identities = 29/140 (20%), Positives = 52/140 (37%), Gaps = 8/140 (5%)
Query: 137 RTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHP 196
R + + PA + ++++P P +++ P ++ P + P P P P
Sbjct: 384 RLGVAGGAGAPAAAAPSAAAAAPA----AAPAPAAAAPAAAAAPAPAAAPQPAPAPAPAP 439
Query: 197 SQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTPPLPSVPTEK 256
APP + PA PPP+ ++ P AP ++ +P P P+
Sbjct: 440 ---APPSPAGNAPAGGAPSPPPAAAPSAQPAPAPAAAPEPTAAPAPAPPAAPAPAAAPAA 496
Query: 257 PTAKSTNGTAVSANASPRNA 276
P A + A+ R
Sbjct: 497 PAAPAAPA-GADDAATLRER 515
|
Length = 824 |
| >gnl|CDD|217393 pfam03154, Atrophin-1, Atrophin-1 family | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-06
Identities = 47/176 (26%), Positives = 60/176 (34%), Gaps = 5/176 (2%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSP-----PPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPP 55
P P P+ L PP PLS PPS PPP P S P + PP +
Sbjct: 371 PSPFPQMPSNLPPPPALKPLSSLPTHHPPSAHPPPLQLMPQSQPLQSVPAQPPVLTQSQS 430
Query: 56 PSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSS 115
A P S PP P P+ PP + PP +
Sbjct: 431 LPPKASTHPHSGLHSGPPQSPFAQHPFTSGGLPAIGPPPSLPTSTPAAPPRASSGSQPPG 490
Query: 116 SPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSS 171
S P++ PP ++ P + P + P P S SP P V TP +S
Sbjct: 491 SALPSSGGCAGPGPPLPPIQIKEEPLDEAEEPESPPPPPRSPSPEPTVVNTPSHAS 546
|
Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1, that is thought to confer toxicity to the protein, possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders, including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein, CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity. Length = 979 |
| >gnl|CDD|185628 PTZ00449, PTZ00449, 104 kDa microneme/rhoptry antigen; Provisional | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-06
Identities = 57/272 (20%), Positives = 70/272 (25%), Gaps = 23/272 (8%)
Query: 14 PPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPP-----QP 68
PP P S P P S + P V P +P
Sbjct: 510 PPEGPEASGLPPKAPGDKEGEEGEHEDSKESDEPKEGGKPGETKEGEVGKKPGPAKEHKP 569
Query: 69 SSPPPPLDAPPPPEVDPSPPSPAQP--PPQAVAPSPPPPANVPTTPSSS----SPPPANV 122
S P P P+ P P +P P + + P P P SP
Sbjct: 570 SKIPTLSKKPEFPKDPKHPKDPEEPKKPKRPRSAQRPTRPKSPKLPELLDIPKSPKRPES 629
Query: 123 PTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPV-NVPTPPSSSSPPPPSSNPP 181
P +P PP PSS P P S PP P P
Sbjct: 630 PKSPKRPPPP-----QRPSSPERPEG--PKIIKSPKPPKSPKPPFDPKFKEKFYDDYLDA 682
Query: 182 TS----TPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSN 237
+ T + VL P T P +T P PP +P P P +
Sbjct: 683 AAKSKETKTTVVLDESFESILKETLPETPGTPFTTPRPLPPKLPRDEEFPFEPIGDPDAE 742
Query: 238 SSTRGSPSTPPLPSVPTEKPTAKSTNGTAVSA 269
TPP T T + A
Sbjct: 743 QPDDIEFFTPPEEERTFFHETPADTPLPDILA 774
|
Length = 943 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 1e-06
Identities = 16/110 (14%), Positives = 32/110 (29%), Gaps = 4/110 (3%)
Query: 28 PPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSP 87
P +P A PPP+ + P +P + + ++
Sbjct: 54 PAAAAPAAAQPPPAAAPAAVSRPAAPAAEPAPWLVEHAKRLTAQ----REQLVARAAAPA 109
Query: 88 PSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVR 137
AQ P + A ++++ P VP +++ R
Sbjct: 110 APEAQAPAAPAERAAAENAARRLARAAAAAPRPRVPADAAAAVADAVKAR 159
|
Length = 484 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 1e-06
Identities = 27/81 (33%), Positives = 32/81 (39%)
Query: 55 PPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSS 114
+S +PPP SPPPP PP P+ + P P PPP A A S
Sbjct: 515 GSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPADS 574
Query: 115 SSPPPANVPTTPSSSSPPPAN 135
S PPP TPS +
Sbjct: 575 SPPPPIPEEPTPSPTKDSSPE 595
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 1e-06
Identities = 24/81 (29%), Positives = 32/81 (39%), Gaps = 2/81 (2%)
Query: 48 PSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPAN 107
PS + ++ A +P P P+ PPP AP P + + P P SPP P
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPP--APIQPSAPKTKQAATTPSPPPAKASPPIPVP 418
Query: 108 VPTTPSSSSPPPANVPTTPSS 128
T S +PP PS
Sbjct: 419 AEPTEPSPTPPANAANAPPSL 439
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 1e-06
Identities = 23/83 (27%), Positives = 30/83 (36%)
Query: 141 SSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSA 200
S S+ A P P S PPP P P ++ PP + PP + + P +
Sbjct: 514 SGSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPAD 573
Query: 201 PPPVTKSPPASTLSPPPPSVPST 223
P P T SP S P
Sbjct: 574 SSPPPPIPEEPTPSPTKDSSPEE 596
|
Length = 620 |
| >gnl|CDD|217495 pfam03326, Herpes_TAF50, Herpesvirus transcription activation factor (transactivator) | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 1e-06
Identities = 48/226 (21%), Positives = 67/226 (29%), Gaps = 11/226 (4%)
Query: 1 PPPQSSPPAVL---AVPPPSPPLSPPPSTTPPPTSP-PPASPPPSPPTSTP-PSPPTAPP 55
P P S+ P + P+ SP T+ P +P P+S PS
Sbjct: 231 PSPSSARPQQSESFSDVWPASTQSPREETSAEPLAPASPSSRRPSTAQEEQIACSSPQAE 290
Query: 56 PSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSS 115
P + P S P AP + PP+ + + P P S
Sbjct: 291 PEQGVQSYVPQSSDSRPSCFPAPSTTQPTFLPPNTNKKAKRDRRPQMVTPKQEGGAAVSQ 350
Query: 116 SPPPANVPTT---PSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSS 172
+ V PS S P + SS + P+ P+S PP V
Sbjct: 351 NHDGGTVRAPRGRPSGSGQSPPSNSPLLSSLADTPSGAAHQPASLLPPAV---VQQQLED 407
Query: 173 PPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPP 218
P S+ P PS A + A L+P P
Sbjct: 408 ASDKQPPTPGSSLVPQPDEQELGPSVMALLDRDQGILALILAPIPG 453
|
This family includes EBV BRLF1 and similar ORF 50 proteins from other herpesviruses. Length = 500 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 54/202 (26%), Positives = 97/202 (48%), Gaps = 19/202 (9%)
Query: 389 LGEGGFGCV---YKGVLADGREVAVKQLK---IGGSQGEREFRAEVEIISRVHHRHLVSL 442
+G G G V Y +L R VA+K+L + +R +R E+ ++ V+H++++ L
Sbjct: 32 IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 443 VGYCISERERLLVYE--YVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCH 500
+ + ++ L ++ Y+ + + +L + +D + GI +LH
Sbjct: 89 LN-VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS--- 144
Query: 501 PRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSG 560
IIHRD+K SNI++ S ++ DFGLA+ A + + T + T Y APE
Sbjct: 145 AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA----GTSFMMTPYVVTRYYRAPEVILGM 200
Query: 561 KLTEKSDVYSFGVVLLELITGR 582
E D++S G ++ E+I G
Sbjct: 201 GYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 37/140 (26%), Positives = 68/140 (48%), Gaps = 15/140 (10%)
Query: 490 RGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTF 549
G+ Y+H IIHRD+K N+ ++ E ++ DFGLA+ A + + +V TR
Sbjct: 128 CGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHA-DAEMTGYVVTR----- 178
Query: 550 GYMAPEYATSG-KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEAL 608
Y APE + + D++S G ++ E++TG+ G + L + + L +
Sbjct: 179 WYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFK-----GKDYLDQLTQILKVTGV 233
Query: 609 EHEDFEALVDSRLEKNYVDS 628
+F ++ + K+Y+ S
Sbjct: 234 PGPEFVQKLEDKAAKSYIKS 253
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-06
Identities = 28/161 (17%), Positives = 47/161 (29%), Gaps = 3/161 (1%)
Query: 129 SSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPP 188
+ P A + A A P+ ++PP P ++++ ++ P +P+P
Sbjct: 372 AGPATAAAAPVAQPAPAAAAPAAAAPAPAAPPAAPAAAPAAAAAARAVAAAPARRSPAPE 431
Query: 189 VLTPPPHPSQSAPPPVTKSPPASTLSP---PPPSVPSTSSPPAVSPPAPPSNSSTRGSPS 245
L S P PA +P P+ A + AP +
Sbjct: 432 ALAAARQASARGPGGAPAPAPAPAAAPAAAARPAAAGPRPVAAAAAAAPARAAPAAAPAP 491
Query: 246 TPPLPSVPTEKPTAKSTNGTAVSANASPRNAGVLGTGGAVA 286
P E P ++ A A A A
Sbjct: 492 ADDDPPPWEELPPEFASPAPAQPDAAPAGWVAESIPDPATA 532
|
Length = 700 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 51.4 bits (124), Expect = 2e-06
Identities = 20/96 (20%), Positives = 29/96 (30%), Gaps = 3/96 (3%)
Query: 168 PSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPP 227
P++ P P PP S P+ + PP + P + P P+ P
Sbjct: 361 PAAPLPEPEV--PPQSAAPAASAQATAAPTAAVAPPQAPAVPPPP-ASAPQQAPAVPLPE 417
Query: 228 AVSPPAPPSNSSTRGSPSTPPLPSVPTEKPTAKSTN 263
S R +T S P A+ N
Sbjct: 418 TTSQLLAARQQLQRAQGATKAKKSEPAAASRARPVN 453
|
Length = 647 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 51.4 bits (124), Expect = 2e-06
Identities = 12/71 (16%), Positives = 23/71 (32%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
++ A A P P +P P+ P P + + P+ P A ++
Sbjct: 49 AAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPAAPPAAAAAAAP 108
Query: 61 VNSPPPQPSSP 71
+ +P
Sbjct: 109 AAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 51.4 bits (124), Expect = 2e-06
Identities = 18/103 (17%), Positives = 35/103 (33%), Gaps = 2/103 (1%)
Query: 140 PSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQS 199
P+S P A S ++++ P++ P P+ P PP + +
Sbjct: 22 PNSVDPSWREFFADYGPGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPA 81
Query: 200 APPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRG 242
APP + A+ P + ++ + + RG
Sbjct: 82 APPKPAAAAAAAA--APAAPPAAAAAAAPAAAAVEDEVTPLRG 122
|
Length = 1228 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 51.4 bits (124), Expect = 2e-06
Identities = 24/108 (22%), Positives = 41/108 (37%), Gaps = 12/108 (11%)
Query: 80 PPEVDPS--PPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVR 137
P VDPS P AP+ A + ++ P A P P+ + P A
Sbjct: 22 PNSVDPSWREFFADYGPGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAA--- 78
Query: 138 TTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTP 185
++ P PA A ++ + PP ++++ P ++ TP
Sbjct: 79 --APAAPPKPAAAAAAAAAPAAPP-----AAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 51.0 bits (123), Expect = 2e-06
Identities = 12/84 (14%), Positives = 25/84 (29%), Gaps = 1/84 (1%)
Query: 62 NSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPAN 121
+ A +P + A P P+ PA P P++++ A
Sbjct: 37 GPGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPA-APPKPAAAAAAAAA 95
Query: 122 VPTTPSSSSPPPANVRTTPSSSSP 145
P++++ +P
Sbjct: 96 PAAPPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 50.7 bits (122), Expect = 2e-06
Identities = 13/88 (14%), Positives = 28/88 (31%)
Query: 146 PPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVT 205
P + T ++++ + ++ P + P + P P P + +A
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPA 97
Query: 206 KSPPASTLSPPPPSVPSTSSPPAVSPPA 233
P A+ + P + P A
Sbjct: 98 APPAAAAAAAPAAAAVEDEVTPLRGAAA 125
|
Length = 1228 |
| >gnl|CDD|235124 PRK03427, PRK03427, cell division protein ZipA; Provisional | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 28/127 (22%), Positives = 38/127 (29%), Gaps = 2/127 (1%)
Query: 35 PASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPP 94
+ P+ + P+ P S P+ PP +A PP+ P P PA P
Sbjct: 70 RVNHAPANAQEHEAARPSPQHQYQPPYASAQPRQPVQQPP-EAQVPPQHAPRPAQPAPQP 128
Query: 95 PQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATP 154
Q P P P S PA P + A P ++ P P
Sbjct: 129 VQQ-PAYQPQPEQPLQQPVSPQVAPAPQPVHSAPQPAQQAFQPAEPVAAPQPEPVAEPAP 187
Query: 155 SSSSPPP 161
P
Sbjct: 188 VMDKPKR 194
|
Length = 333 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 2e-06
Identities = 18/76 (23%), Positives = 30/76 (39%)
Query: 111 TPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSS 170
S + A TP+ + PP + + A P+ P + + PP+ VP P+
Sbjct: 364 FISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAEPTE 423
Query: 171 SSPPPPSSNPPTSTPS 186
SP PP++
Sbjct: 424 PSPTPPANAANAPPSL 439
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 2e-06
Identities = 13/79 (16%), Positives = 18/79 (22%)
Query: 36 ASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPP 95
S S + P P+ +P + P P + P P
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAE 420
Query: 96 QAVAPSPPPPANVPTTPSS 114
PP PS
Sbjct: 421 PTEPSPTPPANAANAPPSL 439
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 2e-06
Identities = 21/82 (25%), Positives = 31/82 (37%)
Query: 28 PPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSP 87
P A+ + P+P P P P+ ++P PP PP P+
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAE 420
Query: 88 PSPAQPPPQAVAPSPPPPANVP 109
P+ P P A A + PP N+
Sbjct: 421 PTEPSPTPPANAANAPPSLNLE 442
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 50.7 bits (122), Expect = 2e-06
Identities = 20/80 (25%), Positives = 32/80 (40%)
Query: 100 PSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSP 159
PS + ++ P N P+ P + ++ SPPPA +
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAE 420
Query: 160 PPVNVPTPPSSSSPPPPSSN 179
P PTPP++++ PPS N
Sbjct: 421 PTEPSPTPPANAANAPPSLN 440
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 50.7 bits (122), Expect = 2e-06
Identities = 21/77 (27%), Positives = 27/77 (35%)
Query: 39 PPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAV 98
+ +P P +P+ P QPS+P A P P P +
Sbjct: 363 AFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAEPT 422
Query: 99 APSPPPPANVPTTPSSS 115
PSP PPAN P S
Sbjct: 423 EPSPTPPANAANAPPSL 439
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 50.7 bits (122), Expect = 2e-06
Identities = 20/67 (29%), Positives = 24/67 (35%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
P + PA PPP+P P T T+P P SPP P P P
Sbjct: 372 SAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAEPTEPSPTPPAN 431
Query: 61 VNSPPPQ 67
+ PP
Sbjct: 432 AANAPPS 438
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 50.7 bits (122), Expect = 2e-06
Identities = 14/69 (20%), Positives = 20/69 (28%)
Query: 2 PPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAV 61
+ P P P P P + + P+ PP P P +P
Sbjct: 371 ASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAEPTEPSPTPPA 430
Query: 62 NSPPPQPSS 70
N+ PS
Sbjct: 431 NAANAPPSL 439
|
Length = 620 |
| >gnl|CDD|236669 PRK10263, PRK10263, DNA translocase FtsK; Provisional | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-06
Identities = 37/133 (27%), Positives = 45/133 (33%), Gaps = 4/133 (3%)
Query: 8 PAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQ 67
P V V P P++P P P P P P P A Q
Sbjct: 747 PIVEPVQQPQQPVAPQQQYQQPQQPVAPQPQYQQPQQPVAPQPQYQQPQQPVAPQPQYQQ 806
Query: 68 PSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPS 127
P P P P+ +P Q P Q VAP P P + P + PTTP
Sbjct: 807 PQQPVAPQPQYQQPQQPVAPQPQYQQPQQPVAPQPQDTLLHPLLMRNGDSRPLHKPTTPL 866
Query: 128 SS----SPPPANV 136
S +PPP+ V
Sbjct: 867 PSLDLLTPPPSEV 879
|
Length = 1355 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 17/61 (27%), Positives = 21/61 (34%), Gaps = 2/61 (3%)
Query: 28 PPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSP 87
P P P+ P P P+ PA P P P+ P APP DP+
Sbjct: 385 PSAAWGAPTPAAPAAPPPAAAPPVPPAAPARPAAARPAPAPAPPAAA--APPARSADPAA 442
Query: 88 P 88
Sbjct: 443 A 443
|
Length = 576 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 25/105 (23%), Positives = 33/105 (31%), Gaps = 12/105 (11%)
Query: 41 SPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAP 100
S P T + A P+ A P S P AP P PQ A
Sbjct: 161 SVPLDTSTTTDPATTPAPAAPVDTTPTNSQTPAVATAPAPA-----------VDPQQNAV 209
Query: 101 SPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSP 145
P ANV T ++ +P P + A V T + +
Sbjct: 210 VAPSQANV-DTAATPAPAAPATPDGAAPLPTDQAGVSTPAADPNA 253
|
Length = 331 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 33/82 (40%), Positives = 37/82 (45%), Gaps = 3/82 (3%)
Query: 28 PPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSP 87
P + PA PPP P T+ P APPP P P PQP P APPPP DP+
Sbjct: 34 PATANADPAPPPPPPSTAAAAPAPAAPPPPPPPAAPPAPQPDDPNA---APPPPPADPNA 90
Query: 88 PSPAQPPPQAVAPSPPPPANVP 109
P P P A P P P +
Sbjct: 91 PPPPPVDPNAPPPPAPEPGRID 112
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|234818 PRK00708, PRK00708, sec-independent translocase; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 25/107 (23%), Positives = 39/107 (36%), Gaps = 3/107 (2%)
Query: 36 ASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQP-- 93
A+ P T P+ T P +PP P P P A + +P +PA+P
Sbjct: 99 ATSMSEPATENKPAEVTTPVEPMGLPETPPAVPVPAPAPAVAAAAAQAAAAPKAPAKPRA 158
Query: 94 -PPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTT 139
P+ A + P P T + A PT +++P +
Sbjct: 159 KSPRPAAKAAPKPTETITAKKAKKTAAAPKPTADKTATPAKKTTKKK 205
|
Length = 209 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 7/98 (7%)
Query: 489 ARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAK-IALELDSNTHVSTRVMG 547
A+G+ +L + IHRD+ + NILL + ++ DFGLA+ I + D R+
Sbjct: 189 AKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL-- 243
Query: 548 TFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKP 584
+MAPE T +SDV+SFGV+L E+ + G P
Sbjct: 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 54/199 (27%), Positives = 97/199 (48%), Gaps = 19/199 (9%)
Query: 389 LGEGGFGCV---YKGVLADGREVAVKQLK---IGGSQGEREFRAEVEIISRVHHRHLVSL 442
+G G G V Y VL R VA+K+L + +R +R E+ ++ V+H++++SL
Sbjct: 25 IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 81
Query: 443 VGYCISERERLLVYE--YVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCH 500
+ + ++ L ++ Y+ + + +L + +D + GI +LH
Sbjct: 82 LN-VFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS--- 137
Query: 501 PRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSG 560
IIHRD+K SNI++ S ++ DFGLA+ A + + T + T Y APE
Sbjct: 138 AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA----GTSFMMTPYVVTRYYRAPEVILGM 193
Query: 561 KLTEKSDVYSFGVVLLELI 579
E D++S G ++ E++
Sbjct: 194 GYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|240289 PTZ00144, PTZ00144, dihydrolipoamide succinyltransferase; Provisional | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 20/76 (26%), Positives = 26/76 (34%), Gaps = 3/76 (3%)
Query: 51 PTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPT 110
P A P++ A P P P P PA P AP+ PP PT
Sbjct: 124 PPAAAPAAAAAAKAEKTTPEKPKAAAPTPEPPAASKPTPPAAAKPPEPAPAAKPP---PT 180
Query: 111 TPSSSSPPPANVPTTP 126
+ + P VP +
Sbjct: 181 PVARADPRETRVPMSR 196
|
Length = 418 |
| >gnl|CDD|217469 pfam03276, Gag_spuma, Spumavirus gag protein | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 29/86 (33%), Positives = 36/86 (41%), Gaps = 4/86 (4%)
Query: 16 PSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPP-QPSSPPPP 74
P PPP PP S +P S+ P +P + P P QPS+PP
Sbjct: 183 PGAIQPPPP---SSLPGLPPGSSSLAPSASSTPGNRLPRVSFNPFLPGPSPAQPSAPPAS 239
Query: 75 LDAPPPPEVDPSPPSPAQPPPQAVAP 100
+ APP P V P PPPQ + P
Sbjct: 240 IPAPPIPPVIQYVAPPPVPPPQPIIP 265
|
Length = 582 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 3e-06
Identities = 27/83 (32%), Positives = 34/83 (40%)
Query: 67 QPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTP 126
Q S PPPP+ P PP+P P PQ A +PPP P ++ + A
Sbjct: 513 QSGSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPA 572
Query: 127 SSSSPPPANVRTTPSSSSPPPAN 149
SS PPP TPS +
Sbjct: 573 DSSPPPPIPEEPTPSPTKDSSPE 595
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 3e-06
Identities = 25/79 (31%), Positives = 30/79 (37%), Gaps = 1/79 (1%)
Query: 66 PQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTT 125
P + P PSP P Q AP A P+ P + + PP VP
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAE 420
Query: 126 PSSSSP-PPANVRTTPSSS 143
P+ SP PPAN P S
Sbjct: 421 PTEPSPTPPANAANAPPSL 439
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 3e-06
Identities = 20/78 (25%), Positives = 29/78 (37%)
Query: 142 SSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAP 201
S+ A+ ++ P N PP+ P P + +TPSPP P A
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAE 420
Query: 202 PPVTKSPPASTLSPPPPS 219
P P + + PPS
Sbjct: 421 PTEPSPTPPANAANAPPS 438
|
Length = 620 |
| >gnl|CDD|184918 PRK14954, PRK14954, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 3e-06
Identities = 27/84 (32%), Positives = 30/84 (35%), Gaps = 11/84 (13%)
Query: 1 PPPQSSPPA---VLAVPPPSPPLSPPP-----STTPPPTSPPPASPPPSPPTSTPPSPPT 52
P P SP P P P P P P PAS P P PP +
Sbjct: 382 PSPAGSPDVKKKAPEPDLPQPDRHPGPAKPEAPGARPAELPSPASAP--TPEQQPPVARS 439
Query: 53 APPPSSPAVNSPPPQPSSPPPPLD 76
AP P SP S P +S P +D
Sbjct: 440 APLPPSPQA-SAPRNVASGKPGVD 462
|
Length = 620 |
| >gnl|CDD|221188 pfam11725, AvrE, Pathogenicity factor | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 3e-06
Identities = 44/247 (17%), Positives = 72/247 (29%), Gaps = 14/247 (5%)
Query: 20 LSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPP 79
+T P A+P PT S + +S ++ S + P +
Sbjct: 2 QLISINTATKTAVQPEATPSAGAPTGLQQSSESPTQRASHSLASEGKKNRKKMPKVFQKS 61
Query: 80 PPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTT 139
P A P + P + PT + P + T SSP + +
Sbjct: 62 SA---PRQIQAAPPQALNPTAAAPQSSRGPTLRELLALPEDDGETQAPESSPSARRLTRS 118
Query: 140 PSSSSPPPANVPATPSSSSPPPVNVPT---PPSSSSPPPPSSNPPTSTPSPPVLTPPPHP 196
+ ++ P + SSSS PP S T S T
Sbjct: 119 EGVARHEMEDLAGRPVVKPDADRQLRQDILNKSSSSRRPPVSKEEG-TSSKMPATALASA 177
Query: 197 SQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTPPLPSVPTEK 256
+ + + A+ S S S +PPA P ++ +P P L +
Sbjct: 178 ALFKDDEIRQEVDAARSDQASQSRLSRSRG---NPPAIPPDA----APRQPMLTRSAGGR 230
Query: 257 PTAKSTN 263
+ N
Sbjct: 231 FEGEDEN 237
|
This family is secreted by gram-negative Gammaproteobacteria such as Pseudomonas syringae of tomato and the fire blight plant pathogen Erwinia amylovora, amongst others. It is an essential pathogenicity factor of approximately 198 kDa. Its injection into the host-plant is dependent upon the bacterial type III or Hrp secretion system. The family is long and carries a number of predicted functional regions, including an ERMS or endoplasmic reticulum membrane retention signal at both the C- and the N-termini, a leucine-zipper motif from residues 539-560, and a nuclear localisation signal at 1358-1361. this conserved AvrE-family of effectors is among the few that are required for full virulence of many phytopathogenic pseudomonads, erwinias and pantoeas. Length = 1771 |
| >gnl|CDD|236768 PRK10819, PRK10819, transport protein TonB; Provisional | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 36/133 (27%), Positives = 48/133 (36%), Gaps = 1/133 (0%)
Query: 5 SSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA-VNS 63
+S V+ +P P+ P+S P PPP P P P P P A V
Sbjct: 33 TSVHQVIELPAPAQPISVTMVAPADLEPPQAVQPPPEPVVEPEPEPEPIPEPPKEAPVVI 92
Query: 64 PPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVP 123
P P+P P P P P + P P + SP SS++ A+ P
Sbjct: 93 PKPEPKPKPKPKPKPKPVKKVEEQPKREVKPVEPRPASPFENTAPARPTSSTATAAASKP 152
Query: 124 TTPSSSSPPPANV 136
T SS P +
Sbjct: 153 VTSVSSGPRALSR 165
|
Length = 246 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 4e-06
Identities = 13/90 (14%), Positives = 29/90 (32%)
Query: 123 PTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPT 182
P + ++ + A S+ + PA + +PP P P + ++ P
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPA 97
Query: 183 STPSPPVLTPPPHPSQSAPPPVTKSPPAST 212
+ P+ P + + A+
Sbjct: 98 APPAAAAAAAPAAAAVEDEVTPLRGAAAAV 127
|
Length = 1228 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 4e-06
Identities = 15/81 (18%), Positives = 31/81 (38%)
Query: 112 PSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSS 171
S+++P A ++S+P A P++ +P P A + P ++
Sbjct: 39 GSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPAA 98
Query: 172 SPPPPSSNPPTSTPSPPVLTP 192
P ++ P + +TP
Sbjct: 99 PPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|235124 PRK03427, PRK03427, cell division protein ZipA; Provisional | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 4e-06
Identities = 27/97 (27%), Positives = 31/97 (31%), Gaps = 5/97 (5%)
Query: 1 PPPQSSPPAVLAVPP-PSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSP 59
P Q P A + P P P P P P P P P AP P
Sbjct: 103 QPVQQPPEAQVPPQHAPRPAQPAPQPVQQPAYQPQPEQPLQQP---VSPQVAPAPQPVHS 159
Query: 60 AVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQ 96
A P Q P P+ AP P V P +P +
Sbjct: 160 AP-QPAQQAFQPAEPVAAPQPEPVAEPAPVMDKPKRK 195
|
Length = 333 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 4e-06
Identities = 22/78 (28%), Positives = 35/78 (44%)
Query: 111 TPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSS 170
+ S+S+ P S P P P++++PPP P P+++ P+
Sbjct: 514 SGSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPAD 573
Query: 171 SSPPPPSSNPPTSTPSPP 188
SSPPPP PT +P+
Sbjct: 574 SSPPPPIPEEPTPSPTKD 591
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 4e-06
Identities = 16/74 (21%), Positives = 22/74 (29%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
P S A + P P P P P + + S PP+ + P P
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAE 420
Query: 61 VNSPPPQPSSPPPP 74
P P P +
Sbjct: 421 PTEPSPTPPANAAN 434
|
Length = 620 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 4e-06
Identities = 20/94 (21%), Positives = 35/94 (37%), Gaps = 3/94 (3%)
Query: 80 PPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTT 139
P + + P P A + P + P +++P PA P + +P ANV T
Sbjct: 163 PLDTSTTTDPATTPAPAAPVDTTPTNSQTPAV--ATAPAPAVDPQQNAVVAPSQANV-DT 219
Query: 140 PSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSP 173
++ +P P + V TP + +
Sbjct: 220 AATPAPAAPATPDGAAPLPTDQAGVSTPAADPNA 253
|
Length = 331 |
| >gnl|CDD|223041 PHA03321, PHA03321, tegument protein VP11/12; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 4e-06
Identities = 56/264 (21%), Positives = 72/264 (27%), Gaps = 33/264 (12%)
Query: 12 AVPPPSPPLSPPPSTTPPPTSPPPASPPPSP--PTSTPPSPPTAPPPSSPAVNSPPPQPS 69
+ PP P + PPP P S P + P +
Sbjct: 427 SRQPPGAPAPRRDNDPPPPPRARPGSTPACARRARAQRARDAGPEYVDPLGALRRLPAGA 486
Query: 70 SPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPT----- 124
+PPP A P P + P PP T PP A P
Sbjct: 487 APPPEPAAAPSPATYYTRMGGGPPRL------PPRNRATETLRPDWGPPAAAPPEQMEDP 540
Query: 125 --TPSSSSPPPANVRTTPSSSSPPPANVPATPS-------SSSPPPVNVPTPPSSSSPPP 175
P + ++S P A P S P +PTP +P P
Sbjct: 541 YLEPDDDRFDRRDGAAAAATSHPREAPAPDDDPIYEGVSDSEEPVYEEIPTPRVYQNPLP 600
Query: 176 PSSNPPTSTPSPPVLTPPPHPSQSAPPPVTK-------SPPASTLSPPPPSVPSTSSPPA 228
P PP L P P P+ SPP + PPP S PPA
Sbjct: 601 ---RPMEGAGEPPDLDAPTSPWVEEENPIYGWGDSPLFSPPPAARFPPPDPALS-PEPPA 656
Query: 229 VSPPAPPSNSSTRGSPSTPPLPSV 252
+ P + P+ S
Sbjct: 657 LPAHRPRPGALAPDGPANLAALSA 680
|
Length = 694 |
| >gnl|CDD|185594 PTZ00395, PTZ00395, Sec24-related protein; Provisional | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 4e-06
Identities = 32/152 (21%), Positives = 62/152 (40%), Gaps = 13/152 (8%)
Query: 106 ANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVP-ATPSSSSPPPVNV 164
+N + +S P N P+S++P ++PP +N P + P +S+PP N+
Sbjct: 410 SNAGYSNPGNSNPGYNNA--PNSNTP----------YNNPPNSNTPYSNPPNSNPPYSNL 457
Query: 165 PTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTS 224
P + S P S+ PP+S + ++A P P A+ + + +
Sbjct: 458 PYSNTPYSNAPLSNAPPSSAKDHHSAYHAAYQHRAANQPAANLPTANQPAANNFHGAAGN 517
Query: 225 SPPAVSPPAPPSNSSTRGSPSTPPLPSVPTEK 256
S P ++ G+ +T P+ ++
Sbjct: 518 SVGNPFASRPFGSAPYGGNAATTADPNGIAKR 549
|
Length = 1560 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 5e-06
Identities = 25/89 (28%), Positives = 36/89 (40%), Gaps = 5/89 (5%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
P P +PP+ P SPPP+ P P + P P + P+PP AP P++
Sbjct: 435 PAPAPAPPSPAGNAPAGGAPSPPPAAAPSAQPAPAPAAAPEPTAAPAPAPPAAPAPAAA- 493
Query: 61 VNSPPPQPSSPPPPLDAPPPPEVDPSPPS 89
P P++P P A + P
Sbjct: 494 ----PAAPAAPAAPAGADDAATLRERWPE 518
|
Length = 824 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 49.9 bits (120), Expect = 5e-06
Identities = 14/83 (16%), Positives = 31/83 (37%)
Query: 167 PPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSP 226
P S+++P ++ + +P P+ AP P + PA+ P + + +
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPA 97
Query: 227 PAVSPPAPPSNSSTRGSPSTPPL 249
+ A + ++ PL
Sbjct: 98 APPAAAAAAAPAAAAVEDEVTPL 120
|
Length = 1228 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 5e-06
Identities = 24/126 (19%), Positives = 35/126 (27%), Gaps = 5/126 (3%)
Query: 148 ANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKS 207
A+ P P P P P ++ + +PS P QSA P
Sbjct: 369 ASGGRGPKQHIKPVFTQPAAA----PQPSAAAAASPSPSQSSAAAQPSAPQSATQPAGTP 424
Query: 208 PPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTPPLPSVPTEKPTAKSTNGTAV 267
P S P V S+ P P + S T +P +
Sbjct: 425 PTVSVDPPAAVPVNPPSTAPQAVRP-AQFKEEKKIPVSKVSSLGPSTLRPIQEKAEQATG 483
Query: 268 SANASP 273
+ +P
Sbjct: 484 NIKEAP 489
|
Length = 614 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 5e-06
Identities = 20/82 (24%), Positives = 31/82 (37%)
Query: 106 ANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVP 165
+ + ++ +PPP P + +PP T +PPP AT +SS+ P
Sbjct: 513 QSGSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPA 572
Query: 166 TPPSSSSPPPPSSNPPTSTPSP 187
P + PT SP
Sbjct: 573 DSSPPPPIPEEPTPSPTKDSSP 594
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 5e-06
Identities = 19/82 (23%), Positives = 31/82 (37%), Gaps = 5/82 (6%)
Query: 103 PPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPV 162
+ + + ++P PA P+ P + P A P + P +S P PV
Sbjct: 363 AFISEIANASAPANPTPAPNPSPPPAPIQPSA-----PKTKQAATTPSPPPAKASPPIPV 417
Query: 163 NVPTPPSSSSPPPPSSNPPTST 184
S +PP ++N P S
Sbjct: 418 PAEPTEPSPTPPANAANAPPSL 439
|
Length = 620 |
| >gnl|CDD|240289 PTZ00144, PTZ00144, dihydrolipoamide succinyltransferase; Provisional | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 5e-06
Identities = 23/88 (26%), Positives = 32/88 (36%), Gaps = 10/88 (11%)
Query: 25 STTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVD 84
T P + PA+ + T P P A P+ + P P + P
Sbjct: 119 DTGGAPPAAAPAAAAAAKAEKTTPEKPKAAAPTPEPPAASKPTPPAAAKP---------- 168
Query: 85 PSPPSPAQPPPQAVAPSPPPPANVPTTP 112
P P A+PPP VA + P VP +
Sbjct: 169 PEPAPAAKPPPTPVARADPRETRVPMSR 196
|
Length = 418 |
| >gnl|CDD|184923 PRK14959, PRK14959, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 5e-06
Identities = 31/96 (32%), Positives = 39/96 (40%)
Query: 22 PPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPP 81
P P T P + P A PS P+P AP P P ++PP P S PP AP P
Sbjct: 398 PTPGTQGPQGTAPAAGMTPSSAAPATPAPSAAPSPRVPWDDAPPAPPRSGIPPRPAPRMP 457
Query: 82 EVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSP 117
E P P +P + AP + + S P
Sbjct: 458 EASPVPGAPDSVASASDAPPTLGDPSDTAEHTPSGP 493
|
Length = 624 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 5e-06
Identities = 33/108 (30%), Positives = 55/108 (50%), Gaps = 6/108 (5%)
Query: 474 PVMDWATRVKVAAGAARGIAYL-HEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIA 532
P + + V + A G+ +L ++C +HRD+ + N+L+ ++ DFGLA+
Sbjct: 234 PALSYMDLVGFSYQVANGMEFLASKNC----VHRDLAARNVLICEGKLVKICDFGLARDI 289
Query: 533 LELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT 580
+ DSN +MAPE + T SDV+SFG++L E+ T
Sbjct: 290 MR-DSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|219339 pfam07223, DUF1421, Protein of unknown function (DUF1421) | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 6e-06
Identities = 52/215 (24%), Positives = 61/215 (28%), Gaps = 28/215 (13%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSP- 59
PPQ P P PPPS PP + P + P PP P PP P
Sbjct: 102 LPPQQVQSVPQQPTPQQEPYYPPPSQPQPPPAQQPQAQQPQPPPQVPQQQQYQSPPQQPQ 161
Query: 60 -AVNSPPPQPSSPPPPLDAPP---------------PPEVDPSPPSPAQPPPQAVAPSPP 103
N PP S+P P P + PP PP Q P
Sbjct: 162 YQQNPPPQAQSAPQVSGLYPEESPYQPQSYPPNEPLPSSMAMQPPYSGAPPSQQFYGPPQ 221
Query: 104 PPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVN 163
P P P + S PP + S PP P+ + S
Sbjct: 222 PS------PYMYGGPGGRPNSGFPSGQQPPPSQGQEGYGYSGPP---PSKGNHGSVASYA 272
Query: 164 VPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQ 198
S S PS P +T P L P
Sbjct: 273 PQGSSQSYSTAYPSL--PAATVLPQALPMSSAPMS 305
|
This family represents a conserved region approximately 350 residues long within a number of plant proteins of unknown function. Length = 357 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 6e-06
Identities = 18/79 (22%), Positives = 20/79 (25%)
Query: 64 PPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVP 123
P S P P PA P A P +S P P
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAE 420
Query: 124 TTPSSSSPPPANVRTTPSS 142
T S +PP PS
Sbjct: 421 PTEPSPTPPANAANAPPSL 439
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 6e-06
Identities = 22/88 (25%), Positives = 31/88 (35%), Gaps = 4/88 (4%)
Query: 152 ATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPAS 211
+ S+S+ P S P P P + +PP PPP P+ + + +
Sbjct: 513 QSGSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPA 572
Query: 212 TLSPPPPSVPSTSSPPAVSPPAPPSNSS 239
SPPPP P SP S
Sbjct: 573 DSSPPPP----IPEEPTPSPTKDSSPEE 596
|
Length = 620 |
| >gnl|CDD|237863 PRK14949, PRK14949, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 6e-06
Identities = 28/169 (16%), Positives = 49/169 (28%), Gaps = 11/169 (6%)
Query: 21 SPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPP 80
S P +PP +PP ++ P ++P S + + P
Sbjct: 636 GKKSSADRKPKTPPSRAPP-----ASLSKPASSPDASQTSASFDLDPDFELATHQSVPEA 690
Query: 81 PEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTP 140
S A PP P PP +S++ P N S S A+ +
Sbjct: 691 ALASGS----APAPPPVPDPYDRPPWEEAPEVASANDGPNNAAEGNLSESVEDASN-SEL 745
Query: 141 SSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPV 189
+ + P + + P + +SS + S +
Sbjct: 746 QAVEQQATHQPQVQAEAQSPA-STTALTQTSSEVQDTELNLVLLSSGSI 793
|
Length = 944 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 6e-06
Identities = 22/71 (30%), Positives = 26/71 (36%), Gaps = 6/71 (8%)
Query: 36 ASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPP 95
A PPS P A PP + A PP P++P P A P P P A PP
Sbjct: 381 APAPPSAAWGAPTPAAPAAPPPAAA---PPVPPAAPARPAAARPAP---APAPPAAAAPP 434
Query: 96 QAVAPSPPPPA 106
A +
Sbjct: 435 ARSADPAAAAS 445
|
Length = 576 |
| >gnl|CDD|222997 PHA03132, PHA03132, thymidine kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 6e-06
Identities = 26/196 (13%), Positives = 40/196 (20%), Gaps = 9/196 (4%)
Query: 7 PPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPP---TAPPPSSPAVNS 63
P S + PP P P ++ PP PP +S
Sbjct: 55 YPPRETGSGGGVATSTIYTVPRPPRGPEQTLDKPDSLPASRELPPGPTPVPPGGFRGASS 114
Query: 64 PPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVP 123
P S P V +P + + ++ P S
Sbjct: 115 PRLGADSTSPRFLYQVNFPVILAPIGESNSSSEELSEEEEHS--RPPPSESLKVKNGGKV 172
Query: 124 TTPSSSSPPPANVR----TTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSN 179
S T ++ + PS ++
Sbjct: 173 YPKGFSKHKTHKRSEFSGLTKKAARKRKGSFVFKPSQLKELSGSLKNLLHLDDSAETDPA 232
Query: 180 PPTSTPSPPVLTPPPH 195
VL PP
Sbjct: 233 TRQVPVPVHVLYPPLL 248
|
Length = 580 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 6e-06
Identities = 50/185 (27%), Positives = 84/185 (45%), Gaps = 22/185 (11%)
Query: 424 FRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPNDTLHYHLHAE-GRPVMDWATRV 482
F ++S+V H HL + G C+ E ++V E+V + L L E GR + W ++
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KI 120
Query: 483 KVAAGAARGIAYLHEDCHPRIIHRDIKSSNILL-------DSSFEARVADFGLAKIALEL 535
VA A ++YL + ++H ++ + NILL +S +++D G++ AL
Sbjct: 121 TVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR 177
Query: 536 DSNTHVSTRVMGTFGYMAPEYATSG-KLTEKSDVYSFGVVLLEL-ITGRKPVDASQPLGD 593
+ ++APE G L+ +D +SFG LLE+ G P+ P
Sbjct: 178 EERVE-------RIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230
Query: 594 ESLVE 598
E E
Sbjct: 231 ERFYE 235
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|236382 PRK09111, PRK09111, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 49.1 bits (118), Expect = 6e-06
Identities = 17/72 (23%), Positives = 23/72 (31%)
Query: 36 ASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPP 95
PP P P + A +P ++P A V + + A PP
Sbjct: 389 EGPPSPGGGGGGPPGGGGAPGAPAAAAAPGAAAAAPAAGGPAAALAAVPDAAAAAAAPPA 448
Query: 96 QAVAPSPPPPAN 107
A AP P N
Sbjct: 449 PAAAPQPAVRLN 460
|
Length = 598 |
| >gnl|CDD|221745 pfam12737, Mating_C, C-terminal domain of homeodomain 1 | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 6e-06
Identities = 56/260 (21%), Positives = 75/260 (28%), Gaps = 17/260 (6%)
Query: 3 PQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPS---------PPTA 53
+ P +P P+ S P P+ PP PT T PS
Sbjct: 136 SSPAKPPEACLPSPAASTQDELSEASAAPLPTPSLSPPHTPTDTAPSGKRKRRLSDGFQL 195
Query: 54 PPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANV-PTTP 112
P P P S PQ S P PL A + + P PPP + P
Sbjct: 196 PAPKRPQ-TSSRPQTVSDPLPLHATTDWDTWFQATVSSSPSLLLTGDIPPPVSVFAPDDS 254
Query: 113 SSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPV-----NVPTP 167
+ N P P T SSS VPA SSS
Sbjct: 255 TPLDISLFNFPLIPLLPPEALDLPAPTAVSSSSSTFAVPALTSSSVDQSATPLDQGFSNF 314
Query: 168 PSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPS-VPSTSSP 226
S+ P + + P + P + S S PS +
Sbjct: 315 GSNMYSEPLNPTNDSLLYGLPSSSSLYANRTIFPAWASTSVSPLDFSTLFNQPSPSPMAS 374
Query: 227 PAVSPPAPPSNSSTRGSPST 246
++ PA P++ S PS+
Sbjct: 375 QSILAPAQPTSPSPVALPSS 394
|
Mating in fungi is controlled by the loci that determine the mating type of an individual, and only individuals with differing mating types can mate. Basidiomycete fungi have evolved a unique mating system, termed tetrapolar or bifactorial incompatibility, in which mating type is determined by two unlinked loci; compatibility at both loci is required for mating to occur. The multi-allelic tetrapolar mating system is considered to be a novel innovation that could have only evolved once, and is thus unique to the mushroom fungi. This domain is C-terminal to the homeodomain transcription factor region. Length = 418 |
| >gnl|CDD|223065 PHA03378, PHA03378, EBNA-3B; Provisional | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 7e-06
Identities = 59/260 (22%), Positives = 85/260 (32%), Gaps = 22/260 (8%)
Query: 3 PQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPP--------SPPTAP 54
P P + PP +P PP+ P P A+ + P + P +P A
Sbjct: 686 PIQWAPGTMQPPPRAPTPMRPPAAPPGRAQRPAAATGRARPPAAAPGRARPPAAAPGRAR 745
Query: 55 PPSSPAVNSPPPQ--PSSPPPPLDAPPPPEVDPSP---PSPAQPPPQAVAPSPPPPAN-V 108
PP++ + PP P PP AP P P P P+P Q P A P PPP A
Sbjct: 746 PPAAAPGRARPPAAAPGRARPPAAAPGAPTPQPPPQAPPAPQQRPRGAPTPQPPPQAGPT 805
Query: 109 PTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPP 168
+ P PT V+ S P A + +P P + +
Sbjct: 806 SMQLMPRAAPGQQGPTKQILRQLLTGGVKRGRPSLKKPAALERQAAAGPTPSPGSGTSDK 865
Query: 169 SSSSPP--PPSSNPPT------STPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSV 220
+P PP P S + T P++ P T PP
Sbjct: 866 IVQAPVFYPPVLQPIQVMRQLGSVRAAAASTVTQAPTEYTGERRGVGPMHPTDIPPSKRA 925
Query: 221 PSTSSPPAVSPPAPPSNSST 240
+ + + P S+S +
Sbjct: 926 KTDAYVESQPPHGGQSHSFS 945
|
Length = 991 |
| >gnl|CDD|185616 PTZ00436, PTZ00436, 60S ribosomal protein L19-like protein; Provisional | Back alignment and domain information |
|---|
Score = 48.4 bits (114), Expect = 7e-06
Identities = 32/132 (24%), Positives = 55/132 (41%), Gaps = 1/132 (0%)
Query: 141 SSSSPPPANVPATPSSSSPPPVNVPTPPS-SSSPPPPSSNPPTSTPSPPVLTPPPHPSQS 199
S+ + PA A P+ ++ PP P+ +++ P ++ PP +PP P +
Sbjct: 216 SAKAAAPAKAAAAPAKAAAPPAKAAAAPAKAAAAPAKAAAPPAKAAAPPAKAAAPPAKAA 275
Query: 200 APPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTPPLPSVPTEKPTA 259
APP +PPA +PP + + + A A + + P+ P P A
Sbjct: 276 APPAKAAAPPAKAAAPPAKAAAAPAKAAAAPAKAAAAPAKAAAPPAKAAAPPAKAATPPA 335
Query: 260 KSTNGTAVSANA 271
K+ A +A A
Sbjct: 336 KAAAPPAKAAAA 347
|
Length = 357 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 7e-06
Identities = 25/117 (21%), Positives = 38/117 (32%), Gaps = 11/117 (9%)
Query: 110 TTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPS 169
P P ++ P + S S P+ S+++ P
Sbjct: 368 DASGGRGPKQHIKPVFTQPAAAPQPSAAAAASPS-------PSQSSAAAQPSAPQSATQP 420
Query: 170 SSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSP 226
+ +PP S +PP + P P T P Q+ P K +S PST P
Sbjct: 421 AGTPPTVSVDPPAAVPVNPPSTAP----QAVRPAQFKEEKKIPVSKVSSLGPSTLRP 473
|
Length = 614 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 7e-06
Identities = 14/97 (14%), Positives = 22/97 (22%), Gaps = 5/97 (5%)
Query: 2 PPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPP-----PASPPPSPPTSTPPSPPTAPPP 56
P + PP A S P +P P + + AP
Sbjct: 59 PAAAQPPPAAAPAAVSRPAAPAAEPAPWLVEHAKRLTAQREQLVARAAAPAAPEAQAPAA 118
Query: 57 SSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQP 93
+ + AP P + + A
Sbjct: 119 PAERAAAENAARRLARAAAAAPRPRVPADAAAAVADA 155
|
Length = 484 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 7e-06
Identities = 20/84 (23%), Positives = 26/84 (30%), Gaps = 3/84 (3%)
Query: 62 NSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPAN 121
+ + PPP PPP P P PPPP T +SS+ P
Sbjct: 514 SGSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPP---TATQASSNAPAQI 570
Query: 122 VPTTPSSSSPPPANVRTTPSSSSP 145
+ P + SSP
Sbjct: 571 PADSSPPPPIPEEPTPSPTKDSSP 594
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 7e-06
Identities = 19/76 (25%), Positives = 29/76 (38%), Gaps = 1/76 (1%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
++ P P+P P P P + A+ P PP P P P+ P+
Sbjct: 366 SEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAEPTEPS 425
Query: 61 VNSPPPQPSSPPPPLD 76
PP ++ PP L+
Sbjct: 426 PT-PPANAANAPPSLN 440
|
Length = 620 |
| >gnl|CDD|165527 PHA03269, PHA03269, envelope glycoprotein C; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (116), Expect = 7e-06
Identities = 36/131 (27%), Positives = 51/131 (38%), Gaps = 12/131 (9%)
Query: 19 PLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPL--- 75
+ P T T P +P P S P P AP ++ S P + P P
Sbjct: 25 NIPIPELHTSAATQKPDPAPAPHQAASRAPDPAVAPTSAA----SRKPDLAQAPTPAASE 80
Query: 76 ---DAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPP 132
AP P + P PA P A AP P A T+ + + PA+ T+ +S P
Sbjct: 81 KFDPAPAPHQAASRAPDPAVAPQLAAAPK-PDAAEAFTSAAQAHEAPADAGTSAASKKPD 139
Query: 133 PA-NVRTTPSS 142
PA + + +P
Sbjct: 140 PAAHTQHSPPP 150
|
Length = 566 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 7e-06
Identities = 23/99 (23%), Positives = 37/99 (37%), Gaps = 5/99 (5%)
Query: 82 EVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPS 141
P + A P+P P V TTP++S P P + P N PS
Sbjct: 158 SGQSVPLDTSTTTDPATTPAPAAP--VDTTPTNSQTPAVATAPAP--AVDPQQNAVVAPS 213
Query: 142 SSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNP 180
++ A P++ + P P P + P+++P
Sbjct: 214 QANVDTA-ATPAPAAPATPDGAAPLPTDQAGVSTPAADP 251
|
Length = 331 |
| >gnl|CDD|220309 pfam09606, Med15, ARC105 or Med15 subunit of Mediator complex non-fungal | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 7e-06
Identities = 43/233 (18%), Positives = 51/233 (21%), Gaps = 16/233 (6%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPP-------------PSPPTSTP 47
P + P+ P P P P P P
Sbjct: 256 QGQGGMQPQQMQGGQMQVPMQQQP-PQQQPQQSQLGMLPNQMQQMPGGGQGGPGQPMGPP 314
Query: 48 PSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPAN 107
P P A P AV Q + N
Sbjct: 315 PQRPGAVPQGGQAVQQGVMSAGQQQLKQMKLRNMRGQQQTQQQQQQQGGNHPAAHQQQMN 374
Query: 108 VPTTPSS--SSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVP 165
+ N+ P SSP P T S PP
Sbjct: 375 QQVGQGGQMVALGYLNIQGNQGGLGANPMQQGQPGMMSSPSPVPQVQTNQSMPQPPQPSV 434
Query: 166 TPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPP 218
P PP S PSPP L P P P S P ++ +SP P
Sbjct: 435 PSPGGPGSQPPQSVSGGMIPSPPALMPSPSPQMSQSPASQRTIQQDMVSPGGP 487
|
The approx. 70 residue Med15 domain of the ARC-Mediator co-activator is a three-helix bundle with marked similarity to the KIX domain. The sterol regulatory element binding protein (SREBP) family of transcription activators use the ARC105 subunit to activate target genes in the regulation of cholesterol and fatty acid homeostasis. In addition, Med15 is a critical transducer of gene activation signals that control early metazoan development. Length = 768 |
| >gnl|CDD|218056 pfam04388, Hamartin, Hamartin protein | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 7e-06
Identities = 27/118 (22%), Positives = 37/118 (31%), Gaps = 4/118 (3%)
Query: 18 PPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDA 77
S P+++P PP S P + TS + + S L +
Sbjct: 277 SRSSAYPNSSPRQALPPSISLPQNTSTSGSLHSAQTSRRPNTTFDK--AASSGTKDSLWS 334
Query: 78 PP-PPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPA 134
P + P S P P T S PA +TPS+S PPP
Sbjct: 335 PSSLCGMATPPSSIGMSPLILSLSPSHLSGRAPGTTGSGKGEPA-SESTPSTSPPPPG 391
|
This family includes the hamartin protein which is thought to function as a tumour suppressor. The hamartin protein interacts with the tuberin protein pfam03542. Tuberous sclerosis complex (TSC) is an autosomal dominant disorder and is characterized by the presence of hamartomas in many organs, such as brain, skin, heart, lung, and kidney. It is caused by mutation either TSC1 or TSC2 tumour suppressor gene. TSC1 encodes a protein, hamartin, containing two coiled-coil regions, which have been shown to mediate binding to tuberin. The TSC2 gene codes for tuberin pfam03542. These two proteins function within the same pathway(s) regulating cell cycle, cell growth, adhesion, and vesicular trafficking. Length = 667 |
| >gnl|CDD|237182 PRK12727, PRK12727, flagellar biosynthesis regulator FlhF; Provisional | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 7e-06
Identities = 40/218 (18%), Positives = 66/218 (30%), Gaps = 13/218 (5%)
Query: 26 TTPPPTSPPPASPPPSP-PTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVD 84
T T A+P P+P + P +P AP S N Q + A
Sbjct: 57 TARSDTPATAAAPAPAPQAPTKPAAPVHAPLKLSANANMSQRQRVA-----SAAEDMIAA 111
Query: 85 PSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSS- 143
+ P P QA A +P A++P+ + + A V T P A +
Sbjct: 112 MALRQPVSVPRQAPAAAPVRAASIPSPAAQALAHAAAVRTAPRQEHALSAVPEQLFADFL 171
Query: 144 SPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPP 203
+ P + P VP ++ + + P
Sbjct: 172 TTAPVPRAPVQAPVVAAPAPVPAIAAALAAHAAYAQDDDEQLDDD------GFDLDDALP 225
Query: 204 VTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTR 241
P A P+ P+ + A + PAP ++ +
Sbjct: 226 QILPPAALPPIVVAPAAPAALAAVAAAAPAPQNDEELK 263
|
Length = 559 |
| >gnl|CDD|236766 PRK10811, rne, ribonuclease E; Reviewed | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 7e-06
Identities = 33/235 (14%), Positives = 51/235 (21%), Gaps = 39/235 (16%)
Query: 2 PPQSSPPAVLAVPPP---------SPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPT 52
P QS P +A P P+ P P + P
Sbjct: 820 PTQSPMPLTVACASPEMASGKVWIRYPVVRPQDVQVEEQREAEE-VQVQPVVAEVPVAAA 878
Query: 53 APPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTP 112
P S V + P + P P EV + A P
Sbjct: 879 VEPVVSAPVVEAVAEVVEEPVVVAEPQPEEVVV-VETTHPEVIAAPVTEQPQVITESDVA 937
Query: 113 SSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSS 172
+ P P ++ + V +
Sbjct: 938 VAQEVAEHAEPVVE------------------PQDETADIEEAAETAEVVVAEPEVVAQP 979
Query: 173 PPPPSSNPPTSTPSPPVLTPPPHPSQSAPP---------PVTKSPPASTLSPPPP 218
P + + + P P+Q P+T++ PA P P
Sbjct: 980 AAPVVAEVAAEVETVTAVEPEVAPAQVPEATVEHNHATAPMTRA-PAPEYVPEAP 1033
|
Length = 1068 |
| >gnl|CDD|165527 PHA03269, PHA03269, envelope glycoprotein C; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (116), Expect = 8e-06
Identities = 38/138 (27%), Positives = 50/138 (36%), Gaps = 10/138 (7%)
Query: 38 PPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQA 97
P S T P +PA P S P P A P P AQ P A
Sbjct: 23 NTNIPIPELHTSAATQKPDPAPA---PHQAASRAPDP--AVAPTSAASRKPDLAQAPTPA 77
Query: 98 VAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSS 157
A PA P +S +P PA P ++ P A T+ + + PA+ + +S
Sbjct: 78 -ASEKFDPAPAPHQAASRAPDPAVAPQLAAAPKPDAAEAFTSAAQAHEAPADAGTSAASK 136
Query: 158 SPPPVNVPTPPSSSSPPP 175
P P + SPPP
Sbjct: 137 KP----DPAAHTQHSPPP 150
|
Length = 566 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 8e-06
Identities = 19/66 (28%), Positives = 23/66 (34%)
Query: 63 SPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANV 122
P +P P A PPP P P A P A P+P P P + S PA
Sbjct: 384 PPSAAWGAPTPAAPAAPPPAAAPPVPPAAPARPAAARPAPAPAPPAAAAPPARSADPAAA 443
Query: 123 PTTPSS 128
+
Sbjct: 444 ASAGDR 449
|
Length = 576 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 9e-06
Identities = 19/126 (15%), Positives = 41/126 (32%), Gaps = 5/126 (3%)
Query: 123 PTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPT 182
P + P + +P A A + + PP P++++ + P
Sbjct: 365 PGQSGGGAGPATAAAAPVAQPAPAAAAPAAAAPAPAAPPAAPAAAPAAAAAARAVAAAPA 424
Query: 183 STPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRG 242
P + + P +P + P + P+ ++ PA + P P + ++
Sbjct: 425 RRSPAPEALAAARQASARGPGGAPAPAPA-----PAAAPAAAARPAAAGPRPVAAAAAAA 479
Query: 243 SPSTPP 248
P
Sbjct: 480 PARAAP 485
|
Length = 700 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 49.1 bits (118), Expect = 9e-06
Identities = 13/81 (16%), Positives = 29/81 (35%)
Query: 172 SPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSP 231
P ++ + + + P + P P + +P P P+ ++ A +P
Sbjct: 37 GPGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAP 96
Query: 232 PAPPSNSSTRGSPSTPPLPSV 252
APP+ ++ + V
Sbjct: 97 AAPPAAAAAAAPAAAAVEDEV 117
|
Length = 1228 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 49.1 bits (118), Expect = 9e-06
Identities = 13/77 (16%), Positives = 26/77 (33%)
Query: 181 PTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSST 240
P ST +P + SAP + + +P PP+ + ++PP + A + +
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPA 97
Query: 241 RGSPSTPPLPSVPTEKP 257
+
Sbjct: 98 APPAAAAAAAPAAAAVE 114
|
Length = 1228 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 9e-06
Identities = 24/86 (27%), Positives = 35/86 (40%), Gaps = 3/86 (3%)
Query: 14 PPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSP-PPQPSSPP 72
P +P + P TTP + P + P+P + P PS V++ P P++P
Sbjct: 172 PATTPAPAAPVDTTPTNSQTPAVATAPAP--AVDPQQNAVVAPSQANVDTAATPAPAAPA 229
Query: 73 PPLDAPPPPEVDPSPPSPAQPPPQAV 98
P A P P +PA P V
Sbjct: 230 TPDGAAPLPTDQAGVSTPAADPNALV 255
|
Length = 331 |
| >gnl|CDD|221745 pfam12737, Mating_C, C-terminal domain of homeodomain 1 | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 9e-06
Identities = 58/240 (24%), Positives = 70/240 (29%), Gaps = 18/240 (7%)
Query: 2 PPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAV 61
P QS A PSP SP S P S P P SSP+
Sbjct: 58 PRQSRRSKRAAHAYPSPERSPALS--SERLLSPSPSVLDLSPVLASPQTGKRRRSSSPSD 115
Query: 62 NSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPAN 121
+ + S P D+ PP P P A A+ P+ S PP
Sbjct: 116 DEDEAERPSKRPRSDSISSSSSPAKPPEACLPSPAASTQDELSEASAAPLPTPSLSPPHT 175
Query: 122 VPTTPSS-------SSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPP 174
T S S P +SS P P ++ SSSP
Sbjct: 176 PTDTAPSGKRKRRLSDGFQLPAPKRPQTSSRPQTVSDPLPLHATTDWDTWFQATVSSSPS 235
Query: 175 PPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPP-PPSVPSTSSPPAVSPPA 233
T PPV P S P+ S L P PP +P AVS +
Sbjct: 236 L----LLTGDIPPPVSVFAPDDS----TPLDISLFNFPLIPLLPPEALDLPAPTAVSSSS 287
|
Mating in fungi is controlled by the loci that determine the mating type of an individual, and only individuals with differing mating types can mate. Basidiomycete fungi have evolved a unique mating system, termed tetrapolar or bifactorial incompatibility, in which mating type is determined by two unlinked loci; compatibility at both loci is required for mating to occur. The multi-allelic tetrapolar mating system is considered to be a novel innovation that could have only evolved once, and is thus unique to the mushroom fungi. This domain is C-terminal to the homeodomain transcription factor region. Length = 418 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 48.7 bits (117), Expect = 1e-05
Identities = 16/87 (18%), Positives = 30/87 (34%), Gaps = 5/87 (5%)
Query: 79 PPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRT 138
P P+ + A + + P + +PP A P P + A
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAAPAAK--APAAPAPAPPAAAAPAAPPKPAAAAAA--- 92
Query: 139 TPSSSSPPPANVPATPSSSSPPPVNVP 165
+ ++PP A A P++++ P
Sbjct: 93 AAAPAAPPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 48.3 bits (116), Expect = 1e-05
Identities = 16/81 (19%), Positives = 26/81 (32%)
Query: 70 SPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSS 129
P + S P A AP+ P PA ++ P PA ++
Sbjct: 37 GPGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAP 96
Query: 130 SPPPANVRTTPSSSSPPPANV 150
+ PPA +++ V
Sbjct: 97 AAPPAAAAAAAPAAAAVEDEV 117
|
Length = 1228 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 1e-05
Identities = 18/76 (23%), Positives = 25/76 (32%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
+S PA P P P + P T +P P P ++PP P A P
Sbjct: 367 EIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAEPTEPSP 426
Query: 61 VNSPPPQPSSPPPPLD 76
+ P L+
Sbjct: 427 TPPANAANAPPSLNLE 442
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 1e-05
Identities = 21/86 (24%), Positives = 22/86 (25%)
Query: 155 SSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLS 214
S S N P PP P P P PPP P P S A
Sbjct: 511 ESQSGSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQI 570
Query: 215 PPPPSVPSTSSPPAVSPPAPPSNSST 240
P S P P S+
Sbjct: 571 PADSSPPPPIPEEPTPSPTKDSSPEE 596
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 1e-05
Identities = 22/82 (26%), Positives = 35/82 (42%), Gaps = 1/82 (1%)
Query: 5 SSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPT-APPPSSPAVNS 63
S+ + +A +P P+ +PPP P++P +TP PP A PP
Sbjct: 362 SAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAEP 421
Query: 64 PPPQPSSPPPPLDAPPPPEVDP 85
P P+ P +APP ++
Sbjct: 422 TEPSPTPPANAANAPPSLNLEE 443
|
Length = 620 |
| >gnl|CDD|237863 PRK14949, PRK14949, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 1e-05
Identities = 33/226 (14%), Positives = 50/226 (22%), Gaps = 37/226 (16%)
Query: 52 TAPPPSSPAVNSP-PPQPSSPPPPLDAPPPPEVDP-------------------SPPSPA 91
S A P S A D SP
Sbjct: 576 NVQSAQSAAEAQPSSQSLSPISAVTTAAASLADDDILDAVLAARDSLLSDLDALSPKEGD 635
Query: 92 QPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVP 151
A PP+ P S P+SS + A
Sbjct: 636 GKKSSADRKPKTPPSRAPPASLSK----------PASSPDASQTSASFDLDPDFELATHQ 685
Query: 152 ATPSSSSPPPVNVPTPPSSSSPP--PPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPP 209
+ P ++ P PP P PP P + + S +
Sbjct: 686 SVPEAALASGSA-PAPPPVPDPYDRPPWEEAPEVASANDGPNNAAEGNLSESVEDASNSE 744
Query: 210 ASTLSP---PPPSVPSTSSPPAVSPPAPPSNSSTRG-SPSTPPLPS 251
+ P V + + PA + ++S + + L S
Sbjct: 745 LQAVEQQATHQPQVQAEAQSPASTTALTQTSSEVQDTELNLVLLSS 790
|
Length = 944 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 1e-05
Identities = 18/98 (18%), Positives = 31/98 (31%), Gaps = 8/98 (8%)
Query: 150 VPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPP 209
VP S+++ P + P S P +T P P Q+A P
Sbjct: 162 VPLDTSTTTDPATTPAPAAPVDTTPTNSQTPAVATAP----APAVDPQQNAVVA----PS 213
Query: 210 ASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTP 247
+ + P+ + P + P P + + P
Sbjct: 214 QANVDTAATPAPAAPATPDGAAPLPTDQAGVSTPAADP 251
|
Length = 331 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 1e-05
Identities = 21/87 (24%), Positives = 33/87 (37%), Gaps = 2/87 (2%)
Query: 101 SPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPP 160
S P + T P+++ P A V TTP++S P P+ A V + ++
Sbjct: 161 SVPLDTSTTTDPATTPAPAAPVDTTPTNSQTPAVATAPAPAVDPQQNAVVAPSQANVDTA 220
Query: 161 --PVNVPTPPSSSSPPPPSSNPPTSTP 185
P + P P+ STP
Sbjct: 221 ATPAPAAPATPDGAAPLPTDQAGVSTP 247
|
Length = 331 |
| >gnl|CDD|236768 PRK10819, PRK10819, transport protein TonB; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 36/138 (26%), Positives = 46/138 (33%), Gaps = 11/138 (7%)
Query: 30 PTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPS 89
P P S P P PPP P +P P P+ PP P
Sbjct: 42 PAPAQPISVTMVAPADLEPPQAVQPPP------EPVVEPEPEPEPIPEPPKEAPVVIPKP 95
Query: 90 PAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPAN 149
+P P+ P P P V P V P+S A R T S++ A+
Sbjct: 96 EPKPKPK-PKPKPKPVKKVEEQP---KREVKPVEPRPASPFENTAPARPTS-STATAAAS 150
Query: 150 VPATPSSSSPPPVNVPTP 167
P T SS P ++ P
Sbjct: 151 KPVTSVSSGPRALSRNQP 168
|
Length = 246 |
| >gnl|CDD|225987 COG3456, COG3456, Predicted component of the type VI protein secretion system, contains a FHA domain [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-05
Identities = 36/137 (26%), Positives = 51/137 (37%), Gaps = 10/137 (7%)
Query: 53 APPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTP 112
P S P SP SS D E +P P P Q P P
Sbjct: 108 EPDESDPDTGSPQSAVSSTDMDDDFLADIEPEPRLPPGLTDPLQLADPVPN--------- 158
Query: 113 SSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSS-SSPPPVNVPTPPSSS 171
S+ P + + + + P PA + S +S P + PA+ +P P ++ PP ++
Sbjct: 159 GFSADPLSALQSESLIAQPDPAGGAPSISRNSEAPLSDPASAGGIDTPFPDDLDVPPIAA 218
Query: 172 SPPPPSSNPPTSTPSPP 188
SPP P P S P
Sbjct: 219 SPPGPQEGPTISASQPA 235
|
Length = 430 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 32/129 (24%), Positives = 46/129 (35%), Gaps = 40/129 (31%)
Query: 504 IHRDIKSSNILLDSSFEARVADFGLA-----------------------KIALELDSNTH 540
IHRDIK NIL+D ++ DFGL + + E
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182
Query: 541 VSTRVM-----------------GTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRK 583
+ + GT Y+APE T+ D +S GV+L E++ G+
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 242
Query: 584 PVDASQPLG 592
P A P
Sbjct: 243 PFLADTPAE 251
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|237015 PRK11901, PRK11901, hypothetical protein; Reviewed | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 29/160 (18%), Positives = 53/160 (33%), Gaps = 8/160 (5%)
Query: 86 SPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTT-----P 140
+ SP+ + N S+PP + PT + P R
Sbjct: 91 NQSSPSAANNTSDGHDASGVKNTAPPQDISAPPISPTPTQAAPPQTPNGQQRIELPGNIS 150
Query: 141 SSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSA 200
+ S V A ++ +PT P++ +P + P + + P TPP P+
Sbjct: 151 DALSQQQGQVNAASQNAQGNTSTLPTAPATVAPSKGAK-VPATAETHP--TPPQKPATKK 207
Query: 201 PPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSST 240
P + P P + + A + + P++ T
Sbjct: 208 PAVNHHKTATVAVPPATSGKPKSGAASARALSSAPASHYT 247
|
Length = 327 |
| >gnl|CDD|237015 PRK11901, PRK11901, hypothetical protein; Reviewed | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 34/174 (19%), Positives = 60/174 (34%), Gaps = 25/174 (14%)
Query: 40 PSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVA 99
S +S S P+A +S ++ + ++PP + APP + P+P A P
Sbjct: 84 SSSLSSGNQSSPSAANNTSDGHDASGVKNTAPPQDISAPP---ISPTPTQAAPPQTPNGQ 140
Query: 100 PSPPPPANVP-----------TTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPA 148
P N+ ++ + +PT P++ +P ++
Sbjct: 141 QRIELPGNISDALSQQQGQVNAASQNAQGNTSTLPTAPATVAPSKG----AKVPATAETH 196
Query: 149 NVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPP 202
P ++ P VN + + PP S P + S L SAP
Sbjct: 197 PTPPQKPATKKPAVNHHKTATVAVPPATSGKPKSGAASARAL-------SSAPA 243
|
Length = 327 |
| >gnl|CDD|222095 pfam13388, DUF4106, Protein of unknown function (DUF4106) | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 28/96 (29%), Positives = 34/96 (35%), Gaps = 3/96 (3%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
P + A PP+PP P P + P T P P P
Sbjct: 159 PAGGTYILASGTYIPPNPPREAPAPGLPKTFTSSHGHRHRHAPKPTQ-QPTVQNPAQQPT 217
Query: 61 VNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQ 96
V +P QP P P P P+P +PAQ PPQ
Sbjct: 218 VQNPAQQPQQQPQQ--QPVQPAQQPTPQNPAQQPPQ 251
|
This family of proteins are found in large numbers in the Trichomonas vaginalis proteome. The function of this protein is unknown. Length = 422 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 2e-05
Identities = 24/125 (19%), Positives = 40/125 (32%), Gaps = 2/125 (1%)
Query: 137 RTTPSSSSPPPANVPATPSSSSPPPVNVPTP--PSSSSPPPPSSNPPTSTPSPPVLTPPP 194
R S PA A P + P P P+ ++PP + P + + + P
Sbjct: 364 RPGQSGGGAGPATAAAAPVAQPAPAAAAPAAAAPAPAAPPAAPAAAPAAAAAARAVAAAP 423
Query: 195 HPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTPPLPSVPT 254
AP + + AS P P+ + A + A P+ + R +
Sbjct: 424 ARRSPAPEALAAARQASARGPGGAPAPAPAPAAAPAAAARPAAAGPRPVAAAAAAAPARA 483
Query: 255 EKPTA 259
A
Sbjct: 484 APAAA 488
|
Length = 700 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 2e-05
Identities = 8/80 (10%), Positives = 21/80 (26%)
Query: 165 PTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTS 224
T +++ ++ +P P +PP + + P+
Sbjct: 40 STAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPAAP 99
Query: 225 SPPAVSPPAPPSNSSTRGSP 244
A + + +P
Sbjct: 100 PAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 47.6 bits (114), Expect = 2e-05
Identities = 13/80 (16%), Positives = 31/80 (38%)
Query: 116 SPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPP 175
P PT ++++ A+ ++ P A PA P++++P P ++++ P
Sbjct: 37 GPGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAP 96
Query: 176 PSSNPPTSTPSPPVLTPPPH 195
+ + +P
Sbjct: 97 AAPPAAAAAAAPAAAAVEDE 116
|
Length = 1228 |
| >gnl|CDD|178748 PLN03209, PLN03209, translocon at the inner envelope of chloroplast subunit 62; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 46/175 (26%), Positives = 65/175 (37%), Gaps = 14/175 (8%)
Query: 91 AQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPP-PANVRTTPSSS------ 143
A+ P Q V P A+ P P + P P+ P PP P V P S
Sbjct: 321 AKIPSQRVPPKESDAADGP-KPVPTKPVTPEAPSPPIEEEPPQPKAVVPRPLSPYTAYED 379
Query: 144 -SPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPP 202
PP + +P PSSS +V + P S P S + P + P ++ P
Sbjct: 380 LKPPTSPIPTPPSSSPASSKSVDAVAKPAEPDVVPS--PGSASNVPEVEPAQVEAKKTRP 437
Query: 203 PVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTPPLPSVPTEKP 257
SP A PP+ PS ++P VSP ++S + P + P
Sbjct: 438 ---LSPYARYEDLKPPTSPSPTAPTGVSPSVSSTSSVPAVPDTAPATAATDAAAP 489
|
Length = 576 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 2e-05
Identities = 20/72 (27%), Positives = 30/72 (41%)
Query: 138 TTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPS 197
+ + + PPP P P+ + P P T P + PPPP + S+ +P + P
Sbjct: 518 SNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPADSSPP 577
Query: 198 QSAPPPVTKSPP 209
P T SP
Sbjct: 578 PPIPEEPTPSPT 589
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 2e-05
Identities = 21/84 (25%), Positives = 31/84 (36%), Gaps = 4/84 (4%)
Query: 97 AVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSS 156
A + PP + P + PP PT + PP P+++ P+
Sbjct: 517 ASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPP---PPPTATQASSNAPAQIPAD 573
Query: 157 SSPPPVNVPTPPSSSSPPPPSSNP 180
SSPPP +P P+ S S
Sbjct: 574 SSPPP-PIPEEPTPSPTKDSSPEE 596
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 2e-05
Identities = 16/74 (21%), Positives = 23/74 (31%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
A P P PP P++P +P + P P P+ P
Sbjct: 363 AFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAEPT 422
Query: 61 VNSPPPQPSSPPPP 74
SP P ++ P
Sbjct: 423 EPSPTPPANAANAP 436
|
Length = 620 |
| >gnl|CDD|165527 PHA03269, PHA03269, envelope glycoprotein C; Provisional | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 2e-05
Identities = 33/152 (21%), Positives = 51/152 (33%), Gaps = 21/152 (13%)
Query: 113 SSSSPPPANVPTT-----PSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTP 167
+ N+P ++ P PA +S +P PA P + +S P PTP
Sbjct: 17 LIIANLNTNIPIPELHTSAATQKPDPAPAPHQAASRAPDPAVAPTSAASRKPDLAQAPTP 76
Query: 168 PSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPP 227
+S P P PH + S P +P + P + TS+
Sbjct: 77 AASEKFDP---------------APAPHQAASRAPDPAVAPQLAAAPKPDAAEAFTSAAQ 121
Query: 228 AVSPPAPPSNSSTRGSPSTPPLPSVPTEKPTA 259
A PA + +S P + + P A
Sbjct: 122 AHEAPA-DAGTSAASKKPDPAAHTQHSPPPFA 152
|
Length = 566 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 2e-05
Identities = 18/68 (26%), Positives = 22/68 (32%), Gaps = 3/68 (4%)
Query: 30 PTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPS 89
P P A P+P P P APP A P +P P A P P+ +
Sbjct: 382 PAPPSAAWGAPTPAAPAAPPPAAAPPVPPAAPARPAAARPAPAPAPPAAAAP---PARSA 438
Query: 90 PAQPPPQA 97
A
Sbjct: 439 DPAAAASA 446
|
Length = 576 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 32/81 (39%), Positives = 39/81 (48%), Gaps = 2/81 (2%)
Query: 43 PTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSP 102
P + P PPP S A +P P PPPP APP P+ P P+ A PPP A +P
Sbjct: 34 PATANADPAPPPPPPSTAAAAPAPAAPPPPPPPAAPPAPQ--PDDPNAAPPPPPADPNAP 91
Query: 103 PPPANVPTTPSSSSPPPANVP 123
PPP P P +P P +
Sbjct: 92 PPPPVDPNAPPPPAPEPGRID 112
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|184923 PRK14959, PRK14959, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 2e-05
Identities = 40/131 (30%), Positives = 54/131 (41%), Gaps = 4/131 (3%)
Query: 30 PTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPS 89
P P S PS ++ PS A P+S + P + P P + PS +
Sbjct: 363 PRLMPVESLRPSGGGASAPSGSAAEGPASGGAATIPTPGTQGPQG--TAPAAGMTPSSAA 420
Query: 90 PAQPPPQAVAPSPPPP-ANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPA 148
PA P P A APSP P + P P S PP P P +S P A +S +PP
Sbjct: 421 PATPAPSA-APSPRVPWDDAPPAPPRSGIPPRPAPRMPEASPVPGAPDSVASASDAPPTL 479
Query: 149 NVPATPSSSSP 159
P+ + +P
Sbjct: 480 GDPSDTAEHTP 490
|
Length = 624 |
| >gnl|CDD|223066 PHA03379, PHA03379, EBNA-3A; Provisional | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-05
Identities = 45/222 (20%), Positives = 56/222 (25%), Gaps = 20/222 (9%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASP----PPSPPTSTPPSPPTAPPP 56
PP + P V + PPP P P PP
Sbjct: 418 PPVEKPRPEVPQSLETATSHGSAQVPEPPPVHDLEPGPLHDQHSMAPCPVAQLPPGPLQD 477
Query: 57 SSPAVNSPPPQPSSPPPPLDAPPP--PEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSS 114
P P P P P P V P S +Q P A AP P P P
Sbjct: 478 LEPGDQLPGVVQDGRPACAPVPAPAGPIVRPWEASLSQVPGVAFAPVMPQP-----MPVE 532
Query: 115 SSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPP 174
P P P +PP ++ +S P P PP S S
Sbjct: 533 PVPVPTVALERPVCPAPPLIAMQGPGETSGIVRV------RERWRPAPWTPNPPRSPSQM 586
Query: 175 PPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPP 216
+ PP +T+ P + P
Sbjct: 587 SVRDRLARLRAEAQPYQ---ASVEVQPPQLTQVSPQQPMEYP 625
|
Length = 935 |
| >gnl|CDD|227665 COG5373, COG5373, Predicted membrane protein [Function unknown] | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-05
Identities = 23/92 (25%), Positives = 29/92 (31%), Gaps = 4/92 (4%)
Query: 29 PPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPP 88
A+ P + +P A PA P PPP AP
Sbjct: 36 RSLVAEGAAGPVAKAAEQMAAPEAAEAAPLPAAAESIASPEVPPPVPPAPA----QEGEA 91
Query: 89 SPAQPPPQAVAPSPPPPANVPTTPSSSSPPPA 120
A+ P APS P P PS ++ P A
Sbjct: 92 PAAEQPSAVPAPSAAPAPAEPVEPSLAANPFA 123
|
Length = 931 |
| >gnl|CDD|219916 pfam08580, KAR9, Yeast cortical protein KAR9 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 2e-05
Identities = 44/236 (18%), Positives = 65/236 (27%), Gaps = 29/236 (12%)
Query: 3 PQSSPPAVLAVPPPSPPL----SPPPSTTPPPTSPPPAS---------------PPPSPP 43
P SSP + + + PP S TP S + P P
Sbjct: 397 PSSSPSSSVIMTPPDSGPGSNVSSRRVGTPGSKSDRVGAVLLRRMNIKPTLASIPDEKPS 456
Query: 44 TSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPS----PAQPPPQAVA 99
+ P SS + PPP P P + + P P Q++
Sbjct: 457 NISVFEDSETSPNSSTLLRDPPP-KKCGEESGHLPNNPFFNKLKLTLSSIPPLSPRQSII 515
Query: 100 PSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSP 159
P P + SS S + + S P P V ++ +V
Sbjct: 516 TLPTPSRP-ASRISSLSLRLGSYSGSIVSPPPYPTLVSRKGAAGLSFNRSVSDIEGERIG 574
Query: 160 PPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSP 215
+PT P P T++ P P P V + + L P
Sbjct: 575 RYNLLPT----RIPALPFKAESTTSSRRSSSLPSPTGVIGFPGSVPRFDHENLLPP 626
|
The KAR9 protein in Saccharomyces cerevisiae is a cytoskeletal protein required for karyogamy, correct positioning of the mitotic spindle and for orientation of cytoplasmic microtubules. KAR9 localises at the shmoo tip in mating cells and at the tip of the growing bud in anaphase. Length = 626 |
| >gnl|CDD|184927 PRK14963, PRK14963, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 19/77 (24%), Positives = 24/77 (31%), Gaps = 1/77 (1%)
Query: 33 PPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQ 92
P +PP P V S P++ P P+ DP P P
Sbjct: 346 PSEGVAAVAPPAPAPADLTQRLNRLEKEVRSLRSAPTAAATA-AGAPLPDFDPRPRGPPA 404
Query: 93 PPPQAVAPSPPPPANVP 109
P P A +PP A
Sbjct: 405 PEPARSAEAPPLVAPAA 421
|
Length = 504 |
| >gnl|CDD|218107 pfam04484, DUF566, Family of unknown function (DUF566) | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 32/127 (25%), Positives = 49/127 (38%), Gaps = 1/127 (0%)
Query: 109 PTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPP 168
+ S S+ A+ P + S + + T+ +SS P N PA+P SSSP +
Sbjct: 3 ASVSSGSTSGDASSPRSSSRRRLSSSFLSTS-ASSRPRRLNAPASPPSSSPARNTSSSSS 61
Query: 169 SSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPA 228
S PSS S V PS +A + + +++ S P T+S
Sbjct: 62 FGLSKQRPSSLSRGRLSSRFVSPSRGSPSAAASLNGSLATASTSGSSSPSRSRRTTSSDL 121
Query: 229 VSPPAPP 235
S P
Sbjct: 122 SSGNGPS 128
|
Family of related proteins that is plant specific. Length = 313 |
| >gnl|CDD|183756 PRK12799, motB, flagellar motor protein MotB; Reviewed | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 23/124 (18%), Positives = 40/124 (32%), Gaps = 5/124 (4%)
Query: 36 ASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPP-PPEVDPSPPSPAQPP 94
P + S+ + +A PSS A+ P P+ P + + +
Sbjct: 298 TVPVAAVTPSSAVTQSSAITPSSAAI----PSPAVIPSSVTTQSATTTQASAVALSSAGV 353
Query: 95 PQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATP 154
+ P A P + P P + T SS+ + P++S P
Sbjct: 354 LPSDVTLPGTVALPAAEPVNMQPQPMSTTETQQSSTGNITSTANGPTTSLPAAPASNIPV 413
Query: 155 SSSS 158
S +S
Sbjct: 414 SPTS 417
|
Length = 421 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 31/93 (33%), Positives = 50/93 (53%), Gaps = 6/93 (6%)
Query: 489 ARGIAYL-HEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMG 547
ARG+ +L ++C +HRD+ + N+LL ++ DFGLA+ + DSN
Sbjct: 247 ARGMEFLASKNC----VHRDLAARNVLLAQGKIVKICDFGLARDIMH-DSNYVSKGSTFL 301
Query: 548 TFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT 580
+MAPE T SDV+S+G++L E+ +
Sbjct: 302 PVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|218397 pfam05044, Prox1, Homeobox prospero-like protein (PROX1) | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 2e-05
Identities = 52/237 (21%), Positives = 69/237 (29%), Gaps = 20/237 (8%)
Query: 18 PPLSPPPSTTPPPTSPPPASPPPSPPTST--PPSPPTAPPPSSPAVNSPPPQPS---SPP 72
P + P P SP T T P S A P+P +
Sbjct: 488 PERAAPEQLFKDLMLPSQMLDRKSPRTHTVNDRGQCFGDPDISTAAMFIIPKPPDSFANV 547
Query: 73 PPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPP 132
P P P P P Q A S + TP + TP + S
Sbjct: 548 AAAALYNSPFCMPQTPQPQDAPEQTEALS------LVVTPKKKRHKVTDTRITPRTVSRI 601
Query: 133 PA-NVRTTPSSSSPPPANVPATPSSS---SPPPVNVPTPPSSSSPPPPSSNPPTSTPSPP 188
A P++ + P++ S+S PPP P P P + P S
Sbjct: 602 LALRDAVGPAAGTHHQPLHPSSLSASMGFHPPPFRHPFPL-----PLTVAIPNPSLHQSE 656
Query: 189 VLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPS 245
V P S P P SP P ++ P +S P +S S S
Sbjct: 657 VFMGYPFQSPHLGAPSGSPPGKDRDSPDLPRPTTSLHPKLLSAHHHPGSSPDGLSLS 713
|
The homeobox gene Prox1 is expressed in a subpopulation of endothelial cells that, after budding from veins, gives rise to the mammalian lymphatic system. Prox1 has been found to be an early specific marker for the developing liver and pancreas in the mammalian foregut endoderm. This family contains an atypical homeobox domain. Length = 908 |
| >gnl|CDD|215145 PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygenase NCED | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 20/74 (27%), Positives = 27/74 (36%)
Query: 23 PPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPE 82
+ T S +S S +S P S P P+ +S PS P P + P P
Sbjct: 3 SSNPTSRSQSHASSSSSSSSQSSPPSSTSPRPRRRKPSASSLLHTPSILPLPKLSSPSPP 62
Query: 83 VDPSPPSPAQPPPQ 96
PP+ PQ
Sbjct: 63 SVTLPPAATTQTPQ 76
|
Length = 590 |
| >gnl|CDD|217310 pfam02993, MCPVI, Minor capsid protein VI | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 22/107 (20%), Positives = 28/107 (26%), Gaps = 6/107 (5%)
Query: 75 LDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPA 134
L+ E P QA+ P P P P++ PP P
Sbjct: 106 LEKVLGEEEPAPQEETVADPIQALQPRPRPDVEEVLVPAAPEPPSYEETI------KPGP 159
Query: 135 NVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPP 181
P S TP + PP P PP P +
Sbjct: 160 APVEEPVDSMAIAVPAIDTPVTLELPPAPQPPPPVVPQPSTMVVHRR 206
|
This minor capsid protein may act as a link between the external capsid and the internal DNA-protein core. The C-terminal 11 residues may function as a protease cofactor leading to enzyme activation. Length = 238 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 47.2 bits (113), Expect = 3e-05
Identities = 16/81 (19%), Positives = 30/81 (37%), Gaps = 4/81 (4%)
Query: 175 PPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAP 234
P S+ PT+ + A P K+P A +PP + P+ PA + A
Sbjct: 38 PGSTAAPTAAAAAAAAAASA----PAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAA 93
Query: 235 PSNSSTRGSPSTPPLPSVPTE 255
+ ++ + + + E
Sbjct: 94 AAPAAPPAAAAAAAPAAAAVE 114
|
Length = 1228 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 47.2 bits (113), Expect = 3e-05
Identities = 13/87 (14%), Positives = 25/87 (28%), Gaps = 4/87 (4%)
Query: 171 SSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVS 230
+ + + P P+ AP +PPA P+ P + A +
Sbjct: 37 GPGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPA----AAAPAAPPKPAAAAAA 92
Query: 231 PPAPPSNSSTRGSPSTPPLPSVPTEKP 257
AP + + + + P
Sbjct: 93 AAAPAAPPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 47.2 bits (113), Expect = 3e-05
Identities = 17/85 (20%), Positives = 29/85 (34%), Gaps = 2/85 (2%)
Query: 67 QPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTP 126
P S P A + +PA P +P P P++ P A
Sbjct: 37 GPGSTAAPTAAAAAAA--AAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAA 94
Query: 127 SSSSPPPANVRTTPSSSSPPPANVP 151
+ ++PP A P++++ P
Sbjct: 95 APAAPPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|184918 PRK14954, PRK14954, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 3e-05
Identities = 24/89 (26%), Positives = 33/89 (37%), Gaps = 5/89 (5%)
Query: 146 PPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVT 205
V +P+ S P P P P +P + P P P PS ++ P
Sbjct: 376 NDGGVAPSPAGSPDVKKKAPEPD----LPQPDRHPGPAKPEAPGARPAELPSPASAPTPE 431
Query: 206 KSPPASTLSPPPPSVPSTSSPPAVSPPAP 234
+ PP S P P P S+P V+ P
Sbjct: 432 QQPP-VARSAPLPPSPQASAPRNVASGKP 459
|
Length = 620 |
| >gnl|CDD|223880 COG0810, TonB, Periplasmic protein TonB, links inner and outer membranes [Cell envelope biogenesis, outer membrane] | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 31/130 (23%), Positives = 42/130 (32%), Gaps = 12/130 (9%)
Query: 30 PTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPS 89
P+ P PP P PP +P +PP P PP P+ P P
Sbjct: 42 FLLAAKVLEAPTEEPQPEPEPPEEQPK-------PPTEPETPPEP--TPPKPKEKPKPEK 92
Query: 90 PAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPAN 149
+ P P P P V P PP T + + P R ++S+ A
Sbjct: 93 KPKKPKPKPKPKPKPKPKVKPQPKPKKPPS---KTAAKAPAAPNQPARPPSAASASGAAT 149
Query: 150 VPATPSSSSP 159
P+ S
Sbjct: 150 GPSASYLSGL 159
|
Length = 244 |
| >gnl|CDD|236768 PRK10819, PRK10819, transport protein TonB; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 28/120 (23%), Positives = 39/120 (32%), Gaps = 5/120 (4%)
Query: 51 PTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPT 110
PP + P +P P P+ PP P +P P+ P P P V
Sbjct: 57 DLEPPQAVQPPPEPVVEPEPEPEPIPEPPKEAPVVIPKPEPKPKPK-PKPKPKPVKKVEE 115
Query: 111 TPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSP-PPANVPATPSSSSPPPVNVPTPPS 169
P V P+S A R T S+++ V + S N P P+
Sbjct: 116 QPK---REVKPVEPRPASPFENTAPARPTSSTATAAASKPVTSVSSGPRALSRNQPQYPA 172
|
Length = 246 |
| >gnl|CDD|219916 pfam08580, KAR9, Yeast cortical protein KAR9 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 3e-05
Identities = 41/258 (15%), Positives = 66/258 (25%), Gaps = 16/258 (6%)
Query: 21 SPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPP 80
+ +P SP +S +PP + P N + +P D
Sbjct: 380 ISVSGSDYSNPGSSIDTPSSSPSSSVIMTPPDSGP----GSNVSSRRVGTPGSKSDRVGA 435
Query: 81 PEVD-----PSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPAN 135
+ P+ S P ++ + ++ PPP P
Sbjct: 436 VLLRRMNIKPTLASIPDEKPSNISVFEDSETSPNSSTLLRDPPPKKCGEESGHLPNNPFF 495
Query: 136 VRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPH 195
+ + SS PP + + + P P S S + + P P
Sbjct: 496 NKLKLTLSSIPPLSPRQSIITLPTP----SRPASRISSLSLRLGSYSGSIVSPPPYPTLV 551
Query: 196 PSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTPPLPSVPTE 255
+ A S S + + P P P ST S + LPS
Sbjct: 552 SRKGAAGL---SFNRSVSDIEGERIGRYNLLPTRIPALPFKAESTTSSRRSSSLPSPTGV 608
Query: 256 KPTAKSTNGTAVSANASP 273
S P
Sbjct: 609 IGFPGSVPRFDHENLLPP 626
|
The KAR9 protein in Saccharomyces cerevisiae is a cytoskeletal protein required for karyogamy, correct positioning of the mitotic spindle and for orientation of cytoplasmic microtubules. KAR9 localises at the shmoo tip in mating cells and at the tip of the growing bud in anaphase. Length = 626 |
| >gnl|CDD|223033 PHA03291, PHA03291, envelope glycoprotein I; Provisional | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 20/72 (27%), Positives = 29/72 (40%)
Query: 16 PSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPL 75
P+ P P +T P T+P P++ P T+ P T P + P+ P P
Sbjct: 205 PATPRPTPRTTASPETTPTPSTTTSPPSTTIPAPSTTIAAPQAGTTPEAEGTPAPPTPGG 264
Query: 76 DAPPPPEVDPSP 87
PP P+P
Sbjct: 265 GEAPPANATPAP 276
|
Length = 401 |
| >gnl|CDD|223079 PHA03419, PHA03419, E4 protein; Provisional | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 3e-05
Identities = 30/114 (26%), Positives = 35/114 (30%), Gaps = 5/114 (4%)
Query: 12 AVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSP 71
P PP +P PS+ PPP P P PP + T PP
Sbjct: 47 TGYPFCPPTTPHPSSQPPPCPPSPGHPPQTNDTHEKDLALQPPPGGKKKEKKKKETEKPA 106
Query: 72 PPPLDAPPPPEVDPSPPS--PAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVP 123
PE P PPP+ +PPPP SP P P
Sbjct: 107 QGGEKPDQGPEAKGEGEGHEPEDPPPE---DTPPPPGGEGEVEGGPSPGPGPGP 157
|
Length = 200 |
| >gnl|CDD|223044 PHA03325, PHA03325, nuclear-egress-membrane-like protein; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 29/155 (18%), Positives = 41/155 (26%), Gaps = 10/155 (6%)
Query: 78 PPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVR 137
P P S +A A A+ + S P P+S PPP
Sbjct: 266 SSLPTSAPKRRSRRAGAMRAAAGETADLADDDGSEHSDPEP------LPASLPPPPVRRP 319
Query: 138 T--TPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPH 195
P + P + P + SSS S ++ P +
Sbjct: 320 RVKHPEAGKEEPDGARNAEAKEPAQPATSTSSKGSSSAQNKDSG--STGPGSSLAAASSF 377
Query: 196 PSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVS 230
S P PSV S PP++
Sbjct: 378 LEDDDFGSPPLDLTTSLRHMPSPSVTSAPEPPSIP 412
|
Length = 418 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 4e-05
Identities = 16/84 (19%), Positives = 32/84 (38%)
Query: 130 SPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPV 189
P T ++++ A+ PA ++ P P PP++++P P + +
Sbjct: 37 GPGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAP 96
Query: 190 LTPPPHPSQSAPPPVTKSPPASTL 213
PP + +AP + L
Sbjct: 97 AAPPAAAAAAAPAAAAVEDEVTPL 120
|
Length = 1228 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 4e-05
Identities = 15/75 (20%), Positives = 27/75 (36%)
Query: 129 SSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPP 188
S + + + ++P PA P+ P + P +++ PPP+ P
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAE 420
Query: 189 VLTPPPHPSQSAPPP 203
P P P +A
Sbjct: 421 PTEPSPTPPANAANA 435
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 4e-05
Identities = 17/82 (20%), Positives = 25/82 (30%), Gaps = 3/82 (3%)
Query: 157 SSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPP 216
S + + ++P P + P P P P Q+A P AS P
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQP---SAPKTKQAATTPSPPPAKASPPIPV 417
Query: 217 PPSVPSTSSPPAVSPPAPPSNS 238
P S P + P +
Sbjct: 418 PAEPTEPSPTPPANAANAPPSL 439
|
Length = 620 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 4e-05
Identities = 20/87 (22%), Positives = 34/87 (39%), Gaps = 2/87 (2%)
Query: 114 SSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSP 173
S++ PA P + P N +T +++P PA P + +P NV T ++
Sbjct: 167 STTTDPATTPAPAAPVDTTPTNSQTPAVATAPAPAVDPQQNAVVAPSQANVDTA--ATPA 224
Query: 174 PPPSSNPPTSTPSPPVLTPPPHPSQSA 200
P + P + P P P+
Sbjct: 225 PAAPATPDGAAPLPTDQAGVSTPAADP 251
|
Length = 331 |
| >gnl|CDD|223880 COG0810, TonB, Periplasmic protein TonB, links inner and outer membranes [Cell envelope biogenesis, outer membrane] | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 4e-05
Identities = 29/117 (24%), Positives = 32/117 (27%), Gaps = 2/117 (1%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
P P P PP P T P T P P P P P P
Sbjct: 45 AAKVLEAPTEEPQPEPEPPEEQPKPPTEPETPPEPTPPKPKEKPKPE--KKPKKPKPKPK 102
Query: 61 VNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSP 117
P P P PP +P +P QP A S A P+ S
Sbjct: 103 PKPKPKPKVKPQPKPKKPPSKTAAKAPAAPNQPARPPSAASASGAATGPSASYLSGL 159
|
Length = 244 |
| >gnl|CDD|177464 PHA02682, PHA02682, ORF080 virion core protein; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (108), Expect = 4e-05
Identities = 38/122 (31%), Positives = 49/122 (40%), Gaps = 5/122 (4%)
Query: 30 PTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPS 89
P+ P +P P+ P P AP +PAV P P P+ PP PPP V P+P
Sbjct: 76 PSGQSPLAPSPACAAPAPACPACAPAAPAPAVTCPAPAPACPPATAPTCPPPAVCPAPAR 135
Query: 90 PAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPAN 149
PA P + PP P + P PA P + PPP + + PA
Sbjct: 136 PAPACPPSTRQCPPAPP-----LPTPKPAPAAKPIFLHNQLPPPDYPAASCPTIETAPAA 190
Query: 150 VP 151
P
Sbjct: 191 SP 192
|
Length = 280 |
| >gnl|CDD|218621 pfam05518, Totivirus_coat, Totivirus coat protein | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 4e-05
Identities = 25/124 (20%), Positives = 30/124 (24%), Gaps = 12/124 (9%)
Query: 23 PPSTTPPPTSPPPASPPPSPPTSTP-PSPPTAPPPSSPAVNSPPPQPSSPPP-------- 73
S PP P + P P P PA + P + + P
Sbjct: 631 IISGFPPVFKTALPRPDYNRGGEAGGPGVPGPVPVGMPAHTARPSRVARGDPVRPTAHHA 690
Query: 74 PLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPP 133
L AP P P PP P P A SS P P +
Sbjct: 691 ALRAPQAPRPGGPPGGGGGLPP---PPDLPAAAGPAPCGSSLIASPTAPPEPEPPGAEQA 747
Query: 134 ANVR 137
Sbjct: 748 DGAE 751
|
Length = 753 |
| >gnl|CDD|177614 PHA03377, PHA03377, EBNA-3C; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 4e-05
Identities = 56/275 (20%), Positives = 74/275 (26%), Gaps = 21/275 (7%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
PP S P+ P SPP+ PPST P + P P P ST P PA
Sbjct: 552 PPKVS--PSDRGPPKASPPVMAPPSTGPRVMATPSTGPRDMAPPSTGPRQQAKCKDGPPA 609
Query: 61 VNSPPPQPSSPPPPLDAPPPPEV---DPSPPSPAQPPPQ----------AVAPSPPPPAN 107
QP S P AP + + P P+ P +
Sbjct: 610 SGPHEKQPPSSAPRDMAPSVVRMFLRERLLEQSTGPKPKSFWEMRAGRDGSGIQQEPSSR 669
Query: 108 VPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTP 167
S+ P P+ +P+ S + + S + P + P
Sbjct: 670 RQPATQSTPPRPSWLPSVFVLPSVDAGRAQPSEESHLSSMSPTQPISHEEQPRYEDPDDP 729
Query: 168 PSSSSPPPPSSNPPTSTPSPPVLTPP----PHPSQSAPPPVTKSPPASTLSPPPPSVPST 223
S P + P P P P+P P P P P
Sbjct: 730 LDLSLHPDQAPPPSHQAPYSGHEEPQAQQAPYPGYWEPRP--PQAPYLGYQEPQAQGVQV 787
Query: 224 SSPPAVSPPAPPSNSSTRGSPSTPPLPSVPTEKPT 258
SS P + P R S P
Sbjct: 788 SSYPGYAGPWGLRAQHPRYRHSWAYWSQYPGHGHP 822
|
Length = 1000 |
| >gnl|CDD|215130 PLN02217, PLN02217, probable pectinesterase/pectinesterase inhibitor | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 4e-05
Identities = 35/127 (27%), Positives = 55/127 (43%), Gaps = 13/127 (10%)
Query: 104 PPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVN 163
P VP P + P + +TP+ S+ TT SS SP P+T SPP +
Sbjct: 551 PGKGVPYIPGLFAGNPGSTNSTPTGSAASS---NTTFSSDSPSTVVAPST----SPPAGH 603
Query: 164 VPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPST 223
+ +PP++ S +P TS P+ + +P PS S ++ P S+
Sbjct: 604 LGSPPATPSK---IVSPSTSPPASHLGSPSTTPSSPESSIKVASTETAS---PESSIKVA 657
Query: 224 SSPPAVS 230
S+ +VS
Sbjct: 658 STESSVS 664
|
Length = 670 |
| >gnl|CDD|215130 PLN02217, PLN02217, probable pectinesterase/pectinesterase inhibitor | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 4e-05
Identities = 39/128 (30%), Positives = 50/128 (39%), Gaps = 14/128 (10%)
Query: 118 PPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPS 177
P VP P + P + +TP+ S+ T SS SP V P S+SPP
Sbjct: 551 PGKGVPYIPGLFAGNPGSTNSTPTGSAASSN---TTFSSDSPSTVVAP----STSPPAGH 603
Query: 178 SNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSN 237
P +TPS V PS S P SP + SP +S SP +
Sbjct: 604 LGSPPATPSKIV-----SPSTSPPASHLGSPSTTPSSPESSI--KVASTETASPESSIKV 656
Query: 238 SSTRGSPS 245
+ST S S
Sbjct: 657 ASTESSVS 664
|
Length = 670 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 5e-05
Identities = 20/114 (17%), Positives = 32/114 (28%), Gaps = 5/114 (4%)
Query: 120 ANVPTTPSSSSPPPANVRTT-PSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSS 178
A + +S + P + P A P+ +++SP P S+P
Sbjct: 360 AQLTQKGDDASGGRGPKQHIKPVFTQPAAAPQPSAAAAASPSPSQSSAAAQPSAPQSA-- 417
Query: 179 NPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPP 232
+ P V PP PP T S ++ P
Sbjct: 418 -TQPAGTPPTVSVDPPAAVP-VNPPSTAPQAVRPAQFKEEKKIPVSKVSSLGPS 469
|
Length = 614 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 5e-05
Identities = 17/94 (18%), Positives = 25/94 (26%), Gaps = 4/94 (4%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTP--PPTSPPPASPPPSPPTSTPPSPPTAPPPSS 58
P S P A A P P T + A P P+ A
Sbjct: 70 PAAVSRPAAPAAEPAPWLVEHAKRLTAQREQLVARAAAPAAPEAQAPAAPAERAAAEN-- 127
Query: 59 PAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQ 92
A ++P P + A V + + +
Sbjct: 128 AARRLARAAAAAPRPRVPADAAAAVADAVKARIE 161
|
Length = 484 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 5e-05
Identities = 25/83 (30%), Positives = 35/83 (42%), Gaps = 3/83 (3%)
Query: 20 LSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPP 79
L P + + PA+P P+P S PP+P P + + P P + P P
Sbjct: 359 LLPSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASP---PI 415
Query: 80 PPEVDPSPPSPAQPPPQAVAPSP 102
P +P+ PSP P A AP
Sbjct: 416 PVPAEPTEPSPTPPANAANAPPS 438
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 5e-05
Identities = 15/75 (20%), Positives = 25/75 (33%)
Query: 125 TPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTST 184
S + A TP+ + PP + + P+PP + + PP +
Sbjct: 364 FISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAEPTE 423
Query: 185 PSPPVLTPPPHPSQS 199
PSP + S
Sbjct: 424 PSPTPPANAANAPPS 438
|
Length = 620 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 5e-05
Identities = 20/103 (19%), Positives = 34/103 (33%), Gaps = 4/103 (3%)
Query: 164 VPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPST 223
VP S+++ P + P + TP + + + + PS +
Sbjct: 162 VPLDTSTTTDPATTPAPAAPVDT----TPTNSQTPAVATAPAPAVDPQQNAVVAPSQANV 217
Query: 224 SSPPAVSPPAPPSNSSTRGSPSTPPLPSVPTEKPTAKSTNGTA 266
+ +P AP + P+ S P P A N TA
Sbjct: 218 DTAATPAPAAPATPDGAAPLPTDQAGVSTPAADPNALVMNFTA 260
|
Length = 331 |
| >gnl|CDD|236382 PRK09111, PRK09111, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 46.4 bits (111), Expect = 5e-05
Identities = 12/68 (17%), Positives = 18/68 (26%)
Query: 28 PPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSP 87
PP PP P+ AP ++ A + P + P A
Sbjct: 391 PPSPGGGGGGPPGGGGAPGAPAAAAAPGAAAAAPAAGGPAAALAAVPDAAAAAAAPPAPA 450
Query: 88 PSPAQPPP 95
+P
Sbjct: 451 AAPQPAVR 458
|
Length = 598 |
| >gnl|CDD|236382 PRK09111, PRK09111, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 46.0 bits (110), Expect = 5e-05
Identities = 15/73 (20%), Positives = 21/73 (28%), Gaps = 2/73 (2%)
Query: 14 PPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPP 73
PP P P + +P + P + AV ++PP
Sbjct: 391 PPSPGGGGGGPPGGGGA--PGAPAAAAAPGAAAAAPAAGGPAAALAAVPDAAAAAAAPPA 448
Query: 74 PLDAPPPPEVDPS 86
P AP P S
Sbjct: 449 PAAAPQPAVRLNS 461
|
Length = 598 |
| >gnl|CDD|221745 pfam12737, Mating_C, C-terminal domain of homeodomain 1 | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 5e-05
Identities = 54/235 (22%), Positives = 72/235 (30%), Gaps = 10/235 (4%)
Query: 1 PPPQSSPPAVLAVP--PPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSS 58
P P+ SP P L P P T S PS P+ P S
Sbjct: 72 PSPERSPALSSERLLSPSPSVLDLSPVLASPQTGKRRRSSSPS-DDEDEAERPSKRPRSD 130
Query: 59 PAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTP----SS 114
+S P P L +P D + A P P P P + +
Sbjct: 131 SISSSSSP-AKPPEACLPSPAASTQDELSEASAAPLPTPSLSPPHTPTDTAPSGKRKRRL 189
Query: 115 SSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPAN-VPATPSSSSPPPVNVPTPPSSSSP 173
S P P +SS P P ++ AT SSS + PP S
Sbjct: 190 SDGFQLPAPKRPQTSSRPQTVSDPLPLHATTDWDTWFQATVSSSPSLLLTGDIPPPVSVF 249
Query: 174 PPPSSNPPT-STPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPP 227
P S P S + P++ P + P P S +ST + P + S
Sbjct: 250 APDDSTPLDISLFNFPLIPLLPPEALDLPAPTAVSSSSSTFAVPALTSSSVDQSA 304
|
Mating in fungi is controlled by the loci that determine the mating type of an individual, and only individuals with differing mating types can mate. Basidiomycete fungi have evolved a unique mating system, termed tetrapolar or bifactorial incompatibility, in which mating type is determined by two unlinked loci; compatibility at both loci is required for mating to occur. The multi-allelic tetrapolar mating system is considered to be a novel innovation that could have only evolved once, and is thus unique to the mushroom fungi. This domain is C-terminal to the homeodomain transcription factor region. Length = 418 |
| >gnl|CDD|237015 PRK11901, PRK11901, hypothetical protein; Reviewed | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 5e-05
Identities = 29/164 (17%), Positives = 47/164 (28%), Gaps = 9/164 (5%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTST------PPSPPTAP 54
P ++ + +PP + PP SP P P + P + A
Sbjct: 94 SPSAANNTSDGHDASGVKNTAPPQDISAPPISPTPTQAAPPQTPNGQQRIELPGNISDAL 153
Query: 55 PPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSS 114
VN+ L P P P P+
Sbjct: 154 SQQQGQVNAASQNAQGNTSTLPTAPATVAPSKGAKVPATAETHPTPPQKPAT---KKPAV 210
Query: 115 SSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSS 158
+ A V P++S P + + + SS P ++ SS+S
Sbjct: 211 NHHKTATVAVPPATSGKPKSGAASARALSSAPASHYTLQLSSAS 254
|
Length = 327 |
| >gnl|CDD|222095 pfam13388, DUF4106, Protein of unknown function (DUF4106) | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 5e-05
Identities = 25/82 (30%), Positives = 33/82 (40%), Gaps = 5/82 (6%)
Query: 39 PPSPPTSTP-PSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQA 97
PP+PP P P P S + P+P+ P P P+ +PAQ P Q
Sbjct: 173 PPNPPREAPAPGLPKTFTSSHGHRHRHAPKPTQQP----TVQNPAQQPTVQNPAQQPQQQ 228
Query: 98 VAPSPPPPANVPTTPSSSSPPP 119
P PA PT + + PP
Sbjct: 229 PQQQPVQPAQQPTPQNPAQQPP 250
|
This family of proteins are found in large numbers in the Trichomonas vaginalis proteome. The function of this protein is unknown. Length = 422 |
| >gnl|CDD|217453 pfam03251, Tymo_45kd_70kd, Tymovirus 45/70Kd protein | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 5e-05
Identities = 55/243 (22%), Positives = 71/243 (29%), Gaps = 20/243 (8%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
P P P +L P P P + PS P S P+SP P + P A
Sbjct: 231 PQPVRHSPGILG-PSPLHPHTTRPSPPRPAFSRSPSSPLSPLPRPSTRRGLLPNPRLPRA 289
Query: 61 VNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPA 120
P P+S PP P + P + P P P +S
Sbjct: 290 SRGHLPPPTSSAPP-----------RPNGGLRRPLHLHSSRPNSPNLRPRRIRKNSLQQT 338
Query: 121 NVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSS---SPPPVNVPTPPSSSSPPPPS 177
S S N+R+ P + P P+ P SP P
Sbjct: 339 RARLGHSKSLGQSPNLRS-SQLPPPTKRRLRLLPVPPPKVQALPLTALAPLVRHSPSIPL 397
Query: 178 SNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSN 237
+PP++ PS + H P SP P T P PPA P
Sbjct: 398 PHPPSALPSHVGASSSKHHRLPPSVL----PGPRLSSPSPSPSLPTRRPGTPPPPASPPT 453
Query: 238 SST 240
S
Sbjct: 454 PSP 456
|
Tymoviruses are single stranded RNA viruses. This family includes a protein of unknown function that has been named based on its molecular weight. Tymoviruses such as the ononis yellow mosaic tymovirus encode only three proteins. Of these two are overlapping this protein overlaps a larger ORF that is thought to be the polymerase. Length = 458 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-05
Identities = 57/245 (23%), Positives = 96/245 (39%), Gaps = 43/245 (17%)
Query: 383 FSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGERE----FRAEVEIISRVHHRH 438
F + V+G G FG V D V ++ E+E RAE +I+
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 439 LVSLVGYCISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHE 497
+V + Y ++ L L+ E++P + L + + + T+ +A I +H+
Sbjct: 63 VVKMF-YSFQDKLNLYLIMEFLPGGDM-MTLLMKKDTLTEEETQFYIAE-TVLAIDSIHQ 119
Query: 498 DCHPRIIHRDIKSSNILLDSSFEARVADFGLA-------------KIALELDSN------ 538
IHRDIK N+LLDS +++DFGL + L S+
Sbjct: 120 ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNM 176
Query: 539 -------------THVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPV 585
++ +GT Y+APE + D +S GV++ E++ G P
Sbjct: 177 NSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236
Query: 586 DASQP 590
+ P
Sbjct: 237 CSETP 241
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|222010 pfam13254, DUF4045, Domain of unknown function (DUF4045) | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 5e-05
Identities = 55/247 (22%), Positives = 78/247 (31%), Gaps = 21/247 (8%)
Query: 2 PPQSSPPAVLAVPP-PSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
PP++ P P PS P S S + P+ PPSP S P P +
Sbjct: 96 PPEARPDEGFVRPSLPSHPRSRSASVSNSKDGDRPSDLPPSP--SKTMDPRRWSPTKATW 153
Query: 61 VNSPPPQPSSPPPPLDAPPPPE--------------VDPSPPSPAQPPPQAVAPSPPPPA 106
+ S +P SP P PE VD + + PPP
Sbjct: 154 LESALNKPESPKHKPQPPQQPEWKKDLSRLRQSRASVDLGRTNSFKEVTPVGLMRTPPPG 213
Query: 107 NVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPT 166
+ +PS S P ++P++ S P + SS ++ P P + P
Sbjct: 214 SHSKSPSKSGIP--DLPSSRDSEKTKPEKPQQETSSMDTEKSSAP-KPRETLDPKSPEKA 270
Query: 167 PPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSP 226
PP ++ S + S PS +P P P SP S
Sbjct: 271 PPIDTTEEELKSPEASPKESEEASARKRSPSLLSPSP-KAESPKPLASPGKSPRDPLSPR 329
Query: 227 PAVSPPA 233
P P
Sbjct: 330 PKPQSPP 336
|
This presumed domain is functionally uncharacterized. This domain family is found in bacteria and eukaryotes, and is typically between 384 and 430 amino acids in length. Length = 414 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 6e-05
Identities = 47/206 (22%), Positives = 64/206 (31%), Gaps = 10/206 (4%)
Query: 75 LDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPA 134
+ AP PP V A + PPPP P+ ++ PP V + + P A
Sbjct: 252 IAAPAPPPVVGEGADRAPETARGATGPPPPPE--AAAPNGAAAPPDGVWGAALAGA-PLA 308
Query: 135 NVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPP--PSSNPPTSTPSPPV--L 190
P + V P P P P PT TP + L
Sbjct: 309 LPAPPDPPPPAPAGDAEEEDDEDGAMEVVSPLPRPRQHYPLGFPKRRRPTWTPPSSLEDL 368
Query: 191 TPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAP---PSNSSTRGSPSTP 247
+ H + A P K A + P P + P P P+ + T S P
Sbjct: 369 SAGRHHPKRASLPTRKRRSARHAATPFARGPGGDDQTRPAAPVPASVPTPAPTPVPASAP 428
Query: 248 PLPSVPTEKPTAKSTNGTAVSANASP 273
P P+ P S +G A P
Sbjct: 429 PPPATPLPSAEPGSDDGPAPPPERQP 454
|
Length = 3151 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 6e-05
Identities = 21/81 (25%), Positives = 30/81 (37%), Gaps = 4/81 (4%)
Query: 177 SSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPS 236
S T+ PP PP P+ + P P P +T PP P P ++ A S
Sbjct: 515 GSASNTAKTPPPPQKSPPPPAPTPPLP----QPTATAPPPTPPPPPPTATQASSNAPAQI 570
Query: 237 NSSTRGSPSTPPLPSVPTEKP 257
+ + P P P+ K
Sbjct: 571 PADSSPPPPIPEEPTPSPTKD 591
|
Length = 620 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 6e-05
Identities = 15/55 (27%), Positives = 24/55 (43%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPP 55
P ++PP A P P + P + P P PPA+ P ++ P + +A
Sbjct: 394 PAAPAAPPPAAAPPVPPAAPARPAAARPAPAPAPPAAAAPPARSADPAAAASAGD 448
|
Length = 576 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 6e-05
Identities = 18/70 (25%), Positives = 29/70 (41%), Gaps = 4/70 (5%)
Query: 77 APPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANV 136
APP P+ PP A AP PP ++ PA P P++++PP +
Sbjct: 383 APPSAAWGAPTPAAPAAPPPAAAPPVPP----AAPARPAAARPAPAPAPPAAAAPPARSA 438
Query: 137 RTTPSSSSPP 146
++S+
Sbjct: 439 DPAAAASAGD 448
|
Length = 576 |
| >gnl|CDD|236940 PRK11633, PRK11633, cell division protein DedD; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 6e-05
Identities = 21/82 (25%), Positives = 26/82 (31%), Gaps = 6/82 (7%)
Query: 2 PPQSSPPAVLAVPPPSPPLSPPPSTTPPPT---SPPPASPPPSPPTSTPPSPPTAPPPSS 58
PP+ + AV A +P L P P P P PP P P P
Sbjct: 67 PPEGAAEAVRAGDAAAPSLDPATVAPPNTPVEPEPAPVEPPKPKPVEKPKPKPKPQQKVE 126
Query: 59 PAVNSPPPQPSSPPPPLDAPPP 80
P P+P P + P
Sbjct: 127 AP---PAPKPEPKPVVEEKAAP 145
|
Length = 226 |
| >gnl|CDD|222997 PHA03132, PHA03132, thymidine kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 6e-05
Identities = 28/143 (19%), Positives = 36/143 (25%), Gaps = 10/143 (6%)
Query: 76 DAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPAN 135
D PP S + P PP T PA+ P + PP
Sbjct: 52 DDLYPP---RETGSGGGVATSTIYTVPRPPRGPEQTLDKPDSLPASRELPPGPTPVPPGG 108
Query: 136 VRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPH 195
R S + P + P + P S+SS S S PPP
Sbjct: 109 FRGASSPRLGADSTSPRFLYQVNFPVILAPIGESNSSSEELSEEEEHS-------RPPPS 161
Query: 196 PSQSAPPPVTKSPPASTLSPPPP 218
S P +
Sbjct: 162 ESLKVKNGGKVYPKGFSKHKTHK 184
|
Length = 580 |
| >gnl|CDD|223061 PHA03369, PHA03369, capsid maturational protease; Provisional | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 6e-05
Identities = 24/114 (21%), Positives = 34/114 (29%), Gaps = 7/114 (6%)
Query: 20 LSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPP 79
L+ P + P + P P +V P P + PP+
Sbjct: 353 LTAPSRVLAAAAKVAVIAAPQTHTGPADRQRPQRPDGIPYSV--PARSPMTAYPPVPQFC 410
Query: 80 PPEVDPSPPSPAQP----PPQAVAPSPPPPANVPTTPSS-SSPPPANVPTTPSS 128
SP +P P P+ V P PP P N P S ++ P
Sbjct: 411 GDPGLVSPYNPQSPGTSYGPEPVGPVPPQPTNPYVMPISMANMVYPGHPQEHGH 464
|
Length = 663 |
| >gnl|CDD|183756 PRK12799, motB, flagellar motor protein MotB; Reviewed | Back alignment and domain information |
|---|
Score = 45.9 bits (108), Expect = 6e-05
Identities = 32/134 (23%), Positives = 48/134 (35%), Gaps = 11/134 (8%)
Query: 45 STPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPP 104
+ P A PSS S PSS A P P V PS + +
Sbjct: 295 THGTVPVAAVTPSSAVTQSSAITPSSA-----AIPSPAVIPSSVTTQSATTTQASAVALS 349
Query: 105 PANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNV 164
A V + + A P + P P + T SS+ S+++ P ++
Sbjct: 350 SAGVLPSDVTLPGTVALPAAEPVNMQPQPMSTTETQQSST------GNITSTANGPTTSL 403
Query: 165 PTPPSSSSPPPPSS 178
P P+S+ P P+S
Sbjct: 404 PAAPASNIPVSPTS 417
|
Length = 421 |
| >gnl|CDD|223033 PHA03291, PHA03291, envelope glycoprotein I; Provisional | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 6e-05
Identities = 28/90 (31%), Positives = 37/90 (41%), Gaps = 6/90 (6%)
Query: 15 PPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPP 74
P S P P P T P SP T+ PS T+PP ++ P P + P
Sbjct: 191 PLSAPRLGPADVFVPATPRPTPRTTASPETTPTPSTTTSPPSTTI----PAPSTTIAAPQ 246
Query: 75 LDAPPPPEVDPSPPSPA--QPPPQAVAPSP 102
P E P+PP+P + PP P+P
Sbjct: 247 AGTTPEAEGTPAPPTPGGGEAPPANATPAP 276
|
Length = 401 |
| >gnl|CDD|197891 smart00818, Amelogenin, Amelogenins, cell adhesion proteins, play a role in the biomineralisation of teeth | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 6e-05
Identities = 32/111 (28%), Positives = 38/111 (34%), Gaps = 2/111 (1%)
Query: 8 PAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQ 67
P + P P P P P T T P P P+ P Q
Sbjct: 47 PPTHTLQPHHHIPVLPAQQPVVPQQPLMPVPGQHSMTPTQHHQPNLPQPAQQPFQPQPLQ 106
Query: 68 PSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPP 118
P P P+ P P V P PP P QPP + P P P +P P + P
Sbjct: 107 PPQPQQPM--QPQPPVHPIPPLPPQPPLPPMFPMQPLPPLLPDLPLEAWPA 155
|
They seem to regulate formation of crystallites during the secretory stage of tooth enamel development and are thought to play a major role in the structural organisation and mineralisation of developing enamel. The extracellular matrix of the developing enamel comprises two major classes of protein: the hydrophobic amelogenins and the acidic enamelins. Circular dichroism studies of porcine amelogenin have shown that the protein consists of 3 discrete folding units: the N-terminal region appears to contain beta-strand structures, while the C-terminal region displays characteristics of a random coil conformation. Subsequent studies on the bovine protein have indicated the amelogenin structure to contain a repetitive beta-turn segment and a "beta-spiral" between Gln112 and Leu138, which sequester a (Pro, Leu, Gln) rich region. The beta-spiral offers a probable site for interactions with Ca2+ ions. Muatations in the human amelogenin gene (AMGX) cause X-linked hypoplastic amelogenesis imperfecta, a disease characterised by defective enamel. A 9bp deletion in exon 2 of AMGX results in the loss of codons for Ile5, Leu6, Phe7 and Ala8, and replacement by a new threonine codon, disrupting the 16-residue (Met1-Ala16) amelogenin signal peptide. Length = 165 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 7e-05
Identities = 24/86 (27%), Positives = 32/86 (37%)
Query: 176 PSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPP 235
S++ TP PP +PPP P T + P T PPPP+ SS PA
Sbjct: 515 GSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPADS 574
Query: 236 SNSSTRGSPSTPPLPSVPTEKPTAKS 261
S TP + + K+
Sbjct: 575 SPPPPIPEEPTPSPTKDSSPEEIDKA 600
|
Length = 620 |
| >gnl|CDD|184918 PRK14954, PRK14954, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 7e-05
Identities = 28/132 (21%), Positives = 34/132 (25%), Gaps = 40/132 (30%)
Query: 43 PTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPP---PEVDPSPPSPAQPPPQAVA 99
P +P AP P PQP P P P P PSP S P P+
Sbjct: 384 PAGSPDVKKKAPEP-------DLPQPDRHPGPAKPEAPGARPAELPSPASA--PTPEQQP 434
Query: 100 PSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPS------------SSSPPP 147
P +P +P +S P P +
Sbjct: 435 PVARSAP---------------LPPSPQ-ASAPRNVASGKPGVDLGSWQGKFMNFTRNGS 478
Query: 148 ANVPATPSSSSP 159
P SSS
Sbjct: 479 RKQPVQASSSDA 490
|
Length = 620 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 7e-05
Identities = 23/99 (23%), Positives = 35/99 (35%), Gaps = 9/99 (9%)
Query: 62 NSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPA--NVPTTPSSSSPPP 119
S P S+ P P P + P+ +Q P A AP+P N PS ++
Sbjct: 160 QSVPLDTSTTTDPATTPAPAAPVDTTPTNSQTPAVATAPAPAVDPQQNAVVAPSQANVDT 219
Query: 120 ANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSS 158
A P P A ++ P +TP++
Sbjct: 220 AATPA-------PAAPATPDGAAPLPTDQAGVSTPAADP 251
|
Length = 331 |
| >gnl|CDD|184923 PRK14959, PRK14959, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 7e-05
Identities = 29/91 (31%), Positives = 38/91 (41%), Gaps = 5/91 (5%)
Query: 3 PQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVN 62
PQ + PA P + P +P PS P P P +PP P + PP P P +SP
Sbjct: 405 PQGTAPAAGMTPSSAAPATPAPSAAPSPRVPWDDAPPAPPRSGIPPRPAPRMPEASPVPG 464
Query: 63 SPPPQPSSPPPPLDAPPPPEVDPSPPSPAQP 93
+P S+ PP DPS + P
Sbjct: 465 APDSVASAS-----DAPPTLGDPSDTAEHTP 490
|
Length = 624 |
| >gnl|CDD|114270 pfam05539, Pneumo_att_G, Pneumovirinae attachment membrane glycoprotein G | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 7e-05
Identities = 42/157 (26%), Positives = 60/157 (38%), Gaps = 10/157 (6%)
Query: 104 PPANVPTTPSSSSPPPANVPTTPSS----SSPPPANVRTTPS---SSSPPPANVPATPSS 156
P V T+ ++S P + PT PS S P +T + SS P T +S
Sbjct: 168 PKTAVTTSKTTSWPTEVSHPTYPSQVTPQSQPATQGHQTATANQRLSSTEPVGTQGTTTS 227
Query: 157 SSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPP 216
S+P P PP S P S P ST S T + T ++ SP
Sbjct: 228 SNPEPQT--EPPPSQRGPSGSPQHPPSTTSQDQSTTGDG-QEHTQRRKTPPATSNRRSPH 284
Query: 217 PPSVPSTSSPPAVSPPAPPSNSSTRGSPSTPPLPSVP 253
+ P ++ + P ++T S S+PP S P
Sbjct: 285 STATPPPTTKRQETGRPTPRPTATTQSGSSPPHSSPP 321
|
Length = 408 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 8e-05
Identities = 22/91 (24%), Positives = 37/91 (40%), Gaps = 3/91 (3%)
Query: 129 SSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPS---SSSPPPPSSNPPTSTP 185
S P + T P+++ P A V TP++S P V P+ + S T
Sbjct: 161 SVPLDTSTTTDPATTPAPAAPVDTTPTNSQTPAVATAPAPAVDPQQNAVVAPSQANVDTA 220
Query: 186 SPPVLTPPPHPSQSAPPPVTKSPPASTLSPP 216
+ P P P +AP P ++ ++ + P
Sbjct: 221 ATPAPAAPATPDGAAPLPTDQAGVSTPAADP 251
|
Length = 331 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 8e-05
Identities = 19/90 (21%), Positives = 33/90 (36%), Gaps = 4/90 (4%)
Query: 149 NVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSP 208
++ +P TP +S +P ++ P P + P SQ+
Sbjct: 168 TTTDPATTPAPAAPVDTTPTNSQTPAVATAPAPAVDPQQNAVVAP---SQANVDTAATPA 224
Query: 209 PASTLSPPPPSVPSTSSPPAVSPPAPPSNS 238
PA+ + P + P + VS PA N+
Sbjct: 225 PAAP-ATPDGAAPLPTDQAGVSTPAADPNA 253
|
Length = 331 |
| >gnl|CDD|227665 COG5373, COG5373, Predicted membrane protein [Function unknown] | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 8e-05
Identities = 26/85 (30%), Positives = 32/85 (37%), Gaps = 10/85 (11%)
Query: 18 PPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPP-----QPSSPP 72
P++ +P A P P + + P PPP PA QPS+ P
Sbjct: 45 GPVAKAAEQ---MAAPEAAEAAPLPAAAESIASPEVPPPVPPAPAQEGEAPAAEQPSAVP 101
Query: 73 PPLDAPPPPEVDPSPPSPAQPPPQA 97
P AP P E P PS A P A
Sbjct: 102 APSAAPAPAE--PVEPSLAANPFAA 124
|
Length = 931 |
| >gnl|CDD|227665 COG5373, COG5373, Predicted membrane protein [Function unknown] | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 8e-05
Identities = 18/69 (26%), Positives = 25/69 (36%), Gaps = 5/69 (7%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTT--PPPTSPPPASPPPSPPT---STPPSPPTAPP 55
+ A P P + ++ PPP P PA +P S P+P AP
Sbjct: 49 KAAEQMAAPEAAEAAPLPAAAESIASPEVPPPVPPAPAQEGEAPAAEQPSAVPAPSAAPA 108
Query: 56 PSSPAVNSP 64
P+ P S
Sbjct: 109 PAEPVEPSL 117
|
Length = 931 |
| >gnl|CDD|223044 PHA03325, PHA03325, nuclear-egress-membrane-like protein; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 8e-05
Identities = 33/167 (19%), Positives = 46/167 (27%), Gaps = 22/167 (13%)
Query: 31 TSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPP--------PQPSSPPPPLDAPPPPE 82
+ S PTS P A P P PPPP
Sbjct: 257 LTSSAFMLNSSLPTSAPKRRSRRAGAMRAAAGETADLADDDGSEHSDPEPLPASLPPPPV 316
Query: 83 VDPS---PPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTT 139
P P + + P A PA PA ++ SSS + +T
Sbjct: 317 RRPRVKHPEAGKEEPDGARNAEAKEPAQ-----------PATSTSSKGSSSAQNKDSGST 365
Query: 140 PSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPS 186
SS A+ PP+++ T P +S P +
Sbjct: 366 GPGSSLAAASSFLEDDDFGSPPLDLTTSLRHMPSPSVTSAPEPPSIP 412
|
Length = 418 |
| >gnl|CDD|215533 PLN02983, PLN02983, biotin carboxyl carrier protein of acetyl-CoA carboxylase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 8e-05
Identities = 34/83 (40%), Positives = 42/83 (50%), Gaps = 4/83 (4%)
Query: 12 AVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSP 71
A+P P PP PPP + PPASPP + P PS P + PP +PA P P S
Sbjct: 140 ALPQPPPPAPVVMMQPPPPHAMPPASPPAAQPA---PSAPASSPPPTPASPPPAKAPKSS 196
Query: 72 PPPLDAPPPPEVDPSPPSPAQPP 94
PPL +P S P+P +PP
Sbjct: 197 HPPLKSPMAGTFYRS-PAPGEPP 218
|
Length = 274 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 9e-05
Identities = 22/112 (19%), Positives = 35/112 (31%), Gaps = 7/112 (6%)
Query: 126 PSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTP 185
T +++P P+ A S SP + PS+ P ++ P + P
Sbjct: 371 GGRGPKQHIKPVFTQPAAAPQPSAAAAA--SPSPSQSSAAAQPSA---PQSATQPAGTPP 425
Query: 186 SPPVLTPPPHP--SQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPP 235
+ V P P S P + P S S+ P + P
Sbjct: 426 TVSVDPPAAVPVNPPSTAPQAVRPAQFKEEKKIPVSKVSSLGPSTLRPIQEK 477
|
Length = 614 |
| >gnl|CDD|237863 PRK14949, PRK14949, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 9e-05
Identities = 49/280 (17%), Positives = 74/280 (26%), Gaps = 16/280 (5%)
Query: 5 SSPPAVLAVPPPSPPLSPP-PSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNS 63
+ AV + S PS T AS + + + S
Sbjct: 480 ADNSAVPEQIDSTAEQSVVNPSVTDTQVDDTSASNNSAADNTVDDNYSAEDTLESN--GL 537
Query: 64 PPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVP 123
+ PLDA V S S + A SS + +
Sbjct: 538 DEGDYAQDSAPLDAYQDDYVAFSSESYNALSDDEQHSANVQSAQSAAEAQPSSQSLSPIS 597
Query: 124 TTPSSSSPP------PANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPS 177
++++ A + S S A P P P S +PP
Sbjct: 598 AVTTAAASLADDDILDAVLAARDSLLSDLDALSPKEGDGKKSSADRKPKTPPSRAPPASL 657
Query: 178 SNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLS---PPPPSVPSTSS-PPAVSPPA 233
S P +S + P A+ S P PP VP PP P
Sbjct: 658 SKPASSPDASQTSASFDLDPDFELATHQSVPEAALASGSAPAPPPVPDPYDRPPWEEAPE 717
Query: 234 PPSNSSTRGSPSTPPLPSVPTEKPTAKSTNGTAVSANASP 273
+S P+ ++ A ++ AV A+
Sbjct: 718 V---ASANDGPNNAAEGNLSESVEDASNSELQAVEQQATH 754
|
Length = 944 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 9e-05
Identities = 24/97 (24%), Positives = 36/97 (37%), Gaps = 8/97 (8%)
Query: 115 SSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPP 174
S P + T P+++ P A V TTP++S P P + P N PS ++
Sbjct: 161 SVPLDTSTTTDPATTPAPAAPVDTTPTNSQTPAVATAPAP--AVDPQQNAVVAPSQANVD 218
Query: 175 PPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPAS 211
+ P P P+ A S PA+
Sbjct: 219 TAA--TPAPAAPATPDGAAPLPTDQAGV----STPAA 249
|
Length = 331 |
| >gnl|CDD|130706 TIGR01645, half-pint, poly-U binding splicing factor, half-pint family | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 9e-05
Identities = 33/171 (19%), Positives = 58/171 (33%), Gaps = 4/171 (2%)
Query: 101 SPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPP 160
+PP P T S+ P A ++++ A ++ P A PATPSSS P
Sbjct: 283 TPPDALLQPATVSAI--PAAAAVAAAAATAKIMAAEAVAGAAVLGPRAQSPATPSSSLP- 339
Query: 161 PVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSV 220
++ SS + P + P + P P P S ++PP
Sbjct: 340 -TDIGNKAVVSSAKKEAEEVPPLPQAAPAVVKPGPMEIPTPVPPPGLAIPSLVAPPGLVA 398
Query: 221 PSTSSPPAVSPPAPPSNSSTRGSPSTPPLPSVPTEKPTAKSTNGTAVSANA 271
P+ +P ++ P ++ ++P+ + A
Sbjct: 399 PTEINPSFLASPRKKMKREKLPVTFGALDDTLAWKEPSKEDQTSEDGKMLA 449
|
The proteins represented by this model contain three RNA recognition motifs (rrm: pfam00076) and have been characterized as poly-pyrimidine tract binding proteins associated with RNA splicing factors. In the case of PUF60 (GP|6176532), in complex with p54, and in the presence of U2AF, facilitates association of U2 snRNP with pre-mRNA. Length = 612 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 9e-05
Identities = 50/208 (24%), Positives = 75/208 (36%), Gaps = 58/208 (27%)
Query: 504 IHRDIKSSNILLDSSFEARVADFGL------AKIALELDSNTHVSTRVM----------- 546
IHRDIK NIL+D ++ DFGL + S HV M
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 547 ---------------------------GTFGYMAPEYATSGKLTEKSDVYSFGVVLLELI 579
GT Y+APE T+ D +S GV+L E++
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 580 TGRKPVDASQPLGDE-SLVEWARPL---LAEALEHEDFEALV------DSRLEKNYVDS- 628
G+ P A PL + ++ W L L E + ++ + RL KN D
Sbjct: 243 VGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEI 302
Query: 629 ---EMFWMIEAAAACVRHSATKRPRMSQ 653
F I+ ++ + SA P+++
Sbjct: 303 KAHPFFKTIDFSSDLRQQSAPYIPKITH 330
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|233045 TIGR00601, rad23, UV excision repair protein Rad23 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 9e-05
Identities = 19/88 (21%), Positives = 28/88 (31%), Gaps = 14/88 (15%)
Query: 52 TAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTT 111
+ P + V P P+S P P +PP + P AV P
Sbjct: 75 SKPKTGTGKVAPPAATPTSAPTPTPSPPA----SPASGMSAAPASAVEEKSPSE------ 124
Query: 112 PSSSSPPPANVPTTPSSSSPPPANVRTT 139
A P +PS+S P + +
Sbjct: 125 ----ESATATAPESPSTSVPSSGSDAAS 148
|
All proteins in this family for which functions are known are components of a multiprotein complex used for targeting nucleotide excision repair to specific parts of the genome. In humans, Rad23 complexes with the XPC protein. This family is based on the phylogenomic analysis of JA Eisen (1999, Ph.D. Thesis, Stanford University) [DNA metabolism, DNA replication, recombination, and repair]. Length = 378 |
| >gnl|CDD|234938 PRK01297, PRK01297, ATP-dependent RNA helicase RhlB; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 9e-05
Identities = 18/69 (26%), Positives = 22/69 (31%)
Query: 34 PPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQP 93
PA PPSP + P PP + +P P P E P P S +
Sbjct: 16 QPAPAPPSPAAAPAPPPPAKTAAPATKAAAPAAAAPRAEKPKKDKPRRERKPKPASLWKL 75
Query: 94 PPQAVAPSP 102
V P
Sbjct: 76 EDFVVEPQE 84
|
Length = 475 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 1e-04
Identities = 19/120 (15%), Positives = 38/120 (31%)
Query: 167 PPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSP 226
P +++ P+ + P P +A P +P A+ +P P + +P
Sbjct: 366 PAAAAEAAAPAEKKTPARPEAAAPAAAPVAQAAAAPAPAAAPAAAASAPAAPPAAAPPAP 425
Query: 227 PAVSPPAPPSNSSTRGSPSTPPLPSVPTEKPTAKSTNGTAVSANASPRNAGVLGTGGAVA 286
A A P+ + + P+ P + V+ + +A A
Sbjct: 426 VAAPAAAAPAAAPAAAPAAVALAPAPPAQAAPETVAIPVRVAPEPAVASAAPAPAAAPAA 485
|
Length = 618 |
| >gnl|CDD|237605 PRK14086, dnaA, chromosomal replication initiation protein; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 23/115 (20%), Positives = 27/115 (23%), Gaps = 6/115 (5%)
Query: 124 TTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTS 183
T S+ P +S P P P PP P PT+
Sbjct: 87 TVDPSAGEPAPPPPHARRTSEPELPRPGRRPYEGYGGPRADDRPPG----LPRQDQLPTA 142
Query: 184 TPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPP--PSVPSTSSPPAVSPPAPPS 236
P+ P P P L PP P S P P
Sbjct: 143 RPAYPAYQQRPEPGAWPRAADDYGWQQQRLGFPPRAPYASPASYAPEQERDREPY 197
|
Length = 617 |
| >gnl|CDD|218439 pfam05109, Herpes_BLLF1, Herpes virus major outer envelope glycoprotein (BLLF1) | Back alignment and domain information |
|---|
Score = 45.2 bits (106), Expect = 1e-04
Identities = 53/257 (20%), Positives = 84/257 (32%), Gaps = 4/257 (1%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
P P A PP+ S P +T+P T P + +P ++ PS T+ +
Sbjct: 528 PTPIVIGVTTTATSPPTGTTSVPNATSPQVTEESPVNNTNTPVVTSAPSVLTSAVTTGQH 587
Query: 61 VNSPPPQPSSPPPPLDAPPPPEVDPS---PPSPAQPPPQAVAPSPPPPANVPTTPSSSSP 117
P P P + P + + P + P + P+ VP+T S+
Sbjct: 588 GTGSSPTSQQPGIPSSSHSTPRSNSTSTTPLLTSAHPTGGENITEETPS-VPSTTHVSTL 646
Query: 118 PPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPS 177
P P T S S P + + +P ++S P T + +
Sbjct: 647 SPGPGPGTTSQVSGPGNSSTSRYPGEVHVTEGMPNPNATSPSAPSGQKTAVPTVTSTGGK 706
Query: 178 SNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSN 237
+N T S L P + T A+T PP S SPP
Sbjct: 707 ANSTTKETSGSTLMASTSPHTNEGAFRTTPYNATTYLPPSTSSKLRPRWTFTSPPVTTKQ 766
Query: 238 SSTRGSPSTPPLPSVPT 254
++ P+ P S +
Sbjct: 767 ATVPVPPTQHPDHSNLS 783
|
This family consists of the BLLF1 viral late glycoprotein, also termed gp350/220. It is the most abundantly expressed glycoprotein in the viral envelope of the Herpesviruses and is the major antigen responsible for stimulating the production of neutralising antibodies in vivo. Length = 830 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 1e-04
Identities = 15/97 (15%), Positives = 30/97 (30%), Gaps = 5/97 (5%)
Query: 176 PSSNPPT-----STPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVS 230
P+S P+ + P P + +A + A P P+ + A +
Sbjct: 22 PNSVDPSWREFFADYGPGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPA 81
Query: 231 PPAPPSNSSTRGSPSTPPLPSVPTEKPTAKSTNGTAV 267
P P+ ++ + P + P A +
Sbjct: 82 APPKPAAAAAAAAAPAAPPAAAAAAAPAAAAVEDEVT 118
|
Length = 1228 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 45.3 bits (108), Expect = 1e-04
Identities = 13/82 (15%), Positives = 28/82 (34%)
Query: 192 PPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTPPLPS 251
P + +A + ++ + P P+ +P + AP + + + P+
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPA 97
Query: 252 VPTEKPTAKSTNGTAVSANASP 273
P A + AV +P
Sbjct: 98 APPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 1e-04
Identities = 17/108 (15%), Positives = 34/108 (31%), Gaps = 3/108 (2%)
Query: 56 PSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSS 115
P + A + P + P + P P + + A A +
Sbjct: 53 PPAAAAPAAAQPPPAAAPAAVSRPAAPAAEPAPWLVEHAKRLTAQREQLVARAAAPAAPE 112
Query: 116 SPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVN 163
+ PA ++ A R ++++ P VPA +++ V
Sbjct: 113 AQAPA---APAERAAAENAARRLARAAAAAPRPRVPADAAAAVADAVK 157
|
Length = 484 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (108), Expect = 1e-04
Identities = 20/80 (25%), Positives = 29/80 (36%), Gaps = 1/80 (1%)
Query: 165 PTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTS 224
+ +++ PPP P P L P + PP P A+ S P+
Sbjct: 515 GSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPP-PPTATQASSNAPAQIPAD 573
Query: 225 SPPAVSPPAPPSNSSTRGSP 244
S P P P+ S T+ S
Sbjct: 574 SSPPPPIPEEPTPSPTKDSS 593
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 1e-04
Identities = 19/76 (25%), Positives = 30/76 (39%), Gaps = 2/76 (2%)
Query: 115 SSPPPANVPTTPSSSSPPPANVRTTPSSSSPP--PANVPATPSSSSPPPVNVPTPPSSSS 172
S + + + ++P PA + P + P P A + S PP P P +
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAE 420
Query: 173 PPPPSSNPPTSTPSPP 188
P PS PP + + P
Sbjct: 421 PTEPSPTPPANAANAP 436
|
Length = 620 |
| >gnl|CDD|222997 PHA03132, PHA03132, thymidine kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 1e-04
Identities = 32/192 (16%), Positives = 41/192 (21%), Gaps = 18/192 (9%)
Query: 82 EVDPSPPSPAQPPPQAVAPSP-PPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTP 140
D SP A P + S T S + + T P
Sbjct: 16 SSDESPEGSRDENFDAERDDFLTPLGSTSEATSEDDDDLYPPRETGSGGGVATSTIYTVP 75
Query: 141 SSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTP------SPPVLTPPP 194
P T P + PP + PP +S SP L
Sbjct: 76 RPPRGPEQ----TLDKPDSLPASRELPPGPTPVPPGGFRGASSPRLGADSTSPRFLYQVN 131
Query: 195 HPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTPPLPSVPT 254
P AP + S S P S V + P
Sbjct: 132 FPVILAPIGESNSSSEELSEEEEHSRPPPSESLKVKN-------GGKVYPKGFSKHKTHK 184
Query: 255 EKPTAKSTNGTA 266
+ T A
Sbjct: 185 RSEFSGLTKKAA 196
|
Length = 580 |
| >gnl|CDD|240289 PTZ00144, PTZ00144, dihydrolipoamide succinyltransferase; Provisional | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 16/78 (20%), Positives = 24/78 (30%), Gaps = 2/78 (2%)
Query: 63 SPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANV 122
P ++P A P + A P A P PPA + + P
Sbjct: 121 GGAPPAAAPAAAAAAKAEKTTPEKPKAAAPTPEPPAASKPTPPAAAKPPEPAPAAKP--P 178
Query: 123 PTTPSSSSPPPANVRTTP 140
PT + + P V +
Sbjct: 179 PTPVARADPRETRVPMSR 196
|
Length = 418 |
| >gnl|CDD|184923 PRK14959, PRK14959, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-04
Identities = 36/117 (30%), Positives = 50/117 (42%), Gaps = 6/117 (5%)
Query: 15 PPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPP 74
PS + P++ T P P + P T P+ P ++PA +P PS P
Sbjct: 380 APSGSAAEGPASGGAATIPTPGT---QGPQGTAPAAGMTPSSAAPATPAPSAAPSPRVPW 436
Query: 75 LDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSP 131
DAPP P PP PA P+A SP P A +S +PP P+ + +P
Sbjct: 437 DDAPPAPPRSGIPPRPAPRMPEA---SPVPGAPDSVASASDAPPTLGDPSDTAEHTP 490
|
Length = 624 |
| >gnl|CDD|236766 PRK10811, rne, ribonuclease E; Reviewed | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 1e-04
Identities = 28/162 (17%), Positives = 44/162 (27%), Gaps = 13/162 (8%)
Query: 8 PAVLAVPPPSPPLSPPPSTT-PPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPP- 65
A + +P + P P +T P AP P V +
Sbjct: 876 AAAVEPVVSAPVVEAVAEVVEEPVVVAEPQPEEVVVVETTHPEVIAAPVTEQPQVITESD 935
Query: 66 ----------PQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSS 115
+P P A + + A+P A +P + +
Sbjct: 936 VAVAQEVAEHAEPVVEPQDETADIEEAAETAEVVVAEPEVVAQPAAPVVAEVAAEVETVT 995
Query: 116 SPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSS 157
+ P V + N T P + +P P VP P S
Sbjct: 996 AVEPE-VAPAQVPEATVEHNHATAPMTRAPAPEYVPEAPRHS 1036
|
Length = 1068 |
| >gnl|CDD|223066 PHA03379, PHA03379, EBNA-3A; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 51/230 (22%), Positives = 65/230 (28%), Gaps = 20/230 (8%)
Query: 32 SPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPP--EVDPSPPS 89
+ P P PP P P P A + Q PPP D P P + P
Sbjct: 408 ASEPTYGTPRPPVEKPR--PEVPQSLETATSHGSAQVPEPPPVHDLEPGPLHDQHSMAPC 465
Query: 90 PAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPAN 149
P P P +P P A VP +P VR +S S P
Sbjct: 466 PVAQLPPGPLQDLEPGDQLPGVVQDGRPACAPVP------APAGPIVRPWEASLSQVPGV 519
Query: 150 VPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPP 209
A P VP P + P P + P S P
Sbjct: 520 AFAPVMPQPMPVEPVPVPTVA------LERPVCPAPPLIAMQGPGETSGIVRVRERWRPA 573
Query: 210 ASTLSPPPPSVPST--SSPPAVSPPAPPSNSSTRGSPSTPPLPSVPTEKP 257
T +PP + + A P +S P P L V ++P
Sbjct: 574 PWTPNPPRSPSQMSVRDRLARLRAEAQPYQASVEVQP--PQLTQVSPQQP 621
|
Length = 935 |
| >gnl|CDD|223066 PHA03379, PHA03379, EBNA-3A; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 53/267 (19%), Positives = 70/267 (26%), Gaps = 19/267 (7%)
Query: 8 PAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQ 67
P P P L P PA P P + P P S + P
Sbjct: 466 PVAQLPPGPLQDLEPGDQLPGVVQDGRPA-CAPVPAPAGPIVRPWEASLSQVPGVAFAPV 524
Query: 68 PSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPS 127
P P P P P PA PP P + + P P P P
Sbjct: 525 MPQPMPVEPVPVPTVALERPVCPA--PPLIAMQGPGETSGIVRVRERWRPAPW-TPNPPR 581
Query: 128 SSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSP 187
S S R + A PP + S P P
Sbjct: 582 SPSQMSVRDRL---ARLRAEAQPYQASVEVQPPQL-----------TQVSPQQPMEYPLE 627
Query: 188 PVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTP 247
P P S V ++ + P +P P + P P +S P P
Sbjct: 628 PEQQMFPGSPFSQVADVMRAGGVPAMQPQYFDLPLQ-QPISQGAPLAPLRASMGPVPPVP 686
Query: 248 PLPSVPTEKPTAKSTNGTAVSANASPR 274
+ P + N A +A+ P+
Sbjct: 687 ATQPQYFDIPLTEPINQGASAAHFLPQ 713
|
Length = 935 |
| >gnl|CDD|114270 pfam05539, Pneumo_att_G, Pneumovirinae attachment membrane glycoprotein G | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 44/176 (25%), Positives = 59/176 (33%), Gaps = 13/176 (7%)
Query: 34 PPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPP----QPSSPPPPLDAPPPPEVD----- 84
P + S TS P PS S P Q ++ L + P
Sbjct: 168 PKTAVTTSKTTSWPTEVSHPTYPSQVTPQSQPATQGHQTATANQRLSSTEPVGTQGTTTS 227
Query: 85 PSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPP-PANVRTTPSSS 143
+P +PPP PS P TT S T +PP +N R+ S++
Sbjct: 228 SNPEPQTEPPPSQRGPSGSPQHPPSTTSQDQSTTGDGQEHTQRRKTPPATSNRRSPHSTA 287
Query: 144 SPPPANVPATPSSSSPPPVN---VPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHP 196
+PPP +P P + P SSPP +NP T PP P
Sbjct: 288 TPPPTTKRQETGRPTPRPTATTQSGSSPPHSSPPGVQANPTTQNLVDCKELDPPKP 343
|
Length = 408 |
| >gnl|CDD|234938 PRK01297, PRK01297, ATP-dependent RNA helicase RhlB; Provisional | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 15/65 (23%), Positives = 21/65 (32%), Gaps = 1/65 (1%)
Query: 12 AVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSP 71
A P P SP + PPP + A + + P P P+P+S
Sbjct: 14 AEQPAPAPPSPAAAPAPPPPAKTAAPATKAAAPAAAAPRAEKPKKDKPR-RERKPKPASL 72
Query: 72 PPPLD 76
D
Sbjct: 73 WKLED 77
|
Length = 475 |
| >gnl|CDD|226406 COG3889, COG3889, Predicted solute binding protein [General function prediction only] | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 1e-04
Identities = 32/169 (18%), Positives = 51/169 (30%), Gaps = 16/169 (9%)
Query: 34 PPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEV-------DPS 86
P P PP P +S + + P + V
Sbjct: 681 PDKLKPILKLFRDPPVGW-LPYTNSLYKATTLSSEAKNPDTVKIGQALTVYGSLEVFPAG 739
Query: 87 PPSPAQPPPQAVAPSPPPPANVPTTP-SSSSPPPANVPTTPSSSSPPPANVRTTPSSSSP 145
P + V PA+ T ++S A VP +P+ + T S S+
Sbjct: 740 ENWGFIPTTKRVKVRIMDPASGTGTSITTSGTFTAEVPQSPTKTET-------TLSYSAY 792
Query: 146 PPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPP 194
++ +S T ++SSP P + PT T + T P
Sbjct: 793 SNTSILIETTSVVITKTVTQTQTTTSSPSPTQTTSPTQTSTSTTTTTSP 841
|
Length = 872 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 1e-04
Identities = 29/85 (34%), Positives = 42/85 (49%), Gaps = 5/85 (5%)
Query: 454 LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNI 513
LV EY+ + LH G D VK + A + YLH IIHRD+K N+
Sbjct: 81 LVMEYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNM 135
Query: 514 LLDSSFEARVADFGLAKIALELDSN 538
L+ + ++ DFGL+K+ L + N
Sbjct: 136 LISNEGHIKLTDFGLSKVTLNRELN 160
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|220603 pfam10152, DUF2360, Predicted coiled-coil domain-containing protein (DUF2360) | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 19/65 (29%), Positives = 25/65 (38%), Gaps = 3/65 (4%)
Query: 45 STPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPP 104
PP S+ PPP P P +A PP + PA+P P+A A +
Sbjct: 52 DVTVQTTPPPPASAITNGGPPPPP---PARAEAASPPPPEAPAEPPAEPEPEAPAENTVT 108
Query: 105 PANVP 109
A P
Sbjct: 109 VAKDP 113
|
This is the conserved 140 amino acid region of a family of proteins conserved from nematodes to humans. One C. elegans member is annotated as a Daf-16-dependent longevity protein 1 but this could not be confirmed. The function is unknown. Length = 147 |
| >gnl|CDD|240420 PTZ00441, PTZ00441, sporozoite surface protein 2 (SSP2); Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 39/164 (23%), Positives = 49/164 (29%), Gaps = 5/164 (3%)
Query: 19 PLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAP 78
P+ P P P P P P P P P V P P PP
Sbjct: 283 PVEPEPLPVPAPVPPTPEDDNPRPTDDEFAVPN---FNEGLDVPDNPQDPVPPPNEGKDG 339
Query: 79 PPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRT 138
P E + PP + P ++ PP P NVP +S P P + P
Sbjct: 340 NPNEENLFPPGDDEVPDES--NVPPNPPNVPGGSNSEFSSDVENPPNPPNPDIPEQEPNI 397
Query: 139 TPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPT 182
S+ P +VP P N P P + P
Sbjct: 398 PEDSNKEVPEDVPMEPEDDRDNNFNEPKKPENKGDGQNEPVIPK 441
|
Length = 576 |
| >gnl|CDD|236333 PRK08691, PRK08691, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 1e-04
Identities = 28/184 (15%), Positives = 48/184 (26%), Gaps = 7/184 (3%)
Query: 3 PQSSPPAVLAVPPPSPP----LSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSS 58
PQ P A A P + T P ++ PP +S
Sbjct: 394 PQPRPEAETAQTPVQTASAAAMPSEGKTAGPVSNQENNDVPPWEDAPDEAQTAAGTAQTS 453
Query: 59 PAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPP--PPANVPTTPSSSS 116
+ +PP + + + ++ P + + P T +
Sbjct: 454 AKSIQTASEAETPPENQVSKNKAADNETDAPLSEVPSENPIQATPNDEAVETETFAHEAP 513
Query: 117 PPPANVPTTPSSSSPPPANVRTTPSS-SSPPPANVPATPSSSSPPPVNVPTPPSSSSPPP 175
P P + PP P PA+ + + + S+PPP
Sbjct: 514 AEPFYGYGFPDNDCPPEDGAEIPPPDWEHAAPADTAGGGADEEAEAGGIGGNNTPSAPPP 573
Query: 176 PSSN 179
S
Sbjct: 574 EFST 577
|
Length = 709 |
| >gnl|CDD|237011 PRK11892, PRK11892, pyruvate dehydrogenase subunit beta; Provisional | Back alignment and domain information |
|---|
Score = 44.5 bits (106), Expect = 1e-04
Identities = 13/51 (25%), Positives = 20/51 (39%)
Query: 41 SPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPA 91
S + P + A + A + + ++P P A P EV P PA
Sbjct: 85 SDAGAAPAAAAEAAAAAPAAAAAAAAKKAAPAPAAPAAPAAEVAADPDIPA 135
|
Length = 464 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 2e-04
Identities = 25/139 (17%), Positives = 27/139 (19%), Gaps = 4/139 (2%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPP--SS 58
P A P P S + S P P
Sbjct: 786 SSPPVRAEAAFRRPGRLRRSGPAADAASRTASKRKSRSHTPDGGSESSGPARPPGAAARP 845
Query: 59 PAVNSPPPQPSSPPPPLDAPP--PPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSS 116
P S S P P PP P P A P A P+
Sbjct: 846 PPARSSESSKSKPAAAGGRARGKNGRRRPRPPEPRARPGAAAPPKAAAAAPPAGAPAPRP 905
Query: 117 PPPANVPTTPSSSSPPPAN 135
P V P P
Sbjct: 906 RPAPRVKLGPMPPGGPDPR 924
|
Length = 1352 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 2e-04
Identities = 24/99 (24%), Positives = 31/99 (31%), Gaps = 2/99 (2%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
PP + P + S P P PP P P P PP P P+ A
Sbjct: 709 PPAGQADDPAAQPPQAAQGASAPSPAADDPVPLPPEPDDPPDPAGAPAQPPPPPAPAPAA 768
Query: 61 VNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVA 99
+ P PS P + PS + + VA
Sbjct: 769 APAAAPPPSPPSEE--EEMAEDDAPSMDDEDRRDAEEVA 805
|
Length = 824 |
| >gnl|CDD|223065 PHA03378, PHA03378, EBNA-3B; Provisional | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 2e-04
Identities = 50/262 (19%), Positives = 77/262 (29%), Gaps = 8/262 (3%)
Query: 25 STTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVD 84
+T PP+ P P + +P T + P+S P+ PL P
Sbjct: 522 ATLLPPSPPQPRAGRRAPCVYTEDLDIESDEPASTEPVHDQLLPAPGLGPLQIQPLTSPT 581
Query: 85 PSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSS 144
S + + P P P+ P P++ S P + P P + P
Sbjct: 582 TSQLASSAPSYAQTPWPVPHPSQTPEPPTTQSHIPET--SAPRQWPMPLRPIPMRPLRMQ 639
Query: 145 PPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPV 204
P NV P+ PP V TP + S + P P
Sbjct: 640 PITFNVLVFPTPHQPPQVE-ITPYKPTWTQIGHIPYQPSPTGANTMLPI-----QWAPGT 693
Query: 205 TKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTPPLPSVPTEKPTAKSTNG 264
+ PP + PP+ P + + + + PP + +P A +
Sbjct: 694 MQPPPRAPTPMRPPAAPPGRAQRPAAATGRARPPAAAPGRARPPAAAPGRARPPAAAPGR 753
Query: 265 TAVSANASPRNAGVLGTGGAVA 286
A A R GA
Sbjct: 754 ARPPAAAPGRARPPAAAPGAPT 775
|
Length = 991 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 2e-04
Identities = 17/79 (21%), Positives = 25/79 (31%)
Query: 171 SSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVS 230
S ++ +P P P P K+ A+T PPP+ S P
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAE 420
Query: 231 PPAPPSNSSTRGSPSTPPL 249
P P + + P L
Sbjct: 421 PTEPSPTPPANAANAPPSL 439
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 2e-04
Identities = 12/76 (15%), Positives = 24/76 (31%)
Query: 118 PPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPS 177
+ S+ + P +P + P+ ++++P P P P P+
Sbjct: 363 AFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAEPT 422
Query: 178 SNPPTSTPSPPVLTPP 193
PT + P
Sbjct: 423 EPSPTPPANAANAPPS 438
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 2e-04
Identities = 20/84 (23%), Positives = 27/84 (32%), Gaps = 4/84 (4%)
Query: 154 PSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTL 213
PS+ N P + + P PS P PS P P + P
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPV--- 417
Query: 214 SPPPPSVPSTSSPPAVSPPAPPSN 237
P P+ PS + P + P N
Sbjct: 418 -PAEPTEPSPTPPANAANAPPSLN 440
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 2e-04
Identities = 21/83 (25%), Positives = 33/83 (39%), Gaps = 3/83 (3%)
Query: 120 ANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSS---SPPPP 176
+ + ++ +PPP P + +PP AT +PPP +SS + P
Sbjct: 513 QSGSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPA 572
Query: 177 SSNPPTSTPSPPVLTPPPHPSQS 199
S+PP P P +P S
Sbjct: 573 DSSPPPPIPEEPTPSPTKDSSPE 595
|
Length = 620 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 2e-04
Identities = 23/72 (31%), Positives = 33/72 (45%), Gaps = 8/72 (11%)
Query: 38 PPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQA 97
PP + + P+ P APPP++ +PP P++P P A P P P PA P A
Sbjct: 384 PPSAAWGAPTPAAPAAPPPAA----APPVPPAAPARPAAARPAPA----PAPPAAAAPPA 435
Query: 98 VAPSPPPPANVP 109
+ P A+
Sbjct: 436 RSADPAAAASAG 447
|
Length = 576 |
| >gnl|CDD|240289 PTZ00144, PTZ00144, dihydrolipoamide succinyltransferase; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 2e-04
Identities = 18/71 (25%), Positives = 25/71 (35%), Gaps = 3/71 (4%)
Query: 12 AVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSP 71
PP + P + P P + PT PP+ PP++ P P P
Sbjct: 122 GAPPAAAPAAAA---AAKAEKTTPEKPKAAAPTPEPPAASKPTPPAAAKPPEPAPAAKPP 178
Query: 72 PPPLDAPPPPE 82
P P+ P E
Sbjct: 179 PTPVARADPRE 189
|
Length = 418 |
| >gnl|CDD|185594 PTZ00395, PTZ00395, Sec24-related protein; Provisional | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 2e-04
Identities = 34/136 (25%), Positives = 51/136 (37%), Gaps = 13/136 (9%)
Query: 19 PLSPPPSTTPPPTSPPPASPPPS-PPTSTPP--SPPTAPPPSSPAVNSPPPQPSSPPPPL 75
S P ++ P + P ++ P + PP S P +PP + PP S N P PL
Sbjct: 413 GYSNPGNSNPGYNNAPNSNTPYNNPPNSNTPYSNPPNSNPPYS---NLPYSNTPYSNAPL 469
Query: 76 DAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPP----PANVPTTPSSSSP 131
PP S Q A + P AN+PT ++ N P +S P
Sbjct: 470 SNAPPSSAKDH-HSAYHAAYQHRAAN-QPAANLPTANQPAANNFHGAAGNSVGNPFASRP 527
Query: 132 -PPANVRTTPSSSSPP 146
A ++++ P
Sbjct: 528 FGSAPYGGNAATTADP 543
|
Length = 1560 |
| >gnl|CDD|220309 pfam09606, Med15, ARC105 or Med15 subunit of Mediator complex non-fungal | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-04
Identities = 29/102 (28%), Positives = 37/102 (36%), Gaps = 3/102 (2%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
P Q P +++ P P P + S PP P+ P P P S PP + SP
Sbjct: 401 NPMQQGQPGMMSSPSPVPQVQTNQSMPQPPQ---PSVPSPGGPGSQPPQSVSGGMIPSPP 457
Query: 61 VNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSP 102
P P P P + SP P P Q+ SP
Sbjct: 458 ALMPSPSPQMSQSPASQRTIQQDMVSPGGPLNTPGQSSVNSP 499
|
The approx. 70 residue Med15 domain of the ARC-Mediator co-activator is a three-helix bundle with marked similarity to the KIX domain. The sterol regulatory element binding protein (SREBP) family of transcription activators use the ARC105 subunit to activate target genes in the regulation of cholesterol and fatty acid homeostasis. In addition, Med15 is a critical transducer of gene activation signals that control early metazoan development. Length = 768 |
| >gnl|CDD|237182 PRK12727, PRK12727, flagellar biosynthesis regulator FlhF; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 37/209 (17%), Positives = 55/209 (26%), Gaps = 19/209 (9%)
Query: 13 VPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPP 72
+P +P T P P + S +A A+ P
Sbjct: 64 ATAAAPAPAPQAPTKPAAPVHAPLKLSANANMSQRQRVASAAEDMIAAMALRQPVSVPRQ 123
Query: 73 PPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPP 132
P AP PSP + A AV +P + P A+ TT P
Sbjct: 124 APAAAPVRAASIPSPAAQALAHAAAVRTAPRQEHALSAVPEQLF---ADFLTTAPVPRAP 180
Query: 133 PANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTST---PSPPV 189
+ PA VPA + + + + + P +
Sbjct: 181 ------VQAPVVAAPAPVPAIAA-------ALAAHAAYAQDDDEQLDDDGFDLDDALPQI 227
Query: 190 LTPPPHPSQSAPPPVTKSPPASTLSPPPP 218
L P P P + A + P P
Sbjct: 228 LPPAALPPIVVAPAAPAALAAVAAAAPAP 256
|
Length = 559 |
| >gnl|CDD|236766 PRK10811, rne, ribonuclease E; Reviewed | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 2e-04
Identities = 26/162 (16%), Positives = 40/162 (24%)
Query: 74 PLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPP 133
P+ P +V+ + VA P A P + A V P + P
Sbjct: 846 PVVRPQDVQVEEQREAEEVQVQPVVAEVPVAAAVEPVVSAPVVEAVAEVVEEPVVVAEPQ 905
Query: 134 ANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPP 193
++ P P T +V + P P T
Sbjct: 906 PEEVVVVETTHPEVIAAPVTEQPQVITESDVAVAQEVAEHAEPVVEPQDETADIEEAAET 965
Query: 194 PHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPP 235
+ P V + T+ P V+P P
Sbjct: 966 AEVVVAEPEVVAQPAAPVVAEVAAEVETVTAVEPEVAPAQVP 1007
|
Length = 1068 |
| >gnl|CDD|237015 PRK11901, PRK11901, hypothetical protein; Reviewed | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 27/154 (17%), Positives = 47/154 (30%), Gaps = 27/154 (17%)
Query: 28 PPPTSPPPASPPPSPPTSTPPSPP---TAPPPSSPAVNSPPPQPSSPPPPLDAP------ 78
P++ S +PP +APP S + PPQ + ++ P
Sbjct: 93 SSPSAANNTSDGHDASGVKNTAPPQDISAPPISPTPTQAAPPQTPNGQQRIELPGNISDA 152
Query: 79 ----------------PPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANV 122
P+ P+ P A P+ P ++ P N
Sbjct: 153 LSQQQGQVNAASQNAQGNTSTLPTAPATVAPSKGAKVPATAETHPTPPQKPATKKPAVNH 212
Query: 123 PTTPSSSSPPPANVRTTPSSSSPPPANVPATPSS 156
T + + PP + P S + + + P+S
Sbjct: 213 HKTATVAVPPATS--GKPKSGAASARALSSAPAS 244
|
Length = 327 |
| >gnl|CDD|222095 pfam13388, DUF4106, Protein of unknown function (DUF4106) | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-04
Identities = 24/96 (25%), Positives = 33/96 (34%), Gaps = 5/96 (5%)
Query: 16 PSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPS----PPTAPPPS-SPAVNSPPPQPSS 70
P+ S T P +PP +P P P + S AP P+ P V +P QP+
Sbjct: 159 PAGGTYILASGTYIPPNPPREAPAPGLPKTFTSSHGHRHRHAPKPTQQPTVQNPAQQPTV 218
Query: 71 PPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPA 106
P P+ P P+ P P
Sbjct: 219 QNPAQQPQQQPQQQPVQPAQQPTPQNPAQQPPQTEQ 254
|
This family of proteins are found in large numbers in the Trichomonas vaginalis proteome. The function of this protein is unknown. Length = 422 |
| >gnl|CDD|223066 PHA03379, PHA03379, EBNA-3A; Provisional | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 2e-04
Identities = 61/298 (20%), Positives = 79/298 (26%), Gaps = 30/298 (10%)
Query: 7 PPAVLAVPPP---SPPLSPPPSTTPPPTSPPPASP---PPSPPTSTPPSPPTAPPPSSPA 60
PP P P ++P P PP P P P+ P P+ P
Sbjct: 446 PPVHDLEPGPLHDQHSMAPCPVAQLPPGPLQDLEPGDQLPGVVQDGRPACAPVPAPAGPI 505
Query: 61 VNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSP--- 117
V S P AP P+ P P P P PP P +S
Sbjct: 506 VRPWEASLSQVPGVAFAPVMPQPMPVEPVPVPTVALERPVCPAPPLIAMQGPGETSGIVR 565
Query: 118 ------PPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSS 171
P P P S S VR + A+ P V
Sbjct: 566 VRERWRPAPWTPNPPRSPSQMS--VRDRLARLRAEAQPYQASVEVQPPQLTQVSPQQPME 623
Query: 172 SPPPPSSNPPTSTPSPPV----------LTPPPHPSQSAPPPVTKSPPASTLSP---PPP 218
P P +P V P + P+++ P + L P P
Sbjct: 624 YPLEPEQQMFPGSPFSQVADVMRAGGVPAMQPQYFDLPLQQPISQGAPLAPLRASMGPVP 683
Query: 219 SVPSTSSPPAVSPPAPPSNSSTRGSPSTPPLPSVPTEKPTAKSTNGTAVSANASPRNA 276
VP+T P P N + P P P G +S + P A
Sbjct: 684 PVPATQPQYFDIPLTEPINQGASAAHFLPQQPMEGPLVPERWMFQGATLSQSVRPGVA 741
|
Length = 935 |
| >gnl|CDD|183756 PRK12799, motB, flagellar motor protein MotB; Reviewed | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 22/117 (18%), Positives = 38/117 (32%), Gaps = 2/117 (1%)
Query: 21 SPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPP 80
P S ++ P+S P P S T ++ A P + P
Sbjct: 304 VTPSSAVTQSSAITPSSAAIPSPAVIPSSVTTQSATTTQASAVALSSAGVLPSDVTLPGT 363
Query: 81 PEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVR 137
+ + P QP P + T +++ P + +P P+S+ P R
Sbjct: 364 VALPAAEPVNMQPQP-MSTTETQQSSTGNITSTANGPTTS-LPAAPASNIPVSPTSR 418
|
Length = 421 |
| >gnl|CDD|183756 PRK12799, motB, flagellar motor protein MotB; Reviewed | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 24/121 (19%), Positives = 37/121 (30%), Gaps = 3/121 (2%)
Query: 24 PSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEV 83
P P+S S +P ++ PSP P S + L +
Sbjct: 300 PVAAVTPSSAVTQSSAITPSSAAIPSPAVIP---SSVTTQSATTTQASAVALSSAGVLPS 356
Query: 84 DPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSS 143
D + P P P P + T SS+ + P++S P S +
Sbjct: 357 DVTLPGTVALPAAEPVNMQPQPMSTTETQQSSTGNITSTANGPTTSLPAAPASNIPVSPT 416
Query: 144 S 144
S
Sbjct: 417 S 417
|
Length = 421 |
| >gnl|CDD|215145 PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygenase NCED | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 2e-04
Identities = 20/79 (25%), Positives = 27/79 (34%), Gaps = 2/79 (2%)
Query: 16 PSPPLSPPPSTTPPPTSPPPASPPPS--PPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPP 73
S P S S +S S PPS P P + +P++ P S PP
Sbjct: 3 SSNPTSRSQSHASSSSSSSSQSSPPSSTSPRPRRRKPSASSLLHTPSILPLPKLSSPSPP 62
Query: 74 PLDAPPPPEVDPSPPSPAQ 92
+ PP +P Q
Sbjct: 63 SVTLPPAATTQTPQLNPLQ 81
|
Length = 590 |
| >gnl|CDD|217310 pfam02993, MCPVI, Minor capsid protein VI | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 26/128 (20%), Positives = 33/128 (25%), Gaps = 22/128 (17%)
Query: 43 PTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSP 102
P+P P P+P + A P P PS +P P V
Sbjct: 110 LGEEEPAPQEETVADPIQALQPRPRPDVEEVLVPAAPEP---PSYEETIKPGPAPVEEPV 166
Query: 103 PPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPV 162
A TP + PPA PPP VP +
Sbjct: 167 DSMA-----------IAVPAIDTPVTLELPPA--------PQPPPPVVPQPSTMVVHRRS 207
Query: 163 NVPTPPSS 170
+ SS
Sbjct: 208 RIKRTRSS 215
|
This minor capsid protein may act as a link between the external capsid and the internal DNA-protein core. The C-terminal 11 residues may function as a protease cofactor leading to enzyme activation. Length = 238 |
| >gnl|CDD|223033 PHA03291, PHA03291, envelope glycoprotein I; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 51/256 (19%), Positives = 75/256 (29%), Gaps = 35/256 (13%)
Query: 7 PPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPP 66
P + A P +PP S PA P S P P +P P
Sbjct: 160 PLGLAAFPAEGTLAAPPLGEGSADGSCDPA---------LPLSAPRLGPADVFVPATPRP 210
Query: 67 QPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTP 126
P + P P P PPS P P +P + + P P P
Sbjct: 211 TPRTTASPETTPTPSTTTS-PPSTTIPAPSTTIAAPQAGTTPEAEGTPAPPTPGGGEAPP 269
Query: 127 SSSSPPPANVRTTPSSSSPPPANVPAT-----------------PSSSSPPPVNVPTPPS 169
++++P P R + + +PA+ P + PPS
Sbjct: 270 ANATPAPEASRYELTVTQIIQIAIPASIIACVFLGSCACCLHRRCRRRRRRPARIYRPPS 329
Query: 170 SSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAV 229
+P + N L P P +K + T+ P ++ S PAV
Sbjct: 330 PVAPSISAVNEAALARLGDELKRHP----PESPRRSKRRSSQTMVPSLTAISEESEAPAV 385
Query: 230 ----SPPAPPSNSSTR 241
P P + R
Sbjct: 386 VELSRSPRRPGGPTAR 401
|
Length = 401 |
| >gnl|CDD|177614 PHA03377, PHA03377, EBNA-3C; Provisional | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 2e-04
Identities = 58/224 (25%), Positives = 64/224 (28%), Gaps = 31/224 (13%)
Query: 5 SSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNS- 63
S A A P LS T P P P P P APPPS A S
Sbjct: 691 PSVDAGRAQPSEESHLSSMSPTQPISHEEQPRYEDPDDPLDLSLHPDQAPPPSHQAPYSG 750
Query: 64 --PPPQPSSPPPPLDAPPPPEVDPSPPSPAQ-PPPQAVAPSPPPPANVPTTPSSSSP--- 117
P +P P P PP +P Q P Q V S P P + P
Sbjct: 751 HEEPQAQQAPYPGYWEPRPP---QAPYLGYQEPQAQGVQVSSYPGYAGPWGLRAQHPRYR 807
Query: 118 ------------PPANVPTTPSSSSPPP-----ANVRTTPSSSSPP--PANVPATPSSSS 158
P P PP A S P P S
Sbjct: 808 HSWAYWSQYPGHGHPQGPWAPRPPHLPPQWDGSAGHGQDQVSQFPHLQSETGPPRLQLSQ 867
Query: 159 PPPVNVPTPPSSSSPPPPSSNPPTST--PSPPVLTPPPHPSQSA 200
P + SSS P SS P + P P PPP P Q +
Sbjct: 868 VPQLPYSQTLVSSSAPSWSSPQPRAPIRPIPTRFPPPPMPLQDS 911
|
Length = 1000 |
| >gnl|CDD|215130 PLN02217, PLN02217, probable pectinesterase/pectinesterase inhibitor | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-04
Identities = 29/87 (33%), Positives = 36/87 (41%), Gaps = 4/87 (4%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPP--TSTPPSPPTAPPPSS 58
P +S P A + S PST P++ PPA SPP S SP T+PP S
Sbjct: 566 PGSTNSTPTGSAASSNTTFSSDSPSTVVAPSTSPPAGHLGSPPATPSKIVSPSTSPPASH 625
Query: 59 PAVNSPPPQPSSPPPPLDAPPPPEVDP 85
+ SP PSSP + P
Sbjct: 626 --LGSPSTTPSSPESSIKVASTETASP 650
|
Length = 670 |
| >gnl|CDD|130706 TIGR01645, half-pint, poly-U binding splicing factor, half-pint family | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 2e-04
Identities = 41/164 (25%), Positives = 52/164 (31%), Gaps = 24/164 (14%)
Query: 70 SPPPPLDAPPPPEVDPSPPSPAQPPPQAV---------APSPPPPANVPTTPSSSSPPPA 120
+PP L P P+ + A A A P A P TPSSS P
Sbjct: 283 TPPDALLQPATVSAIPAAAAVAAAAATAKIMAAEAVAGAAVLGPRAQSPATPSSSLPTDI 342
Query: 121 NVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNP 180
SS+ V P A P+ P P+ +PTP PS
Sbjct: 343 GNKAVVSSAKKEAEEVPPLP----------QAAPAVVKPGPMEIPTPVPPPGLAIPSLVA 392
Query: 181 PT-----STPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPS 219
P + +P L P + PVT TL+ PS
Sbjct: 393 PPGLVAPTEINPSFLASPRKKMKREKLPVTFGALDDTLAWKEPS 436
|
The proteins represented by this model contain three RNA recognition motifs (rrm: pfam00076) and have been characterized as poly-pyrimidine tract binding proteins associated with RNA splicing factors. In the case of PUF60 (GP|6176532), in complex with p54, and in the presence of U2AF, facilitates association of U2 snRNP with pre-mRNA. Length = 612 |
| >gnl|CDD|233045 TIGR00601, rad23, UV excision repair protein Rad23 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 2e-04
Identities = 19/61 (31%), Positives = 23/61 (37%), Gaps = 4/61 (6%)
Query: 12 AVPPPSPPLSPPPSTTPPPTSPPP-ASPPPS---PPTSTPPSPPTAPPPSSPAVNSPPPQ 67
PP + P S P T PP SP S P+ S TA P SP+ + P
Sbjct: 84 VAPPAATPTSAPTPTPSPPASPASGMSAAPASAVEEKSPSEESATATAPESPSTSVPSSG 143
Query: 68 P 68
Sbjct: 144 S 144
|
All proteins in this family for which functions are known are components of a multiprotein complex used for targeting nucleotide excision repair to specific parts of the genome. In humans, Rad23 complexes with the XPC protein. This family is based on the phylogenomic analysis of JA Eisen (1999, Ph.D. Thesis, Stanford University) [DNA metabolism, DNA replication, recombination, and repair]. Length = 378 |
| >gnl|CDD|236333 PRK08691, PRK08691, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 2e-04
Identities = 34/198 (17%), Positives = 52/198 (26%), Gaps = 22/198 (11%)
Query: 24 PSTTPPPTSPPPASPPPSPPTSTPPSPPTAP-----PPSSPAVNSPPPQPSSPPPPLDAP 78
PS P P P T +P P Q ++ PP +
Sbjct: 380 PSAQTAEKETAAKKPQPRPEAETAQTPVQTASAAAMPSEGKTAGPVSNQENNDVPPWEDA 439
Query: 79 PPPEVDPSPPSP-----------AQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPS 127
P + + A+ PP+ N P S P + TP+
Sbjct: 440 PDEAQTAAGTAQTSAKSIQTASEAETPPENQVSKNKAADNETDAPLSEVPSENPIQATPN 499
Query: 128 SSSPPPANVRTTPSSSSPPPANVPATPSSSSPPP--VNVPTPPSSSSPPPPSSNPPTSTP 185
T + P P + PP +P P + P ++
Sbjct: 500 DE---AVETETFAHEAPAEPFYGYGFPDNDCPPEDGAEIPPPDWEHAAPADTAGGGADEE 556
Query: 186 SPPVLTPPPHPSQSAPPP 203
+ + SAPPP
Sbjct: 557 AEAGGIGGN-NTPSAPPP 573
|
Length = 709 |
| >gnl|CDD|166942 PRK00404, tatB, sec-independent translocase; Provisional | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 2e-04
Identities = 21/54 (38%), Positives = 28/54 (51%)
Query: 21 SPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPP 74
PP PPT+ PA P+PP ++ P+ P AP + PA + PP P PP
Sbjct: 85 PAPPEPVTPPTAQSPAPAVPTPPPTSTPAVPPAPAAAVPAPAAAPPPSDPPQPP 138
|
Length = 141 |
| >gnl|CDD|220749 pfam10428, SOG2, RAM signalling pathway protein | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 2e-04
Identities = 25/135 (18%), Positives = 43/135 (31%), Gaps = 5/135 (3%)
Query: 69 SSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSS 128
SS PPL V SP S P TP+ P ++ + +
Sbjct: 146 SSLGPPLQHRKRDAVTASPSSMIARNTPISDRLRPRSV----TPTRGRRPSSSPRSLSNP 201
Query: 129 SSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPP 188
++ + + PP +N + S+ S N+ S ++P S T T
Sbjct: 202 TTLESPSNLQVTTDVPPPYSNGTSRSSTMSSS-ANLSIISSLATPRSGESFRSTPTSGSS 260
Query: 189 VLTPPPHPSQSAPPP 203
+ P ++
Sbjct: 261 SINPVSGLDEAEEDR 275
|
SOG2 proteins in Saccharomyces cerevisiae are involved in cell separation and cytokinesis. Length = 419 |
| >gnl|CDD|220749 pfam10428, SOG2, RAM signalling pathway protein | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 23/133 (17%), Positives = 43/133 (32%), Gaps = 15/133 (11%)
Query: 64 PPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSP--PPPANVPTTPSSSSPPPAN 121
PP + A P + + P + P++V P+ P ++ + + ++ +
Sbjct: 149 GPPLQHRKRDAVTASPSSMIARNTPISDRLRPRSVTPTRGRRPSSSPRSLSNPTTLESPS 208
Query: 122 VPTTPSSSSPPPANVRTTPSSSS-------PPPANVPATPSSSSPPPVNVPTPPSSSSPP 174
+ PP +N + S+ S P + S TP S SS
Sbjct: 209 NLQVTTDVPPPYSNGTSRSSTMSSSANLSIISSLATPRSGESF------RSTPTSGSSSI 262
Query: 175 PPSSNPPTSTPSP 187
P S +
Sbjct: 263 NPVSGLDEAEEDR 275
|
SOG2 proteins in Saccharomyces cerevisiae are involved in cell separation and cytokinesis. Length = 419 |
| >gnl|CDD|227430 COG5099, COG5099, RNA-binding protein of the Puf family, translational repressor [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 44/227 (19%), Positives = 69/227 (30%), Gaps = 9/227 (3%)
Query: 21 SPPPSTTPPPTSPPPASPPPSP-PTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPP 79
+P S++ P T+ +S P TS P PSS + + S PP + P
Sbjct: 172 TPASSSSQPLTNLVVSSIKRFPYLTSLSPFFNYLIDPSSDSATASADTSPSFNPPPNLSP 231
Query: 80 PPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTT 139
S SP P Q+V + ++ +S + +
Sbjct: 232 NNLFSTSDLSPL-PDTQSVENNIILNSSSSINELTSIYGSVPSIRNLRGLNSALVSFLNV 290
Query: 140 PSSSSPPPA-NVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPH--- 195
SSS A N + SP + SSP + T+ +PP P
Sbjct: 291 SSSSLAFSALNGKEVSPTGSPSTRSFARVLPKSSPNNLLTEILTTGVNPPQSLPSLLNPV 350
Query: 196 ---PSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSS 239
S + ++ S S+ S PS+S
Sbjct: 351 FLSTSTGFSLTNLSGYLNPNKNLKKNTLSSLSNLGYSSNVPSPSSSE 397
|
Length = 777 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 3e-04
Identities = 39/187 (20%), Positives = 52/187 (27%), Gaps = 10/187 (5%)
Query: 20 LSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAP-----PPSSPAVNSPPPQPSSPPPP 74
S P P P SPP P + P +S
Sbjct: 758 FSNPSLVPAKLAEALALLEPAEPQRGAGSSPPVRAEAAFRRPGRLRRSGPAADAASRTAS 817
Query: 75 LDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPA 134
D S P A PPP + ++ S + P P
Sbjct: 818 KRKSRSHTPDGGSESSGPARPPGAAARPPPARSSESSKSKPAAAGGRARGKNGRRRPRPP 877
Query: 135 NVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTS----TPSPPVL 190
R P +++PP A A P + +P P P P P PP P P +
Sbjct: 878 EPRARPGAAAPPKAA-AAAPPAGAPAPRPRPAPRVKLGPMPPGGPDPRGGFRRVPPGDLH 936
Query: 191 TPPPHPS 197
TP P +
Sbjct: 937 TPAPSAA 943
|
Length = 1352 |
| >gnl|CDD|178748 PLN03209, PLN03209, translocon at the inner envelope of chloroplast subunit 62; Provisional | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-04
Identities = 34/132 (25%), Positives = 46/132 (34%), Gaps = 18/132 (13%)
Query: 1 PPPQSSPPAVLAVPPPSP-------PLSP-------PPSTTPPPTSPPPASPPPSPPTST 46
P + + P+ PLSP P T+P PT+P SP S +S
Sbjct: 412 VVPSPGSASNVPEVEPAQVEAKKTRPLSPYARYEDLKPPTSPSPTAPTGVSPSVSSTSSV 471
Query: 47 PPSPPTAPPPSSPAVNSPPPQPSSPPPPL----DAPPPPEVDPSPPSPAQPPPQAVAPSP 102
P P TAP ++ +PPP P P D PP P+ P P
Sbjct: 472 PAVPDTAPATAATDAAAPPPANMRPLSPYAVYDDLKPPTSPSPAAPVGKVAPSSTNEVVK 531
Query: 103 PPPANVPTTPSS 114
+ PT +
Sbjct: 532 VGNSAPPTALAD 543
|
Length = 576 |
| >gnl|CDD|217392 pfam03153, TFIIA, Transcription factor IIA, alpha/beta subunit | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 3e-04
Identities = 33/169 (19%), Positives = 51/169 (30%), Gaps = 13/169 (7%)
Query: 106 ANVPTTPSSSSPPP--------ANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSS 157
A P PS +PPP P T + + P + + + + P AN PAT +
Sbjct: 45 AEFPWDPSPQAPPPVAQLPQPLPQPPPTQALQALPAGDQQQHNTPTGSPAANPPATFALP 104
Query: 158 -SPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPP 216
P + T P P P P +P P+Q + + S
Sbjct: 105 AGPAGPTIQTEPGQLYPV----QVPVMVTQNPANSPLDQPAQQRALQQLQQRYGAPASGQ 160
Query: 217 PPSVPSTSSPPAVSPPAPPSNSSTRGSPSTPPLPSVPTEKPTAKSTNGT 265
PS ++ S N T + + +GT
Sbjct: 161 LPSQQQSAQKNDESQLQQQPNGETPPQQTDGAGDDESEALVRLREADGT 209
|
Transcription initiation factor IIA (TFIIA) is a heterotrimer, the three subunits being known as alpha, beta, and gamma, in order of molecular weight. The N and C-terminal domains of the gamma subunit are represented in pfam02268 and pfam02751, respectively. This family represents the precursor that yields both the alpha and beta subunits. The TFIIA heterotrimer is an essential general transcription initiation factor for the expression of genes transcribed by RNA polymerase II. Together with TFIID, TFIIA binds to the promoter region; this is the first step in the formation of a pre-initiation complex (PIC). Binding of the rest of the transcription machinery follows this step. After initiation, the PIC does not completely dissociate from the promoter. Some components, including TFIIA, remain attached and re-initiate a subsequent round of transcription. Length = 332 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 3e-04
Identities = 16/108 (14%), Positives = 28/108 (25%), Gaps = 3/108 (2%)
Query: 134 ANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPP--SSNPPTSTPSPPVLT 191
P+++ PPPA PA S + P P P + + P
Sbjct: 53 PPAAAAPAAAQPPPAAAPAAVSRPAAPAAE-PAPWLVEHAKRLTAQREQLVARAAAPAAP 111
Query: 192 PPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSS 239
P+ A ++ + A + A +
Sbjct: 112 EAQAPAAPAERAAAENAARRLARAAAAAPRPRVPADAAAAVADAVKAR 159
|
Length = 484 |
| >gnl|CDD|184918 PRK14954, PRK14954, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-04
Identities = 20/102 (19%), Positives = 30/102 (29%), Gaps = 12/102 (11%)
Query: 168 PSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPP 227
P P+ +P +P P P + P P A P P+++ P
Sbjct: 376 NDGGVAPSPAGSPDVKKKAPEP--DLPQPDRHPGP---AKPEAPGARPAELPSPASAPTP 430
Query: 228 AVSPPAPPSNSSTRGSPSTPPLPSVPTEKPTAKSTNGTAVSA 269
PP S PP P + A G + +
Sbjct: 431 EQQPPVARS-------APLPPSPQASAPRNVASGKPGVDLGS 465
|
Length = 620 |
| >gnl|CDD|184918 PRK14954, PRK14954, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-04
Identities = 21/80 (26%), Positives = 27/80 (33%), Gaps = 11/80 (13%)
Query: 47 PPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPP--------PPEVDPSPPSPAQPPPQAV 98
P SP V P+P P P P P PSP S P P+
Sbjct: 376 NDGGVAPSPAGSPDVKKKAPEPDLPQPDRHPGPAKPEAPGARPAELPSPASA--PTPEQQ 433
Query: 99 APSPPPPANVPTTPSSSSPP 118
P +P +P +S+P
Sbjct: 434 PPVARSAP-LPPSPQASAPR 452
|
Length = 620 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 37/125 (29%), Positives = 43/125 (34%), Gaps = 35/125 (28%)
Query: 8 PAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAV-NSPPP 66
PA P PP P + P + PP PPP+ P + P P A PP PA N+PPP
Sbjct: 34 PATANADPAPPPPPPSTAAAAPAPAAPPPPPPPAAPPAPQPDDPNAAPPPPPADPNAPPP 93
Query: 67 QPSSPPPPLDAPPPP----------------------------------EVDPSPPSPAQ 92
P P P P P + PP P Q
Sbjct: 94 PPVDPNAPPPPAPEPGRIDNAVGGFSYVVPAGWVESDATHLDYGSALLSKTTGEPPMPGQ 153
Query: 93 PPPQA 97
PPP A
Sbjct: 154 PPPVA 158
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|225987 COG3456, COG3456, Predicted component of the type VI protein secretion system, contains a FHA domain [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 3e-04
Identities = 35/134 (26%), Positives = 47/134 (35%), Gaps = 9/134 (6%)
Query: 29 PPTSPPPASPPPSPPTSTPP----SPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVD 84
P S P P S +ST P P P + P Q + P P + P
Sbjct: 109 PDESDPDTGSPQSAVSSTDMDDDFLADIEPEPRLPPGLTDPLQLADPVPNGFSADPLSAL 168
Query: 85 PSPPSPAQPPPQAVAPSPPPPANVP--TTPSSSS---PPPANVPTTPSSSSPPPANVRTT 139
S AQP P APS + P S+ P P ++ P ++SPP T
Sbjct: 169 QSESLIAQPDPAGGAPSISRNSEAPLSDPASAGGIDTPFPDDLDVPPIAASPPGPQEGPT 228
Query: 140 PSSSSPPPANVPAT 153
S+S P +
Sbjct: 229 ISASQPAQRDHAVL 242
|
Length = 430 |
| >gnl|CDD|223044 PHA03325, PHA03325, nuclear-egress-membrane-like protein; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 32/168 (19%), Positives = 44/168 (26%), Gaps = 15/168 (8%)
Query: 48 PSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPAN 107
S PT+ P + L E P PA PP PP
Sbjct: 266 SSLPTSAPKRRSRRAGAMRAAAGETADLADDDGSEHSDPEPLPASLPP------PPVRRP 319
Query: 108 VPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTP 167
P + P + A P++S+ + A S
Sbjct: 320 RVKHPEAGKEEPDG-------ARNAEAKEPAQPATSTSSKGSSSAQNKDSGSTGPGSSLA 372
Query: 168 PSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSP 215
+SS P + + P SAP P S P + LS
Sbjct: 373 AASSFLEDDDFGSPPLDLTTSLRHMPSPSVTSAPEPP--SIPLTYLSD 418
|
Length = 418 |
| >gnl|CDD|218621 pfam05518, Totivirus_coat, Totivirus coat protein | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 3e-04
Identities = 29/140 (20%), Positives = 39/140 (27%), Gaps = 18/140 (12%)
Query: 105 PANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPAT-PSSSSPPPV- 162
A V S PP P P R + P VP P+ ++ P
Sbjct: 624 RATVGEMIISGFPPVFKTA------LPRPDYNRGGEAGGPGVPGPVPVGMPAHTARPSRV 677
Query: 163 -----NVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPP 217
PT ++ P + P L PPP +A P P +
Sbjct: 678 ARGDPVRPTAHHAALRAPQAPRPGGPPGGGGGLPPPPDLPAAAGP-----APCGSSLIAS 732
Query: 218 PSVPSTSSPPAVSPPAPPSN 237
P+ P PP N
Sbjct: 733 PTAPPEPEPPGAEQADGAEN 752
|
Length = 753 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 3e-04
Identities = 32/125 (25%), Positives = 48/125 (38%), Gaps = 44/125 (35%)
Query: 504 IHRDIKSSNILLDSSFEARVADFGLA---------------------------------- 529
IHRDIK NIL+D +++DFGL+
Sbjct: 123 IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVD 182
Query: 530 KIALELDSNTHVST-----RVM-----GTFGYMAPEYATSGKLTEKSDVYSFGVVLLELI 579
I L + S ++T R+M GT Y+APE ++ D +S G ++ E +
Sbjct: 183 SINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECL 242
Query: 580 TGRKP 584
G P
Sbjct: 243 IGWPP 247
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|237782 PRK14666, uvrC, excinuclease ABC subunit C; Provisional | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 3e-04
Identities = 24/105 (22%), Positives = 33/105 (31%), Gaps = 10/105 (9%)
Query: 3 PQSSPPAVLAVP--PPSP-----PLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPP 55
PQS+ P + VP P + L+P T P P +P S+ P P A
Sbjct: 303 PQSTIPPRIVVPWLPDTEGREGDDLAPTAVCTDAGLLPDTPLLPDAPEGSSDPVVPVAAA 362
Query: 56 PS---SPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQA 97
S P+S A P + A P+
Sbjct: 363 TPVDASLPDVRTGTAPTSLANVSHADPAVAQPTQAATLAGAAPKG 407
|
Length = 694 |
| >gnl|CDD|183854 PRK13042, PRK13042, superantigen-like protein; Reviewed | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 25/68 (36%), Positives = 29/68 (42%), Gaps = 8/68 (11%)
Query: 19 PLSPPPSTTP-PPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDA 77
P S PPST P S P A+ PPS P P A PSS V +P P
Sbjct: 41 PQSTPPSTKVEAPQSKPNATTPPSTKVEAPQQTPNATTPSSTKVE-------TPQSPTTK 93
Query: 78 PPPPEVDP 85
P E++P
Sbjct: 94 QVPTEINP 101
|
Length = 291 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (103), Expect = 3e-04
Identities = 29/102 (28%), Positives = 50/102 (49%), Gaps = 23/102 (22%)
Query: 502 RIIHRDIKSSNILLDSSFE-----------------ARVADFGLAKIALELDSNTHVSTR 544
R++HRD+K NI L + A++ DFGL+K + ++S H
Sbjct: 145 RVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK-NIGIESMAH---S 200
Query: 545 VMGTFGYMAPEYA--TSGKLTEKSDVYSFGVVLLELITGRKP 584
+GT Y +PE + +KSD+++ G ++ EL +G+ P
Sbjct: 201 CVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242
|
Length = 1021 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.0 bits (102), Expect = 3e-04
Identities = 48/194 (24%), Positives = 75/194 (38%), Gaps = 45/194 (23%)
Query: 425 RAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRP--------VM 476
E EI++ + H L +L +E LV +Y P L L + +P
Sbjct: 49 LTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLL--QRQPGKCLSEEVAR 106
Query: 477 DWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAK------ 530
+A V +A + YLH I++RD+K NILL S ++DF L+K
Sbjct: 107 FYAAEVLLA------LEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157
Query: 531 -------IALELDSNTH----------VSTRVM---GTFGYMAPEYATSGKLTEKSDVYS 570
S+ + S R GT Y+APE + D ++
Sbjct: 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWT 217
Query: 571 FGVVLLELITGRKP 584
G++L E++ G P
Sbjct: 218 LGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 4e-04
Identities = 26/144 (18%), Positives = 44/144 (30%)
Query: 66 PQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTT 125
+P+ P + PP + + P + A S +P + +
Sbjct: 775 LEPAEPQRGAGSSPPVRAEAAFRRPGRLRRSGPAADAASRTASKRKSRSHTPDGGSESSG 834
Query: 126 PSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTP 185
P+ A SS S A + P PP + P ++ P +
Sbjct: 835 PARPPGAAARPPPARSSESSKSKPAAAGGRARGKNGRRRPRPPEPRARPGAAAPPKAAAA 894
Query: 186 SPPVLTPPPHPSQSAPPPVTKSPP 209
+PP P P P + + PP
Sbjct: 895 APPAGAPAPRPRPAPRVKLGPMPP 918
|
Length = 1352 |
| >gnl|CDD|236940 PRK11633, PRK11633, cell division protein DedD; Provisional | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 4e-04
Identities = 16/67 (23%), Positives = 17/67 (25%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
S PA +A P P P P P P P P P P P
Sbjct: 80 AAAPSLDPATVAPPNTPVEPEPAPVEPPKPKPVEKPKPKPKPQQKVEAPPAPKPEPKPVV 139
Query: 61 VNSPPPQ 67
P
Sbjct: 140 EEKAAPT 146
|
Length = 226 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 24/66 (36%), Positives = 30/66 (45%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
PPP A A P +PP PPP+ P P P + PP PP PP P++P
Sbjct: 43 PPPPPPSTAAAAPAPAAPPPPPPPAAPPAPQPDDPNAAPPPPPADPNAPPPPPVDPNAPP 102
Query: 61 VNSPPP 66
+P P
Sbjct: 103 PPAPEP 108
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|234818 PRK00708, PRK00708, sec-independent translocase; Provisional | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 4e-04
Identities = 24/107 (22%), Positives = 38/107 (35%), Gaps = 8/107 (7%)
Query: 53 APPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTP 112
A S PA + P + ++P P+ P P PA P P A P
Sbjct: 99 ATSMSEPATENKPAEVTTPVEPMGLPETP--------PAVPVPAPAPAVAAAAAQAAAAP 150
Query: 113 SSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSP 159
+ + P A P + ++P P T + A P +++P
Sbjct: 151 KAPAKPRAKSPRPAAKAAPKPTETITAKKAKKTAAAPKPTADKTATP 197
|
Length = 209 |
| >gnl|CDD|218621 pfam05518, Totivirus_coat, Totivirus coat protein | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 4e-04
Identities = 28/120 (23%), Positives = 31/120 (25%), Gaps = 16/120 (13%)
Query: 3 PQSSPPAVLAVPPPSPPLSP------PPSTTPPPTSPPPASPPPSPPTSTPPSPPT---- 52
S P V P P + P P P P + PS P PT
Sbjct: 631 IISGFPPVFKTALPRPDYNRGGEAGGPGVPGPVPVGMPAHTARPSRVARGDPVRPTAHHA 690
Query: 53 ---APPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPS---PPSPAQPPPQAVAPSPPPPA 106
AP P PPP L A P S A P P+ A
Sbjct: 691 ALRAPQAPRPGGPPGGGGGLPPPPDLPAAAGPAPCGSSLIASPTAPPEPEPPGAEQADGA 750
|
Length = 753 |
| >gnl|CDD|233045 TIGR00601, rad23, UV excision repair protein Rad23 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 4e-04
Identities = 18/75 (24%), Positives = 25/75 (33%), Gaps = 7/75 (9%)
Query: 25 STTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVD 84
P T +P PSPP S +A P S+ SP + ++ A P
Sbjct: 84 VAPPAATPTSAPTPTPSPPASPASGM-SAAPASAVEEKSPSEESAT------ATAPESPS 136
Query: 85 PSPPSPAQPPPQAVA 99
S PS +
Sbjct: 137 TSVPSSGSDAASTLV 151
|
All proteins in this family for which functions are known are components of a multiprotein complex used for targeting nucleotide excision repair to specific parts of the genome. In humans, Rad23 complexes with the XPC protein. This family is based on the phylogenomic analysis of JA Eisen (1999, Ph.D. Thesis, Stanford University) [DNA metabolism, DNA replication, recombination, and repair]. Length = 378 |
| >gnl|CDD|233045 TIGR00601, rad23, UV excision repair protein Rad23 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 4e-04
Identities = 21/80 (26%), Positives = 28/80 (35%), Gaps = 8/80 (10%)
Query: 27 TPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPS 86
+ P T +PP + PTS P+P +PP S P S P + S
Sbjct: 75 SKPKTGTGKVAPPAATPTS-APTPTPSPPAS-------PASGMSAAPASAVEEKSPSEES 126
Query: 87 PPSPAQPPPQAVAPSPPPPA 106
+ A P PS A
Sbjct: 127 ATATAPESPSTSVPSSGSDA 146
|
All proteins in this family for which functions are known are components of a multiprotein complex used for targeting nucleotide excision repair to specific parts of the genome. In humans, Rad23 complexes with the XPC protein. This family is based on the phylogenomic analysis of JA Eisen (1999, Ph.D. Thesis, Stanford University) [DNA metabolism, DNA replication, recombination, and repair]. Length = 378 |
| >gnl|CDD|166942 PRK00404, tatB, sec-independent translocase; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 4e-04
Identities = 20/55 (36%), Positives = 26/55 (47%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPP 55
PP P P+P + PP T+ P P PA+ P+P + PPS P PP
Sbjct: 84 PPAPPEPVTPPTAQSPAPAVPTPPPTSTPAVPPAPAAAVPAPAAAPPPSDPPQPP 138
|
Length = 141 |
| >gnl|CDD|235899 PRK06975, PRK06975, bifunctional uroporphyrinogen-III synthetase/uroporphyrin-III C-methyltransferase; Reviewed | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 4e-04
Identities = 18/56 (32%), Positives = 21/56 (37%), Gaps = 2/56 (3%)
Query: 8 PAVLAVPPPSPPLSPPPST--TPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAV 61
A P PS S T P + A PP P +TPP PP S A+
Sbjct: 271 QPATAAPAPSRMTDTNDSKSVTSQPAAAAAAPAPPPNPPATPPEPPARRGRGSAAL 326
|
Length = 656 |
| >gnl|CDD|165468 PHA03201, PHA03201, uracil DNA glycosylase; Provisional | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 4e-04
Identities = 27/87 (31%), Positives = 36/87 (41%), Gaps = 7/87 (8%)
Query: 154 PSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKS-----P 208
S SP P P+PP + P P ++P + PSPP P P ++A P + P
Sbjct: 4 ARSRSPSPPRRPSPPRPTPPRSPDASPEETPPSPPGPGAEPPPGRAAGPAAPRRRPRGCP 63
Query: 209 PASTLSPPPPSVPST--SSPPAVSPPA 233
T S P P PA +PP
Sbjct: 64 AGVTFSSSAPPRPPLGLDDAPAATPPP 90
|
Length = 318 |
| >gnl|CDD|221818 pfam12868, DUF3824, Domain of unknwon function (DUF3824) | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 4e-04
Identities = 29/79 (36%), Positives = 33/79 (41%)
Query: 15 PPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPP 74
P P PP P P ++ P PP STP PP P +PA PPP PP
Sbjct: 53 PYDPTPYPPSPPVSDPRYYPNSNYFPPPPGSTPVPPPGPQPGYNPADYPPPPGAVPPPQN 112
Query: 75 LDAPPPPEVDPSPPSPAQP 93
PP P DP P P +
Sbjct: 113 YPYPPGPGQDPYAPRPRRA 131
|
This is a repeating domain found in fungal proteins. It is proline-rich, and the function is not known. Length = 135 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 4e-04
Identities = 30/151 (19%), Positives = 56/151 (37%), Gaps = 18/151 (11%)
Query: 389 LGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVS--LVGYC 446
L G VY + + +K + + EV I+ + + L ++
Sbjct: 6 LKGGLTNRVYL-LGTKDEDYVLKI--NPSREKGADREREVAILQLLARKGLPVPKVLASG 62
Query: 447 ISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPR--II 504
S+ L+ E++ +TL + E + D A ++ A +A LH+ P +
Sbjct: 63 ESDGWSYLLMEWIEGETL-DEVSEEEKE--DIAEQL------AELLAKLHQ--LPLLVLC 111
Query: 505 HRDIKSSNILLDSSFEARVADFGLAKIALEL 535
H D+ NIL+D + D+ A
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWEYAGYGPPA 142
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 54/244 (22%), Positives = 93/244 (38%), Gaps = 41/244 (16%)
Query: 383 FSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGERE----FRAEVEIISRVHHRH 438
F + V+G G FG V D + ++ E+E RAE +I+
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 439 LVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHED 498
+V + +R L+ E++P + L + + + AT+ +A I +H+
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKD-TLSEEATQFYIAE-TVLAIDAIHQ- 119
Query: 499 CHPRIIHRDIKSSNILLDSSFEARVADFGLA----------------------------- 529
IHRDIK N+LLD+ +++DFGL
Sbjct: 120 --LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177
Query: 530 ---KIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVD 586
K + ++ +GT Y+APE + D +S GV++ E++ G P
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237
Query: 587 ASQP 590
+ P
Sbjct: 238 SETP 241
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 5e-04
Identities = 31/130 (23%), Positives = 40/130 (30%), Gaps = 21/130 (16%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPP--------ASPPPSPPTSTP----- 47
P P A +P + P PPP ASP P+ P + P
Sbjct: 464 PAAAGPRPVAAAAAAAPARAAPAAAPAPADDDPPPWEELPPEFASPAPAQPDAAPAGWVA 523
Query: 48 ---PSPPTAPPPSS-PAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQP--PPQAVAPS 101
P P TA P + + P +P A P V P PP + P
Sbjct: 524 ESIPDPATADPDDAFETLAPAPAAAPAPRAA--AATEPVVAPRPPRASASGLPDMFDGDW 581
Query: 102 PPPPANVPTT 111
P A +P
Sbjct: 582 PALAARLPVR 591
|
Length = 700 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 43.0 bits (102), Expect = 5e-04
Identities = 16/77 (20%), Positives = 26/77 (33%)
Query: 139 TPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQ 198
+ ++ +PPP P + +PP +PPPP ++ + P P
Sbjct: 518 SNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPADSSPP 577
Query: 199 SAPPPVTKSPPASTLSP 215
P P SP
Sbjct: 578 PPIPEEPTPSPTKDSSP 594
|
Length = 620 |
| >gnl|CDD|218881 pfam06070, Herpes_UL32, Herpesvirus large structural phosphoprotein UL32 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 5e-04
Identities = 35/263 (13%), Positives = 63/263 (23%), Gaps = 14/263 (5%)
Query: 15 PPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPP 74
+ PP+ S + +PPS P+S ++ + P
Sbjct: 438 SIAVSSDGITDVLDPPSPLRLHSSDKVIDSVSPPSKRRVSAPAS-RLDDAKRPEVTATPE 496
Query: 75 LDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPA 134
++V + + S PP + + +
Sbjct: 497 SSGSDSEGGASGREDETSSDAESVVSIKELRPRIGFI-NKSPPPKSPPKSRRTLIVALSL 555
Query: 135 NVRTTPSSSSPPPA--------NVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPS 186
+T S P P+ + A ++ SS P S
Sbjct: 556 ASPSTAGSPRPKPSLGKFVIGTDPFAFANTVRLTDNMRGGNGVGSSVKPKGSASSKPLTG 615
Query: 187 P-PVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPS 245
P L P + P + + +PS + P S+ +
Sbjct: 616 PGSDLKPATLNGK-TPSSSLVGAARNAGASSKVKIPSGLG--GFTSPISLLESALEDVLT 672
Query: 246 TPPLPSVPTEKPTAKSTNGTAVS 268
+ V P TNG
Sbjct: 673 SATSTPVKKNDPYLWDTNGEKAG 695
|
The large phosphorylated protein (UL32-like) of herpes viruses is the polypeptide most frequently reactive in immuno-blotting analyses with antisera when compared with other viral proteins. Length = 777 |
| >gnl|CDD|223061 PHA03369, PHA03369, capsid maturational protease; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 5e-04
Identities = 18/96 (18%), Positives = 29/96 (30%), Gaps = 4/96 (4%)
Query: 36 ASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPP 95
+ PS + P + + +P P + P SP + P P
Sbjct: 352 SLTAPSRVLAAAAKVAVIAAPQTHTGPADRQRPQRPDGIPYSVPAR----SPMTAYPPVP 407
Query: 96 QAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSP 131
Q P +P +S P P P ++P
Sbjct: 408 QFCGDPGLVSPYNPQSPGTSYGPEPVGPVPPQPTNP 443
|
Length = 663 |
| >gnl|CDD|217469 pfam03276, Gag_spuma, Spumavirus gag protein | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 5e-04
Identities = 31/109 (28%), Positives = 39/109 (35%), Gaps = 9/109 (8%)
Query: 38 PPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDP--SPPSPAQPP- 94
P PP P S PS+ P + P +P PSPAQP
Sbjct: 179 GGNIPGAIQPPPPS---SLPGLPPGSSSLAPSASSTPGNRLPRVSFNPFLPGPSPAQPSA 235
Query: 95 PQAVAPSPPPPANVPTTPSSSSPPP-ANVPTT--PSSSSPPPANVRTTP 140
P A P+PP P + PPP +P + + PAN R P
Sbjct: 236 PPASIPAPPIPPVIQYVAPPPVPPPQPIIPIQHIRAVTGETPANPRDIP 284
|
Length = 582 |
| >gnl|CDD|236382 PRK09111, PRK09111, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 43.0 bits (102), Expect = 5e-04
Identities = 18/85 (21%), Positives = 24/85 (28%), Gaps = 14/85 (16%)
Query: 23 PPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPE 82
PPS PP P P ++P + P P L A P
Sbjct: 391 PPSPGGGGGGPPGGGGAPGAP----------AAAAAPGAAAAAPAAGGPAAALAAVP--- 437
Query: 83 VDPSPPSPAQPPPQAVAPSPPPPAN 107
D + + A P P A +
Sbjct: 438 -DAAAAAAAPPAPAAAPQPAVRLNS 461
|
Length = 598 |
| >gnl|CDD|183756 PRK12799, motB, flagellar motor protein MotB; Reviewed | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 5e-04
Identities = 31/124 (25%), Positives = 48/124 (38%), Gaps = 5/124 (4%)
Query: 84 DPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSS 143
+ P A P AV S + PS + P T S++ A+ S+
Sbjct: 296 HGTVPVAAVTPSSAVTQSSAITPSSAAIPSPAVIP---SSVTTQSATTTQASAVALSSAG 352
Query: 144 -SPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSN-PPTSTPSPPVLTPPPHPSQSAP 201
P +P T + + PVN+ P S++ SS TST + P + P P+ + P
Sbjct: 353 VLPSDVTLPGTVALPAAEPVNMQPQPMSTTETQQSSTGNITSTANGPTTSLPAAPASNIP 412
Query: 202 PPVT 205
T
Sbjct: 413 VSPT 416
|
Length = 421 |
| >gnl|CDD|218621 pfam05518, Totivirus_coat, Totivirus coat protein | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 5e-04
Identities = 23/122 (18%), Positives = 32/122 (26%), Gaps = 9/122 (7%)
Query: 10 VLAVPPPSPPLSPPPSTTPPPTSPPPASP---PPSPPTSTPPSPPTA---PPPSSPAVNS 63
+ PP P P + P P P P T A P + +
Sbjct: 632 ISGFPPVFKTALPRPDYNRGGEAGGPGVPGPVPVGMPAHTARPSRVARGDPVRPTAHHAA 691
Query: 64 -PPPQPSSPPPPLDAPP--PPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPA 120
PQ P P PP D + P ++ SP P + +
Sbjct: 692 LRAPQAPRPGGPPGGGGGLPPPPDLPAAAGPAPCGSSLIASPTAPPEPEPPGAEQADGAE 751
Query: 121 NV 122
N
Sbjct: 752 NQ 753
|
Length = 753 |
| >gnl|CDD|222010 pfam13254, DUF4045, Domain of unknown function (DUF4045) | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 5e-04
Identities = 33/148 (22%), Positives = 48/148 (32%), Gaps = 16/148 (10%)
Query: 23 PPSTTPPPTSPPPASPPPSPPTSTPPSPP-------TAPPPSSPAVNSPPPQPSSPPPPL 75
+ +PPP S SP S P P T P +S + SS P P
Sbjct: 200 EVTPVGLMRTPPPGSHSKSPSKSGIPDLPSSRDSEKTKPEKPQQETSSMDTEKSSAPKPR 259
Query: 76 DAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPAN 135
+ P + +PP +P P + + SP +PS + P
Sbjct: 260 ETLDPKSPEKAPPIDTTEEELK-SPEASPKESEEASARKRSPS----LLSPSPKAESPKP 314
Query: 136 VRTTPSSSSPPPANVPATPSSSSPPPVN 163
+ + S P + P PPVN
Sbjct: 315 LASPGKSPRDPLSPRPKP----QSPPVN 338
|
This presumed domain is functionally uncharacterized. This domain family is found in bacteria and eukaryotes, and is typically between 384 and 430 amino acids in length. Length = 414 |
| >gnl|CDD|233045 TIGR00601, rad23, UV excision repair protein Rad23 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 5e-04
Identities = 16/73 (21%), Positives = 28/73 (38%)
Query: 151 PATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPA 210
P T + PP PT + +P PP+S + +P PS+ + P+
Sbjct: 77 PKTGTGKVAPPAATPTSAPTPTPSPPASPASGMSAAPASAVEEKSPSEESATATAPESPS 136
Query: 211 STLSPPPPSVPST 223
+++ ST
Sbjct: 137 TSVPSSGSDAAST 149
|
All proteins in this family for which functions are known are components of a multiprotein complex used for targeting nucleotide excision repair to specific parts of the genome. In humans, Rad23 complexes with the XPC protein. This family is based on the phylogenomic analysis of JA Eisen (1999, Ph.D. Thesis, Stanford University) [DNA metabolism, DNA replication, recombination, and repair]. Length = 378 |
| >gnl|CDD|233045 TIGR00601, rad23, UV excision repair protein Rad23 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 5e-04
Identities = 21/77 (27%), Positives = 29/77 (37%), Gaps = 4/77 (5%)
Query: 137 RTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHP 196
+T +PP A + P+ + PP +P S S P S+ S P
Sbjct: 78 KTGTGKVAPPAATPTSAPTPTPSPP---ASPASGMSAAPASAVEEKSPSEESATATAPES 134
Query: 197 SQSAPPPVTKSPPASTL 213
S P + S ASTL
Sbjct: 135 P-STSVPSSGSDAASTL 150
|
All proteins in this family for which functions are known are components of a multiprotein complex used for targeting nucleotide excision repair to specific parts of the genome. In humans, Rad23 complexes with the XPC protein. This family is based on the phylogenomic analysis of JA Eisen (1999, Ph.D. Thesis, Stanford University) [DNA metabolism, DNA replication, recombination, and repair]. Length = 378 |
| >gnl|CDD|183854 PRK13042, PRK13042, superantigen-like protein; Reviewed | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 5e-04
Identities = 22/67 (32%), Positives = 28/67 (41%), Gaps = 4/67 (5%)
Query: 25 STTPPPTS-PPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPP---LDAPPP 80
+TTP T P S PPS P S P A P S V +P P++ P ++ P
Sbjct: 30 ATTPSSTKVEAPQSTPPSTKVEAPQSKPNATTPPSTKVEAPQQTPNATTPSSTKVETPQS 89
Query: 81 PEVDPSP 87
P P
Sbjct: 90 PTTKQVP 96
|
Length = 291 |
| >gnl|CDD|177328 PHA01929, PHA01929, putative scaffolding protein | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 5e-04
Identities = 26/96 (27%), Positives = 37/96 (38%), Gaps = 4/96 (4%)
Query: 8 PAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSP----AVNS 63
++A PP+ +P P+ P +P P +P P+ P P+S V
Sbjct: 13 AGLVANVPPAAAPTPQPNPVIQPQAPVQPGQPGAPQQLAIPTQQPQPVPTSAMTPHVVQQ 72
Query: 64 PPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVA 99
P QP+ PP PE PP PA P +
Sbjct: 73 APAQPAPAAPPAAGAALPEALEVPPPPAFTPNGEIV 108
|
Length = 306 |
| >gnl|CDD|219927 pfam08601, PAP1, Transcription factor PAP1 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 5e-04
Identities = 31/157 (19%), Positives = 50/157 (31%), Gaps = 9/157 (5%)
Query: 93 PPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPA 152
P P P ++ SS P N +T S+ S P N S SS N
Sbjct: 34 PGACGTKNCPIPKLAKNSSVSSPVPGLLN--STESNVSSPNNNPNGYTSPSSAAMNNKSN 91
Query: 153 TPSSSSPPPVN---VPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPP 209
+ + +P S ++ S+ P +Q T P
Sbjct: 92 NRAVDPSANASAASTNSPNGLQSSATQYNSNDNSSSDSPSSGSDGFTNQLLSSLGTSPEP 151
Query: 210 ASTLSPPPPSVPSTSSPPAVSPPAPP-SNSSTRGSPS 245
++ PP + S ++ A+ A SN + S +
Sbjct: 152 STE---SPPQLASVNNFAAIRNNAESNSNVPSAASST 185
|
The transcription factor Pap1 regulates antioxidant-gene transcription in response to H2O2. This region is cysteine rich. Alkylation of cysteine residues following treatment with a cysteine alkylating agent can mask the accessibility of the nuclear exporter Crm1, triggering nuclear accumulation and Pap1 dependent transcriptional expression. Length = 344 |
| >gnl|CDD|185628 PTZ00449, PTZ00449, 104 kDa microneme/rhoptry antigen; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 6e-04
Identities = 41/210 (19%), Positives = 52/210 (24%), Gaps = 20/210 (9%)
Query: 2 PPQSSPPAVLAVP--PPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAP-PPSS 58
P P +L +P P P P PPP P P P P PP +P PP
Sbjct: 609 PKSPKLPELLDIPKSPKRPESPKSPKRPPPPQRPSSPERPEGPKIIKSPKPPKSPKPPFD 668
Query: 59 PAVNS--------PPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPT 110
P + + E P P P P PP +P
Sbjct: 669 PKFKEKFYDDYLDAAAKSKETKTTVVLDESFESILKETLPETPGTPFTTPRPLPPK-LPR 727
Query: 111 TPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSS 170
P + P + P T P PA
Sbjct: 728 DEEFPFEPIGD----PDAEQPDDIEFFTPPEEERTFFHETPADTPLPDILAEEFKEEDIH 783
Query: 171 S---SPPPPSSNPPTSTPSPPVLTPPPHPS 197
+ P P + + P HPS
Sbjct: 784 AETGEPDEAMKRPDSPSEHEDK-PPGDHPS 812
|
Length = 943 |
| >gnl|CDD|217495 pfam03326, Herpes_TAF50, Herpesvirus transcription activation factor (transactivator) | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 6e-04
Identities = 34/187 (18%), Positives = 42/187 (22%), Gaps = 11/187 (5%)
Query: 5 SSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSP 64
S P A P PP + P P S P
Sbjct: 305 SRPSCFPAPSTTQPTFLPPNTNKKAKRDRRPQMVTPKQEGGAAVSQNHDGGTVRAPRGRP 364
Query: 65 PPQPSSPPPPLDAPPPPEVDPSPP----SPAQPPPQAVAPSPPPPANVPTTPSSSSPP-P 119
SPP PS + PP P TP SS P P
Sbjct: 365 SGSGQSPPSNSPLLSSLADTPSGAAHQPASLLPPAVVQQQLEDASDKQPPTPGSSLVPQP 424
Query: 120 ANVPTTPSSSSPPPANVR--TTPSSSSPPPANVPATPSSSSPPPV----NVPTPPSSSSP 173
PS + + + P ++ P+ T P S SP
Sbjct: 425 DEQELGPSVMALLDRDQGILALILAPIPGLYDLSGPPNLLLDTISQELQQSTTDPLSDSP 484
Query: 174 PPPSSNP 180
S
Sbjct: 485 RRQLSFF 491
|
This family includes EBV BRLF1 and similar ORF 50 proteins from other herpesviruses. Length = 500 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 6e-04
Identities = 20/96 (20%), Positives = 34/96 (35%), Gaps = 7/96 (7%)
Query: 138 TTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPS 197
T +++ P PA P ++P P ++ +P PS + P+
Sbjct: 165 DTSTTTDPATTPAPAAPVDTTPTNSQTPAVATAPAPAVDPQQNAVVAPSQANVDTAATPA 224
Query: 198 QSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPA 233
+AP + P P+ + S PA P A
Sbjct: 225 PAAPATPDGAAPL-------PTDQAGVSTPAADPNA 253
|
Length = 331 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 6e-04
Identities = 23/73 (31%), Positives = 28/73 (38%)
Query: 60 AVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPP 119
N+ P P PP A P P P PP PA PP P P P++ PPP
Sbjct: 36 TANADPAPPPPPPSTAAAAPAPAAPPPPPPPAAPPAPQPDDPNAAPPPPPADPNAPPPPP 95
Query: 120 ANVPTTPSSSSPP 132
+ P + P
Sbjct: 96 VDPNAPPPPAPEP 108
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|225987 COG3456, COG3456, Predicted component of the type VI protein secretion system, contains a FHA domain [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 6e-04
Identities = 23/99 (23%), Positives = 30/99 (30%), Gaps = 3/99 (3%)
Query: 19 PLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAP 78
P PP T P + P + + P S S P + S P +
Sbjct: 140 PRLPPGLTDPLQLADPVPNGFSADPLSALQSESLIAQPDPAGGAPSISRNSEAP---LSD 196
Query: 79 PPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSP 117
P P P +A SPP P PT +S
Sbjct: 197 PASAGGIDTPFPDDLDVPPIAASPPGPQEGPTISASQPA 235
|
Length = 430 |
| >gnl|CDD|219916 pfam08580, KAR9, Yeast cortical protein KAR9 | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 6e-04
Identities = 37/174 (21%), Positives = 56/174 (32%), Gaps = 15/174 (8%)
Query: 112 PSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSP----PPVNVPTP 167
S SS + S S + + SS P ++V TP S P V TP
Sbjct: 367 DSQSSKIQQIRDSISVSGSDYSNPGSSIDTPSSSPSSSVIMTPPDSGPGSNVSSRRVGTP 426
Query: 168 PSSSSPPPPSSNPPTSTPSPPVLTPPP---HPSQSAPPPVTKSPPASTL--SPPPPSVPS 222
S S + P L P + S SP +STL PPP
Sbjct: 427 GSKSDRVGAVLLRRMNIK--PTLASIPDEKPSNISVFEDSETSPNSSTLLRDPPPKKCGE 484
Query: 223 TS----SPPAVSPPAPPSNSSTRGSPSTPPLPSVPTEKPTAKSTNGTAVSANAS 272
S + P + +S SP + +P ++ ++ + + S
Sbjct: 485 ESGHLPNNPFFNKLKLTLSSIPPLSPRQSIITLPTPSRPASRISSLSLRLGSYS 538
|
The KAR9 protein in Saccharomyces cerevisiae is a cytoskeletal protein required for karyogamy, correct positioning of the mitotic spindle and for orientation of cytoplasmic microtubules. KAR9 localises at the shmoo tip in mating cells and at the tip of the growing bud in anaphase. Length = 626 |
| >gnl|CDD|223033 PHA03291, PHA03291, envelope glycoprotein I; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 6e-04
Identities = 18/72 (25%), Positives = 27/72 (37%)
Query: 2 PPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAV 61
P P P + P ++ P T P P++ +P T P P P +P
Sbjct: 205 PATPRPTPRTTASPETTPTPSTTTSPPSTTIPAPSTTIAAPQAGTTPEAEGTPAPPTPGG 264
Query: 62 NSPPPQPSSPPP 73
PP ++P P
Sbjct: 265 GEAPPANATPAP 276
|
Length = 401 |
| >gnl|CDD|177464 PHA02682, PHA02682, ORF080 virion core protein; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (98), Expect = 6e-04
Identities = 37/121 (30%), Positives = 48/121 (39%), Gaps = 4/121 (3%)
Query: 6 SPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPP 65
+P A P P+ P P + P T P PA P T P P P P+ PA PP
Sbjct: 83 APSPACAAPAPACPACAPAAPAPAVTCPAPAPACPPATAPTCPPPAVCPAPARPAPACPP 142
Query: 66 PQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTT 125
PP APP P P+P + + P P A+ PT ++ + P P
Sbjct: 143 STRQCPP----APPLPTPKPAPAAKPIFLHNQLPPPDYPAASCPTIETAPAASPVLEPRI 198
Query: 126 P 126
P
Sbjct: 199 P 199
|
Length = 280 |
| >gnl|CDD|177614 PHA03377, PHA03377, EBNA-3C; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 6e-04
Identities = 56/273 (20%), Positives = 77/273 (28%), Gaps = 49/273 (17%)
Query: 35 PASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPP------ 88
P P PS S P P P V P S P + PPP
Sbjct: 450 PERPGPSDQPSVPVEPAHLTPVEHTTVILHQPPQSPPTVAIKPAPPPSRRRRGACVVYDD 509
Query: 89 --------SPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTT--PSSSSPPPANVRT 138
+ P+ P S P PS PP A+
Sbjct: 510 DIIEVIDVETTEEEESVTQPAKPHRKVQDGFQRSGRRQKRATPPKVSPSDRGPPKASPPV 569
Query: 139 T-PSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTP---SPPVLTPP- 193
P S+ P P+T PP P + PP+S P P +P + P
Sbjct: 570 MAPPSTGPRVMATPSTGPRDMAPPSTGPRQQAKCKDGPPASGPHEKQPPSSAPRDMAPSV 629
Query: 194 ----------PHPSQSAP-----------------PPVTKSPPASTLSPPPPS-VPSTSS 225
+ P P ++ PA+ +PP PS +PS
Sbjct: 630 VRMFLRERLLEQSTGPKPKSFWEMRAGRDGSGIQQEPSSRRQPATQSTPPRPSWLPSVFV 689
Query: 226 PPAVSPPAPPSNSSTRGSPSTPPLPSVPTEKPT 258
P+V + + S +P P E+P
Sbjct: 690 LPSVDAGRAQPSEESHLSSMSPTQPISHEEQPR 722
|
Length = 1000 |
| >gnl|CDD|215533 PLN02983, PLN02983, biotin carboxyl carrier protein of acetyl-CoA carboxylase | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 6e-04
Identities = 28/65 (43%), Positives = 34/65 (52%), Gaps = 6/65 (9%)
Query: 3 PQSSPPA-VLAVPPPSPPLSPPPSTTP--PPTSPPPASPPPSPPTSTPPSPPTAPPPSSP 59
PQ PPA V+ + PP P PP S P S P +SPPP+P + P P AP S P
Sbjct: 142 PQPPPPAPVVMMQPPPPHAMPPASPPAAQPAPSAPASSPPPTPAS---PPPAKAPKSSHP 198
Query: 60 AVNSP 64
+ SP
Sbjct: 199 PLKSP 203
|
Length = 274 |
| >gnl|CDD|220749 pfam10428, SOG2, RAM signalling pathway protein | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 6e-04
Identities = 24/125 (19%), Positives = 39/125 (31%), Gaps = 13/125 (10%)
Query: 32 SPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPA 91
PP T++P S P S + P+ P +P S P+
Sbjct: 149 GPPLQHRKRDAVTASPSSMIARNTPISDRLRPRSVTPTRGRRPSSSP----RSLSNPTTL 204
Query: 92 QPP--PQAVAPSPPPPANVPTTPSSSS-------PPPANVPTTPSSSSPPPANVRTTPSS 142
+ P Q PPP +N + S+ S P + S P + ++ +
Sbjct: 205 ESPSNLQVTTDVPPPYSNGTSRSSTMSSSANLSIISSLATPRSGESFRSTPTSGSSSINP 264
Query: 143 SSPPP 147
S
Sbjct: 265 VSGLD 269
|
SOG2 proteins in Saccharomyces cerevisiae are involved in cell separation and cytokinesis. Length = 419 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 7e-04
Identities = 28/130 (21%), Positives = 38/130 (29%), Gaps = 10/130 (7%)
Query: 184 TPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGS 243
P P P + AP PV +P ST + P PP
Sbjct: 361 VPVPAPQPAKPTAA--APSPVRPTPAPSTRPKAAAAANIPPKEPVRETATPP------PV 412
Query: 244 PSTPPLPSVPTEKPTAKSTNGTAVSANASPRNAGVLGTGGAVAIGIAVGFLVLSLLVMAV 303
P P P VP +A A+ + P+ IA G ++ L A+
Sbjct: 413 PPRPVAPPVPHTPESAPKLTRAAIPVDEKPKYTPPAPPKEEEKALIADGDVLEQL--EAI 470
Query: 304 WFAHKRKKKR 313
W R
Sbjct: 471 WKQILRDVPP 480
|
Length = 585 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (101), Expect = 7e-04
Identities = 19/77 (24%), Positives = 29/77 (37%), Gaps = 1/77 (1%)
Query: 165 PTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPS-VPST 223
P+ S + PT P+P P PS +P PP VP+
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAE 420
Query: 224 SSPPAVSPPAPPSNSST 240
+ P+ +PPA +N+
Sbjct: 421 PTEPSPTPPANAANAPP 437
|
Length = 620 |
| >gnl|CDD|236382 PRK09111, PRK09111, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 42.6 bits (101), Expect = 7e-04
Identities = 11/71 (15%), Positives = 19/71 (26%), Gaps = 4/71 (5%)
Query: 45 STPPSPPTAPPP----SSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAP 100
P PP + A + ++ P P + P + A
Sbjct: 391 PPSPGGGGGGPPGGGGAPGAPAAAAAPGAAAAAPAAGGPAAALAAVPDAAAAAAAPPAPA 450
Query: 101 SPPPPANVPTT 111
+ P PA +
Sbjct: 451 AAPQPAVRLNS 461
|
Length = 598 |
| >gnl|CDD|236766 PRK10811, rne, ribonuclease E; Reviewed | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 7e-04
Identities = 22/140 (15%), Positives = 30/140 (21%), Gaps = 11/140 (7%)
Query: 1 PPPQSSPPAVLAVPPPS---PPLSPPPSTTPPPTSPPPASP--PPSPPTSTPPSPPTAPP 55
P + P V P + P T P + P P
Sbjct: 897 EPVVVAEPQPEEVVVVETTHPEVIAAPVTEQPQVITESDVAVAQEVAEHAEPVVEPQDET 956
Query: 56 PSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVP------ 109
+ P + P P V +P
Sbjct: 957 ADIEEAAETAEVVVAEPEVVAQPAAPVVAEVAAEVETVTAVEPEVAPAQVPEATVEHNHA 1016
Query: 110 TTPSSSSPPPANVPTTPSSS 129
T P + +P P VP P S
Sbjct: 1017 TAPMTRAPAPEYVPEAPRHS 1036
|
Length = 1068 |
| >gnl|CDD|223044 PHA03325, PHA03325, nuclear-egress-membrane-like protein; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 7e-04
Identities = 22/113 (19%), Positives = 27/113 (23%)
Query: 3 PQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVN 62
S P + A PP P P P + P+ T+ SS A N
Sbjct: 300 EHSDPEPLPASLPPPPVRRPRVKHPEAGKEEPDGARNAEAKEPAQPATSTSSKGSSSAQN 359
Query: 63 SPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSS 115
A E D P P + P PS
Sbjct: 360 KDSGSTGPGSSLAAASSFLEDDDFGSPPLDLTTSLRHMPSPSVTSAPEPPSIP 412
|
Length = 418 |
| >gnl|CDD|114270 pfam05539, Pneumo_att_G, Pneumovirinae attachment membrane glycoprotein G | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 7e-04
Identities = 34/152 (22%), Positives = 44/152 (28%), Gaps = 6/152 (3%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSP--PTSTPPSPPTAPPPSS 58
P Q A S TT P PPPS P+ +P PP+
Sbjct: 199 PATQGHQTATANQRLSSTEPVGTQGTTTSSNPEPQTEPPPSQRGPSGSPQHPPSTTSQDQ 258
Query: 59 PAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPP 118
S PP SP S A PPP P PT + S
Sbjct: 259 ----STTGDGQEHTQRRKTPPATSNRRSPHSTATPPPTTKRQETGRPTPRPTATTQSGSS 314
Query: 119 PANVPTTPSSSSPPPANVRTTPSSSSPPPANV 150
P + ++P N+ P P ++
Sbjct: 315 PPHSSPPGVQANPTTQNLVDCKELDPPKPNSI 346
|
Length = 408 |
| >gnl|CDD|233045 TIGR00601, rad23, UV excision repair protein Rad23 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 7e-04
Identities = 17/75 (22%), Positives = 28/75 (37%), Gaps = 3/75 (4%)
Query: 169 SSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPA 228
+ P ++ PT TPSPP P SA P + + + P + S
Sbjct: 83 KVAPPAATPTSAPTPTPSPP---ASPASGMSAAPASAVEEKSPSEESATATAPESPSTSV 139
Query: 229 VSPPAPPSNSSTRGS 243
S + +++ GS
Sbjct: 140 PSSGSDAASTLVVGS 154
|
All proteins in this family for which functions are known are components of a multiprotein complex used for targeting nucleotide excision repair to specific parts of the genome. In humans, Rad23 complexes with the XPC protein. This family is based on the phylogenomic analysis of JA Eisen (1999, Ph.D. Thesis, Stanford University) [DNA metabolism, DNA replication, recombination, and repair]. Length = 378 |
| >gnl|CDD|220749 pfam10428, SOG2, RAM signalling pathway protein | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 7e-04
Identities = 24/115 (20%), Positives = 36/115 (31%), Gaps = 2/115 (1%)
Query: 109 PTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPP--PVNVPT 166
T S SS N P + R SSSP + P T S S +VP
Sbjct: 159 AVTASPSSMIARNTPISDRLRPRSVTPTRGRRPSSSPRSLSNPTTLESPSNLQVTTDVPP 218
Query: 167 PPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVP 221
P S+ + + + + L P P + S + +S +
Sbjct: 219 PYSNGTSRSSTMSSSANLSIISSLATPRSGESFRSTPTSGSSSINPVSGLDEAEE 273
|
SOG2 proteins in Saccharomyces cerevisiae are involved in cell separation and cytokinesis. Length = 419 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 8e-04
Identities = 18/111 (16%), Positives = 34/111 (30%), Gaps = 8/111 (7%)
Query: 120 ANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSN 179
P+++ PPPA P++ S P A +P V ++ +
Sbjct: 53 PPAAAAPAAAQPPPAAA---PAAVSRPAAPAAE----PAPWLVEHAKRLTAQREQLVARA 105
Query: 180 PPTSTPSPPVLTPPPHPSQSAPPPV-TKSPPASTLSPPPPSVPSTSSPPAV 229
+ P P + + A+ P P+ + + AV
Sbjct: 106 AAPAAPEAQAPAAPAERAAAENAARRLARAAAAAPRPRVPADAAAAVADAV 156
|
Length = 484 |
| >gnl|CDD|222997 PHA03132, PHA03132, thymidine kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 8e-04
Identities = 38/183 (20%), Positives = 47/183 (25%), Gaps = 12/183 (6%)
Query: 1 PPPQSSPPAVLAVPPPSP--PLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSS 58
P P P L P P PP T PP AS P ST P
Sbjct: 75 PRPPRGPEQTLDKPDSLPASRELPPGPTPVPPGGFRGASSPRLGADSTSPRFLYQVNF-- 132
Query: 59 PAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPP 118
P + +P + +S L P S V P S
Sbjct: 133 PVILAPIGESNSSSEELSEEEEHSRPPPSESLKVKNGGKVYPKGFSKHKTHKRSEFSGLT 192
Query: 119 PANVPTTPSSSSPPPANVR------TTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSS 172
S P+ ++ PAT P PV+V PP +
Sbjct: 193 KKAARKRKGSFVFKPSQLKELSGSLKNLLHLDDSAETDPATR--QVPVPVHVLYPPLLTE 250
Query: 173 PPP 175
P
Sbjct: 251 YVP 253
|
Length = 580 |
| >gnl|CDD|223880 COG0810, TonB, Periplasmic protein TonB, links inner and outer membranes [Cell envelope biogenesis, outer membrane] | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 8e-04
Identities = 24/130 (18%), Positives = 37/130 (28%)
Query: 48 PSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPAN 107
+ P P+P P P +P+PP P + P P P P
Sbjct: 42 FLLAAKVLEAPTEEPQPEPEPPEEQPKPPTEPETPPEPTPPKPKEKPKPEKKPKKPKPKP 101
Query: 108 VPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTP 167
P P P P S + A + P A+ + S ++
Sbjct: 102 KPKPKPKPKVKPQPKPKKPPSKTAAKAPAAPNQPARPPSAASASGAATGPSASYLSGLRR 161
Query: 168 PSSSSPPPPS 177
+P P+
Sbjct: 162 AIRRAPRYPA 171
|
Length = 244 |
| >gnl|CDD|237015 PRK11901, PRK11901, hypothetical protein; Reviewed | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 8e-04
Identities = 36/166 (21%), Positives = 54/166 (32%), Gaps = 28/166 (16%)
Query: 4 QSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPT----------- 52
QSSP A + P S PP SP P+ PP P
Sbjct: 92 QSSPSAANNTSDGHDASGVKNTAPPQDISAPPISPTPTQA--APPQTPNGQQRIELPGNI 149
Query: 53 -------------APPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQA-V 98
A + ++ P P++ P P + P+P Q P
Sbjct: 150 SDALSQQQGQVNAASQNAQGNTSTLPTAPATVAPS-KGAKVPATAETHPTPPQKPATKKP 208
Query: 99 APSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSS 144
A + A V P++S P + + + SS P ++ SS+S
Sbjct: 209 AVNHHKTATVAVPPATSGKPKSGAASARALSSAPASHYTLQLSSAS 254
|
Length = 327 |
| >gnl|CDD|233045 TIGR00601, rad23, UV excision repair protein Rad23 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 8e-04
Identities = 20/74 (27%), Positives = 27/74 (36%), Gaps = 1/74 (1%)
Query: 109 PTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPP 168
P T + PPA PT+ + +P P S+ P + V S P P
Sbjct: 77 PKTGTGKVAPPAATPTSAPTPTPSPP-ASPASGMSAAPASAVEEKSPSEESATATAPESP 135
Query: 169 SSSSPPPPSSNPPT 182
S+S P S T
Sbjct: 136 STSVPSSGSDAAST 149
|
All proteins in this family for which functions are known are components of a multiprotein complex used for targeting nucleotide excision repair to specific parts of the genome. In humans, Rad23 complexes with the XPC protein. This family is based on the phylogenomic analysis of JA Eisen (1999, Ph.D. Thesis, Stanford University) [DNA metabolism, DNA replication, recombination, and repair]. Length = 378 |
| >gnl|CDD|200219 TIGR02927, SucB_Actino, 2-oxoglutarate dehydrogenase, E2 component, dihydrolipoamide succinyltransferase | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 8e-04
Identities = 41/193 (21%), Positives = 57/193 (29%), Gaps = 12/193 (6%)
Query: 50 PPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVP 109
P A +PA P P P P AP P P+P +P P
Sbjct: 79 PGEAGSEPAPAAPEPEAAPE-PEAPAPAPTPAAEAPAPAAPQAGGSGEATEVKMPELGES 137
Query: 110 TTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPP-ANVPATPSSSSPPPVNVPT-- 166
T + + V T P + P P A + V V T
Sbjct: 138 VTEGTVTSWLKAVGDTVEVDEPLLEVSTDKVDTEIPSPVAGTLLEIRAPEDDTVEVGTVL 197
Query: 167 ------PPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPP--PP 218
+ + P + P+ S P P +AP P +P + + P
Sbjct: 198 AIIGDANAAPAEPAEEEAPAPSEAGSEPAPDPAARAPHAAPDPPAPAPAPAKTAAPAAAA 257
Query: 219 SVPSTSSPPAVSP 231
V S S P V+P
Sbjct: 258 PVSSGDSGPYVTP 270
|
This model represents an Actinobacterial clade of E2 enzyme, a component of the 2-oxoglutarate dehydrogenase complex involved in the TCA cycle. These proteins have multiple domains including the catalytic domain (pfam00198), one or two biotin domains (pfam00364) and an E3-component binding domain (pfam02817). Length = 579 |
| >gnl|CDD|236940 PRK11633, PRK11633, cell division protein DedD; Provisional | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 9e-04
Identities = 25/99 (25%), Positives = 30/99 (30%), Gaps = 3/99 (3%)
Query: 140 PSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHP-SQ 198
P P AT + + PP + PS +P T P + P P P
Sbjct: 47 PGDRDEPDMMPAATQALPTQPPEGAAEAVRAGDAAAPSLDPATVAPPNTPVEPEPAPVEP 106
Query: 199 SAPPPVTKSPPAST--LSPPPPSVPSTSSPPAVSPPAPP 235
P PV K P P P P V A P
Sbjct: 107 PKPKPVEKPKPKPKPQQKVEAPPAPKPEPKPVVEEKAAP 145
|
Length = 226 |
| >gnl|CDD|235899 PRK06975, PRK06975, bifunctional uroporphyrinogen-III synthetase/uroporphyrin-III C-methyltransferase; Reviewed | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 9e-04
Identities = 18/54 (33%), Positives = 24/54 (44%), Gaps = 1/54 (1%)
Query: 28 PPPTSPPPASPPPSPPTSTPPSP-PTAPPPSSPAVNSPPPQPSSPPPPLDAPPP 80
P A+P PS T T S T+ P ++ A +PPP P + PP A
Sbjct: 267 DAAAQPATAAPAPSRMTDTNDSKSVTSQPAAAAAAPAPPPNPPATPPEPPARRG 320
|
Length = 656 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 9e-04
Identities = 25/107 (23%), Positives = 46/107 (42%), Gaps = 13/107 (12%)
Query: 425 RAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKV 484
R E ++SR + + V Y + + +V EY+ L V++ ++
Sbjct: 45 RNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKD--------VIE-EGNDEL 95
Query: 485 AAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKI 531
R + LH+ I+H D+ +SNI++ + + DFGL K
Sbjct: 96 LREIGRLVGKLHKA---GIVHGDLTTSNIIVRDD-KLYLIDFGLGKY 138
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 0.001
Identities = 32/175 (18%), Positives = 51/175 (29%), Gaps = 4/175 (2%)
Query: 112 PSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSS 171
PP S + + + + A PP P P +
Sbjct: 19 EFFPRPPATPGDAADDLLSGSQGQLVSDSAELAAVTVVAGAAACDRFEPPTGPPPGPGTE 78
Query: 172 SPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSP 231
+P S + PT + S P PP S P PPP+ P S P +S
Sbjct: 79 APANESRSTPTWSLSTLAPASPAREGSPTPP--GPSSPDPPPPTPPPASPPPSPAPDLSE 136
Query: 232 PAPPSNSSTRGSPSTPPLPSVPTEKPTAKSTN--GTAVSANASPRNAGVLGTGGA 284
P S ++PP + + + A+ ++ A + A
Sbjct: 137 MLRPVGSPGPPPAASPPAAGASPAAVASDAASSRQAALPLSSPEETARAPSSPPA 191
|
Length = 1352 |
| >gnl|CDD|185616 PTZ00436, PTZ00436, 60S ribosomal protein L19-like protein; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (96), Expect = 0.001
Identities = 27/138 (19%), Positives = 49/138 (35%)
Query: 155 SSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLS 214
+ ++ P P +++PP ++ P + P P +APP +PPA +
Sbjct: 217 AKAAAPAKAAAAPAKAAAPPAKAAAAPAKAAAAPAKAAAPPAKAAAPPAKAAAPPAKAAA 276
Query: 215 PPPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTPPLPSVPTEKPTAKSTNGTAVSANASPR 274
PP + + A A + + +P+ P AK+ A +A +
Sbjct: 277 PPAKAAAPPAKAAAPPAKAAAAPAKAAAAPAKAAAAPAKAAAPPAKAAAPPAKAATPPAK 336
Query: 275 NAGVLGTGGAVAIGIAVG 292
A A +G G
Sbjct: 337 AAAPPAKAAAAPVGKKAG 354
|
Length = 357 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 0.001
Identities = 15/98 (15%), Positives = 27/98 (27%), Gaps = 2/98 (2%)
Query: 73 PPLDAPPPPEVDPSPPSPAQPP-PQAVAPSPPPP-ANVPTTPSSSSPPPANVPTTPSSSS 130
PP A P P +PA P A A P P ++ P++
Sbjct: 53 PPAAAAPAAAQPPPAAAPAAVSRPAAPAAEPAPWLVEHAKRLTAQREQLVARAAAPAAPE 112
Query: 131 PPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPP 168
+++ + +++ P V
Sbjct: 113 AQAPAAPAERAAAENAARRLARAAAAAPRPRVPADAAA 150
|
Length = 484 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 0.001
Identities = 18/78 (23%), Positives = 24/78 (30%)
Query: 126 PSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTP 185
PS+ AN + + P + P P S P S P S P
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAE 420
Query: 186 SPPVLTPPPHPSQSAPPP 203
PP + +APP
Sbjct: 421 PTEPSPTPPANAANAPPS 438
|
Length = 620 |
| >gnl|CDD|184918 PRK14954, PRK14954, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.001
Identities = 19/89 (21%), Positives = 27/89 (30%), Gaps = 3/89 (3%)
Query: 195 HPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTPPLPSVPT 254
P SP +P P P P AP + + SP++ P P
Sbjct: 375 RNDGGVAPSPAGSPDVKKKAPEPDLPQPDRHPGPAKPEAPGARPAELPSPASAPTPE--- 431
Query: 255 EKPTAKSTNGTAVSANASPRNAGVLGTGG 283
++P + S AS G G
Sbjct: 432 QQPPVARSAPLPPSPQASAPRNVASGKPG 460
|
Length = 620 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 0.001
Identities = 18/82 (21%), Positives = 32/82 (39%), Gaps = 13/82 (15%)
Query: 155 SSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLS 214
+ + P P++ + PPP++ PP +P P ++ AP P
Sbjct: 381 APAPPSAAWGAPTPAAPAAPPPAAAPPVPPAAP----ARPAAARPAPAPA---------P 427
Query: 215 PPPPSVPSTSSPPAVSPPAPPS 236
P + P+ S+ PA + A
Sbjct: 428 PAAAAPPARSADPAAAASAGDR 449
|
Length = 576 |
| >gnl|CDD|236940 PRK11633, PRK11633, cell division protein DedD; Provisional | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 0.001
Identities = 22/95 (23%), Positives = 29/95 (30%), Gaps = 5/95 (5%)
Query: 118 PPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPS 177
P A + PP + + P+ PAT + P P P P P
Sbjct: 57 PAATQAL---PTQPPEGAAEAVRAGDAAAPSLDPAT--VAPPNTPVEPEPAPVEPPKPKP 111
Query: 178 SNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPAST 212
P P P P + P PV + A T
Sbjct: 112 VEKPKPKPKPQQKVEAPPAPKPEPKPVVEEKAAPT 146
|
Length = 226 |
| >gnl|CDD|217495 pfam03326, Herpes_TAF50, Herpesvirus transcription activation factor (transactivator) | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 0.001
Identities = 44/209 (21%), Positives = 55/209 (26%), Gaps = 23/209 (11%)
Query: 85 PSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSS 144
P P SP +P P + P + S S PA+ + +S P + PSS
Sbjct: 223 PQPQSPLKPSPSSARPQ--------QSESFSDVWPASTQSPREETSAEPLAPAS-PSSRR 273
Query: 145 PPPANVPATPSSSSPPPVN------VPTPPSSSSPPPPSSNPPTSTPSPPVLT---PPPH 195
P A SS VP S P+ + T PP
Sbjct: 274 PSTAQEEQIACSSPQAEPEQGVQSYVPQSSDSRPSCFPAPSTTQPTFLPPNTNKKAKRDR 333
Query: 196 PSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSN----SSTRGSPSTPPLPS 251
Q P S P S +PPSN SS +PS
Sbjct: 334 RPQMVTPKQEGGAAVSQNHDGGTVRAPRGRPSG-SGQSPPSNSPLLSSLADTPSGAAHQP 392
Query: 252 VPTEKPTAKSTNGTAVSANASPRNAGVLG 280
P S P L
Sbjct: 393 ASLLPPAVVQQQLEDASDKQPPTPGSSLV 421
|
This family includes EBV BRLF1 and similar ORF 50 proteins from other herpesviruses. Length = 500 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 0.001
Identities = 14/76 (18%), Positives = 23/76 (30%)
Query: 2 PPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAV 61
P ++P +P ++ P+ P +P + + P AP A
Sbjct: 176 PAPAAPVDTTPTNSQTPAVATAPAPAVDPQQNAVVAPSQANVDTAATPAPAAPATPDGAA 235
Query: 62 NSPPPQPSSPPPPLDA 77
P Q P D
Sbjct: 236 PLPTDQAGVSTPAADP 251
|
Length = 331 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 22/74 (29%), Positives = 29/74 (39%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
P ++ PA PP + +P P+ PPP P P + P PP A P + P
Sbjct: 34 PATANADPAPPPPPPSTAAAAPAPAAPPPPPPPAAPPAPQPDDPNAAPPPPPADPNAPPP 93
Query: 61 VNSPPPQPSSPPPP 74
P P P P
Sbjct: 94 PPVDPNAPPPPAPE 107
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|240289 PTZ00144, PTZ00144, dihydrolipoamide succinyltransferase; Provisional | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 0.001
Identities = 16/80 (20%), Positives = 25/80 (31%), Gaps = 3/80 (3%)
Query: 75 LDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPA 134
PP + + P P P S +PP A P P+ ++ PP
Sbjct: 120 TGGAPPAAAPAAAAAAKAEKTTPEKPKAAAPTPEPPAASKPTPPAAAKPPEPAPAAKPPP 179
Query: 135 NVRTTPSSSSPPPANVPATP 154
+ + P VP +
Sbjct: 180 T---PVARADPRETRVPMSR 196
|
Length = 418 |
| >gnl|CDD|217469 pfam03276, Gag_spuma, Spumavirus gag protein | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 0.001
Identities = 23/86 (26%), Positives = 30/86 (34%), Gaps = 4/86 (4%)
Query: 151 PATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPA 210
P + PPP PP SS P+++ +P P + P P P A
Sbjct: 180 GNIPGAIQPPP----PSSLPGLPPGSSSLAPSASSTPGNRLPRVSFNPFLPGPSPAQPSA 235
Query: 211 STLSPPPPSVPSTSSPPAVSPPAPPS 236
S P P +P A P PP
Sbjct: 236 PPASIPAPPIPPVIQYVAPPPVPPPQ 261
|
Length = 582 |
| >gnl|CDD|217469 pfam03276, Gag_spuma, Spumavirus gag protein | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 25/91 (27%), Positives = 37/91 (40%), Gaps = 4/91 (4%)
Query: 92 QPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPA-NVRTTPSSSSPPPANV 150
+ A PPPP+++P P SS + +TP + P + N S + P A
Sbjct: 178 RGGNIPGAIQPPPPSSLPGLPPGSSSLAPSASSTPGNRLPRVSFNPFLPGPSPAQPSAPP 237
Query: 151 PATPSSSSPPPVNVPTPPSSSSPPPPSSNPP 181
+ P+ PP + PP PPP P
Sbjct: 238 ASIPAPPIPPVIQYVAPP---PVPPPQPIIP 265
|
Length = 582 |
| >gnl|CDD|221188 pfam11725, AvrE, Pathogenicity factor | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 0.001
Identities = 35/212 (16%), Positives = 56/212 (26%), Gaps = 31/212 (14%)
Query: 94 PPQAVAPSPPPPANVPTTPSSSSPPP----------------ANVPTTPSSSSPPPANVR 137
AV P P A PT SS P +P SS P
Sbjct: 10 TKTAVQPEATPSAGAPTGLQQSSESPTQRASHSLASEGKKNRKKMPKVFQKSSAPRQIQA 69
Query: 138 TTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPS 197
P + +P A ++ + + +P + P S + T S V
Sbjct: 70 APPQALNPTAAAPQSSRGPTLRELLALPEDDGETQAPESSPSARRLTRSEGVARHEMEDL 129
Query: 198 QSAPPPVTKSPP----------ASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTP 247
P + +S+ PP TSS + +
Sbjct: 130 AGRPVVKPDADRQLRQDILNKSSSSRRPPVSKEEGTSSKMPATAL-ASAALFKDDEIRQE 188
Query: 248 PLPSVP----TEKPTAKSTNGTAVSANASPRN 275
+ + + N A+ +A+PR
Sbjct: 189 VDAARSDQASQSRLSRSRGNPPAIPPDAAPRQ 220
|
This family is secreted by gram-negative Gammaproteobacteria such as Pseudomonas syringae of tomato and the fire blight plant pathogen Erwinia amylovora, amongst others. It is an essential pathogenicity factor of approximately 198 kDa. Its injection into the host-plant is dependent upon the bacterial type III or Hrp secretion system. The family is long and carries a number of predicted functional regions, including an ERMS or endoplasmic reticulum membrane retention signal at both the C- and the N-termini, a leucine-zipper motif from residues 539-560, and a nuclear localisation signal at 1358-1361. this conserved AvrE-family of effectors is among the few that are required for full virulence of many phytopathogenic pseudomonads, erwinias and pantoeas. Length = 1771 |
| >gnl|CDD|184923 PRK14959, PRK14959, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 0.001
Identities = 30/120 (25%), Positives = 46/120 (38%), Gaps = 12/120 (10%)
Query: 85 PSPPSPAQPPPQAVAPSPPPPANV---PTTPSSSSPPPANVPTTPSSSSPPPANVRTTPS 141
S A+ P A + P P T P++ P + P TP+ S+ P
Sbjct: 380 APSGSAAEGPASGGAATIPTPGTQGPQGTAPAAGMTPSSAAPATPAPSAAP--------- 430
Query: 142 SSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAP 201
S P + P P S PP P P +S P + +++ +PP L P ++ P
Sbjct: 431 SPRVPWDDAPPAPPRSGIPPRPAPRMPEASPVPGAPDSVASASDAPPTLGDPSDTAEHTP 490
|
Length = 624 |
| >gnl|CDD|184923 PRK14959, PRK14959, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 0.001
Identities = 28/102 (27%), Positives = 40/102 (39%), Gaps = 17/102 (16%)
Query: 127 SSSSPPPANVR---TTPSSSSPPPANVPATPSSSSPPPVNV------PTPPSSSSPPPPS 177
+++ P P T P++ P + PATP+ S+ P V P PP S PP P+
Sbjct: 394 AATIPTPGTQGPQGTAPAAGMTPSSAAPATPAPSAAPSPRVPWDDAPPAPPRSGIPPRPA 453
Query: 178 SNPPTSTPSP--------PVLTPPPHPSQSAPPPVTKSPPAS 211
P ++P P PP S T S P +
Sbjct: 454 PRMPEASPVPGAPDSVASASDAPPTLGDPSDTAEHTPSGPRT 495
|
Length = 624 |
| >gnl|CDD|184923 PRK14959, PRK14959, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 26/99 (26%), Positives = 42/99 (42%), Gaps = 5/99 (5%)
Query: 86 SPPSPAQPPPQAVAP--SPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSS 143
+ P+P PQ AP P + P TP+ S+ P VP + +PP + + P+
Sbjct: 396 TIPTPGTQGPQGTAPAAGMTPSSAAPATPAPSAAPSPRVPWDDAPPAPPRSGIPPRPAPR 455
Query: 144 SPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPT 182
P + VP P S + PP+ P + + P+
Sbjct: 456 MPEASPVPGAPDSVAS---ASDAPPTLGDPSDTAEHTPS 491
|
Length = 624 |
| >gnl|CDD|184923 PRK14959, PRK14959, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 38/137 (27%), Positives = 53/137 (38%), Gaps = 10/137 (7%)
Query: 120 ANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSN 179
A +P S P+ + S S ++ P P + ++ PSS
Sbjct: 360 AMLPRLMPVESLRPSGGGASAPSGSAAEGPASGGAATIPTPGTQGPQGTAPAAGMTPSSA 419
Query: 180 PPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSP-PPPSVPSTSSPPAVSPPAPPSNS 238
P +TP+P P P APP +PP S + P P P +P S P AP S +
Sbjct: 420 AP-ATPAPSAAPSPRVPWDDAPP----APPRSGIPPRPAPRMPEASPVPG----APDSVA 470
Query: 239 STRGSPSTPPLPSVPTE 255
S +P T PS E
Sbjct: 471 SASDAPPTLGDPSDTAE 487
|
Length = 624 |
| >gnl|CDD|236382 PRK09111, PRK09111, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 42.2 bits (100), Expect = 0.001
Identities = 12/67 (17%), Positives = 19/67 (28%)
Query: 2 PPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAV 61
PP P +P + P + PA+ P+ + P A
Sbjct: 391 PPSPGGGGGGPPGGGGAPGAPAAAAAPGAAAAAPAAGGPAAALAAVPDAAAAAAAPPAPA 450
Query: 62 NSPPPQP 68
+P P
Sbjct: 451 AAPQPAV 457
|
Length = 598 |
| >gnl|CDD|236382 PRK09111, PRK09111, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 0.001
Identities = 14/77 (18%), Positives = 18/77 (23%), Gaps = 6/77 (7%)
Query: 49 SPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANV 108
P P P + A P + P A A + PPA
Sbjct: 391 PPSPGGGGGGPPGGGGAPGAPAAAAAPGAAAAAPAAGGPAAALAAVPDAAAAAAAPPAPA 450
Query: 109 PTTPSSSSPPPANVPTT 125
P PA +
Sbjct: 451 AA------PQPAVRLNS 461
|
Length = 598 |
| >gnl|CDD|183756 PRK12799, motB, flagellar motor protein MotB; Reviewed | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 0.001
Identities = 30/130 (23%), Positives = 51/130 (39%), Gaps = 10/130 (7%)
Query: 110 TTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPS 169
T P ++ P + V SS+ P+ S++ P PA +P++ ++ S
Sbjct: 298 TVPVAAVTPSSAVTQ---SSAITPS------SAAIPSPAVIPSSVTTQSATTTQASAVAL 348
Query: 170 SSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAV 229
SS+ PS T + P P Q T+ ++ + P+TS P A
Sbjct: 349 SSAGVLPSDVTLPGTVALPAAEPVNMQPQPMSTTETQQ-SSTGNITSTANGPTTSLPAAP 407
Query: 230 SPPAPPSNSS 239
+ P S +S
Sbjct: 408 ASNIPVSPTS 417
|
Length = 421 |
| >gnl|CDD|215145 PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygenase NCED | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 0.001
Identities = 29/81 (35%), Positives = 38/81 (46%), Gaps = 2/81 (2%)
Query: 112 PSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSS 171
SSS+P + SSSS + + PSS+SP P + SS P +P P SS
Sbjct: 1 SSSSNPTSRSQSHASSSSSSSSQS--SPPSSTSPRPRRRKPSASSLLHTPSILPLPKLSS 58
Query: 172 SPPPPSSNPPTSTPSPPVLTP 192
PP + PP +T P L P
Sbjct: 59 PSPPSVTLPPAATTQTPQLNP 79
|
Length = 590 |
| >gnl|CDD|215145 PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygenase NCED | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 0.001
Identities = 18/56 (32%), Positives = 21/56 (37%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPP 56
QSSPP+ + P S P P P PSPP+ T P T P
Sbjct: 20 SSSQSSPPSSTSPRPRRRKPSASSLLHTPSILPLPKLSSPSPPSVTLPPAATTQTP 75
|
Length = 590 |
| >gnl|CDD|217310 pfam02993, MCPVI, Minor capsid protein VI | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 25/101 (24%), Positives = 30/101 (29%), Gaps = 4/101 (3%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
+ P V P L P P P A PPS + P P P
Sbjct: 110 LGEEEPAPQEETVADPIQALQPRPRPDVEEVLVPAAPEPPSYEETIKP----GPAPVEEP 165
Query: 61 VNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPS 101
V+S + P+ PP P PP QP V
Sbjct: 166 VDSMAIAVPAIDTPVTLELPPAPQPPPPVVPQPSTMVVHRR 206
|
This minor capsid protein may act as a link between the external capsid and the internal DNA-protein core. The C-terminal 11 residues may function as a protease cofactor leading to enzyme activation. Length = 238 |
| >gnl|CDD|217453 pfam03251, Tymo_45kd_70kd, Tymovirus 45/70Kd protein | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 0.001
Identities = 58/245 (23%), Positives = 76/245 (31%), Gaps = 21/245 (8%)
Query: 20 LSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPP 79
L P PS P SP P P P +T PSPP SP+ P S L
Sbjct: 225 LHPLPSPQPVRHSPGILGPSPLHPHTTRPSPPRPAFSRSPSSPLSPLPRPSTRRGLL--- 281
Query: 80 PPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTT 139
P+P P P+ P P P + P+S + P +R
Sbjct: 282 -----PNPRLPRASRGHLPPPTSSAP---PRPNGGLRRPLHLHSSRPNSPNLRPRRIRKN 333
Query: 140 PSSSSPPP-ANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPP----- 193
+ + + S + +P P P P L P
Sbjct: 334 SLQQTRARLGHSKSLGQSPNLRSSQLPPPTKRRLRLLPVPPPKVQALPLTALAPLVRHSP 393
Query: 194 ----PHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTPPL 249
PHP + P V S PP S P+ SP P T P++PP
Sbjct: 394 SIPLPHPPSALPSHVGASSSKHHRLPPSVLPGPRLSSPSPSPSLPTRRPGTPPPPASPPT 453
Query: 250 PSVPT 254
PS P+
Sbjct: 454 PSPPS 458
|
Tymoviruses are single stranded RNA viruses. This family includes a protein of unknown function that has been named based on its molecular weight. Tymoviruses such as the ononis yellow mosaic tymovirus encode only three proteins. Of these two are overlapping this protein overlaps a larger ORF that is thought to be the polymerase. Length = 458 |
| >gnl|CDD|233045 TIGR00601, rad23, UV excision repair protein Rad23 | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 19/59 (32%), Positives = 23/59 (38%), Gaps = 4/59 (6%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSP-PPASPPPSPPTSTPPSPPTAPPPSS 58
P + P PSPP SP + P S SP T+T P P+ PSS
Sbjct: 87 PAATPTSAPT---PTPSPPASPASGMSAAPASAVEEKSPSEESATATAPESPSTSVPSS 142
|
All proteins in this family for which functions are known are components of a multiprotein complex used for targeting nucleotide excision repair to specific parts of the genome. In humans, Rad23 complexes with the XPC protein. This family is based on the phylogenomic analysis of JA Eisen (1999, Ph.D. Thesis, Stanford University) [DNA metabolism, DNA replication, recombination, and repair]. Length = 378 |
| >gnl|CDD|236333 PRK08691, PRK08691, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 0.001
Identities = 36/217 (16%), Positives = 51/217 (23%), Gaps = 22/217 (10%)
Query: 30 PTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPP------PLDAPPPPEV 83
P + + SP A P P+P + A P E
Sbjct: 360 PLAAASCDANAVIENTELQSPSAQTAEKETAAKKPQPRPEAETAQTPVQTASAAAMPSEG 419
Query: 84 DPSPP----SPAQPPPQAVAPSPP----PPANVPTTPSSSSPPPANVPTTPSSSSPPPAN 135
+ P PP AP A ++ P S + N
Sbjct: 420 KTAGPVSNQENNDVPPWEDAPDEAQTAAGTAQTSAKSIQTASEAETPPENQVSKNKAADN 479
Query: 136 VRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPH 195
P S P + ATP + + + P P P PP
Sbjct: 480 ETDAPLSEVPSENPIQATP-NDEAVETETFAHEAPAEPFYGYGFPDNDCPPEDGAEIPPP 538
Query: 196 PSQSAPPPVT-------KSPPASTLSPPPPSVPSTSS 225
+ A P T ++ PS P
Sbjct: 539 DWEHAAPADTAGGGADEEAEAGGIGGNNTPSAPPPEF 575
|
Length = 709 |
| >gnl|CDD|200219 TIGR02927, SucB_Actino, 2-oxoglutarate dehydrogenase, E2 component, dihydrolipoamide succinyltransferase | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 16/66 (24%), Positives = 22/66 (33%), Gaps = 3/66 (4%)
Query: 6 SPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPP---SPPTAPPPSSPAVN 62
+ PA A P P P + P + P P + P + P A P S +
Sbjct: 205 AAPAEPAEEEAPAPSEAGSEPAPDPAARAPHAAPDPPAPAPAPAKTAAPAAAAPVSSGDS 264
Query: 63 SPPPQP 68
P P
Sbjct: 265 GPYVTP 270
|
This model represents an Actinobacterial clade of E2 enzyme, a component of the 2-oxoglutarate dehydrogenase complex involved in the TCA cycle. These proteins have multiple domains including the catalytic domain (pfam00198), one or two biotin domains (pfam00364) and an E3-component binding domain (pfam02817). Length = 579 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 0.001
Identities = 28/108 (25%), Positives = 50/108 (46%), Gaps = 12/108 (11%)
Query: 425 RAEVEIISRVHHRHL-VSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVK 483
R E I+SR + V V Y + ++V EY+ + L +++ G ++
Sbjct: 47 RREARIMSRARKAGVNVPAV-YFVDPENFIIVMEYIEGEPLKDLINSNGME------ELE 99
Query: 484 VAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKI 531
++ R + LH IIH D+ +SN++L + + DFGLA+
Sbjct: 100 LSREIGRLVGKLHSA---GIIHGDLTTSNMILSGG-KIYLIDFGLAEF 143
|
Length = 211 |
| >gnl|CDD|219094 pfam06583, Neogenin_C, Neogenin C-terminus | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 38/177 (21%), Positives = 49/177 (27%), Gaps = 2/177 (1%)
Query: 27 TPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPS 86
P P S PP P S P P + SP L P +
Sbjct: 79 MRPKMMIPMDSQPPQPVVSAHPIHTLDNPQYPGILPSPRCGYLHHQFSLRPMPFSTLTVQ 138
Query: 87 PPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPP 146
++V P P P++ S PS S P T P S
Sbjct: 139 RLYQHGDRAESVESVRQTPEP-PYLPAAQSESSNAAEEAPSRSIPTAHVRPTHPLKSFAV 197
Query: 147 PANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPP 203
PA +PA+ S+ P + P P S S + P P P
Sbjct: 198 PA-LPASMSTIEPKLPSTPLLTQQGPTLPKHSVKTASVGTLGRARSPLLPVTVPSAP 253
|
This family represents the C-terminus of eukaryotic neogenin precursor proteins, which contains several potential phosphorylation sites. Neogenin is a member of the N-CAM family of cell adhesion molecules (and therefore contains multiple copies of pfam00047 and pfam00041) and is closely related to the DCC tumour suppressor gene product - these proteins may play an integral role in regulating differentiation programmes and/or cell migration events within many adult and embryonic tissues. Length = 295 |
| >gnl|CDD|237082 PRK12373, PRK12373, NADH dehydrogenase subunit E; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 22/85 (25%), Positives = 29/85 (34%), Gaps = 1/85 (1%)
Query: 19 PLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPT-APPPSSPAVNSPPPQPSSPPPPLDA 77
PL P P P A+ P S T + T A P + A N+ P+ A
Sbjct: 229 PLLAPWQGDAAPVPPSEAARPKSADAETNAALKTPATAPKAAAKNAKAPEAQPVSGTAAA 288
Query: 78 PPPPEVDPSPPSPAQPPPQAVAPSP 102
P P+ + A P P P
Sbjct: 289 EPAPKEAAKAAAAAAKPALEDKPRP 313
|
Length = 400 |
| >gnl|CDD|234022 TIGR02813, omega_3_PfaA, polyketide-type polyunsaturated fatty acid synthase PfaA | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 0.001
Identities = 24/94 (25%), Positives = 29/94 (30%), Gaps = 9/94 (9%)
Query: 20 LSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPP-------QPSSP- 71
LSP + P S +P S P+ P P SP V S P +P
Sbjct: 1119 LSPLATQAPVIKSVVTQAPVVQVTISVAPAAPVLPAVVSPPVVSAAPAQSVATAVAMAPV 1178
Query: 72 -PPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPP 104
P+ P VD P PQA
Sbjct: 1179 AEVPIAVPVQQSVDYMPSVAQAAAPQASVNDSAI 1212
|
Members of the seed for this alignment are involved in omega-3 polyunsaturated fatty acid biosynthesis, such as the protein PfaA from the eicosapentaenoic acid biosynthesis operon in Photobacterium profundum strain SS9. PfaA is encoded together with PfaB, PfaC, and PfaD, and the functions of the individual polypeptides have not yet been described. More distant homologs of PfaA, also included with the reach of this model, appear to be involved in polyketide-like biosynthetic mechanisms of polyunsaturated fatty acid biosynthesis, an alternative to the more familiar iterated mechanism of chain extension and desaturation, and in most cases are encoded near genes for homologs of PfaB, PfaC, and/or PfaD. Length = 2582 |
| >gnl|CDD|234022 TIGR02813, omega_3_PfaA, polyketide-type polyunsaturated fatty acid synthase PfaA | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.001
Identities = 23/106 (21%), Positives = 34/106 (32%), Gaps = 7/106 (6%)
Query: 2 PPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPP--SPPTSTPPSPPTAPPPSSP 59
P S V + ++P P SPP S P S T+ +P P + P
Sbjct: 1127 PVIKSVVTQAPVVQVTISVAPAAPVLPAVVSPPVVSAAPAQSVATAVAMAPVAEVPIAVP 1186
Query: 60 AVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPP 105
S PS + P+ + + Q + VA P
Sbjct: 1187 VQQSVDYMPS-----VAQAAAPQASVNDSAIQQVMMEVVAEKTGYP 1227
|
Members of the seed for this alignment are involved in omega-3 polyunsaturated fatty acid biosynthesis, such as the protein PfaA from the eicosapentaenoic acid biosynthesis operon in Photobacterium profundum strain SS9. PfaA is encoded together with PfaB, PfaC, and PfaD, and the functions of the individual polypeptides have not yet been described. More distant homologs of PfaA, also included with the reach of this model, appear to be involved in polyketide-like biosynthetic mechanisms of polyunsaturated fatty acid biosynthesis, an alternative to the more familiar iterated mechanism of chain extension and desaturation, and in most cases are encoded near genes for homologs of PfaB, PfaC, and/or PfaD. Length = 2582 |
| >gnl|CDD|221173 pfam11702, DUF3295, Protein of unknown function (DUF3295) | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.001
Identities = 32/133 (24%), Positives = 49/133 (36%), Gaps = 7/133 (5%)
Query: 67 QPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTP 126
+P + P P AP P S P+PA P ++ A P P + S+ +
Sbjct: 77 EPLALPMPNLAPITP--PSSEPTPAPPSSESTATRTPDPNQQALESTESTSTTSADCNDS 134
Query: 127 SSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPS 186
SS P N T +SSS +P+T P ++ + S S + P + +
Sbjct: 135 EQSSTPNLNSSDTSTSSSGA---LPSTSVVRGFSPSHISS--SYRSTAQLNKAPSPTKSA 189
Query: 187 PPVLTPPPHPSQS 199
P P P
Sbjct: 190 EPTAAPQAKPELP 202
|
This family is conserved in fungi but the function is not known. Length = 509 |
| >gnl|CDD|220840 pfam10667, DUF2486, Protein of unknown function (DUF2486) | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 27/168 (16%), Positives = 46/168 (27%), Gaps = 9/168 (5%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPP-------PSPPTSTPPSPPTA 53
SS P + V P P+ S+ A+ P P + +P A
Sbjct: 3 QANDSSIPTLTDVLVPGHPVPARSSSADAAGPHDDAAEPVLTDQIVPGAEQAASAAPVHA 62
Query: 54 PPPSSPAVNSPPPQPS-SPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTP 112
++ +P +P P A P P+ P A A + P
Sbjct: 63 AREATADPEFVAVEPVPTPHVPAVALPGDTDAPAEPGAAPHVVAERAAAMQAPLPSALAA 122
Query: 113 SSSSPPPANV-PTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSP 159
PPA ++P +S + ++ +
Sbjct: 123 DDPQAPPAGATAADAGDAAPDATPPAAGDASPPAAAQAAASAAAALTD 170
|
This family is made up of members from various Burkholderia spp. The function is unknown. Length = 245 |
| >gnl|CDD|225499 COG2948, VirB10, Type IV secretory pathway, VirB10 components [Intracellular trafficking and secretion] | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 21/103 (20%), Positives = 30/103 (29%), Gaps = 8/103 (7%)
Query: 34 PPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPA-- 91
+ P +PP P P P + P P P D D A
Sbjct: 51 KRINNTQPPSNVERGTPPLPPLPDDPPLPPPLPVDLGAPVLPDQQVEEAKDQPRRLRAAE 110
Query: 92 ------QPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSS 128
A A P++++PPPA P+ S+
Sbjct: 111 LAATSGSRVESDRAVGRVRAALANAAPAAAAPPPAGQPSGQSA 153
|
Length = 360 |
| >gnl|CDD|216257 pfam01034, Syndecan, Syndecan domain | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.001
Identities = 41/165 (24%), Positives = 58/165 (35%), Gaps = 26/165 (15%)
Query: 177 SSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPS 236
S P+ +T P P +T S P + +T+S + P +
Sbjct: 58 SGATPSDDEDSEPVTTSATP-----------PKLTTTSSSPSNDTTTASTSTKTSPTVST 106
Query: 237 NSSTRGSPSTPPLPSVPTEKPTAKSTNGTAVSANASPRN----AGVLGTGGAVAIGIAVG 292
+T SPS T T T G + +A +N VL AV G VG
Sbjct: 107 TVTTTTSPSETDTEEATTTVSTETPTEGGSSAATDPSKNLLERKEVL---AAVIAGGVVG 163
Query: 293 FLVLSLLVMAVWFAHKRKKKRAGEHIGYTLPSPYASS---QKSDS 334
L LVM + ++ KKK G Y L P ++ QK
Sbjct: 164 LLFAVFLVMFL--VYRMKKKDEGS---YALEEPKQANAGYQKPAK 203
|
Syndecans are transmembrane heparin sulfate proteoglycans which are implicated in the binding of extracellular matrix components and growth factors. Length = 207 |
| >gnl|CDD|218883 pfam06075, DUF936, Plant protein of unknown function (DUF936) | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 37/214 (17%), Positives = 57/214 (26%), Gaps = 9/214 (4%)
Query: 17 SPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLD 76
+ S + S S +A SSP V P P+ S L
Sbjct: 117 AADSLAFFSDAVIQVIKRKKASSAPRRGSWDSSSKSASIDSSPTVIGPRPR-SFSELNLT 175
Query: 77 APPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANV 136
P +V S P P P ++ S + + P
Sbjct: 176 DRTPAKVRSSRSELGAPSPSGGTSCPSSSGGRRSSIGSRRLRGSASLRKKVAVLSAPR-- 233
Query: 137 RTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHP 196
P S S + P SSS+ P ++ S + + P
Sbjct: 234 --KPGSRSSDCKSSPRARSSSAKSPFKSSIQRKATKALSKLSLRASPKDTSKSSKSEVAP 291
Query: 197 SQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVS 230
+ + V S T +V S P ++S
Sbjct: 292 PKKSEAKVPSSSKKWTDG----NVSWDSLPSSLS 321
|
This family consists of several hypothetical proteins from Arabidopsis thaliana and Oryza sativa. The function of this family is unknown. Length = 564 |
| >gnl|CDD|220271 pfam09507, CDC27, DNA polymerase subunit Cdc27 | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 35/229 (15%), Positives = 49/229 (21%), Gaps = 21/229 (9%)
Query: 51 PTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPT 110
A P ++P V P P +P ++PP ++P + T
Sbjct: 125 KQAGPITNPNVKRRTGVGLPPVAPAASPALKPTANGKRPSSKPPKSIMSPEVKVKSAKKT 184
Query: 111 TPSS--SSPPPANVPT---TPSSSSPPPANVRTTPS-SSSPPPANVPATPSSSSPPPVN- 163
+S ++ T S PP S +S S
Sbjct: 185 QDTSKETTTEKTEGKTSVKAASLKRNPPKKSNIMSSFFKKKTKEKKEKKEASESTVKEES 244
Query: 164 ------VPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPV--TKSPPASTLSP 215
S P + P P S S K
Sbjct: 245 EEESGKRDVILEDESAEPTGLDEDEDEDEPK---PSGERSDSEEETEEKEKEKRKRLKKM 301
Query: 216 PPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTPPLPSVPTEKPTAKSTNG 264
P S P PPLP EK +
Sbjct: 302 MEDEDEDEEMEIVPESPVEEEESEE---PEPPPLPKKEEEKEEVTVSPD 347
|
This protein forms the C subunit of DNA polymerase delta. It carries the essential residues for binding to the Pol1 subunit of polymerase alpha, from residues 293-332, which are characterized by the motif D--G--VT, referred to as the DPIM motif. The first 160 residues of the protein form the minimal domain for binding to the B subunit, Cdc1, of polymerase delta, the final 10 C-terminal residues, 362-372, being the DNA sliding clamp, PCNA, binding motif. Length = 427 |
| >gnl|CDD|220648 pfam10243, MIP-T3, Microtubule-binding protein MIP-T3 | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 33/201 (16%), Positives = 47/201 (23%), Gaps = 13/201 (6%)
Query: 3 PQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTP-------PSPPTAPP 55
+ V P P P + PP P
Sbjct: 103 GKEEEKEKEQVKEEKKKKKEKPKEEPKDRKPKEEAKEKRPPKEKEKEKEKKVEEPRDREE 162
Query: 56 PSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPS-- 113
+P PP P + P Q +AV P P
Sbjct: 163 EKKRERVRAKSRPKKPPKK-KPPNKKKEPPEEEKQRQAAREAVKGKPEEPDVNEEREKEE 221
Query: 114 --SSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSS 171
P S R + SS P + + T P +S
Sbjct: 222 DDGKDRETTTSPMEEDESRQSSEISRRSSSSLKKPDPSPSMASPETRESSKRTETRPRTS 281
Query: 172 SPPPPSSNPPTSTPSPPVLTP 192
PP S+ P ++ P+PP +
Sbjct: 282 LRPP-SARPASARPAPPRVKR 301
|
This protein, which interacts with both microtubules and TRAF3 (tumour necrosis factor receptor-associated factor 3), is conserved from worms to humans. The N-terminal region is the microtubule binding domain and is well-conserved; the C-terminal 100 residues, also well-conserved, constitute the coiled-coil region which binds to TRAF3. The central region of the protein is rich in lysine and glutamic acid and carries KKE motifs which may also be necessary for tubulin-binding, but this region is the least well-conserved. Length = 506 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.002
Identities = 30/128 (23%), Positives = 36/128 (28%), Gaps = 9/128 (7%)
Query: 16 PSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPL 75
S + P PP A+ P P S+ S A + PP P
Sbjct: 821 SRSHTPDGGSESSGPARPPGAAARPPPARSSESSKSKPAAAGGRARGKNGRRRPRPPEPR 880
Query: 76 DAPPPPEVDPSPPSP-AQPPPQAVAPSPPPPANVPTTPSSSSPPPAN-----VPTTPSSS 129
P P + A PP A AP P P V P P VP +
Sbjct: 881 ARPGAA---APPKAAAAAPPAGAPAPRPRPAPRVKLGPMPPGGPDPRGGFRRVPPGDLHT 937
Query: 130 SPPPANVR 137
P A
Sbjct: 938 PAPSAAAL 945
|
Length = 1352 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.002
Identities = 26/162 (16%), Positives = 48/162 (29%), Gaps = 8/162 (4%)
Query: 94 PPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPAT 153
P V + ++ P ++ P +R S + A+ A+
Sbjct: 760 NPSLVPAKLAEALALLEPAEPQRGAGSSPPVRAEAAFRRPGRLR--RSGPAADAASRTAS 817
Query: 154 PSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTP--PPHPSQSAPPPVTKSPPAS 211
S + S S P + P P + P+ + K+
Sbjct: 818 KRKSRSHTPD----GGSESSGPARPPGAAARPPPARSSESSKSKPAAAGGRARGKNGRRR 873
Query: 212 TLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTPPLPSVP 253
P P + P ++PP + APP+ + P + P
Sbjct: 874 PRPPEPRARPGAAAPPKAAAAAPPAGAPAPRPRPAPRVKLGP 915
|
Length = 1352 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.002
Identities = 31/176 (17%), Positives = 48/176 (27%), Gaps = 12/176 (6%)
Query: 84 DPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSS 143
+P + + PP +A A P + P++ + S +P + + P+
Sbjct: 779 EPQRGAGSSPPVRAEAAFRRPGRLRRSGPAADAASRTASKRKSRSHTPDGGSESSGPARP 838
Query: 144 SPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPP 203
A P SS S + P P P A
Sbjct: 839 PGAAARPPPARSSESSKSKPAAAGGRARGKNGRRR----PRPPEPRARPGAAAPPKAAAA 894
Query: 204 VTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTPPLPSVPTEKPTA 259
+ + P P V P PP RG P + T P+A
Sbjct: 895 APPAGAPAPRPRPAPRVKLG--------PMPPGGPDPRGGFRRVPPGDLHTPAPSA 942
|
Length = 1352 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 0.002
Identities = 15/107 (14%), Positives = 31/107 (28%), Gaps = 4/107 (3%)
Query: 168 PSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPP 227
+ P + P + + + A + P P +P
Sbjct: 381 LERRLGVAGGAGAPAAAAPSAA-AAAPAAAPAPAAAAPAAAAAPAPAAAPQPAP---APA 436
Query: 228 AVSPPAPPSNSSTRGSPSTPPLPSVPTEKPTAKSTNGTAVSANASPR 274
P P+ ++ G +PP + P+ +P +A +P
Sbjct: 437 PAPAPPSPAGNAPAGGAPSPPPAAAPSAQPAPAPAAAPEPTAAPAPA 483
|
Length = 824 |
| >gnl|CDD|218439 pfam05109, Herpes_BLLF1, Herpes virus major outer envelope glycoprotein (BLLF1) | Back alignment and domain information |
|---|
Score = 41.3 bits (96), Expect = 0.002
Identities = 46/201 (22%), Positives = 71/201 (35%), Gaps = 15/201 (7%)
Query: 3 PQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVN 62
SSP + P S P + T+P S P+ + P+ P + +
Sbjct: 589 TGSSPTSQQPGIPSS--SHSTPRSNSTSTTPLLTSAHPTGGENITEETPSVPSTTHVSTL 646
Query: 63 SPPPQPSS---PPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPP--PPANVPTTPSSSSP 117
SP P P + P ++ + P P A +PS P VPT S+
Sbjct: 647 SPGPGPGTTSQVSGPGNSSTSRYPGEVHVTEGMPNPNATSPSAPSGQKTAVPTVTSTGGK 706
Query: 118 PPANVPTTPSSSSPPPANVRTTPSSSSPPPAN----VPATPSSSSPPPVNVPTPPSSSS- 172
+ T S+ + T + P N +P + SS P +PP ++
Sbjct: 707 ANSTTKETSGSTLMASTSPHTNEGAFRTTPYNATTYLPPSTSSKLRPRWTFTSPPVTTKQ 766
Query: 173 ---PPPPSSNPPTSTPSPPVL 190
P PP+ +P S S VL
Sbjct: 767 ATVPVPPTQHPDHSNLSMLVL 787
|
This family consists of the BLLF1 viral late glycoprotein, also termed gp350/220. It is the most abundantly expressed glycoprotein in the viral envelope of the Herpesviruses and is the major antigen responsible for stimulating the production of neutralising antibodies in vivo. Length = 830 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 0.002
Identities = 22/122 (18%), Positives = 34/122 (27%), Gaps = 10/122 (8%)
Query: 91 AQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANV 150
A P A A + PPPA P S + P A P A
Sbjct: 52 APPAAAAPAAAQPPPAAAPAAVSRPAAPAAE--PAPWLVEHAKRLTA----QREQLVARA 105
Query: 151 PATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPA 210
A + + P ++ + + + P P V P + +A K+
Sbjct: 106 AAPAAPEAQAPAAPAERAAAENAARRLARAAAAAPRPRV----PADAAAAVADAVKARIE 161
Query: 211 ST 212
Sbjct: 162 RI 163
|
Length = 484 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 0.002
Identities = 16/105 (15%), Positives = 32/105 (30%), Gaps = 5/105 (4%)
Query: 148 ANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTP--PPHPSQSAPPPVT 205
A P+++ PPP P S + P P + + +AP
Sbjct: 53 PPAAAAPAAAQPPPAAAPAAVSRPAAPAAEPAPWLVEHAKRLTAQREQLVARAAAPAAPE 112
Query: 206 KSPPASTLSPP---PPSVPSTSSPPAVSPPAPPSNSSTRGSPSTP 247
PA+ + + A P P++++ + +
Sbjct: 113 AQAPAAPAERAAAENAARRLARAAAAAPRPRVPADAAAAVADAVK 157
|
Length = 484 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 0.002
Identities = 19/78 (24%), Positives = 27/78 (34%), Gaps = 3/78 (3%)
Query: 174 PPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPA 233
S S P+ P P P P + P S P + + PS P + P + PA
Sbjct: 363 AFISEIANASAPANPTPAPNPSPPPAPIQP---SAPKTKQAATTPSPPPAKASPPIPVPA 419
Query: 234 PPSNSSTRGSPSTPPLPS 251
P+ S + P
Sbjct: 420 EPTEPSPTPPANAANAPP 437
|
Length = 620 |
| >gnl|CDD|236669 PRK10263, PRK10263, DNA translocase FtsK; Provisional | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.002
Identities = 26/96 (27%), Positives = 32/96 (33%), Gaps = 11/96 (11%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
P V P P P P P P P P P AP P
Sbjct: 786 APQPQYQQPQQPVAPQPQYQQPQQPVAPQPQYQQPQQPVAPQPQYQQPQQPVAPQPQDTL 845
Query: 61 V---------NSPPPQPSSPPPPLD--APPPPEVDP 85
+ + P +P++P P LD PPP EV+P
Sbjct: 846 LHPLLMRNGDSRPLHKPTTPLPSLDLLTPPPSEVEP 881
|
Length = 1355 |
| >gnl|CDD|236669 PRK10263, PRK10263, DNA translocase FtsK; Provisional | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 27/176 (15%), Positives = 40/176 (22%), Gaps = 1/176 (0%)
Query: 82 EVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPS 141
E DP P AVA + P V + + P + P
Sbjct: 306 EYDPLLNGAPITEPVAVAAAATTATQSWAAPVEPVTQTPPVASVDVPPAQPTVAWQPVPG 365
Query: 142 SSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAP 201
+ P PA P + P P +P P P +
Sbjct: 366 PQTGEPVIAPA-PEGYPQQSQYAQPAVQYNEPLQQPVQPQQPYYAPAAEQPAQQPYYAPA 424
Query: 202 PPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTPPLPSVPTEKP 257
P P +P P + P ++ P P +
Sbjct: 425 PEQPAQQPYYAPAPEQPVAGNAWQAEEQQSTFAPQSTYQTEQTYQQPAAQEPLYQQ 480
|
Length = 1355 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.002
Identities = 21/64 (32%), Positives = 31/64 (48%), Gaps = 1/64 (1%)
Query: 99 APSPPPPANVPTTP-SSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSS 157
AP+PP A TP + ++PPPA P P ++ PA R P+ + P A PA +
Sbjct: 381 APAPPSAAWGAPTPAAPAAPPPAAAPPVPPAAPARPAAARPAPAPAPPAAAAPPARSADP 440
Query: 158 SPPP 161
+
Sbjct: 441 AAAA 444
|
Length = 576 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.002
Identities = 19/64 (29%), Positives = 28/64 (43%)
Query: 85 PSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSS 144
P+PPS A P AP+ PPPA P P ++ PA P+ + P A + +
Sbjct: 382 PAPPSAAWGAPTPAAPAAPPPAAAPPVPPAAPARPAAARPAPAPAPPAAAAPPARSADPA 441
Query: 145 PPPA 148
+
Sbjct: 442 AAAS 445
|
Length = 576 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.002
Identities = 16/63 (25%), Positives = 26/63 (41%)
Query: 141 SSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSA 200
+ + P A TP++ + PP P ++P P++ P P+PP PP S
Sbjct: 381 APAPPSAAWGAPTPAAPAAPPPAAAPPVPPAAPARPAAARPAPAPAPPAAAAPPARSADP 440
Query: 201 PPP 203
Sbjct: 441 AAA 443
|
Length = 576 |
| >gnl|CDD|236940 PRK11633, PRK11633, cell division protein DedD; Provisional | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.002
Identities = 13/84 (15%), Positives = 20/84 (23%)
Query: 138 TTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPS 197
T + PP A + + P P + + P P P P + P
Sbjct: 60 TQALPTQPPEGAAEAVRAGDAAAPSLDPATVAPPNTPVEPEPAPVEPPKPKPVEKPKPKP 119
Query: 198 QSAPPPVTKSPPASTLSPPPPSVP 221
+ P P
Sbjct: 120 KPQQKVEAPPAPKPEPKPVVEEKA 143
|
Length = 226 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.002
Identities = 17/89 (19%), Positives = 34/89 (38%)
Query: 191 TPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTPPLP 250
T + AP + P ++ +P + P+ + P + PS ++ + + P
Sbjct: 168 TTTDPATTPAPAAPVDTTPTNSQTPAVATAPAPAVDPQQNAVVAPSQANVDTAATPAPAA 227
Query: 251 SVPTEKPTAKSTNGTAVSANASPRNAGVL 279
+ T+ VS A+ NA V+
Sbjct: 228 PATPDGAAPLPTDQAGVSTPAADPNALVM 256
|
Length = 331 |
| >gnl|CDD|140276 PTZ00249, PTZ00249, variable surface protein Vir28; Provisional | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 32/164 (19%), Positives = 49/164 (29%), Gaps = 16/164 (9%)
Query: 79 PPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRT 138
PP E + + A A PP + + + PP P P S S P A+ R
Sbjct: 217 PPREEQKAVTAHAHRRISGEA-RPPKHISFSSPHAHGRPPVETRPPNPVSVSSPQAHGRH 275
Query: 139 TPSSSSPPPANVPA-------TPSSSSPPPVNVPTPPSSSSPPPP-------SSNPPTST 184
+ +PP VP+ + +P V+ + + SS P
Sbjct: 276 PGETHTPPLVTVPSSKAHDRNPVQTPTPTSVSGYSSQAKGLEKQAGGESERTSSVPSEQF 335
Query: 185 PSP-PVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPP 227
P P PVL P ++ + P
Sbjct: 336 PLPLPVLLPLGQSGPLESSESEETDEYAGPKGLPEPELELVELQ 379
|
Length = 516 |
| >gnl|CDD|217835 pfam03999, MAP65_ASE1, Microtubule associated protein (MAP65/ASE1 family) | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 33/182 (18%), Positives = 53/182 (29%), Gaps = 20/182 (10%)
Query: 55 PPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSS 114
+ V PP + PS PS + + + + P P S
Sbjct: 450 ANKTSTVMEPPYGSTESS-----------VPSTPST-RRNDRNITSNTPSLKRTPNLTKS 497
Query: 115 S---SPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPP--PVNVPTPPS 169
S + T + P + T P + ++ S + ++ +P S
Sbjct: 498 SLSQEASLISKSTGNTHKHSTPRRLTTLPKLPAASRSSKGNLIRSGANGNASSDLSSPGS 557
Query: 170 SSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSP---PASTLSPPPPSVPSTSSP 226
+S P S P + S P K S LSPP SV +T
Sbjct: 558 INSKSPEHSVPLVRVFDIHLRASTTKGRHSTPSTNEKKKRLLKRSPLSPPKESVATTPRL 617
Query: 227 PA 228
+
Sbjct: 618 NS 619
|
Length = 619 |
| >gnl|CDD|234818 PRK00708, PRK00708, sec-independent translocase; Provisional | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 22/104 (21%), Positives = 33/104 (31%), Gaps = 7/104 (6%)
Query: 5 SSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPP--PSSPAVN 62
+S P+ +P P T P P P+P + + A P P+ P
Sbjct: 100 TSMSEPATENKPAEVTTPVEPMGLPETPPAVPVPAPAPAVAAAAAQAAAAPKAPAKPRAK 159
Query: 63 SPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPA 106
SP P + P P + + P+ A PA
Sbjct: 160 SPRPAAKAAPKPTETITAKK-----AKKTAAAPKPTADKTATPA 198
|
Length = 209 |
| >gnl|CDD|240289 PTZ00144, PTZ00144, dihydrolipoamide succinyltransferase; Provisional | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.002
Identities = 13/72 (18%), Positives = 20/72 (27%)
Query: 173 PPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPP 232
P + + P + + PP P + PP P+ PP
Sbjct: 125 PAAAPAAAAAAKAEKTTPEKPKAAAPTPEPPAASKPTPPAAAKPPEPAPAAKPPPTPVAR 184
Query: 233 APPSNSSTRGSP 244
A P + S
Sbjct: 185 ADPRETRVPMSR 196
|
Length = 418 |
| >gnl|CDD|240289 PTZ00144, PTZ00144, dihydrolipoamide succinyltransferase; Provisional | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.002
Identities = 19/70 (27%), Positives = 26/70 (37%)
Query: 2 PPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAV 61
PP ++P A A P + P P P + P P P P A PP +P
Sbjct: 124 PPAAAPAAAAAAKAEKTTPEKPKAAAPTPEPPAASKPTPPAAAKPPEPAPAAKPPPTPVA 183
Query: 62 NSPPPQPSSP 71
+ P + P
Sbjct: 184 RADPRETRVP 193
|
Length = 418 |
| >gnl|CDD|221188 pfam11725, AvrE, Pathogenicity factor | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.002
Identities = 27/193 (13%), Positives = 49/193 (25%), Gaps = 8/193 (4%)
Query: 4 QSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPA-SPPPSPPTSTPPSPPTAPPPSSPAVN 62
+SS P + PP P+ P +S P + P + PS+ +
Sbjct: 60 KSSAPRQIQAAPPQAL---NPTAAAPQSSRGPTLRELLALPEDDGETQAPESSPSARRLT 116
Query: 63 SPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSS--SSPPPA 120
L P + D ++ + PP + T S ++ +
Sbjct: 117 RSEGVARHEMEDLAGRPVVKPDADRQLRQDILNKSSSSRRPPVSKEEGTSSKMPATALAS 176
Query: 121 NVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSS--SSPPPPSS 178
R+ +S S + P+ P S
Sbjct: 177 AALFKDDEIRQEVDAARSDQASQSRLSRSRGNPPAIPPDAAPRQPMLTRSAGGRFEGEDE 236
Query: 179 NPPTSTPSPPVLT 191
N + +T
Sbjct: 237 NLERNLQPQSPIT 249
|
This family is secreted by gram-negative Gammaproteobacteria such as Pseudomonas syringae of tomato and the fire blight plant pathogen Erwinia amylovora, amongst others. It is an essential pathogenicity factor of approximately 198 kDa. Its injection into the host-plant is dependent upon the bacterial type III or Hrp secretion system. The family is long and carries a number of predicted functional regions, including an ERMS or endoplasmic reticulum membrane retention signal at both the C- and the N-termini, a leucine-zipper motif from residues 539-560, and a nuclear localisation signal at 1358-1361. this conserved AvrE-family of effectors is among the few that are required for full virulence of many phytopathogenic pseudomonads, erwinias and pantoeas. Length = 1771 |
| >gnl|CDD|184923 PRK14959, PRK14959, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 28/112 (25%), Positives = 42/112 (37%), Gaps = 5/112 (4%)
Query: 166 TPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSS 225
+ PS S+ P+S + P+P P + P + +P P P + PS
Sbjct: 379 SAPSGSAAEGPASGGAATIPTPGTQGPQGTAPAAGMTPSSAAPAT----PAPSAAPSPRV 434
Query: 226 PPAVSPPAPP-SNSSTRGSPSTPPLPSVPTEKPTAKSTNGTAVSANASPRNA 276
P +PPAPP S R +P P VP + S + + A
Sbjct: 435 PWDDAPPAPPRSGIPPRPAPRMPEASPVPGAPDSVASASDAPPTLGDPSDTA 486
|
Length = 624 |
| >gnl|CDD|236382 PRK09111, PRK09111, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 0.002
Identities = 13/71 (18%), Positives = 22/71 (30%), Gaps = 1/71 (1%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTP-PSPPTAPPPSSP 59
PP +P + + P A P + + P + A PP+
Sbjct: 391 PPSPGGGGGGPPGGGGAPGAPAAAAAPGAAAAAPAAGGPAAALAAVPDAAAAAAAPPAPA 450
Query: 60 AVNSPPPQPSS 70
A P + +S
Sbjct: 451 AAPQPAVRLNS 461
|
Length = 598 |
| >gnl|CDD|218056 pfam04388, Hamartin, Hamartin protein | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 37/150 (24%), Positives = 45/150 (30%), Gaps = 21/150 (14%)
Query: 42 PPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPP------ 95
PT T + SS NS P Q P L ++ P
Sbjct: 264 DPTETSSEDGYSFSRSSAYPNSSPRQALPPSISLPQNTSTSGSLHSAQTSRRPNTTFDKA 323
Query: 96 ---QAVAP--SPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANV 150
SP + T PSS P + +P S T S PA
Sbjct: 324 ASSGTKDSLWSPSSLCGMATPPSSIGMSPLILSLSP---SHLSGRAPGTTGSGKGEPA-S 379
Query: 151 PATPSSSSPPP------VNVPTPPSSSSPP 174
+TPS+S PPP V SS S P
Sbjct: 380 ESTPSTSPPPPGLADDIVRAIFATSSRSAP 409
|
This family includes the hamartin protein which is thought to function as a tumour suppressor. The hamartin protein interacts with the tuberin protein pfam03542. Tuberous sclerosis complex (TSC) is an autosomal dominant disorder and is characterized by the presence of hamartomas in many organs, such as brain, skin, heart, lung, and kidney. It is caused by mutation either TSC1 or TSC2 tumour suppressor gene. TSC1 encodes a protein, hamartin, containing two coiled-coil regions, which have been shown to mediate binding to tuberin. The TSC2 gene codes for tuberin pfam03542. These two proteins function within the same pathway(s) regulating cell cycle, cell growth, adhesion, and vesicular trafficking. Length = 667 |
| >gnl|CDD|218107 pfam04484, DUF566, Family of unknown function (DUF566) | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.002
Identities = 34/129 (26%), Positives = 48/129 (37%), Gaps = 6/129 (4%)
Query: 124 TTPSSSSPPPANVRTTPSSSSP--PPANVPATPSSSSPPPVNVPTPPSSSSPPPP--SSN 179
S SS + ++P SSS ++ +T +SS P +N P P SSSP SS+
Sbjct: 1 RAASVSSGSTSGDASSPRSSSRRRLSSSFLSTSASSRPRRLNAPASPPSSSPARNTSSSS 60
Query: 180 PPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSS 239
+ P S P SP A+ + STS SP +S
Sbjct: 61 SFGLSKQRPSSLSRGRLSSRFVSPSRGSPSAAASLNGSLATASTSGSS--SPSRSRRTTS 118
Query: 240 TRGSPSTPP 248
+ S P
Sbjct: 119 SDLSSGNGP 127
|
Family of related proteins that is plant specific. Length = 313 |
| >gnl|CDD|218621 pfam05518, Totivirus_coat, Totivirus coat protein | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.002
Identities = 22/126 (17%), Positives = 31/126 (24%), Gaps = 4/126 (3%)
Query: 73 PPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPP 132
PP + P +A P P P P+ ++ P P +
Sbjct: 631 IISGFPPVFKTALPRPD-YNRGGEAGGPGVPGP-VPVGMPAHTARPSRVARGDPVRPTAH 688
Query: 133 PANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTP 192
A +R + P P P SS + PP P PP
Sbjct: 689 HAALRAPQAPRPGGPPGGGGGLPPPPDLPAAAGPAPCGSSLIASPTAPP--EPEPPGAEQ 746
Query: 193 PPHPSQ 198
Sbjct: 747 ADGAEN 752
|
Length = 753 |
| >gnl|CDD|215533 PLN02983, PLN02983, biotin carboxyl carrier protein of acetyl-CoA carboxylase | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 25/62 (40%), Positives = 30/62 (48%), Gaps = 1/62 (1%)
Query: 173 PPPPSSNPPTSTPSPPVLTP-PPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSP 231
PPPP+ P P + P P +Q AP SPP + SPPP P +S PP SP
Sbjct: 144 PPPPAPVVMMQPPPPHAMPPASPPAAQPAPSAPASSPPPTPASPPPAKAPKSSHPPLKSP 203
Query: 232 PA 233
A
Sbjct: 204 MA 205
|
Length = 274 |
| >gnl|CDD|130706 TIGR01645, half-pint, poly-U binding splicing factor, half-pint family | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 32/186 (17%), Positives = 46/186 (24%), Gaps = 41/186 (22%)
Query: 12 AVPPPSPPLSPPPSTTPPPTSPPPAS--------------------------PPPSPPTS 45
V PP L P P A+ P+ P+S
Sbjct: 281 CVTPPDALLQP----ATVSAIPAAAAVAAAAATAKIMAAEAVAGAAVLGPRAQSPATPSS 336
Query: 46 TPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDA-PPPPEVDPSPPSPAQ-------PPPQA 97
+ P+ S A P P P P P+P P PP
Sbjct: 337 SLPTDIGNKAVVSSAKKEAEEVPPLPQAAPAVVKPGPMEIPTPVPPPGLAIPSLVAPPGL 396
Query: 98 VAPSPPPPANV--PTTPSSSSPPPAN-VPTTPSSSSPPPANVRTTPSSSSPPPANVPATP 154
VAP+ P+ + P P + + P+ T A
Sbjct: 397 VAPTEINPSFLASPRKKMKREKLPVTFGALDDTLAWKEPSKEDQTSEDGKMLAIMGEAAA 456
Query: 155 SSSSPP 160
+ + P
Sbjct: 457 ALALEP 462
|
The proteins represented by this model contain three RNA recognition motifs (rrm: pfam00076) and have been characterized as poly-pyrimidine tract binding proteins associated with RNA splicing factors. In the case of PUF60 (GP|6176532), in complex with p54, and in the presence of U2AF, facilitates association of U2 snRNP with pre-mRNA. Length = 612 |
| >gnl|CDD|234938 PRK01297, PRK01297, ATP-dependent RNA helicase RhlB; Provisional | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 16/58 (27%), Positives = 23/58 (39%), Gaps = 1/58 (1%)
Query: 2 PPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSP 59
P +PP+ A P P PP + + +P A+P P P P P+S
Sbjct: 16 QPAPAPPSPAAAPAPPPP-AKTAAPATKAAAPAAAAPRAEKPKKDKPRRERKPKPASL 72
|
Length = 475 |
| >gnl|CDD|234938 PRK01297, PRK01297, ATP-dependent RNA helicase RhlB; Provisional | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.002
Identities = 17/54 (31%), Positives = 22/54 (40%), Gaps = 2/54 (3%)
Query: 28 PPPTSPPPASPPPSPP-TSTPPSPPTAPPPSSPAVNSPPP-QPSSPPPPLDAPP 79
P P SP A PP P T+ P + AP ++P P +P P A
Sbjct: 19 PAPPSPAAAPAPPPPAKTAAPATKAAAPAAAAPRAEKPKKDKPRRERKPKPASL 72
|
Length = 475 |
| >gnl|CDD|220603 pfam10152, DUF2360, Predicted coiled-coil domain-containing protein (DUF2360) | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 0.002
Identities = 18/64 (28%), Positives = 25/64 (39%)
Query: 34 PPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQP 93
P PP S + PPP + A + PP P +P P P P + + A+
Sbjct: 53 VTVQTTPPPPASAITNGGPPPPPPARAEAASPPPPEAPAEPPAEPEPEAPAENTVTVAKD 112
Query: 94 PPQA 97
P A
Sbjct: 113 PRYA 116
|
This is the conserved 140 amino acid region of a family of proteins conserved from nematodes to humans. One C. elegans member is annotated as a Daf-16-dependent longevity protein 1 but this could not be confirmed. The function is unknown. Length = 147 |
| >gnl|CDD|240420 PTZ00441, PTZ00441, sporozoite surface protein 2 (SSP2); Provisional | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 36/167 (21%), Positives = 50/167 (29%), Gaps = 22/167 (13%)
Query: 72 PPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSP 131
P PL P P P +P + P+ +VP P PPP +P
Sbjct: 286 PEPLPVPAPVPPTPEDDNPRPTDDEFAVPNFNEGLDVPDNPQDPVPPPNE----GKDGNP 341
Query: 132 PPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLT 191
N+ P +NVP P P P S +S + +PP
Sbjct: 342 NEENLFPPGDDEVPDESNVPPNP----------PNVPGGS-----NSEFSSDVENPPNPP 386
Query: 192 PPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNS 238
P P Q P + P P ++ + P P N
Sbjct: 387 NPDIPEQEPNIPEDSNKEVPEDVPMEPEDDRDNN---FNEPKKPENK 430
|
Length = 576 |
| >gnl|CDD|235899 PRK06975, PRK06975, bifunctional uroporphyrinogen-III synthetase/uroporphyrin-III C-methyltransferase; Reviewed | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.002
Identities = 14/56 (25%), Positives = 20/56 (35%)
Query: 7 PPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVN 62
A A P+P + + TS P A+ P PP+ P PP +
Sbjct: 268 AAAQPATAAPAPSRMTDTNDSKSVTSQPAAAAAAPAPPPNPPATPPEPPARRGRGS 323
|
Length = 656 |
| >gnl|CDD|165468 PHA03201, PHA03201, uracil DNA glycosylase; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 24/85 (28%), Positives = 35/85 (41%)
Query: 165 PTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTS 224
+P P PP PP S + P TPP P A PP ++ + P P+
Sbjct: 7 RSPSPPRRPSPPRPTPPRSPDASPEETPPSPPGPGAEPPPGRAAGPAAPRRRPRGCPAGV 66
Query: 225 SPPAVSPPAPPSNSSTRGSPSTPPL 249
+ + +PP PP + + PPL
Sbjct: 67 TFSSSAPPRPPLGLDDAPAATPPPL 91
|
Length = 318 |
| >gnl|CDD|225499 COG2948, VirB10, Type IV secretory pathway, VirB10 components [Intracellular trafficking and secretion] | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.002
Identities = 26/113 (23%), Positives = 29/113 (25%), Gaps = 11/113 (9%)
Query: 2 PPQSSPPAVLAVPPPSPPLSPPPSTTPP-PTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
P V PP PPL P PP P P P A
Sbjct: 54 NNTQPPSNVERGTPPLPPLPDDPPLPPPLPVDLGAPVLPDQQVEEAKDQPRRLRAAELAA 113
Query: 61 ----------VNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPP 103
+ P A PPP PS S + AV P+ P
Sbjct: 114 TSGSRVESDRAVGRVRAALANAAPAAAAPPPAGQPSGQSAKEDFAGAVNPTQP 166
|
Length = 360 |
| >gnl|CDD|215187 PLN02328, PLN02328, lysine-specific histone demethylase 1 homolog | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.002
Identities = 28/97 (28%), Positives = 32/97 (32%), Gaps = 18/97 (18%)
Query: 25 STTPPPTSPPP-----ASPPPSPPTSTPPSPP------TAPPPSSPAVNSPP----PQPS 69
+ T P P S SP T SP +SP SP P P
Sbjct: 3 TETKEPEDPADNVNDVVSEASSPETDLSLSPSQSEQNIENDGQNSPETQSPLTELQPSPL 62
Query: 70 SPPPPLDAPPPPEVDPSPPSPAQPP--PQAVAPSPPP 104
P LDAP S Q P P + P+PPP
Sbjct: 63 PPNTTLDAPVSDSQGDE-SSSEQQPQNPNSTEPAPPP 98
|
Length = 808 |
| >gnl|CDD|221179 pfam11711, Tim54, Inner membrane protein import complex subunit Tim54 | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.002
Identities = 22/94 (23%), Positives = 33/94 (35%), Gaps = 6/94 (6%)
Query: 30 PTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPS 89
P PP + + P + + P A P+ PA + P P E + P
Sbjct: 197 PPEPPEPTVDEAAPETEVEATPAAESPAEPAEETAETTPEE-----TEDAPEEENNKPVK 251
Query: 90 PAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVP 123
P P P ++P P A +P P +P
Sbjct: 252 PPVPKP-YISPDEYPSAPLPPELPQLLQPSLVIP 284
|
Mitochondrial function depends on the import of hundreds of different proteins synthesised in the cytosol. Protein import is a multi-step pathway which includes the binding of precursor proteins to surface receptors, translocation of the precursor across one or both mitochondrial membranes, and folding and assembly of the imported protein inside the mitochondrion. Most precursor proteins carry amino-terminal targeting signals, called pre-sequences, and are imported into mitochondria via import complexes located in both the outer and the inner membrane (IM). The IM complex, TIM, is made up of at least two proteins which mediate translocation of proteins into the matrix by removing their signal peptide and another pair of proteins, Tim54 and Tim22, that insert the polytopic proteins, that carry internal targetting information, into the inner membrane. Length = 377 |
| >gnl|CDD|171499 PRK12438, PRK12438, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.002
Identities = 16/54 (29%), Positives = 21/54 (38%), Gaps = 1/54 (1%)
Query: 11 LAVPPPSPPLSPPPSTTPPPTSPPPASPPPSP-PTSTPPSPPTAPPPSSPAVNS 63
+A P S PP PP P PP + P + PP P PP + +
Sbjct: 902 VATAPGGDAASAPPPGAGPPAPPQAVPPPRTTQPPAAPPRGPDVPPAAVAELRE 955
|
Length = 991 |
| >gnl|CDD|218440 pfam05110, AF-4, AF-4 proto-oncoprotein | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.002
Identities = 42/242 (17%), Positives = 57/242 (23%), Gaps = 17/242 (7%)
Query: 24 PSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEV 83
P +PP A P ++ ++ S + S SS + PP
Sbjct: 374 TEKPPSRNTPPSAPSSNPEPAASSSGSSSSSSGSESSSGSDSESESSSSDSEENEPPRTA 433
Query: 84 DPSPPSPAQPPPQ------AVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVR 137
P P P+ Q V P PA ++ P SS S +
Sbjct: 434 SPEPEPPSTNKWQLDNWLNKVNPHKVSPAESVSSNPPIKQPMEKEGKVKSSGSQYHPESK 493
Query: 138 TTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPP----SSNPPTSTPSPPVLTPP 193
P SS P T P+ S PP P
Sbjct: 494 EPPPKSSSKEKRRPRTAQKGPESGRGKQKSPAQSEAPPQRRTVGKKQPKKPEKASAGDER 553
Query: 194 PHPSQSAPPPVTKSPPASTLSPPPPSV-------PSTSSPPAVSPPAPPSNSSTRGSPST 246
+ P + P P PS P S P +
Sbjct: 554 TGLRPESEPGTLPYGSSVQTPPDRPKAATKGSRKPSPRKEPKSSVPPAAEKRKYKSPSKI 613
Query: 247 PP 248
P
Sbjct: 614 VP 615
|
This family consists of AF4 (Proto-oncogene AF4) and FMR2 (Fragile X E mental retardation syndrome) nuclear proteins. These proteins have been linked to human diseases such as acute lymphoblastic leukaemia and mental retardation. The family also contains a Drosophila AF4 protein homologue Lilliputian which contains an AT-hook domain. Lilliputian represents a novel pair-rule gene that acts in cytoskeleton regulation, segmentation and morphogenesis in Drosophila. Length = 1154 |
| >gnl|CDD|152960 pfam12526, DUF3729, Protein of unknown function (DUF3729) | Back alignment and domain information |
|---|
Score = 38.1 bits (89), Expect = 0.002
Identities = 29/77 (37%), Positives = 30/77 (38%)
Query: 30 PTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPS 89
+ P A P PP P P PP AV PP PP D PP PPS
Sbjct: 29 FSPPESAHPDDPPPVGDPRPPVVDTPPPVSAVWVLPPPSEPAAPPPDPEPPVPGPAGPPS 88
Query: 90 PAQPPPQAVAPSPPPPA 106
P PP A P PPP
Sbjct: 89 PLAPPAPARKPPLPPPR 105
|
This family of proteins is found in viruses. Proteins in this family are typically between 145 and 1707 amino acids in length. The family is found in association with pfam01443, pfam01661, pfam05417, pfam01660, pfam00978. There is a single completely conserved residue L that may be functionally important. Length = 115 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.002
Identities = 32/143 (22%), Positives = 53/143 (37%), Gaps = 37/143 (25%)
Query: 405 GREVAVKQ------------LKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERER 452
G VK+ K+ + RE R I+++ + + Y +
Sbjct: 19 GLPAVVKERIPKRYRHPELDEKLRRERTRREAR----ILAKAREAGVPVPIVYDVDPDNG 74
Query: 453 LLVYEYVPNDTLHYHLHAEGRPVMD--WATRVKVAAGAARGIAYLHEDCHPRIIHRDIKS 510
L+V EY+ EG + D R + R + LH+ I+H D+ +
Sbjct: 75 LIVMEYI-----------EGELLKDALEEARPDLLREVGRLVGKLHKA---GIVHGDLTT 120
Query: 511 SNILLDSSFEARV--ADFGLAKI 531
SNI+L R+ DFGL +
Sbjct: 121 SNIILSGG---RIYFIDFGLGEF 140
|
Length = 204 |
| >gnl|CDD|139494 PRK13335, PRK13335, superantigen-like protein; Reviewed | Back alignment and domain information |
|---|
Score = 40.5 bits (94), Expect = 0.002
Identities = 23/85 (27%), Positives = 35/85 (41%), Gaps = 6/85 (7%)
Query: 111 TPSSSSPPPANVPTTPSS-----SSPPPANVRT-TPSSSSPPPANVPATPSSSSPPPVNV 164
TP P N T +S S P ++ S++ P T + S+ P V
Sbjct: 73 TPKLEKAPNTNEEKTSASKIEKISQPKQEEQKSLNISATPAPKQEQSQTTTESTTPKTKV 132
Query: 165 PTPPSSSSPPPPSSNPPTSTPSPPV 189
TPPS+++P P S + SP +
Sbjct: 133 TTPPSTNTPQPMQSTKSDTPQSPTI 157
|
Length = 356 |
| >gnl|CDD|139494 PRK13335, PRK13335, superantigen-like protein; Reviewed | Back alignment and domain information |
|---|
Score = 40.5 bits (94), Expect = 0.002
Identities = 20/102 (19%), Positives = 35/102 (34%), Gaps = 11/102 (10%)
Query: 93 PPPQAVAPSPPPPANVPTTPSSSSPPPANVPTT--PSSSSPPPANVRTTPSSSSPPPANV 150
P + + + S P + ++ +P +TT S++P
Sbjct: 74 PKLEKAPNTNEEKTSASKIEKISQPKQEEQKSLNISATPAPKQEQSQTTTESTTP----- 128
Query: 151 PATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTP 192
++PP N P P S+ P S PT + +TP
Sbjct: 129 --KTKVTTPPSTNTPQPMQSTKSDTPQS--PTIKQAQTDMTP 166
|
Length = 356 |
| >gnl|CDD|183558 PRK12495, PRK12495, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.002
Identities = 25/92 (27%), Positives = 35/92 (38%), Gaps = 4/92 (4%)
Query: 77 APPPPEVDPSPPSPAQPPPQAVA---PSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPP 133
AP SP AQP +A A +PP ++ T +++ PPA + P
Sbjct: 86 APSDAGSQASPDDDAQPAAEAEAADQSAPPEASSTSATDEAATDPPATAAARDGPTPDPT 145
Query: 134 ANVRTTPSSSSP-PPANVPATPSSSSPPPVNV 164
A T SP V P + S P +V
Sbjct: 146 AQPATPDERRSPRQRPPVSGEPPTPSTPDAHV 177
|
Length = 226 |
| >gnl|CDD|240271 PTZ00108, PTZ00108, DNA topoisomerase 2-like protein; Provisional | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 0.002
Identities = 18/143 (12%), Positives = 29/143 (20%), Gaps = 2/143 (1%)
Query: 107 NVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPT 166
N + P S ++ SS + P
Sbjct: 1219 NSSGSDQEDDEEQKTKPKKSSVKRLKSKKNNSSKSSEDNDEFSSDDLSKEGKPKNAPKRV 1278
Query: 167 PPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSP 226
SPPPPS P + + P + S A +
Sbjct: 1279 SAVQYSPPPPSKRPDGESNGGSKPSSPTKKKV--KKRLEGSLAALKKKKKSEKKTARKKK 1336
Query: 227 PAVSPPAPPSNSSTRGSPSTPPL 249
++ S+R
Sbjct: 1337 SKTRVKQASASQSSRLLRRPRKK 1359
|
Length = 1388 |
| >gnl|CDD|218439 pfam05109, Herpes_BLLF1, Herpes virus major outer envelope glycoprotein (BLLF1) | Back alignment and domain information |
|---|
Score = 40.9 bits (95), Expect = 0.003
Identities = 37/183 (20%), Positives = 59/183 (32%), Gaps = 19/183 (10%)
Query: 101 SPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPP 160
+P +V + P P++ S PPA+ T S A P+S +P
Sbjct: 425 APDTTKSVIFVYTLVHVEPHKTTAVPTTPSLPPASTGPTVS---------TADPTSGTPT 475
Query: 161 PVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSV 220
T P +SP +++ + SP P+ + P K+ + P P V
Sbjct: 476 GTTSSTLPEDTSPTSRTTSATPNATSPTPAVTTPNATS---PTTQKTSDTPNATSPTPIV 532
Query: 221 PSTSSPPAVSPPAPPSNSSTRGSPSTPPLPSVPTEKPTAKSTNGTAVSANASPRNAGVLG 280
+ P + S P V E P + SA + +A G
Sbjct: 533 ---IGVTTTATSPPTGTT----SVPNATSPQVTEESPVNNTNTPVVTSAPSVLTSAVTTG 585
Query: 281 TGG 283
G
Sbjct: 586 QHG 588
|
This family consists of the BLLF1 viral late glycoprotein, also termed gp350/220. It is the most abundantly expressed glycoprotein in the viral envelope of the Herpesviruses and is the major antigen responsible for stimulating the production of neutralising antibodies in vivo. Length = 830 |
| >gnl|CDD|217392 pfam03153, TFIIA, Transcription factor IIA, alpha/beta subunit | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.003
Identities = 22/136 (16%), Positives = 35/136 (25%), Gaps = 6/136 (4%)
Query: 120 ANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSS--SSPPPVNVPTPPSSSSPPPPS 177
+ V P SP P P A + N PT +++PP
Sbjct: 42 SGVAEFPWDPSPQAPPPVAQLPQPLPQPPPTQALQALPAGDQQQHNTPTGSPAANPPATF 101
Query: 178 SNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSN 237
+ P P + T P P + PA++ P + +
Sbjct: 102 ALPA-GPAGPTIQTEPGQLYPVQVPVMVTQNPANSPLDQP---AQQRALQQLQQRYGAPA 157
Query: 238 SSTRGSPSTPPLPSVP 253
S S +
Sbjct: 158 SGQLPSQQQSAQKNDE 173
|
Transcription initiation factor IIA (TFIIA) is a heterotrimer, the three subunits being known as alpha, beta, and gamma, in order of molecular weight. The N and C-terminal domains of the gamma subunit are represented in pfam02268 and pfam02751, respectively. This family represents the precursor that yields both the alpha and beta subunits. The TFIIA heterotrimer is an essential general transcription initiation factor for the expression of genes transcribed by RNA polymerase II. Together with TFIID, TFIIA binds to the promoter region; this is the first step in the formation of a pre-initiation complex (PIC). Binding of the rest of the transcription machinery follows this step. After initiation, the PIC does not completely dissociate from the promoter. Some components, including TFIIA, remain attached and re-initiate a subsequent round of transcription. Length = 332 |
| >gnl|CDD|236669 PRK10263, PRK10263, DNA translocase FtsK; Provisional | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.003
Identities = 38/148 (25%), Positives = 47/148 (31%), Gaps = 6/148 (4%)
Query: 40 PSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVA 99
P P TP P P A QP P P P+ +P Q P Q VA
Sbjct: 740 PHEPLFTPIVEPVQQPQQPVAPQQQYQQPQQPVAPQPQYQQPQQPVAPQPQYQQPQQPVA 799
Query: 100 PSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSP 159
P P P P + P P P + P + + P +
Sbjct: 800 PQPQYQQ--PQQPVAPQPQYQQ-PQQPVAPQPQYQQPQQPVAPQPQDTLLHPLLMRNGDS 856
Query: 160 PPVNVPTPPSSS---SPPPPSSNPPTST 184
P++ PT P S PPPS P T
Sbjct: 857 RPLHKPTTPLPSLDLLTPPPSEVEPVDT 884
|
Length = 1355 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.003
Identities = 19/92 (20%), Positives = 33/92 (35%), Gaps = 2/92 (2%)
Query: 181 PTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSST 240
P T + P P+ T S + + P P+V + V+P +++
Sbjct: 163 PLDTSTTTDPATTPAPAAPVDTTPTNSQTPAVATAPAPAVDPQQNAV-VAPSQANVDTAA 221
Query: 241 RGSPSTPPLPSVPTEKPTAK-STNGTAVSANA 271
+P+ P P PT + + A NA
Sbjct: 222 TPAPAAPATPDGAAPLPTDQAGVSTPAADPNA 253
|
Length = 331 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.003
Identities = 26/86 (30%), Positives = 40/86 (46%)
Query: 157 SSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPP 216
+ V + P ++++ P P PP++ + P PP P A PP + + PP
Sbjct: 24 AGASAVAIALPATANADPAPPPPPPSTAAAAPAPAAPPPPPPPAAPPAPQPDDPNAAPPP 83
Query: 217 PPSVPSTSSPPAVSPPAPPSNSSTRG 242
PP+ P+ PP V P APP + G
Sbjct: 84 PPADPNAPPPPPVDPNAPPPPAPEPG 109
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|218107 pfam04484, DUF566, Family of unknown function (DUF566) | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.003
Identities = 25/127 (19%), Positives = 41/127 (32%), Gaps = 4/127 (3%)
Query: 94 PPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPAT 153
+ S A+ P + S + + T+ SS + PSSS + ++
Sbjct: 2 AASVSSGSTSGDASSPRSSSRRRLSSSFLSTSASSRPRRLNAPASPPSSSPARNTSSSSS 61
Query: 154 PSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPP----VLTPPPHPSQSAPPPVTKSPP 209
S P ++ SS PS P++ S + S S T S
Sbjct: 62 FGLSKQRPSSLSRGRLSSRFVSPSRGSPSAAASLNGSLATASTSGSSSPSRSRRTTSSDL 121
Query: 210 ASTLSPP 216
+S P
Sbjct: 122 SSGNGPS 128
|
Family of related proteins that is plant specific. Length = 313 |
| >gnl|CDD|177464 PHA02682, PHA02682, ORF080 virion core protein; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (93), Expect = 0.003
Identities = 34/116 (29%), Positives = 48/116 (41%), Gaps = 8/116 (6%)
Query: 14 PPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPP-------- 65
P PL+P P+ P + P +P P T P+P A PP++ PP
Sbjct: 76 PSGQSPLAPSPACAAPAPACPACAPAAPAPAVTCPAPAPACPPATAPTCPPPAVCPAPAR 135
Query: 66 PQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPAN 121
P P+ PP PP P + P+PA P PPP + P+ + P A+
Sbjct: 136 PAPACPPSTRQCPPAPPLPTPKPAPAAKPIFLHNQLPPPDYPAASCPTIETAPAAS 191
|
Length = 280 |
| >gnl|CDD|215130 PLN02217, PLN02217, probable pectinesterase/pectinesterase inhibitor | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.003
Identities = 35/127 (27%), Positives = 50/127 (39%), Gaps = 16/127 (12%)
Query: 146 PPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVT 205
P VP P + P + + P+ S+ SN S+ SP + P +
Sbjct: 551 PGKGVPYIPGLFAGNPGSTNSTPTGSAAS---SNTTFSSDSPSTVVAP-----------S 596
Query: 206 KSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTPPLPSVPTEKPTAKSTNGT 265
SPPA L PP + PS P+ SPPA S +PS+P TA +
Sbjct: 597 TSPPAGHLGSPPAT-PSKIVSPSTSPPA-SHLGSPSTTPSSPESSIKVASTETASPESSI 654
Query: 266 AVSANAS 272
V++ S
Sbjct: 655 KVASTES 661
|
Length = 670 |
| >gnl|CDD|215130 PLN02217, PLN02217, probable pectinesterase/pectinesterase inhibitor | Back alignment and domain information |
|---|
Score = 40.5 bits (94), Expect = 0.003
Identities = 33/110 (30%), Positives = 45/110 (40%), Gaps = 13/110 (11%)
Query: 23 PPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA--VNSPPPQPSSPPPPLDAPPP 80
P ST PT A+ + +S PS AP S PA + SPP PS P +PP
Sbjct: 566 PGSTNSTPTGS--AASSNTTFSSDSPSTVVAPSTSPPAGHLGSPPATPSKIVSPSTSPPA 623
Query: 81 PEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSS 130
+ +P+ SP V +T ++S V +T SS S
Sbjct: 624 SHLGSPSTTPS---------SPESSIKVASTETASPESSIKVASTESSVS 664
|
Length = 670 |
| >gnl|CDD|197891 smart00818, Amelogenin, Amelogenins, cell adhesion proteins, play a role in the biomineralisation of teeth | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.003
Identities = 24/94 (25%), Positives = 29/94 (30%), Gaps = 1/94 (1%)
Query: 1 PPPQSSPPAVLAVP-PPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSP 59
P Q P +P P ++P P P P P P P P P
Sbjct: 62 PAQQPVVPQQPLMPVPGQHSMTPTQHHQPNLPQPAQQPFQPQPLQPPQPQQPMQPQPPVH 121
Query: 60 AVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQP 93
+ PPQP PP P PP + P
Sbjct: 122 PIPPLPPQPPLPPMFPMQPLPPLLPDLPLEAWPA 155
|
They seem to regulate formation of crystallites during the secretory stage of tooth enamel development and are thought to play a major role in the structural organisation and mineralisation of developing enamel. The extracellular matrix of the developing enamel comprises two major classes of protein: the hydrophobic amelogenins and the acidic enamelins. Circular dichroism studies of porcine amelogenin have shown that the protein consists of 3 discrete folding units: the N-terminal region appears to contain beta-strand structures, while the C-terminal region displays characteristics of a random coil conformation. Subsequent studies on the bovine protein have indicated the amelogenin structure to contain a repetitive beta-turn segment and a "beta-spiral" between Gln112 and Leu138, which sequester a (Pro, Leu, Gln) rich region. The beta-spiral offers a probable site for interactions with Ca2+ ions. Muatations in the human amelogenin gene (AMGX) cause X-linked hypoplastic amelogenesis imperfecta, a disease characterised by defective enamel. A 9bp deletion in exon 2 of AMGX results in the loss of codons for Ile5, Leu6, Phe7 and Ala8, and replacement by a new threonine codon, disrupting the 16-residue (Met1-Ala16) amelogenin signal peptide. Length = 165 |
| >gnl|CDD|215533 PLN02983, PLN02983, biotin carboxyl carrier protein of acetyl-CoA carboxylase | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.003
Identities = 25/62 (40%), Positives = 30/62 (48%), Gaps = 2/62 (3%)
Query: 64 PPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPP--PPANVPTTPSSSSPPPAN 121
P P P +P + PPP + P+ P AQP P A A SPP P + P SS PP
Sbjct: 142 PQPPPPAPVVMMQPPPPHAMPPASPPAAQPAPSAPASSPPPTPASPPPAKAPKSSHPPLK 201
Query: 122 VP 123
P
Sbjct: 202 SP 203
|
Length = 274 |
| >gnl|CDD|233045 TIGR00601, rad23, UV excision repair protein Rad23 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.003
Identities = 18/67 (26%), Positives = 26/67 (38%), Gaps = 1/67 (1%)
Query: 95 PQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATP 154
P+ PPA PT+ + +P P S+ P + V S A P +P
Sbjct: 77 PKTGTGKVAPPAATPTSAPTPTPSPP-ASPASGMSAAPASAVEEKSPSEESATATAPESP 135
Query: 155 SSSSPPP 161
S+S P
Sbjct: 136 STSVPSS 142
|
All proteins in this family for which functions are known are components of a multiprotein complex used for targeting nucleotide excision repair to specific parts of the genome. In humans, Rad23 complexes with the XPC protein. This family is based on the phylogenomic analysis of JA Eisen (1999, Ph.D. Thesis, Stanford University) [DNA metabolism, DNA replication, recombination, and repair]. Length = 378 |
| >gnl|CDD|166942 PRK00404, tatB, sec-independent translocase; Provisional | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.003
Identities = 21/66 (31%), Positives = 26/66 (39%), Gaps = 4/66 (6%)
Query: 58 SPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSP 117
+P PP+P +PP P P +PA PP AP+ PA P S P
Sbjct: 80 APLTPPAPPEPVTPPTAQSPAPAVPTPPPTSTPAVPP----APAAAVPAPAAAPPPSDPP 135
Query: 118 PPANVP 123
P P
Sbjct: 136 QPPRAP 141
|
Length = 141 |
| >gnl|CDD|166942 PRK00404, tatB, sec-independent translocase; Provisional | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.003
Identities = 16/50 (32%), Positives = 20/50 (40%)
Query: 2 PPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPP 51
P ++ AVP P P +P P P PA+ PP PP P
Sbjct: 92 TPPTAQSPAPAVPTPPPTSTPAVPPAPAAAVPAPAAAPPPSDPPQPPRAP 141
|
Length = 141 |
| >gnl|CDD|220749 pfam10428, SOG2, RAM signalling pathway protein | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.003
Identities = 24/126 (19%), Positives = 37/126 (29%), Gaps = 6/126 (4%)
Query: 12 AVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTA--PPPSSPAVNSPPP--Q 67
+ P + T P+S + P S PT P SSP S P +
Sbjct: 146 SSLGPPLQHRKRDAVTASPSSMIARNTPISDRLRPRSVTPTRGRRPSSSPRSLSNPTTLE 205
Query: 68 PSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPS 127
S PPP + + S + S P + S P + ++ +
Sbjct: 206 SPSNLQVTTDVPPPYSNGTSRSSTMSS--SANLSIISSLATPRSGESFRSTPTSGSSSIN 263
Query: 128 SSSPPP 133
S
Sbjct: 264 PVSGLD 269
|
SOG2 proteins in Saccharomyces cerevisiae are involved in cell separation and cytokinesis. Length = 419 |
| >gnl|CDD|220749 pfam10428, SOG2, RAM signalling pathway protein | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.003
Identities = 21/114 (18%), Positives = 34/114 (29%), Gaps = 3/114 (2%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASP--PPSPPTSTPPSPPTAPPPS- 57
+SP +++A P P S TP P +SP +P T PS
Sbjct: 158 DAVTASPSSMIARNTPISDRLRPRSVTPTRGRRPSSSPRSLSNPTTLESPSNLQVTTDVP 217
Query: 58 SPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTT 111
P N + + P + P + + S P + +
Sbjct: 218 PPYSNGTSRSSTMSSSANLSIISSLATPRSGESFRSTPTSGSSSINPVSGLDEA 271
|
SOG2 proteins in Saccharomyces cerevisiae are involved in cell separation and cytokinesis. Length = 419 |
| >gnl|CDD|227430 COG5099, COG5099, RNA-binding protein of the Puf family, translational repressor [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.003
Identities = 43/249 (17%), Positives = 64/249 (25%), Gaps = 44/249 (17%)
Query: 39 PPSPPTSTPPSP--PTAPPPSSPAVNSPPPQPSSPPPPLDAPPP------------PEVD 84
SPP+ST P+S SP P +S P
Sbjct: 21 KKSPPSSTTSQELMNGNSTPNS---FSPIPSKASSSATFTLNLPINNSVNHKITSSSSSR 77
Query: 85 PSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPA-----NVPTTPS------------ 127
P + + + PSSS P + S
Sbjct: 78 RKPSGSWSVAISSSTSG--SQSLLMELPSSSFNPSTSSRNKSNSALSSTQQGNANSSVTL 135
Query: 128 SSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSP 187
SSS + + P + AT + S +N P SS + P
Sbjct: 136 SSSTASSMFNSNKLPLPNPNHSNSATTNQSGSSFINTPASSSSQPLTNLVVSSIKRFPYL 195
Query: 188 PVLTPP-PHPSQSAPPPVTKSPPASTLSPPPPSVP--STSSPPAVSPPAPP-----SNSS 239
L+P + + T S S PPP++ + S +SP +
Sbjct: 196 TSLSPFFNYLIDPSSDSATASADTSPSFNPPPNLSPNNLFSTSDLSPLPDTQSVENNIIL 255
Query: 240 TRGSPSTPP 248
S
Sbjct: 256 NSSSSINEL 264
|
Length = 777 |
| >gnl|CDD|237782 PRK14666, uvrC, excinuclease ABC subunit C; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.003
Identities = 25/108 (23%), Positives = 33/108 (30%), Gaps = 4/108 (3%)
Query: 68 PSSPPPPLDAPP--PPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANV-PT 124
P S PP P P A A P +P P SS P V
Sbjct: 303 PQSTIPPRIVVPWLPDTEGREGDDLAPTAVCTDAGLLPDTPLLPDAPEGSSDPVVPVAAA 362
Query: 125 TPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSS 172
TP +S P T P+S + PA + + P ++
Sbjct: 363 TPVDASLPDVRTGTAPTSLANVSHADPA-VAQPTQAATLAGAAPKGAT 409
|
Length = 694 |
| >gnl|CDD|183854 PRK13042, PRK13042, superantigen-like protein; Reviewed | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 22/57 (38%), Positives = 28/57 (49%), Gaps = 2/57 (3%)
Query: 3 PQSSPPAV-LAVPPPSPPLSPPPST-TPPPTSPPPASPPPSPPTSTPPSPPTAPPPS 57
PQS+PP+ + P P + PPST P P A+ P S TP SP T P+
Sbjct: 41 PQSTPPSTKVEAPQSKPNATTPPSTKVEAPQQTPNATTPSSTKVETPQSPTTKQVPT 97
|
Length = 291 |
| >gnl|CDD|225689 COG3147, DedD, Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.003
Identities = 20/80 (25%), Positives = 26/80 (32%), Gaps = 1/80 (1%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
PP+ + + P PP PA P + T P PP PP+
Sbjct: 69 QPPEGVAQEIQDAGDAAAASVDPQPVAQPPVESTPAGVPVAAQTPKPVKPPK-QPPAGAV 127
Query: 61 VNSPPPQPSSPPPPLDAPPP 80
P P+P P A P
Sbjct: 128 PAKPTPKPEPKPVAEPAAAP 147
|
Length = 226 |
| >gnl|CDD|225689 COG3147, DedD, Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.003
Identities = 22/85 (25%), Positives = 27/85 (31%), Gaps = 2/85 (2%)
Query: 38 PPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQA 97
P + P PP S P P+ A PP E P+ A P+
Sbjct: 58 PAVVQVVALPTQPPEGVAQEIQDAGD-AAAASVDPQPV-AQPPVESTPAGVPVAAQTPKP 115
Query: 98 VAPSPPPPANVPTTPSSSSPPPANV 122
V P PPA + P P V
Sbjct: 116 VKPPKQPPAGAVPAKPTPKPEPKPV 140
|
Length = 226 |
| >gnl|CDD|225689 COG3147, DedD, Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.003
Identities = 22/94 (23%), Positives = 25/94 (26%), Gaps = 4/94 (4%)
Query: 15 PPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPS----PPTAPPPSSPAVNSPPPQPSS 70
PP P P A P P A V PP + +
Sbjct: 44 PPKPQGDRDEPRVLPAVVQVVALPTQPPEGVAQEIQDAGDAAAASVDPQPVAQPPVESTP 103
Query: 71 PPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPP 104
P+ A P V P PA P P P P
Sbjct: 104 AGVPVAAQTPKPVKPPKQPPAGAVPAKPTPKPEP 137
|
Length = 226 |
| >gnl|CDD|236652 PRK10118, PRK10118, flagellar hook-length control protein; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.003
Identities = 28/120 (23%), Positives = 39/120 (32%), Gaps = 10/120 (8%)
Query: 47 PPSPPTAPPPSSPAVNSPPPQPSS-----PPPPLDAPPPPEVDPSPPSPAQPPPQAVAP- 100
P T P +P+ P +P+ P P D D P
Sbjct: 151 PGQDNTTPVADAPSTVLPAEKPTLLTKDMPSAPQDETHTLSSDEHEKGLTSAQLTTAQPD 210
Query: 101 -SPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSP 159
+P PA T ++ + A V +TP SP A T + P A P S+P
Sbjct: 211 DAPGTPAQPLTPLAAEAQAKAEVISTP---SPVTAAASPTITPHQTQPLPTAAAPVLSAP 267
|
Length = 408 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.003
Identities = 52/213 (24%), Positives = 82/213 (38%), Gaps = 55/213 (25%)
Query: 425 RAEVEIISRVHHRHLVSLVGYCISERERL-LVYEYVPN-DTLHYHLHAEGRPVMDWATRV 482
+AE +I++ + +V L Y +++ L V +Y+P D + + E P + R
Sbjct: 49 KAERDILAEADNEWVVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFP--EVLARF 105
Query: 483 KVAAGAARGIAYLHEDCHPR-IIHRDIKSSNILLDSSFEARVADFGLA------------ 529
+A + E H IHRDIK NIL+D ++ DFGL
Sbjct: 106 YIAE-----LTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY 160
Query: 530 -------KIALELD------SNTHVSTRVM-------------------GTFGYMAPEYA 557
+ ++E SN R+ GT Y+APE
Sbjct: 161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVL 220
Query: 558 TSGKLTEKSDVYSFGVVLLELITGRKPVDASQP 590
T+ D +S GV+L E++ G+ P A P
Sbjct: 221 LRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTP 253
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|233870 TIGR02442, Cob-chelat-sub, cobaltochelatase subunit | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.003
Identities = 13/79 (16%), Positives = 15/79 (18%), Gaps = 4/79 (5%)
Query: 22 PPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPP 81
P P P P P P P P
Sbjct: 306 PHRRRRKPFEQPQGKDEKDLEEKPEEPGPDPEKPDEGEDDAEQSGPRGHPTP----GNDD 361
Query: 82 EVDPSPPSPAQPPPQAVAP 100
E +P P A + P
Sbjct: 362 EKEPDPQEEADGQGSSTDP 380
|
Cobaltochelatase is responsible for the insertion of cobalt into the corrin ring of coenzyme B12 during its biosynthesis. Two versions have been well described. CbiK/CbiX is a monomeric, anaerobic version which acts early in the biosynthesis (pfam06180). CobNST is a trimeric, ATP-dependent, aerobic version which acts late in the biosynthesis (TIGR02257/TIGR01650/TIGR01651). A number of genomes (actinobacteria, cyanobacteria, betaproteobacteria and pseudomonads) which apparently biosynthesize B12, encode a cobN gene but are demonstrably lacking cobS and cobT. These genomes do, however contain a homolog (modelled here) of the magnesium chelatase subunits BchI/BchD family. Aside from the cyanobacteria (which have a separate magnesium chelatase trimer), these species do not make chlorins, so do not have any use for a magnesium chelatase. Furthermore, in nearly all cases the members of this family are proximal to either CobN itself or other genes involved in cobalt transport or B12 biosynthesis. Length = 633 |
| >gnl|CDD|237191 PRK12757, PRK12757, cell division protein FtsN; Provisional | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.003
Identities = 15/68 (22%), Positives = 22/68 (32%)
Query: 2 PPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAV 61
PQ V P + P P +PP + P P + P P + AV
Sbjct: 111 TPQVPRSTVQIQQQAQQQQPPATTAQPQPVTPPRQTTAPVQPQTPAPVRTQPAAPVTQAV 170
Query: 62 NSPPPQPS 69
+P +
Sbjct: 171 EAPKVEAE 178
|
Length = 256 |
| >gnl|CDD|220708 pfam10349, WWbp, WW-domain ligand protein | Back alignment and domain information |
|---|
Score = 37.4 bits (87), Expect = 0.003
Identities = 22/77 (28%), Positives = 26/77 (33%)
Query: 4 QSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNS 63
Q + P PP + P A PP PP P+PP P P +
Sbjct: 35 QRAQPVSRESGYYPPPGAYVHLEPLPAYGQYAAPPPYGPPPPYYPAPPGVYPTPPPPNSG 94
Query: 64 PPPQPSSPPPPLDAPPP 80
P PPPP PP
Sbjct: 95 YMADPQEPPPPYPGPPQ 111
|
The WWbp domain is characterized by several short PY and PT-like motifs of the PPPPY form. These appear to bind directly to the WW domains of WWP1 and WWP2 and other such diverse proteins as dystrophin and YAP (Yes-associated protein). This is the WW-domain binding protein WWbp via PY and PY_like motifs. The presence of a phosphotyrosine residue in the pWBP-1 peptide abolishes WW domain binding which suggests a potential regulatory role for tyrosine phosphorylation in modulating WW domain-ligand interactions. Given the likelihood that WWP1 and WWP2 function as E3 ubiquitin-protein ligases, it is possible that initial substrate-specific recognition occurs via WW domain-substrate protein interaction followed by ubiquitin transfer and subsequent proteolysis. This domain lies just downstream of the GRAM (pfam02893) in many members. Length = 111 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.004
Identities = 21/117 (17%), Positives = 34/117 (29%), Gaps = 17/117 (14%)
Query: 182 TSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTR 241
P P + +APPP P P + +P + APP+ S
Sbjct: 381 APAPPSAAWGAPTPAAPAAPPPAAAPPVPPAAPARPAAARPAPAPAPPAAAAPPARS--- 437
Query: 242 GSPSTPPLPSVPTEKPTAKSTNGTAVS--ANASPRNAGVLGTGGAVAIG---IAVGF 293
+ P +A V+ P L G + + + +GF
Sbjct: 438 ---------ADPAAAASAGDRWRAFVAFVKGKKPALGASLEQGSPLGVSAGLLEIGF 485
|
Length = 576 |
| >gnl|CDD|223061 PHA03369, PHA03369, capsid maturational protease; Provisional | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.004
Identities = 21/111 (18%), Positives = 30/111 (27%), Gaps = 1/111 (0%)
Query: 90 PAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPAN 149
A A A A T + P S P + + P
Sbjct: 354 TAPSRVLAAAAKVAVIAAPQTHTGPADRQRPQRPDGIPYSVPARSPMTAYPPVPQFCGDP 413
Query: 150 VPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSA 200
+P + P + P PP P +NP S + P HP +
Sbjct: 414 GLVSPYNPQSPGTSYGPEPVGPVPPQP-TNPYVMPISMANMVYPGHPQEHG 463
|
Length = 663 |
| >gnl|CDD|240289 PTZ00144, PTZ00144, dihydrolipoamide succinyltransferase; Provisional | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.004
Identities = 17/84 (20%), Positives = 27/84 (32%), Gaps = 7/84 (8%)
Query: 82 EVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPS 141
E+D PA P A A ++ +P P ++ P
Sbjct: 117 EIDTGGAPPAAAPAAAAAAKAEKTTPEKPKAAAPTPEPPAASKPTPPAAAKPP---EPAP 173
Query: 142 SSSPPPANVPATPSSSSPPPVNVP 165
++ PPP V + + P VP
Sbjct: 174 AAKPPPTPV----ARADPRETRVP 193
|
Length = 418 |
| >gnl|CDD|240289 PTZ00144, PTZ00144, dihydrolipoamide succinyltransferase; Provisional | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.004
Identities = 19/79 (24%), Positives = 27/79 (34%), Gaps = 10/79 (12%)
Query: 130 SPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPV 189
+ P A + PP + PTPP+++ PP P+
Sbjct: 125 PAAAPAAAAAAKAEKTTPEKPKAAAPTPEPPAASKPTPPAAAKPPEPAPAAK-------- 176
Query: 190 LTPPPHPSQSAPPPVTKSP 208
PPP P A P T+ P
Sbjct: 177 --PPPTPVARADPRETRVP 193
|
Length = 418 |
| >gnl|CDD|236768 PRK10819, PRK10819, transport protein TonB; Provisional | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.004
Identities = 32/123 (26%), Positives = 41/123 (33%), Gaps = 15/123 (12%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
PPQ+ PPP P + P P P P PP +P P P P P
Sbjct: 59 EPPQAVQ------PPPEPVVEPEPEPEPIP-EPPKEAPVVIPKPEPKPKPKPKP------ 105
Query: 61 VNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPA 120
P P P P E P+ P P + + + A+ P T SS P
Sbjct: 106 --KPKPVKKVEEQPKREVKPVEPRPASPFENTAPARPTSSTATAAASKPVTSVSSGPRAL 163
Query: 121 NVP 123
+
Sbjct: 164 SRN 166
|
Length = 246 |
| >gnl|CDD|236382 PRK09111, PRK09111, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 0.004
Identities = 8/71 (11%), Positives = 17/71 (23%)
Query: 4 QSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNS 63
+ P P P + A+ P + + + ++ A +
Sbjct: 389 EGPPSPGGGGGGPPGGGGAPGAPAAAAAPGAAAAAPAAGGPAAALAAVPDAAAAAAAPPA 448
Query: 64 PPPQPSSPPPP 74
P P
Sbjct: 449 PAAAPQPAVRL 459
|
Length = 598 |
| >gnl|CDD|236382 PRK09111, PRK09111, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 0.004
Identities = 12/66 (18%), Positives = 21/66 (31%)
Query: 171 SSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVS 230
P P P +A PA+ L+ P + + ++PPA +
Sbjct: 391 PPSPGGGGGGPPGGGGAPGAPAAAAAPGAAAAAPAAGGPAAALAAVPDAAAAAAAPPAPA 450
Query: 231 PPAPPS 236
P+
Sbjct: 451 AAPQPA 456
|
Length = 598 |
| >gnl|CDD|220309 pfam09606, Med15, ARC105 or Med15 subunit of Mediator complex non-fungal | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.004
Identities = 44/221 (19%), Positives = 58/221 (26%), Gaps = 14/221 (6%)
Query: 38 PPPSPPTSTPPSPPTAPPPSSPAVNSPP--PQPSSPPPPLDAPPPPEVDPSPPSPAQPPP 95
P PP N P P PPP+ + P Q
Sbjct: 270 QMQVPMQQQPPQQQPQQSQLGMLPNQMQQMPGGGQGGPGQPMGPPPQRPGAVPQGGQAVQ 329
Query: 96 QAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPA-----NVRTTPSS--SSPPPA 148
Q V + + + P A N + +
Sbjct: 330 QGVMSAGQQQLKQMKLRNMRGQQQTQQQQQQQGGNHPAAHQQQMNQQVGQGGQMVALGYL 389
Query: 149 NVPATPSSSSPPPVNVPTPPSSSSPPP-PSSNPPTSTPSPP-VLTPPPHPSQSAPPPVTK 206
N+ P+ P SSP P P S P PP P P S PP
Sbjct: 390 NIQGNQGGLGANPMQQGQPGMMSSPSPVPQVQTNQSMPQPPQPSVPSPGGPGSQPPQ--- 446
Query: 207 SPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTP 247
S + PP +PS S + SP + + SP P
Sbjct: 447 SVSGGMIPSPPALMPSPSPQMSQSPASQRTIQQDMVSPGGP 487
|
The approx. 70 residue Med15 domain of the ARC-Mediator co-activator is a three-helix bundle with marked similarity to the KIX domain. The sterol regulatory element binding protein (SREBP) family of transcription activators use the ARC105 subunit to activate target genes in the regulation of cholesterol and fatty acid homeostasis. In addition, Med15 is a critical transducer of gene activation signals that control early metazoan development. Length = 768 |
| >gnl|CDD|237015 PRK11901, PRK11901, hypothetical protein; Reviewed | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.004
Identities = 40/195 (20%), Positives = 72/195 (36%), Gaps = 18/195 (9%)
Query: 89 SPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPA 148
SP + Q + + N+ + SSS + + S P A T+ +
Sbjct: 60 SPTEHESQQSSNNAGAEKNIDLSGSSS--------LSSGNQSSPSAANNTSDGHDASGVK 111
Query: 149 NVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPS--PPVLTPPP----HPSQSAPP 202
N A P S PP++ PTP ++ P P+ P L+ SQ+A
Sbjct: 112 N-TAPPQDISAPPIS-PTPTQAAPPQTPNGQQRIELPGNISDALSQQQGQVNAASQNAQG 169
Query: 203 PVTKSPPA-STLSPPPPSVPSTSSPPAVSPPAPPSNSS-TRGSPSTPPLPSVPTEKPTAK 260
+ P A +T++P + ++ +PP P+ T + P K
Sbjct: 170 NTSTLPTAPATVAPSKGAKVPATAETHPTPPQKPATKKPAVNHHKTATVAVPPATSGKPK 229
Query: 261 STNGTAVSANASPRN 275
S +A + +++P +
Sbjct: 230 SGAASARALSSAPAS 244
|
Length = 327 |
| >gnl|CDD|184927 PRK14963, PRK14963, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.004
Identities = 23/100 (23%), Positives = 31/100 (31%), Gaps = 7/100 (7%)
Query: 9 AVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQP 68
A+ P PP+ P + + S PTA ++ A P P
Sbjct: 341 ALGGAPSEGVAAVAPPAPAPADLTQRLN--RLEKEVRSLRSAPTAAATAAGA---PLPDF 395
Query: 69 SSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANV 108
P AP P +PP A P A A +V
Sbjct: 396 DPRPRGPPAPEPARSAEAPPLVA--PAAAPAGLALRWRDV 433
|
Length = 504 |
| >gnl|CDD|215145 PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygenase NCED | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.004
Identities = 28/75 (37%), Positives = 38/75 (50%), Gaps = 1/75 (1%)
Query: 142 SSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPT-STPSPPVLTPPPHPSQSA 200
SSS P + + +SSS + +PPSS+SP P P S P + P P S +
Sbjct: 1 SSSSNPTSRSQSHASSSSSSSSQSSPPSSTSPRPRRRKPSASSLLHTPSILPLPKLSSPS 60
Query: 201 PPPVTKSPPASTLSP 215
PP VT P A+T +P
Sbjct: 61 PPSVTLPPAATTQTP 75
|
Length = 590 |
| >gnl|CDD|215145 PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygenase NCED | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.004
Identities = 17/87 (19%), Positives = 30/87 (34%), Gaps = 9/87 (10%)
Query: 35 PASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPP 94
+S P+ + + S ++ S +S P+P P + PS P
Sbjct: 1 SSSSNPTSRSQSHASSSSSSSSQSSPPSSTSPRPRRRKPSASSL------LHTPSILPLP 54
Query: 95 PQAVAPSPPPPANVPTTPSSSSPPPAN 121
SP PP+ +++ P N
Sbjct: 55 KL---SSPSPPSVTLPPAATTQTPQLN 78
|
Length = 590 |
| >gnl|CDD|223044 PHA03325, PHA03325, nuclear-egress-membrane-like protein; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.004
Identities = 39/184 (21%), Positives = 61/184 (33%), Gaps = 21/184 (11%)
Query: 4 QSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNS 63
Q + A + S P S P A+ + + + P PA
Sbjct: 256 QLTSSA--FMLNSSLPTSAPKR-RSRRAGAMRAAAGETADLADDDGSEHSDPEPLPA--- 309
Query: 64 PPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVP 123
S PPPP+ P P + + P A PA P T +SS +
Sbjct: 310 -----SLPPPPVRRPRV----KHPEAGKEEPDGARNAEAKEPAQ-PATSTSSKGSSSAQN 359
Query: 124 TTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTS 183
S+ P + SS + + P + ++P+P +S+P PPS P +
Sbjct: 360 KDSGSTGPGSSLAAA---SSFLEDDDFGSPPLDLTTSLRHMPSPSVTSAPEPPS--IPLT 414
Query: 184 TPSP 187
S
Sbjct: 415 YLSD 418
|
Length = 418 |
| >gnl|CDD|237011 PRK11892, PRK11892, pyruvate dehydrogenase subunit beta; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 0.004
Identities = 13/62 (20%), Positives = 23/62 (37%), Gaps = 6/62 (9%)
Query: 6 SPPAVL------AVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSP 59
+P AVL A + P + + P + A+ + P P+ P A + P
Sbjct: 72 TPIAVLLEEGESASDAGAAPAAAAEAAAAAPAAAAAAAAKKAAPAPAAPAAPAAEVAADP 131
Query: 60 AV 61
+
Sbjct: 132 DI 133
|
Length = 464 |
| >gnl|CDD|218883 pfam06075, DUF936, Plant protein of unknown function (DUF936) | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.004
Identities = 30/209 (14%), Positives = 56/209 (26%), Gaps = 16/209 (7%)
Query: 81 PEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPP---ANVPTTPSSSSPPPANVR 137
PE + S A AV S A++ ++P+ P P +
Sbjct: 112 PEDLVAADSLA-FFSDAVIQVIKRKKASSAPRRGSWDSSSKSASIDSSPTVIGPRPRSFS 170
Query: 138 TTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTP----- 192
+ P + +P P + PSSS S S +
Sbjct: 171 ELNLTDRTPAKVRSSRSELGAPSPSGGTSCPSSSGGRRSSIGSRRLRGSASLRKKVAVLS 230
Query: 193 -------PPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPS 245
+S+P + S + S S ++ ++ S++ +
Sbjct: 231 APRKPGSRSSDCKSSPRARSSSAKSPFKSSIQRKATKALSKLSLRASPKDTSKSSKSEVA 290
Query: 246 TPPLPSVPTEKPTAKSTNGTAVSANASPR 274
P + K T+G +
Sbjct: 291 PPKKSEAKVPSSSKKWTDGNVSWDSLPSS 319
|
This family consists of several hypothetical proteins from Arabidopsis thaliana and Oryza sativa. The function of this family is unknown. Length = 564 |
| >gnl|CDD|220648 pfam10243, MIP-T3, Microtubule-binding protein MIP-T3 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.004
Identities = 34/215 (15%), Positives = 49/215 (22%), Gaps = 33/215 (15%)
Query: 23 PPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPE 82
P + T P P S P P + PP E
Sbjct: 88 PAAKTKPAKEPKNESGKEEEKEKEQVKEEKKKKKEKPK--EEPKDRKPKEEAKEKRPPKE 145
Query: 83 VD-------PSPPSPAQPP--------PQAVAPSPPPPANVPTTPSSSSPPPANVPTTPS 127
+ P + + P P N P
Sbjct: 146 KEKEKEKKVEEPRDREEEKKRERVRAKSRPKKPPKKKPPNKKKEPPEEEKQRQAAREAVK 205
Query: 128 SSSPPP---------ANVRTTPSSSSPPPANVPATPSSSSPPPVNVP-----TPPSSSSP 173
P + +++ P + SS + PS +SP
Sbjct: 206 GKPEEPDVNEEREKEEDDGKDRETTTSPMEEDESRQSSEISRRSSSSLKKPDPSPSMASP 265
Query: 174 PPPSSNPPTSTPSPPVLTPP-PHPSQSAP-PPVTK 206
S+ T T L PP P+ + P PP K
Sbjct: 266 ETRESSKRTETRPRTSLRPPSARPASARPAPPRVK 300
|
This protein, which interacts with both microtubules and TRAF3 (tumour necrosis factor receptor-associated factor 3), is conserved from worms to humans. The N-terminal region is the microtubule binding domain and is well-conserved; the C-terminal 100 residues, also well-conserved, constitute the coiled-coil region which binds to TRAF3. The central region of the protein is rich in lysine and glutamic acid and carries KKE motifs which may also be necessary for tubulin-binding, but this region is the least well-conserved. Length = 506 |
| >gnl|CDD|220648 pfam10243, MIP-T3, Microtubule-binding protein MIP-T3 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.004
Identities = 26/178 (14%), Positives = 35/178 (19%), Gaps = 6/178 (3%)
Query: 2 PPQSSPPAVLAVPP---PSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSS 58
P+ P PP P S P PP
Sbjct: 123 KPKEEPKDRKPKEEAKEKRPPKEKEKEKEKKVEEPRDREEEKKRERVRAKSRPKKPPKKK 182
Query: 59 PAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPP 118
P P P + + P S
Sbjct: 183 PPNKKKEPPEEEKQRQAAREAVKGKPEEPDVNEEREKEEDDGKDRETTTSPMEEDESRQS 242
Query: 119 PANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPP 176
+ SS P + + P +S PP P+S+ P PP
Sbjct: 243 SEISRRSSSSLKKPDPSPSMASPETRESSKRTETRPRTSLRPPS---ARPASARPAPP 297
|
This protein, which interacts with both microtubules and TRAF3 (tumour necrosis factor receptor-associated factor 3), is conserved from worms to humans. The N-terminal region is the microtubule binding domain and is well-conserved; the C-terminal 100 residues, also well-conserved, constitute the coiled-coil region which binds to TRAF3. The central region of the protein is rich in lysine and glutamic acid and carries KKE motifs which may also be necessary for tubulin-binding, but this region is the least well-conserved. Length = 506 |
| >gnl|CDD|221179 pfam11711, Tim54, Inner membrane protein import complex subunit Tim54 | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.004
Identities = 24/92 (26%), Positives = 34/92 (36%), Gaps = 3/92 (3%)
Query: 74 PLDAPPPPE---VDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSS 130
PLD P PPE + +P + + P A +P+ P TTP + P P
Sbjct: 194 PLDPPEPPEPTVDEAAPETEVEATPAAESPAEPAEETAETTPEETEDAPEEENNKPVKPP 253
Query: 131 PPPANVRTTPSSSSPPPANVPATPSSSSPPPV 162
P + S+P P +P S P
Sbjct: 254 VPKPYISPDEYPSAPLPPELPQLLQPSLVIPF 285
|
Mitochondrial function depends on the import of hundreds of different proteins synthesised in the cytosol. Protein import is a multi-step pathway which includes the binding of precursor proteins to surface receptors, translocation of the precursor across one or both mitochondrial membranes, and folding and assembly of the imported protein inside the mitochondrion. Most precursor proteins carry amino-terminal targeting signals, called pre-sequences, and are imported into mitochondria via import complexes located in both the outer and the inner membrane (IM). The IM complex, TIM, is made up of at least two proteins which mediate translocation of proteins into the matrix by removing their signal peptide and another pair of proteins, Tim54 and Tim22, that insert the polytopic proteins, that carry internal targetting information, into the inner membrane. Length = 377 |
| >gnl|CDD|219404 pfam07415, Herpes_LMP2, Gammaherpesvirus latent membrane protein (LMP2) protein | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.004
Identities = 22/102 (21%), Positives = 24/102 (23%), Gaps = 10/102 (9%)
Query: 19 PLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAP 78
PL + P P+S S PP PS PPP
Sbjct: 8 PLGAGGPRSHGGPDGDEGDSNPYYPSSFGSSWDRPGPPVPE----DYDAPSHRPPPYGGS 63
Query: 79 PPPEVDPSPPSPAQPPP------QAVAPSPPPPANVPTTPSS 114
P Q P Q PPP P S
Sbjct: 64 NGDRHGGYQPLGQQDPSLYAGLGQNGGGGLPPPPYSPRDQGS 105
|
This family consists of several Gammaherpesvirus latent membrane protein (LMP2) proteins. Epstein-Barr virus is a human Gammaherpesvirus that infects and establishes latency in B lymphocytes in vivo. The latent membrane protein 2 (LMP2) gene is expressed in latently infected B cells and encodes two protein isoforms, LMP2A and LMP2B, that are identical except for an additional N-terminal 119 aa cytoplasmic domain which is present in the LMP2A isoform. LMP2A is thought to play a key role in either the establishment or the maintenance of latency and/or the reactivation of productive infection from the latent state. The significance of LMP2B and its role in pathogenesis remain unclear. Length = 489 |
| >gnl|CDD|237000 PRK11855, PRK11855, dihydrolipoamide acetyltransferase; Reviewed | Back alignment and domain information |
|---|
Score = 40.2 bits (95), Expect = 0.004
Identities = 14/66 (21%), Positives = 22/66 (33%), Gaps = 7/66 (10%)
Query: 3 PQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPS----- 57
S V+ V +P + P+ P + A P + P + A +
Sbjct: 184 SVGSLLVVIEVAAAAPAAAAAPAAAAPAAAAAAAPAPAPAAAAAPAAAAPAAAAAPGKAP 243
Query: 58 --SPAV 61
SPAV
Sbjct: 244 HASPAV 249
|
Length = 547 |
| >gnl|CDD|130689 TIGR01628, PABP-1234, polyadenylate binding protein, human types 1, 2, 3, 4 family | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.004
Identities = 25/125 (20%), Positives = 37/125 (29%), Gaps = 16/125 (12%)
Query: 77 APPPPEVDPSPPSPAQPP-----PQAVAPSPP------PPANVPTTPSSSSPPPANVPTT 125
P P + QPP PQ P P P P N
Sbjct: 382 MRQLPMGSPMGGAMGQPPYYGQGPQQQFNGQPLGWPRMSMMPTPMGPGGPLRP--NGLAP 439
Query: 126 PSSSSPPPANVRTTPSSSSPPPANVPATPSSSS-PPPVNVPTPPSSSSPPPPSSNPPTST 184
++ P N + ++ PP V P+ S P ++P P S++S +
Sbjct: 440 MNAVRAPSRNAQ--NAAQKPPMQPVMYPPNYQSLPLSQDLPQPQSTASQGGQNKKLAQVL 497
Query: 185 PSPPV 189
S
Sbjct: 498 ASATP 502
|
These eukaryotic proteins recognize the poly-A of mRNA and consists of four tandem RNA recognition domains at the N-terminus (rrm: pfam00076) followed by a PABP-specific domain (pfam00658) at the C-terminus. The protein is involved in the transport of mRNA's from the nucleus to the cytoplasm. There are four paralogs in Homo sapiens which are expressed in testis (GP:11610605_PABP3 ), platelets (SP:Q13310_PABP4 ), broadly expressed (SP:P11940_PABP1) and of unknown tissue range (SP:Q15097_PABP2). Length = 562 |
| >gnl|CDD|224343 COG1426, COG1426, Predicted transcriptional regulator contains Xre-like HTH domain [Function unknown] | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.004
Identities = 22/124 (17%), Positives = 38/124 (30%), Gaps = 8/124 (6%)
Query: 106 ANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVP 165
A + + P + + +S A TTPS + + S SS P
Sbjct: 127 AWLAQEEPPTLPDQSVASVSQNSQDVSLATSSTTPSEGT-------TSASPSSATTSFTP 179
Query: 166 TPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSS 225
T + + P++ P T P + +A T T + + + S
Sbjct: 180 TVTAIAPVVAPTAKPVTVPKQPAADLAASSTAPAAKEMATGQEAVPT-AGSGVTTVAGKS 238
Query: 226 PPAV 229
V
Sbjct: 239 AALV 242
|
Length = 284 |
| >gnl|CDD|224343 COG1426, COG1426, Predicted transcriptional regulator contains Xre-like HTH domain [Function unknown] | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.004
Identities = 18/104 (17%), Positives = 35/104 (33%), Gaps = 5/104 (4%)
Query: 145 PPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPP----VLTPPPHPSQSA 200
PP + +S S +V SS++P +++ S+ + V P + +A
Sbjct: 133 EPPTLPDQSVASVSQNSQDVSLATSSTTPSEGTTSASPSSATTSFTPTVTAIAPVVAPTA 192
Query: 201 PPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSP 244
P PA+ L+ + + P + S
Sbjct: 193 KPVTVPKQPAADLAASSTAPAAK-EMATGQEAVPTAGSGVTTVA 235
|
Length = 284 |
| >gnl|CDD|220401 pfam09786, CytochromB561_N, Cytochrome B561, N terminal | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.004
Identities = 29/112 (25%), Positives = 46/112 (41%), Gaps = 9/112 (8%)
Query: 137 RTTPSSSSP-PPANVPATPSSSSPPPVNVPTP----PSSSSPPPPSSNPPTSTPSPPVLT 191
T S + PPA+ +TP ++S P V + PS S+ P +P ++ P LT
Sbjct: 110 FTVVSQAKKSPPASKTSTPMNTSEPLVPGHSSFSDSPSRSASPSRKFSPSSTIQQSPQLT 169
Query: 192 PPPHPSQSAPPPVTKSPPASTLSPP---PPSVPSTSSPPAVSPPAPPSNSST 240
P P+ + + S S+L P SSP A+ + +T
Sbjct: 170 PSNKPASPSSSYQSPSYS-SSLGPVNSSGNRSNLRSSPWALRSSGDKKDITT 220
|
Members of this family are found in the N terminal region of cytochrome B561, as well as in various other putative uncharacterized proteins. Length = 559 |
| >gnl|CDD|221185 pfam11719, Drc1-Sld2, DNA replication and checkpoint protein | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.004
Identities = 38/190 (20%), Positives = 55/190 (28%), Gaps = 22/190 (11%)
Query: 45 STPPSPPTAPPPSSPAVNSPPPQPSSPPP--PLDAPPPPEVDPSPPSPAQPPPQA----- 97
+ PSP S + P+ P P D+P S + P PQ
Sbjct: 52 TIEPSPKKRKHSSPDGESQSTPRKRIPSDVDPYDSPSALRSPSSLKTELGPTPQRDGKVL 111
Query: 98 ----VAPSPPPPANVPTTPSSSSPPPANVPT-TPSSSSPPPANVRTTPSSSSPPPANVPA 152
+ S PP + P+ +S + P TPS P
Sbjct: 112 SLFDLLSSSTPPESTPSKRKLASSVASATPFSTPSKRRETLDAEDEDRPEYGP---RSER 168
Query: 153 TPSSSSP--PPVNVPTP----PSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPV-T 205
TP SS TP SS +P + + + L +P P+
Sbjct: 169 TPLSSGKKVMLDLFFTPTSWRYSSETPSFLRRSNQDVSATSNPLNSAEPDFGVSPSPLRP 228
Query: 206 KSPPASTLSP 215
+ P LS
Sbjct: 229 QRPVGKGLSE 238
|
Genome duplication is precisely regulated by cyclin-dependent kinases CDKs, which bring about the onset of S phase by activating replication origins and then prevent relicensing of origins until mitosis is completed. The optimum sequence motif for CDK phosphorylation is S/T-P-K/R-K/R, and Drc1-Sld2 is found to have at least 11 potential phosphorylation sites. Drc1 is required for DNA synthesis and S-M replication checkpoint control. Drc1 associates with Cdc2 and is phosphorylated at the onset of S phase when Cdc2 is activated. Thus Cdc2 promotes DNA replication by phosphorylating Drc1 and regulating its association with Cut5. Sld2 and Sld3 represent the minimal set of S-CDK substrates required for DNA replication. Length = 397 |
| >gnl|CDD|236154 PRK08119, PRK08119, flagellar motor switch protein; Validated | Back alignment and domain information |
|---|
Score = 39.8 bits (94), Expect = 0.004
Identities = 10/74 (13%), Positives = 14/74 (18%), Gaps = 2/74 (2%)
Query: 28 PPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSP 87
+ + P+ P P P V P+
Sbjct: 226 EEEEEEEEVEEEEAQASPAAEPATAQAAPAPKQ--EQQQAPPQRQEPEKEAQPVNVQPAQ 283
Query: 88 PSPAQPPPQAVAPS 101
PPP A
Sbjct: 284 FQSFDPPPLATTEP 297
|
Length = 382 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 727 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.98 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.89 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.88 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.86 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.86 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.86 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.86 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.85 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.85 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.82 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.82 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.82 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.81 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.8 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.79 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.78 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.78 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.78 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.76 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.73 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.72 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.67 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.67 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.61 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.58 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.54 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.54 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.49 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.47 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.46 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.4 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.39 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.35 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.31 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.31 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.25 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.21 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.18 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.1 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 99.01 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.0 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 99.0 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.94 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.94 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.9 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.81 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.76 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.75 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 98.7 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.64 | |
| PHA03247 | 3151 | large tegument protein UL36; Provisional | 98.6 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.59 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.57 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.56 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.52 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.46 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.46 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.41 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.41 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.4 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 98.38 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.36 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.34 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.33 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 98.29 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 98.24 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 98.23 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 98.22 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 98.15 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 98.15 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 98.14 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 98.06 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 98.03 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.95 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.86 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.77 | |
| PLN02236 | 344 | choline kinase | 97.77 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 97.7 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.59 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.59 | |
| KOG1924 | 1102 | consensus RhoA GTPase effector DIA/Diaphanous [Sig | 97.55 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 97.53 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 97.5 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.48 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 97.44 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.44 | |
| KOG1924 | 1102 | consensus RhoA GTPase effector DIA/Diaphanous [Sig | 97.42 | |
| PF08693 | 40 | SKG6: Transmembrane alpha-helix domain; InterPro: | 97.39 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 97.36 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-55 Score=471.77 Aligned_cols=290 Identities=61% Similarity=0.986 Sum_probs=254.2
Q ss_pred CCccccHHHHHHHhcCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEe
Q 041135 367 SRSWFTYDELIQATNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYC 446 (727)
Q Consensus 367 ~~~~~~~~el~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~ 446 (727)
....|+++||..++++|...++||+|+||.||+|.+.+|+.||||++.....+..++|.+|+++|.+++|+|||+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 45679999999999999999999999999999999999999999988765443255699999999999999999999999
Q ss_pred eccc-eeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEe
Q 041135 447 ISER-ERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVAD 525 (727)
Q Consensus 447 ~~~~-~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~D 525 (727)
.+.+ +.+|||||+.+|+|.++|+......++|..|++|+.++|+||+|||+.+.+.|||||||++|||||+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9998 599999999999999999886543689999999999999999999999888899999999999999999999999
Q ss_pred eccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHH
Q 041135 526 FGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLA 605 (727)
Q Consensus 526 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~ 605 (727)
||||+..... .........||.+|++||++..+.++.|+|||||||+|+||++|+.+++.....+...+++|++..+.
T Consensus 221 FGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~ 298 (361)
T KOG1187|consen 221 FGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE 298 (361)
T ss_pred ccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence 9999754210 11111111799999999999999999999999999999999999999987766666779999976654
Q ss_pred HhhchhhHHHHHHHHhh-cccch-hHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhcc
Q 041135 606 EALEHEDFEALVDSRLE-KNYVD-SEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLD 662 (727)
Q Consensus 606 ~~~~~~~~~~l~d~~l~-~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 662 (727)
+ +.+.+++|.+|. ..+.. .++..+.+++.+|++.++++||+|.||+++|+.+.
T Consensus 299 ~----~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 299 E----GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred C----cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 3 478999999987 66664 68888999999999999999999999999997654
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=427.86 Aligned_cols=258 Identities=30% Similarity=0.470 Sum_probs=223.9
Q ss_pred hcCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeec
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYV 459 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 459 (727)
.+.+++++.||+|.||.||+|+++....||||.++.. ....+.|.+|+++|++|+|.|||+|+|+|..++.+|||||||
T Consensus 205 r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m 283 (468)
T KOG0197|consen 205 REELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYM 283 (468)
T ss_pred HHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEec
Confidence 3445677899999999999999987779999999865 444578999999999999999999999999988999999999
Q ss_pred cCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCc
Q 041135 460 PNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNT 539 (727)
Q Consensus 460 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 539 (727)
..|+|.+||+...+..+...+++.|+.|||+||+||+++ ++|||||.++||||++++.|||+||||||.. .++..
T Consensus 284 ~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~--~d~~Y 358 (468)
T KOG0197|consen 284 PKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLI--GDDEY 358 (468)
T ss_pred ccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEccccccccc--CCCce
Confidence 999999999987777899999999999999999999999 9999999999999999999999999999943 23333
Q ss_pred cccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHH
Q 041135 540 HVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVD 618 (727)
Q Consensus 540 ~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d 618 (727)
.......-.+.|.|||.++.++|+.|+|||||||+||||+| |+.||.+... .++.+.++
T Consensus 359 ~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn--------------------~ev~~~le 418 (468)
T KOG0197|consen 359 TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN--------------------EEVLELLE 418 (468)
T ss_pred eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH--------------------HHHHHHHh
Confidence 34455566889999999999999999999999999999999 9999876442 22333445
Q ss_pred HHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 619 SRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 619 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
...+......+...+.+||+.||+.+|++||+++.+...|+.+..
T Consensus 419 ~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 419 RGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred ccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 555556666777889999999999999999999999999988754
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-49 Score=422.32 Aligned_cols=256 Identities=35% Similarity=0.571 Sum_probs=213.1
Q ss_pred CccccceeccCCceEEEEEEEcCCcE-EEEEEeeeCCchh--HHHHHHHHHHHHHcCCCCceeEeeEeeccc-eeeEEEe
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLADGRE-VAVKQLKIGGSQG--EREFRAEVEIISRVHHRHLVSLVGYCISER-ERLLVYE 457 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~~g~~-vaVK~l~~~~~~~--~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~-~~~lV~E 457 (727)
++.+.+.||+|+||+||+|.++ |+. ||||++....... .+.|.+|+.+|++++|+|||+|+|+|.+.. .++||||
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~-g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE 120 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWR-GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE 120 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeC-CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence 3455567999999999999996 555 9999997544333 458999999999999999999999999887 7899999
Q ss_pred eccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCc-EEeeCCCCCceEECCCC-cEEEEeeccchhhhcc
Q 041135 458 YVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPR-IIHRDIKSSNILLDSSF-EARVADFGLAKIALEL 535 (727)
Q Consensus 458 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~-ivHrDLkp~NILl~~~~-~vkL~DFGla~~~~~~ 535 (727)
|+.+|+|.++|+...+..+++..+++|+.||++||+|||++ + |||||||++||||+.++ ++||+|||+++.....
T Consensus 121 y~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 121 YMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred eCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 99999999999885555799999999999999999999999 7 99999999999999997 9999999999864221
Q ss_pred CCCccccccccCCccccccCccc--CCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhH
Q 041135 536 DSNTHVSTRVMGTFGYMAPEYAT--SGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDF 613 (727)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~ 613 (727)
. ...+...||..|||||++. +..|+.|+||||||||||||++|+.||...... .. .
T Consensus 198 ~---~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~------~~-------------~ 255 (362)
T KOG0192|consen 198 K---TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV------QV-------------A 255 (362)
T ss_pred c---ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH------HH-------------H
Confidence 1 2333468999999999999 668999999999999999999999999865421 11 1
Q ss_pred HHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 614 EALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 614 ~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
..++...++..........+..||++||+.||++||++.+|+..|+.+..
T Consensus 256 ~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 256 SAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred HHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 11222233333334456678899999999999999999999999998865
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-49 Score=442.01 Aligned_cols=260 Identities=28% Similarity=0.480 Sum_probs=221.2
Q ss_pred cCccccceeccCCceEEEEEEEc------CCcEEEEEEeeeCCch-hHHHHHHHHHHHHHcCCCCceeEeeEeeccceee
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA------DGREVAVKQLKIGGSQ-GEREFRAEVEIISRVHHRHLVSLVGYCISERERL 453 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vaVK~l~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 453 (727)
.+.++.+.||+|.||+||+|+.. +...||||.++..+.. ..++|++|+++|..|+|+|||+|+|+|.+++-++
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 44566789999999999999853 3467999999987766 6789999999999999999999999999999999
Q ss_pred EEEeeccCCccchhcccCC------------CCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcE
Q 041135 454 LVYEYVPNDTLHYHLHAEG------------RPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEA 521 (727)
Q Consensus 454 lV~Ey~~~gsL~~~L~~~~------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~v 521 (727)
+|||||..|+|.+||+.+. ...++..+.+.|+.|||.||+||-++ .+|||||..+||||+++..|
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEE
Confidence 9999999999999997542 12278899999999999999999999 89999999999999999999
Q ss_pred EEEeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhh
Q 041135 522 RVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWA 600 (727)
Q Consensus 522 kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~ 600 (727)
||+||||+|.....|.. +...+.+..++||+||.|+.++|+.++|||||||||||+++ |+.||.+..+ +
T Consensus 643 KIsDfGLsRdiYssDYY-k~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn---~------ 712 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYY-KVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN---Q------ 712 (774)
T ss_pred Eecccccchhhhhhhhh-cccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch---H------
Confidence 99999999976543322 23335567899999999999999999999999999999999 9999977542 1
Q ss_pred HHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccCC
Q 041135 601 RPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDGA 664 (727)
Q Consensus 601 ~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 664 (727)
+-++.+.++++ ....+.+..++++||..||+.+|.+||+++||-.+|+.....
T Consensus 713 ----------EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 713 ----------EVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred ----------HHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 12223333344 455677788899999999999999999999999999987653
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=397.29 Aligned_cols=201 Identities=31% Similarity=0.503 Sum_probs=182.2
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeC--CchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIG--GSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
..+|.+.+.||+|.||.||+|+++ ++..||||.+... ..+..+.+..||++|+.|+|+|||+|+++++.++.+||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 356888889999999999999975 5899999999765 3445567899999999999999999999999999999999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCC------CcEEEEeeccch
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSS------FEARVADFGLAK 530 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~------~~vkL~DFGla~ 530 (727)
|||.||+|.+||+.+++ +.+..+..++.||+.||++||++ +||||||||.||||+.+ -.+||+|||+||
T Consensus 89 EyC~gGDLs~yi~~~~~--l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRGR--LPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EeCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 99999999999998875 99999999999999999999999 99999999999999754 469999999999
Q ss_pred hhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCC
Q 041135 531 IALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQ 589 (727)
Q Consensus 531 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~ 589 (727)
.+. ...+...+||+..|||||+++.++|+.|+|+||+|+|||+|++|+.||+...
T Consensus 164 ~L~----~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 164 FLQ----PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred hCC----chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 753 3455677899999999999999999999999999999999999999998654
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=407.26 Aligned_cols=248 Identities=23% Similarity=0.352 Sum_probs=210.4
Q ss_pred cCccccceeccCCceEEEEEEE-cCCcEEEEEEeeeC---CchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVL-ADGREVAVKQLKIG---GSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vaVK~l~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
.+|...++||+|||+.||+++. ..|+.||+|++... .....+++.+||++.+.|+|+|||+|+++|++.+++|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5689999999999999999997 78999999999642 3344578999999999999999999999999999999999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccC
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 536 (727)
|+|.+++|.++++++. .+++.++..+++||+.||.|||++ +|||||||..||||+++.+|||+|||||..+.
T Consensus 98 ELC~~~sL~el~Krrk--~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le--- 169 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRK--PLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLE--- 169 (592)
T ss_pred EecCCccHHHHHHhcC--CCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeec---
Confidence 9999999999998443 599999999999999999999999 99999999999999999999999999998652
Q ss_pred CCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHH
Q 041135 537 SNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEAL 616 (727)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l 616 (727)
........+|||+.|.|||++.+..++..+||||+|||||-||.|+.||+... +. +.
T Consensus 170 ~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~------vk-----------------et 226 (592)
T KOG0575|consen 170 YDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT------VK-----------------ET 226 (592)
T ss_pred CcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch------HH-----------------HH
Confidence 22234456899999999999999999999999999999999999999997532 11 11
Q ss_pred HHHHhhccc--chhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 617 VDSRLEKNY--VDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 617 ~d~~l~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
.+.....+| .........+||..+|+.||.+||++++|+++=-
T Consensus 227 y~~Ik~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~F 271 (592)
T KOG0575|consen 227 YNKIKLNEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPF 271 (592)
T ss_pred HHHHHhcCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHh
Confidence 111111222 1122334678999999999999999999998733
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-47 Score=389.82 Aligned_cols=251 Identities=31% Similarity=0.470 Sum_probs=207.1
Q ss_pred ccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEeeccc-eeeEEEeec
Q 041135 383 FSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYCISER-ERLLVYEYV 459 (727)
Q Consensus 383 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~-~~~lV~Ey~ 459 (727)
++.++.||+|..|.|||++++ +++.+|+|.+..+.. ...+++.+|+++|++.+|+|||.++|.|.++. .+.|+||||
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM 160 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM 160 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence 445688999999999999987 588899999965443 33468999999999999999999999999998 599999999
Q ss_pred cCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCc
Q 041135 460 PNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNT 539 (727)
Q Consensus 460 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 539 (727)
++|+|+.++...++ +.+..+-+|+++|++||.|||+.. +||||||||+||||+..|+|||||||.++.+...
T Consensus 161 DgGSLd~~~k~~g~--i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---- 232 (364)
T KOG0581|consen 161 DGGSLDDILKRVGR--IPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---- 232 (364)
T ss_pred CCCCHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh----
Confidence 99999999987765 899999999999999999999632 8999999999999999999999999999865322
Q ss_pred cccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHH-
Q 041135 540 HVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVD- 618 (727)
Q Consensus 540 ~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d- 618 (727)
....++||..|||||.+.+..|+.++||||||+.|+||..|+.||..... ....|+. .+..+++
T Consensus 233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~----~~~~~~~----------Ll~~Iv~~ 297 (364)
T KOG0581|consen 233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP----PYLDIFE----------LLCAIVDE 297 (364)
T ss_pred -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC----CCCCHHH----------HHHHHhcC
Confidence 45567899999999999999999999999999999999999999976511 1111111 1112222
Q ss_pred --HHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 619 --SRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 619 --~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
..+... .....+..|+..||++||.+|++++|++++=.
T Consensus 298 ppP~lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpf 337 (364)
T KOG0581|consen 298 PPPRLPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPF 337 (364)
T ss_pred CCCCCCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHH
Confidence 122221 13344888999999999999999999998844
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-47 Score=417.01 Aligned_cols=260 Identities=26% Similarity=0.421 Sum_probs=221.2
Q ss_pred cCccccceeccCCceEEEEEEEcC----CcEEEEEEeeeCCch-hHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLAD----GREVAVKQLKIGGSQ-GEREFRAEVEIISRVHHRHLVSLVGYCISERERLLV 455 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~~----g~~vaVK~l~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 455 (727)
...+|.++||.|.||+||+|+++. ...||||.||....+ ...+|+.|+.||.+++|+||++|.|+.....-.+||
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 346788999999999999999863 457999999977544 446899999999999999999999999999999999
Q ss_pred EeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhcc
Q 041135 456 YEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALEL 535 (727)
Q Consensus 456 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 535 (727)
.|||++|.|+.||+.+++ .+.+.+++.|+++|+.||.||-++ ++|||||.++||||+.+..+||+||||+|.+.+.
T Consensus 709 TEyMENGsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 784 (996)
T ss_pred hhhhhCCcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccC
Confidence 999999999999998876 499999999999999999999999 9999999999999999999999999999966433
Q ss_pred CCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHH
Q 041135 536 DSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFE 614 (727)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~ 614 (727)
........+..-.++|.|||.+..++++.++|||||||||||.|+ |..||-...+ .+..
T Consensus 785 ~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN--------------------QdVI 844 (996)
T KOG0196|consen 785 PEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--------------------QDVI 844 (996)
T ss_pred CCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch--------------------HHHH
Confidence 322222223344689999999999999999999999999999998 9999864321 1222
Q ss_pred HHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccCC
Q 041135 615 ALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDGA 664 (727)
Q Consensus 615 ~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 664 (727)
..++..++.....++...|.+||++||++|-.+||.|.||+..|+++...
T Consensus 845 kaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 845 KAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred HHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 33344455556677888899999999999999999999999999998543
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-46 Score=396.02 Aligned_cols=262 Identities=29% Similarity=0.437 Sum_probs=219.3
Q ss_pred hcCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhH-HHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEee
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGE-REFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~-~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 458 (727)
...+.+.++||+|.||+|.+++..++..||||+++..+..+. .+|.+|+++|.+|+|+|||+|+|+|..++.+++|+||
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 456788899999999999999998889999999997766555 7899999999999999999999999999999999999
Q ss_pred ccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCC
Q 041135 459 VPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSN 538 (727)
Q Consensus 459 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 538 (727)
+++|+|.+||.++....+..+..++|+.||+.||+||.+. +||||||.++|||+|.++++||+|||++|.+...+ .
T Consensus 617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~-y 692 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD-Y 692 (807)
T ss_pred HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCC-c
Confidence 9999999999988665567778899999999999999999 99999999999999999999999999999654332 3
Q ss_pred ccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh--CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHH
Q 041135 539 THVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT--GRKPVDASQPLGDESLVEWARPLLAEALEHEDFEAL 616 (727)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt--G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l 616 (727)
.+...+.+..++|||+|.+..++++.++|||+|||.|||++. .+.||.... +++.++-+.. +
T Consensus 693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt---~e~vven~~~-------------~ 756 (807)
T KOG1094|consen 693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT---DEQVVENAGE-------------F 756 (807)
T ss_pred eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh---HHHHHHhhhh-------------h
Confidence 445566778899999999999999999999999999999865 677876533 2333332222 2
Q ss_pred HHHHhhccc---chhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhc
Q 041135 617 VDSRLEKNY---VDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661 (727)
Q Consensus 617 ~d~~l~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 661 (727)
++..-+..+ ...+...++++|.+||+.|-++||++++|...|++.
T Consensus 757 ~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 757 FRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred cCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 222111111 233455688999999999999999999999999864
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-46 Score=386.89 Aligned_cols=255 Identities=25% Similarity=0.364 Sum_probs=207.8
Q ss_pred HhcCccccceeccCCceEEEEEEE-cCCcEEEEEEeeeCCch-------hHHHHHHHHHHHHHcCCCCceeEeeEeeccc
Q 041135 379 ATNGFSAHNVLGEGGFGCVYKGVL-ADGREVAVKQLKIGGSQ-------GEREFRAEVEIISRVHHRHLVSLVGYCISER 450 (727)
Q Consensus 379 ~~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vaVK~l~~~~~~-------~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~ 450 (727)
..+.|.+.+.||+|+||.|-+|.. ++|+.||||+++..... ....+++|+++|++|+|||||+++++|...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 345688899999999999999985 46999999999643221 2234679999999999999999999999999
Q ss_pred eeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCC---CcEEEEeec
Q 041135 451 ERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSS---FEARVADFG 527 (727)
Q Consensus 451 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~---~~vkL~DFG 527 (727)
..||||||++||+|.+++-.++. +.+.....+++||+.||.|||++ ||+||||||+||||..+ ..+||+|||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~--l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKY--LREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccc--cccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccc
Confidence 99999999999999999988776 77778899999999999999999 99999999999999655 789999999
Q ss_pred cchhhhccCCCccccccccCCccccccCcccCCC---CCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHH
Q 041135 528 LAKIALELDSNTHVSTRVMGTFGYMAPEYATSGK---LTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLL 604 (727)
Q Consensus 528 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~---~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l 604 (727)
||+.. .+......+|||+.|+|||++.++. +..++||||+|||||-+|+|..||...... ..+.+
T Consensus 325 lAK~~----g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~--~sl~e------ 392 (475)
T KOG0615|consen 325 LAKVS----GEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD--PSLKE------ 392 (475)
T ss_pred hhhcc----ccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC--ccHHH------
Confidence 99964 2445667789999999999998764 345889999999999999999999764321 11111
Q ss_pred HHhhchhhHHHHHHHHhh--cccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhh
Q 041135 605 AEALEHEDFEALVDSRLE--KNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDT 660 (727)
Q Consensus 605 ~~~~~~~~~~~l~d~~l~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 660 (727)
++..+++. ..+..+...+.++||.+||..||++|+++.|++++-|.
T Consensus 393 ----------QI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~ 440 (475)
T KOG0615|consen 393 ----------QILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWF 440 (475)
T ss_pred ----------HHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhh
Confidence 11111111 11233445567899999999999999999999998664
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=377.74 Aligned_cols=242 Identities=29% Similarity=0.406 Sum_probs=201.1
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEE
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLV 455 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 455 (727)
.++|+++++||+|+||+||.++.+ +++.+|+|+++... ..+.+..++|..+|.+++|++||+|+..|++.+.+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 356999999999999999999865 48899999996432 23446788999999999999999999999999999999
Q ss_pred EeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhcc
Q 041135 456 YEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALEL 535 (727)
Q Consensus 456 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 535 (727)
+||+.||.|+.+|++++. +.+..+..++.+|+.||.|||++ +||||||||+|||||++|+++|+||||++.....
T Consensus 104 ld~~~GGeLf~hL~~eg~--F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGR--FSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD 178 (357)
T ss_pred EeccCCccHHHHHHhcCC--cchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence 999999999999998876 88998999999999999999999 9999999999999999999999999999854322
Q ss_pred CCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHH
Q 041135 536 DSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEA 615 (727)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~ 615 (727)
......+|||..|||||++++..|+..+|+|||||+|||||+|..||.+.+. .++.+.
T Consensus 179 ---~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~------~~~~~~------------- 236 (357)
T KOG0598|consen 179 ---GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV------KKMYDK------------- 236 (357)
T ss_pred ---CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH------HHHHHH-------------
Confidence 2233448999999999999999999999999999999999999999986442 122111
Q ss_pred HHHHHhhcccchhHHHHHHHHHHHHhccCCCCCC
Q 041135 616 LVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRP 649 (727)
Q Consensus 616 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP 649 (727)
+...++ ..+..-....+.+|++++|..||++|.
T Consensus 237 I~~~k~-~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 237 ILKGKL-PLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred HhcCcC-CCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 111111 011111233467889999999999996
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-46 Score=366.42 Aligned_cols=257 Identities=25% Similarity=0.422 Sum_probs=204.7
Q ss_pred CccccceeccCCceEEEEEE-EcCCcEEEEEEeeeC--CchhHHHHHHHHHHHHHcCCCCceeEee-Eeeccce-eeEEE
Q 041135 382 GFSAHNVLGEGGFGCVYKGV-LADGREVAVKQLKIG--GSQGEREFRAEVEIISRVHHRHLVSLVG-YCISERE-RLLVY 456 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~-~~~g~~vaVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~~-~~~~~~~-~~lV~ 456 (727)
+|+++++||+|.||.|||+. +.+|..||.|.++.+ +.+..+++..|+.+|++|+|+|||++++ .|.++.+ ++|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 47888999999999999998 568999999998743 3344568999999999999999999998 4545544 89999
Q ss_pred eeccCCccchhccc--CCCCcccHHHHHHHHHHHHHHHHHHHhcCCC-cEEeeCCCCCceEECCCCcEEEEeeccchhhh
Q 041135 457 EYVPNDTLHYHLHA--EGRPVMDWATRVKVAAGAARGIAYLHEDCHP-RIIHRDIKSSNILLDSSFEARVADFGLAKIAL 533 (727)
Q Consensus 457 Ey~~~gsL~~~L~~--~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~-~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~ 533 (727)
|||.+|+|..+++. +.+..+.+..+++++.|++.||.++|.+... -|+||||||.||+|+.+|.|||+||||++++
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l- 178 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL- 178 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh-
Confidence 99999999998863 3455799999999999999999999994321 2999999999999999999999999999975
Q ss_pred ccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhH
Q 041135 534 ELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDF 613 (727)
Q Consensus 534 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~ 613 (727)
+.........+||++||+||.+++..|+.|+||||+||+||||+.-+.||.+. ++.+. .+.+..+++
T Consensus 179 --~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L-----~~KI~qgd~ 245 (375)
T KOG0591|consen 179 --SSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSL-----CKKIEQGDY 245 (375)
T ss_pred --cchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHH-----HHHHHcCCC
Confidence 33445556789999999999999999999999999999999999999999764 22222 222222222
Q ss_pred HHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhh
Q 041135 614 EALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDT 660 (727)
Q Consensus 614 ~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 660 (727)
..+-+ .--...+.+||..|+..|++.||+.-.++..+..
T Consensus 246 ~~~p~--------~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 246 PPLPD--------EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred CCCcH--------HHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 11111 1112336788899999999999995555554443
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-45 Score=422.07 Aligned_cols=259 Identities=29% Similarity=0.475 Sum_probs=214.9
Q ss_pred cCccccceeccCCceEEEEEEEcC--Cc----EEEEEEeeeCC-chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceee
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLAD--GR----EVAVKQLKIGG-SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERL 453 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~~--g~----~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 453 (727)
+..++.+.||+|+||.||+|.+.+ |. .||||.++... .++..+|.+|..+|++++|+|||+|+|+|.+.+..+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 446678899999999999999753 33 49999997554 455678999999999999999999999999999999
Q ss_pred EEEeeccCCccchhcccCC-----CCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeecc
Q 041135 454 LVYEYVPNDTLHYHLHAEG-----RPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGL 528 (727)
Q Consensus 454 lV~Ey~~~gsL~~~L~~~~-----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGl 528 (727)
||+|||+||+|..||++.+ ...+...+++.|+.|||+|++||+++ ++|||||.++||||++...|||+||||
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccch
Confidence 9999999999999998752 34689999999999999999999999 899999999999999999999999999
Q ss_pred chhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHh
Q 041135 529 AKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEA 607 (727)
Q Consensus 529 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~ 607 (727)
||++.+.+.... ....+...+||+||.++.+.|+.|+|||||||+||||++ |..||....+.+
T Consensus 849 ArDiy~~~yyr~-~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~--------------- 912 (1025)
T KOG1095|consen 849 ARDIYDKDYYRK-HGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE--------------- 912 (1025)
T ss_pred hHhhhhchheec-cCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH---------------
Confidence 997654433222 222456789999999999999999999999999999999 999997654311
Q ss_pred hchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 608 LEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 608 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
.+..++.+. +......+...+++||+.||+.+|++||++..|++++..+..
T Consensus 913 ----v~~~~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~ 963 (1025)
T KOG1095|consen 913 ----VLLDVLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN 963 (1025)
T ss_pred ----HHHHHHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence 111111111 334445556668899999999999999999999999888754
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-45 Score=364.55 Aligned_cols=268 Identities=22% Similarity=0.323 Sum_probs=206.4
Q ss_pred cCccccceeccCCceEEEEEEEcC-CcEEEEEEeeeCCc-hh-HHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEe
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLAD-GREVAVKQLKIGGS-QG-EREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYE 457 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~~-g~~vaVK~l~~~~~-~~-~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 457 (727)
++|+.+.++|+|+||.|||+++++ |+.||||++..... .. .+-.+|||++|++|+|+|+|.|+++|.....++||||
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 457888999999999999999865 99999999975433 22 2457899999999999999999999999999999999
Q ss_pred eccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCC
Q 041135 458 YVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDS 537 (727)
Q Consensus 458 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 537 (727)
||+...|.++-+.-. .++.+.+.++++|+++|+.|+|++ +||||||||+||||+.++.+||||||+||.+..
T Consensus 82 ~~dhTvL~eLe~~p~--G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--- 153 (396)
T KOG0593|consen 82 YCDHTVLHELERYPN--GVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA--- 153 (396)
T ss_pred ecchHHHHHHHhccC--CCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC---
Confidence 998877766544333 388999999999999999999999 999999999999999999999999999997642
Q ss_pred CccccccccCCccccccCcccC-CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHH-H---HHhhc-hh
Q 041135 538 NTHVSTRVMGTFGYMAPEYATS-GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPL-L---AEALE-HE 611 (727)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~-l---~~~~~-~~ 611 (727)
.....+..+.|.+|+|||.+.+ ..|...+|||++|||+.||++|..-|.+....+...++....+- + ...+. +.
T Consensus 154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence 2334456678999999999998 57999999999999999999999999876543322222221110 0 00000 01
Q ss_pred hHHHHHH------HHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 612 DFEALVD------SRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 612 ~~~~l~d------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
.|..+.- ..|+.+|. .....+++|++.||+.||++|.+-+|++.+
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~p-~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKYP-KISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred ceeeeecCCCCCccchhhhcc-cchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 1111100 11122222 223358899999999999999999999865
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=383.66 Aligned_cols=266 Identities=28% Similarity=0.495 Sum_probs=212.1
Q ss_pred HHHHHHhcCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCch--hHHHHHHHHHHHHHcCCCCceeEeeEeeccce
Q 041135 374 DELIQATNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQ--GEREFRAEVEIISRVHHRHLVSLVGYCISERE 451 (727)
Q Consensus 374 ~el~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~--~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~ 451 (727)
++|..-.+.+.++..||+|.||+||+|+|. ..||||+++..... ..+.|++|+.+|++-+|.||+-|+|||.....
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 555555677888899999999999999985 36999999876543 44689999999999999999999999998877
Q ss_pred eeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchh
Q 041135 452 RLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKI 531 (727)
Q Consensus 452 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 531 (727)
.||+.+|+|.+|+.+||..+ ..|+....+.|++||++||.|||.+ +|||||||..||||+++++|||+||||+..
T Consensus 463 -AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatv 537 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATV 537 (678)
T ss_pred -eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceee
Confidence 99999999999999998765 4689999999999999999999999 999999999999999999999999999964
Q ss_pred hhccCCCccccccccCCccccccCcccCC---CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhh
Q 041135 532 ALELDSNTHVSTRVMGTFGYMAPEYATSG---KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEAL 608 (727)
Q Consensus 532 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~---~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~ 608 (727)
.... ........-.|...|||||+++.+ .|+..+|||+||||+|||++|.+||..... +..+....++++.
T Consensus 538 k~~w-~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~--dqIifmVGrG~l~--- 611 (678)
T KOG0193|consen 538 KTRW-SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR--DQIIFMVGRGYLM--- 611 (678)
T ss_pred eeee-ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh--hheEEEecccccC---
Confidence 2211 122222334578899999999754 588999999999999999999999984332 1111111111110
Q ss_pred chhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 609 EHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 609 ~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
.+.. .....+...|.+|+..||.+++++||.+.+|+..|+.+..
T Consensus 612 --pd~s---------~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 612 --PDLS---------KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred --ccch---------hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 0000 1122345568899999999999999999999998887743
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=371.13 Aligned_cols=264 Identities=24% Similarity=0.390 Sum_probs=212.7
Q ss_pred hcCccccceeccCCceEEEEEEE-cCCcEEEEEEeeeCCchhH-HHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEe
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVL-ADGREVAVKQLKIGGSQGE-REFRAEVEIISRVHHRHLVSLVGYCISERERLLVYE 457 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vaVK~l~~~~~~~~-~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 457 (727)
.++|++.++||.|..+.||+|+. ..++.||||++..+.-+.. +.+++|+..|+.++|+||++++..|..+..+|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 45699999999999999999985 4579999999987654444 789999999999999999999999999999999999
Q ss_pred eccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCC
Q 041135 458 YVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDS 537 (727)
Q Consensus 458 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 537 (727)
||.+|++.++++..-...+++..+..|++++++||.|||.+ |.||||||+.||||+++|.|||+|||.+..+.+...
T Consensus 105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 99999999999887777799999999999999999999999 999999999999999999999999998866544332
Q ss_pred Ccccc-ccccCCccccccCcccC--CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHH
Q 041135 538 NTHVS-TRVMGTFGYMAPEYATS--GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFE 614 (727)
Q Consensus 538 ~~~~~-~~~~gt~~y~aPE~l~~--~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~ 614 (727)
..... ..+.|+..|||||+++. ..|+.|+|||||||..+||.+|..||....++.. +-..+++.- -
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv----------Ll~tLqn~p-p 250 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV----------LLLTLQNDP-P 250 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH----------HHHHhcCCC-C
Confidence 22222 55789999999999765 4699999999999999999999999987665321 111111110 0
Q ss_pred HHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 615 ALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 615 ~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
.+....+..+-...-...+.+++..||.+||.+||++.+++++
T Consensus 251 ~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 251 TLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred CcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 0000111111111112258899999999999999999999886
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-44 Score=384.61 Aligned_cols=250 Identities=23% Similarity=0.381 Sum_probs=213.1
Q ss_pred cCccccceeccCCceEEEEEEE-cCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeec
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVL-ADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYV 459 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 459 (727)
..|...++||+|.-|.||.++. .+++.||||++.......++.+.+|+.+|+.++|+|||++++.|..++++|+|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 4577778999999999999984 568999999999887777788999999999999999999999999999999999999
Q ss_pred cCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCc
Q 041135 460 PNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNT 539 (727)
Q Consensus 460 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 539 (727)
+||+|.+.+.... +++.++..|++++++||+|||.+ +|+|||||.+||||+.+|.+||+||||+..+. ...
T Consensus 353 ~ggsLTDvVt~~~---~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~---~~~ 423 (550)
T KOG0578|consen 353 EGGSLTDVVTKTR---MTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQIS---EEQ 423 (550)
T ss_pred CCCchhhhhhccc---ccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccc---ccc
Confidence 9999999886653 89999999999999999999999 99999999999999999999999999998653 223
Q ss_pred cccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHH
Q 041135 540 HVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDS 619 (727)
Q Consensus 540 ~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~ 619 (727)
.....++||++|||||++..+.|+.|.||||||+|++||+-|+.||-..+..... .+++ ..+
T Consensus 424 ~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAl-------yLIa-----------~ng 485 (550)
T KOG0578|consen 424 SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-------YLIA-----------TNG 485 (550)
T ss_pred CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHH-------HHHh-----------hcC
Confidence 3456689999999999999999999999999999999999999999764432111 1111 112
Q ss_pred HhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 620 RLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 620 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
.............+.+|+.+||..|+++|+++.|||++
T Consensus 486 ~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 486 TPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 22333334445568899999999999999999999987
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=369.86 Aligned_cols=269 Identities=31% Similarity=0.465 Sum_probs=209.4
Q ss_pred ccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHH--cCCCCceeEeeEeeccc----eeeEEE
Q 041135 383 FSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISR--VHHRHLVSLVGYCISER----ERLLVY 456 (727)
Q Consensus 383 ~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~--l~HpnIv~l~~~~~~~~----~~~lV~ 456 (727)
.+++++||+|+||.||||.+. ++.||||++.. ++.+.|++|.++++. ++|+||++|+++-.... +++||+
T Consensus 212 l~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred hhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence 455688999999999999995 69999999863 566789999999985 57999999999876555 789999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcC------CCcEEeeCCCCCceEECCCCcEEEEeeccch
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDC------HPRIIHRDIKSSNILLDSSFEARVADFGLAK 530 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~------~~~ivHrDLkp~NILl~~~~~vkL~DFGla~ 530 (727)
||.++|+|.+||..+ .++|....+|+..|++||+|||+.. ++.|+|||||.+||||.+|+++.|+|||||.
T Consensus 288 ~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl 364 (534)
T KOG3653|consen 288 EFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL 364 (534)
T ss_pred eeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence 999999999999887 4899999999999999999999754 5679999999999999999999999999998
Q ss_pred hhhccCCCccccccccCCccccccCcccCCC------CCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHH
Q 041135 531 IALELDSNTHVSTRVMGTFGYMAPEYATSGK------LTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLL 604 (727)
Q Consensus 531 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~------~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l 604 (727)
.+.. ........+.+||.+|||||+|.+.. .-.+.||||+|+|||||+++..-++... .. ++...+-
T Consensus 365 ~~~p-~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~-vp-----~Yqlpfe 437 (534)
T KOG3653|consen 365 RLEP-GKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGP-VP-----EYQLPFE 437 (534)
T ss_pred EecC-CCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCC-CC-----cccCchh
Confidence 7642 22233344578999999999997642 2247999999999999999877664211 11 1112222
Q ss_pred HHhhchhhHHHHHHHHhhcc----cch-----hHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccCCC
Q 041135 605 AEALEHEDFEALVDSRLEKN----YVD-----SEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDGAS 665 (727)
Q Consensus 605 ~~~~~~~~~~~l~d~~l~~~----~~~-----~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 665 (727)
.+.-.+..++++.+..++++ +.. ..+..+.+.++.||+.|++.|.++.-+.+++.++....
T Consensus 438 ~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 438 AEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred HHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 23333444444433333222 111 23455889999999999999999999999998886543
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-44 Score=381.33 Aligned_cols=268 Identities=26% Similarity=0.387 Sum_probs=230.8
Q ss_pred HHHHHHHhcCccccceeccCCceEEEEEEEcC-CcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccce
Q 041135 373 YDELIQATNGFSAHNVLGEGGFGCVYKGVLAD-GREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERE 451 (727)
Q Consensus 373 ~~el~~~~~~~~~~~~LG~G~fg~Vy~~~~~~-g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~ 451 (727)
+|+|+....++.+.++||-|.||.||.|.|+. ...||||.|+. +....++|++|..+|+.|+|+|+|+|+|+|..+-.
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence 46777777778888999999999999999864 67899999974 44556799999999999999999999999999999
Q ss_pred eeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchh
Q 041135 452 RLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKI 531 (727)
Q Consensus 452 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 531 (727)
+|||+|||.+|+|.+||++..+..+.-..+++|+.||..||+||..+ ++|||||.++||||.++..|||+||||+|+
T Consensus 338 FYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred eEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhh
Confidence 99999999999999999998888888889999999999999999999 999999999999999999999999999997
Q ss_pred hhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhch
Q 041135 532 ALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEH 610 (727)
Q Consensus 532 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~ 610 (727)
..... .....+....+.|.|||.|..+.++.|+|||+|||+||||.| |-.||.+.+ .
T Consensus 415 MtgDT--YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid--------------------l 472 (1157)
T KOG4278|consen 415 MTGDT--YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID--------------------L 472 (1157)
T ss_pred hcCCc--eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc--------------------H
Confidence 63222 222233445789999999999999999999999999999999 778887643 1
Q ss_pred hhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccCCCc
Q 041135 611 EDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDGASD 666 (727)
Q Consensus 611 ~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 666 (727)
.....+++...+.+....+...+++||+.||+++|.+||++.||.+.|+.+.....
T Consensus 473 SqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sS 528 (1157)
T KOG4278|consen 473 SQVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSS 528 (1157)
T ss_pred HHHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcccc
Confidence 22344555566666677788889999999999999999999999999998865443
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=376.55 Aligned_cols=269 Identities=21% Similarity=0.264 Sum_probs=208.3
Q ss_pred HhcCccccceeccCCceEEEEEEE-cCCcEEEEEEeeeCCchhHH-HHHHHHHHHHHcC-CCCceeEeeEeeccc-eeeE
Q 041135 379 ATNGFSAHNVLGEGGFGCVYKGVL-ADGREVAVKQLKIGGSQGER-EFRAEVEIISRVH-HRHLVSLVGYCISER-ERLL 454 (727)
Q Consensus 379 ~~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vaVK~l~~~~~~~~~-~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~-~~~l 454 (727)
..++|.++++||.|.||.||+|+. ..|+.||||+++..-...++ .-+||++.|++|+ |+|||+|++++.+.+ .+|+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 456799999999999999999985 46899999999754333333 3458999999998 999999999999988 9999
Q ss_pred EEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhc
Q 041135 455 VYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALE 534 (727)
Q Consensus 455 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 534 (727)
||||| ..+|+++++.+ +..|.+..+..|+.||++||+|+|++ |+.||||||+||||..+..+||+||||||....
T Consensus 88 VfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 88 VFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred eHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccccc
Confidence 99999 56888888877 56899999999999999999999999 999999999999999888999999999996533
Q ss_pred cCCCccccccccCCccccccCcccC-CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhH
Q 041135 535 LDSNTHVSTRVMGTFGYMAPEYATS-GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDF 613 (727)
Q Consensus 535 ~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~ 613 (727)
. .-.+..+.|.+|+|||+|.. +.|+.+.|||++|||++||++-+.-|.+....+ ++...+.- +..-......
T Consensus 163 k----pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~D--qi~KIc~V-LGtP~~~~~~ 235 (538)
T KOG0661|consen 163 K----PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEID--QIYKICEV-LGTPDKDSWP 235 (538)
T ss_pred C----CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHH--HHHHHHHH-hCCCccccch
Confidence 2 23345678899999999865 678999999999999999999999898765432 22222211 1100000000
Q ss_pred H-HHHHHHhhcc-----------cchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 614 E-ALVDSRLEKN-----------YVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 614 ~-~l~d~~l~~~-----------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
+ ..+-..++-. ........+++||.+||.+||++||++.|++++--
T Consensus 236 eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pf 293 (538)
T KOG0661|consen 236 EGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPF 293 (538)
T ss_pred hHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcc
Confidence 0 0111111111 12224456889999999999999999999998743
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=375.72 Aligned_cols=269 Identities=23% Similarity=0.316 Sum_probs=202.2
Q ss_pred cCccccceeccCCceEEEEEEE-cCCcEEEEEEeeeCCchh--HHHHHHHHHHHHHcCCCCceeEeeEeecc--ceeeEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVL-ADGREVAVKQLKIGGSQG--EREFRAEVEIISRVHHRHLVSLVGYCISE--RERLLV 455 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vaVK~l~~~~~~~--~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~--~~~~lV 455 (727)
+.|+.+++||+|.||.||||+. .+|+.||+|+++....+. .....+||.||++|+|+||++|.+...+. ..+|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 4577789999999999999994 579999999998765332 35677999999999999999999998876 689999
Q ss_pred EeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhcc
Q 041135 456 YEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALEL 535 (727)
Q Consensus 456 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 535 (727)
||||++ +|.-++... ...|++.++..+++||+.||+|||++ +|+|||||..|||||.+|.+||+|||||+++..
T Consensus 197 FeYMdh-DL~GLl~~p-~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~- 270 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSP-GVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTP- 270 (560)
T ss_pred Eecccc-hhhhhhcCC-CcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccC-
Confidence 999966 455455443 33599999999999999999999999 999999999999999999999999999997632
Q ss_pred CCCccccccccCCccccccCcccCC-CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHH-HHHHhhchhhH
Q 041135 536 DSNTHVSTRVMGTFGYMAPEYATSG-KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARP-LLAEALEHEDF 613 (727)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~-~l~~~~~~~~~ 613 (727)
......+..+.|++|++||+|+|. .|+.+.|+||.||||.||+.|+..|.+.........+-.+-+ --...|....+
T Consensus 271 -~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kL 349 (560)
T KOG0600|consen 271 -SGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKL 349 (560)
T ss_pred -CCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccC
Confidence 222335667789999999999985 699999999999999999999999987654322211111000 00000000000
Q ss_pred H--H------HHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 614 E--A------LVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 614 ~--~------l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
- . -...++++.| ..-....++|+..+|..||.+|.++.++++.
T Consensus 350 P~~~~~kp~~~y~r~l~E~~-~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 350 PHATIFKPQQPYKRRLRETF-KDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred CcccccCCCCcccchHHHHh-ccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 0 0 0011111111 1112236789999999999999999998875
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=366.05 Aligned_cols=263 Identities=26% Similarity=0.385 Sum_probs=207.3
Q ss_pred HHHHhcCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHH--cCCCCceeEeeEeeccc---
Q 041135 376 LIQATNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISR--VHHRHLVSLVGYCISER--- 450 (727)
Q Consensus 376 l~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~--l~HpnIv~l~~~~~~~~--- 450 (727)
.+.+..+..+++.||+|.||+||+|+|+ |+.||||++. ..+++.|.+|.++++. |+|.||+.|++.-..++
T Consensus 206 QRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~---srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~ 281 (513)
T KOG2052|consen 206 QRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFS---SRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSW 281 (513)
T ss_pred HHhhhheeEEEEEecCccccceeecccc-CCceEEEEec---ccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence 3445677899999999999999999996 8999999885 4567889999999986 49999999998754332
Q ss_pred -eeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcC-----CCcEEeeCCCCCceEECCCCcEEEE
Q 041135 451 -ERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDC-----HPRIIHRDIKSSNILLDSSFEARVA 524 (727)
Q Consensus 451 -~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-----~~~ivHrDLkp~NILl~~~~~vkL~ 524 (727)
++|||.+|.++|+|++||.++ .++.+..+++++.++.||+|||... ++.|.|||||.+||||..++.+.|+
T Consensus 282 TQLwLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA 358 (513)
T KOG2052|consen 282 TQLWLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 358 (513)
T ss_pred EEEEEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence 689999999999999999875 4899999999999999999999643 6789999999999999999999999
Q ss_pred eeccchhhhccCCC-ccccccccCCccccccCcccCCC----C--CchhHHHHHhHHHHHHHhCC----------CCCCC
Q 041135 525 DFGLAKIALELDSN-THVSTRVMGTFGYMAPEYATSGK----L--TEKSDVYSFGVVLLELITGR----------KPVDA 587 (727)
Q Consensus 525 DFGla~~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~----~--~~ksDVwS~Gvil~eLltG~----------~Pf~~ 587 (727)
|||||......... .......+||.+|||||+|.... | -..+||||||+||||+..+. .||..
T Consensus 359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd 438 (513)
T KOG2052|consen 359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYD 438 (513)
T ss_pred eceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCccc
Confidence 99999765433221 22233468999999999996532 2 24799999999999998733 33332
Q ss_pred CCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHhhcc---------cchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 041135 588 SQPLGDESLVEWARPLLAEALEHEDFEALVDSRLEKN---------YVDSEMFWMIEAAAACVRHSATKRPRMSQVVRAL 658 (727)
Q Consensus 588 ~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~---------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 658 (727)
... .+..++++.+....++ .....+..|.+||+.||..+|..|-++-.|.+.|
T Consensus 439 ~Vp------------------~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl 500 (513)
T KOG2052|consen 439 VVP------------------SDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTL 500 (513)
T ss_pred CCC------------------CCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHH
Confidence 211 1222333322211111 2456778899999999999999999999999999
Q ss_pred hhccC
Q 041135 659 DTLDG 663 (727)
Q Consensus 659 ~~~~~ 663 (727)
.++.+
T Consensus 501 ~~l~~ 505 (513)
T KOG2052|consen 501 AKLSN 505 (513)
T ss_pred HHHhc
Confidence 98864
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=375.34 Aligned_cols=254 Identities=25% Similarity=0.346 Sum_probs=209.4
Q ss_pred HhcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHHHHHHc-CCCCceeEeeEeeccceee
Q 041135 379 ATNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVEIISRV-HHRHLVSLVGYCISERERL 453 (727)
Q Consensus 379 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~ 453 (727)
..++|.++++||+|+|++||+|+.+ .+++||||++.... .+..+.+.+|.++|.+| +|+.|++|+..|+|+..+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 3467999999999999999999854 58999999985432 22334578899999999 7999999999999999999
Q ss_pred EEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhh
Q 041135 454 LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIAL 533 (727)
Q Consensus 454 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~ 533 (727)
+|+||+++|+|.++|++.+. |++.....++.+|+.||+|||++ |||||||||+|||||+|+++||+|||-|+.+.
T Consensus 151 FvLe~A~nGdll~~i~K~Gs--fde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKYGS--FDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred EEEEecCCCcHHHHHHHhCc--chHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 99999999999999998876 89988999999999999999999 99999999999999999999999999998764
Q ss_pred ccCCC----------ccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHH
Q 041135 534 ELDSN----------THVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPL 603 (727)
Q Consensus 534 ~~~~~----------~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~ 603 (727)
..... ......++||..|++||+|..+..+..+|||+||||||+|+.|+.||.+.+..
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney------------ 293 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY------------ 293 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH------------
Confidence 32211 11113489999999999999999999999999999999999999999865421
Q ss_pred HHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 041135 604 LAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRAL 658 (727)
Q Consensus 604 l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 658 (727)
..|+++++-. -.|...-...+.+|++++|..||.+|.+..||.++.
T Consensus 294 -------liFqkI~~l~--y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 294 -------LIFQKIQALD--YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred -------HHHHHHHHhc--ccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 0122222211 112222224477899999999999999999998763
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=368.38 Aligned_cols=260 Identities=28% Similarity=0.408 Sum_probs=205.9
Q ss_pred cCccccceeccCCceEEEEEEEcC-CcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccc--eeeEEEe
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLAD-GREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISER--ERLLVYE 457 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~~-g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~--~~~lV~E 457 (727)
.+|...+.||+|.||.||++.+.+ |+.+|||.+...+....+.+.+|+++|++|+|+|||+++|...... .++|+||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 346677999999999999999764 8999999998764444667999999999999999999999855444 6899999
Q ss_pred eccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECC-CCcEEEEeeccchhhhccC
Q 041135 458 YVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDS-SFEARVADFGLAKIALELD 536 (727)
Q Consensus 458 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~-~~~vkL~DFGla~~~~~~~ 536 (727)
|+.+|+|.+++.+.+. .+.+..++++.+||++||+|||++ +|||||||++||||+. ++.+||+|||+++......
T Consensus 97 y~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred ccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999998876 699999999999999999999999 9999999999999999 7999999999998653211
Q ss_pred CCccccccccCCccccccCcccCC-CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHH
Q 041135 537 SNTHVSTRVMGTFGYMAPEYATSG-KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEA 615 (727)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~l~~~-~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~ 615 (727)
..........||..|||||++..+ ....++|||||||+++||+||+.||... ....++...+..
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~---------- 237 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGR---------- 237 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhc----------
Confidence 122223347899999999999964 3445999999999999999999999753 011111111100
Q ss_pred HHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhcc
Q 041135 616 LVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLD 662 (727)
Q Consensus 616 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 662 (727)
.. ..............+|+.+|+..|+++||++.+++++.....
T Consensus 238 --~~-~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 238 --ED-SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred --cC-CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence 00 001222223334678899999999999999999999966543
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=386.38 Aligned_cols=265 Identities=26% Similarity=0.419 Sum_probs=216.1
Q ss_pred HHHHHhcCccccceeccCCceEEEEEEEcC--C--cE-EEEEEeeeCC---chhHHHHHHHHHHHHHcCCCCceeEeeEe
Q 041135 375 ELIQATNGFSAHNVLGEGGFGCVYKGVLAD--G--RE-VAVKQLKIGG---SQGEREFRAEVEIISRVHHRHLVSLVGYC 446 (727)
Q Consensus 375 el~~~~~~~~~~~~LG~G~fg~Vy~~~~~~--g--~~-vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~ 446 (727)
.|+...++..+.++||+|+||.||+|+++. + .. ||||..+... .....+|++|+++|++++|+|||+|||++
T Consensus 151 ~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa 230 (474)
T KOG0194|consen 151 KWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA 230 (474)
T ss_pred ccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 344455667778999999999999999753 2 23 8999988522 45557899999999999999999999999
Q ss_pred eccceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEee
Q 041135 447 ISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADF 526 (727)
Q Consensus 447 ~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DF 526 (727)
.++.-+|||||+|.||+|.++|+.+.. .++..++++++.++++||+|||++ ++|||||.++|||++.++.+||+||
T Consensus 231 ~~~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDF 306 (474)
T KOG0194|consen 231 VLEEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDF 306 (474)
T ss_pred cCCCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCcc
Confidence 999999999999999999999998765 689999999999999999999999 9999999999999999999999999
Q ss_pred ccchhhhccCCCccccc-cccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHH
Q 041135 527 GLAKIALELDSNTHVST-RVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLL 604 (727)
Q Consensus 527 Gla~~~~~~~~~~~~~~-~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l 604 (727)
||++... ...... ......+|+|||.+..+.|+.++|||||||++||+++ |..||.+.... +.
T Consensus 307 GLs~~~~----~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~------~v----- 371 (474)
T KOG0194|consen 307 GLSRAGS----QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY------EV----- 371 (474)
T ss_pred ccccCCc----ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH------HH-----
Confidence 9998532 111111 2246789999999999999999999999999999999 88899765421 10
Q ss_pred HHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccCCCc
Q 041135 605 AEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDGASD 666 (727)
Q Consensus 605 ~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 666 (727)
...++....+..........+..++..||..++++|++|.+|.+.|+.+....+
T Consensus 372 --------~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 372 --------KAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred --------HHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 111112223333444556667888899999999999999999999998865443
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=373.61 Aligned_cols=245 Identities=29% Similarity=0.447 Sum_probs=212.5
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc--hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEe
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS--QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYE 457 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 457 (727)
++|.+.+.||+|.||+||||+.+ +.+.||+|.+....+ ++.+.+++|++++++|+|+|||.++++|+...++|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888999999999999999865 578999999865443 334679999999999999999999999999999999999
Q ss_pred eccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCC
Q 041135 458 YVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDS 537 (727)
Q Consensus 458 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 537 (727)
||.| +|+.+|...+. +.++.+..|+.+++.||.|||++ +|+|||+|++||||+.++.+|+||||||+.. ..
T Consensus 82 ~a~g-~L~~il~~d~~--lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m---~~ 152 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGK--LPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAM---ST 152 (808)
T ss_pred hhhh-hHHHHHHhccC--CCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhc---cc
Confidence 9977 99999987765 89999999999999999999999 9999999999999999999999999999963 45
Q ss_pred CccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHH
Q 041135 538 NTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALV 617 (727)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~ 617 (727)
++.+.+.+.||+.|||||++.++.|+..+|+||+|||||||+.|+.||... .+.+++
T Consensus 153 ~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-----------------------si~~Lv 209 (808)
T KOG0597|consen 153 NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-----------------------SITQLV 209 (808)
T ss_pred CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-----------------------HHHHHH
Confidence 677788899999999999999999999999999999999999999999532 122233
Q ss_pred HHHhhc--ccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 618 DSRLEK--NYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 618 d~~l~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
...+.. .+.......+..|++..|.+||.+|.++.+++.+
T Consensus 210 ~~I~~d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 210 KSILKDPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred HHHhcCCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 322222 2344555668899999999999999999999876
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=376.11 Aligned_cols=260 Identities=27% Similarity=0.409 Sum_probs=202.5
Q ss_pred hcCccccceeccCCceEEEEEEEc------CCcEEEEEEeeeCCc-hhHHHHHHHHHHHHHc-CCCCceeEeeEeeccc-
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA------DGREVAVKQLKIGGS-QGEREFRAEVEIISRV-HHRHLVSLVGYCISER- 450 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~- 450 (727)
.++|++.++||+|+||.||+|.+. +++.||||+++.... ...+.+.+|+++|+++ +|+||++++++|...+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 457899999999999999999742 356899999875433 3345789999999999 8999999999987644
Q ss_pred eeeEEEeeccCCccchhcccCC----------------------------------------------------------
Q 041135 451 ERLLVYEYVPNDTLHYHLHAEG---------------------------------------------------------- 472 (727)
Q Consensus 451 ~~~lV~Ey~~~gsL~~~L~~~~---------------------------------------------------------- 472 (727)
.+++||||+.+|+|.++|+...
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 5789999999999998886532
Q ss_pred --CCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCccccccccCCcc
Q 041135 473 --RPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFG 550 (727)
Q Consensus 473 --~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~ 550 (727)
...+++.++++++.||++||+|||++ +|+|||||++||||++++.+||+|||+++...... .........++..
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~-~~~~~~~~~~~~~ 241 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDP-DYVRKGSARLPLK 241 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCc-chhcccCCCCCcc
Confidence 12377888999999999999999999 99999999999999999999999999997542211 1111223456788
Q ss_pred ccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHhhcccchhH
Q 041135 551 YMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSE 629 (727)
Q Consensus 551 y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~ 629 (727)
|+|||++.+..++.++|||||||+||||++ |+.||...... ..+. ..+..+. ........
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~--~~~~--------~~~~~~~---------~~~~~~~~ 302 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN--EEFC--------QRLKDGT---------RMRAPENA 302 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc--HHHH--------HHHhcCC---------CCCCCCCC
Confidence 999999999999999999999999999997 99999764321 1100 0000000 00111122
Q ss_pred HHHHHHHHHHHhccCCCCCCCHHHHHHHHhhcc
Q 041135 630 MFWMIEAAAACVRHSATKRPRMSQVVRALDTLD 662 (727)
Q Consensus 630 ~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 662 (727)
...+.+|+.+||+.||++||++.||++.|+.+.
T Consensus 303 ~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 303 TPEIYRIMLACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 345789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=377.32 Aligned_cols=241 Identities=27% Similarity=0.432 Sum_probs=200.4
Q ss_pred ccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeeccCCcc
Q 041135 385 AHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPNDTL 464 (727)
Q Consensus 385 ~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL 464 (727)
.++-||.|+.|.||+|+++ ++.||||+++. .-..+|+-|++|+|+||+.|.|+|...-.++||||||..|-|
T Consensus 128 ELeWlGSGaQGAVF~Grl~-netVAVKKV~e-------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLH-NETVAVKKVRE-------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhhccCcccceeeeecc-CceehhHHHhh-------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 3466999999999999995 78999998762 223578899999999999999999999999999999999999
Q ss_pred chhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCcccccc
Q 041135 465 HYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTR 544 (727)
Q Consensus 465 ~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 544 (727)
.++|+.... +....++.+.++||.||.|||.+ +|||||||.-||||..+..|||+|||-++.+.+. . ..-.
T Consensus 200 ~~VLka~~~--itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--S--TkMS 270 (904)
T KOG4721|consen 200 YEVLKAGRP--ITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--S--TKMS 270 (904)
T ss_pred HHHHhccCc--cCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh--h--hhhh
Confidence 999987765 88889999999999999999999 9999999999999999999999999999865432 1 1224
Q ss_pred ccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHhhcc
Q 041135 545 VMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRLEKN 624 (727)
Q Consensus 545 ~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~ 624 (727)
++||..|||||++++...++|+|||||||||||||||..||...+.. -+.|.. ... .|...
T Consensus 271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss----AIIwGV-------GsN--------sL~Lp 331 (904)
T KOG4721|consen 271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS----AIIWGV-------GSN--------SLHLP 331 (904)
T ss_pred hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh----eeEEec-------cCC--------ccccc
Confidence 78999999999999999999999999999999999999999764321 112211 011 11122
Q ss_pred cchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhc
Q 041135 625 YVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661 (727)
Q Consensus 625 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 661 (727)
....+..-+.-|++.||+..+..||+|++|+.+|+-+
T Consensus 332 vPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 332 VPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred CcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 2333444466789999999999999999999999854
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-43 Score=343.02 Aligned_cols=269 Identities=23% Similarity=0.362 Sum_probs=208.8
Q ss_pred cCccccceeccCCceEEEEEEE-cCCcEEEEEEeeeCCchh--HHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEe
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVL-ADGREVAVKQLKIGGSQG--EREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYE 457 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vaVK~l~~~~~~~--~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 457 (727)
++|..+++||+|.||.||+|+. ..|+.||||+++..+..+ .....|||+.|+.++|+||+.|+++|-+.+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 3577789999999999999995 569999999998765443 3467899999999999999999999999999999999
Q ss_pred eccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCC
Q 041135 458 YVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDS 537 (727)
Q Consensus 458 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 537 (727)
|+ ..+|...++.+.. .+...++..++.++++||+|||++ .|+||||||.|+||+.+|.+||+|||||+.+...+
T Consensus 82 fm-~tdLe~vIkd~~i-~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~- 155 (318)
T KOG0659|consen 82 FM-PTDLEVVIKDKNI-ILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN- 155 (318)
T ss_pred ec-cccHHHHhccccc-ccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCC-
Confidence 99 5688888876654 688999999999999999999999 99999999999999999999999999999864332
Q ss_pred CccccccccCCccccccCcccCC-CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHH-------HHHhhc
Q 041135 538 NTHVSTRVMGTFGYMAPEYATSG-KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPL-------LAEALE 609 (727)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~l~~~-~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~-------l~~~~~ 609 (727)
......+.|.+|+|||.+.|. .|+...||||.|||+.||+.|..-|.+.... +++....+-+ +-+...
T Consensus 156 --~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDi--dQL~~If~~LGTP~~~~WP~~~~ 231 (318)
T KOG0659|consen 156 --RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDI--DQLSKIFRALGTPTPDQWPEMTS 231 (318)
T ss_pred --cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchH--HHHHHHHHHcCCCCcccCccccc
Confidence 222333779999999999874 6999999999999999999998877765432 2222221110 000011
Q ss_pred hhhHHHHH--HHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 610 HEDFEALV--DSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 610 ~~~~~~l~--d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
-.++.++. -..............+++|+..+|..||.+|.++.|++++=.
T Consensus 232 lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~y 283 (318)
T KOG0659|consen 232 LPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPY 283 (318)
T ss_pred cccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchh
Confidence 11111111 001111133344455689999999999999999999988744
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=356.40 Aligned_cols=251 Identities=23% Similarity=0.364 Sum_probs=213.4
Q ss_pred HhcCccccceeccCCceEEEEEEE-cCCcEEEEEEeeeCC---chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeE
Q 041135 379 ATNGFSAHNVLGEGGFGCVYKGVL-ADGREVAVKQLKIGG---SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLL 454 (727)
Q Consensus 379 ~~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 454 (727)
...+|++.+.||+|.||+|-+++. ..|+.||||.++... .++...+++||++|+.|+|+||+.++.+|++.+.++|
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 345688999999999999999984 679999999997543 4445568899999999999999999999999999999
Q ss_pred EEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhc
Q 041135 455 VYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALE 534 (727)
Q Consensus 455 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 534 (727)
||||..+|.|++|+.+++. +.+.+..+|++||..|+.|+|++ +++|||||.+|||||.|+.+||+||||+..+.
T Consensus 131 vMEYaS~GeLYDYiSer~~--LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~- 204 (668)
T KOG0611|consen 131 VMEYASGGELYDYISERGS--LSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYA- 204 (668)
T ss_pred EEEecCCccHHHHHHHhcc--ccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhc-
Confidence 9999999999999988776 99999999999999999999999 99999999999999999999999999998653
Q ss_pred cCCCccccccccCCccccccCcccCCCC-CchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhH
Q 041135 535 LDSNTHVSTRVMGTFGYMAPEYATSGKL-TEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDF 613 (727)
Q Consensus 535 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~ 613 (727)
...+...+||...|.+||++++..| ...+|.|||||+||.|+.|.+||++.+.
T Consensus 205 ---~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh----------------------- 258 (668)
T KOG0611|consen 205 ---DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH----------------------- 258 (668)
T ss_pred ---cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH-----------------------
Confidence 3445678899999999999999877 4789999999999999999999997531
Q ss_pred HHHHHHHhhcccch-hHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhc
Q 041135 614 EALVDSRLEKNYVD-SEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661 (727)
Q Consensus 614 ~~l~d~~l~~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 661 (727)
..++...-++.|.+ .......-||++||..+|++|-++.+|..+.|--
T Consensus 259 k~lvrQIs~GaYrEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 259 KRLVRQISRGAYREPETPSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred HHHHHHhhcccccCCCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 11222222233322 1223355689999999999999999999998744
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=370.38 Aligned_cols=253 Identities=23% Similarity=0.347 Sum_probs=206.7
Q ss_pred HhcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeC----Cc-hhHHHHHHHHHHHHHcC-CCCceeEeeEeeccce
Q 041135 379 ATNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIG----GS-QGEREFRAEVEIISRVH-HRHLVSLVGYCISERE 451 (727)
Q Consensus 379 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~----~~-~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~ 451 (727)
..++|.+.+.||+|.||+|++|++. +|+.||||++... .. ...+.+.+|+.+|++++ |+||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 3467999999999999999999854 6899999977543 12 23456778999999999 9999999999999999
Q ss_pred eeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCC-CcEEEEeeccch
Q 041135 452 RLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSS-FEARVADFGLAK 530 (727)
Q Consensus 452 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~-~~vkL~DFGla~ 530 (727)
+|+|||||.||+|++++...++ +.+.+..++++||+.||+|||++ +|+|||||++||||+.+ +.+||+|||++.
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~g~--l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNKGR--LKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred EEEEEEecCCccHHHHHHHcCC--CChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 9999999999999999988554 78899999999999999999999 99999999999999999 999999999998
Q ss_pred hhhccCCCccccccccCCccccccCcccCCC-CC-chhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhh
Q 041135 531 IALELDSNTHVSTRVMGTFGYMAPEYATSGK-LT-EKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEAL 608 (727)
Q Consensus 531 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~-~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~ 608 (727)
... .........+|+..|+|||++.+.. |+ .++||||+|||||.|++|+.||+..+. ....
T Consensus 170 ~~~---~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~------~~l~-------- 232 (370)
T KOG0583|consen 170 ISP---GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV------PNLY-------- 232 (370)
T ss_pred ccC---CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH------HHHH--------
Confidence 542 2344566789999999999999877 75 899999999999999999999986321 1111
Q ss_pred chhhHHHHHHHHhhcccchhH-HHHHHHHHHHHhccCCCCCCCHHHHHHHHhh
Q 041135 609 EHEDFEALVDSRLEKNYVDSE-MFWMIEAAAACVRHSATKRPRMSQVVRALDT 660 (727)
Q Consensus 609 ~~~~~~~l~d~~l~~~~~~~~-~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 660 (727)
..+....+. +.... ...+..|+++||..||.+|.++.+|+++=+.
T Consensus 233 -----~ki~~~~~~--~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~ 278 (370)
T KOG0583|consen 233 -----RKIRKGEFK--IPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWF 278 (370)
T ss_pred -----HHHhcCCcc--CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhh
Confidence 111111111 11111 3446788999999999999999999965443
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=374.66 Aligned_cols=249 Identities=25% Similarity=0.374 Sum_probs=208.5
Q ss_pred CccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc---hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEe
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS---QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYE 457 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 457 (727)
-|++++.||+|+-|.|.+|++. +|+.+|||++..... .....+.+||-+|+.|.|+||++||++|++..++|||+|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 4788899999999999999964 699999999965422 223568999999999999999999999999999999999
Q ss_pred eccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCC
Q 041135 458 YVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDS 537 (727)
Q Consensus 458 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 537 (727)
|+.||.|+++|..++. +.+.+..++++||+.|+.|+|.. +|||||||++|+|||..+.+||+|||+|.+. .
T Consensus 93 yv~gGELFdylv~kG~--l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe----~ 163 (786)
T KOG0588|consen 93 YVPGGELFDYLVRKGP--LPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLE----V 163 (786)
T ss_pred ecCCchhHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecc----c
Confidence 9999999999988876 88899999999999999999998 9999999999999999999999999999753 3
Q ss_pred CccccccccCCccccccCcccCCCC-CchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHH
Q 041135 538 NTHVSTRVMGTFGYMAPEYATSGKL-TEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEAL 616 (727)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~l~~~~~-~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l 616 (727)
.......-||.+.|.+||+++|..| +.++||||.|||||.||+|++||+..+ + +.++ ...+.+.|+
T Consensus 164 ~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN------i----r~LL-lKV~~G~f~-- 230 (786)
T KOG0588|consen 164 PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN------I----RVLL-LKVQRGVFE-- 230 (786)
T ss_pred CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc------H----HHHH-HHHHcCccc--
Confidence 3455667899999999999999887 589999999999999999999998432 1 1111 111122211
Q ss_pred HHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhh
Q 041135 617 VDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDT 660 (727)
Q Consensus 617 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 660 (727)
. .........+|+.+||..||++|.++.||+++-.-
T Consensus 231 ------M--Ps~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l 266 (786)
T KOG0588|consen 231 ------M--PSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFL 266 (786)
T ss_pred ------C--CCcCCHHHHHHHHHHhccCccccccHHHHhhCchh
Confidence 1 12233446788999999999999999999998553
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=358.71 Aligned_cols=247 Identities=20% Similarity=0.329 Sum_probs=199.4
Q ss_pred ceeccCCceEEEEEEEcCCcEEEEEEeeeCCchh---HHHHHHHHHHHHHcCCCCceeEeeEeec----cceeeEEEeec
Q 041135 387 NVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQG---EREFRAEVEIISRVHHRHLVSLVGYCIS----ERERLLVYEYV 459 (727)
Q Consensus 387 ~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~---~~~~~~Ei~~l~~l~HpnIv~l~~~~~~----~~~~~lV~Ey~ 459 (727)
..||+|++|.||+|++ +|+.||||+++...... .+.|.+|+++|++++|+||++++|+|.+ ....+|||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 6799999999999998 68999999997543322 3568899999999999999999999977 34678999999
Q ss_pred cCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCc
Q 041135 460 PNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNT 539 (727)
Q Consensus 460 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 539 (727)
.+|+|.++++.+. .+++...++++.+++.||.|||+.. +++|||||++|||+++++.+||+|||+++.....
T Consensus 105 ~~g~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~---- 176 (283)
T PHA02988 105 TRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP---- 176 (283)
T ss_pred CCCcHHHHHhhCC--CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhccc----
Confidence 9999999998754 4889999999999999999999742 7889999999999999999999999999854211
Q ss_pred cccccccCCccccccCcccC--CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHH
Q 041135 540 HVSTRVMGTFGYMAPEYATS--GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALV 617 (727)
Q Consensus 540 ~~~~~~~gt~~y~aPE~l~~--~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~ 617 (727)
.....|+..|+|||++.+ ..++.++|||||||++|||++|+.||..... . ++.. .++
T Consensus 177 --~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~---~---~~~~-------------~i~ 235 (283)
T PHA02988 177 --PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT---K---EIYD-------------LII 235 (283)
T ss_pred --cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH---H---HHHH-------------HHH
Confidence 123467889999999976 6899999999999999999999999975431 1 1111 111
Q ss_pred HHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 618 DSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 618 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
...............+.+|+.+||+.||++||++.||++.|+.+..
T Consensus 236 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 236 NKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred hcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 1111111222234568899999999999999999999999998753
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=342.82 Aligned_cols=236 Identities=27% Similarity=0.381 Sum_probs=198.4
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc---hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS---QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
.+|++++.||.|+||+|.+++.+ +|..+|+|++..... +..+...+|.++|+.+.|+++++|++.|.+...+||||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 35788899999999999999976 588999999975433 23345778999999999999999999999999999999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccC
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 536 (727)
||+.||.|+.+|++.++ +++.....++.+|+.||+|||++ +|++|||||+|||||.+|.+||+|||+|+...
T Consensus 124 eyv~GGElFS~Lrk~~r--F~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~--- 195 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSGR--FSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVS--- 195 (355)
T ss_pred eccCCccHHHHHHhcCC--CCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEec---
Confidence 99999999999998877 99999999999999999999999 99999999999999999999999999998542
Q ss_pred CCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHH
Q 041135 537 SNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEAL 616 (727)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l 616 (727)
...-.+|||+.|+|||++..+.|+.++|.|+|||++|||+.|..||...+.+ ..++++
T Consensus 196 ---~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~-------------------~iY~KI 253 (355)
T KOG0616|consen 196 ---GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI-------------------QIYEKI 253 (355)
T ss_pred ---CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH-------------------HHHHHH
Confidence 1245689999999999999999999999999999999999999999765531 112333
Q ss_pred HHHHhhcccchhHHHHHHHHHHHHhccCCCCC
Q 041135 617 VDSRLEKNYVDSEMFWMIEAAAACVRHSATKR 648 (727)
Q Consensus 617 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R 648 (727)
+...+. |...-...+.+|++..|+.|-.+|
T Consensus 254 ~~~~v~--fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 254 LEGKVK--FPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred HhCccc--CCcccCHHHHHHHHHHHhhhhHhh
Confidence 333221 222223346677888888887777
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=365.89 Aligned_cols=254 Identities=22% Similarity=0.284 Sum_probs=204.1
Q ss_pred HhcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeE
Q 041135 379 ATNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLL 454 (727)
Q Consensus 379 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 454 (727)
..++|+++++||+|+||.||+|+.+ .|+.+|+|+|+... ....+.++.|-++|...++++||+|+..|++.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 4578999999999999999999965 59999999997543 2333568899999999999999999999999999999
Q ss_pred EEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhc
Q 041135 455 VYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALE 534 (727)
Q Consensus 455 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 534 (727)
||||++||++..+|.+.+- |.+.....++.+++.|++.||++ |||||||||+|+|||.+|++||+||||+.-+..
T Consensus 219 iMEylPGGD~mTLL~~~~~--L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKDT--LTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred EEEecCCccHHHHHHhcCc--CchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhh
Confidence 9999999999999988765 88889999999999999999999 999999999999999999999999999953211
Q ss_pred cC---------------------CCc----c-------------------ccccccCCccccccCcccCCCCCchhHHHH
Q 041135 535 LD---------------------SNT----H-------------------VSTRVMGTFGYMAPEYATSGKLTEKSDVYS 570 (727)
Q Consensus 535 ~~---------------------~~~----~-------------------~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS 570 (727)
.. ... . .....+||+.|||||+|++..|+..+|+||
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS 373 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS 373 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence 00 000 0 001246999999999999999999999999
Q ss_pred HhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHH--hhcccchhHHHHHHHHHHHHhccCCCCC
Q 041135 571 FGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSR--LEKNYVDSEMFWMIEAAAACVRHSATKR 648 (727)
Q Consensus 571 ~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~--l~~~~~~~~~~~l~~li~~cl~~dP~~R 648 (727)
|||||||||.|..||....... . +..++.-+ |...-......+..+||++||. |+++|
T Consensus 374 LG~ImyEmLvGyPPF~s~tp~~------T-------------~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~R 433 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETPQE------T-------------YRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENR 433 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCHHH------H-------------HHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHh
Confidence 9999999999999998766421 1 11111111 2111122223557899999999 99999
Q ss_pred CC---HHHHHHH
Q 041135 649 PR---MSQVVRA 657 (727)
Q Consensus 649 Ps---~~evl~~ 657 (727)
.- +.||.++
T Consensus 434 LG~~G~~EIK~H 445 (550)
T KOG0605|consen 434 LGSKGAEEIKKH 445 (550)
T ss_pred cCcccHHHHhcC
Confidence 86 5566554
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=371.28 Aligned_cols=240 Identities=30% Similarity=0.420 Sum_probs=203.4
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHHHHHHcC-CCCceeEeeEeeccceeeE
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVEIISRVH-HRHLVSLVGYCISERERLL 454 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~l 454 (727)
.++|.++++||+|.||+|+++.++ +++.+|||+++... ..+.+..+.|.+|+.... |+.|++|+.+|+..+++|+
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 467999999999999999999976 47899999998654 344567889999999885 9999999999999999999
Q ss_pred EEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhc
Q 041135 455 VYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALE 534 (727)
Q Consensus 455 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 534 (727)
||||+.||++..+.+.. .+++..+..++..|+.||.|||++ +|||||||.+|||||.+|++||+||||++..
T Consensus 447 vmey~~Ggdm~~~~~~~---~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~-- 518 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHIHTD---VFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEG-- 518 (694)
T ss_pred EEEecCCCcEEEEEecc---cccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccccccccc--
Confidence 99999999955444432 489999999999999999999999 9999999999999999999999999999853
Q ss_pred cCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHH
Q 041135 535 LDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFE 614 (727)
Q Consensus 535 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~ 614 (727)
.........+|||+.|||||++.+..|+..+|+|+|||+|||||.|+.||.+.+. +
T Consensus 519 -m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE-----------------------e 574 (694)
T KOG0694|consen 519 -MGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE-----------------------E 574 (694)
T ss_pred -CCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH-----------------------H
Confidence 2233355678999999999999999999999999999999999999999987541 2
Q ss_pred HHHHHHhhcc--cchhHHHHHHHHHHHHhccCCCCCCCH
Q 041135 615 ALVDSRLEKN--YVDSEMFWMIEAAAACVRHSATKRPRM 651 (727)
Q Consensus 615 ~l~d~~l~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~ 651 (727)
+++|..+..+ |..-.....+.|++++|.++|++|.-+
T Consensus 575 e~FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 575 EVFDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 2333333332 444455668899999999999999987
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=357.07 Aligned_cols=262 Identities=24% Similarity=0.324 Sum_probs=209.5
Q ss_pred HHhcCccccceeccCCceEEEEEEE-cCCcEEEEEEeeeCCc--------------hhHHHHHHHHHHHHHcCCCCceeE
Q 041135 378 QATNGFSAHNVLGEGGFGCVYKGVL-ADGREVAVKQLKIGGS--------------QGEREFRAEVEIISRVHHRHLVSL 442 (727)
Q Consensus 378 ~~~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vaVK~l~~~~~--------------~~~~~~~~Ei~~l~~l~HpnIv~l 442 (727)
...+.|++++.||+|.||+|.+|+. .+|+.||||++..... ...+++++||.+|++|+|+|||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 3457899999999999999999995 4689999999853211 112578999999999999999999
Q ss_pred eeEeec--cceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCc
Q 041135 443 VGYCIS--ERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFE 520 (727)
Q Consensus 443 ~~~~~~--~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~ 520 (727)
+++..+ .+.+|||+|||..|.+...-... ..+++.+.++++++++.||+|||.+ +||||||||.|+||+++|+
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d~--~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPDK--PELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCCCc--ccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCc
Confidence 999876 45789999999998876543332 2389999999999999999999999 9999999999999999999
Q ss_pred EEEEeeccchhhhcc--CCCccccccccCCccccccCcccCCC----CCchhHHHHHhHHHHHHHhCCCCCCCCCCCCch
Q 041135 521 ARVADFGLAKIALEL--DSNTHVSTRVMGTFGYMAPEYATSGK----LTEKSDVYSFGVVLLELITGRKPVDASQPLGDE 594 (727)
Q Consensus 521 vkL~DFGla~~~~~~--~~~~~~~~~~~gt~~y~aPE~l~~~~----~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~ 594 (727)
|||+|||.+..+... ........+..||+.|+|||.+.++. .+.+.||||+||.||.|+.|+.||.....
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~---- 324 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE---- 324 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH----
Confidence 999999998754221 11222334578999999999998743 45789999999999999999999975321
Q ss_pred hhHHhhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 595 SLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 595 ~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
...+++++...|.-.-..++...+.+||+++|++||++|.+..+|..+.+-.+.
T Consensus 325 ---------------~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 325 ---------------LELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred ---------------HHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 123444555555433333445668899999999999999999999999886654
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=375.07 Aligned_cols=252 Identities=25% Similarity=0.406 Sum_probs=213.3
Q ss_pred ccccceeccCCceEEEEEEEcC--C--cEEEEEEeeeCCch-hHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEe
Q 041135 383 FSAHNVLGEGGFGCVYKGVLAD--G--REVAVKQLKIGGSQ-GEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYE 457 (727)
Q Consensus 383 ~~~~~~LG~G~fg~Vy~~~~~~--g--~~vaVK~l~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 457 (727)
+++.++||+|.||.|++|.|.. | ..||||+++..... ...+|++|+.+|.+|+|+|||+|||+..+ ..++||||
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E 190 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE 190 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence 4566899999999999999863 3 46899999866544 56789999999999999999999999987 67889999
Q ss_pred eccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCC
Q 041135 458 YVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDS 537 (727)
Q Consensus 458 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 537 (727)
++..|+|.+.|++..+..|-...+..++.||++||.||..+ ++|||||..+||||-....|||+||||.|.+...+.
T Consensus 191 LaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred hcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 99999999999986566788889999999999999999999 999999999999999998999999999997765555
Q ss_pred CccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHH
Q 041135 538 NTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFEAL 616 (727)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l 616 (727)
.+.+.......+.|+|||.|+.++|+.++|||+|||.||||++ |+.||.+... ..+.+.
T Consensus 268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g--------------------~qIL~~ 327 (1039)
T KOG0199|consen 268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG--------------------IQILKN 327 (1039)
T ss_pred ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH--------------------HHHHHh
Confidence 5555555667889999999999999999999999999999999 8899976432 112233
Q ss_pred HHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 041135 617 VDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRAL 658 (727)
Q Consensus 617 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 658 (727)
+|.+-+......+.+.|+++|++||.+++++||+|..|.+.+
T Consensus 328 iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 328 IDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred ccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 343333344556777899999999999999999999998443
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=359.93 Aligned_cols=257 Identities=25% Similarity=0.428 Sum_probs=202.4
Q ss_pred cCccccceeccCCceEEEEEEEc-CCc----EEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGR----EVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLL 454 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~----~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 454 (727)
.+|++.++||+|+||.||+|++. +|+ .||||+++.... ...+++.+|+.+++.++|+||++++|+|..+ ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46899999999999999999864 333 389999875432 3456789999999999999999999999865 5679
Q ss_pred EEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhc
Q 041135 455 VYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALE 534 (727)
Q Consensus 455 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 534 (727)
|+||+.+|+|.++++.+.. .+.+..+++++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++....
T Consensus 86 v~e~~~~g~l~~~l~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eeecCCCCCHHHHHHhccc-cCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccccC
Confidence 9999999999999876542 478899999999999999999999 999999999999999999999999999986532
Q ss_pred cCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhH
Q 041135 535 LDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDF 613 (727)
Q Consensus 535 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~ 613 (727)
.. .........++..|++||++.+..++.++|||||||+||||++ |+.||+.... ..+
T Consensus 162 ~~-~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~---~~~----------------- 220 (316)
T cd05108 162 DE-KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA---SEI----------------- 220 (316)
T ss_pred CC-cceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---HHH-----------------
Confidence 11 1111222345678999999999999999999999999999998 9999975321 111
Q ss_pred HHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 614 EALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 614 ~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
..++...............+.+++.+||..+|++||++.+|+..|..+..
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 221 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred HHHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 11111111111111223457889999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=354.83 Aligned_cols=252 Identities=28% Similarity=0.377 Sum_probs=201.5
Q ss_pred CccccceeccCCceEEEEEEE-cCCcEEEEEEeeeCC---chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEe
Q 041135 382 GFSAHNVLGEGGFGCVYKGVL-ADGREVAVKQLKIGG---SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYE 457 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~-~~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 457 (727)
.|++.++||+|+||.||+|.+ .+|+.||||++.... ......+.+|+++|++++|+||++++++|.+++..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 377889999999999999986 468999999986432 2233467899999999999999999999999999999999
Q ss_pred eccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCC
Q 041135 458 YVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDS 537 (727)
Q Consensus 458 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 537 (727)
|+.+|+|..++.......+++..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++....
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~--- 154 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPE--- 154 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC---
Confidence 99999998887655444689999999999999999999999 999999999999999999999999999975321
Q ss_pred CccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHH
Q 041135 538 NTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALV 617 (727)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~ 617 (727)
........|+..|+|||++.+..++.++|||||||+||||++|+.||.......... .. ...+
T Consensus 155 -~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~--~~--------------~~~~ 217 (285)
T cd05631 155 -GETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKRE--EV--------------DRRV 217 (285)
T ss_pred -CCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHH--HH--------------HHHh
Confidence 111234578999999999999999999999999999999999999998654211000 00 0000
Q ss_pred HHHhhcccchhHHHHHHHHHHHHhccCCCCCCC-----HHHHHHH
Q 041135 618 DSRLEKNYVDSEMFWMIEAAAACVRHSATKRPR-----MSQVVRA 657 (727)
Q Consensus 618 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 657 (727)
. .....+.......+.+|+++||+.||++|++ +.+|+++
T Consensus 218 ~-~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 218 K-EDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred h-cccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 0 0011122222345788999999999999997 7888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=368.38 Aligned_cols=258 Identities=28% Similarity=0.421 Sum_probs=213.7
Q ss_pred HhcCccccceeccCCceEEEEEEEcC---C--cEEEEEEeeeCC-chhHHHHHHHHHHHHHcCCCCceeEeeEeecccee
Q 041135 379 ATNGFSAHNVLGEGGFGCVYKGVLAD---G--REVAVKQLKIGG-SQGEREFRAEVEIISRVHHRHLVSLVGYCISERER 452 (727)
Q Consensus 379 ~~~~~~~~~~LG~G~fg~Vy~~~~~~---g--~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 452 (727)
.++...+.++||+|-||.||+|.+.+ | -.||||..+.+. ..+.+.|++|..+|++++|+|||+|+|+|.+ ...
T Consensus 387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~ 465 (974)
T KOG4257|consen 387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPM 465 (974)
T ss_pred ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cce
Confidence 34556677899999999999998643 3 358899988644 3456789999999999999999999999976 467
Q ss_pred eEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhh
Q 041135 453 LLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIA 532 (727)
Q Consensus 453 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~ 532 (727)
|||||++..|.|+.||+.+.. .+....+..+++||+.+|.|||+. ++|||||..+||||.....|||+||||+|..
T Consensus 466 WivmEL~~~GELr~yLq~nk~-sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQNKD-SLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYL 541 (974)
T ss_pred eEEEecccchhHHHHHHhccc-cchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhc
Confidence 999999999999999987654 588889999999999999999999 9999999999999999999999999999976
Q ss_pred hccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchh
Q 041135 533 LELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHE 611 (727)
Q Consensus 533 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~ 611 (727)
.+ ...+........+.|||||.++-++++.++|||.|||+|||+|. |..||.+..+.+.-..+ +++
T Consensus 542 ed--~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i-----------EnG 608 (974)
T KOG4257|consen 542 ED--DAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI-----------ENG 608 (974)
T ss_pred cc--cchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEe-----------cCC
Confidence 33 33334446667899999999999999999999999999999987 99999886653321111 111
Q ss_pred hHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 612 DFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 612 ~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
-+......+.-.|+.|+.+||..||.+||.+.||...|..+.+
T Consensus 609 ---------eRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 609 ---------ERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred ---------CCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 1223345566678899999999999999999999999988753
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=370.10 Aligned_cols=259 Identities=25% Similarity=0.377 Sum_probs=202.8
Q ss_pred hcCccccceeccCCceEEEEEEE------cCCcEEEEEEeeeCC-chhHHHHHHHHHHHHHc-CCCCceeEeeEeeccce
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVL------ADGREVAVKQLKIGG-SQGEREFRAEVEIISRV-HHRHLVSLVGYCISERE 451 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~------~~g~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~ 451 (727)
.++|++.++||+|+||.||+|++ .++..||||+++... ....+.+.+|+++|+.+ +|+||++++++|.++..
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 34688899999999999999974 235689999987433 33445788999999999 89999999999999999
Q ss_pred eeEEEeeccCCccchhcccCC-----------------------------------------------------------
Q 041135 452 RLLVYEYVPNDTLHYHLHAEG----------------------------------------------------------- 472 (727)
Q Consensus 452 ~~lV~Ey~~~gsL~~~L~~~~----------------------------------------------------------- 472 (727)
.++|||||.+|+|.++++...
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999998886432
Q ss_pred --------------CCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCC
Q 041135 473 --------------RPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSN 538 (727)
Q Consensus 473 --------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 538 (727)
...+++..+++|+.||++||+|||++ +|+|||||++||||++++.+||+|||+++...... .
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~ 269 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDS-N 269 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcc-c
Confidence 12468889999999999999999998 99999999999999999999999999997542211 1
Q ss_pred ccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHH
Q 041135 539 THVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALV 617 (727)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~ 617 (727)
........++..|+|||++.+..++.++|||||||+||||++ |..||...... ..+.. .+
T Consensus 270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~--~~~~~-----------------~~ 330 (375)
T cd05104 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD--SKFYK-----------------MI 330 (375)
T ss_pred ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch--HHHHH-----------------HH
Confidence 111222345678999999999999999999999999999998 88888653211 11111 11
Q ss_pred HHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhc
Q 041135 618 DSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661 (727)
Q Consensus 618 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 661 (727)
...............+.+|+.+||+.||++||++.||++.|++.
T Consensus 331 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 331 KEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HhCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 11111111111234578999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=352.56 Aligned_cols=251 Identities=33% Similarity=0.557 Sum_probs=196.7
Q ss_pred cccceeccCCceEEEEEEEc-----CCcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEe
Q 041135 384 SAHNVLGEGGFGCVYKGVLA-----DGREVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYE 457 (727)
Q Consensus 384 ~~~~~LG~G~fg~Vy~~~~~-----~g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 457 (727)
++.+.||.|.||.||+|.+. .+..|+||+++.... +..++|.+|+++|++++|+||++++|+|.+.+..++|||
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 45689999999999999986 267899999965433 346789999999999999999999999998888999999
Q ss_pred eccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCC
Q 041135 458 YVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDS 537 (727)
Q Consensus 458 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 537 (727)
|+.+|+|.++|+......+++..+++|+.||++||.|||++ +|+||||+++||||++++.+||+|||+++..... .
T Consensus 82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~-~ 157 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK-S 157 (259)
T ss_dssp --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTS-S
T ss_pred ccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc-c
Confidence 99999999999988555699999999999999999999999 9999999999999999999999999999754211 1
Q ss_pred CccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHH
Q 041135 538 NTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFEAL 616 (727)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l 616 (727)
.........+...|+|||++.+..++.++||||||++||||++ |+.+|.... ...+ ...+
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~---~~~~----------------~~~~ 218 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD---NEEI----------------IEKL 218 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC---HHHH----------------HHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccc----------------cccc
Confidence 1222333457789999999999999999999999999999999 778876432 1111 1111
Q ss_pred HHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 041135 617 VDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRAL 658 (727)
Q Consensus 617 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 658 (727)
..............++.+|+..||+.+|++||+|.+|++.|
T Consensus 219 -~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 219 -KQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -HTTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -cccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 11111222333445688999999999999999999999987
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=349.65 Aligned_cols=257 Identities=28% Similarity=0.485 Sum_probs=212.6
Q ss_pred HhcCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEee
Q 041135 379 ATNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 379 ~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 458 (727)
..++|+++++||+|+||.||+|++.+++.|++|+++........++.+|+++|+.++|+||+++++++.+....++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 45668899999999999999999988999999999876665667899999999999999999999999999999999999
Q ss_pred ccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCC
Q 041135 459 VPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSN 538 (727)
Q Consensus 459 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 538 (727)
+.+++|.++++......+++..+++++.||+.||.|||++ +|+|||||++||||++++.+||+|||++..... .
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~---~ 157 (261)
T cd05148 84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKE---D 157 (261)
T ss_pred cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCC---c
Confidence 9999999999876656689999999999999999999999 999999999999999999999999999975421 1
Q ss_pred ccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHH
Q 041135 539 THVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALV 617 (727)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~ 617 (727)
........++..|++||++.++.++.++|||+|||+||+|++ |+.||..... ....+ .+
T Consensus 158 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~---~~~~~----------------~~- 217 (261)
T cd05148 158 VYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN---HEVYD----------------QI- 217 (261)
T ss_pred cccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH---HHHHH----------------HH-
Confidence 111223346678999999998899999999999999999998 8999965431 11111 01
Q ss_pred HHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhc
Q 041135 618 DSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661 (727)
Q Consensus 618 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 661 (727)
...............+.+++.+||+.||++||++++|++.|+.+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 218 TAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred HhCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 11111111223345588999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=347.44 Aligned_cols=255 Identities=26% Similarity=0.430 Sum_probs=207.3
Q ss_pred cCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeecc
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVP 460 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 460 (727)
++|+++++||+|+||.||+|.+.++..||||.+.... ...+.+.+|+++++.++|+||+++++++.+.+..++||||+.
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 5689999999999999999998888899999886432 345689999999999999999999999999999999999999
Q ss_pred CCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCcc
Q 041135 461 NDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTH 540 (727)
Q Consensus 461 ~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 540 (727)
+++|.++++......+.+..++.++.||++||+|||++ +|+|||||++|||+++++.+||+|||+++..... ...
T Consensus 85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~--~~~ 159 (261)
T cd05072 85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDN--EYT 159 (261)
T ss_pred CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCC--cee
Confidence 99999999766555688999999999999999999998 9999999999999999999999999999754221 111
Q ss_pred ccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHH
Q 041135 541 VSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDS 619 (727)
Q Consensus 541 ~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~ 619 (727)
......++..|+|||++.++.++.++|||||||++|||++ |+.||..... .....+. ..
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~---~~~~~~~-----------------~~ 219 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN---SDVMSAL-----------------QR 219 (261)
T ss_pred ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH---HHHHHHH-----------------Hc
Confidence 1223345678999999998889999999999999999998 9999965321 1111110 00
Q ss_pred HhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhc
Q 041135 620 RLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661 (727)
Q Consensus 620 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 661 (727)
.............+.+|+.+||+.+|++||++++|++.|+++
T Consensus 220 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 220 GYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 011111112234578999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=356.79 Aligned_cols=262 Identities=27% Similarity=0.419 Sum_probs=201.6
Q ss_pred cCccccceeccCCceEEEEEEEcC-----------------CcEEEEEEeeeCCch-hHHHHHHHHHHHHHcCCCCceeE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLAD-----------------GREVAVKQLKIGGSQ-GEREFRAEVEIISRVHHRHLVSL 442 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~~-----------------g~~vaVK~l~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l 442 (727)
++|++.++||+|+||.||+|++++ +..||||+++..... ...+|.+|+++|++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 468889999999999999998542 336999998754333 34579999999999999999999
Q ss_pred eeEeeccceeeEEEeeccCCccchhcccCC-----------------CCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEe
Q 041135 443 VGYCISERERLLVYEYVPNDTLHYHLHAEG-----------------RPVMDWATRVKVAAGAARGIAYLHEDCHPRIIH 505 (727)
Q Consensus 443 ~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~-----------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH 505 (727)
+++|.+.+..+|||||+.+|+|.+++.... ...+.+..+++|+.||++||.|||++ +|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence 999999999999999999999998875432 12467888999999999999999999 9999
Q ss_pred eCCCCCceEECCCCcEEEEeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh--CCC
Q 041135 506 RDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT--GRK 583 (727)
Q Consensus 506 rDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt--G~~ 583 (727)
||||++||||++++.+||+|||+++.....+ .........++..|+|||++.++.++.++|||||||+||||++ |..
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGD-YYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCc-eeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 9999999999999999999999997542221 1122233456789999999998899999999999999999987 556
Q ss_pred CCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 584 PVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 584 Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
||.... ...+.++....+.... ..............+.+|+.+||+.||++||++.||++.|+
T Consensus 241 p~~~~~---~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 241 PYGELT---DEQVIENAGEFFRDQG----------RQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCcCC---HHHHHHHHHHHhhhcc----------ccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 776432 1222222111111000 00000111223346889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=348.71 Aligned_cols=255 Identities=22% Similarity=0.370 Sum_probs=203.3
Q ss_pred cCccccceeccCCceEEEEEEEc----CCcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA----DGREVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLV 455 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~----~g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 455 (727)
++|++.++||+|+||.||+|.++ .+..||+|+++.... .....|.+|+.+|++++|+||++++|++..++..+||
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46889999999999999999863 356899999876543 3345789999999999999999999999999999999
Q ss_pred EeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhcc
Q 041135 456 YEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALEL 535 (727)
Q Consensus 456 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 535 (727)
|||+.+|+|.+++.... ..+.+..+++++.||+.||+|||++ +|+|||||++||||+.++.+||+|||++.....
T Consensus 85 ~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~- 159 (266)
T cd05064 85 TEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS- 159 (266)
T ss_pred EEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccccc-
Confidence 99999999999987643 2588999999999999999999999 999999999999999999999999998764311
Q ss_pred CCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHH
Q 041135 536 DSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFE 614 (727)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~ 614 (727)
..........++..|+|||++.++.++.++|||||||++|||++ |+.||..... ..+.+.
T Consensus 160 -~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~---~~~~~~--------------- 220 (266)
T cd05064 160 -EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG---QDVIKA--------------- 220 (266)
T ss_pred -cchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH---HHHHHH---------------
Confidence 11111122345678999999999999999999999999999875 9999975421 111110
Q ss_pred HHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhc
Q 041135 615 ALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661 (727)
Q Consensus 615 ~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 661 (727)
+ ...............+.+++.+||+.+|++||++.||++.|+++
T Consensus 221 -~-~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 221 -V-EDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -H-HCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 0 00011111222344588899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=378.77 Aligned_cols=254 Identities=28% Similarity=0.421 Sum_probs=210.7
Q ss_pred ccccceeccCCceEEEEEEEc-CC----cEEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 383 FSAHNVLGEGGFGCVYKGVLA-DG----REVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 383 ~~~~~~LG~G~fg~Vy~~~~~-~g----~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
++..++||.|+||+||||.|- +| -.||||++..... +..++|++|+-+|.+|+|+||++|+|+|.... +.||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 345688999999999999863 33 4689998865433 44578999999999999999999999998766 78999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccC
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 536 (727)
+|+.+|.|.+|++.++. .+..++++.|++||++||.|||++ ++|||||.++||||..-..+||.|||+++.+. .+
T Consensus 777 q~mP~G~LlDyvr~hr~-~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~-~d 851 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHRD-NIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLA-PD 851 (1177)
T ss_pred HhcccchHHHHHHHhhc-cccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccC-cc
Confidence 99999999999987644 578899999999999999999999 99999999999999999999999999998653 34
Q ss_pred CCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHH
Q 041135 537 SNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFEA 615 (727)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~ 615 (727)
............+.|||-|.++...|+.++|||+|||.+||||| |..||++... .++.+
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~--------------------~eI~d 911 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA--------------------EEIPD 911 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH--------------------HHhhH
Confidence 44444445556789999999999999999999999999999999 9999987542 22333
Q ss_pred HHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhcc
Q 041135 616 LVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLD 662 (727)
Q Consensus 616 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 662 (727)
+++...+.....-+...++.+|.+||..|.+.||.++++...+..+.
T Consensus 912 lle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 912 LLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred HHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence 44433333344445566788899999999999999999999988774
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=382.53 Aligned_cols=262 Identities=23% Similarity=0.352 Sum_probs=212.2
Q ss_pred HhcCccccceeccCCceEEEEEEEcCC-cEEEEEEeeeCCchhHHHHHHHHHHHHHcC-CCCceeEeeE-eec------c
Q 041135 379 ATNGFSAHNVLGEGGFGCVYKGVLADG-REVAVKQLKIGGSQGEREFRAEVEIISRVH-HRHLVSLVGY-CIS------E 449 (727)
Q Consensus 379 ~~~~~~~~~~LG~G~fg~Vy~~~~~~g-~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~-~~~------~ 449 (727)
...++++.+.|.+|||+.||+|.+..+ .+||+|++...+....+.+++||++|++|+ |+|||.++|. ... .
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 345678899999999999999998766 999999998888888889999999999997 9999999993 221 1
Q ss_pred ceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccc
Q 041135 450 RERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLA 529 (727)
Q Consensus 450 ~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla 529 (727)
.+++|+||||.||.|-++|..+....|++.++++|++|+++|+.+||.. .+.|||||||-+||||+.++.+||||||-|
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 3678999999999999999876655699999999999999999999996 667999999999999999999999999998
Q ss_pred hhhhccC-CCcc-----ccccccCCccccccCccc---CCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhh
Q 041135 530 KIALELD-SNTH-----VSTRVMGTFGYMAPEYAT---SGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWA 600 (727)
Q Consensus 530 ~~~~~~~-~~~~-----~~~~~~gt~~y~aPE~l~---~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~ 600 (727)
.-..... .... .......|+-|++||++. +...++|+|||+|||+||-||....||+.....
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l--------- 264 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL--------- 264 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce---------
Confidence 6322111 1111 111245789999999874 567899999999999999999999999865221
Q ss_pred HHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccCC
Q 041135 601 RPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDGA 664 (727)
Q Consensus 601 ~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 664 (727)
.+++....-........+|.+||+.||+.||++||++.||++.+..+...
T Consensus 265 --------------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 265 --------------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred --------------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 11111221122234556689999999999999999999999999988653
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=360.50 Aligned_cols=249 Identities=24% Similarity=0.418 Sum_probs=209.7
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchh-HHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEee
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQG-EREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~-~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 458 (727)
..|+.+++||+|.||.||||... .++.||||++......+ .+++++|+.+|..++++||.++||.|..+..+|++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 34777799999999999999964 58899999998765544 46899999999999999999999999999999999999
Q ss_pred ccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCC
Q 041135 459 VPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSN 538 (727)
Q Consensus 459 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 538 (727)
|.||++.+.|+...- +++..+..|+++++.||.|||.+ +.+|||||+.||||..+|.+||+|||.+..+. ..
T Consensus 93 ~~gGsv~~lL~~~~~--~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~---~~ 164 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGNI--LDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLT---NT 164 (467)
T ss_pred hcCcchhhhhccCCC--CccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeee---ch
Confidence 999999999977653 58888889999999999999999 99999999999999999999999999997542 22
Q ss_pred ccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHH
Q 041135 539 THVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVD 618 (727)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d 618 (727)
......++||+.|||||++++..|+.|+||||||++.+||++|..||....++....++-. -.-
T Consensus 165 ~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk----------------~~P 228 (467)
T KOG0201|consen 165 VKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPK----------------SAP 228 (467)
T ss_pred hhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccC----------------CCC
Confidence 3334678999999999999998999999999999999999999999988776543322210 001
Q ss_pred HHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 619 SRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 619 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
..|.+.| ...|.+|+..||++||+.||++.+++++
T Consensus 229 P~L~~~~----S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 229 PRLDGDF----SPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred Ccccccc----CHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 2233322 2337889999999999999999999876
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=344.59 Aligned_cols=255 Identities=28% Similarity=0.433 Sum_probs=207.2
Q ss_pred hcCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeec
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYV 459 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 459 (727)
.++|++.+.||+|+||.||+|.+.+++.||||.++... ...+++.+|+++|++++|+||+++++++..++..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 45688999999999999999998888899999987543 34567999999999999999999999999999999999999
Q ss_pred cCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCc
Q 041135 460 PNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNT 539 (727)
Q Consensus 460 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 539 (727)
.+++|.+++.......+++..++.++.||+.||.|||++ +|+|||||++|||+++++.+||+|||+++..... ..
T Consensus 84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~ 158 (261)
T cd05068 84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKED--IY 158 (261)
T ss_pred cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCC--cc
Confidence 999999999776545689999999999999999999999 9999999999999999999999999999865311 11
Q ss_pred cccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHH
Q 041135 540 HVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVD 618 (727)
Q Consensus 540 ~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d 618 (727)
.......+...|++||++.+..++.++|||||||++|||++ |+.||..... ..+.. .++
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~-----------------~~~ 218 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN---AEVLQ-----------------QVD 218 (261)
T ss_pred cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHHH-----------------HHH
Confidence 11112233467999999999899999999999999999999 9999975421 11000 011
Q ss_pred HHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhh
Q 041135 619 SRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDT 660 (727)
Q Consensus 619 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 660 (727)
..............+.+++.+||+.+|++||++++|++.|+.
T Consensus 219 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 219 QGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred cCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 111111122233568899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=363.52 Aligned_cols=248 Identities=27% Similarity=0.379 Sum_probs=193.3
Q ss_pred ccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeecc
Q 041135 383 FSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVP 460 (727)
Q Consensus 383 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 460 (727)
|+++++||+|+||.||+|++. +|+.||||++..... .....+.+|+++|++++|+||++++++|.+++.+++||||+.
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 155 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD 155 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCC
Confidence 456688999999999999975 689999999865433 234678999999999999999999999999999999999999
Q ss_pred CCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCcc
Q 041135 461 NDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTH 540 (727)
Q Consensus 461 ~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 540 (727)
+|+|.... .+.+..++.|+.||++||+|||++ +|+|||||++||||++++.+||+|||+++.+... ..
T Consensus 156 ~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~---~~ 223 (353)
T PLN00034 156 GGSLEGTH------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT---MD 223 (353)
T ss_pred CCcccccc------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccc---cc
Confidence 99986532 245677889999999999999999 9999999999999999999999999999754221 11
Q ss_pred ccccccCCccccccCcccC-----CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHH
Q 041135 541 VSTRVMGTFGYMAPEYATS-----GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEA 615 (727)
Q Consensus 541 ~~~~~~gt~~y~aPE~l~~-----~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~ 615 (727)
......|+..|+|||++.. ...+.++||||||||||||++|+.||...... +|.......
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~------~~~~~~~~~--------- 288 (353)
T PLN00034 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG------DWASLMCAI--------- 288 (353)
T ss_pred cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc------cHHHHHHHH---------
Confidence 2234578999999998853 23456899999999999999999999743211 111100000
Q ss_pred HHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 616 LVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 616 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
...............+.+|+++||+.||++||++.||+++-.
T Consensus 289 --~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~ 330 (353)
T PLN00034 289 --CMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPF 330 (353)
T ss_pred --hccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 000001111223345889999999999999999999998744
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=359.68 Aligned_cols=269 Identities=23% Similarity=0.320 Sum_probs=207.6
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEe
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYE 457 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 457 (727)
.++|+++++||+|+||.||++++. +|..||+|+++.... .....+.+|+++|++++|+||++++++|.+++..+||||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 467999999999999999999976 588899999876533 334579999999999999999999999999999999999
Q ss_pred eccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCC
Q 041135 458 YVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDS 537 (727)
Q Consensus 458 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 537 (727)
|+.+++|.+++..... +.+..+.+++.||+.||.|||+.+ +|+|||||++||||+.++.+||+|||+++....
T Consensus 84 ~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--- 156 (331)
T cd06649 84 HMDGGSLDQVLKEAKR--IPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--- 156 (331)
T ss_pred cCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccc---
Confidence 9999999999876543 788999999999999999999852 699999999999999999999999999975422
Q ss_pred CccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHH-H-----------
Q 041135 538 NTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLL-A----------- 605 (727)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l-~----------- 605 (727)
.......|+..|+|||++.+..++.++|||||||+||||++|+.||...... .+........ .
T Consensus 157 --~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 231 (331)
T cd06649 157 --SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK---ELEAIFGRPVVDGEEGEPHSISP 231 (331)
T ss_pred --cccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHhcccccccccCCccccCc
Confidence 1223456899999999999999999999999999999999999999653321 1111000000 0
Q ss_pred --------------HhhchhhHHHHHHHHhhccc----chhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhh
Q 041135 606 --------------EALEHEDFEALVDSRLEKNY----VDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDT 660 (727)
Q Consensus 606 --------------~~~~~~~~~~l~d~~l~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 660 (727)
.......+..+++....... .......+.+|+.+||++||++||+++||+++...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~ 304 (331)
T cd06649 232 RPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFI 304 (331)
T ss_pred ccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHH
Confidence 00000001112222111111 11123458899999999999999999999988653
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=368.85 Aligned_cols=260 Identities=26% Similarity=0.393 Sum_probs=203.3
Q ss_pred hcCccccceeccCCceEEEEEEEc------CCcEEEEEEeeeCCch-hHHHHHHHHHHHHHc-CCCCceeEeeEeeccce
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA------DGREVAVKQLKIGGSQ-GEREFRAEVEIISRV-HHRHLVSLVGYCISERE 451 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vaVK~l~~~~~~-~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~ 451 (727)
.++|+++++||+|+||.||+|++. ++..||||+++..... ....+.+|+++|+.+ +|+||++++++|.+...
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 456889999999999999999742 2457999999754433 345688999999999 89999999999999999
Q ss_pred eeEEEeeccCCccchhcccCC-----------------------------------------------------------
Q 041135 452 RLLVYEYVPNDTLHYHLHAEG----------------------------------------------------------- 472 (727)
Q Consensus 452 ~~lV~Ey~~~gsL~~~L~~~~----------------------------------------------------------- 472 (727)
.+||||||.+|+|.++++.+.
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 999999999999998875421
Q ss_pred ---------CCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCccccc
Q 041135 473 ---------RPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVST 543 (727)
Q Consensus 473 ---------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 543 (727)
...+++..+++|+.||++||+|||++ +|+|||||++|||+++++.+||+|||+++..... .......
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~-~~~~~~~ 272 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMND-SNYVVKG 272 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCC-cceeecc
Confidence 12367888999999999999999998 9999999999999999999999999999754221 1111222
Q ss_pred cccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHhh
Q 041135 544 RVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRLE 622 (727)
Q Consensus 544 ~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l~ 622 (727)
...++..|||||++.+..++.++|||||||+||||++ |+.||...... .. +...+.....
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~--~~-----------------~~~~~~~~~~ 333 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN--SK-----------------FYKMVKRGYQ 333 (374)
T ss_pred CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc--HH-----------------HHHHHHcccC
Confidence 3345678999999999999999999999999999997 99999753211 00 1111111111
Q ss_pred cccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhcc
Q 041135 623 KNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLD 662 (727)
Q Consensus 623 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 662 (727)
..........+.+++.+||+.||++||++.+|++.|+++.
T Consensus 334 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 334 MSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred ccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 1111112345788999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=344.58 Aligned_cols=251 Identities=25% Similarity=0.431 Sum_probs=202.1
Q ss_pred cCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeecc
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVP 460 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 460 (727)
++|++.+.||+|+||.||+++++++..+|+|.++.. .....+|.+|+++|++++|+||++++++|.++...++||||+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 458888999999999999999988889999988633 3335678999999999999999999999999999999999999
Q ss_pred CCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCcc
Q 041135 461 NDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTH 540 (727)
Q Consensus 461 ~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 540 (727)
+|+|.++++.... .+++..++.++.||+.||+|||++ +|+|||||++||+|++++.+||+|||+++...... ..
T Consensus 83 ~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~--~~ 156 (256)
T cd05114 83 NGCLLNYLRQRQG-KLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE--YT 156 (256)
T ss_pred CCcHHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCc--ee
Confidence 9999998875432 488999999999999999999999 99999999999999999999999999997542211 11
Q ss_pred ccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHH
Q 041135 541 VSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDS 619 (727)
Q Consensus 541 ~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~ 619 (727)
......++..|+|||++.+..++.++|||||||+||||++ |+.||..... ....++ +.+.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~---~~~~~~----------------i~~~ 217 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN---YEVVEM----------------ISRG 217 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH----------------HHCC
Confidence 1122345678999999998889999999999999999999 8999965431 111111 0000
Q ss_pred HhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 041135 620 RLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRAL 658 (727)
Q Consensus 620 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 658 (727)
. ...........+.+|+.+||+.+|++||++.+|++.|
T Consensus 218 ~-~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 218 F-RLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred C-CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 0 0001111234578999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=355.61 Aligned_cols=247 Identities=24% Similarity=0.339 Sum_probs=202.3
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
++|++.++||+|+||.||+|+.. +|+.||||++.... .+..+.+.+|+++|++++|+||+++++++.++...|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36889999999999999999975 58999999986432 233456889999999999999999999999999999999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccC
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 536 (727)
||+.+|+|.++++.++. +.+..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~~~~~--~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~-- 153 (291)
T cd05612 81 EYVPGGELFSYLRNSGR--FSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-- 153 (291)
T ss_pred eCCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC--
Confidence 99999999999876654 88899999999999999999999 999999999999999999999999999975421
Q ss_pred CCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHH
Q 041135 537 SNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEAL 616 (727)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l 616 (727)
.....+|+..|+|||++.+..++.++|||||||+||||++|+.||..... .+.. ..+
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~------~~~~-------------~~i 210 (291)
T cd05612 154 ----RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP------FGIY-------------EKI 210 (291)
T ss_pred ----CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHH-------------HHH
Confidence 11235689999999999998999999999999999999999999975431 1111 111
Q ss_pred HHHHhhcccchhHHHHHHHHHHHHhccCCCCCCC-----HHHHHHHHh
Q 041135 617 VDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPR-----MSQVVRALD 659 (727)
Q Consensus 617 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~L~ 659 (727)
....+ .+.......+.+|+++||+.||.+|++ +.|++++-+
T Consensus 211 ~~~~~--~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~ 256 (291)
T cd05612 211 LAGKL--EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRW 256 (291)
T ss_pred HhCCc--CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCcc
Confidence 11111 111122335788999999999999995 888887644
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=353.88 Aligned_cols=270 Identities=21% Similarity=0.278 Sum_probs=201.4
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC--chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEe
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG--SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYE 457 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 457 (727)
++|++.+.||+|+||.||+|+++ +++.||||+++... ....+.+.+|+++++.++|+||++++++|.+++..|||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46899999999999999999986 57889999987543 2234568899999999999999999999999999999999
Q ss_pred eccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCC
Q 041135 458 YVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDS 537 (727)
Q Consensus 458 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 537 (727)
|+.++.|..+.... ..+.+..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++......
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 154 (287)
T cd07848 81 YVEKNMLELLEEMP--NGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS- 154 (287)
T ss_pred cCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccccccc-
Confidence 99998776655433 2488899999999999999999999 99999999999999999999999999998642211
Q ss_pred CccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhH-H----HHHHhhchhh
Q 041135 538 NTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWAR-P----LLAEALEHED 612 (727)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~-~----~l~~~~~~~~ 612 (727)
........|+..|+|||++.+..++.++|||||||+||||++|+.||................ . .+........
T Consensus 155 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 155 -NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred -cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 112234568999999999999899999999999999999999999997643211110000000 0 0000000000
Q ss_pred HHHHHHH------HhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 613 FEALVDS------RLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 613 ~~~l~d~------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
+...... .+...+.......+.+|+++||+.||++|++++||+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000 00000111123358899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=404.47 Aligned_cols=261 Identities=28% Similarity=0.542 Sum_probs=210.2
Q ss_pred cCccccceeccCCceEEEEEEE-cCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeec
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVL-ADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYV 459 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 459 (727)
..|+..++||+|+||.||+|++ .+|+.||||+++.... ...+|+++|++++|+|||+++|+|.++...|+||||+
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~ 765 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence 4577788999999999999997 4789999999864322 2235688999999999999999999999999999999
Q ss_pred cCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCc
Q 041135 460 PNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNT 539 (727)
Q Consensus 460 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 539 (727)
++|+|.++++. ++|..+++|+.||++||+|||..+..+|+|||||++|||++.++..++. ||+.....
T Consensus 766 ~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~------ 833 (968)
T PLN00113 766 EGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC------ 833 (968)
T ss_pred CCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc------
Confidence 99999999953 7899999999999999999996656699999999999999999888875 66654321
Q ss_pred cccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHH
Q 041135 540 HVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDS 619 (727)
Q Consensus 540 ~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~ 619 (727)
......|+..|||||++.++.++.++|||||||+||||++|+.||+.... ....+++|++.... ......+++.
T Consensus 834 -~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~----~~~~~~~~~~ 907 (968)
T PLN00113 834 -TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYS----DCHLDMWIDP 907 (968)
T ss_pred -cCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcC----ccchhheeCc
Confidence 11223678999999999999999999999999999999999999965432 23456677654322 2223344444
Q ss_pred Hhhcc--cchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 620 RLEKN--YVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 620 ~l~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
.+... ...++...+++++.+||+.||++||+|+||++.|+++..
T Consensus 908 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 908 SIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred cccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 44332 234556678899999999999999999999999998754
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=359.96 Aligned_cols=242 Identities=23% Similarity=0.327 Sum_probs=196.5
Q ss_pred ceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeeccCC
Q 041135 387 NVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPND 462 (727)
Q Consensus 387 ~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 462 (727)
++||+|+||.||+++.+ +|+.||||+++... ......+.+|+++|++++|+||++++++|..++..||||||+.+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999864 68999999997432 223356788999999999999999999999999999999999999
Q ss_pred ccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCcccc
Q 041135 463 TLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVS 542 (727)
Q Consensus 463 sL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 542 (727)
+|.+++..+. .+.+..+..|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++.... .....
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~---~~~~~ 152 (323)
T cd05571 81 ELFFHLSRER--VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS---DGATM 152 (323)
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCccccc---CCCcc
Confidence 9999887654 388999999999999999999999 999999999999999999999999999874321 11222
Q ss_pred ccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHhh
Q 041135 543 TRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRLE 622 (727)
Q Consensus 543 ~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l~ 622 (727)
...+|+..|+|||++.+..++.++|||||||+||||++|+.||...+. ..+. . .+....
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~---~~~~---~-------------~~~~~~-- 211 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLF---E-------------LILMEE-- 211 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH---HHHH---H-------------HHHcCC--
Confidence 346799999999999999999999999999999999999999965321 1100 0 000000
Q ss_pred cccchhHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 041135 623 KNYVDSEMFWMIEAAAACVRHSATKRP-----RMSQVVRA 657 (727)
Q Consensus 623 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 657 (727)
..+.......+.+|+++||+.||++|+ ++.+|+++
T Consensus 212 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 212 IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 111222334578899999999999999 79998876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=348.45 Aligned_cols=256 Identities=29% Similarity=0.525 Sum_probs=204.9
Q ss_pred cCccccceeccCCceEEEEEEEcC------CcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceee
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLAD------GREVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYCISERERL 453 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~~------g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 453 (727)
++|++.+.||+|+||.||+|.+.. +..|++|.++.... .....|.+|+++|++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 358889999999999999998643 25799999875433 23457899999999999999999999999999999
Q ss_pred EEEeeccCCccchhcccCCC--------------CcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCC
Q 041135 454 LVYEYVPNDTLHYHLHAEGR--------------PVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSF 519 (727)
Q Consensus 454 lV~Ey~~~gsL~~~L~~~~~--------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~ 519 (727)
++|||+.+++|.+++..... ..+++..++.++.||++||+|||++ +|+|||||++||||++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence 99999999999998865421 3578889999999999999999999 999999999999999999
Q ss_pred cEEEEeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHH
Q 041135 520 EARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVE 598 (727)
Q Consensus 520 ~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~ 598 (727)
.+||+|||+++.....+ .........++..|+|||++.++.++.++|||||||+||||++ |..||.+... ..+.+
T Consensus 162 ~~~L~dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~---~~~~~ 237 (283)
T cd05048 162 TVKISDFGLSRDIYSAD-YYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN---QEVIE 237 (283)
T ss_pred cEEECCCcceeeccccc-cccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHH
Confidence 99999999997543221 1122334456788999999998899999999999999999998 9999975431 11111
Q ss_pred hhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhh
Q 041135 599 WARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDT 660 (727)
Q Consensus 599 ~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 660 (727)
.+...............+.+|+++||+.||++||++.||+++|++
T Consensus 238 -----------------~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 238 -----------------MIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred -----------------HHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 111111111122234568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=361.66 Aligned_cols=246 Identities=27% Similarity=0.358 Sum_probs=200.8
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
++|++.+.||+|+||.||+|+++ +|+.||||+++... ....+.+.+|+++|++++|+||+++++++.+++..|+||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 46899999999999999999975 58899999987432 233456889999999999999999999999999999999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccC
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 536 (727)
||+.+|+|.+++...+. +.+..+..++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++....
T Consensus 98 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~-- 170 (329)
T PTZ00263 98 EFVVGGELFTHLRKAGR--FPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD-- 170 (329)
T ss_pred cCCCCChHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCC--
Confidence 99999999999876654 78888999999999999999999 999999999999999999999999999975421
Q ss_pred CCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHH
Q 041135 537 SNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEAL 616 (727)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l 616 (727)
.....+|+..|+|||++.+..++.++|||||||+||||++|+.||..... .+.. +.+
T Consensus 171 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~------~~~~-------------~~i 227 (329)
T PTZ00263 171 ----RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP------FRIY-------------EKI 227 (329)
T ss_pred ----CcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH------HHHH-------------HHH
Confidence 11235789999999999999999999999999999999999999965321 0110 111
Q ss_pred HHHHhhcccchhHHHHHHHHHHHHhccCCCCCCC-----HHHHHHHH
Q 041135 617 VDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPR-----MSQVVRAL 658 (727)
Q Consensus 617 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~L 658 (727)
....+ .+.......+.+|+++||+.||++|++ +.+|+++-
T Consensus 228 ~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp 272 (329)
T PTZ00263 228 LAGRL--KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHP 272 (329)
T ss_pred hcCCc--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCC
Confidence 11111 111112234778999999999999996 67877663
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=360.16 Aligned_cols=255 Identities=24% Similarity=0.300 Sum_probs=204.0
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
++|+++++||+|+||.||+|++. +|+.||||+++... ......+.+|+++|..++|+||+++++++.+++..||||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36899999999999999999976 48899999997432 223456889999999999999999999999999999999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccC
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 536 (727)
||+.+|+|.+++..... +.+..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~~~--l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLGV--LSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred eCCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 99999999999976543 78899999999999999999999 999999999999999999999999999975422
Q ss_pred CCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHH
Q 041135 537 SNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEAL 616 (727)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l 616 (727)
.....+|+..|+|||++.+..++.++|||||||+||||++|+.||...... .... .+.. +...
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~---~~~~---~i~~-------~~~~ 216 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN---ETWE---NLKY-------WKET 216 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHH---HHHH---HHHh-------cccc
Confidence 233467899999999999999999999999999999999999999764321 1100 0000 0000
Q ss_pred HHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 617 VDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 617 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
+...............+.+|+.+||..++++|+++.||+++-.
T Consensus 217 ~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~ 259 (333)
T cd05600 217 LQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPF 259 (333)
T ss_pred ccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcc
Confidence 0000000000112345778999999999999999999998743
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=343.32 Aligned_cols=255 Identities=26% Similarity=0.412 Sum_probs=206.6
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeec
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYV 459 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 459 (727)
.+|++.++||+|+||.||+|.++ +++.|++|+++.. .....++.+|+++|++++|+||++++++|..+...++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 45788899999999999999965 4889999998643 334567899999999999999999999999999999999999
Q ss_pred cCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCc
Q 041135 460 PNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNT 539 (727)
Q Consensus 460 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 539 (727)
.+++|.+++.......+.+..++.++.||++||+|||++ +|+|||||++|||+++++.+||+|||+++...... .
T Consensus 85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~--~ 159 (263)
T cd05052 85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--Y 159 (263)
T ss_pred CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccce--e
Confidence 999999999776655689999999999999999999998 99999999999999999999999999997542211 1
Q ss_pred cccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHH
Q 041135 540 HVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVD 618 (727)
Q Consensus 540 ~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d 618 (727)
.......++..|+|||++.+..++.++|||||||+||||++ |..||..... .++.. .+.
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~------~~~~~--------------~~~ 219 (263)
T cd05052 160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------SQVYE--------------LLE 219 (263)
T ss_pred eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHH--------------HHH
Confidence 11112234568999999999999999999999999999998 9999865321 11110 011
Q ss_pred HHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhc
Q 041135 619 SRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661 (727)
Q Consensus 619 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 661 (727)
..............+.+++.+||+.+|++||++.+|++.|+.+
T Consensus 220 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 220 KGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 1111122222345688999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=328.61 Aligned_cols=251 Identities=26% Similarity=0.384 Sum_probs=212.6
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
++|++++.||+|.||.||+|+.+ ++-.||+|++.... .+-...+++|+++.+.|+|+||++++++|.++...||++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 45899999999999999999965 57789999985432 233467999999999999999999999999999999999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccC
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 536 (727)
||..+|.|+..|+......+++.....++.|++.||.|+|.. +|||||||++|+|++.++.+||+|||.+...
T Consensus 102 Eya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~---- 174 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA---- 174 (281)
T ss_pred EecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeec----
Confidence 999999999999977666799999999999999999999999 9999999999999999999999999998642
Q ss_pred CCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHH
Q 041135 537 SNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEAL 616 (727)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l 616 (727)
.......+|||+.|++||...+..++..+|+|++||+.||+|.|..||..... .+.+.++
T Consensus 175 -p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~-------------------~etYkrI 234 (281)
T KOG0580|consen 175 -PSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH-------------------SETYKRI 234 (281)
T ss_pred -CCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh-------------------HHHHHHH
Confidence 23445668999999999999999999999999999999999999999976431 1122222
Q ss_pred HHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhh
Q 041135 617 VDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDT 660 (727)
Q Consensus 617 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 660 (727)
... +-.+.........++|.+|+.++|.+|....|++++-+-
T Consensus 235 ~k~--~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI 276 (281)
T KOG0580|consen 235 RKV--DLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWI 276 (281)
T ss_pred HHc--cccCCcccChhHHHHHHHHhccCccccccHHHHhhhHHH
Confidence 221 112233444557889999999999999999999988653
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=343.25 Aligned_cols=252 Identities=28% Similarity=0.451 Sum_probs=203.2
Q ss_pred cCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeecc
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVP 460 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 460 (727)
++|++.+.||+|+||.||+|++.++..||||.++.. .....+|.+|+.++++++|+||++++++|.+....++||||+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 458889999999999999999877778999998743 3335679999999999999999999999999888999999999
Q ss_pred CCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCcc
Q 041135 461 NDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTH 540 (727)
Q Consensus 461 ~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 540 (727)
+|+|.+++..... .+.+..+++++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++..... ...
T Consensus 83 ~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~--~~~ 156 (256)
T cd05113 83 NGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD--EYT 156 (256)
T ss_pred CCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCC--cee
Confidence 9999999876543 589999999999999999999999 9999999999999999999999999998754221 111
Q ss_pred ccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHH
Q 041135 541 VSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDS 619 (727)
Q Consensus 541 ~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~ 619 (727)
......++..|++||++.+..++.++|||||||+||||++ |+.||..... ..+.+ .+.+.
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~~~----------------~~~~~ 217 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN---SETVE----------------KVSQG 217 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH---HHHHH----------------HHhcC
Confidence 1222345678999999998889999999999999999998 9999865331 11111 00000
Q ss_pred HhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 620 RLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 620 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
............+.+++.+||+.+|++||++.+|++.|+
T Consensus 218 -~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 218 -LRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred -CCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 000111112346889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=355.35 Aligned_cols=268 Identities=21% Similarity=0.355 Sum_probs=199.0
Q ss_pred CccccceeccCCceEEEEEEEc-CCcEEEEEEeeeC--CchhHHHHHHHHHHHHHcCCCCceeEeeEeecc-----ceee
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIG--GSQGEREFRAEVEIISRVHHRHLVSLVGYCISE-----RERL 453 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~-----~~~~ 453 (727)
+|++.++||+|+||.||+|+.. +|+.||||+++.. .......+.+|+++|++++|+||+++++++... ...|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4888999999999999999965 6899999998643 223345688999999999999999999988643 2579
Q ss_pred EEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhh
Q 041135 454 LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIAL 533 (727)
Q Consensus 454 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~ 533 (727)
||||||. ++|.+++..... +++..++.|+.||++||+|||++ +|+|||||++|||++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELME-SDLHQVIKANDD--LTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEecCC-CCHHHHHHhccc--CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 9999995 678888866543 88999999999999999999999 99999999999999999999999999997543
Q ss_pred ccCCCccccccccCCccccccCcccC--CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHH------
Q 041135 534 ELDSNTHVSTRVMGTFGYMAPEYATS--GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLA------ 605 (727)
Q Consensus 534 ~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~------ 605 (727)
............+|+..|+|||++.+ ..++.++|||||||++|||++|+.+|....... ...+....+.
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~---~~~~~~~~~~~~~~~~ 231 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH---QLDLITDLLGTPSPET 231 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH---HHHHHHHHhCCCCHHH
Confidence 22222222344678999999999876 678999999999999999999999997643211 1111100000
Q ss_pred -HhhchhhHHHHHHHHhhccc------chhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 041135 606 -EALEHEDFEALVDSRLEKNY------VDSEMFWMIEAAAACVRHSATKRPRMSQVVRAL 658 (727)
Q Consensus 606 -~~~~~~~~~~l~d~~l~~~~------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 658 (727)
..+.......++........ .......+.+|+.+||+.||++||+++||+++-
T Consensus 232 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp 291 (338)
T cd07859 232 ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADP 291 (338)
T ss_pred HHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCc
Confidence 00001111111111100000 001123467899999999999999999999873
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=363.95 Aligned_cols=261 Identities=24% Similarity=0.370 Sum_probs=204.8
Q ss_pred HhcCccccceeccCCceEEEEEEEcC------CcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcC-CCCceeEeeEeeccc
Q 041135 379 ATNGFSAHNVLGEGGFGCVYKGVLAD------GREVAVKQLKIGGS-QGEREFRAEVEIISRVH-HRHLVSLVGYCISER 450 (727)
Q Consensus 379 ~~~~~~~~~~LG~G~fg~Vy~~~~~~------g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~ 450 (727)
..++|.++++||+|+||.||+|++.. +..||||+++.... ...+.|.+|+++|++++ |+||++++++|.+..
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 35678999999999999999998531 34799999975433 33457999999999996 999999999999999
Q ss_pred eeeEEEeeccCCccchhcccCC----------------------------------------------------------
Q 041135 451 ERLLVYEYVPNDTLHYHLHAEG---------------------------------------------------------- 472 (727)
Q Consensus 451 ~~~lV~Ey~~~gsL~~~L~~~~---------------------------------------------------------- 472 (727)
..|||||||.+|+|.++|+.+.
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 9999999999999998876431
Q ss_pred ------------------------------------CCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEEC
Q 041135 473 ------------------------------------RPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLD 516 (727)
Q Consensus 473 ------------------------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~ 516 (727)
...+++.++++++.||++||+|||++ +|+|||||++||||+
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEe
Confidence 12367888899999999999999998 999999999999999
Q ss_pred CCCcEEEEeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchh
Q 041135 517 SSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDES 595 (727)
Q Consensus 517 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~ 595 (727)
+++.+||+|||+++...... .........++..|+|||++.+..++.++|||||||+||||++ |+.||...... ..
T Consensus 272 ~~~~~kL~DfGla~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~--~~ 348 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDS-NYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD--ST 348 (400)
T ss_pred CCCEEEEEeCCcceeccccc-cccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh--HH
Confidence 99999999999997542211 1111223456788999999999899999999999999999997 99998753211 00
Q ss_pred hHHhhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhcc
Q 041135 596 LVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLD 662 (727)
Q Consensus 596 l~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 662 (727)
+. ..+...............+.+|+.+||+.||++||++.+|++.|+.+.
T Consensus 349 ~~-----------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 349 FY-----------------NKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred HH-----------------HHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 00 001111111111223445889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=360.15 Aligned_cols=266 Identities=20% Similarity=0.283 Sum_probs=199.6
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEee
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 458 (727)
.++|+++++||+|+||.||+++.. +++.||||+.. ...+.+|+++|++|+|+||++++++|..+...++||||
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 367999999999999999999964 58899999753 24578999999999999999999999999999999999
Q ss_pred ccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCC
Q 041135 459 VPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSN 538 (727)
Q Consensus 459 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 538 (727)
+. ++|..++..... +.+.+++.|+.||++||+|||++ +|||||||++||||+.++.+||+|||+++..... .
T Consensus 165 ~~-~~L~~~l~~~~~--l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~--~ 236 (391)
T PHA03212 165 YK-TDLYCYLAAKRN--IAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI--N 236 (391)
T ss_pred CC-CCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccc--c
Confidence 95 678777765543 78999999999999999999999 9999999999999999999999999999743221 1
Q ss_pred ccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCch-hhHHhhHHHHHHhh---------
Q 041135 539 THVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDE-SLVEWARPLLAEAL--------- 608 (727)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~-~l~~~~~~~l~~~~--------- 608 (727)
........||..|+|||++.+..++.++||||||||||||++|+.+|......... ........++....
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 12233467999999999999999999999999999999999999887544322111 00000111111000
Q ss_pred chhhHHHHHHHHhhc---cc--------chhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 609 EHEDFEALVDSRLEK---NY--------VDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 609 ~~~~~~~l~d~~l~~---~~--------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
....+..++...... .. .......+.+|+++||+.||++||+++||+++-.
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~ 378 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAA 378 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChh
Confidence 000111111000000 00 0112335788999999999999999999997644
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=355.74 Aligned_cols=268 Identities=23% Similarity=0.330 Sum_probs=204.9
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEe
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYE 457 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 457 (727)
.++|++.++||+|+||.||+++++ +|..||+|+++.... .....+.+|+++|++++|+||++++++|.+++..+||||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 367999999999999999999976 578899998875433 334578999999999999999999999999999999999
Q ss_pred eccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCC
Q 041135 458 YVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDS 537 (727)
Q Consensus 458 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 537 (727)
|+.+++|.++++..+. +.+..+..++.+|++||.|||+.+ +|+|||||++||||++++.+||+|||+++.....
T Consensus 84 ~~~~~~L~~~l~~~~~--~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-- 157 (333)
T cd06650 84 HMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (333)
T ss_pred cCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence 9999999999976543 788899999999999999999742 6999999999999999999999999999754221
Q ss_pred CccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHH--------------
Q 041135 538 NTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPL-------------- 603 (727)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~-------------- 603 (727)
......|+..|+|||++.+..++.++|||||||++|||++|+.||....... +.......
T Consensus 158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 231 (333)
T cd06650 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKE---LELMFGCPVEGDPAESETSPRP 231 (333)
T ss_pred ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhH---HHHHhcCcccCCccccccCccc
Confidence 1223468899999999999899999999999999999999999997543211 10000000
Q ss_pred ------HHHh-hc---hhhHHHHHHHHhhccc----chhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 604 ------LAEA-LE---HEDFEALVDSRLEKNY----VDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 604 ------l~~~-~~---~~~~~~l~d~~l~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
+... .. ......+.+..+.... .......+.+|+.+||++||++||++.||+++-.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~ 301 (333)
T cd06650 232 RPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAF 301 (333)
T ss_pred CCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHH
Confidence 0000 00 0001111111111110 0012234789999999999999999999987744
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=344.97 Aligned_cols=256 Identities=27% Similarity=0.475 Sum_probs=205.3
Q ss_pred cCccccceeccCCceEEEEEEEcC------CcEEEEEEeeeCCch-hHHHHHHHHHHHHHcCCCCceeEeeEeeccceee
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLAD------GREVAVKQLKIGGSQ-GEREFRAEVEIISRVHHRHLVSLVGYCISERERL 453 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~~------g~~vaVK~l~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 453 (727)
++|.+.+.||+|+||.||+|++.+ ++.||||+++..... ..+.+.+|+++|++++|+||+++++++..+...+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 457888999999999999998643 478999998765444 4568999999999999999999999999999999
Q ss_pred EEEeeccCCccchhcccCC------------CCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcE
Q 041135 454 LVYEYVPNDTLHYHLHAEG------------RPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEA 521 (727)
Q Consensus 454 lV~Ey~~~gsL~~~L~~~~------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~v 521 (727)
+||||+.+++|.++++..+ ...+.+..++.++.||+.||.|||++ +|+|||||++||||+.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence 9999999999999987543 23478889999999999999999999 99999999999999999999
Q ss_pred EEEeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhh
Q 041135 522 RVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWA 600 (727)
Q Consensus 522 kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~ 600 (727)
||+|||+++...... .........++..|+|||++.++.++.++|||||||+||||++ |+.||..... ..+.+.
T Consensus 162 kl~d~g~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~---~~~~~~- 236 (280)
T cd05049 162 KIGDFGMSRDVYTTD-YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN---EEVIEC- 236 (280)
T ss_pred EECCcccceecccCc-ceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHH-
Confidence 999999997542211 1112233456788999999999999999999999999999998 9999865331 111111
Q ss_pred HHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhh
Q 041135 601 RPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDT 660 (727)
Q Consensus 601 ~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 660 (727)
+....+ ..........+.+|+++||+.||++||++.||++.|++
T Consensus 237 ---------------~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 237 ---------------ITQGRL-LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred ---------------HHcCCc-CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 000111 11112233558899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=346.48 Aligned_cols=280 Identities=20% Similarity=0.317 Sum_probs=214.0
Q ss_pred HHHhcCccccceeccCCceEEEEEEEc-CCcEEEEEEee--eCCchhHHHHHHHHHHHHHcCCCCceeEeeEeec-----
Q 041135 377 IQATNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLK--IGGSQGEREFRAEVEIISRVHHRHLVSLVGYCIS----- 448 (727)
Q Consensus 377 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~--~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~----- 448 (727)
......|..++.||+|+||.|+.++.+ +|+.||||++. ..+....+...+|+++|+.++|+||+.+++++.-
T Consensus 18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~ 97 (359)
T KOG0660|consen 18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK 97 (359)
T ss_pred EeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence 344566777899999999999999864 68999999987 5556667788999999999999999999999865
Q ss_pred cceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeecc
Q 041135 449 ERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGL 528 (727)
Q Consensus 449 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGl 528 (727)
-+.+|+|+|+| +.+|.+.++.+.. ++...+..+++||++||.|+|+. +|+|||||+.|+|++.+..+|||||||
T Consensus 98 f~DvYiV~elM-etDL~~iik~~~~--L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 98 FNDVYLVFELM-ETDLHQIIKSQQD--LTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred cceeEEehhHH-hhHHHHHHHcCcc--ccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccc
Confidence 34779999999 7899999987754 89999999999999999999999 999999999999999999999999999
Q ss_pred chhhhccCCCccccccccCCccccccCcccC-CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHH----
Q 041135 529 AKIALELDSNTHVSTRVMGTFGYMAPEYATS-GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPL---- 603 (727)
Q Consensus 529 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~---- 603 (727)
||..... ......+..+.|.+|.|||++.. .+|+.+.||||.||||.|||+|+.-|.+.+......++-...+.
T Consensus 172 AR~~~~~-~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e 250 (359)
T KOG0660|consen 172 ARYLDKF-FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEE 250 (359)
T ss_pred eeecccc-CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHH
Confidence 9976433 33445566788999999999865 57999999999999999999999999887654332222111110
Q ss_pred HHHhhchhhHHHHHHHHhhc---cc---chhHHHHHHHHHHHHhccCCCCCCCHHHHHHH--HhhccC
Q 041135 604 LAEALEHEDFEALVDSRLEK---NY---VDSEMFWMIEAAAACVRHSATKRPRMSQVVRA--LDTLDG 663 (727)
Q Consensus 604 l~~~~~~~~~~~l~d~~l~~---~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~~ 663 (727)
....+........+...-.. .| .....-..++|+++||.+||.+|.+++|.+++ |....+
T Consensus 251 ~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hd 318 (359)
T KOG0660|consen 251 DLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHD 318 (359)
T ss_pred HHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcC
Confidence 00011111111111110000 00 11122247899999999999999999999987 444433
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=354.57 Aligned_cols=243 Identities=23% Similarity=0.324 Sum_probs=196.0
Q ss_pred ceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeeccCC
Q 041135 387 NVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPND 462 (727)
Q Consensus 387 ~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 462 (727)
++||+|+||.||+++.. +|+.||||+++... ......+.+|+++|++++|+||++++++|..++..||||||+.+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999864 68999999997532 233456778999999999999999999999999999999999999
Q ss_pred ccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCcccc
Q 041135 463 TLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVS 542 (727)
Q Consensus 463 sL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 542 (727)
+|..++..+. .+++..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++.... .....
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~---~~~~~ 152 (323)
T cd05595 81 ELFFHLSRER--VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS---DGATM 152 (323)
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccC---CCCcc
Confidence 9998887654 388999999999999999999999 999999999999999999999999999874321 11122
Q ss_pred ccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHhh
Q 041135 543 TRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRLE 622 (727)
Q Consensus 543 ~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l~ 622 (727)
...+|+..|+|||++.++.++.++|||||||+||||++|+.||...+.. .+ .. .+....+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~---~~---~~-------------~~~~~~~- 212 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RL---FE-------------LILMEEI- 212 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH---HH---HH-------------HHhcCCC-
Confidence 3457899999999999999999999999999999999999999754311 00 00 0000000
Q ss_pred cccchhHHHHHHHHHHHHhccCCCCCC-----CHHHHHHHH
Q 041135 623 KNYVDSEMFWMIEAAAACVRHSATKRP-----RMSQVVRAL 658 (727)
Q Consensus 623 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L 658 (727)
.+.......+.+|+++||+.||++|+ ++.+|+++-
T Consensus 213 -~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~ 252 (323)
T cd05595 213 -RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 252 (323)
T ss_pred -CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCC
Confidence 11112234577899999999999998 888888763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=345.16 Aligned_cols=273 Identities=26% Similarity=0.373 Sum_probs=203.8
Q ss_pred cCccccceeccCCceEEEEEEEc-----CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeec--cceee
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-----DGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCIS--ERERL 453 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-----~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~--~~~~~ 453 (727)
++|++++.||+|+||.||+|.++ +++.||||+++.......+.|.+|+++|++++|+||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46888999999999999999753 578999999876666666789999999999999999999998754 34678
Q ss_pred EEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhh
Q 041135 454 LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIAL 533 (727)
Q Consensus 454 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~ 533 (727)
+||||+.+++|.+++.... ..+++..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++...
T Consensus 84 lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 9999999999999986543 2489999999999999999999999 99999999999999999999999999998643
Q ss_pred ccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhH
Q 041135 534 ELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDF 613 (727)
Q Consensus 534 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~ 613 (727)
.............+...|++||++.+..++.++|||||||+||||++|..++...... +.+..............+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE----FMRMMGNDKQGQMIVYHL 235 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh----hhhhcccccccccchHHH
Confidence 2211111112223455699999999989999999999999999999987765432110 000000000000000011
Q ss_pred HHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhc
Q 041135 614 EALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661 (727)
Q Consensus 614 ~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 661 (727)
.+++...............+.+|+.+||+.+|++||++.||++.|+.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 236 IELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 111111111111122334588999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=340.24 Aligned_cols=256 Identities=28% Similarity=0.448 Sum_probs=205.1
Q ss_pred cCccccceeccCCceEEEEEEEcC----CcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLAD----GREVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLV 455 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~~----g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 455 (727)
++|++.++||+|+||.||+|+++. ...||||+++.... ....+|.+|+.+|++++|+||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 468899999999999999999743 45799999875433 3345789999999999999999999999999999999
Q ss_pred EeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhcc
Q 041135 456 YEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALEL 535 (727)
Q Consensus 456 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 535 (727)
|||+.+++|.+++..... .+++..+++++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++.....
T Consensus 84 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 84 TEYMENGSLDKFLRENDG-KFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEcCCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 999999999999876543 589999999999999999999998 9999999999999999999999999999865311
Q ss_pred CCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHH
Q 041135 536 DSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFE 614 (727)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~ 614 (727)
. .........++..|++||.+.+..++.++||||||+++|||++ |+.||..... ..+.+
T Consensus 160 ~-~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~---~~~~~---------------- 219 (266)
T cd05033 160 E-ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN---QDVIK---------------- 219 (266)
T ss_pred c-cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH---HHHHH----------------
Confidence 1 1112223345678999999999899999999999999999998 9999864321 11111
Q ss_pred HHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhc
Q 041135 615 ALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661 (727)
Q Consensus 615 ~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 661 (727)
.+...............+.+|+++||+.+|++||++.||+++|+++
T Consensus 220 -~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 220 -AVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -HHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0000001111122234578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=355.31 Aligned_cols=254 Identities=25% Similarity=0.314 Sum_probs=199.6
Q ss_pred CccccceeccCCceEEEEEEEc----CCcEEEEEEeeeCC----chhHHHHHHHHHHHHHc-CCCCceeEeeEeecccee
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLA----DGREVAVKQLKIGG----SQGEREFRAEVEIISRV-HHRHLVSLVGYCISERER 452 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~----~g~~vaVK~l~~~~----~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~ 452 (727)
+|+++++||+|+||.||+++.. +|+.||||+++... ....+.+.+|+++|+++ +|+||+++++++.+++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4889999999999999999853 57899999986422 22335688899999999 499999999999999999
Q ss_pred eEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhh
Q 041135 453 LLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIA 532 (727)
Q Consensus 453 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~ 532 (727)
+|||||+.+|+|.+++..+.. +.+..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++.+
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDN--FSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 999999999999999876543 88999999999999999999999 9999999999999999999999999999754
Q ss_pred hccCCCccccccccCCccccccCcccCC-CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchh
Q 041135 533 LELDSNTHVSTRVMGTFGYMAPEYATSG-KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHE 611 (727)
Q Consensus 533 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~ 611 (727)
.... .......+|+..|+|||++.+. .++.++||||||||||||++|+.||.......... .....
T Consensus 156 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~--~~~~~--------- 222 (332)
T cd05614 156 LSEE--KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS--EVSRR--------- 222 (332)
T ss_pred cccC--CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH--HHHHH---------
Confidence 2211 1122345799999999999875 47889999999999999999999997543221111 11000
Q ss_pred hHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCC-----CHHHHHHHHh
Q 041135 612 DFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRP-----RMSQVVRALD 659 (727)
Q Consensus 612 ~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L~ 659 (727)
++. ....+.......+.+|+.+||+.||++|+ ++.+++++-+
T Consensus 223 ----~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~ 269 (332)
T cd05614 223 ----ILK--CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPF 269 (332)
T ss_pred ----Hhc--CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCC
Confidence 000 01111222334577899999999999999 7778877643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=347.35 Aligned_cols=266 Identities=23% Similarity=0.332 Sum_probs=199.1
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEee
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 458 (727)
++|++.++||+|+||.||+|+.+ +++.||||+++.... .....+.+|+++|++++|+||+++++++.++...++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56899999999999999999875 588999999875432 2345678999999999999999999999999999999999
Q ss_pred ccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCC
Q 041135 459 VPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSN 538 (727)
Q Consensus 459 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 538 (727)
+.+ +|.+++...+ ..+.+..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||+++.... .
T Consensus 85 ~~~-~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~---~ 156 (288)
T cd07871 85 LDS-DLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSV---P 156 (288)
T ss_pred CCc-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccC---C
Confidence 975 7888776543 2478889999999999999999999 999999999999999999999999999975321 1
Q ss_pred ccccccccCCccccccCcccC-CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHH--------HHhhc
Q 041135 539 THVSTRVMGTFGYMAPEYATS-GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLL--------AEALE 609 (727)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l--------~~~~~ 609 (727)
........|+..|+|||++.+ ..++.++|||||||++|||++|+.+|....... ........+ .....
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07871 157 TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKE---ELHLIFRLLGTPTEETWPGITS 233 (288)
T ss_pred CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCChHHhhcccc
Confidence 112234567899999999876 568999999999999999999999997643211 111110000 00000
Q ss_pred hhhHHHHHHHHhhcc----cchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 610 HEDFEALVDSRLEKN----YVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 610 ~~~~~~l~d~~l~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
...+........... ........+.+|+++||+.||.+|++++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 234 NEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred chhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 011111110000000 001112346799999999999999999999865
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=337.98 Aligned_cols=271 Identities=22% Similarity=0.259 Sum_probs=205.3
Q ss_pred CccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhH--HHHHHHHHHHHHcCCCCceeEeeEeec--cceeeEEE
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGE--REFRAEVEIISRVHHRHLVSLVGYCIS--ERERLLVY 456 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~--~~~~~Ei~~l~~l~HpnIv~l~~~~~~--~~~~~lV~ 456 (727)
.|+.++.|++|.||.||+|+++ +++.||+|+++......- -.-.|||++|.+++|+|||.+-.+... -+.+||||
T Consensus 77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VM 156 (419)
T KOG0663|consen 77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVM 156 (419)
T ss_pred HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeH
Confidence 3677799999999999999965 688999999986543221 346799999999999999999887764 34789999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccC
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 536 (727)
|||+. +|..+|+... ..+...++..++.|+++||+|||.+ .|+|||||++|+|+.+.|.+||+||||||.+.
T Consensus 157 e~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg--- 228 (419)
T KOG0663|consen 157 EYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYG--- 228 (419)
T ss_pred HHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhc---
Confidence 99965 7777776655 3588889999999999999999999 89999999999999999999999999999653
Q ss_pred CCccccccccCCccccccCcccCC-CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhh-------
Q 041135 537 SNTHVSTRVMGTFGYMAPEYATSG-KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEAL------- 608 (727)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~l~~~-~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~------- 608 (727)
......+..+.|++|+|||.|.+. .|+...|+||+|||+.||+.++.-|.+....+..+.+-...+...+.+
T Consensus 229 sp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~l 308 (419)
T KOG0663|consen 229 SPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSEL 308 (419)
T ss_pred CCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcccc
Confidence 233445677889999999999885 599999999999999999999999987654432222211111000000
Q ss_pred ---chhhHHHHHHHHhhcccchh-HHHHHHHHHHHHhccCCCCCCCHHHHHHHHhh
Q 041135 609 ---EHEDFEALVDSRLEKNYVDS-EMFWMIEAAAACVRHSATKRPRMSQVVRALDT 660 (727)
Q Consensus 609 ---~~~~~~~l~d~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 660 (727)
+.-.+....-..++.+|... ....-++|+..+|..||.+|-++.|.+++=..
T Consensus 309 p~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F 364 (419)
T KOG0663|consen 309 PAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYF 364 (419)
T ss_pred chhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccccc
Confidence 00001111112233333332 22446788999999999999999999887443
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=343.83 Aligned_cols=269 Identities=27% Similarity=0.370 Sum_probs=204.7
Q ss_pred ccccceeccCCceEEEEEEE-----cCCcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEeecc--ceeeE
Q 041135 383 FSAHNVLGEGGFGCVYKGVL-----ADGREVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYCISE--RERLL 454 (727)
Q Consensus 383 ~~~~~~LG~G~fg~Vy~~~~-----~~g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~--~~~~l 454 (727)
|+++++||+|+||.||++.+ .+++.||||+++.... .....|.+|+++|++++|+||++++++|... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 48889999999999988753 3578899999875433 3456788999999999999999999998754 35789
Q ss_pred EEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhc
Q 041135 455 VYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALE 534 (727)
Q Consensus 455 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 534 (727)
||||+.+++|.+++... .+++..++.|+.||++||+|||++ +|+|||||++||||++++.+||+|||+++....
T Consensus 86 v~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred EecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 99999999999998654 389999999999999999999999 999999999999999999999999999975432
Q ss_pred cCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHH
Q 041135 535 LDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFE 614 (727)
Q Consensus 535 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~ 614 (727)
............++..|++||++.+..++.++|||||||+||||++|+.||....... ..+..+.. .......+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~----~~~~~~~~~ 234 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQ----GQMTVVRLI 234 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccc----cccchhhhh
Confidence 2111111223345677999999998899999999999999999999999986543210 01111100 001111122
Q ss_pred HHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhcc
Q 041135 615 ALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLD 662 (727)
Q Consensus 615 ~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 662 (727)
.+++..............+.+|+.+||+.+|++||++++|++.|+.+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 235 ELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 222222221122223456889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=338.70 Aligned_cols=253 Identities=30% Similarity=0.459 Sum_probs=203.6
Q ss_pred cCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeecc
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVP 460 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 460 (727)
++|+++++||+|+||.||+|.+.++..||+|.++.... ..+.+.+|+++|++++|+||+++++++. ....++||||+.
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 46888999999999999999988888999999875433 3467999999999999999999999885 456799999999
Q ss_pred CCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCcc
Q 041135 461 NDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTH 540 (727)
Q Consensus 461 ~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 540 (727)
+++|.++++......+++..+++++.||+.||+|||++ +|+|||||++|||+++++.+||+|||+++...... ..
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~--~~ 158 (260)
T cd05070 84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE--YT 158 (260)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcc--cc
Confidence 99999999775555689999999999999999999999 99999999999999999999999999997542211 11
Q ss_pred ccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHH
Q 041135 541 VSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDS 619 (727)
Q Consensus 541 ~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~ 619 (727)
......++..|+|||++.+..++.++|||||||++|||++ |+.||..... ....+ .+..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~~~-----------------~~~~ 218 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN---REVLE-----------------QVER 218 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH---HHHHH-----------------HHHc
Confidence 1122345678999999998899999999999999999999 8899965321 11111 0111
Q ss_pred HhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhh
Q 041135 620 RLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDT 660 (727)
Q Consensus 620 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 660 (727)
.............+.+|+++||..+|++||++.+|++.|++
T Consensus 219 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 219 GYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11111122233458899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=354.01 Aligned_cols=244 Identities=26% Similarity=0.385 Sum_probs=196.3
Q ss_pred cceeccCCceEEEEEEE----cCCcEEEEEEeeeCC----chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEe
Q 041135 386 HNVLGEGGFGCVYKGVL----ADGREVAVKQLKIGG----SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYE 457 (727)
Q Consensus 386 ~~~LG~G~fg~Vy~~~~----~~g~~vaVK~l~~~~----~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 457 (727)
+++||+|+||.||+++. .+|+.||||+++... ......+.+|+++|+.++|+||++++++|.+++..|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 36899999999999985 357899999987432 2233567889999999999999999999999999999999
Q ss_pred eccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCC
Q 041135 458 YVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDS 537 (727)
Q Consensus 458 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 537 (727)
|+.+++|.+++...+. +.+..+..++.||++||+|||++ +|+|||||++||||+.++.+||+|||+++....
T Consensus 81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--- 152 (323)
T cd05584 81 YLSGGELFMHLEREGI--FMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIH--- 152 (323)
T ss_pred CCCCchHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeeccc---
Confidence 9999999999876553 77888899999999999999999 999999999999999999999999999874321
Q ss_pred CccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHH
Q 041135 538 NTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALV 617 (727)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~ 617 (727)
........+|+..|+|||++.+..++.++|||||||+||||++|+.||..... .+. +..++
T Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~------~~~-------------~~~~~ 213 (323)
T cd05584 153 EGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR------KKT-------------IDKIL 213 (323)
T ss_pred CCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH------HHH-------------HHHHH
Confidence 11223345789999999999998899999999999999999999999975431 011 11111
Q ss_pred HHHhhcccchhHHHHHHHHHHHHhccCCCCCC-----CHHHHHHHH
Q 041135 618 DSRLEKNYVDSEMFWMIEAAAACVRHSATKRP-----RMSQVVRAL 658 (727)
Q Consensus 618 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L 658 (727)
...+ .........+.+|+++||+.||++|+ ++.+++++-
T Consensus 214 ~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~ 257 (323)
T cd05584 214 KGKL--NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHP 257 (323)
T ss_pred cCCC--CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCC
Confidence 1111 11112234578999999999999999 888887763
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=337.89 Aligned_cols=267 Identities=24% Similarity=0.342 Sum_probs=218.8
Q ss_pred cHHHHHHHhcCccccceeccCCceEEEEEEEcC------CcEEEEEEeeeCCchhH-HHHHHHHHHHHHcCCCCceeEee
Q 041135 372 TYDELIQATNGFSAHNVLGEGGFGCVYKGVLAD------GREVAVKQLKIGGSQGE-REFRAEVEIISRVHHRHLVSLVG 444 (727)
Q Consensus 372 ~~~el~~~~~~~~~~~~LG~G~fg~Vy~~~~~~------g~~vaVK~l~~~~~~~~-~~~~~Ei~~l~~l~HpnIv~l~~ 444 (727)
...++.....++++..++-+|.||+||+|+|.+ .+.|.||.++....+.. ..|+.|..+|..+.|+|++.+.+
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 345566667789999999999999999997653 45688898876655443 56889999999999999999999
Q ss_pred Eeeccc-eeeEEEeeccCCccchhccc------CCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECC
Q 041135 445 YCISER-ERLLVYEYVPNDTLHYHLHA------EGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDS 517 (727)
Q Consensus 445 ~~~~~~-~~~lV~Ey~~~gsL~~~L~~------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~ 517 (727)
++.++. ..+++|.++.-|+|..||.. +..+.++..+++.++.|++.||+|||++ +|||.||.++|++||+
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDD 431 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehh
Confidence 998654 55889999999999999972 2234577888999999999999999999 9999999999999999
Q ss_pred CCcEEEEeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhh
Q 041135 518 SFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESL 596 (727)
Q Consensus 518 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l 596 (727)
..++||+|-.|+|+++..|.. ....+.....+||++|.+.+..|+.++|||||||+||||++ |+.||...++.
T Consensus 432 ~LqVkltDsaLSRDLFP~DYh-cLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf----- 505 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYH-CLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF----- 505 (563)
T ss_pred heeEEeccchhccccCccccc-ccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH-----
Confidence 999999999999988665543 33445567889999999999999999999999999999999 99999765432
Q ss_pred HHhhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhcc
Q 041135 597 VEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLD 662 (727)
Q Consensus 597 ~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 662 (727)
+++..+....+.....++..+|+.+|.-||..+|++||++.|++..|.++.
T Consensus 506 ---------------Em~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 506 ---------------EMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred ---------------HHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 223333333333334455667899999999999999999999999998764
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=338.45 Aligned_cols=250 Identities=25% Similarity=0.412 Sum_probs=201.4
Q ss_pred CccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeeccC
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPN 461 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 461 (727)
+|++.+.||+|+||.||+|+++++..+|||+++... ....++.+|++++++++|+||+++++++.+....++||||+.+
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 478889999999999999998877889999986432 3345788999999999999999999999999999999999999
Q ss_pred CccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCccc
Q 041135 462 DTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHV 541 (727)
Q Consensus 462 gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 541 (727)
++|.++++.+.. .+++..++.++.||++||+|||++ +|+|||||++|||+++++.+||+|||+++...+. ....
T Consensus 84 ~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~--~~~~ 157 (256)
T cd05059 84 GCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD--QYTS 157 (256)
T ss_pred CCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccc--cccc
Confidence 999999876543 589999999999999999999999 9999999999999999999999999999754221 1111
Q ss_pred cccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHH
Q 041135 542 STRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSR 620 (727)
Q Consensus 542 ~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~ 620 (727)
.....++..|++||++.+..++.++|||||||+||||++ |+.||..... ....+. +...
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~-----------------~~~~ 217 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN---SEVVES-----------------VSAG 217 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH---HHHHHH-----------------HHcC
Confidence 112234568999999999999999999999999999999 8999975321 111100 0001
Q ss_pred hhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 041135 621 LEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRAL 658 (727)
Q Consensus 621 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 658 (727)
............+.+|+.+||..+|++||++.||++.|
T Consensus 218 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 218 YRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 11111122344688999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=339.45 Aligned_cols=254 Identities=26% Similarity=0.434 Sum_probs=205.5
Q ss_pred hcCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeec
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYV 459 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 459 (727)
.++|+++++||+|+||.||+|..++++.||||.+.... ....+|.+|+++|++++|+||+++++++. .+..++||||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 45789999999999999999999889999999987433 33567999999999999999999999874 45689999999
Q ss_pred cCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCc
Q 041135 460 PNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNT 539 (727)
Q Consensus 460 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 539 (727)
.+++|.+++.......+++.+++.++.||+.||+|||++ +|+|||||++||+|++++.++|+|||+++.... ...
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~--~~~ 157 (260)
T cd05067 83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIED--NEY 157 (260)
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCC--CCc
Confidence 999999998766555689999999999999999999998 999999999999999999999999999975421 111
Q ss_pred cccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHH
Q 041135 540 HVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVD 618 (727)
Q Consensus 540 ~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d 618 (727)
.......++..|++||++.+..++.++|||||||++|||++ |+.||..... ..+.+. +.
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~-----------------~~ 217 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN---PEVIQN-----------------LE 217 (260)
T ss_pred ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh---HHHHHH-----------------HH
Confidence 11223446778999999998889999999999999999999 9999975431 111110 11
Q ss_pred HHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhh
Q 041135 619 SRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDT 660 (727)
Q Consensus 619 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 660 (727)
..............+.+++.+||+.+|++||++++|++.|+.
T Consensus 218 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 218 RGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 111111112223458899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=353.64 Aligned_cols=243 Identities=26% Similarity=0.350 Sum_probs=196.4
Q ss_pred ceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeeccCC
Q 041135 387 NVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPND 462 (727)
Q Consensus 387 ~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 462 (727)
++||+|+||.||+++.. +|+.||||+++... ......+.+|+++|+.++|+||+++++++.+++..||||||+.+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999864 58999999997432 233457889999999999999999999999999999999999999
Q ss_pred ccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCcccc
Q 041135 463 TLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVS 542 (727)
Q Consensus 463 sL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 542 (727)
+|..++.... .+.+..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++.... .....
T Consensus 81 ~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~---~~~~~ 152 (328)
T cd05593 81 ELFFHLSRER--VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT---DAATM 152 (328)
T ss_pred CHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCC---ccccc
Confidence 9998887654 388999999999999999999999 999999999999999999999999999874321 11122
Q ss_pred ccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHhh
Q 041135 543 TRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRLE 622 (727)
Q Consensus 543 ~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l~ 622 (727)
...+|+..|+|||++.+..++.++|||||||+||||++|+.||..... . +....+. ...
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~---~---~~~~~~~-----~~~---------- 211 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---E---KLFELIL-----MED---------- 211 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH---H---HHHHHhc-----cCC----------
Confidence 345799999999999999999999999999999999999999965321 1 1111000 000
Q ss_pred cccchhHHHHHHHHHHHHhccCCCCCC-----CHHHHHHHH
Q 041135 623 KNYVDSEMFWMIEAAAACVRHSATKRP-----RMSQVVRAL 658 (727)
Q Consensus 623 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L 658 (727)
..+.......+.+|+++||+.||++|+ ++.||+++-
T Consensus 212 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~ 252 (328)
T cd05593 212 IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHS 252 (328)
T ss_pred ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCC
Confidence 011112233477899999999999997 899998763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=351.65 Aligned_cols=240 Identities=25% Similarity=0.348 Sum_probs=193.6
Q ss_pred eccCCceEEEEEEEc-CCcEEEEEEeeeC---CchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeeccCCcc
Q 041135 389 LGEGGFGCVYKGVLA-DGREVAVKQLKIG---GSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPNDTL 464 (727)
Q Consensus 389 LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL 464 (727)
||+|+||.||+|++. +++.||||+++.. .......+.+|+++|++++|+||++++++|.+++..||||||+.+|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999975 5789999998643 223345688999999999999999999999999999999999999999
Q ss_pred chhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCcccccc
Q 041135 465 HYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTR 544 (727)
Q Consensus 465 ~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 544 (727)
.+++..++. +++..++.++.||++||+|||++ +|+|||||++||||+.++.+||+|||+++.... .......
T Consensus 81 ~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~---~~~~~~~ 152 (312)
T cd05585 81 FHHLQREGR--FDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMK---DDDKTNT 152 (312)
T ss_pred HHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCcc---CCCcccc
Confidence 999976554 88999999999999999999999 999999999999999999999999999975321 1122334
Q ss_pred ccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHhhcc
Q 041135 545 VMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRLEKN 624 (727)
Q Consensus 545 ~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~ 624 (727)
.+|+..|+|||++.+..++.++|||||||+||||++|+.||.... ..++...+ +...+ .
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~------~~~~~~~~-------------~~~~~--~ 211 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN------VNEMYRKI-------------LQEPL--R 211 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC------HHHHHHHH-------------HcCCC--C
Confidence 679999999999999999999999999999999999999997532 11111111 11111 1
Q ss_pred cchhHHHHHHHHHHHHhccCCCCCCC---HHHHHHH
Q 041135 625 YVDSEMFWMIEAAAACVRHSATKRPR---MSQVVRA 657 (727)
Q Consensus 625 ~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~ 657 (727)
+.......+.+|+.+||+.||++|++ +.|++++
T Consensus 212 ~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 212 FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred CCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 11222345778999999999999986 5565554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=342.54 Aligned_cols=256 Identities=27% Similarity=0.476 Sum_probs=202.3
Q ss_pred cCccccceeccCCceEEEEEEE-----cCCcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVL-----ADGREVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLL 454 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~-----~~g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 454 (727)
++|++.++||+|+||.||+|++ .+++.|+||.++.... +....+.+|+++|++++|+||+++++++..+...|+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4588889999999999999985 2467899999874333 334678999999999999999999999999999999
Q ss_pred EEeeccCCccchhcccCC---------------CCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCC
Q 041135 455 VYEYVPNDTLHYHLHAEG---------------RPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSF 519 (727)
Q Consensus 455 V~Ey~~~gsL~~~L~~~~---------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~ 519 (727)
||||+.+++|.+++..+. ...+++..++.++.||+.||+|||++ +|+|||||++||||++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 999999999999885322 23478888999999999999999999 999999999999999999
Q ss_pred cEEEEeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHH
Q 041135 520 EARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVE 598 (727)
Q Consensus 520 ~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~ 598 (727)
.+||+|||+++...... .........++..|++||++.+..++.++|||||||+||||++ |..||..... ..+.+
T Consensus 162 ~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~---~~~~~ 237 (283)
T cd05090 162 HVKISDLGLSREIYSAD-YYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN---QEVIE 237 (283)
T ss_pred cEEeccccccccccCCc-ceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHH
Confidence 99999999997543221 1112233446778999999998889999999999999999998 9889865321 11111
Q ss_pred hhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhh
Q 041135 599 WARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDT 660 (727)
Q Consensus 599 ~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 660 (727)
. ++..............+.+++.+||+.||++||++.+|+++|++
T Consensus 238 ~-----------------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 238 M-----------------VRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred H-----------------HHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1 11000011112223457889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=359.57 Aligned_cols=254 Identities=25% Similarity=0.291 Sum_probs=204.3
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
++|+++++||+|+||.||+|+.. +|+.||||+++... ......+.+|+++|..++|+||++++++|.+++..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46899999999999999999975 68999999997432 233457889999999999999999999999999999999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccC
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 536 (727)
||+.+++|.+++.... .+.+..++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 81 EYMPGGDLMNLLIRKD--VFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred cCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 9999999999997763 488999999999999999999998 99999999999999999999999999997543221
Q ss_pred C--------------------------CccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCC
Q 041135 537 S--------------------------NTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQP 590 (727)
Q Consensus 537 ~--------------------------~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~ 590 (727)
. .........|+..|+|||++.+..++.++||||||||||||++|+.||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 0 01122345789999999999999999999999999999999999999976431
Q ss_pred CCchhhHHhhHHHHHHhhchhhHHHHHH--HHhhcccchhHHHHHHHHHHHHhccCCCCCCC-HHHHHHHHh
Q 041135 591 LGDESLVEWARPLLAEALEHEDFEALVD--SRLEKNYVDSEMFWMIEAAAACVRHSATKRPR-MSQVVRALD 659 (727)
Q Consensus 591 ~~~~~l~~~~~~~l~~~~~~~~~~~l~d--~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~L~ 659 (727)
. +... .++. ..+...........+.+|+++||. ||++|++ ++||+++..
T Consensus 236 ~------~~~~-------------~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~ 287 (350)
T cd05573 236 Q------ETYN-------------KIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPF 287 (350)
T ss_pred H------HHHH-------------HHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCC
Confidence 1 1111 1111 011111111123457788999997 9999999 999998744
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=338.11 Aligned_cols=254 Identities=28% Similarity=0.429 Sum_probs=203.4
Q ss_pred cCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeecc
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVP 460 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 460 (727)
++|+++++||+|+||.||+|++.++..||||+++... ...+.|.+|++++++++|+||+++++++.+ ...++||||+.
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCC
Confidence 4589999999999999999998777789999987433 234578999999999999999999998754 55799999999
Q ss_pred CCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCcc
Q 041135 461 NDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTH 540 (727)
Q Consensus 461 ~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 540 (727)
+|+|.++++......+++..++.++.||++||+|||+. +|+|||||++|||+++++.+||+|||+++...... ..
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~--~~ 158 (262)
T cd05071 84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE--YT 158 (262)
T ss_pred CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccc--cc
Confidence 99999999765545688999999999999999999999 99999999999999999999999999997542211 11
Q ss_pred ccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHH
Q 041135 541 VSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDS 619 (727)
Q Consensus 541 ~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~ 619 (727)
......++..|++||++.++.++.++|||||||++|||++ |+.||..... ..+ .... ..
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~---~~~-------~~~~----------~~ 218 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REV-------LDQV----------ER 218 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh---HHH-------HHHH----------hc
Confidence 1223446778999999998899999999999999999999 8888865321 110 0000 00
Q ss_pred HhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhc
Q 041135 620 RLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661 (727)
Q Consensus 620 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 661 (727)
.............+.+|+.+||+.+|++||++.++++.|+..
T Consensus 219 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 219 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 000111122345578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=344.50 Aligned_cols=259 Identities=26% Similarity=0.460 Sum_probs=207.8
Q ss_pred cCccccceeccCCceEEEEEEEc------CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA------DGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLL 454 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 454 (727)
++|.+.++||+|+||.||+|+.. ++..|++|.++.......+.+.+|++++++++|+||+++++++.+....++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 35888899999999999999753 345689999876655556789999999999999999999999999999999
Q ss_pred EEeeccCCccchhcccCC--------------CCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCc
Q 041135 455 VYEYVPNDTLHYHLHAEG--------------RPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFE 520 (727)
Q Consensus 455 V~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~ 520 (727)
||||+.+++|.+++..+. ...+++..++.++.||+.||+|||++ +|+|||||++||||++++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence 999999999999986532 23478999999999999999999999 9999999999999999999
Q ss_pred EEEEeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHh
Q 041135 521 ARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEW 599 (727)
Q Consensus 521 vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~ 599 (727)
+||+|||+++...... .........++..|+|||++.+..++.++|||||||+||||++ |+.||..... ..+.+.
T Consensus 162 ~~l~dfg~a~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~~~~~~ 237 (291)
T cd05094 162 VKIGDFGMSRDVYSTD-YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN---TEVIEC 237 (291)
T ss_pred EEECCCCcccccCCCc-eeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH
Confidence 9999999997543211 1122233456788999999999999999999999999999998 9999865431 111110
Q ss_pred hHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 600 ARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 600 ~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
+....+ ..........+.+|+.+||+.+|++||++++|++.|+++..
T Consensus 238 ----------------~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 238 ----------------ITQGRV-LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred ----------------HhCCCC-CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 001101 01111223458899999999999999999999999998843
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=342.54 Aligned_cols=257 Identities=25% Similarity=0.454 Sum_probs=202.4
Q ss_pred HhcCccccceeccCCceEEEEEEEc------CCcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEeeccce
Q 041135 379 ATNGFSAHNVLGEGGFGCVYKGVLA------DGREVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYCISERE 451 (727)
Q Consensus 379 ~~~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~ 451 (727)
..++|++.++||+|+||.||+|++. .+..||||+++.... ....+|.+|+.+++.++|+||++++++|.++..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567999999999999999999753 246799999864332 344578999999999999999999999999999
Q ss_pred eeEEEeeccCCccchhcccCC--------CCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEE
Q 041135 452 RLLVYEYVPNDTLHYHLHAEG--------RPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARV 523 (727)
Q Consensus 452 ~~lV~Ey~~~gsL~~~L~~~~--------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL 523 (727)
.++||||+.+++|.++++... ...+++..++.++.||++||+|||+. +|+|||||++||||++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEE
Confidence 999999999999999886532 12357888999999999999999998 9999999999999999999999
Q ss_pred EeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHH
Q 041135 524 ADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARP 602 (727)
Q Consensus 524 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~ 602 (727)
+|||+++....... ........++..|+|||++.++.++.++|||||||+||||++ |..||..... ....++
T Consensus 161 ~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~---~~~~~~--- 233 (277)
T cd05062 161 GDFGMTRDIYETDY-YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN---EQVLRF--- 233 (277)
T ss_pred CCCCCccccCCcce-eecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH---
Confidence 99999975422111 111222355788999999999899999999999999999999 7888865321 111110
Q ss_pred HHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 603 LLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 603 ~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
+.+..+ ..........+.+|+.+||+.+|++||++.||++.|+
T Consensus 234 -------------~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 234 -------------VMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred -------------HHcCCc-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 000000 0112223446889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=354.30 Aligned_cols=260 Identities=26% Similarity=0.395 Sum_probs=202.3
Q ss_pred hcCccccceeccCCceEEEEEEEc------CCcEEEEEEeeeCCc-hhHHHHHHHHHHHHHc-CCCCceeEeeEeecc-c
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA------DGREVAVKQLKIGGS-QGEREFRAEVEIISRV-HHRHLVSLVGYCISE-R 450 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~-~ 450 (727)
.++|+++++||+|+||.||+|++. .++.||||+++.... ...+.+.+|++++.++ +|+||++++++|... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 356899999999999999999742 247899999875432 2335688899999999 799999999988754 5
Q ss_pred eeeEEEeeccCCccchhcccCC----------------------------------------------------------
Q 041135 451 ERLLVYEYVPNDTLHYHLHAEG---------------------------------------------------------- 472 (727)
Q Consensus 451 ~~~lV~Ey~~~gsL~~~L~~~~---------------------------------------------------------- 472 (727)
.+++||||+.+++|.++|....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 6789999999999998875422
Q ss_pred -CCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCccccccccCCccc
Q 041135 473 -RPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGY 551 (727)
Q Consensus 473 -~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y 551 (727)
...+++..+++++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++.+.... .........++..|
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~-~~~~~~~~~~~~~y 241 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDP-DYVRKGDARLPLKW 241 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCc-chhhccCCCCCccc
Confidence 12578999999999999999999999 99999999999999999999999999998653211 11112234567789
Q ss_pred cccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHhhcccchhHH
Q 041135 552 MAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEM 630 (727)
Q Consensus 552 ~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~ 630 (727)
+|||++.+..++.++|||||||+||||++ |+.||...... +.+.. .+.............
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~--~~~~~-----------------~~~~~~~~~~~~~~~ 302 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID--EEFCR-----------------RLKEGTRMRAPEYAT 302 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc--HHHHH-----------------HHhccCCCCCCccCC
Confidence 99999999999999999999999999998 99999753221 11100 111111111112223
Q ss_pred HHHHHHHHHHhccCCCCCCCHHHHHHHHhhcc
Q 041135 631 FWMIEAAAACVRHSATKRPRMSQVVRALDTLD 662 (727)
Q Consensus 631 ~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 662 (727)
..+.+|+.+||+.+|++||++.||+++|+.+.
T Consensus 303 ~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~ 334 (337)
T cd05054 303 PEIYSIMLDCWHNNPEDRPTFSELVEILGDLL 334 (337)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 45889999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=357.32 Aligned_cols=203 Identities=25% Similarity=0.365 Sum_probs=175.4
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
++|+++++||+|+||.||+|+.. +|+.||||+++... ......+++|+++|.+++|+||+++++++.++...||||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46899999999999999999865 58899999997432 223356889999999999999999999999999999999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccC
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 536 (727)
||+.||+|.+++..++. +++..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++.+....
T Consensus 81 E~~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 81 EFLPGGDMMTLLMKKDT--LTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred cCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 99999999999976554 89999999999999999999999 99999999999999999999999999987532111
Q ss_pred CC--------------------------------ccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCC
Q 041135 537 SN--------------------------------THVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKP 584 (727)
Q Consensus 537 ~~--------------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~P 584 (727)
.. .......+||..|+|||++.+..++.++|||||||+||||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 00 0011235799999999999999999999999999999999999999
Q ss_pred CCCC
Q 041135 585 VDAS 588 (727)
Q Consensus 585 f~~~ 588 (727)
|...
T Consensus 236 f~~~ 239 (363)
T cd05628 236 FCSE 239 (363)
T ss_pred CCCC
Confidence 9754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=341.30 Aligned_cols=256 Identities=28% Similarity=0.443 Sum_probs=201.7
Q ss_pred hcCccccceeccCCceEEEEEEEcC------CcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEeecccee
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLAD------GREVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYCISERER 452 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~~------g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 452 (727)
.++|++.++||+|+||.||+|.+.+ +..|++|.+..... .....|.+|+.++++++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 3568899999999999999998753 56789998864433 3345799999999999999999999999999899
Q ss_pred eEEEeeccCCccchhcccCCC-----CcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCC---cEEEE
Q 041135 453 LLVYEYVPNDTLHYHLHAEGR-----PVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSF---EARVA 524 (727)
Q Consensus 453 ~lV~Ey~~~gsL~~~L~~~~~-----~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~---~vkL~ 524 (727)
++||||+.+++|.++++.... ..+++..+++++.||++||+|||++ +|+|||||++|||++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEec
Confidence 999999999999999865432 2589999999999999999999999 999999999999998654 69999
Q ss_pred eeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHH
Q 041135 525 DFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPL 603 (727)
Q Consensus 525 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~ 603 (727)
|||+++....... .........+..|++||++.+..++.++|||||||+||||++ |+.||..... ..+.
T Consensus 162 dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~---~~~~------ 231 (277)
T cd05036 162 DFGMARDIYRASY-YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN---QEVM------ 231 (277)
T ss_pred cCccccccCCccc-eecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHH------
Confidence 9999986421111 111122334568999999999999999999999999999997 9999975432 1110
Q ss_pred HHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 604 LAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 604 l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
+.+.......+.......+.+|+++||+.+|++||++.+|+++|+
T Consensus 232 -----------~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 232 -----------EFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred -----------HHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 111111111122223345789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=337.01 Aligned_cols=258 Identities=21% Similarity=0.346 Sum_probs=205.2
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
++|++.++||+|+||.||+|+.. +|+.||||.++... ......+.+|+++|+.++|+||+++++++.+.+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 46899999999999999999964 68999999886422 233456889999999999999999999999999999999
Q ss_pred eeccCCccchhcccC--CCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhc
Q 041135 457 EYVPNDTLHYHLHAE--GRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALE 534 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 534 (727)
||+.+++|.+++... ....+.+..++.++.||++||+|||++ +|+|||||++||||+.++.++|+|||+++....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 999999999887532 233578889999999999999999999 999999999999999999999999999875422
Q ss_pred cCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHH
Q 041135 535 LDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFE 614 (727)
Q Consensus 535 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~ 614 (727)
. ........|+..|+|||++.+..++.++|||||||++|||++|+.||...... ..++...+ ..
T Consensus 159 ~---~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~----~~~~~~~~-----~~---- 222 (267)
T cd08228 159 K---TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LFSLCQKI-----EQ---- 222 (267)
T ss_pred h---hHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc----HHHHHHHH-----hc----
Confidence 1 11122356888999999999888999999999999999999999998643211 11111100 00
Q ss_pred HHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhc
Q 041135 615 ALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661 (727)
Q Consensus 615 ~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 661 (727)
..............+.+++.+||+.+|++||++.+|++.|+++
T Consensus 223 ----~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 223 ----CDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred ----CCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 0000001112234588999999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=354.72 Aligned_cols=251 Identities=23% Similarity=0.339 Sum_probs=211.3
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc--hhHHHHHHHHHHHHHcCCCCceeEeeEeeccce-eeEEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS--QGEREFRAEVEIISRVHHRHLVSLVGYCISERE-RLLVY 456 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~-~~lV~ 456 (727)
++|..+++||+|+||.+++.+++ ++..|++|.++.... ...+...+|+.++++++|+|||.+++.|.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 46888899999999999999865 578999999976542 334568899999999999999999999999888 89999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccC
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 536 (727)
+||+||+|.+.+.+..+..+.++.+++++.||+.||.|||++ +|+|||||..|||++.++.|||.|||+|+.....
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~- 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE- 159 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCc-
Confidence 999999999999888777899999999999999999999998 9999999999999999999999999999975332
Q ss_pred CCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHH
Q 041135 537 SNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEAL 616 (727)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l 616 (727)
......+.||..||.||++.+..|+.|+|||||||++|||++-+..|.+.+.. .+ +.++
T Consensus 160 --~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~---~L----------------i~ki 218 (426)
T KOG0589|consen 160 --DSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS---EL----------------ILKI 218 (426)
T ss_pred --hhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH---HH----------------HHHH
Confidence 23455688999999999999999999999999999999999999999875421 11 1111
Q ss_pred HHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 617 VDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 617 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
+... ...........+..|++.||+.+|+.||++.+|+.+
T Consensus 219 ~~~~-~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 219 NRGL-YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred hhcc-CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1111 111223344557889999999999999999999887
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=359.56 Aligned_cols=255 Identities=23% Similarity=0.298 Sum_probs=199.6
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
++|+++++||+|+||.||+|+.. +|+.||||+++... ......+++|+++|+.++|+||++++++|.++...||||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46899999999999999999975 58999999997432 233456889999999999999999999999999999999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccC
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 536 (727)
||+.+|+|.+++..++. +.+..+..|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++.+....
T Consensus 81 E~~~~g~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 81 EYLPGGDMMTLLMKKDT--FTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred CCCCCcHHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 99999999999876553 89999999999999999999999 99999999999999999999999999987532111
Q ss_pred CCc-----------------------------------cccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhC
Q 041135 537 SNT-----------------------------------HVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITG 581 (727)
Q Consensus 537 ~~~-----------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG 581 (727)
... ......+||..|+|||++.+..++.++|||||||+||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 000 011124699999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCC---HHHHHHHH
Q 041135 582 RKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPR---MSQVVRAL 658 (727)
Q Consensus 582 ~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~L 658 (727)
+.||...... +....++ ... ..+...........+.+|+++||. ++.+|++ +.||+++-
T Consensus 236 ~~Pf~~~~~~------~~~~~i~----~~~-------~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~ 297 (364)
T cd05599 236 YPPFCSDNPQ------ETYRKII----NWK-------ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHP 297 (364)
T ss_pred CCCCCCCCHH------HHHHHHH----cCC-------CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCC
Confidence 9999754321 1111000 000 000000000112346788888986 8999998 88888764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=355.53 Aligned_cols=246 Identities=24% Similarity=0.318 Sum_probs=200.0
Q ss_pred cCccccceeccCCceEEEEEEEcC--CcEEEEEEeeeCC---chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLAD--GREVAVKQLKIGG---SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLV 455 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~~--g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 455 (727)
++|++.+.||+|+||.||+|++++ +..||||++.... ....+.+.+|+++|+.++|+||++++++|.+++..|||
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 458899999999999999998643 3689999986432 23345688999999999999999999999999999999
Q ss_pred EeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhcc
Q 041135 456 YEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALEL 535 (727)
Q Consensus 456 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 535 (727)
|||+.+|+|.+++..+.. +.+..+..++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++....
T Consensus 110 ~Ey~~~g~L~~~i~~~~~--~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~- 183 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNKR--FPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT- 183 (340)
T ss_pred EeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCC-
Confidence 999999999999977654 88999999999999999999999 999999999999999999999999999975321
Q ss_pred CCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHH
Q 041135 536 DSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEA 615 (727)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~ 615 (727)
.....+|+..|+|||++.+..++.++|||||||+||||++|+.||...... .+ +..
T Consensus 184 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~---~~----------------~~~ 239 (340)
T PTZ00426 184 -----RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL---LI----------------YQK 239 (340)
T ss_pred -----CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH---HH----------------HHH
Confidence 123457899999999999988999999999999999999999999754311 00 001
Q ss_pred HHHHHhhcccchhHHHHHHHHHHHHhccCCCCCC-----CHHHHHHHH
Q 041135 616 LVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRP-----RMSQVVRAL 658 (727)
Q Consensus 616 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L 658 (727)
+.+..+ .+.......+.+++++||+.|+++|. +++||+++-
T Consensus 240 i~~~~~--~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp 285 (340)
T PTZ00426 240 ILEGII--YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHP 285 (340)
T ss_pred HhcCCC--CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCC
Confidence 111110 11111223467899999999999995 899988763
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=360.31 Aligned_cols=255 Identities=22% Similarity=0.269 Sum_probs=196.0
Q ss_pred CccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEe
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYE 457 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 457 (727)
.|+++++||+|+||.||+|++. +++.||||+++... ......+++|+++|++++|+||++++++|.+.+.+|||||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5888999999999999999864 58899999997532 2334578899999999999999999999999999999999
Q ss_pred eccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCC
Q 041135 458 YVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDS 537 (727)
Q Consensus 458 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 537 (727)
|+.+|+|.+++..... +.+..+..++.||+.||+|||++ +|+|||||++||||+.++++||+|||+++.+.....
T Consensus 82 ~~~gg~L~~~l~~~~~--~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 82 YIPGGDMMSLLIRMEV--FPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred cCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 9999999999876554 78888999999999999999999 999999999999999999999999999863311000
Q ss_pred C--------------------------------------------ccccccccCCccccccCcccCCCCCchhHHHHHhH
Q 041135 538 N--------------------------------------------THVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGV 573 (727)
Q Consensus 538 ~--------------------------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gv 573 (727)
. .......+||..|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 0 00112357999999999999989999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHH--HhccCCCCCCCH
Q 041135 574 VLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAA--CVRHSATKRPRM 651 (727)
Q Consensus 574 il~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~--cl~~dP~~RPs~ 651 (727)
|||||++|+.||....... . ...++ .. ...+...........+.+|+.+ |+..++.+|+++
T Consensus 237 il~elltG~~Pf~~~~~~~--~----~~~i~----~~-------~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~ 299 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTE--T----QLKVI----NW-------ENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGA 299 (381)
T ss_pred HHHHHHhCCCCCcCCCHHH--H----HHHHH----cc-------ccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCH
Confidence 9999999999997643210 0 00000 00 0000000000112335566666 455566679999
Q ss_pred HHHHHHH
Q 041135 652 SQVVRAL 658 (727)
Q Consensus 652 ~evl~~L 658 (727)
.||+++-
T Consensus 300 ~~~l~hp 306 (381)
T cd05626 300 DDIKAHP 306 (381)
T ss_pred HHHhcCc
Confidence 9999874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=337.63 Aligned_cols=257 Identities=27% Similarity=0.463 Sum_probs=203.5
Q ss_pred cCccccceeccCCceEEEEEEEcC-C---cEEEEEEeeeCC-chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLAD-G---REVAVKQLKIGG-SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLV 455 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~~-g---~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 455 (727)
++|+..++||+|+||.||+|++.. + ..|+||+++... ....+++.+|++++++++|+||+++++++.+.+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 357788999999999999999752 3 379999987543 33456789999999999999999999999999999999
Q ss_pred EeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhcc
Q 041135 456 YEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALEL 535 (727)
Q Consensus 456 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 535 (727)
|||+.+++|.++++.+. ..+++..++.++.|++.||+|||++ +|+|||||++|||+++++.+||+|||+++.....
T Consensus 85 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 85 TEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 99999999999987643 2488999999999999999999999 9999999999999999999999999999754322
Q ss_pred CCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHH
Q 041135 536 DSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFE 614 (727)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~ 614 (727)
............+..|++||++.++.++.++|||||||+||||++ |+.||..... . ++...
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~---~---~~~~~------------ 222 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN---H---EVMKA------------ 222 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH---H---HHHHH------------
Confidence 211111112233567999999998899999999999999999997 9999965321 1 11110
Q ss_pred HHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhc
Q 041135 615 ALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661 (727)
Q Consensus 615 ~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 661 (727)
+...............+.+++.+||+.+|++||++.+|++.|+++
T Consensus 223 --i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 223 --INDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred --HhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 111111111222344578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=342.96 Aligned_cols=263 Identities=25% Similarity=0.354 Sum_probs=196.1
Q ss_pred cCccccceeccCCceEEEEEEEc--CCcEEEEEEeeeCCch--hHHHHHHHHHHHHHc---CCCCceeEeeEeec-----
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA--DGREVAVKQLKIGGSQ--GEREFRAEVEIISRV---HHRHLVSLVGYCIS----- 448 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~--~g~~vaVK~l~~~~~~--~~~~~~~Ei~~l~~l---~HpnIv~l~~~~~~----- 448 (727)
++|++++.||+|+||.||+|+.. +|+.||||+++..... ....+.+|+++++.+ +|+||++++++|..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36889999999999999999863 4688999998754322 234567788887766 69999999999852
Q ss_pred cceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeecc
Q 041135 449 ERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGL 528 (727)
Q Consensus 449 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGl 528 (727)
....++||||+. ++|.+++.......+++..++.|+.||++||+|||++ +|+|||||++||||+.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 346899999996 6888888765555689999999999999999999999 999999999999999999999999999
Q ss_pred chhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhh
Q 041135 529 AKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEAL 608 (727)
Q Consensus 529 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~ 608 (727)
++.... ........|+..|+|||++.+..++.++|||||||+||||++|+.+|...... ... ..++....
T Consensus 157 ~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~---~~~---~~i~~~~~ 226 (290)
T cd07862 157 ARIYSF----QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV---DQL---GKILDVIG 226 (290)
T ss_pred eEeccC----CcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH---HHH---HHHHHHhC
Confidence 975421 12233457899999999999889999999999999999999999999764321 111 11111000
Q ss_pred --chhhHHHH---HHHHhhc-------ccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 609 --EHEDFEAL---VDSRLEK-------NYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 609 --~~~~~~~l---~d~~l~~-------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
....+... ....+.. +........+.+|+.+||+.||++||++.|++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 227 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred CCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 00000000 0000000 0001122346789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=342.87 Aligned_cols=259 Identities=26% Similarity=0.462 Sum_probs=207.0
Q ss_pred cCccccceeccCCceEEEEEEEc------CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA------DGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLL 454 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 454 (727)
++|.+.+.||+|+||.||+++.. ++..||||.++.........+.+|+++|++++|+||++++++|......++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 46888999999999999999852 245689999876555556789999999999999999999999999999999
Q ss_pred EEeeccCCccchhcccCC-----------CCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEE
Q 041135 455 VYEYVPNDTLHYHLHAEG-----------RPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARV 523 (727)
Q Consensus 455 V~Ey~~~gsL~~~L~~~~-----------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL 523 (727)
||||+.+++|.++++... ...+.+..+++++.||+.||+|||++ +|+|||||++|||+++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEe
Confidence 999999999999886432 23489999999999999999999998 9999999999999999999999
Q ss_pred EeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHH
Q 041135 524 ADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARP 602 (727)
Q Consensus 524 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~ 602 (727)
+|||+++...... .........++..|+|||++.+..++.++|||||||++|||++ |+.||..... ..+.+
T Consensus 162 ~dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~---~~~~~---- 233 (288)
T cd05093 162 GDFGMSRDVYSTD-YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---NEVIE---- 233 (288)
T ss_pred ccCCccccccCCc-eeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHH----
Confidence 9999997542211 1111223445778999999999899999999999999999998 8999865431 11110
Q ss_pred HHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 603 LLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 603 ~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
.+...... .........+.+|+.+||+.+|.+||++.||++.|+++.+
T Consensus 234 ------------~i~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 234 ------------CITQGRVL-QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred ------------HHHcCCcC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 01110000 0111123458899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=335.36 Aligned_cols=248 Identities=26% Similarity=0.391 Sum_probs=195.8
Q ss_pred eeccCCceEEEEEEEc---CCcEEEEEEeeeCCc--hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeeccCC
Q 041135 388 VLGEGGFGCVYKGVLA---DGREVAVKQLKIGGS--QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPND 462 (727)
Q Consensus 388 ~LG~G~fg~Vy~~~~~---~g~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 462 (727)
+||+|+||.||+|.++ +++.||||+++.... ...+++.+|+.+|+.++|+||+++++++.. +..+|||||+.++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 6899999999999753 578899999864432 234678999999999999999999998864 5678999999999
Q ss_pred ccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCcccc
Q 041135 463 TLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVS 542 (727)
Q Consensus 463 sL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 542 (727)
+|.+++.... .+++..+++++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++............
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 81 PLNKFLQKNK--HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 9999987654 488999999999999999999999 99999999999999999999999999997543222111111
Q ss_pred ccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHh
Q 041135 543 TRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRL 621 (727)
Q Consensus 543 ~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l 621 (727)
....++..|+|||++.+..++.++|||||||++|||++ |+.||..... ..+. +.++...
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~-----------------~~i~~~~ 215 (257)
T cd05116 156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG---NEVT-----------------QMIESGE 215 (257)
T ss_pred CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHH-----------------HHHHCCC
Confidence 22344678999999988889999999999999999998 9999975421 1111 1111111
Q ss_pred hcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhc
Q 041135 622 EKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661 (727)
Q Consensus 622 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 661 (727)
...........+.+||.+||+.||++||++.+|++.|++.
T Consensus 216 ~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 216 RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 1112222334578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=350.85 Aligned_cols=245 Identities=29% Similarity=0.430 Sum_probs=194.5
Q ss_pred ccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHHHHH---HcCCCCceeEeeEeeccceeeEE
Q 041135 383 FSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVEIIS---RVHHRHLVSLVGYCISERERLLV 455 (727)
Q Consensus 383 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~---~l~HpnIv~l~~~~~~~~~~~lV 455 (727)
|+++++||+|+||.||+|+++ +|+.||||+++... ....+.+.+|++++. .++|+||+++++++.+++..|||
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 678899999999999999875 58999999997432 223345777776654 56799999999999999999999
Q ss_pred EeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhcc
Q 041135 456 YEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALEL 535 (727)
Q Consensus 456 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 535 (727)
|||+.+++|..+++.. .+++..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~- 153 (324)
T cd05589 81 MEYAAGGDLMMHIHTD---VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG- 153 (324)
T ss_pred EcCCCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCC-
Confidence 9999999998887653 489999999999999999999999 999999999999999999999999999874321
Q ss_pred CCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHH
Q 041135 536 DSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEA 615 (727)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~ 615 (727)
........+|+..|+|||++.+..++.++|||||||+||||++|+.||..... . +.. ..
T Consensus 154 --~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~---~---~~~-------------~~ 212 (324)
T cd05589 154 --FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE---E---EVF-------------DS 212 (324)
T ss_pred --CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH---H---HHH-------------HH
Confidence 11223346789999999999999999999999999999999999999975431 0 111 11
Q ss_pred HHHHHhhcccchhHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 041135 616 LVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRP-----RMSQVVRA 657 (727)
Q Consensus 616 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 657 (727)
+..... .+.......+.+++++||+.||++|+ ++.+|+++
T Consensus 213 i~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 213 IVNDEV--RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred HHhCCC--CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 111111 11122234577899999999999999 56666665
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=360.42 Aligned_cols=256 Identities=21% Similarity=0.244 Sum_probs=197.0
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
++|+++++||+|+||.||+++.. +|+.||||++.... ....+.+++|+++|++++|+||++++++|.+....||||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46899999999999999999864 68999999986432 223456889999999999999999999999999999999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccC
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 536 (727)
||+.+|+|.+++...+. +.+..+..++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++.+....
T Consensus 81 E~~~gg~L~~~l~~~~~--~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 81 EFLPGGDLMTMLIKYDT--FSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred eCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 99999999999876543 78889999999999999999999 99999999999999999999999999996332110
Q ss_pred CCc--------------------------------------------cccccccCCccccccCcccCCCCCchhHHHHHh
Q 041135 537 SNT--------------------------------------------HVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFG 572 (727)
Q Consensus 537 ~~~--------------------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~G 572 (727)
... ......+||..|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 000 000124699999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCC---C
Q 041135 573 VVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKR---P 649 (727)
Q Consensus 573 vil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R---P 649 (727)
||||||++|+.||...... +....+.. .. ..+...........+.+|+.+||. ++.+| +
T Consensus 236 vil~elltG~~Pf~~~~~~------~~~~~i~~----~~-------~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~ 297 (377)
T cd05629 236 AIMFECLIGWPPFCSENSH------ETYRKIIN----WR-------ETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRG 297 (377)
T ss_pred hhhhhhhcCCCCCCCCCHH------HHHHHHHc----cC-------CccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCC
Confidence 9999999999999754321 00000000 00 000000000112346788899997 66665 5
Q ss_pred CHHHHHHHHh
Q 041135 650 RMSQVVRALD 659 (727)
Q Consensus 650 s~~evl~~L~ 659 (727)
++.|++++-.
T Consensus 298 ~~~~~l~hp~ 307 (377)
T cd05629 298 GAHEIKSHPF 307 (377)
T ss_pred CHHHHhcCCC
Confidence 9999988743
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=348.41 Aligned_cols=268 Identities=21% Similarity=0.328 Sum_probs=197.3
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCch-hHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEe
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQ-GEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYE 457 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 457 (727)
.++|++.++||+|+||.||+|+.. +|+.||||+++..... ....+.+|+++|+.++|+||+++++++.++...++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 367999999999999999999976 6889999998754322 23467889999999999999999999999999999999
Q ss_pred eccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCC
Q 041135 458 YVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDS 537 (727)
Q Consensus 458 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 537 (727)
|+. ++|.+++..+. ..+....+..++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++....
T Consensus 84 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--- 155 (303)
T cd07869 84 YVH-TDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSV--- 155 (303)
T ss_pred CCC-cCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccC---
Confidence 995 56666665432 2478889999999999999999999 999999999999999999999999999874321
Q ss_pred CccccccccCCccccccCcccC-CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHH--
Q 041135 538 NTHVSTRVMGTFGYMAPEYATS-GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFE-- 614 (727)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~-- 614 (727)
.........|+..|+|||++.+ ..++.++|||||||+||||++|+.||...... ....+.....+... ....+.
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~-~~~~~~~~ 232 (303)
T cd07869 156 PSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI--QDQLERIFLVLGTP-NEDTWPGV 232 (303)
T ss_pred CCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHHhCCC-Chhhccch
Confidence 1122234568899999999875 45889999999999999999999999764321 11111110000000 000000
Q ss_pred ----HHHHHHhh--------cccc-hhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 041135 615 ----ALVDSRLE--------KNYV-DSEMFWMIEAAAACVRHSATKRPRMSQVVRAL 658 (727)
Q Consensus 615 ----~l~d~~l~--------~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 658 (727)
.+....+. ..+. ......+.+|+.+||+.||++|+++.|++++=
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~ 289 (303)
T cd07869 233 HSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHE 289 (303)
T ss_pred hhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCc
Confidence 00000000 0000 00112467899999999999999999998763
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=366.32 Aligned_cols=252 Identities=19% Similarity=0.276 Sum_probs=202.5
Q ss_pred CccccceeccCCceEEEEEEEc-C-CcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeec
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLA-D-GREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYV 459 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~-~-g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 459 (727)
.|.+.++||+|+||.||+|... + ++.||+|++..........+++|+++|+.++|+|||+++++|..++..||||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 3888999999999999999854 3 6788999876655555567889999999999999999999999999999999999
Q ss_pred cCCccchhcccC--CCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCC
Q 041135 460 PNDTLHYHLHAE--GRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDS 537 (727)
Q Consensus 460 ~~gsL~~~L~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 537 (727)
.+|+|.++|+.. ....+++..+..++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++.+....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~- 223 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV- 223 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc-
Confidence 999999887542 233578899999999999999999999 99999999999999999999999999998543211
Q ss_pred CccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHH
Q 041135 538 NTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALV 617 (727)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~ 617 (727)
........+|+..|+|||++.+..++.++|||||||+||||++|+.||..... .+.... ++
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~------~~~~~~-------------~~ 284 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ------REIMQQ-------------VL 284 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHH-------------HH
Confidence 11223456799999999999999999999999999999999999999975321 111111 11
Q ss_pred HHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 618 DSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 618 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
.... ..+.......+.+|+.+||..||++||++.+|+.+
T Consensus 285 ~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 285 YGKY-DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred hCCC-CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 1100 01111223457889999999999999999999754
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=341.58 Aligned_cols=258 Identities=28% Similarity=0.440 Sum_probs=204.1
Q ss_pred CccccceeccCCceEEEEEEEc------CCcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeE
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLA------DGREVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLL 454 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~------~g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 454 (727)
+|++.++||+|+||.||+|+.. .+..|++|.+..... ...+.+.+|+++|+.++|+||++++++|..++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4788899999999999999853 235788998865443 334678999999999999999999999999999999
Q ss_pred EEeeccCCccchhcccCC----------------------CCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCc
Q 041135 455 VYEYVPNDTLHYHLHAEG----------------------RPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSN 512 (727)
Q Consensus 455 V~Ey~~~gsL~~~L~~~~----------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~N 512 (727)
||||+.+++|.+++.... ...+++..++.++.||+.||+|||++ +|+|||||++|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 999999999998875421 13478899999999999999999998 99999999999
Q ss_pred eEECCCCcEEEEeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCC
Q 041135 513 ILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPL 591 (727)
Q Consensus 513 ILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~ 591 (727)
|||++++.+||+|||+++........ .......++..|++||++.+..++.++|||||||+||||++ |+.||.....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~- 235 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSY-VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP- 235 (290)
T ss_pred EEEcCCCcEEeccccccccccCccch-hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH-
Confidence 99999999999999999754322211 11223456778999999998899999999999999999998 9999965321
Q ss_pred CchhhHHhhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 592 GDESLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 592 ~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
..+.+ .++..+...........+.+|+.+||+.+|++||++.||++.|+++..
T Consensus 236 --~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 236 --ERLFN-----------------LLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred --HHHHH-----------------HHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 11111 111111111122233458899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=335.60 Aligned_cols=256 Identities=29% Similarity=0.444 Sum_probs=207.4
Q ss_pred HhcCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEee
Q 041135 379 ATNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 379 ~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 458 (727)
..++|++.++||+|+||.||+|++++++.|+||.++... ....++.+|++++++++|+||+++++++..+...++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 346789999999999999999998888899999987433 3456799999999999999999999999998899999999
Q ss_pred ccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCC
Q 041135 459 VPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSN 538 (727)
Q Consensus 459 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 538 (727)
+.+++|.+++.......+.+..++.++.+|+.||.|||++ +|+|||||++||+|++++.+||+|||+++..... .
T Consensus 83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~--~ 157 (261)
T cd05034 83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDD--E 157 (261)
T ss_pred cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccch--h
Confidence 9999999999876655689999999999999999999999 9999999999999999999999999998754221 1
Q ss_pred ccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHH
Q 041135 539 THVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALV 617 (727)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~ 617 (727)
........++..|++||.+.+..++.++|||||||++|||++ |+.||..... ....+. +
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~---~~~~~~----------------~- 217 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN---REVLEQ----------------V- 217 (261)
T ss_pred hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH----------------H-
Confidence 111122334568999999999899999999999999999998 9999965321 111110 0
Q ss_pred HHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhh
Q 041135 618 DSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDT 660 (727)
Q Consensus 618 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 660 (727)
...+...........+.+++.+||+.+|++||++++|++.|+.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 218 ERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0000111111223468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=334.15 Aligned_cols=253 Identities=28% Similarity=0.425 Sum_probs=202.7
Q ss_pred cCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeecc
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVP 460 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 460 (727)
++|++.++||+|+||.||+|.+.++..|+||++.... ...+.+.+|+++|++++|+||+++++++.. +..++||||+.
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCC
Confidence 4588889999999999999998777789999886433 334678999999999999999999998754 56789999999
Q ss_pred CCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCcc
Q 041135 461 NDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTH 540 (727)
Q Consensus 461 ~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 540 (727)
+++|.++++......+.+..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++...... ..
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~--~~ 158 (260)
T cd05069 84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE--YT 158 (260)
T ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCc--cc
Confidence 99999999776555689999999999999999999998 99999999999999999999999999997542211 11
Q ss_pred ccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHH
Q 041135 541 VSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDS 619 (727)
Q Consensus 541 ~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~ 619 (727)
......++..|++||++.++.++.++|||||||+||||++ |+.||..... ....++. ..
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~-----------------~~ 218 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN---REVLEQV-----------------ER 218 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH-----------------Hc
Confidence 1122345678999999998899999999999999999999 8999975321 1111110 00
Q ss_pred HhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhh
Q 041135 620 RLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDT 660 (727)
Q Consensus 620 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 660 (727)
.............+.+|+++||..||++||++++|++.|++
T Consensus 219 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 219 GYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 00011112234568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=352.48 Aligned_cols=244 Identities=23% Similarity=0.304 Sum_probs=195.7
Q ss_pred ceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeeccCC
Q 041135 387 NVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPND 462 (727)
Q Consensus 387 ~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 462 (727)
++||+|+||.||+++.. +|+.||||+++... ......+.+|+++++.++|+||++++++|.+++..||||||+.+|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999864 68999999997432 233456788999999999999999999999999999999999999
Q ss_pred ccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHh-cCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCccc
Q 041135 463 TLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHE-DCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHV 541 (727)
Q Consensus 463 sL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 541 (727)
+|..++.... .+.+..++.++.||+.||+|||+ + +|+|||||++||||++++.+||+|||+++..... ...
T Consensus 81 ~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~---~~~ 152 (325)
T cd05594 81 ELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD---GAT 152 (325)
T ss_pred cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCC---Ccc
Confidence 9998887654 38899999999999999999997 6 8999999999999999999999999998743211 112
Q ss_pred cccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHh
Q 041135 542 STRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRL 621 (727)
Q Consensus 542 ~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l 621 (727)
....+|+..|+|||++.++.++.++|||||||+||||++|+.||..... . +.... +....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~---~---~~~~~-------------i~~~~- 212 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---E---KLFEL-------------ILMEE- 212 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH---H---HHHHH-------------HhcCC-
Confidence 2345799999999999999999999999999999999999999965321 1 11000 00000
Q ss_pred hcccchhHHHHHHHHHHHHhccCCCCCC-----CHHHHHHHHh
Q 041135 622 EKNYVDSEMFWMIEAAAACVRHSATKRP-----RMSQVVRALD 659 (727)
Q Consensus 622 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L~ 659 (727)
..+.......+.+|+++||+.||++|+ ++.+|+++-.
T Consensus 213 -~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~ 254 (325)
T cd05594 213 -IRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKF 254 (325)
T ss_pred -CCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCC
Confidence 011112233477899999999999997 8999987743
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=364.64 Aligned_cols=273 Identities=22% Similarity=0.258 Sum_probs=197.0
Q ss_pred HHHHHHhcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCC------CCceeEeeEe
Q 041135 374 DELIQATNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRVHH------RHLVSLVGYC 446 (727)
Q Consensus 374 ~el~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H------pnIv~l~~~~ 446 (727)
+++....++|+++++||+|+||.||+|++. .++.||||+++... ....++..|+++++.++| .+|++++++|
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 344445688999999999999999999864 57889999986432 234466778888887754 4588899988
Q ss_pred ecc-ceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHh-cCCCcEEeeCCCCCceEECCCC-----
Q 041135 447 ISE-RERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHE-DCHPRIIHRDIKSSNILLDSSF----- 519 (727)
Q Consensus 447 ~~~-~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivHrDLkp~NILl~~~~----- 519 (727)
..+ .+.|||||++ +++|.+++..++ .+.+..++.|+.||+.||+|||+ . +|||||||++||||+.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKHG--PFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCccccc
Confidence 765 4778999988 677877776654 38899999999999999999997 5 899999999999998665
Q ss_pred -----------cEEEEeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCC
Q 041135 520 -----------EARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDAS 588 (727)
Q Consensus 520 -----------~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~ 588 (727)
.+||+|||++... .......+||..|+|||++.+..++.++||||||||||||++|+.||+..
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~------~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 348 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDE------RHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH 348 (467)
T ss_pred ccccccCCCCceEEECCCCccccC------ccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 4999999988632 11233467999999999999999999999999999999999999999875
Q ss_pred CCCCchhhHHhhHH-H---HHHhhchhhHHHHHHHH---------------hhcccc--hhHHHHHHHHHHHHhccCCCC
Q 041135 589 QPLGDESLVEWARP-L---LAEALEHEDFEALVDSR---------------LEKNYV--DSEMFWMIEAAAACVRHSATK 647 (727)
Q Consensus 589 ~~~~~~~l~~~~~~-~---l~~~~~~~~~~~l~d~~---------------l~~~~~--~~~~~~l~~li~~cl~~dP~~ 647 (727)
.......+++.... + +...........+++.. ...... ......+++||.+||+.||++
T Consensus 349 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~ 428 (467)
T PTZ00284 349 DNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQK 428 (467)
T ss_pred ChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhh
Confidence 43211111111000 0 00000000001111100 000000 001234779999999999999
Q ss_pred CCCHHHHHHHHh
Q 041135 648 RPRMSQVVRALD 659 (727)
Q Consensus 648 RPs~~evl~~L~ 659 (727)
|++++||+++=.
T Consensus 429 R~ta~e~L~Hp~ 440 (467)
T PTZ00284 429 RLNARQMTTHPY 440 (467)
T ss_pred CCCHHHHhcCcc
Confidence 999999998643
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=342.04 Aligned_cols=253 Identities=28% Similarity=0.360 Sum_probs=201.7
Q ss_pred CccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc---hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEe
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS---QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYE 457 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 457 (727)
.|++.++||+|+||.||+++.. +++.||||++..... .....+.+|+++|+.++|+||++++++|.++...++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4788899999999999999964 688999999864322 223457789999999999999999999999999999999
Q ss_pred eccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCC
Q 041135 458 YVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDS 537 (727)
Q Consensus 458 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 537 (727)
|+.+|+|.+++.......+.+..++.++.||++||.|||++ +|+|||||++|||+++++.++|+|||+++....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~--- 154 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPE--- 154 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCC---
Confidence 99999999888665445689999999999999999999999 999999999999999999999999999875321
Q ss_pred CccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHH
Q 041135 538 NTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALV 617 (727)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~ 617 (727)
........|+..|++||++.+..++.++|||||||+||||++|+.||....... ..+. +...+
T Consensus 155 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~---~~~~-------------~~~~~ 217 (285)
T cd05605 155 -GETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV---KREE-------------VERRV 217 (285)
T ss_pred -CCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh---HHHH-------------HHHHh
Confidence 111223468999999999999899999999999999999999999997543210 0000 00001
Q ss_pred HHHhhcccchhHHHHHHHHHHHHhccCCCCCC-----CHHHHHHHH
Q 041135 618 DSRLEKNYVDSEMFWMIEAAAACVRHSATKRP-----RMSQVVRAL 658 (727)
Q Consensus 618 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L 658 (727)
.. ....+.......+.+|+.+||+.||++|+ ++++|+++-
T Consensus 218 ~~-~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~ 262 (285)
T cd05605 218 KE-DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHP 262 (285)
T ss_pred hh-cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCc
Confidence 10 01112222334578899999999999999 888887763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=343.67 Aligned_cols=259 Identities=29% Similarity=0.435 Sum_probs=205.2
Q ss_pred HhcCccccceeccCCceEEEEEEEcC------CcEEEEEEeeeCC-chhHHHHHHHHHHHHHc-CCCCceeEeeEeeccc
Q 041135 379 ATNGFSAHNVLGEGGFGCVYKGVLAD------GREVAVKQLKIGG-SQGEREFRAEVEIISRV-HHRHLVSLVGYCISER 450 (727)
Q Consensus 379 ~~~~~~~~~~LG~G~fg~Vy~~~~~~------g~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~ 450 (727)
..++|++.+.||+|+||.||++++.+ ...||+|+++... .+...++.+|+++++++ +|+||++++++|..++
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 34568899999999999999998642 3679999987543 23345688999999999 7999999999999999
Q ss_pred eeeEEEeeccCCccchhcccC--------------CCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEEC
Q 041135 451 ERLLVYEYVPNDTLHYHLHAE--------------GRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLD 516 (727)
Q Consensus 451 ~~~lV~Ey~~~gsL~~~L~~~--------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~ 516 (727)
..++||||+.+|+|..+++.+ ....+++..+++++.||+.||+|||++ +|+|||||++|||++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEc
Confidence 999999999999999998642 234588999999999999999999998 999999999999999
Q ss_pred CCCcEEEEeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchh
Q 041135 517 SSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDES 595 (727)
Q Consensus 517 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~ 595 (727)
+++.+||+|||+++....... ........++..|++||++.+..++.++|||||||++|||++ |..||..... ..
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~ 242 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDY-YRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV---EE 242 (293)
T ss_pred CCCeEEeCccccccccccccc-eeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH---HH
Confidence 999999999999986432111 111122345678999999998899999999999999999998 9888864321 00
Q ss_pred hHHhhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhc
Q 041135 596 LVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661 (727)
Q Consensus 596 l~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 661 (727)
+ .+.+...............+.+|+.+||+.+|++||++.||++.|+.+
T Consensus 243 ~-----------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 243 L-----------------FKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred H-----------------HHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 0 011111111112223344688999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=333.73 Aligned_cols=254 Identities=25% Similarity=0.395 Sum_probs=203.0
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc-----hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS-----QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLL 454 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 454 (727)
++|++.++||+|+||.||+|+.. +++.|+||.++.... ...+.+.+|++++++++|+||+++++++.+++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46889999999999999999864 589999999864322 123568899999999999999999999999999999
Q ss_pred EEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhc
Q 041135 455 VYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALE 534 (727)
Q Consensus 455 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 534 (727)
||||+.+++|.+++..... +.+..+++++.||+.||.|||+. +|+|||||++||||++++.+||+|||+++....
T Consensus 82 v~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGA--LTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EEEECCCCcHHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 9999999999998876543 78889999999999999999999 999999999999999999999999999975432
Q ss_pred cCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHH
Q 041135 535 LDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFE 614 (727)
Q Consensus 535 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~ 614 (727)
............|+..|+|||++.+..++.++|||||||++|||++|+.||...+.. .. +.
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~--------------~~ 217 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM-----AA--------------IF 217 (263)
T ss_pred cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH-----HH--------------HH
Confidence 211111112346788999999999988999999999999999999999999653211 00 00
Q ss_pred HHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 041135 615 ALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRAL 658 (727)
Q Consensus 615 ~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 658 (727)
..........+.......+.+++++||..+|++||++.||+++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~ 261 (263)
T cd06625 218 KIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHF 261 (263)
T ss_pred HHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence 00111111112223344578899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=332.82 Aligned_cols=250 Identities=29% Similarity=0.457 Sum_probs=205.7
Q ss_pred cCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeecc
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVP 460 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 460 (727)
++|++.+.||+|+||.||+|... |+.||||.++.... ..+.+.+|+.++++++|+||+++++++.++...++||||+.
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 46888999999999999999875 88999999975543 46789999999999999999999999999899999999999
Q ss_pred CCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCcc
Q 041135 461 NDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTH 540 (727)
Q Consensus 461 ~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 540 (727)
+++|.++++......+.+..++.++.||+.||.|||++ +|+|||||++|||+++++.+||+|||+++.....
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~----- 155 (256)
T cd05039 84 KGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG----- 155 (256)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccc-----
Confidence 99999999876655689999999999999999999999 9999999999999999999999999999754211
Q ss_pred ccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHH
Q 041135 541 VSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDS 619 (727)
Q Consensus 541 ~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~ 619 (727)
.....++..|++||++.++.++.++|||||||++|||++ |+.||..... ..+.+ .+..
T Consensus 156 -~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~-----------------~~~~ 214 (256)
T cd05039 156 -QDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVP-----------------HVEK 214 (256)
T ss_pred -cccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH---HHHHH-----------------HHhc
Confidence 112345678999999998899999999999999999997 9999865321 11100 0000
Q ss_pred HhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhc
Q 041135 620 RLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661 (727)
Q Consensus 620 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 661 (727)
.............+.+++++||..+|++||+++||++.|+.+
T Consensus 215 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 215 GYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred CCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 011111122234578999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=358.31 Aligned_cols=260 Identities=25% Similarity=0.377 Sum_probs=203.7
Q ss_pred hcCccccceeccCCceEEEEEEEc------CCcEEEEEEeeeCCchh-HHHHHHHHHHHHHcC-CCCceeEeeEeeccce
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA------DGREVAVKQLKIGGSQG-EREFRAEVEIISRVH-HRHLVSLVGYCISERE 451 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vaVK~l~~~~~~~-~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~ 451 (727)
.++|.++++||+|+||.||+|++. .++.||||+++...... .+.+.+|+++|.++. |+||++++++|.....
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 345778899999999999999864 24689999997543332 347889999999997 9999999999999999
Q ss_pred eeEEEeeccCCccchhcccCCC----------------------------------------------------------
Q 041135 452 RLLVYEYVPNDTLHYHLHAEGR---------------------------------------------------------- 473 (727)
Q Consensus 452 ~~lV~Ey~~~gsL~~~L~~~~~---------------------------------------------------------- 473 (727)
.+|||||+.+|+|.++|+.+..
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 9999999999999998865321
Q ss_pred --------------------------------------CcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEE
Q 041135 474 --------------------------------------PVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILL 515 (727)
Q Consensus 474 --------------------------------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl 515 (727)
..+++..+++|+.||++||+|||+. +|+|||||++||||
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEE
Confidence 2367778899999999999999998 99999999999999
Q ss_pred CCCCcEEEEeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCch
Q 041135 516 DSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDE 594 (727)
Q Consensus 516 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~ 594 (727)
++++.+||+|||+++....... ........++..|++||++.+..++.++|||||||+||||++ |+.||...... +
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~--~ 349 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSN-YISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN--E 349 (401)
T ss_pred eCCCEEEEEecCcceecccccc-cccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch--H
Confidence 9999999999999975422111 111223456788999999998889999999999999999998 88998654211 0
Q ss_pred hhHHhhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhcc
Q 041135 595 SLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLD 662 (727)
Q Consensus 595 ~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 662 (727)
. +...+...+...........+.+|+.+||..+|++||+++||++.|+++.
T Consensus 350 ~-----------------~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 350 Q-----------------FYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred H-----------------HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 0 00111111111111222345889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=339.22 Aligned_cols=257 Identities=25% Similarity=0.393 Sum_probs=200.0
Q ss_pred cCccccceeccCCceEEEEEEEc-CCc----EEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGR----EVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLL 454 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~----~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 454 (727)
++|++++.||+|+||.||+|++. +|+ .|++|++..... ....++..|+.++++++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 45788899999999999999874 344 477787754332 233578889999999999999999998864 45788
Q ss_pred EEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhc
Q 041135 455 VYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALE 534 (727)
Q Consensus 455 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 534 (727)
|+||+.+|+|.++++.... .+++..++.|+.||+.||+|||++ +|+|||||++|||+++++.+||+|||+++....
T Consensus 86 i~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRD-SLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEEeCCCCcHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 9999999999999976433 489999999999999999999998 999999999999999999999999999986432
Q ss_pred cCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhH
Q 041135 535 LDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDF 613 (727)
Q Consensus 535 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~ 613 (727)
.. .........++..|++||++.++.++.++|||||||++|||++ |+.||...... .+.
T Consensus 162 ~~-~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~---~~~---------------- 221 (279)
T cd05111 162 DD-KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH---EVP---------------- 221 (279)
T ss_pred CC-cccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHH----------------
Confidence 21 1122234557788999999999899999999999999999998 99999754311 111
Q ss_pred HHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 614 EALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 614 ~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
+++...............+.+++.+||..||++||++.||++.|..+.+
T Consensus 222 -~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 222 -DLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred -HHHHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 1111000000011122346788999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=332.53 Aligned_cols=250 Identities=27% Similarity=0.428 Sum_probs=204.7
Q ss_pred CccccceeccCCceEEEEEEEc-CCcEEEEEEeeeC--CchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEee
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIG--GSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 458 (727)
+|++.+.||+|+||.||+|+++ +|+.|++|.+... .....+++.+|++++++++|+||+++++++.+++..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4788899999999999999975 5899999998643 234456799999999999999999999999999999999999
Q ss_pred ccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCC
Q 041135 459 VPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSN 538 (727)
Q Consensus 459 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 538 (727)
+.+++|.++++......+.+..+++++.||++||.|||++ +|+|||||++|||++.++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~--- 154 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN--- 154 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCc---
Confidence 9999999999876555689999999999999999999998 9999999999999999999999999998754321
Q ss_pred ccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHH
Q 041135 539 THVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVD 618 (727)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d 618 (727)
........|+..|+|||++.++.++.++|||||||++|||++|+.||..... .... +. +..
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~---~~-------------~~~ 215 (256)
T cd08529 155 TNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ---GALI---LK-------------IIR 215 (256)
T ss_pred cchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---HHHH---HH-------------HHc
Confidence 1222345688899999999999999999999999999999999999975431 1111 00 000
Q ss_pred HHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 619 SRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 619 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
.. ...........+.+++++||+.+|++||++.+|+++
T Consensus 216 ~~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 216 GV-FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CC-CCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 00 011111223458899999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=334.30 Aligned_cols=249 Identities=26% Similarity=0.405 Sum_probs=195.6
Q ss_pred eeccCCceEEEEEEEc---CCcEEEEEEeeeCCch-hHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeeccCCc
Q 041135 388 VLGEGGFGCVYKGVLA---DGREVAVKQLKIGGSQ-GEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPNDT 463 (727)
Q Consensus 388 ~LG~G~fg~Vy~~~~~---~g~~vaVK~l~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gs 463 (727)
.||+|+||.||+|++. ++..||||++...... ..+.|.+|+++|++++|+||++++++|.. ...++||||+.+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 3899999999999864 3567999998755332 34579999999999999999999998864 56799999999999
Q ss_pred cchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCccccc
Q 041135 464 LHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVST 543 (727)
Q Consensus 464 L~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 543 (727)
|.+++..+. ..+++..+++++.||++||+|||++ +|+|||||++|||++.++.+||+|||+++.............
T Consensus 81 L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 81 LNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred HHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence 999986543 2589999999999999999999998 999999999999999999999999999975432221111112
Q ss_pred cccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHhh
Q 041135 544 RVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRLE 622 (727)
Q Consensus 544 ~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l~ 622 (727)
...++..|+|||++.+..++.++|||||||++|||++ |+.||..... .. +...+.....
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~-----------------~~~~~~~~~~ 216 (257)
T cd05115 157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG---PE-----------------VMSFIEQGKR 216 (257)
T ss_pred CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH---HH-----------------HHHHHHCCCC
Confidence 2234578999999998889999999999999999996 9999975421 11 1111111111
Q ss_pred cccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhc
Q 041135 623 KNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661 (727)
Q Consensus 623 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 661 (727)
..........+.+++.+||..++++||++.+|++.|+.+
T Consensus 217 ~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 217 LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 122223345678899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=336.11 Aligned_cols=257 Identities=26% Similarity=0.426 Sum_probs=202.9
Q ss_pred cCccccceeccCCceEEEEEEEc-C---CcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-D---GREVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLV 455 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~---g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 455 (727)
.+|++.++||+|+||.||+|++. + +..||||.++.... ...+.|.+|+++|++++|+||+++++++.+++..|+|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46888999999999999999864 2 34799998865432 3346789999999999999999999999999999999
Q ss_pred EeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhcc
Q 041135 456 YEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALEL 535 (727)
Q Consensus 456 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 535 (727)
|||+.+++|.+++..+.. .+++.++++|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++.....
T Consensus 84 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 84 TEYMENGSLDAFLRKHDG-QFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEcCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 999999999999976543 478999999999999999999999 9999999999999999999999999999865322
Q ss_pred CCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHH
Q 041135 536 DSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFE 614 (727)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~ 614 (727)
...........++..|++||++.++.++.++|||+|||++|||++ |+.||...... ....+
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~---~~~~~--------------- 221 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ---DVIKA--------------- 221 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH---HHHHH---------------
Confidence 211111122334568999999998899999999999999999887 99998654311 11110
Q ss_pred HHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhc
Q 041135 615 ALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661 (727)
Q Consensus 615 ~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 661 (727)
+.+ .............+.+++.+||+.++++||+|.+|++.|+++
T Consensus 222 -~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 222 -IEE-GYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -HhC-CCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 000 000111112234578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=347.89 Aligned_cols=247 Identities=26% Similarity=0.370 Sum_probs=196.4
Q ss_pred CccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHHHHHHcCC-CCceeEeeEeeccceeeEEE
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVEIISRVHH-RHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H-pnIv~l~~~~~~~~~~~lV~ 456 (727)
+|++++.||+|+||.||+|+.+ +++.||||+++... ....+.+..|++++..++| .+|+++++++.+.+..||||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4888999999999999999875 47889999987432 2334568889999999976 56888999999999999999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccC
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 536 (727)
||+.+|+|.+++..... +.+..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~~~~--~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~-- 153 (324)
T cd05587 81 EYVNGGDLMYHIQQVGK--FKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF-- 153 (324)
T ss_pred cCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC--
Confidence 99999999998876554 78899999999999999999999 999999999999999999999999999864211
Q ss_pred CCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHH
Q 041135 537 SNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEAL 616 (727)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l 616 (727)
........+|+..|+|||++.+..++.++|||||||+||||++|+.||..... ..+. ..+
T Consensus 154 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~~----------------~~i 213 (324)
T cd05587 154 -GGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE---DELF----------------QSI 213 (324)
T ss_pred -CCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHH----------------HHH
Confidence 11122345789999999999999999999999999999999999999975431 1110 011
Q ss_pred HHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCH-----HHHHHH
Q 041135 617 VDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRM-----SQVVRA 657 (727)
Q Consensus 617 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~ 657 (727)
.+. ...+.......+.+|+++||+.||.+|++. .+|+++
T Consensus 214 ~~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 214 MEH--NVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred HcC--CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 111 111122223457789999999999999976 555544
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=332.13 Aligned_cols=248 Identities=25% Similarity=0.398 Sum_probs=196.5
Q ss_pred ceeccCCceEEEEEEEc-CCcEEEEEEeeeCC-chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeeccCCcc
Q 041135 387 NVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG-SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPNDTL 464 (727)
Q Consensus 387 ~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL 464 (727)
++||+|+||.||+|++. +|+.||||.+.... ......+.+|+++|++++|+||++++++|......+|||||+.+++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999974 68899999876433 23346799999999999999999999999999999999999999999
Q ss_pred chhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCcccccc
Q 041135 465 HYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTR 544 (727)
Q Consensus 465 ~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 544 (727)
.+++.... ..+++..++.++.||+.||+|||++ +|+|||||++|||++.++.+||+|||+++...... .......
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~ 155 (252)
T cd05084 81 LTFLRTEG-PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGV-YASTGGM 155 (252)
T ss_pred HHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCccccccc-ccccCCC
Confidence 99986543 2478999999999999999999999 99999999999999999999999999987532111 0001111
Q ss_pred ccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHhhc
Q 041135 545 VMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRLEK 623 (727)
Q Consensus 545 ~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l~~ 623 (727)
..++..|+|||.+.++.++.++|||||||++|||++ |..||..... .. ....+......
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~---~~-----------------~~~~~~~~~~~ 215 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN---QQ-----------------TREAIEQGVRL 215 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH---HH-----------------HHHHHHcCCCC
Confidence 223467999999999999999999999999999998 8888864321 00 11111111111
Q ss_pred ccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 624 NYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 624 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
.........+.+|+++||+.+|++||++.||++.|+
T Consensus 216 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 216 PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 222223456889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=342.64 Aligned_cols=258 Identities=26% Similarity=0.389 Sum_probs=205.6
Q ss_pred cCccccceeccCCceEEEEEEEc------CCcEEEEEEeeeCCc-hhHHHHHHHHHHHHHc-CCCCceeEeeEeecccee
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA------DGREVAVKQLKIGGS-QGEREFRAEVEIISRV-HHRHLVSLVGYCISERER 452 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~ 452 (727)
++|.+.++||+|+||.||+|... .+..||||+++.... ...+.+.+|+++|+++ +|+||++++++|...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 46889999999999999999742 245799999875433 3345789999999999 799999999999999999
Q ss_pred eEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhh
Q 041135 453 LLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIA 532 (727)
Q Consensus 453 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~ 532 (727)
|+||||+.+|+|.++++......+++.+++.++.||+.||+|||++ +|+|||||++|||+++++.+||+|||+++..
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~ 191 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDI 191 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcccccc
Confidence 9999999999999999765555589999999999999999999999 9999999999999999999999999999754
Q ss_pred hccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchh
Q 041135 533 LELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHE 611 (727)
Q Consensus 533 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~ 611 (727)
.... .........++..|+|||++.++.++.++|||||||+||||++ |+.||...... ..
T Consensus 192 ~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~--~~---------------- 252 (302)
T cd05055 192 MNDS-NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD--SK---------------- 252 (302)
T ss_pred cCCC-ceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch--HH----------------
Confidence 3221 1111223345778999999999999999999999999999998 99998654311 00
Q ss_pred hHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhc
Q 041135 612 DFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661 (727)
Q Consensus 612 ~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 661 (727)
+...++..............+.+|+++||+.+|++||++.||++.|+++
T Consensus 253 -~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 253 -FYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred -HHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 1111111111111112234588999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=331.98 Aligned_cols=259 Identities=22% Similarity=0.376 Sum_probs=207.4
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
++|++.++||+|+||.||+|... +|+.|+||.++... ....+.+.+|+++|++++|+||+++++++.+++..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57899999999999999999976 78999999886422 233567899999999999999999999999999999999
Q ss_pred eeccCCccchhcccC--CCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhc
Q 041135 457 EYVPNDTLHYHLHAE--GRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALE 534 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 534 (727)
||+.+++|..++... ....+.+..+++++.+|++||.|||++ +|+|||||++||+|+.++.++|+|||+++.+..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999888642 234578999999999999999999999 999999999999999999999999999875422
Q ss_pred cCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHH
Q 041135 535 LDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFE 614 (727)
Q Consensus 535 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~ 614 (727)
. ........++..|+|||++.+..++.++|||||||++|||++|+.||..... .+.++...+.
T Consensus 159 ~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~---------- 221 (267)
T cd08224 159 K---TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKIE---------- 221 (267)
T ss_pred C---CcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHHHHhhhh----------
Confidence 1 1112334678899999999998999999999999999999999999965331 1111111000
Q ss_pred HHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhcc
Q 041135 615 ALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLD 662 (727)
Q Consensus 615 ~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 662 (727)
...............+.+++.+||..+|++||++.+|++.|+++.
T Consensus 222 ---~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 222 ---KCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred ---cCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 000000001122335788999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=341.44 Aligned_cols=256 Identities=27% Similarity=0.416 Sum_probs=201.0
Q ss_pred cCccccceeccCCceEEEEEEEcC-C--cEEEEEEeeeC-CchhHHHHHHHHHHHHHc-CCCCceeEeeEeeccceeeEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLAD-G--REVAVKQLKIG-GSQGEREFRAEVEIISRV-HHRHLVSLVGYCISERERLLV 455 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~~-g--~~vaVK~l~~~-~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lV 455 (727)
++|++.++||+|+||.||+|++++ | ..+++|.++.. .....+.+.+|+++++++ +|+||+++++++.+....++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 468899999999999999998754 3 34788888743 234456789999999999 799999999999999999999
Q ss_pred EeeccCCccchhcccCC--------------CCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcE
Q 041135 456 YEYVPNDTLHYHLHAEG--------------RPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEA 521 (727)
Q Consensus 456 ~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~v 521 (727)
|||+.+++|.++++... ...+.+..+++|+.||+.||+|||++ +|+|||||++||||++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 99999999999986532 12478889999999999999999998 99999999999999999999
Q ss_pred EEEeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhh
Q 041135 522 RVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWA 600 (727)
Q Consensus 522 kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~ 600 (727)
||+|||++..... .........+..|++||++.+..++.++|||||||+||||++ |+.||..... . ++.
T Consensus 159 kl~dfg~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~---~---~~~ 228 (297)
T cd05089 159 KIADFGLSRGEEV----YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC---A---ELY 228 (297)
T ss_pred EECCcCCCccccc----eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---H---HHH
Confidence 9999999863211 001111233567999999998889999999999999999997 9999965321 1 110
Q ss_pred HHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 601 RPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 601 ~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
. . +...+...........+.+|+.+||+.+|.+||++.+|++.|+.+..
T Consensus 229 ~-------------~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~ 277 (297)
T cd05089 229 E-------------K-LPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277 (297)
T ss_pred H-------------H-HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 0 0 01111111111223457899999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=348.83 Aligned_cols=249 Identities=21% Similarity=0.341 Sum_probs=196.1
Q ss_pred ceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHHHHHHc-CCCCceeEeeEeeccceeeEEEeeccC
Q 041135 387 NVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVEIISRV-HHRHLVSLVGYCISERERLLVYEYVPN 461 (727)
Q Consensus 387 ~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 461 (727)
++||+|+||.||+|+++ +++.||||+++... ......+.+|+.+++++ +|+||++++++|.+....||||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999975 58899999997532 22335688999999998 699999999999999999999999999
Q ss_pred CccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCccc
Q 041135 462 DTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHV 541 (727)
Q Consensus 462 gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 541 (727)
|+|.+++..++. +.+..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++.... ....
T Consensus 81 g~L~~~~~~~~~--l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~---~~~~ 152 (329)
T cd05588 81 GDLMFHMQRQRK--LPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR---PGDT 152 (329)
T ss_pred CCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCcccccccc---CCCc
Confidence 999988876543 89999999999999999999999 999999999999999999999999999874221 1112
Q ss_pred cccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCC--chhhHHhhHHHHHHhhchhhHHHHHHH
Q 041135 542 STRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLG--DESLVEWARPLLAEALEHEDFEALVDS 619 (727)
Q Consensus 542 ~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~--~~~l~~~~~~~l~~~~~~~~~~~l~d~ 619 (727)
....+|+..|+|||++.+..++.++|||||||+||||++|+.||+...... .....++.... +...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~------------~~~~ 220 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQV------------ILEK 220 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHH------------HHcC
Confidence 234678999999999999999999999999999999999999997533221 11111111111 1111
Q ss_pred HhhcccchhHHHHHHHHHHHHhccCCCCCCC------HHHHHHH
Q 041135 620 RLEKNYVDSEMFWMIEAAAACVRHSATKRPR------MSQVVRA 657 (727)
Q Consensus 620 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs------~~evl~~ 657 (727)
.+ .........+.+|+++||+.||++|++ +.+|+++
T Consensus 221 ~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 221 QI--RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred CC--CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 11 111122334788999999999999997 6777655
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=348.70 Aligned_cols=247 Identities=26% Similarity=0.367 Sum_probs=196.5
Q ss_pred CccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHHHHHHc-CCCCceeEeeEeeccceeeEEE
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVEIISRV-HHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
+|+++++||+|+||.||+|+.. +++.||||+++... ....+.+..|++++..+ +|++|+++++++.+.+..||||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4888999999999999999875 47899999987432 22234567788888877 5899999999999999999999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccC
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 536 (727)
||+.+|+|.+++..... +.+..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~~~~--~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~-- 153 (323)
T cd05616 81 EYVNGGDLMYQIQQVGR--FKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW-- 153 (323)
T ss_pred cCCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC--
Confidence 99999999998876544 88999999999999999999999 999999999999999999999999999874321
Q ss_pred CCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHH
Q 041135 537 SNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEAL 616 (727)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l 616 (727)
........+|+..|+|||++.++.++.++|||||||+||||++|+.||..... ..+. ..+
T Consensus 154 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~---~~~~----------------~~i 213 (323)
T cd05616 154 -DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DELF----------------QSI 213 (323)
T ss_pred -CCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH---HHHH----------------HHH
Confidence 11223346789999999999999999999999999999999999999975431 1111 111
Q ss_pred HHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCH-----HHHHHH
Q 041135 617 VDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRM-----SQVVRA 657 (727)
Q Consensus 617 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~ 657 (727)
.+..+ .+.......+.+|+.+||+.||++|++. .+|+++
T Consensus 214 ~~~~~--~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 214 MEHNV--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred HhCCC--CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 11111 1122233457889999999999999984 555443
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=336.02 Aligned_cols=254 Identities=23% Similarity=0.272 Sum_probs=207.1
Q ss_pred CccccceeccCCceEEEEEEEcC-CcEEEEEEeeeCCc---hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEe
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLAD-GREVAVKQLKIGGS---QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYE 457 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~~-g~~vaVK~l~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 457 (727)
.|++++.||+|.-|+||++++++ +..+|+|++..... +.....+.|-+||+.++|+.|..||+.|+.+...|||||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 47778999999999999999875 58999999965432 233456779999999999999999999999999999999
Q ss_pred eccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhc---
Q 041135 458 YVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALE--- 534 (727)
Q Consensus 458 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~--- 534 (727)
||.||+|..+++++....+.+..+..++.+++.||+|||.+ |||.|||||+||||.++|++.|+||.|+....-
T Consensus 158 yCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt 234 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT 234 (459)
T ss_pred cCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence 99999999999998888899999999999999999999999 999999999999999999999999998853210
Q ss_pred ------------------------------cCC--------------------CccccccccCCccccccCcccCCCCCc
Q 041135 535 ------------------------------LDS--------------------NTHVSTRVMGTFGYMAPEYATSGKLTE 564 (727)
Q Consensus 535 ------------------------------~~~--------------------~~~~~~~~~gt~~y~aPE~l~~~~~~~ 564 (727)
... .......++||-.|+|||++.+...+.
T Consensus 235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgs 314 (459)
T KOG0610|consen 235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGS 314 (459)
T ss_pred eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCc
Confidence 000 001112367999999999999999999
Q ss_pred hhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccC
Q 041135 565 KSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHS 644 (727)
Q Consensus 565 ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~d 644 (727)
++|+|+|||+|||||.|+.||.+.++.. .+..++...+.-.........+.+||++.|.+|
T Consensus 315 AVDWWtfGIflYEmLyG~TPFKG~~~~~-------------------Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKd 375 (459)
T KOG0610|consen 315 AVDWWTFGIFLYEMLYGTTPFKGSNNKE-------------------TLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKD 375 (459)
T ss_pred hhhHHHHHHHHHHHHhCCCCcCCCCchh-------------------hHHHHhcCCCcCCCCCcchhHHHHHHHHHhccC
Confidence 9999999999999999999998866421 122222222221112234566889999999999
Q ss_pred CCCCCC----HHHHHHH
Q 041135 645 ATKRPR----MSQVVRA 657 (727)
Q Consensus 645 P~~RPs----~~evl~~ 657 (727)
|.+|.. +.||-++
T Consensus 376 P~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 376 PSKRLGSKRGAAEIKRH 392 (459)
T ss_pred hhhhhccccchHHhhcC
Confidence 999999 7776554
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=339.37 Aligned_cols=255 Identities=26% Similarity=0.441 Sum_probs=201.3
Q ss_pred CccccceeccCCceEEEEEEEcC------CcEEEEEEeeeCCch-hHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeE
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLAD------GREVAVKQLKIGGSQ-GEREFRAEVEIISRVHHRHLVSLVGYCISERERLL 454 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~~------g~~vaVK~l~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 454 (727)
+|++.++||+|+||.||+|++.+ ++.||||+++..... ..+.+.+|+.+++.++|+||+++++++.+....++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 46778999999999999998632 478999999754433 23568899999999999999999999999999999
Q ss_pred EEeeccCCccchhcccCC--------------CCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCc
Q 041135 455 VYEYVPNDTLHYHLHAEG--------------RPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFE 520 (727)
Q Consensus 455 V~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~ 520 (727)
++||+.+++|.+++.... ...+.+..+++++.||++||+|||++ +|+|||||++|||+++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence 999999999998874321 22478888999999999999999999 9999999999999999999
Q ss_pred EEEEeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHh
Q 041135 521 ARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEW 599 (727)
Q Consensus 521 vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~ 599 (727)
+||+|||+++....... ........++..|+|||++.++.++.++|||||||+||||++ |..+|..... . ++
T Consensus 163 ~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~---~~ 235 (283)
T cd05091 163 VKISDLGLFREVYAADY-YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---Q---DV 235 (283)
T ss_pred eEecccccccccccchh-eeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH---H---HH
Confidence 99999999875422211 112223456778999999998899999999999999999998 8888865321 1 11
Q ss_pred hHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhh
Q 041135 600 ARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDT 660 (727)
Q Consensus 600 ~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 660 (727)
. +.+.+. ....+......++.+|+.+||+.+|++||++++|+..|+.
T Consensus 236 ~-------------~~i~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 236 I-------------EMIRNR-QVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred H-------------HHHHcC-CcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1 111111 1111223344568899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=357.37 Aligned_cols=253 Identities=22% Similarity=0.266 Sum_probs=200.3
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeC---CchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEE
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIG---GSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLV 455 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 455 (727)
.++|++.++||+|+||.||+++.. +|+.||||+++.. .......+.+|+++|+.++|+||+++++++.++...|||
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 467999999999999999999975 5889999998642 222334578899999999999999999999999999999
Q ss_pred EeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhcc
Q 041135 456 YEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALEL 535 (727)
Q Consensus 456 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 535 (727)
|||+.||+|.++++.. .+.+..+..++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++....
T Consensus 122 ~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~- 194 (370)
T cd05596 122 MEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA- 194 (370)
T ss_pred EcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccC-
Confidence 9999999999988654 367888899999999999999999 999999999999999999999999999975421
Q ss_pred CCCccccccccCCccccccCcccCC----CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchh
Q 041135 536 DSNTHVSTRVMGTFGYMAPEYATSG----KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHE 611 (727)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~ 611 (727)
.........+|+..|+|||++.+. .++.++|||||||+||||++|+.||..... ...
T Consensus 195 -~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~------------ 255 (370)
T cd05596 195 -NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGT------------ 255 (370)
T ss_pred -CCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH------HHH------------
Confidence 111122345799999999998753 478899999999999999999999975431 110
Q ss_pred hHHHHHHHHhhcccch--hHHHHHHHHHHHHhccCCCC--CCCHHHHHHHHh
Q 041135 612 DFEALVDSRLEKNYVD--SEMFWMIEAAAACVRHSATK--RPRMSQVVRALD 659 (727)
Q Consensus 612 ~~~~l~d~~l~~~~~~--~~~~~l~~li~~cl~~dP~~--RPs~~evl~~L~ 659 (727)
+..+++......+.. .....+.+|+++||+.++++ |+++.||+++-.
T Consensus 256 -~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~ 306 (370)
T cd05596 256 -YSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPF 306 (370)
T ss_pred -HHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcc
Confidence 111111110001111 12345778999999999987 999999988754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=334.35 Aligned_cols=255 Identities=25% Similarity=0.414 Sum_probs=200.0
Q ss_pred ccccceeccCCceEEEEEEEcC----CcEEEEEEeeeCCc--hhHHHHHHHHHHHHHcCCCCceeEeeEeeccce-----
Q 041135 383 FSAHNVLGEGGFGCVYKGVLAD----GREVAVKQLKIGGS--QGEREFRAEVEIISRVHHRHLVSLVGYCISERE----- 451 (727)
Q Consensus 383 ~~~~~~LG~G~fg~Vy~~~~~~----g~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~----- 451 (727)
|++++.||+|+||.||+|.+.. +..||||+++.... .....+.+|+++|+.++|+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678999999999999998643 36799999875432 334578999999999999999999999876554
Q ss_pred -eeEEEeeccCCccchhcccC----CCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEee
Q 041135 452 -RLLVYEYVPNDTLHYHLHAE----GRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADF 526 (727)
Q Consensus 452 -~~lV~Ey~~~gsL~~~L~~~----~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DF 526 (727)
.++||||+.+|+|..++... ....+++..++.++.||+.||+|||++ +|+|||||++|||+++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 68999999999999887542 234588999999999999999999998 9999999999999999999999999
Q ss_pred ccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHH
Q 041135 527 GLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLA 605 (727)
Q Consensus 527 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~ 605 (727)
|+++....... ........++..|++||++.+..++.++|||||||++|||++ |..||..... ..+.++
T Consensus 158 g~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~---~~~~~~------ 227 (273)
T cd05035 158 GLSKKIYSGDY-YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN---HEIYDY------ 227 (273)
T ss_pred cceeecccccc-ccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH------
Confidence 99985432221 111122345678999999998889999999999999999999 8888865331 111110
Q ss_pred HhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhc
Q 041135 606 EALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661 (727)
Q Consensus 606 ~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 661 (727)
+.+. ............+.+++++||+.||++||++.||++.|+++
T Consensus 228 ----------~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 228 ----------LRHG-NRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred ----------HHcC-CCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1110 01111223345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=358.50 Aligned_cols=255 Identities=23% Similarity=0.273 Sum_probs=197.1
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
.+|++++.||+|+||.||+|+.. +|+.||||++.... ......+.+|+++|++++|+||++++++|.+++.+||||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36899999999999999999965 58899999986432 223456889999999999999999999999999999999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccC
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 536 (727)
|||.+|+|.+++...+ .+.+..+..++.||+.||+|||++ +|+|||||++||||+.++.+||+|||++..+....
T Consensus 81 E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 81 DYIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 9999999999997654 378888899999999999999999 99999999999999999999999999985321000
Q ss_pred C----------------------------------------CccccccccCCccccccCcccCCCCCchhHHHHHhHHHH
Q 041135 537 S----------------------------------------NTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLL 576 (727)
Q Consensus 537 ~----------------------------------------~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~ 576 (727)
. ........+|+..|||||++.+..++.++||||||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 0 000112357999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCC---CHHH
Q 041135 577 ELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRP---RMSQ 653 (727)
Q Consensus 577 eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~e 653 (727)
||++|+.||...... ++...+.. .. ..+...........+.+++.+|+ .+|++|+ ++.|
T Consensus 236 ell~G~~Pf~~~~~~------~~~~~i~~----~~-------~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~e 297 (376)
T cd05598 236 EMLVGQPPFLADTPA------ETQLKVIN----WE-------TTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADE 297 (376)
T ss_pred ehhhCCCCCCCCCHH------HHHHHHhc----cC-------ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHH
Confidence 999999999764321 11100000 00 00000111112234566777766 4999999 8899
Q ss_pred HHHHH
Q 041135 654 VVRAL 658 (727)
Q Consensus 654 vl~~L 658 (727)
|+++-
T Consensus 298 ll~h~ 302 (376)
T cd05598 298 IKAHP 302 (376)
T ss_pred HhCCC
Confidence 98773
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=342.67 Aligned_cols=259 Identities=27% Similarity=0.406 Sum_probs=203.9
Q ss_pred cCccccceeccCCceEEEEEEEc--------CCcEEEEEEeeeCC-chhHHHHHHHHHHHHHc-CCCCceeEeeEeeccc
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA--------DGREVAVKQLKIGG-SQGEREFRAEVEIISRV-HHRHLVSLVGYCISER 450 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~--------~g~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~ 450 (727)
++|.+.+.||+|+||.||++++. ++..||+|+++... .....++.+|+++++++ +|+||++++++|.++.
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 56899999999999999999853 23579999987543 23446788999999999 7999999999999999
Q ss_pred eeeEEEeeccCCccchhcccCC--------------CCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEEC
Q 041135 451 ERLLVYEYVPNDTLHYHLHAEG--------------RPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLD 516 (727)
Q Consensus 451 ~~~lV~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~ 516 (727)
..|+||||+.+|+|.+++..+. ...+.+.++++++.||+.||+|||++ +|+|||||++|||++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEEc
Confidence 9999999999999999987542 13478899999999999999999998 999999999999999
Q ss_pred CCCcEEEEeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchh
Q 041135 517 SSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDES 595 (727)
Q Consensus 517 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~ 595 (727)
.++.+||+|||+++....... ........++..|+|||++.+..++.++|||||||+||||++ |+.||.....
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~----- 248 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDY-YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV----- 248 (307)
T ss_pred CCCcEEECCCcccccccccch-hhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH-----
Confidence 999999999999975422111 111122234568999999999899999999999999999998 8888864321
Q ss_pred hHHhhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 596 LVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 596 l~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
.+.. ..+...............+.+|+.+||..+|++||++.+|++.|+.+..
T Consensus 249 -~~~~--------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 249 -EELF--------------KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred -HHHH--------------HHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 1110 0111111111222234467889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=329.57 Aligned_cols=247 Identities=27% Similarity=0.415 Sum_probs=197.9
Q ss_pred ceeccCCceEEEEEEEcCCcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeeccCCccc
Q 041135 387 NVLGEGGFGCVYKGVLADGREVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPNDTLH 465 (727)
Q Consensus 387 ~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~ 465 (727)
++||+|+||.||+|.+.++..||+|+++.... .....+.+|++++++++|+||++++++|.+....++||||+.+++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 46999999999999988899999999875433 23457889999999999999999999999999999999999999999
Q ss_pred hhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCccccccc
Q 041135 466 YHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRV 545 (727)
Q Consensus 466 ~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~ 545 (727)
+++..... .+++..++.++.||+++|.|||++ +++|||||++||+|++++.+||+|||+++.... .........
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~--~~~~~~~~~ 154 (250)
T cd05085 81 SFLRKKKD-ELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDD--GIYSSSGLK 154 (250)
T ss_pred HHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccc--cccccCCCC
Confidence 98865432 478999999999999999999998 999999999999999999999999999874321 111111122
Q ss_pred cCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHhhcc
Q 041135 546 MGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRLEKN 624 (727)
Q Consensus 546 ~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~ 624 (727)
.+...|++||++.++.++.++|||||||++|||++ |..||..... ..... .+.......
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~---~~~~~-----------------~~~~~~~~~ 214 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN---QQARE-----------------QVEKGYRMS 214 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH---HHHHH-----------------HHHcCCCCC
Confidence 44678999999999899999999999999999998 9999965321 00000 001111111
Q ss_pred cchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 625 YVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 625 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
........+.+|+.+||..+|++||++.||++.|.
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 215 CPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 22223456889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=347.25 Aligned_cols=243 Identities=25% Similarity=0.357 Sum_probs=194.2
Q ss_pred ceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHHHHHHc-CCCCceeEeeEeeccceeeEEEeeccC
Q 041135 387 NVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVEIISRV-HHRHLVSLVGYCISERERLLVYEYVPN 461 (727)
Q Consensus 387 ~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 461 (727)
++||+|+||.||+|++. +|+.||||+++... ....+.+..|+++|..+ +|+||++++++|.+++..||||||+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999975 47899999987432 23335677899999876 799999999999999999999999999
Q ss_pred CccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCccc
Q 041135 462 DTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHV 541 (727)
Q Consensus 462 gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 541 (727)
|+|..++..... +.+..++.++.||++||+|||++ +|+|||||++||||+.++.+||+|||+++.... ....
T Consensus 81 ~~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~---~~~~ 152 (321)
T cd05591 81 GDLMFQIQRSRK--FDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGIL---NGVT 152 (321)
T ss_pred CcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceeccc---CCcc
Confidence 999988876544 88899999999999999999999 999999999999999999999999999874321 1122
Q ss_pred cccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHh
Q 041135 542 STRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRL 621 (727)
Q Consensus 542 ~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l 621 (727)
....+|+..|+|||++.+..++.++|||||||+||||++|+.||..... ..+. . .+.....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~---~~~~---~-------------~i~~~~~ 213 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE---DDLF---E-------------SILHDDV 213 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH---HHHH---H-------------HHHcCCC
Confidence 3345789999999999999999999999999999999999999975431 1111 1 1111000
Q ss_pred hcccchhHHHHHHHHHHHHhccCCCCCC-------CHHHHHHHH
Q 041135 622 EKNYVDSEMFWMIEAAAACVRHSATKRP-------RMSQVVRAL 658 (727)
Q Consensus 622 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-------s~~evl~~L 658 (727)
.+.......+.+|+++||+.||++|+ ++.+|+++-
T Consensus 214 --~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp 255 (321)
T cd05591 214 --LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHP 255 (321)
T ss_pred --CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCC
Confidence 01111223577899999999999999 778887663
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=331.15 Aligned_cols=250 Identities=28% Similarity=0.414 Sum_probs=197.5
Q ss_pred ceeccCCceEEEEEEEcC----CcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeeccC
Q 041135 387 NVLGEGGFGCVYKGVLAD----GREVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPN 461 (727)
Q Consensus 387 ~~LG~G~fg~Vy~~~~~~----g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 461 (727)
++||+|+||.||+|++.. +..||+|.++.... ...+++.+|+++|++++|+||+++++++. ....++||||+.+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999998532 26899999875544 24567999999999999999999999876 4467999999999
Q ss_pred CccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCccc
Q 041135 462 DTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHV 541 (727)
Q Consensus 462 gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 541 (727)
++|.+++.... .+.+..++.++.||+.||+|||.+ +|+|||||++||||++++.+||+|||+++...........
T Consensus 80 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~ 154 (257)
T cd05060 80 GPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA 154 (257)
T ss_pred CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence 99999997765 489999999999999999999998 9999999999999999999999999999865322211111
Q ss_pred cccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHH
Q 041135 542 STRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSR 620 (727)
Q Consensus 542 ~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~ 620 (727)
.....++..|++||.+.+..++.++|||||||+||||++ |+.||..... ..+..+.. . .
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~~~--------~---------~ 214 (257)
T cd05060 155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAMLE--------S---------G 214 (257)
T ss_pred ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHH--------c---------C
Confidence 122234568999999999999999999999999999998 9999975431 11111110 0 0
Q ss_pred hhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhcc
Q 041135 621 LEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLD 662 (727)
Q Consensus 621 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 662 (727)
............+.+|+.+||..+|++||++.+|++.|+++.
T Consensus 215 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 215 ERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 000111222345789999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=352.66 Aligned_cols=253 Identities=23% Similarity=0.252 Sum_probs=199.8
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
++|++.++||+|+||.||+++.. +|+.||||+++... ....+.+.+|+++++.++|+||+++++++.++...||||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46899999999999999999865 68899999997532 233456889999999999999999999999999999999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccC
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 536 (727)
||+.+|+|.+++.... ..+++..+..++.||++||+|||++ +|+|||||++||||+.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~- 155 (330)
T cd05601 81 EYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN- 155 (330)
T ss_pred CCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCC-
Confidence 9999999999987652 2488999999999999999999999 9999999999999999999999999999754221
Q ss_pred CCccccccccCCccccccCccc------CCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhch
Q 041135 537 SNTHVSTRVMGTFGYMAPEYAT------SGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEH 610 (727)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~l~------~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~ 610 (727)
.........|+..|+|||++. +..++.++||||||||||||++|+.||...... +....++ ..
T Consensus 156 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~~i~----~~ 224 (330)
T cd05601 156 -KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA------KTYNNIM----NF 224 (330)
T ss_pred -CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH------HHHHHHH----cC
Confidence 111223357899999999987 456789999999999999999999999754311 1111110 00
Q ss_pred hhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 611 EDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 611 ~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
.. .+...........+.+|+..||+ ++++|+++.+|+++
T Consensus 225 ~~-------~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 225 QR-------FLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred CC-------ccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 00 00000011123447788899997 99999999999876
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=333.32 Aligned_cols=254 Identities=25% Similarity=0.422 Sum_probs=205.1
Q ss_pred hcCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeec
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYV 459 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 459 (727)
.++|++.++||+|+||.||+|++.++..|+||.++.. ....+.+.+|+++|++++|+||+++++++.+ ...++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 4679999999999999999999877888999988643 2345678999999999999999999999887 7789999999
Q ss_pred cCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCc
Q 041135 460 PNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNT 539 (727)
Q Consensus 460 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 539 (727)
.+++|.+++.......+++..++.++.||+.||.|||++ +|+|||||++||+|+.++.+||+|||+++.+... ..
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~--~~ 157 (260)
T cd05073 83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDN--EY 157 (260)
T ss_pred CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCC--Cc
Confidence 999999999776555688999999999999999999998 9999999999999999999999999999754221 11
Q ss_pred cccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHH
Q 041135 540 HVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVD 618 (727)
Q Consensus 540 ~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d 618 (727)
.......++..|++||++.++.++.++|||||||++|||++ |+.||..... ..+.++. .
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~---~~~~~~~-----------------~ 217 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---PEVIRAL-----------------E 217 (260)
T ss_pred ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH---HHHHHHH-----------------h
Confidence 11222345678999999998889999999999999999999 9999975321 1111110 0
Q ss_pred HHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhh
Q 041135 619 SRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDT 660 (727)
Q Consensus 619 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 660 (727)
..............+.+++.+||+.+|++||++.+|++.|+.
T Consensus 218 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 218 RGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 000001112233458899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=333.82 Aligned_cols=259 Identities=21% Similarity=0.345 Sum_probs=206.4
Q ss_pred cCccccceeccCCceEEEEEEE-cCCcEEEEEEeeeCC---chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVL-ADGREVAVKQLKIGG---SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
++|++.+.||+|+||.||+|+. .+|+.|+||.+.... .....++.+|+++++.++|+||++++++|.+++..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999999995 478999999886532 233457889999999999999999999999999999999
Q ss_pred eeccCCccchhcccC--CCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhc
Q 041135 457 EYVPNDTLHYHLHAE--GRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALE 534 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 534 (727)
||+.+++|.+++... ....+.+..+++++.||++||.|||++ +|+|+|||++||+++.++.++|+|||+++....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999988642 234588999999999999999999999 999999999999999999999999999875422
Q ss_pred cCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHH
Q 041135 535 LDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFE 614 (727)
Q Consensus 535 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~ 614 (727)
. ........|+..|+|||++.+..++.++||||||+++|||++|..||..... ...++...
T Consensus 159 ~---~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~------------ 219 (267)
T cd08229 159 K---TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKK------------ 219 (267)
T ss_pred C---CcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc----hHHHHhhh------------
Confidence 1 1122345688899999999988899999999999999999999999964321 11111110
Q ss_pred HHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhcc
Q 041135 615 ALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLD 662 (727)
Q Consensus 615 ~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 662 (727)
+................+.+++.+||+.+|++||+|.+|++.|+++.
T Consensus 220 -~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 220 -IEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred -hhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 00000000011123345788999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=355.44 Aligned_cols=253 Identities=22% Similarity=0.266 Sum_probs=198.2
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeC---CchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEE
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIG---GSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLV 455 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 455 (727)
.++|++.++||+|+||.||++++. +++.||+|++... .......+.+|+++++.++|+||+++++++.++...|||
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV 121 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 467999999999999999999975 4789999998632 222345688999999999999999999999999999999
Q ss_pred EeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhcc
Q 041135 456 YEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALEL 535 (727)
Q Consensus 456 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 535 (727)
|||+.+|+|.+++... .+.+..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++....
T Consensus 122 ~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~- 194 (370)
T cd05621 122 MEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE- 194 (370)
T ss_pred EcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceeccc-
Confidence 9999999999998654 378889999999999999999999 999999999999999999999999999975421
Q ss_pred CCCccccccccCCccccccCcccCC----CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchh
Q 041135 536 DSNTHVSTRVMGTFGYMAPEYATSG----KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHE 611 (727)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~ 611 (727)
.........+|+..|+|||++.+. .++.++|||||||+||||++|+.||..... ...
T Consensus 195 -~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~------~~~------------ 255 (370)
T cd05621 195 -TGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL------VGT------------ 255 (370)
T ss_pred -CCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH------HHH------------
Confidence 111122346799999999999764 378899999999999999999999975431 111
Q ss_pred hHHHHHHHHhhcccc--hhHHHHHHHHHHHHhccCCCC--CCCHHHHHHHHh
Q 041135 612 DFEALVDSRLEKNYV--DSEMFWMIEAAAACVRHSATK--RPRMSQVVRALD 659 (727)
Q Consensus 612 ~~~~l~d~~l~~~~~--~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~L~ 659 (727)
+..+++......+. ......+.+++++||..++.+ |+++.|++++-+
T Consensus 256 -~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~ 306 (370)
T cd05621 256 -YSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPF 306 (370)
T ss_pred -HHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcc
Confidence 11111111111111 112334667888898755543 889999988744
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=355.18 Aligned_cols=263 Identities=22% Similarity=0.315 Sum_probs=198.3
Q ss_pred CccccceeccCCceEEEEEEE-cCCcEEEEEEeeeC--CchhHHHHHHHHHHHHHcCCCCceeEeeEeeccc-----eee
Q 041135 382 GFSAHNVLGEGGFGCVYKGVL-ADGREVAVKQLKIG--GSQGEREFRAEVEIISRVHHRHLVSLVGYCISER-----ERL 453 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~-~~g~~vaVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~-----~~~ 453 (727)
+|+++++||+|+||.||+|+. .+|+.||||++... .....+.+.+|+++|+.++|+||+++++++.... ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478899999999999999996 46899999998643 2233467889999999999999999999998776 789
Q ss_pred EEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhh
Q 041135 454 LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIAL 533 (727)
Q Consensus 454 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~ 533 (727)
+||||+. ++|.+++.... .+++..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||+++...
T Consensus 81 lv~e~~~-~~l~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ--PLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEeeccc-cCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 9999996 56777665544 489999999999999999999999 99999999999999999999999999997542
Q ss_pred ccCCCccccccccCCccccccCcccCC-CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhh
Q 041135 534 ELDSNTHVSTRVMGTFGYMAPEYATSG-KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHED 612 (727)
Q Consensus 534 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~ 612 (727)
.. .........++..|+|||++.+. .++.++||||||||||||++|+.+|.+.........+ ...+....
T Consensus 155 ~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i-------~~~~g~~~ 225 (372)
T cd07853 155 PD--ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLI-------TDLLGTPS 225 (372)
T ss_pred cC--ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHH-------HHHcCCCC
Confidence 11 11222334678899999999874 5789999999999999999999999865432111100 00000000
Q ss_pred HHHH-------HHHHhhc-----------ccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 613 FEAL-------VDSRLEK-----------NYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 613 ~~~l-------~d~~l~~-----------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
...+ ....+.. .........+.+|+.+||+.||++|+++.|++++-.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 290 (372)
T cd07853 226 LEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY 290 (372)
T ss_pred HHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHh
Confidence 0000 0000000 011112345789999999999999999999998743
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=335.81 Aligned_cols=249 Identities=25% Similarity=0.331 Sum_probs=195.5
Q ss_pred eccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeeccCCcc
Q 041135 389 LGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPNDTL 464 (727)
Q Consensus 389 LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL 464 (727)
||+|+||.||+++.+ +|+.||+|++.... ......+..|+++|++++|+||+++++++.++...+|||||+.|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999865 58999999986422 12234566799999999999999999999999999999999999999
Q ss_pred chhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCcccccc
Q 041135 465 HYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTR 544 (727)
Q Consensus 465 ~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 544 (727)
.+++.......+++..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||++..... ......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~----~~~~~~ 153 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKD----GKTITQ 153 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCC----Cceeec
Confidence 9888766655689999999999999999999999 999999999999999999999999999875422 112233
Q ss_pred ccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHhhcc
Q 041135 545 VMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRLEKN 624 (727)
Q Consensus 545 ~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~ 624 (727)
..|+..|+|||++.+..++.++|||||||+||||++|+.||....... ...++.+..+ ...+...
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~--~~~~~~~~~~-------------~~~~~~~ 218 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV--AKEELKRRTL-------------EDEVKFE 218 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh--hHHHHHHHhh-------------ccccccc
Confidence 568899999999999899999999999999999999999997543211 1111111111 0000000
Q ss_pred cchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhh
Q 041135 625 YVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDT 660 (727)
Q Consensus 625 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 660 (727)
.......+.+|+.+||+.||++|+++.|+++.+..
T Consensus 219 -~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~ 253 (277)
T cd05607 219 -HQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRK 253 (277)
T ss_pred -cccCCHHHHHHHHHHhccCHhhCCCCccchhhhhc
Confidence 00112347889999999999999999887655443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=331.33 Aligned_cols=250 Identities=26% Similarity=0.405 Sum_probs=200.3
Q ss_pred ceeccCCceEEEEEEEcC--C--cEEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeeccC
Q 041135 387 NVLGEGGFGCVYKGVLAD--G--REVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPN 461 (727)
Q Consensus 387 ~~LG~G~fg~Vy~~~~~~--g--~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 461 (727)
++||+|+||.||+|.+.+ + ..||||.++.... ...+.+.+|+++|++++|+||+++++++.+ ...++||||+.+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998743 3 3689999986655 556789999999999999999999999988 888999999999
Q ss_pred CccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCccc
Q 041135 462 DTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHV 541 (727)
Q Consensus 462 gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 541 (727)
++|.+++.......+.+..++.++.||++||+|||++ +|+|||||++||||+.++.+||+|||+++.+.........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 9999998776534689999999999999999999999 9999999999999999999999999999865332222122
Q ss_pred cccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHH
Q 041135 542 STRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSR 620 (727)
Q Consensus 542 ~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~ 620 (727)
.....++..|++||++.+..++.++|||||||++|||++ |+.||..... ..+.+ .+.. ..
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~---~~~~-------------~~ 217 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG---SQILK---KIDK-------------EG 217 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH---HHHHH---HHHh-------------cC
Confidence 223457789999999999899999999999999999998 9999965321 11111 0000 00
Q ss_pred hhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 621 LEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 621 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
............+.+++.+||+.+|++||++.+|++.|.
T Consensus 218 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 218 ERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 000111122346889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=356.62 Aligned_cols=203 Identities=26% Similarity=0.341 Sum_probs=173.2
Q ss_pred CccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEe
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYE 457 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 457 (727)
.|+++++||+|+||.||+|+.. +++.||||++.... ......+.+|+++|++++|+||++++++|.++..+|||||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5889999999999999999864 58899999986432 2234578899999999999999999999999999999999
Q ss_pred eccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCC
Q 041135 458 YVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDS 537 (727)
Q Consensus 458 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 537 (727)
||.+|+|.+++.+.+ .+.+..+..++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++.+.....
T Consensus 82 ~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 82 YIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 999999999987654 378888999999999999999999 999999999999999999999999999853211000
Q ss_pred --------------------------------------------CccccccccCCccccccCcccCCCCCchhHHHHHhH
Q 041135 538 --------------------------------------------NTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGV 573 (727)
Q Consensus 538 --------------------------------------------~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gv 573 (727)
........+||..|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 000112357999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCC
Q 041135 574 VLLELITGRKPVDASQ 589 (727)
Q Consensus 574 il~eLltG~~Pf~~~~ 589 (727)
+||||++|+.||....
T Consensus 237 il~elltG~~Pf~~~~ 252 (382)
T cd05625 237 ILYEMLVGQPPFLAQT 252 (382)
T ss_pred HHHHHHhCCCCCCCCC
Confidence 9999999999997643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=346.95 Aligned_cols=249 Identities=22% Similarity=0.361 Sum_probs=194.9
Q ss_pred ceeccCCceEEEEEEEc-CCcEEEEEEeeeC---CchhHHHHHHHHHHHHHc-CCCCceeEeeEeeccceeeEEEeeccC
Q 041135 387 NVLGEGGFGCVYKGVLA-DGREVAVKQLKIG---GSQGEREFRAEVEIISRV-HHRHLVSLVGYCISERERLLVYEYVPN 461 (727)
Q Consensus 387 ~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~---~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 461 (727)
++||+|+||.||+|++. +++.||||+++.. .......+.+|+.++.++ +|+||+++++++.++...||||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999975 5789999999753 223345678899998877 799999999999999999999999999
Q ss_pred CccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCccc
Q 041135 462 DTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHV 541 (727)
Q Consensus 462 gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 541 (727)
|+|..++..... +.+..++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++.... ....
T Consensus 81 ~~L~~~~~~~~~--l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~---~~~~ 152 (329)
T cd05618 81 GDLMFHMQRQRK--LPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR---PGDT 152 (329)
T ss_pred CCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccC---CCCc
Confidence 999988866543 88999999999999999999999 999999999999999999999999999974321 1112
Q ss_pred cccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCc--hhhHHhhHHHHHHhhchhhHHHHHHH
Q 041135 542 STRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGD--ESLVEWARPLLAEALEHEDFEALVDS 619 (727)
Q Consensus 542 ~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~--~~l~~~~~~~l~~~~~~~~~~~l~d~ 619 (727)
....+|+..|+|||++.+..++.++|||||||+||||++|+.||........ .....+.... +...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~------------i~~~ 220 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV------------ILEK 220 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHH------------HhcC
Confidence 2346789999999999999999999999999999999999999964322111 1111111110 1111
Q ss_pred HhhcccchhHHHHHHHHHHHHhccCCCCCCC------HHHHHHH
Q 041135 620 RLEKNYVDSEMFWMIEAAAACVRHSATKRPR------MSQVVRA 657 (727)
Q Consensus 620 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs------~~evl~~ 657 (727)
.+ .+.......+.+|+++||+.||++|++ +.+|+++
T Consensus 221 ~~--~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 221 QI--RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred CC--CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 11 112223345778999999999999998 5676655
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=340.72 Aligned_cols=260 Identities=27% Similarity=0.410 Sum_probs=204.7
Q ss_pred hcCccccceeccCCceEEEEEEEc--------CCcEEEEEEeeeCC-chhHHHHHHHHHHHHHc-CCCCceeEeeEeecc
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA--------DGREVAVKQLKIGG-SQGEREFRAEVEIISRV-HHRHLVSLVGYCISE 449 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~--------~g~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~ 449 (727)
.++|.+.+.||+|+||.||+|++. ++..||||+++... ....+++.+|+.+++.+ +|+||++++++|...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 456888999999999999999742 24579999886432 34456799999999999 799999999999999
Q ss_pred ceeeEEEeeccCCccchhcccCC--------------CCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEE
Q 041135 450 RERLLVYEYVPNDTLHYHLHAEG--------------RPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILL 515 (727)
Q Consensus 450 ~~~~lV~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl 515 (727)
...++||||+.+|+|.+++.... ...+.+..+++++.||++||.|||++ +|+|||||++||||
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEE
Confidence 99999999999999999987542 13477888999999999999999999 99999999999999
Q ss_pred CCCCcEEEEeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCch
Q 041135 516 DSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDE 594 (727)
Q Consensus 516 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~ 594 (727)
++++.+||+|||+++....... ........++..|+|||++.+..++.++|||||||+||||++ |..+|....
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~----- 244 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDY-YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP----- 244 (304)
T ss_pred cCCCcEEECCCccceecccccc-cccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC-----
Confidence 9999999999999975432211 111223445678999999999889999999999999999998 788886432
Q ss_pred hhHHhhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 595 SLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 595 ~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
..++.. .+...............+.+|+.+||+.+|++||++.||++.|+++..
T Consensus 245 -~~~~~~--------------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 245 -VEELFK--------------LLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred -HHHHHH--------------HHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 111111 011111111122234568889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=331.27 Aligned_cols=249 Identities=28% Similarity=0.438 Sum_probs=201.2
Q ss_pred cCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEee-ccceeeEEEeec
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCI-SERERLLVYEYV 459 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~-~~~~~~lV~Ey~ 459 (727)
++|++.++||+|+||.||++... |..|++|.++.. ...+.+.+|+.++++++|+||+++++++. ++...++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 46889999999999999999875 788999998643 33467899999999999999999999765 456789999999
Q ss_pred cCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCc
Q 041135 460 PNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNT 539 (727)
Q Consensus 460 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 539 (727)
.+++|.++++.+....+.+..+++++.||+.||+|||++ +|+|||||++|||+++++.+||+|||+++.....
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~---- 155 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---- 155 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceecccc----
Confidence 999999999876665689999999999999999999998 9999999999999999999999999998753211
Q ss_pred cccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHH
Q 041135 540 HVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVD 618 (727)
Q Consensus 540 ~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d 618 (727)
.....++..|++||++.+..++.++|||||||++|||++ |+.||.... +.++... +.
T Consensus 156 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~------~~~~~~~--------------~~ 213 (256)
T cd05082 156 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP------LKDVVPR--------------VE 213 (256)
T ss_pred --CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC------HHHHHHH--------------Hh
Confidence 122344568999999998899999999999999999998 999986432 1111100 01
Q ss_pred HHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhc
Q 041135 619 SRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661 (727)
Q Consensus 619 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 661 (727)
..............+.+++.+||+.+|++||++.+|++.|+.+
T Consensus 214 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 214 KGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 1111111122344578999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=339.37 Aligned_cols=259 Identities=27% Similarity=0.441 Sum_probs=203.1
Q ss_pred HhcCccccceeccCCceEEEEEEEcC------CcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEeeccce
Q 041135 379 ATNGFSAHNVLGEGGFGCVYKGVLAD------GREVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYCISERE 451 (727)
Q Consensus 379 ~~~~~~~~~~LG~G~fg~Vy~~~~~~------g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~ 451 (727)
..++|++.++||+|+||.||+|+.++ +..||||.++.... .....+.+|+.+++.++|+||+++++++.+...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 35679999999999999999997542 45799998864432 233568899999999999999999999999999
Q ss_pred eeEEEeeccCCccchhcccCC--------CCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEE
Q 041135 452 RLLVYEYVPNDTLHYHLHAEG--------RPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARV 523 (727)
Q Consensus 452 ~~lV~Ey~~~gsL~~~L~~~~--------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL 523 (727)
.++||||+.+|+|.++++... ...+.+..+++++.||+.||.|||++ +|+|||||++|||+++++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEE
Confidence 999999999999999986532 23356778899999999999999999 9999999999999999999999
Q ss_pred EeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHH
Q 041135 524 ADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARP 602 (727)
Q Consensus 524 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~ 602 (727)
+|||+++....... ........++..|++||.+.++.++.++|||||||+||||++ |+.||..... ..+.+
T Consensus 161 ~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~---~~~~~---- 232 (288)
T cd05061 161 GDFGMTRDIYETDY-YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN---EQVLK---- 232 (288)
T ss_pred CcCCcccccccccc-ccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHH----
Confidence 99999975432111 111222345778999999999899999999999999999998 7888865321 11110
Q ss_pred HHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhc
Q 041135 603 LLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661 (727)
Q Consensus 603 ~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 661 (727)
.+++... ..........+.+|+++||+.||++||++.+|++.|++.
T Consensus 233 ------------~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 233 ------------FVMDGGY-LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred ------------HHHcCCC-CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 0111100 011122235688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=332.53 Aligned_cols=255 Identities=25% Similarity=0.397 Sum_probs=196.1
Q ss_pred ccccceeccCCceEEEEEEEcCCc---EEEEEEeeeCC--chhHHHHHHHHHHHHHcCCCCceeEeeEeecc------ce
Q 041135 383 FSAHNVLGEGGFGCVYKGVLADGR---EVAVKQLKIGG--SQGEREFRAEVEIISRVHHRHLVSLVGYCISE------RE 451 (727)
Q Consensus 383 ~~~~~~LG~G~fg~Vy~~~~~~g~---~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~------~~ 451 (727)
|.+.++||+|+||.||+|++.++. .||||.++... ....+.+.+|+++|+.++|+||++++++|... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 456789999999999999976432 58999886532 33456789999999999999999999987532 24
Q ss_pred eeEEEeeccCCccchhcccC----CCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeec
Q 041135 452 RLLVYEYVPNDTLHYHLHAE----GRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFG 527 (727)
Q Consensus 452 ~~lV~Ey~~~gsL~~~L~~~----~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFG 527 (727)
.++||||+.+|+|.+++... ....+++..++.++.||+.||+|||++ +|+|||||++|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence 68999999999998876422 223478999999999999999999998 99999999999999999999999999
Q ss_pred cchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHH
Q 041135 528 LAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAE 606 (727)
Q Consensus 528 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~ 606 (727)
+++....... ........++..|++||++.+..++.++|||||||++|||++ |+.||..... ..+.+
T Consensus 158 ~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~-------- 225 (272)
T cd05075 158 LSKKIYNGDY-YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN---SEIYD-------- 225 (272)
T ss_pred cccccCcccc-eecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHH--------
Confidence 9986432111 111122345678999999999999999999999999999999 8888865321 11110
Q ss_pred hhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhc
Q 041135 607 ALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661 (727)
Q Consensus 607 ~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 661 (727)
.+..+. ...........+.+++.+||+.||++||++.+|++.|+++
T Consensus 226 ~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 226 YLRQGN---------RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred HHHcCC---------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 000000 0011122234478999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=335.91 Aligned_cols=260 Identities=24% Similarity=0.395 Sum_probs=205.9
Q ss_pred hcCccccceeccCCceEEEEEEEcC-----CcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEeec-ccee
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLAD-----GREVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYCIS-ERER 452 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~~-----g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~-~~~~ 452 (727)
.++|++.++||+|+||.||+|.+.+ +..|++|+++.... .....+.+|+++|++++|+||+++++++.. +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4578899999999999999999865 68899999875433 334568899999999999999999998876 4677
Q ss_pred eEEEeeccCCccchhcccCCC------CcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEee
Q 041135 453 LLVYEYVPNDTLHYHLHAEGR------PVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADF 526 (727)
Q Consensus 453 ~lV~Ey~~~gsL~~~L~~~~~------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DF 526 (727)
++++||+.+++|.+++..... ..+.+..++.++.||+.||+|||++ +|+|||||++|||+++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCC
Confidence 899999999999999865422 3588999999999999999999998 9999999999999999999999999
Q ss_pred ccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHH
Q 041135 527 GLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLA 605 (727)
Q Consensus 527 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~ 605 (727)
|+++.+...+ .........++..|+|||++.+..++.++|||||||+||||++ |+.||...+. ..+..+.
T Consensus 162 g~~~~~~~~~-~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~----- 232 (280)
T cd05043 162 ALSRDLFPMD-YHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP---FEMAAYL----- 232 (280)
T ss_pred CCcccccCCc-eEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH---HHHHHHH-----
Confidence 9997543221 1111223456778999999998889999999999999999999 9999975432 1111110
Q ss_pred HhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 606 EALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 606 ~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
.. .............+.+++++||..||++||++.||++.|+.+..
T Consensus 233 ---~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 233 ---KD---------GYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred ---Hc---------CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 00 00000111123457899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=335.76 Aligned_cols=255 Identities=24% Similarity=0.372 Sum_probs=201.8
Q ss_pred hcCccccceeccCCceEEEEEEE-cCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEee
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVL-ADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 458 (727)
.++|++.+.||+|+||.||+|+. .+|+.||||+++.........+++|+.++++++|+||++++++|..++..|+||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35689999999999999999996 46889999999765555556788999999999999999999999999999999999
Q ss_pred ccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCC
Q 041135 459 VPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSN 538 (727)
Q Consensus 459 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 538 (727)
+.+++|.++++.+. .+++..+..++.||++||+|||++ +|+|||||++||||++++.+||+|||+++.....
T Consensus 88 ~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~--- 159 (267)
T cd06646 88 CGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITAT--- 159 (267)
T ss_pred CCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccc---
Confidence 99999999887654 378999999999999999999998 9999999999999999999999999999754211
Q ss_pred ccccccccCCccccccCccc---CCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHH
Q 041135 539 THVSTRVMGTFGYMAPEYAT---SGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEA 615 (727)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~l~---~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~ 615 (727)
........|+..|++||.+. ...++.++|||||||++|||++|+.||......... ..+ ....+.
T Consensus 160 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~--~~~---------~~~~~~- 227 (267)
T cd06646 160 IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL--FLM---------SKSNFQ- 227 (267)
T ss_pred ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh--eee---------ecCCCC-
Confidence 11122346888999999985 345788999999999999999999998643321100 000 000000
Q ss_pred HHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 041135 616 LVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRAL 658 (727)
Q Consensus 616 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 658 (727)
...+. ........+.+++++||+.+|++||++++|+++|
T Consensus 228 --~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 228 --PPKLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred --CCCCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 00000 0011224578999999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=344.93 Aligned_cols=241 Identities=27% Similarity=0.405 Sum_probs=190.4
Q ss_pred ceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHHHHHHc-CCCCceeEeeEeeccceeeEEEeeccC
Q 041135 387 NVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVEIISRV-HHRHLVSLVGYCISERERLLVYEYVPN 461 (727)
Q Consensus 387 ~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 461 (727)
++||+|+||.||+|++. +++.||||+++... ....+.+..|.+++..+ +|+||+++++++..+...||||||+.|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 47889999997432 22334566677777754 799999999999999999999999999
Q ss_pred CccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCccc
Q 041135 462 DTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHV 541 (727)
Q Consensus 462 gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 541 (727)
|+|.++++.... +.+..+..++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++..... ...
T Consensus 81 g~L~~~~~~~~~--~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~---~~~ 152 (316)
T cd05592 81 GDLMFHIQSSGR--FDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG---EGK 152 (316)
T ss_pred CcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCC---CCc
Confidence 999998876554 88899999999999999999999 9999999999999999999999999999753211 122
Q ss_pred cccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHh
Q 041135 542 STRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRL 621 (727)
Q Consensus 542 ~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l 621 (727)
....+|+..|+|||++.+..++.++|||||||+||||++|+.||.+... ..+ ... +...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~---~~~---~~~-------------i~~~-- 211 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE---DEL---FDS-------------ILND-- 211 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH---HHH---HHH-------------HHcC--
Confidence 3446799999999999999999999999999999999999999975431 111 000 0000
Q ss_pred hcccchhHHHHHHHHHHHHhccCCCCCCCHH-HHHH
Q 041135 622 EKNYVDSEMFWMIEAAAACVRHSATKRPRMS-QVVR 656 (727)
Q Consensus 622 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~ 656 (727)
...+.......+.+|+.+||+.||++|+++. ++++
T Consensus 212 ~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 212 RPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 0111112233467899999999999999875 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=344.82 Aligned_cols=242 Identities=26% Similarity=0.383 Sum_probs=191.8
Q ss_pred ceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHHHHHHc-CCCCceeEeeEeeccceeeEEEeeccC
Q 041135 387 NVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVEIISRV-HHRHLVSLVGYCISERERLLVYEYVPN 461 (727)
Q Consensus 387 ~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 461 (727)
++||+|+||.||+|+++ +|+.||||+++... ......+..|++++..+ +|+||+++++++.+++..||||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999975 58899999997532 22345577788888764 899999999999999999999999999
Q ss_pred CccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCccc
Q 041135 462 DTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHV 541 (727)
Q Consensus 462 gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 541 (727)
|+|..++..+.. +++..++.++.||++||+|||++ +|+|||||++||||+.++.+||+|||+++... .....
T Consensus 81 g~L~~~i~~~~~--~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~---~~~~~ 152 (316)
T cd05620 81 GDLMFHIQDKGR--FDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENV---FGDNR 152 (316)
T ss_pred CcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecc---cCCCc
Confidence 999998876544 78899999999999999999999 99999999999999999999999999987421 11122
Q ss_pred cccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHh
Q 041135 542 STRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRL 621 (727)
Q Consensus 542 ~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l 621 (727)
....+|+..|+|||++.+..++.++|||||||+||||++|+.||..... ..+.+ .+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~---~~~~~----------------~~~~~-- 211 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE---DELFE----------------SIRVD-- 211 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHHH----------------HHHhC--
Confidence 3446799999999999999999999999999999999999999975321 11110 00000
Q ss_pred hcccchhHHHHHHHHHHHHhccCCCCCCCHH-HHHHH
Q 041135 622 EKNYVDSEMFWMIEAAAACVRHSATKRPRMS-QVVRA 657 (727)
Q Consensus 622 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~~ 657 (727)
...+.......+.+|+++||+.||++|+++. +|+++
T Consensus 212 ~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h 248 (316)
T cd05620 212 TPHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGH 248 (316)
T ss_pred CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 0111111233477899999999999999985 55533
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=333.60 Aligned_cols=257 Identities=26% Similarity=0.435 Sum_probs=201.7
Q ss_pred cCccccceeccCCceEEEEEEEcC-C---cEEEEEEeeeCC-chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLAD-G---REVAVKQLKIGG-SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLV 455 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~~-g---~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 455 (727)
.+|++.++||+|+||.||+|++.. | ..||||+++... .....+|.+|++++++++|+||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 347889999999999999999753 3 369999987543 33446899999999999999999999999999999999
Q ss_pred EeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhcc
Q 041135 456 YEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALEL 535 (727)
Q Consensus 456 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 535 (727)
|||+.+++|.+++..... .+++.+++.++.|++.||+|||++ +|+|||||++||||+.++.+||+|||+++.....
T Consensus 84 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 84 TEFMENGALDSFLRQNDG-QFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred EecCCCCcHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 999999999999876433 578999999999999999999998 9999999999999999999999999998754322
Q ss_pred CCCcccccc--ccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhh
Q 041135 536 DSNTHVSTR--VMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHED 612 (727)
Q Consensus 536 ~~~~~~~~~--~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~ 612 (727)
......... ..++..|++||++.+..++.++|||||||++|||++ |..||..... ..+.++.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~---~~~~~~i------------ 224 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN---QDVINAI------------ 224 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH---HHHHHHH------------
Confidence 211111111 112457999999999999999999999999999886 9999865331 1111111
Q ss_pred HHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhc
Q 041135 613 FEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661 (727)
Q Consensus 613 ~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 661 (727)
...............+.+++.+||..++++||++.+|+..|+++
T Consensus 225 -----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 225 -----EQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred -----HcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00001111112234578899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=337.01 Aligned_cols=255 Identities=27% Similarity=0.448 Sum_probs=203.0
Q ss_pred cCccccceeccCCceEEEEEEEc------CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA------DGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLL 454 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 454 (727)
++|++.++||+|+||.||+++.. ++..|++|.++.........|.+|+++++.++|+||+++++++.++...++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 45778899999999999999742 356899999876666666789999999999999999999999999999999
Q ss_pred EEeeccCCccchhcccCCC-------------CcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcE
Q 041135 455 VYEYVPNDTLHYHLHAEGR-------------PVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEA 521 (727)
Q Consensus 455 V~Ey~~~gsL~~~L~~~~~-------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~v 521 (727)
||||+.+++|.++++.... ..+.+..++.++.||+.||+|||++ +|+|||||++|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCE
Confidence 9999999999998875431 2478899999999999999999998 99999999999999999999
Q ss_pred EEEeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhh
Q 041135 522 RVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWA 600 (727)
Q Consensus 522 kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~ 600 (727)
||+|||+++...... .........++..|++||++.+..++.++|||||||+||||++ |+.||...... ...
T Consensus 162 kL~dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~--- 234 (280)
T cd05092 162 KIGDFGMSRDIYSTD-YYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT---EAI--- 234 (280)
T ss_pred EECCCCceeEcCCCc-eeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH---HHH---
Confidence 999999997542111 1111223345678999999999999999999999999999998 89998643211 100
Q ss_pred HHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 601 RPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 601 ~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
..+ ...............+.+|+.+||+.||++||++.||++.|+
T Consensus 235 -------------~~~-~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 235 -------------ECI-TQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred -------------HHH-HcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 000 000111111122345779999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=345.07 Aligned_cols=242 Identities=28% Similarity=0.389 Sum_probs=193.0
Q ss_pred ceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHHHHHHc-CCCCceeEeeEeeccceeeEEEeeccC
Q 041135 387 NVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVEIISRV-HHRHLVSLVGYCISERERLLVYEYVPN 461 (727)
Q Consensus 387 ~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 461 (727)
++||+|+||.||+|+++ +|+.||||+++... ....+.+.+|++++..+ +|+||+++++++.+.+..||||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 58899999987432 23345677888888876 699999999999999999999999999
Q ss_pred CccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCccc
Q 041135 462 DTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHV 541 (727)
Q Consensus 462 gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 541 (727)
|+|.+++..... +++..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++.... ....
T Consensus 81 g~L~~~i~~~~~--l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~---~~~~ 152 (320)
T cd05590 81 GDLMFHIQKSRR--FDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF---NGKT 152 (320)
T ss_pred chHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc---CCCc
Confidence 999998876654 88999999999999999999999 999999999999999999999999999874311 1122
Q ss_pred cccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHh
Q 041135 542 STRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRL 621 (727)
Q Consensus 542 ~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l 621 (727)
....+|+..|+|||++.+..++.++|||||||+||||++|+.||..... .+....+. ....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~------~~~~~~i~-------------~~~~ 213 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE------DDLFEAIL-------------NDEV 213 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH------HHHHHHHh-------------cCCC
Confidence 3345799999999999998999999999999999999999999975431 11111111 0000
Q ss_pred hcccchhHHHHHHHHHHHHhccCCCCCCCH------HHHHHH
Q 041135 622 EKNYVDSEMFWMIEAAAACVRHSATKRPRM------SQVVRA 657 (727)
Q Consensus 622 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~~ 657 (727)
.+.......+.+|+++||+.||++|+++ ++++++
T Consensus 214 --~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 214 --VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred --CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 1111123347789999999999999998 566554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=358.44 Aligned_cols=267 Identities=23% Similarity=0.276 Sum_probs=196.7
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEee
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 458 (727)
..+|.+.++||+|+||.||+|++. .++.||||... ...+.+|+++|++|+|+|||++++++..++..+|||||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 446999999999999999999975 47889999643 23467899999999999999999999999999999999
Q ss_pred ccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCC
Q 041135 459 VPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSN 538 (727)
Q Consensus 459 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 538 (727)
+. ++|..++..... .+++.++++|+.||++||+|||++ +|||||||++||||+.++.+||+|||+++..... ..
T Consensus 242 ~~-~~L~~~l~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~-~~ 315 (461)
T PHA03211 242 YR-SDLYTYLGARLR-PLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGS-WS 315 (461)
T ss_pred cC-CCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccc-cc
Confidence 95 677777755332 589999999999999999999999 9999999999999999999999999999754221 11
Q ss_pred ccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCC-C----chhhHHhhHHHH---HHhhc-
Q 041135 539 THVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPL-G----DESLVEWARPLL---AEALE- 609 (727)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~-~----~~~l~~~~~~~l---~~~~~- 609 (727)
........||..|+|||++.+..++.++||||||||||||++|..++...... . ...+.+..+... .+...
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 12233467999999999999999999999999999999999988765332211 1 111111111100 00000
Q ss_pred -hhhHHHHHHHHhhc----ccc-------hhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 041135 610 -HEDFEALVDSRLEK----NYV-------DSEMFWMIEAAAACVRHSATKRPRMSQVVRAL 658 (727)
Q Consensus 610 -~~~~~~l~d~~l~~----~~~-------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 658 (727)
...+...+..+... .+. ......+.+|+++||+.||++||++.|||++-
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp 456 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLP 456 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCc
Confidence 00000000000000 000 01112477899999999999999999999873
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=339.51 Aligned_cols=263 Identities=25% Similarity=0.393 Sum_probs=200.6
Q ss_pred cCccccceeccCCceEEEEEEEcC---------------CcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEee
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLAD---------------GREVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVG 444 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~~---------------g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~ 444 (727)
++|++.++||+|+||.||+++..+ ...||||+++.... .....|.+|+++|++++|+||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 468899999999999999987642 23589999875433 33457999999999999999999999
Q ss_pred EeeccceeeEEEeeccCCccchhcccCC----------CCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceE
Q 041135 445 YCISERERLLVYEYVPNDTLHYHLHAEG----------RPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNIL 514 (727)
Q Consensus 445 ~~~~~~~~~lV~Ey~~~gsL~~~L~~~~----------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIL 514 (727)
+|......++||||+.+++|.+++.... ...+.+..+++++.||++||+|||++ +|+|||||++|||
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEE
Confidence 9999999999999999999999885432 12368889999999999999999999 9999999999999
Q ss_pred ECCCCcEEEEeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh--CCCCCCCCCCCC
Q 041135 515 LDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT--GRKPVDASQPLG 592 (727)
Q Consensus 515 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt--G~~Pf~~~~~~~ 592 (727)
|++++.+||+|||+++...... .........++..|+|||++.++.++.++|||||||++|||++ |..||.....
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~-- 238 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGD-YYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD-- 238 (295)
T ss_pred EcCCCcEEecccccccccccCc-ceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh--
Confidence 9999999999999997542211 1112223455778999999999999999999999999999998 5567764321
Q ss_pred chhhHHhhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhh
Q 041135 593 DESLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDT 660 (727)
Q Consensus 593 ~~~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 660 (727)
...+......+.. ................+.+|+++||+.||++||++++|++.|+.
T Consensus 239 -~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 239 -EQVIENTGEFFRN----------QGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred -HHHHHHHHHhhhh----------ccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 1111111110000 00000000111123468899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=334.69 Aligned_cols=256 Identities=26% Similarity=0.429 Sum_probs=204.3
Q ss_pred hcCccccceeccCCceEEEEEEEcC------CcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEeecccee
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLAD------GREVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYCISERER 452 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~~------g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 452 (727)
.++|++.++||+|+||.||+|.+++ +..||||.+..... .....+.+|+.+|+.++|+||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 3578899999999999999998643 36899999865432 3345788999999999999999999999999999
Q ss_pred eEEEeeccCCccchhcccCC--------CCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEE
Q 041135 453 LLVYEYVPNDTLHYHLHAEG--------RPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVA 524 (727)
Q Consensus 453 ~lV~Ey~~~gsL~~~L~~~~--------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~ 524 (727)
++||||+.+|+|.+++.... ...+.+..++.++.||+.||.|||++ +|+|||||++||||++++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEEC
Confidence 99999999999999886532 22468889999999999999999998 99999999999999999999999
Q ss_pred eeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHH
Q 041135 525 DFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPL 603 (727)
Q Consensus 525 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~ 603 (727)
|||+++.....+. ........++..|+|||++.++.++.++|||||||++|||++ |+.+|..... ..+.++
T Consensus 162 dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~~~~~~---- 233 (277)
T cd05032 162 DFGMTRDIYETDY-YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN---EEVLKF---- 233 (277)
T ss_pred CcccchhhccCcc-cccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH---HHHHHH----
Confidence 9999976532221 112233456789999999998889999999999999999998 8999864321 111110
Q ss_pred HHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 604 LAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 604 l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
+...............+.+|+.+||+.+|++||++.+|++.|+
T Consensus 234 -------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 234 -------------VIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred -------------HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 0100011112223456889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=345.76 Aligned_cols=237 Identities=28% Similarity=0.389 Sum_probs=188.2
Q ss_pred ceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHH-HHHHcCCCCceeEeeEeeccceeeEEEeeccC
Q 041135 387 NVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVE-IISRVHHRHLVSLVGYCISERERLLVYEYVPN 461 (727)
Q Consensus 387 ~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~-~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 461 (727)
++||+|+||.||+|++. +|+.||||++.... ......+.+|.. +++.++|+||+++++++.+.+..||||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999975 68999999986432 222344555555 56789999999999999999999999999999
Q ss_pred CccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCccc
Q 041135 462 DTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHV 541 (727)
Q Consensus 462 gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 541 (727)
|+|.+++..+.. +.+..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||+++.... ....
T Consensus 81 g~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~---~~~~ 152 (323)
T cd05575 81 GELFFHLQRERS--FPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE---HSKT 152 (323)
T ss_pred CCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCccccc---CCCc
Confidence 999998876543 78889999999999999999999 999999999999999999999999999874321 1122
Q ss_pred cccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHh
Q 041135 542 STRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRL 621 (727)
Q Consensus 542 ~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l 621 (727)
....+|+..|+|||++.+..++.++|||||||+||||++|+.||..... .+... .++...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~------~~~~~-------------~i~~~~~ 213 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT------AEMYD-------------NILNKPL 213 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH------HHHHH-------------HHHcCCC
Confidence 3345789999999999999999999999999999999999999975321 11111 1111111
Q ss_pred hcccchhHHHHHHHHHHHHhccCCCCCCCHH
Q 041135 622 EKNYVDSEMFWMIEAAAACVRHSATKRPRMS 652 (727)
Q Consensus 622 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 652 (727)
. ........+.+|+++||+.|+++|++++
T Consensus 214 ~--~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 214 R--LKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred C--CCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 1 1112234578899999999999999885
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=348.78 Aligned_cols=267 Identities=23% Similarity=0.298 Sum_probs=196.8
Q ss_pred HhcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeC--CchhHHHHHHHHHHHHHcCCCCceeEeeEeeccc-----
Q 041135 379 ATNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIG--GSQGEREFRAEVEIISRVHHRHLVSLVGYCISER----- 450 (727)
Q Consensus 379 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~----- 450 (727)
..++|++.+.||+|+||.||+++.. +|+.||||++... .......+.+|+.+|+.++|+||++++++|....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4577999999999999999999864 5899999998643 2233467889999999999999999999986543
Q ss_pred -eeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccc
Q 041135 451 -ERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLA 529 (727)
Q Consensus 451 -~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla 529 (727)
..|+||||+.++ |..+++. .+++..+..++.||++||+|||++ +|+|||||++||||+.++.+||+|||++
T Consensus 99 ~~~~lv~e~~~~~-l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 99 QDVYLVMELMDAN-LCQVIHM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred ceeEEEEeCCCcC-HHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCc
Confidence 469999999764 5444433 278888999999999999999999 9999999999999999999999999999
Q ss_pred hhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHH---HH
Q 041135 530 KIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLL---AE 606 (727)
Q Consensus 530 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l---~~ 606 (727)
+.... ........|+..|+|||++.+..++.++|||||||+||||++|+.+|...+... .+......+. .+
T Consensus 171 ~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~--~~~~~~~~~~~~~~~ 244 (359)
T cd07876 171 RTACT----NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHID--QWNKVIEQLGTPSAE 244 (359)
T ss_pred ccccc----CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCcHH
Confidence 75321 122234578999999999999999999999999999999999999998653211 1110000000 00
Q ss_pred hhc--hhhHHHHHHHHhhc------------------ccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 607 ALE--HEDFEALVDSRLEK------------------NYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 607 ~~~--~~~~~~l~d~~l~~------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
.+. ...+..++...... .........+.+|+.+||+.||++|+++.||+++-+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 317 (359)
T cd07876 245 FMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPY 317 (359)
T ss_pred HHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCch
Confidence 000 00000000000000 000011234789999999999999999999998754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=341.35 Aligned_cols=256 Identities=28% Similarity=0.443 Sum_probs=200.0
Q ss_pred cCccccceeccCCceEEEEEEEc-CCc--EEEEEEeeeCC-chhHHHHHHHHHHHHHc-CCCCceeEeeEeeccceeeEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGR--EVAVKQLKIGG-SQGEREFRAEVEIISRV-HHRHLVSLVGYCISERERLLV 455 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~--~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lV 455 (727)
++|++.+.||+|+||.||+|+++ +|. .+++|.++... ......+.+|+++|.++ +|+||++++++|.+++..|+|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 46888999999999999999975 354 45777765432 23445788999999999 899999999999999999999
Q ss_pred EeeccCCccchhcccCC--------------CCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcE
Q 041135 456 YEYVPNDTLHYHLHAEG--------------RPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEA 521 (727)
Q Consensus 456 ~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~v 521 (727)
|||+.+++|.++++..+ ...+++..++.++.||++||+|||++ +|+|||||++||||++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcE
Confidence 99999999999986542 12478899999999999999999998 99999999999999999999
Q ss_pred EEEeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhh
Q 041135 522 RVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWA 600 (727)
Q Consensus 522 kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~ 600 (727)
||+|||+++.... ........++..|++||++.+..++.++|||||||+||||++ |..||..... ..+.+
T Consensus 164 kl~dfg~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~-- 234 (303)
T cd05088 164 KIADFGLSRGQEV----YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELYE-- 234 (303)
T ss_pred EeCccccCcccch----hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh---HHHHH--
Confidence 9999999863211 011112234667999999988889999999999999999998 9999964331 11110
Q ss_pred HHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 601 RPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 601 ~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
.+...............+.+|+.+||+.+|++||++.+|+..|+.+..
T Consensus 235 ---------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~ 282 (303)
T cd05088 235 ---------------KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 282 (303)
T ss_pred ---------------HHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 000011111111123357899999999999999999999999987743
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=336.69 Aligned_cols=254 Identities=28% Similarity=0.363 Sum_probs=201.7
Q ss_pred CccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc---hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEe
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS---QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYE 457 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 457 (727)
.|++.++||+|+||.||++.+. +++.||||.+..... .....+.+|+.+|++++|+||+.+++++.+++..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3778899999999999999865 588999999864322 223457789999999999999999999999999999999
Q ss_pred eccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCC
Q 041135 458 YVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDS 537 (727)
Q Consensus 458 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 537 (727)
|+.+++|.+++.......+.+..++.++.||+.||.|||++ +|+|||||++|||+++++.++|+|||++......
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~-- 155 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-- 155 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCC--
Confidence 99999999988665555689999999999999999999998 9999999999999999999999999998753211
Q ss_pred CccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHH
Q 041135 538 NTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALV 617 (727)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~ 617 (727)
.......|+..|+|||++.+..++.++|||||||++|||++|+.||.......... .... ++
T Consensus 156 --~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~---~~~~-------------~~ 217 (285)
T cd05630 156 --QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE---EVER-------------LV 217 (285)
T ss_pred --ccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHH---HHHh-------------hh
Confidence 11223478999999999999999999999999999999999999997643211100 0000 00
Q ss_pred HHHhhcccchhHHHHHHHHHHHHhccCCCCCCC-----HHHHHHHHh
Q 041135 618 DSRLEKNYVDSEMFWMIEAAAACVRHSATKRPR-----MSQVVRALD 659 (727)
Q Consensus 618 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~L~ 659 (727)
+ .+...+.......+.+|+++||+.||++|++ +.|++++-+
T Consensus 218 ~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~ 263 (285)
T cd05630 218 K-EVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPL 263 (285)
T ss_pred h-hhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChh
Confidence 0 0001111122334778999999999999999 888887643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=329.05 Aligned_cols=250 Identities=22% Similarity=0.340 Sum_probs=202.3
Q ss_pred CccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC-chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeec
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG-SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYV 459 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 459 (727)
+|++.++||+|+||.||+++.. +++.||+|.++... ....+.+.+|+.+++.++|+||+++++++.++...|+||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4788999999999999999865 58899999986533 334567889999999999999999999999999999999999
Q ss_pred cCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCc
Q 041135 460 PNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNT 539 (727)
Q Consensus 460 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 539 (727)
.+++|.+++.......+.+..+++++.||+.||.|||++ +|+|+|||++|||+++++.++|+|||+++.... ..
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~---~~ 154 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS---PG 154 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecc---cc
Confidence 999999988765555678999999999999999999999 999999999999999999999999999875421 11
Q ss_pred cccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHH
Q 041135 540 HVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDS 619 (727)
Q Consensus 540 ~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~ 619 (727)
.......|+..|+|||++.+..++.++||||||+++|+|++|+.||..... ...... +..+.
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~------~~~~~~-----~~~~~------- 216 (255)
T cd08219 155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW------KNLILK-----VCQGS------- 216 (255)
T ss_pred cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH------HHHHHH-----HhcCC-------
Confidence 122345688899999999988899999999999999999999999975321 010000 00000
Q ss_pred HhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 620 RLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 620 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
. ..........+.+|+.+||+.||++||++.+|+..
T Consensus 217 -~-~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 217 -Y-KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -C-CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 0 00111122347789999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=333.84 Aligned_cols=257 Identities=26% Similarity=0.411 Sum_probs=201.1
Q ss_pred cCccccceeccCCceEEEEEEEc-CCc----EEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGR----EVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLL 454 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~----~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 454 (727)
++|+++++||+|+||.||+|++. +|+ .||||+++.... ...+++.+|+.+++.++|+||++++++|... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEE
Confidence 56888999999999999999853 444 489999875433 3356788999999999999999999999754 5689
Q ss_pred EEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhc
Q 041135 455 VYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALE 534 (727)
Q Consensus 455 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 534 (727)
+|||+.+|+|.++++.+. ..+.+..++.++.||+.||+|||++ +|+|||||++|||+++++.+||+|||+++....
T Consensus 86 ~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 86 VTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 999999999999987643 2488999999999999999999999 999999999999999999999999999985422
Q ss_pred cCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhH
Q 041135 535 LDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDF 613 (727)
Q Consensus 535 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~ 613 (727)
... ........++..|++||++.+..++.++|||||||+||||++ |..||+.... ..+..+
T Consensus 162 ~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~-------------- 223 (279)
T cd05109 162 DET-EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA---REIPDL-------------- 223 (279)
T ss_pred ccc-eeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH--------------
Confidence 111 111122335678999999999999999999999999999998 8999865321 111111
Q ss_pred HHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 614 EALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 614 ~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
+...............+.+++.+||+.||++||++.+|++.|+.+..
T Consensus 224 ---~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 224 ---LEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred ---HHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 11111111111223457789999999999999999999999987743
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=337.61 Aligned_cols=271 Identities=23% Similarity=0.371 Sum_probs=202.4
Q ss_pred CccccceeccCCceEEEEEEE-----cCCcEEEEEEeeeCC-chhHHHHHHHHHHHHHcCCCCceeEeeEeecc--ceee
Q 041135 382 GFSAHNVLGEGGFGCVYKGVL-----ADGREVAVKQLKIGG-SQGEREFRAEVEIISRVHHRHLVSLVGYCISE--RERL 453 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~-----~~g~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~--~~~~ 453 (727)
.|+++++||+|+||.||++++ .++..||||.++... ......+.+|+++|++++|+||++++++|.+. ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 478889999999999999984 247889999987543 33346799999999999999999999999875 5678
Q ss_pred EEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhh
Q 041135 454 LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIAL 533 (727)
Q Consensus 454 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~ 533 (727)
+||||+.+++|.+++..... .+++..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++...
T Consensus 85 lv~e~~~g~~L~~~l~~~~~-~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNKN-KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred EEEEccCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccccc
Confidence 99999999999999865432 479999999999999999999999 99999999999999999999999999998653
Q ss_pred ccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhH
Q 041135 534 ELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDF 613 (727)
Q Consensus 534 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~ 613 (727)
.............++..|+|||++.+..++.++|||||||++|||++++.++...... +.+.......+ ......
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~----~~~~~~~~~~~-~~~~~~ 235 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTL----FLKMIGPTHGQ-MTVTRL 235 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccch----hhhhccccccc-ccHHHH
Confidence 2222112223355677899999999888999999999999999999987654321110 00000000000 000000
Q ss_pred HHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhc
Q 041135 614 EALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661 (727)
Q Consensus 614 ~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 661 (727)
...+...............+.+|+.+||+.+|++||++.+|++.|+.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 236 VRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 001110001111122345688999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=334.83 Aligned_cols=253 Identities=24% Similarity=0.415 Sum_probs=199.2
Q ss_pred HhcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHc-CCCCceeEeeEeecc------c
Q 041135 379 ATNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRV-HHRHLVSLVGYCISE------R 450 (727)
Q Consensus 379 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~------~ 450 (727)
..+.|++.+.||+|+||.||+|++. +++.||||++.... .....+.+|+.+++++ +|+||++++++|... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 4566888899999999999999875 57889999987543 3456789999999998 699999999998753 4
Q ss_pred eeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccch
Q 041135 451 ERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAK 530 (727)
Q Consensus 451 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~ 530 (727)
..|+||||+.+++|.+++.......+.+..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCce
Confidence 679999999999999998875555689999999999999999999999 99999999999999999999999999997
Q ss_pred hhhccCCCccccccccCCccccccCccc-----CCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHH
Q 041135 531 IALELDSNTHVSTRVMGTFGYMAPEYAT-----SGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLA 605 (727)
Q Consensus 531 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~ 605 (727)
.... .........|+..|++||++. +..++.++|||||||+||||++|+.||...... ..+. .
T Consensus 160 ~~~~---~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~-----~~~~--~-- 227 (272)
T cd06637 160 QLDR---TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-----RALF--L-- 227 (272)
T ss_pred eccc---ccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH-----HHHH--H--
Confidence 5421 112233457889999999986 335788999999999999999999999643211 0000 0
Q ss_pred HhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 606 EALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 606 ~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
+................+.+|+.+||..+|++||++.||+++
T Consensus 228 ----------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 228 ----------IPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred ----------HhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 000000000111122357899999999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=347.29 Aligned_cols=238 Identities=26% Similarity=0.353 Sum_probs=191.6
Q ss_pred ceeccCCceEEEEEEE----cCCcEEEEEEeeeCCc--hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeecc
Q 041135 387 NVLGEGGFGCVYKGVL----ADGREVAVKQLKIGGS--QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVP 460 (727)
Q Consensus 387 ~~LG~G~fg~Vy~~~~----~~g~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 460 (727)
++||+|+||.||+++. .+|+.||||+++.... .....+.+|+++|++++|+||++++++|.+++..||||||+.
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6799999999999875 3578999999974322 233457789999999999999999999999999999999999
Q ss_pred CCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCcc
Q 041135 461 NDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTH 540 (727)
Q Consensus 461 ~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 540 (727)
+|+|.+++..+. .+++..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||+++.... ...
T Consensus 82 ~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~---~~~ 153 (318)
T cd05582 82 GGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESID---HEK 153 (318)
T ss_pred CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCC---CCC
Confidence 999999987654 389999999999999999999999 999999999999999999999999999975422 112
Q ss_pred ccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHH
Q 041135 541 VSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSR 620 (727)
Q Consensus 541 ~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~ 620 (727)
.....+|+..|+|||++.+..++.++|||||||+||||++|+.||..... . +... .+....
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~---~---~~~~-------------~i~~~~ 214 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR---K---ETMT-------------MILKAK 214 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH---H---HHHH-------------HHHcCC
Confidence 22346789999999999988899999999999999999999999975421 1 1111 111111
Q ss_pred hhcccchhHHHHHHHHHHHHhccCCCCCCCHHH
Q 041135 621 LEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQ 653 (727)
Q Consensus 621 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 653 (727)
+ .+.......+.+|+++||+.||++|+++.+
T Consensus 215 ~--~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 215 L--GMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred C--CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 1 111112334778999999999999999555
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=363.40 Aligned_cols=256 Identities=25% Similarity=0.320 Sum_probs=202.4
Q ss_pred HHhcCccccceeccCCceEEEEEEE-cCCcEEEEEEeeeCC--chhHHHHHHHHHHHHHcCCCCceeEeeEeeccc----
Q 041135 378 QATNGFSAHNVLGEGGFGCVYKGVL-ADGREVAVKQLKIGG--SQGEREFRAEVEIISRVHHRHLVSLVGYCISER---- 450 (727)
Q Consensus 378 ~~~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~---- 450 (727)
...++|++.++||+|+||.||+|+. .+|+.||||+++... ......+.+|+.+|..++|.||+++++.+....
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 3456899999999999999999985 468999999987543 233456889999999999999999988775432
Q ss_pred ----eeeEEEeeccCCccchhcccCC--CCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEE
Q 041135 451 ----ERLLVYEYVPNDTLHYHLHAEG--RPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVA 524 (727)
Q Consensus 451 ----~~~lV~Ey~~~gsL~~~L~~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~ 524 (727)
.+++||||+.+|+|.++|+.+. ...+.+..+..|+.||+.||+|||++ +|+|||||++||||+.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEE
Confidence 3679999999999999886532 33588899999999999999999999 99999999999999999999999
Q ss_pred eeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHH
Q 041135 525 DFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLL 604 (727)
Q Consensus 525 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l 604 (727)
|||+++.+.... ........+|+..|+|||++.+..++.++|||||||+||||++|+.||..... .++....+
T Consensus 186 DFGls~~~~~~~-~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~------~~~~~~~~ 258 (496)
T PTZ00283 186 DFGFSKMYAATV-SDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM------EEVMHKTL 258 (496)
T ss_pred ecccCeeccccc-cccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHh
Confidence 999997543211 11223346799999999999999999999999999999999999999975321 11111111
Q ss_pred HHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 605 AEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 605 ~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
.... ..........+.+|+.+||+.||++||++.+|+++
T Consensus 259 -------------~~~~-~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 259 -------------AGRY-DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred -------------cCCC-CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 0000 11112233457899999999999999999999875
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=328.95 Aligned_cols=252 Identities=26% Similarity=0.454 Sum_probs=201.7
Q ss_pred cCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeecc
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVP 460 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 460 (727)
.+|++.+.||+|+||.||+|.+.+++.++||+++... ....++.+|++++++++|+||+++++++......++||||+.
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 3578889999999999999998778899999886432 334678999999999999999999999999999999999999
Q ss_pred CCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCcc
Q 041135 461 NDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTH 540 (727)
Q Consensus 461 ~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 540 (727)
+++|.+++..+.. .+.+..++.++.+|+.||+|||++ +|+|||||++||+++.++.+||+|||+++..... ...
T Consensus 83 ~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~--~~~ 156 (256)
T cd05112 83 HGCLSDYLRAQRG-KFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD--QYT 156 (256)
T ss_pred CCcHHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccC--ccc
Confidence 9999999876432 478899999999999999999998 9999999999999999999999999998754221 111
Q ss_pred ccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHH
Q 041135 541 VSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDS 619 (727)
Q Consensus 541 ~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~ 619 (727)
......++.+|++||++.++.++.++|||||||++|||++ |+.||..... ..+. ... ..
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~-------~~~----------~~ 216 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN---SEVV-------ETI----------NA 216 (256)
T ss_pred ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH---HHHH-------HHH----------hC
Confidence 1122335678999999998899999999999999999998 9999865321 1111 100 00
Q ss_pred HhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 620 RLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 620 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
.............+.+|+++||+.+|++||++.||+++|.
T Consensus 217 ~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 217 GFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 0000011112345889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=334.25 Aligned_cols=271 Identities=24% Similarity=0.328 Sum_probs=203.3
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCch--hHHHHHHHHHHHHHcCCCC-ceeEeeEeeccc------
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQ--GEREFRAEVEIISRVHHRH-LVSLVGYCISER------ 450 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~--~~~~~~~Ei~~l~~l~Hpn-Iv~l~~~~~~~~------ 450 (727)
..|..+++||+|.||.||+|+.+ +|+.||+|+++....+ .-....+|+.+|+.|+|.| ||+|++++..++
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 34666688999999999999954 6899999999876543 2245789999999999999 999999999877
Q ss_pred eeeEEEeeccCCccchhcccCCC--CcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeecc
Q 041135 451 ERLLVYEYVPNDTLHYHLHAEGR--PVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGL 528 (727)
Q Consensus 451 ~~~lV~Ey~~~gsL~~~L~~~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGl 528 (727)
.++|||||+ .-+|..++..... ..++...++.+++||++||+|||++ +|+||||||.||||+++|.+||+|||+
T Consensus 91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccch
Confidence 789999999 6688888876553 3577789999999999999999999 999999999999999999999999999
Q ss_pred chhhhccCCCccccccccCCccccccCcccCC-CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHh
Q 041135 529 AKIALELDSNTHVSTRVMGTFGYMAPEYATSG-KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEA 607 (727)
Q Consensus 529 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~ 607 (727)
|+.+.- .....+..++|..|+|||++.+. .|+...||||+|||++||++++.-|.+.... +.+.... .++..-
T Consensus 167 Ara~~i---p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~--~ql~~If-~~lGtP 240 (323)
T KOG0594|consen 167 ARAFSI---PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI--DQLFRIF-RLLGTP 240 (323)
T ss_pred HHHhcC---CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH--HHHHHHH-HHcCCC
Confidence 995421 12224556789999999999986 7999999999999999999999989875531 1111111 110000
Q ss_pred h--chhhHHHHHHHHh-------hcccch---hHHHHHHHHHHHHhccCCCCCCCHHHHHHH--Hhhc
Q 041135 608 L--EHEDFEALVDSRL-------EKNYVD---SEMFWMIEAAAACVRHSATKRPRMSQVVRA--LDTL 661 (727)
Q Consensus 608 ~--~~~~~~~l~d~~l-------~~~~~~---~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~ 661 (727)
. .-.....+.+... ...+.. .......+++.+||+.++.+|.+++.++.+ +..+
T Consensus 241 ~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 241 NEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred CccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 0 0000000000000 000000 011247899999999999999999999987 4444
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=346.38 Aligned_cols=261 Identities=27% Similarity=0.409 Sum_probs=200.4
Q ss_pred hcCccccceeccCCceEEEEEEE------cCCcEEEEEEeeeCCc-hhHHHHHHHHHHHHHc-CCCCceeEeeEeecc-c
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVL------ADGREVAVKQLKIGGS-QGEREFRAEVEIISRV-HHRHLVSLVGYCISE-R 450 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~------~~g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~-~ 450 (727)
.++|+++++||+|+||.||+|++ .+++.||||+++.... .....+.+|+++|.++ +|+||++++++|... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 35689999999999999999974 3467899999975433 2345788999999999 689999999988654 4
Q ss_pred eeeEEEeeccCCccchhcccCC----------------------------------------------------------
Q 041135 451 ERLLVYEYVPNDTLHYHLHAEG---------------------------------------------------------- 472 (727)
Q Consensus 451 ~~~lV~Ey~~~gsL~~~L~~~~---------------------------------------------------------- 472 (727)
..++||||+.+|+|.++++...
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 6789999999999998876432
Q ss_pred -------CCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCccccccc
Q 041135 473 -------RPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRV 545 (727)
Q Consensus 473 -------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~ 545 (727)
...+++..+++++.||++||+|||++ +|+|||||++||||++++.+||+|||+++...... ........
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~ 241 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDP-DYVRKGDA 241 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCc-chhhcCCC
Confidence 12367888899999999999999999 99999999999999999999999999997542211 11112223
Q ss_pred cCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHhhcc
Q 041135 546 MGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRLEKN 624 (727)
Q Consensus 546 ~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~ 624 (727)
.++..|++||++.+..++.++|||||||+||||++ |..||...... ..+. ..+..+ ....
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~--------~~~~~~---------~~~~ 302 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEFC--------RRLKEG---------TRMR 302 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc--HHHH--------HHHhcc---------CCCC
Confidence 45678999999999899999999999999999997 99998653211 0000 000000 0000
Q ss_pred cchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 625 YVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 625 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
........+.+++.+||+.+|++||++.||+++|+.+.+
T Consensus 303 ~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 303 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 011112347889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=344.27 Aligned_cols=252 Identities=25% Similarity=0.323 Sum_probs=211.6
Q ss_pred HhcCccccceeccCCceEEEEEEEcC-CcEEEEEEeeeCCch---hHHHHHHHHHHHHHcC-CCCceeEeeEeeccceee
Q 041135 379 ATNGFSAHNVLGEGGFGCVYKGVLAD-GREVAVKQLKIGGSQ---GEREFRAEVEIISRVH-HRHLVSLVGYCISERERL 453 (727)
Q Consensus 379 ~~~~~~~~~~LG~G~fg~Vy~~~~~~-g~~vaVK~l~~~~~~---~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~ 453 (727)
..+.|++.++||+|.||.||+++.+. |+.+|+|++...... +...+.+|+.+|++|. |+|||.|+++|++...++
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 34568888999999999999999765 999999999754433 3468999999999998 999999999999999999
Q ss_pred EEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECC----CCcEEEEeeccc
Q 041135 454 LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDS----SFEARVADFGLA 529 (727)
Q Consensus 454 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~----~~~vkL~DFGla 529 (727)
||||+|.||.|++.+... .+++.+...++.||+.++.|||+. +|+|||||++|||+.. ++.+||+|||++
T Consensus 113 lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred EEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 999999999999998776 289999999999999999999998 9999999999999953 358999999999
Q ss_pred hhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhc
Q 041135 530 KIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALE 609 (727)
Q Consensus 530 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~ 609 (727)
..... .......+||..|+|||++....|+..+||||+||++|.|++|..||.+......
T Consensus 187 ~~~~~----~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~---------------- 246 (382)
T KOG0032|consen 187 KFIKP----GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEI---------------- 246 (382)
T ss_pred eEccC----CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHH----------------
Confidence 86422 4456678999999999999999999999999999999999999999987543211
Q ss_pred hhhHHHHHHH--HhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 610 HEDFEALVDS--RLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 610 ~~~~~~l~d~--~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
+..+... .....+.......+.++++.||..|+.+|.++.+++++-|
T Consensus 247 ---~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpW 295 (382)
T KOG0032|consen 247 ---FLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPW 295 (382)
T ss_pred ---HHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence 1111111 1122333444556789999999999999999999999855
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=343.46 Aligned_cols=242 Identities=26% Similarity=0.389 Sum_probs=194.7
Q ss_pred ceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHHHHHHc-CCCCceeEeeEeeccceeeEEEeeccC
Q 041135 387 NVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVEIISRV-HHRHLVSLVGYCISERERLLVYEYVPN 461 (727)
Q Consensus 387 ~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 461 (727)
++||+|+||.||+|++. +++.||||+++... ......+.+|+++++.+ +|+||+++++++.+.+..|+||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999976 47899999997432 23345677899999888 699999999999999999999999999
Q ss_pred CccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCccc
Q 041135 462 DTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHV 541 (727)
Q Consensus 462 gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 541 (727)
|+|.+++..... +.+..++.++.||+.||.|||++ +|+|||||++||||++++.+||+|||+++.... ....
T Consensus 81 ~~L~~~~~~~~~--l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~---~~~~ 152 (318)
T cd05570 81 GDLMFHIQRSGR--FDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL---GGVT 152 (318)
T ss_pred CCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCc---CCCc
Confidence 999988876654 89999999999999999999999 999999999999999999999999999874211 1112
Q ss_pred cccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHh
Q 041135 542 STRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRL 621 (727)
Q Consensus 542 ~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l 621 (727)
....+|+..|+|||++.+..++.++|||||||+||||++|+.||..... ..+ .. .+.....
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~---~~~---~~-------------~i~~~~~ 213 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE---DEL---FQ-------------SILEDEV 213 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH---HHH---HH-------------HHHcCCC
Confidence 2345789999999999999999999999999999999999999975431 111 00 0100000
Q ss_pred hcccchhHHHHHHHHHHHHhccCCCCCCCH-----HHHHHH
Q 041135 622 EKNYVDSEMFWMIEAAAACVRHSATKRPRM-----SQVVRA 657 (727)
Q Consensus 622 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~ 657 (727)
.+.......+.+|+++||+.||++|+++ .+++++
T Consensus 214 --~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 214 --RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred --CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 1111223457899999999999999999 888765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=354.03 Aligned_cols=267 Identities=23% Similarity=0.299 Sum_probs=204.5
Q ss_pred CccccceeccCCceEEEEEEE-cCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcC-C-----CCceeEeeEeeccceeeE
Q 041135 382 GFSAHNVLGEGGFGCVYKGVL-ADGREVAVKQLKIGGSQGEREFRAEVEIISRVH-H-----RHLVSLVGYCISERERLL 454 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~-H-----pnIv~l~~~~~~~~~~~l 454 (727)
+|.++++||+|.||.|.||.+ ++++.||||+++.. ..-...-..|+++|..|+ | -|||+++++|...+++||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 789999999999999999985 46999999999744 333455677999999996 3 489999999999999999
Q ss_pred EEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECC--CCcEEEEeeccchhh
Q 041135 455 VYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDS--SFEARVADFGLAKIA 532 (727)
Q Consensus 455 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~--~~~vkL~DFGla~~~ 532 (727)
|+|.+ ..+|+++|+.+.-..+....+..|+.||++||.+||+. +|||+||||+||||.+ ...|||+|||.++..
T Consensus 266 VfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 99998 77999999998888899999999999999999999999 9999999999999964 347999999999854
Q ss_pred hccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHH-----HHHHh
Q 041135 533 LELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARP-----LLAEA 607 (727)
Q Consensus 533 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~-----~l~~~ 607 (727)
.. . ....+.+..|+|||+|.|..|+.+.|||||||||.||++|..-|.+.+..+...++.-..+ ++...
T Consensus 342 ~q-----~-vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~ 415 (586)
T KOG0667|consen 342 SQ-----R-VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA 415 (586)
T ss_pred CC-----c-ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 21 1 1145678899999999999999999999999999999999887876554321111110000 00000
Q ss_pred h------ch-----------h--------hHHHHHHH-Hhhc-----------ccchhHHHHHHHHHHHHhccCCCCCCC
Q 041135 608 L------EH-----------E--------DFEALVDS-RLEK-----------NYVDSEMFWMIEAAAACVRHSATKRPR 650 (727)
Q Consensus 608 ~------~~-----------~--------~~~~l~d~-~l~~-----------~~~~~~~~~l~~li~~cl~~dP~~RPs 650 (727)
- .. . .....+.. .++. .....+...+++++++||++||.+|++
T Consensus 416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t 495 (586)
T KOG0667|consen 416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT 495 (586)
T ss_pred cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence 0 00 0 00000000 0110 011134456899999999999999999
Q ss_pred HHHHHHHHh
Q 041135 651 MSQVVRALD 659 (727)
Q Consensus 651 ~~evl~~L~ 659 (727)
..|.+++-.
T Consensus 496 p~qal~Hpf 504 (586)
T KOG0667|consen 496 PAQALNHPF 504 (586)
T ss_pred HHHHhcCcc
Confidence 999998844
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=340.88 Aligned_cols=260 Identities=28% Similarity=0.433 Sum_probs=203.6
Q ss_pred hcCccccceeccCCceEEEEEEEc--------CCcEEEEEEeeeCC-chhHHHHHHHHHHHHHc-CCCCceeEeeEeecc
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA--------DGREVAVKQLKIGG-SQGEREFRAEVEIISRV-HHRHLVSLVGYCISE 449 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~--------~g~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~ 449 (727)
.++|.++++||+|+||.||+|+.. .+..||+|+++... .....++.+|+++++++ +|+||++++++|.++
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 356889999999999999999752 24579999987543 23346788999999999 599999999999999
Q ss_pred ceeeEEEeeccCCccchhcccCC--------------CCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEE
Q 041135 450 RERLLVYEYVPNDTLHYHLHAEG--------------RPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILL 515 (727)
Q Consensus 450 ~~~~lV~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl 515 (727)
...++||||+.+|+|.+++.... ...+.+.++++++.||+.||.|||++ +|+|||||++||||
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEE
Confidence 99999999999999999986532 23478899999999999999999998 99999999999999
Q ss_pred CCCCcEEEEeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCch
Q 041135 516 DSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDE 594 (727)
Q Consensus 516 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~ 594 (727)
++++.+||+|||+++.....+... ......++..|++||++.++.++.++|||||||++|||++ |+.||..... .
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~---~ 243 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYK-KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV---E 243 (314)
T ss_pred cCCCcEEEcccccccccccccccc-ccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH---H
Confidence 999999999999997543221111 1112234567999999999899999999999999999999 8888865321 1
Q ss_pred hhHHhhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 595 SLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 595 ~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
.+.+ .+...............+.+|+.+||+.+|++||++.||++.|+++..
T Consensus 244 ~~~~-----------------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 244 ELFK-----------------LLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred HHHH-----------------HHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 1111 011111111122233457789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=340.28 Aligned_cols=241 Identities=25% Similarity=0.365 Sum_probs=190.8
Q ss_pred ceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHHHHHHc-CCCCceeEeeEeeccceeeEEEeeccC
Q 041135 387 NVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVEIISRV-HHRHLVSLVGYCISERERLLVYEYVPN 461 (727)
Q Consensus 387 ~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 461 (727)
++||+|+||.||+|++. +++.||||+++... ......+..|..++..+ +|+||+++++++.+.+..||||||+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999975 47899999997532 22334567788888764 899999999999999999999999999
Q ss_pred CccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCccc
Q 041135 462 DTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHV 541 (727)
Q Consensus 462 gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 541 (727)
|+|.+++.... .+++..++.++.||++||+|||++ +|+|||||++||||+.++.+||+|||+++.... ....
T Consensus 81 g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~---~~~~ 152 (316)
T cd05619 81 GDLMFHIQSCH--KFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENML---GDAK 152 (316)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCC---CCCc
Confidence 99999987654 378899999999999999999999 999999999999999999999999999874211 1112
Q ss_pred cccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHh
Q 041135 542 STRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRL 621 (727)
Q Consensus 542 ~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l 621 (727)
.....|+..|+|||++.+..++.++|||||||+||||++|+.||..... ..+.+. + ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~---~~~~~~---i-------------~~~-- 211 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE---EELFQS---I-------------RMD-- 211 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH---HHHHHH---H-------------HhC--
Confidence 2345789999999999999999999999999999999999999975331 111110 0 000
Q ss_pred hcccchhHHHHHHHHHHHHhccCCCCCCCHH-HHHH
Q 041135 622 EKNYVDSEMFWMIEAAAACVRHSATKRPRMS-QVVR 656 (727)
Q Consensus 622 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~ 656 (727)
...+.......+.+|+.+||+.||++|+++. +|++
T Consensus 212 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 212 NPCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CCCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 0001111223467899999999999999997 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=346.46 Aligned_cols=242 Identities=26% Similarity=0.358 Sum_probs=190.2
Q ss_pred ceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHH-HHHHcCCCCceeEeeEeeccceeeEEEeeccC
Q 041135 387 NVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVE-IISRVHHRHLVSLVGYCISERERLLVYEYVPN 461 (727)
Q Consensus 387 ~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~-~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 461 (727)
++||+|+||.||+|+.. +|+.||||++.... ......+.+|.. +++.++|+||++++++|..++..||||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999864 68999999986432 223345556655 46778999999999999999999999999999
Q ss_pred CccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCccc
Q 041135 462 DTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHV 541 (727)
Q Consensus 462 gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 541 (727)
|+|..++..... +.+..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||+++.... ....
T Consensus 81 ~~L~~~l~~~~~--~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~---~~~~ 152 (325)
T cd05604 81 GELFFHLQRERS--FPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA---QSDT 152 (325)
T ss_pred CCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCC---CCCC
Confidence 999988876543 88999999999999999999999 999999999999999999999999999874321 1122
Q ss_pred cccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHh
Q 041135 542 STRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRL 621 (727)
Q Consensus 542 ~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l 621 (727)
....+|+..|+|||++.+..++.++|||||||+||||++|+.||..... .+.. ..++...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~------~~~~-------------~~~~~~~~ 213 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV------AEMY-------------DNILHKPL 213 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH------HHHH-------------HHHHcCCc
Confidence 3346799999999999999999999999999999999999999975321 1111 11111111
Q ss_pred hcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 622 EKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 622 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
. ........+.+++++||+.++++|+++++.++.
T Consensus 214 ~--~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~ 247 (325)
T cd05604 214 V--LRPGASLTAWSILEELLEKDRQRRLGAKEDFLE 247 (325)
T ss_pred c--CCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence 1 111223457789999999999999988644433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=333.63 Aligned_cols=272 Identities=26% Similarity=0.377 Sum_probs=206.9
Q ss_pred cCccccceeccCCceEEEEEEEc-----CCcEEEEEEeeeCCch-hHHHHHHHHHHHHHcCCCCceeEeeEeec--ccee
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-----DGREVAVKQLKIGGSQ-GEREFRAEVEIISRVHHRHLVSLVGYCIS--ERER 452 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-----~g~~vaVK~l~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~--~~~~ 452 (727)
++|++.+.||+|+||.||+|++. +++.||||+++..... ..+.|.+|+++++.++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45778899999999999999864 3678999999755443 45789999999999999999999999987 5578
Q ss_pred eEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhh
Q 041135 453 LLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIA 532 (727)
Q Consensus 453 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~ 532 (727)
++||||+.+++|.+++..... .+++..++.++.||+.||+|||++ +|+|||||++|||++.++.+||+|||++...
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred EEEEecCCCCCHHHHHHhCcc-ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 999999999999999976543 489999999999999999999998 9999999999999999999999999999865
Q ss_pred hccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhh
Q 041135 533 LELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHED 612 (727)
Q Consensus 533 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~ 612 (727)
..............+...|++||++.+..++.++||||||+++|||++|+.+|....... ..++... ........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~----~~~~~~~-~~~~~~~~ 234 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEF----LRMIGIA-QGQMIVTR 234 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchh----ccccccc-cccccHHH
Confidence 322111111222345667999999998899999999999999999999999886532111 0000000 00000111
Q ss_pred HHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhc
Q 041135 613 FEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661 (727)
Q Consensus 613 ~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 661 (727)
+..++...............+.+|+.+||+.+|++||++.||+++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 235 LLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1112211111111122235688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=329.25 Aligned_cols=253 Identities=30% Similarity=0.469 Sum_probs=200.7
Q ss_pred ccccceeccCCceEEEEEEEcC-CcEEEEEEeeeCCchhHH--HHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeec
Q 041135 383 FSAHNVLGEGGFGCVYKGVLAD-GREVAVKQLKIGGSQGER--EFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYV 459 (727)
Q Consensus 383 ~~~~~~LG~G~fg~Vy~~~~~~-g~~vaVK~l~~~~~~~~~--~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 459 (727)
|+++++||+|+||.||+++..+ ++.||+|++......... ...+|++++++++|+||+++++++.++...++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 6788999999999999999764 668999999866544332 3456999999999999999999999999999999999
Q ss_pred cCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCc
Q 041135 460 PNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNT 539 (727)
Q Consensus 460 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 539 (727)
.+++|.++|.... .+++..++.++.||++||+|||++ +|+|||||++|||+++++.++|+|||++... ....
T Consensus 81 ~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~---~~~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQKNK--PLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKL---SENN 152 (260)
T ss_dssp TTEBHHHHHHHHS--SBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEES---TSTT
T ss_pred ccccccccccccc--cccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc---cccc
Confidence 9999999998443 389999999999999999999999 9999999999999999999999999998643 1122
Q ss_pred cccccccCCccccccCccc-CCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHH
Q 041135 540 HVSTRVMGTFGYMAPEYAT-SGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVD 618 (727)
Q Consensus 540 ~~~~~~~gt~~y~aPE~l~-~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d 618 (727)
.......++..|+|||++. +..++.++||||||+++|+|++|+.+|..... ........... .....
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~---~~~~~~~~~~~---------~~~~~ 220 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS---DDQLEIIEKIL---------KRPLP 220 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH---HHHHHHHHHHH---------HTHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc---hhhhhhhhhcc---------ccccc
Confidence 3344567889999999998 88899999999999999999999999986411 11111110000 00000
Q ss_pred HHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 619 SRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 619 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
.... ........+.+++++||+.||++||++.+|+++
T Consensus 221 ~~~~--~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 221 SSSQ--QSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HHTT--SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred cccc--ccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000 001112568899999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=351.30 Aligned_cols=259 Identities=22% Similarity=0.261 Sum_probs=200.2
Q ss_pred HHHHHhcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeC---CchhHHHHHHHHHHHHHcCCCCceeEeeEeeccc
Q 041135 375 ELIQATNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIG---GSQGEREFRAEVEIISRVHHRHLVSLVGYCISER 450 (727)
Q Consensus 375 el~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~ 450 (727)
++....++|++.+.||+|+||.||+++++ +++.||+|++... .......+.+|+++++.++|+||+++++++.++.
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 34444578999999999999999999976 5789999998632 2223456789999999999999999999999999
Q ss_pred eeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccch
Q 041135 451 ERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAK 530 (727)
Q Consensus 451 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~ 530 (727)
..||||||+.+|+|.+++... .+....+..++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~ 190 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence 999999999999999988654 378888899999999999999999 99999999999999999999999999997
Q ss_pred hhhccCCCccccccccCCccccccCcccCC----CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHH
Q 041135 531 IALELDSNTHVSTRVMGTFGYMAPEYATSG----KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAE 606 (727)
Q Consensus 531 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~ 606 (727)
.... .........+||..|+|||++.+. .++.++|||||||+||||++|+.||..... ...
T Consensus 191 ~~~~--~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~------- 255 (371)
T cd05622 191 KMNK--EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGT------- 255 (371)
T ss_pred EcCc--CCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH------HHH-------
Confidence 5421 111222346799999999999754 378899999999999999999999975431 111
Q ss_pred hhchhhHHHHHHHHhhcccc--hhHHHHHHHHHHHHhccCCCC--CCCHHHHHHHHhh
Q 041135 607 ALEHEDFEALVDSRLEKNYV--DSEMFWMIEAAAACVRHSATK--RPRMSQVVRALDT 660 (727)
Q Consensus 607 ~~~~~~~~~l~d~~l~~~~~--~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~L~~ 660 (727)
+..++...-...+. ......+.+|+..||..+..+ |+++.||+++...
T Consensus 256 ------~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~ 307 (371)
T cd05622 256 ------YSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFF 307 (371)
T ss_pred ------HHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCccc
Confidence 11111100000010 112334678889999844433 7899999988653
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=339.27 Aligned_cols=271 Identities=23% Similarity=0.332 Sum_probs=204.4
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCch-hHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEee
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQ-GEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 458 (727)
++|++.++||+|+||.||++++. +|..||+|+++..... ....+.+|+++|++++|+||++++++|.+++..+|||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46899999999999999999865 5788999988754332 335688999999999999999999999999999999999
Q ss_pred ccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCC
Q 041135 459 VPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSN 538 (727)
Q Consensus 459 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 538 (727)
+.+++|.++++.... +.+..+..++.||++||+|||+.+ +|+|||||++|||+++++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--- 153 (308)
T cd06615 81 MDGGSLDQVLKKAGR--IPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 153 (308)
T ss_pred cCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc---
Confidence 999999999976643 788899999999999999999732 8999999999999999999999999998754211
Q ss_pred ccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHh-----------
Q 041135 539 THVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEA----------- 607 (727)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~----------- 607 (727)
......|+..|++||++.+..++.++|||||||++|||++|+.||...+..............+...
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 154 --MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred --ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCC
Confidence 1234568899999999988889999999999999999999999997543211111000000000000
Q ss_pred --hchhhHHHHHHHHhhcc---c-chhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhh
Q 041135 608 --LEHEDFEALVDSRLEKN---Y-VDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDT 660 (727)
Q Consensus 608 --~~~~~~~~l~d~~l~~~---~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 660 (727)
.......++.+...... . .......+.+|+.+||..+|++||++.||+++...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~ 290 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFI 290 (308)
T ss_pred CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence 00000111111111110 0 00112347899999999999999999999998654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=337.15 Aligned_cols=250 Identities=20% Similarity=0.282 Sum_probs=206.4
Q ss_pred cCccccceeccCCceEEEEEEE-cCCcEEEEEEeeeCCch--hHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEe
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVL-ADGREVAVKQLKIGGSQ--GEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYE 457 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vaVK~l~~~~~~--~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 457 (727)
.-|.+.+.||+|.|+.|-+|++ -.|+.||||++...... ....+.+|++.|+.++|+|||+||++......+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 3477788999999999999985 37999999999644332 23568899999999999999999999999999999999
Q ss_pred eccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEEC-CCCcEEEEeeccchhhhccC
Q 041135 458 YVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLD-SSFEARVADFGLAKIALELD 536 (727)
Q Consensus 458 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~-~~~~vkL~DFGla~~~~~~~ 536 (727)
+-.+|+|++|+.++.. .+.+....+++.||+.|+.|+|+. .+||||||++||++- +-|-|||.|||++..+..
T Consensus 98 LGD~GDl~DyImKHe~-Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P-- 171 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEE-GLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP-- 171 (864)
T ss_pred ecCCchHHHHHHhhhc-cccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCC--
Confidence 9999999999977654 588999999999999999999999 899999999999885 567899999999975532
Q ss_pred CCccccccccCCccccccCcccCCCCCc-hhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHH
Q 041135 537 SNTHVSTRVMGTFGYMAPEYATSGKLTE-KSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEA 615 (727)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~-ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~ 615 (727)
....+..||.+.|.|||+|.+..|+. ++||||||||||.|++|+.||+..+. .+.+..
T Consensus 172 --G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND-------------------SETLTm 230 (864)
T KOG4717|consen 172 --GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND-------------------SETLTM 230 (864)
T ss_pred --cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc-------------------hhhhhh
Confidence 23456689999999999999998874 89999999999999999999986542 122333
Q ss_pred HHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 616 LVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 616 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
++|...- ..........+||..||..||.+|-+.+||+..-|
T Consensus 231 ImDCKYt--vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~W 272 (864)
T KOG4717|consen 231 IMDCKYT--VPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSW 272 (864)
T ss_pred hhccccc--CchhhhHHHHHHHHHHHhcCchhhccHHHHhcccc
Confidence 4443221 11223344678999999999999999999988755
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=334.41 Aligned_cols=246 Identities=27% Similarity=0.351 Sum_probs=193.0
Q ss_pred eccCCceEEEEEEEc-CCcEEEEEEeeeCCc---hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeeccCCcc
Q 041135 389 LGEGGFGCVYKGVLA-DGREVAVKQLKIGGS---QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPNDTL 464 (727)
Q Consensus 389 LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL 464 (727)
||+|+||.||++++. +|+.||||++..... ...+.+..|+++|++++|+||++++++|..+...+|||||+.+|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999865 688999999864322 2235678899999999999999999999999999999999999999
Q ss_pred chhcccC--CCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCcccc
Q 041135 465 HYHLHAE--GRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVS 542 (727)
Q Consensus 465 ~~~L~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 542 (727)
..++... ....+++..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||+++..... ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~---~~~~ 154 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG---QSKT 154 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCC---Cccc
Confidence 8877432 233589999999999999999999999 9999999999999999999999999999754221 1122
Q ss_pred ccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHhh
Q 041135 543 TRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRLE 622 (727)
Q Consensus 543 ~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l~ 622 (727)
....|+..|+|||++.+..++.++|||||||+||||++|+.||........ ..+... .++...
T Consensus 155 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~~~~-------------~~~~~~-- 217 (280)
T cd05608 155 KGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQ-------------RILNDS-- 217 (280)
T ss_pred cccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh--HHHHHH-------------hhcccC--
Confidence 345789999999999999999999999999999999999999975432110 000000 000000
Q ss_pred cccchhHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 041135 623 KNYVDSEMFWMIEAAAACVRHSATKRP-----RMSQVVRA 657 (727)
Q Consensus 623 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 657 (727)
..+.......+.+|+.+||+.||++|+ ++++++++
T Consensus 218 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 218 VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 011122234577899999999999999 66777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=343.01 Aligned_cols=249 Identities=22% Similarity=0.318 Sum_probs=194.8
Q ss_pred ceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc---hhHHHHHHHHHHHHHc-CCCCceeEeeEeeccceeeEEEeeccC
Q 041135 387 NVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS---QGEREFRAEVEIISRV-HHRHLVSLVGYCISERERLLVYEYVPN 461 (727)
Q Consensus 387 ~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~---~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 461 (727)
++||+|+||.||+|++. +++.||||+++.... ...+.+.+|+.++.++ +|+||+++++++.+...+||||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999975 578999999975422 2335688999999888 699999999999999999999999999
Q ss_pred CccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCccc
Q 041135 462 DTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHV 541 (727)
Q Consensus 462 gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 541 (727)
|+|..++...+. +.+..++.|+.||++||+|||++ +|+|||||++||||+.++.+||+|||+++.... ....
T Consensus 81 ~~L~~~~~~~~~--l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~---~~~~ 152 (327)
T cd05617 81 GDLMFHMQRQRK--LPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG---PGDT 152 (327)
T ss_pred CcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccC---CCCc
Confidence 999988866543 89999999999999999999999 999999999999999999999999999874211 1122
Q ss_pred cccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHh
Q 041135 542 STRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRL 621 (727)
Q Consensus 542 ~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l 621 (727)
....+|+..|+|||++.+..++.++|||||||+||||++|+.||............++.... +....+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~------------~~~~~~ 220 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQV------------ILEKPI 220 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHH------------HHhCCC
Confidence 23467999999999999999999999999999999999999999754322211111111111 111111
Q ss_pred hcccchhHHHHHHHHHHHHhccCCCCCCCH------HHHHHH
Q 041135 622 EKNYVDSEMFWMIEAAAACVRHSATKRPRM------SQVVRA 657 (727)
Q Consensus 622 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~~ 657 (727)
.+.......+.+++++||+.||++|+++ .+|+++
T Consensus 221 --~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 221 --RIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred --CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 1111222346789999999999999984 566554
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=317.06 Aligned_cols=265 Identities=24% Similarity=0.325 Sum_probs=208.7
Q ss_pred HhcCccccceeccCCceEEEEEE-EcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccc-----ee
Q 041135 379 ATNGFSAHNVLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISER-----ER 452 (727)
Q Consensus 379 ~~~~~~~~~~LG~G~fg~Vy~~~-~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~-----~~ 452 (727)
..++|++.++||+|||+.||+++ +.+++.+|+|++.....++.+..++|++..++++|+||+++++++..+. ..
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 35679999999999999999998 5678999999998877788889999999999999999999999887554 48
Q ss_pred eEEEeeccCCccchhcccC--CCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccch
Q 041135 453 LLVYEYVPNDTLHYHLHAE--GRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAK 530 (727)
Q Consensus 453 ~lV~Ey~~~gsL~~~L~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~ 530 (727)
||++.|...|+|.+.+... ++..+++.++++|+.+|++||++||+. .+.++|||||+.|||+.+.+.++|.|||.++
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcc
Confidence 9999999999999887643 344799999999999999999999998 2249999999999999999999999999886
Q ss_pred hhhccCCCcc------ccccccCCccccccCcccC---CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhH
Q 041135 531 IALELDSNTH------VSTRVMGTFGYMAPEYATS---GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWAR 601 (727)
Q Consensus 531 ~~~~~~~~~~------~~~~~~gt~~y~aPE~l~~---~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~ 601 (727)
...-.-.... .......|.-|+|||.+.- ...++++|||||||+||+||.|..||+..-..++ ++
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg-Sl----- 251 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG-SL----- 251 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC-eE-----
Confidence 4321111111 0112356889999999864 4578999999999999999999999975432211 10
Q ss_pred HHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhc
Q 041135 602 PLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661 (727)
Q Consensus 602 ~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 661 (727)
...+....+.......-...+.+|+++||+.||.+||++.+|+.+++.+
T Consensus 252 -----------aLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 252 -----------ALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred -----------EEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 0001111111111122344588999999999999999999999999875
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=345.28 Aligned_cols=242 Identities=26% Similarity=0.347 Sum_probs=189.4
Q ss_pred ceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHH-HHHHcCCCCceeEeeEeeccceeeEEEeeccC
Q 041135 387 NVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVE-IISRVHHRHLVSLVGYCISERERLLVYEYVPN 461 (727)
Q Consensus 387 ~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~-~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 461 (727)
+.||+|+||.||+|++. +++.||||++.... ......+.+|.. +++.++|+||+++++++.+++..||||||+.+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999975 57889999986432 122334444544 56788999999999999999999999999999
Q ss_pred CccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCccc
Q 041135 462 DTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHV 541 (727)
Q Consensus 462 gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 541 (727)
|+|.+++..... +.+..+..++.||++||+|||++ +|+|||||++||||+.++.+||+|||+++.... ....
T Consensus 81 ~~L~~~~~~~~~--~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~---~~~~ 152 (325)
T cd05602 81 GELFYHLQRERC--FLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIE---HNGT 152 (325)
T ss_pred CcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCccccc---CCCC
Confidence 999999876543 77888889999999999999999 999999999999999999999999999975321 1122
Q ss_pred cccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHh
Q 041135 542 STRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRL 621 (727)
Q Consensus 542 ~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l 621 (727)
....+|+..|+|||++.+..++.++|||||||+||||++|+.||..... .+... .++...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~-------------~i~~~~~ 213 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT------AEMYD-------------NILNKPL 213 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH------HHHHH-------------HHHhCCc
Confidence 3346799999999999999999999999999999999999999975331 11111 1111111
Q ss_pred hcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 622 EKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 622 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
.+.......+.+++++||+.|+.+|+++.+.+..
T Consensus 214 --~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 214 --QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred --CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence 1112223457889999999999999988754433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=343.15 Aligned_cols=260 Identities=27% Similarity=0.410 Sum_probs=204.0
Q ss_pred hcCccccceeccCCceEEEEEEEcC--------CcEEEEEEeeeCC-chhHHHHHHHHHHHHHc-CCCCceeEeeEeecc
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLAD--------GREVAVKQLKIGG-SQGEREFRAEVEIISRV-HHRHLVSLVGYCISE 449 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~~--------g~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~ 449 (727)
..+|++++.||+|+||.||+|+..+ +..||||+++... ....+++.+|+++++++ +|+||++++++|.++
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 3468899999999999999997421 2368999887433 23346799999999999 799999999999999
Q ss_pred ceeeEEEeeccCCccchhcccCC--------------CCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEE
Q 041135 450 RERLLVYEYVPNDTLHYHLHAEG--------------RPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILL 515 (727)
Q Consensus 450 ~~~~lV~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl 515 (727)
+..++||||+.+|+|.++|..+. ...+.+.++++++.||++||+|||++ +|+|||||++||||
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEE
Confidence 99999999999999999986532 23478889999999999999999999 99999999999999
Q ss_pred CCCCcEEEEeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCch
Q 041135 516 DSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDE 594 (727)
Q Consensus 516 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~ 594 (727)
++++.+||+|||+++....... ........++..|+|||++.+..++.++|||||||+||||++ |+.+|....
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~----- 241 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDY-YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP----- 241 (334)
T ss_pred cCCCcEEECCcccceecccccc-cccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC-----
Confidence 9999999999999975432111 111122334568999999999999999999999999999998 888886532
Q ss_pred hhHHhhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 595 SLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 595 ~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
..++.. .+...............+.+|+++||+.+|++||++.||++.|+++..
T Consensus 242 -~~~~~~--------------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 242 -VEELFK--------------LLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred -HHHHHH--------------HHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 111111 111111111122234468899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=333.77 Aligned_cols=251 Identities=27% Similarity=0.369 Sum_probs=199.0
Q ss_pred ccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc---hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEee
Q 041135 383 FSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS---QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 383 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 458 (727)
|+..++||+|+||+||+|.+. +|+.||||++..... .....+.+|+++|+.++|+||+.+++++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 677899999999999999875 588999999864332 2234578899999999999999999999999999999999
Q ss_pred ccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCC
Q 041135 459 VPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSN 538 (727)
Q Consensus 459 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 538 (727)
+.+++|.+++.......+.+..++.++.||+.||.|||++ +|+|||||++|||+++++.+||+|||+++....
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~---- 154 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPE---- 154 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCC----
Confidence 9999999888765544689999999999999999999998 999999999999999999999999999864321
Q ss_pred ccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHH
Q 041135 539 THVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVD 618 (727)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d 618 (727)
........|+..|+|||++.+..++.++|||||||++|||++|+.||....... ....+.. .+..
T Consensus 155 ~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~--~~~~~~~-------------~~~~ 219 (285)
T cd05632 155 GESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV--KREEVDR-------------RVLE 219 (285)
T ss_pred CCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHH-------------hhhc
Confidence 111234578999999999999999999999999999999999999997543110 0000000 0000
Q ss_pred HHhhcccchhHHHHHHHHHHHHhccCCCCCCC-----HHHHHHH
Q 041135 619 SRLEKNYVDSEMFWMIEAAAACVRHSATKRPR-----MSQVVRA 657 (727)
Q Consensus 619 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 657 (727)
. ...+.......+.+|+.+||+.||++|++ +++|+++
T Consensus 220 ~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 220 T--EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred c--ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 0 01112222334778999999999999999 6666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=334.24 Aligned_cols=257 Identities=26% Similarity=0.418 Sum_probs=202.1
Q ss_pred hcCccccceeccCCceEEEEEEEc------CCcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEeecccee
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA------DGREVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYCISERER 452 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 452 (727)
.++|++++.||+|+||.||+|++. ++..||||+++.... ....+|.+|++++++++|+||++++++|.++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 356889999999999999999863 467899999875433 3346799999999999999999999999999999
Q ss_pred eEEEeeccCCccchhcccCC--------------------CCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCc
Q 041135 453 LLVYEYVPNDTLHYHLHAEG--------------------RPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSN 512 (727)
Q Consensus 453 ~lV~Ey~~~gsL~~~L~~~~--------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~N 512 (727)
++||||+.+|+|.+++.... ...+.+.+++.++.||+.||+|||++ +|+|||||++|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhh
Confidence 99999999999999886431 12467888999999999999999999 99999999999
Q ss_pred eEECCCCcEEEEeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCC
Q 041135 513 ILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPL 591 (727)
Q Consensus 513 ILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~ 591 (727)
||+++++.+||+|||+++....... ........++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~- 238 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADY-YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH- 238 (288)
T ss_pred eEecCCCceEECccccceecccCcc-ccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH-
Confidence 9999999999999999875322111 111222344667999999998899999999999999999998 8888864321
Q ss_pred CchhhHHhhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhh
Q 041135 592 GDESLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDT 660 (727)
Q Consensus 592 ~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 660 (727)
.++.. .+.+..+ ..........+.+|+.+||+.+|++||++.||++.|++
T Consensus 239 -----~~~~~-------------~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 -----EEVIY-------------YVRDGNV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -----HHHHH-------------HHhcCCC-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 11111 0101100 00111223568899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=343.66 Aligned_cols=257 Identities=24% Similarity=0.276 Sum_probs=194.9
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeC---CchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIG---GSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
++|++++.||+|+||.||++++. +++.||||+++.. .....+.+++|+.++..++|+||++++++|.+++.+||||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46899999999999999999975 5889999998642 1223456889999999999999999999999999999999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccC
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 536 (727)
||+.+|+|.+++.+.. ..+.+..+..++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++.+..
T Consensus 81 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~-- 154 (331)
T cd05597 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA-- 154 (331)
T ss_pred ecCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC--
Confidence 9999999999986532 2478899999999999999999999 999999999999999999999999999875422
Q ss_pred CCccccccccCCccccccCcccC-----CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchh
Q 041135 537 SNTHVSTRVMGTFGYMAPEYATS-----GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHE 611 (727)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~ 611 (727)
.........+|+..|+|||++.+ +.++.++|||||||+||||++|+.||..... .+....++ ...
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~------~~~~~~i~----~~~ 224 (331)
T cd05597 155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIM----NHK 224 (331)
T ss_pred CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH------HHHHHHHH----cCC
Confidence 11112223568999999999873 4578899999999999999999999975321 11111111 000
Q ss_pred hHHHHHHHHhhcccchhHHHHHHHHHHHHhccCC--CCCCCHHHHHHHHh
Q 041135 612 DFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSA--TKRPRMSQVVRALD 659 (727)
Q Consensus 612 ~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP--~~RPs~~evl~~L~ 659 (727)
... .+... .......+.+|+++||..+. ..|+++.+++++-+
T Consensus 225 ~~~-----~~~~~-~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~ 268 (331)
T cd05597 225 EHF-----QFPPD-VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPF 268 (331)
T ss_pred Ccc-----cCCCc-cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCC
Confidence 000 00000 00122345677777775543 34789999988844
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=330.26 Aligned_cols=248 Identities=28% Similarity=0.454 Sum_probs=194.2
Q ss_pred ceeccCCceEEEEEEEcC-Cc--EEEEEEeeeCC-chhHHHHHHHHHHHHHc-CCCCceeEeeEeeccceeeEEEeeccC
Q 041135 387 NVLGEGGFGCVYKGVLAD-GR--EVAVKQLKIGG-SQGEREFRAEVEIISRV-HHRHLVSLVGYCISERERLLVYEYVPN 461 (727)
Q Consensus 387 ~~LG~G~fg~Vy~~~~~~-g~--~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 461 (727)
++||+|+||.||+|++.+ |. .+++|.++... ....+.+.+|++++.++ +|+||++++++|...+..++||||+.+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 468999999999999754 43 46888886433 33456789999999999 799999999999999999999999999
Q ss_pred CccchhcccCC--------------CCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeec
Q 041135 462 DTLHYHLHAEG--------------RPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFG 527 (727)
Q Consensus 462 gsL~~~L~~~~--------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFG 527 (727)
|+|.++++.+. ...+.+..+++++.||+.||+|||++ +|+|||||++|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 99999986532 12478899999999999999999998 99999999999999999999999999
Q ss_pred cchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHH
Q 041135 528 LAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAE 606 (727)
Q Consensus 528 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~ 606 (727)
+++.... .........+..|+|||++.+..++.++|||||||+||||++ |..||..... ..+ +..
T Consensus 158 l~~~~~~----~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~---~~~-------~~~ 223 (270)
T cd05047 158 LSRGQEV----YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AEL-------YEK 223 (270)
T ss_pred Cccccch----hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH---HHH-------HHH
Confidence 9863211 111111234567999999998899999999999999999997 9999965321 110 000
Q ss_pred hhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhc
Q 041135 607 ALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661 (727)
Q Consensus 607 ~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 661 (727)
+...............+.+|+.+||+.+|.+||++.+|++.|+.+
T Consensus 224 ----------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 224 ----------LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred ----------HhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 000011111112234578999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=326.16 Aligned_cols=249 Identities=31% Similarity=0.498 Sum_probs=202.1
Q ss_pred ceeccCCceEEEEEEEcC----CcEEEEEEeeeCCchh-HHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeeccC
Q 041135 387 NVLGEGGFGCVYKGVLAD----GREVAVKQLKIGGSQG-EREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPN 461 (727)
Q Consensus 387 ~~LG~G~fg~Vy~~~~~~----g~~vaVK~l~~~~~~~-~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 461 (727)
++||+|+||.||+|+..+ +..|+||+++...... .+.+.+|+++++.++|+||+++++++.++...+|||||+.+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999754 7889999997554433 57899999999999999999999999999999999999999
Q ss_pred CccchhcccCC-------CCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhc
Q 041135 462 DTLHYHLHAEG-------RPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALE 534 (727)
Q Consensus 462 gsL~~~L~~~~-------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 534 (727)
++|.+++.... ...+++.++++++.||++||+|||++ +|+|||||++||||++++.+||+|||+++....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 99999987652 24589999999999999999999998 999999999999999999999999999986532
Q ss_pred cCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhH
Q 041135 535 LDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDF 613 (727)
Q Consensus 535 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~ 613 (727)
... ........++..|+|||.+.+..++.++|||||||++|||++ |+.||..... ..+.+.
T Consensus 158 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~-------------- 219 (262)
T cd00192 158 DDY-YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN---EEVLEY-------------- 219 (262)
T ss_pred ccc-cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH---HHHHHH--------------
Confidence 221 122334567889999999998889999999999999999999 6999976421 111110
Q ss_pred HHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 614 EALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 614 ~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
+.+ .............+.+++++||+.++++||++.||++.|+
T Consensus 220 --~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 220 --LRK-GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred --HHc-CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 000 0111112222456889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=344.67 Aligned_cols=266 Identities=21% Similarity=0.274 Sum_probs=197.2
Q ss_pred HHhcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC--chhHHHHHHHHHHHHHcCCCCceeEeeEeecc-----
Q 041135 378 QATNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG--SQGEREFRAEVEIISRVHHRHLVSLVGYCISE----- 449 (727)
Q Consensus 378 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~----- 449 (727)
...++|++.+.||+|+||.||+++.. .++.||||++.... ......+.+|+.+|+.++|+||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 44578999999999999999999864 58899999986432 23345788999999999999999999988643
Q ss_pred -ceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeecc
Q 041135 450 -RERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGL 528 (727)
Q Consensus 450 -~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGl 528 (727)
...|+||||+.+ +|.+++.. .+++..++.++.||++||+|||++ +|+|||||++||||+.++.+||+|||+
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcc
Confidence 356999999965 45555543 378889999999999999999999 999999999999999999999999999
Q ss_pred chhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHH-----
Q 041135 529 AKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPL----- 603 (727)
Q Consensus 529 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~----- 603 (727)
++.... ........|+..|+|||++.+..++.++|||||||+||||++|+.+|.+..... .+......+
T Consensus 166 ~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~ 239 (355)
T cd07874 166 ARTAGT----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID--QWNKVIEQLGTPCP 239 (355)
T ss_pred cccCCC----ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCH
Confidence 975321 122234578999999999999999999999999999999999999997643211 111000000
Q ss_pred -HHHhhchhhHHHHHHHHh------------------hcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 041135 604 -LAEALEHEDFEALVDSRL------------------EKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRAL 658 (727)
Q Consensus 604 -l~~~~~~~~~~~l~d~~l------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 658 (727)
+...+ ...+..+++... ...........+.+|+.+||+.||++||++.||+++-
T Consensus 240 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp 312 (355)
T cd07874 240 EFMKKL-QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHP 312 (355)
T ss_pred HHHHhh-cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCc
Confidence 00000 000011110000 0000111123578999999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=344.02 Aligned_cols=237 Identities=27% Similarity=0.370 Sum_probs=187.3
Q ss_pred ceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHH-HHHHcCCCCceeEeeEeeccceeeEEEeeccC
Q 041135 387 NVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVE-IISRVHHRHLVSLVGYCISERERLLVYEYVPN 461 (727)
Q Consensus 387 ~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~-~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 461 (727)
++||+|+||.||+|++. +|+.||||++.... ......+.+|+. +++.++|+||++++++|.+.+..||||||+.+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 58899999986432 122334555554 57889999999999999999999999999999
Q ss_pred CccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCccc
Q 041135 462 DTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHV 541 (727)
Q Consensus 462 gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 541 (727)
|+|..++.... .+.+..+..++.||++||+|||++ +|+|||||++||||+.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~---~~~ 152 (321)
T cd05603 81 GELFFHLQRER--CFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP---EET 152 (321)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCC---CCc
Confidence 99988886554 378888999999999999999998 9999999999999999999999999998743211 122
Q ss_pred cccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHh
Q 041135 542 STRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRL 621 (727)
Q Consensus 542 ~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l 621 (727)
....+|+..|+|||++.+..++.++|||||||+||||++|+.||...+. .... +.++...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~-------------~~i~~~~~ 213 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV------SQMY-------------DNILHKPL 213 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH------HHHH-------------HHHhcCCC
Confidence 3346789999999999998999999999999999999999999975421 1110 11111111
Q ss_pred hcccchhHHHHHHHHHHHHhccCCCCCCCHH
Q 041135 622 EKNYVDSEMFWMIEAAAACVRHSATKRPRMS 652 (727)
Q Consensus 622 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 652 (727)
.+.......+.+++++||+.|+.+|++..
T Consensus 214 --~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 214 --QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred --CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 11222334578999999999999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=328.27 Aligned_cols=252 Identities=27% Similarity=0.461 Sum_probs=201.5
Q ss_pred CccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCc------hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEE
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGS------QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLV 455 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~------~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 455 (727)
+|++.++||+|+||.||+|...+|+.||||.++.... +....+.+|+++|++++|+||++++++|.++...++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4788899999999999999988899999999875322 1224688999999999999999999999999999999
Q ss_pred EeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhcc
Q 041135 456 YEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALEL 535 (727)
Q Consensus 456 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 535 (727)
|||+.+++|.+++.+... +.+..+..++.||+.||+|||+. +|+|+|||++|||+++++.+||+|||+++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 81 MEFVPGGSISSILNRFGP--LPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EecCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 999999999999976543 78899999999999999999998 9999999999999999999999999999754221
Q ss_pred CC---CccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhh
Q 041135 536 DS---NTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHED 612 (727)
Q Consensus 536 ~~---~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~ 612 (727)
.. .........|+..|++||++.+..++.++|||+|||++|||++|+.||...+... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-----~~------------- 217 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-----AM------------- 217 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-----HH-------------
Confidence 11 1112233568899999999999889999999999999999999999997533111 00
Q ss_pred HHHHHHH-HhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 613 FEALVDS-RLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 613 ~~~l~d~-~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
..+... .............+.+++++||+.+|++||++.||+++
T Consensus 218 -~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 218 -FYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred -HHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000000 00011112223457889999999999999999999863
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=335.95 Aligned_cols=250 Identities=23% Similarity=0.385 Sum_probs=203.5
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeec
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYV 459 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 459 (727)
.+|++.+.||+|+||.||+|+.. +++.|+||.+........+.+.+|+++++.++|+||++++++|..+...|+||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 56888999999999999999864 68899999998766666678999999999999999999999999999999999999
Q ss_pred cCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCc
Q 041135 460 PNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNT 539 (727)
Q Consensus 460 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 539 (727)
.+++|.+++... .+++.+++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++..... .
T Consensus 100 ~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~---~ 170 (296)
T cd06654 100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE---Q 170 (296)
T ss_pred CCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccc---c
Confidence 999999988653 378899999999999999999999 9999999999999999999999999998753211 1
Q ss_pred cccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHH
Q 041135 540 HVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDS 619 (727)
Q Consensus 540 ~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~ 619 (727)
.......|+..|+|||++.+..++.++|||+|||++|||++|+.||....... .+..+ .. ..
T Consensus 171 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~--~~~~~--------~~--------~~ 232 (296)
T cd06654 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--ALYLI--------AT--------NG 232 (296)
T ss_pred cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH--hHHHH--------hc--------CC
Confidence 11233468889999999998889999999999999999999999997543211 00000 00 00
Q ss_pred HhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 620 RLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 620 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
.............+.+|+.+||..+|++||++.||+++
T Consensus 233 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 233 TPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 00001111223457789999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=334.41 Aligned_cols=264 Identities=27% Similarity=0.406 Sum_probs=203.7
Q ss_pred hcCccccceeccCCceEEEEEEEcC-----------------CcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCcee
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLAD-----------------GREVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVS 441 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~~-----------------g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~ 441 (727)
.++|+++++||+|+||.||+|++.+ +..||+|++..... ...+.+.+|+++|++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3568899999999999999998642 24589999875433 34567999999999999999999
Q ss_pred EeeEeeccceeeEEEeeccCCccchhcccCC---------CCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCc
Q 041135 442 LVGYCISERERLLVYEYVPNDTLHYHLHAEG---------RPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSN 512 (727)
Q Consensus 442 l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~---------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~N 512 (727)
++++|..+...++||||+.+++|.+++.... ...+++..++.++.||+.||+|||++ +|+|||||++|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 9999999999999999999999999987643 12588999999999999999999998 99999999999
Q ss_pred eEECCCCcEEEEeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh--CCCCCCCCCC
Q 041135 513 ILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT--GRKPVDASQP 590 (727)
Q Consensus 513 ILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt--G~~Pf~~~~~ 590 (727)
|||++++.+||+|||+++.....+ .........++..|+|||++.++.++.++|||||||++|||++ |..||....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~- 238 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSD-YYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT- 238 (296)
T ss_pred eeecCCCceEEccccceeecccCc-ceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC-
Confidence 999999999999999997543221 1122234456788999999998899999999999999999998 667775432
Q ss_pred CCchhhHHhhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhh
Q 041135 591 LGDESLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDT 660 (727)
Q Consensus 591 ~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 660 (727)
...........+ ... ...............+.+|+.+||+.||++||++.||++.|++
T Consensus 239 --~~~~~~~~~~~~----~~~------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 239 --DQQVIENAGHFF----RDD------GRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred --hHHHHHHHHhcc----ccc------cccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 111111111000 000 0000001111122468899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=336.99 Aligned_cols=198 Identities=25% Similarity=0.385 Sum_probs=160.3
Q ss_pred cceeccCCceEEEEEEEc---CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeec--cceeeEEEeecc
Q 041135 386 HNVLGEGGFGCVYKGVLA---DGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCIS--ERERLLVYEYVP 460 (727)
Q Consensus 386 ~~~LG~G~fg~Vy~~~~~---~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~--~~~~~lV~Ey~~ 460 (727)
.++||+|+||.||+|+.+ +++.||||+++.. .....+.+|+++|++++|+||+++++++.. +...|+||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999865 4678999988643 223567899999999999999999999864 456789999985
Q ss_pred CCccchhcccC-------CCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEE----CCCCcEEEEeeccc
Q 041135 461 NDTLHYHLHAE-------GRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILL----DSSFEARVADFGLA 529 (727)
Q Consensus 461 ~gsL~~~L~~~-------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl----~~~~~vkL~DFGla 529 (727)
+ +|.+++... ....+.+..++.|+.||+.||+|||++ +|+|||||++|||| +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 4 666655422 123478889999999999999999999 99999999999999 45678999999999
Q ss_pred hhhhccCCCccccccccCCccccccCcccCC-CCCchhHHHHHhHHHHHHHhCCCCCCCCC
Q 041135 530 KIALELDSNTHVSTRVMGTFGYMAPEYATSG-KLTEKSDVYSFGVVLLELITGRKPVDASQ 589 (727)
Q Consensus 530 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~ksDVwS~Gvil~eLltG~~Pf~~~~ 589 (727)
+................|+..|+|||++.+. .++.++|||||||++|||++|+.+|....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 8643221112223346789999999999874 58999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=341.63 Aligned_cols=241 Identities=26% Similarity=0.381 Sum_probs=192.8
Q ss_pred CccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHHHHHHcC-CCCceeEeeEeeccceeeEEE
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVEIISRVH-HRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~lV~ 456 (727)
+|++.++||+|+||.||+|+.. +|+.||||+++... ....+.+..|+++++.+. |++|+++++++.+.+..||||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4778899999999999999865 58899999987432 223356778999998886 577888999999999999999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccC
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 536 (727)
||+.+|+|.+++..... +.+.+++.|+.||+.||+|||++ +|+|||||++||||++++.+||+|||+++....
T Consensus 81 Ey~~~g~L~~~i~~~~~--l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~-- 153 (323)
T cd05615 81 EYVNGGDLMYHIQQVGK--FKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV-- 153 (323)
T ss_pred cCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCC--
Confidence 99999999999876554 88999999999999999999999 999999999999999999999999999874321
Q ss_pred CCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHH
Q 041135 537 SNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEAL 616 (727)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l 616 (727)
........+|+..|+|||++.++.++.++|||||||+||||++|+.||..... ..+. ..+
T Consensus 154 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~~----------------~~i 213 (323)
T cd05615 154 -DGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE---DELF----------------QSI 213 (323)
T ss_pred -CCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH---HHHH----------------HHH
Confidence 11122345689999999999998999999999999999999999999975431 1111 111
Q ss_pred HHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCH
Q 041135 617 VDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRM 651 (727)
Q Consensus 617 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 651 (727)
+...+ .+.......+.+|+.+||+.+|.+|++.
T Consensus 214 ~~~~~--~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 214 MEHNV--SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred HhCCC--CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 11111 1112223457789999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=350.03 Aligned_cols=204 Identities=25% Similarity=0.377 Sum_probs=175.5
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
++|+++++||+|+||.||+++.+ +|+.||||+++... ......+++|+++|..++|+||+++++++.+++.+||||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46889999999999999999875 58899999997432 233456889999999999999999999999999999999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccC
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 536 (727)
||+.+|+|.+++..++. +.+..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++.+....
T Consensus 81 E~~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 81 EFLPGGDMMTLLMKKDT--LSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred eCCCCccHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 99999999999876554 88999999999999999999999 99999999999999999999999999987432111
Q ss_pred CC--------------------------------ccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCC
Q 041135 537 SN--------------------------------THVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKP 584 (727)
Q Consensus 537 ~~--------------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~P 584 (727)
.. .......+||..|+|||++.+..++.++|||||||+||||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 00 0011235799999999999999999999999999999999999999
Q ss_pred CCCCC
Q 041135 585 VDASQ 589 (727)
Q Consensus 585 f~~~~ 589 (727)
|....
T Consensus 236 f~~~~ 240 (360)
T cd05627 236 FCSET 240 (360)
T ss_pred CCCCC
Confidence 97543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=330.97 Aligned_cols=254 Identities=23% Similarity=0.357 Sum_probs=199.1
Q ss_pred cCccccceeccCCceEEEEEEE-cCCcEEEEEEeeeCC-chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEee
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVL-ADGREVAVKQLKIGG-SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 458 (727)
++|+++++||+|+||.||+|++ .+++.||||++.... ....+++.+|+++|++++|+||++++++|..++..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3688889999999999999986 468899999986543 23346789999999999999999999999999999999999
Q ss_pred ccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCC
Q 041135 459 VPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSN 538 (727)
Q Consensus 459 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 538 (727)
+.+++|..+. .+.+..+..++.||+.||+|||++ +|+|||||++|||++.++.+||+|||++.....
T Consensus 81 ~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~---- 147 (279)
T cd06619 81 MDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN---- 147 (279)
T ss_pred CCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccc----
Confidence 9999986553 267788899999999999999999 999999999999999999999999999975421
Q ss_pred ccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHH
Q 041135 539 THVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVD 618 (727)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d 618 (727)
......+|+..|+|||++.+..++.++|||||||++|||++|+.||.......... .+ ... +..+.+
T Consensus 148 -~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~--~~-~~~---------~~~~~~ 214 (279)
T cd06619 148 -SIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL--MP-LQL---------LQCIVD 214 (279)
T ss_pred -ccccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc--ch-HHH---------HHHHhc
Confidence 12233578899999999999999999999999999999999999997533211110 00 000 000110
Q ss_pred HHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhh
Q 041135 619 SRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDT 660 (727)
Q Consensus 619 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 660 (727)
..............+.+|+.+||+.+|++||+++||+++...
T Consensus 215 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~ 256 (279)
T cd06619 215 EDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFI 256 (279)
T ss_pred cCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccc
Confidence 000000011122347889999999999999999999987543
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=338.94 Aligned_cols=271 Identities=21% Similarity=0.314 Sum_probs=198.8
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCch-hHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEee
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQ-GEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 458 (727)
++|.++++||+|+||.||+|+.+ +++.||||+++..... ....+.+|+++|++++|+||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56899999999999999999875 5788999998754332 234678899999999999999999999999999999999
Q ss_pred ccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCC
Q 041135 459 VPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSN 538 (727)
Q Consensus 459 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 538 (727)
+.+ +|.+++.... ..+.+..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||+++.... .
T Consensus 86 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~---~ 157 (309)
T cd07872 86 LDK-DLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSV---P 157 (309)
T ss_pred CCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCC---C
Confidence 975 6766665443 2478889999999999999999999 999999999999999999999999999975321 1
Q ss_pred ccccccccCCccccccCcccC-CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHH-HHHHhhch-hhHHH
Q 041135 539 THVSTRVMGTFGYMAPEYATS-GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARP-LLAEALEH-EDFEA 615 (727)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~-~l~~~~~~-~~~~~ 615 (727)
........++..|+|||++.+ ..++.++|||||||+||||++|+.+|................. ...+.+.. .....
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 158 TKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred ccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence 112233467889999999865 4688999999999999999999999976543211111100000 00000000 00000
Q ss_pred HHHHHhhcc-------cchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 616 LVDSRLEKN-------YVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 616 l~d~~l~~~-------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
+.+...... ........+.+|+++||+.||++|+++.|++++-.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 288 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAY 288 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChh
Confidence 000000000 00112335679999999999999999999998644
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=335.00 Aligned_cols=263 Identities=25% Similarity=0.397 Sum_probs=201.1
Q ss_pred cCccccceeccCCceEEEEEEEc-----------------CCcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-----------------DGREVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSL 442 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-----------------~g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l 442 (727)
++|++.++||+|+||.||++++. ++..||||+++.... ....+|.+|+++|++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999998643 234689999875433 334679999999999999999999
Q ss_pred eeEeeccceeeEEEeeccCCccchhcccCCC---------CcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCce
Q 041135 443 VGYCISERERLLVYEYVPNDTLHYHLHAEGR---------PVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNI 513 (727)
Q Consensus 443 ~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~---------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NI 513 (727)
++++.+++..++||||+.+++|.+++..... ..+++..+++++.||+.||+|||++ +|+|||||++||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheE
Confidence 9999999999999999999999998865431 2467788999999999999999999 999999999999
Q ss_pred EECCCCcEEEEeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh--CCCCCCCCCCC
Q 041135 514 LLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT--GRKPVDASQPL 591 (727)
Q Consensus 514 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt--G~~Pf~~~~~~ 591 (727)
||++++.+||+|||+++.+..... ........++..|++||++.++.++.++|||||||+||||++ |..||.....
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDY-YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD- 239 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcc-eeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh-
Confidence 999999999999999975422111 111223345678999999988899999999999999999998 6778864321
Q ss_pred CchhhHHhhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhh
Q 041135 592 GDESLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDT 660 (727)
Q Consensus 592 ~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 660 (727)
....+.....+... ...........+...+.+|+.+||+.||++||++.||++.|++
T Consensus 240 --~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 240 --EQVIENTGEFFRDQ----------GRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred --HHHHHHHHHHHhhc----------cccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11111111000000 0000000111233568899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=328.68 Aligned_cols=256 Identities=26% Similarity=0.386 Sum_probs=202.4
Q ss_pred cCccccceeccCCceEEEEEEEcC----CcEEEEEEeeeCC-chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLAD----GREVAVKQLKIGG-SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLV 455 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~~----g~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 455 (727)
++|.+.++||+|+||.||+|.+.+ ...|+||.+.... ....+.+.+|+.++++++|+||++++++|.+ ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 458888999999999999998643 2468999887554 3445679999999999999999999999875 457899
Q ss_pred EeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhcc
Q 041135 456 YEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALEL 535 (727)
Q Consensus 456 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 535 (727)
|||+.+++|.+++..... .+++..++.++.+|+.||+|||++ +++|||||++||||+.++.+||+|||+++.....
T Consensus 85 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 85 MELAPLGELRSYLQVNKY-SLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EEcCCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 999999999999976432 489999999999999999999998 9999999999999999999999999999754221
Q ss_pred CCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHH
Q 041135 536 DSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFE 614 (727)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~ 614 (727)
.........+...|+|||.+.+..++.++|||||||++|||++ |+.||...... ....+ +...
T Consensus 161 --~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~~--------~~~~--- 224 (270)
T cd05056 161 --SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN---DVIGR--------IENG--- 224 (270)
T ss_pred --cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHH--------HHcC---
Confidence 1111222334568999999988889999999999999999986 99999754321 11110 0000
Q ss_pred HHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 615 ALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 615 ~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
............+.+|+.+||..+|++||++.+|++.|+++..
T Consensus 225 ------~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 225 ------ERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred ------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0001112233468899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=355.19 Aligned_cols=261 Identities=23% Similarity=0.340 Sum_probs=191.5
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeecc--------c
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISE--------R 450 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~--------~ 450 (727)
.++|+++++||+|+||.||+|+.. +++.||||++... .....+|+.+|+.++|+|||++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 467999999999999999999975 5889999988532 23456799999999999999999886432 2
Q ss_pred eeeEEEeeccCCccchhccc--CCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCC-cEEEEeec
Q 041135 451 ERLLVYEYVPNDTLHYHLHA--EGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSF-EARVADFG 527 (727)
Q Consensus 451 ~~~lV~Ey~~~gsL~~~L~~--~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~-~vkL~DFG 527 (727)
.+++||||+.+ +|.+++.. .....+.+..++.++.||+.||+|||++ +|||||||++||||+.++ .+||+|||
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccc
Confidence 46789999975 55555432 2233588999999999999999999999 999999999999998654 79999999
Q ss_pred cchhhhccCCCccccccccCCccccccCcccCC-CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHH
Q 041135 528 LAKIALELDSNTHVSTRVMGTFGYMAPEYATSG-KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAE 606 (727)
Q Consensus 528 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~ 606 (727)
+++.+... .......|+..|+|||++.+. .++.++|||||||+||||++|+.||.+.... ..+.....
T Consensus 217 la~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~--~~~~~i~~----- 285 (440)
T PTZ00036 217 SAKNLLAG----QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV--DQLVRIIQ----- 285 (440)
T ss_pred cchhccCC----CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHH-----
Confidence 99854221 112235688999999998764 6899999999999999999999999764321 11111111
Q ss_pred hhchhhHHHH--H-------------HHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 607 ALEHEDFEAL--V-------------DSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 607 ~~~~~~~~~l--~-------------d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
.+.....+.+ + ...+...+.......+.+|+.+||..||++|+++.|++++-.
T Consensus 286 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~ 353 (440)
T PTZ00036 286 VLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPF 353 (440)
T ss_pred HhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChh
Confidence 0000000000 0 001111111122345789999999999999999999997743
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=342.99 Aligned_cols=193 Identities=23% Similarity=0.332 Sum_probs=164.1
Q ss_pred HhcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEe
Q 041135 379 ATNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYE 457 (727)
Q Consensus 379 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 457 (727)
...+|++++.||+|+||.||+|+.. +++.||||+... .....|+.+|++++|+||++++++|.+....++|||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 3467999999999999999999975 467899997542 234569999999999999999999999999999999
Q ss_pred eccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCC
Q 041135 458 YVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDS 537 (727)
Q Consensus 458 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 537 (727)
|+. ++|.+++.... ..+.+..+++|+.||+.||.|||++ +|||||||++||||+.++.+||+|||+++....
T Consensus 138 ~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~--- 209 (357)
T PHA03209 138 HYS-SDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV--- 209 (357)
T ss_pred ccC-CcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCcccccccc---
Confidence 995 57777775533 2589999999999999999999999 999999999999999999999999999974311
Q ss_pred CccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCC
Q 041135 538 NTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVD 586 (727)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~ 586 (727)
........|+..|+|||++.+..++.++|||||||+||||+++..++.
T Consensus 210 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 210 -APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred -CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 112234568999999999999999999999999999999999665543
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=323.27 Aligned_cols=248 Identities=27% Similarity=0.408 Sum_probs=198.2
Q ss_pred ceeccCCceEEEEEEEcCCcEEEEEEeeeCCch-hHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeeccCCccc
Q 041135 387 NVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQ-GEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPNDTLH 465 (727)
Q Consensus 387 ~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~ 465 (727)
++||+|+||.||++.+.+++.|+||+++..... ....+.+|++++++++|+||+++++++.+....++||||+.+++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999999877999999998755443 4568999999999999999999999999999999999999999999
Q ss_pred hhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCccccccc
Q 041135 466 YHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRV 545 (727)
Q Consensus 466 ~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~ 545 (727)
+++..... .+++..++.++.+++.||+|||++ +|+|||||++||||+.++.+||+|||+++..... .........
T Consensus 81 ~~l~~~~~-~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKKKN-RLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGG-IYTVSDGLK 155 (251)
T ss_pred HHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCC-cceeccccC
Confidence 99865432 478899999999999999999999 9999999999999999999999999999753211 111111122
Q ss_pred cCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHhhcc
Q 041135 546 MGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRLEKN 624 (727)
Q Consensus 546 ~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~ 624 (727)
.++..|++||++.++.++.++|||||||++|||++ |..||...... ... ..+.......
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~---~~~-----------------~~~~~~~~~~ 215 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ---QTR-----------------ERIESGYRMP 215 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH---HHH-----------------HHHhcCCCCC
Confidence 34567999999998899999999999999999999 88888653311 000 0111111111
Q ss_pred cchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 625 YVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 625 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
.......++.+|+.+||..+|++||++.||++.|+
T Consensus 216 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 216 APQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 12223346889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=321.33 Aligned_cols=254 Identities=22% Similarity=0.326 Sum_probs=207.8
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeC--CchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIG--GSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
.+.|++.++||+|.|+.||++.+. .|+.+|+|+++.+ ...+.+++.+|+++-+.|+|+||++|.+.+.++...||||
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 345778899999999999999864 5899999988643 2346688999999999999999999999999999999999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEEC---CCCcEEEEeeccchhhh
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLD---SSFEARVADFGLAKIAL 533 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~---~~~~vkL~DFGla~~~~ 533 (727)
|+|.|++|..-+-.+ ..+++...-.+++||+++|.|+|.+ +|||||+|++|+||- ..--+||+|||+|..+.
T Consensus 90 e~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred ecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 999999997655444 4588889999999999999999999 999999999999994 34469999999998653
Q ss_pred ccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhH
Q 041135 534 ELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDF 613 (727)
Q Consensus 534 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~ 613 (727)
......+..||++|||||+++...|+..+|||+.|||||-||.|+.||.+.+. +..+
T Consensus 165 ----~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~-------------------~rly 221 (355)
T KOG0033|consen 165 ----DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-------------------HRLY 221 (355)
T ss_pred ----CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH-------------------HHHH
Confidence 33345567899999999999999999999999999999999999999976331 1112
Q ss_pred HHHHHHHh--hcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhc
Q 041135 614 EALVDSRL--EKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661 (727)
Q Consensus 614 ~~l~d~~l--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 661 (727)
+.++.... ...+.........+|+++||..||.+|.++.|.+++-+-.
T Consensus 222 e~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~ 271 (355)
T KOG0033|consen 222 EQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWIC 271 (355)
T ss_pred HHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhc
Confidence 22222222 2223333445577899999999999999999999886644
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=343.22 Aligned_cols=256 Identities=23% Similarity=0.263 Sum_probs=194.8
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeC---CchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIG---GSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
++|+++++||+|+||.||++++. +++.||||+++.. .......+.+|+.++..++|+||+++++++.+++..||||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999975 5788999998642 1223345888999999999999999999999999999999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccC
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 536 (727)
||+.||+|.++++.... .+.+..+..++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++....
T Consensus 81 Ey~~gg~L~~~l~~~~~-~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~-- 154 (331)
T cd05624 81 DYYVGGDLLTLLSKFED-RLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ-- 154 (331)
T ss_pred eCCCCCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccC--
Confidence 99999999999976432 478889999999999999999999 999999999999999999999999999975421
Q ss_pred CCccccccccCCccccccCcccC-----CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchh
Q 041135 537 SNTHVSTRVMGTFGYMAPEYATS-----GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHE 611 (727)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~ 611 (727)
.........+|+..|+|||++.+ +.++.++|||||||+||||++|+.||..... .+....+. ...
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~------~~~~~~i~----~~~ 224 (331)
T cd05624 155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIM----NHE 224 (331)
T ss_pred CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH------HHHHHHHH----cCC
Confidence 11112233579999999999876 4678899999999999999999999975331 11111010 000
Q ss_pred hHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCC--CCCHHHHHHHH
Q 041135 612 DFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATK--RPRMSQVVRAL 658 (727)
Q Consensus 612 ~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~L 658 (727)
.. ..+.. ........+.+|+.+||..+..+ |.++++++++.
T Consensus 225 ~~-----~~~p~-~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~ 267 (331)
T cd05624 225 ER-----FQFPS-HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHA 267 (331)
T ss_pred Cc-----ccCCC-ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCC
Confidence 00 00000 01112345777888888865443 45788877663
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=347.95 Aligned_cols=269 Identities=21% Similarity=0.235 Sum_probs=200.7
Q ss_pred hcCccccceeccCCceEEEEEEEc---CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA---DGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~---~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
..+|++++.||+|+||.||++... .++.|+||.+... ..+.+|+++|++|+|+||++++++|..+...++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 457999999999999999999754 3578999987532 34578999999999999999999999999999999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccC
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 536 (727)
||+. ++|.+++.... .+.+.+++.|+.||+.||+|||++ +|||||||++||||+.++.+||+|||+++......
T Consensus 166 e~~~-~~l~~~l~~~~--~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 166 PKYK-CDLFTYVDRSG--PLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred hhcC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 9995 67777774433 489999999999999999999999 99999999999999999999999999997543221
Q ss_pred CCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchh-hHHhhHHHHH--Hhhchh--
Q 041135 537 SNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDES-LVEWARPLLA--EALEHE-- 611 (727)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~-l~~~~~~~l~--~~~~~~-- 611 (727)
.........|+..|+|||++.+..++.++|||||||+||||++|+.||.+........ +....+.+-. ..+...
T Consensus 240 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 240 -DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred -ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 1122234679999999999999999999999999999999999999997755432111 1111110000 000000
Q ss_pred -hHHHHH---HHHhhcccch-------hHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhh
Q 041135 612 -DFEALV---DSRLEKNYVD-------SEMFWMIEAAAACVRHSATKRPRMSQVVRALDT 660 (727)
Q Consensus 612 -~~~~l~---d~~l~~~~~~-------~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 660 (727)
.+...+ ....+..+.. .....+.+|+++||..||++||++.||+.+-..
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f 378 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLF 378 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchh
Confidence 000000 0001111110 112346788999999999999999999988544
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=327.50 Aligned_cols=252 Identities=25% Similarity=0.406 Sum_probs=194.7
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc-----hhHHHHHHHHHHHHHcCCCCceeEeeEeecc--cee
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS-----QGEREFRAEVEIISRVHHRHLVSLVGYCISE--RER 452 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~--~~~ 452 (727)
.+|++.++||+|+||.||+|... +|+.|++|+++.... +....+.+|+++|++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 36888999999999999999864 588999998864321 2335688999999999999999999998753 567
Q ss_pred eEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhh
Q 041135 453 LLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIA 532 (727)
Q Consensus 453 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~ 532 (727)
++||||+.+++|.+++..... +++..++.++.||++||+|||++ +|+|||||++||+++.++.+||+|||+++..
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGA--LTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 899999999999999876544 78899999999999999999998 9999999999999999999999999999754
Q ss_pred hccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhh
Q 041135 533 LELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHED 612 (727)
Q Consensus 533 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~ 612 (727)
..............++..|+|||++.+..++.++|||||||++|||++|+.||...... .. .
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~-----~~-~------------ 218 (266)
T cd06651 157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM-----AA-I------------ 218 (266)
T ss_pred ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH-----HH-H------------
Confidence 22111111122356888999999999988999999999999999999999999753211 00 0
Q ss_pred HHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 613 FEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 613 ~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
..+........+.......+.+++ .||..+|++||+++||+++
T Consensus 219 -~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 219 -FKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred -HHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 000000001111111122344555 6888999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=332.99 Aligned_cols=253 Identities=22% Similarity=0.354 Sum_probs=200.5
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEee
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 458 (727)
.+.|+++++||+|+||.||+|++. +++.|++|++........+.+.+|++++++++|+||++++++|..+...++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 356889999999999999999975 4889999999876666667899999999999999999999999999999999999
Q ss_pred ccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCC
Q 041135 459 VPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSN 538 (727)
Q Consensus 459 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 538 (727)
+.+++|..++.+.. ..+++..++.++.||++||+|||++ +|+|||||++|||++.++.+||+|||++..... .
T Consensus 91 ~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~---~ 163 (292)
T cd06644 91 CPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK---T 163 (292)
T ss_pred CCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccc---c
Confidence 99999988776543 2489999999999999999999998 999999999999999999999999999864321 1
Q ss_pred ccccccccCCccccccCcccC-----CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhH
Q 041135 539 THVSTRVMGTFGYMAPEYATS-----GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDF 613 (727)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~l~~-----~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~ 613 (727)
........++..|++||++.+ ..++.++|||||||++|||++|+.||...... +....+ .....
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~~~----~~~~~- 232 (292)
T cd06644 164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKI----AKSEP- 232 (292)
T ss_pred ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH------HHHHHH----hcCCC-
Confidence 111233467889999999853 44688999999999999999999998653310 000000 00000
Q ss_pred HHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 614 EALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 614 ~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
..+ .........+.+|+++||..+|++||++.||+++
T Consensus 233 -----~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 233 -----PTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred -----ccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000 0011122347789999999999999999999875
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=348.88 Aligned_cols=246 Identities=28% Similarity=0.442 Sum_probs=198.2
Q ss_pred CccccceeccCCceEEEEEEE-cCCcEEEEEEeeeCCchhH---HHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEe
Q 041135 382 GFSAHNVLGEGGFGCVYKGVL-ADGREVAVKQLKIGGSQGE---REFRAEVEIISRVHHRHLVSLVGYCISERERLLVYE 457 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~-~~g~~vaVK~l~~~~~~~~---~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 457 (727)
.|..++.||.|+||.||.++. .+.+.||||++...+.+.. +++..|+++|++|+|+|+|.+.|||..+...|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 377788999999999999995 4678899999986665544 578899999999999999999999999999999999
Q ss_pred eccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCC
Q 041135 458 YVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDS 537 (727)
Q Consensus 458 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 537 (727)
||- |+-.++|.-..+ .+.+.++..|+.+.+.||+|||++ +.||||||+.||||.+.|.|||+|||.|....
T Consensus 107 YCl-GSAsDlleVhkK-plqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~---- 177 (948)
T KOG0577|consen 107 YCL-GSASDLLEVHKK-PLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMA---- 177 (948)
T ss_pred HHh-ccHHHHHHHHhc-cchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcC----
Confidence 994 555555543322 478889999999999999999999 99999999999999999999999999997532
Q ss_pred CccccccccCCccccccCccc---CCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHH
Q 041135 538 NTHVSTRVMGTFGYMAPEYAT---SGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFE 614 (727)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~l~---~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~ 614 (727)
....++||++|||||++. .+.|+-|+|||||||.+.||.-.+.|+...+.+. +...++.. +
T Consensus 178 ---PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS-------ALYHIAQN-e----- 241 (948)
T KOG0577|consen 178 ---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALYHIAQN-E----- 241 (948)
T ss_pred ---chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH-------HHHHHHhc-C-----
Confidence 234578999999999986 4689999999999999999999999876543221 11111110 0
Q ss_pred HHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 041135 615 ALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRAL 658 (727)
Q Consensus 615 ~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 658 (727)
...|. ..+....+.+|+..||++-|.+||+..+++++-
T Consensus 242 ---sPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~ 279 (948)
T KOG0577|consen 242 ---SPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHR 279 (948)
T ss_pred ---CCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcc
Confidence 01111 223445588899999999999999999998874
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=342.53 Aligned_cols=252 Identities=23% Similarity=0.280 Sum_probs=194.3
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
++|++.++||+|+||.||+++++ +++.||||++.... ......+.+|+.++..++|+||+++++++.+....||||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46899999999999999999976 47789999986321 222345888999999999999999999999999999999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccC
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 536 (727)
||+.+|+|.++++.... .+.+..+..++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++.+..
T Consensus 81 ey~~~g~L~~~l~~~~~-~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~-- 154 (332)
T cd05623 81 DYYVGGDLLTLLSKFED-RLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME-- 154 (332)
T ss_pred eccCCCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheeccc--
Confidence 99999999999976432 478889999999999999999999 999999999999999999999999999875421
Q ss_pred CCccccccccCCccccccCccc-----CCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchh
Q 041135 537 SNTHVSTRVMGTFGYMAPEYAT-----SGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHE 611 (727)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~ 611 (727)
.........+|+..|+|||++. .+.++.++|||||||+||||++|+.||..... .+....+.
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~------~~~~~~i~------- 221 (332)
T cd05623 155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIM------- 221 (332)
T ss_pred CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH------HHHHHHHh-------
Confidence 1122223457999999999986 34678899999999999999999999975421 11111111
Q ss_pred hHHHHHHHHhhccc---chhHHHHHHHHHHHHhccCCCC--CCCHHHHHHH
Q 041135 612 DFEALVDSRLEKNY---VDSEMFWMIEAAAACVRHSATK--RPRMSQVVRA 657 (727)
Q Consensus 612 ~~~~l~d~~l~~~~---~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 657 (727)
....+..+ .......+.+|+++|+..++++ |+++.|++++
T Consensus 222 ------~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 222 ------NHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ------CCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 10000000 0112334667788887654433 6889998877
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=329.27 Aligned_cols=256 Identities=26% Similarity=0.414 Sum_probs=203.1
Q ss_pred cCccccceeccCCceEEEEEEEc------CCcEEEEEEeeeCCch-hHHHHHHHHHHHHHcCCCCceeEeeEeeccceee
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA------DGREVAVKQLKIGGSQ-GEREFRAEVEIISRVHHRHLVSLVGYCISERERL 453 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vaVK~l~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 453 (727)
++|++++.||+|+||.||+|+.+ +.+.|++|.+...... ..+++.+|+++|++++|+||++++++|.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 56889999999999999999864 2467999988654433 3467999999999999999999999999989999
Q ss_pred EEEeeccCCccchhcccCCC-------CcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEee
Q 041135 454 LVYEYVPNDTLHYHLHAEGR-------PVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADF 526 (727)
Q Consensus 454 lV~Ey~~~gsL~~~L~~~~~-------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DF 526 (727)
+||||+.+|+|.++++.... ..+.+..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence 99999999999999876541 1489999999999999999999999 9999999999999999999999999
Q ss_pred ccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHH
Q 041135 527 GLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLA 605 (727)
Q Consensus 527 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~ 605 (727)
|+++..... .........++..|++||.+.+..++.++|||||||++|||++ |..||..... ..++..
T Consensus 162 ~~~~~~~~~--~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~---~~~~~~------ 230 (275)
T cd05046 162 SLSKDVYNS--EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD---EEVLNR------ 230 (275)
T ss_pred ccccccCcc--cccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch---HHHHHH------
Confidence 998743211 1112223456778999999998889999999999999999999 7888854321 111110
Q ss_pred HhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhh
Q 041135 606 EALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDT 660 (727)
Q Consensus 606 ~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 660 (727)
.....+...........+.+++.+||+.+|++||++.||++.|++
T Consensus 231 ----------~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 231 ----------LQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred ----------HHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 000111111112233468899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=335.74 Aligned_cols=255 Identities=24% Similarity=0.293 Sum_probs=203.1
Q ss_pred cCccccceeccCCceEEEEEEEcC-CcEEEEEEeeeCCch---hHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLAD-GREVAVKQLKIGGSQ---GEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~~-g~~vaVK~l~~~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
++|++.++||+|+||.||+|+..+ |+.||||.+...... ..+.+.+|+++|+.++|+||+++++++.++...|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 468899999999999999999764 899999999754332 3457889999999999999999999999999999999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccC
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 536 (727)
||+.+++|.+++.......+++..++.++.||++||+|||++ +|+|||||++||||+.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 999999999998765555689999999999999999999999 99999999999999999999999999987532111
Q ss_pred CC--------------------------ccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCC
Q 041135 537 SN--------------------------THVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQP 590 (727)
Q Consensus 537 ~~--------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~ 590 (727)
.. ........|+..|++||++.+..++.++|||||||++|||++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 00 0011234688899999999998899999999999999999999999975432
Q ss_pred CCchhhHHhhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCC----HHHHHHH
Q 041135 591 LGDESLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPR----MSQVVRA 657 (727)
Q Consensus 591 ~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~evl~~ 657 (727)
. .. +..+++..+...........+.+|+++||..||++|++ +.||+++
T Consensus 238 ~--~~-----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 238 D--ET-----------------FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred H--HH-----------------HHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 1 00 11111111111111113456889999999999999999 6666664
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=322.77 Aligned_cols=250 Identities=22% Similarity=0.362 Sum_probs=201.0
Q ss_pred CccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC--chhHHHHHHHHHHHHHcCCCCceeEeeEeec-cceeeEEEe
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG--SQGEREFRAEVEIISRVHHRHLVSLVGYCIS-ERERLLVYE 457 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~-~~~~~lV~E 457 (727)
+|++++.||+|+||.||+++.+ +++.|+||++.... ....+.+.+|++++++++|+||+++++.+.. +...++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4889999999999999999965 47889999986533 2344578899999999999999999998764 446789999
Q ss_pred eccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCC
Q 041135 458 YVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDS 537 (727)
Q Consensus 458 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 537 (727)
|+.+++|.+++.......+.+.+++.++.+|+.||+|||++ +|+|||||++|||+++++.+||+|||++.....
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~--- 154 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN--- 154 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecc---
Confidence 99999999998775555689999999999999999999999 999999999999999999999999999975421
Q ss_pred CccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHH
Q 041135 538 NTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALV 617 (727)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~ 617 (727)
.........++..|+|||++.+..++.++|||||||++|||++|+.+|...+. ..+...+ .
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~------~~~~~~~-------------~ 215 (257)
T cd08223 155 QCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM------NSLVYRI-------------I 215 (257)
T ss_pred cCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHHH-------------H
Confidence 11223345688899999999999999999999999999999999999874321 1111111 1
Q ss_pred HHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 618 DSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 618 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
...+ ..........+.+|+.+||+.+|++||++.+|+++
T Consensus 216 ~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 216 EGKL-PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred hcCC-CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1111 11112233458899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=325.83 Aligned_cols=252 Identities=31% Similarity=0.455 Sum_probs=192.1
Q ss_pred ceeccCCceEEEEEEEcC----CcEEEEEEeeeCC-chhHHHHHHHHHHHHHcCCCCceeEeeEee-ccceeeEEEeecc
Q 041135 387 NVLGEGGFGCVYKGVLAD----GREVAVKQLKIGG-SQGEREFRAEVEIISRVHHRHLVSLVGYCI-SERERLLVYEYVP 460 (727)
Q Consensus 387 ~~LG~G~fg~Vy~~~~~~----g~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~-~~~~~~lV~Ey~~ 460 (727)
++||+|+||.||+|++.+ +..||||++.... ....+.+.+|+.+++.++|+||++++++|. .+...++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998642 4579999885432 334567889999999999999999999876 4556789999999
Q ss_pred CCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCc-
Q 041135 461 NDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNT- 539 (727)
Q Consensus 461 ~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~- 539 (727)
+|+|.++++.... .+.+..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||+++.........
T Consensus 81 ~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 81 HGDLRNFIRSETH-NPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred CCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 9999999876433 367788899999999999999998 99999999999999999999999999997542211111
Q ss_pred cccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhC-CCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHH
Q 041135 540 HVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITG-RKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVD 618 (727)
Q Consensus 540 ~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG-~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d 618 (727)
.......++..|+|||++.+..++.++|||||||++|||++| ..+|..... .+....+. .+
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~------~~~~~~~~-----~~------- 218 (262)
T cd05058 157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS------FDITVYLL-----QG------- 218 (262)
T ss_pred cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHh-----cC-------
Confidence 111234567789999999988999999999999999999995 555543211 11111000 00
Q ss_pred HHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhcc
Q 041135 619 SRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLD 662 (727)
Q Consensus 619 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 662 (727)
............+.+++.+||..+|++||++.||++.|+++.
T Consensus 219 --~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 219 --RRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred --CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 000001111245789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=323.85 Aligned_cols=254 Identities=24% Similarity=0.375 Sum_probs=204.0
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeec
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYV 459 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 459 (727)
++|++.+.||+|+||.||+|+.. +++.++||++........+.+.+|++++++++|+||+++++++.++...|++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57889999999999999999975 57889999998766666678999999999999999999999999999999999999
Q ss_pred cCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCc
Q 041135 460 PNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNT 539 (727)
Q Consensus 460 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 539 (727)
.+++|.+++.... ..+++..++.++.||+.||+|||++ +|+|||||++||+|++++.+||+|||++...... .
T Consensus 83 ~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~---~ 155 (262)
T cd06613 83 GGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT---I 155 (262)
T ss_pred CCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhh---h
Confidence 9999999887652 2488999999999999999999998 9999999999999999999999999999754321 1
Q ss_pred cccccccCCccccccCcccCC---CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHH
Q 041135 540 HVSTRVMGTFGYMAPEYATSG---KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEAL 616 (727)
Q Consensus 540 ~~~~~~~gt~~y~aPE~l~~~---~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l 616 (727)
.......++..|++||.+.+. .++.++|||||||++|||++|+.||....... ..... ....+..
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~--~~~~~----~~~~~~~------ 223 (262)
T cd06613 156 AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR--ALFLI----SKSNFPP------ 223 (262)
T ss_pred hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHH----HhccCCC------
Confidence 122335688899999999876 88999999999999999999999997543211 00000 0000000
Q ss_pred HHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 617 VDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 617 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
..+ .........+.+|+++||..+|.+||++.+|+.+
T Consensus 224 --~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 224 --PKL--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred --ccc--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 0111223457899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=325.89 Aligned_cols=247 Identities=27% Similarity=0.465 Sum_probs=199.6
Q ss_pred cCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeecc
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVP 460 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 460 (727)
++|++.++||+|+||.||+|+. +++.||||+++.. ...+.+.+|+.+|++++|+||+++++++..+ ..++||||+.
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4588999999999999999986 5788999998643 2346789999999999999999999998765 4799999999
Q ss_pred CCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCcc
Q 041135 461 NDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTH 540 (727)
Q Consensus 461 ~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 540 (727)
+++|.+++.......+.+..++.++.||++||.|||++ +++|||||++|||++.++.+||+|||+++.....
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~----- 153 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----- 153 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc-----
Confidence 99999999876655689999999999999999999998 9999999999999999999999999998753211
Q ss_pred ccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHH
Q 041135 541 VSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDS 619 (727)
Q Consensus 541 ~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~ 619 (727)
.........|++||++.++.++.++|||||||++|||++ |+.||..... .++. ..+..
T Consensus 154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------~~~~--------------~~~~~ 212 (254)
T cd05083 154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL------KEVK--------------ECVEK 212 (254)
T ss_pred -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH------HHHH--------------HHHhC
Confidence 112234567999999998899999999999999999998 9999865431 1110 01111
Q ss_pred HhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhh
Q 041135 620 RLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDT 660 (727)
Q Consensus 620 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 660 (727)
.............+.+++++||+.+|++||++++|++.|++
T Consensus 213 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 213 GYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 11111112223457899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=331.06 Aligned_cols=253 Identities=22% Similarity=0.355 Sum_probs=200.6
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeec
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYV 459 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 459 (727)
++|++.++||+|+||.||+|+.. +++.||||+++.........+.+|+.+++.++|+||+++++++.+++..|+||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 46888899999999999999864 58899999998665555567889999999999999999999999999999999999
Q ss_pred cCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCc
Q 041135 460 PNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNT 539 (727)
Q Consensus 460 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 539 (727)
.+++|.++++..+. +++.+++.++.||+.||+|||++ +|+|||||++|||++.++.+||+|||++..... ..
T Consensus 89 ~~~~L~~~~~~~~~--~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~---~~ 160 (267)
T cd06645 89 GGGSLQDIYHVTGP--LSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITA---TI 160 (267)
T ss_pred CCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccC---cc
Confidence 99999999876554 88999999999999999999999 999999999999999999999999999875421 11
Q ss_pred cccccccCCccccccCccc---CCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHH
Q 041135 540 HVSTRVMGTFGYMAPEYAT---SGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEAL 616 (727)
Q Consensus 540 ~~~~~~~gt~~y~aPE~l~---~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l 616 (727)
.......|+..|+|||++. .+.++.++|||||||++|||++|+.||.......... . .........
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~--~----~~~~~~~~~----- 229 (267)
T cd06645 161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF--L----MTKSNFQPP----- 229 (267)
T ss_pred cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHH--h----hhccCCCCC-----
Confidence 1223457889999999984 4568899999999999999999999986433211000 0 000000000
Q ss_pred HHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 617 VDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 617 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
.+.. .......+.+++++||..+|++||++++|+++
T Consensus 230 ---~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 230 ---KLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred ---cccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 0000 00112347789999999999999999998864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=325.40 Aligned_cols=252 Identities=25% Similarity=0.367 Sum_probs=196.5
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC-----chhHHHHHHHHHHHHHcCCCCceeEeeEeecc--cee
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG-----SQGEREFRAEVEIISRVHHRHLVSLVGYCISE--RER 452 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~-----~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~--~~~ 452 (727)
++|++.++||+|+||.||+|+.. +|+.|+||+++... ....+.+.+|+++|++++|+||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46889999999999999999875 58999999886432 12235788999999999999999999998764 467
Q ss_pred eEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhh
Q 041135 453 LLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIA 532 (727)
Q Consensus 453 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~ 532 (727)
++||||+.+++|.+++..... +++..+++++.||+.||+|||++ +|+|||||++|||++.++.+||+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGA--LTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 899999999999999876543 78888999999999999999999 9999999999999999999999999999754
Q ss_pred hccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhh
Q 041135 533 LELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHED 612 (727)
Q Consensus 533 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~ 612 (727)
..............|+..|+|||++.+..++.++|||||||++|||++|+.||...... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----~~~------------- 218 (265)
T cd06652 157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM-----AAI------------- 218 (265)
T ss_pred ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH-----HHH-------------
Confidence 32211111223356888999999999888999999999999999999999999643210 000
Q ss_pred HHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 613 FEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 613 ~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
...................+.+++.+||. ++++||+++||+++
T Consensus 219 -~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 219 -FKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred -HHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 00000001111122233456788889984 89999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=333.93 Aligned_cols=261 Identities=27% Similarity=0.374 Sum_probs=195.8
Q ss_pred ccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccc-----eeeEEE
Q 041135 383 FSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISER-----ERLLVY 456 (727)
Q Consensus 383 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~-----~~~lV~ 456 (727)
|...+++|.|.||.||+|++. .++.||||++... .+.-.+|+++|++++|+|||+|+.+|.... ...|||
T Consensus 26 ~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d----~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl 101 (364)
T KOG0658|consen 26 YEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQD----KRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL 101 (364)
T ss_pred EEeeEEEeecccceEEEEEEcCCCceeEEEEecCC----CCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence 566799999999999999975 4789999998632 234457999999999999999999887432 235899
Q ss_pred eeccCCccchhcccC--CCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCC-CcEEEEeeccchhhh
Q 041135 457 EYVPNDTLHYHLHAE--GRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSS-FEARVADFGLAKIAL 533 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~-~~vkL~DFGla~~~~ 533 (727)
||++. +|.++++.. .+..+...++.-+.+||++||.|||+. +|+||||||.|||||.+ |.+||||||.|+.+.
T Consensus 102 eymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 102 EYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred HhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 99965 666666531 233478888899999999999999998 99999999999999965 899999999998764
Q ss_pred ccCCCccccccccCCccccccCcccCC-CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHH---HHhh-
Q 041135 534 ELDSNTHVSTRVMGTFGYMAPEYATSG-KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLL---AEAL- 608 (727)
Q Consensus 534 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l---~~~~- 608 (727)
....+ .....+..|+|||.+.+. +|+.+.||||.||||.||+.|+.-|.+... .+++++.++-+- .+.+
T Consensus 178 ~~epn----iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~--~dQL~eIik~lG~Pt~e~I~ 251 (364)
T KOG0658|consen 178 KGEPN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS--VDQLVEIIKVLGTPTREDIK 251 (364)
T ss_pred cCCCc----eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH--HHHHHHHHHHhCCCCHHHHh
Confidence 32222 234568899999999874 799999999999999999999999988543 344554433210 0000
Q ss_pred --c----hhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 609 --E----HEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 609 --~----~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
+ ...+.++....+..-+.......+++|+.++|..+|.+|-++.|++.+
T Consensus 252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 0 011111222222222334445568899999999999999999999866
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=323.25 Aligned_cols=251 Identities=25% Similarity=0.366 Sum_probs=204.0
Q ss_pred CccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC--chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEee
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG--SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 458 (727)
+|+++++||+|+||.||.++.. +++.|++|.+.... ....+++.+|+++|++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 4888999999999999999854 58899999986543 34456788999999999999999999999999999999999
Q ss_pred ccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCC
Q 041135 459 VPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSN 538 (727)
Q Consensus 459 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 538 (727)
+.+++|.+++.......+++.+++.++.|+++||.|||++ +|+|||||++||++++++.+||+|||+++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~-- 155 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY-- 155 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc--
Confidence 9999999999776455689999999999999999999998 99999999999999999999999999997542211
Q ss_pred ccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHH
Q 041135 539 THVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVD 618 (727)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d 618 (727)
.......|+..|++||++.+..++.++||||||+++|||++|+.+|..... .+.... +..
T Consensus 156 -~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~-------------~~~ 215 (256)
T cd08221 156 -SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP------LNLVVK-------------IVQ 215 (256)
T ss_pred -ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH------HHHHHH-------------HHc
Confidence 122345688999999999988899999999999999999999999965321 111111 111
Q ss_pred HHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 041135 619 SRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRAL 658 (727)
Q Consensus 619 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 658 (727)
..+.. ........+.+++.+||..+|++||++.+|++++
T Consensus 216 ~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 216 GNYTP-VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CCCCC-CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 11100 1112234578899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=328.43 Aligned_cols=256 Identities=27% Similarity=0.425 Sum_probs=202.2
Q ss_pred cCccccceeccCCceEEEEEEEcC-Cc----EEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLAD-GR----EVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLL 454 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~~-g~----~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 454 (727)
.+|++++.||+|+||.||+|.+++ |+ .||+|+++.... ....++.+|+++|++++|+||++++++|.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 458889999999999999998643 33 589998865443 334678999999999999999999999987 78899
Q ss_pred EEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhc
Q 041135 455 VYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALE 534 (727)
Q Consensus 455 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 534 (727)
||||+.+|+|.++++.+.. .+++..+++++.||+.||+|||++ +|+|||||++|||+++++.+||+|||+++....
T Consensus 86 v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKD-NIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EEecCCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 9999999999999876543 389999999999999999999998 999999999999999999999999999986532
Q ss_pred cCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhH
Q 041135 535 LDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDF 613 (727)
Q Consensus 535 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~ 613 (727)
.. .........++..|++||.+....++.++|||||||++|||++ |+.||+.... . ++.
T Consensus 162 ~~-~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~---~~~------------- 221 (279)
T cd05057 162 DE-KEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA---V---EIP------------- 221 (279)
T ss_pred cc-cceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH---H---HHH-------------
Confidence 11 1111122334578999999988889999999999999999998 9999975421 1 110
Q ss_pred HHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhcc
Q 041135 614 EALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLD 662 (727)
Q Consensus 614 ~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 662 (727)
..+...............+.+++.+||..++.+||++.+|++.|+.+.
T Consensus 222 -~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05057 222 -DLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA 269 (279)
T ss_pred -HHHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 111100001111112345778999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=330.25 Aligned_cols=265 Identities=26% Similarity=0.359 Sum_probs=205.9
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEee
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 458 (727)
++|+++++||+|+||.||+++.. +|+.||+|++..... ...+.+.+|+++++.++|+||+++++++......+|||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 46888899999999999999865 588999998875533 3456789999999999999999999999999999999999
Q ss_pred ccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCC
Q 041135 459 VPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSN 538 (727)
Q Consensus 459 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 538 (727)
+.+++|.+++...+ .+.+..+..++.+|+.||.|||+.+ +|+|||||++||++++++.++|+|||++......
T Consensus 85 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~--- 157 (284)
T cd06620 85 MDCGSLDRIYKKGG--PIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--- 157 (284)
T ss_pred CCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh---
Confidence 99999999887654 3789999999999999999999732 8999999999999999999999999998643211
Q ss_pred ccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHH
Q 041135 539 THVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVD 618 (727)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d 618 (727)
......|+..|++||++.+..++.++|||||||++|||++|+.||.......+... ....++ ..+..++.
T Consensus 158 --~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~--~~~~~~------~~~~~~~~ 227 (284)
T cd06620 158 --IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQD--DPMGIL------DLLQQIVQ 227 (284)
T ss_pred --ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhh--hhhHHH------HHHHHHhh
Confidence 11235689999999999888999999999999999999999999986543211100 000000 00111111
Q ss_pred HHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhcc
Q 041135 619 SRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLD 662 (727)
Q Consensus 619 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 662 (727)
.....-........+.+|+.+||+.||++||++.||++++..++
T Consensus 228 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 228 EPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred ccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 10000001112345788999999999999999999999865543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=326.37 Aligned_cols=240 Identities=24% Similarity=0.414 Sum_probs=188.4
Q ss_pred ceeccCCceEEEEEEEcC-------------CcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceee
Q 041135 387 NVLGEGGFGCVYKGVLAD-------------GREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERL 453 (727)
Q Consensus 387 ~~LG~G~fg~Vy~~~~~~-------------g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 453 (727)
+.||+|+||.||+|++.+ ...|+||.+..........|.+|+.+|+.++|+||++++++|..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998532 2358889876554455567889999999999999999999999999999
Q ss_pred EEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCc-------EEEEee
Q 041135 454 LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFE-------ARVADF 526 (727)
Q Consensus 454 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~-------vkL~DF 526 (727)
|||||+.+|.|..+++.+.. .+++..+++|+.||++||+|||++ +|+|||||++||||+.++. +||+||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSD-VLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEEecccCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 99999999999988865432 488999999999999999999999 9999999999999986654 899999
Q ss_pred ccchhhhccCCCccccccccCCccccccCccc-CCCCCchhHHHHHhHHHHHHH-hCCCCCCCCCCCCchhhHHhhHHHH
Q 041135 527 GLAKIALELDSNTHVSTRVMGTFGYMAPEYAT-SGKLTEKSDVYSFGVVLLELI-TGRKPVDASQPLGDESLVEWARPLL 604 (727)
Q Consensus 527 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~ksDVwS~Gvil~eLl-tG~~Pf~~~~~~~~~~l~~~~~~~l 604 (727)
|++..... .....++..|+|||++. +..++.++|||||||+||||+ .|+.||...... +.
T Consensus 157 g~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~------~~----- 218 (262)
T cd05077 157 GIPITVLS-------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA------EK----- 218 (262)
T ss_pred CCCccccC-------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh------HH-----
Confidence 99864321 12245778899999987 466899999999999999998 588887643211 00
Q ss_pred HHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 605 AEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 605 ~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
..+...... ........+.+|+.+||+.||++||++.+|++.|+
T Consensus 219 ---------~~~~~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 219 ---------ERFYEGQCM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred ---------HHHHhcCcc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 000000000 11112245788999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=330.67 Aligned_cols=264 Identities=24% Similarity=0.333 Sum_probs=194.3
Q ss_pred CccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCch--hHHHHHHHHHHHHHc---CCCCceeEeeEeec-----cc
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQ--GEREFRAEVEIISRV---HHRHLVSLVGYCIS-----ER 450 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~--~~~~~~~Ei~~l~~l---~HpnIv~l~~~~~~-----~~ 450 (727)
+|++++.||+|+||.||+|+.+ +|+.||||+++..... ....+.+|+++++.+ +|+||++++++|.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4888999999999999999875 5889999998754322 234566788777765 69999999999864 24
Q ss_pred eeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccch
Q 041135 451 ERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAK 530 (727)
Q Consensus 451 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~ 530 (727)
..++||||+.+ +|..+++......+.+..++.++.||+.||+|||++ +|+|||||++|||+++++.+||+|||+++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCccc
Confidence 57899999974 787787765555689999999999999999999999 99999999999999999999999999997
Q ss_pred hhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhch
Q 041135 531 IALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEH 610 (727)
Q Consensus 531 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~ 610 (727)
.... ........|+..|+|||++.+..++.++|||||||++|||++|+.+|...... ..+.+... .+.. ...
T Consensus 157 ~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~--~~~~~~~~-~~~~-~~~ 228 (288)
T cd07863 157 IYSC----QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA--DQLGKIFD-LIGL-PPE 228 (288)
T ss_pred cccC----cccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH--HHHHHHHH-HhCC-CCh
Confidence 5421 11223456789999999999989999999999999999999999999654321 11111100 0000 000
Q ss_pred hhHHHHHH---HHhh-------cccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 611 EDFEALVD---SRLE-------KNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 611 ~~~~~l~d---~~l~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
..+...+. ..+. ..........+.+|+.+||+.||++|+++.||+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 229 DDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred hhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000000 0000 00011123347799999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=329.29 Aligned_cols=252 Identities=23% Similarity=0.348 Sum_probs=198.9
Q ss_pred ccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeeccC
Q 041135 383 FSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPN 461 (727)
Q Consensus 383 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 461 (727)
|++.+.||+|+||.||+|++. ++..+++|.+........+.+.+|+++++.++|+||++++++|..+...++||||+.+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 567789999999999999976 4778899988765555567789999999999999999999999999999999999999
Q ss_pred CccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCccc
Q 041135 462 DTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHV 541 (727)
Q Consensus 462 gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 541 (727)
++|..++.+.. ..+++..++.++.||++||+|||++ +|+|||||++|||++.++.+||+|||+++.... ....
T Consensus 87 ~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~---~~~~ 159 (282)
T cd06643 87 GAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR---TIQR 159 (282)
T ss_pred CcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccc---cccc
Confidence 99988876533 2489999999999999999999999 999999999999999999999999999875421 1112
Q ss_pred cccccCCccccccCccc-----CCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHH
Q 041135 542 STRVMGTFGYMAPEYAT-----SGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEAL 616 (727)
Q Consensus 542 ~~~~~gt~~y~aPE~l~-----~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l 616 (727)
.....++..|++||++. +..++.++|||||||++|||++|+.||...... ..+... ....
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~~--------~~~~----- 224 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM--RVLLKI--------AKSE----- 224 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH--HHHHHH--------hhcC-----
Confidence 23356889999999984 345778999999999999999999998753311 000000 0000
Q ss_pred HHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 617 VDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 617 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
...+ .........+.+|+++||+.+|++||++.+|+++-.
T Consensus 225 -~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 264 (282)
T cd06643 225 -PPTL--AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPF 264 (282)
T ss_pred -CCCC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCC
Confidence 0000 001112235789999999999999999999987754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=324.81 Aligned_cols=250 Identities=24% Similarity=0.410 Sum_probs=201.9
Q ss_pred cCccccceeccCCceEEEEEEEcC-CcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeec
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLAD-GREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYV 459 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~~-g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 459 (727)
++|++.+.||+|+||.||+|++.+ ++.|++|.++.... .+++.+|++++++++|+||+++++++.++...|+|+||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 568889999999999999999865 78999999875422 678999999999999999999999999999999999999
Q ss_pred cCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCc
Q 041135 460 PNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNT 539 (727)
Q Consensus 460 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 539 (727)
.+++|.+++.... ..+++..++.++.||++||.|||+. +|+||||+++||++++++.+||+|||++...... .
T Consensus 81 ~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~---~ 153 (256)
T cd06612 81 GAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT---M 153 (256)
T ss_pred CCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccC---c
Confidence 9999999986543 3589999999999999999999999 9999999999999999999999999999754321 1
Q ss_pred cccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHH
Q 041135 540 HVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDS 619 (727)
Q Consensus 540 ~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~ 619 (727)
.......++..|++||++.+..++.++||||||||+|||++|+.||......... .. ...... .
T Consensus 154 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~---------~~--~~~~~~-----~ 217 (256)
T cd06612 154 AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI---------FM--IPNKPP-----P 217 (256)
T ss_pred cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh---------hh--hccCCC-----C
Confidence 1223345788999999999999999999999999999999999999754321100 00 000000 0
Q ss_pred HhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 620 RLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 620 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
.+ .........+.+++.+||+.+|++||++.||+++
T Consensus 218 ~~--~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 218 TL--SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred CC--CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 00 0011112347889999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=340.97 Aligned_cols=253 Identities=24% Similarity=0.391 Sum_probs=205.6
Q ss_pred hcCccccceeccCCceEEEEEEEcCCcEEEEEEeeeC--CchhHHHHHHHHHHHHHcC-CCCceeEeeEeeccceeeEEE
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIG--GSQGEREFRAEVEIISRVH-HRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~--~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~lV~ 456 (727)
...|+++++||+||.++||++...+.+.||+|++... +.+....|++|+.+|.+|+ |.+||+||+|-..++.+||||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 3458899999999999999999888888999887543 3444578999999999996 999999999999999999999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccC
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 536 (727)
||- ..+|..+|+.+.....+| .++.+..||+.++.++|.+ ||||.||||.|+|| -.|.+||+|||+|..+. .+
T Consensus 440 E~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~-~D 512 (677)
T KOG0596|consen 440 ECG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLL-VKGRLKLIDFGIANAIQ-PD 512 (677)
T ss_pred ecc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEE-EeeeEEeeeechhcccC-cc
Confidence 975 778999998877655556 7888999999999999999 99999999999999 45699999999998653 34
Q ss_pred CCccccccccCCccccccCcccCC-----------CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHH
Q 041135 537 SNTHVSTRVMGTFGYMAPEYATSG-----------KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLA 605 (727)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~l~~~-----------~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~ 605 (727)
...-.....+||+.||+||.+... +...++||||||||||+|+-|+.||..... .|+
T Consensus 513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-------~~a----- 580 (677)
T KOG0596|consen 513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-------QIA----- 580 (677)
T ss_pred ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-------HHH-----
Confidence 444455668999999999998642 256799999999999999999999964321 121
Q ss_pred HhhchhhHHHHHHHHhhcccchhHHHH-HHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 606 EALEHEDFEALVDSRLEKNYVDSEMFW-MIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 606 ~~~~~~~~~~l~d~~l~~~~~~~~~~~-l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
.+..+.+...+.+|..--..+ ++++|+.||..||.+|++..|||++
T Consensus 581 ------Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 581 ------KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ------HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 234445544433443322223 8999999999999999999999987
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=326.04 Aligned_cols=257 Identities=23% Similarity=0.343 Sum_probs=200.6
Q ss_pred HHHhcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEE
Q 041135 377 IQATNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLV 455 (727)
Q Consensus 377 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 455 (727)
+..++.+....+||+|+||.||+|++. +++.|+||.+........+.+.+|++++++++|+||+++++++..++..++|
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 334555666688999999999999965 5778999998876666677899999999999999999999999999999999
Q ss_pred EeeccCCccchhcccCC-CCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECC-CCcEEEEeeccchhhh
Q 041135 456 YEYVPNDTLHYHLHAEG-RPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDS-SFEARVADFGLAKIAL 533 (727)
Q Consensus 456 ~Ey~~~gsL~~~L~~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~-~~~vkL~DFGla~~~~ 533 (727)
|||+.+++|.++++... ....++..++.++.||++||+|||++ +|+|||||++||+|+. ++.+||+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 99999999999987642 21237888899999999999999998 9999999999999976 6799999999987542
Q ss_pred ccCCCccccccccCCccccccCcccCCC--CCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchh
Q 041135 534 ELDSNTHVSTRVMGTFGYMAPEYATSGK--LTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHE 611 (727)
Q Consensus 534 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~ 611 (727)
.. ........|+..|++||++.+.. ++.++|||||||++|||++|+.||...... ....+.....
T Consensus 161 ~~---~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~---~~~~~~~~~~------- 227 (268)
T cd06624 161 GI---NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP---QAAMFKVGMF------- 227 (268)
T ss_pred cC---CCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccCh---hhhHhhhhhh-------
Confidence 11 11122345788999999987643 788999999999999999999999653321 0111100000
Q ss_pred hHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 612 DFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 612 ~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
.....+.......+.+|+++||+.+|++||++.||+++
T Consensus 228 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 228 --------KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred --------ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 00011111223447789999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=344.52 Aligned_cols=265 Identities=22% Similarity=0.294 Sum_probs=196.4
Q ss_pred HhcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeC--CchhHHHHHHHHHHHHHcCCCCceeEeeEeecc------
Q 041135 379 ATNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIG--GSQGEREFRAEVEIISRVHHRHLVSLVGYCISE------ 449 (727)
Q Consensus 379 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~------ 449 (727)
..++|++.++||+|+||.||+++.. .++.||||++... .......+.+|+.+++.++|+||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4567999999999999999999864 5889999998643 233346788999999999999999999987643
Q ss_pred ceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccc
Q 041135 450 RERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLA 529 (727)
Q Consensus 450 ~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla 529 (727)
...|+||||+.+ .|.+++.. .+++..++.++.||++||+|||++ +|+|||||++||||+.++.+||+|||++
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 356999999965 55555543 278889999999999999999999 9999999999999999999999999999
Q ss_pred hhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHH------
Q 041135 530 KIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPL------ 603 (727)
Q Consensus 530 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~------ 603 (727)
+.... ........|+..|+|||++.+..++.++|||||||+||||++|+.||...+... .+......+
T Consensus 174 ~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~~ 247 (364)
T cd07875 174 RTAGT----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID--QWNKVIEQLGTPCPE 247 (364)
T ss_pred cccCC----CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCCHH
Confidence 75321 112234568999999999999999999999999999999999999997654211 111110000
Q ss_pred HHHhhchhhHHHHHHHH---------------hh---cccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 041135 604 LAEALEHEDFEALVDSR---------------LE---KNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRAL 658 (727)
Q Consensus 604 l~~~~~~~~~~~l~d~~---------------l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 658 (727)
+...+. ..+...+..+ +. ..........+.+|+.+||+.||++|+++.||+++-
T Consensus 248 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp 319 (364)
T cd07875 248 FMKKLQ-PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319 (364)
T ss_pred HHHhhh-HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence 000000 0000000000 00 000011123577999999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=330.66 Aligned_cols=267 Identities=22% Similarity=0.327 Sum_probs=197.1
Q ss_pred CccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc--hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEee
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS--QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 458 (727)
+|++.+.||+|+||.||+|+.. +|+.||||+++.... .....+.+|++++++++|+||+++++++.++...|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4788999999999999999975 689999999865432 2335788999999999999999999999999999999999
Q ss_pred ccCCccchhcccCC-CCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCC
Q 041135 459 VPNDTLHYHLHAEG-RPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDS 537 (727)
Q Consensus 459 ~~~gsL~~~L~~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 537 (727)
+. ++|.+++.... ...+++..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||+++....
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--- 153 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI--- 153 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCC---
Confidence 97 57777775433 24689999999999999999999999 999999999999999999999999999874321
Q ss_pred CccccccccCCccccccCcccCC-CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHH---HHHhh----c
Q 041135 538 NTHVSTRVMGTFGYMAPEYATSG-KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPL---LAEAL----E 609 (727)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~l~~~-~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~---l~~~~----~ 609 (727)
.........++..|+|||++.+. .++.++|||||||++|||++|+.+|...... ..+....+.+ ....+ .
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
T cd07861 154 PVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI--DQLFRIFRILGTPTEDVWPGVTS 231 (285)
T ss_pred CcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHhCCCChhhhhcchh
Confidence 11122334578899999998764 4788999999999999999999999764321 1111100000 00000 0
Q ss_pred hhhHHHHHHHHhhc---ccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 610 HEDFEALVDSRLEK---NYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 610 ~~~~~~l~d~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
...+...+...... .........+.+|+++||+.||++||++.+|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 232 LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00000000000000 0001122346789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=322.60 Aligned_cols=251 Identities=31% Similarity=0.489 Sum_probs=201.6
Q ss_pred ccccceeccCCceEEEEEEEcC-----CcEEEEEEeeeCCch-hHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 383 FSAHNVLGEGGFGCVYKGVLAD-----GREVAVKQLKIGGSQ-GEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 383 ~~~~~~LG~G~fg~Vy~~~~~~-----g~~vaVK~l~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
|++.+.||+|+||.||++++.+ +..||+|+++..... ..+.+.+|+++|+.++|+||+++++++.+.+..++||
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 4577899999999999999754 488999999765443 5678999999999999999999999999999999999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccC
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 536 (727)
||+.+++|.+++.......+.+..++.++.||+.||+|||++ +|+|||||++||++++++.+||+|||+++......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 999999999999765544489999999999999999999999 99999999999999999999999999997653221
Q ss_pred CCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHH
Q 041135 537 SNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFEA 615 (727)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~ 615 (727)
. .......++..|++||.+.+..++.++|||+|||++|||++ |+.||..... ..+.+.
T Consensus 158 ~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~---~~~~~~---------------- 216 (258)
T smart00219 158 Y--YKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN---EEVLEY---------------- 216 (258)
T ss_pred c--cccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH----------------
Confidence 1 11112336789999999988889999999999999999998 7888865221 111111
Q ss_pred HHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 041135 616 LVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRAL 658 (727)
Q Consensus 616 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 658 (727)
+...............+.+++++||+.+|++||++.||++.|
T Consensus 217 -~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 217 -LKKGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -HhcCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 000001111112344588899999999999999999999864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=327.39 Aligned_cols=253 Identities=26% Similarity=0.370 Sum_probs=190.0
Q ss_pred ceeccCCceEEEEEEEcC---CcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeeccCC
Q 041135 387 NVLGEGGFGCVYKGVLAD---GREVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPND 462 (727)
Q Consensus 387 ~~LG~G~fg~Vy~~~~~~---g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 462 (727)
+.||+|+||.||+|++.+ +..+++|.++.... .....+.+|+.++++++|+||++++++|.+....++||||+.+|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 469999999999998653 45799998875543 33457889999999999999999999999999999999999999
Q ss_pred ccchhcccCC---CCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCc
Q 041135 463 TLHYHLHAEG---RPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNT 539 (727)
Q Consensus 463 sL~~~L~~~~---~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 539 (727)
+|.++++... ....++..+++++.||++||+|||++ +|+|||||++|||++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~-~~ 156 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED-YY 156 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcc-ee
Confidence 9999986532 22456778889999999999999999 99999999999999999999999999997432111 11
Q ss_pred cccccccCCccccccCcccCC-------CCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchh
Q 041135 540 HVSTRVMGTFGYMAPEYATSG-------KLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHE 611 (727)
Q Consensus 540 ~~~~~~~gt~~y~aPE~l~~~-------~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~ 611 (727)
.......++..|+|||++.+. .++.++|||||||++|||++ |+.||...... ....+ .. . .
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~---~~~~~---~~----~-~ 225 (269)
T cd05087 157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE---QVLTY---TV----R-E 225 (269)
T ss_pred ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH---HHHHH---Hh----h-c
Confidence 112335678889999998643 35789999999999999996 99999654321 11000 00 0 0
Q ss_pred hHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 612 DFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 612 ~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
....+.+..+ .......+.+|+..|| .+|++||+++||++.|.
T Consensus 226 ~~~~~~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 226 QQLKLPKPRL----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred ccCCCCCCcc----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 0000001111 1112234677889999 68999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=333.94 Aligned_cols=251 Identities=23% Similarity=0.378 Sum_probs=203.8
Q ss_pred hcCccccceeccCCceEEEEEEE-cCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEee
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVL-ADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 458 (727)
.++|++++.||+|+||.||+|+. .+|+.||||.+........+.+.+|+.+++.++|+||++++++|..+...|+||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 36789999999999999999996 46899999999866666667789999999999999999999999999999999999
Q ss_pred ccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCC
Q 041135 459 VPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSN 538 (727)
Q Consensus 459 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 538 (727)
+.+++|.+++... .+.+..++.++.|++.||.|||+. +|+|||||++||||+.++.+||+|||++..... .
T Consensus 98 ~~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~---~ 168 (297)
T cd06656 98 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP---E 168 (297)
T ss_pred cCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccC---C
Confidence 9999999988653 378889999999999999999998 999999999999999999999999999875321 1
Q ss_pred ccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHH
Q 041135 539 THVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVD 618 (727)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d 618 (727)
........++..|++||.+.+..++.++|||||||++|+|++|+.||...+..... ... ...+
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~--~~~--------~~~~------- 231 (297)
T cd06656 169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL--YLI--------ATNG------- 231 (297)
T ss_pred ccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe--eee--------ccCC-------
Confidence 11223356888999999999988999999999999999999999999764321100 000 0000
Q ss_pred HHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 619 SRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 619 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
.............+.+|+.+||+.+|++||++++|+++
T Consensus 232 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 232 -TPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred -CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000111122346789999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=331.52 Aligned_cols=250 Identities=23% Similarity=0.386 Sum_probs=203.5
Q ss_pred cCccccceeccCCceEEEEEEE-cCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeec
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVL-ADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYV 459 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 459 (727)
.+|++.+.||.|+||.||+|+. .+|+.|+||.+........+.+.+|+++++.++|+||++++++|.++...|+||||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4589999999999999999985 468999999997665555678899999999999999999999999999999999999
Q ss_pred cCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCc
Q 041135 460 PNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNT 539 (727)
Q Consensus 460 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 539 (727)
.+++|.+++... .+++.+++.++.||+.||+|||++ +|+|||||++||+++.++.+||+|||++...... .
T Consensus 99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~---~ 169 (296)
T cd06655 99 AGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE---Q 169 (296)
T ss_pred CCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccc---c
Confidence 999999988653 379999999999999999999999 9999999999999999999999999998754221 1
Q ss_pred cccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHH
Q 041135 540 HVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDS 619 (727)
Q Consensus 540 ~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~ 619 (727)
.......++..|++||.+.+..++.++|||||||++|||++|+.||...+... ....+.. ....
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~------~~~~~~~--~~~~-------- 233 (296)
T cd06655 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR------ALYLIAT--NGTP-------- 233 (296)
T ss_pred ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHh--cCCc--------
Confidence 12233568889999999999889999999999999999999999997643210 0000000 0000
Q ss_pred HhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 620 RLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 620 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
.+ .........+.+|+++||..||++||++.+|+++
T Consensus 234 ~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 234 EL--QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred cc--CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 00 0111122357789999999999999999999876
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=322.95 Aligned_cols=250 Identities=20% Similarity=0.358 Sum_probs=202.4
Q ss_pred CccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC--chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEee
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG--SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 458 (727)
+|++.++||+|+||.||+++.. +|+.|+||++.... .....++.+|++++++++|+||+++++++.+.+..+|||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 5888999999999999999864 68899999987432 23345789999999999999999999999999999999999
Q ss_pred ccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCC
Q 041135 459 VPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSN 538 (727)
Q Consensus 459 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 538 (727)
+.+++|.+++.......+.+..+++++.||+.||.|||++ +|+|+||+++||||+.++.++|+|||++..... .
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~---~ 154 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS---T 154 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCc---c
Confidence 9999999988765544578899999999999999999998 999999999999999999999999999975422 1
Q ss_pred ccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHH
Q 041135 539 THVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVD 618 (727)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d 618 (727)
........|+..|++||++.++.++.++|||||||++|||++|+.+|...+. .+....+ +.
T Consensus 155 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~-------------~~ 215 (256)
T cd08218 155 VELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM------KNLVLKI-------------IR 215 (256)
T ss_pred hhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH------HHHHHHH-------------hc
Confidence 1122234678899999999998999999999999999999999999864321 1111110 00
Q ss_pred HHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 619 SRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 619 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
... ..........+.+++++||+.+|++||++++|+++
T Consensus 216 ~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 216 GSY-PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CCC-CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 000 01111223457899999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=348.96 Aligned_cols=252 Identities=25% Similarity=0.374 Sum_probs=205.1
Q ss_pred CccccceeccCCceEEEEEEEcC-CcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeecc
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLAD-GREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVP 460 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~~-g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 460 (727)
.|.|+..||.|+||+||+|..++ +...|.|+|........++|+-||+||..++|++||+|++.|+.++.+||+.|||.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 36678899999999999998765 44567788887777778899999999999999999999999999999999999999
Q ss_pred CCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCcc
Q 041135 461 NDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTH 540 (727)
Q Consensus 461 ~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 540 (727)
||-++.++..-++ .|.+.++..+++|++.||.|||++ +|||||||+.|||++-+|.++|+|||.+... .....
T Consensus 113 GGAVDaimlEL~r-~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn---~~t~q 185 (1187)
T KOG0579|consen 113 GGAVDAIMLELGR-VLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKN---KSTRQ 185 (1187)
T ss_pred CchHhHHHHHhcc-ccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccc---hhHHh
Confidence 9999988766554 589999999999999999999999 9999999999999999999999999988532 22333
Q ss_pred ccccccCCccccccCcccC-----CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHH
Q 041135 541 VSTRVMGTFGYMAPEYATS-----GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEA 615 (727)
Q Consensus 541 ~~~~~~gt~~y~aPE~l~~-----~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~ 615 (727)
....+.||++|||||+++. ..|++++|||||||.|.||..+..|....+.+. -++. ....+.
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR---------VllK-iaKSeP--- 252 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR---------VLLK-IAKSEP--- 252 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH---------HHHH-HhhcCC---
Confidence 4456899999999999864 468999999999999999999999876544321 1110 000000
Q ss_pred HHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 041135 616 LVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRAL 658 (727)
Q Consensus 616 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 658 (727)
..| -........+.+|+++||.+||..||++.+|+++-
T Consensus 253 ---PTL--lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hp 290 (1187)
T KOG0579|consen 253 ---PTL--LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHP 290 (1187)
T ss_pred ---Ccc--cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCc
Confidence 000 01233445588999999999999999999998864
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=324.14 Aligned_cols=251 Identities=24% Similarity=0.423 Sum_probs=199.7
Q ss_pred CccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCch---------hHHHHHHHHHHHHHcCCCCceeEeeEeeccce
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQ---------GEREFRAEVEIISRVHHRHLVSLVGYCISERE 451 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~---------~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~ 451 (727)
+|.+.+.||+|+||.||+|... +++.||||.+...... ..+.+.+|++++++++|+||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4678899999999999999864 5789999988643221 12468899999999999999999999999999
Q ss_pred eeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchh
Q 041135 452 RLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKI 531 (727)
Q Consensus 452 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 531 (727)
.++||||+.+++|.+++...+. +++..+..++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGA--FEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccC--ccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 9999999999999999976543 78889999999999999999998 999999999999999999999999999976
Q ss_pred hhccCCC---ccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhh
Q 041135 532 ALELDSN---THVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEAL 608 (727)
Q Consensus 532 ~~~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~ 608 (727)
....... ........|+..|++||++.+..++.++|||+|||++|||++|+.||...... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~---------- 220 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL-----QA---------- 220 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH-----HH----------
Confidence 5321111 11112345788999999999988999999999999999999999999753210 00
Q ss_pred chhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 609 EHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 609 ~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
+..+.. .............+.+++++||+.||++||++.||+++
T Consensus 221 ----~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 221 ----IFKIGE-NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred ----HHHHhc-cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 000000 11111122233457889999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=336.19 Aligned_cols=201 Identities=17% Similarity=0.276 Sum_probs=167.5
Q ss_pred ccceeccC--CceEEEEEEEc-CCcEEEEEEeeeCCc--hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeec
Q 041135 385 AHNVLGEG--GFGCVYKGVLA-DGREVAVKQLKIGGS--QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYV 459 (727)
Q Consensus 385 ~~~~LG~G--~fg~Vy~~~~~-~g~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 459 (727)
++++||+| +||+||+++.+ +|+.||||+++.... ...+.+.+|+++++.++|+||++++++|..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 56889999 78899999864 689999999975432 33356788999999999999999999999999999999999
Q ss_pred cCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCc
Q 041135 460 PNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNT 539 (727)
Q Consensus 460 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 539 (727)
.+|+|.+++..+....+++..+++++.||++||+|||++ +|+|||||++||||+.++.++|+|||.+..........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 999999998765444589999999999999999999998 99999999999999999999999998764332111110
Q ss_pred c----ccccccCCccccccCcccC--CCCCchhHHHHHhHHHHHHHhCCCCCCCC
Q 041135 540 H----VSTRVMGTFGYMAPEYATS--GKLTEKSDVYSFGVVLLELITGRKPVDAS 588 (727)
Q Consensus 540 ~----~~~~~~gt~~y~aPE~l~~--~~~~~ksDVwS~Gvil~eLltG~~Pf~~~ 588 (727)
. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 0 1112356778999999976 35889999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=332.56 Aligned_cols=257 Identities=28% Similarity=0.445 Sum_probs=199.5
Q ss_pred cCccccceeccCCceEEEEEEEc-CCc----EEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGR----EVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLL 454 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~----~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 454 (727)
++|++.+.||+|+||.||+|++. +|+ .||+|+++.... ....++.+|+.++++++|+||++++|+|... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 45788899999999999999864 344 478888864433 2234788999999999999999999998754 4679
Q ss_pred EEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhc
Q 041135 455 VYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALE 534 (727)
Q Consensus 455 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 534 (727)
|+||+.+|+|.+++..+.. .+.+..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++....
T Consensus 86 v~e~~~~g~l~~~~~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHKD-NIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred eehhcCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccC
Confidence 9999999999999876432 478889999999999999999999 999999999999999999999999999985432
Q ss_pred cCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhH
Q 041135 535 LDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDF 613 (727)
Q Consensus 535 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~ 613 (727)
.. .........++..|++||++.+..++.++|||||||+||||++ |+.||..... ..+.++
T Consensus 162 ~~-~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~---~~~~~~-------------- 223 (303)
T cd05110 162 DE-KEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT---REIPDL-------------- 223 (303)
T ss_pred cc-cccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH--------------
Confidence 11 1111223445678999999999899999999999999999997 8999865321 111111
Q ss_pred HHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 614 EALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 614 ~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
+...............+.+++.+||..+|++||++++|++.|+.+..
T Consensus 224 ---~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~ 270 (303)
T cd05110 224 ---LEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR 270 (303)
T ss_pred ---HHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 11000000111123457889999999999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=313.31 Aligned_cols=251 Identities=23% Similarity=0.364 Sum_probs=203.2
Q ss_pred HHhcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc--------hhHHHHHHHHHHHHHc-CCCCceeEeeEee
Q 041135 378 QATNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS--------QGEREFRAEVEIISRV-HHRHLVSLVGYCI 447 (727)
Q Consensus 378 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~--------~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~ 447 (727)
...++|.-.++||+|..+.|.++.++ +|.++|+|++..... ...+.-++|+.+|+++ .|+||+.|.++|+
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 34456777889999999999999865 588999999864322 1124566899999998 5999999999999
Q ss_pred ccceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeec
Q 041135 448 SERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFG 527 (727)
Q Consensus 448 ~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFG 527 (727)
.+..+++|+|.|..|.|+++|...- .+++++..+|++||++|++|||.+ +|||||||++|||+|++.++||+|||
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~V--tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSKV--TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhhe--eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccc
Confidence 9999999999999999999997653 489999999999999999999999 99999999999999999999999999
Q ss_pred cchhhhccCCCccccccccCCccccccCcccC------CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhH
Q 041135 528 LAKIALELDSNTHVSTRVMGTFGYMAPEYATS------GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWAR 601 (727)
Q Consensus 528 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~------~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~ 601 (727)
+++.+. .......+|||++|+|||.+.. ..|+...|+|++|||||-||.|+.||-....
T Consensus 169 Fa~~l~----~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ----------- 233 (411)
T KOG0599|consen 169 FACQLE----PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ----------- 233 (411)
T ss_pred eeeccC----CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH-----------
Confidence 998652 2334567899999999998864 3588899999999999999999999953210
Q ss_pred HHHHHhhchhhHHHHHHHHhhccc------chhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhh
Q 041135 602 PLLAEALEHEDFEALVDSRLEKNY------VDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDT 660 (727)
Q Consensus 602 ~~l~~~~~~~~~~~l~d~~l~~~~------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 660 (727)
++ ++.-.+.++| ..+......+||.+||+.||.+|.+++|++.+-..
T Consensus 234 -ml-----------MLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff 286 (411)
T KOG0599|consen 234 -ML-----------MLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFF 286 (411)
T ss_pred -HH-----------HHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHH
Confidence 00 0111112222 12223347789999999999999999999987443
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=333.28 Aligned_cols=198 Identities=25% Similarity=0.392 Sum_probs=159.6
Q ss_pred cceeccCCceEEEEEEEcC---CcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeec--cceeeEEEeecc
Q 041135 386 HNVLGEGGFGCVYKGVLAD---GREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCIS--ERERLLVYEYVP 460 (727)
Q Consensus 386 ~~~LG~G~fg~Vy~~~~~~---g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~--~~~~~lV~Ey~~ 460 (727)
.++||+|+||.||+|+.++ +..||||.++... ....+.+|+++|++++|+||++++++|.. +...++||||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 3689999999999999653 5789999886432 23568899999999999999999999854 557799999996
Q ss_pred CCccchhcccC-------CCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEE----CCCCcEEEEeeccc
Q 041135 461 NDTLHYHLHAE-------GRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILL----DSSFEARVADFGLA 529 (727)
Q Consensus 461 ~gsL~~~L~~~-------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl----~~~~~vkL~DFGla 529 (727)
+ +|.+++... ....+.+..++.|+.||+.||+|||++ +|+|||||++|||| ++++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 555554321 123478889999999999999999999 99999999999999 56679999999999
Q ss_pred hhhhccCCCccccccccCCccccccCcccCC-CCCchhHHHHHhHHHHHHHhCCCCCCCCC
Q 041135 530 KIALELDSNTHVSTRVMGTFGYMAPEYATSG-KLTEKSDVYSFGVVLLELITGRKPVDASQ 589 (727)
Q Consensus 530 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~ksDVwS~Gvil~eLltG~~Pf~~~~ 589 (727)
+................|+..|+|||++.+. .++.++|||||||+||||++|+.+|....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 8653222222223345789999999999764 58999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=328.12 Aligned_cols=239 Identities=25% Similarity=0.398 Sum_probs=187.5
Q ss_pred eeccCCceEEEEEEEcC-------------------------CcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeE
Q 041135 388 VLGEGGFGCVYKGVLAD-------------------------GREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSL 442 (727)
Q Consensus 388 ~LG~G~fg~Vy~~~~~~-------------------------g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l 442 (727)
+||+|+||.||+|.+.. +..|+||++..........|.+|+++++.++|+||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997521 13588998876555555678899999999999999999
Q ss_pred eeEeeccceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCC---
Q 041135 443 VGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSF--- 519 (727)
Q Consensus 443 ~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~--- 519 (727)
+++|.++...+|||||+.+|+|..++..... .+.+..+++|+.||++||+|||++ +|+|||||++||||++++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKG-RVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCccc
Confidence 9999999999999999999999988865332 478899999999999999999998 999999999999997543
Q ss_pred ----cEEEEeeccchhhhccCCCccccccccCCccccccCcccC-CCCCchhHHHHHhHHHHHHH-hCCCCCCCCCCCCc
Q 041135 520 ----EARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATS-GKLTEKSDVYSFGVVLLELI-TGRKPVDASQPLGD 593 (727)
Q Consensus 520 ----~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDVwS~Gvil~eLl-tG~~Pf~~~~~~~~ 593 (727)
.+||+|||++..... .....++..|++||++.+ ..++.++|||||||++|||+ +|+.||......
T Consensus 158 ~~~~~~kl~d~g~~~~~~~-------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-- 228 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALS-------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS-- 228 (274)
T ss_pred CccceeeecCCcccccccc-------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChH--
Confidence 489999999864311 112356788999999876 56899999999999999995 689988754321
Q ss_pred hhhHHhhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 594 ESLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 594 ~~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
.... .+.... .........+.+||.+||+.+|++||++.+|++.|.
T Consensus 229 -~~~~-----------------~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 229 -EKER-----------------FYEKKH--RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred -HHHH-----------------HHHhcc--CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 1100 001000 011111234788999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=341.39 Aligned_cols=268 Identities=21% Similarity=0.295 Sum_probs=197.9
Q ss_pred HHHHhcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC--chhHHHHHHHHHHHHHcCCCCceeEeeEeecc---
Q 041135 376 LIQATNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG--SQGEREFRAEVEIISRVHHRHLVSLVGYCISE--- 449 (727)
Q Consensus 376 l~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~--- 449 (727)
+....++|++++.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+++|++++|+||++++++|...
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07878 10 VWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI 89 (343)
T ss_pred HhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence 3455688999999999999999999864 67899999986432 22345678899999999999999999987543
Q ss_pred ---ceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEee
Q 041135 450 ---RERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADF 526 (727)
Q Consensus 450 ---~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DF 526 (727)
...|+++|++ +++|.++++.. .+++..++.|+.||++||+|||++ +|+|||||++||||++++.+||+||
T Consensus 90 ~~~~~~~~~~~~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Df 162 (343)
T cd07878 90 ENFNEVYLVTNLM-GADLNNIVKCQ---KLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDF 162 (343)
T ss_pred cccCcEEEEeecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCC
Confidence 3568999988 77888777543 389999999999999999999999 9999999999999999999999999
Q ss_pred ccchhhhccCCCccccccccCCccccccCcccC-CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHH--
Q 041135 527 GLAKIALELDSNTHVSTRVMGTFGYMAPEYATS-GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPL-- 603 (727)
Q Consensus 527 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~-- 603 (727)
|+++.... ......|+..|+|||++.+ ..++.++|||||||+||||++|+.+|...... ..+..+....
T Consensus 163 g~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~ 234 (343)
T cd07878 163 GLARQADD------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI--DQLKRIMEVVGT 234 (343)
T ss_pred ccceecCC------CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHhCC
Confidence 99975421 1233568999999999977 56889999999999999999999999764321 1111110000
Q ss_pred ----HHHhhchhhHHHHHHHHhhccc-------chhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 604 ----LAEALEHEDFEALVDSRLEKNY-------VDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 604 ----l~~~~~~~~~~~l~d~~l~~~~-------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
+...+........+. .+.... .......+.+|+.+||+.||++|+++.||+++-.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~ 300 (343)
T cd07878 235 PSPEVLKKISSEHARKYIQ-SLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPY 300 (343)
T ss_pred CCHHHHHhcchhhHHHHhh-ccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcc
Confidence 000000000000000 000000 0001123678999999999999999999998743
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=326.63 Aligned_cols=250 Identities=28% Similarity=0.487 Sum_probs=196.2
Q ss_pred ceeccCCceEEEEEEEcC-------CcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEee
Q 041135 387 NVLGEGGFGCVYKGVLAD-------GREVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 387 ~~LG~G~fg~Vy~~~~~~-------g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 458 (727)
+.||+|+||.||+|++.+ ++.|+||.+..... ....++.+|+++|+.++|+||++++++|......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 469999999999998643 25799998864432 3456789999999999999999999999999999999999
Q ss_pred ccCCccchhcccCC-----CCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCC-----cEEEEeecc
Q 041135 459 VPNDTLHYHLHAEG-----RPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSF-----EARVADFGL 528 (727)
Q Consensus 459 ~~~gsL~~~L~~~~-----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~-----~vkL~DFGl 528 (727)
+.+++|.++++... ...+++.+++.++.||++||+|||+. +|+|||||++||||+.++ .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999986532 23478899999999999999999998 999999999999999877 899999999
Q ss_pred chhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHh
Q 041135 529 AKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEA 607 (727)
Q Consensus 529 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~ 607 (727)
++....... ........++..|++||++.++.++.++|||||||+||||++ |+.||..... .....+
T Consensus 158 ~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~---~~~~~~-------- 225 (269)
T cd05044 158 ARDIYKSDY-YRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN---QEVLQH-------- 225 (269)
T ss_pred ccccccccc-cccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH---HHHHHH--------
Confidence 975432211 111223345778999999999999999999999999999998 9999964321 111110
Q ss_pred hchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhh
Q 041135 608 LEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDT 660 (727)
Q Consensus 608 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 660 (727)
+...............+.+|+.+||..+|++||++++|++.|++
T Consensus 226 ---------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 226 ---------VTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ---------HhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 00000001112233457899999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=328.93 Aligned_cols=260 Identities=24% Similarity=0.393 Sum_probs=202.4
Q ss_pred cHHHHHHHhcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHc-CCCCceeEeeEeec-
Q 041135 372 TYDELIQATNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRV-HHRHLVSLVGYCIS- 448 (727)
Q Consensus 372 ~~~el~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~- 448 (727)
++.++....+.|++.++||+|+||.||+|++. +++.||+|++.... ....++..|+.+++++ +|+||++++++|..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 34455556778999999999999999999974 58899999886433 3345788999999998 69999999999853
Q ss_pred -----cceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEE
Q 041135 449 -----ERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARV 523 (727)
Q Consensus 449 -----~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL 523 (727)
....|+||||+.+|+|.+++.......+.+..++.++.||++||+|||++ +|+|||||++||+|++++.+||
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEE
Confidence 45789999999999999998765555688888999999999999999999 9999999999999999999999
Q ss_pred EeeccchhhhccCCCccccccccCCccccccCccc-----CCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHH
Q 041135 524 ADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYAT-----SGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVE 598 (727)
Q Consensus 524 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~ 598 (727)
+|||+++..... ........|+..|+|||++. +..++.++|||||||++|||++|+.||..........
T Consensus 163 ~dfg~~~~~~~~---~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~--- 236 (282)
T cd06636 163 VDFGVSAQLDRT---VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF--- 236 (282)
T ss_pred eeCcchhhhhcc---ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh---
Confidence 999998754211 11123356888999999986 3467889999999999999999999996533210000
Q ss_pred hhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 599 WARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 599 ~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
.+................+.+|+.+||+.||++||++.||+++
T Consensus 237 ----------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 237 ----------------LIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred ----------------hHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 0000000000011123458899999999999999999999764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=325.60 Aligned_cols=250 Identities=22% Similarity=0.365 Sum_probs=202.9
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC-chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEee
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG-SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 458 (727)
++|++.+.||.|+||.||+|++. +|+.|+||++.... ......+.+|+++++.++|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36888899999999999999975 58899999987543 33446788999999999999999999999999999999999
Q ss_pred ccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCC
Q 041135 459 VPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSN 538 (727)
Q Consensus 459 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 538 (727)
+.+++|.++++.. .+++..++.++.||+.||.|||++ +|+||||+++||+|++++.++|+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~--- 151 (274)
T cd06609 81 CGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTST--- 151 (274)
T ss_pred eCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccc---
Confidence 9999999998765 489999999999999999999998 9999999999999999999999999999764321
Q ss_pred ccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHH
Q 041135 539 THVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVD 618 (727)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d 618 (727)
........++..|++||++.+..++.++|||+|||+||||++|+.||...... .....+ .
T Consensus 152 ~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~------~~~~~~--------------~ 211 (274)
T cd06609 152 MSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM------RVLFLI--------------P 211 (274)
T ss_pred ccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH------HHHHHh--------------h
Confidence 12223356788999999999988999999999999999999999999754321 000000 0
Q ss_pred HHhhcccchh-HHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 619 SRLEKNYVDS-EMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 619 ~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
.......... ....+.+++.+||..+|++||++++|+++-.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~ 253 (274)
T cd06609 212 KNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKF 253 (274)
T ss_pred hcCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChh
Confidence 0000000111 2234778999999999999999999988643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=328.94 Aligned_cols=249 Identities=23% Similarity=0.384 Sum_probs=200.6
Q ss_pred CccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC-chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeec
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG-SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYV 459 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 459 (727)
.|++.+.||+|+||.||+|.+. +|+.||||.++... ....+.+.+|++++++++|+||++++++|..+...|+||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 4677788999999999999864 57889999987443 333457899999999999999999999999999999999999
Q ss_pred cCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCc
Q 041135 460 PNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNT 539 (727)
Q Consensus 460 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 539 (727)
.+++|.+++..+ .+.+..++.++.||++||.|||++ +|+|+||+++||++++++.+||+|||+++..... .
T Consensus 85 ~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~---~ 155 (277)
T cd06642 85 GGGSALDLLKPG---PLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT---Q 155 (277)
T ss_pred CCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCc---c
Confidence 999999988653 478899999999999999999998 9999999999999999999999999999754221 1
Q ss_pred cccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHH
Q 041135 540 HVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDS 619 (727)
Q Consensus 540 ~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~ 619 (727)
.......|+..|++||++.+..++.++|||||||++|||++|+.||....... ... .+..
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~-----------------~~~~ 215 (277)
T cd06642 156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR---VLF-----------------LIPK 215 (277)
T ss_pred hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh---HHh-----------------hhhc
Confidence 12223467889999999999899999999999999999999999986433210 000 0000
Q ss_pred HhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 620 RLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 620 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
.............+.+++.+||+.+|++||++.+|+++-.
T Consensus 216 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06642 216 NSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKF 255 (277)
T ss_pred CCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHH
Confidence 0011111223345789999999999999999999998643
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=329.91 Aligned_cols=263 Identities=23% Similarity=0.352 Sum_probs=202.8
Q ss_pred ccHHHHHHHhcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHc-CCCCceeEeeEee-
Q 041135 371 FTYDELIQATNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRV-HHRHLVSLVGYCI- 447 (727)
Q Consensus 371 ~~~~el~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~- 447 (727)
+.++++....++|++.+.||+|+||.||++++. +|+.||||+++... .....+.+|+++++++ +|+||++++++|.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 445677778899999999999999999999875 57899999876422 2345788999999999 6999999999884
Q ss_pred ----ccceeeEEEeeccCCccchhcccC--CCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcE
Q 041135 448 ----SERERLLVYEYVPNDTLHYHLHAE--GRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEA 521 (727)
Q Consensus 448 ----~~~~~~lV~Ey~~~gsL~~~L~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~v 521 (727)
.+...+|||||+.+++|.++++.. ....+.+..++.++.||++||.|||++ +|+|||||++||++++++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCE
Confidence 345689999999999999887532 223578889999999999999999998 99999999999999999999
Q ss_pred EEEeeccchhhhccCCCccccccccCCccccccCcccC-----CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhh
Q 041135 522 RVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATS-----GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESL 596 (727)
Q Consensus 522 kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l 596 (727)
||+|||+++..... ........|+..|+|||++.. ..++.++|||||||++|||++|+.||....... .+
T Consensus 164 kl~dfg~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~--~~ 238 (286)
T cd06638 164 KLVDFGVSAQLTST---RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR--AL 238 (286)
T ss_pred EEccCCceeecccC---CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH--HH
Confidence 99999998754211 112233468899999999853 447889999999999999999999997543210 00
Q ss_pred HHhhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 041135 597 VEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRAL 658 (727)
Q Consensus 597 ~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 658 (727)
..+ .... ...+ .........+.+|+.+||+.||++||++.||++++
T Consensus 239 ~~~--------~~~~------~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 239 FKI--------PRNP------PPTL--HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred hhc--------cccC------CCcc--cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 000 0000 0000 00011123478899999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=325.06 Aligned_cols=251 Identities=23% Similarity=0.377 Sum_probs=203.7
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC-chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEee
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG-SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 458 (727)
+.|+.+++||+|+||.||+|++. +++.||||+++... ......+.+|++++++++|+||++++++|.++...+|||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 34777899999999999999975 58899999987543 34456789999999999999999999999999999999999
Q ss_pred ccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCC
Q 041135 459 VPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSN 538 (727)
Q Consensus 459 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 538 (727)
+.+++|.+++... .+++..+..++.|+++||+|||++ +|+|+||+++||+|+.++.++|+|||++......
T Consensus 84 ~~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~--- 154 (277)
T cd06640 84 LGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT--- 154 (277)
T ss_pred CCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCC---
Confidence 9999999988653 378889999999999999999998 9999999999999999999999999999754221
Q ss_pred ccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHH
Q 041135 539 THVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVD 618 (727)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d 618 (727)
........++..|++||++.+..++.++|||||||++|||++|+.||........ .. .+.
T Consensus 155 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---~~-----------------~~~ 214 (277)
T cd06640 155 QIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV---LF-----------------LIP 214 (277)
T ss_pred ccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH---hh-----------------hhh
Confidence 1122334678899999999988899999999999999999999999975432110 00 000
Q ss_pred HHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhh
Q 041135 619 SRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDT 660 (727)
Q Consensus 619 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 660 (727)
..............+.+|+++||+.+|++||++.+|+++-..
T Consensus 215 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 256 (277)
T cd06640 215 KNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFI 256 (277)
T ss_pred cCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHh
Confidence 000111222334557899999999999999999999888554
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=320.92 Aligned_cols=248 Identities=25% Similarity=0.428 Sum_probs=200.1
Q ss_pred CccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc-----hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEE
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS-----QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLV 455 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 455 (727)
+|+..+.||+|+||.||+|... +++.|+||.+..... +..+.+.+|+++|+.++|+||+++++++.++...++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677899999999999999976 789999999875432 2346789999999999999999999999999999999
Q ss_pred EeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhcc
Q 041135 456 YEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALEL 535 (727)
Q Consensus 456 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 535 (727)
|||+.+++|.+++.... .+++..++.++.||++||+|||+. +|+||||+++||+++.++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 81 LELVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 99999999999987654 378999999999999999999999 9999999999999999999999999998754221
Q ss_pred CCCccccccccCCccccccCcccCCC-CCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHH
Q 041135 536 DSNTHVSTRVMGTFGYMAPEYATSGK-LTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFE 614 (727)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~ 614 (727)
. ......|+..|++||.+.... ++.++|||+|||++|+|++|+.||...... ..+..+
T Consensus 156 ~----~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~--~~~~~~--------------- 214 (258)
T cd06632 156 S----FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV--AAVFKI--------------- 214 (258)
T ss_pred c----cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH--HHHHHH---------------
Confidence 1 223456888999999998776 899999999999999999999999754310 000000
Q ss_pred HHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 615 ALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 615 ~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
................+.+++++||+.+|++||++.+|+++
T Consensus 215 --~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 215 --GRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred --HhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 00000001111223447789999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=324.67 Aligned_cols=238 Identities=27% Similarity=0.444 Sum_probs=189.9
Q ss_pred ceeccCCceEEEEEEEcCCc-----------EEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEE
Q 041135 387 NVLGEGGFGCVYKGVLADGR-----------EVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLV 455 (727)
Q Consensus 387 ~~LG~G~fg~Vy~~~~~~g~-----------~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 455 (727)
++||+|+||.||+|++.+.. .|++|.++..... ...+.+|+.+|++++|+||++++++|.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999976433 5788877644333 6789999999999999999999999988 778999
Q ss_pred EeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCC-------cEEEEeecc
Q 041135 456 YEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSF-------EARVADFGL 528 (727)
Q Consensus 456 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~-------~vkL~DFGl 528 (727)
|||+.+|+|.+++..... .+++..++.++.||+.||+|||++ +|+|||||++||||+.++ .+||+|||+
T Consensus 79 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 999999999999976543 588999999999999999999998 999999999999999887 799999999
Q ss_pred chhhhccCCCccccccccCCccccccCcccCC--CCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHH
Q 041135 529 AKIALELDSNTHVSTRVMGTFGYMAPEYATSG--KLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLA 605 (727)
Q Consensus 529 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~ 605 (727)
++.... .....+...|++||++.+. .++.++|||||||++|||++ |..+|....... ...+.
T Consensus 155 a~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~---~~~~~----- 219 (259)
T cd05037 155 PITVLS-------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE---KERFY----- 219 (259)
T ss_pred cccccc-------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh---HHHHH-----
Confidence 975422 1223466789999999876 78999999999999999999 577776543111 00000
Q ss_pred HhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 606 EALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 606 ~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
. ............+.+++.+||..+|++||++.+|++.|+
T Consensus 220 ------------~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 220 ------------Q--DQHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred ------------h--cCCCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 000011111256889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=324.77 Aligned_cols=253 Identities=25% Similarity=0.367 Sum_probs=187.1
Q ss_pred ceeccCCceEEEEEEEcC---CcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeeccCC
Q 041135 387 NVLGEGGFGCVYKGVLAD---GREVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPND 462 (727)
Q Consensus 387 ~~LG~G~fg~Vy~~~~~~---g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 462 (727)
++||+|+||.||+|+..+ ...++||.+..... .....|.+|+++++.++|+||++++++|.+....+|||||+.+|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999997543 34688887764432 33456889999999999999999999999999999999999999
Q ss_pred ccchhcccCCC---CcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCc
Q 041135 463 TLHYHLHAEGR---PVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNT 539 (727)
Q Consensus 463 sL~~~L~~~~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 539 (727)
+|.+++..... ....+..+++++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~-~~ 156 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPED-YY 156 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccch-he
Confidence 99999876432 2346778899999999999999999 99999999999999999999999999986432111 11
Q ss_pred cccccccCCccccccCcccC-------CCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchh
Q 041135 540 HVSTRVMGTFGYMAPEYATS-------GKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHE 611 (727)
Q Consensus 540 ~~~~~~~gt~~y~aPE~l~~-------~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~ 611 (727)
.......++..|+|||++.. ..++.++|||||||+||||++ |..||..... ... +.......
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~---~~~-------~~~~~~~~ 226 (269)
T cd05042 157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD---EQV-------LKQVVREQ 226 (269)
T ss_pred eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH---HHH-------HHHHhhcc
Confidence 11123345678999998753 356789999999999999999 7888865321 110 01100000
Q ss_pred hHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 612 DFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 612 ~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
. ..+.+..+ .......+.+++..|| .||++||+++||++.|.
T Consensus 227 ~-~~~~~~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 227 D-IKLPKPQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred C-ccCCCCcc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 0 00001111 1122234567788888 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=324.55 Aligned_cols=266 Identities=22% Similarity=0.316 Sum_probs=200.1
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc--hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEe
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS--QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYE 457 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 457 (727)
++|++.++||+|+||.||+|+++ +|+.||+|++..... ...+.+.+|++++++++|+||++++++|......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46889999999999999999976 589999999865432 233568899999999999999999999999999999999
Q ss_pred eccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCC
Q 041135 458 YVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDS 537 (727)
Q Consensus 458 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 537 (727)
|+.++.|..++.... .+++..++.++.||++||+|||++ +|+|||||++||+|+.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 154 (286)
T cd07847 81 YCDHTVLNELEKNPR--GVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPG- 154 (286)
T ss_pred ccCccHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCc-
Confidence 999999988776544 389999999999999999999998 99999999999999999999999999997542211
Q ss_pred CccccccccCCccccccCcccC-CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHh-------hc
Q 041135 538 NTHVSTRVMGTFGYMAPEYATS-GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEA-------LE 609 (727)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~-------~~ 609 (727)
.......++..|++||++.+ ..++.++|||||||++|||++|+.||.+..... .+..+.. .+... +.
T Consensus 155 --~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~--~~~~~~~-~~~~~~~~~~~~~~ 229 (286)
T cd07847 155 --DDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVD--QLYLIRK-TLGDLIPRHQQIFS 229 (286)
T ss_pred --ccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHH-HhCCCChHHhhhcc
Confidence 11223457788999999876 457899999999999999999999997654221 1111110 00000 00
Q ss_pred hhhH-HHHHHHHhhcc-----cchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 610 HEDF-EALVDSRLEKN-----YVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 610 ~~~~-~~l~d~~l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
...+ ..+........ ........+.+|+.+||+.+|++||++.||+.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 230 TNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred cccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0000 00000000000 001113457899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=321.16 Aligned_cols=254 Identities=27% Similarity=0.387 Sum_probs=201.4
Q ss_pred CccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCch--hHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEee
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQ--GEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~--~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 458 (727)
+|++.+.||+|+||.||+|+.. +++.|+||.++..... ..+.+.+|++++++++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4788899999999999999865 6889999999765443 567899999999999999999999999999999999999
Q ss_pred ccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCC
Q 041135 459 VPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSN 538 (727)
Q Consensus 459 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 538 (727)
+.+++|.++++.... +.+..++.|+.+|++||+|||++ +|+||||+++||++++++.+||+|||++.........
T Consensus 81 ~~~~~L~~~~~~~~~--~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 81 CSGGTLEELLEHGRI--LDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred CCCCcHHHHHhhcCC--CChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 999999999876543 78889999999999999999999 9999999999999999999999999999765322221
Q ss_pred ccc-cccccCCccccccCcccCCC---CCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHH
Q 041135 539 THV-STRVMGTFGYMAPEYATSGK---LTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFE 614 (727)
Q Consensus 539 ~~~-~~~~~gt~~y~aPE~l~~~~---~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~ 614 (727)
... .....++..|++||++.+.. ++.++|||+||+++|||++|+.||...... |...... ....
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-------~~~~~~~---~~~~-- 223 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-------FQIMFHV---GAGH-- 223 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-------HHHHHHH---hcCC--
Confidence 111 12356788999999998766 889999999999999999999999754311 1000000 0000
Q ss_pred HHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 615 ALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 615 ~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
...+. ........+.+++++||+.+|++||++.||+.+
T Consensus 224 ---~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 224 ---KPPIP--DSLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred ---CCCCC--cccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000 011113346789999999999999999998763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=363.13 Aligned_cols=262 Identities=21% Similarity=0.311 Sum_probs=202.7
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc---hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS---QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
++|++.++||+|+||.||+|+.. +|+.||||+++.... ...+.|.+|++++++++|+||+++++++.+++..|+||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57999999999999999999975 589999999874322 23457899999999999999999999999999999999
Q ss_pred eeccCCccchhcccCC---------CCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeec
Q 041135 457 EYVPNDTLHYHLHAEG---------RPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFG 527 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~---------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFG 527 (727)
||+.||+|.+++.... ...+++..+++++.||++||+|||++ +|+|||||++||||+.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999886421 12356778899999999999999999 99999999999999999999999999
Q ss_pred cchhhhccCC---------------CccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCC
Q 041135 528 LAKIALELDS---------------NTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLG 592 (727)
Q Consensus 528 la~~~~~~~~---------------~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~ 592 (727)
+++....... ........+||..|||||++.+..++.++|||||||+||||++|+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9975411110 0011123579999999999999999999999999999999999999997532110
Q ss_pred chhhHHhhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCC-CHHHHHHHHhhccC
Q 041135 593 DESLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRP-RMSQVVRALDTLDG 663 (727)
Q Consensus 593 ~~~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~~ 663 (727)
+ .+ ....... ............+.+++.+||+.||++|+ +++++++.|+...+
T Consensus 239 ---i-~~-----~~~i~~P---------~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 239 ---I-SY-----RDVILSP---------IEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred ---h-hh-----hhhccCh---------hhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 0 00 0000000 00000011223477899999999999996 57778888877643
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=325.88 Aligned_cols=240 Identities=23% Similarity=0.411 Sum_probs=189.8
Q ss_pred ceeccCCceEEEEEEEcC--------CcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEee
Q 041135 387 NVLGEGGFGCVYKGVLAD--------GREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 387 ~~LG~G~fg~Vy~~~~~~--------g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 458 (727)
+.||+|+||.||+|..+. ...|++|++........+.+.+|+.+|+.++|+||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998642 234888887655555556889999999999999999999999998999999999
Q ss_pred ccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCc--------EEEEeeccch
Q 041135 459 VPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFE--------ARVADFGLAK 530 (727)
Q Consensus 459 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~--------vkL~DFGla~ 530 (727)
+.+|+|..+++.++. .+++..+++++.||+.||+|||++ +|+|||||++|||++.++. +||+|||++.
T Consensus 81 ~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 81 VKFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred CCCCcHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 999999999976543 588999999999999999999999 9999999999999987664 6999999986
Q ss_pred hhhccCCCccccccccCCccccccCcccC-CCCCchhHHHHHhHHHHHHHhCC-CCCCCCCCCCchhhHHhhHHHHHHhh
Q 041135 531 IALELDSNTHVSTRVMGTFGYMAPEYATS-GKLTEKSDVYSFGVVLLELITGR-KPVDASQPLGDESLVEWARPLLAEAL 608 (727)
Q Consensus 531 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDVwS~Gvil~eLltG~-~Pf~~~~~~~~~~l~~~~~~~l~~~~ 608 (727)
.... .....++..|+|||++.+ ..++.++|||||||++|||++|. .+|...... ..
T Consensus 157 ~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~------~~--------- 214 (258)
T cd05078 157 TVLP-------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ------KK--------- 214 (258)
T ss_pred ccCC-------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH------HH---------
Confidence 4321 123457888999999987 45789999999999999999984 555432210 00
Q ss_pred chhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 609 EHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 609 ~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
..+... ...+.......+.+|+.+||+.||++||++++|++.|+
T Consensus 215 -----~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 215 -----LQFYED--RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -----HHHHHc--cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000011 11122222345789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=329.27 Aligned_cols=263 Identities=24% Similarity=0.341 Sum_probs=199.4
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc--hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEe
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS--QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYE 457 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 457 (727)
++|++.++||+|+||.||+|+++ +|+.||||++..... ...+.+.+|+++|+.++|+||++++++|.++...++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46889999999999999999986 489999998764322 234568899999999999999999999999999999999
Q ss_pred eccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCC
Q 041135 458 YVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDS 537 (727)
Q Consensus 458 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 537 (727)
|+.++.|.+++..... +++..++.++.||++||+|||+. +|+||||+++||++++++.+||+|||+++.....
T Consensus 81 ~~~~~~l~~~~~~~~~--~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~-- 153 (286)
T cd07846 81 FVDHTVLDDLEKYPNG--LDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP-- 153 (286)
T ss_pred cCCccHHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCC--
Confidence 9999999887765433 89999999999999999999998 9999999999999999999999999998754221
Q ss_pred CccccccccCCccccccCcccC-CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhc-hhhHHH
Q 041135 538 NTHVSTRVMGTFGYMAPEYATS-GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALE-HEDFEA 615 (727)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~-~~~~~~ 615 (727)
........++..|++||++.+ ..++.++|||||||++|||++|+.+|...... ..+.+ +...... ......
T Consensus 154 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~-----~~~~~-~~~~~~~~~~~~~~ 226 (286)
T cd07846 154 -GEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI-----DQLYH-IIKCLGNLIPRHQE 226 (286)
T ss_pred -ccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH-----HHHHH-HHHHhCCCchhhHH
Confidence 122233567889999999876 35788999999999999999999998654321 11110 0000000 000000
Q ss_pred ------HHHHHhhccc---------chhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 616 ------LVDSRLEKNY---------VDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 616 ------l~d~~l~~~~---------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
+++....... .......+.+|+++||+.+|++||++.+|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 227 IFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred HhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0000000000 11123458899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=320.82 Aligned_cols=258 Identities=26% Similarity=0.418 Sum_probs=205.0
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC-chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEee
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG-SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 458 (727)
++|++.+.||.|+||.||+|... ++..|+||++.... ......+.+|+++|+.++|+||+++++.+.+++..++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46899999999999999999964 57899999986543 23456899999999999999999999999999999999999
Q ss_pred ccCCccchhcccCCC-CcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCC
Q 041135 459 VPNDTLHYHLHAEGR-PVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDS 537 (727)
Q Consensus 459 ~~~gsL~~~L~~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 537 (727)
+.+++|.++++.... ..+++..+..++.||+.||+|||++ +|+|||||++||++++++.+||+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999876432 4689999999999999999999998 999999999999999999999999999976543222
Q ss_pred Cc-cccccccCCccccccCcccCC-CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHH
Q 041135 538 NT-HVSTRVMGTFGYMAPEYATSG-KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEA 615 (727)
Q Consensus 538 ~~-~~~~~~~gt~~y~aPE~l~~~-~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~ 615 (727)
.. .......|+..|++||++... .++.++|||||||++|||++|+.||....... .+.++ ....
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~~~~--------~~~~---- 223 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--VLMLT--------LQND---- 223 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--hHHHH--------hcCC----
Confidence 21 122345688999999999877 78999999999999999999999997543211 01110 0000
Q ss_pred HHHHHhhccc-chhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 616 LVDSRLEKNY-VDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 616 l~d~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
...+.... .......+.+|+.+||..||++||++.||+++
T Consensus 224 --~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 224 --PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred --CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00000000 01223457899999999999999999999874
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=318.91 Aligned_cols=249 Identities=23% Similarity=0.374 Sum_probs=200.8
Q ss_pred CccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC--chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEee
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG--SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 458 (727)
+|++.+.||+|+||.||++... +++.||||++.... ......+.+|+++|+.++|+||+++++++..+...++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4888999999999999999864 68899999986542 23346789999999999999999999999999999999999
Q ss_pred ccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCC-CcEEEEeeccchhhhccCC
Q 041135 459 VPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSS-FEARVADFGLAKIALELDS 537 (727)
Q Consensus 459 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~-~~vkL~DFGla~~~~~~~~ 537 (727)
+.+++|.+++.......+++..+++++.+|++||+|||++ +|+|||||++||+|+++ +.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~-- 155 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK-- 155 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC--
Confidence 9999999999876555689999999999999999999998 99999999999999854 46899999999754221
Q ss_pred CccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHH
Q 041135 538 NTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALV 617 (727)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~ 617 (727)
.......|+..|++||++.+..++.++|||||||++|+|++|+.+|+..+.. .......
T Consensus 156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~------~~~~~~~------------- 214 (256)
T cd08220 156 --SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP------ALVLKIM------------- 214 (256)
T ss_pred --ccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH------HHHHHHH-------------
Confidence 1222356788999999999888999999999999999999999999754311 1111000
Q ss_pred HHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 618 DSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 618 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
.. ............+.+++.+||+.+|++||++.||+++
T Consensus 215 ~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 215 SG-TFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred hc-CCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 00 0001111223347889999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=339.97 Aligned_cols=241 Identities=26% Similarity=0.341 Sum_probs=186.2
Q ss_pred eccCCceEEEEEEEc-CCcEEEEEEeeeCCc---hhHHHHHHHHHHHHHc---CCCCceeEeeEeeccceeeEEEeeccC
Q 041135 389 LGEGGFGCVYKGVLA-DGREVAVKQLKIGGS---QGEREFRAEVEIISRV---HHRHLVSLVGYCISERERLLVYEYVPN 461 (727)
Q Consensus 389 LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~---~~~~~~~~Ei~~l~~l---~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 461 (727)
||+|+||.||+|+.+ +|+.||||++..... .....+.+|.+++..+ +|+||+++++++.+....||||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999975 589999999864322 2223455677777665 699999999999999999999999999
Q ss_pred CccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCccc
Q 041135 462 DTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHV 541 (727)
Q Consensus 462 gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 541 (727)
|+|.+++..+.. +.+..++.|+.||++||+|||++ +|+|||||++||||+.++.+||+|||+++.... ....
T Consensus 81 g~L~~~l~~~~~--~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~---~~~~ 152 (330)
T cd05586 81 GELFWHLQKEGR--FSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLT---DNKT 152 (330)
T ss_pred ChHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCC---CCCC
Confidence 999988876544 88999999999999999999999 999999999999999999999999999874321 1122
Q ss_pred cccccCCccccccCcccCC-CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHH
Q 041135 542 STRVMGTFGYMAPEYATSG-KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSR 620 (727)
Q Consensus 542 ~~~~~gt~~y~aPE~l~~~-~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~ 620 (727)
....+|+..|+|||++.+. .++.++|||||||+||||++|+.||..... .+....+ ..+. ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~------~~~~~~i-----~~~~------~~ 215 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT------QQMYRNI-----AFGK------VR 215 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH------HHHHHHH-----HcCC------CC
Confidence 3346799999999999765 488999999999999999999999975321 1110000 0000 00
Q ss_pred hhcccchhHHHHHHHHHHHHhccCCCCCC----CHHHHHHH
Q 041135 621 LEKNYVDSEMFWMIEAAAACVRHSATKRP----RMSQVVRA 657 (727)
Q Consensus 621 l~~~~~~~~~~~l~~li~~cl~~dP~~RP----s~~evl~~ 657 (727)
+... .....+.+|+++||+.||++|+ ++.||+++
T Consensus 216 ~~~~---~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 216 FPKN---VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred CCCc---cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 1111 1123467899999999999998 56666654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=326.47 Aligned_cols=255 Identities=23% Similarity=0.392 Sum_probs=200.5
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC-chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEee
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG-SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 458 (727)
++|++++.||+|+||.||++++. +|+.||+|.++... ......+.+|+++|++++|+||+++++++..++..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 35888999999999999999976 68999999987542 23346788999999999999999999999999999999999
Q ss_pred ccCCccchhcccCC-CCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCC
Q 041135 459 VPNDTLHYHLHAEG-RPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDS 537 (727)
Q Consensus 459 ~~~gsL~~~L~~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 537 (727)
+.+++|..+++... ...+++..+++++.+|++||.|||+.+ +|+|||||++|||++.++.+||+|||+++....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--- 155 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA--- 155 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccC---
Confidence 99999998887642 235899999999999999999999632 899999999999999999999999999875421
Q ss_pred CccccccccCCccccccCcccCCC------CCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchh
Q 041135 538 NTHVSTRVMGTFGYMAPEYATSGK------LTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHE 611 (727)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~l~~~~------~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~ 611 (727)
.......++..|++||++.+.. ++.++|||||||+||||++|+.||...... ....
T Consensus 156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~------------- 217 (286)
T cd06622 156 --SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA---NIFA------------- 217 (286)
T ss_pred --CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh---hHHH-------------
Confidence 1122345788999999986543 578999999999999999999999653211 0000
Q ss_pred hHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 612 DFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 612 ~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
.+..+.+.. ...........+.+|+.+||+.+|++||++.+|+++-+
T Consensus 218 ~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~ 264 (286)
T cd06622 218 QLSAIVDGD-PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPW 264 (286)
T ss_pred HHHHHhhcC-CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChh
Confidence 011111110 01112223345778999999999999999999998644
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=327.05 Aligned_cols=254 Identities=23% Similarity=0.362 Sum_probs=202.5
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeec
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYV 459 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 459 (727)
++|++.+.||+|+||.||+|++. +++.||+|+++.......+.|.+|+++|++++|+||+++++++..+...||||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 46888999999999999999975 58899999998766666678999999999999999999999999999999999999
Q ss_pred cCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCc
Q 041135 460 PNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNT 539 (727)
Q Consensus 460 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 539 (727)
.+++|.+++...+. .+++..+++++.||+.||.|||++ +|+|||||++|||++.++.+||+|||++...... .
T Consensus 85 ~~~~L~~~~~~~~~-~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~---~ 157 (280)
T cd06611 85 DGGALDSIMLELER-GLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST---L 157 (280)
T ss_pred CCCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccc---c
Confidence 99999998866432 489999999999999999999999 9999999999999999999999999998754211 1
Q ss_pred cccccccCCccccccCcccC-----CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHH
Q 041135 540 HVSTRVMGTFGYMAPEYATS-----GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFE 614 (727)
Q Consensus 540 ~~~~~~~gt~~y~aPE~l~~-----~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~ 614 (727)
.......++..|++||++.. ..++.++|||||||++|||++|+.||...... +....+ .. ...
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~------~~~~~~----~~-~~~- 225 (280)
T cd06611 158 QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM------RVLLKI----LK-SEP- 225 (280)
T ss_pred cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH------HHHHHH----hc-CCC-
Confidence 12234568889999999853 34678999999999999999999999754321 000000 00 000
Q ss_pred HHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 615 ALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 615 ~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
..+ .........+.+++.+||+.+|++||++.+|+++-.
T Consensus 226 ----~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 264 (280)
T cd06611 226 ----PTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPF 264 (280)
T ss_pred ----CCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChh
Confidence 000 001111234778999999999999999999988743
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=321.40 Aligned_cols=253 Identities=25% Similarity=0.404 Sum_probs=198.3
Q ss_pred CccccceeccCCceEEEEEEEcC--CcEEEEEEeeeCC----------chhHHHHHHHHHHHHH-cCCCCceeEeeEeec
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLAD--GREVAVKQLKIGG----------SQGEREFRAEVEIISR-VHHRHLVSLVGYCIS 448 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~~--g~~vaVK~l~~~~----------~~~~~~~~~Ei~~l~~-l~HpnIv~l~~~~~~ 448 (727)
+|++.+.||+|+||.||+|+++. ++.+|||.+.... .....++.+|+.++.+ ++|+||++++++|.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999999765 6889999886432 1223457788888875 799999999999999
Q ss_pred cceeeEEEeeccCCccchhccc--CCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEee
Q 041135 449 ERERLLVYEYVPNDTLHYHLHA--EGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADF 526 (727)
Q Consensus 449 ~~~~~lV~Ey~~~gsL~~~L~~--~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DF 526 (727)
++..+|||||+.+++|.+++.. .....+++..+++++.||+.||.|||+.. +|+|||||++|||++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 9999999999999999888743 22335888999999999999999999631 7999999999999999999999999
Q ss_pred ccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHH
Q 041135 527 GLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAE 606 (727)
Q Consensus 527 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~ 606 (727)
|++....... ......|+..|++||++.++.++.++|||||||++|||++|+.||..... ......
T Consensus 159 g~~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~------~~~~~~---- 224 (269)
T cd08528 159 GLAKQKQPES----KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM------LSLATK---- 224 (269)
T ss_pred cceeeccccc----ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH------HHHHHH----
Confidence 9997542211 23345688999999999998899999999999999999999999864321 111110
Q ss_pred hhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 607 ALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 607 ~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
+.+..............+.+++++||+.||++||++.||..+|+
T Consensus 225 ---------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 225 ---------IVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ---------HhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 00110000000112235788999999999999999999999885
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=328.20 Aligned_cols=262 Identities=19% Similarity=0.283 Sum_probs=194.9
Q ss_pred CccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCch--hHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEee
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQ--GEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~--~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 458 (727)
+|++.++||+|+||.||+|++. +|+.|++|+++..... ....+.+|++++++++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4788899999999999999975 5899999998754322 235678899999999999999999999999999999999
Q ss_pred ccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCC
Q 041135 459 VPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSN 538 (727)
Q Consensus 459 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 538 (727)
+.+ +|.+++.... ..+++..++.++.||++||.|||++ +|+|||||++|||++.++.+||+|||+++.... .
T Consensus 81 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~---~ 152 (284)
T cd07839 81 CDQ-DLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGI---P 152 (284)
T ss_pred CCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCC---C
Confidence 975 6666665432 2489999999999999999999999 999999999999999999999999999975421 1
Q ss_pred ccccccccCCccccccCcccCCC-CCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhh-----
Q 041135 539 THVSTRVMGTFGYMAPEYATSGK-LTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHED----- 612 (727)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~l~~~~-~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~----- 612 (727)
........++..|+|||++.+.. ++.++|||||||++|||++|+.||...... .+..+.+... +....
T Consensus 153 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~-----~~~~~~~~~~-~~~~~~~~~~ 226 (284)
T cd07839 153 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-----DDQLKRIFRL-LGTPTEESWP 226 (284)
T ss_pred CCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH-----HHHHHHHHHH-hCCCChHHhH
Confidence 11122345788999999987754 789999999999999999999986533211 1111111110 00000
Q ss_pred -HHHHHHHHhhcc---------cchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 613 -FEALVDSRLEKN---------YVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 613 -~~~l~d~~l~~~---------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
+..+.+...... ........+.+|+++||+.||.+||++.||+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 227 GVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred HhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 000000000000 001122356789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=326.74 Aligned_cols=267 Identities=25% Similarity=0.362 Sum_probs=201.9
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC--chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEe
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG--SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYE 457 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 457 (727)
++|++.++||+|+||.||+|++. +++.|+||+++... ......+.+|+++|++++|+||++++++|.+++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36889999999999999999976 58899999986432 2334678999999999999999999999999999999999
Q ss_pred eccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCC
Q 041135 458 YVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDS 537 (727)
Q Consensus 458 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 537 (727)
|+.++.|..++.... .+++.+++.++.||++||+|||++ +|+|||||++||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~- 154 (288)
T cd07833 81 YVERTLLELLEASPG--GLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARP- 154 (288)
T ss_pred cCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCc-
Confidence 999888876665443 388999999999999999999999 99999999999999999999999999997653221
Q ss_pred CccccccccCCccccccCcccCC-CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHH-------Hhh-
Q 041135 538 NTHVSTRVMGTFGYMAPEYATSG-KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLA-------EAL- 608 (727)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~l~~~-~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~-------~~~- 608 (727)
........++..|++||++.+. .++.++|||||||+||||++|+.+|...... +.+. .....+. ..+
T Consensus 155 -~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07833 155 -ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI--DQLY-LIQKCLGPLPPSHQELFS 230 (288)
T ss_pred -cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHH-HHHHHhCCCCHHHhhhcc
Confidence 1122345678899999999888 8899999999999999999999999754321 1110 0000000 000
Q ss_pred chhhHHH-----HH-HHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 609 EHEDFEA-----LV-DSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 609 ~~~~~~~-----l~-d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
....+.. .. ...+...+.......+.+|+++||..+|++||++++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 0000000 00 0001111222224568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=328.32 Aligned_cols=267 Identities=22% Similarity=0.338 Sum_probs=198.9
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEee
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 458 (727)
++|.++++||+|+||.||+|+.+ +++.||||.++.... .....+.+|+++|++++|+||+++++++..+...++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 56899999999999999999875 578999999875432 2334678899999999999999999999999999999999
Q ss_pred ccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCC
Q 041135 459 VPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSN 538 (727)
Q Consensus 459 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 538 (727)
+. ++|..++..... .+.+..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||+++.... .
T Consensus 86 ~~-~~l~~~l~~~~~-~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~---~ 157 (301)
T cd07873 86 LD-KDLKQYLDDCGN-SINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSI---P 157 (301)
T ss_pred cc-cCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCC---C
Confidence 96 578777765432 478899999999999999999999 999999999999999999999999999975321 1
Q ss_pred ccccccccCCccccccCcccCC-CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHH
Q 041135 539 THVSTRVMGTFGYMAPEYATSG-KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALV 617 (727)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~l~~~-~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~ 617 (727)
........++..|++||++.+. .++.++|||||||+||||++|+.+|...... .........+... ....+..++
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~---~~~~~~~~~~~~~-~~~~~~~~~ 233 (301)
T cd07873 158 TKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE---EQLHFIFRILGTP-TEETWPGIL 233 (301)
T ss_pred CCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHcCCC-Chhhchhhh
Confidence 1112234568899999998764 5788999999999999999999999765321 1111111100000 000011110
Q ss_pred HH---------Hhhc----ccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 618 DS---------RLEK----NYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 618 d~---------~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
.. .... .........+.+|+.+||+.||.+|+++.||+++-+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~ 288 (301)
T cd07873 234 SNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPY 288 (301)
T ss_pred ccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 00 0000 000112234678999999999999999999998644
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=364.92 Aligned_cols=256 Identities=20% Similarity=0.321 Sum_probs=196.6
Q ss_pred HHhcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC--chhHHHHHHHHHHHHHcCCCCceeEeeEeec--ccee
Q 041135 378 QATNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG--SQGEREFRAEVEIISRVHHRHLVSLVGYCIS--ERER 452 (727)
Q Consensus 378 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~--~~~~ 452 (727)
...++|+++++||+|+||.||+|++. .++.||+|++.... ......|.+|+.+|++|+|+|||+++++|.+ ...+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 34568999999999999999999975 46788999887542 2334678999999999999999999998865 3568
Q ss_pred eEEEeeccCCccchhcccCC--CCcccHHHHHHHHHHHHHHHHHHHhcC----CCcEEeeCCCCCceEECC---------
Q 041135 453 LLVYEYVPNDTLHYHLHAEG--RPVMDWATRVKVAAGAARGIAYLHEDC----HPRIIHRDIKSSNILLDS--------- 517 (727)
Q Consensus 453 ~lV~Ey~~~gsL~~~L~~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~----~~~ivHrDLkp~NILl~~--------- 517 (727)
||||||+.+|+|.++|.... ...+.+..++.|+.||+.||+|||+.. ..+|||||||++||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 99999999999999886532 235899999999999999999999852 125999999999999964
Q ss_pred --------CCcEEEEeeccchhhhccCCCccccccccCCccccccCcccC--CCCCchhHHHHHhHHHHHHHhCCCCCCC
Q 041135 518 --------SFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATS--GKLTEKSDVYSFGVVLLELITGRKPVDA 587 (727)
Q Consensus 518 --------~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~ksDVwS~Gvil~eLltG~~Pf~~ 587 (727)
.+.+||+|||+++.+.. .......+|+..|+|||++.+ ..++.++||||||||||||++|+.||..
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~----~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGI----ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred ccccccCCCCceEEccCCccccccc----cccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 23599999999975421 112234578999999999865 4588999999999999999999999975
Q ss_pred CCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 588 SQPLGDESLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 588 ~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
... +..+.. ...... .+ ........+.+||..||..+|++||++.||+.+
T Consensus 246 ~~~-----~~qli~----~lk~~p--------~l---pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 246 ANN-----FSQLIS----ELKRGP--------DL---PIKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred CCc-----HHHHHH----HHhcCC--------CC---CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 321 111110 000000 00 001123457889999999999999999999854
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=327.09 Aligned_cols=256 Identities=21% Similarity=0.304 Sum_probs=200.2
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc---hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS---QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
++|++.+.||+|+||.||++++. .++.|+||.+..... .....+.+|+++++.++|+||+++++++..+...+|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46889999999999999999975 478999999875432 23457889999999999999999999999999999999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccC
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 536 (727)
||+.|++|.+++...+ .+.+..+..++.||++||+|||++ +|+|||||++||||+.++.+||+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 81 EYVEGGDCATLLKNIG--ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred ecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 9999999999997654 378899999999999999999998 99999999999999999999999999986421000
Q ss_pred C------------CccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHH
Q 041135 537 S------------NTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLL 604 (727)
Q Consensus 537 ~------------~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l 604 (727)
. .........++..|+|||++.+..++.++|||||||+||||++|+.||.+... .++....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~------~~~~~~~- 228 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP------EELFGQV- 228 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHH-
Confidence 0 00111234578899999999988899999999999999999999999964321 1111110
Q ss_pred HHhhchhhHHHHHHHHhhcc-cchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhh
Q 041135 605 AEALEHEDFEALVDSRLEKN-YVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDT 660 (727)
Q Consensus 605 ~~~~~~~~~~~l~d~~l~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 660 (727)
....+... ........+.+|+++||+.+|++|+++.++.+.|+.
T Consensus 229 ------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 229 ------------ISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred ------------HhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 00000000 000123347899999999999999997666666655
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=360.61 Aligned_cols=264 Identities=26% Similarity=0.391 Sum_probs=211.0
Q ss_pred HHHHhcCccccceeccCCceEEEEEEEcC--------CcEEEEEEeeeCCc-hhHHHHHHHHHHHHHc-CCCCceeEeeE
Q 041135 376 LIQATNGFSAHNVLGEGGFGCVYKGVLAD--------GREVAVKQLKIGGS-QGEREFRAEVEIISRV-HHRHLVSLVGY 445 (727)
Q Consensus 376 l~~~~~~~~~~~~LG~G~fg~Vy~~~~~~--------g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l-~HpnIv~l~~~ 445 (727)
++...+++++.+.||+|.||.||+|.... ...||||+++.... .+.+.+..|+++|+.+ +|+||+.|+|+
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 33344556777899999999999998531 45799999986544 3456899999999998 59999999999
Q ss_pred eeccceeeEEEeeccCCccchhcccCC------------C--CcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCC
Q 041135 446 CISERERLLVYEYVPNDTLHYHLHAEG------------R--PVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSS 511 (727)
Q Consensus 446 ~~~~~~~~lV~Ey~~~gsL~~~L~~~~------------~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~ 511 (727)
|...+..++|+||+.+|+|.++|+.++ . ..+...+++.++.||+.||+||++. ++|||||.++
T Consensus 371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaR 447 (609)
T KOG0200|consen 371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAAR 447 (609)
T ss_pred eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhhh
Confidence 999999999999999999999998765 0 1388899999999999999999999 9999999999
Q ss_pred ceEECCCCcEEEEeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCC
Q 041135 512 NILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQP 590 (727)
Q Consensus 512 NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~ 590 (727)
||||+++..+||+|||||+.....+.............+|||||.+....|+.|+|||||||+||||++ |..||.+...
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~ 527 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP 527 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence 999999999999999999864322222111111114678999999999999999999999999999999 8899975211
Q ss_pred CCchhhHHhhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhc
Q 041135 591 LGDESLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661 (727)
Q Consensus 591 ~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 661 (727)
...+ .+.+....+......+...+++||+.||+.+|++||++.|+++.|+.+
T Consensus 528 --~~~l-----------------~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 528 --TEEL-----------------LEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred --HHHH-----------------HHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 1111 112222233334444566788999999999999999999999999985
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=317.81 Aligned_cols=250 Identities=23% Similarity=0.362 Sum_probs=199.4
Q ss_pred CccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC--chhHHHHHHHHHHHHHcCCCCceeEeeEeec--cceeeEEE
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG--SQGEREFRAEVEIISRVHHRHLVSLVGYCIS--ERERLLVY 456 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~--~~~~~lV~ 456 (727)
+|++++.||.|+||.||++... +|+.||+|+++... ....+.+.+|+++|++++|+||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4788899999999999999864 67899999987543 2334568899999999999999999998764 45679999
Q ss_pred eeccCCccchhcccC--CCCcccHHHHHHHHHHHHHHHHHHH-----hcCCCcEEeeCCCCCceEECCCCcEEEEeeccc
Q 041135 457 EYVPNDTLHYHLHAE--GRPVMDWATRVKVAAGAARGIAYLH-----EDCHPRIIHRDIKSSNILLDSSFEARVADFGLA 529 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~--~~~~l~~~~~~~i~~qia~gL~yLH-----~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla 529 (727)
||+.+++|.+++... ....+++..++.++.||++||+||| +. +|+|||||++||+|++++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999988653 2345899999999999999999999 66 9999999999999999999999999999
Q ss_pred hhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhc
Q 041135 530 KIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALE 609 (727)
Q Consensus 530 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~ 609 (727)
..... .........++..|++||++.+..++.++|||+||+++|+|++|+.||..... ..+.+
T Consensus 158 ~~~~~---~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~----------- 220 (265)
T cd08217 158 KILGH---DSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ---LQLAS----------- 220 (265)
T ss_pred ccccC---CcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH---HHHHH-----------
Confidence 85422 11112334688899999999998899999999999999999999999975431 11111
Q ss_pred hhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 610 HEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 610 ~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
.+...............+.+++++||+.+|++||++.+|+++
T Consensus 221 ------~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 221 ------KIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ------HHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 011111111222334568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=328.54 Aligned_cols=250 Identities=24% Similarity=0.360 Sum_probs=199.1
Q ss_pred ccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeeccC
Q 041135 383 FSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPN 461 (727)
Q Consensus 383 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 461 (727)
|.....||+|+||.||++... ++..||||++........+.+.+|+.+++.++|+||++++++|..++..|+||||+.+
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 334467999999999999864 5889999998765555567799999999999999999999999999999999999999
Q ss_pred CccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCccc
Q 041135 462 DTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHV 541 (727)
Q Consensus 462 gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 541 (727)
++|.+++... .+++..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||++...... ...
T Consensus 104 ~~L~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~---~~~ 174 (292)
T cd06658 104 GALTDIVTHT---RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE---VPK 174 (292)
T ss_pred CcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccc---ccc
Confidence 9999887543 378899999999999999999999 9999999999999999999999999998754211 112
Q ss_pred cccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHh
Q 041135 542 STRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRL 621 (727)
Q Consensus 542 ~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l 621 (727)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||...... ... .. +...+...+
T Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---~~~---~~----------~~~~~~~~~ 238 (292)
T cd06658 175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL---QAM---RR----------IRDNLPPRV 238 (292)
T ss_pred CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHH---HH----------HHhcCCCcc
Confidence 23356889999999999888999999999999999999999999753211 000 00 000001111
Q ss_pred hcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 622 EKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 622 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
... ......+.+++.+||..||.+||++.||+++-.
T Consensus 239 ~~~--~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~ 274 (292)
T cd06658 239 KDS--HKVSSVLRGFLDLMLVREPSQRATAQELLQHPF 274 (292)
T ss_pred ccc--cccCHHHHHHHHHHccCChhHCcCHHHHhhChh
Confidence 110 112234678899999999999999999998733
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=325.23 Aligned_cols=262 Identities=25% Similarity=0.351 Sum_probs=202.4
Q ss_pred ccHHHHHHHhcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHc-CCCCceeEeeEeec
Q 041135 371 FTYDELIQATNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRV-HHRHLVSLVGYCIS 448 (727)
Q Consensus 371 ~~~~el~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~ 448 (727)
+.++++....++|++.+.||+|+||.||+++.. +|+.+|||++.... .....+.+|+.+++++ +|+||++++++|..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 445566677889999999999999999999974 58899999986432 2345788999999999 79999999999875
Q ss_pred c-----ceeeEEEeeccCCccchhcccC--CCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcE
Q 041135 449 E-----RERLLVYEYVPNDTLHYHLHAE--GRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEA 521 (727)
Q Consensus 449 ~-----~~~~lV~Ey~~~gsL~~~L~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~v 521 (727)
. ...|+||||+.+++|.++++.. ....+.+..++.++.||+.||+|||++ +|+|||||++|||+++++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCE
Confidence 3 3579999999999999887632 233588999999999999999999998 99999999999999999999
Q ss_pred EEEeeccchhhhccCCCccccccccCCccccccCcccCC-----CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhh
Q 041135 522 RVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSG-----KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESL 596 (727)
Q Consensus 522 kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l 596 (727)
||+|||+++...... .......|+..|++||++..+ .++.++|||||||++|||++|+.||...... ..+
T Consensus 168 kl~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~--~~~ 242 (291)
T cd06639 168 KLVDFGVSAQLTSTR---LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV--KTL 242 (291)
T ss_pred EEeecccchhccccc---ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH--HHH
Confidence 999999997542211 112234678899999998654 3678999999999999999999999653211 011
Q ss_pred HHhhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 597 VEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 597 ~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
.++. . .... .+ .........+.+|+.+||+.+|++||++.||+++
T Consensus 243 ~~~~--------~-~~~~-----~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 243 FKIP--------R-NPPP-----TL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HHHh--------c-CCCC-----CC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0000 0 0000 00 0111223358899999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=326.82 Aligned_cols=266 Identities=22% Similarity=0.348 Sum_probs=196.5
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCch-hHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEee
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQ-GEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 458 (727)
++|++.+.||+|+||.||+|+.+ +|+.||||.+...... ....+.+|+++|++++|+||+++++++.++...++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 56899999999999999999975 6899999998754322 224577899999999999999999999999999999999
Q ss_pred ccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCC
Q 041135 459 VPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSN 538 (727)
Q Consensus 459 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 538 (727)
+.+ +|.+++..... .+.+..++.++.||++||.|||++ +|+|||||++|||++.++.+||+|||+++.... .
T Consensus 85 ~~~-~L~~~~~~~~~-~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~---~ 156 (291)
T cd07844 85 LDT-DLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSV---P 156 (291)
T ss_pred CCC-CHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCC---C
Confidence 975 88888765443 578999999999999999999999 999999999999999999999999999874311 1
Q ss_pred ccccccccCCccccccCcccC-CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHH
Q 041135 539 THVSTRVMGTFGYMAPEYATS-GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALV 617 (727)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~ 617 (727)
........++..|+|||++.+ ..++.++|||||||++|||++|+.+|....... ..+.. ....+.. .....+....
T Consensus 157 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~-~~~~~-~~~~~~~-~~~~~~~~~~ 233 (291)
T cd07844 157 SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE-DQLHK-IFRVLGT-PTEETWPGVS 233 (291)
T ss_pred CccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH-HHHHH-HHHhcCC-CChhhhhhhh
Confidence 111222346788999999876 458899999999999999999999996543110 11100 0000000 0000000000
Q ss_pred --------------HHHhhccc-chhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 618 --------------DSRLEKNY-VDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 618 --------------d~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
...+.... .......+.+++.+||+.+|++||++.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 234 SNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred hccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 00000000 00112456789999999999999999998864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=320.31 Aligned_cols=254 Identities=24% Similarity=0.384 Sum_probs=202.8
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEee
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 458 (727)
++|++.+.||+|+||.||++.++ +++.|++|++..... ....++.+|++++++++|+||++++++|..+...+||+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35788899999999999999976 588999999876543 3446789999999999999999999999999999999999
Q ss_pred ccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHh-cCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCC
Q 041135 459 VPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHE-DCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDS 537 (727)
Q Consensus 459 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 537 (727)
+.+++|.+++.... ..+.+..+.+++.||++||+|||+ . +|+|||||++||+|++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~- 155 (265)
T cd06605 81 MDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL- 155 (265)
T ss_pred cCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHH-
Confidence 99999999987653 358889999999999999999999 7 99999999999999999999999999987542211
Q ss_pred CccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHH
Q 041135 538 NTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALV 617 (727)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~ 617 (727)
.....++..|++||++.+..++.++|||||||+||+|++|+.||...... .....+.....+
T Consensus 156 ----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~------------- 217 (265)
T cd06605 156 ----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP-PDGIFELLQYIV------------- 217 (265)
T ss_pred ----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc-cccHHHHHHHHh-------------
Confidence 11256888999999999999999999999999999999999999754321 111111111111
Q ss_pred HHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 618 DSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 618 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
...............+.++|.+||..+|++||++.||+.+
T Consensus 218 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 218 NEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred cCCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 1000000000123347789999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=321.03 Aligned_cols=255 Identities=24% Similarity=0.429 Sum_probs=197.9
Q ss_pred CccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCch----------hHHHHHHHHHHHHHcCCCCceeEeeEeeccc
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQ----------GEREFRAEVEIISRVHHRHLVSLVGYCISER 450 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~----------~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~ 450 (727)
+|.+.+.||+|+||.||+|+.. +|+.||||.++..... ..+.+.+|++++++++|+||+++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4778899999999999999864 6899999988642111 1245788999999999999999999999999
Q ss_pred eeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccch
Q 041135 451 ERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAK 530 (727)
Q Consensus 451 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~ 530 (727)
..++||||+.+++|.++++... .+++..+..++.||+.||.|||++ +++|||||++||+++.++.+||+|||+++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG--RFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccccc
Confidence 9999999999999999997764 488899999999999999999998 99999999999999999999999999997
Q ss_pred hhhccCCCccccccccCCccccccCcccCCC--CCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhh
Q 041135 531 IALELDSNTHVSTRVMGTFGYMAPEYATSGK--LTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEAL 608 (727)
Q Consensus 531 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~ 608 (727)
...... .........|+..|++||++.+.. ++.++||||||+++|||++|..||...... ..+ ... .
T Consensus 157 ~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~-~~~----~ 225 (272)
T cd06629 157 KSDDIY-DNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI-----AAM-FKL----G 225 (272)
T ss_pred cccccc-cccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH-----HHH-HHh----h
Confidence 532211 111123356888999999988754 789999999999999999999999643211 000 000 0
Q ss_pred chhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 609 EHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 609 ~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
... . ...+...........+.+++.+||..+|++||++++|+++
T Consensus 226 ~~~-~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 226 NKR-S----APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ccc-c----CCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 000 0 0000011111123457889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=328.14 Aligned_cols=264 Identities=23% Similarity=0.310 Sum_probs=199.4
Q ss_pred CccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCch-----hHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEE
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQ-----GEREFRAEVEIISRVHHRHLVSLVGYCISERERLLV 455 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~-----~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 455 (727)
+|++.++||+|+||.||+|... +|+.|+||+++..... ....+.+|++++++++|+||+++++++.++...++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4788899999999999999975 5899999999755432 234677899999999999999999999999999999
Q ss_pred EeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhcc
Q 041135 456 YEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALEL 535 (727)
Q Consensus 456 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 535 (727)
|||+ +++|.++++... ..+++..++.++.||++||+|||++ +|+|||||++||||+.++.+||+|||+++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 9999 999999987655 3589999999999999999999999 9999999999999999999999999999754321
Q ss_pred CCCccccccccCCccccccCcccC-CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHH
Q 041135 536 DSNTHVSTRVMGTFGYMAPEYATS-GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFE 614 (727)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~ 614 (727)
. .......++..|+|||++.+ ..++.++|||||||++|||++|..+|....... .+....+ .+.. .....+.
T Consensus 156 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~--~~~~~~~-~~~~-~~~~~~~ 228 (298)
T cd07841 156 N---RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID--QLGKIFE-ALGT-PTEENWP 228 (298)
T ss_pred C---ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH--HHHHHHH-HcCC-Cchhhhh
Confidence 1 11223356788999999865 457899999999999999999987776543211 1111100 0000 0000000
Q ss_pred ------HHHHHHhh-----cccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 615 ------ALVDSRLE-----KNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 615 ------~l~d~~l~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
..+..... ..........+.+|+.+||+.+|++|+++.||+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 229 GVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred hcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000000 00112223457899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=320.54 Aligned_cols=265 Identities=22% Similarity=0.312 Sum_probs=201.2
Q ss_pred CccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC--chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEee
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG--SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 458 (727)
+|++.+.||+|+||.||+|++. +|+.|+||++.... ......+.+|+.++++++|+||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4888999999999999999974 68999999997654 23346799999999999999999999999999999999999
Q ss_pred ccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCC
Q 041135 459 VPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSN 538 (727)
Q Consensus 459 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 538 (727)
+ +++|.+++.... ..+++.+++.++.||++||+|||++ +|+|||||++||+++.++.++|+|||+++......
T Consensus 81 ~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~-- 153 (286)
T cd07832 81 M-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE-- 153 (286)
T ss_pred c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC--
Confidence 9 999999886544 3589999999999999999999999 99999999999999999999999999997543221
Q ss_pred ccccccccCCccccccCcccCC-CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHH--------hhc
Q 041135 539 THVSTRVMGTFGYMAPEYATSG-KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAE--------ALE 609 (727)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~l~~~-~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~--------~~~ 609 (727)
........|+..|+|||++.+. .++.++|||+|||++|||++|+.+|...... ....+....+.. ...
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI---EQLAIVFRTLGTPNEETWPGLTS 230 (286)
T ss_pred CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH---HHHHHHHHHcCCCChHHHhhccC
Confidence 1122335688999999998754 4689999999999999999998877654321 111111110000 000
Q ss_pred hhhHHHHHH-----HHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 610 HEDFEALVD-----SRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 610 ~~~~~~l~d-----~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
...+..+.. ..+. .........+.+|+.+||+.+|++|+++++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 231 LPDYNKITFPESKPIPLE-EIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cchhhcccCCCCCcchHH-HhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000 0000 0111223668899999999999999999999876
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=315.75 Aligned_cols=249 Identities=25% Similarity=0.345 Sum_probs=201.5
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhH---HHHHHHHHHHHHcCCCCceeEeeEeeccceeeEE
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGE---REFRAEVEIISRVHHRHLVSLVGYCISERERLLV 455 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~---~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 455 (727)
.++|.++++||+|.||+|.+++-+ .|+.+|||+++.+-.... ..-+.|-++|+..+|+.+..|...|+..+.+++|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 467999999999999999999854 689999999985433322 3456799999999999999999999999999999
Q ss_pred EeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhcc
Q 041135 456 YEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALEL 535 (727)
Q Consensus 456 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 535 (727)
|||+.||.|+.+|.+.+ .+++.....+...|+.||.|||++ +||.||||.+|+|||.||++||+||||++...
T Consensus 247 MeyanGGeLf~HLsrer--~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I-- 319 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRER--VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEI-- 319 (516)
T ss_pred EEEccCceEeeehhhhh--cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcc--
Confidence 99999999999887754 488888888999999999999999 99999999999999999999999999998432
Q ss_pred CCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHH
Q 041135 536 DSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEA 615 (727)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~ 615 (727)
........+|||+.|+|||++....|..++|+|.+|||||||++|++||...+.. .+ ++.
T Consensus 320 -~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~---kL----------------FeL 379 (516)
T KOG0690|consen 320 -KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE---KL----------------FEL 379 (516)
T ss_pred -cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh---HH----------------HHH
Confidence 2223345689999999999999999999999999999999999999999764421 11 111
Q ss_pred HHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCC-----HHHHHHH
Q 041135 616 LVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPR-----MSQVVRA 657 (727)
Q Consensus 616 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 657 (727)
++... .+|..........|+..+|.+||.+|.. ++||.++
T Consensus 380 Il~ed--~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 380 ILMED--LKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred HHhhh--ccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 11111 1233333334567788899999999973 5666554
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=317.46 Aligned_cols=252 Identities=26% Similarity=0.399 Sum_probs=205.8
Q ss_pred cCccccceeccCCceEEEEEEEcC-CcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEee
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLAD-GREVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~~-g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 458 (727)
++|++.+.||+|+||.||+|++.+ |+.|+||++..... .....+.+|++++.+++|+||+++++++......++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 368889999999999999999764 89999999876544 4457899999999999999999999999999999999999
Q ss_pred ccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHh-cCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCC
Q 041135 459 VPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHE-DCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDS 537 (727)
Q Consensus 459 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 537 (727)
+.+++|.+++.... .+++..+++++.||++||+|||+ + +++||||+++||+|+.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~- 154 (264)
T cd06623 81 MDGGSLADLLKKVG--KIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL- 154 (264)
T ss_pred cCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCC-
Confidence 99999999997653 48999999999999999999999 8 99999999999999999999999999987542211
Q ss_pred CccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHH
Q 041135 538 NTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALV 617 (727)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~ 617 (727)
.......++..|++||.+.+..++.++|||+||+++|||++|+.||..........+..+ +.
T Consensus 155 --~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~----------------~~ 216 (264)
T cd06623 155 --DQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQA----------------IC 216 (264)
T ss_pred --CcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHH----------------Hh
Confidence 111234678899999999999999999999999999999999999976543111111110 00
Q ss_pred HHHhhcccchh-HHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 618 DSRLEKNYVDS-EMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 618 d~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
.. ........ ....+.+++++||..++++||++.||+++
T Consensus 217 ~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 217 DG-PPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred cC-CCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00 00111111 23468899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=320.12 Aligned_cols=255 Identities=25% Similarity=0.403 Sum_probs=196.4
Q ss_pred ccccceeccCCceEEEEEEEc----CCcEEEEEEeeeCC--chhHHHHHHHHHHHHHcCCCCceeEeeEeeccc------
Q 041135 383 FSAHNVLGEGGFGCVYKGVLA----DGREVAVKQLKIGG--SQGEREFRAEVEIISRVHHRHLVSLVGYCISER------ 450 (727)
Q Consensus 383 ~~~~~~LG~G~fg~Vy~~~~~----~g~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~------ 450 (727)
|++.++||+|+||.||+|.+. .|+.||||+++... ....+++.+|+++|++++|+||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999864 36889999986532 334567889999999999999999999886532
Q ss_pred eeeEEEeeccCCccchhcccC----CCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEee
Q 041135 451 ERLLVYEYVPNDTLHYHLHAE----GRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADF 526 (727)
Q Consensus 451 ~~~lV~Ey~~~gsL~~~L~~~----~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DF 526 (727)
..++++||+.+|+|.+++... ....+++..+++++.||+.||+|||++ +|+|||||++|||+++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 237889999999998876432 122478889999999999999999998 9999999999999999999999999
Q ss_pred ccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHH
Q 041135 527 GLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLA 605 (727)
Q Consensus 527 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~ 605 (727)
|+++...... .........+...|++||.+.++.++.++|||||||++|||++ |+.+|..... ..+..+
T Consensus 158 g~~~~~~~~~-~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~~~~------ 227 (273)
T cd05074 158 GLSKKIYSGD-YYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYNY------ 227 (273)
T ss_pred cccccccCCc-ceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHHHHH------
Confidence 9998542211 1111222345678999999999889999999999999999999 8888865321 111110
Q ss_pred HhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhc
Q 041135 606 EALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661 (727)
Q Consensus 606 ~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 661 (727)
..... .+ .........+.+++.+||+.+|++||++.||++.|+++
T Consensus 228 -~~~~~--------~~--~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 228 -LIKGN--------RL--KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred -HHcCC--------cC--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00000 00 01112234688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=319.23 Aligned_cols=255 Identities=24% Similarity=0.423 Sum_probs=200.4
Q ss_pred CccccceeccCCceEEEEEEE-cCCcEEEEEEeeeCCc------hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeE
Q 041135 382 GFSAHNVLGEGGFGCVYKGVL-ADGREVAVKQLKIGGS------QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLL 454 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~-~~g~~vaVK~l~~~~~------~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 454 (727)
+|+..++||+|+||.||+|+. .+|+.||||+++.... ...+.+++|+++|++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999986 4689999999864321 124678999999999999999999999999999999
Q ss_pred EEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCC-cEEEEeeccchhhh
Q 041135 455 VYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSF-EARVADFGLAKIAL 533 (727)
Q Consensus 455 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~-~vkL~DFGla~~~~ 533 (727)
||||+.+++|.+++...+ .+++..+++++.||+.||+|||++ +|+|||||++||+++.++ .+||+|||++....
T Consensus 81 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred EEeccCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 999999999999987654 378899999999999999999999 999999999999998775 69999999987543
Q ss_pred ccCCC-ccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhh
Q 041135 534 ELDSN-THVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHED 612 (727)
Q Consensus 534 ~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~ 612 (727)
..... ........|+..|++||++.+..++.++|||+|||++|||++|+.||........... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~---~~----------- 221 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL---IF----------- 221 (268)
T ss_pred cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHH---HH-----------
Confidence 22111 1112235688899999999988899999999999999999999999975432211110 00
Q ss_pred HHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 613 FEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 613 ~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
..................+.+++.+||..+|++||++.||+++
T Consensus 222 --~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 222 --KIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred --HHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 0000000111222233457789999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=320.03 Aligned_cols=253 Identities=25% Similarity=0.367 Sum_probs=187.2
Q ss_pred ceeccCCceEEEEEEEcCCc---EEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeeccCC
Q 041135 387 NVLGEGGFGCVYKGVLADGR---EVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPND 462 (727)
Q Consensus 387 ~~LG~G~fg~Vy~~~~~~g~---~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 462 (727)
++||+|+||.||+|++.++. .+++|.++.... ...+.+.+|+++++.++|+||++++++|.+....||||||+.+|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 36999999999999865433 456676654432 34568999999999999999999999999999999999999999
Q ss_pred ccchhcccCC--CCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCcc
Q 041135 463 TLHYHLHAEG--RPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTH 540 (727)
Q Consensus 463 sL~~~L~~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 540 (727)
+|.++++... ...+.+..++.++.||++||+|||++ +|+|||||++|||++.++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~-~~~~ 156 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKE-DYIE 156 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcc-hhhh
Confidence 9999987642 22456677889999999999999998 9999999999999999999999999998632111 1111
Q ss_pred ccccccCCccccccCcccC-------CCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhh
Q 041135 541 VSTRVMGTFGYMAPEYATS-------GKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHED 612 (727)
Q Consensus 541 ~~~~~~gt~~y~aPE~l~~-------~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~ 612 (727)
......++..|+|||++.. ..++.++|||||||++|||++ |..||..... .++...++. +.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~------~~~~~~~~~-----~~ 225 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD------REVLNHVIK-----DQ 225 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHh-----hc
Confidence 2234567889999999853 235779999999999999997 5667754321 111111111 11
Q ss_pred HHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 613 FEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 613 ~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
...+.+..+...+ ...+.+++..|| .+|++||+++||++.|.
T Consensus 226 ~~~~~~~~~~~~~----~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 226 QVKLFKPQLELPY----SERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred ccccCCCccCCCC----cHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 1111122222222 234667888999 67999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=325.34 Aligned_cols=272 Identities=20% Similarity=0.298 Sum_probs=197.8
Q ss_pred CccccceeccCCceEEEEEEEcC---CcEEEEEEeeeCC---chhHHHHHHHHHHHHHcCCCCceeEeeEeecc--ceee
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLAD---GREVAVKQLKIGG---SQGEREFRAEVEIISRVHHRHLVSLVGYCISE--RERL 453 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~~---g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~--~~~~ 453 (727)
+|++.++||+|+||.||+|+... ++.||||++.... ....+.+.+|+.++++++|+||++++++|.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 47889999999999999999754 7899999997633 33345688899999999999999999999988 7899
Q ss_pred EEEeeccCCccchhcccC---CCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECC----CCcEEEEee
Q 041135 454 LVYEYVPNDTLHYHLHAE---GRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDS----SFEARVADF 526 (727)
Q Consensus 454 lV~Ey~~~gsL~~~L~~~---~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~----~~~vkL~DF 526 (727)
|||||+.+ +|.+++... ....+.+..++.|+.||+.||+|||++ +|+|||||++||||+. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 455554322 123578899999999999999999999 9999999999999999 899999999
Q ss_pred ccchhhhccCCCccccccccCCccccccCcccCC-CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhh---HHhhHH
Q 041135 527 GLAKIALELDSNTHVSTRVMGTFGYMAPEYATSG-KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESL---VEWARP 602 (727)
Q Consensus 527 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l---~~~~~~ 602 (727)
|+++................++..|+|||++.+. .++.++|||||||+||||++|+.+|........... ......
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 9998653222212223345678899999988764 578999999999999999999999976543220000 000000
Q ss_pred HHHHh-----------hchhhHHHHHHHHhhcccc-----------hhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 603 LLAEA-----------LEHEDFEALVDSRLEKNYV-----------DSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 603 ~l~~~-----------~~~~~~~~l~d~~l~~~~~-----------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
++... .....+..+.+......+. ......+.+++++||+.||++||++.||+++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00000 0000111111111111111 0223357889999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=323.97 Aligned_cols=267 Identities=22% Similarity=0.322 Sum_probs=197.6
Q ss_pred CccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc--hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEee
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS--QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 458 (727)
+|++++.||+|+||.||+|+.. +|+.|+||+++.... .....+.+|+++|++++|+||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788999999999999999875 589999999875432 2235788999999999999999999999999999999999
Q ss_pred ccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCC
Q 041135 459 VPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSN 538 (727)
Q Consensus 459 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 538 (727)
+. ++|..++.......+++..++.++.||++||+|||++ +|+||||+++||+|++++.+||+|||+++.... .
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~---~ 153 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV---P 153 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhccc---C
Confidence 95 5788888765555689999999999999999999999 999999999999999999999999999875421 1
Q ss_pred ccccccccCCccccccCcccCCC-CCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHH---HHh----hch
Q 041135 539 THVSTRVMGTFGYMAPEYATSGK-LTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLL---AEA----LEH 610 (727)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~l~~~~-~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l---~~~----~~~ 610 (727)
........++..|++||++.+.. ++.++|||||||++|||++|+.+|...... ..+.+..+..- ... ...
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07860 154 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--DQLFRIFRTLGTPDEVVWPGVTSL 231 (284)
T ss_pred ccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHhCCCChhhhhhhhHH
Confidence 11122345678899999987654 588999999999999999999999754311 11111110000 000 000
Q ss_pred hhHHHHHHHHhhcc---cchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 611 EDFEALVDSRLEKN---YVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 611 ~~~~~l~d~~l~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
......+....... ........+.+++.+||+.||++||+++||+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 232 PDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 00000000000000 000112346789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=321.59 Aligned_cols=253 Identities=26% Similarity=0.418 Sum_probs=198.1
Q ss_pred HhcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHc-CCCCceeEeeEeeccc------
Q 041135 379 ATNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRV-HHRHLVSLVGYCISER------ 450 (727)
Q Consensus 379 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~------ 450 (727)
..++|++.+.||+|+||.||+|+.+ +++.|++|++..... ..+.+.+|+++++++ +|+||++++++|.+..
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 3578999999999999999999975 578899999875433 346799999999999 6999999999997644
Q ss_pred eeeEEEeeccCCccchhcccCC--CCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeecc
Q 041135 451 ERLLVYEYVPNDTLHYHLHAEG--RPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGL 528 (727)
Q Consensus 451 ~~~lV~Ey~~~gsL~~~L~~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGl 528 (727)
..+|||||+.+++|.++++... ...+++..++.++.||++||+|||++ +|+||||+++||+|++++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCcc
Confidence 4899999999999999886533 34589999999999999999999998 999999999999999999999999999
Q ss_pred chhhhccCCCccccccccCCccccccCcccC-----CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHH
Q 041135 529 AKIALELDSNTHVSTRVMGTFGYMAPEYATS-----GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPL 603 (727)
Q Consensus 529 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~ 603 (727)
+..... .........|+..|+|||++.. ..++.++|||+|||+||||++|+.||...... ..+..
T Consensus 160 ~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~----- 229 (275)
T cd06608 160 SAQLDS---TLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM--RALFK----- 229 (275)
T ss_pred ceeccc---chhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH--HHHHH-----
Confidence 875321 1122234568889999998854 34678999999999999999999999643211 00000
Q ss_pred HHHhhchhhHHHHHHHHh-hcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 604 LAEALEHEDFEALVDSRL-EKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 604 l~~~~~~~~~~~l~d~~l-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
+..... ...........+.+|+++||..||++||++.||+++
T Consensus 230 ------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 230 ------------IPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred ------------hhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 000000 000011123357789999999999999999999874
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=326.93 Aligned_cols=249 Identities=29% Similarity=0.372 Sum_probs=203.6
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeee---CCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEE
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKI---GGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLV 455 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~---~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 455 (727)
.+.|+..++||+||||.||-++.+ +|+.+|.|++.. ...+.+...++|..+|.+++.+.||.|-..|+..+.++||
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 477999999999999999999865 599999998843 3345556788999999999999999999999999999999
Q ss_pred EeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhcc
Q 041135 456 YEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALEL 535 (727)
Q Consensus 456 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 535 (727)
|..|.||+|..+|.+.+...+++...+.++.+|+.||++||+. +||.|||||+|||||++|+|+|+|+|||..+.+
T Consensus 264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~- 339 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPE- 339 (591)
T ss_pred EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCC-
Confidence 9999999999999988878899999999999999999999999 999999999999999999999999999986532
Q ss_pred CCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHH
Q 041135 536 DSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEA 615 (727)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~ 615 (727)
.......+||.+|||||+++++.|+...|+|+|||+||||+.|+.||...... ..++++++
T Consensus 340 ---g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK----------------vk~eEvdr 400 (591)
T KOG0986|consen 340 ---GKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK----------------VKREEVDR 400 (591)
T ss_pred ---CCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh----------------hhHHHHHH
Confidence 12223448999999999999999999999999999999999999999753321 11112221
Q ss_pred HHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHH
Q 041135 616 LVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMS 652 (727)
Q Consensus 616 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 652 (727)
.+.. ...+|.+.-......|++..|.+|+++|.--+
T Consensus 401 r~~~-~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 401 RTLE-DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred HHhc-chhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 1110 11123333333466778889999999987544
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=323.07 Aligned_cols=245 Identities=26% Similarity=0.361 Sum_probs=199.8
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
++|++.+.||+|+||.||++++. +++.||||+++... ....+.+.+|+++|++++|+||+++++++.++...++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46889999999999999999975 58999999986432 233456889999999999999999999999999999999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccC
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 536 (727)
||+.+++|.+++.... .+.+..++.++.||++||+|||++ +|+||||+++||||++++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 81 EYVPGGELFSHLRKSG--RFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred ecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 9999999999987764 488999999999999999999998 9999999999999999999999999999754221
Q ss_pred CCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHH
Q 041135 537 SNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEAL 616 (727)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l 616 (727)
.....|+..|++||.+.++.++.++||||||+++|||++|+.||..... ... .. .+
T Consensus 155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~-------~~---------~~ 210 (290)
T cd05580 155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP---IQI-------YE---------KI 210 (290)
T ss_pred -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH---HHH-------HH---------HH
Confidence 2345688999999999888889999999999999999999999975431 000 00 01
Q ss_pred HHHHhhcccchhHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 041135 617 VDSRLEKNYVDSEMFWMIEAAAACVRHSATKRP-----RMSQVVRA 657 (727)
Q Consensus 617 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 657 (727)
+.... .+.......+.+++++||..||.+|+ +++|++++
T Consensus 211 ~~~~~--~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 211 LEGKV--RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred hcCCc--cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 11000 11111234577899999999999999 77777654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=322.03 Aligned_cols=249 Identities=24% Similarity=0.385 Sum_probs=205.7
Q ss_pred CccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeecc
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVP 460 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 460 (727)
-|.++++||+|.||.|||+.++ .|+.||||.+... .+.+++.+||.+|++++.++||++||.|.....+|||||||.
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 3778899999999999999976 4999999998754 456889999999999999999999999999999999999999
Q ss_pred CCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCcc
Q 041135 461 NDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTH 540 (727)
Q Consensus 461 ~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 540 (727)
-|++.++++.+.+ .+.+.++..|++..++||+|||.. .-||||||+.||||+.+|.+||+|||.|..+.+ .-.
T Consensus 112 AGSiSDI~R~R~K-~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD---TMA 184 (502)
T KOG0574|consen 112 AGSISDIMRARRK-PLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD---TMA 184 (502)
T ss_pred CCcHHHHHHHhcC-CccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhh---hHH
Confidence 9999999876554 689999999999999999999999 899999999999999999999999999975432 222
Q ss_pred ccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHH
Q 041135 541 VSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSR 620 (727)
Q Consensus 541 ~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~ 620 (727)
....+.||..|||||++..-.|+.++||||||+...||..|+.||....++.....+--.- ...|
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~P--------PPTF------- 249 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKP--------PPTF------- 249 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCC--------CCCC-------
Confidence 3445789999999999999999999999999999999999999998765543221110000 0000
Q ss_pred hhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 621 LEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 621 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
+..+.....+-++++.||-++|++|-++.+|+++
T Consensus 250 ---~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 250 ---KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred ---CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 0112223346788999999999999999888765
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=319.15 Aligned_cols=247 Identities=23% Similarity=0.407 Sum_probs=199.6
Q ss_pred CccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeec
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYV 459 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 459 (727)
-|++.+.||+|+||.||+|.+. +++.||||++..... .....+.+|++++++++|+||++++++|.++...|+||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 3778899999999999999864 688999998864432 33467889999999999999999999999999999999999
Q ss_pred cCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCc
Q 041135 460 PNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNT 539 (727)
Q Consensus 460 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 539 (727)
.+++|.+++... .+++..++.++.||+.||.|||++ +|+|+|||++||+++.++.++|+|||++...... .
T Consensus 85 ~~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~---~ 155 (277)
T cd06641 85 GGGSALDLLEPG---PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT---Q 155 (277)
T ss_pred CCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccc---h
Confidence 999999988653 378999999999999999999998 9999999999999999999999999998754221 1
Q ss_pred cccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHH
Q 041135 540 HVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDS 619 (727)
Q Consensus 540 ~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~ 619 (727)
.......++..|++||++.+..++.++|||||||++|||++|..||...... .+.. .+..
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~--------------~~~~ 215 (277)
T cd06641 156 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM------KVLF--------------LIPK 215 (277)
T ss_pred hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH------HHHH--------------HHhc
Confidence 1122346788999999999888999999999999999999999999653211 0000 0000
Q ss_pred HhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 620 RLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 620 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
.............+.+++.+||+.+|++||++.+|+++
T Consensus 216 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 216 NNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00111112223457889999999999999999999996
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=325.29 Aligned_cols=251 Identities=24% Similarity=0.384 Sum_probs=203.0
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeec
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYV 459 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 459 (727)
++|++.+.||+|+||.||+|+.. +++.|+||.+........+.+.+|+.++++++|+||++++++|...+..|+||||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 56888999999999999999864 67899999987655555677899999999999999999999999999999999999
Q ss_pred cCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCc
Q 041135 460 PNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNT 539 (727)
Q Consensus 460 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 539 (727)
.+++|.+++.+. .+.+.+++.++.||+.||.|||++ +|+|||||++||+++.++.+||+|||++...... .
T Consensus 99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~---~ 169 (293)
T cd06647 99 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE---Q 169 (293)
T ss_pred CCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccc---c
Confidence 999999998654 378889999999999999999999 9999999999999999999999999998754221 1
Q ss_pred cccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHH
Q 041135 540 HVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDS 619 (727)
Q Consensus 540 ~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~ 619 (727)
.......|+..|++||++.++.++.++|||+|||++|||++|+.||........ +..+ ...+
T Consensus 170 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~--~~~~--------~~~~-------- 231 (293)
T cd06647 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LYLI--------ATNG-------- 231 (293)
T ss_pred cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh--eeeh--------hcCC--------
Confidence 122334688899999999988899999999999999999999999976432110 0000 0000
Q ss_pred HhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 041135 620 RLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRAL 658 (727)
Q Consensus 620 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 658 (727)
.............+.+++++||..+|++||++.+|+.+-
T Consensus 232 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~ 270 (293)
T cd06647 232 TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHP 270 (293)
T ss_pred CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 000001111223477899999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=316.45 Aligned_cols=250 Identities=20% Similarity=0.367 Sum_probs=201.4
Q ss_pred CccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC--chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEee
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG--SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 458 (727)
+|++.+.||+|+||.||+|+.+ +|..||+|.+.... ....+.+.+|++++++++|+||++++++|.++...++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4788999999999999999975 58899999986532 23445788999999999999999999999999999999999
Q ss_pred ccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCC-cEEEEeeccchhhhccCC
Q 041135 459 VPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSF-EARVADFGLAKIALELDS 537 (727)
Q Consensus 459 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~-~vkL~DFGla~~~~~~~~ 537 (727)
+.+++|.+++.......+++..++.++.||++||.|||++ +|+|||||++||+|++++ .+||+|||++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~--- 154 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND--- 154 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccC---
Confidence 9999999998776555689999999999999999999998 999999999999998875 569999999975422
Q ss_pred CccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHH
Q 041135 538 NTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALV 617 (727)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~ 617 (727)
.........|+..|+|||++.+..++.++|||||||++|||++|+.||..... .++.....
T Consensus 155 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~------------- 215 (257)
T cd08225 155 SMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL------HQLVLKIC------------- 215 (257)
T ss_pred CcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHh-------------
Confidence 11122234688899999999988899999999999999999999999965321 11111111
Q ss_pred HHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 618 DSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 618 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
...+. .........+.+++++||..+|++||++.||+++
T Consensus 216 ~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 216 QGYFA-PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred cccCC-CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11110 0111223458899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=322.01 Aligned_cols=268 Identities=20% Similarity=0.281 Sum_probs=194.6
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchh-HHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEe
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQG-EREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYE 457 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~-~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 457 (727)
.++|++++.||+|+||.||+|+.. +|+.|+||+++...... ...+.+|+++|+.++|+||+++++++.++...|+|||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 467999999999999999999864 58899999987554332 3467899999999999999999999999999999999
Q ss_pred eccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCC
Q 041135 458 YVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDS 537 (727)
Q Consensus 458 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 537 (727)
|+. ++|..++.... ..+.+..+..++.||++||+|||++ +|+|||||++||||+.++.+||+|||+++.....
T Consensus 84 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-- 156 (291)
T cd07870 84 YMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIP-- 156 (291)
T ss_pred ccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCC--
Confidence 996 55655554332 2367888899999999999999998 9999999999999999999999999999753211
Q ss_pred CccccccccCCccccccCcccCC-CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHH--------Hhh
Q 041135 538 NTHVSTRVMGTFGYMAPEYATSG-KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLA--------EAL 608 (727)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~l~~~-~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~--------~~~ 608 (727)
........++..|++||++.+. .++.++|||||||+||||++|+.+|+...... +.+.+. ...+. ...
T Consensus 157 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 157 -SQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF-EQLEKI-WTVLGVPTEDTWPGVS 233 (291)
T ss_pred -CCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH-HHHHHH-HHHcCCCChhhhhhhh
Confidence 1112234578899999998764 57889999999999999999999997643211 111100 00000 000
Q ss_pred chhhH-HHHHHHHhhccc-----chhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 609 EHEDF-EALVDSRLEKNY-----VDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 609 ~~~~~-~~l~d~~l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
....+ ..+......... .......+.+++.+||..||++|+++.|++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 00000 000000000000 00012346789999999999999999998864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=330.54 Aligned_cols=271 Identities=21% Similarity=0.332 Sum_probs=198.6
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC-chhHHHHHHHHHHHHHcCCCCceeEeeEeecc-----cee
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG-SQGEREFRAEVEIISRVHHRHLVSLVGYCISE-----RER 452 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~-----~~~ 452 (727)
.++|++.++||+|+||.||+|+.. +|+.||||+++... ......+.+|+.+|++++|+||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 467999999999999999999864 68999999986432 33446688999999999999999999987654 357
Q ss_pred eEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhh
Q 041135 453 LLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIA 532 (727)
Q Consensus 453 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~ 532 (727)
|+|+||+.+ +|..++..+ .+.+..++.++.||++||+|||++ +|+|||||++||||+.++.+||+|||+++..
T Consensus 84 ~lv~e~~~~-~l~~~~~~~---~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 84 YIVQELMET-DLYKLIKTQ---HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred EEEehhccc-CHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeec
Confidence 999999964 676666543 488999999999999999999999 9999999999999999999999999999754
Q ss_pred hccCCCccccccccCCccccccCcccC-CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchh
Q 041135 533 LELDSNTHVSTRVMGTFGYMAPEYATS-GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHE 611 (727)
Q Consensus 533 ~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~ 611 (727)
..............|+..|+|||++.+ ..++.++|||||||++|||++|+.+|...+.. ....+...++... ..+
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~---~~~~~~~~~~~~~-~~~ 232 (336)
T cd07849 157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL---HQLNLILGVLGTP-SQE 232 (336)
T ss_pred cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHcCCC-CHH
Confidence 322222222234578899999998765 46889999999999999999999999754321 1111111100000 001
Q ss_pred hHHHHHHHHh-------hcc-------cchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH--Hhhc
Q 041135 612 DFEALVDSRL-------EKN-------YVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA--LDTL 661 (727)
Q Consensus 612 ~~~~l~d~~l-------~~~-------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~ 661 (727)
.+..+++... ... ........+.+|+.+||+.+|++||++.||+++ |+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 1111111000 000 001123457899999999999999999999998 4443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=350.93 Aligned_cols=274 Identities=18% Similarity=0.239 Sum_probs=188.8
Q ss_pred HhcCccccceeccCCceEEEEEEEcC--CcEEEEE------------------EeeeCCchhHHHHHHHHHHHHHcCCCC
Q 041135 379 ATNGFSAHNVLGEGGFGCVYKGVLAD--GREVAVK------------------QLKIGGSQGEREFRAEVEIISRVHHRH 438 (727)
Q Consensus 379 ~~~~~~~~~~LG~G~fg~Vy~~~~~~--g~~vaVK------------------~l~~~~~~~~~~~~~Ei~~l~~l~Hpn 438 (727)
..++|+++++||+|+||+||+|.++. +..+++| .++ ........+++|+++|++++|+|
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 35789999999999999999987542 2222222 111 11223456889999999999999
Q ss_pred ceeEeeEeeccceeeEEEeeccCCccchhcccCC---CCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEE
Q 041135 439 LVSLVGYCISERERLLVYEYVPNDTLHYHLHAEG---RPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILL 515 (727)
Q Consensus 439 Iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~---~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl 515 (727)
||++++++.+.+..|+|+|++. ++|..++.... ........+++|+.||+.||+|||++ +|||||||++||||
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence 9999999999999999999995 45555554321 11234566788999999999999999 99999999999999
Q ss_pred CCCCcEEEEeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCC-CCCCCCCCch
Q 041135 516 DSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKP-VDASQPLGDE 594 (727)
Q Consensus 516 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~P-f~~~~~~~~~ 594 (727)
+.++.+||+|||+++.+.. .........+|+..|+|||++.+..++.++||||||||||||++|..+ |.........
T Consensus 301 ~~~~~vkL~DFGla~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~ 378 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEK--EREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK 378 (501)
T ss_pred CCCCCEEEEeCCCceecCc--ccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence 9999999999999986422 112223346799999999999999999999999999999999998764 4332211112
Q ss_pred hhHHhhHHHH--HHhhc--hhhHHHHHHHH-hhcc--cch------hHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 595 SLVEWARPLL--AEALE--HEDFEALVDSR-LEKN--YVD------SEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 595 ~l~~~~~~~l--~~~~~--~~~~~~l~d~~-l~~~--~~~------~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
.+.+....+. .+.+. ...+.+.++.. +... ... .....+.+++.+||+.||++||++.|++.+-.
T Consensus 379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~ 456 (501)
T PHA03210 379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPL 456 (501)
T ss_pred HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChh
Confidence 2222111100 00000 00011111100 0000 000 01123567889999999999999999998744
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=325.32 Aligned_cols=250 Identities=21% Similarity=0.335 Sum_probs=199.8
Q ss_pred ccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeeccC
Q 041135 383 FSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPN 461 (727)
Q Consensus 383 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 461 (727)
|.....||+|+||.||+|+.. +++.||||++........+.+.+|+.+++.++|+||++++++|..++..|+||||+.+
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 344567999999999999865 6899999999766555567789999999999999999999999999999999999999
Q ss_pred CccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCccc
Q 041135 462 DTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHV 541 (727)
Q Consensus 462 gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 541 (727)
++|..++... .+++..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||++..... ....
T Consensus 103 ~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~---~~~~ 173 (297)
T cd06659 103 GALTDIVSQT---RLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK---DVPK 173 (297)
T ss_pred CCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccc---cccc
Confidence 9999877543 378999999999999999999999 999999999999999999999999999875421 1112
Q ss_pred cccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHh
Q 041135 542 STRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRL 621 (727)
Q Consensus 542 ~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l 621 (727)
.....|+..|+|||++.+..++.++|||||||+||||++|+.||..... ...... + . ... ...+
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~---~~~~~~---~-~----~~~-----~~~~ 237 (297)
T cd06659 174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP---VQAMKR---L-R----DSP-----PPKL 237 (297)
T ss_pred ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHH---H-h----ccC-----CCCc
Confidence 2335688999999999988999999999999999999999999975321 111100 0 0 000 0000
Q ss_pred hcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 622 EKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 622 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
. ........+.+++.+||+.+|++||++.+|+++-.
T Consensus 238 ~--~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~ 273 (297)
T cd06659 238 K--NAHKISPVLRDFLERMLTREPQERATAQELLDHPF 273 (297)
T ss_pred c--ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChh
Confidence 0 01112234778999999999999999999999644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=310.46 Aligned_cols=248 Identities=27% Similarity=0.456 Sum_probs=203.4
Q ss_pred CccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeecc
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVP 460 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 460 (727)
+|++.+.||+|+||.||+++.. +|+.|+||+++.........+.+|++++++++|+||+++++++..+...++++||+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4778899999999999999975 688999999986655566789999999999999999999999999999999999999
Q ss_pred CCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCcc
Q 041135 461 NDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTH 540 (727)
Q Consensus 461 ~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 540 (727)
+++|.+++.... ..+++..++.++.||++||+|||++ +++||||+++||++++++.+||+|||++........
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 153 (253)
T cd05122 81 GGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--- 153 (253)
T ss_pred CCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc---
Confidence 999999887653 3589999999999999999999998 999999999999999999999999999975432111
Q ss_pred ccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHH
Q 041135 541 VSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSR 620 (727)
Q Consensus 541 ~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~ 620 (727)
.....++..|++||++.+..++.++|||+||++||+|++|+.||...... +.... ... .
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~-------------~~~-~ 212 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM------KALFK-------------IAT-N 212 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH------HHHHH-------------HHh-c
Confidence 23456888999999999888999999999999999999999999754311 00000 000 0
Q ss_pred hhcccchh--HHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 621 LEKNYVDS--EMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 621 l~~~~~~~--~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
........ ....+.+++++||+.||++||++.||+++
T Consensus 213 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 213 GPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred CCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00001111 13458899999999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=323.27 Aligned_cols=263 Identities=21% Similarity=0.300 Sum_probs=198.7
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchh--HHHHHHHHHHHHHcCCCCceeEeeEeecc--ceeeEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQG--EREFRAEVEIISRVHHRHLVSLVGYCISE--RERLLV 455 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~--~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~--~~~~lV 455 (727)
++|++.+.||+|+||.||+|++. +++.|+||.++...... ...+.+|+++|++++|+||+++++++... ...|||
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888899999999999999976 58899999997543322 23567899999999999999999999877 789999
Q ss_pred EeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhcc
Q 041135 456 YEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALEL 535 (727)
Q Consensus 456 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 535 (727)
|||+. ++|.+++..... .+++..+++++.||++||+|||++ +|+|||||++||||++++.+||+|||+++.....
T Consensus 85 ~e~~~-~~L~~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQ-PFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred ehhcC-cCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 99997 488887765432 589999999999999999999999 9999999999999999999999999999754322
Q ss_pred CCCccccccccCCccccccCcccCC-CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhh------
Q 041135 536 DSNTHVSTRVMGTFGYMAPEYATSG-KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEAL------ 608 (727)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~------ 608 (727)
. .......++..|+|||++.+. .++.++|||||||++|||++|+.+|....... . ...+.....
T Consensus 160 ~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~---~---~~~~~~~~~~~~~~~ 230 (293)
T cd07843 160 L---KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID---Q---LNKIFKLLGTPTEKI 230 (293)
T ss_pred c---cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHH---H---HHHHHHHhCCCchHH
Confidence 1 112334578899999998765 46899999999999999999999997643211 1 111110000
Q ss_pred ----------chhhHHHHHHHHhhcccchh-HHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 609 ----------EHEDFEALVDSRLEKNYVDS-EMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 609 ----------~~~~~~~l~d~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
....+.......+...+... ....+.+|+++||+.+|++||++.||+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 231 WPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred HHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00000001111112222221 24457899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=319.47 Aligned_cols=253 Identities=25% Similarity=0.364 Sum_probs=204.4
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEee
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 458 (727)
.+.|++.+.||+|+||.||+|++. +++.|++|+++.... ....+.+|+++|++++|+||++++++|..+...|+||||
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 96 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY 96 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence 456888899999999999999986 688999999976544 566789999999999999999999999999999999999
Q ss_pred ccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCC
Q 041135 459 VPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSN 538 (727)
Q Consensus 459 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 538 (727)
+.+++|.+++.... ..+++..++.++.||+.||+|||+. +|+|+|||++||+|+.++.+||+|||++......
T Consensus 97 ~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~--- 169 (286)
T cd06614 97 MDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE--- 169 (286)
T ss_pred cCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccc---
Confidence 99999999998765 3589999999999999999999998 9999999999999999999999999998754221
Q ss_pred ccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHH
Q 041135 539 THVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVD 618 (727)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d 618 (727)
........++..|++||++.+..++.++|||+|||+||||++|+.||...... ..... +..
T Consensus 170 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~------~~~~~-------------~~~ 230 (286)
T cd06614 170 KSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL------RALFL-------------ITT 230 (286)
T ss_pred hhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH------HHHHH-------------HHh
Confidence 11223345788999999999888999999999999999999999998653211 00000 000
Q ss_pred HHhhc-ccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 619 SRLEK-NYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 619 ~~l~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
..... .........+.+++++||+.++.+||++.+|+++..
T Consensus 231 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 272 (286)
T cd06614 231 KGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPF 272 (286)
T ss_pred cCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChH
Confidence 00000 000112245788999999999999999999987644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=325.17 Aligned_cols=251 Identities=26% Similarity=0.417 Sum_probs=197.1
Q ss_pred CccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc---hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEe
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS---QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYE 457 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 457 (727)
.|+..+.||+|+||.||+|+.. +|+.||||++..... .....+.+|+++|++++|+||++++++|.++...+||||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 4778899999999999999964 588999999864322 233568899999999999999999999999999999999
Q ss_pred eccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCC
Q 041135 458 YVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDS 537 (727)
Q Consensus 458 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 537 (727)
|+.+ +|.+++.... ..+++..++.++.||++||.|||++ +|+||||+++||+++.++.+||+|||++.....
T Consensus 106 ~~~g-~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~--- 177 (317)
T cd06635 106 YCLG-SASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASP--- 177 (317)
T ss_pred CCCC-CHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCC---
Confidence 9965 6666654432 2489999999999999999999999 999999999999999999999999999864321
Q ss_pred CccccccccCCccccccCccc---CCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHH
Q 041135 538 NTHVSTRVMGTFGYMAPEYAT---SGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFE 614 (727)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~l~---~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~ 614 (727)
.....|+..|++||++. ++.++.++|||||||++|||++|+.||...... .. +.
T Consensus 178 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------~~-------------~~ 234 (317)
T cd06635 178 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SA-------------LY 234 (317)
T ss_pred ----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH------HH-------------HH
Confidence 12346788999999984 456889999999999999999999998653210 00 00
Q ss_pred HHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 615 ALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 615 ~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
.+................+.+|+.+||+.+|.+||++.+|++++..+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 235 HIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred HHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence 1111111011111223457889999999999999999999998876643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=319.37 Aligned_cols=254 Identities=23% Similarity=0.365 Sum_probs=192.8
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC-chhHHHHHHHHHH-HHHcCCCCceeEeeEeeccceeeEEEe
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG-SQGEREFRAEVEI-ISRVHHRHLVSLVGYCISERERLLVYE 457 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~-~~~~~~~~~Ei~~-l~~l~HpnIv~l~~~~~~~~~~~lV~E 457 (727)
++|++.+.||+|+||.||+|+++ +|+.||||+++... .....++..|+.+ ++.++|+||+++++++..+...|+|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46889999999999999999975 58999999987543 2334456667765 556789999999999999999999999
Q ss_pred eccCCccchhcccC--CCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhcc
Q 041135 458 YVPNDTLHYHLHAE--GRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALEL 535 (727)
Q Consensus 458 y~~~gsL~~~L~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 535 (727)
|+. |+|.++++.. ....+++..++.++.||+.||+|||+++ +|+|||||++|||++.++.+||+|||+++....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~- 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD- 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeeccccccccc-
Confidence 996 6776666432 2245899999999999999999999853 799999999999999999999999999975421
Q ss_pred CCCccccccccCCccccccCcccC----CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchh
Q 041135 536 DSNTHVSTRVMGTFGYMAPEYATS----GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHE 611 (727)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~l~~----~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~ 611 (727)
........|+..|++||++.+ ..++.++|||+|||+||||++|+.||...... +..
T Consensus 157 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~------------- 216 (283)
T cd06617 157 ---SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP----FQQ------------- 216 (283)
T ss_pred ---ccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC----HHH-------------
Confidence 111233467889999998865 44688999999999999999999999643211 000
Q ss_pred hHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 612 DFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 612 ~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
+...+...............+.+++.+||..+|++||++.+|+++-.
T Consensus 217 -~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~ 263 (283)
T cd06617 217 -LKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPF 263 (283)
T ss_pred -HHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCch
Confidence 00011100000000111234788999999999999999999988633
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=318.71 Aligned_cols=260 Identities=25% Similarity=0.317 Sum_probs=201.2
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEeecc--ceeeEEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYCISE--RERLLVY 456 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~--~~~~lV~ 456 (727)
++|++.+.||.|+||.||+|++. +++.||+|++..... .....+.+|+++|++++|+||++++++|.+. ...+|||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46888999999999999999975 588999999875433 3456799999999999999999999998654 3689999
Q ss_pred eeccCCccchhcccC--CCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhc
Q 041135 457 EYVPNDTLHYHLHAE--GRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALE 534 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 534 (727)
||+.+++|.+++... ....+.+..++.|+.||+.||+|||+. +|+||||+++||++++++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999998876532 233478889999999999999999999 999999999999999999999999999874321
Q ss_pred cCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCC--CCchhhHHhhHHHHHHhhchhh
Q 041135 535 LDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQP--LGDESLVEWARPLLAEALEHED 612 (727)
Q Consensus 535 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~--~~~~~l~~~~~~~l~~~~~~~~ 612 (727)
.......++..|++||.+.+..++.++|||+|||++|||++|+.||+.... .....+..+.. ...
T Consensus 158 -----~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------~~~ 224 (287)
T cd06621 158 -----SLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV--------NMP 224 (287)
T ss_pred -----cccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHh--------cCC
Confidence 111234578899999999999999999999999999999999999986532 11111111110 000
Q ss_pred HHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 613 FEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 613 ~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
...+ ..... ........+.+|+.+||+.+|++||++.||+++-.
T Consensus 225 ~~~~-~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~ 268 (287)
T cd06621 225 NPEL-KDEPG--NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPW 268 (287)
T ss_pred chhh-ccCCC--CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcc
Confidence 0000 00000 00112345789999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=335.97 Aligned_cols=253 Identities=25% Similarity=0.339 Sum_probs=208.4
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc--hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS--QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
...|.+.+.||+|.|+.|.+|++. .|.+||||.+..... ...+.+.+|+++|+.|+|+|||+|+.+......+|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 456889999999999999999964 599999999865432 22356899999999999999999999999999999999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccC
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 536 (727)
||+.+|.|+++|.++++ +.+.+...++.|+..+++|||++ +|||||||.+||||+.+..+||+|||++.++.
T Consensus 135 eya~~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~--- 206 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD--- 206 (596)
T ss_pred EeccCchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec---
Confidence 99999999999999887 66688899999999999999999 99999999999999999999999999998652
Q ss_pred CCccccccccCCccccccCcccCCCC-CchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHH
Q 041135 537 SNTHVSTRVMGTFGYMAPEYATSGKL-TEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEA 615 (727)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~l~~~~~-~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~ 615 (727)
........||+.-|.|||++++..| ..++|+|++|||||-|++|.+||++..-..-. +.
T Consensus 207 -~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr-------------------~r 266 (596)
T KOG0586|consen 207 -YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR-------------------PR 266 (596)
T ss_pred -ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc-------------------ch
Confidence 3445667899999999999999776 57999999999999999999999975421100 01
Q ss_pred HHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhcc
Q 041135 616 LVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLD 662 (727)
Q Consensus 616 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 662 (727)
.+..+++..+... ...-+|++++|-.+|.+|.++++|++.-+...
T Consensus 267 vl~gk~rIp~~ms--~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~ 311 (596)
T KOG0586|consen 267 VLRGKYRIPFYMS--CDCEDLLRKFLVLNPSKRGPCDQIMKDRWRND 311 (596)
T ss_pred heeeeecccceee--chhHHHHHHhhccCccccCCHHHhhhhcccch
Confidence 1111122222111 12456788999999999999999998866443
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=318.53 Aligned_cols=250 Identities=23% Similarity=0.417 Sum_probs=199.2
Q ss_pred CccccceeccCCceEEEEEEE-cCCcEEEEEEeeeCC-chhHHHHHHHHHHHHHcC---CCCceeEeeEeeccceeeEEE
Q 041135 382 GFSAHNVLGEGGFGCVYKGVL-ADGREVAVKQLKIGG-SQGEREFRAEVEIISRVH---HRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~-~~g~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~---HpnIv~l~~~~~~~~~~~lV~ 456 (727)
.|++.++||+|+||.||+|++ .+|+.|+||.++... .....++.+|++++++++ |+||++++++|.++...+|||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477889999999999999996 468999999987543 234467889999999997 999999999999999999999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccC
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 536 (727)
||+.+++|.++++.. .+++..++.++.||++||.|||+. +|+||||+++||++++++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 82 EYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred ecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 999999999988654 488999999999999999999999 99999999999999999999999999997643222
Q ss_pred CCccccccccCCccccccCcccCC-CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHH
Q 041135 537 SNTHVSTRVMGTFGYMAPEYATSG-KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEA 615 (727)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~l~~~-~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~ 615 (727)
.......|+..|+|||++.++ .++.++|||||||+||+|++|+.||....... ...+ +....
T Consensus 156 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~---~~~~--------~~~~~--- 218 (277)
T cd06917 156 ---SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR---AMML--------IPKSK--- 218 (277)
T ss_pred ---cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh---hhhc--------cccCC---
Confidence 222334688899999998754 46889999999999999999999997543211 0000 00000
Q ss_pred HHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 616 LVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 616 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
...+... .....+.+++.+||+.||++||++.||+++-.
T Consensus 219 --~~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~ 257 (277)
T cd06917 219 --PPRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLKSKW 257 (277)
T ss_pred --CCCCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhChH
Confidence 0001110 12345788999999999999999999988643
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=319.76 Aligned_cols=260 Identities=18% Similarity=0.280 Sum_probs=184.5
Q ss_pred cCccccceeccCCceEEEEEEEcC----CcEEEEEEeeeCCchhH-----------HHHHHHHHHHHHcCCCCceeEeeE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLAD----GREVAVKQLKIGGSQGE-----------REFRAEVEIISRVHHRHLVSLVGY 445 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~~----g~~vaVK~l~~~~~~~~-----------~~~~~Ei~~l~~l~HpnIv~l~~~ 445 (727)
++|++.++||+|+||.||+|++.+ +..+++|+......... .....++..+..++|.||++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 579999999999999999999754 34566665443322111 112233344556689999999998
Q ss_pred eeccc----eeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcE
Q 041135 446 CISER----ERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEA 521 (727)
Q Consensus 446 ~~~~~----~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~v 521 (727)
+.... ..++++|++.. .+.+++.... ...+..++.|+.||++||+|||++ +|+|||||++||||+.++.+
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRIK--CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHhhc--cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCcE
Confidence 76543 34678887743 4555554332 256778899999999999999999 99999999999999999999
Q ss_pred EEEeeccchhhhccCCCc----cccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhH
Q 041135 522 RVADFGLAKIALELDSNT----HVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLV 597 (727)
Q Consensus 522 kL~DFGla~~~~~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~ 597 (727)
||+|||+++.+....... .......||..|+|||++.+..++.++|||||||+||||++|+.||....... .+.
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~--~~~ 243 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG--NLI 243 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch--HHH
Confidence 999999998653211111 11123469999999999999999999999999999999999999998653221 111
Q ss_pred HhhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 598 EWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 598 ~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
.... .+.+..+....+. .......+.++++.||..++++||++.+|++.|+
T Consensus 244 ~~~~--------~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 244 HAAK--------CDFIKRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHhH--------HHHHHHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 1111 0111111111111 1122355889999999999999999999999873
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=321.55 Aligned_cols=250 Identities=25% Similarity=0.392 Sum_probs=195.0
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc---hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS---QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
+.|++.++||+|+||.||+|+.. +|+.||||++..... +..+++.+|+++++.++|+||++++++|.+++..||||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45888899999999999999975 588999999864332 23357889999999999999999999999999999999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccC
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 536 (727)
||+.+ .|.+++..... .+.+..+..++.||+.||.|||++ +|+||||+++||++++++.+||+|||+++....
T Consensus 95 e~~~g-~l~~~~~~~~~-~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~-- 167 (307)
T cd06607 95 EYCLG-SASDILEVHKK-PLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP-- 167 (307)
T ss_pred HhhCC-CHHHHHHHccc-CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCC--
Confidence 99974 55555543322 489999999999999999999998 999999999999999999999999999874321
Q ss_pred CCccccccccCCccccccCccc---CCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhH
Q 041135 537 SNTHVSTRVMGTFGYMAPEYAT---SGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDF 613 (727)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~l~---~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~ 613 (727)
.....++..|+|||++. .+.++.++|||||||++|||++|+.||...... .... .....
T Consensus 168 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~------~~~~----~~~~~--- 229 (307)
T cd06607 168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALY----HIAQN--- 229 (307)
T ss_pred -----CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH------HHHH----HHhcC---
Confidence 12345788999999884 356888999999999999999999998653211 0000 00000
Q ss_pred HHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhc
Q 041135 614 EALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661 (727)
Q Consensus 614 ~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 661 (727)
.............+.+|+.+||..+|++||++.+|+.+....
T Consensus 230 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~ 271 (307)
T cd06607 230 ------DSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVL 271 (307)
T ss_pred ------CCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhc
Confidence 000000111233578999999999999999999999876543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=318.79 Aligned_cols=248 Identities=22% Similarity=0.347 Sum_probs=199.9
Q ss_pred ccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeeccC
Q 041135 383 FSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPN 461 (727)
Q Consensus 383 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 461 (727)
|...++||+|+||.||+++.. +++.|+||+++.......+.+.+|+.+++.++|+||+++++++...+..++|+||+.+
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 455679999999999999864 6889999998765555566789999999999999999999999999999999999999
Q ss_pred CccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCccc
Q 041135 462 DTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHV 541 (727)
Q Consensus 462 gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 541 (727)
++|.+++... .+++..++.++.||+.||+|||++ +|+|||||++||+|+.++.+||+|||++...... ...
T Consensus 101 ~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~---~~~ 171 (285)
T cd06648 101 GALTDIVTHT---RMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE---VPR 171 (285)
T ss_pred CCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccC---Ccc
Confidence 9999988762 378999999999999999999999 9999999999999999999999999998754221 112
Q ss_pred cccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHh
Q 041135 542 STRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRL 621 (727)
Q Consensus 542 ~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l 621 (727)
.....|+..|++||++.+..++.++|||||||++|||++|+.||...+. .+....+.. .. ...+
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~------~~~~~~~~~-----~~-----~~~~ 235 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP------LQAMKRIRD-----NL-----PPKL 235 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH------HHHHHHHHh-----cC-----CCCC
Confidence 2335688999999999988899999999999999999999999965321 111111100 00 0000
Q ss_pred hcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 622 EKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 622 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
.. .......+.+|+.+||+.+|++||++.+|+++
T Consensus 236 ~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 236 KN--LHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred cc--cccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 00 11123458899999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=313.90 Aligned_cols=252 Identities=25% Similarity=0.377 Sum_probs=198.0
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC-----chhHHHHHHHHHHHHHcCCCCceeEeeEeecc--cee
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG-----SQGEREFRAEVEIISRVHHRHLVSLVGYCISE--RER 452 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~-----~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~--~~~ 452 (727)
++|++.++||+|+||.||+|++. +|+.|++|++.... .+....+++|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46889999999999999999864 58999999875321 23345788999999999999999999998764 457
Q ss_pred eEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhh
Q 041135 453 LLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIA 532 (727)
Q Consensus 453 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~ 532 (727)
++||||+.+++|.+++..... +.+..+++++.||++||.|||++ +|+|||||++||+++.++.+||+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~--l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGA--LTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 899999999999998876543 78889999999999999999999 9999999999999999999999999999754
Q ss_pred hccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhh
Q 041135 533 LELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHED 612 (727)
Q Consensus 533 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~ 612 (727)
..............++..|++||++.+..++.++|||||||+||||++|+.||...... . .
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~--------------~ 217 (264)
T cd06653 157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM-----A--------------A 217 (264)
T ss_pred ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH-----H--------------H
Confidence 22111111122356889999999999888999999999999999999999999643211 0 0
Q ss_pred HHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 613 FEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 613 ~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
+.++........+.......+.+++++||.. +.+||++.+++.+
T Consensus 218 ~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~~-~~~r~~~~~~~~~ 261 (264)
T cd06653 218 IFKIATQPTKPMLPDGVSDACRDFLKQIFVE-EKRRPTAEFLLRH 261 (264)
T ss_pred HHHHHcCCCCCCCCcccCHHHHHHHHHHhcC-cccCccHHHHhcC
Confidence 1111111111122233334588899999995 5999999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=315.92 Aligned_cols=266 Identities=22% Similarity=0.313 Sum_probs=197.8
Q ss_pred ccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc--hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeec
Q 041135 383 FSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS--QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYV 459 (727)
Q Consensus 383 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 459 (727)
|++.++||+|++|.||+|++. +|..|+||++..... .....+.+|++++++++|+||+++++++.++...|+||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567899999999999999864 699999999875432 22356889999999999999999999999999999999999
Q ss_pred cCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCc
Q 041135 460 PNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNT 539 (727)
Q Consensus 460 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 539 (727)
+++|.+++.......+++..++.++.||++||+|||++ +|+||||+++|||++.++.+||+|||+++.... ..
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~---~~ 153 (283)
T cd07835 81 -DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGV---PV 153 (283)
T ss_pred -CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCC---Cc
Confidence 46888888776545689999999999999999999998 999999999999999999999999999974321 11
Q ss_pred cccccccCCccccccCcccCC-CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHH---HHHhhch-hhHH
Q 041135 540 HVSTRVMGTFGYMAPEYATSG-KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPL---LAEALEH-EDFE 614 (727)
Q Consensus 540 ~~~~~~~gt~~y~aPE~l~~~-~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~---l~~~~~~-~~~~ 614 (727)
.......++..|+|||++.+. .++.++|||||||++|||++|+.+|...... ..+.+..+.. ....+.. ..+.
T Consensus 154 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07835 154 RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI--DQLFRIFRTLGTPDEDVWPGVTSLP 231 (283)
T ss_pred cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCChHHhhhhhhch
Confidence 111223567889999988764 5788999999999999999999999764321 1111111100 0000000 0000
Q ss_pred HHHHHHhh------cccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 615 ALVDSRLE------KNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 615 ~l~d~~l~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
........ ..........+.+++.+||+.+|++||+++||+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 232 DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000000 00011122457899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=338.17 Aligned_cols=244 Identities=25% Similarity=0.409 Sum_probs=194.6
Q ss_pred cceeccCCceEEEEEEEc-CCcEEEEEEeeeC----CchhHHHHHHHHHHHHHcCCCCceeEeeEeeccce--eeEEEee
Q 041135 386 HNVLGEGGFGCVYKGVLA-DGREVAVKQLKIG----GSQGEREFRAEVEIISRVHHRHLVSLVGYCISERE--RLLVYEY 458 (727)
Q Consensus 386 ~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~----~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~--~~lV~Ey 458 (727)
..+||+|+|-+||||.+. +|.+||--.++.. .....+.|..|+.+|+.|+|+|||+|+++|.+... +.+|+|+
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 367999999999999864 4778875443322 23444789999999999999999999999987665 7899999
Q ss_pred ccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECC-CCcEEEEeeccchhhhccCC
Q 041135 459 VPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDS-SFEARVADFGLAKIALELDS 537 (727)
Q Consensus 459 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~-~~~vkL~DFGla~~~~~~~~ 537 (727)
+..|+|+.|+++.++ ++.+.++.|++||++||.|||++ ++.|||||||.+||+|+. .|.|||+|+|||.....
T Consensus 125 ~TSGtLr~Y~kk~~~--vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~--- 198 (632)
T KOG0584|consen 125 FTSGTLREYRKKHRR--VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK--- 198 (632)
T ss_pred ccCCcHHHHHHHhcc--CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc---
Confidence 999999999998877 88899999999999999999996 789999999999999975 57999999999986532
Q ss_pred CccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHH
Q 041135 538 NTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALV 617 (727)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~ 617 (727)
.....++||+.|||||+.. ..|++.+||||||++|+||+|+..||..=.+ ..++. ++++
T Consensus 199 --s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n---------~AQIY---------KKV~ 257 (632)
T KOG0584|consen 199 --SHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN---------PAQIY---------KKVT 257 (632)
T ss_pred --cccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC---------HHHHH---------HHHH
Confidence 2233478999999999988 7899999999999999999999999964221 11111 1122
Q ss_pred HHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 618 DSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 618 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
.+....-+..-..-.+.+||.+||.. .++|+++.|||+.
T Consensus 258 SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 258 SGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred cCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 22111112222233477899999999 8999999999876
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=316.89 Aligned_cols=248 Identities=25% Similarity=0.309 Sum_probs=201.6
Q ss_pred CccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEe
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYE 457 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 457 (727)
+|++.+.||.|+||.||+|+.. +|+.||+|++.... ....+.+.+|++++++++|+||+++++++.++...++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4888999999999999999975 58999999987432 2345689999999999999999999999999999999999
Q ss_pred eccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCC
Q 041135 458 YVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDS 537 (727)
Q Consensus 458 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 537 (727)
|+.+++|.+++.... .+.+..++.++.||++||.|||++ +|+|+|||++||++++++.+||+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 81 LLLGGDLRYHLSQKV--KFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred CCCCCCHHHHHHhcC--CcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 999999999987663 488999999999999999999999 99999999999999999999999999987542211
Q ss_pred CccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHH
Q 041135 538 NTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALV 617 (727)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~ 617 (727)
......|+..|++||++.+..++.++|||+|||++|+|++|+.||......... +... ..
T Consensus 155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~----~~~~-------------~~ 214 (258)
T cd05578 155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRD----QIRA-------------KQ 214 (258)
T ss_pred ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHH----HHHH-------------Hh
Confidence 223456888999999999888999999999999999999999999865432111 1100 00
Q ss_pred HHHhhcccchhHHHHHHHHHHHHhccCCCCCCCH--HHHHH
Q 041135 618 DSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRM--SQVVR 656 (727)
Q Consensus 618 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~--~evl~ 656 (727)
.. ....+.......+.+++.+||+.||.+|+++ +|+++
T Consensus 215 ~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 215 ET-ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred cc-ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 00 1111222233568899999999999999999 66553
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=316.65 Aligned_cols=261 Identities=23% Similarity=0.314 Sum_probs=197.7
Q ss_pred ccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC--chhHHHHHHHHHHHHHcCCCCceeEeeEeecc--ceeeEEEe
Q 041135 383 FSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG--SQGEREFRAEVEIISRVHHRHLVSLVGYCISE--RERLLVYE 457 (727)
Q Consensus 383 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~--~~~~lV~E 457 (727)
|++.++||+|+||.||+|+.. +|+.||||+++... ......+.+|++++++++|+||+++++++.+. +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 677899999999999999976 48899999998653 23345788999999999999999999999988 78999999
Q ss_pred eccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCC
Q 041135 458 YVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDS 537 (727)
Q Consensus 458 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 537 (727)
|+.+ +|..++.... ..+++..++.++.||++||+|||++ +|+|+|||++||||++++.+||+|||+++.......
T Consensus 81 ~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 81 YMDH-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred cccc-cHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 9975 7777775542 3589999999999999999999998 999999999999999999999999999976532211
Q ss_pred CccccccccCCccccccCcccC-CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHH-----------
Q 041135 538 NTHVSTRVMGTFGYMAPEYATS-GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLA----------- 605 (727)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~----------- 605 (727)
.......++..|++||.+.+ ..++.++|||+|||++|||++|+.+|...... ...........
T Consensus 156 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07840 156 --ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL---EQLEKIFELCGSPTDENWPGVS 230 (287)
T ss_pred --ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCchhhccccc
Confidence 11233456788999998765 45789999999999999999999999765421 11111100000
Q ss_pred ------HhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 606 ------EALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 606 ------~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
.......+...+... +...+...+++++++||+.+|++||++.+|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 231 KLPWFENLKPKKPYKRRLREF----FKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred cchhhhhccccccchhHHHHH----hcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 000000001111111 111124468899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=309.58 Aligned_cols=252 Identities=27% Similarity=0.407 Sum_probs=205.0
Q ss_pred CccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc--hhHHHHHHHHHHHHHcCCCCceeEeeEeecc--ceeeEEE
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS--QGEREFRAEVEIISRVHHRHLVSLVGYCISE--RERLLVY 456 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~--~~~~lV~ 456 (727)
+|++.+.||+|+||.||+|+.. +|+.|+||+++.... ...+.+.+|++++++++|+||+++++++.+. ...++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778899999999999999976 689999999876543 4456899999999999999999999999988 8899999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccC
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 536 (727)
||+.+++|.+++.... .+++..++.++.|+++||+|||+. +++||||+++||+|+.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 81 EYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 9999999999987665 589999999999999999999998 99999999999999999999999999997653222
Q ss_pred CCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHH
Q 041135 537 SNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEAL 616 (727)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l 616 (727)
.. .......++..|++||.+.+..++.++|||+||++||+|++|+.||..... ..... ..+
T Consensus 156 ~~-~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~-------------~~~ 216 (260)
T cd06606 156 TG-EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-----PMAAL-------------YKI 216 (260)
T ss_pred cc-ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----hHHHH-------------Hhc
Confidence 10 012345688899999999988899999999999999999999999976541 00000 000
Q ss_pred HHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 617 VDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 617 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
................+.+++.+||..++++||++.||+++
T Consensus 217 ~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 217 GSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred cccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 00011111222234568899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=327.25 Aligned_cols=263 Identities=22% Similarity=0.332 Sum_probs=197.5
Q ss_pred HHhcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeC--CchhHHHHHHHHHHHHHcCCCCceeEeeEeecc-----
Q 041135 378 QATNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIG--GSQGEREFRAEVEIISRVHHRHLVSLVGYCISE----- 449 (727)
Q Consensus 378 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~----- 449 (727)
...++|++.+.||+|+||.||+|+.. +|+.||||++... .......+.+|++++++++|+||++++++|...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 35578999999999999999999964 6899999998632 233345678899999999999999999998643
Q ss_pred -ceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeecc
Q 041135 450 -RERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGL 528 (727)
Q Consensus 450 -~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGl 528 (727)
...||||||+. ++|.+++... ++...+..++.||++||+|||++ +|+|||||++||||+.++.+||+|||+
T Consensus 93 ~~~~~lv~e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 93 FQDVYLVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred cCcEEEEEeccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCcc
Confidence 34699999995 4777766543 78889999999999999999999 999999999999999999999999999
Q ss_pred chhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhh
Q 041135 529 AKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEAL 608 (727)
Q Consensus 529 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~ 608 (727)
++.... ........++..|+|||++.+..++.++|||||||+||+|++|+.+|...+.. ..|.. ++....
T Consensus 165 ~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~-----~~~~~-~~~~~~ 234 (353)
T cd07850 165 ARTAGT----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHI-----DQWNK-IIEQLG 234 (353)
T ss_pred ceeCCC----CCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHH-----HHHHH-HHHhcC
Confidence 975421 11123346788999999999999999999999999999999999999764321 11111 000000
Q ss_pred c-hhhH--------HHHHHHH---------------hhc----ccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 041135 609 E-HEDF--------EALVDSR---------------LEK----NYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRAL 658 (727)
Q Consensus 609 ~-~~~~--------~~l~d~~---------------l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 658 (727)
. ...+ ...++.+ +.. .........+.+|+++||+.||++|+++.||+++=
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~ 312 (353)
T cd07850 235 TPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHP 312 (353)
T ss_pred CCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcCh
Confidence 0 0000 0000000 000 00111234577999999999999999999999773
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=326.11 Aligned_cols=277 Identities=23% Similarity=0.359 Sum_probs=200.4
Q ss_pred HhcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeC--CchhHHHHHHHHHHHHHc-CCCCceeEeeEeecc--cee
Q 041135 379 ATNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIG--GSQGEREFRAEVEIISRV-HHRHLVSLVGYCISE--RER 452 (727)
Q Consensus 379 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~--~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~--~~~ 452 (727)
..++|++.+.||+|+||.||+|++. +|+.||||++... .......+.+|+.+++++ +|+||++++++|... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3467889999999999999999975 5889999988532 223345678899999999 999999999998653 367
Q ss_pred eEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhh
Q 041135 453 LLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIA 532 (727)
Q Consensus 453 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~ 532 (727)
||||||+. ++|..++..+ .+++..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++..
T Consensus 85 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 99999996 5888887654 478899999999999999999998 9999999999999999999999999999865
Q ss_pred hccCCC--ccccccccCCccccccCcccC-CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhH-HHH---H
Q 041135 533 LELDSN--THVSTRVMGTFGYMAPEYATS-GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWAR-PLL---A 605 (727)
Q Consensus 533 ~~~~~~--~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~-~~l---~ 605 (727)
...... ........|+..|++||++.+ ..++.++|||||||++|||++|+.+|................ ... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 332211 112234568899999998865 457889999999999999999999997543211100000000 000 0
Q ss_pred HhhchhhHHHHHHHHhhcc------cchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH--Hhhcc
Q 041135 606 EALEHEDFEALVDSRLEKN------YVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA--LDTLD 662 (727)
Q Consensus 606 ~~~~~~~~~~l~d~~l~~~------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~ 662 (727)
..+.......+++...... ........+.+++.+||+.||++||++.+|+++ |+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~ 302 (337)
T cd07852 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFH 302 (337)
T ss_pred HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhc
Confidence 0000000111111000000 011123457899999999999999999999986 44443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=316.56 Aligned_cols=263 Identities=23% Similarity=0.379 Sum_probs=198.1
Q ss_pred CccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCch-hHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeec
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQ-GEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYV 459 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 459 (727)
+|++.++||+|+||.||+|+.. +|+.||||+++..... ....+.+|++++++++|+||++++++|.+.+..+|||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4888999999999999999975 5889999999765433 2356788999999999999999999999999999999999
Q ss_pred cCCccchhcccCC-CCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCC
Q 041135 460 PNDTLHYHLHAEG-RPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSN 538 (727)
Q Consensus 460 ~~gsL~~~L~~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 538 (727)
.+ +|.+++.... ...+++..+++++.||++||+|||++ +|+|||||++||++++++.+||+|||+++.....
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~--- 153 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIP--- 153 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC---
Confidence 75 7777765543 23589999999999999999999998 9999999999999999999999999999754211
Q ss_pred ccccccccCCccccccCcccCC-CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhh--chhhHHH
Q 041135 539 THVSTRVMGTFGYMAPEYATSG-KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEAL--EHEDFEA 615 (727)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~l~~~-~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~--~~~~~~~ 615 (727)
........++..|++||++.+. .++.++|||+|||++|||++|+.+|......+ .+.. ++.... ....+..
T Consensus 154 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~--~~~~----~~~~~~~~~~~~~~~ 227 (284)
T cd07836 154 VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED--QLLK----IFRIMGTPTESTWPG 227 (284)
T ss_pred ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH--HHHH----HHHHhCCCChhhHHH
Confidence 1112234568899999998764 57889999999999999999999997654211 1111 110000 0000000
Q ss_pred HHH-HHhh-----------cccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 616 LVD-SRLE-----------KNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 616 l~d-~~l~-----------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
+.+ ..+. ..........+.+++.+||+.||++|+++.||+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 228 ISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred HhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000 0000 00111123457899999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=309.45 Aligned_cols=250 Identities=22% Similarity=0.377 Sum_probs=203.9
Q ss_pred CccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc--hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEee
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS--QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 458 (727)
+|++.+.||+|+||.||++.+. +++.|+||++..... .....+.+|+++++.++|+||+++++.+..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4788899999999999999975 588999999975543 4556789999999999999999999999999999999999
Q ss_pred ccCCccchhcccCC--CCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccC
Q 041135 459 VPNDTLHYHLHAEG--RPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536 (727)
Q Consensus 459 ~~~gsL~~~L~~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 536 (727)
+.+++|.+++.... ...+++..++.++.+|++||+|||++ +|+||||+++||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999887643 34689999999999999999999999 99999999999999999999999999997542211
Q ss_pred CCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHH
Q 041135 537 SNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEAL 616 (727)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l 616 (727)
.......|+..|++||.+.+..++.++|||+||+++|+|++|+.||..... .+.... +
T Consensus 158 ---~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------~~~~~~-------------~ 215 (258)
T cd08215 158 ---DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL------LELALK-------------I 215 (258)
T ss_pred ---ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH------HHHHHH-------------H
Confidence 223345688899999999988899999999999999999999999965431 111110 0
Q ss_pred HHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 617 VDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 617 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
.... ...........+.+++++||..+|++||++.||+++
T Consensus 216 ~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 216 LKGQ-YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred hcCC-CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000 011111223457889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=319.85 Aligned_cols=270 Identities=20% Similarity=0.280 Sum_probs=195.0
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCch--hHHHHHHHHHHHHHcCCCCceeEeeEeeccc------
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQ--GEREFRAEVEIISRVHHRHLVSLVGYCISER------ 450 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~--~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~------ 450 (727)
.++|++.++||+|+||.||+|+.. +|+.||||++...... ....+.+|++++++++|+||++++++|....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 356999999999999999999975 5899999998654322 2345678999999999999999999987654
Q ss_pred --eeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeecc
Q 041135 451 --ERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGL 528 (727)
Q Consensus 451 --~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGl 528 (727)
..++||||+.+ +|.+++.... ..+.+.+++.++.||++||+|||++ +|+|||||++||||+.++.+||+|||+
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCC
Confidence 45999999965 6766665433 2489999999999999999999999 999999999999999999999999999
Q ss_pred chhhhccCCC-ccccccccCCccccccCcccCC-CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHH-HH
Q 041135 529 AKIALELDSN-THVSTRVMGTFGYMAPEYATSG-KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPL-LA 605 (727)
Q Consensus 529 a~~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~-~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~-l~ 605 (727)
+......... ........++..|+|||++.+. .++.++|||||||++|||++|+.+|.................. ..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 9755322211 1112334678899999998765 4788999999999999999999999765432111111110000 00
Q ss_pred Hhhch-------------hhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 606 EALEH-------------EDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 606 ~~~~~-------------~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
..+.. ......+...+... .+...+.+|+.+||..||++||+++||+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~---~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPY---VKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccc---cCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 00000 00000111111100 012346789999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=317.25 Aligned_cols=268 Identities=22% Similarity=0.316 Sum_probs=196.0
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc--hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEe
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS--QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYE 457 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 457 (727)
++|++.+.||+|+||.||+|+++ +|+.||||+++.... .....+.+|++++++++|+||+++++++.++...|+|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 56899999999999999999975 688999999864332 223568899999999999999999999999999999999
Q ss_pred eccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECC-CCcEEEEeeccchhhhccC
Q 041135 458 YVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDS-SFEARVADFGLAKIALELD 536 (727)
Q Consensus 458 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~-~~~vkL~DFGla~~~~~~~ 536 (727)
|+. ++|.+++.......+++..++.++.||+.||+|||++ +|+|||||++||||+. ++.+||+|||+++....
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~-- 155 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI-- 155 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC--
Confidence 995 5677776555444568888899999999999999999 9999999999999985 56799999999975321
Q ss_pred CCccccccccCCccccccCcccCC-CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHH---HHHhhc-hh
Q 041135 537 SNTHVSTRVMGTFGYMAPEYATSG-KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPL---LAEALE-HE 611 (727)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~l~~~-~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~---l~~~~~-~~ 611 (727)
.........++..|++||++.+. .++.++|||||||++|||++|+.+|......+ .+.+..... ....+. ..
T Consensus 156 -~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 232 (294)
T PLN00009 156 -PVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID--ELFKIFRILGTPNEETWPGVT 232 (294)
T ss_pred -CccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChhhccccc
Confidence 11112234567899999998764 57899999999999999999999997643211 111000000 000000 00
Q ss_pred hHHHHHHHHh--hc----ccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 612 DFEALVDSRL--EK----NYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 612 ~~~~l~d~~l--~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
.+........ .. .........+.+++.+||+.+|++||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred cchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000000 00 0011123347889999999999999999999975
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=313.11 Aligned_cols=248 Identities=25% Similarity=0.365 Sum_probs=196.8
Q ss_pred eccCCceEEEEEEEcC-CcEEEEEEeeeCCc---hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeeccCCcc
Q 041135 389 LGEGGFGCVYKGVLAD-GREVAVKQLKIGGS---QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPNDTL 464 (727)
Q Consensus 389 LG~G~fg~Vy~~~~~~-g~~vaVK~l~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL 464 (727)
||+|+||.||++++.+ |+.|+||++..... ...+.+.+|++++++++|+||+++++++..+...|+||||+.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999864 89999999865433 3446789999999999999999999999999999999999999999
Q ss_pred chhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCC-----c
Q 041135 465 HYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSN-----T 539 (727)
Q Consensus 465 ~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~-----~ 539 (727)
.++++..+ .+++..++.++.||++||+|||++ +|+||||+++|||+++++.+||+|||++......... .
T Consensus 81 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 81 ASLLENVG--SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 99987655 489999999999999999999999 9999999999999999999999999998754221110 1
Q ss_pred cccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHH
Q 041135 540 HVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDS 619 (727)
Q Consensus 540 ~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~ 619 (727)
.......++..|++||++.+..++.++|||+||+++|||++|+.+|..... . ++.. .+...
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~---~---~~~~-------------~~~~~ 216 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP---E---EIFQ-------------NILNG 216 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH---H---HHHH-------------HHhcC
Confidence 122345678899999999988899999999999999999999999975431 1 1110 01110
Q ss_pred HhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhh
Q 041135 620 RLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDT 660 (727)
Q Consensus 620 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 660 (727)
.+...........+.+++++||+.++++||++.+|.+.|+.
T Consensus 217 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 217 KIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred CcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 11000000013457899999999999999999766666654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=305.35 Aligned_cols=278 Identities=19% Similarity=0.263 Sum_probs=201.1
Q ss_pred hcCccccceeccCCceEEEEEEEcC-----CcEEEEEEeeeCCchh--HHHHHHHHHHHHHcCCCCceeEeeEeec-cce
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLAD-----GREVAVKQLKIGGSQG--EREFRAEVEIISRVHHRHLVSLVGYCIS-ERE 451 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~~-----g~~vaVK~l~~~~~~~--~~~~~~Ei~~l~~l~HpnIv~l~~~~~~-~~~ 451 (727)
...|+++++||+|.||.||||.-++ .+.+|||+++...... .....+|+.+++.|+|+||+.|..+|.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 3568999999999999999996432 2379999997553322 2467899999999999999999999987 778
Q ss_pred eeEEEeeccCCccchhccc---CCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCC----CcEEEE
Q 041135 452 RLLVYEYVPNDTLHYHLHA---EGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSS----FEARVA 524 (727)
Q Consensus 452 ~~lV~Ey~~~gsL~~~L~~---~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~----~~vkL~ 524 (727)
++|+|||.+...+ .+++- .....+....+..|+.||+.|+.|||++ .|+|||||+.||||..+ |.|||+
T Consensus 103 v~l~fdYAEhDL~-~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEHDLW-HIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhhhHH-HHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEee
Confidence 8999999977554 44432 1224678889999999999999999999 89999999999999776 899999
Q ss_pred eeccchhhhccCCCccccccccCCccccccCcccCC-CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCch---hhHHhh
Q 041135 525 DFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSG-KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDE---SLVEWA 600 (727)
Q Consensus 525 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~---~l~~~~ 600 (727)
||||+|.+...-..-.....++.|++|+|||.|.+. .|+.+.|||++|||+.|||+-+.-|.+.+..... ...+-+
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 999999876544444445668889999999999885 6899999999999999999988877654321111 011111
Q ss_pred HHHHHH-----------hhchhhHHHHHHHHhhcccchh-H----------HHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 041135 601 RPLLAE-----------ALEHEDFEALVDSRLEKNYVDS-E----------MFWMIEAAAACVRHSATKRPRMSQVVRAL 658 (727)
Q Consensus 601 ~~~l~~-----------~~~~~~~~~l~d~~l~~~~~~~-~----------~~~l~~li~~cl~~dP~~RPs~~evl~~L 658 (727)
.+++.- ..+-.++..++...-+..+... . ....++|+.++|..||.+|.+++|.+++.
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence 111110 0000111111111110111000 0 11167889999999999999999998875
Q ss_pred hhc
Q 041135 659 DTL 661 (727)
Q Consensus 659 ~~~ 661 (727)
-..
T Consensus 339 yF~ 341 (438)
T KOG0666|consen 339 YFT 341 (438)
T ss_pred ccc
Confidence 544
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=326.90 Aligned_cols=272 Identities=20% Similarity=0.324 Sum_probs=200.5
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeC--CchhHHHHHHHHHHHHHcCCCCceeEeeEeecc-----ce
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIG--GSQGEREFRAEVEIISRVHHRHLVSLVGYCISE-----RE 451 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~-----~~ 451 (727)
.++|++.++||+|+||.||+|+.. +|+.||||+++.. .......+.+|+.+|+.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457999999999999999999864 5899999998643 233345678899999999999999999988654 34
Q ss_pred eeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchh
Q 041135 452 RLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKI 531 (727)
Q Consensus 452 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 531 (727)
.||||||+. ++|.+++...+ .+.+..++.++.||++||.|||++ +|+|||||++|||++.++.+||+|||+++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ--TLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 799999995 67877776554 389999999999999999999999 999999999999999999999999999975
Q ss_pred hhccCCCccccccccCCccccccCcccC-CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHH-----
Q 041135 532 ALELDSNTHVSTRVMGTFGYMAPEYATS-GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLA----- 605 (727)
Q Consensus 532 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~----- 605 (727)
.... ........++..|+|||.+.+ ..++.++|||||||++|||++|+.+|...+... ........+.
T Consensus 158 ~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~ 231 (337)
T cd07858 158 TSEK---GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH---QLKLITELLGSPSEE 231 (337)
T ss_pred cCCC---cccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH---HHHHHHHHhCCCChH
Confidence 4221 122233467889999998875 468899999999999999999999997643211 0100000000
Q ss_pred --HhhchhhHHHHHHHHhhc------ccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH--HhhccC
Q 041135 606 --EALEHEDFEALVDSRLEK------NYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA--LDTLDG 663 (727)
Q Consensus 606 --~~~~~~~~~~l~d~~l~~------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~~ 663 (727)
..+........++..... .........+.+|+++||+.+|++||+++||+++ |+.+.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~ 299 (337)
T cd07858 232 DLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD 299 (337)
T ss_pred HhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence 000011111111100000 0011223457899999999999999999999988 555543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=319.08 Aligned_cols=256 Identities=25% Similarity=0.377 Sum_probs=193.9
Q ss_pred CccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcC-CCCceeEeeEeeccceeeEEEee
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS-QGEREFRAEVEIISRVH-HRHLVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~lV~Ey 458 (727)
+|...++||+|+||.||++++. +|+.||||++..... .....+.+|+.++.++. |+||+++++++.++...+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4556788999999999999865 589999999875433 34457889999999996 99999999999999999999999
Q ss_pred ccCCccch---hcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhcc
Q 041135 459 VPNDTLHY---HLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALEL 535 (727)
Q Consensus 459 ~~~gsL~~---~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 535 (727)
+.. +|.+ ++.......+.+..+.+++.++++||+|||+.. +|+|||||++|||++.++.+||+|||+++.....
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 864 4433 333333345889999999999999999999742 8999999999999999999999999999754321
Q ss_pred CCCccccccccCCccccccCcccCC---CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhh
Q 041135 536 DSNTHVSTRVMGTFGYMAPEYATSG---KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHED 612 (727)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~l~~~---~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~ 612 (727)
. ......|+..|++||++.+. .++.++|||||||++|||++|+.||.... ...+. +.+... ..
T Consensus 162 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~----~~~~~~-~~ 227 (288)
T cd06616 162 I----AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQ----LTQVVK-GD 227 (288)
T ss_pred C----ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHH----HhhhcC-CC
Confidence 1 12234678899999999876 68899999999999999999999996532 11110 000000 00
Q ss_pred HHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 613 FEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 613 ~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
...+...........+.+|+.+||+.+|++||++.+|+++-.
T Consensus 228 -----~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~ 269 (288)
T cd06616 228 -----PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPF 269 (288)
T ss_pred -----CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 001111111123445889999999999999999999988733
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=315.75 Aligned_cols=264 Identities=20% Similarity=0.248 Sum_probs=193.7
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCch--hHHHHHHHHHHHHHcC-CCCceeEeeEeeccce-----
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQ--GEREFRAEVEIISRVH-HRHLVSLVGYCISERE----- 451 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~--~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~----- 451 (727)
++|++.++||+|+||.||+|++. +|+.||||+++..... ....+.+|+.+++++. |+||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46889999999999999999975 5899999988654322 2356888999999995 6999999999987665
Q ss_pred eeEEEeeccCCccchhcccCC---CCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECC-CCcEEEEeec
Q 041135 452 RLLVYEYVPNDTLHYHLHAEG---RPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDS-SFEARVADFG 527 (727)
Q Consensus 452 ~~lV~Ey~~~gsL~~~L~~~~---~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~-~~~vkL~DFG 527 (727)
.|+||||+.+ +|.+++.... ...+++..++.++.||++||+|||++ +|+|||||++||||+. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999986 6777765432 23579999999999999999999999 9999999999999998 8899999999
Q ss_pred cchhhhccCCCccccccccCCccccccCcccC-CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHH
Q 041135 528 LAKIALELDSNTHVSTRVMGTFGYMAPEYATS-GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAE 606 (727)
Q Consensus 528 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~ 606 (727)
+++.+... ........++..|+|||++.+ ..++.++|||||||+||||++|..+|...... . ....++..
T Consensus 157 ~~~~~~~~---~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~-----~-~~~~~~~~ 227 (295)
T cd07837 157 LGRAFSIP---VKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL-----Q-QLLHIFKL 227 (295)
T ss_pred cceecCCC---ccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH-----H-HHHHHHHH
Confidence 98754211 111122356788999998865 45789999999999999999999999754321 1 11111110
Q ss_pred hhc--hhhHHHHHHHH-----------hhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 607 ALE--HEDFEALVDSR-----------LEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 607 ~~~--~~~~~~l~d~~-----------l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
... ...+....... ............+.+||.+||..||.+||+++||+.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 228 LGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000 00000000000 0000011123447889999999999999999999865
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=320.98 Aligned_cols=271 Identities=17% Similarity=0.228 Sum_probs=197.3
Q ss_pred ccccceeccCCceEEEEEEEcCCcEEEEEEeeeC--CchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeecc
Q 041135 383 FSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIG--GSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVP 460 (727)
Q Consensus 383 ~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 460 (727)
+.+.+.+|.|+++.||+++. +|+.||||+++.. .....+.+.+|+++|+.++|+||+++++++.+++..+++|||+.
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82 (314)
T ss_pred hhhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence 34455566677777777665 6899999999754 23445679999999999999999999999999999999999999
Q ss_pred CCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCC--
Q 041135 461 NDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSN-- 538 (727)
Q Consensus 461 ~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~-- 538 (727)
+++|.+++.......+.+..+..++.||++||+|||++ +|+|||||++||||+.++.+||+|||++.........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 83 YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 99999999876555688999999999999999999999 9999999999999999999999999988654322111
Q ss_pred --ccccccccCCccccccCcccCC--CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHH
Q 041135 539 --THVSTRVMGTFGYMAPEYATSG--KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFE 614 (727)
Q Consensus 539 --~~~~~~~~gt~~y~aPE~l~~~--~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~ 614 (727)
........++..|+|||++.+. .++.++|||||||++|||++|+.||...... ..+.+.........+....+.
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 237 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT--QMLLEKVRGTVPCLLDKSTYP 237 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhccCccccccCchh
Confidence 1111234567789999998763 5788999999999999999999999754321 111111100000000000000
Q ss_pred H---------------HHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 615 A---------------LVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 615 ~---------------l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
. .........+.......+.+|+++||..||++||+++||+++-.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~ 297 (314)
T cd08216 238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSF 297 (314)
T ss_pred hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCch
Confidence 0 00000011111122335778999999999999999999998744
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=315.92 Aligned_cols=267 Identities=22% Similarity=0.294 Sum_probs=196.8
Q ss_pred ccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcC-CCCceeEeeEeeccceeeEEEeec
Q 041135 383 FSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS-QGEREFRAEVEIISRVH-HRHLVSLVGYCISERERLLVYEYV 459 (727)
Q Consensus 383 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~lV~Ey~ 459 (727)
|++.+.||+|+||.||+|+.. +++.|+||+++.... .......+|+..+++++ |+||++++++|.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 677899999999999999986 478899999864432 22334567999999999 999999999999999999999999
Q ss_pred cCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCc
Q 041135 460 PNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNT 539 (727)
Q Consensus 460 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 539 (727)
+|+|.+++.......+.+..++.++.||+++|.|||++ +|+|+|||++||+|++++.+||+|||++......
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~---- 152 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR---- 152 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCC----
Confidence 88898888776545689999999999999999999998 9999999999999999999999999999754221
Q ss_pred cccccccCCccccccCcccC-CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchh-hHHhhHHHHHHhh-chhhHHHH
Q 041135 540 HVSTRVMGTFGYMAPEYATS-GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDES-LVEWARPLLAEAL-EHEDFEAL 616 (727)
Q Consensus 540 ~~~~~~~gt~~y~aPE~l~~-~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~-l~~~~~~~l~~~~-~~~~~~~l 616 (727)
.......++..|+|||++.+ ..++.++||||||+++|||++|+.+|.......... ...+........+ ....+...
T Consensus 153 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 153 PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred CCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 11223457889999998854 457899999999999999999999996553211100 0000000000000 00000000
Q ss_pred HHHHhh-------cccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 617 VDSRLE-------KNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 617 ~d~~l~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
++..+. ..........+.+++++||+.+|++||+++||+.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 000000 00011113458899999999999999999999865
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=313.75 Aligned_cols=244 Identities=25% Similarity=0.326 Sum_probs=187.6
Q ss_pred eeccCCceEEEEEEEc-CCcEEEEEEeeeCCc---hhHHHHHHHHHHHHH---cCCCCceeEeeEeeccceeeEEEeecc
Q 041135 388 VLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS---QGEREFRAEVEIISR---VHHRHLVSLVGYCISERERLLVYEYVP 460 (727)
Q Consensus 388 ~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~---~~~~~~~~Ei~~l~~---l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 460 (727)
+||+|+||.||+++.. +|+.||||.+..... .....+.+|..+++. .+|+||+.+++++..++..++||||+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999975 588999998864322 222334455544444 369999999999999999999999999
Q ss_pred CCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCcc
Q 041135 461 NDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTH 540 (727)
Q Consensus 461 ~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 540 (727)
+++|.+++..++. +.+..+..|+.||+.||+|||++ +|+|||||++|||+++++.+||+|||++......
T Consensus 81 ~~~L~~~i~~~~~--l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~----- 150 (279)
T cd05633 81 GGDLHYHLSQHGV--FSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----- 150 (279)
T ss_pred CCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceecccc-----
Confidence 9999998876544 89999999999999999999999 9999999999999999999999999998743211
Q ss_pred ccccccCCccccccCcccC-CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHH
Q 041135 541 VSTRVMGTFGYMAPEYATS-GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDS 619 (727)
Q Consensus 541 ~~~~~~gt~~y~aPE~l~~-~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~ 619 (727)
......|+..|+|||.+.+ ..++.++|||||||+||||++|+.||..........+.+ .. .
T Consensus 151 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~----~~--------------~ 212 (279)
T cd05633 151 KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR----MT--------------L 212 (279)
T ss_pred CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHH----Hh--------------h
Confidence 1223468999999999874 568899999999999999999999997643221111000 00 0
Q ss_pred HhhcccchhHHHHHHHHHHHHhccCCCCCC-----CHHHHHHHHh
Q 041135 620 RLEKNYVDSEMFWMIEAAAACVRHSATKRP-----RMSQVVRALD 659 (727)
Q Consensus 620 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L~ 659 (727)
.............+.+++++||+.||++|+ +++||+++..
T Consensus 213 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~ 257 (279)
T cd05633 213 TVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVF 257 (279)
T ss_pred cCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCcc
Confidence 011111122234577899999999999999 5999888743
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=324.93 Aligned_cols=271 Identities=23% Similarity=0.326 Sum_probs=203.0
Q ss_pred CccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC--chhHHHHHHHHHHHHHcCCCCceeEeeEeeccc-----eee
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG--SQGEREFRAEVEIISRVHHRHLVSLVGYCISER-----ERL 453 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~-----~~~ 453 (727)
+|++.+.||+|+||.||+|+.. +|+.|+||++.... ....+.+.+|+++|+.++|+||+++++++.... ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4888999999999999999975 48999999987543 334567999999999999999999999998775 789
Q ss_pred EEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhh
Q 041135 454 LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIAL 533 (727)
Q Consensus 454 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~ 533 (727)
+||||+. ++|.++++... .+++..++.++.||++||+|||++ +|+|||||++||||+.++.+||+|||++....
T Consensus 81 lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred EEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 9999997 57888886654 589999999999999999999999 99999999999999999999999999998643
Q ss_pred ccCCCccccccccCCccccccCcccCC-CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHH----Hh-
Q 041135 534 ELDSNTHVSTRVMGTFGYMAPEYATSG-KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLA----EA- 607 (727)
Q Consensus 534 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~----~~- 607 (727)
.............++..|++||++.+. .++.++|||||||++|+|++|+.+|...... ...+.....+. +.
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~ 231 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI---DQLNLIVEVLGTPSEEDL 231 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH---HHHHHHHHhcCCCChhHh
Confidence 222111123345678899999999887 7899999999999999999999999765421 11110000000 00
Q ss_pred --hchhhHHHHHHHHhhc-c-----cchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH--Hhhc
Q 041135 608 --LEHEDFEALVDSRLEK-N-----YVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA--LDTL 661 (727)
Q Consensus 608 --~~~~~~~~l~d~~l~~-~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~ 661 (727)
.........+...... . ........+.+++++||+.+|++||++.+|+++ |+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 0001111111100000 0 011123457899999999999999999999987 4444
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=313.39 Aligned_cols=245 Identities=29% Similarity=0.391 Sum_probs=193.6
Q ss_pred eccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeeccCCcc
Q 041135 389 LGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPNDTL 464 (727)
Q Consensus 389 LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL 464 (727)
||+|+||.||++... +|+.|+||++.... ....+.+.+|+++|++++|+||+++++++...+..|+||||+.+++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999864 58899999986432 22344677899999999999999999999999999999999999999
Q ss_pred chhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCcccccc
Q 041135 465 HYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTR 544 (727)
Q Consensus 465 ~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 544 (727)
.+++.......+.+.+++.++.||++||.|||++ +|+||||+++||||++++.+||+|||+++.... ......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~----~~~~~~ 153 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKG----GKKIKG 153 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhcc----CCcccc
Confidence 9998776655689999999999999999999999 999999999999999999999999999875422 111223
Q ss_pred ccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHhhcc
Q 041135 545 VMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRLEKN 624 (727)
Q Consensus 545 ~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~ 624 (727)
..++..|++||++.++.++.++|||+|||++|+|++|+.||.......... + +.... .. ....
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~-----~~~~~--------~~--~~~~ 216 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE--E-----LKRRT--------LE--MAVE 216 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH--H-----HHhcc--------cc--cccc
Confidence 457789999999998889999999999999999999999997654311110 0 00000 00 0011
Q ss_pred cchhHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 041135 625 YVDSEMFWMIEAAAACVRHSATKRP-----RMSQVVRA 657 (727)
Q Consensus 625 ~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 657 (727)
+.......+.+++++||+.+|++|+ ++.+|+++
T Consensus 217 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 217 YPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred CCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence 1112234578999999999999999 66666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=305.63 Aligned_cols=248 Identities=26% Similarity=0.439 Sum_probs=201.9
Q ss_pred CccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc--hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEee
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS--QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 458 (727)
+|++.+.||+|+||.||+++.. +++.|+||.+..... .....+.+|++++++++|+||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4788899999999999999865 578999999976544 3456799999999999999999999999999999999999
Q ss_pred ccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCC
Q 041135 459 VPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSN 538 (727)
Q Consensus 459 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 538 (727)
+.+++|.+++.... .+++..++.++.|++.||.|||++ +|+|||||++||+|+.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~-- 153 (254)
T cd06627 81 AENGSLRQIIKKFG--PFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS-- 153 (254)
T ss_pred CCCCcHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc--
Confidence 99999999987664 489999999999999999999999 99999999999999999999999999998653221
Q ss_pred ccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHH
Q 041135 539 THVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVD 618 (727)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d 618 (727)
.......++..|++||.+.+..++.++|||+||+++|+|++|+.||..... ..... . ..
T Consensus 154 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-----~~~~~----~----------~~- 212 (254)
T cd06627 154 -KDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-----MAALF----R----------IV- 212 (254)
T ss_pred -ccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-----HHHHH----H----------Hh-
Confidence 112345678899999999888889999999999999999999999975331 00000 0 00
Q ss_pred HHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 619 SRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 619 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
..............+.+++.+||..+|++||++.+++..
T Consensus 213 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 213 QDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred ccCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 000111112223457789999999999999999999853
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=308.01 Aligned_cols=248 Identities=25% Similarity=0.378 Sum_probs=200.8
Q ss_pred CccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC--chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEee
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG--SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 458 (727)
+|++.++||+|+||.||+++.. +|+.++||++.... .....++.+|++++++++|+||+++++++.++...++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4788999999999999999864 67899999987533 23345788999999999999999999999999999999999
Q ss_pred ccCCccchhcccC--CCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccC
Q 041135 459 VPNDTLHYHLHAE--GRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536 (727)
Q Consensus 459 ~~~gsL~~~L~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 536 (727)
+.+++|.+++... ....+++..++.++.||++||+|||++ +|+||||+++||++++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 9999999988652 224589999999999999999999999 9999999999999999999999999999765322
Q ss_pred CCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHH
Q 041135 537 SNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEAL 616 (727)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l 616 (727)
......++..|++||.+.+..++.++||||||+++|||++|+.||...+. ..+.. ......
T Consensus 157 ----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~--------~~~~~~---- 217 (256)
T cd08530 157 ----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM---QDLRY--------KVQRGK---- 217 (256)
T ss_pred ----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHH--------HHhcCC----
Confidence 22234578899999999998999999999999999999999999975431 10000 000000
Q ss_pred HHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 617 VDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 617 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
...........+.+++++||..++++||++.||+++
T Consensus 218 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 218 -----YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred -----CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 011111233458899999999999999999999865
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=309.66 Aligned_cols=243 Identities=26% Similarity=0.311 Sum_probs=196.2
Q ss_pred eccCCceEEEEEEEc-CCcEEEEEEeeeCCc---hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeeccCCcc
Q 041135 389 LGEGGFGCVYKGVLA-DGREVAVKQLKIGGS---QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPNDTL 464 (727)
Q Consensus 389 LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL 464 (727)
||+|+||.||+|+.. +++.|+||++..... ...+.+.+|++++++++|+||+++++++.++...++||||+.+++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 799999999999975 488999999864332 3346799999999999999999999999999999999999999999
Q ss_pred chhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCcccccc
Q 041135 465 HYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTR 544 (727)
Q Consensus 465 ~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 544 (727)
.+++.+... +.+..++.++.||++||+|||++ +++|+|||++||+|+.++.+||+|||+++...... ....
T Consensus 81 ~~~l~~~~~--l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~----~~~~ 151 (262)
T cd05572 81 WTILRDRGL--FDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ----KTWT 151 (262)
T ss_pred HHHHhhcCC--CCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc----cccc
Confidence 999977543 88999999999999999999998 99999999999999999999999999998543211 2223
Q ss_pred ccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHhhcc
Q 041135 545 VMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRLEKN 624 (727)
Q Consensus 545 ~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~ 624 (727)
..++..|++||++.+..++.++|||+|||+||||++|+.||...... ..++. ..+.+......
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~-------------~~~~~~~~~~~ 214 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED----PMEIY-------------NDILKGNGKLE 214 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC----HHHHH-------------HHHhccCCCCC
Confidence 46788999999998888999999999999999999999999764320 01111 11111111112
Q ss_pred cchhHHHHHHHHHHHHhccCCCCCCC-----HHHHHHH
Q 041135 625 YVDSEMFWMIEAAAACVRHSATKRPR-----MSQVVRA 657 (727)
Q Consensus 625 ~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 657 (727)
+.......+.+++++||+.+|++|++ ++|++++
T Consensus 215 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~ 252 (262)
T cd05572 215 FPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH 252 (262)
T ss_pred CCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence 22222456889999999999999999 7777764
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=312.01 Aligned_cols=260 Identities=19% Similarity=0.227 Sum_probs=192.2
Q ss_pred ccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC-chhHHHHHHHHHHHHHcC-CCCceeEeeEeecc--ceeeEEEe
Q 041135 383 FSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG-SQGEREFRAEVEIISRVH-HRHLVSLVGYCISE--RERLLVYE 457 (727)
Q Consensus 383 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~--~~~~lV~E 457 (727)
|++.++||+|+||.||+|+.. +++.||||+++... ........+|+.+|+++. |+||++++++|.++ +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 677899999999999999864 58899999987532 222334567999999885 99999999999987 88999999
Q ss_pred eccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCC
Q 041135 458 YVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDS 537 (727)
Q Consensus 458 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 537 (727)
|+.+ +|.+++.... ..+++.+++.++.||++||+|||++ +|+|||||++||+|+. +.+||+|||+++.....
T Consensus 81 ~~~~-~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~-- 152 (282)
T cd07831 81 LMDM-NLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSK-- 152 (282)
T ss_pred cCCc-cHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccC--
Confidence 9964 6666665433 2589999999999999999999999 9999999999999999 99999999999754221
Q ss_pred CccccccccCCccccccCcccC-CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHH
Q 041135 538 NTHVSTRVMGTFGYMAPEYATS-GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEAL 616 (727)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l 616 (727)
.......++..|+|||++.+ +.++.++|||||||+||||++|+.+|...+. ...+.+....+... ...+...
T Consensus 153 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~---~~~~~~~~~~~~~~--~~~~~~~ 225 (282)
T cd07831 153 --PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE---LDQIAKIHDVLGTP--DAEVLKK 225 (282)
T ss_pred --CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH---HHHHHHHHHHcCCC--CHHHHHh
Confidence 11123457889999998754 5578899999999999999999999976432 11122211111000 0000000
Q ss_pred HHHHhhcc-------------cchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 617 VDSRLEKN-------------YVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 617 ~d~~l~~~-------------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
+...-... ........+.+|+++||+.+|++||++.+|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 226 FRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred hcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00000000 011224568899999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=311.36 Aligned_cols=261 Identities=26% Similarity=0.342 Sum_probs=195.7
Q ss_pred ccccceeccCCceEEEEEEEcC-CcEEEEEEeeeCCch--hHHHHHHHHHHHHHc---CCCCceeEeeEeeccce-----
Q 041135 383 FSAHNVLGEGGFGCVYKGVLAD-GREVAVKQLKIGGSQ--GEREFRAEVEIISRV---HHRHLVSLVGYCISERE----- 451 (727)
Q Consensus 383 ~~~~~~LG~G~fg~Vy~~~~~~-g~~vaVK~l~~~~~~--~~~~~~~Ei~~l~~l---~HpnIv~l~~~~~~~~~----- 451 (727)
|++.++||+|+||.||+|++++ |+.||||+++..... ....+.+|+++++++ +|+||++++++|.+.+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 6778999999999999999864 899999999744322 234577788888766 59999999999988776
Q ss_pred eeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchh
Q 041135 452 RLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKI 531 (727)
Q Consensus 452 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 531 (727)
.+++|||+.+ +|.+++.......+++..++.++.||++||.|||++ +|+|||||++|||+++++.+||+|||++..
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCccee
Confidence 8999999964 788887665444689999999999999999999999 999999999999999999999999999975
Q ss_pred hhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchh
Q 041135 532 ALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHE 611 (727)
Q Consensus 532 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~ 611 (727)
.... .......++..|++||++.+..++.++|||||||++|||++|+.+|...... +....++.......
T Consensus 157 ~~~~----~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~------~~~~~~~~~~~~~~ 226 (287)
T cd07838 157 YSFE----MALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA------DQLDKIFDVIGLPS 226 (287)
T ss_pred ccCC----cccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH------HHHHHHHHHcCCCC
Confidence 4211 1122345788999999999999999999999999999999999998754321 11111111100000
Q ss_pred hHH---------HHHHHHhh---cccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 612 DFE---------ALVDSRLE---KNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 612 ~~~---------~l~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
... ........ ..........+.+++++||+.||++||++.||+.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 227 EEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred hHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 000 00000000 00011223457789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=306.76 Aligned_cols=269 Identities=23% Similarity=0.385 Sum_probs=207.2
Q ss_pred cHHHHHHHhcCccccceeccCCceEEEEEE-EcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcC-CCCceeEeeEeecc
Q 041135 372 TYDELIQATNGFSAHNVLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGEREFRAEVEIISRVH-HRHLVSLVGYCISE 449 (727)
Q Consensus 372 ~~~el~~~~~~~~~~~~LG~G~fg~Vy~~~-~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~ 449 (727)
+++++.+.++ ++||+|+|+.|--++ +.+|.+||||++..........+.+|++++.+.+ |+||++|++||+++
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 4677766665 779999999998887 6689999999998766666778999999999996 99999999999999
Q ss_pred ceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCC---cEEEEee
Q 041135 450 RERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSF---EARVADF 526 (727)
Q Consensus 450 ~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~---~vkL~DF 526 (727)
..+|||||.|.||.|..+++++.. +++.+..+++++|+.||+|||.+ ||.|||||++|||-.+-. -||||||
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~~~--F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDf 223 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKRKH--FNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDF 223 (463)
T ss_pred ceEEEEEecccCchHHHHHHHhhh--ccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeecc
Confidence 999999999999999999987654 99999999999999999999999 999999999999996543 4899999
Q ss_pred ccchhhhccCC----CccccccccCCccccccCccc-----CCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhH
Q 041135 527 GLAKIALELDS----NTHVSTRVMGTFGYMAPEYAT-----SGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLV 597 (727)
Q Consensus 527 Gla~~~~~~~~----~~~~~~~~~gt~~y~aPE~l~-----~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~ 597 (727)
.|..-...... .+.....-+|...|||||+.. ...|+.+.|.||||||||.||+|..||.+.-..+ +
T Consensus 224 DLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~d----C 299 (463)
T KOG0607|consen 224 DLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGAD----C 299 (463)
T ss_pred ccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCc----C
Confidence 99864321111 111223457899999999874 2468999999999999999999999998754321 2
Q ss_pred HhhHHHHHHhhchhhHHHHHHHHhhcccc--hhH----HHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 041135 598 EWARPLLAEALEHEDFEALVDSRLEKNYV--DSE----MFWMIEAAAACVRHSATKRPRMSQVVRAL 658 (727)
Q Consensus 598 ~~~~~~l~~~~~~~~~~~l~d~~l~~~~~--~~~----~~~l~~li~~cl~~dP~~RPs~~evl~~L 658 (727)
-|-++-.........|+.+ -++.|. +++ .....+++...|..|+.+|-++.+++++-
T Consensus 300 GWdrGe~Cr~CQ~~LFesI----QEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhP 362 (463)
T KOG0607|consen 300 GWDRGEVCRVCQNKLFESI----QEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHP 362 (463)
T ss_pred CccCCCccHHHHHHHHHHH----hccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCc
Confidence 2332222111112222222 233332 222 22356788889999999999999998853
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=322.50 Aligned_cols=268 Identities=19% Similarity=0.267 Sum_probs=195.0
Q ss_pred ceeccC--CceEEEEEEEc-CCcEEEEEEeeeCCc--hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeeccC
Q 041135 387 NVLGEG--GFGCVYKGVLA-DGREVAVKQLKIGGS--QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPN 461 (727)
Q Consensus 387 ~~LG~G--~fg~Vy~~~~~-~g~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 461 (727)
..||+| +||.||++++. +|+.||||+++.... ...+.+++|+.+++.++|+||++++++|..++..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 99999999974 689999999875432 2235788999999999999999999999999999999999999
Q ss_pred CccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCccc
Q 041135 462 DTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHV 541 (727)
Q Consensus 462 gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 541 (727)
++|.+++.......+.+..++.++.||++||+|||++ +|+|||||++||||+.++.+||+||+.+............
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 9999998876555688999999999999999999998 9999999999999999999999999876433211111100
Q ss_pred ----cccccCCccccccCcccCC--CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHH---------HH--
Q 041135 542 ----STRVMGTFGYMAPEYATSG--KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARP---------LL-- 604 (727)
Q Consensus 542 ----~~~~~gt~~y~aPE~l~~~--~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~---------~l-- 604 (727)
.....++..|++||++.++ .++.++|||||||+||||++|+.||...... ..+.+.... .+
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT--QMLLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH--HHHHHHhcCCCCCCccccccch
Confidence 1112345679999999764 4789999999999999999999999764321 111110000 00
Q ss_pred -HHhhch--hhHH--------------HHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 605 -AEALEH--EDFE--------------ALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 605 -~~~~~~--~~~~--------------~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
...... ..+. .+.+..+...........+.+|+++||+.||++||+++||+++-.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~ 310 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAF 310 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHH
Confidence 000000 0000 000001111111223445889999999999999999999987754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=313.50 Aligned_cols=252 Identities=27% Similarity=0.360 Sum_probs=196.0
Q ss_pred CccccceeccCCceEEEEEEE----cCCcEEEEEEeeeCC----chhHHHHHHHHHHHHHc-CCCCceeEeeEeecccee
Q 041135 382 GFSAHNVLGEGGFGCVYKGVL----ADGREVAVKQLKIGG----SQGEREFRAEVEIISRV-HHRHLVSLVGYCISERER 452 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~----~~g~~vaVK~l~~~~----~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~ 452 (727)
+|++.+.||+|+||.||+++. .+|+.||+|+++... ....+.+.+|+++|+++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478889999999999999986 368899999987432 22345688999999999 599999999999999999
Q ss_pred eEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhh
Q 041135 453 LLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIA 532 (727)
Q Consensus 453 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~ 532 (727)
++||||+.+++|.+++..+.. +.+..+..++.||++||.|||++ +|+|||||++||||++++.+||+|||+++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 81 HLILDYINGGELFTHLSQRER--FKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 999999999999999876543 78889999999999999999998 9999999999999999999999999999754
Q ss_pred hccCCCccccccccCCccccccCcccCC--CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhch
Q 041135 533 LELDSNTHVSTRVMGTFGYMAPEYATSG--KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEH 610 (727)
Q Consensus 533 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~ 610 (727)
.... ........|+..|++||++.+. .++.++|||+|||+||||++|+.||...... ....++...+.
T Consensus 156 ~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~------ 225 (290)
T cd05613 156 HEDE--VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK--NSQAEISRRIL------ 225 (290)
T ss_pred cccc--ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc--ccHHHHHHHhh------
Confidence 2211 1112235688899999998763 4678999999999999999999999643211 11111111100
Q ss_pred hhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 041135 611 EDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRP-----RMSQVVRA 657 (727)
Q Consensus 611 ~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 657 (727)
. ....+.......+.+|+++||+.||++|+ ++++++.+
T Consensus 226 -------~--~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 226 -------K--SEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred -------c--cCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 0 00112222334578899999999999997 66776654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=323.70 Aligned_cols=273 Identities=18% Similarity=0.293 Sum_probs=201.6
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC--chhHHHHHHHHHHHHHcCCCCceeEeeEeec----ccee
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG--SQGEREFRAEVEIISRVHHRHLVSLVGYCIS----ERER 452 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~----~~~~ 452 (727)
.++|++.+.||+|+||.||+|+.+ +|+.||||++.... ......+.+|+.+|++++|+||++++++|.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 367899999999999999999865 58999999987532 2334567889999999999999999998763 3467
Q ss_pred eEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhh
Q 041135 453 LLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIA 532 (727)
Q Consensus 453 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~ 532 (727)
++||||+. ++|.+++..... +++..++.++.||++||.|||++ +|+|||||++|||+++++.+||+|||+++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQP--LTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEEehhh-hhHHHHhccCCC--CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceee
Confidence 99999995 688888876544 89999999999999999999998 9999999999999999999999999999754
Q ss_pred hccCC-CccccccccCCccccccCcccC-CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHH------
Q 041135 533 LELDS-NTHVSTRVMGTFGYMAPEYATS-GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLL------ 604 (727)
Q Consensus 533 ~~~~~-~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l------ 604 (727)
..... .........|+..|++||++.+ ..++.++|||||||++|||++|+.+|....... ........+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~---~~~~~~~~~g~~~~~ 234 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH---QLKLILSVLGSPSEE 234 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH---HHHHHHHHhCCChhH
Confidence 22111 1112234578899999999866 468899999999999999999999997643211 111100000
Q ss_pred -HHhhchhhHHHHHHHHhh-ccc-----chhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhc
Q 041135 605 -AEALEHEDFEALVDSRLE-KNY-----VDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661 (727)
Q Consensus 605 -~~~~~~~~~~~l~d~~l~-~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 661 (727)
........+...++..-. ... .......+.+++++||+.+|++||++.+|+.+.+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~ 298 (334)
T cd07855 235 VLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLA 298 (334)
T ss_pred hhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhh
Confidence 000001111111111000 000 111245688999999999999999999999875543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=348.98 Aligned_cols=253 Identities=29% Similarity=0.450 Sum_probs=193.2
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC-chhHHHHHHHHHHHHHcCCCCceeEeeEeec---------
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG-SQGEREFRAEVEIISRVHHRHLVSLVGYCIS--------- 448 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~--------- 448 (727)
.++|+.+++||+||||.|||++.+ ||+.||||+|.... .+....+.+|+++|++|+|+|||+++..|.+
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 456788899999999999999965 89999999998664 2334678999999999999999998842200
Q ss_pred --------------------------------------------------------------------------------
Q 041135 449 -------------------------------------------------------------------------------- 448 (727)
Q Consensus 449 -------------------------------------------------------------------------------- 448 (727)
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence
Q ss_pred ----------------------c--------ceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhc
Q 041135 449 ----------------------E--------RERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHED 498 (727)
Q Consensus 449 ----------------------~--------~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~ 498 (727)
+ ..+||=||||+..+|+++++++.... .....++++++|++||.|+|++
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH~~ 716 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIHDQ 716 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHHhC
Confidence 0 13478899999999999988765311 4678899999999999999999
Q ss_pred CCCcEEeeCCCCCceEECCCCcEEEEeeccchhhh------cc---------CCCccccccccCCccccccCcccCC---
Q 041135 499 CHPRIIHRDIKSSNILLDSSFEARVADFGLAKIAL------EL---------DSNTHVSTRVMGTFGYMAPEYATSG--- 560 (727)
Q Consensus 499 ~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~------~~---------~~~~~~~~~~~gt~~y~aPE~l~~~--- 560 (727)
|||||||||.||+||+++.|||+|||+|.... +. .......+..+||..|+|||++.+.
T Consensus 717 ---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~ 793 (1351)
T KOG1035|consen 717 ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN 793 (1351)
T ss_pred ---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence 99999999999999999999999999998621 00 1112234567899999999999765
Q ss_pred CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHhhc--ccchhHHHHHHHHHH
Q 041135 561 KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRLEK--NYVDSEMFWMIEAAA 638 (727)
Q Consensus 561 ~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l~~--~~~~~~~~~l~~li~ 638 (727)
.|+.|.|+|||||||+||+. ||... ++.... +..+.++.+.. .|...+...-..+|+
T Consensus 794 ~Yn~KiDmYSLGIVlFEM~y---PF~Ts--MERa~i----------------L~~LR~g~iP~~~~f~~~~~~~e~slI~ 852 (1351)
T KOG1035|consen 794 KYNSKIDMYSLGIVLFEMLY---PFGTS--MERASI----------------LTNLRKGSIPEPADFFDPEHPEEASLIR 852 (1351)
T ss_pred cccchhhhHHHHHHHHHHhc---cCCch--HHHHHH----------------HHhcccCCCCCCcccccccchHHHHHHH
Confidence 49999999999999999984 45432 111111 11122222222 233334445568999
Q ss_pred HHhccCCCCCCCHHHHHHH
Q 041135 639 ACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 639 ~cl~~dP~~RPs~~evl~~ 657 (727)
+++++||.+||++.|||+.
T Consensus 853 ~Ll~hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 853 WLLSHDPSKRPTATELLNS 871 (1351)
T ss_pred HHhcCCCccCCCHHHHhhc
Confidence 9999999999999999875
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=314.44 Aligned_cols=267 Identities=24% Similarity=0.308 Sum_probs=197.0
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchh--HHHHHHHHHHHHHcCCCCceeEeeEeecc--ceeeE
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQG--EREFRAEVEIISRVHHRHLVSLVGYCISE--RERLL 454 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~--~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~--~~~~l 454 (727)
.++|++.++||+|+||.||+|+++ +|+.||||+++...... ...+.+|+++|++++|+||+++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 356899999999999999999975 58999999997543322 23567899999999999999999998765 46799
Q ss_pred EEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhc
Q 041135 455 VYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALE 534 (727)
Q Consensus 455 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 534 (727)
||||+.+ +|.+++.... ..+.+.+++.++.||++||+|||++ +|+|||||++|||+++++.+||+|||+++....
T Consensus 86 v~e~~~~-~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEecCCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 9999965 6777765432 3589999999999999999999999 999999999999999999999999999976432
Q ss_pred cCCCccccccccCCccccccCcccC-CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhch---
Q 041135 535 LDSNTHVSTRVMGTFGYMAPEYATS-GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEH--- 610 (727)
Q Consensus 535 ~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~--- 610 (727)
.. .......++..|+|||++.+ ..++.++|||||||++|||++|+.+|...... ... ..+.. .+..
T Consensus 161 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~---~~~---~~~~~-~~~~~~~ 230 (309)
T cd07845 161 PA---KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI---EQL---DLIIQ-LLGTPNE 230 (309)
T ss_pred cc---CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHH---HHHHH-hcCCCCh
Confidence 11 11223345778999999876 45789999999999999999999999754321 111 11110 0000
Q ss_pred hhHHHHHH------HHhhcc-c------chhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhc
Q 041135 611 EDFEALVD------SRLEKN-Y------VDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661 (727)
Q Consensus 611 ~~~~~l~d------~~l~~~-~------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 661 (727)
..+..+.+ -.+... + .......+.+||.+||+.||++||++.||+++-+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~ 294 (309)
T cd07845 231 SIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK 294 (309)
T ss_pred hhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhc
Confidence 00000000 000000 0 000123467899999999999999999999875543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=314.51 Aligned_cols=245 Identities=22% Similarity=0.349 Sum_probs=196.6
Q ss_pred cceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeeccCCcc
Q 041135 386 HNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPNDTL 464 (727)
Q Consensus 386 ~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL 464 (727)
..+||+|+||.||+++.+ +|+.||||++..........+.+|+.+++.++|+||++++++|..++..++||||+.+++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 367999999999999874 6899999998765555566799999999999999999999999999999999999999999
Q ss_pred chhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCcccccc
Q 041135 465 HYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTR 544 (727)
Q Consensus 465 ~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 544 (727)
.+++... .+++..++.++.||+.||+|||++ +|+|||||++||+|++++.++|+|||++...... ......
T Consensus 105 ~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~---~~~~~~ 175 (292)
T cd06657 105 TDIVTHT---RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE---VPRRKS 175 (292)
T ss_pred HHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccc---cccccc
Confidence 9887543 378899999999999999999999 9999999999999999999999999998754221 111233
Q ss_pred ccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHhhcc
Q 041135 545 VMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRLEKN 624 (727)
Q Consensus 545 ~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~ 624 (727)
..|+..|++||++.+..++.++|||||||++|||++|+.||...... ..... +... +...+.
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~---~~~~~----~~~~---------~~~~~~-- 237 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKM----IRDN---------LPPKLK-- 237 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHH----HHhh---------CCcccC--
Confidence 56788999999998888999999999999999999999999753211 11110 0000 000000
Q ss_pred cchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 625 YVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 625 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
........+.+++.+||+.+|.+|+++.+|+++
T Consensus 238 ~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 238 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred CcccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 011123347788999999999999999999885
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=329.47 Aligned_cols=246 Identities=25% Similarity=0.400 Sum_probs=201.1
Q ss_pred eeccCCceEEEEEEEcC-CcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeeccCCccch
Q 041135 388 VLGEGGFGCVYKGVLAD-GREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPNDTLHY 466 (727)
Q Consensus 388 ~LG~G~fg~Vy~~~~~~-g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~ 466 (727)
+||+|.||+||-|++.+ ...+|||.+...+.+..+-+..||.+.++|+|.|||+++|.|.+++.+-|.||.+.||+|..
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 69999999999999754 56799999988888888889999999999999999999999999999999999999999999
Q ss_pred hcccC-CCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEEC-CCCcEEEEeeccchhhhccCCCcccccc
Q 041135 467 HLHAE-GRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLD-SSFEARVADFGLAKIALELDSNTHVSTR 544 (727)
Q Consensus 467 ~L~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~-~~~~vkL~DFGla~~~~~~~~~~~~~~~ 544 (727)
+|+.+ +...-++..+-.+.+||++||.|||++ .|||||||-+||||+ -.|.+||+|||-++.+.. -......
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg---inP~TET 735 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG---INPCTET 735 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhcc---CCccccc
Confidence 99765 332347788889999999999999999 999999999999996 578999999999987532 2334456
Q ss_pred ccCCccccccCcccCC--CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHhh
Q 041135 545 VMGTFGYMAPEYATSG--KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRLE 622 (727)
Q Consensus 545 ~~gt~~y~aPE~l~~~--~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l~ 622 (727)
+.||+.|||||++..+ .|..++|||||||.+.||.||+.||-....... + .++-+-+ +..
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA------A------MFkVGmy------KvH 797 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA------A------MFKVGMY------KVH 797 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH------h------hhhhcce------ecC
Confidence 7899999999999875 589999999999999999999999975432110 0 0000000 111
Q ss_pred cccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 623 KNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 623 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
.....+.......+|++|+..|+.+||++.+++.-
T Consensus 798 P~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 798 PPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred CCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 22334445567789999999999999999999864
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=314.37 Aligned_cols=268 Identities=25% Similarity=0.346 Sum_probs=196.7
Q ss_pred HHhcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc--hhHHHHHHHHHHHHHcCCCCceeEeeEeeccc----
Q 041135 378 QATNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS--QGEREFRAEVEIISRVHHRHLVSLVGYCISER---- 450 (727)
Q Consensus 378 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~---- 450 (727)
...++|++.++||+|+||.||+|+++ +|+.||||+++.... .....+.+|++++++++|+||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34567999999999999999999976 588999999975432 22356788999999999999999999987654
Q ss_pred ------eeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEE
Q 041135 451 ------ERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVA 524 (727)
Q Consensus 451 ------~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~ 524 (727)
..+|||||+.+ .|..++... ...+++..++.|+.||+.||+|||++ +|+|||||++||+|++++.+||+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeC
Confidence 78999999976 555555543 23589999999999999999999999 99999999999999999999999
Q ss_pred eeccchhhhccCCCccccccccCCccccccCcccCC-CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHH
Q 041135 525 DFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSG-KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPL 603 (727)
Q Consensus 525 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~ 603 (727)
|||++........ .......++..|++||++.+. .++.++|||+|||++|||++|+.+|...... ..+ +.....
T Consensus 159 dfg~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~--~~~-~~~~~~ 233 (302)
T cd07864 159 DFGLARLYNSEES--RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL--AQL-ELISRL 233 (302)
T ss_pred cccccccccCCcc--cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH--HHH-HHHHHH
Confidence 9999976532221 112233567789999988654 5788999999999999999999999754321 111 111000
Q ss_pred HHHhhchhhHHHHH--------------HHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 604 LAEALEHEDFEALV--------------DSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 604 l~~~~~~~~~~~l~--------------d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
.... ....+..+. ...+...+ ......+.+++.+||+.+|++||++.+|+++
T Consensus 234 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 234 CGSP-CPAVWPDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred hCCC-Chhhcccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000 000000000 00000001 0113457899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=312.49 Aligned_cols=251 Identities=25% Similarity=0.373 Sum_probs=203.0
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeC---CchhHHHHHHHHHHHHHcC-CCCceeEeeEeeccceeeEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIG---GSQGEREFRAEVEIISRVH-HRHLVSLVGYCISERERLLV 455 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~---~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~lV 455 (727)
++|++.+.||+|+||.||+|+.. +|+.|+||++... .....+.+.+|++++++++ |+||+++++++.+++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46889999999999999999975 6899999998642 2233467889999999998 99999999999999999999
Q ss_pred EeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhcc
Q 041135 456 YEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALEL 535 (727)
Q Consensus 456 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 535 (727)
|||+.+++|.+++...+ .+.+..++.|+.||+.||.|||++ +|+|+|||++||+|+.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 81 LEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred EcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 99999999999997765 489999999999999999999998 9999999999999999999999999999765322
Q ss_pred CCC-----------------ccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHH
Q 041135 536 DSN-----------------THVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVE 598 (727)
Q Consensus 536 ~~~-----------------~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~ 598 (727)
... ........++..|++||++.+..++.++|||+||+++|+|++|+.||..... ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~-- 230 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE---YLT-- 230 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH---HHH--
Confidence 211 0112234678899999999988899999999999999999999999975431 000
Q ss_pred hhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCH----HHHHHH
Q 041135 599 WARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRM----SQVVRA 657 (727)
Q Consensus 599 ~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~evl~~ 657 (727)
+..+.+ ....+.......+.+|+++||+.+|++||++ ++|+++
T Consensus 231 --------------~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 231 --------------FQKILK--LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred --------------HHHHHh--cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 011111 1112222224458899999999999999999 777654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=311.77 Aligned_cols=256 Identities=27% Similarity=0.319 Sum_probs=199.8
Q ss_pred CccccceeccCCceEEEEEEEc----CCcEEEEEEeeeCC----chhHHHHHHHHHHHHHc-CCCCceeEeeEeecccee
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLA----DGREVAVKQLKIGG----SQGEREFRAEVEIISRV-HHRHLVSLVGYCISERER 452 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~----~g~~vaVK~l~~~~----~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~ 452 (727)
+|++.+.||+|+||.||+++.. +++.||||+++... ....+.+.+|+++++++ +|+||+++++++..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4788899999999999999853 57889999987432 22335688999999999 599999999999999999
Q ss_pred eEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhh
Q 041135 453 LLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIA 532 (727)
Q Consensus 453 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~ 532 (727)
+|||||+.+++|.+++..+. .+.+..++.++.|+++||+|||+. +|+|||||++||||+.++.+||+|||+++.+
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE--HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC--CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 99999999999999887654 378899999999999999999998 9999999999999999999999999998764
Q ss_pred hccCCCccccccccCCccccccCcccCCC--CCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhch
Q 041135 533 LELDSNTHVSTRVMGTFGYMAPEYATSGK--LTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEH 610 (727)
Q Consensus 533 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~ 610 (727)
.... ........|+..|++||.+.+.. .+.++|||+||+++|||++|+.||....... ...++...+
T Consensus 156 ~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~------- 224 (288)
T cd05583 156 LAEE--EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEISRRI------- 224 (288)
T ss_pred cccc--ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHHHHH-------
Confidence 3221 11122356889999999987765 7889999999999999999999996432211 111111110
Q ss_pred hhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhc
Q 041135 611 EDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661 (727)
Q Consensus 611 ~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 661 (727)
+.. ...........+.+++.+||+.+|++||++.++.+.|+..
T Consensus 225 ------~~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 225 ------LKS--KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred ------Hcc--CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 000 0111111223477899999999999999999888887765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=312.35 Aligned_cols=263 Identities=20% Similarity=0.294 Sum_probs=198.0
Q ss_pred ccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCch--hHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeec
Q 041135 383 FSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQ--GEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYV 459 (727)
Q Consensus 383 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~--~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 459 (727)
|++.+.||+|+||.||+|+.. +|+.++||+++..... ....+.+|+++|++++|+||+++++++.++...++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567789999999999999875 6889999998754332 3467889999999999999999999999999999999999
Q ss_pred cCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCc
Q 041135 460 PNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNT 539 (727)
Q Consensus 460 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 539 (727)
.+ +|.+++.... ..+++..++.++.||++||+|||++ +|+|||||++||++++++.+||+|||++.......
T Consensus 81 ~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--- 152 (283)
T cd05118 81 DT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--- 152 (283)
T ss_pred CC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc---
Confidence 75 7777776543 3589999999999999999999999 99999999999999999999999999997543221
Q ss_pred cccccccCCccccccCcccCC-CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHH
Q 041135 540 HVSTRVMGTFGYMAPEYATSG-KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVD 618 (727)
Q Consensus 540 ~~~~~~~gt~~y~aPE~l~~~-~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d 618 (727)
.......++..|++||.+.+. .++.++|||+|||+||+|++|+.+|......+ .+.. ....+.. .....+..+.+
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~--~~~~-~~~~~~~-~~~~~~~~~~~ 228 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID--QLFK-IFRTLGT-PDPEVWPKFTS 228 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-HHHHcCC-CchHhcccchh
Confidence 122234578889999999876 78999999999999999999999997644211 1100 0000000 00000000000
Q ss_pred ------HHhh-------cccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 619 ------SRLE-------KNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 619 ------~~l~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
.... ..........+.+++.+||+.||.+||++.+|+.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 229 LARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0000 00011223468899999999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=319.90 Aligned_cols=268 Identities=21% Similarity=0.347 Sum_probs=194.8
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC--chhHHHHHHHHHHHHHcCCCCceeEeeEeecc------c
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG--SQGEREFRAEVEIISRVHHRHLVSLVGYCISE------R 450 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~------~ 450 (727)
.++|.+.+.||+|+||.||+|+.. +|+.||||+++... ......+.+|+++|++++|+||++++++|... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 578999999999999999999964 68999999986432 22235688999999999999999999998754 2
Q ss_pred eeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccch
Q 041135 451 ERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAK 530 (727)
Q Consensus 451 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~ 530 (727)
..++|+||+.+ +|..++. ..+.+..+..++.||++||+|||++ +|+|||||++|||++.++.+||+|||+++
T Consensus 94 ~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~ 165 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLAR 165 (342)
T ss_pred eEEEEeccccc-CHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence 46899999954 5655542 2378899999999999999999999 99999999999999999999999999987
Q ss_pred hhhccCCCccccccccCCccccccCcccC-CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhH------HH
Q 041135 531 IALELDSNTHVSTRVMGTFGYMAPEYATS-GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWAR------PL 603 (727)
Q Consensus 531 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~------~~ 603 (727)
.... ......++..|+|||++.+ ..++.++|||||||+||||++|+.+|.+..... .+..... ..
T Consensus 166 ~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~ 237 (342)
T cd07879 166 HADA------EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD--QLTQILKVTGVPGPE 237 (342)
T ss_pred CCCC------CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCCHH
Confidence 4311 1123457888999999876 468899999999999999999999997643211 0000000 00
Q ss_pred HHHhhchhhHHHHHHH---Hhhccc---chhHHHHHHHHHHHHhccCCCCCCCHHHHHHH--HhhccC
Q 041135 604 LAEALEHEDFEALVDS---RLEKNY---VDSEMFWMIEAAAACVRHSATKRPRMSQVVRA--LDTLDG 663 (727)
Q Consensus 604 l~~~~~~~~~~~l~d~---~l~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~~ 663 (727)
+...+........+.. .....+ .......+.+|+++||+.||++|+++.||+.+ ++.+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 238 FVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred HHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 0000000000000000 000000 00122347799999999999999999999966 665543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=306.71 Aligned_cols=242 Identities=24% Similarity=0.317 Sum_probs=188.0
Q ss_pred ceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc---hhHHHHHHHHHHHH-HcCCCCceeEeeEeeccceeeEEEeeccC
Q 041135 387 NVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS---QGEREFRAEVEIIS-RVHHRHLVSLVGYCISERERLLVYEYVPN 461 (727)
Q Consensus 387 ~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~---~~~~~~~~Ei~~l~-~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 461 (727)
+.||+|+||.||+|+.. +|+.||||+++.... .....+..|..++. .++|+||++++++|..++..|+||||+.+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999874 588999999864322 22234555655544 45899999999999999999999999999
Q ss_pred CccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCccc
Q 041135 462 DTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHV 541 (727)
Q Consensus 462 gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 541 (727)
++|..+++.... +.+..+.+++.||+.||.|||++ +|+||||+++||||++++.+||+|||+++....
T Consensus 82 ~~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------- 149 (260)
T cd05611 82 GDCASLIKTLGG--LPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------- 149 (260)
T ss_pred CCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-------
Confidence 999999876543 78899999999999999999998 999999999999999999999999999875321
Q ss_pred cccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHh
Q 041135 542 STRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRL 621 (727)
Q Consensus 542 ~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l 621 (727)
.....|+..|++||.+.+..++.++|||+||++||||++|..||..... . +... .+.....
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~---~~~~-------------~~~~~~~ 210 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP---D---AVFD-------------NILSRRI 210 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH---H---HHHH-------------HHHhccc
Confidence 2234678899999999988899999999999999999999999975331 1 1000 0000000
Q ss_pred --hcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 622 --EKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 622 --~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
...........+.+++++||+.+|++|+++.++.+.|.
T Consensus 211 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 211 NWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred CCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 00011122345889999999999999997765555444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=307.26 Aligned_cols=251 Identities=21% Similarity=0.290 Sum_probs=193.5
Q ss_pred HHHHHHHhcCcccccee--ccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHc-CCCCceeEeeEeec
Q 041135 373 YDELIQATNGFSAHNVL--GEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRV-HHRHLVSLVGYCIS 448 (727)
Q Consensus 373 ~~el~~~~~~~~~~~~L--G~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~ 448 (727)
+.++....++|++.+.+ |+|+||.||+++.+ +++.+|+|.+....... .|+.++..+ +|+||++++++|..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~ 80 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTT 80 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEec
Confidence 34555666778887777 99999999999864 57889999886432211 133333323 69999999999999
Q ss_pred cceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCC-cEEEEeec
Q 041135 449 ERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSF-EARVADFG 527 (727)
Q Consensus 449 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~-~vkL~DFG 527 (727)
.+..|+||||+.+++|.+++..+. .+++.+++.++.||++||+|||+. +|+|||||++||+++.++ .++|+|||
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg 155 (267)
T PHA03390 81 LKGHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYG 155 (267)
T ss_pred CCeeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCc
Confidence 999999999999999999997764 589999999999999999999999 999999999999999988 99999999
Q ss_pred cchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHh
Q 041135 528 LAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEA 607 (727)
Q Consensus 528 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~ 607 (727)
+++.... .....|+..|+|||++.+..++.++|||||||++|||++|+.||...... ...+..+..
T Consensus 156 ~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-~~~~~~~~~------ 221 (267)
T PHA03390 156 LCKIIGT-------PSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE-ELDLESLLK------ 221 (267)
T ss_pred cceecCC-------CccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc-hhhHHHHHH------
Confidence 9874321 12235788999999999989999999999999999999999999743321 111111111
Q ss_pred hchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCC-HHHHHHH
Q 041135 608 LEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPR-MSQVVRA 657 (727)
Q Consensus 608 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~ 657 (727)
.....+ .........+.+|+.+||+.+|++|++ ++||+++
T Consensus 222 --------~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 222 --------RQQKKL--PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred --------hhcccC--CcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 000000 111123345788999999999999995 6998864
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=317.63 Aligned_cols=270 Identities=22% Similarity=0.314 Sum_probs=199.2
Q ss_pred HHHHHhcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC--chhHHHHHHHHHHHHHcCCCCceeEeeEeec-cc
Q 041135 375 ELIQATNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG--SQGEREFRAEVEIISRVHHRHLVSLVGYCIS-ER 450 (727)
Q Consensus 375 el~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~-~~ 450 (727)
++..+.++|++.++||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+++|++++|+||++++++|.. ..
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 34557788999999999999999999865 68999999885422 2334678899999999999999999999876 55
Q ss_pred eeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccch
Q 041135 451 ERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAK 530 (727)
Q Consensus 451 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~ 530 (727)
..++||||+ +++|..+++.. .+.+..+..++.||++||+|||++ +|+|||||++|||+++++.+||+|||+++
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred cEEEEeehh-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccc
Confidence 789999998 56888777643 367888889999999999999999 99999999999999999999999999987
Q ss_pred hhhccCCCccccccccCCccccccCcccC-CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchh-hHHhhH----HHH
Q 041135 531 IALELDSNTHVSTRVMGTFGYMAPEYATS-GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDES-LVEWAR----PLL 604 (727)
Q Consensus 531 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~-l~~~~~----~~l 604 (727)
.... ......++..|++||++.+ ..++.++|||+|||++|||++|+.+|.......... +.+++. .+.
T Consensus 157 ~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 230 (328)
T cd07856 157 IQDP------QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVI 230 (328)
T ss_pred ccCC------CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 4311 1123456788999999876 568999999999999999999999997643211000 000000 000
Q ss_pred HHhhchhhHHHHHHH-Hhhcccc-----hhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 041135 605 AEALEHEDFEALVDS-RLEKNYV-----DSEMFWMIEAAAACVRHSATKRPRMSQVVRAL 658 (727)
Q Consensus 605 ~~~~~~~~~~~l~d~-~l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 658 (727)
.... .....+++.. ....... ......+.++|++||+.+|++|+++.+|+.+-
T Consensus 231 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~ 289 (328)
T cd07856 231 NTIC-SENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHP 289 (328)
T ss_pred Hhcc-chhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCC
Confidence 0000 0111111110 0000101 11234588999999999999999999998873
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=355.68 Aligned_cols=255 Identities=29% Similarity=0.378 Sum_probs=203.3
Q ss_pred HhcCccccceeccCCceEEEEEE-EcCCcEEEEEEeeeCCch--hHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEE
Q 041135 379 ATNGFSAHNVLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQ--GEREFRAEVEIISRVHHRHLVSLVGYCISERERLLV 455 (727)
Q Consensus 379 ~~~~~~~~~~LG~G~fg~Vy~~~-~~~g~~vaVK~l~~~~~~--~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 455 (727)
.+-+|+...+||.|.||.||-|. ..+|+-.|||-++..... ....+.+|+.+|..|+|+|||+++|+-.+.+..+|.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 34567888999999999999998 456899999988765443 235688999999999999999999999999999999
Q ss_pred EeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhcc
Q 041135 456 YEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALEL 535 (727)
Q Consensus 456 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 535 (727)
||||++|+|.+.+...+. .++.....+..|++.||.|||++ ||||||||+.||||+.+|.+|++|||.|+.+...
T Consensus 1313 MEyC~~GsLa~ll~~gri--~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGRI--EDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHHhccCcHHHHHHhcch--hhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 999999999999876543 66666777889999999999999 9999999999999999999999999999865432
Q ss_pred C-CCccccccccCCccccccCcccCC---CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchh
Q 041135 536 D-SNTHVSTRVMGTFGYMAPEYATSG---KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHE 611 (727)
Q Consensus 536 ~-~~~~~~~~~~gt~~y~aPE~l~~~---~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~ 611 (727)
. .........+||..|||||++.+. ...-++||||||||++||+||+.||...+. +|+--+.-..
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-------e~aIMy~V~~---- 1456 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-------EWAIMYHVAA---- 1456 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-------hhHHHhHHhc----
Confidence 1 112223457899999999999764 356799999999999999999999986553 2321100000
Q ss_pred hHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 612 DFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 612 ~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
.-......+....-.+|+..||..||++|.++.||+++
T Consensus 1457 --------gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1457 --------GHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred --------cCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 00111233344456789999999999999999888776
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=323.54 Aligned_cols=267 Identities=19% Similarity=0.301 Sum_probs=195.0
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeecc----------
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISE---------- 449 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~---------- 449 (727)
.+|.+.+.||+|+||.||+|+.. +|+.||||++........+.+.+|+++|++++|+||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 57899999999999999999875 5889999999876666667789999999999999999999876543
Q ss_pred ----ceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEEC-CCCcEEEE
Q 041135 450 ----RERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLD-SSFEARVA 524 (727)
Q Consensus 450 ----~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~-~~~~vkL~ 524 (727)
...|+||||+. ++|.+++... .+.+..++.++.||++||+|||++ +|+|||||++||||+ +++.+||+
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQG---PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEEC
Confidence 35789999996 5787777543 378899999999999999999998 999999999999997 45679999
Q ss_pred eeccchhhhccCCCccccccccCCccccccCcccC-CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHH
Q 041135 525 DFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATS-GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPL 603 (727)
Q Consensus 525 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~ 603 (727)
|||+++................++..|+|||++.+ ..++.++|||||||+||||++|+.||........ +.......
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~--~~~~~~~~ 235 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ--MQLILESV 235 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhc
Confidence 99999754221111111223457889999998765 5688899999999999999999999975432111 00000000
Q ss_pred --HHHhhchhhHHHHHHHHhh-----cc-----cchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 604 --LAEALEHEDFEALVDSRLE-----KN-----YVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 604 --l~~~~~~~~~~~l~d~~l~-----~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
.... ....+...+...+. .. ........+.+|+++||+.||++|+++.||+++
T Consensus 236 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 236 PVVREE-DRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred CCCChH-HhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 0000 00000000000000 00 011122457789999999999999999999865
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=312.69 Aligned_cols=253 Identities=25% Similarity=0.394 Sum_probs=193.2
Q ss_pred cCccccceeccCCceEEEEEEEcC-CcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcC-CCCceeEeeEeeccceeeEEEe
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLAD-GREVAVKQLKIGGS-QGEREFRAEVEIISRVH-HRHLVSLVGYCISERERLLVYE 457 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~~-g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E 457 (727)
++|++.+.||+|+||.||+|++++ |+.||||+++.... ....++.+|+.++.++. |+||++++++|.++...|+|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 568889999999999999999865 89999999975433 23456777888777775 9999999999999999999999
Q ss_pred eccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCC
Q 041135 458 YVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDS 537 (727)
Q Consensus 458 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 537 (727)
|+. ++|.+++.... ..+++..+.+++.||++||+|||+.. +|+||||+++|||+++++.+||+|||++......
T Consensus 95 ~~~-~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~-- 168 (296)
T cd06618 95 LMS-TCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS-- 168 (296)
T ss_pred ccC-cCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccCC--
Confidence 985 46666554422 25889999999999999999999732 8999999999999999999999999998754221
Q ss_pred CccccccccCCccccccCcccCCC----CCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhH
Q 041135 538 NTHVSTRVMGTFGYMAPEYATSGK----LTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDF 613 (727)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~l~~~~----~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~ 613 (727)
.......++..|+|||++.+.. ++.++|||||||+||||++|+.||...... .+....
T Consensus 169 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~----------- 230 (296)
T cd06618 169 --KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVLTK----------- 230 (296)
T ss_pred --CcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHHHH-----------
Confidence 1112345778899999997654 788999999999999999999999643210 111111
Q ss_pred HHHHHHHh-hcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 614 EALVDSRL-EKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 614 ~~l~d~~l-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
+++... ...........+.+|+.+||+.||++||++.+|+++..
T Consensus 231 --~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~ 275 (296)
T cd06618 231 --ILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF 275 (296)
T ss_pred --HhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 111000 00000112345789999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=302.56 Aligned_cols=259 Identities=22% Similarity=0.289 Sum_probs=201.6
Q ss_pred HHhcCcccc-ceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHc-CCCCceeEeeEeec----cc
Q 041135 378 QATNGFSAH-NVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRV-HHRHLVSLVGYCIS----ER 450 (727)
Q Consensus 378 ~~~~~~~~~-~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~----~~ 450 (727)
.++++|++. ++||-|-.|+|..+.++ .|+.+|+|++. +..+.++|+++.-.. .|+|||+++++|.+ ..
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~-----Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL-----DSPKARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHh-----cCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 345667664 47999999999999865 68999999986 346778899876655 59999999999875 34
Q ss_pred eeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECC---CCcEEEEeec
Q 041135 451 ERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDS---SFEARVADFG 527 (727)
Q Consensus 451 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~---~~~vkL~DFG 527 (727)
.+++|||+|+||.|+..++.++...+++.+...|++||+.|+.|||++ +|.|||||++|+|... |..+||+|||
T Consensus 133 cLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccc
Confidence 668999999999999999999988899999999999999999999999 9999999999999964 5679999999
Q ss_pred cchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHh
Q 041135 528 LAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEA 607 (727)
Q Consensus 528 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~ 607 (727)
+|+.. ........-|.|.+|.|||++...+|+...|+||+|||||-||+|..||-...... +.--.+ ..
T Consensus 210 FAK~t----~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a---ispgMk----~r 278 (400)
T KOG0604|consen 210 FAKET----QEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---ISPGMK----RR 278 (400)
T ss_pred ccccc----CCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc---CChhHH----hH
Confidence 99843 22233445678999999999999999999999999999999999999997654311 000000 00
Q ss_pred hchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhc
Q 041135 608 LEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661 (727)
Q Consensus 608 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 661 (727)
+..+.++ +-+ .-.........++|+.+|+.+|++|.++.|++++-+-.
T Consensus 279 I~~gqy~-FP~-----pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~ 326 (400)
T KOG0604|consen 279 IRTGQYE-FPE-----PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWIN 326 (400)
T ss_pred hhccCcc-CCC-----hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhc
Confidence 1111000 000 00112233466899999999999999999999886643
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=313.17 Aligned_cols=266 Identities=24% Similarity=0.338 Sum_probs=193.5
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchh--HHHHHHHHHHHHHcCCCCceeEeeEeeccc------
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQG--EREFRAEVEIISRVHHRHLVSLVGYCISER------ 450 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~--~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~------ 450 (727)
.++|++.++||+|+||.||+|+++ +++.|+||++......+ ...+.+|+++|++++|+||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 367999999999999999999975 58999999986543322 346789999999999999999999875433
Q ss_pred --eeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeecc
Q 041135 451 --ERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGL 528 (727)
Q Consensus 451 --~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGl 528 (727)
.+++||||+.+ +|..++.... ..+++..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||+
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPS-VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCcc
Confidence 46999999965 5555554432 2589999999999999999999999 999999999999999999999999999
Q ss_pred chhhhccCCCc--------cccccccCCccccccCcccCC-CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHh
Q 041135 529 AKIALELDSNT--------HVSTRVMGTFGYMAPEYATSG-KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEW 599 (727)
Q Consensus 529 a~~~~~~~~~~--------~~~~~~~gt~~y~aPE~l~~~-~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~ 599 (727)
++......... .......++..|+|||++.+. .++.++|||||||++|||++|+.+|........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~------ 235 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ------ 235 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHH------
Confidence 97543221111 111234568889999988764 578999999999999999999999975443211
Q ss_pred hHHHHHHhhc--hhhHH---HH-----------HHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 600 ARPLLAEALE--HEDFE---AL-----------VDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 600 ~~~~l~~~~~--~~~~~---~l-----------~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
...++..... ...+. .+ ....+...+ ......+.+++++||+.||++||++.||+.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 236 LHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERF-GKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHc-ccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 1111110000 00000 00 000000000 1112457899999999999999999998864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=311.93 Aligned_cols=245 Identities=26% Similarity=0.397 Sum_probs=191.6
Q ss_pred ccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc---hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEee
Q 041135 383 FSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS---QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 383 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 458 (727)
|...+.||+|+||.||+|+.. +|+.|+||++..... ...+.+.+|+++++.++|+||++++++|.++...|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 666788999999999999864 588999999864332 2335688999999999999999999999999999999999
Q ss_pred ccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCC
Q 041135 459 VPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSN 538 (727)
Q Consensus 459 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 538 (727)
+. |+|.+++.... ..+.+..++.++.||+.||.|||++ +|+|||||++||++++++.+||+|||++....
T Consensus 103 ~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~----- 172 (313)
T cd06633 103 CL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSS----- 172 (313)
T ss_pred CC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccC-----
Confidence 96 46666664432 2488999999999999999999999 99999999999999999999999999986321
Q ss_pred ccccccccCCccccccCccc---CCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHH
Q 041135 539 THVSTRVMGTFGYMAPEYAT---SGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEA 615 (727)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~l~---~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~ 615 (727)
......|+..|++||++. ++.++.++|||||||+||||++|+.||...+... ......
T Consensus 173 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~------~~~~~~----------- 233 (313)
T cd06633 173 --PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIA----------- 233 (313)
T ss_pred --CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHH-----------
Confidence 122356888999999984 4568889999999999999999999986543210 000000
Q ss_pred HHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 041135 616 LVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRAL 658 (727)
Q Consensus 616 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 658 (727)
...............+.+|+.+||+.+|++||++.+|+++-
T Consensus 234 --~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~ 274 (313)
T cd06633 234 --QNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHD 274 (313)
T ss_pred --hcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 00000001111123477899999999999999999999763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=307.77 Aligned_cols=243 Identities=26% Similarity=0.355 Sum_probs=187.3
Q ss_pred eeccCCceEEEEEEEc-CCcEEEEEEeeeCCc---hhHHHHHHHHHHH---HHcCCCCceeEeeEeeccceeeEEEeecc
Q 041135 388 VLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS---QGEREFRAEVEII---SRVHHRHLVSLVGYCISERERLLVYEYVP 460 (727)
Q Consensus 388 ~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~---~~~~~~~~Ei~~l---~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 460 (727)
+||+|+||.||+++.. +|+.||||++..... .....+..|..++ +..+|+||+.+++++.+.+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 588999999864322 2222344454443 44579999999999999999999999999
Q ss_pred CCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCcc
Q 041135 461 NDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTH 540 (727)
Q Consensus 461 ~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 540 (727)
|++|.+++.... .+.+..++.++.||++||+|||+. +|+|||||++|||+++++.+||+|||+++.+...
T Consensus 81 g~~L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~----- 150 (278)
T cd05606 81 GGDLHYHLSQHG--VFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----- 150 (278)
T ss_pred CCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCcc-----
Confidence 999998886654 489999999999999999999998 9999999999999999999999999998754211
Q ss_pred ccccccCCccccccCcccCC-CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHH
Q 041135 541 VSTRVMGTFGYMAPEYATSG-KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDS 619 (727)
Q Consensus 541 ~~~~~~gt~~y~aPE~l~~~-~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~ 619 (727)
......|+..|++||++.++ .++.++|||||||+||||++|+.||............ . ...
T Consensus 151 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~---~--------------~~~- 212 (278)
T cd05606 151 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID---R--------------MTL- 212 (278)
T ss_pred CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH---H--------------Hhh-
Confidence 12234689999999999754 6889999999999999999999999765322111100 0 000
Q ss_pred HhhcccchhHHHHHHHHHHHHhccCCCCCC-----CHHHHHHHH
Q 041135 620 RLEKNYVDSEMFWMIEAAAACVRHSATKRP-----RMSQVVRAL 658 (727)
Q Consensus 620 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L 658 (727)
.............+.+++.+||..++.+|+ ++.+++++-
T Consensus 213 ~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~ 256 (278)
T cd05606 213 TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHP 256 (278)
T ss_pred ccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCc
Confidence 000111111234578899999999999999 899998653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=317.34 Aligned_cols=267 Identities=20% Similarity=0.315 Sum_probs=197.3
Q ss_pred HHHHhcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC--chhHHHHHHHHHHHHHcCCCCceeEeeEeeccc--
Q 041135 376 LIQATNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG--SQGEREFRAEVEIISRVHHRHLVSLVGYCISER-- 450 (727)
Q Consensus 376 l~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~-- 450 (727)
+....++|++++.||+|+||.||+|+.. +|+.||||+++... ......+.+|+++|++++|+||++++++|..+.
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 4456778999999999999999999854 68999999985432 223356889999999999999999999987653
Q ss_pred ----eeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEee
Q 041135 451 ----ERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADF 526 (727)
Q Consensus 451 ----~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DF 526 (727)
..+|||||+ +++|.+++... .+++..++.++.||++||+|||++ +|+|||||++|||++.++.+||+||
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKHE---KLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeec
Confidence 458999999 77888777542 388999999999999999999999 9999999999999999999999999
Q ss_pred ccchhhhccCCCccccccccCCccccccCcccC-CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhH----
Q 041135 527 GLAKIALELDSNTHVSTRVMGTFGYMAPEYATS-GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWAR---- 601 (727)
Q Consensus 527 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~---- 601 (727)
|+++.... ......++..|++||++.+ ..++.++|||||||++|+|++|+.||...... ..+.+...
T Consensus 163 g~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~--~~~~~~~~~~~~ 234 (343)
T cd07880 163 GLARQTDS------EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL--DQLMEIMKVTGT 234 (343)
T ss_pred cccccccc------CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCC
Confidence 99975321 1223457889999999876 45889999999999999999999999754321 01110000
Q ss_pred --HHHHHhhchhhHHHHHHHHhhc------ccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 602 --PLLAEALEHEDFEALVDSRLEK------NYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 602 --~~l~~~~~~~~~~~l~d~~l~~------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
..+...+........+...... .........+.+++.+||+.||++|+++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 235 PSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred CCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000011111111111100000 0011122347899999999999999999999965
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=320.79 Aligned_cols=272 Identities=21% Similarity=0.298 Sum_probs=200.0
Q ss_pred HHHHHHHhcCccccceeccCCceEEEEEEE-cCCcEEEEEEeeeCC--chhHHHHHHHHHHHHHcCCCCceeEeeEeecc
Q 041135 373 YDELIQATNGFSAHNVLGEGGFGCVYKGVL-ADGREVAVKQLKIGG--SQGEREFRAEVEIISRVHHRHLVSLVGYCISE 449 (727)
Q Consensus 373 ~~el~~~~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~ 449 (727)
..++....++|++.+.||+|+||.||+|.. .+|+.||||+++... ....+.+.+|++++++++|+||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 456677889999999999999999999985 468999999986432 22345688899999999999999999988643
Q ss_pred ------ceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEE
Q 041135 450 ------RERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARV 523 (727)
Q Consensus 450 ------~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL 523 (727)
...|++++++ +++|.+++..+ .+++..++.++.||++||+|||++ +|+|||||++||++++++.+||
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl 161 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKI 161 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEE
Confidence 3467888877 78888777543 388999999999999999999999 9999999999999999999999
Q ss_pred EeeccchhhhccCCCccccccccCCccccccCcccC-CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHH
Q 041135 524 ADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATS-GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARP 602 (727)
Q Consensus 524 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~ 602 (727)
+|||+++.... ......++..|+|||++.+ ..++.++|||||||++|||++|+.+|....... .+....+.
T Consensus 162 ~dfg~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~ 233 (345)
T cd07877 162 LDFGLARHTDD------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID--QLKLILRL 233 (345)
T ss_pred ecccccccccc------cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHH
Confidence 99999875311 1223467889999999876 468889999999999999999999996543211 11110000
Q ss_pred ------HHHHhhchhhHHHHHH---HHhhccc---chhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 603 ------LLAEALEHEDFEALVD---SRLEKNY---VDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 603 ------~l~~~~~~~~~~~l~d---~~l~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
.+...+........+. ......+ .......+.+|+.+||+.|+++|+++.+++++-.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 302 (345)
T cd07877 234 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 302 (345)
T ss_pred hCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChh
Confidence 0000000000001100 0000000 0011234789999999999999999999998754
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=313.33 Aligned_cols=251 Identities=25% Similarity=0.390 Sum_probs=195.4
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
+.|+..+.||+|+||.||+|+.. +++.|+||.+.... ....+++.+|+++|+.++|+||+++++++.+....++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34777789999999999999975 57889999986432 233456889999999999999999999999999999999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccC
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 536 (727)
||+. |+|.+++.... ..+++..++.++.||+.||.|||++ +|+|||||++|||++.++.+||+|||++.....
T Consensus 95 e~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~-- 167 (308)
T cd06634 95 EYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 167 (308)
T ss_pred EccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecC--
Confidence 9996 56666654332 2478999999999999999999998 999999999999999999999999999875321
Q ss_pred CCccccccccCCccccccCccc---CCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhH
Q 041135 537 SNTHVSTRVMGTFGYMAPEYAT---SGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDF 613 (727)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~l~---~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~ 613 (727)
.....++..|+|||++. .+.++.++|||||||++|||++|+.||...+.. +...
T Consensus 168 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~------------ 224 (308)
T cd06634 168 -----ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALY------------ 224 (308)
T ss_pred -----cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH------HHHH------------
Confidence 12345788999999985 356788999999999999999999998643211 0000
Q ss_pred HHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhcc
Q 041135 614 EALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLD 662 (727)
Q Consensus 614 ~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 662 (727)
.+................+.+|+++||+.+|++||++.+|+++...+.
T Consensus 225 -~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 225 -HIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred -HHhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 000000000011123345788999999999999999999998866554
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=330.79 Aligned_cols=200 Identities=30% Similarity=0.429 Sum_probs=170.9
Q ss_pred cccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC-chhHHHHHHHHHHHHHcCCCCceeEeeEeeccc------eeeEE
Q 041135 384 SAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG-SQGEREFRAEVEIISRVHHRHLVSLVGYCISER------ERLLV 455 (727)
Q Consensus 384 ~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~------~~~lV 455 (727)
...+.||+|+||.||+|+++ .|+.||||.++... ....+.+.+|+++|++|+|+|||+++++-+... ..++|
T Consensus 16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlv 95 (732)
T KOG4250|consen 16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLV 95 (732)
T ss_pred eehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEE
Confidence 34477999999999999954 69999999997543 345567999999999999999999999866544 45899
Q ss_pred EeeccCCccchhcccCC-CCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEE--CCCC--cEEEEeeccch
Q 041135 456 YEYVPNDTLHYHLHAEG-RPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILL--DSSF--EARVADFGLAK 530 (727)
Q Consensus 456 ~Ey~~~gsL~~~L~~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl--~~~~--~vkL~DFGla~ 530 (727)
||||.||+|+.+|++-. ...+.+.+++.++.+++.||.|||++ +|||||||+.||++ +++| ..||+|||+|+
T Consensus 96 mEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar 172 (732)
T KOG4250|consen 96 MEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR 172 (732)
T ss_pred EeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence 99999999999997632 34699999999999999999999999 99999999999999 3334 48999999999
Q ss_pred hhhccCCCccccccccCCccccccCccc-CCCCCchhHHHHHhHHHHHHHhCCCCCCCCCC
Q 041135 531 IALELDSNTHVSTRVMGTFGYMAPEYAT-SGKLTEKSDVYSFGVVLLELITGRKPVDASQP 590 (727)
Q Consensus 531 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~ 590 (727)
.+.+ + .....++||..|++||++. .+.|+..+|.|||||++||+.||..||.....
T Consensus 173 el~d---~-s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~ 229 (732)
T KOG4250|consen 173 ELDD---N-SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGG 229 (732)
T ss_pred cCCC---C-CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCC
Confidence 6522 2 2556789999999999998 48899999999999999999999999976544
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=304.54 Aligned_cols=249 Identities=21% Similarity=0.339 Sum_probs=193.2
Q ss_pred CccccceeccCCceEEEEEEEcC-CcEEEEEEeeeC-----CchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEE
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLAD-GREVAVKQLKIG-----GSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLV 455 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~~-g~~vaVK~l~~~-----~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 455 (727)
+|.+.++||+|+||.||++++.. +..+++|+++.. .......+.+|++++++++|+||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47888999999999999998653 445666665432 122334677899999999999999999999999999999
Q ss_pred EeeccCCccchhccc--CCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhh
Q 041135 456 YEYVPNDTLHYHLHA--EGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIAL 533 (727)
Q Consensus 456 ~Ey~~~gsL~~~L~~--~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~ 533 (727)
|||+.+++|.+++.. .....+++..++.++.||++||.|||++ +|+|||||++||++++ +.+||+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999988764 2234589999999999999999999998 9999999999999975 569999999987542
Q ss_pred ccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhH
Q 041135 534 ELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDF 613 (727)
Q Consensus 534 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~ 613 (727)
.. ........|+..|++||.+.+..++.++|||+||+++|+|++|+.+|.... .......
T Consensus 157 ~~---~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~------~~~~~~~----------- 216 (260)
T cd08222 157 GS---CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN------FLSVVLR----------- 216 (260)
T ss_pred CC---cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHH-----------
Confidence 21 122233557889999999988888999999999999999999999986432 1111110
Q ss_pred HHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 614 EALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 614 ~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
+.. .............+.+++++||+.+|++||++.||+++
T Consensus 217 --~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 217 --IVE-GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred --HHc-CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 000 00111112233457889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=314.38 Aligned_cols=270 Identities=21% Similarity=0.260 Sum_probs=196.5
Q ss_pred cCcc-ccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchh--------------HHHHHHHHHHHHHcCCCCceeEee
Q 041135 381 NGFS-AHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQG--------------EREFRAEVEIISRVHHRHLVSLVG 444 (727)
Q Consensus 381 ~~~~-~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~--------------~~~~~~Ei~~l~~l~HpnIv~l~~ 444 (727)
++|. +.++||+|+||.||+|+.. +|+.||||+++...... ...+.+|+++|++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 3454 4577999999999999965 68999999986543221 125789999999999999999999
Q ss_pred EeeccceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEE
Q 041135 445 YCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVA 524 (727)
Q Consensus 445 ~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~ 524 (727)
+|..++..++||||+. |+|.+++..... +.+..++.++.||++||+|||++ +|+|||||++||||+.++.+||+
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~--~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~ 161 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKIR--LTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIA 161 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEEC
Confidence 9999999999999996 588888865443 88999999999999999999998 99999999999999999999999
Q ss_pred eeccchhhhccC-----------CCccccccccCCccccccCcccCC-CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCC
Q 041135 525 DFGLAKIALELD-----------SNTHVSTRVMGTFGYMAPEYATSG-KLTEKSDVYSFGVVLLELITGRKPVDASQPLG 592 (727)
Q Consensus 525 DFGla~~~~~~~-----------~~~~~~~~~~gt~~y~aPE~l~~~-~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~ 592 (727)
|||+++...... ..........++..|++||++.+. .++.++|||||||++|||++|+.+|...+..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~- 240 (335)
T PTZ00024 162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI- 240 (335)
T ss_pred CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-
Confidence 999997542100 001111223567889999999764 4689999999999999999999999765421
Q ss_pred chhhHHhhHHHHHHhhchhhHHHHHH------------HHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhh
Q 041135 593 DESLVEWARPLLAEALEHEDFEALVD------------SRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDT 660 (727)
Q Consensus 593 ~~~l~~~~~~~l~~~~~~~~~~~l~d------------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 660 (727)
.........+... ....+....+ ..+.. ........+.+++.+||+.+|++|+++.||+.+-+.
T Consensus 241 --~~~~~i~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~ 316 (335)
T PTZ00024 241 --DQLGRIFELLGTP-NEDNWPQAKKLPLYTEFTPRKPKDLKT-IFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYF 316 (335)
T ss_pred --HHHHHHHHHhCCC-chhhCcchhhcccccccCcCCcccHHH-hCcCCChHHHHHHHHHcCCCchhccCHHHHhcCccc
Confidence 1111100000000 0000000000 00000 001123347799999999999999999999987554
Q ss_pred c
Q 041135 661 L 661 (727)
Q Consensus 661 ~ 661 (727)
.
T Consensus 317 ~ 317 (335)
T PTZ00024 317 K 317 (335)
T ss_pred C
Confidence 3
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=340.49 Aligned_cols=145 Identities=30% Similarity=0.411 Sum_probs=131.2
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc---hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS---QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
++|+++++||+|+||.||+|++. +++.||||+++.... .....+.+|+++|+.++|+||+++++++.....+||||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57999999999999999999976 589999999974332 22367889999999999999999999999999999999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccch
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAK 530 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~ 530 (727)
||+.+++|.++++..+. +.+..+++|+.||+.||+|||.+ +|||||||++||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~~--l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYGY--FDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999876543 78889999999999999999998 99999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=293.03 Aligned_cols=250 Identities=26% Similarity=0.408 Sum_probs=191.7
Q ss_pred ccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcC-CCCceeEeeEeeccceeeEEEeec
Q 041135 383 FSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS-QGEREFRAEVEIISRVH-HRHLVSLVGYCISERERLLVYEYV 459 (727)
Q Consensus 383 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~lV~Ey~ 459 (727)
++++..||.|..|.||+++++ .|...|||.+...+. ++.+.++..++++.+.+ .++||+.+|||..+...+|.||.|
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM 173 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM 173 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence 445677999999999999976 488999999975543 44467778888877665 899999999999999999999988
Q ss_pred cCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCc
Q 041135 460 PNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNT 539 (727)
Q Consensus 460 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 539 (727)
...++.+|++... .+.+..+-++...+++||.||.+++ +|+|||||++|||||+.|.+||||||++-++.+..
T Consensus 174 -s~C~ekLlkrik~-piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk--- 246 (391)
T KOG0983|consen 174 -STCAEKLLKRIKG-PIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK--- 246 (391)
T ss_pred -HHHHHHHHHHhcC-CchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc---
Confidence 4455555554333 4777788889999999999999886 99999999999999999999999999997653322
Q ss_pred cccccccCCccccccCcccC---CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHH
Q 041135 540 HVSTRVMGTFGYMAPEYATS---GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEAL 616 (727)
Q Consensus 540 ~~~~~~~gt~~y~aPE~l~~---~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l 616 (727)
..++..|-..|||||.+.- .+|+.++|||||||.|+||.||+.||.+.+.. .+ . +...++.+
T Consensus 247 -AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td-Fe----~----ltkvln~e----- 311 (391)
T KOG0983|consen 247 -AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD-FE----V----LTKVLNEE----- 311 (391)
T ss_pred -ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc-HH----H----HHHHHhcC-----
Confidence 2344568889999999863 46899999999999999999999999874421 11 1 11111100
Q ss_pred HHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 617 VDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 617 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
-..|.... .-...+.+|+..||.+|..+||.+.+|+++
T Consensus 312 -PP~L~~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 312 -PPLLPGHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred -CCCCCccc--CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 01111110 011237789999999999999999999876
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=316.60 Aligned_cols=247 Identities=26% Similarity=0.379 Sum_probs=195.4
Q ss_pred cceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc--hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeeccCC
Q 041135 386 HNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS--QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPND 462 (727)
Q Consensus 386 ~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 462 (727)
.++||.|.||+||-|+++ +|+.||||++..... +.+..+++|+.+|++++|+.||.|...|+..+.+|+|||.+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 478999999999999965 699999999965432 44578999999999999999999999999999999999999655
Q ss_pred ccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCC---CcEEEEeeccchhhhccCCCc
Q 041135 463 TLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSS---FEARVADFGLAKIALELDSNT 539 (727)
Q Consensus 463 sL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~---~~vkL~DFGla~~~~~~~~~~ 539 (727)
-|.-+| ...+..+.+..-..++.||+.||.|||-+ +|||+|||++||||.+. -++||||||+||++. +.
T Consensus 649 MLEMIL-SsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIg----Ek 720 (888)
T KOG4236|consen 649 MLEMIL-SSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIG----EK 720 (888)
T ss_pred HHHHHH-HhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecc----hh
Confidence 554444 43344588888888999999999999999 99999999999999654 379999999999753 33
Q ss_pred cccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHH
Q 041135 540 HVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDS 619 (727)
Q Consensus 540 ~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~ 619 (727)
.....++||..|+|||+|+++.|+..-|+||.|||+|.-|+|..||.....+.+ ++ .+..|
T Consensus 721 sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdInd-QI------------QNAaF------ 781 (888)
T KOG4236|consen 721 SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIND-QI------------QNAAF------ 781 (888)
T ss_pred hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhH-Hh------------hcccc------
Confidence 455668999999999999999999999999999999999999999976432211 10 00000
Q ss_pred HhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 620 RLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 620 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
....+...+.....++||...|+..=++|-++++.+.+.+
T Consensus 782 MyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~W 821 (888)
T KOG4236|consen 782 MYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPW 821 (888)
T ss_pred ccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchh
Confidence 0111222333344678888888888888888887766644
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=308.29 Aligned_cols=263 Identities=24% Similarity=0.342 Sum_probs=198.2
Q ss_pred ccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC--chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeec
Q 041135 383 FSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG--SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYV 459 (727)
Q Consensus 383 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 459 (727)
|++.+.||+|+||.||+|+.. +++.|++|+++... ....+.+.+|++++++++|+||+++++++.+....++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 566788999999999999976 48999999997653 233457889999999999999999999999999999999999
Q ss_pred cCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCc
Q 041135 460 PNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNT 539 (727)
Q Consensus 460 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 539 (727)
. ++|.+++.... ..+++..+++++.||++||+|||++ +|+||||+++||++++++.+||+|||+++..... .
T Consensus 81 ~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~---~ 152 (282)
T cd07829 81 D-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIP---L 152 (282)
T ss_pred C-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCC---c
Confidence 7 58988887653 2489999999999999999999999 9999999999999999999999999999754221 1
Q ss_pred cccccccCCccccccCcccCC-CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHH-
Q 041135 540 HVSTRVMGTFGYMAPEYATSG-KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALV- 617 (727)
Q Consensus 540 ~~~~~~~gt~~y~aPE~l~~~-~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~- 617 (727)
.......++..|+|||++.+. .++.++|||+|||++|||++|+.+|...... .........+.. .....+..+.
T Consensus 153 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~---~~~~~~~~~~~~-~~~~~~~~~~~ 228 (282)
T cd07829 153 RTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI---DQLFKIFQILGT-PTEESWPGVTK 228 (282)
T ss_pred cccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH---HHHHHHHHHhCC-CcHHHHHhhcc
Confidence 122234567789999999776 7899999999999999999999999764421 111111100000 0000000000
Q ss_pred ----HHHhhc-------ccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 618 ----DSRLEK-------NYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 618 ----d~~l~~-------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
+..+.. .........+.+++++||..+|++||++.+|+.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 229 LPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 000000 0001113458899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=308.44 Aligned_cols=267 Identities=21% Similarity=0.279 Sum_probs=192.6
Q ss_pred CccccceeccCCceEEEEEEEc-C--CcEEEEEEeeeCC--chhHHHHHHHHHHHHHc-CCCCceeEeeEeecc----ce
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLA-D--GREVAVKQLKIGG--SQGEREFRAEVEIISRV-HHRHLVSLVGYCISE----RE 451 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~-~--g~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~----~~ 451 (727)
+|++.+.||+|+||.||+++.. . +..||||++.... ....+.+.+|+++++++ +|+||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788899999999999999975 3 6789999986432 22345688999999999 599999999976432 45
Q ss_pred eeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchh
Q 041135 452 RLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKI 531 (727)
Q Consensus 452 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 531 (727)
.|+++||+. ++|.+++.... .+++..++.++.||+.||+|||++ +|+|||||++|||+++++.+||+|||+++.
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ--PLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 688889885 67888876544 488999999999999999999999 999999999999999999999999999975
Q ss_pred hhccCCC-ccccccccCCccccccCcccC-CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHH----
Q 041135 532 ALELDSN-THVSTRVMGTFGYMAPEYATS-GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLA---- 605 (727)
Q Consensus 532 ~~~~~~~-~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~---- 605 (727)
+...... ........|+..|+|||++.+ ..++.++|||||||++|+|++|+.+|...... .........+.
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~ 231 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV---DQLNQILQVLGTPDE 231 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH---HHHHHHHHHhCCCCH
Confidence 4322111 111234578999999998866 46899999999999999999999999764321 11111000000
Q ss_pred ---HhhchhhHHHHHHHH--h-hc---ccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 606 ---EALEHEDFEALVDSR--L-EK---NYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 606 ---~~~~~~~~~~l~d~~--l-~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
..+........+... . .. .........+.+|+.+||+.||++|+++.||+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000000000 0 00 0001123458899999999999999999999866
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=305.70 Aligned_cols=241 Identities=28% Similarity=0.387 Sum_probs=198.0
Q ss_pred cCccccceeccCCceEEEEEEEcC-CcEEEEEEeeeCC---chhHHHHHHHHHHHHHcC-CCCceeEeeEeeccceeeEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLAD-GREVAVKQLKIGG---SQGEREFRAEVEIISRVH-HRHLVSLVGYCISERERLLV 455 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~~-g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~lV 455 (727)
.+|.++.+||+|+||+|.+|..++ .+.+|||+++..- ..+.+.-+.|.++|.... -+.+++|..+|+.-+.+|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 468889999999999999998653 6779999997432 222344567888888764 68899999999999999999
Q ss_pred EeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhcc
Q 041135 456 YEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALEL 535 (727)
Q Consensus 456 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 535 (727)
|||+.||+|..++++.++ +.+...+.++.+|+-||-|||++ +||.||||.+|||||.+|++||+|||+++...
T Consensus 429 MEyvnGGDLMyhiQQ~Gk--FKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni-- 501 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVGK--FKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI-- 501 (683)
T ss_pred EEEecCchhhhHHHHhcc--cCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccccc--
Confidence 999999999999988876 77888899999999999999999 99999999999999999999999999997421
Q ss_pred CCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHH
Q 041135 536 DSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEA 615 (727)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~ 615 (727)
-.......+|||+.|+|||++....|...+|+|+|||+|||||.|+.||++.+. + +.+..
T Consensus 502 -~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE---~----------------elF~a 561 (683)
T KOG0696|consen 502 -FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE---D----------------ELFQA 561 (683)
T ss_pred -cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH---H----------------HHHHH
Confidence 122234468999999999999999999999999999999999999999998642 1 12233
Q ss_pred HHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCC
Q 041135 616 LVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPR 650 (727)
Q Consensus 616 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs 650 (727)
+++.. ..|......+.+.|++..|.+.|.+|..
T Consensus 562 I~ehn--vsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 562 IMEHN--VSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred HHHcc--CcCcccccHHHHHHHHHHhhcCCccccC
Confidence 33322 2344455566788999999999999964
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=326.92 Aligned_cols=261 Identities=24% Similarity=0.389 Sum_probs=212.8
Q ss_pred cHHHHHHHhcCccccceeccCCceEEEEEEE-cCCcEEEEEEeeeCCchhHHHHHHHHHHHHHc-CCCCceeEeeEeec-
Q 041135 372 TYDELIQATNGFSAHNVLGEGGFGCVYKGVL-ADGREVAVKQLKIGGSQGEREFRAEVEIISRV-HHRHLVSLVGYCIS- 448 (727)
Q Consensus 372 ~~~el~~~~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~- 448 (727)
.++.+-.-++.|++.+.||+|.+|+||+++. ++|+.+|||++... ...+++++.|.++|+.+ +|+|++.++|+|..
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 3444444567799999999999999999985 56889999988654 34456888999999988 59999999999863
Q ss_pred ----cceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEE
Q 041135 449 ----ERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVA 524 (727)
Q Consensus 449 ----~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~ 524 (727)
++++|||||||.+|+.-+++++.....+.|..+..|++.++.||.+||.+ .++|||||-.||||+.++.|||+
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEe
Confidence 56899999999999999998876677799999999999999999999999 89999999999999999999999
Q ss_pred eeccchhhhccCCCccccccccCCccccccCcccCC-----CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHh
Q 041135 525 DFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSG-----KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEW 599 (727)
Q Consensus 525 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~ 599 (727)
|||++.. .+..........||+.|||||++... .|+.++|+||||++..||--|..|+....++....++
T Consensus 166 DFGvSaQ---ldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I-- 240 (953)
T KOG0587|consen 166 DFGVSAQ---LDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI-- 240 (953)
T ss_pred eeeeeee---eecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC--
Confidence 9999975 35555666678999999999999653 4788999999999999999999999765543211110
Q ss_pred hHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 600 ARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 600 ~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
.................+.++|..||.+|-++||.+.+++++
T Consensus 241 ----------------pRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 241 ----------------PRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred ----------------CCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 001111122234455568899999999999999999998876
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=319.33 Aligned_cols=265 Identities=21% Similarity=0.334 Sum_probs=198.3
Q ss_pred HHhcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeC--CchhHHHHHHHHHHHHHcCCCCceeEeeEeeccce---
Q 041135 378 QATNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIG--GSQGEREFRAEVEIISRVHHRHLVSLVGYCISERE--- 451 (727)
Q Consensus 378 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~--- 451 (727)
...++|++.+.||+|+||.||+|++. +++.||||++... .......+.+|+.++++++|+||+++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 34678999999999999999999975 5789999988643 22334567889999999999999999998876554
Q ss_pred ---eeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeecc
Q 041135 452 ---RLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGL 528 (727)
Q Consensus 452 ---~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGl 528 (727)
.++|+||+ +++|.+++... .+++..+++++.||++||+|||++ +|+|||||++|||+++++.+||+|||+
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKCQ---KLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccccc
Confidence 89999999 67888887653 489999999999999999999999 999999999999999999999999999
Q ss_pred chhhhccCCCccccccccCCccccccCcccC-CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhH------
Q 041135 529 AKIALELDSNTHVSTRVMGTFGYMAPEYATS-GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWAR------ 601 (727)
Q Consensus 529 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~------ 601 (727)
+..... ......++..|++||++.+ ..++.++|||||||++|||++|+.+|....... .+.....
T Consensus 165 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~--~~~~i~~~~~~~~ 236 (343)
T cd07851 165 ARHTDD------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID--QLKRIMNLVGTPD 236 (343)
T ss_pred cccccc------cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHhcCCCC
Confidence 975421 1223457888999999865 367899999999999999999999997543211 1100000
Q ss_pred HHHHHhhchhhHHHHHHHHhhc---cc---chhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 602 PLLAEALEHEDFEALVDSRLEK---NY---VDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 602 ~~l~~~~~~~~~~~l~d~~l~~---~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
..+...+.......++...... .+ .......+.+|+++||+.+|++||++.||+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 237 EELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0000111111111111111100 00 01123468899999999999999999999876
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=295.92 Aligned_cols=236 Identities=29% Similarity=0.360 Sum_probs=192.1
Q ss_pred eccCCceEEEEEEEc-CCcEEEEEEeeeCCch---hHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeeccCCcc
Q 041135 389 LGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQ---GEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPNDTL 464 (727)
Q Consensus 389 LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL 464 (727)
||+|+||.||+++.. +++.|+||+++..... ....+.+|++++++++|+||+++++.+..+...++||||+.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999975 4899999998754322 345789999999999999999999999999999999999999999
Q ss_pred chhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCcccccc
Q 041135 465 HYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTR 544 (727)
Q Consensus 465 ~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 544 (727)
.+++.... .+++..++.++.||++||.|||+. +++|+|||++||++++++.++|+|||++....... .....
T Consensus 81 ~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~ 152 (250)
T cd05123 81 FSHLSKEG--RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG---SRTNT 152 (250)
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC---CcccC
Confidence 99997664 389999999999999999999998 99999999999999999999999999997542211 12334
Q ss_pred ccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHhhcc
Q 041135 545 VMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRLEKN 624 (727)
Q Consensus 545 ~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~ 624 (727)
..++..|++||.+.+...+.++|||+||+++|||++|+.||..... ..+. + .+.... ..
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~---~-------------~~~~~~--~~ 211 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIY---E-------------KILKDP--LR 211 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHH---H-------------HHhcCC--CC
Confidence 5678899999999988899999999999999999999999975431 1110 0 011111 11
Q ss_pred cchhHHHHHHHHHHHHhccCCCCCCCHHH
Q 041135 625 YVDSEMFWMIEAAAACVRHSATKRPRMSQ 653 (727)
Q Consensus 625 ~~~~~~~~l~~li~~cl~~dP~~RPs~~e 653 (727)
+.......+.+++++||..||++|+++.+
T Consensus 212 ~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 212 FPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 22222345789999999999999999944
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=308.29 Aligned_cols=257 Identities=27% Similarity=0.399 Sum_probs=196.4
Q ss_pred cCccccceeccCCceEEEEEEE-cCCcEEEEEEeeeCCchh-------HHHHHHHHHHHHHcCCCCceeEeeEeecc-ce
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVL-ADGREVAVKQLKIGGSQG-------EREFRAEVEIISRVHHRHLVSLVGYCISE-RE 451 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vaVK~l~~~~~~~-------~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~-~~ 451 (727)
++|-++++||+|||+.|||+.+ ...+.||||+-..+.... .+...+|.++.+.|+|+.||++|+||..+ +.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 4588899999999999999984 457889999875443211 13467899999999999999999999754 56
Q ss_pred eeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEEC---CCCcEEEEeecc
Q 041135 452 RLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLD---SSFEARVADFGL 528 (727)
Q Consensus 452 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~---~~~~vkL~DFGl 528 (727)
++-|+|||+|.+|+.||+.+.. +++++...|++||+.||.||.+. .+.|||-|||+.||||- ..|.+||.||||
T Consensus 543 FCTVLEYceGNDLDFYLKQhkl--mSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQHKL--MSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred ceeeeeecCCCchhHHHHhhhh--hhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 7889999999999999988764 99999999999999999999996 67899999999999994 457899999999
Q ss_pred chhhhccCCC----ccccccccCCccccccCcccCC----CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhh
Q 041135 529 AKIALELDSN----THVSTRVMGTFGYMAPEYATSG----KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWA 600 (727)
Q Consensus 529 a~~~~~~~~~----~~~~~~~~gt~~y~aPE~l~~~----~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~ 600 (727)
++...+.... -.......||++|+.||++.-+ +.+.|+||||+|||+|.+|-|+.||..+... ..+
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ--QdI---- 693 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ--QDI---- 693 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH--HHH----
Confidence 9875432221 1123346899999999998654 5789999999999999999999999864321 111
Q ss_pred HHHHHHhhchhhHHHHHHHHhhcccc--hhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 601 RPLLAEALEHEDFEALVDSRLEKNYV--DSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 601 ~~~l~~~~~~~~~~~l~d~~l~~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
+.+ ..+... -+..|. .........||++||...-++|.++.+|...
T Consensus 694 ---Lqe----NTIlkA----tEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d 741 (775)
T KOG1151|consen 694 ---LQE----NTILKA----TEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD 741 (775)
T ss_pred ---Hhh----hchhcc----eeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence 111 111110 011121 1122346678999999999999988887543
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=305.13 Aligned_cols=268 Identities=22% Similarity=0.293 Sum_probs=205.5
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCC------CCceeEeeEeecccee
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRVHH------RHLVSLVGYCISERER 452 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H------pnIv~l~~~~~~~~~~ 452 (727)
.++|.++++||+|.||+|.++.+. .+..||||+++.-. ...+..+-|+++|.+|.+ --+|.+.++|...+++
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 788999999999999999999864 37899999987432 223456779999999942 2377888899999999
Q ss_pred eEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEEC----------------
Q 041135 453 LLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLD---------------- 516 (727)
Q Consensus 453 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~---------------- 516 (727)
+||+|.+ |-+++++|..+....+....+..|++||+++++|||++ +|+|-||||+|||+-
T Consensus 167 Civfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred EEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCccce
Confidence 9999988 77999999998888899999999999999999999999 999999999999992
Q ss_pred ----CCCcEEEEeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCC
Q 041135 517 ----SSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLG 592 (727)
Q Consensus 517 ----~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~ 592 (727)
.+..|||+|||.|+...+ . ...++.|..|+|||++++-.++..+||||+||||+||++|..-|...+..+
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~~e----~--hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFDHE----H--HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred eccCCCcceEEEecCCcceecc----C--cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 134589999999985322 1 145678999999999999999999999999999999999999998766332
Q ss_pred chhhHHhhH-HHHHHhhchhhHHHH-HHHHhh-----------------------cccchhHHHHHHHHHHHHhccCCCC
Q 041135 593 DESLVEWAR-PLLAEALEHEDFEAL-VDSRLE-----------------------KNYVDSEMFWMIEAAAACVRHSATK 647 (727)
Q Consensus 593 ~~~l~~~~~-~~l~~~~~~~~~~~l-~d~~l~-----------------------~~~~~~~~~~l~~li~~cl~~dP~~ 647 (727)
...+.+... ++....+....-++. ..++|+ ....+.+...|++|+++||..||.+
T Consensus 317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~ 396 (415)
T KOG0671|consen 317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR 396 (415)
T ss_pred HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence 222221111 110111111100000 001111 1124556677999999999999999
Q ss_pred CCCHHHHHHHH
Q 041135 648 RPRMSQVVRAL 658 (727)
Q Consensus 648 RPs~~evl~~L 658 (727)
|.+++|++.+-
T Consensus 397 RiTl~EAL~Hp 407 (415)
T KOG0671|consen 397 RITLREALSHP 407 (415)
T ss_pred cccHHHHhcCH
Confidence 99999998763
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=313.66 Aligned_cols=209 Identities=25% Similarity=0.331 Sum_probs=176.9
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCch---hHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQ---GEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
.-|..++.||-|+||+|.+++.. ....||+|.|+..+.. ....+++|.+||...+...||+||..|.+++.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 45888899999999999999854 4667899998754432 2345788999999999999999999999999999999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccC
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 536 (727)
||+.||++..+|.+.+. |.+.....++.++.+|+++.|++ |+||||||++|||||.||++||.||||+.-+.-..
T Consensus 709 dYIPGGDmMSLLIrmgI--FeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMGI--FEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred eccCCccHHHHHHHhcc--CHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceecc
Confidence 99999999999887765 88888888999999999999999 99999999999999999999999999996432100
Q ss_pred C-C--------------------------------------ccccccccCCccccccCcccCCCCCchhHHHHHhHHHHH
Q 041135 537 S-N--------------------------------------THVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLE 577 (727)
Q Consensus 537 ~-~--------------------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~e 577 (727)
. . ......++||..|+|||+|....|+..+|+|+.||||||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence 0 0 000112569999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCCch
Q 041135 578 LITGRKPVDASQPLGDE 594 (727)
Q Consensus 578 LltG~~Pf~~~~~~~~~ 594 (727)
|+.|+.||......+..
T Consensus 864 m~~g~~pf~~~tp~~tq 880 (1034)
T KOG0608|consen 864 MLVGQPPFLADTPGETQ 880 (1034)
T ss_pred HhhCCCCccCCCCCcce
Confidence 99999999887765543
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=334.32 Aligned_cols=261 Identities=25% Similarity=0.278 Sum_probs=206.5
Q ss_pred HHHHHHHhcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeC---CchhHHHHHHHHHHHHHcCCCCceeEeeEeec
Q 041135 373 YDELIQATNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIG---GSQGEREFRAEVEIISRVHHRHLVSLVGYCIS 448 (727)
Q Consensus 373 ~~el~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~ 448 (727)
+.++....++|.++++||+|+||.|.+++++ .++.||+|+++.. ...+...|+.|-++|..-+.+.|++|+..|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 3455555689999999999999999999976 4788999998752 23334569999999999999999999999999
Q ss_pred cceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeecc
Q 041135 449 ERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGL 528 (727)
Q Consensus 449 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGl 528 (727)
+.++||||||+.||+|..+|.+.+ .+.++....++..|+.||+.||+. |+|||||||+|||||.+|++||+|||.
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGs 221 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGS 221 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchh
Confidence 999999999999999999998877 488888889999999999999999 999999999999999999999999998
Q ss_pred chhhhccCCCccccccccCCccccccCcccC-----CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHH
Q 041135 529 AKIALELDSNTHVSTRVMGTFGYMAPEYATS-----GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPL 603 (727)
Q Consensus 529 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~ 603 (727)
+.... ..+.......+||+.|.+||+|.. +.|+..+|+||+||++||||.|..||.. +.+++
T Consensus 222 Clkm~--~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa------dslve----- 288 (1317)
T KOG0612|consen 222 CLKMD--ADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA------DSLVE----- 288 (1317)
T ss_pred HHhcC--CCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH------HHHHH-----
Confidence 86542 233344556789999999999962 5789999999999999999999999953 23333
Q ss_pred HHHhhchhhHHHHHHHHhhcccc--hhHHHHHHHHHHHHhccCCCCCCC---HHHHHHHHhh
Q 041135 604 LAEALEHEDFEALVDSRLEKNYV--DSEMFWMIEAAAACVRHSATKRPR---MSQVVRALDT 660 (727)
Q Consensus 604 l~~~~~~~~~~~l~d~~l~~~~~--~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~L~~ 660 (727)
.+.+++++.-.-.|. ........+||++.+. +++.|.. +.+|..+.-.
T Consensus 289 --------TY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF 341 (1317)
T KOG0612|consen 289 --------TYGKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFF 341 (1317)
T ss_pred --------HHHHHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccc
Confidence 233333332222222 1223345566666554 5577777 8888777543
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=269.73 Aligned_cols=199 Identities=23% Similarity=0.384 Sum_probs=165.8
Q ss_pred ccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhH--HHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeec
Q 041135 383 FSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGE--REFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYV 459 (727)
Q Consensus 383 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~--~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 459 (727)
|...++||+|.||+||||+.+ .++.||+|+++..+..+. ....+||-+|+.++|.|||+++++...+..+-||+|||
T Consensus 4 ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c 83 (292)
T KOG0662|consen 4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_pred hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh
Confidence 555688999999999999965 588899999986544332 56889999999999999999999999999999999999
Q ss_pred cCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCc
Q 041135 460 PNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNT 539 (727)
Q Consensus 460 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 539 (727)
. .+|..|.....+ .++.+.+..++.|+++||.|+|++ +++|||||+.|+||+.+|++||+||||++.+. -..
T Consensus 84 d-qdlkkyfdslng-~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafg---ipv 155 (292)
T KOG0662|consen 84 D-QDLKKYFDSLNG-DLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFG---IPV 155 (292)
T ss_pred h-HHHHHHHHhcCC-cCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcC---Cce
Confidence 4 466666543322 388999999999999999999999 99999999999999999999999999998652 111
Q ss_pred cccccccCCccccccCcccCC-CCCchhHHHHHhHHHHHHHh-CCCCCCCCC
Q 041135 540 HVSTRVMGTFGYMAPEYATSG-KLTEKSDVYSFGVVLLELIT-GRKPVDASQ 589 (727)
Q Consensus 540 ~~~~~~~gt~~y~aPE~l~~~-~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~ 589 (727)
......+.|.+|..|+++.+. .|+...|+||-|||+.||.. |+.-|.+.+
T Consensus 156 rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~d 207 (292)
T KOG0662|consen 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 207 (292)
T ss_pred EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCc
Confidence 222334578999999999885 48889999999999999988 666676654
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=321.94 Aligned_cols=265 Identities=22% Similarity=0.289 Sum_probs=172.1
Q ss_pred HhcCccccceeccCCceEEEEEEEcC-----CcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeE------ee
Q 041135 379 ATNGFSAHNVLGEGGFGCVYKGVLAD-----GREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGY------CI 447 (727)
Q Consensus 379 ~~~~~~~~~~LG~G~fg~Vy~~~~~~-----g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~------~~ 447 (727)
..++|++.++||+|+||.||+|++.+ +..||||+++.... .+.+..| .++...+.+++.++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 45789999999999999999999754 68999998763221 1111111 1222222233322221 24
Q ss_pred ccceeeEEEeeccCCccchhcccCCCC------------------cccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCC
Q 041135 448 SERERLLVYEYVPNDTLHYHLHAEGRP------------------VMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIK 509 (727)
Q Consensus 448 ~~~~~~lV~Ey~~~gsL~~~L~~~~~~------------------~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLk 509 (727)
++...+|||||+.+++|.++++..... ......+..|+.||++||+|||++ +|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence 566789999999999999888654210 112334568999999999999998 99999999
Q ss_pred CCceEECC-CCcEEEEeeccchhhhccCCCccccccccCCccccccCcccCC----------------------CCCchh
Q 041135 510 SSNILLDS-SFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSG----------------------KLTEKS 566 (727)
Q Consensus 510 p~NILl~~-~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----------------------~~~~ks 566 (727)
++||||++ ++.+||+|||+++.+.. .........+++..|||||.+... .+..++
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~--~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRV--GINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccc--ccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 99999985 57999999999975421 122233456789999999965422 244567
Q ss_pred HHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHh----hccc--chhHHHHHHHHHHHH
Q 041135 567 DVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRL----EKNY--VDSEMFWMIEAAAAC 640 (727)
Q Consensus 567 DVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l----~~~~--~~~~~~~l~~li~~c 640 (727)
||||||||||||+++..+++. .+..+.+.+.........+...+.... ...+ ...+.....+|+++|
T Consensus 361 DVwSlGviL~el~~~~~~~~~-------~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~m 433 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSDS-------NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSM 433 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCch-------HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHH
Confidence 999999999999998766542 111111111110000001111111100 0000 111122355899999
Q ss_pred hccCCCCCCCHHHHHHHHh
Q 041135 641 VRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 641 l~~dP~~RPs~~evl~~L~ 659 (727)
|+.||++|++++|++++=.
T Consensus 434 L~~dP~kR~ta~e~L~Hpf 452 (566)
T PLN03225 434 MRFKGRQRISAKAALAHPY 452 (566)
T ss_pred ccCCcccCCCHHHHhCCcC
Confidence 9999999999999999733
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=291.01 Aligned_cols=273 Identities=22% Similarity=0.338 Sum_probs=198.9
Q ss_pred CccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchh--HHHHHHHHHHHHHcCCCCceeEeeEeec--------cc
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQG--EREFRAEVEIISRVHHRHLVSLVGYCIS--------ER 450 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~--~~~~~~Ei~~l~~l~HpnIv~l~~~~~~--------~~ 450 (727)
.|..+.+||+|.||.||+|+.+ .|+.||+|++..++..+ -....+|+++|..|+|+|+++|++.|.. ..
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 3555688999999999999965 47788998775433222 2467889999999999999999999864 23
Q ss_pred eeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccch
Q 041135 451 ERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAK 530 (727)
Q Consensus 451 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~ 530 (727)
.+||||++|+. +|.-+|... ...++..++.+++.+++.||.|+|.+ .|+|||+|+.||||+.++.+||+|||++|
T Consensus 98 t~ylVf~~ceh-DLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecccccc
Confidence 57999999965 555555433 23488999999999999999999999 99999999999999999999999999998
Q ss_pred hhhccCC-CccccccccCCccccccCcccCC-CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhH-HHHHHh
Q 041135 531 IALELDS-NTHVSTRVMGTFGYMAPEYATSG-KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWAR-PLLAEA 607 (727)
Q Consensus 531 ~~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~-~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~-~~l~~~ 607 (727)
.+...+. .....++.+.|+.|+.||.+.+. .|+...|||.-||||.||++|..-|.++.......++..+- .+-.+.
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev 252 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV 252 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence 6643322 22234556779999999999875 68999999999999999999999888765432222221110 000111
Q ss_pred hchhh----HH------------HHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhcc
Q 041135 608 LEHED----FE------------ALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLD 662 (727)
Q Consensus 608 ~~~~~----~~------------~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 662 (727)
+-.-+ +. ..+..++.. |.. ....++|+..+|..||.+|+++++++++-....
T Consensus 253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp-~~k--d~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k 320 (376)
T KOG0669|consen 253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKP-YVK--DDEALDLLEKLLKLDPTKRIDADQALNHDFFWK 320 (376)
T ss_pred CCCcccchHHHhccCCCCCcchhhhhhhhccc-ccC--ChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence 10000 11 111111110 111 124678999999999999999999998866543
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=306.04 Aligned_cols=253 Identities=23% Similarity=0.279 Sum_probs=209.5
Q ss_pred cCccccceeccCCceEEEEEEEcCCc-EEEEEEeeeC---CchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLADGR-EVAVKQLKIG---GSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~~g~-~vaVK~l~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
.+++++..||-|+||+|-+++.+... .+|+|+++.. +.+..+.+..|.++|..++.+.||+||..|.++..+|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 34666778999999999999876433 3788887643 3444567889999999999999999999999999999999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccC
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 536 (727)
|-|-||.|..+|+.++. ++......++..+++|++|||++ +||.|||||+|+|||.+|-+||.|||+|+.+..
T Consensus 500 EaClGGElWTiLrdRg~--Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~-- 572 (732)
T KOG0614|consen 500 EACLGGELWTILRDRGS--FDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS-- 572 (732)
T ss_pred HhhcCchhhhhhhhcCC--cccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhcc--
Confidence 99999999999988776 88888899999999999999999 999999999999999999999999999986532
Q ss_pred CCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHH
Q 041135 537 SNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEAL 616 (727)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l 616 (727)
....-.+|||..|.|||++.++..+.++|.|+||+++||||+|..||.+.+++...++ +
T Consensus 573 --g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~-------------------I 631 (732)
T KOG0614|consen 573 --GRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNL-------------------I 631 (732)
T ss_pred --CCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHH-------------------H
Confidence 2233458999999999999999999999999999999999999999998776532221 1
Q ss_pred HHHHhhcccchhHHHHHHHHHHHHhccCCCCCCC-----HHHHHHHHhhc
Q 041135 617 VDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPR-----MSQVVRALDTL 661 (727)
Q Consensus 617 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~L~~~ 661 (727)
+.+.-...+.....++..+||++.+..+|.+|.. +.+|.++-+..
T Consensus 632 LkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~ 681 (732)
T KOG0614|consen 632 LKGIDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFE 681 (732)
T ss_pred HhhhhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhh
Confidence 2222223345556677889999999999999986 66777665544
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=290.21 Aligned_cols=254 Identities=24% Similarity=0.369 Sum_probs=190.8
Q ss_pred ccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc-hhHHHHHHHHHHHHHc-CCCCceeEeeEeeccceeeEEEeec
Q 041135 383 FSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS-QGEREFRAEVEIISRV-HHRHLVSLVGYCISERERLLVYEYV 459 (727)
Q Consensus 383 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~ 459 (727)
++.+..||.|.||.|+|-.++ .|+..|||+++.... .+.+.|+.|.+...+- +.+|||+++|.+..++..||.||+|
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM 145 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM 145 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence 444578999999999998876 589999999987655 4456788888876654 6899999999999999999999998
Q ss_pred cCCccch---hcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccC
Q 041135 460 PNDTLHY---HLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536 (727)
Q Consensus 460 ~~gsL~~---~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 536 (727)
..+|+. +.....+..+.+..+-.|....+.||+||.+.+ +||||||||+|||||..|.+||||||++..+.+.
T Consensus 146 -d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S- 221 (361)
T KOG1006|consen 146 -DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS- 221 (361)
T ss_pred -hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH-
Confidence 445443 333334445888888889999999999999876 8999999999999999999999999999765322
Q ss_pred CCccccccccCCccccccCcccC--CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHH
Q 041135 537 SNTHVSTRVMGTFGYMAPEYATS--GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFE 614 (727)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~l~~--~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~ 614 (727)
...+.-.|-.-|||||.+.. ..|+-++||||||+.|+|+.||+.||.+.+. +.+-+..+. .++..
T Consensus 222 ---iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~Vv-----~gdpp 288 (361)
T KOG1006|consen 222 ---IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQVV-----IGDPP 288 (361)
T ss_pred ---HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHHH-----cCCCC
Confidence 12233467788999999964 3589999999999999999999999975321 111111110 01111
Q ss_pred HHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 615 ALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 615 ~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
.+.... -...-...|.+++..||.+|-.+||.+.+|+++
T Consensus 289 ~l~~~~----~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 289 ILLFDK----ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred eecCcc----cccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 110000 011123458899999999999999999998765
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=313.39 Aligned_cols=267 Identities=20% Similarity=0.274 Sum_probs=183.0
Q ss_pred hcCccccceeccCCceEEEEEEE-----------------cCCcEEEEEEeeeCCchhHHH--------------HHHHH
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVL-----------------ADGREVAVKQLKIGGSQGERE--------------FRAEV 428 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~-----------------~~g~~vaVK~l~~~~~~~~~~--------------~~~Ei 428 (727)
.++|++.++||+|+||.||+|.+ .+++.||||+++.......++ +..|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 56799999999999999999964 235689999987543322223 33477
Q ss_pred HHHHHcCCCCc-----eeEeeEeec--------cceeeEEEeeccCCccchhcccCCC----------------------
Q 041135 429 EIISRVHHRHL-----VSLVGYCIS--------ERERLLVYEYVPNDTLHYHLHAEGR---------------------- 473 (727)
Q Consensus 429 ~~l~~l~HpnI-----v~l~~~~~~--------~~~~~lV~Ey~~~gsL~~~L~~~~~---------------------- 473 (727)
.++.+++|.++ ++++++|.. ++..||||||+.+++|.++|+....
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77788876654 677888753 3467999999999999998864311
Q ss_pred CcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCccccccccCCccccc
Q 041135 474 PVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMA 553 (727)
Q Consensus 474 ~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~a 553 (727)
..+++..++.|+.||++||+|||++ +|+|||||++|||++.++.+||+|||+++..... .........++..|++
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~--~~~~~~~g~~tp~Y~a 378 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTG--INFNPLYGMLDPRYSP 378 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccC--CccCccccCCCcceeC
Confidence 1246778899999999999999998 9999999999999999999999999999753211 1111112345789999
Q ss_pred cCcccCCC--------------------C--CchhHHHHHhHHHHHHHhCCC-CCCCCCCCCchhhHHhhHHHHHHhhch
Q 041135 554 PEYATSGK--------------------L--TEKSDVYSFGVVLLELITGRK-PVDASQPLGDESLVEWARPLLAEALEH 610 (727)
Q Consensus 554 PE~l~~~~--------------------~--~~ksDVwS~Gvil~eLltG~~-Pf~~~~~~~~~~l~~~~~~~l~~~~~~ 610 (727)
||.+.... + ..+.||||+|||||||++|.. +|....... ..+..+ ...+
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~-~~~~~~-~~~~------ 450 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFN-TELRQY-DNDL------ 450 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhh-hHHhhc-cchH------
Confidence 99886432 1 134799999999999999876 665322111 000000 0000
Q ss_pred hhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCC---CCCCCHHHHHHHHh
Q 041135 611 EDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSA---TKRPRMSQVVRALD 659 (727)
Q Consensus 611 ~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~evl~~L~ 659 (727)
..+.......+.-...........+|+++||..++ .+|+++.|++++-+
T Consensus 451 ~~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~ 502 (507)
T PLN03224 451 NRWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRF 502 (507)
T ss_pred HHHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCC
Confidence 00111111111111122234457889999999866 68999999998744
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=310.73 Aligned_cols=243 Identities=23% Similarity=0.261 Sum_probs=197.0
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHc-CCCCceeEeeEeeccceeeEEEe
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRV-HHRHLVSLVGYCISERERLLVYE 457 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E 457 (727)
.+.|.+...||.|+|+.|.++.+. +++..+||++... ..+..+|+.++... +|+||+++.+.|.++.+.|+|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 567888888999999999999864 5889999998643 33455678777766 69999999999999999999999
Q ss_pred eccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEE-CCCCcEEEEeeccchhhhccC
Q 041135 458 YVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILL-DSSFEARVADFGLAKIALELD 536 (727)
Q Consensus 458 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl-~~~~~vkL~DFGla~~~~~~~ 536 (727)
++.|+.|.+.+..+.. +. ..+..|+.+|+.+|+|||++ ||||||||++|||+ ++.++++|+|||+++.....
T Consensus 397 ~l~g~ell~ri~~~~~--~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPE--FC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred hccccHHHHHHHhcch--hH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 9999999888766543 23 67778999999999999998 99999999999999 68999999999999854221
Q ss_pred CCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHH
Q 041135 537 SNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEAL 616 (727)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l 616 (727)
...-+.|..|.|||++....|+.++||||||++||+||+|+.+|...... .++
T Consensus 470 -----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~----------------------~ei 522 (612)
T KOG0603|consen 470 -----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG----------------------IEI 522 (612)
T ss_pred -----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch----------------------HHH
Confidence 22346788999999999999999999999999999999999999764421 111
Q ss_pred HHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhh
Q 041135 617 VDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDT 660 (727)
Q Consensus 617 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 660 (727)
+.......+.........+|+..||+.||.+|++|++|..+-+.
T Consensus 523 ~~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 523 HTRIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HHhhcCCccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 11112222223334457789999999999999999999888665
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=316.15 Aligned_cols=247 Identities=26% Similarity=0.370 Sum_probs=189.0
Q ss_pred ccccceeccCCce-EEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHc-CCCCceeEeeEeeccceeeEEEeecc
Q 041135 383 FSAHNVLGEGGFG-CVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRV-HHRHLVSLVGYCISERERLLVYEYVP 460 (727)
Q Consensus 383 ~~~~~~LG~G~fg-~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~ 460 (727)
|.-.+++|.|+.| .||+|.+ +|+.||||++.. .......+|+..|+.- +|+|||++++.-.+.+..||..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 4445779999998 5899999 589999999863 2344678999999987 5999999999999999999999999
Q ss_pred CCccchhcccC--CCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECC-----CCcEEEEeeccchhhh
Q 041135 461 NDTLHYHLHAE--GRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDS-----SFEARVADFGLAKIAL 533 (727)
Q Consensus 461 ~gsL~~~L~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~-----~~~vkL~DFGla~~~~ 533 (727)
..+|.+++... ........+.+.++.|+++||++||+. +||||||||.||||+. ..+++|+|||+++.+.
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 66899888763 221222245678899999999999998 9999999999999965 3579999999998764
Q ss_pred ccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhC-CCCCCCCCCCCchhhHHhhHHHHHHhhchhh
Q 041135 534 ELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITG-RKPVDASQPLGDESLVEWARPLLAEALEHED 612 (727)
Q Consensus 534 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG-~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~ 612 (727)
..........+..||-+|+|||++....-+.++|||+||||+|+.++| .+||...-... .+ ++... ..
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~-~N-------Il~~~---~~ 731 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ-AN-------ILTGN---YT 731 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh-hh-------hhcCc---cc
Confidence 443333345567899999999999999889999999999999999995 99997532110 00 00000 00
Q ss_pred HHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 613 FEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 613 ~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
+. .|.. ..++ ...+||.+|++.+|.+||++.+|+.+
T Consensus 732 L~-----~L~~--~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 732 LV-----HLEP--LPDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred ee-----eecc--CchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 00 0100 1111 56789999999999999999999754
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=287.29 Aligned_cols=220 Identities=21% Similarity=0.208 Sum_probs=174.9
Q ss_pred CCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeeccCCccchhccc
Q 041135 392 GGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPNDTLHYHLHA 470 (727)
Q Consensus 392 G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~ 470 (727)
|.||.||+++.. +|+.||+|+++... .+.+|...+....|+||+++++++.+.+..+|||||+.+|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999964 68899999987432 344566666667799999999999999999999999999999998876
Q ss_pred CCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCccccccccCCcc
Q 041135 471 EGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFG 550 (727)
Q Consensus 471 ~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~ 550 (727)
... +.+..++.++.||++||+|||++ +|+|||||++|||++.++.++|+|||++..... ......++..
T Consensus 79 ~~~--l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~------~~~~~~~~~~ 147 (237)
T cd05576 79 FLN--IPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED------SCDGEAVENM 147 (237)
T ss_pred hcC--CCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccc------ccccCCcCcc
Confidence 543 88999999999999999999998 999999999999999999999999998864321 1122345677
Q ss_pred ccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHhhcccchhHH
Q 041135 551 YMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEM 630 (727)
Q Consensus 551 y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~ 630 (727)
|++||++.++.++.++|||||||++|||++|+.+|........ ....+ .+ .....
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~---------------~~~~~------~~----~~~~~ 202 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN---------------THTTL------NI----PEWVS 202 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc---------------ccccc------CC----cccCC
Confidence 9999999888899999999999999999999987753211000 00000 01 11112
Q ss_pred HHHHHHHHHHhccCCCCCCCHH
Q 041135 631 FWMIEAAAACVRHSATKRPRMS 652 (727)
Q Consensus 631 ~~l~~li~~cl~~dP~~RPs~~ 652 (727)
..+.+|+++||+.||++|+++.
T Consensus 203 ~~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 203 EEARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHHHHHccCCHHHhcCCC
Confidence 3477899999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=280.75 Aligned_cols=237 Identities=28% Similarity=0.354 Sum_probs=192.2
Q ss_pred CceEEEEEEEcC-CcEEEEEEeeeCCchh-HHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeeccCCccchhccc
Q 041135 393 GFGCVYKGVLAD-GREVAVKQLKIGGSQG-EREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPNDTLHYHLHA 470 (727)
Q Consensus 393 ~fg~Vy~~~~~~-g~~vaVK~l~~~~~~~-~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~ 470 (727)
+||.||+|++.+ |+.|++|++....... .+.+.+|++++++++|+||+++++++......++||||+.+++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999864 8999999997655544 67899999999999999999999999999999999999999999999876
Q ss_pred CCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCccccccccCCcc
Q 041135 471 EGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFG 550 (727)
Q Consensus 471 ~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~ 550 (727)
... +++..++.++.+++++|.|||+. +|+|+||+++||++++++.++|+|||++....... ......++..
T Consensus 81 ~~~--~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~ 151 (244)
T smart00220 81 RGR--LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG----LLTTFVGTPE 151 (244)
T ss_pred ccC--CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc----ccccccCCcC
Confidence 544 78999999999999999999999 99999999999999999999999999997543211 2334567889
Q ss_pred ccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHhhcccch-hH
Q 041135 551 YMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRLEKNYVD-SE 629 (727)
Q Consensus 551 y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~-~~ 629 (727)
|++||.+.+..++.++|||+||+++|+|++|..+|..... ...+.++. ........... ..
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~--~~~~~~~~----------------~~~~~~~~~~~~~~ 213 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ--LLELFKKI----------------GKPKPPFPPPEWKI 213 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHH----------------hccCCCCccccccC
Confidence 9999999988899999999999999999999999865311 11111110 00000000000 02
Q ss_pred HHHHHHHHHHHhccCCCCCCCHHHHHH
Q 041135 630 MFWMIEAAAACVRHSATKRPRMSQVVR 656 (727)
Q Consensus 630 ~~~l~~li~~cl~~dP~~RPs~~evl~ 656 (727)
...+.+++++||..+|++||++.+|++
T Consensus 214 ~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 214 SPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred CHHHHHHHHHHccCCchhccCHHHHhh
Confidence 345888999999999999999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=287.56 Aligned_cols=263 Identities=22% Similarity=0.307 Sum_probs=197.3
Q ss_pred cccceeccCCceEEEEEEE-cCCcEEEEEEeeeC--CchhHHHHHHHHHHHHHcCCCCceeEeeEeecc-----ceeeEE
Q 041135 384 SAHNVLGEGGFGCVYKGVL-ADGREVAVKQLKIG--GSQGEREFRAEVEIISRVHHRHLVSLVGYCISE-----RERLLV 455 (727)
Q Consensus 384 ~~~~~LG~G~fg~Vy~~~~-~~g~~vaVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~-----~~~~lV 455 (727)
+-.+-||.|+||.||...+ ++|+.|++|++..- +....+.+.+|+++|..++|.||+.+++...-. +++|+|
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 3457799999999999885 57999999988522 223346788999999999999999998876532 356888
Q ss_pred EeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhcc
Q 041135 456 YEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALEL 535 (727)
Q Consensus 456 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 535 (727)
+|+| ..+|.+++-.-. .++.+.++-+++||++||.|||+. +|+|||||+.|+||+.|..+|||||||+|... .
T Consensus 136 TELm-QSDLHKIIVSPQ--~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee-~ 208 (449)
T KOG0664|consen 136 TELM-QSDLHKIIVSPQ--ALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWD-Q 208 (449)
T ss_pred HHHH-HhhhhheeccCC--CCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccc-h
Confidence 9988 567777775543 378888999999999999999999 99999999999999999999999999998542 2
Q ss_pred CCCccccccccCCccccccCcccCC-CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHH
Q 041135 536 DSNTHVSTRVMGTFGYMAPEYATSG-KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFE 614 (727)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~ 614 (727)
+. ....+..+.|-+|+|||++++. +|+.+.||||.|||+.|||.++.-|....+....+++.-+ +....++
T Consensus 209 d~-~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdL-------LGTPs~E 280 (449)
T KOG0664|consen 209 RD-RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDL-------LGTPSQE 280 (449)
T ss_pred hh-hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHH-------hCCCcHH
Confidence 22 2233445678899999999985 6899999999999999999999999887765444333221 1111111
Q ss_pred HH-------HHHHhhccc-------------chhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhc
Q 041135 615 AL-------VDSRLEKNY-------------VDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661 (727)
Q Consensus 615 ~l-------~d~~l~~~~-------------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 661 (727)
++ ....|+... ........+.+...++..|+++|.+..+.+.++..-
T Consensus 281 aMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~ 347 (449)
T KOG0664|consen 281 AMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLE 347 (449)
T ss_pred HHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccc
Confidence 11 112222211 112223456778889999999999999998876643
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=280.18 Aligned_cols=249 Identities=22% Similarity=0.322 Sum_probs=196.5
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc---hhHHHHHHHHHHHHHc-CCCCceeEeeEeeccceeeE
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS---QGEREFRAEVEIISRV-HHRHLVSLVGYCISERERLL 454 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~---~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~l 454 (727)
.++|.++++||+|+|++|.+++++ ..+.+|+|+++.+-. ++..=++.|..+..+. +|+.+|.|..+|..+..+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 467999999999999999999975 578899999875432 2233356688888766 69999999999999999999
Q ss_pred EEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhc
Q 041135 455 VYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALE 534 (727)
Q Consensus 455 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 534 (727)
|.||+.||+|..+++++++ +.++....+...|+.||.|||++ |||.||||.+|||||.+|++||.|+|+++....
T Consensus 329 vieyv~ggdlmfhmqrqrk--lpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred EEEEecCcceeeehhhhhc--CcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCCC
Confidence 9999999999888877665 88888889999999999999999 999999999999999999999999999985322
Q ss_pred cCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCC-chhhHHhhHHHHHHhhchhhH
Q 041135 535 LDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLG-DESLVEWARPLLAEALEHEDF 613 (727)
Q Consensus 535 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~-~~~l~~~~~~~l~~~~~~~~~ 613 (727)
.......+|||+.|.|||++++.+|....|+|+|||+|+||+.|+.||+...... +.+-.+++.+++-
T Consensus 404 ---~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvil-------- 472 (593)
T KOG0695|consen 404 ---PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVIL-------- 472 (593)
T ss_pred ---CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHh--------
Confidence 2233456899999999999999999999999999999999999999998643211 2223333332221
Q ss_pred HHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCC
Q 041135 614 EALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPR 650 (727)
Q Consensus 614 ~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs 650 (727)
+..++. ......+...+++..|++||.+|..
T Consensus 473 ----ekqiri--prslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 473 ----EKQIRI--PRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred ----hhcccc--cceeehhhHHHHHHhhcCCcHHhcC
Confidence 111111 1111223556788899999998853
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=283.73 Aligned_cols=270 Identities=20% Similarity=0.296 Sum_probs=202.1
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcC--------CCCceeEeeEeec---
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRVH--------HRHLVSLVGYCIS--- 448 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~--------HpnIv~l~~~~~~--- 448 (727)
.+|.++++||=|.|++||++.+. +.+.||+|+.+. .....+..+.||++|++++ ..+||+|+++|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 67999999999999999999864 578899999873 2333456788999999884 2579999999975
Q ss_pred -cceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCC---------
Q 041135 449 -ERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSS--------- 518 (727)
Q Consensus 449 -~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~--------- 518 (727)
+.+++||+|++ |.+|..+|.....+.+....+.+|++||+.||.|||..| +|||-|||++||||..+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~~~~~~~ 233 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEIDPAKDAR 233 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccccchhhhhh
Confidence 55899999999 777778887777778999999999999999999999999 99999999999999210
Q ss_pred --------------------------------------------------------------------------------
Q 041135 519 -------------------------------------------------------------------------------- 518 (727)
Q Consensus 519 -------------------------------------------------------------------------------- 518 (727)
T Consensus 234 ~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~ 313 (590)
T KOG1290|consen 234 EAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNE 313 (590)
T ss_pred hhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccc
Confidence
Q ss_pred -----------------------------------------------------------------------------CcE
Q 041135 519 -----------------------------------------------------------------------------FEA 521 (727)
Q Consensus 519 -----------------------------------------------------------------------------~~v 521 (727)
.+|
T Consensus 314 ~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~v 393 (590)
T KOG1290|consen 314 STVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRV 393 (590)
T ss_pred cchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeE
Confidence 024
Q ss_pred EEEeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCC---CCchhhHH
Q 041135 522 RVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQP---LGDESLVE 598 (727)
Q Consensus 522 kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~---~~~~~l~~ 598 (727)
||+|||.|.+.. ...+.-..|..|+|||++.+..|+..+|||||+||+|||+||..-|+-... ..+++.+.
T Consensus 394 KIaDlGNACW~~------khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA 467 (590)
T KOG1290|consen 394 KIADLGNACWVH------KHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIA 467 (590)
T ss_pred EEeeccchhhhh------hhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHH
Confidence 666666665531 122333467889999999999999999999999999999999998865432 22222222
Q ss_pred ----hhHHHHHHhh-----------chhhHHHH-------HHHHhhc--ccchhHHHHHHHHHHHHhccCCCCCCCHHHH
Q 041135 599 ----WARPLLAEAL-----------EHEDFEAL-------VDSRLEK--NYVDSEMFWMIEAAAACVRHSATKRPRMSQV 654 (727)
Q Consensus 599 ----~~~~~l~~~~-----------~~~~~~~l-------~d~~l~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 654 (727)
.+..+..... .++++..+ +...|.. ++..++...+.+|+.-||+++|++|+++.++
T Consensus 468 ~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~c 547 (590)
T KOG1290|consen 468 LIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQC 547 (590)
T ss_pred HHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHH
Confidence 1111111111 11111111 2222333 2467788889999999999999999999999
Q ss_pred HHHHhh
Q 041135 655 VRALDT 660 (727)
Q Consensus 655 l~~L~~ 660 (727)
+++-+-
T Consensus 548 l~hPwL 553 (590)
T KOG1290|consen 548 LKHPWL 553 (590)
T ss_pred hcCccc
Confidence 987553
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.7e-33 Score=292.86 Aligned_cols=222 Identities=23% Similarity=0.250 Sum_probs=185.6
Q ss_pred CCCCCCCCCCccccHHHHHHHhcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcC--
Q 041135 359 SESGVLGNSRSWFTYDELIQATNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRVH-- 435 (727)
Q Consensus 359 s~~~~~~~~~~~~~~~el~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~-- 435 (727)
.....|.+...+|.+.--+....+|.+....|+|-|++|.+|... -|..||||+|+.+ ..+.+.=++|++||++|+
T Consensus 410 ~L~DNWdDaEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~A 488 (752)
T KOG0670|consen 410 GLQDNWDDAEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDA 488 (752)
T ss_pred ccccCcccccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhcc
Confidence 334456666677776666677889999999999999999999864 4889999999854 344556678999999995
Q ss_pred ----CCCceeEeeEeeccceeeEEEeeccCCccchhcccCCC-CcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCC
Q 041135 436 ----HRHLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGR-PVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKS 510 (727)
Q Consensus 436 ----HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp 510 (727)
.-|+++|+..|...+++|||||-+ .-+|.++|+..++ ..|....+..++.||+.||..|..+ +|+|.||||
T Consensus 489 D~Edk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKP 564 (752)
T KOG0670|consen 489 DPEDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKP 564 (752)
T ss_pred CchhhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCc
Confidence 468999999999999999999988 6688888877653 4688889999999999999999998 999999999
Q ss_pred CceEECCC-CcEEEEeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCC
Q 041135 511 SNILLDSS-FEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQ 589 (727)
Q Consensus 511 ~NILl~~~-~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~ 589 (727)
+||||++. ..+||||||.|.+..+..- +-......|.|||+++|..|+...|+||.||.||||+||+.-|.+..
T Consensus 565 DNiLVNE~k~iLKLCDfGSA~~~~enei-----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T 639 (752)
T KOG0670|consen 565 DNILVNESKNILKLCDFGSASFASENEI-----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT 639 (752)
T ss_pred cceEeccCcceeeeccCccccccccccc-----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC
Confidence 99999865 5799999999986543222 22334567999999999999999999999999999999999998765
Q ss_pred C
Q 041135 590 P 590 (727)
Q Consensus 590 ~ 590 (727)
+
T Consensus 640 N 640 (752)
T KOG0670|consen 640 N 640 (752)
T ss_pred c
Confidence 4
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-32 Score=263.31 Aligned_cols=262 Identities=19% Similarity=0.312 Sum_probs=196.8
Q ss_pred hcCccccceeccCCceEEEEEE-EcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcC-CCCceeEeeEeeccc--eeeEE
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGEREFRAEVEIISRVH-HRHLVSLVGYCISER--ERLLV 455 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~-~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~--~~~lV 455 (727)
.++|++++++|+|.|++||.|+ ..+++.++||+++. ...+.+.+|+++|+.|. |+||+.|+++..+.. ...||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 4679999999999999999998 45788999999974 34578999999999997 999999999998755 44799
Q ss_pred EeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECC-CCcEEEEeeccchhhhc
Q 041135 456 YEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDS-SFEARVADFGLAKIALE 534 (727)
Q Consensus 456 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~-~~~vkL~DFGla~~~~~ 534 (727)
+||+.+.+...+-. .++..++..++.+|++||+|+|++ ||+|||+||.||+||. ...++|+|||||.+...
T Consensus 114 FE~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 114 FEYVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred hhhhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 99998887765443 367788999999999999999999 9999999999999985 45799999999987532
Q ss_pred cCCCccccccccCCccccccCcccC-CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhh-----
Q 041135 535 LDSNTHVSTRVMGTFGYMAPEYATS-GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEAL----- 608 (727)
Q Consensus 535 ~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~----- 608 (727)
.. ...-.+....|.-||.+.. ..|+..-|+|||||+|.+|+..+.||-.... ..++++..++-+-.+.+
T Consensus 186 ~~----eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~d-N~DQLVkIakVLGt~el~~Yl~ 260 (338)
T KOG0668|consen 186 GK----EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD-NYDQLVKIAKVLGTDELYAYLN 260 (338)
T ss_pred Cc----eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCC-CHHHHHHHHHHhChHHHHHHHH
Confidence 11 1122345677899999875 4689999999999999999999999865432 23455655442211111
Q ss_pred -----chhhHHHHHHHHhhccc---chh-----HHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 609 -----EHEDFEALVDSRLEKNY---VDS-----EMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 609 -----~~~~~~~l~d~~l~~~~---~~~-----~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
....+..++...-+..+ ... ..-+.++|+.+.|..|..+|++++|.+.+
T Consensus 261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 11222222222111111 000 01247789999999999999999998876
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-30 Score=252.47 Aligned_cols=211 Identities=35% Similarity=0.541 Sum_probs=182.7
Q ss_pred eccCCceEEEEEEEcC-CcEEEEEEeeeCCch-hHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeeccCCccch
Q 041135 389 LGEGGFGCVYKGVLAD-GREVAVKQLKIGGSQ-GEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPNDTLHY 466 (727)
Q Consensus 389 LG~G~fg~Vy~~~~~~-g~~vaVK~l~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~ 466 (727)
||+|.||.||+++..+ |+.++||++...... ..+.+.+|+++++.++|.+|+++++++......+++|||+.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999864 899999998755432 34679999999999999999999999999999999999999999999
Q ss_pred hcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECC-CCcEEEEeeccchhhhccCCCccccccc
Q 041135 467 HLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDS-SFEARVADFGLAKIALELDSNTHVSTRV 545 (727)
Q Consensus 467 ~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~-~~~vkL~DFGla~~~~~~~~~~~~~~~~ 545 (727)
++.... ..+++..++.++.+++++|+|||++ +++|+||++.||+++. ++.++|+|||++........ .....
T Consensus 81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~ 153 (215)
T cd00180 81 LLKENE-GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---LLKTI 153 (215)
T ss_pred HHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc---hhhcc
Confidence 987652 2478999999999999999999999 9999999999999999 89999999999975422111 22335
Q ss_pred cCCccccccCcccCC-CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHhhcc
Q 041135 546 MGTFGYMAPEYATSG-KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRLEKN 624 (727)
Q Consensus 546 ~gt~~y~aPE~l~~~-~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~ 624 (727)
.+...|++||.+... .++.+.|+|+||++||+|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 577889999999887 888999999999999999
Q ss_pred cchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 041135 625 YVDSEMFWMIEAAAACVRHSATKRPRMSQVVRAL 658 (727)
Q Consensus 625 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 658 (727)
..+.+++.+|++.++++|+++.++++.|
T Consensus 188 ------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 2367888999999999999999998754
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=251.83 Aligned_cols=199 Identities=26% Similarity=0.408 Sum_probs=161.1
Q ss_pred ccccceeccCCceEEEEEEEc-CCcEEEEEEeeeC-CchhHHHHHHHHHHHHHc-CCCCceeEeeEeeccceeeEEEeec
Q 041135 383 FSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIG-GSQGEREFRAEVEIISRV-HHRHLVSLVGYCISERERLLVYEYV 459 (727)
Q Consensus 383 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~-~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~ 459 (727)
+..+..||+|++|.|-+-++. +|...|||+++.. +.+..+.+++|+++..+. .++.+|.|||.+.++...||.||.|
T Consensus 48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M 127 (282)
T KOG0984|consen 48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM 127 (282)
T ss_pred hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh
Confidence 344567999999999888864 6999999999753 344556788888887665 6999999999999999999999998
Q ss_pred cCCccchhccc--CCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCC
Q 041135 460 PNDTLHYHLHA--EGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDS 537 (727)
Q Consensus 460 ~~gsL~~~L~~--~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 537 (727)
..+|+.|-+. ..+..+.+..+-+|+..+++||.|||++. .|||||+|++||||+.+|+|||||||++-.+.+.-.
T Consensus 128 -~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA 204 (282)
T KOG0984|consen 128 -DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA 204 (282)
T ss_pred -hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhhhH
Confidence 4566554322 12234788888999999999999999987 899999999999999999999999999875432111
Q ss_pred CccccccccCCccccccCcccC----CCCCchhHHHHHhHHHHHHHhCCCCCCCC
Q 041135 538 NTHVSTRVMGTFGYMAPEYATS----GKLTEKSDVYSFGVVLLELITGRKPVDAS 588 (727)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~l~~----~~~~~ksDVwS~Gvil~eLltG~~Pf~~~ 588 (727)
.+...|-..|||||.+.. ..|+-|+||||||+.++||.+++.||+..
T Consensus 205 ----kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 205 ----KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred ----HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 122356778999998864 36889999999999999999999999864
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-30 Score=260.29 Aligned_cols=259 Identities=24% Similarity=0.330 Sum_probs=192.5
Q ss_pred cCccccceeccCCceEEEEEEE-cCCcEEEEEEeeeC--CchhHHHHHHHHHHHHHcCCCCceeEeeEeecc------ce
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVL-ADGREVAVKQLKIG--GSQGEREFRAEVEIISRVHHRHLVSLVGYCISE------RE 451 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vaVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~------~~ 451 (727)
.+|.-++.+|.|.- .|..+.+ -.++.||+|++... +....+...+|+.++..++|.||++++.+|.-. ..
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 45666778888887 5555543 24889999987432 233446678899999999999999999998633 36
Q ss_pred eeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchh
Q 041135 452 RLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKI 531 (727)
Q Consensus 452 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 531 (727)
.|+||||| ..+|...++. .++-+.+..|+.|++.|+.|||+. +|+||||||+||+|..++.+||.|||+|+.
T Consensus 96 ~y~v~e~m-~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVILM----ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred HHHHHHhh-hhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcc
Confidence 69999999 5677777763 377889999999999999999999 999999999999999999999999999984
Q ss_pred hhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHH--------
Q 041135 532 ALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPL-------- 603 (727)
Q Consensus 532 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~-------- 603 (727)
. ......+..+.+..|.|||++.+..+...+||||+|||+.||++|+.-|.+.+.. ..|.+-+
T Consensus 168 e----~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~i-----dQ~~ki~~~lgtpd~ 238 (369)
T KOG0665|consen 168 E----DTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHI-----DQWNKIIEQLGTPDP 238 (369)
T ss_pred c----CcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHH-----HHHHHHHHHhcCCCH
Confidence 2 2224566678899999999999988999999999999999999999999865433 2332211
Q ss_pred ---------HHHhhch------hhHHHHHHH-Hhh--cccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 604 ---------LAEALEH------EDFEALVDS-RLE--KNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 604 ---------l~~~~~~------~~~~~l~d~-~l~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
.+..... -.+.+++-. .+. .+........+.+++.+||..+|++|-+++++|++
T Consensus 239 ~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 239 SFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 0000000 000000000 000 00111233346789999999999999999999987
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=252.57 Aligned_cols=199 Identities=33% Similarity=0.455 Sum_probs=173.0
Q ss_pred ccccceeccCCceEEEEEEEcC-CcEEEEEEeeeCCch-hHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeecc
Q 041135 383 FSAHNVLGEGGFGCVYKGVLAD-GREVAVKQLKIGGSQ-GEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVP 460 (727)
Q Consensus 383 ~~~~~~LG~G~fg~Vy~~~~~~-g~~vaVK~l~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 460 (727)
|++.+.||+|+||.||+|++.+ ++.++||.+...... ..+.+.+|++.+++++|+||+++++++......++++||+.
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5677899999999999999875 889999999865554 56789999999999999999999999999999999999999
Q ss_pred CCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCcc
Q 041135 461 NDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTH 540 (727)
Q Consensus 461 ~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 540 (727)
+++|.+++...... +++..++.++.+++.+|.|||++ +++|+||++.||+++.++.++|+|||++....... ..
T Consensus 81 ~~~L~~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~--~~ 154 (225)
T smart00221 81 GGDLFDYLRKKGGK-LSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL--AA 154 (225)
T ss_pred CCCHHHHHHhcccC-CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc--cc
Confidence 99999998765432 78899999999999999999998 99999999999999999999999999997653221 01
Q ss_pred ccccccCCccccccCcc-cCCCCCchhHHHHHhHHHHHHHhCCCCCCC
Q 041135 541 VSTRVMGTFGYMAPEYA-TSGKLTEKSDVYSFGVVLLELITGRKPVDA 587 (727)
Q Consensus 541 ~~~~~~gt~~y~aPE~l-~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~ 587 (727)
......+...|++||.+ ....++.++|||+||+++|||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 22345677889999998 666788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-31 Score=287.84 Aligned_cols=253 Identities=23% Similarity=0.389 Sum_probs=202.7
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEee
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 458 (727)
.++|.++..||.|.||.|||++.+ .|+..|||+++.....+...+++|+-+++..+|+|||.++|.+.....+|+.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 467889999999999999999964 5889999999998888888899999999999999999999999999999999999
Q ss_pred ccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCC
Q 041135 459 VPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSN 538 (727)
Q Consensus 459 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 538 (727)
|.||+|.+.-+..+. +++.++..+++..++||+|||++ +-+|||||-.|||+++.|.+||+|||.+-.+ ...
T Consensus 94 cgggslQdiy~~Tgp--lselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqi---tat 165 (829)
T KOG0576|consen 94 CGGGSLQDIYHVTGP--LSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQI---TAT 165 (829)
T ss_pred cCCCcccceeeeccc--chhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhh---hhh
Confidence 999999998877665 88999999999999999999999 8999999999999999999999999998643 233
Q ss_pred ccccccccCCccccccCcc---cCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHH
Q 041135 539 THVSTRVMGTFGYMAPEYA---TSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEA 615 (727)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~l---~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~ 615 (727)
......+.||.+|||||+. +.+.|..++|||++|+...||-.-+.|.....++....+ .. ...++
T Consensus 166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~L--------mT---kS~~q- 233 (829)
T KOG0576|consen 166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFL--------MT---KSGFQ- 233 (829)
T ss_pred hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHH--------hh---ccCCC-
Confidence 3445568899999999976 456799999999999999998765554322221110000 00 00000
Q ss_pred HHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 041135 616 LVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVR 656 (727)
Q Consensus 616 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 656 (727)
-..|+. .......+.+|++.|+.++|++||++..+|.
T Consensus 234 --pp~lkD--k~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 234 --PPTLKD--KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred --CCcccC--CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 001111 1223345789999999999999999987654
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-30 Score=274.99 Aligned_cols=197 Identities=24% Similarity=0.376 Sum_probs=167.9
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCch--------hHHHHHHHHHHHHHcC---CCCceeEeeEee
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQ--------GEREFRAEVEIISRVH---HRHLVSLVGYCI 447 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~--------~~~~~~~Ei~~l~~l~---HpnIv~l~~~~~ 447 (727)
..+|..++.||+|+||.|++|+++ +..+|+||++..+... ..-.+-.||.+|..|+ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 345899999999999999999986 4678999988643211 1113456999999997 999999999999
Q ss_pred ccceeeEEEeec-cCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEee
Q 041135 448 SERERLLVYEYV-PNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADF 526 (727)
Q Consensus 448 ~~~~~~lV~Ey~-~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DF 526 (727)
+++.+||+||-. +|.+|++++..+.+ +++.+...|++||+.|+++||+. +|||||||-+||.|+.+|-+||+||
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~kp~--m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFKPR--MDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhccCc--cchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeec
Confidence 999999999965 45688899987766 99999999999999999999999 9999999999999999999999999
Q ss_pred ccchhhhccCCCccccccccCCccccccCcccCCCC-CchhHHHHHhHHHHHHHhCCCCCC
Q 041135 527 GLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKL-TEKSDVYSFGVVLLELITGRKPVD 586 (727)
Q Consensus 527 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~ksDVwS~Gvil~eLltG~~Pf~ 586 (727)
|.+... .......++||..|.|||++.|..| ...-|||+|||+||-++-...||-
T Consensus 715 gsaa~~-----ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAYT-----KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhh-----cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 998643 2233455789999999999999876 567899999999999998888874
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=251.10 Aligned_cols=250 Identities=20% Similarity=0.354 Sum_probs=181.6
Q ss_pred HHhcCccccceeccCCceEEEEEEEcC-CcEEEEEEeeeCCchhHHHHHHHHHHHHHc-CCCCceeEeeE-eeccceeeE
Q 041135 378 QATNGFSAHNVLGEGGFGCVYKGVLAD-GREVAVKQLKIGGSQGEREFRAEVEIISRV-HHRHLVSLVGY-CISERERLL 454 (727)
Q Consensus 378 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~-g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~-~~~~~~~~l 454 (727)
...+.|.+.+.||+|.||.+-+++++. .+.+++|.+... ....++|.+|+.---.| .|.||+.-+++ |+..+..++
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF 99 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF 99 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence 345679999999999999999999875 678899987532 23356888888765555 48999987765 555667789
Q ss_pred EEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEEC--CCCcEEEEeeccchhh
Q 041135 455 VYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLD--SSFEARVADFGLAKIA 532 (727)
Q Consensus 455 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~--~~~~vkL~DFGla~~~ 532 (727)
++||++.|+|...+...+ +.+....+++.|++.||+|||++ +|||||||.+||||- +..+|||||||+.+..
T Consensus 100 ~qE~aP~gdL~snv~~~G---igE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 100 VQEFAPRGDLRSNVEAAG---IGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred eeccCccchhhhhcCccc---ccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeeccccccc
Confidence 999999999998886643 77888899999999999999999 999999999999993 3458999999998742
Q ss_pred hccCCCccccccccCCccccccCcccCC-----CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHh
Q 041135 533 LELDSNTHVSTRVMGTFGYMAPEYATSG-----KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEA 607 (727)
Q Consensus 533 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~ 607 (727)
+.. ...+..+..|.+||.+... ......|||.||+|+|.+|+|+.||+. ....+..+.+|..-.-..
T Consensus 174 ---g~t---V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQk-a~~~d~~Y~~~~~w~~rk- 245 (378)
T KOG1345|consen 174 ---GTT---VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQK-ASIMDKPYWEWEQWLKRK- 245 (378)
T ss_pred ---Cce---ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchh-hhccCchHHHHHHHhccc-
Confidence 111 1223346679999987532 246689999999999999999999984 334455555554321111
Q ss_pred hchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHH
Q 041135 608 LEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQ 653 (727)
Q Consensus 608 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 653 (727)
..++..+|.. -..+++++.++.|..++++|=...+
T Consensus 246 ----------~~~~P~~F~~-fs~~a~r~Fkk~lt~~~~drcki~~ 280 (378)
T KOG1345|consen 246 ----------NPALPKKFNP-FSEKALRLFKKSLTPRFKDRCKIWT 280 (378)
T ss_pred ----------CccCchhhcc-cCHHHHHHHHHhcCCcccccchhHH
Confidence 1122222211 1223566777888888888833333
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.5e-29 Score=258.86 Aligned_cols=271 Identities=24% Similarity=0.361 Sum_probs=199.4
Q ss_pred HHHHhcCccccceeccCCceEEEEEEEc----CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcC-CCCceeEeeEeeccc
Q 041135 376 LIQATNGFSAHNVLGEGGFGCVYKGVLA----DGREVAVKQLKIGGSQGEREFRAEVEIISRVH-HRHLVSLVGYCISER 450 (727)
Q Consensus 376 l~~~~~~~~~~~~LG~G~fg~Vy~~~~~----~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~ 450 (727)
+....+.|.++++||+|.|+.||++.+. ..+.||+|.+... ..-..+.+|+++|..+. +.||+++.+++..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 3445678999999999999999999854 3678999988643 33456899999999995 999999999999999
Q ss_pred eeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECC-CCcEEEEeeccc
Q 041135 451 ERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDS-SFEARVADFGLA 529 (727)
Q Consensus 451 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~-~~~vkL~DFGla 529 (727)
+..+||||+++....+++.. ++..++..+++.+++||.++|.+ ||||||||+.|+|.+. .++-.|+|||||
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred eeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhH
Confidence 99999999999988888754 67889999999999999999999 9999999999999974 567899999999
Q ss_pred hhhhccC-----------------------------------------CCccccccccCCccccccCcccC-CCCCchhH
Q 041135 530 KIALELD-----------------------------------------SNTHVSTRVMGTFGYMAPEYATS-GKLTEKSD 567 (727)
Q Consensus 530 ~~~~~~~-----------------------------------------~~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksD 567 (727)
....... ..........||.+|.|||++.+ ...+.+.|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 7311000 00001112469999999999975 46788999
Q ss_pred HHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHH-----------HHH--hhc----------hhhHHHH-HHHHhhc
Q 041135 568 VYSFGVVLLELITGRKPVDASQPLGDESLVEWARPL-----------LAE--ALE----------HEDFEAL-VDSRLEK 623 (727)
Q Consensus 568 VwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~-----------l~~--~~~----------~~~~~~l-~d~~l~~ 623 (727)
|||.|||++.+++++.||-.... +...+.+.+--+ ... .+. ...++.+ +..+...
T Consensus 261 iws~GVI~Lslls~~~PFf~a~d-d~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~ 339 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKAKD-DADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKS 339 (418)
T ss_pred eeeccceeehhhccccccccCcc-ccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccc
Confidence 99999999999999999965432 122222222110 000 000 0011111 1111110
Q ss_pred cc--------chhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 624 NY--------VDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 624 ~~--------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
+. .+....++++|+.+|+..||.+|-++++.|++
T Consensus 340 ~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 340 RQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred cccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 11 11112368899999999999999999998876
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-27 Score=238.17 Aligned_cols=261 Identities=20% Similarity=0.296 Sum_probs=203.4
Q ss_pred CccccceeccCCceEEEEEE-EcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcC-CCCceeEeeEeeccceeeEEEeec
Q 041135 382 GFSAHNVLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGEREFRAEVEIISRVH-HRHLVSLVGYCISERERLLVYEYV 459 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~-~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~lV~Ey~ 459 (727)
.|+++++||+|.||.+|.|+ +-+++.||||.-... .+.-.++.|.+.++.|. ..+|..++.|..++.+..||||++
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 48899999999999999998 557999999975422 23457889999999986 689999999999998999999998
Q ss_pred cCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECC-----CCcEEEEeeccchhhhc
Q 041135 460 PNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDS-----SFEARVADFGLAKIALE 534 (727)
Q Consensus 460 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~-----~~~vkL~DFGla~~~~~ 534 (727)
|-+|++++.-.++ .|+.++++.|+.||+.-++|+|++ .+|.|||||+|+||.. ...+.|+|||+|+...+
T Consensus 107 -GPSLEDLFD~CgR-~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 107 -GPSLEDLFDLCGR-RFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred -CcCHHHHHHHhcC-cccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 8888887765554 589999999999999999999999 9999999999999963 34699999999998876
Q ss_pred cCCCccccc----cccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhch
Q 041135 535 LDSNTHVST----RVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEH 610 (727)
Q Consensus 535 ~~~~~~~~~----~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~ 610 (727)
.....+... .+.||.+||+-.-+++++.+.+.|+-+||-|++++|.|.+||.+..........+. +.+.-..
T Consensus 182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeK----IGe~Kr~ 257 (449)
T KOG1165|consen 182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEK----IGETKRS 257 (449)
T ss_pred ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHH----hcccccc
Confidence 665555433 36899999999999999999999999999999999999999998765433322221 1122222
Q ss_pred hhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhcc
Q 041135 611 EDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLD 662 (727)
Q Consensus 611 ~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 662 (727)
..++.+++. +.. ++..-++..-.++.++-|+++-+...+..+-
T Consensus 258 T~i~~Lc~g-----~P~----efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvl 300 (449)
T KOG1165|consen 258 TPIEVLCEG-----FPE----EFATYLRYVRRLDFFETPDYDYLRKLFDDVL 300 (449)
T ss_pred CCHHHHHhc-----CHH----HHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 334444332 221 2444444555667788899887777666553
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-26 Score=247.59 Aligned_cols=263 Identities=21% Similarity=0.242 Sum_probs=199.6
Q ss_pred CccccceeccCCceEEEEEEEcCC--cEEEEEEeeeCCchhHHHHHHHHHHHHHcCC----CCceeEeeEe-eccceeeE
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLADG--REVAVKQLKIGGSQGEREFRAEVEIISRVHH----RHLVSLVGYC-ISERERLL 454 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~~g--~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H----pnIv~l~~~~-~~~~~~~l 454 (727)
+|++.++||+|+||.||++...+. ..+|+|............+..|+.+|..+.+ .++..+++.+ ..+...||
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999997553 5789998775544333378889999999873 6899999999 47778899
Q ss_pred EEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCC-----CcEEEEeeccc
Q 041135 455 VYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSS-----FEARVADFGLA 529 (727)
Q Consensus 455 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~-----~~vkL~DFGla 529 (727)
||+.+ |.+|.++........++..+.++|+.|++.+|++||+. |+||||||+.|++++.. ..++|+|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99988 88999887665556799999999999999999999999 99999999999999754 46999999999
Q ss_pred hh--hhccCCC--ccc---cccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHH
Q 041135 530 KI--ALELDSN--THV---STRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARP 602 (727)
Q Consensus 530 ~~--~~~~~~~--~~~---~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~ 602 (727)
+. +...... ... .....||.+|++.+++.+...+.+.|+||++.++.||+.|.+||.......... +
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~--~---- 248 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKS--K---- 248 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHH--H----
Confidence 83 3222211 111 123569999999999999999999999999999999999999997654322111 0
Q ss_pred HHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccCC
Q 041135 603 LLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDGA 664 (727)
Q Consensus 603 ~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 664 (727)
+.......+...+.......+.+++..+-..+...+|++..+...|+.+...
T Consensus 249 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 249 ----------FEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred ----------HHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 0000000110001111223455666666678999999999999998877543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=225.93 Aligned_cols=263 Identities=21% Similarity=0.278 Sum_probs=202.7
Q ss_pred hcCccccceeccCCceEEEEEE-EcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCC-CCceeEeeEeeccceeeEEEe
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGEREFRAEVEIISRVHH-RHLVSLVGYCISERERLLVYE 457 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~-~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H-pnIv~l~~~~~~~~~~~lV~E 457 (727)
.++|.++++||.|+||.+|+|. +.+|++||||+-... .....+..|.++++.|+| ..|..+..|+.+.....||||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 3569999999999999999998 467999999986432 233568899999999985 567778888888888899999
Q ss_pred eccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCC---CcEEEEeeccchhhhc
Q 041135 458 YVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSS---FEARVADFGLAKIALE 534 (727)
Q Consensus 458 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~---~~vkL~DFGla~~~~~ 534 (727)
.+ |-+|.+++.-..+ .++.++++.++-|++.-|+|+|.+ ++|||||||+|+|.+-+ .++.|+|||||+.+.+
T Consensus 92 LL-GPsLEdLfnfC~R-~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCSR-RFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred cc-CccHHHHHHHHhh-hhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 98 8888887654332 489999999999999999999999 89999999999999643 4689999999998876
Q ss_pred cCCCccc----cccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhch
Q 041135 535 LDSNTHV----STRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEH 610 (727)
Q Consensus 535 ~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~ 610 (727)
.....+. ..+..||.+|.+-..+.+.+.+.+.|+-|+|.+|.++..|.+||++.......+..+. +. +.-..
T Consensus 167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEk---I~-EkK~s 242 (341)
T KOG1163|consen 167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEK---IS-EKKMS 242 (341)
T ss_pred ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHH---HH-HhhcC
Confidence 6655544 3357899999999999888899999999999999999999999998654332222111 11 11111
Q ss_pred hhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhcc
Q 041135 611 EDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLD 662 (727)
Q Consensus 611 ~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 662 (727)
..++. |-..|. .++...+..|-....++-|+..-|.+.++-+.
T Consensus 243 ~~ie~-----LC~G~P----~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLf 285 (341)
T KOG1163|consen 243 TPIEV-----LCKGFP----AEFAMYLNYCRGLGFEEKPDYMYLRQLFRILF 285 (341)
T ss_pred CCHHH-----HhCCCc----HHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHH
Confidence 11111 122222 23556677898999999999888877776553
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.4e-27 Score=281.39 Aligned_cols=200 Identities=17% Similarity=0.167 Sum_probs=138.7
Q ss_pred HcCC-CCceeEeeEe-------eccceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEE
Q 041135 433 RVHH-RHLVSLVGYC-------ISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRII 504 (727)
Q Consensus 433 ~l~H-pnIv~l~~~~-------~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iv 504 (727)
.++| .||++++++| .+...++++|||+ +++|+++|+... ..+++.+++.|++||++||+|||++ +||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---gIv 102 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD-RSVDAFECFHVFRQIVEIVNAAHSQ---GIV 102 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc-ccccHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 3445 5788888877 2334567889987 679999997543 3489999999999999999999998 999
Q ss_pred eeCCCCCceEECCCC-------------------cEEEEeeccchhhhccCCC-------------ccccccccCCcccc
Q 041135 505 HRDIKSSNILLDSSF-------------------EARVADFGLAKIALELDSN-------------THVSTRVMGTFGYM 552 (727)
Q Consensus 505 HrDLkp~NILl~~~~-------------------~vkL~DFGla~~~~~~~~~-------------~~~~~~~~gt~~y~ 552 (727)
||||||+||||+..+ .+||+|||+++........ .......+||..||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 999999999996544 4555566655432100000 00011246788999
Q ss_pred ccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHhhcccchhHHHH
Q 041135 553 APEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFW 632 (727)
Q Consensus 553 aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~ 632 (727)
|||++.+..++.++||||||||||||++|..+|.... .....+.. ..+.... ......
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--------~~~~~~~~---------~~~~~~~-----~~~~~~ 240 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--------RTMSSLRH---------RVLPPQI-----LLNWPK 240 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--------HHHHHHHH---------hhcChhh-----hhcCHH
Confidence 9999999999999999999999999999887764211 00000000 0000000 011223
Q ss_pred HHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 633 MIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 633 l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
+.+++.+||+.+|.+||+|.||+++-.
T Consensus 241 ~~~~~~~~L~~~P~~Rps~~eil~h~~ 267 (793)
T PLN00181 241 EASFCLWLLHPEPSCRPSMSELLQSEF 267 (793)
T ss_pred HHHHHHHhCCCChhhCcChHHHhhchh
Confidence 457888999999999999999987643
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-26 Score=229.59 Aligned_cols=249 Identities=22% Similarity=0.368 Sum_probs=200.4
Q ss_pred ccccceeccCCceEEEEEEEcCCcEEEEEEeeeCC--chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeecc
Q 041135 383 FSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGG--SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVP 460 (727)
Q Consensus 383 ~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 460 (727)
+.++.+|.+...|+.|+|++. |..+++|+++... .+..++|..|+-.|+-+.|+||+.++|.|...-++.+|..||.
T Consensus 192 lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp 270 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP 270 (448)
T ss_pred hhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence 445567889999999999995 6778888886433 3445789999999999999999999999999999999999999
Q ss_pred CCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEE--eeccchhhhccCCC
Q 041135 461 NDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVA--DFGLAKIALELDSN 538 (727)
Q Consensus 461 ~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~--DFGla~~~~~~~~~ 538 (727)
.|+|+..|++......+..+.++++.+|++|++|||+. ++-|.--.|..+.|+||++.+++|. |-.++.
T Consensus 271 ~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsf-------- 341 (448)
T KOG0195|consen 271 FGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSF-------- 341 (448)
T ss_pred chHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeee--------
Confidence 99999999999888889999999999999999999996 4344555689999999999987764 333322
Q ss_pred ccccccccCCccccccCcccCCC---CCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHH
Q 041135 539 THVSTRVMGTFGYMAPEYATSGK---LTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEA 615 (727)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~l~~~~---~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~ 615 (727)
...+......||+||.++.+. .-.++|+|||.|+||||.|...||....+++... +
T Consensus 342 --qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm-------------------k 400 (448)
T KOG0195|consen 342 --QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM-------------------K 400 (448)
T ss_pred --eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh-------------------h
Confidence 112234567899999998754 3358999999999999999999998766543221 1
Q ss_pred HHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhcc
Q 041135 616 LVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLD 662 (727)
Q Consensus 616 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 662 (727)
+.-..|+..........+.+||.-|++.||.+||.++.|+-.|+++.
T Consensus 401 ialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 401 IALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred hhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 22234444555566677899999999999999999999999999874
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-25 Score=240.44 Aligned_cols=168 Identities=23% Similarity=0.234 Sum_probs=130.8
Q ss_pred HHHhcCccccceeccCCceEEEEEEEc--CCcEEEEEEeeeC-----CchhHHHHHHHHHHHHHcCCCCcee-EeeEeec
Q 041135 377 IQATNGFSAHNVLGEGGFGCVYKGVLA--DGREVAVKQLKIG-----GSQGEREFRAEVEIISRVHHRHLVS-LVGYCIS 448 (727)
Q Consensus 377 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~--~g~~vaVK~l~~~-----~~~~~~~~~~Ei~~l~~l~HpnIv~-l~~~~~~ 448 (727)
....++|.+.++||+|+||+||+|+++ +|+.||||++... .....+.|.+|+++|++++|+||+. ++++
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 345577999999999999999999875 5777899987532 1223456999999999999999985 4432
Q ss_pred cceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCC-CCCceEECCCCcEEEEeec
Q 041135 449 ERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDI-KSSNILLDSSFEARVADFG 527 (727)
Q Consensus 449 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDL-kp~NILl~~~~~vkL~DFG 527 (727)
+..|||||||.|++|... ... . ...++.+++++|+|||++ +|+|||| |++||||+.++.+||+|||
T Consensus 91 -~~~~LVmE~~~G~~L~~~-~~~-----~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHLA-RPH-----G---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred -CCcEEEEEccCCCCHHHh-Ccc-----c---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECc
Confidence 457999999999999632 111 1 146788999999999999 9999999 9999999999999999999
Q ss_pred cchhhhccCCCccc-----cccccCCccccccCcccCC
Q 041135 528 LAKIALELDSNTHV-----STRVMGTFGYMAPEYATSG 560 (727)
Q Consensus 528 la~~~~~~~~~~~~-----~~~~~gt~~y~aPE~l~~~ 560 (727)
+|+.+......... ....+++..|++||++.-.
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 99865433222121 1456788999999998654
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.4e-25 Score=215.40 Aligned_cols=168 Identities=21% Similarity=0.223 Sum_probs=125.0
Q ss_pred CccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCccc
Q 041135 462 DTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHV 541 (727)
Q Consensus 462 gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 541 (727)
|+|.++++.++ ..+++.+++.|+.||++||+|||++ + |++|||++.++.+|+ ||+++....
T Consensus 1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~------- 61 (176)
T smart00750 1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTP------- 61 (176)
T ss_pred CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecc-------
Confidence 67888887543 2589999999999999999999998 5 999999999999999 999875421
Q ss_pred cccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHh
Q 041135 542 STRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRL 621 (727)
Q Consensus 542 ~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l 621 (727)
....|+..|||||++.+..++.++|||||||+||||++|+.||....... .....++........ ..
T Consensus 62 -~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-----~~~~~~~~~~~~~~~-~~------ 128 (176)
T smart00750 62 -EQSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-----AILEILLNGMPADDP-RD------ 128 (176)
T ss_pred -ccCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-----HHHHHHHHHhccCCc-cc------
Confidence 11257899999999999999999999999999999999999996543211 111111111000000 00
Q ss_pred hcccchhHH--HHHHHHHHHHhccCCCCCCCHHHHHHHHhhcc
Q 041135 622 EKNYVDSEM--FWMIEAAAACVRHSATKRPRMSQVVRALDTLD 662 (727)
Q Consensus 622 ~~~~~~~~~--~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 662 (727)
........ ..+.+++++||+.+|++||++.||++++..+.
T Consensus 129 -~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 129 -RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred -cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 00000111 25889999999999999999999999998764
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9e-24 Score=222.54 Aligned_cols=262 Identities=29% Similarity=0.384 Sum_probs=197.7
Q ss_pred ccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCch---hHHHHHHHHHHHHHcCCC-CceeEeeEeeccceeeEEEee
Q 041135 383 FSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQ---GEREFRAEVEIISRVHHR-HLVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 383 ~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~---~~~~~~~Ei~~l~~l~Hp-nIv~l~~~~~~~~~~~lV~Ey 458 (727)
|.+.+.||.|+||.||++.+. ..+++|.+...... ....+.+|+.+++.+.|. +|+++++++......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 677889999999999999986 78899998754433 367899999999999988 799999999777778999999
Q ss_pred ccCCccchhcccCCC-CcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCC-cEEEEeeccchhhhccC
Q 041135 459 VPNDTLHYHLHAEGR-PVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSF-EARVADFGLAKIALELD 536 (727)
Q Consensus 459 ~~~gsL~~~L~~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~-~vkL~DFGla~~~~~~~ 536 (727)
+.++.|.+++..... ..+.......++.|++.+|+|+|+. +++|||||++|||++..+ .++|+|||+++.+....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999976665432 2588889999999999999999999 899999999999999988 79999999997543222
Q ss_pred CCc---cccccccCCccccccCcccC---CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhch
Q 041135 537 SNT---HVSTRVMGTFGYMAPEYATS---GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEH 610 (727)
Q Consensus 537 ~~~---~~~~~~~gt~~y~aPE~l~~---~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~ 610 (727)
... .......|+..|++||.+.+ ..+....|+|++|++++++++|..||...... .........+......
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~ 233 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPTP 233 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCCc
Confidence 211 13456789999999999988 57889999999999999999999997654421 0000000011000000
Q ss_pred hhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 611 EDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 611 ~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
.....+...........+.+++..|+..++..|.++.+.+..
T Consensus 234 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 -----SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred -----ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000001123467889999999999999999988765
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-24 Score=247.90 Aligned_cols=258 Identities=22% Similarity=0.284 Sum_probs=188.9
Q ss_pred cccceeccCCceEEEEEEEc-CCcEEEEEEeeeC--CchhHH----HHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 384 SAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIG--GSQGER----EFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 384 ~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~--~~~~~~----~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
...+++|.|.+|.|+..... ....++.|.++.. ....+. .+..|+.+-..|+|+|++..+..+.+....+.+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 45678999999977776633 3343444433211 111111 2556777777889999998888888777777779
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhcc-
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALEL- 535 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~- 535 (727)
|||.+ +|..++...+. +...++..++.||+.||.|||++ ||.|||||++|||+..+|.+||+|||.+..+...
T Consensus 401 E~~~~-Dlf~~~~~~~~--~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGK--LTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred hcccH-HHHHHHhcccc--cchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 99999 99998877643 88889999999999999999999 9999999999999999999999999999765422
Q ss_pred CCCccccccccCCccccccCcccCCCCCc-hhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHH
Q 041135 536 DSNTHVSTRVMGTFGYMAPEYATSGKLTE-KSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFE 614 (727)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~-ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~ 614 (727)
+.......+++|.-.|+|||++.+.+|+. ..||||.|||+..|++|+.+|......+...... ...-..... ....
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~--~~~~~~~~~-~~~~ 551 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN--NYSDQRNIF-EGPN 551 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh--ccccccccc-cChH
Confidence 22235667889999999999999998875 6899999999999999999998765543321000 000000000 0011
Q ss_pred HHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 615 ALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 615 ~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
.+ ......+...+|.+||+.||.+|-++++|++.=|
T Consensus 552 ~~---------~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W 587 (601)
T KOG0590|consen 552 RL---------LSLLPRETRIIIYRMLQLDPTKRITIEQILNDEW 587 (601)
T ss_pred HH---------HHhchhhHHHHHHHHccCChhheecHHHHhhChH
Confidence 11 1112234567889999999999999999987644
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.9e-23 Score=208.53 Aligned_cols=171 Identities=16% Similarity=0.145 Sum_probs=134.3
Q ss_pred HhcCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHH---------HHHHHHHHHHcCCCCceeEeeEeecc
Q 041135 379 ATNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGERE---------FRAEVEIISRVHHRHLVSLVGYCISE 449 (727)
Q Consensus 379 ~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~---------~~~Ei~~l~~l~HpnIv~l~~~~~~~ 449 (727)
..++|+++++||+|+||.||+... ++..+|||+++.......+. +++|++.+.+++|++|..+.+++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 368899999999999999999766 57789999997544333322 68999999999999999999886643
Q ss_pred --------ceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcE
Q 041135 450 --------RERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEA 521 (727)
Q Consensus 450 --------~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~v 521 (727)
...+|||||++|.+|.++.. ++. .++.+|+.+|..||++ +|+|||||+.||+++.++ +
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g-i 173 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG-L 173 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-E
Confidence 35789999999999977632 222 3456899999999999 999999999999999888 9
Q ss_pred EEEeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHH
Q 041135 522 RVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELI 579 (727)
Q Consensus 522 kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLl 579 (727)
+|+|||+.+...+.. ... .+++.+.+..++|+|+|||.|..+.
T Consensus 174 ~liDfg~~~~~~e~~-a~d--------------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 174 RIIDLSGKRCTAQRK-AKD--------------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEECCCcccccchh-hHH--------------HHHHHhHhcccccccceeEeehHHH
Confidence 999999886431111 000 0344556778999999999888765
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.9e-22 Score=200.45 Aligned_cols=138 Identities=17% Similarity=0.188 Sum_probs=108.0
Q ss_pred cceeccCCceEEEEEEEcCCcEEEEEEeeeCCch--h-------H-----------------HHHHHHHHHHHHcCCCCc
Q 041135 386 HNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQ--G-------E-----------------REFRAEVEIISRVHHRHL 439 (727)
Q Consensus 386 ~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~--~-------~-----------------~~~~~Ei~~l~~l~HpnI 439 (727)
.+.||+|+||.||+|++.+|+.||||+++..... . . ....+|+++|.++.+.+|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4789999999999999888999999999754211 1 0 122359999999988776
Q ss_pred eeEeeEeeccceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHH-HhcCCCcEEeeCCCCCceEECCC
Q 041135 440 VSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYL-HEDCHPRIIHRDIKSSNILLDSS 518 (727)
Q Consensus 440 v~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yL-H~~~~~~ivHrDLkp~NILl~~~ 518 (727)
.....+... ..+|||||+.|++|...+.... .+++.++++++.||+.+|.|| |+. +|+|||||++||||+ +
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~--~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-~ 153 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKDA--PLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-D 153 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-C
Confidence 443332222 2389999999887765433322 478899999999999999999 687 999999999999998 4
Q ss_pred CcEEEEeeccchh
Q 041135 519 FEARVADFGLAKI 531 (727)
Q Consensus 519 ~~vkL~DFGla~~ 531 (727)
+.++|+|||+|..
T Consensus 154 ~~v~LiDFG~a~~ 166 (190)
T cd05147 154 GKLYIIDVSQSVE 166 (190)
T ss_pred CcEEEEEcccccc
Confidence 7899999999974
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=2e-21 Score=193.31 Aligned_cols=140 Identities=17% Similarity=0.164 Sum_probs=110.5
Q ss_pred ccceeccCCceEEEEEEEcCCcEEEEEEeeeCCch---------------------h-----HHHHHHHHHHHHHcCCCC
Q 041135 385 AHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQ---------------------G-----EREFRAEVEIISRVHHRH 438 (727)
Q Consensus 385 ~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~---------------------~-----~~~~~~Ei~~l~~l~Hpn 438 (727)
+.+.||+|+||.||+|++.+|+.||||+++..... . ...+++|++.+.++.|.+
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 1 INGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CCceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 35789999999999999878999999999754211 0 112467999999999988
Q ss_pred ceeEeeEeeccceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHh-cCCCcEEeeCCCCCceEECC
Q 041135 439 LVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHE-DCHPRIIHRDIKSSNILLDS 517 (727)
Q Consensus 439 Iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivHrDLkp~NILl~~ 517 (727)
|.....+... ..||||||+.|+.+...+.... .++..++.+|+.+++.+|.+||. + ||+|||||++||||+
T Consensus 81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~--~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~- 152 (190)
T cd05145 81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLKDV--PLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH- 152 (190)
T ss_pred CCCceEEEec--CCEEEEEEecCCCchhhhhhhc--cCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-
Confidence 7544443333 2489999999886544322222 36788899999999999999999 8 999999999999998
Q ss_pred CCcEEEEeeccchhh
Q 041135 518 SFEARVADFGLAKIA 532 (727)
Q Consensus 518 ~~~vkL~DFGla~~~ 532 (727)
++.++|+|||+++..
T Consensus 153 ~~~~~liDFG~a~~~ 167 (190)
T cd05145 153 DGKPYIIDVSQAVEL 167 (190)
T ss_pred CCCEEEEEcccceec
Confidence 789999999999753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.1e-22 Score=231.06 Aligned_cols=198 Identities=24% Similarity=0.279 Sum_probs=155.2
Q ss_pred HHHhcCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcC---CCCceeEeeEeeccceee
Q 041135 377 IQATNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVH---HRHLVSLVGYCISERERL 453 (727)
Q Consensus 377 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~---HpnIv~l~~~~~~~~~~~ 453 (727)
....++|.|.++||+|+||.||+|...+|+.||||+-+.-+.- +|.-=.+++.+|+ -+.|..+..++...+..+
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~ 770 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASV 770 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence 3345679999999999999999999988999999987533221 1111122333333 233444545555566778
Q ss_pred EEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEEC-------CCCcEEEEee
Q 041135 454 LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLD-------SSFEARVADF 526 (727)
Q Consensus 454 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~-------~~~~vkL~DF 526 (727)
||+||...|+|.+++...+ .++|..++.|+.||++.|++||.+ +|||+||||+|+||. +...++|+||
T Consensus 771 lv~ey~~~Gtlld~~N~~~--~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLINTNK--VMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred eeeeccccccHHHhhccCC--CCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEec
Confidence 9999999999999998554 499999999999999999999999 999999999999994 2446999999
Q ss_pred ccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCC
Q 041135 527 GLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRK 583 (727)
Q Consensus 527 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~ 583 (727)
|.+.+..-.... ......++|-.+-..|+..|+.++++.|.|.|.-+++.||.|+.
T Consensus 846 G~siDm~lfp~~-~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 846 GRSIDMKLFPDG-TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ccceeeeEcCCC-cEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 999654322222 23455678899999999999999999999999999999999875
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.3e-23 Score=224.83 Aligned_cols=186 Identities=30% Similarity=0.365 Sum_probs=156.9
Q ss_pred eeccCCceEEEEEEE----cCCcEEEEEEeeeCCchh--HHHHHHHHHHHHHcC-CCCceeEeeEeeccceeeEEEeecc
Q 041135 388 VLGEGGFGCVYKGVL----ADGREVAVKQLKIGGSQG--EREFRAEVEIISRVH-HRHLVSLVGYCISERERLLVYEYVP 460 (727)
Q Consensus 388 ~LG~G~fg~Vy~~~~----~~g~~vaVK~l~~~~~~~--~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~lV~Ey~~ 460 (727)
.+|+|.||.|++++. +.|.-+|+|+++...... ......|..++..++ |+.+|++...++.+...+++++|+.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999998762 346778888876433211 124556888888887 9999999999999999999999999
Q ss_pred CCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCcc
Q 041135 461 NDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTH 540 (727)
Q Consensus 461 ~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 540 (727)
||+|...+..... ++......+...++-++++||+. +|+|||+|.+||+++.+|++|+.|||+++.+.+...
T Consensus 81 gg~lft~l~~~~~--f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~--- 152 (612)
T KOG0603|consen 81 GGDLFTRLSKEVM--FDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI--- 152 (612)
T ss_pred cchhhhccccCCc--hHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhh---
Confidence 9999888876654 67777778888899999999999 999999999999999999999999999987643221
Q ss_pred ccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCC
Q 041135 541 VSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDA 587 (727)
Q Consensus 541 ~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~ 587 (727)
.|||..|||||+++ ......|.|+||++++||++|..+|..
T Consensus 153 ----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 153 ----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred ----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 18999999999998 467889999999999999999999975
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.3e-22 Score=228.92 Aligned_cols=252 Identities=23% Similarity=0.272 Sum_probs=180.2
Q ss_pred CccccceeccCCceEEEEEEEcCCcEEEEEEeeeCC-chhHHHHHHHHHH--HHHcCCCCceeEeeEeeccceeeEEEee
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGG-SQGEREFRAEVEI--ISRVHHRHLVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~-~~~~~~~~~Ei~~--l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 458 (727)
+|...+.||.+.|=+|++|++++|. |+||++-..+ ....+.|.++++- ...++|+|++.+.-+...+...|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5777899999999999999998887 8999886444 3333445544443 4456899999998877777777888898
Q ss_pred ccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhh-ccCC
Q 041135 459 VPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIAL-ELDS 537 (727)
Q Consensus 459 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~-~~~~ 537 (727)
+ ..+|++.|..+ ..+...+.+.|+.||++||.-+|+. ||+|||||.+||||+.=.=+.|+||.--+-.. ..|.
T Consensus 103 v-khnLyDRlSTR--PFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 103 V-KHNLYDRLSTR--PFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred H-hhhhhhhhccc--hHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 8 55788888654 4588889999999999999999999 99999999999999987778899997554211 1111
Q ss_pred ---CccccccccCCccccccCcccCC-----------CCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHH
Q 041135 538 ---NTHVSTRVMGTFGYMAPEYATSG-----------KLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARP 602 (727)
Q Consensus 538 ---~~~~~~~~~gt~~y~aPE~l~~~-----------~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~ 602 (727)
.......-..-..|.|||.+... .++.+.||||+|||++||++ |+.+|.-. ++..+
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------QL~aY--- 247 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------QLLAY--- 247 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------HHHhH---
Confidence 11111111223469999988542 26778999999999999999 78888521 12221
Q ss_pred HHHHhhc-hhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhc
Q 041135 603 LLAEALE-HEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661 (727)
Q Consensus 603 ~l~~~~~-~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 661 (727)
... ..+.+.+++ .++. ..+.+|+..|++.||++|.+++++|+..++.
T Consensus 248 ----r~~~~~~~e~~Le-~Ied-------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 248 ----RSGNADDPEQLLE-KIED-------VSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred ----hccCccCHHHHHH-hCcC-------ccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 111 111111111 1111 1367889999999999999999999985543
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-21 Score=215.29 Aligned_cols=217 Identities=24% Similarity=0.414 Sum_probs=162.6
Q ss_pred HHHcCCCCceeEeeEeeccceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcE-EeeCCC
Q 041135 431 ISRVHHRHLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRI-IHRDIK 509 (727)
Q Consensus 431 l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~i-vHrDLk 509 (727)
|+.+.|.|+.+|+|.+.++...++|.+||..|+|.+.+.. ....+++.....++++|++||+|||.. .| .|+.|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeeec
Confidence 4578899999999999999999999999999999999977 344699999999999999999999987 44 999999
Q ss_pred CCceEECCCCcEEEEeeccchhhhccCCCccccccccCCccccccCcccCCC-------CCchhHHHHHhHHHHHHHhCC
Q 041135 510 SSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGK-------LTEKSDVYSFGVVLLELITGR 582 (727)
Q Consensus 510 p~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-------~~~ksDVwS~Gvil~eLltG~ 582 (727)
..|+++|..+.+||.|||+.....+ ...........-...|.|||.+.+.. .+.+.||||||+|++|+++.+
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~-~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEE-TAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred cccceeeeeEEEEechhhhcccccc-cccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 9999999999999999999876432 11111111223456799999998641 467899999999999999999
Q ss_pred CCCCCCCCCCch-hhHHhhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhc
Q 041135 583 KPVDASQPLGDE-SLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661 (727)
Q Consensus 583 ~Pf~~~~~~~~~-~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 661 (727)
.+|+......+. .++.+++. .....+ ...+.... +....++.++++||..+|++||++++|-..++.+
T Consensus 156 ~~~~~~~~~~~~~eii~~~~~-----~~~~~~----rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~ 224 (484)
T KOG1023|consen 156 GPFDLRNLVEDPDEIILRVKK-----GGSNPF----RPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI 224 (484)
T ss_pred CccccccccCChHHHHHHHHh-----cCCCCc----Ccchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence 999875433221 22222111 000000 01110000 1122588899999999999999999999999887
Q ss_pred cC
Q 041135 662 DG 663 (727)
Q Consensus 662 ~~ 663 (727)
..
T Consensus 225 ~~ 226 (484)
T KOG1023|consen 225 NK 226 (484)
T ss_pred cc
Confidence 54
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=186.96 Aligned_cols=188 Identities=16% Similarity=0.109 Sum_probs=137.4
Q ss_pred cccceeccCCceEEEEEEEcCCcEEEEEEeeeCCch----hHHHHHHHHHHHHHcC-CCCceeEeeEeeccceeeEEEee
Q 041135 384 SAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQ----GEREFRAEVEIISRVH-HRHLVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 384 ~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~----~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~lV~Ey 458 (727)
.+...|++|+||+||++.. .+..++.+.+.....- ....+++|+++|++|+ |.+|.+++++ ...+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3567899999999997766 6788887777543221 1125789999999995 5889999886 346899999
Q ss_pred ccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCC-CCCceEECCCCcEEEEeeccchhhhccCC
Q 041135 459 VPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDI-KSSNILLDSSFEARVADFGLAKIALELDS 537 (727)
Q Consensus 459 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDL-kp~NILl~~~~~vkL~DFGla~~~~~~~~ 537 (727)
+.|.+|...+.. ....++.|++++|++||++ ||+|||| |+.|||++.++.++|+|||++........
T Consensus 80 I~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 80 LAGAAMYQRPPR---------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred ecCccHHhhhhh---------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 999998654321 1135778999999999999 9999999 79999999999999999999974322110
Q ss_pred C------cc----ccccccCCccccccCcccCC-CCC-chhHHHHHhHHHHHHHhCCCCCCCC
Q 041135 538 N------TH----VSTRVMGTFGYMAPEYATSG-KLT-EKSDVYSFGVVLLELITGRKPVDAS 588 (727)
Q Consensus 538 ~------~~----~~~~~~gt~~y~aPE~l~~~-~~~-~ksDVwS~Gvil~eLltG~~Pf~~~ 588 (727)
. .. ......++..|+.|+...-- ..+ ...+.++.|+.+|.++||+.++-..
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 0 00 01112356667777643321 223 5789999999999999998876543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.7e-20 Score=184.25 Aligned_cols=137 Identities=20% Similarity=0.259 Sum_probs=107.4
Q ss_pred cccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHc-----CCCCceeEeeEeeccc---e-eeE
Q 041135 384 SAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRV-----HHRHLVSLVGYCISER---E-RLL 454 (727)
Q Consensus 384 ~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l-----~HpnIv~l~~~~~~~~---~-~~l 454 (727)
.-.++||+|+||.||+ +.+....+||++........+.+.+|+++|+.+ +|+||++++|++.++. . ..+
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 3457899999999996 433333479988766555667899999999999 5799999999998864 3 347
Q ss_pred EEee--ccCCccchhcccCCCCcccHHHHHHHHHHHHHHH-HHHHhcCCCcEEeeCCCCCceEECC----CCcEEEEeec
Q 041135 455 VYEY--VPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGI-AYLHEDCHPRIIHRDIKSSNILLDS----SFEARVADFG 527 (727)
Q Consensus 455 V~Ey--~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL-~yLH~~~~~~ivHrDLkp~NILl~~----~~~vkL~DFG 527 (727)
|+|| +.+++|.+++.+. . +++. ..++.+++.++ +|||++ +|||||||++|||++. ++.++|+||+
T Consensus 83 I~e~~G~~~~tL~~~l~~~-~--~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC-R--YEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EecCCCCcchhHHHHHHcc-c--ccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 8999 5579999999653 2 4444 35677888777 999999 9999999999999974 3489999955
Q ss_pred cch
Q 041135 528 LAK 530 (727)
Q Consensus 528 la~ 530 (727)
.+.
T Consensus 155 G~~ 157 (210)
T PRK10345 155 GES 157 (210)
T ss_pred CCc
Confidence 443
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.3e-20 Score=191.24 Aligned_cols=231 Identities=22% Similarity=0.317 Sum_probs=144.8
Q ss_pred ccccceeccCCceEEEEEEEcC-CcEEEEEEeeeCCch---hHHHHHHHHHHHHHcC----------CCCceeEeeEeec
Q 041135 383 FSAHNVLGEGGFGCVYKGVLAD-GREVAVKQLKIGGSQ---GEREFRAEVEIISRVH----------HRHLVSLVGYCIS 448 (727)
Q Consensus 383 ~~~~~~LG~G~fg~Vy~~~~~~-g~~vaVK~l~~~~~~---~~~~~~~Ei~~l~~l~----------HpnIv~l~~~~~~ 448 (727)
+...+.||.|+|+.||++++.+ |+.+|||++...... ..+++++|.-.+..+. |-.++--++....
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 5567899999999999999864 899999998765432 2345666655444432 2222222222211
Q ss_pred ---------c---c-----eeeEEEeeccCCccchhcc---cCCC--CcccHHHHHHHHHHHHHHHHHHHhcCCCcEEee
Q 041135 449 ---------E---R-----ERLLVYEYVPNDTLHYHLH---AEGR--PVMDWATRVKVAAGAARGIAYLHEDCHPRIIHR 506 (727)
Q Consensus 449 ---------~---~-----~~~lV~Ey~~~gsL~~~L~---~~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHr 506 (727)
. . ..+++|.-+ .++|.+++. .... ..+....++.+..|+++.+++||.+ ||||+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEec
Confidence 1 1 235677766 567766643 2222 2344556677779999999999999 99999
Q ss_pred CCCCCceEECCCCcEEEEeeccchhhhccCCCccccccccCCccccccCcccC--------CCCCchhHHHHHhHHHHHH
Q 041135 507 DIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATS--------GKLTEKSDVYSFGVVLLEL 578 (727)
Q Consensus 507 DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~~~ksDVwS~Gvil~eL 578 (727)
|||++|+||+.+|.++|+||+......+ .... ...+..|.+||.... -.++.+.|.|+||++||.|
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~-----~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGT-----RYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTE-----EEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCc-----eeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 9999999999999999999998764311 1111 334577999997643 2478899999999999999
Q ss_pred HhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCC
Q 041135 579 ITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKR 648 (727)
Q Consensus 579 ltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R 648 (727)
++|+.||+......... | ++ .... +....+.+||+.+|+.++++|
T Consensus 244 WC~~lPf~~~~~~~~~~---~------------~f---------~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 244 WCGRLPFGLSSPEADPE---W------------DF---------SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHSS-STCCCGGGSTSG---G------------GG---------TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHccCCCCCCCcccccc---c------------cc---------hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999998654322111 1 00 0111 334457788999999999987
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.3e-20 Score=187.37 Aligned_cols=142 Identities=17% Similarity=0.183 Sum_probs=112.3
Q ss_pred hcCccccceeccCCceEEEEEE--EcCCcEEEEEEeeeCCch------------------------hHHHHHHHHHHHHH
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGV--LADGREVAVKQLKIGGSQ------------------------GEREFRAEVEIISR 433 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~--~~~g~~vaVK~l~~~~~~------------------------~~~~~~~Ei~~l~~ 433 (727)
...|++.+.||+|+||.||+|+ ..+|+.||||+++..... ....+.+|+++|.+
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~ 106 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR 106 (237)
T ss_pred CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 3458899999999999999998 568999999998754210 11235789999999
Q ss_pred cCCCC--ceeEeeEeeccceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCc-EEeeCCCC
Q 041135 434 VHHRH--LVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPR-IIHRDIKS 510 (727)
Q Consensus 434 l~Hpn--Iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~-ivHrDLkp 510 (727)
+.+.+ +.+++++ ...+|||||+.|++|..++.... .+...+...++.||+.+|++||++ + |+|||||+
T Consensus 107 L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp 177 (237)
T smart00090 107 LYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV--EPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSE 177 (237)
T ss_pred HHhcCCCCCeeeEe----cCceEEEEEecCCcccccccccC--CcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCCh
Confidence 97633 3444443 23489999999988876653332 255666789999999999999999 8 99999999
Q ss_pred CceEECCCCcEEEEeeccchh
Q 041135 511 SNILLDSSFEARVADFGLAKI 531 (727)
Q Consensus 511 ~NILl~~~~~vkL~DFGla~~ 531 (727)
+||||+ ++.++|+|||++..
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhc
Confidence 999999 88999999999874
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.8e-20 Score=191.27 Aligned_cols=198 Identities=22% Similarity=0.246 Sum_probs=135.4
Q ss_pred CCCCceeEeeEeec---------------------------cceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHH
Q 041135 435 HHRHLVSLVGYCIS---------------------------ERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAG 487 (727)
Q Consensus 435 ~HpnIv~l~~~~~~---------------------------~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~q 487 (727)
+|+|||+++++|.+ ...+||||..+ ..+|+.+|..+. .+......|+.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~---~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH---RSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC---CchHHHHHHHHH
Confidence 49999999988754 23568888876 457888886654 455566778999
Q ss_pred HHHHHHHHHhcCCCcEEeeCCCCCceEE--CCCC--cEEEEeeccchhhhccCC---CccccccccCCccccccCcccCC
Q 041135 488 AARGIAYLHEDCHPRIIHRDIKSSNILL--DSSF--EARVADFGLAKIALELDS---NTHVSTRVMGTFGYMAPEYATSG 560 (727)
Q Consensus 488 ia~gL~yLH~~~~~~ivHrDLkp~NILl--~~~~--~vkL~DFGla~~~~~~~~---~~~~~~~~~gt~~y~aPE~l~~~ 560 (727)
+++|+.|||++ ||.|||||.+|||| |+|+ .+.|+|||++-......- ........-|...-||||+....
T Consensus 350 lLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 350 LLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 99999999999 99999999999999 3443 588999998842111000 01111234577889999998642
Q ss_pred C------CCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHH
Q 041135 561 K------LTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMI 634 (727)
Q Consensus 561 ~------~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~ 634 (727)
. .-.|+|.|+.|.+.||++....||-....+ +. +...+.+-.-.. ..+.....+.
T Consensus 427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem----~L-----------~~r~Yqe~qLPa----lp~~vpp~~r 487 (598)
T KOG4158|consen 427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM----LL-----------DTRTYQESQLPA----LPSRVPPVAR 487 (598)
T ss_pred CCCceeeccchhhhhhhhhhHHHHhccCCcccccchh----ee-----------chhhhhhhhCCC----CcccCChHHH
Confidence 1 235999999999999999999999652211 10 111111111111 1223334467
Q ss_pred HHHHHHhccCCCCCCCHHHHHHHH
Q 041135 635 EAAAACVRHSATKRPRMSQVVRAL 658 (727)
Q Consensus 635 ~li~~cl~~dP~~RPs~~evl~~L 658 (727)
+++...|+.||.+|++..-..+.|
T Consensus 488 qlV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 488 QLVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHHHHhcCCccccCCccHHHhHH
Confidence 889999999999999866444443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.1e-19 Score=181.41 Aligned_cols=134 Identities=23% Similarity=0.370 Sum_probs=113.7
Q ss_pred ceeccCCceEEEEEEEcCCcEEEEEEeeeCCch--------hHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEee
Q 041135 387 NVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQ--------GEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 387 ~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~--------~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 458 (727)
+.||+|+||.||+|++ +|..|+||+....... ....+.+|++++..++|.||.....++.+....+|||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 6799999999999988 6788999986532211 123578899999999999988777777777788999999
Q ss_pred ccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchh
Q 041135 459 VPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKI 531 (727)
Q Consensus 459 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 531 (727)
+.|++|.+++.... . .+..++.+|+.+|.+||+. +|+||||++.|||++ ++.++|+|||+++.
T Consensus 81 ~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999998886432 2 7889999999999999999 999999999999999 78999999999863
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.7e-19 Score=176.82 Aligned_cols=145 Identities=20% Similarity=0.209 Sum_probs=114.7
Q ss_pred HHHHHHHhcCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCc----------------------hhHHHHHHHHHH
Q 041135 373 YDELIQATNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGS----------------------QGEREFRAEVEI 430 (727)
Q Consensus 373 ~~el~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~----------------------~~~~~~~~Ei~~ 430 (727)
+.++......|.+.+.||+|+||.||+|.+.+|+.||||+++.... .....+.+|+.+
T Consensus 7 ~~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 86 (198)
T cd05144 7 LHTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAA 86 (198)
T ss_pred HHHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHH
Confidence 3455555556888999999999999999988899999998764321 011236788999
Q ss_pred HHHcCCC--CceeEeeEeeccceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCC
Q 041135 431 ISRVHHR--HLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDI 508 (727)
Q Consensus 431 l~~l~Hp--nIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDL 508 (727)
+.++.|. .+..+++. ...++||||+.|++|..++.. .....++.+|+++|.+||+. +|+||||
T Consensus 87 l~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl 151 (198)
T cd05144 87 LKALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKH---GIIHGDL 151 (198)
T ss_pred HHHHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHC---CCCcCCC
Confidence 9999877 44455543 345899999999998765431 24567889999999999998 9999999
Q ss_pred CCCceEECCCCcEEEEeeccchhh
Q 041135 509 KSSNILLDSSFEARVADFGLAKIA 532 (727)
Q Consensus 509 kp~NILl~~~~~vkL~DFGla~~~ 532 (727)
|++||||+++++++|+|||++..+
T Consensus 152 ~p~Nill~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 152 SEFNILVDDDEKIYIIDWPQMVST 175 (198)
T ss_pred CcccEEEcCCCcEEEEECCccccC
Confidence 999999999999999999999643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.78 E-value=7.3e-19 Score=175.85 Aligned_cols=130 Identities=22% Similarity=0.369 Sum_probs=106.2
Q ss_pred eeccCCceEEEEEEEcCCcEEEEEEeeeCCch--------hHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeec
Q 041135 388 VLGEGGFGCVYKGVLADGREVAVKQLKIGGSQ--------GEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYV 459 (727)
Q Consensus 388 ~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~--------~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 459 (727)
+||+|+||.||+|.+ +|..|+||+....... ....+.+|+++++.++|.+|.....++.+....+|||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999996 5788999986533211 1245778999999999887655555555666778999999
Q ss_pred cCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchh
Q 041135 460 PNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKI 531 (727)
Q Consensus 460 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 531 (727)
.|++|.+++..... .++.+|+++|.+||+. +|+||||+++|||++ ++.++|+|||+++.
T Consensus 80 ~g~~l~~~~~~~~~---------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND---------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH---------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999887754311 7899999999999999 999999999999999 78999999999864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.9e-18 Score=198.91 Aligned_cols=136 Identities=23% Similarity=0.331 Sum_probs=111.6
Q ss_pred cCccccceeccCCceEEEEEEEcCCcEEEEEEeeeC--Cc------hhHHHHHHHHHHHHHcCCCCceeEeeEeecccee
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIG--GS------QGEREFRAEVEIISRVHHRHLVSLVGYCISERER 452 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~--~~------~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 452 (727)
..|...++||+|+||.||+|.+.+ +.+++|+.... .. ...+.+.+|+++|++++|.+|+..+.++.+....
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~-~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLG-RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred cccCccceeccCCcEEEEEEeecC-ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 445678999999999999998854 34444443211 11 1124688999999999999999888888777788
Q ss_pred eEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchh
Q 041135 453 LLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKI 531 (727)
Q Consensus 453 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 531 (727)
+|||||+.|++|.+++. ....++.+|+++|.|||++ +|+|||||++|||| +++.++|+|||+++.
T Consensus 412 ~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999988875 3567899999999999999 99999999999999 677999999999974
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.8e-19 Score=206.73 Aligned_cols=213 Identities=22% Similarity=0.342 Sum_probs=142.7
Q ss_pred hcCccccceeccCCceEEEEEEEcC-CcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEee
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLAD-GREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~~-g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 458 (727)
..+|..+++|..|+||.||+.+++. .+.+|+|+-+. ..+ |+ ||+.+.| ..++|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq------~li------lR-----nilt~a~------npfvv--- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ------NLI------LR-----NILTFAG------NPFVV--- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhccccc------chh------hh-----ccccccC------Cccee---
Confidence 4679999999999999999998864 56677753221 111 11 1222211 11222
Q ss_pred ccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccC--
Q 041135 459 VPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD-- 536 (727)
Q Consensus 459 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-- 536 (727)
|+-...++..+.... +++.+++|||+. +|+|||+|++|+||+.-|++|+.||||.+......
T Consensus 136 ---gDc~tllk~~g~lPv----------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 ---GDCATLLKNIGPLPV----------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred ---chhhhhcccCCCCcc----------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 444455554433111 227799999999 99999999999999999999999999997643211
Q ss_pred ----------CCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHH
Q 041135 537 ----------SNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAE 606 (727)
Q Consensus 537 ----------~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~ 606 (727)
........+|||..|.|||++..+.|..-+|+|++|+|+||++-|+.+|.+..... .+..++..
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee------lfg~visd 273 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE------LFGQVISD 273 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH------HHhhhhhh
Confidence 11122335799999999999999999999999999999999999999998865421 11111111
Q ss_pred hhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHH
Q 041135 607 ALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMS 652 (727)
Q Consensus 607 ~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 652 (727)
.+. ..++ .......+.+++.++|+.++..|---.
T Consensus 274 ~i~----------wpE~--dea~p~Ea~dli~~LL~qnp~~Rlgt~ 307 (1205)
T KOG0606|consen 274 DIE----------WPEE--DEALPPEAQDLIEQLLRQNPLCRLGTG 307 (1205)
T ss_pred hcc----------cccc--CcCCCHHHHHHHHHHHHhChHhhcccc
Confidence 100 0000 112223366778888888888886443
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.4e-19 Score=195.73 Aligned_cols=124 Identities=26% Similarity=0.425 Sum_probs=105.8
Q ss_pred eeeEEEeeccCCccchhccc-CCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccc
Q 041135 451 ERLLVYEYVPNDTLHYHLHA-EGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLA 529 (727)
Q Consensus 451 ~~~lV~Ey~~~gsL~~~L~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla 529 (727)
.+||.|++|...+|.++|.+ ......++...+.++.|++.|++| + +.+|||+|+.||++..+..+||.||||.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence 56899999999999999974 344567888999999999999999 5 8999999999999999999999999998
Q ss_pred hhhhccC---CCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh
Q 041135 530 KIALELD---SNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT 580 (727)
Q Consensus 530 ~~~~~~~---~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt 580 (727)
....... ......+...||..||+||.|.+..|+.|+|||+||+||+||+.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 6542221 01123345789999999999999999999999999999999996
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.4e-17 Score=154.45 Aligned_cols=135 Identities=19% Similarity=0.159 Sum_probs=115.1
Q ss_pred ccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCC--CCceeEeeEeeccceeeEEEeeccCC
Q 041135 385 AHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHH--RHLVSLVGYCISERERLLVYEYVPND 462 (727)
Q Consensus 385 ~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H--pnIv~l~~~~~~~~~~~lV~Ey~~~g 462 (727)
+++.||+|.++.||+++.. +..++||+++.... ...+.+|+.+++.++| .++.++++++...+..+++|||+.++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~-~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK-DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEec-CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 4578999999999999985 47899999865433 5678999999999986 58999999988888899999999988
Q ss_pred ccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchh
Q 041135 463 TLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKI 531 (727)
Q Consensus 463 sL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 531 (727)
.+..+ +......++.+++++|++||.....+|+||||+++|||+++++.++|+|||+++.
T Consensus 79 ~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 87654 4456678899999999999986434799999999999999989999999999863
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.8e-17 Score=162.66 Aligned_cols=136 Identities=20% Similarity=0.224 Sum_probs=99.7
Q ss_pred cceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhH--HH----------------------HHHHHHHHHHcCCCC--c
Q 041135 386 HNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGE--RE----------------------FRAEVEIISRVHHRH--L 439 (727)
Q Consensus 386 ~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~--~~----------------------~~~Ei~~l~~l~Hpn--I 439 (727)
.+.||+|+||.||+|++.+|+.||||+++....... .. ...|.+.+.++.+.+ +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 578999999999999988899999999875322111 11 135666666665433 4
Q ss_pred eeEeeEeeccceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHh-cCCCcEEeeCCCCCceEECCC
Q 041135 440 VSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHE-DCHPRIIHRDIKSSNILLDSS 518 (727)
Q Consensus 440 v~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivHrDLkp~NILl~~~ 518 (727)
.+++++. ..+|||||+.++.+......... .. .+...++.+++.+|.+||. + +|+|||||++||+|+ +
T Consensus 82 ~~~~~~~----~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~-~ 150 (187)
T cd05119 82 PKPIDLN----RHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD-D 150 (187)
T ss_pred CceEecC----CCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-C
Confidence 4555432 35899999999654322111111 11 5678899999999999999 7 999999999999999 8
Q ss_pred CcEEEEeeccchhh
Q 041135 519 FEARVADFGLAKIA 532 (727)
Q Consensus 519 ~~vkL~DFGla~~~ 532 (727)
+.++|+|||++...
T Consensus 151 ~~~~liDfg~a~~~ 164 (187)
T cd05119 151 GKVYIIDVPQAVEI 164 (187)
T ss_pred CcEEEEECcccccc
Confidence 89999999999743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.2e-16 Score=160.60 Aligned_cols=134 Identities=19% Similarity=0.248 Sum_probs=104.2
Q ss_pred ceec-cCCceEEEEEEEcCCcEEEEEEeeeCCc-------------hhHHHHHHHHHHHHHcCCCCc--eeEeeEeeccc
Q 041135 387 NVLG-EGGFGCVYKGVLADGREVAVKQLKIGGS-------------QGEREFRAEVEIISRVHHRHL--VSLVGYCISER 450 (727)
Q Consensus 387 ~~LG-~G~fg~Vy~~~~~~g~~vaVK~l~~~~~-------------~~~~~~~~Ei~~l~~l~HpnI--v~l~~~~~~~~ 450 (727)
.+|| .||.|.||+++.. |..++||+++.... .....+.+|++++.+|+|.+| ++.++++..+.
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 5677 8888899988874 78899998854221 122457889999999998775 67777754432
Q ss_pred ----eeeEEEeeccC-CccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEe
Q 041135 451 ----ERLLVYEYVPN-DTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVAD 525 (727)
Q Consensus 451 ----~~~lV~Ey~~~-gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~D 525 (727)
..+|||||+.| .+|.+++... .+... ++.+|+.+|.+||++ ||+|||||++||||+.++.++|+|
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LID 185 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLID 185 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEEE
Confidence 22599999997 6888887543 13332 367899999999999 999999999999999988999999
Q ss_pred eccchh
Q 041135 526 FGLAKI 531 (727)
Q Consensus 526 FGla~~ 531 (727)
||.++.
T Consensus 186 fg~~~~ 191 (239)
T PRK01723 186 FDRGEL 191 (239)
T ss_pred CCCccc
Confidence 999874
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.3e-18 Score=195.92 Aligned_cols=259 Identities=22% Similarity=0.296 Sum_probs=193.5
Q ss_pred CccccceeccCCceEEEEEEEcC--CcEEEEEEeeeCC--chhHHHHHHHHHHHHHcC-CCCceeEeeEeeccceeeEEE
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLAD--GREVAVKQLKIGG--SQGEREFRAEVEIISRVH-HRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~~--g~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~lV~ 456 (727)
.|.+.+.||+|.|+.|-+..... ...+|+|.+.... .........|..+-..+. |.|++++++...+.+..++++
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 36667779999999998887543 4456666665433 222234555777777776 999999999999999999999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHH-hcCCCcEEeeCCCCCceEECCCC-cEEEEeeccchhhhc
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLH-EDCHPRIIHRDIKSSNILLDSSF-EARVADFGLAKIALE 534 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH-~~~~~~ivHrDLkp~NILl~~~~-~vkL~DFGla~~~~~ 534 (727)
||..|+++...+.......+.......++.|+..+|.|+| +. ++.|||||++|.+++..+ .+|++|||+|..+..
T Consensus 101 ~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred CcccccccccccccCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 9999999998884222224667777889999999999999 77 999999999999999999 999999999987755
Q ss_pred cCCCccccccccC-CccccccCcccCC-CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhh
Q 041135 535 LDSNTHVSTRVMG-TFGYMAPEYATSG-KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHED 612 (727)
Q Consensus 535 ~~~~~~~~~~~~g-t~~y~aPE~l~~~-~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~ 612 (727)
...........+| +..|+|||.+.+. ......|+||.|+++.-+++|..+|+...... ..+..|... .
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-~~~~~~~~~--------~- 247 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-GRYSSWKSN--------K- 247 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc-ccceeeccc--------c-
Confidence 4455555566788 9999999999884 56778999999999999999999998755432 111222110 0
Q ss_pred HHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 613 FEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 613 ~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
...............++++.+|+..+++.|.+.+++...-+
T Consensus 248 ------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~ 288 (601)
T KOG0590|consen 248 ------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNW 288 (601)
T ss_pred ------cccccCccccCChhhhhcccccccCCchhcccccccccccc
Confidence 00001112222334667778888899999999988865533
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.8e-14 Score=159.54 Aligned_cols=139 Identities=24% Similarity=0.275 Sum_probs=100.8
Q ss_pred ceeccCCceEEEEEEEcCCcEEEEEEeeeCCchh----------------------------------------HHHHHH
Q 041135 387 NVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQG----------------------------------------EREFRA 426 (727)
Q Consensus 387 ~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~----------------------------------------~~~~~~ 426 (727)
+.||.|++|.||+|++++|+.||||+.+.+.... +-+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 5799999999999999999999999986431100 113555
Q ss_pred HHHHHHHcC----CCCceeEeeEeec-cceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHH-HHHHHHhcCC
Q 041135 427 EVEIISRVH----HRHLVSLVGYCIS-ERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAAR-GIAYLHEDCH 500 (727)
Q Consensus 427 Ei~~l~~l~----HpnIv~l~~~~~~-~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~-gL~yLH~~~~ 500 (727)
|.+.+.+++ |.+-+.+-.+|.+ ....+|||||+.|+.|.+++..... .. ++.+++..+++ .+..+|..
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~---~~~~ia~~~~~~~l~ql~~~-- 276 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GL---DRKALAENLARSFLNQVLRD-- 276 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CC---CHHHHHHHHHHHHHHHHHhC--
Confidence 666666653 3333444333332 3456899999999999887653211 12 34556666665 46788888
Q ss_pred CcEEeeCCCCCceEECCCCcEEEEeeccchhh
Q 041135 501 PRIIHRDIKSSNILLDSSFEARVADFGLAKIA 532 (727)
Q Consensus 501 ~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~ 532 (727)
|++|+|+|+.||+|+++++++|+|||++..+
T Consensus 277 -g~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 277 -GFFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred -CceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 9999999999999999999999999998753
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.8e-14 Score=160.26 Aligned_cols=166 Identities=19% Similarity=0.249 Sum_probs=128.0
Q ss_pred EcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeeccCCccchhcccCCCCcccHHHH
Q 041135 402 LADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATR 481 (727)
Q Consensus 402 ~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~ 481 (727)
..++..|.|+.++..........++-++.|+.|+|+||+++++.+..++.+|||+|.+. -|..+|.+. ....+
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l-----~~~~v 106 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL-----GKEEV 106 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh-----HHHHH
Confidence 44688899988876655445668889999999999999999999999999999999884 455555543 35566
Q ss_pred HHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCccccccccCCccccccCcccCCC
Q 041135 482 VKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGK 561 (727)
Q Consensus 482 ~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 561 (727)
...+.||+.||.|||..| +++|++|.-..|+|+..|++||++|.++........ .......-..|..|+.+....
T Consensus 107 ~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~---~~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 107 CLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA---PAKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc---ccccchhhhcccChhhcCccc
Confidence 677899999999999766 899999999999999999999999999865322221 111112223355666544332
Q ss_pred CCchhHHHHHhHHHHHHHhC
Q 041135 562 LTEKSDVYSFGVVLLELITG 581 (727)
Q Consensus 562 ~~~ksDVwS~Gvil~eLltG 581 (727)
...|.|.|||++||++.|
T Consensus 182 --~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 --WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred --cchhhhhHHHHHHHHhCc
Confidence 457999999999999999
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.54 E-value=2.9e-15 Score=165.42 Aligned_cols=249 Identities=20% Similarity=0.232 Sum_probs=179.0
Q ss_pred Cccccceecc--CCceEEEEEEE---cCCcEEEEEEeeeCCc--hhHHHHHHHHHHHHHcC-CCCceeEeeEeeccceee
Q 041135 382 GFSAHNVLGE--GGFGCVYKGVL---ADGREVAVKQLKIGGS--QGEREFRAEVEIISRVH-HRHLVSLVGYCISERERL 453 (727)
Q Consensus 382 ~~~~~~~LG~--G~fg~Vy~~~~---~~g~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~ 453 (727)
.|.+.+.+|. |.+|.||++.. .++..+|+|+-+..-. .....-.+|+...++++ |.|.++.+..+...+..|
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4666788999 99999999986 3578899998543322 33334456777777775 999999999999999999
Q ss_pred EEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHH----HHHHHHhcCCCcEEeeCCCCCceEECCC-CcEEEEeecc
Q 041135 454 LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAAR----GIAYLHEDCHPRIIHRDIKSSNILLDSS-FEARVADFGL 528 (727)
Q Consensus 454 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~----gL~yLH~~~~~~ivHrDLkp~NILl~~~-~~vkL~DFGl 528 (727)
+-+|+| +.+|..+.+.... .+....++.++.++.. ||.++|.. +|+|-|+|+.||++..+ ..++++|||+
T Consensus 195 iqtE~~-~~sl~~~~~~~~~-~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 195 IQTELC-GESLQSYCHTPCN-FLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred eeeccc-cchhHHhhhcccc-cCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCcce
Confidence 999999 4777777765433 4666777888888888 99999999 99999999999999999 8899999999
Q ss_pred chhhhccCC--CccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHH
Q 041135 529 AKIALELDS--NTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAE 606 (727)
Q Consensus 529 a~~~~~~~~--~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~ 606 (727)
...+.+.+- ......+..|...|+++|.+++ .++...|||+||.+++|-.+|...+...... .|..
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~------~W~~----- 337 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNS------SWSQ----- 337 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCC------Cccc-----
Confidence 986644331 1222234478889999998774 6889999999999999998877655433111 1110
Q ss_pred hhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 041135 607 ALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVR 656 (727)
Q Consensus 607 ~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 656 (727)
+-...+..+|.......+..++..+++.++..|++...++.
T Consensus 338 ---------~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 338 ---------LRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ---------cccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 00001112222222333444677788888888887766543
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.54 E-value=7.1e-14 Score=158.15 Aligned_cols=143 Identities=22% Similarity=0.225 Sum_probs=93.8
Q ss_pred hcCccccceeccCCceEEEEEEEcC-CcEEEEEEeeeCCch----------------------------------hH---
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLAD-GREVAVKQLKIGGSQ----------------------------------GE--- 421 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~~-g~~vaVK~l~~~~~~----------------------------------~~--- 421 (727)
...|+. +.||.|++|.||+|++++ |++||||+++.+-.+ ..
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345665 789999999999999987 999999999643100 01
Q ss_pred ---HHHHHHHHHHHHcC----CCCceeEeeEeec-cceeeEEEeeccCCccchh--cccCCCCcccHHHHHHHHHHHHH-
Q 041135 422 ---REFRAEVEIISRVH----HRHLVSLVGYCIS-ERERLLVYEYVPNDTLHYH--LHAEGRPVMDWATRVKVAAGAAR- 490 (727)
Q Consensus 422 ---~~~~~Ei~~l~~l~----HpnIv~l~~~~~~-~~~~~lV~Ey~~~gsL~~~--L~~~~~~~l~~~~~~~i~~qia~- 490 (727)
-+|.+|+..+.+++ +.+.+.+-.++.+ ....+|||||+.|+.|.++ +...+ .+.. .++...++
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g---~d~~---~la~~~v~~ 271 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG---TDMK---LLAERGVEV 271 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC---CCHH---HHHHHHHHH
Confidence 12445555555543 3344444444433 3456899999999999764 32222 2222 12222221
Q ss_pred HHHHHHhcCCCcEEeeCCCCCceEECCCC----cEEEEeeccchhh
Q 041135 491 GIAYLHEDCHPRIIHRDIKSSNILLDSSF----EARVADFGLAKIA 532 (727)
Q Consensus 491 gL~yLH~~~~~~ivHrDLkp~NILl~~~~----~vkL~DFGla~~~ 532 (727)
-+.-++.. ||+|+|+||.||+|+.++ +++++|||++..+
T Consensus 272 ~~~Qif~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 272 FFTQVFRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred HHHHHHhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 12223345 999999999999999888 9999999998754
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.2e-13 Score=134.01 Aligned_cols=130 Identities=18% Similarity=0.109 Sum_probs=97.6
Q ss_pred cceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCce-eEeeEeeccceeeEEEeeccCCcc
Q 041135 386 HNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLV-SLVGYCISERERLLVYEYVPNDTL 464 (727)
Q Consensus 386 ~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv-~l~~~~~~~~~~~lV~Ey~~~gsL 464 (727)
++.|+.|.++.||+++.. |+.|+||+...... ....+.+|+++|+.+.+.+++ ++++++. ...++||||++|..+
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence 367899999999999875 78899998754322 234578899999998765544 5555432 345899999999887
Q ss_pred chhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcC--CCcEEeeCCCCCceEECCCCcEEEEeeccch
Q 041135 465 HYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDC--HPRIIHRDIKSSNILLDSSFEARVADFGLAK 530 (727)
Q Consensus 465 ~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--~~~ivHrDLkp~NILl~~~~~vkL~DFGla~ 530 (727)
.... . ....++.+++++|..||... ..+++||||++.||+++ ++.++|+|||++.
T Consensus 79 ~~~~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 79 LTED-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cccc-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 6431 1 11345678999999999982 12369999999999999 6689999999986
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.5e-14 Score=147.72 Aligned_cols=213 Identities=20% Similarity=0.314 Sum_probs=144.7
Q ss_pred HHHHHHHHHHHcCCCCceeEeeEeeccc-----eeeEEEeeccCCccchhcccCC--CCcccHHHHHHHHHHHHHHHHHH
Q 041135 423 EFRAEVEIISRVHHRHLVSLVGYCISER-----ERLLVYEYVPNDTLHYHLHAEG--RPVMDWATRVKVAAGAARGIAYL 495 (727)
Q Consensus 423 ~~~~Ei~~l~~l~HpnIv~l~~~~~~~~-----~~~lV~Ey~~~gsL~~~L~~~~--~~~l~~~~~~~i~~qia~gL~yL 495 (727)
..+.-+..|-.+.|.|||+++.||.+.. ...++.||+.-|+|..+|++.. ...+......+|+.||+.||.||
T Consensus 113 k~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yL 192 (458)
T KOG1266|consen 113 KRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYL 192 (458)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhh
Confidence 3444556666778999999999987644 4688999999999999998643 23467788899999999999999
Q ss_pred HhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccC-CCccccccccCCccccccCcccCCCCCchhHHHHHhHH
Q 041135 496 HEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD-SNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVV 574 (727)
Q Consensus 496 H~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvi 574 (727)
|+ |.+.|+|+++..+-|++..++-+||.--.......... ..........+-.+|.++|+-.....+-.+|||+||+.
T Consensus 193 hs-~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmc 271 (458)
T KOG1266|consen 193 HS-CDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMC 271 (458)
T ss_pred hc-cCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHH
Confidence 99 58899999999999999999888875322211100000 00111122345678999998877778889999999999
Q ss_pred HHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHH
Q 041135 575 LLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQV 654 (727)
Q Consensus 575 l~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 654 (727)
.+||.-|..--.... +.++. ...+...+. .+... .-..++..|++-.|..||+|+++
T Consensus 272 AlemailEiq~tnse-----S~~~~----------ee~ia~~i~-~len~-------lqr~~i~kcl~~eP~~rp~ar~l 328 (458)
T KOG1266|consen 272 ALEMAILEIQSTNSE-----SKVEV----------EENIANVII-GLENG-------LQRGSITKCLEGEPNGRPDARLL 328 (458)
T ss_pred HHHHHHheeccCCCc-----ceeeh----------hhhhhhhee-eccCc-------cccCcCcccccCCCCCCcchhhh
Confidence 999988765311111 00000 000000000 01110 01246778999999999999998
Q ss_pred HHHHh
Q 041135 655 VRALD 659 (727)
Q Consensus 655 l~~L~ 659 (727)
+.+.-
T Consensus 329 lfHpl 333 (458)
T KOG1266|consen 329 LFHPL 333 (458)
T ss_pred hcCce
Confidence 77643
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.46 E-value=5.3e-13 Score=132.14 Aligned_cols=135 Identities=16% Similarity=0.179 Sum_probs=99.7
Q ss_pred cceeccCCceEEEEEEEcC-------CcEEEEEEeeeCCc----------------------hhHHHHH----HHHHHHH
Q 041135 386 HNVLGEGGFGCVYKGVLAD-------GREVAVKQLKIGGS----------------------QGEREFR----AEVEIIS 432 (727)
Q Consensus 386 ~~~LG~G~fg~Vy~~~~~~-------g~~vaVK~l~~~~~----------------------~~~~~~~----~Ei~~l~ 432 (727)
...||.|.-+.||.|...+ +..+|||+++.... ...+.+. +|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4679999999999998543 47999999863210 0012233 7999999
Q ss_pred HcCC--CCceeEeeEeeccceeeEEEeeccCCccch-hcccCCCCcccHHHHHHHHHHHHHHHHHH-HhcCCCcEEeeCC
Q 041135 433 RVHH--RHLVSLVGYCISERERLLVYEYVPNDTLHY-HLHAEGRPVMDWATRVKVAAGAARGIAYL-HEDCHPRIIHRDI 508 (727)
Q Consensus 433 ~l~H--pnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~-~L~~~~~~~l~~~~~~~i~~qia~gL~yL-H~~~~~~ivHrDL 508 (727)
++.. -++.+.+++ ...+|||||+.++.+.. .|+.. .++..+...++.+++.+|.+| |+. +||||||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~---~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDL 151 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA---KLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADL 151 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc---ccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence 9863 566677765 34589999997764432 22221 244556778889999999999 787 9999999
Q ss_pred CCCceEECCCCcEEEEeeccchh
Q 041135 509 KSSNILLDSSFEARVADFGLAKI 531 (727)
Q Consensus 509 kp~NILl~~~~~vkL~DFGla~~ 531 (727)
+..|||++ ++.++|+|||.+..
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~ 173 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVE 173 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCcee
Confidence 99999997 46899999998864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.40 E-value=2.7e-12 Score=129.97 Aligned_cols=142 Identities=20% Similarity=0.297 Sum_probs=111.7
Q ss_pred ceeccCCceEEEEEEEcCCcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCC--CceeEeeEeeccc---eeeEEEeecc
Q 041135 387 NVLGEGGFGCVYKGVLADGREVAVKQLKIGGS-QGEREFRAEVEIISRVHHR--HLVSLVGYCISER---ERLLVYEYVP 460 (727)
Q Consensus 387 ~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~Hp--nIv~l~~~~~~~~---~~~lV~Ey~~ 460 (727)
+.|+.|.++.||+++..+|+.++||+...... .....+.+|+++++.+++. ++.++++++.... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999987778999998764332 1345789999999999764 4577888776543 5689999999
Q ss_pred CCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 041135 461 NDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDC----------------------------------------- 499 (727)
Q Consensus 461 ~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~----------------------------------------- 499 (727)
|..|.+.+.. ..++..++..++.+++++|.+||+..
T Consensus 84 G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 84 GRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 9988876642 13677778888888888888888521
Q ss_pred ------------CCcEEeeCCCCCceEECC--CCcEEEEeeccchh
Q 041135 500 ------------HPRIIHRDIKSSNILLDS--SFEARVADFGLAKI 531 (727)
Q Consensus 500 ------------~~~ivHrDLkp~NILl~~--~~~vkL~DFGla~~ 531 (727)
...++|+|+++.|||++. ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 246899999999999988 66789999998863
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.4e-13 Score=152.13 Aligned_cols=248 Identities=17% Similarity=0.165 Sum_probs=173.6
Q ss_pred hcCccccceeccCCceEEEEEEEc--CCcEEEEEEeeeCCchhHHH--HHHHHHHHHHcC-CCCceeEeeEeeccceeeE
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA--DGREVAVKQLKIGGSQGERE--FRAEVEIISRVH-HRHLVSLVGYCISERERLL 454 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~--~g~~vaVK~l~~~~~~~~~~--~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~l 454 (727)
..+|.++..||.|.|+.||+...+ ++..|++|.+.........+ -..|+-+...+. |.|+++++..|....+.||
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 467899999999999999998754 57889999886543333322 345666666664 9999999988888888899
Q ss_pred EEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCC-CcEEEEeeccchhhh
Q 041135 455 VYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSS-FEARVADFGLAKIAL 533 (727)
Q Consensus 455 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~-~~vkL~DFGla~~~~ 533 (727)
-.|||+++++...+... ..++...++++..|++.++.++|+. .++|+|+|++||++..+ +..++.|||++..+.
T Consensus 344 p~e~~~~~s~~l~~~~~--~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRSVTS--QMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA 418 (524)
T ss_pred chhhhcCcchhhhhHHH--HhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccccccc
Confidence 99999999987665322 2378888999999999999999999 99999999999999876 788999999986321
Q ss_pred ccCCCccccccccCCccc-cccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhh
Q 041135 534 ELDSNTHVSTRVMGTFGY-MAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHED 612 (727)
Q Consensus 534 ~~~~~~~~~~~~~gt~~y-~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~ 612 (727)
-. .......+..| .+++.+....+..+.|+|+||+-+.|.++|..--.. .+.|..
T Consensus 419 ~~-----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~--------~~~~~~----------- 474 (524)
T KOG0601|consen 419 FS-----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES--------GVQSLT----------- 474 (524)
T ss_pred ee-----cccccccccccccchhhccccccccccccccccccccccccCcccCcc--------ccccee-----------
Confidence 00 01111223334 345555566788999999999999999987642211 111111
Q ss_pred HHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhc
Q 041135 613 FEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661 (727)
Q Consensus 613 ~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 661 (727)
+....+..... ....+..+.+.++..++..|+.+.++..+.+..
T Consensus 475 ---i~~~~~p~~~~--~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 475 ---IRSGDTPNLPG--LKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred ---eecccccCCCc--hHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 00010100000 113355667778888999998888877665543
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.35 E-value=5e-12 Score=120.49 Aligned_cols=143 Identities=19% Similarity=0.256 Sum_probs=107.0
Q ss_pred ccceeccCCceEEEEEEEcCCcEEEEEEeeeC--------CchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 385 AHNVLGEGGFGCVYKGVLADGREVAVKQLKIG--------GSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 385 ~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~--------~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
.+.+|.+|+-+.|+++.+. |+.++||.--.. ........++|+++|.++.--.|.--.-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 5688999999999999984 888888754211 1122356788999999987544443333455555667999
Q ss_pred eeccC-CccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCC---cEEEEeeccchh
Q 041135 457 EYVPN-DTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSF---EARVADFGLAKI 531 (727)
Q Consensus 457 Ey~~~-gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~---~vkL~DFGla~~ 531 (727)
||+.| .++.+++...............++..|-+.|.-||.+ +|||+||..+||+|..++ .+.|+||||+..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99977 4778887765544445555578899999999999999 999999999999996543 458999999863
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.5e-11 Score=117.90 Aligned_cols=131 Identities=23% Similarity=0.369 Sum_probs=97.6
Q ss_pred ceeccCCceEEEEEEEcCCcEEEEEEeeeCC---ch-----hHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEee
Q 041135 387 NVLGEGGFGCVYKGVLADGREVAVKQLKIGG---SQ-----GEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 387 ~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~---~~-----~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 458 (727)
.+|++|+-+.+|++.+. |..+++|.-..+. .+ ......+|+++|.+++--.|---+-+..+.....|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 46889999999999774 5557776542211 11 113466899999988744443333344456667899999
Q ss_pred ccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchh
Q 041135 459 VPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKI 531 (727)
Q Consensus 459 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 531 (727)
++|-.|.++|... ...++..+-+-+.-||.. +|||+||..+||+|..+. +.++||||+.+
T Consensus 81 I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA---------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc---------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888665 245677788888899999 999999999999997764 99999999873
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.31 E-value=9.7e-11 Score=126.95 Aligned_cols=168 Identities=20% Similarity=0.269 Sum_probs=127.6
Q ss_pred ceEEEEEEE-cCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEee----ccceeeEEEeeccC-Cccchh
Q 041135 394 FGCVYKGVL-ADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCI----SERERLLVYEYVPN-DTLHYH 467 (727)
Q Consensus 394 fg~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~----~~~~~~lV~Ey~~~-gsL~~~ 467 (727)
-.+.||+.. .||..|++|+++....+.......-+++++++.|.|||.|.++|. .+..++|||+|+++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 357888875 479999999995544444445566788999999999999998886 35578999999987 355443
Q ss_pred ccc-------------CCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhc
Q 041135 468 LHA-------------EGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALE 534 (727)
Q Consensus 468 L~~-------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 534 (727)
-.. .......+..+|.++.||..||.+||+. |+..+-|.+++||++.+.+++|...|+...+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 211 1123467789999999999999999999 999999999999999998999988887764422
Q ss_pred cCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCC
Q 041135 535 LDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKP 584 (727)
Q Consensus 535 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~P 584 (727)
.. . |-+. -..+.|.=.||+||+.|.+|+..
T Consensus 446 d~-~----------------~~le---~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DP-T----------------EPLE---SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CC-C----------------cchh---HHhhhhHHHHHHHHHHHhhcccc
Confidence 11 0 1111 23478999999999999999654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.9e-12 Score=149.82 Aligned_cols=207 Identities=22% Similarity=0.294 Sum_probs=150.8
Q ss_pred HhcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeE
Q 041135 379 ATNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLL 454 (727)
Q Consensus 379 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 454 (727)
..++|.+.+-+-+|.|+.++.++-. .|...++|..+... ..+.+..+++-.++-..+|+.+++...-+.-....+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 3456777888999999999987643 24444555443211 1223344455555544556777766655555667899
Q ss_pred EEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhc
Q 041135 455 VYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALE 534 (727)
Q Consensus 455 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 534 (727)
|++|+.+++|...|+..+. .+.+-....+..+...++|||.. .++|||+++.|+|+..++..++.|||+......
T Consensus 882 ~~~~~~~~~~~Skl~~~~~--~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSGC--LSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred hhHHhccCCchhhhhcCCC--cccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccccccc
Confidence 9999999999999987663 44444555667788999999998 799999999999999999999999984321100
Q ss_pred c---------------------C-----C--CccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCC
Q 041135 535 L---------------------D-----S--NTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVD 586 (727)
Q Consensus 535 ~---------------------~-----~--~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~ 586 (727)
. . . .........||..|++||.+.+......+|+|++|++++|.++|..+|.
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence 0 0 0 0011233578999999999999999999999999999999999999998
Q ss_pred CCCC
Q 041135 587 ASQP 590 (727)
Q Consensus 587 ~~~~ 590 (727)
....
T Consensus 1037 a~tp 1040 (1205)
T KOG0606|consen 1037 AETP 1040 (1205)
T ss_pred Ccch
Confidence 7553
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.21 E-value=2e-10 Score=119.90 Aligned_cols=140 Identities=19% Similarity=0.105 Sum_probs=101.8
Q ss_pred ceeccCCceEEEEEEEcCCcEEEEEEeeeCCchh-H----------HHHHHHHHHHHHcCC--CCceeEeeEeec-----
Q 041135 387 NVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQG-E----------REFRAEVEIISRVHH--RHLVSLVGYCIS----- 448 (727)
Q Consensus 387 ~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~-~----------~~~~~Ei~~l~~l~H--pnIv~l~~~~~~----- 448 (727)
+.+-+.....|+++.+ +|+.|.||+........ . ..+.+|++.+.+|.. -.+..+++++..
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3444444456777776 58899999774332110 1 147899999999853 334455666543
Q ss_pred cceeeEEEeeccCC-ccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECC-------CCc
Q 041135 449 ERERLLVYEYVPND-TLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDS-------SFE 520 (727)
Q Consensus 449 ~~~~~lV~Ey~~~g-sL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~-------~~~ 520 (727)
....+||||++.+. +|.+++........+...+..++.+|++.+.-||.+ ||+|+||+++||||+. ++.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCce
Confidence 23568999999886 788887542222355667789999999999999999 9999999999999975 468
Q ss_pred EEEEeeccch
Q 041135 521 ARVADFGLAK 530 (727)
Q Consensus 521 vkL~DFGla~ 530 (727)
+.|+||+.++
T Consensus 184 ~~LIDl~r~~ 193 (268)
T PRK15123 184 LSVIDLHRAQ 193 (268)
T ss_pred EEEEECCccc
Confidence 9999999875
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.8e-10 Score=113.63 Aligned_cols=124 Identities=25% Similarity=0.335 Sum_probs=83.6
Q ss_pred EEEEEEEcCCcEEEEEEeeeCCc-------------h-------------hHHHHHHHHHHHHHcCCC--CceeEeeEee
Q 041135 396 CVYKGVLADGREVAVKQLKIGGS-------------Q-------------GEREFRAEVEIISRVHHR--HLVSLVGYCI 447 (727)
Q Consensus 396 ~Vy~~~~~~g~~vaVK~l~~~~~-------------~-------------~~~~~~~Ei~~l~~l~Hp--nIv~l~~~~~ 447 (727)
.||.|...+|..||||+.+.... . .....++|++.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999998899999999864210 0 012366899999999755 566776553
Q ss_pred ccceeeEEEeecc--CCccchhcccCCCCcccHHHHHHHHHHHHHHHHH-HHhcCCCcEEeeCCCCCceEECCCCcEEEE
Q 041135 448 SERERLLVYEYVP--NDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAY-LHEDCHPRIIHRDIKSSNILLDSSFEARVA 524 (727)
Q Consensus 448 ~~~~~~lV~Ey~~--~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~y-LH~~~~~~ivHrDLkp~NILl~~~~~vkL~ 524 (727)
..+|||||+. |..|..+.... ++..+...++.+++..+.. ||+. ||||+||...|||++++ .+.|+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE-
T ss_pred ---CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEEE
Confidence 3479999998 55554433221 2245667788888886666 5677 99999999999999888 99999
Q ss_pred eeccchh
Q 041135 525 DFGLAKI 531 (727)
Q Consensus 525 DFGla~~ 531 (727)
|||.+..
T Consensus 149 Df~qav~ 155 (188)
T PF01163_consen 149 DFGQAVD 155 (188)
T ss_dssp -GTTEEE
T ss_pred ecCccee
Confidence 9999864
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=4.9e-10 Score=113.66 Aligned_cols=136 Identities=21% Similarity=0.226 Sum_probs=101.2
Q ss_pred cCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCch----------------------hHHHHHHHHHHHHHcCCC-
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQ----------------------GEREFRAEVEIISRVHHR- 437 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~----------------------~~~~~~~Ei~~l~~l~Hp- 437 (727)
.-..+.++||.|.-+.||.|...+|.++|||.-+..... .....++|+++|.+|.-.
T Consensus 91 ~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G 170 (304)
T COG0478 91 IVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG 170 (304)
T ss_pred hHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence 345677899999999999999999999999976533110 112366799999988644
Q ss_pred -CceeEeeEeeccceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEEC
Q 041135 438 -HLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLD 516 (727)
Q Consensus 438 -nIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~ 516 (727)
.|.+-+++ +...+||||++|-.|...-. +....-.|+..|++-+.-+-.. ||||+||..-||||+
T Consensus 171 ~~VP~P~~~----nRHaVvMe~ieG~eL~~~r~-------~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~ 236 (304)
T COG0478 171 VKVPKPIAW----NRHAVVMEYIEGVELYRLRL-------DVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVT 236 (304)
T ss_pred CCCCCcccc----ccceeeeehcccceeecccC-------cccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEe
Confidence 66666654 34579999999877754331 2334445566666666666666 999999999999999
Q ss_pred CCCcEEEEeeccch
Q 041135 517 SSFEARVADFGLAK 530 (727)
Q Consensus 517 ~~~~vkL~DFGla~ 530 (727)
+||.++|+||--+.
T Consensus 237 ~dg~~~vIDwPQ~v 250 (304)
T COG0478 237 EDGDIVVIDWPQAV 250 (304)
T ss_pred cCCCEEEEeCcccc
Confidence 99999999997664
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.01 E-value=1e-08 Score=115.63 Aligned_cols=140 Identities=22% Similarity=0.248 Sum_probs=93.9
Q ss_pred ceeccCCceEEEEEEEcCCcEEEEEEeeeCCc----------------------------------------hhHHHHHH
Q 041135 387 NVLGEGGFGCVYKGVLADGREVAVKQLKIGGS----------------------------------------QGEREFRA 426 (727)
Q Consensus 387 ~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~----------------------------------------~~~~~~~~ 426 (727)
+-|+.++-|.||+|++++|+.||||+.+.+-. ..+-++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 56899999999999999999999998742210 01123556
Q ss_pred HHHHHHHcC----CCCceeEeeEee-ccceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCC
Q 041135 427 EVEIISRVH----HRHLVSLVGYCI-SERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHP 501 (727)
Q Consensus 427 Ei~~l~~l~----HpnIv~l~~~~~-~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ 501 (727)
|...+.+++ +..-+++=.+|+ .....+|+|||+.|.-+.++..... ..++.+.+...+.++. +..+-..
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~~d--- 284 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLLRD--- 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHHhc---
Confidence 666666653 222233333443 3456789999999999988742222 2245444433333322 2223333
Q ss_pred cEEeeCCCCCceEECCCCcEEEEeeccchhh
Q 041135 502 RIIHRDIKSSNILLDSSFEARVADFGLAKIA 532 (727)
Q Consensus 502 ~ivHrDLkp~NILl~~~~~vkL~DFGla~~~ 532 (727)
|++|.|.++.||+|+.++++.+.|||+...+
T Consensus 285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred CccccCCCccceEEecCCcEEEEcCcceecC
Confidence 8999999999999999999999999998643
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.00 E-value=2.7e-09 Score=113.16 Aligned_cols=263 Identities=20% Similarity=0.230 Sum_probs=158.3
Q ss_pred ccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHc-CCCCceeEeeE------eec-cceeeE
Q 041135 383 FSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRV-HHRHLVSLVGY------CIS-ERERLL 454 (727)
Q Consensus 383 ~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~------~~~-~~~~~l 454 (727)
....+.||+|+.+.+|-... -+..+.|+++.--.-...+ .+..|.+. .|+-+-.-+.+ .-+ +..+.+
T Consensus 13 i~~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 13 IPPGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred cCCCccccCCccceeeecch--hhchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 34567799999999995422 2334567775432222222 23333333 45543331111 111 223567
Q ss_pred EEeeccCCc-cchhc----ccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccc
Q 041135 455 VYEYVPNDT-LHYHL----HAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLA 529 (727)
Q Consensus 455 V~Ey~~~gs-L~~~L----~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla 529 (727)
+|..+.+.. +..++ +++.....+|..++++++.|+.+.+.||++ |.+-+|+..+||||.+++.|.|+|-..-
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccce
Confidence 787776642 12222 123345689999999999999999999999 9999999999999999999999986543
Q ss_pred hhhhccCCCccccccccCCccccccCccc-----CCCCCchhHHHHHhHHHHHHHhC-CCCCCCCCCCCchhhHHhhHHH
Q 041135 530 KIALELDSNTHVSTRVMGTFGYMAPEYAT-----SGKLTEKSDVYSFGVVLLELITG-RKPVDASQPLGDESLVEWARPL 603 (727)
Q Consensus 530 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~ksDVwS~Gvil~eLltG-~~Pf~~~~~~~~~~l~~~~~~~ 603 (727)
.. ..+......-+|...|..||.-. +..-+...|.|.|||+|++||.| ++||.+.......-- -
T Consensus 165 qi----~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~------p 234 (637)
T COG4248 165 QI----NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPN------P 234 (637)
T ss_pred ee----ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCC------c
Confidence 21 22333344567889999999755 34557789999999999999986 999987544322110 0
Q ss_pred HHHhhchhhHHHHHHHHhhccc-c-----hhHHHHHHHHHHHHhccC--CCCCCCHHHHHHHHhhccC
Q 041135 604 LAEALEHEDFEALVDSRLEKNY-V-----DSEMFWMIEAAAACVRHS--ATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 604 l~~~~~~~~~~~l~d~~l~~~~-~-----~~~~~~l~~li~~cl~~d--P~~RPs~~evl~~L~~~~~ 663 (727)
+...+.++.|...-+.+..... . .-..-.+..|..+|+... +.-||+.+..+..|..+.+
T Consensus 235 ~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~ 302 (637)
T COG4248 235 LETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ 302 (637)
T ss_pred chhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence 0001111222111111110000 0 000111334555677654 5689999998888877654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.00 E-value=6.2e-09 Score=103.56 Aligned_cols=155 Identities=14% Similarity=0.087 Sum_probs=112.7
Q ss_pred HHHHHHHhcCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCC------chhHHHHHHHHHHHHHcCC--CCceeEee
Q 041135 373 YDELIQATNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGG------SQGEREFRAEVEIISRVHH--RHLVSLVG 444 (727)
Q Consensus 373 ~~el~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~------~~~~~~~~~Ei~~l~~l~H--pnIv~l~~ 444 (727)
++.+.....++...---|+||.+-|++..+. |+.+-||+-...- ......|.+|+..|++|.. -.+.+++.
T Consensus 10 f~~~w~~~~~wve~pN~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf 88 (216)
T PRK09902 10 FNHWWATEGDWVEEPNYRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVF 88 (216)
T ss_pred HHHHHhCCCceecCCCcCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccce
Confidence 4555555544443344577999999998774 5578899764111 2245689999999999963 33445552
Q ss_pred Eeec----cceeeEEEeeccC-CccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCC
Q 041135 445 YCIS----ERERLLVYEYVPN-DTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSF 519 (727)
Q Consensus 445 ~~~~----~~~~~lV~Ey~~~-gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~ 519 (727)
+... ...-+||+|-+.| .+|.+++........+...+..++.+|++.|.-||.. |+.|+|+..+|||++.++
T Consensus 89 ~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g 165 (216)
T PRK09902 89 GEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEG 165 (216)
T ss_pred eeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCC
Confidence 2211 1245899998764 5787787665444567788899999999999999999 999999999999998666
Q ss_pred c--EEEEeeccchh
Q 041135 520 E--ARVADFGLAKI 531 (727)
Q Consensus 520 ~--vkL~DFGla~~ 531 (727)
. ++++||.-++.
T Consensus 166 ~~~v~lIDlEk~r~ 179 (216)
T PRK09902 166 KAEAGFLDLEKSRR 179 (216)
T ss_pred CeeEEEEEhhccch
Confidence 6 99999987763
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.2e-10 Score=130.79 Aligned_cols=153 Identities=20% Similarity=0.311 Sum_probs=102.7
Q ss_pred HHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCC-----C-ccccccccCCccccccCcccC
Q 041135 486 AGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDS-----N-THVSTRVMGTFGYMAPEYATS 559 (727)
Q Consensus 486 ~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~-----~-~~~~~~~~gt~~y~aPE~l~~ 559 (727)
.+++.||.|||... ++||++|.+++|+++.++.+||+.|+++........ . ....-...-...|.|||++.+
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 34458999999875 999999999999999999999999998864322111 0 001111234578999999999
Q ss_pred CCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHH
Q 041135 560 GKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAA 638 (727)
Q Consensus 560 ~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~ 638 (727)
...+.++|+|||||++|-+.. |+.-|..........+. ...+..-...+..+...++.+-+.
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~-----------------~~~~~~~~~~~s~~~p~el~~~l~ 246 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS-----------------RNLLNAGAFGYSNNLPSELRESLK 246 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhh-----------------hcccccccccccccCcHHHHHHHH
Confidence 889999999999999999995 44444433221111100 000111111122334455778888
Q ss_pred HHhccCCCCCCCHHHHHHH
Q 041135 639 ACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 639 ~cl~~dP~~RPs~~evl~~ 657 (727)
+++..+...||++.++...
T Consensus 247 k~l~~~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 247 KLLNGDSAVRPTLDLLLSI 265 (700)
T ss_pred HHhcCCcccCcchhhhhcc
Confidence 9999999999977776543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.94 E-value=5e-09 Score=105.65 Aligned_cols=106 Identities=25% Similarity=0.272 Sum_probs=85.2
Q ss_pred HHHHHHHHHHHHHcC--CCCceeEeeEeecc----ceeeEEEeeccCC-ccchhcccCCCCcccHHHHHHHHHHHHHHHH
Q 041135 421 EREFRAEVEIISRVH--HRHLVSLVGYCISE----RERLLVYEYVPND-TLHYHLHAEGRPVMDWATRVKVAAGAARGIA 493 (727)
Q Consensus 421 ~~~~~~Ei~~l~~l~--HpnIv~l~~~~~~~----~~~~lV~Ey~~~g-sL~~~L~~~~~~~l~~~~~~~i~~qia~gL~ 493 (727)
.....+|++.+..|. .-.+.+.+++.... ...+||+|++++. +|.+++..... ++......++.+|++.+.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIA 132 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHH
Confidence 346888999988885 34455667766542 2458999999885 78888876433 566678899999999999
Q ss_pred HHHhcCCCcEEeeCCCCCceEECCCC---cEEEEeeccchh
Q 041135 494 YLHEDCHPRIIHRDIKSSNILLDSSF---EARVADFGLAKI 531 (727)
Q Consensus 494 yLH~~~~~~ivHrDLkp~NILl~~~~---~vkL~DFGla~~ 531 (727)
-||.+ ||+|+||++.||||+.+. .+.|+||+.++.
T Consensus 133 ~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 133 KLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999 999999999999998876 899999998763
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.90 E-value=2.1e-08 Score=101.09 Aligned_cols=151 Identities=21% Similarity=0.250 Sum_probs=102.3
Q ss_pred ccHHHHHHHhcCccccce---eccCCceEEEEEEEcCCcEEEEEEeeeCCchhH-------------------H----H-
Q 041135 371 FTYDELIQATNGFSAHNV---LGEGGFGCVYKGVLADGREVAVKQLKIGGSQGE-------------------R----E- 423 (727)
Q Consensus 371 ~~~~el~~~~~~~~~~~~---LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~-------------------~----~- 423 (727)
.+++.|....++..+..+ |..|.-+.||+|...++..||||+++....... + .
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 345566666666655554 556777789999988899999999964321111 0 1
Q ss_pred HHHHHHHHHHcC--CCCceeEeeEeeccceeeEEEeeccCCccc-hhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCC
Q 041135 424 FRAEVEIISRVH--HRHLVSLVGYCISERERLLVYEYVPNDTLH-YHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCH 500 (727)
Q Consensus 424 ~~~Ei~~l~~l~--HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~-~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~ 500 (727)
.++|+..|.++. +-.+.+-+++. ...|||||+....+- -.|..-. +...+...+..++++.+.-|...+
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv~---~e~~e~~~~~~~~v~~~~~l~~~a- 186 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKDVP---LELEEAEGLYEDVVEYMRRLYKEA- 186 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcccCC---cCchhHHHHHHHHHHHHHHHHHhc-
Confidence 235677777664 44444555543 347999999655221 1232221 233366778888888888888733
Q ss_pred CcEEeeCCCCCceEECCCCcEEEEeeccchh
Q 041135 501 PRIIHRDIKSSNILLDSSFEARVADFGLAKI 531 (727)
Q Consensus 501 ~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 531 (727)
++||+||..-|||++ ++.+.|+|||-|..
T Consensus 187 -~LVHgDLSEyNiL~~-~~~p~iID~~QaV~ 215 (268)
T COG1718 187 -GLVHGDLSEYNILVH-DGEPYIIDVSQAVT 215 (268)
T ss_pred -CcccccchhhheEEE-CCeEEEEECccccc
Confidence 999999999999999 77999999998864
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.81 E-value=5e-08 Score=99.77 Aligned_cols=138 Identities=17% Similarity=0.180 Sum_probs=87.2
Q ss_pred ceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCC--ceeEeeEeeccceeeEEEeeccCCc-
Q 041135 387 NVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRH--LVSLVGYCISERERLLVYEYVPNDT- 463 (727)
Q Consensus 387 ~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~Hpn--Iv~l~~~~~~~~~~~lV~Ey~~~gs- 463 (727)
..||+|..+.||+. .|..+++|...... ....+.+|.++|+.+..-. +.+.++++.+.+...+|||++.|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 56899999999984 25568889876432 3356799999999997443 4678888877778889999999863
Q ss_pred cchh---------------------cccCCCCcccHHHH-HHHHH----------HHHH-HHHHHHhcC-CCcEEeeCCC
Q 041135 464 LHYH---------------------LHAEGRPVMDWATR-VKVAA----------GAAR-GIAYLHEDC-HPRIIHRDIK 509 (727)
Q Consensus 464 L~~~---------------------L~~~~~~~l~~~~~-~~i~~----------qia~-gL~yLH~~~-~~~ivHrDLk 509 (727)
+... ||...........+ .++.. .+.+ ..++|.... ...++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 2111 12110001111100 00000 0111 122222111 2358999999
Q ss_pred CCceEECCCCcEEEEeeccch
Q 041135 510 SSNILLDSSFEARVADFGLAK 530 (727)
Q Consensus 510 p~NILl~~~~~vkL~DFGla~ 530 (727)
+.||++++++ +.|+||+.+.
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCcEEEcCCC-cEEEechhcC
Confidence 9999999888 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.76 E-value=7.1e-08 Score=96.35 Aligned_cols=136 Identities=17% Similarity=0.210 Sum_probs=95.2
Q ss_pred hcCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHH---------HHHHHHHHHHcCC---CCceeEeeEee
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGERE---------FRAEVEIISRVHH---RHLVSLVGYCI 447 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~---------~~~Ei~~l~~l~H---pnIv~l~~~~~ 447 (727)
.++|++.+++-......|.+-.. +|+.+++|..+......++. ..+++..+.+++. -.+..++.+..
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 57788889998888888888777 57899999987655444433 2344555555532 23333233222
Q ss_pred c-----cceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEE
Q 041135 448 S-----ERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEAR 522 (727)
Q Consensus 448 ~-----~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vk 522 (727)
. ....+|||||++|..|.++.. ++. .++..|.++|.-||+. |++|+|+.+.|++|+++ .++
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~-~i~ 174 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN-GIR 174 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC-cEE
Confidence 1 234568999999988876542 221 2445677889999999 99999999999999865 599
Q ss_pred EEeeccch
Q 041135 523 VADFGLAK 530 (727)
Q Consensus 523 L~DFGla~ 530 (727)
++||+..+
T Consensus 175 iID~~~k~ 182 (229)
T PF06176_consen 175 IIDTQGKR 182 (229)
T ss_pred EEECcccc
Confidence 99998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.75 E-value=6.5e-08 Score=98.40 Aligned_cols=142 Identities=20% Similarity=0.223 Sum_probs=86.4
Q ss_pred cceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCC--CceeEeeEeec---cceeeEEEeecc
Q 041135 386 HNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHR--HLVSLVGYCIS---ERERLLVYEYVP 460 (727)
Q Consensus 386 ~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~Hp--nIv~l~~~~~~---~~~~~lV~Ey~~ 460 (727)
++.|+.|..+.||+....+ ..++||+.... .....+.+|+.+++.|... .+.++++++.. ....+++|+|+.
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 4679999999999999876 69999986543 4567888999999998633 35677765533 234689999999
Q ss_pred CCccch----------------hc---ccC--CCCcccH-H--------HHHHH------------HHHHHH-HHHHHHh
Q 041135 461 NDTLHY----------------HL---HAE--GRPVMDW-A--------TRVKV------------AAGAAR-GIAYLHE 497 (727)
Q Consensus 461 ~gsL~~----------------~L---~~~--~~~~l~~-~--------~~~~i------------~~qia~-gL~yLH~ 497 (727)
|..+.. +| +.. ....+.+ . ..... +..+.+ .++.|++
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 987766 11 111 0000110 0 00000 111222 3334433
Q ss_pred c----CCCcEEeeCCCCCceEEC-CCCcEEEEeeccch
Q 041135 498 D----CHPRIIHRDIKSSNILLD-SSFEARVADFGLAK 530 (727)
Q Consensus 498 ~----~~~~ivHrDLkp~NILl~-~~~~vkL~DFGla~ 530 (727)
. ....++|+|+.+.|||++ +++++.|+||+.+.
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 2 234799999999999999 66777899999875
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.5e-06 Score=95.54 Aligned_cols=76 Identities=20% Similarity=0.222 Sum_probs=54.8
Q ss_pred cceeccCCceEEEEEEEcCC-cEEEEEEeeeC-----C--chhHHHHHHHHHHHHHcC---CCCceeEeeEeeccceeeE
Q 041135 386 HNVLGEGGFGCVYKGVLADG-REVAVKQLKIG-----G--SQGEREFRAEVEIISRVH---HRHLVSLVGYCISERERLL 454 (727)
Q Consensus 386 ~~~LG~G~fg~Vy~~~~~~g-~~vaVK~l~~~-----~--~~~~~~~~~Ei~~l~~l~---HpnIv~l~~~~~~~~~~~l 454 (727)
.+.||.|.++.||++...+| +.|+||.-... . ....+.+..|.+.|+.+. ..++.+++.+ +.+..+|
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 36799999999999998877 58999985311 1 123456777888888763 3467778776 3455789
Q ss_pred EEeeccCCc
Q 041135 455 VYEYVPNDT 463 (727)
Q Consensus 455 V~Ey~~~gs 463 (727)
||||+.+..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998743
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.64 E-value=2.7e-07 Score=95.37 Aligned_cols=138 Identities=20% Similarity=0.154 Sum_probs=86.1
Q ss_pred eccCCc-eEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcC-CCCceeEeeEeeccceeeEEEeeccCCccch
Q 041135 389 LGEGGF-GCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVH-HRHLVSLVGYCISERERLLVYEYVPNDTLHY 466 (727)
Q Consensus 389 LG~G~f-g~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~ 466 (727)
|..|.+ ..||+.... +..++||+..... ..++.+|+++|+.+. +--+.++++++..++..+|||||++|..|..
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 445555 789998764 5788888865332 446788999999885 4445578888777667799999999977653
Q ss_pred hc-------------------ccCCC--Cccc--HHHHHHHHH--------------------HHHHHHHHHHhc----C
Q 041135 467 HL-------------------HAEGR--PVMD--WATRVKVAA--------------------GAARGIAYLHED----C 499 (727)
Q Consensus 467 ~L-------------------~~~~~--~~l~--~~~~~~i~~--------------------qia~gL~yLH~~----~ 499 (727)
.. |.... ..+. ....+.... .+...++.|-.. .
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 31 11110 0000 000000000 011122222111 1
Q ss_pred CCcEEeeCCCCCceEECCCCcEEEEeeccch
Q 041135 500 HPRIIHRDIKSSNILLDSSFEARVADFGLAK 530 (727)
Q Consensus 500 ~~~ivHrDLkp~NILl~~~~~vkL~DFGla~ 530 (727)
...++|+|+.+.|||+++++.+.|+||+.+.
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 2469999999999999998778999999875
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PHA03247 large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Probab=98.60 E-value=5e-05 Score=95.30 Aligned_cols=11 Identities=27% Similarity=0.380 Sum_probs=5.3
Q ss_pred HHHHHHHHhcc
Q 041135 633 MIEAAAACVRH 643 (727)
Q Consensus 633 l~~li~~cl~~ 643 (727)
|.-||+.|..+
T Consensus 3111 lAlLi~ACr~i 3121 (3151)
T PHA03247 3111 LAVLIEACRRI 3121 (3151)
T ss_pred HHHHHHHHHHH
Confidence 44455555443
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.59 E-value=7e-09 Score=115.21 Aligned_cols=186 Identities=16% Similarity=0.143 Sum_probs=137.3
Q ss_pred CccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCC-ceeEeeEeeccceeeEEEeecc
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRH-LVSLVGYCISERERLLVYEYVP 460 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~Hpn-Iv~l~~~~~~~~~~~lV~Ey~~ 460 (727)
.+...+.+++|+++++||.+-...+...+|.+.. ....+-++++|.+++|+| .++.++-+..+...+++++++.
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~h~fvs~-----~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s 317 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ-----TLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICS 317 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhheeceeecc-----chhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhc
Confidence 3455567899999999998754344444665542 245677899999999999 7888888888888999999998
Q ss_pred CC-ccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCc
Q 041135 461 ND-TLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNT 539 (727)
Q Consensus 461 ~g-sL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 539 (727)
++ +....+. .....+...+...+++.-+++|+|||+. .-+||| |||..+ +..|+.||+....+...
T Consensus 318 ~~rs~~~~~~-~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~---- 384 (829)
T KOG0576|consen 318 TGRSSALEMT-VSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRT---- 384 (829)
T ss_pred CCccccccCC-hhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCcc----
Confidence 87 2221111 1112245555667778888999999987 458999 777655 68999999988754221
Q ss_pred cccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCC
Q 041135 540 HVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPV 585 (727)
Q Consensus 540 ~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf 585 (727)
.......++..|++||+...+.+..+.|+|++|+-..+|--|..|-
T Consensus 385 ~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 385 MKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred cccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 1334567899999999999999999999999998777776666554
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.57 E-value=2.5e-07 Score=104.27 Aligned_cols=138 Identities=22% Similarity=0.247 Sum_probs=91.4
Q ss_pred ceeccCCceEEEEEEEcCCcEEEEEEeeeCCch-------------------------------------hHHHHHHHHH
Q 041135 387 NVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQ-------------------------------------GEREFRAEVE 429 (727)
Q Consensus 387 ~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~-------------------------------------~~~~~~~Ei~ 429 (727)
+-||.-..|.||+|++++|+.||||+-+..-.. .+-+|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 579999999999999999999999986421100 0123555665
Q ss_pred HHHHc----CCCCc---eeEeeEeec-cceeeEEEeeccCCccchh--cccCCCCcccHHHHHHHHHHHHHHHHHHHhcC
Q 041135 430 IISRV----HHRHL---VSLVGYCIS-ERERLLVYEYVPNDTLHYH--LHAEGRPVMDWATRVKVAAGAARGIAYLHEDC 499 (727)
Q Consensus 430 ~l~~l----~HpnI---v~l~~~~~~-~~~~~lV~Ey~~~gsL~~~--L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 499 (727)
...++ +|-++ |.+=.++++ ....+|+||||.|.-+.+. |.++ .++..++...+.++. ++...
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~---gi~~~~i~~~l~~~~-----~~qIf 318 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKR---GISPHDILNKLVEAY-----LEQIF 318 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHc---CCCHHHHHHHHHHHH-----HHHHH
Confidence 55544 35451 222233333 3467899999999888765 3333 355555444444432 22223
Q ss_pred CCcEEeeCCCCCceEEC----CCCcEEEEeeccchhh
Q 041135 500 HPRIIHRDIKSSNILLD----SSFEARVADFGLAKIA 532 (727)
Q Consensus 500 ~~~ivHrDLkp~NILl~----~~~~vkL~DFGla~~~ 532 (727)
..|++|+|=+|.||+|+ .++++.|.|||+...+
T Consensus 319 ~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 319 KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred hcCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 33899999999999998 3678999999998754
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.56 E-value=7.4e-07 Score=108.03 Aligned_cols=146 Identities=15% Similarity=0.270 Sum_probs=93.4
Q ss_pred cceeccCCceEEEEEEEcCC---cEEEEEEeeeCCc-hhHHHHHHHHHHHHHcC-CCCc--eeEeeEeecc---ceeeEE
Q 041135 386 HNVLGEGGFGCVYKGVLADG---REVAVKQLKIGGS-QGEREFRAEVEIISRVH-HRHL--VSLVGYCISE---RERLLV 455 (727)
Q Consensus 386 ~~~LG~G~fg~Vy~~~~~~g---~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~-HpnI--v~l~~~~~~~---~~~~lV 455 (727)
++.|+.|.++.+|+..+.++ ..+++|+...... .....+.+|+++|+.|. |.+| .+++++|.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 57789999999999887654 4677777543221 23357889999999996 6665 7888888764 356899
Q ss_pred EeeccCCccchh-----------------------cccCCCC---------cccH--HHHHHHH---------------H
Q 041135 456 YEYVPNDTLHYH-----------------------LHAEGRP---------VMDW--ATRVKVA---------------A 486 (727)
Q Consensus 456 ~Ey~~~gsL~~~-----------------------L~~~~~~---------~l~~--~~~~~i~---------------~ 486 (727)
|||+.|..+.+. ||..... ...+ .++.++. -
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 999988654321 1111100 0000 1111111 1
Q ss_pred HHHHHHHHHHhcCC--------CcEEeeCCCCCceEECC-CC-cEEEEeeccchh
Q 041135 487 GAARGIAYLHEDCH--------PRIIHRDIKSSNILLDS-SF-EARVADFGLAKI 531 (727)
Q Consensus 487 qia~gL~yLH~~~~--------~~ivHrDLkp~NILl~~-~~-~vkL~DFGla~~ 531 (727)
.+.+.+++|..+.. ..|||+|++..|||++. +. .+-|+||+++..
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 23344667754331 35999999999999974 33 357999999865
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.52 E-value=5e-07 Score=86.48 Aligned_cols=128 Identities=20% Similarity=0.259 Sum_probs=90.7
Q ss_pred cccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCce-eEeeEeeccceeeEEEeeccCC
Q 041135 384 SAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLV-SLVGYCISERERLLVYEYVPND 462 (727)
Q Consensus 384 ~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv-~l~~~~~~~~~~~lV~Ey~~~g 462 (727)
...++|++|++|.||+|.+. |..+|+|+-+.. .....+..|+++|..++--++- +++.|..+ ++.|||+.|-
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~ 97 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGR 97 (201)
T ss_pred hhhhhhhcccccEEEEeecc-CceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCc
Confidence 44578999999999999996 568999986543 3346799999999999876665 45544332 4669999887
Q ss_pred ccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCC--CceEECCCCcEEEEeeccchh
Q 041135 463 TLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKS--SNILLDSSFEARVADFGLAKI 531 (727)
Q Consensus 463 sL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp--~NILl~~~~~vkL~DFGla~~ 531 (727)
.|.+..... +.+. +..+++.---|... ||-|+.|.= +||+++++ .+.|+||.-|+.
T Consensus 98 ~L~~~~~~~-----~rk~----l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~-~~~iIDFd~At~ 155 (201)
T COG2112 98 PLGKLEIGG-----DRKH----LLRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDR-DVYIIDFDSATF 155 (201)
T ss_pred chhhhhhcc-----cHHH----HHHHHHHHHHHHHh---ccchhhhcCCceeEEecCC-cEEEEEccchhh
Confidence 876554321 2222 33455554445665 899999875 56666555 899999998873
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.46 E-value=2e-06 Score=85.04 Aligned_cols=125 Identities=26% Similarity=0.455 Sum_probs=90.0
Q ss_pred cCccccceeccCCc-eEEEEEEEcCCcEEEEEEeeeCC---c------------------hhHHHHHHHHHHHHHcC---
Q 041135 381 NGFSAHNVLGEGGF-GCVYKGVLADGREVAVKQLKIGG---S------------------QGEREFRAEVEIISRVH--- 435 (727)
Q Consensus 381 ~~~~~~~~LG~G~f-g~Vy~~~~~~g~~vaVK~l~~~~---~------------------~~~~~~~~Ei~~l~~l~--- 435 (727)
.+++.++.||.|.. |.|||+++ +|+.+|||+++... . ....-|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 67888999999999 99999999 48899999943210 0 11124778988888875
Q ss_pred CCCc--eeEeeEeeccc------------------eeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHH
Q 041135 436 HRHL--VSLVGYCISER------------------ERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYL 495 (727)
Q Consensus 436 HpnI--v~l~~~~~~~~------------------~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yL 495 (727)
+.++ |+++||..-.. ...||.||+.... .+. .+-+.+|.+-|..|
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~----~~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQ----IRDIPQMLRDLKIL 180 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccc----hhHHHHHHHHHHHH
Confidence 4566 89999874321 1246667664433 122 23355677778899
Q ss_pred HhcCCCcEEeeCCCCCceEECCCCcEEEEeeccc
Q 041135 496 HEDCHPRIIHRDIKSSNILLDSSFEARVADFGLA 529 (727)
Q Consensus 496 H~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla 529 (727)
|+. +|+-+|+|.+|.. .-||+|||.+
T Consensus 181 ~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKL---GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHC---CeeeccCcccccc-----CCEEEecccC
Confidence 998 9999999999986 4689999864
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.2e-06 Score=90.02 Aligned_cols=73 Identities=15% Similarity=0.236 Sum_probs=48.5
Q ss_pred ceeccCCce-EEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCC---CceeEeeEeeccc---eeeEEEeec
Q 041135 387 NVLGEGGFG-CVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHR---HLVSLVGYCISER---ERLLVYEYV 459 (727)
Q Consensus 387 ~~LG~G~fg-~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~Hp---nIv~l~~~~~~~~---~~~lV~Ey~ 459 (727)
+.|+.|+.. .||+. +..++||..+. ......+.+|+++|+.|... .+.++++.+...+ ..++|||++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 457777776 59975 34677887553 22345789999999988632 3445555544322 348899999
Q ss_pred cCCccc
Q 041135 460 PNDTLH 465 (727)
Q Consensus 460 ~~gsL~ 465 (727)
.|..+.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 997764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.41 E-value=2.2e-06 Score=101.73 Aligned_cols=199 Identities=19% Similarity=0.205 Sum_probs=138.3
Q ss_pred HHHHHHHHHHHHcCCCCceeEeeEeecccee----eEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHh
Q 041135 422 REFRAEVEIISRVHHRHLVSLVGYCISERER----LLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHE 497 (727)
Q Consensus 422 ~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~----~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~ 497 (727)
.....|++.+.++.|.|++.+++|..+.... .+.-|||...++...+...+. +.....+.+..++++||.|+|+
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~--i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGS--IPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccc--cCHHHHHHHHHHHhhhHHHHHH
Confidence 3455677788888999999999988765433 345678888888888876654 6777888889999999999999
Q ss_pred cCCCcEEeeCCCCC---ceEECCCCcEEEE--eeccchhhhccCCCccccccccCCccccccCcccCCCCCc--hhHHHH
Q 041135 498 DCHPRIIHRDIKSS---NILLDSSFEARVA--DFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTE--KSDVYS 570 (727)
Q Consensus 498 ~~~~~ivHrDLkp~---NILl~~~~~vkL~--DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~--ksDVwS 570 (727)
. .+.|.-|..+ +..++.++.+.+. ||+..+.+.+.. ..........|.+.|.+....+.. ..|+|.
T Consensus 305 ~---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~----~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~ 377 (1351)
T KOG1035|consen 305 L---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNE----KSFSDLLAEIRNADEDLKENTAKKSRLTDLWC 377 (1351)
T ss_pred h---ccceeEEecccccccccCccceeecchhhhcccccCCCcc----cchhhcCccccccccccccccchhhhhhHHHH
Confidence 8 6777777666 5566677777777 888877543221 111223445677888877766554 479999
Q ss_pred HhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCC
Q 041135 571 FGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPR 650 (727)
Q Consensus 571 ~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs 650 (727)
+|.++..++.|...-.... .+...+...+.. .+.++...|+..+.++|..
T Consensus 378 lgll~~~~~~~~~i~~~~~--------------------------~~~~~l~~~~~~----~~~d~~~~~~~~~~~~Rl~ 427 (1351)
T KOG1035|consen 378 LGLLLLQLSQGEDISEKSA--------------------------VPVSLLDVLSTS----ELLDALPKCLDEDSEERLS 427 (1351)
T ss_pred HHHHHhhhhhcCccccccc--------------------------chhhhhccccch----hhhhhhhhhcchhhhhccc
Confidence 9999999998754321100 000011111110 2556677899999999999
Q ss_pred HHHHHHHHh
Q 041135 651 MSQVVRALD 659 (727)
Q Consensus 651 ~~evl~~L~ 659 (727)
..+++.+.-
T Consensus 428 ~~~ll~~~f 436 (1351)
T KOG1035|consen 428 ALELLTHPF 436 (1351)
T ss_pred hhhhhhchh
Confidence 999998754
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.41 E-value=4.2e-06 Score=83.42 Aligned_cols=129 Identities=19% Similarity=0.300 Sum_probs=92.9
Q ss_pred ccceeccCCceEEEEEEEcCCcEEEEEEeeeCC----------------chhHHHHHHHHHHHHHcC------CCCceeE
Q 041135 385 AHNVLGEGGFGCVYKGVLADGREVAVKQLKIGG----------------SQGEREFRAEVEIISRVH------HRHLVSL 442 (727)
Q Consensus 385 ~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~----------------~~~~~~~~~Ei~~l~~l~------HpnIv~l 442 (727)
-...||+|+.-.||. +.++...+||+++... ....++.++|+.-+..+. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 346799999999996 4556778899887554 122456777777776665 7889999
Q ss_pred eeEeeccceeeEEEeeccCC------ccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEEC
Q 041135 443 VGYCISERERLLVYEYVPND------TLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLD 516 (727)
Q Consensus 443 ~~~~~~~~~~~lV~Ey~~~g------sL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~ 516 (727)
+|+.+.+....+|+|.+.+. +|.+++.... ++. .+...+-+-.+||-++ +|+.+||++.||++.
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~---~~~----~~~~~L~~f~~~l~~~---~Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG---LTE----ELRQALDEFKRYLLDH---HIVIRDLNPHNIVVQ 152 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC---ccH----HHHHHHHHHHHHHHHc---CCeecCCCcccEEEE
Confidence 99999999999999988653 3566664432 343 3333444556777777 899999999999995
Q ss_pred CC--C--cEEEEe
Q 041135 517 SS--F--EARVAD 525 (727)
Q Consensus 517 ~~--~--~vkL~D 525 (727)
.+ + .+.|+|
T Consensus 153 ~~~~~~~~lvlID 165 (199)
T PF10707_consen 153 RRDSGEFRLVLID 165 (199)
T ss_pred ecCCCceEEEEEe
Confidence 32 2 567776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.40 E-value=6.1e-06 Score=88.02 Aligned_cols=80 Identities=11% Similarity=0.094 Sum_probs=59.5
Q ss_pred CccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCC---CCceeEeeEeecc---ceeeEE
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHH---RHLVSLVGYCISE---RERLLV 455 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H---pnIv~l~~~~~~~---~~~~lV 455 (727)
...-.+.||.|..+.||+....+| .++||..+. ......|.+|.+.|+.|.. -.|.+++++|.++ +..+||
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV 91 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL 91 (297)
T ss_pred hhheeeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence 344456799999999999877555 477777442 1133588999999999953 3677899888653 567999
Q ss_pred EeeccCCcc
Q 041135 456 YEYVPNDTL 464 (727)
Q Consensus 456 ~Ey~~~gsL 464 (727)
||+++|+.+
T Consensus 92 mE~i~G~~~ 100 (297)
T PRK10593 92 LERLRGVSV 100 (297)
T ss_pred EeccCCEec
Confidence 999998765
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=98.38 E-value=2e-06 Score=91.65 Aligned_cols=141 Identities=16% Similarity=0.171 Sum_probs=87.7
Q ss_pred cceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCC--ceeEeeEe------eccceeeEEEe
Q 041135 386 HNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRH--LVSLVGYC------ISERERLLVYE 457 (727)
Q Consensus 386 ~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~Hpn--Iv~l~~~~------~~~~~~~lV~E 457 (727)
++.|..|....+|+.... +..+++|+... .....+..|++++..|.+.+ +.+++... ..++..++||+
T Consensus 19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTD-SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeC-CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 456777887899998765 45788898753 33456788999998886433 44554421 22345689999
Q ss_pred eccCCccch--------------hcccC----CC-----CcccHHHHH----------HHHHHHHHHHHHHHh----cCC
Q 041135 458 YVPNDTLHY--------------HLHAE----GR-----PVMDWATRV----------KVAAGAARGIAYLHE----DCH 500 (727)
Q Consensus 458 y~~~gsL~~--------------~L~~~----~~-----~~l~~~~~~----------~i~~qia~gL~yLH~----~~~ 500 (727)
|++|..+.. .||.. .. ....|.... .....+..++.+|.+ ...
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999877532 01110 00 011221110 011123344455543 123
Q ss_pred CcEEeeCCCCCceEECCCCcEEEEeeccch
Q 041135 501 PRIIHRDIKSSNILLDSSFEARVADFGLAK 530 (727)
Q Consensus 501 ~~ivHrDLkp~NILl~~~~~vkL~DFGla~ 530 (727)
.++||+|+.+.|||+++++.+.|+||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 479999999999999998778999999875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.36 E-value=4.5e-06 Score=85.62 Aligned_cols=140 Identities=20% Similarity=0.182 Sum_probs=83.8
Q ss_pred cceeccCCceEEEEEEEcC--CcEEEEEEeeeCCchhHHHHHHHHHHHHHcCC-CCceeEeeEeeccceeeEEEeeccCC
Q 041135 386 HNVLGEGGFGCVYKGVLAD--GREVAVKQLKIGGSQGEREFRAEVEIISRVHH-RHLVSLVGYCISERERLLVYEYVPND 462 (727)
Q Consensus 386 ~~~LG~G~fg~Vy~~~~~~--g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H-pnIv~l~~~~~~~~~~~lV~Ey~~~g 462 (727)
++.|..|-...+|+....+ ++.|++|+..... ....+..+|+.+++.+.. ....++++++. ..+||||++|.
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~-~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~ 77 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKT-ELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGR 77 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCc-cceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCC
Confidence 3567888888999998764 6789999765332 222345679999998853 33445555433 24899999987
Q ss_pred ccchh-----------------cccCCCC---------ccc-HHHHHHHHH----------------------HHHHHHH
Q 041135 463 TLHYH-----------------LHAEGRP---------VMD-WATRVKVAA----------------------GAARGIA 493 (727)
Q Consensus 463 sL~~~-----------------L~~~~~~---------~l~-~~~~~~i~~----------------------qia~gL~ 493 (727)
.|... ||..... ... +..+..+.. .+.+.+.
T Consensus 78 ~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 157 (235)
T cd05157 78 TLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEIS 157 (235)
T ss_pred cCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHH
Confidence 65321 1111110 111 112111111 1111112
Q ss_pred HH----Hhc-CCCcEEeeCCCCCceEECC-CCcEEEEeeccch
Q 041135 494 YL----HED-CHPRIIHRDIKSSNILLDS-SFEARVADFGLAK 530 (727)
Q Consensus 494 yL----H~~-~~~~ivHrDLkp~NILl~~-~~~vkL~DFGla~ 530 (727)
.| ... ....++|+||.+.|||+++ ++.+.|+||..|.
T Consensus 158 ~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 158 WLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred HHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 22 111 1236999999999999998 5789999999885
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.34 E-value=2.9e-06 Score=88.41 Aligned_cols=136 Identities=13% Similarity=0.085 Sum_probs=80.7
Q ss_pred eccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCc-eeEeeEeeccceeeEEEeeccCCccchh
Q 041135 389 LGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHL-VSLVGYCISERERLLVYEYVPNDTLHYH 467 (727)
Q Consensus 389 LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnI-v~l~~~~~~~~~~~lV~Ey~~~gsL~~~ 467 (727)
+..|-.+.+|+... +|+.++||+..........+..+|+++|+.+....+ .++++++. .++||||++|..+...
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence 55677889998874 577888987643322221246789999999864433 35555432 3689999998765421
Q ss_pred -----------------cccCC--CCcccHHHH-HHHHHH---------HHHHHHHHHhc-----CCCcEEeeCCCCCce
Q 041135 468 -----------------LHAEG--RPVMDWATR-VKVAAG---------AARGIAYLHED-----CHPRIIHRDIKSSNI 513 (727)
Q Consensus 468 -----------------L~~~~--~~~l~~~~~-~~i~~q---------ia~gL~yLH~~-----~~~~ivHrDLkp~NI 513 (727)
||... ...++...+ ..+..+ +...+..+... ....++|+|+.+.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 12211 111121111 111111 11222222211 123699999999999
Q ss_pred EECCCCcEEEEeeccch
Q 041135 514 LLDSSFEARVADFGLAK 530 (727)
Q Consensus 514 Ll~~~~~vkL~DFGla~ 530 (727)
|+++++ ++|+||+.+.
T Consensus 159 l~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYAS 174 (256)
T ss_pred EEeCCC-CEEEeccccC
Confidence 999876 7899999886
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.33 E-value=2.4e-06 Score=84.74 Aligned_cols=103 Identities=17% Similarity=0.169 Sum_probs=82.4
Q ss_pred HHHHHHHHHcCC-CCceeEeeEeeccceeeEEEeeccCCccchhccc-CCCCcccHHHHHHHHHHHHHHHHHHHhcCCCc
Q 041135 425 RAEVEIISRVHH-RHLVSLVGYCISERERLLVYEYVPNDTLHYHLHA-EGRPVMDWATRVKVAAGAARGIAYLHEDCHPR 502 (727)
Q Consensus 425 ~~Ei~~l~~l~H-pnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ 502 (727)
..|.-+|+.+++ .++.+++|+|-+ ++|.||+..+.+...-.. .......|..+.+|+.++++.+++|+......
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458889999976 699999999943 689999987766422100 01123689999999999999999999854446
Q ss_pred EEeeCCCCCceEECCCCcEEEEeeccchh
Q 041135 503 IIHRDIKSSNILLDSSFEARVADFGLAKI 531 (727)
Q Consensus 503 ivHrDLkp~NILl~~~~~vkL~DFGla~~ 531 (727)
+...|++++|+.|++++++|++|.+.+..
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 89999999999999999999999998754
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.29 E-value=8.5e-07 Score=92.14 Aligned_cols=135 Identities=19% Similarity=0.188 Sum_probs=95.7
Q ss_pred cCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCc--------h--------------hHHHHHHHHHHHHHcC-CC
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGS--------Q--------------GEREFRAEVEIISRVH-HR 437 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~--------~--------------~~~~~~~Ei~~l~~l~-Hp 437 (727)
.-+.+++.||-|.-+.||++-..+|+..++|.-+.... . ..-...+|+.+|+.|. |-
T Consensus 92 ~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 92 SVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 34778899999999999999999999999996542210 0 0112456888888885 32
Q ss_pred -CceeEeeEeeccceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEEC
Q 041135 438 -HLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLD 516 (727)
Q Consensus 438 -nIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~ 516 (727)
-|.+.++++ ..++|||++.|..|...-+-. +.. .|...|..-+.-|..+ |+||+|+.--||+|+
T Consensus 172 fpVPkpiD~~----RH~Vvmelv~g~Pl~~v~~v~-----d~~---~ly~~lm~~Iv~la~~---GlIHgDFNEFNimv~ 236 (465)
T KOG2268|consen 172 FPVPKPIDHN----RHCVVMELVDGYPLRQVRHVE-----DPP---TLYDDLMGLIVRLANH---GLIHGDFNEFNIMVK 236 (465)
T ss_pred CCCCCccccc----ceeeHHHhhcccceeeeeecC-----ChH---HHHHHHHHHHHHHHHc---CceecccchheeEEe
Confidence 344555543 457999999998886654322 222 3333444445566666 999999999999999
Q ss_pred CCCcEEEEeeccch
Q 041135 517 SSFEARVADFGLAK 530 (727)
Q Consensus 517 ~~~~vkL~DFGla~ 530 (727)
+++.++++||--..
T Consensus 237 dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 237 DDDKIVVIDFPQMV 250 (465)
T ss_pred cCCCEEEeechHhh
Confidence 99999999996543
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.24 E-value=8.9e-06 Score=86.04 Aligned_cols=150 Identities=17% Similarity=0.213 Sum_probs=99.3
Q ss_pred HHHHHHhcCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCC--c-----------------------hhHHH-HHHH
Q 041135 374 DELIQATNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGG--S-----------------------QGERE-FRAE 427 (727)
Q Consensus 374 ~el~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~--~-----------------------~~~~~-~~~E 427 (727)
..+.....-..+...|..|.-+.||.+...+|..+|||+++..- . ...+. ...|
T Consensus 137 frll~RG~i~~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE 216 (520)
T KOG2270|consen 137 FRLLNRGVIVEINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKE 216 (520)
T ss_pred HHHHhcCeeeecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHH
Confidence 33333333345556788999999999999999999999985310 0 00111 2357
Q ss_pred HHHHHHcCCCCceeEeeEeeccceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeC
Q 041135 428 VEIISRVHHRHLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRD 507 (727)
Q Consensus 428 i~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrD 507 (727)
++.|.+|+.-.|..---... ...+|||+|+.+...-.-+... ..++...+..+..+++.-|.-|.+.| ++||.|
T Consensus 217 ~RNLkRl~~aGIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd--~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHAD 290 (520)
T KOG2270|consen 217 MRNLKRLNNAGIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKD--ASLSTSKARELYQQCVRIMRRLYQKC--RLVHAD 290 (520)
T ss_pred HHHHHHHHhcCCCCCCceee--ecceEeeeeccCCCCcCccccc--ccCChHHHHHHHHHHHHHHHHHHHHh--ceeccc
Confidence 77777775433221111111 2336999999654433222221 13666678888889999999998888 899999
Q ss_pred CCCCceEECCCCcEEEEeeccch
Q 041135 508 IKSSNILLDSSFEARVADFGLAK 530 (727)
Q Consensus 508 Lkp~NILl~~~~~vkL~DFGla~ 530 (727)
|.--|+|+.+ |.+.|+|.+-+.
T Consensus 291 LSEfN~Lyhd-G~lyiIDVSQSV 312 (520)
T KOG2270|consen 291 LSEFNLLYHD-GKLYIIDVSQSV 312 (520)
T ss_pred hhhhhheEEC-CEEEEEEccccc
Confidence 9999999955 589999998775
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.23 E-value=2.1e-05 Score=83.15 Aligned_cols=71 Identities=15% Similarity=0.211 Sum_probs=57.7
Q ss_pred eeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccch
Q 041135 451 ERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAK 530 (727)
Q Consensus 451 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~ 530 (727)
..|++|++. |+.|.. + ....+++++.|+++.+..|+-|..+. .+-||||.-.||||+ +|.|-|+||-|+|
T Consensus 300 y~yl~~kdh-gt~is~-i-----k~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfklsR 369 (488)
T COG5072 300 YLYLHFKDH-GTPISI-I-----KADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLSR 369 (488)
T ss_pred EEEEEEecC-Cceeee-e-----ecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeeee
Confidence 456777765 444432 1 12578899999999999999998875 899999999999999 9999999999998
Q ss_pred h
Q 041135 531 I 531 (727)
Q Consensus 531 ~ 531 (727)
.
T Consensus 370 l 370 (488)
T COG5072 370 L 370 (488)
T ss_pred c
Confidence 4
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.22 E-value=1.5e-05 Score=85.82 Aligned_cols=155 Identities=15% Similarity=0.182 Sum_probs=87.2
Q ss_pred cHHHHHHHhcCccc-----cceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCC--ceeEee
Q 041135 372 TYDELIQATNGFSA-----HNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRH--LVSLVG 444 (727)
Q Consensus 372 ~~~el~~~~~~~~~-----~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~Hpn--Iv~l~~ 444 (727)
+.+++....+.|.+ .+.|+.|....+|+....+| .+++|++. . .....+..|+++++.|...+ +.+.+.
T Consensus 8 s~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~-~--~~~~~l~~~~~~l~~L~~~glpvP~~i~ 83 (319)
T PRK05231 8 SDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFE-R--LTAEDLPFFLGLMQHLAARGVPVPAPVA 83 (319)
T ss_pred CHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEec-c--CChHHhHHHHHHHHHHHHCCCCCCccee
Confidence 34455444444543 34566777789999887655 68889875 2 23345566777777764222 334442
Q ss_pred E------eeccceeeEEEeeccCCccch-----------h---cccCCC---------Ccc-cHHHHHH-----------
Q 041135 445 Y------CISERERLLVYEYVPNDTLHY-----------H---LHAEGR---------PVM-DWATRVK----------- 483 (727)
Q Consensus 445 ~------~~~~~~~~lV~Ey~~~gsL~~-----------~---L~~~~~---------~~l-~~~~~~~----------- 483 (727)
. ....+..+++|||++|..+.. . ||.... ..+ .|...+.
T Consensus 84 ~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (319)
T PRK05231 84 RRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQA 163 (319)
T ss_pred CCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHH
Confidence 1 123456789999999875421 0 111100 011 1111111
Q ss_pred -HHHH-HHHHHHHHHhc----CCCcEEeeCCCCCceEECCCCcEEEEeeccch
Q 041135 484 -VAAG-AARGIAYLHED----CHPRIIHRDIKSSNILLDSSFEARVADFGLAK 530 (727)
Q Consensus 484 -i~~q-ia~gL~yLH~~----~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~ 530 (727)
.+.+ +...++.+... ...++||+|+++.|||++++....|+||+.+.
T Consensus 164 ~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 164 ALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred HHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 1111 11222333211 23489999999999999977666899999875
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=98.15 E-value=0.00015 Score=78.35 Aligned_cols=73 Identities=19% Similarity=0.240 Sum_probs=48.4
Q ss_pred eeccCCceEEEEEEEcCC-cEEEEEEee----e-C--CchhHHHHHHHHHHHHHcC--CC-CceeEeeEeeccceeeEEE
Q 041135 388 VLGEGGFGCVYKGVLADG-REVAVKQLK----I-G--GSQGEREFRAEVEIISRVH--HR-HLVSLVGYCISERERLLVY 456 (727)
Q Consensus 388 ~LG~G~fg~Vy~~~~~~g-~~vaVK~l~----~-~--~~~~~~~~~~Ei~~l~~l~--Hp-nIv~l~~~~~~~~~~~lV~ 456 (727)
.||.|....||++...+| +.|+||.-. . . ........+.|.+.|+... -+ ++.+++.| +.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 589999999999998654 689999753 1 1 1222345567788887664 23 44555443 455567999
Q ss_pred eeccCC
Q 041135 457 EYVPND 462 (727)
Q Consensus 457 Ey~~~g 462 (727)
|++...
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 999653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=98.15 E-value=3.6e-05 Score=82.56 Aligned_cols=155 Identities=17% Similarity=0.220 Sum_probs=91.5
Q ss_pred HHHHHHHhcCccc-----cceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCC--CceeEeeE
Q 041135 373 YDELIQATNGFSA-----HNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHR--HLVSLVGY 445 (727)
Q Consensus 373 ~~el~~~~~~~~~-----~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~Hp--nIv~l~~~ 445 (727)
.++|....+.|.+ ++.|+.|....+|+....+| .+++|+.+... ...++..|++++..|... .+.+++..
T Consensus 9 ~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t 85 (307)
T TIGR00938 9 DEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKS 85 (307)
T ss_pred HHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccC
Confidence 3455444444433 45677777789999876545 67788765421 234567788888888532 24455442
Q ss_pred e------eccceeeEEEeeccCCccch--------------hcccCCC----------CcccHHHHH------------H
Q 041135 446 C------ISERERLLVYEYVPNDTLHY--------------HLHAEGR----------PVMDWATRV------------K 483 (727)
Q Consensus 446 ~------~~~~~~~lV~Ey~~~gsL~~--------------~L~~~~~----------~~l~~~~~~------------~ 483 (727)
. ..++..++||||++|..+.. .||.... ....|.... .
T Consensus 86 ~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~ 165 (307)
T TIGR00938 86 RDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAH 165 (307)
T ss_pred CCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHH
Confidence 2 12456689999999865421 1121000 011111110 0
Q ss_pred HHHHHHHHHHHHHh----cCCCcEEeeCCCCCceEECCCCcEEEEeeccch
Q 041135 484 VAAGAARGIAYLHE----DCHPRIIHRDIKSSNILLDSSFEARVADFGLAK 530 (727)
Q Consensus 484 i~~qia~gL~yLH~----~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~ 530 (727)
....+.+.+++|.. ....++||+|++..||++++++.+.|+||+.+.
T Consensus 166 ~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 166 MGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 11123345555543 223589999999999999988777899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.14 E-value=1.4e-05 Score=85.36 Aligned_cols=139 Identities=24% Similarity=0.304 Sum_probs=85.5
Q ss_pred ceeccCCceEEEEEEEcC-------CcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCc-eeEeeEeeccceeeEEEee
Q 041135 387 NVLGEGGFGCVYKGVLAD-------GREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHL-VSLVGYCISERERLLVYEY 458 (727)
Q Consensus 387 ~~LG~G~fg~Vy~~~~~~-------g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnI-v~l~~~~~~~~~~~lV~Ey 458 (727)
+.|..|--..||+....+ ++.+++|+..... ....+..+|+++++.+...++ .++++++.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 456667777999988755 5789999875432 233467889999998864333 456665542 368999
Q ss_pred ccCCccchh-----------------cccCCCCc-------c--cHHHHH--------------------------HHHH
Q 041135 459 VPNDTLHYH-----------------LHAEGRPV-------M--DWATRV--------------------------KVAA 486 (727)
Q Consensus 459 ~~~gsL~~~-----------------L~~~~~~~-------l--~~~~~~--------------------------~i~~ 486 (727)
++|..+... ||...... . -+..+. .+..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 998766421 12111100 0 010110 0112
Q ss_pred HHHHHHHHHHh------cCCCcEEeeCCCCCceEECCC----CcEEEEeeccch
Q 041135 487 GAARGIAYLHE------DCHPRIIHRDIKSSNILLDSS----FEARVADFGLAK 530 (727)
Q Consensus 487 qia~gL~yLH~------~~~~~ivHrDLkp~NILl~~~----~~vkL~DFGla~ 530 (727)
.+.+.+.+|.. .....++|+||.+.|||++++ +.++|+||+.|.
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 22233444432 134479999999999999875 889999999885
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=98.06 E-value=0.0005 Score=75.59 Aligned_cols=73 Identities=15% Similarity=0.135 Sum_probs=50.6
Q ss_pred cceeccCCceEEEEEEEcCCcEEEEEEeeeCCc-------hhHHHHHHHHHHHHHcC---CCCceeEeeEeeccceeeEE
Q 041135 386 HNVLGEGGFGCVYKGVLADGREVAVKQLKIGGS-------QGEREFRAEVEIISRVH---HRHLVSLVGYCISERERLLV 455 (727)
Q Consensus 386 ~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~-------~~~~~~~~Ei~~l~~l~---HpnIv~l~~~~~~~~~~~lV 455 (727)
.+.||.|....||+.... ++.|+||+-..... .....-..|.+.|+.+. ..++.+++++|.+ ..+||
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEEE
Confidence 467899999999998764 56799997641111 12333445667776654 3578889988873 45788
Q ss_pred EeeccC
Q 041135 456 YEYVPN 461 (727)
Q Consensus 456 ~Ey~~~ 461 (727)
|||+.+
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999977
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.03 E-value=0.00023 Score=77.83 Aligned_cols=74 Identities=15% Similarity=0.148 Sum_probs=49.9
Q ss_pred cceeccCCceEEEEEEEcC-CcEEEEEEeee----C--CchhHHHHHHHHHHHHHcC--CC-CceeEeeEeeccceeeEE
Q 041135 386 HNVLGEGGFGCVYKGVLAD-GREVAVKQLKI----G--GSQGEREFRAEVEIISRVH--HR-HLVSLVGYCISERERLLV 455 (727)
Q Consensus 386 ~~~LG~G~fg~Vy~~~~~~-g~~vaVK~l~~----~--~~~~~~~~~~Ei~~l~~l~--Hp-nIv~l~~~~~~~~~~~lV 455 (727)
.+.||.|.-..||++.+.+ ++.|+||.-.. . .....+..+.|.+.|+.+. .+ ++.+++.+ +.+...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 4679999999999999743 56899997531 1 1222355677888888764 23 45556543 44556788
Q ss_pred EeeccC
Q 041135 456 YEYVPN 461 (727)
Q Consensus 456 ~Ey~~~ 461 (727)
||++..
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 998854
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.95 E-value=8e-05 Score=78.56 Aligned_cols=70 Identities=14% Similarity=0.043 Sum_probs=41.3
Q ss_pred eccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCC-C--ceeEeeEeeccceeeEEEeeccCCcc
Q 041135 389 LGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHR-H--LVSLVGYCISERERLLVYEYVPNDTL 464 (727)
Q Consensus 389 LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~Hp-n--Iv~l~~~~~~~~~~~lV~Ey~~~gsL 464 (727)
+++|-...||+....+|+.++||+-+ .......+.+|+++|+.|... - +.+++..+ .-+++|+++.|..+
T Consensus 19 ~~~g~~~~v~~i~~~~g~~~VlR~p~--~~~~~~~l~rE~~vL~~L~~~l~vpvP~~~~~~----~~~~~y~~i~G~p~ 91 (276)
T cd05152 19 NESGLDFQVVFAKDTDGVPWVLRIPR--RPDVSERAAAEKRVLALVRKHLPVQVPDWRVHT----PELIAYPKLPGVPA 91 (276)
T ss_pred cCCcceeEEEEEEcCCCCeEEEEecC--CHHHHHHHHHHHHHHHHHHhcCCCCCCceeeec----CceEEEeccCCCcc
Confidence 44555556776655568899999864 222345689999999998631 1 12322222 12456666666543
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.00018 Score=76.74 Aligned_cols=148 Identities=18% Similarity=0.276 Sum_probs=86.4
Q ss_pred ccccceeccCCceEEEEEEEcCCcEEEEEEee-eCCchhHHHHHHHHHHHHHcCC--CCceeEeeEeeccc--eeeEEEe
Q 041135 383 FSAHNVLGEGGFGCVYKGVLADGREVAVKQLK-IGGSQGEREFRAEVEIISRVHH--RHLVSLVGYCISER--ERLLVYE 457 (727)
Q Consensus 383 ~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~-~~~~~~~~~~~~Ei~~l~~l~H--pnIv~l~~~~~~~~--~~~lV~E 457 (727)
..+++.+..|.-..+|+.... ++.++|.+-. ........+..+|+++|+.+.- --+-..+++|.++. ..|.||+
T Consensus 27 ~~~v~~~~~G~sn~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~ 105 (321)
T COG3173 27 LLIVEEISGGWSNDTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVME 105 (321)
T ss_pred CceeeeccCCcccceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEE
Confidence 344445533433345554443 7778887221 2233445677889999988753 23346677777766 5699999
Q ss_pred eccCCccchhcccCCC------------------------------------CcccHHHHHHHH--------HHHHHHHH
Q 041135 458 YVPNDTLHYHLHAEGR------------------------------------PVMDWATRVKVA--------AGAARGIA 493 (727)
Q Consensus 458 y~~~gsL~~~L~~~~~------------------------------------~~l~~~~~~~i~--------~qia~gL~ 493 (727)
|++|..+...+..... ....|...++.+ -.+..-..
T Consensus 106 ~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~ 185 (321)
T COG3173 106 WVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIK 185 (321)
T ss_pred EecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHH
Confidence 9998544332221110 011111111100 01222344
Q ss_pred HHHhcC-----CCcEEeeCCCCCceEECCCCcEEEEeeccchh
Q 041135 494 YLHEDC-----HPRIIHRDIKSSNILLDSSFEARVADFGLAKI 531 (727)
Q Consensus 494 yLH~~~-----~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 531 (727)
||+.+. ...++|+|++..||+|+.++.+-|+||+++..
T Consensus 186 Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 186 WLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred HHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 444432 34699999999999999988899999999874
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.77 E-value=6.3e-05 Score=79.55 Aligned_cols=76 Identities=16% Similarity=0.263 Sum_probs=50.6
Q ss_pred ccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcC---CCCceeEeeEeeccceeeEEEeec
Q 041135 383 FSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVH---HRHLVSLVGYCISERERLLVYEYV 459 (727)
Q Consensus 383 ~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~---HpnIv~l~~~~~~~~~~~lV~Ey~ 459 (727)
.+..+.|+-|....+|+.. .+++.+.||+-. ......|..|.+-|+.|. --.+.+.+++...++..||||||+
T Consensus 19 i~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp --EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeeeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 3445678999999999987 578899999765 344567899999999884 456778999888777779999999
Q ss_pred cCC
Q 041135 460 PND 462 (727)
Q Consensus 460 ~~g 462 (727)
+.+
T Consensus 95 ~~~ 97 (288)
T PF03881_consen 95 EMG 97 (288)
T ss_dssp ---
T ss_pred cCC
Confidence 877
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00025 Score=77.36 Aligned_cols=139 Identities=19% Similarity=0.201 Sum_probs=82.5
Q ss_pred ceeccCCceEEEEEEEcC-----CcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCce-eEeeEeeccceeeEEEeecc
Q 041135 387 NVLGEGGFGCVYKGVLAD-----GREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLV-SLVGYCISERERLLVYEYVP 460 (727)
Q Consensus 387 ~~LG~G~fg~Vy~~~~~~-----g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv-~l~~~~~~~~~~~lV~Ey~~ 460 (727)
+.|-.|-...+|+..+.+ ++.|+||+..... ...-+-.+|+.+++.+...+|. ++++++..+ .|+||+.
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t-~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV-ELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC-CeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 345557778999987532 3678999875433 2223347799999988654444 666665332 5899998
Q ss_pred CCccchh-----------------cccCC---CC-cccHHHHHHHHHH-----------------HHHHHHHHHh-----
Q 041135 461 NDTLHYH-----------------LHAEG---RP-VMDWATRVKVAAG-----------------AARGIAYLHE----- 497 (727)
Q Consensus 461 ~gsL~~~-----------------L~~~~---~~-~l~~~~~~~i~~q-----------------ia~gL~yLH~----- 497 (727)
+..|... ||... .. ..-+.++.+++.+ +...+..|.+
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 7676421 12211 00 1112222222211 1122222221
Q ss_pred cCCCcEEeeCCCCCceEECC-CCcEEEEeeccch
Q 041135 498 DCHPRIIHRDIKSSNILLDS-SFEARVADFGLAK 530 (727)
Q Consensus 498 ~~~~~ivHrDLkp~NILl~~-~~~vkL~DFGla~ 530 (727)
.....++|+||+..|||+++ ++.++|+||.++.
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 11236999999999999976 5689999999885
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00037 Score=75.01 Aligned_cols=138 Identities=22% Similarity=0.337 Sum_probs=84.2
Q ss_pred eccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCce------eEee----EeeccceeeEEEee
Q 041135 389 LGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLV------SLVG----YCISERERLLVYEY 458 (727)
Q Consensus 389 LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv------~l~~----~~~~~~~~~lV~Ey 458 (727)
|.+ .-..||+....+|+. +||+.+.. ....++..|+.+|..|.-..|. .+-| ........+.|++|
T Consensus 34 l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~ 109 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY 109 (331)
T ss_pred ccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence 444 456799998877766 88988754 4566788888888887432221 1111 11111266789999
Q ss_pred ccCCccch-h--------------ccc----------CCCCcccHHH-------------HHHHHHHHHHHHHHHHhcC-
Q 041135 459 VPNDTLHY-H--------------LHA----------EGRPVMDWAT-------------RVKVAAGAARGIAYLHEDC- 499 (727)
Q Consensus 459 ~~~gsL~~-~--------------L~~----------~~~~~l~~~~-------------~~~i~~qia~gL~yLH~~~- 499 (727)
++|..+.. . ||. .......|.. ......++...++.+.+..
T Consensus 110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~ 189 (331)
T COG2334 110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP 189 (331)
T ss_pred cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence 99988772 1 111 0111233320 0122334444444444332
Q ss_pred ---CCc---EEeeCCCCCceEECCCCc-EEEEeeccch
Q 041135 500 ---HPR---IIHRDIKSSNILLDSSFE-ARVADFGLAK 530 (727)
Q Consensus 500 ---~~~---ivHrDLkp~NILl~~~~~-vkL~DFGla~ 530 (727)
.-. |||+|+.+.|||++.+.. +.++|||.+.
T Consensus 190 ~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 190 AHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 223 999999999999998874 8999999885
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00048 Score=73.75 Aligned_cols=64 Identities=9% Similarity=0.151 Sum_probs=41.0
Q ss_pred EEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCC--CceeEeeE------eeccceeeEEEeeccCCcc
Q 041135 396 CVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHR--HLVSLVGY------CISERERLLVYEYVPNDTL 464 (727)
Q Consensus 396 ~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~Hp--nIv~l~~~------~~~~~~~~lV~Ey~~~gsL 464 (727)
.||+....+| .+++|++.. ....+..|+.++..|... .|.+++.. ...++..++|+||+.|..+
T Consensus 11 ~v~~v~t~~g-~~~LK~~~~----~~~~~~~~~~~~~~L~~~g~~vp~~i~t~~g~~~~~~~~~~~~l~~~i~G~~~ 82 (313)
T TIGR02906 11 NVYKVETDSG-NKCLKKINY----PPERLLFILGAQEHLRKNGFNIPKILKTKDGELYVKYNGDLYVLTEWIEGREC 82 (313)
T ss_pred cEEEEEeCCC-CeEEEEcCC----CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEehhccCcCC
Confidence 4898876555 688898742 234466677777777433 34444432 1234567899999998654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.59 E-value=1.8e-05 Score=95.76 Aligned_cols=175 Identities=12% Similarity=0.019 Sum_probs=115.9
Q ss_pred EEEEEeeeCCchhHH-----HHHHHHHHHHHcCCCCceeEeeEeec--cceeeEEEeeccCCccchhcccCCC--CcccH
Q 041135 408 VAVKQLKIGGSQGER-----EFRAEVEIISRVHHRHLVSLVGYCIS--ERERLLVYEYVPNDTLHYHLHAEGR--PVMDW 478 (727)
Q Consensus 408 vaVK~l~~~~~~~~~-----~~~~Ei~~l~~l~HpnIv~l~~~~~~--~~~~~lV~Ey~~~gsL~~~L~~~~~--~~l~~ 478 (727)
+.+|+.+..+.+... ....|.+.++...|.++.....-... ....|.+++|+.+|.+...|.+... ..++.
T Consensus 1255 Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~ 1334 (2724)
T KOG1826|consen 1255 FKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDR 1334 (2724)
T ss_pred eEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchh
Confidence 455555543333322 23344455555678887766554432 3355899999999999988755432 12333
Q ss_pred HHHHHHHHHHHHHHHHHHhcCC--CcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCccccccccCCccccccCc
Q 041135 479 ATRVKVAAGAARGIAYLHEDCH--PRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEY 556 (727)
Q Consensus 479 ~~~~~i~~qia~gL~yLH~~~~--~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~ 556 (727)
..+.....+.+....-+|+..+ .-.+|++||.-|.+|..+..+|+.++||.+.. .......+...++..|+.+++
T Consensus 1335 ~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIk---np~~sf~Gl~l~sp~~v~qli 1411 (2724)
T KOG1826|consen 1335 SPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIK---NPVLSFFGLELCSPIYVLQLI 1411 (2724)
T ss_pred chHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCccccccccccccc---CchHhhhhhhhCCHHHHHHHH
Confidence 3333333332444555454321 13789999999999999999999999999832 111222334567888999999
Q ss_pred ccCCCCCchhHHHHHhHHHHHHHhCCCCC
Q 041135 557 ATSGKLTEKSDVYSFGVVLLELITGRKPV 585 (727)
Q Consensus 557 l~~~~~~~ksDVwS~Gvil~eLltG~~Pf 585 (727)
.+.-+++.++|+|..|+.+|++..|...|
T Consensus 1412 ~N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1412 KNEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred HHHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence 98888999999999999999998775544
|
|
| >KOG1924 consensus RhoA GTPase effector DIA/Diaphanous [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.00023 Score=80.51 Aligned_cols=24 Identities=21% Similarity=0.246 Sum_probs=11.4
Q ss_pred HHHHhccCCCCC--CCHHHHHHHHhh
Q 041135 637 AAACVRHSATKR--PRMSQVVRALDT 660 (727)
Q Consensus 637 i~~cl~~dP~~R--Ps~~evl~~L~~ 660 (727)
-+.+++.+.+.- =-|+++++.|+.
T Consensus 1027 k~alIdm~a~~de~GVmDslLeaLqs 1052 (1102)
T KOG1924|consen 1027 KKALIDMNAEGDETGVMDSLLEALQS 1052 (1102)
T ss_pred hHHHhccccccchhhhHHHHHHHHHh
Confidence 334444443332 235666666654
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.0021 Score=69.49 Aligned_cols=93 Identities=15% Similarity=0.110 Sum_probs=55.6
Q ss_pred ccHHHHHHHhcCcccc---c-eeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCC--CCceeEe-
Q 041135 371 FTYDELIQATNGFSAH---N-VLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHH--RHLVSLV- 443 (727)
Q Consensus 371 ~~~~el~~~~~~~~~~---~-~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H--pnIv~l~- 443 (727)
++-+.+..+.+.+-+. + .+-.+.-..||+....+|..++||+.+.. ......+..|++++..|.. -.|+..+
T Consensus 11 l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~p~~ 89 (325)
T PRK11768 11 LTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVAPLA 89 (325)
T ss_pred CChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCCCcc
Confidence 4445555554433221 1 22344556899998888889999987633 2345677888888887742 2223211
Q ss_pred --e--EeeccceeeEEEeeccCCcc
Q 041135 444 --G--YCISERERLLVYEYVPNDTL 464 (727)
Q Consensus 444 --~--~~~~~~~~~lV~Ey~~~gsL 464 (727)
| +...++..+.|++++.|..+
T Consensus 90 ~~G~~~~~~~g~~~~l~~~~~G~~~ 114 (325)
T PRK11768 90 FNGQTLHEHQGFRFALFPRRGGRAP 114 (325)
T ss_pred CCCCEEEEECCEEEEEEeeeCCCCC
Confidence 1 12234567889999988653
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.0025 Score=68.40 Aligned_cols=31 Identities=19% Similarity=0.312 Sum_probs=28.2
Q ss_pred CcEEeeCCCCCceEECCCCcEEEEeeccchh
Q 041135 501 PRIIHRDIKSSNILLDSSFEARVADFGLAKI 531 (727)
Q Consensus 501 ~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 531 (727)
.+|||+|+...|||+++++.+.|+||..+..
T Consensus 196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 3799999999999999999999999998863
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.00035 Score=77.08 Aligned_cols=164 Identities=17% Similarity=0.230 Sum_probs=92.5
Q ss_pred HHHHHHHHHHHHcCCCCceeEeeEeeccc-eeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCC
Q 041135 422 REFRAEVEIISRVHHRHLVSLVGYCISER-ERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCH 500 (727)
Q Consensus 422 ~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~-~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~ 500 (727)
..+.-.+.+++.+.|.|+..++++..... ..++|||++ +.+|++++..+.. . +. .++ .+
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~l---~------~~-------s~~-~~-- 86 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGNL---K------DE-------SLL-AH-- 86 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhccc---c------hh-------hhc-cc--
Confidence 45667788999999999999999876543 467899998 6778777755421 1 00 011 11
Q ss_pred CcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh
Q 041135 501 PRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT 580 (727)
Q Consensus 501 ~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt 580 (727)
++.|-. | .+++| -++. . | |-. ...|+|||++|.++.|++.
T Consensus 87 -~~~~~~-----~-------~~~td-~~~t-------~------------~--~~~-----~~pKsdVwsl~~i~~el~L 126 (725)
T KOG1093|consen 87 -GVLHLN-----I-------IYITD-HFLT-------K------------Y--PSP-----IGPKSDVWSLGFIILELYL 126 (725)
T ss_pred -ccceeh-----h-------hhccc-cccc-------c------------C--CCC-----CCcchhhhhHHHHHHHHHH
Confidence 333321 1 22333 1110 0 0 000 0139999999999999998
Q ss_pred CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHH
Q 041135 581 GRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQV 654 (727)
Q Consensus 581 G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 654 (727)
|..-|... ...+..+.+..-.........+.... .+..+....++++.+.|+...+..|+...++
T Consensus 127 ~~~l~~~~------~~s~~l~~i~k~~~~d~~~~~~a~e~---~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~ 191 (725)
T KOG1093|consen 127 GISLEAEL------TESEYLEILLKYYTDDQELLSTAMEH---LIQLLADKKRLPLLKKCLWLEPIIRPLPMEL 191 (725)
T ss_pred hhHHHHHH------HHHHHHHHHHHhccCchhHHHHHHHH---HHHHhhhHhHHHHhccCCccccccccchhHH
Confidence 87655322 22233333332222222222222211 2223344557788899999999888865544
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.00062 Score=68.76 Aligned_cols=121 Identities=18% Similarity=0.200 Sum_probs=60.9
Q ss_pred CcEEEEEEeeeCCchhHHHHHHHHHHHHHcCC-CCceeEeeEeeccceeeEEEeeccCCccchh----------------
Q 041135 405 GREVAVKQLKIGGSQGEREFRAEVEIISRVHH-RHLVSLVGYCISERERLLVYEYVPNDTLHYH---------------- 467 (727)
Q Consensus 405 g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H-pnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~---------------- 467 (727)
++.|+||+.... .....+-.+|+.+++.+.. ..-.++++++.++ +|+||+.|..|...
T Consensus 2 ~~~~~~Ri~g~~-t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~g----~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~ 76 (211)
T PF01633_consen 2 PEKYLVRIPGEG-TENFIDRENENEALKLLSEAGLGPKIIYFFENG----RVEEFIEGRTLSPEDFRNPEILKRIAKLLA 76 (211)
T ss_dssp TSEEEEEEEESC-GCSHHHHHHHHHHHHHHHHTTSSS-EEEEETTE----EEEE--SSEE--CGGGGSHHHHHHHHHHHH
T ss_pred CCEEEEEeCCCC-cccccCHHHHHHHHHHHHHcCCCCeEEEEcCCC----cEEEEecccccChhhccChHHHHHHHHHHH
Confidence 467888887654 3334567789999998864 4445666665433 67799977665321
Q ss_pred -cccC-----CCCcccHHHHHHH----------------------HHHHHHHHHHHHh---c--CCCcEEeeCCCCCceE
Q 041135 468 -LHAE-----GRPVMDWATRVKV----------------------AAGAARGIAYLHE---D--CHPRIIHRDIKSSNIL 514 (727)
Q Consensus 468 -L~~~-----~~~~l~~~~~~~i----------------------~~qia~gL~yLH~---~--~~~~ivHrDLkp~NIL 514 (727)
||.. .....-|..+.++ +..+.+-+..+.+ . ....++|+||.+.|||
T Consensus 77 ~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil 156 (211)
T PF01633_consen 77 KLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNIL 156 (211)
T ss_dssp HHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEE
T ss_pred HHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEE
Confidence 0100 0000011111111 1112222222221 0 0126899999999999
Q ss_pred E-CCCCcEEEEeeccch
Q 041135 515 L-DSSFEARVADFGLAK 530 (727)
Q Consensus 515 l-~~~~~vkL~DFGla~ 530 (727)
+ +.++.++|+||..|.
T Consensus 157 ~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 157 INNKDGEVKLIDFEYAG 173 (211)
T ss_dssp ETSSSSCEEE--GTT-E
T ss_pred eccCCCeEEEecHHHHh
Confidence 9 888999999999885
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.0011 Score=71.98 Aligned_cols=139 Identities=17% Similarity=0.171 Sum_probs=80.4
Q ss_pred ceeccCCceEEEEEEEcC----CcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCc-eeEeeEeeccceeeEEEeeccC
Q 041135 387 NVLGEGGFGCVYKGVLAD----GREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHL-VSLVGYCISERERLLVYEYVPN 461 (727)
Q Consensus 387 ~~LG~G~fg~Vy~~~~~~----g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnI-v~l~~~~~~~~~~~lV~Ey~~~ 461 (727)
+.|..|--..+|+....+ +..|+||+...... ..-+-.+|+.+++.+..-+| .++++++. ++ +|.+|+.+
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence 445457777899887543 23788998754322 22345689999999875555 36666653 22 58999977
Q ss_pred Cccch-----------------hcccCCC---Ccc-cHHHHHHHHH----------------------HHHHHHHHHHhc
Q 041135 462 DTLHY-----------------HLHAEGR---PVM-DWATRVKVAA----------------------GAARGIAYLHED 498 (727)
Q Consensus 462 gsL~~-----------------~L~~~~~---~~l-~~~~~~~i~~----------------------qia~gL~yLH~~ 498 (727)
..|.. .||.... ... -|..+.++.. .+.+-+..|...
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 66532 1122110 001 1222222211 112222222221
Q ss_pred -----CCCcEEeeCCCCCceEECC-CCcEEEEeeccch
Q 041135 499 -----CHPRIIHRDIKSSNILLDS-SFEARVADFGLAK 530 (727)
Q Consensus 499 -----~~~~ivHrDLkp~NILl~~-~~~vkL~DFGla~ 530 (727)
...-++|+||.+.|||+++ ++.++|+||+.|.
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 1124899999999999974 5789999999885
|
|
| >KOG1924 consensus RhoA GTPase effector DIA/Diaphanous [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.00057 Score=77.50 Aligned_cols=13 Identities=23% Similarity=0.204 Sum_probs=5.6
Q ss_pred HHHHHhCCCCCCC
Q 041135 575 LLELITGRKPVDA 587 (727)
Q Consensus 575 l~eLltG~~Pf~~ 587 (727)
+||-|.-...|+.
T Consensus 958 lye~L~eYyaFd~ 970 (1102)
T KOG1924|consen 958 LYESLGEYYAFDP 970 (1102)
T ss_pred HHHHHHHHeecCc
Confidence 4444444444443
|
|
| >PF08693 SKG6: Transmembrane alpha-helix domain; InterPro: IPR014805 SKG6 and AXL2 are membrane proteins that show polarised intracellular localisation [, ] | Back alignment and domain information |
|---|
Probab=97.39 E-value=7.1e-05 Score=53.13 Aligned_cols=33 Identities=27% Similarity=0.338 Sum_probs=23.8
Q ss_pred cccCCceeehHHHHHHHHHHHHHHHHHhhhccc
Q 041135 279 LGTGGAVAIGIAVGFLVLSLLVMAVWFAHKRKK 311 (727)
Q Consensus 279 ~~~~~~i~i~v~v~~~~l~lli~~~~~~~~rrk 311 (727)
.+++..|++|+++.++++++++++++|+|+||+
T Consensus 7 ~~~~vaIa~~VvVPV~vI~~vl~~~l~~~~rR~ 39 (40)
T PF08693_consen 7 NSNTVAIAVGVVVPVGVIIIVLGAFLFFWYRRK 39 (40)
T ss_pred CCceEEEEEEEEechHHHHHHHHHHhheEEecc
Confidence 355677889999988887777766666555554
|
This entry represents the highly conserved transmembrane alpha-helical domain found in these proteins [, ]. The full-length AXL2 protein has a negative regulatory function in cytokinesis []. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.00091 Score=67.00 Aligned_cols=75 Identities=17% Similarity=0.199 Sum_probs=55.9
Q ss_pred ceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcC---CCCceeEeeEeeccceeeEEEeeccCCc
Q 041135 387 NVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVH---HRHLVSLVGYCISERERLLVYEYVPNDT 463 (727)
Q Consensus 387 ~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~---HpnIv~l~~~~~~~~~~~lV~Ey~~~gs 463 (727)
+.|.-|..-..|+..+ +...+.||+ +.......|.+|+.-|+.|. .-+|.+++.+..+..+.||||||++-+.
T Consensus 22 ~~v~gG~inea~~v~d-g~~~~FvK~---n~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~ 97 (286)
T COG3001 22 EEVSGGDINEAWRLRD-GTDPFFVKC---NQREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGP 97 (286)
T ss_pred cccCCccccceeEeec-CCcceEEEe---cchhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCC
Confidence 4555565556666544 467788885 33455678999999888885 3567788999899999999999999876
Q ss_pred cc
Q 041135 464 LH 465 (727)
Q Consensus 464 L~ 465 (727)
+.
T Consensus 98 ~d 99 (286)
T COG3001 98 LD 99 (286)
T ss_pred CC
Confidence 65
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 727 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 9e-72 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 7e-71 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-53 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-52 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-46 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-46 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-45 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-42 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-28 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 7e-28 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 7e-28 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-26 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-26 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 8e-24 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-23 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-23 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-23 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-23 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-22 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-22 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-22 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-22 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-22 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-22 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-22 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-22 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-22 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-22 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-22 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 6e-22 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-22 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 8e-22 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 8e-22 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 8e-22 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-21 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-21 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-21 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-21 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-21 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-21 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-21 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-21 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-21 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-21 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-21 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-21 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-21 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-21 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-21 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-21 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-21 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-21 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-21 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 6e-21 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 7e-21 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 7e-21 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 8e-21 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 9e-21 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 9e-21 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 9e-21 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 9e-21 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-20 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-20 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-20 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-20 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-20 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-20 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-20 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-20 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-20 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-20 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-20 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-20 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-20 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-20 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-20 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-20 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-20 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-20 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-20 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-20 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-20 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-20 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-20 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-20 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-20 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-20 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-20 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 6e-20 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 6e-20 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 6e-20 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-20 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 8e-20 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 8e-20 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 8e-20 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 8e-20 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 8e-20 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 9e-20 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 9e-20 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 9e-20 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-19 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-19 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-19 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-19 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-19 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-19 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-19 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-19 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-19 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-19 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-19 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-19 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-19 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-19 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-19 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-19 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-19 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-19 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-19 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-19 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-19 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-19 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-19 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-19 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-19 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-19 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-19 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-19 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 7e-19 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-19 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-19 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 9e-19 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 9e-19 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 9e-19 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 9e-19 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-18 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-18 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-18 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-18 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-18 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-18 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-18 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-18 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-18 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-18 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-18 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-18 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-18 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-18 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-18 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-18 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-18 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-18 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-18 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-18 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-18 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-18 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-18 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-18 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-18 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-18 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-18 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-18 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-18 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-18 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-18 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-18 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-18 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-18 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-18 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-18 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-18 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-18 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-18 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-18 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-18 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-18 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-18 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-18 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-18 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-18 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-18 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-18 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-18 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-18 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-18 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-18 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-18 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-18 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-18 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-18 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-18 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-18 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-18 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-18 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 6e-18 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-18 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-18 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 6e-18 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 6e-18 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 6e-18 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 7e-18 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-18 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-18 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-18 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-18 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 8e-18 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 8e-18 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 8e-18 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-18 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 9e-18 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 9e-18 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 9e-18 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-17 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-17 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-17 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-17 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-17 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-17 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-17 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-17 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-17 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-17 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-17 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-17 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-17 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-17 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-17 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-17 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-17 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-17 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-17 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-17 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 7e-17 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 7e-17 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 9e-17 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-17 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 9e-17 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-16 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-16 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-16 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-16 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-16 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-16 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-16 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-16 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-16 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-16 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-16 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-16 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-16 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-16 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-16 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-16 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-16 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-16 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-16 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-16 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-16 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-16 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-16 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-16 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-16 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-16 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-16 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-16 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-16 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-16 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-16 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-16 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-16 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-16 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 6e-16 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 6e-16 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 6e-16 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 6e-16 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 6e-16 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 6e-16 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-16 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-16 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-16 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 7e-16 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 7e-16 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 7e-16 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 7e-16 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 8e-16 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 8e-16 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 8e-16 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 9e-16 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 9e-16 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 9e-16 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 9e-16 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 9e-16 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-15 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-15 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-15 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-15 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-15 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-15 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-15 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-15 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-15 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-15 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-15 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-15 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-15 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-15 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-15 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-15 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-15 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-15 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-15 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-15 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-15 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-15 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-15 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-15 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-15 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-15 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-15 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-15 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-15 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-15 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-15 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-15 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-15 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-15 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-15 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-15 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-15 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-15 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-15 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 6e-15 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 6e-15 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-15 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-15 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 6e-15 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-15 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 6e-15 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 7e-15 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 7e-15 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-15 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 8e-15 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 8e-15 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 8e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 9e-15 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 9e-15 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-14 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-14 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-14 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-14 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-14 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-14 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-14 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-14 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-14 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-14 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-14 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-14 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-14 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-14 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-14 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-14 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-14 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-14 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-14 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-14 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-14 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-14 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-14 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-14 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-14 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-14 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-14 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-14 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-14 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 6e-14 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 6e-14 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 6e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 7e-14 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 7e-14 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 8e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-14 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 8e-14 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 8e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-14 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 8e-14 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-14 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 9e-14 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 9e-14 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 9e-14 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 9e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 9e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 9e-14 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-13 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-13 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-13 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-13 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-13 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-13 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-13 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-13 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-13 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-13 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-13 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-13 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-13 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-13 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-13 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-13 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 5e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 6e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 6e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 7e-13 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 7e-13 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 8e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 8e-13 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 9e-13 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 9e-13 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 9e-13 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 9e-13 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 9e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-12 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-12 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-12 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-12 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-12 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-12 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-12 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-12 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-12 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-12 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-12 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-12 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-12 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-12 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-12 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-12 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-12 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-12 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-12 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-12 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-12 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 6e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-12 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-12 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-12 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 6e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 7e-12 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 7e-12 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 7e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-12 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-12 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 7e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 7e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 8e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 8e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 8e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-12 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-11 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-11 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-11 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-11 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-11 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-11 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-11 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-11 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-11 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-11 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-11 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-11 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-11 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-11 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-11 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-11 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 5e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-11 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-11 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-11 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-11 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-11 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 7e-11 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 7e-11 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 7e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 7e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-11 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 8e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 8e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 8e-11 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 9e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 9e-11 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-10 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-10 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 7e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 7e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 8e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 8e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 9e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-09 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-09 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-09 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-09 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-09 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 5e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-09 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 6e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-09 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 6e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 6e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-09 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 7e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 8e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 8e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 8e-09 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 8e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 8e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 8e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 8e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-08 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-08 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-08 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 5e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 6e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-08 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 7e-08 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 7e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 7e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 7e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 8e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 8e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 9e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 9e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 5e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 5e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 5e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 7e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 7e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 9e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 9e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-06 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 5e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 7e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 8e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-05 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-05 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 4e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 4e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 565 bits (1458), Expect = 0.0
Identities = 146/301 (48%), Positives = 205/301 (68%), Gaps = 12/301 (3%)
Query: 364 LGNSRSWFTYDELIQATNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQG-ER 422
LG + F+ EL A++ FS N+LG GGFG VYKG LADG VAVK+LK +QG E
Sbjct: 14 LGQLK-RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGEL 72
Query: 423 EFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPNDTLHYHLH--AEGRPVMDWAT 480
+F+ EVE+IS HR+L+ L G+C++ ERLLVY Y+ N ++ L E +P +DW
Sbjct: 73 QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPK 132
Query: 481 RVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTH 540
R ++A G+ARG+AYLH+ C P+IIHRD+K++NILLD FEA V DFGLAK L +TH
Sbjct: 133 RQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK--LMDYKDTH 190
Query: 541 VSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDES--LVE 598
V+T V GT G++APEY ++GK +EK+DV+ +GV+LLELITG++ D ++ D+ L++
Sbjct: 191 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250
Query: 599 WARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRAL 658
W + L L+ + EALVD L+ NY D E+ +I+ A C + S +RP+MS+VVR L
Sbjct: 251 WVKGL----LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306
Query: 659 D 659
+
Sbjct: 307 E 307
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 538 bits (1388), Expect = 0.0
Identities = 128/313 (40%), Positives = 169/313 (53%), Gaps = 11/313 (3%)
Query: 348 NGSNSGFSRSPSESGVLGNSRSWFTYDELIQATNGFSAHNVLGEGGFGCVYKGVLADGRE 407
+NS S V S +L +ATN F ++G G FG VYKGVL DG +
Sbjct: 7 KATNSINDALSSSYLVPFESY-RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAK 65
Query: 408 VAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPNDTLHYH 467
VA+K+ SQG EF E+E +S H HLVSL+G+C E +L+Y+Y+ N L H
Sbjct: 66 VALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRH 125
Query: 468 LHAEGRPV--MDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVAD 525
L+ P M W R+++ GAARG+ YLH IIHRD+KS NILLD +F ++ D
Sbjct: 126 LYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITD 182
Query: 526 FGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPV 585
FG++K ELD TH+ST V GT GY+ PEY G+LTEKSDVYSFGVVL E++ R +
Sbjct: 183 FGISKKGTELD-QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAI 241
Query: 586 DASQPLGDESLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSA 645
S P +L EWA + E +VD L + + A C+ S+
Sbjct: 242 VQSLPREMVNLAEWAVES----HNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSS 297
Query: 646 TKRPRMSQVVRAL 658
RP M V+ L
Sbjct: 298 EDRPSMGDVLWKL 310
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 515 bits (1330), Expect = e-180
Identities = 112/314 (35%), Positives = 175/314 (55%), Gaps = 24/314 (7%)
Query: 359 SESGVLGNSRSWFTYDELIQATNGFS------AHNVLGEGGFGCVYKGVLADGREVAVKQ 412
S S F++ EL TN F N +GEGGFG VYKG + + VAVK+
Sbjct: 4 SLEVSDTRFHS-FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKK 61
Query: 413 LKIG----GSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPNDTLHYHL 468
L + +++F E++++++ H +LV L+G+ + LVY Y+PN +L L
Sbjct: 62 LAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL 121
Query: 469 H-AEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFG 527
+G P + W R K+A GAA GI +LHE+ IHRDIKS+NILLD +F A+++DFG
Sbjct: 122 SCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFG 178
Query: 528 LAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDA 587
LA+ + + + T +++R++GT YMAPE G++T KSD+YSFGVVLLE+ITG VD
Sbjct: 179 LARASEK-FAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDE 236
Query: 588 SQPLGDESLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATK 647
+ + L++ + E + E +D ++ + + + M A+ C+ K
Sbjct: 237 HRE--PQLLLDIKEEIED---EEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNK 290
Query: 648 RPRMSQVVRALDTL 661
RP + +V + L +
Sbjct: 291 RPDIKKVQQLLQEM 304
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 314 bits (807), Expect = e-102
Identities = 82/327 (25%), Positives = 125/327 (38%), Gaps = 38/327 (11%)
Query: 366 NSRSWFTYDELIQATNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFR 425
+S + L + V G FGCV+K L VAVK I Q +
Sbjct: 9 SSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSW-QNE 66
Query: 426 AEVEIISRVHHRHLVSLVGYCI----SERERLLVYEYVPNDTLHYHLHAEGRPVMDWATR 481
EV + + H +++ +G + + L+ + +L L V+ W
Sbjct: 67 YEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK---ANVVSWNEL 123
Query: 482 VKVAAGAARGIAYLHED-------CHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALE 534
+A ARG+AYLHED P I HRDIKS N+LL ++ A +ADFGLA E
Sbjct: 124 CHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK-FE 182
Query: 535 LDSNTHVSTRVMGTFGYMAPEYATSG-----KLTEKSDVYSFGVVLLELITGRKPVDASQ 589
+ + +GT YMAPE + D+Y+ G+VL EL + D
Sbjct: 183 AGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242
Query: 590 PLGDESLVEWARPLLAEALEHEDFEALVDSRLEKNY---------VDSEMFWMIEAAAAC 640
E+ P E +H E + + + K + M + E C
Sbjct: 243 D-------EYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEEC 295
Query: 641 VRHSATKRPRMSQVVRALDTLDGASDL 667
H A R V + + +++
Sbjct: 296 WDHDAEARLSAGCVGERITQMQRLTNI 322
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 241 bits (616), Expect = 1e-73
Identities = 72/341 (21%), Positives = 118/341 (34%), Gaps = 47/341 (13%)
Query: 371 FTYDELIQATNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEI 430
E + ++G G +G VYKG L D R VAVK + F E I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFS---FANRQNFINEKNI 58
Query: 431 --ISRVHHRHLVSLVGYCI-----SERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVK 483
+ + H ++ + E LLV EY PN +L +L DW + +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS---LHTSDWVSSCR 115
Query: 484 VAAGAARGIAYLHED------CHPRIIHRDIKSSNILLDSSFEARVADFGLAKI-----A 532
+A RG+AYLH + P I HRD+ S N+L+ + ++DFGL+
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175
Query: 533 LELDSNTHVSTRVMGTFGYMAPEYATS-------GKLTEKSDVYSFGVVLLELITGRKPV 585
+ + + +GT YMAPE ++ D+Y+ G++ E+ +
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235
Query: 586 DASQPLGDESLVEWARPLLAEALEHEDFEALVDSRLEKNY----------VDSEMFWMIE 635
+ + + + E H FE + + + + E
Sbjct: 236 FPGESVPEYQM-----AFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKE 290
Query: 636 AAAACVRHSATKRPRMSQVVRALDTLDGASDLTNGVKPGQS 676
C A R + L + V P
Sbjct: 291 TIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAH 331
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 2e-66
Identities = 83/286 (29%), Positives = 128/286 (44%), Gaps = 39/286 (13%)
Query: 386 HNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGE--REFRAEVEIISRVHHRHLVSLV 443
+G G FG V++ G +VAVK L E EF EV I+ R+ H ++V +
Sbjct: 42 KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 444 GYCISERERLLVYEYVPNDTLHYHLH-AEGRPVMDWATRVKVAAGAARGIAYLHEDCHPR 502
G +V EY+ +L+ LH + R +D R+ +A A+G+ YLH +P
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPP 159
Query: 503 IIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKL 562
I+HR++KS N+L+D + +V DFGL+++ S S GT +MAPE
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRL---KASTFLSSKSAAGTPEWMAPEVLRDEPS 216
Query: 563 TEKSDVYSFGVVLLELITGRKP------VDASQPLGDESLVEWARPLLAEALEHEDFEAL 616
EKSDVYSFGV+L EL T ++P +G + R + L + A+
Sbjct: 217 NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCK----RLEIPRNL-NPQVAAI 271
Query: 617 VDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLD 662
++ C + KRP + ++ L L
Sbjct: 272 IEG--------------------CWTNEPWKRPSFATIMDLLRPLI 297
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 2e-66
Identities = 63/289 (21%), Positives = 113/289 (39%), Gaps = 48/289 (16%)
Query: 386 HNVLGEGGFGCVYKGVLADGREVAVKQLKIG--GSQGEREFRAEVEIISRVHHRHLVSLV 443
L E G ++KG G ++ VK LK+ ++ R+F E + H +++ ++
Sbjct: 15 LTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73
Query: 444 GYCISERERLL--VYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHP 501
G C S + ++P +L+ LH V+D + VK A ARG+A+LH P
Sbjct: 74 GACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEP 132
Query: 502 RIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPE---YAT 558
I + S ++++D AR++ + + S M ++APE
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVKF--------SFQSPGRMYAPAWVAPEALQKKP 184
Query: 559 SGKLTEKSDVYSFGVVLLELITGRKP------VDASQPLGDESLVEWARPLLAEALEHED 612
+D++SF V+L EL+T P ++ + E L RP + +
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGL----RPTIPPGI-SPH 239
Query: 613 FEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661
L+ C+ KRP+ +V L+ +
Sbjct: 240 VSKLMKI--------------------CMNEDPAKRPKFDMIVPILEKM 268
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 2e-66
Identities = 88/294 (29%), Positives = 140/294 (47%), Gaps = 50/294 (17%)
Query: 387 NVLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGE-------REFRAEVEIISRVHHRH 438
+G+GGFG V+KG + D VA+K L +G S+GE +EF+ EV I+S ++H +
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 439 LVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHED 498
+V L G +V E+VP L++ L + P + W+ ++++ A GI Y+ +
Sbjct: 85 IVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAHP-IKWSVKLRLMLDIALGIEYMQ-N 140
Query: 499 CHPRIIHRDIKSSNILLDSSFE-----ARVADFGLAKIALELDSNTHVSTRVMGTFGYMA 553
+P I+HRD++S NI L S E A+VADFGL++ + H + ++G F +MA
Sbjct: 141 QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ------SVHSVSGLLGNFQWMA 194
Query: 554 PE--YATSGKLTEKSDVYSFGVVLLELITGRKP---VDASQPLGDESLV-EWARPLLAEA 607
PE A TEK+D YSF ++L ++TG P + + E RP + E
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPED 254
Query: 608 LEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661
+++ C KRP S +V+ L L
Sbjct: 255 C-PPRLRNVIEL--------------------CWSGDPKKRPHFSYIVKELSEL 287
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 221 bits (564), Expect = 2e-66
Identities = 90/329 (27%), Positives = 137/329 (41%), Gaps = 50/329 (15%)
Query: 387 NVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYC 446
V+G G FG V K ++VA+KQ++ + F E+ +SRV+H ++V L G C
Sbjct: 14 EVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 447 ISERERLLVYEYVPNDTLHYHLH-AEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIH 505
+ LV EY +L+ LH AE P A + ++G+AYLH +IH
Sbjct: 71 L--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128
Query: 506 RDIKSSNILLDSSFE-ARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTE 564
RD+K N+LL + ++ DFG A T G+ +MAPE +E
Sbjct: 129 RDLKPPNLLLVAGGTVLKICDFGTACD------IQTHMTNNKGSAAWMAPEVFEGSNYSE 182
Query: 565 KSDVYSFGVVLLELITGRKP-VDASQPLGDESLVEWA-----RPLLAEALEHEDFEALVD 618
K DV+S+G++L E+IT RKP + P + WA RP L + L + E+L+
Sbjct: 183 KCDVFSWGIILWEVITRRKPFDEIGGP---AFRIMWAVHNGTRPPLIKNL-PKPIESLMT 238
Query: 619 SRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDGASDLTNGVKPGQSGI 678
C ++RP M ++V+ + L +P Q
Sbjct: 239 R--------------------CWSKDPSQRPSMEEIVKIMTHL--MRYFPGADEPLQYPC 276
Query: 679 FSSAQHSAQIR-----MFQRLAFGGSQDY 702
S R F S D+
Sbjct: 277 QHSLPPGEDGRVEPYVDFAEFYRLWSVDH 305
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 1e-64
Identities = 79/291 (27%), Positives = 122/291 (41%), Gaps = 48/291 (16%)
Query: 387 NVLGEGGFGCVYKGVLADGREVAVKQLKIGG----SQGEREFRAEVEIISRVHHRHLVSL 442
++G GGFG VY+ G EVAVK + SQ R E ++ + + H ++++L
Sbjct: 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 443 VGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPR 502
G C+ E LV E+ L+ L + V A ARG+ YLH++
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVLS---GKRIPPDILVNWAVQIARGMNYLHDEAIVP 128
Query: 503 IIHRDIKSSNILLDSSFEAR--------VADFGLAKIALELDSNTHVSTRVMGTFGYMAP 554
IIHRD+KSSNIL+ E + DFGLA+ T + G + +MAP
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW----HRTTKMSAA-GAYAWMAP 183
Query: 555 EYATSGKLTEKSDVYSFGVVLLELITGRKP---VDASQPLGDESLVEWARPLLAEALEHE 611
E + ++ SDV+S+GV+L EL+TG P +D +A +
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA--------------VAYGVAMN 229
Query: 612 DFEALVDSRLEK-NYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661
L + ++E C RP + ++ L T+
Sbjct: 230 KL------ALPIPSTCPEPFAKLME---DCWNPDPHSRPSFTNILDQLTTI 271
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 4e-63
Identities = 62/303 (20%), Positives = 122/303 (40%), Gaps = 42/303 (13%)
Query: 387 NVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEI--ISRVHHRHLVSLVG 444
+G+G +G V++G G VAVK S+ E+ + E E+ + H +++ +
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 445 YCISER----ERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHED-- 498
++ R + L+ Y +L+ +L +D + +++ A G+A+LH +
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 499 ---CHPRIIHRDIKSSNILLDSSFEARVADFGLAKI-ALELDSNTHVSTRVMGTFGYMAP 554
P I HRD+KS NIL+ + + +AD GLA + + + + +GT YMAP
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 555 E------YATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEAL 608
E ++ D+++FG+VL E+ + + ++ P
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVS--------NGIVEDYKPPFYDVVP 238
Query: 609 EHEDFEALVDSRLEKNY---------VDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659
FE + D + + + C + + R ++ + L
Sbjct: 239 NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298
Query: 660 TLD 662
+D
Sbjct: 299 KID 301
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 1e-62
Identities = 68/308 (22%), Positives = 120/308 (38%), Gaps = 42/308 (13%)
Query: 387 NVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEI--ISRVHHRHLVSLVG 444
+G+G +G V+ G G +VAVK + E + E EI + H +++ +
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVKVFF---TTEEASWFRETEIYQTVLMRHENILGFIA 98
Query: 445 YCI----SERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHED-- 498
I S + L+ +Y N +L+ +L +D + +K+A + G+ +LH +
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYLK---STTLDAKSMLKLAYSSVSGLCHLHTEIF 155
Query: 499 ---CHPRIIHRDIKSSNILLDSSFEARVADFGLAKI-ALELDSNTHVSTRVMGTFGYMAP 554
P I HRD+KS NIL+ + +AD GLA + + +GT YM P
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215
Query: 555 E------YATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEAL 608
E + +D+YSFG++L E+ + E+ P
Sbjct: 216 EVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVS--------GGIVEEYQLPYHDLVP 267
Query: 609 EHEDFEALVDSRLEKNY---------VDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659
+E + + K D + M + C H+ R +V + L
Sbjct: 268 SDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327
Query: 660 TLDGASDL 667
+ + D+
Sbjct: 328 KMSESQDI 335
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 8e-62
Identities = 70/291 (24%), Positives = 112/291 (38%), Gaps = 40/291 (13%)
Query: 387 NVLGEGGFGCVYKGVL-ADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGY 445
VLG+G FG K G + +K+L + +R F EV+++ + H +++ +G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 446 CISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIH 505
++ + EY+ TL + + W+ RV A A G+AYLH IIH
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIKSMDSQ-YPWSQRVSFAKDIASGMAYLHS---MNIIH 131
Query: 506 RDIKSSNILLDSSFEARVADFGLAKIALELDSNTH-----------VSTRVMGTFGYMAP 554
RD+ S N L+ + VADFGLA++ ++ + V+G +MAP
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 555 EYATSGKLTEKSDVYSFGVVLLELITGRKP---VDASQPLGDESLVEWARPLLAEALEHE 611
E EK DV+SFG+VL E+I ++ +
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNC-PP 250
Query: 612 DFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLD 662
F + C KRP ++ L+TL
Sbjct: 251 SFFPI--------------------TVRCCDLDPEKRPSFVKLEHWLETLR 281
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 3e-61
Identities = 75/284 (26%), Positives = 129/284 (45%), Gaps = 40/284 (14%)
Query: 389 LGEGGFGCVYKGVLADGREVAVKQLKIGGSQGE--REFRAEVEIISRVHHRHLVSLVGYC 446
+G G FG VYKG +VAVK L + + + F+ EV ++ + H +++ +GY
Sbjct: 32 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 447 ISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHR 506
+ + +V ++ +L++HLHA + + +A ARG+ YLH IIHR
Sbjct: 90 TAPQ-LAIVTQWCEGSSLYHHLHASETK-FEMKKLIDIARQTARGMDYLHA---KSIIHR 144
Query: 507 DIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPE---YATSGKLT 563
D+KS+NI L ++ DFGLA S +H ++ G+ +MAPE S +
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATE-KSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS 203
Query: 564 EKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWA------RPLLAEALEHEDFEALV 617
+SDVY+FG+VL EL+TG+ P + P L++ +
Sbjct: 204 FQSDVYAFGIVLYELMTGQLPYSNINNR---DQIIEMVGRGSLSPDLSKVRSN------- 253
Query: 618 DSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661
M ++ C++ +RP +++ ++ L
Sbjct: 254 --------CPKRMKRLMA---ECLKKKRDERPSFPRILAEIEEL 286
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 1e-59
Identities = 61/296 (20%), Positives = 114/296 (38%), Gaps = 55/296 (18%)
Query: 387 NVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGE--REFRAEVEIISRVHHRHLVSLVG 444
++G+G FG VY G EVA++ + I + + F+ EV + H ++V +G
Sbjct: 39 ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 445 YCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRII 504
C+S ++ TL+ + + V+D ++A +G+ YLH I+
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHA---KGIL 152
Query: 505 HRDIKSSNILLDSSFEARVADFGLAKI--ALELDSNTHVSTRVMGTFGYMAPE------- 555
H+D+KS N+ D + + + DFGL I L+ G ++APE
Sbjct: 153 HKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSP 211
Query: 556 --YATSGKLTEKSDVYSFGVVLLELITGRKP---VDASQPLGDESLVEWA-----RPLLA 605
++ SDV++ G + EL P A + W +P L+
Sbjct: 212 DTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA-------IIWQMGTGMKPNLS 264
Query: 606 EALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661
+ ++ ++ C +RP ++++ L+ L
Sbjct: 265 QIGMGKEISDILLF--------------------CWAFEQEERPTFTKLMDMLEKL 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 201 bits (512), Expect = 1e-58
Identities = 68/304 (22%), Positives = 116/304 (38%), Gaps = 42/304 (13%)
Query: 386 HNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEI--ISRVHHRHLVSLV 443
+G+G FG V++G G EVAVK S+ ER + E EI + H +++ +
Sbjct: 47 QESIGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFI 102
Query: 444 GYCI----SERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHED- 498
+ + LV +Y + +L +L+ R + +K+A A G+A+LH +
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEI 159
Query: 499 ----CHPRIIHRDIKSSNILLDSSFEARVADFGLAKI-ALELDSNTHVSTRVMGTFGYMA 553
P I HRD+KS NIL+ + +AD GLA D+ +GT YMA
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219
Query: 554 PE------YATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEA 607
PE + +++D+Y+ G+V E+ ++ P
Sbjct: 220 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI--------GGIHEDYQLPYYDLV 271
Query: 608 LEHEDFEALVDSRLEKNY---------VDSEMFWMIEAAAACVRHSATKRPRMSQVVRAL 658
E + E+ + M + C + R ++ + L
Sbjct: 272 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 331
Query: 659 DTLD 662
L
Sbjct: 332 SQLS 335
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 6e-44
Identities = 57/205 (27%), Positives = 93/205 (45%), Gaps = 17/205 (8%)
Query: 388 VLGEGGFGCVYKGV-LADGREVAVKQLKIGG-SQGERE-FRAEVEIISRVHHRHLVSLVG 444
+G G F VYKG+ EVA +L+ ++ ER+ F+ E E++ + H ++V
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 445 YCIS---ERERLLVY-EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCH 500
S ++ +++ E + + TL +L M +G+ +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHT-RT 149
Query: 501 PRIIHRDIKSSNILLDSSF-EARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATS 559
P IIHRD+K NI + ++ D GLA + + V+GT +MAPE
Sbjct: 150 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL-----KRASFAKAVIGTPEFMAPEMYEE 204
Query: 560 GKLTEKSDVYSFGVVLLELITGRKP 584
E DVY+FG+ +LE+ T P
Sbjct: 205 K-YDESVDVYAFGMCMLEMATSEYP 228
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 7e-44
Identities = 88/292 (30%), Positives = 127/292 (43%), Gaps = 36/292 (12%)
Query: 387 NVLGEGGFGCVYKGVL-----ADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVS 441
+ LG+G FG V G VAVKQL+ G +R+F+ E++I+ +H +V
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 442 LVGYCISERER--LLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDC 499
G + LV EY+P+ L L R +D + + ++ +G+ YL
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ-RHRARLDASRLLLYSSQICKGMEYLGSR- 146
Query: 500 HPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTF--GYMAPEYA 557
R +HRD+ + NIL++S ++ADFGLAK L LD + +V G + APE
Sbjct: 147 --RCVHRDLAARNILVESEAHVKIADFGLAK-LLPLDKDYYVVRE-PGQSPIFWYAPESL 202
Query: 558 TSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFEAL 616
+ + +SDV+SFGVVL EL T K S E P L+ LE L
Sbjct: 203 SDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE------L 256
Query: 617 VDS--RLEK-----NYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661
++ RL V M C S RP S + LD L
Sbjct: 257 LEEGQRLPAPPACPAEVHELMK-------LCWAPSPQDRPSFSALGPQLDML 301
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 8e-44
Identities = 56/202 (27%), Positives = 95/202 (47%), Gaps = 12/202 (5%)
Query: 388 VLGEGGFGCVYKGVL-ADGREVAVKQLKIGGSQGER-EFRAEVEIISRVHHRHLVSLVGY 445
+G G FG V+ G L AD VAVK + + +F E I+ + H ++V L+G
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 446 CISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIH 505
C ++ +V E V L EG + T +++ AA G+ YL IH
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFLRTEGARL-RVKTLLQMVGDAAAGMEYLESK---CCIH 236
Query: 506 RDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGY--MAPEYATSGKLT 563
RD+ + N L+ +++DFG+++ + + ++ + APE G+ +
Sbjct: 237 RDLAARNCLVTEKNVLKISDFGMSREEAD---GVYAASGGLRQVPVKWTAPEALNYGRYS 293
Query: 564 EKSDVYSFGVVLLELIT-GRKP 584
+SDV+SFG++L E + G P
Sbjct: 294 SESDVWSFGILLWETFSLGASP 315
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 1e-42
Identities = 60/205 (29%), Positives = 101/205 (49%), Gaps = 13/205 (6%)
Query: 387 NVLGEGGFGCVYKGVLADGRE-----VAVKQLKIGGSQGER-EFRAEVEIISRVHHRHLV 440
VLG G FG VYKG+ E VA+K+L+ S E E +++ V + H+
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 441 SLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCH 500
L+G C++ L+ + +P L ++ E + + + A+G+ YL +
Sbjct: 81 RLLGICLTS-TVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYLEDR-- 136
Query: 501 PRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSG 560
R++HRD+ + N+L+ + ++ DFGLAK L + + + +MA E
Sbjct: 137 -RLVHRDLAARNVLVKTPQHVKITDFGLAK-LLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 561 KLTEKSDVYSFGVVLLELIT-GRKP 584
T +SDV+S+GV + EL+T G KP
Sbjct: 195 IYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 2e-42
Identities = 57/216 (26%), Positives = 95/216 (43%), Gaps = 24/216 (11%)
Query: 388 VLGEGGFGCVYKGV-LADGREVAVKQLKIGG-SQGEREF-RAEVEIISRVHHRHLVSLVG 444
+G G +G K +DG+ + K+L G ++ E++ +EV ++ + H ++V
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 445 YCISERERLL--VYEYVPNDTLHYHL---HAEGRP-----VMDWATRVKVAAGAARGIAY 494
I L V EY L + E + V+ T++ +
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL------TLALKE 126
Query: 495 LHE--DCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYM 552
H D ++HRD+K +N+ LD ++ DFGLA+I L+ +T + +GT YM
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI---LNHDTSFAKTFVGTPYYM 183
Query: 553 APEYATSGKLTEKSDVYSFGVVLLELITGRKPVDAS 588
+PE EKSD++S G +L EL P A
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF 219
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 4e-42
Identities = 62/200 (31%), Positives = 103/200 (51%), Gaps = 14/200 (7%)
Query: 387 NVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYC 446
+G+G FG V G G +VAVK +K + + F AE +++++ H +LV L+G
Sbjct: 27 QTIGKGEFGDVMLGD-YRGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 447 ISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIH 505
+ E+ L +V EY+ +L +L + GR V+ +K + + YL + +H
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVH 140
Query: 506 RDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEK 565
RD+ + N+L+ A+V+DFGL K A + + + APE K + K
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKKFSTK 194
Query: 566 SDVYSFGVVLLELIT-GRKP 584
SDV+SFG++L E+ + GR P
Sbjct: 195 SDVWSFGILLWEIYSFGRVP 214
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-41
Identities = 68/209 (32%), Positives = 105/209 (50%), Gaps = 15/209 (7%)
Query: 389 LGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGE---REFRAEVEIISRVHHRHLVSLVG 444
LG GG VY +VA+K + I + E + F EV S++ H+++VS+
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM-- 76
Query: 445 YCISERERL--LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPR 502
+ E + LV EY+ TL ++ + G + T + GI + H+ R
Sbjct: 77 IDVDEEDDCYYLVMEYIEGPTLSEYIESHGP--LSVDTAINFTNQILDGIKHAHDM---R 131
Query: 503 IIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKL 562
I+HRDIK NIL+DS+ ++ DFG+AK AL S T + V+GT Y +PE A
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAK-ALSETSLTQTNH-VLGTVQYFSPEQAKGEAT 189
Query: 563 TEKSDVYSFGVVLLELITGRKPVDASQPL 591
E +D+YS G+VL E++ G P + +
Sbjct: 190 DECTDIYSIGIVLYEMLVGEPPFNGETAV 218
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-41
Identities = 71/211 (33%), Positives = 100/211 (47%), Gaps = 22/211 (10%)
Query: 387 NVLGEGGFGCVYKGVLADGRE----VAVKQLKIGGSQGER-EFRAEVEIISRVHHRHLVS 441
V+G G FGCVY G L D AVK L GE +F E I+ H +++S
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 442 LVGYCI-SERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCH 500
L+G C+ SE L+V Y+ + L + E + A+G+ YL
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASK-- 147
Query: 501 PRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFG------YMAP 554
+ +HRD+ + N +LD F +VADFGLA+ + + V G +MA
Sbjct: 148 -KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY-----YSVHNKTGAKLPVKWMAL 201
Query: 555 EYATSGKLTEKSDVYSFGVVLLELIT-GRKP 584
E + K T KSDV+SFGV+L EL+T G P
Sbjct: 202 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-41
Identities = 66/203 (32%), Positives = 100/203 (49%), Gaps = 15/203 (7%)
Query: 387 NVLGEGGFGCVYKGVL-----ADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVS 441
LG+G FG V G VAVK+L+ + R+F E+EI+ + H ++V
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 442 LVGYCISERER--LLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDC 499
G C S R L+ EY+P +L +L + + +D ++ + +G+ YL
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGTK- 133
Query: 500 HPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTF--GYMAPEYA 557
R IHRD+ + NIL+++ ++ DFGL K+ L D + G + APE
Sbjct: 134 --RYIHRDLATRNILVENENRVKIGDFGLTKV-LPQDKEFFKV-KEPGESPIFWYAPESL 189
Query: 558 TSGKLTEKSDVYSFGVVLLELIT 580
T K + SDV+SFGVVL EL T
Sbjct: 190 TESKFSVASDVWSFGVVLYELFT 212
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-41
Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 14/207 (6%)
Query: 387 NVLGEGGFGCVYKGVLADGRE----VAVKQLKIGGSQGER-EFRAEVEIISRVHHRHLVS 441
V+G+G FG VY G D + A+K L + F E ++ ++H ++++
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 442 LVGYCISERERLL-VYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCH 500
L+G + + Y+ + L + + + + ARG+ YL E
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQ-- 143
Query: 501 PRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTF--GYMAPEYAT 558
+ +HRD+ + N +LD SF +VADFGLA+ L+ + V + A E
Sbjct: 144 -KFVHRDLAARNCMLDESFTVKVADFGLARDILDREY-YSVQQHRHARLPVKWTALESLQ 201
Query: 559 SGKLTEKSDVYSFGVVLLELIT-GRKP 584
+ + T KSDV+SFGV+L EL+T G P
Sbjct: 202 TYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-41
Identities = 59/201 (29%), Positives = 104/201 (51%), Gaps = 12/201 (5%)
Query: 387 NVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYC 446
+G G FG V+ G + +VA+K ++ G+ E +F E E++ ++ H LV L G C
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 447 ISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHR 506
+ + LV E++ + L +L R + T + + G+AYL E+ +IHR
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYL-EEAC--VIHR 128
Query: 507 DIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGY--MAPEYATSGKLTE 564
D+ + N L+ + +V+DFG+ + L+ D T + F +PE + + +
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTRFVLD-DQYT---SSTGTKFPVKWASPEVFSFSRYSS 184
Query: 565 KSDVYSFGVVLLELIT-GRKP 584
KSDV+SFGV++ E+ + G+ P
Sbjct: 185 KSDVWSFGVLMWEVFSEGKIP 205
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 2e-41
Identities = 62/200 (31%), Positives = 103/200 (51%), Gaps = 14/200 (7%)
Query: 387 NVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYC 446
+G+G FG V G G +VAVK +K + + F AE +++++ H +LV L+G
Sbjct: 199 QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 447 ISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIH 505
+ E+ L +V EY+ +L +L + GR V+ +K + + YL + +H
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVH 312
Query: 506 RDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEK 565
RD+ + N+L+ A+V+DFGL K A + + + APE K + K
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKKFSTK 366
Query: 566 SDVYSFGVVLLELIT-GRKP 584
SDV+SFG++L E+ + GR P
Sbjct: 367 SDVWSFGILLWEIYSFGRVP 386
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 3e-41
Identities = 81/289 (28%), Positives = 120/289 (41%), Gaps = 31/289 (10%)
Query: 387 NVLGEGGFGCVYKGVL-----ADGREVAVKQLKIG-GSQGEREFRAEVEIISRVHHRHLV 440
LGEG FG V G VAVK LK G Q ++ E++I+ ++H H++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 441 SLVGYCISERER--LLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHED 498
G C LV EYVP +L +L R + A + A G+AYLH
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYLP---RHSIGLAQLLLFAQQICEGMAYLHAQ 153
Query: 499 CHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNT-HVSTRVMGTFGYMAPEYA 557
IHRD+ + N+LLD+ ++ DFGLAK A+ V + APE
Sbjct: 154 ---HYIHRDLAARNVLLDNDRLVKIGDFGLAK-AVPEGHEYYRVREDGDSPVFWYAPECL 209
Query: 558 TSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFEAL 616
K SDV+SFGV L EL+T + + + + E L
Sbjct: 210 KEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE------L 263
Query: 617 VDS--RLEK-NYVDSEMFW-MIEAAAACVRHSATKRPRMSQVVRALDTL 661
++ RL + + +E++ M C A+ RP ++ L T+
Sbjct: 264 LERGERLPRPDKCPAEVYHLMKN----CWETEASFRPTFENLIPILKTV 308
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 3e-41
Identities = 66/294 (22%), Positives = 117/294 (39%), Gaps = 39/294 (13%)
Query: 387 NVLGEGGFGCVYKGVLA-----DGREVAVKQLKIG-GSQGEREFRAEVEIISRVHHRHLV 440
LGEG FG V G +VAVK LK G + + E+EI+ ++H ++V
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 441 SLVGYCISERER--LLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHED 498
G C + L+ E++P+ +L +L + ++ ++K A +G+ YL
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYLGSR 145
Query: 499 CHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTF--GYMAPEY 556
+ +HRD+ + N+L++S + ++ DFGL K +E D + + + APE
Sbjct: 146 ---QYVHRDLAARNVLVESEHQVKIGDFGLTKA-IETDKEYYT-VKDDRDSPVFWYAPEC 200
Query: 557 ATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFEA 615
K SDV+SFGV L EL+T + + +
Sbjct: 201 LMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN------ 254
Query: 616 LVDSRLEKNYV-------DSEMFW-MIEAAAACVRHSATKRPRMSQVVRALDTL 661
L++ E++ M + C + R ++ + L
Sbjct: 255 ----TLKEGKRLPCPPNCPDEVYQLMRK----CWEFQPSNRTSFQNLIEGFEAL 300
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 3e-41
Identities = 63/199 (31%), Positives = 102/199 (51%), Gaps = 8/199 (4%)
Query: 387 NVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYC 446
LG G FG V+ G +VAVK LK G + F AE ++ ++ H+ LV L
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVV 77
Query: 447 ISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHR 506
++ ++ EY+ N +L L + + +AA A G+A++ E IHR
Sbjct: 78 -TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHR 133
Query: 507 DIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKS 566
D++++NIL+ + ++ADFGLA++ + + + + APE G T KS
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP--IKWTAPEAINYGTFTIKS 191
Query: 567 DVYSFGVVLLELIT-GRKP 584
DV+SFG++L E++T GR P
Sbjct: 192 DVWSFGILLTEIVTHGRIP 210
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 5e-41
Identities = 63/200 (31%), Positives = 101/200 (50%), Gaps = 12/200 (6%)
Query: 388 VLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCI 447
LG G FG V G +VAVK +K GS E EF E + + ++ H LV G C
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 448 SERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRD 507
E +V EY+ N L +L + G+ + + + +++ G+A+L E IHRD
Sbjct: 74 KEYPIYIVTEYISNGCLLNYLRSHGKGL-EPSQLLEMCYDVCEGMAFL-ESHQ--FIHRD 129
Query: 508 IKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGY--MAPEYATSGKLTEK 565
+ + N L+D +V+DFG+ + L+ + V T+ F APE K + K
Sbjct: 130 LAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTK----FPVKWSAPEVFHYFKYSSK 185
Query: 566 SDVYSFGVVLLELIT-GRKP 584
SDV++FG+++ E+ + G+ P
Sbjct: 186 SDVWAFGILMWEVFSLGKMP 205
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 8e-41
Identities = 78/292 (26%), Positives = 125/292 (42%), Gaps = 19/292 (6%)
Query: 307 HKRKKKRAGEHIGYTLPSPYASSQKSDSVFLRPHSPAPLVGNGSNSGFSRSPSESGVLGN 366
H R + + P S + S + GS + + + + + +
Sbjct: 10 HHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLS 69
Query: 367 SRSWFTYDELIQATNGFSAHNV-----LGEGGFGCVYKGVLADGRE----VAVKQLKIGG 417
+ + + G S+ V +G G FGCVY G L D AVK L
Sbjct: 70 ALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT 129
Query: 418 SQGER-EFRAEVEIISRVHHRHLVSLVGYCI-SERERLLVYEYVPNDTLHYHLHAEGRPV 475
GE +F E I+ H +++SL+G C+ SE L+V Y+ + L + E
Sbjct: 130 DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THN 188
Query: 476 MDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALEL 535
+ A+G+ +L + +HRD+ + N +LD F +VADFGLA+ +
Sbjct: 189 PTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245
Query: 536 DSNTHVSTRVMGTF--GYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKP 584
+ ++ V + +MA E + K T KSDV+SFGV+L EL+T G P
Sbjct: 246 EFDS-VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-40
Identities = 57/214 (26%), Positives = 99/214 (46%), Gaps = 21/214 (9%)
Query: 388 VLGEGGFGCVYKGV-LADGREVAVKQLKIGG-SQGEREF-RAEVEIISRVHHRHLVSLVG 444
+GEG FG DGR+ +K++ I S ERE R EV +++ + H ++V
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 445 YCISERERLLVYEYVPNDTLHYHL-HAEGRP-----VMDWATRVKVAAGAARGIAYLHED 498
+V +Y L + +G ++DW ++ + ++H+
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQI------CLALKHVHD- 143
Query: 499 CHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYAT 558
+I+HRDIKS NI L ++ DFG+A++ L+S ++ +GT Y++PE
Sbjct: 144 --RKILHRDIKSQNIFLTKDGTVQLGDFGIARV---LNSTVELARACIGTPYYLSPEICE 198
Query: 559 SGKLTEKSDVYSFGVVLLELITGRKPVDASQPLG 592
+ KSD+++ G VL EL T + +A
Sbjct: 199 NKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN 232
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 1e-40
Identities = 66/203 (32%), Positives = 100/203 (49%), Gaps = 15/203 (7%)
Query: 387 NVLGEGGFGCVYKGVL-----ADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVS 441
LG+G FG V G VAVK+L+ + R+F E+EI+ + H ++V
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 442 LVGYCISERER--LLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDC 499
G C S R L+ EY+P +L +L + + +D ++ + +G+ YL
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGTK- 164
Query: 500 HPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTF--GYMAPEYA 557
R IHRD+ + NIL+++ ++ DFGL K L D + + G + APE
Sbjct: 165 --RYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEYYKV-KEPGESPIFWYAPESL 220
Query: 558 TSGKLTEKSDVYSFGVVLLELIT 580
T K + SDV+SFGVVL EL T
Sbjct: 221 TESKFSVASDVWSFGVVLYELFT 243
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 1e-40
Identities = 60/201 (29%), Positives = 104/201 (51%), Gaps = 10/201 (4%)
Query: 389 LGEGGFGCVYKGVLADGRE---VAVKQLKIGGSQGER-EFRAEVEIISRVHHRHLVSLVG 444
LG G FG V +GV ++ VA+K LK G + + E E +I+ ++ + ++V L+G
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 445 YCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRII 504
C +E +LV E LH L + + + ++ + G+ YL E+ + +
Sbjct: 78 VCQAEA-LMLVMEMAGGGPLHKFLVGKREEI-PVSNVAELLHQVSMGMKYL-EEKN--FV 132
Query: 505 HRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTE 564
HRD+ + N+LL + A+++DFGL+K DS + + APE K +
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 192
Query: 565 KSDVYSFGVVLLELIT-GRKP 584
+SDV+S+GV + E ++ G+KP
Sbjct: 193 RSDVWSYGVTMWEALSYGQKP 213
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 1e-40
Identities = 77/288 (26%), Positives = 123/288 (42%), Gaps = 42/288 (14%)
Query: 387 NVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYC 446
LG+G FG V+ G VA+K LK G+ F E +++ ++ H LV L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 447 ISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHR 506
SE +V EY+ +L L E + V +AA A G+AY+ +HR
Sbjct: 249 -SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHR 304
Query: 507 DIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKS 566
D++++NIL+ + +VADFGLA++ + + + + APE A G+ T KS
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP--IKWTAPEAALYGRFTIKS 362
Query: 567 DVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDS--RLEK 623
DV+SFG++L EL T GR P + + E L+ V+ R+
Sbjct: 363 DVWSFGILLTELTTKGRVP--------------YPGMVNREVLDQ------VERGYRMPC 402
Query: 624 -----NYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDGASD 666
+ M C R +RP + L+ +++
Sbjct: 403 PPECPESLHDLMCQ-------CWRKEPEERPTFEYLQAFLEDYFTSTE 443
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 4e-40
Identities = 49/221 (22%), Positives = 94/221 (42%), Gaps = 40/221 (18%)
Query: 387 NVLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGY 445
++G GGFG V+K DG+ +K++K + EV+ ++++ H ++V G
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN----NEKAEREVKALAKLDHVNIVHYNGC 72
Query: 446 CISERERL----------------LVYEYVPNDTLHYHLH-AEGRP-----VMDWATRVK 483
+ E+ TL + G ++ ++
Sbjct: 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQI- 131
Query: 484 VAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVST 543
+G+ Y+H ++I+RD+K SNI L + + ++ DFGL L ++ +
Sbjct: 132 -----TKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTS---LKNDGKRTR 180
Query: 544 RVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKP 584
GT YM+PE +S ++ D+Y+ G++L EL+
Sbjct: 181 SK-GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 4e-40
Identities = 65/205 (31%), Positives = 101/205 (49%), Gaps = 13/205 (6%)
Query: 387 NVLGEGGFGCVYKGVLADGRE-----VAVKQLKIG-GSQGEREFRAEVEIISRVHHRHLV 440
VLG G FG V+KGV E V +K ++ G Q + + I + H H+V
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 441 SLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCH 500
L+G C LV +Y+P +L H+ + R + + A+G+ YL E
Sbjct: 79 RLLGLC-PGSSLQLVTQYLPLGSLLDHVR-QHRGALGPQLLLNWGVQIAKGMYYLEEH-- 134
Query: 501 PRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSG 560
++HR++ + N+LL S + +VADFG+A L D + + +MA E G
Sbjct: 135 -GMVHRNLAARNVLLKSPSQVQVADFGVAD-LLPPDDKQLLYSEAKTPIKWMALESIHFG 192
Query: 561 KLTEKSDVYSFGVVLLELIT-GRKP 584
K T +SDV+S+GV + EL+T G +P
Sbjct: 193 KYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 6e-40
Identities = 63/202 (31%), Positives = 98/202 (48%), Gaps = 12/202 (5%)
Query: 387 NVLGEGGFGCVYKGVLADGR-EVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGY 445
+ LG G +G VY+GV VAVK LK + E EF E ++ + H +LV L+G
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 77
Query: 446 CISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIH 505
C E ++ E++ L +L R + + +A + + YL + IH
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIH 134
Query: 506 RDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGY--MAPEYATSGKLT 563
RD+ + N L+ + +VADFGL+++ + D+ T F APE K +
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRL-MTGDTYT---AHAGAKFPIKWTAPESLAYNKFS 190
Query: 564 EKSDVYSFGVVLLELIT-GRKP 584
KSDV++FGV+L E+ T G P
Sbjct: 191 IKSDVWAFGVLLWEIATYGMSP 212
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 6e-40
Identities = 59/199 (29%), Positives = 100/199 (50%), Gaps = 8/199 (4%)
Query: 387 NVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYC 446
LG G FG V+ +VAVK +K GS F AE ++ + H LV L
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 447 ISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHR 506
++ ++ E++ +L L ++ + +A A G+A++ + IHR
Sbjct: 253 -TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHR 308
Query: 507 DIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKS 566
D++++NIL+ +S ++ADFGLA++ + + + + APE G T KS
Sbjct: 309 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP--IKWTAPEAINFGSFTIKS 366
Query: 567 DVYSFGVVLLELIT-GRKP 584
DV+SFG++L+E++T GR P
Sbjct: 367 DVWSFGILLMEIVTYGRIP 385
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 6e-40
Identities = 57/225 (25%), Positives = 91/225 (40%), Gaps = 25/225 (11%)
Query: 388 VLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYC 446
LGEGGF V L DG A+K++ Q E + E ++ +H +++ LV YC
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 447 ISERER----LLVYEYVPNDTLHYHL--HAEGRPVMDWATRVKVAAGAARGIAYLHEDCH 500
+ ER L+ + TL + + + + + G RG+ +H
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA--- 152
Query: 501 PRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVM------GTFGYMAP 554
HRD+K +NILL + + D G A + + + T Y AP
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
Query: 555 E------YATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGD 593
E + + E++DV+S G VL ++ G P D GD
Sbjct: 213 ELFSVQSHCV---IDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD 254
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 7e-40
Identities = 59/201 (29%), Positives = 98/201 (48%), Gaps = 12/201 (5%)
Query: 387 NVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYC 446
LG G FG V G +VA+K +K GS E EF E +++ + H LV L G C
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 447 ISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHR 506
+R ++ EY+ N L +L E R +++ + YL E +HR
Sbjct: 89 TKQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYL-ESKQ--FLHR 144
Query: 507 DIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGY--MAPEYATSGKLTE 564
D+ + N L++ +V+DFGL++ L+ + + V ++ F PE K +
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK----FPVRWSPPEVLMYSKFSS 200
Query: 565 KSDVYSFGVVLLELIT-GRKP 584
KSD+++FGV++ E+ + G+ P
Sbjct: 201 KSDIWAFGVLMWEIYSLGKMP 221
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 8e-40
Identities = 57/295 (19%), Positives = 105/295 (35%), Gaps = 53/295 (17%)
Query: 388 VLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGERE-FRAEVEIISRVHHRHLVSLVGY 445
LG GGFG V++ D A+K++++ + RE EV+ ++++ H +V
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 446 CISE---------RERLLVY---EYVPNDTLHYHLHA-EGRPVMDWATRVKVAAGAARGI 492
+ + ++ +Y + + L ++ + + + + A +
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAV 131
Query: 493 AYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKI---------ALELDSNTHVST 543
+LH ++HRD+K SNI +V DFGL L T
Sbjct: 132 EFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHT 188
Query: 544 RVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPL 603
+GT YM+PE + K D++S G++L EL+ P + R
Sbjct: 189 GQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---------PFSTQME----RVR 235
Query: 604 LAEALEHEDFEALVD--SRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVR 656
+ + F L E V + S +RP ++
Sbjct: 236 TLTDVRNLKFPPLFTQKYPCEYVMVQD-----------MLSPSPMERPEAINIIE 279
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 1e-39
Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 13/203 (6%)
Query: 388 VLGEGGFGCVYKGVLADGRE----VAVKQLKIGGSQGER-EFRAEVEIISRVHHRHLVSL 442
+LGEG FG VY+GV + + VAVK K + + +F +E I+ + H H+V L
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 443 VGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPR 502
+G E ++ E P L ++L + + T V + + +AYL E +
Sbjct: 79 IGII-EEEPTWIIMELYPYGELGHYLE-RNKNSLKVLTLVLYSLQICKAMAYL-ESIN-- 133
Query: 503 IIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKL 562
+HRDI NIL+ S ++ DFGL++ D + + ++ +M+PE +
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDFGLSR--YIEDEDYYKASVTRLPIKWMSPESINFRRF 191
Query: 563 TEKSDVYSFGVVLLELIT-GRKP 584
T SDV+ F V + E+++ G++P
Sbjct: 192 TTASDVWMFAVCMWEILSFGKQP 214
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-39
Identities = 63/205 (30%), Positives = 106/205 (51%), Gaps = 16/205 (7%)
Query: 388 VLGEGGFGCVYKGVLADGR---EVAVKQLKIGGSQGER--EFRAEVEIISRVHHRHLVSL 442
LG G FG V KG + VAVK LK + E AE ++ ++ + ++V +
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 443 VGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPR 502
+G C +E +LV E L+ +L + +++ + G+ YL E+ +
Sbjct: 84 IGICEAES-WMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYL-EESN-- 137
Query: 503 IIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTF--GYMAPEYATSG 560
+HRD+ + N+LL + A+++DFGL+K AL D N + + + G + + APE
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKA-QTHGKWPVKWYAPECINYY 195
Query: 561 KLTEKSDVYSFGVVLLELIT-GRKP 584
K + KSDV+SFGV++ E + G+KP
Sbjct: 196 KFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-39
Identities = 56/203 (27%), Positives = 92/203 (45%), Gaps = 13/203 (6%)
Query: 388 VLGEGGFGCVYKGVLADGRE----VAVKQLKIGGSQGER-EFRAEVEIISRVHHRHLVSL 442
+GEG FG V++G+ VA+K K S R +F E + + H H+V L
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 443 VGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPR 502
+G ++ E L L + +D A+ + A + +AYL R
Sbjct: 82 IGVITENP-VWIIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTALAYLESK---R 136
Query: 503 IIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKL 562
+HRDI + N+L+ S+ ++ DFGL++ + ++ +MAPE +
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFRRF 194
Query: 563 TEKSDVYSFGVVLLELIT-GRKP 584
T SDV+ FGV + E++ G KP
Sbjct: 195 TSASDVWMFGVCMWEILMHGVKP 217
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 3e-39
Identities = 60/205 (29%), Positives = 101/205 (49%), Gaps = 13/205 (6%)
Query: 387 NVLGEGGFGCVYKGVLADGRE-----VAVKQLKIGGSQGER-EFRAEVEIISRVHHRHLV 440
VLG G FG VYKG+ E VA+K+L+ S E E +++ V + H+
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 441 SLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCH 500
L+G C++ L+ + +P L ++ E + + + A+G+ YL +
Sbjct: 81 RLLGICLTS-TVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYLEDR-- 136
Query: 501 PRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSG 560
R++HRD+ + N+L+ + ++ DFGLAK L + + + +MA E
Sbjct: 137 -RLVHRDLAARNVLVKTPQHVKITDFGLAK-LLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 561 KLTEKSDVYSFGVVLLELIT-GRKP 584
T +SDV+S+GV + EL+T G KP
Sbjct: 195 IYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 3e-39
Identities = 61/208 (29%), Positives = 94/208 (45%), Gaps = 19/208 (9%)
Query: 388 VLGEGGFGCVYKGVL----ADGREVAVKQLKIG---GSQGEREFRAEVEIISRVHHRHLV 440
LG+G FG V +G VAVK LK + +F EV + + HR+L+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 441 SLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCH 500
L G ++ +V E P +L L + + T + A A G+ YL
Sbjct: 85 RLYGVVLTPP-MKMVTELAPLGSLLDRLR-KHQGHFLLGTLSRYAVQVAEGMGYLESK-- 140
Query: 501 PRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGT---FGYMAPEYA 557
R IHRD+ + N+LL + ++ DFGL + AL + + +V F + APE
Sbjct: 141 -RFIHRDLAARNLLLATRDLVKIGDFGLMR-ALPQNDDHYVMQE--HRKVPFAWCAPESL 196
Query: 558 TSGKLTEKSDVYSFGVVLLELIT-GRKP 584
+ + SD + FGV L E+ T G++P
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 3e-39
Identities = 47/209 (22%), Positives = 93/209 (44%), Gaps = 24/209 (11%)
Query: 388 VLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGERE---FRAEVEIISRVHHRHLVSLV 443
+G G F VY+ L DG VA+K+++I + E++++ +++H +++
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 444 GYCISERERLLVYEYVPNDTLHYHLHAEGRP--------VMDWATRVKVAAGAARGIAYL 495
I + E +V E L + + V + ++ + ++
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQL------CSALEHM 152
Query: 496 HEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPE 555
H R++HRDIK +N+ + ++ ++ D GL + S T + ++GT YM+PE
Sbjct: 153 HSR---RVMHRDIKPANVFITATGVVKLGDLGLGRF---FSSKTTAAHSLVGTPYYMSPE 206
Query: 556 YATSGKLTEKSDVYSFGVVLLELITGRKP 584
KSD++S G +L E+ + P
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 3e-39
Identities = 64/274 (23%), Positives = 97/274 (35%), Gaps = 39/274 (14%)
Query: 324 SPYASSQKSDSVFLRPH---SPAPLVGNGSNSGFSRSPSESGVLGNSRSWFTYDELIQAT 380
+++++ + P + G S +SP S ++ L
Sbjct: 7 HSSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRL---- 62
Query: 381 NGFSAHNVLGEGGFGCVYKGV-LADGREVAVKQLKIG--GSQGEREFRAEVEIISRV-HH 436
+ LG G +G V+K DGR AVK+ G + AEV +V H
Sbjct: 63 ------SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 437 RHLVSLVGYCISERERL-LVYEYVPNDTLHYHLHAEGRP-----VMDWATRVKVAAGAAR 490
V L E L L E L H A G V +
Sbjct: 117 PCCVRLEQ-AWEEGGILYLQTELCGPS-LQQHCEAWGASLPEAQVWGYLRDT------LL 168
Query: 491 GIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFG 550
+A+LH ++H D+K +NI L ++ DFGL EL + + G
Sbjct: 169 ALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLV---ELGTAGAGEVQE-GDPR 221
Query: 551 YMAPEYATSGKLTEKSDVYSFGVVLLELITGRKP 584
YMAPE G +DV+S G+ +LE+ +
Sbjct: 222 YMAPE-LLQGSYGTAADVFSLGLTILEVACNMEL 254
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 4e-39
Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 10/204 (4%)
Query: 387 NVLGEGGFGCVYKGVLADGRE----VAVKQLKIGGSQGER-EFRAEVEIISRVHHRHLVS 441
++G G G V G L + VA+K LK G ++ +R +F +E I+ + H +++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 442 LVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHP 501
L G R ++V EY+ N +L L V + G G+ YL D
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQF-TIMQLVGMLRGVGAGMRYL-SDLG- 171
Query: 502 RIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGK 561
+HRD+ + N+L+DS+ +V+DFGL+++ + + +T + APE
Sbjct: 172 -YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT 230
Query: 562 LTEKSDVYSFGVVLLELIT-GRKP 584
+ SDV+SFGVV+ E++ G +P
Sbjct: 231 FSSASDVWSFGVVMWEVLAYGERP 254
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 6e-39
Identities = 53/221 (23%), Positives = 93/221 (42%), Gaps = 41/221 (18%)
Query: 388 VLGEGGFGCVYKGVL--------ADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHL 439
LG+G F ++KGV EV +K L F ++S++ H+HL
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 440 VSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDC 499
V G C+ E +LV E+V +L +L + + ++ +++VA A + +L E+
Sbjct: 75 VLNYGVCVCGDENILVQEFVKFGSLDTYLK-KNKNCINILWKLEVAKQLAAAMHFL-EEN 132
Query: 500 HPRIIHRDIKSSNILLDSSFEAR--------VADFGLAKIALELDSNTHVSTRVMGTFGY 551
+IH ++ + NILL + + ++D G++ L D
Sbjct: 133 T--LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD-------------IL 177
Query: 552 ------MAPEYATSGKL-TEKSDVYSFGVVLLELIT-GRKP 584
+ PE + K +D +SFG L E+ + G KP
Sbjct: 178 QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 6e-39
Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 43/226 (19%)
Query: 388 VLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGERE-FRAEVEIISRVHHRHLVSLVGY 445
VLG+G FG V K D R A+K+++ ++ + +EV +++ ++H+++V
Sbjct: 13 VLGQGAFGQVVKARNALDSRYYAIKKIRH--TEEKLSTILSEVMLLASLNHQYVVRYYAA 70
Query: 446 CISERERL-------------LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAAR-- 490
+ R + + EY N TL+ +H+E + R
Sbjct: 71 WLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLN-----QQRDEYWRLFRQI 125
Query: 491 --GIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKI------------ALELD 536
++Y+H IIHRD+K NI +D S ++ DFGLAK
Sbjct: 126 LEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 537 SNTHVSTRVMGTFGYMAPE-YATSGKLTEKSDVYSFGVVLLELITG 581
S+ ++++ + GT Y+A E +G EK D+YS G++ E+I
Sbjct: 183 SSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 8e-39
Identities = 67/211 (31%), Positives = 110/211 (52%), Gaps = 13/211 (6%)
Query: 389 LGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGE---REFRAEVEIISRVHHRHLVSL-- 442
LG GG V+ L D R+VAVK L+ ++ FR E + + ++H +V++
Sbjct: 20 LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 443 VGYCISERERL--LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCH 500
G + L +V EYV TL +H EG M ++V A A + + + H++
Sbjct: 80 TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQN-- 135
Query: 501 PRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSG 560
IIHRD+K +NI++ ++ +V DFG+A+ + ++ + V+GT Y++PE A
Sbjct: 136 -GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 194
Query: 561 KLTEKSDVYSFGVVLLELITGRKPVDASQPL 591
+ +SDVYS G VL E++TG P P+
Sbjct: 195 SVDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-38
Identities = 61/204 (29%), Positives = 104/204 (50%), Gaps = 10/204 (4%)
Query: 387 NVLGEGGFGCVYKGVL--ADGRE--VAVKQLKIGGSQGER-EFRAEVEIISRVHHRHLVS 441
V+G G FG V G L +E VA+K LK+G ++ +R +F E I+ + H +++
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 442 LVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHP 501
L G + ++V EY+ N +L L + V + G A G+ YL D
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLVGMLRGIASGMKYL-SDMG- 167
Query: 502 RIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGK 561
+HRD+ + NIL++S+ +V+DFGL ++ + + + + +PE K
Sbjct: 168 -YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 562 LTEKSDVYSFGVVLLELIT-GRKP 584
T SDV+S+G+VL E+++ G +P
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERP 250
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-38
Identities = 65/206 (31%), Positives = 108/206 (52%), Gaps = 15/206 (7%)
Query: 388 VLGEGGFGCVYKGVLADGRE-----VAVKQLKIGGSQGER-EFRAEVEIISRVHHRHLVS 441
V+G G FG VYKG+L VA+K LK G ++ +R +F E I+ + H +++
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 442 LVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHP 501
L G + +++ EY+ N L L E V + G A G+ YL + +
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLR-EKDGEFSVLQLVGMLRGIAAGMKYL-ANMN- 167
Query: 502 RIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGY--MAPEYATS 559
+HRD+ + NIL++S+ +V+DFGL+++ + T+ ++ G APE +
Sbjct: 168 -YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSG--GKIPIRWTAPEAISY 224
Query: 560 GKLTEKSDVYSFGVVLLELIT-GRKP 584
K T SDV+SFG+V+ E++T G +P
Sbjct: 225 RKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 8e-38
Identities = 48/213 (22%), Positives = 95/213 (44%), Gaps = 23/213 (10%)
Query: 387 NVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGE--REFRAEVEIISRV--HHRHLVSL 442
+G GG V++ + + A+K + + + + +R E+ ++++ H ++ L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 443 VGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPR 502
Y I+++ +V E D L+ L + +D R + +H+
Sbjct: 75 YDYEITDQYIYMVMECGNID-LNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQH---G 128
Query: 503 IIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPE------- 555
I+H D+K +N L+ ++ DFG+A ++ D+ + V +GT YM PE
Sbjct: 129 IVHSDLKPANFLIVDG-MLKLIDFGIAN-QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186
Query: 556 ----YATSGKLTEKSDVYSFGVVLLELITGRKP 584
+ K++ KSDV+S G +L + G+ P
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 8e-38
Identities = 48/213 (22%), Positives = 95/213 (44%), Gaps = 23/213 (10%)
Query: 387 NVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGE--REFRAEVEIISRV--HHRHLVSL 442
+G GG V++ + + A+K + + + + +R E+ ++++ H ++ L
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 443 VGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPR 502
Y I+++ +V E D L+ L + +D R + +H+
Sbjct: 94 YDYEITDQYIYMVMECGNID-LNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQH---G 147
Query: 503 IIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPE------- 555
I+H D+K +N L+ ++ DFG+A ++ D+ + V +GT YM PE
Sbjct: 148 IVHSDLKPANFLIVDG-MLKLIDFGIAN-QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 205
Query: 556 ----YATSGKLTEKSDVYSFGVVLLELITGRKP 584
+ K++ KSDV+S G +L + G+ P
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-37
Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 13/203 (6%)
Query: 388 VLGEGGFGCVYKGVLADGRE----VAVKQLKIGGSQGER-EFRAEVEIISRVHHRHLVSL 442
+GEG FG V++G+ VA+K K S R +F E + + H H+V L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 443 VGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPR 502
+G +E ++ E L L + +D A+ + A + +AYL R
Sbjct: 457 IGVI-TENPVWIIMELCTLGELRSFLQ-VRKFSLDLASLILYAYQLSTALAYLESK---R 511
Query: 503 IIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKL 562
+HRDI + N+L+ S+ ++ DFGL++ +E DS + +++ +MAPE +
Sbjct: 512 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YME-DSTYYKASKGKLPIKWMAPESINFRRF 569
Query: 563 TEKSDVYSFGVVLLELIT-GRKP 584
T SDV+ FGV + E++ G KP
Sbjct: 570 TSASDVWMFGVCMWEILMHGVKP 592
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-37
Identities = 61/219 (27%), Positives = 93/219 (42%), Gaps = 30/219 (13%)
Query: 387 NVLGEGGFGCVYKGVLADGRE----VAVKQLKIGG-SQGER-EFRAEVEIISRVHHRHLV 440
+LGEG FG V +G L VAVK +K+ SQ E EF +E + H +++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 441 SLVGYCISER-----ERLLVYEYVPN-DTLHY---HLHAEGRPVMDWATRVKVAAGAARG 491
L+G CI + +++ ++ D Y G + T +K A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 492 IAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD-----SNTHVSTRVM 546
+ YL +HRD+ + N +L VADFGL+K D + +
Sbjct: 160 MEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK-- 214
Query: 547 GTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKP 584
++A E T KSDV++FGV + E+ T G P
Sbjct: 215 ----WIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-37
Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 10/202 (4%)
Query: 388 VLGEGGFGCVYKGVLADGRE---VAVKQLKIGGSQGER-EFRAEVEIISRVHHRHLVSLV 443
LG G FG V +GV ++ VA+K LK G + + E E +I+ ++ + ++V L+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 444 GYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRI 503
G C +LV E LH L + + + ++ + G+ YL E
Sbjct: 403 GVC-QAEALMLVMEMAGGGPLHKFLVGKREEI-PVSNVAELLHQVSMGMKYLEEK---NF 457
Query: 504 IHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLT 563
+HR++ + N+LL + A+++DFGL+K DS + + APE K +
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 517
Query: 564 EKSDVYSFGVVLLELIT-GRKP 584
+SDV+S+GV + E ++ G+KP
Sbjct: 518 SRSDVWSYGVTMWEALSYGQKP 539
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-37
Identities = 60/200 (30%), Positives = 96/200 (48%), Gaps = 8/200 (4%)
Query: 387 NVLGEGGFGCVYKGVL-ADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGY 445
+ LG G +G VY+GV VAVK LK + E EF E ++ + H +LV L+G
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 284
Query: 446 CISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIH 505
C E ++ E++ L +L R + + +A + + YL + IH
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIH 341
Query: 506 RDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEK 565
R++ + N L+ + +VADFGL+++ H + + APE K + K
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP--IKWTAPESLAYNKFSIK 399
Query: 566 SDVYSFGVVLLELIT-GRKP 584
SDV++FGV+L E+ T G P
Sbjct: 400 SDVWAFGVLLWEIATYGMSP 419
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-37
Identities = 56/220 (25%), Positives = 91/220 (41%), Gaps = 31/220 (14%)
Query: 387 NVLGEGGFGCVYKGVLADGRE----VAVKQLKIGG-SQGERE-FRAEVEIISRVHHRHLV 440
+LG+G FG V + L VAVK LK + + E F E + H H+
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 441 SLVGYCISERER------LLVYEYVPN-DTLHY---HLHAEGRPVMDWATRVKVAAGAAR 490
LVG + R + +++ ++ + D + E + T V+ A
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 491 GIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD-----SNTHVSTRV 545
G+ YL IHRD+ + N +L VADFGL++ D + + +
Sbjct: 149 GMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK- 204
Query: 546 MGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKP 584
++A E T SDV++FGV + E++T G+ P
Sbjct: 205 -----WLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 4e-37
Identities = 61/219 (27%), Positives = 99/219 (45%), Gaps = 30/219 (13%)
Query: 387 NVLGEGGFGCVYKGVLADGRE------VAVKQLKIGGSQGER-EFRAEVEIISRVHHRHL 439
LG+G FG VY+GV + VA+K + S ER EF E ++ + H+
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 440 VSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATR--------VKVAAGAARG 491
V L+G + L++ E + L +L + + + +++A A G
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 492 IAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGY 551
+AYL+ + + +HRD+ + N ++ F ++ DFG+ + E D G G
Sbjct: 151 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD------YYRKGGKGL 201
Query: 552 -----MAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKP 584
M+PE G T SDV+SFGVVL E+ T +P
Sbjct: 202 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 5e-37
Identities = 63/208 (30%), Positives = 96/208 (46%), Gaps = 14/208 (6%)
Query: 387 NVLGEGGFGCVYKGV-LADGREVAVKQL---KIGGSQGEREFRAEVEIISRVHHRHLVSL 442
LG+G FG VY +A+K L ++ + E + R EVEI S + H +++ L
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 443 VGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPR 502
GY L+ EY P T++ L + + T A ++Y H R
Sbjct: 75 YGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTA-TYITELANALSYCHSK---R 129
Query: 503 IIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKL 562
+IHRDIK N+LL S+ E ++ADFG + S+ GT Y+ PE
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTDL--CGTLDYLPPEMIEGRMH 184
Query: 563 TEKSDVYSFGVVLLELITGRKPVDASQP 590
EK D++S GV+ E + G+ P +A+
Sbjct: 185 DEKVDLWSLGVLCYEFLVGKPPFEANTY 212
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 6e-37
Identities = 63/236 (26%), Positives = 115/236 (48%), Gaps = 18/236 (7%)
Query: 355 SRSPSESGVLGNSRSWFTYDELIQATNGFSAHNVLGEGGFGCVYKGV-LADGREVAVKQL 413
S +E G + + Y E + + VLG+G +G VY G L++ +A+K++
Sbjct: 1 SMRSTEEGDCESDLLEYDY-EYDENGDR----VVLGKGTYGIVYAGRDLSNQVRIAIKEI 55
Query: 414 KIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY-EYVPNDTLHYHLHAEG 472
S+ + E+ + + H+++V +G SE + ++ E VP +L L ++
Sbjct: 56 PERDSRYSQPLHEEIALHKHLKHKNIVQYLG-SFSENGFIKIFMEQVPGGSLSALLRSKW 114
Query: 473 RPVMDWATRVKV-AAGAARGIAYLHEDCHPRIIHRDIKSSNILLDS-SFEARVADFGLAK 530
P+ D + G+ YLH++ +I+HRDIK N+L+++ S +++DFG +K
Sbjct: 115 GPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSK 171
Query: 531 IALELDSNTHVSTRVMGTFGYMAPEYATSGKL--TEKSDVYSFGVVLLELITGRKP 584
L + GT YMAPE G + +D++S G ++E+ TG+ P
Sbjct: 172 ---RLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 9e-37
Identities = 61/233 (26%), Positives = 95/233 (40%), Gaps = 52/233 (22%)
Query: 387 NVLGEGGFGCVYKGVLADGRE------VAVKQLKIGGSQGER-EFRAEVEIISRVHHRHL 439
LGE FG VYKG L VA+K LK R EFR E + +R+ H ++
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 440 VSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATR--------------VKVA 485
V L+G ++ +++ Y + LH L +T V +
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 486 AGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRV 545
A A G+ YL ++H+D+ + N+L+ +++D GL R
Sbjct: 135 AQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLF--------------RE 177
Query: 546 MGTFGY-------------MAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKP 584
+ Y MAPE GK + SD++S+GVVL E+ + G +P
Sbjct: 178 VYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 9e-37
Identities = 63/224 (28%), Positives = 101/224 (45%), Gaps = 35/224 (15%)
Query: 387 NVLGEGGFGCVYKGVLADGRE------VAVKQLKIGGSQGEREFRAEVEIISRVHHRHLV 440
LGEG FG V+ + VAVK LK ++F+ E E+++ + H H+V
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 441 SLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATR--------------VKVAA 486
G C ++V+EY+ + L+ L A G M + +A+
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 487 GAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVM 546
A G+ YL +HRD+ + N L+ ++ ++ DFG+++ D RV
Sbjct: 141 QIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD-----YYRVG 192
Query: 547 GTFG-----YMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKP 584
G +M PE K T +SDV+SFGV+L E+ T G++P
Sbjct: 193 GH-TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 1e-36
Identities = 56/279 (20%), Positives = 111/279 (39%), Gaps = 37/279 (13%)
Query: 321 TLPSPYASSQKSDSVFLRPHSPAPLVGNGSNSGFSRSPSESGVLGNSRSWFTYDELIQAT 380
+P + + + F R H +P +G + S S +E +
Sbjct: 10 LVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRI------------ 57
Query: 381 NGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGG--SQGEREFRAEVEIISRVHH-- 436
+S +G GG V++ + + A+K + + +Q +R E+ ++++
Sbjct: 58 --YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 437 RHLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLH 496
++ L Y I+++ +V E D L+ L + +D R + +H
Sbjct: 116 DKIIRLYDYEITDQYIYMVMECGNID-LNSWLKKKKS--IDPWERKSYWKNMLEAVHTIH 172
Query: 497 EDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPE- 555
+ I+H D+K +N L+ ++ DFG+A ++ ++V G YM PE
Sbjct: 173 QH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV-GAVNYMPPEA 227
Query: 556 ----------YATSGKLTEKSDVYSFGVVLLELITGRKP 584
+ K++ KSDV+S G +L + G+ P
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 50/204 (24%), Positives = 82/204 (40%), Gaps = 11/204 (5%)
Query: 388 VLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGE---REFRAEVEIISRVHHRHLVSLV 443
++G GG G VY+ R VA+K + S + E R+ H+V +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 444 GYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRI 503
+ + + + + L L +G + V + + H
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAMLRRQGP--LAPPRAVAIVRQIGSALDAAHAA---GA 155
Query: 504 IHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLT 563
HRD+K NIL+ + A + DFG+A A + T + +GT YMAPE + T
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIAS-ATTDEKLTQLGN-TVGTLYYMAPERFSESHAT 213
Query: 564 EKSDVYSFGVVLLELITGRKPVDA 587
++D+Y+ VL E +TG P
Sbjct: 214 YRADIYALTCVLYECLTGSPPYQG 237
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-36
Identities = 65/220 (29%), Positives = 106/220 (48%), Gaps = 31/220 (14%)
Query: 387 NVLGEGGFGCVYKGVLADGRE---VAVKQLKIGGSQGER-EFRAEVEIISRV-HHRHLVS 441
+V+GEG FG V K + A+K++K S+ + +F E+E++ ++ HH ++++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 442 LVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATR--------------VKVAAG 487
L+G C L EY P+ L L D A + AA
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 488 AARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMG 547
ARG+ YL + + IHRD+ + NIL+ ++ A++ADFGL++ +V MG
Sbjct: 151 VARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKT-MG 201
Query: 548 TF--GYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKP 584
+MA E T SDV+S+GV+L E+++ G P
Sbjct: 202 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 5e-36
Identities = 62/219 (28%), Positives = 100/219 (45%), Gaps = 25/219 (11%)
Query: 387 NVLGEGGFGCVYKGVLADGRE------VAVKQLKIGGSQGER-EFRAEVEIISRV-HHRH 438
LG G FG V + + VAVK LK E+ +E++I+S + H +
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 439 LVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATR------------VKVAA 486
+V+L+G C L++ EY L L + R + + ++
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 487 GAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVM 546
A+G+A+L IHRD+ + N+LL + A++ DFGLA+ + DSN V
Sbjct: 172 QVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN-DSNYIVKGNAR 227
Query: 547 GTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKP 584
+MAPE T +SDV+S+G++L E+ + G P
Sbjct: 228 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 6e-36
Identities = 66/218 (30%), Positives = 101/218 (46%), Gaps = 24/218 (11%)
Query: 387 NVLGEGGFGCVYKGVLADGRE------VAVKQLKIGGSQGEREFRAEVEIISRVHHRHLV 440
LGEG FG V+ + VAVK LK ++F+ E E+++ + H+H+V
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 441 SLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATR-------------VKVAAG 487
G C R L+V+EY+ + L+ L + G A + VA+
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 488 AARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMG 547
A G+ YL +HRD+ + N L+ ++ DFG+++ D V R M
Sbjct: 167 VAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY-YRVGGRTML 222
Query: 548 TFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKP 584
+M PE K T +SDV+SFGVVL E+ T G++P
Sbjct: 223 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 9e-36
Identities = 75/316 (23%), Positives = 120/316 (37%), Gaps = 58/316 (18%)
Query: 387 NVLGEGGFGCVYKGVLADGR------EVAVKQLKIGGSQGER-EFRAEVEIISRVHHRHL 439
LG G FG VY+G ++ +VAVK L S+ + +F E IIS+ +H+++
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 440 VSLVGYCISERERLLVYEYVPNDTLHYHL-----HAEGRPVMDWATRVKVAAGAARGIAY 494
V +G + R ++ E + L L + + VA A G Y
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 495 LHEDCHPRIIHRDIKSSNILLDSSFEARV---ADFGLAKIALELDSNTHVSTRVMGTFGY 551
L E+ IHRDI + N LL RV DFG+A+ G
Sbjct: 156 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS------YYRKGGCAM 206
Query: 552 -----MAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLA 605
M PE G T K+D +SFGV+L E+ + G P
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY-------------------- 246
Query: 606 EALEHEDFEALVDS--RLEK-NYVDSEMFW-MIEAAAACVRHSATKRPRMSQVVRALDTL 661
+ +++ V S R++ ++ M + C +H RP + ++ ++
Sbjct: 247 PSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQ----CWQHQPEDRPNFAIILERIEYC 302
Query: 662 DGASDLTNGVKPGQSG 677
D+ N P + G
Sbjct: 303 TQDPDVINTALPIEYG 318
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 51/219 (23%), Positives = 89/219 (40%), Gaps = 34/219 (15%)
Query: 388 VLGEGGFGCVYKGV-LADGREVAVKQL-KIGGSQGEREFRAEVEIISRVHHRHLVSLVGY 445
+LG+G V++G G A+K I + E E++ +++H+++V L +
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKL--F 73
Query: 446 CISE----RERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAAR----GIAYLHE 497
I E R ++L+ E+ P +L+ L R G+ +L E
Sbjct: 74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAY---GLPESEFLIVLRDVVGGMNHLRE 130
Query: 498 DCHPRIIHRDIKSSNILLDSSFEAR----VADFGLAKIALELDSNTHVSTRVMGTFGYMA 553
+ I+HR+IK NI+ + + + DFG A+ EL+ + + GT Y+
Sbjct: 131 N---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR---ELEDDEQFVSLY-GTEEYLH 183
Query: 554 PE--------YATSGKLTEKSDVYSFGVVLLELITGRKP 584
P+ K D++S GV TG P
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 142 bits (358), Expect = 2e-35
Identities = 65/215 (30%), Positives = 97/215 (45%), Gaps = 19/215 (8%)
Query: 388 VLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGERE-FRAEVEIISRVHHRHLVSLV-- 443
LG GGFG V + + G +VA+KQ + S RE + E++I+ +++H ++VS
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 444 ----GYCISERERLLVYEYVPNDTLHYHLHAEGRP-VMDWATRVKVAAGAARGIAYLHED 498
LL EY L +L+ + + + + + YLHE+
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 140
Query: 499 CHPRIIHRDIKSSNILLDSSFEAR---VADFGLAKIALELDSNTHVSTRVMGTFGYMAPE 555
RIIHRD+K NI+L + + D G AK ELD + V GT Y+APE
Sbjct: 141 ---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK---ELDQGELCTEFV-GTLQYLAPE 193
Query: 556 YATSGKLTEKSDVYSFGVVLLELITGRKPVDASQP 590
K T D +SFG + E ITG +P +
Sbjct: 194 LLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ 228
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 13/205 (6%)
Query: 389 LGEGGFGCVYKGV-LADGREVAVKQL---KIGGSQGEREFRAEVEIISRVHHRHLVSLVG 444
LG+G F VY+ + G EVA+K + + + + + EV+I ++ H ++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 445 YCISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRI 503
Y + + LV E N ++ +L +P + R + G+ YLH I
Sbjct: 79 Y-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQ-IITGMLYLHSH---GI 133
Query: 504 IHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLT 563
+HRD+ SN+LL + ++ADFGLA L++ H T + GT Y++PE AT
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLA-TQLKMPHEKH-YT-LCGTPNYISPEIATRSAHG 190
Query: 564 EKSDVYSFGVVLLELITGRKPVDAS 588
+SDV+S G + L+ GR P D
Sbjct: 191 LESDVWSLGCMFYTLLIGRPPFDTD 215
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-35
Identities = 83/401 (20%), Positives = 136/401 (33%), Gaps = 74/401 (18%)
Query: 301 MAVWFAHKRKKKRAGEHIGYTLPSPYASSQKSDSVFLRPHSPAPLVGNGSNSGFSRSPSE 360
M+ + H S +S L + ++ N + +
Sbjct: 1 MSYYHHHHHHDYDIPTTENLYFQGAMGSELQSPEYKLSKLRTSTIM-TDYNPNYCFAGKT 59
Query: 361 SGVLGN---SRSWFTYDELIQATNGFSAHNVLGEGGFGCVYKGVLADGR------EVAVK 411
S + R T LG G FG VY+G ++ +VAVK
Sbjct: 60 SSISDLKEVPRKNITLIR------------GLGHGAFGEVYEGQVSGMPNDPSPLQVAVK 107
Query: 412 QLKIGGSQGER-EFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPNDTLHYHL-- 468
L S+ + +F E IIS+ +H+++V +G + R ++ E + L L
Sbjct: 108 TLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRE 167
Query: 469 ---HAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARV-- 523
+ + VA A G YL E+ IHRDI + N LL RV
Sbjct: 168 TRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAK 224
Query: 524 -ADFGLAKIALELDSNTHVSTRVMGTFGY-----MAPEYATSGKLTEKSDVYSFGVVLLE 577
DFG+A+ G M PE G T K+D +SFGV+L E
Sbjct: 225 IGDFGMARDIYRAG------YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWE 278
Query: 578 LIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDS--RLEK-NYVDSEMFW- 632
+ + G P + +++ V S R++ ++
Sbjct: 279 IFSLGYMPY--------------------PSKSNQEVLEFVTSGGRMDPPKNCPGPVYRI 318
Query: 633 MIEAAAACVRHSATKRPRMSQVVRALDTLDGASDLTNGVKP 673
M + C +H RP + ++ ++ D+ N P
Sbjct: 319 MTQ----CWQHQPEDRPNFAIILERIEYCTQDPDVINTALP 355
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 140 bits (353), Expect = 3e-35
Identities = 67/199 (33%), Positives = 101/199 (50%), Gaps = 8/199 (4%)
Query: 387 NVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYC 446
LG+G FG V+ G VA+K LK G+ F E +++ ++ H LV L
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 447 ISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHR 506
SE +V EY+ +L L E + V +AA A G+AY+ +HR
Sbjct: 332 -SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHR 387
Query: 507 DIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKS 566
D++++NIL+ + +VADFGLA++ + + + + APE A G+ T KS
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP--IKWTAPEAALYGRFTIKS 445
Query: 567 DVYSFGVVLLELIT-GRKP 584
DV+SFG++L EL T GR P
Sbjct: 446 DVWSFGILLTELTTKGRVP 464
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 15/84 (17%), Positives = 21/84 (25%), Gaps = 1/84 (1%)
Query: 25 STTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVD 84
P + + + P + PS PA PS+ P A P
Sbjct: 6 KPKDASQRRRSLEPAENVHGAGGGAFPASQTPSKPASADGHRGPSAAFAPAAAEPKLFGG 65
Query: 85 PSPPSPAQPPPQAVAPSPPPPANV 108
+ S PQ P
Sbjct: 66 FN-SSDTVTSPQRAGPLAGGVTTF 88
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 5e-06
Identities = 12/83 (14%), Positives = 15/83 (18%), Gaps = 1/83 (1%)
Query: 16 PSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPL 75
P S P P + TP P +A P+ P
Sbjct: 7 PKDASQRRRSLEPAENVHGAGGGAF-PASQTPSKPASADGHRGPSAAFAPAAAEPKLFGG 65
Query: 76 DAPPPPEVDPSPPSPAQPPPQAV 98
P P
Sbjct: 66 FNSSDTVTSPQRAGPLAGGVTTF 88
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 12/80 (15%), Positives = 24/80 (30%)
Query: 126 PSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTP 185
P +S ++ + PA+ + S P + PS++ P +
Sbjct: 7 PKDASQRRRSLEPAENVHGAGGGAFPASQTPSKPASADGHRGPSAAFAPAAAEPKLFGGF 66
Query: 186 SPPVLTPPPHPSQSAPPPVT 205
+ P + VT
Sbjct: 67 NSSDTVTSPQRAGPLAGGVT 86
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 5e-05
Identities = 17/72 (23%), Positives = 21/72 (29%), Gaps = 4/72 (5%)
Query: 14 PPPSPPLSPPPSTTPPPTSPPPASPPPSPPTST----PPSPPTAPPPSSPAVNSPPPQPS 69
L P + PAS PS P S PS AP + P +
Sbjct: 11 SQRRRSLEPAENVHGAGGGAFPASQTPSKPASADGHRGPSAAFAPAAAEPKLFGGFNSSD 70
Query: 70 SPPPPLDAPPPP 81
+ P A P
Sbjct: 71 TVTSPQRAGPLA 82
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 5e-04
Identities = 11/85 (12%), Positives = 17/85 (20%), Gaps = 6/85 (7%)
Query: 40 PSPPTSTPPSPPTAPPPSSPAVNSPP--PQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQA 97
P + S A + P PS P P + +PA P+
Sbjct: 7 PKDASQRRRSLEPAENVHGAGGGAFPASQTPSKPASADGHRGP----SAAFAPAAAEPKL 62
Query: 98 VAPSPPPPANVPTTPSSSSPPPANV 122
+
Sbjct: 63 FGGFNSSDTVTSPQRAGPLAGGVTT 87
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 5e-04
Identities = 16/88 (18%), Positives = 29/88 (32%), Gaps = 6/88 (6%)
Query: 127 SSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPS 186
S R+ + + A A P+S +P P S+ PS+ +
Sbjct: 5 SKPKDASQRRRSLEPAENVHGAGGGAFPASQTPSK-----PASADGHRGPSAAFAPAAAE 59
Query: 187 PPVLTPPPHPSQSAPPPVTKSPPASTLS 214
P + + S + P P A ++
Sbjct: 60 PKLF-GGFNSSDTVTSPQRAGPLAGGVT 86
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-35
Identities = 66/307 (21%), Positives = 110/307 (35%), Gaps = 56/307 (18%)
Query: 383 FSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRV-HHRHLVS 441
F +VLG G G + + D R+VAVK++ + EV+++ H +++
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP---ECFSFADREVQLLRESDEHPNVIR 82
Query: 442 LVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHP 501
+ + + E TL ++ + + + G+A+LH
Sbjct: 83 YFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPI-TLLQQTTSGLAHLHSL--- 137
Query: 502 RIIHRDIKSSNILL-----DSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEY 556
I+HRD+K NIL+ +A ++DFGL K + + V GT G++APE
Sbjct: 138 NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM 197
Query: 557 ---ATSGKLTEKSDVYSFGVVLLELITGRKP------------------VDASQPLGDES 595
T D++S G V +I+ +D P E
Sbjct: 198 LSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHED 257
Query: 596 -----LVEW-------ARPLLAEALEHE---------DFEALVDSRLEKNYVDSEMFWMI 634
L+E RP L+H F V R+EK +D + +
Sbjct: 258 VIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQFFQDVSDRIEKESLDGPIVKQL 317
Query: 635 EAAAACV 641
E V
Sbjct: 318 ERGGRAV 324
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-35
Identities = 64/233 (27%), Positives = 101/233 (43%), Gaps = 44/233 (18%)
Query: 387 NVLGEGGFGCVYKGVLADGRE------VAVKQLKIGGSQGER-EFRAEVEIISRVHHRHL 439
LGEG FG V K + VAVK LK S E + +E ++ +V+H H+
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 440 VSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATR------------------ 481
+ L G C + LL+ EY +L L + +
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 482 ----VKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDS 537
+ A ++G+ YL E +++HRD+ + NIL+ + +++DFGL++ E DS
Sbjct: 149 MGDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205
Query: 538 NTHVSTRVMGTFG-----YMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKP 584
+ G +MA E T +SDV+SFGV+L E++T G P
Sbjct: 206 YV------KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 62/228 (27%), Positives = 105/228 (46%), Gaps = 39/228 (17%)
Query: 387 NVLGEGGFGCVYKGVLADGRE--------VAVKQLKIGGSQGER-EFRAEVEIISRV-HH 436
LGEG FG V + VAVK LK ++ + + +E+E++ + H
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 437 RHLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATR--------------V 482
+++++L+G C + ++ EY L +L A P M+++ V
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 483 KVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD-----S 537
ARG+ YL + IHRD+ + N+L+ + ++ADFGLA+ +D +
Sbjct: 161 SCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 538 NTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKP 584
N + + +MAPE T +SDV+SFGV++ E+ T G P
Sbjct: 218 NGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-34
Identities = 57/233 (24%), Positives = 98/233 (42%), Gaps = 44/233 (18%)
Query: 387 NVLGEGGFGCVYKGVLADGRE------VAVKQLKIGGSQGER-EFRAEVEIISRV-HHRH 438
VLG G FG V + VAVK LK ER +E+++++++ H +
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 439 LVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATR----------------- 481
+V+L+G C L++EY L +L ++ +
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 482 ----VKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD- 536
+ A A+G+ +L +HRD+ + N+L+ ++ DFGLA+ +
Sbjct: 171 FEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 227
Query: 537 ----SNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKP 584
N + + +MAPE G T KSDV+S+G++L E+ + G P
Sbjct: 228 YVVRGNARLPVK------WMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 4e-34
Identities = 71/325 (21%), Positives = 120/325 (36%), Gaps = 74/325 (22%)
Query: 387 NVLGEGGFGCVYKGVLADGRE------VAVKQLKIGGSQGER-EFRAEVEIISRVHHRHL 439
+GEG FG V++ VAVK LK S + +F+ E +++ + ++
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 440 VSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATR------------------ 481
V L+G C + L++EY+ L+ L + P +
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSM-SPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 482 -----VKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536
+ +A A G+AYL E + +HRD+ + N L+ + ++ADFGL++ D
Sbjct: 172 SCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228
Query: 537 SNTHVSTRVMGTFGY-----MAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQP 590
M PE + T +SDV+++GVVL E+ + G +P
Sbjct: 229 ------YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY----- 277
Query: 591 LGDESLVEWARPLLAEALEHEDFEALVDS--RLEK-NYVDSEMFW-MIEAAAACVRHSAT 646
+ HE+ V L E++ M C
Sbjct: 278 ---------------YGMAHEEVIYYVRDGNILACPENCPLELYNLMRL----CWSKLPA 318
Query: 647 KRPRMSQVVRALDTLDGASDLTNGV 671
RP + R L + ++ T GV
Sbjct: 319 DRPSFCSIHRILQRMCERAEGTVGV 343
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-34
Identities = 59/227 (25%), Positives = 97/227 (42%), Gaps = 38/227 (16%)
Query: 387 NVLGEGGFGCVYKGVLAD------GREVAVKQLKIGGSQGER-EFRAEVEIISRV-HHRH 438
LG G FG V + R VAVK LK G + E +E++I+ + HH +
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 439 LVSLVGYC-ISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATR--------------VK 483
+V+L+G C +++ E+ L +L ++ + + +
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 484 VAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVST 543
+ A+G+ +L + IHRD+ + NILL ++ DFGLA+ +
Sbjct: 153 YSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP------D 203
Query: 544 RVMGTFG-----YMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKP 584
V +MAPE T +SDV+SFGV+L E+ + G P
Sbjct: 204 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 5e-34
Identities = 47/229 (20%), Positives = 92/229 (40%), Gaps = 39/229 (17%)
Query: 388 VLGEGGFGCVYKGVLA--DGREVAVKQL-----------------KIGGSQGEREFRAEV 428
L +G F + L D + A+K+ KI +F+ E+
Sbjct: 38 TLNQGKFNKII---LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNEL 94
Query: 429 EIISRVHHRHLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRV------ 482
+II+ + + + ++ G + E ++YEY+ ND++ ++ +
Sbjct: 95 QIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK 154
Query: 483 KVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVS 542
+ +Y+H I HRD+K SNIL+D + +++DFG ++ + +
Sbjct: 155 CIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYM----VDKKIK 208
Query: 543 TRVMGTFGYMAPEYATSGKLT---EKSDVYSFGVVLLELITGRKPVDAS 588
GT+ +M PE S + + K D++S G+ L + P
Sbjct: 209 G-SRGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLK 255
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 5e-34
Identities = 75/308 (24%), Positives = 131/308 (42%), Gaps = 65/308 (21%)
Query: 387 NVLGEGGFGCVYKGVLADGRE--------VAVKQLKIGGSQGER-EFRAEVEIISRV-HH 436
LGEG FG V + VAVK LK ++ + + +E+E++ + H
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 437 RHLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATR--------------V 482
+++++L+G C + ++ EY L +L A P M+++ V
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 483 KVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD-----S 537
ARG+ YL + IHRD+ + N+L+ + ++ADFGLA+ +D +
Sbjct: 207 SCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 263
Query: 538 NTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESL 596
N + + +MAPE T +SDV+SFGV++ E+ T G P
Sbjct: 264 NGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY----------- 306
Query: 597 VEWARPLLAEALEHEDFEALVDS--RLEK-NYVDSEMFWMIEAAAACVRHSATKRPRMSQ 653
+ E+ L+ R++K +E++ M+ C ++RP Q
Sbjct: 307 ---------PGIPVEELFKLLKEGHRMDKPANCTNELYMMMR---DCWHAVPSQRPTFKQ 354
Query: 654 VVRALDTL 661
+V LD +
Sbjct: 355 LVEDLDRI 362
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 5e-34
Identities = 64/229 (27%), Positives = 103/229 (44%), Gaps = 39/229 (17%)
Query: 386 HNVLGEGGFGCVYKGVLAD--------GREVAVKQLKIGGSQGER-EFRAEVEIISRV-H 435
LGEG FG V +VAVK LK ++ + + +E+E++ +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 436 HRHLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATR-------------- 481
H+++++L+G C + ++ EY L +L A P ++++
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 482 VKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHV 541
V A ARG+ YL + IHRD+ + N+L+ ++ADFGLA+ +D
Sbjct: 194 VSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID----- 245
Query: 542 STRVMGTFG-----YMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKP 584
T G +MAPE T +SDV+SFGV+L E+ T G P
Sbjct: 246 -YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 7e-34
Identities = 59/258 (22%), Positives = 103/258 (39%), Gaps = 22/258 (8%)
Query: 338 RPHSPAPLVGNGSNSGFS------RSPSESGVLGNSRSWFTYDELIQATNGFSAHNVLGE 391
+ HS A L S+ + GVL + E + + + +G
Sbjct: 9 QAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGR 68
Query: 392 GGFGCVYKGV-LADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISER 450
G FG V++ G + AVK++++ + E E+ + + +V L G + E
Sbjct: 69 GSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRIVPLYG-AVREG 122
Query: 451 ERLLVY-EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIK 509
+ ++ E + +L + G + + A G+ YLH RI+H D+K
Sbjct: 123 PWVNIFMELLEGGSLGQLIKQMGC--LPEDRALYYLGQALEGLEYLHTR---RILHGDVK 177
Query: 510 SSNILLDSS-FEARVADFGLAKIALELDSNTHVSTR--VMGTFGYMAPEYATSGKLTEKS 566
+ N+LL S A + DFG A + T + GT +MAPE K
Sbjct: 178 ADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKV 237
Query: 567 DVYSFGVVLLELITGRKP 584
D++S ++L ++ G P
Sbjct: 238 DIWSSCCMMLHMLNGCHP 255
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 8e-34
Identities = 59/207 (28%), Positives = 93/207 (44%), Gaps = 14/207 (6%)
Query: 388 VLGEGGFGCVYKGV-LADGREVAVKQL---KIGGSQGEREFRAEVEIISRVHHRHLVSLV 443
LG+G FG VY + +A+K L ++ E + R E+EI S + H +++ +
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 444 GYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRI 503
Y + L+ E+ P L+ L GR + + A + Y HE ++
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKELQKHGR-FDEQRSA-TFMEELADALHYCHER---KV 135
Query: 504 IHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLT 563
IHRDIK N+L+ E ++ADFG + A L T + GT Y+ PE
Sbjct: 136 IHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRT-----MCGTLDYLPPEMIEGKTHD 190
Query: 564 EKSDVYSFGVVLLELITGRKPVDASQP 590
EK D++ GV+ E + G P D+
Sbjct: 191 EKVDLWCAGVLCYEFLVGMPPFDSPSH 217
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 9e-34
Identities = 51/234 (21%), Positives = 93/234 (39%), Gaps = 35/234 (14%)
Query: 388 VLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGERE-FRAEVEIISRVHHRHLVSLVGY 445
+LG+G V++G G A+K + E E++ +++H+++V L +
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKL--F 73
Query: 446 CISE----RERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAAR----GIAYLHE 497
I E R ++L+ E+ P +L+ L R G+ +L E
Sbjct: 74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAY---GLPESEFLIVLRDVVGGMNHLRE 130
Query: 498 DCHPRIIHRDIKSSNILLDSSFEAR----VADFGLAKIALELDSNTHVSTRVMGTFGYMA 553
+ I+HR+IK NI+ + + + DFG A+ EL+ + + GT Y+
Sbjct: 131 N---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR---ELEDDEQFVSLY-GTEEYLH 183
Query: 554 PE--------YATSGKLTEKSDVYSFGVVLLELITGRKP-VDASQPLGDESLVE 598
P+ K D++S GV TG P P ++ ++
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 9e-34
Identities = 59/227 (25%), Positives = 91/227 (40%), Gaps = 25/227 (11%)
Query: 388 VLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGEREFRAEVEIISRV-HHRHLVSLVGY 445
VL EGGF VY+ + GRE A+K+L + R EV + ++ H ++V
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 446 CISERER--------LLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHE 497
+E LL+ E + + E R + T +K+ R + ++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH- 153
Query: 498 DCHPRIIHRDIKSSNILLDSSFEARVADFGLAKI----------ALELDSNTHVSTRVMG 547
P IIHRD+K N+LL + ++ DFG A A TR
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN-T 212
Query: 548 TFGYMAPE--YATSGK-LTEKSDVYSFGVVLLELITGRKPVDASQPL 591
T Y PE S + EK D+++ G +L L + P + L
Sbjct: 213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL 259
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 60/237 (25%), Positives = 93/237 (39%), Gaps = 57/237 (24%)
Query: 387 NVLGEGGFGCVYKGVLADGRE------VAVKQLKIGGSQGER-EFRAEVEIISRV-HHRH 438
LG G FG V + + VAVK LK ER +E++++S + +H +
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 439 LVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATR----------------- 481
+V+L+G C L++ EY L L + R +
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRK-RDSFICSKTSPAIMEDDELALDLEDL 147
Query: 482 VKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHV 541
+ + A+G+A+L IHRD+ + NILL ++ DFGLA
Sbjct: 148 LSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLA------------ 192
Query: 542 STRVMGTFGY-------------MAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKP 584
R + MAPE + T +SDV+S+G+ L EL + G P
Sbjct: 193 --RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-33
Identities = 41/266 (15%), Positives = 77/266 (28%), Gaps = 29/266 (10%)
Query: 383 FSAHNVLGEGGFGCVYKGV------LADGREVAVKQLKIGGSQGEREFRAEVEIISRVHH 436
H++LGEG F VY+ + ++ +K K +E +
Sbjct: 67 VYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQ 126
Query: 437 RHLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRP---VMDWATRVKVAAGAARGIA 493
+ + + +LV E TL ++ VM + A I
Sbjct: 127 HMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIE 186
Query: 494 YLHEDCHPRIIHRDIKSSNILLDSSFEA-----------RVADFGLAKIALELDSNTHVS 542
+H+ IIH DIK N +L + F + D G + T +
Sbjct: 187 QVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFT 243
Query: 543 TRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARP 602
+ T G+ E ++ + D + + ++ G + +E
Sbjct: 244 AKC-ETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM-----KVKNEGGECKPEG 297
Query: 603 LLAEALEHEDFEALVDSRLEKNYVDS 628
L + + L
Sbjct: 298 LFRRLPHLDMWNEFFHVMLNIPDCHH 323
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 6e-33
Identities = 60/223 (26%), Positives = 102/223 (45%), Gaps = 53/223 (23%)
Query: 387 NVLGEGGFGCVYKGV-LADGREVAVKQL---KIGGSQGEREFRAEVEIISRVHHRHLVSL 442
VLG+G FG V G+E AVK + ++ + EV+++ ++ H +++ L
Sbjct: 32 RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91
Query: 443 VGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWAT------RV--------KVAAGA 488
+E D +++L V + T + AA
Sbjct: 92 YE----------FFE----DKGYFYL------VGEVYTGGELFDEIISRKRFSEVDAARI 131
Query: 489 AR----GIAYLHEDCHPRIIHRDIKSSNILLDSSFEA---RVADFGLAKIALELDSNTHV 541
R GI Y+H++ +I+HRD+K N+LL+S + R+ DFGL+ +++ +
Sbjct: 132 IRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTH---FEASKKM 185
Query: 542 STRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKP 584
++ GT Y+APE G EK DV+S GV+L L++G P
Sbjct: 186 KDKI-GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPP 226
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 6e-33
Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 20/209 (9%)
Query: 387 NVLGEGGFGCVYKGV-LADGREVAVKQL---KIGGSQGEREFRAEVEIISRVHHRHLVSL 442
LG G +G V E A+K + + S + EV ++ + H +++ L
Sbjct: 43 KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSK-LLEEVAVLKLLDHPNIMKL 101
Query: 443 VGYCISERERLLVYEYVPNDTLHYHLHAEGR-PVMDWATRVKVAAGAARGIAYLHEDCHP 501
+ +R LV E L + + +D A +K + YLH+
Sbjct: 102 YDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSG---VTYLHKH--- 155
Query: 502 RIIHRDIKSSNILLDSSFEA---RVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYAT 558
I+HRD+K N+LL+S + ++ DFGL+ + ++ + R+ GT Y+APE
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSAV---FENQKKMKERL-GTAYYIAPE-VL 210
Query: 559 SGKLTEKSDVYSFGVVLLELITGRKPVDA 587
K EK DV+S GV+L L+ G P
Sbjct: 211 RKKYDEKCDVWSIGVILFILLAGYPPFGG 239
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 8e-33
Identities = 62/244 (25%), Positives = 101/244 (41%), Gaps = 56/244 (22%)
Query: 366 NSRSWFTYDELIQATNGFSAHNVLGEGGFGCVYKGV-LADGREVAVKQL---KIGGSQGE 421
+ R + ++ +LG+G FG V K +E AVK +
Sbjct: 9 SGRENLYFQGTFAER--YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS 66
Query: 422 REFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWAT- 480
EVE++ ++ H +++ L + E D+ +++ V + T
Sbjct: 67 T-ILREVELLKKLDHPNIMKLFE----------ILE----DSSSFYI------VGELYTG 105
Query: 481 -----RV--------KVAAGAAR----GIAYLHEDCHPRIIHRDIKSSNILLDSSFEA-- 521
+ AA + GI Y+H+ I+HRD+K NILL+S +
Sbjct: 106 GELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCD 162
Query: 522 -RVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT 580
++ DFGL+ NT + R+ GT Y+APE G EK DV+S GV+L L++
Sbjct: 163 IKIIDFGLSTC---FQQNTKMKDRI-GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLS 217
Query: 581 GRKP 584
G P
Sbjct: 218 GTPP 221
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 4e-32
Identities = 69/207 (33%), Positives = 105/207 (50%), Gaps = 13/207 (6%)
Query: 383 FSAHNVLGEGGFGCVYKGVLADGREV-AVKQLK---IGGSQGEREFRAEVEIISRVHHRH 438
F + VLG+GGFG V + ++ A K+L+ I +GE E +I+ +V+ R
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245
Query: 439 LVSLVGYCISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHE 497
+VSL Y ++ L LV + L +H++ G+ A V AA G+ LH
Sbjct: 246 VVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR 304
Query: 498 DCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYA 557
+ RI++RD+K NILLD R++D GLA + + RV GT GYMAPE
Sbjct: 305 E---RIVYRDLKPENILLDDHGHIRISDLGLAV---HVPEGQTIKGRV-GTVGYMAPEVV 357
Query: 558 TSGKLTEKSDVYSFGVVLLELITGRKP 584
+ + T D ++ G +L E+I G+ P
Sbjct: 358 KNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 9e-32
Identities = 57/234 (24%), Positives = 92/234 (39%), Gaps = 63/234 (26%)
Query: 386 HNVLGEGGFGCVYKGV-LADGREVAVKQLK-------------IGGSQGEREFRAEVEII 431
LG G +G V E A+K +K + E E+ ++
Sbjct: 41 VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLL 100
Query: 432 SRVHHRHLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWAT------RV--- 482
+ H +++ L V+E D +++L V ++ ++
Sbjct: 101 KSLDHPNIIKLFD----------VFE----DKKYFYL------VTEFYEGGELFEQIINR 140
Query: 483 -----KVAAGAAR----GIAYLHEDCHPRIIHRDIKSSNILLDSSFEA---RVADFGLAK 530
AA + GI YLH+ I+HRDIK NILL++ ++ DFGL+
Sbjct: 141 HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSS 197
Query: 531 IALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKP 584
+ + R+ GT Y+APE K EK DV+S GV++ L+ G P
Sbjct: 198 F---FSKDYKLRDRL-GTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 54/206 (26%), Positives = 93/206 (45%), Gaps = 16/206 (7%)
Query: 389 LGEGGFGCVYKGV-LADGREVAVKQL---KIGGSQGEREFRAEVEIISRVHHRHLVSLVG 444
LG+GGF ++ A K + + + E+ I + H+H+V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 445 YCISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRI 503
+ + + + +V E +L LH + + + R G YLH + R+
Sbjct: 83 F-FEDNDFVFVVLELCRRRSL-LELHKRRKALTEPEAR-YYLRQIVLGCQYLHRN---RV 136
Query: 504 IHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVM-GTFGYMAPEYATSGKL 562
IHRD+K N+ L+ E ++ DFGLA +E D +V+ GT Y+APE +
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLATK-VEYDGERK---KVLCGTPNYIAPEVLSKKGH 192
Query: 563 TEKSDVYSFGVVLLELITGRKPVDAS 588
+ + DV+S G ++ L+ G+ P + S
Sbjct: 193 SFEVDVWSIGCIMYTLLVGKPPFETS 218
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 7e-31
Identities = 48/243 (19%), Positives = 83/243 (34%), Gaps = 62/243 (25%)
Query: 388 VLGEGGFGCVYKGV-LADGREVAVKQLKIG--GSQGEREFRAEVEIISRV-HHRHLVSLV 443
+G G FG V+K V DG A+K+ K GS E+ EV + + H H+V
Sbjct: 18 KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYF 77
Query: 444 GYCISERERLLVY-EYVPNDTLHYHLHAEGRP--------VMDWATRVKVAAGAARGIAY 494
+E + +L+ EY +L + R + D +V RG+ Y
Sbjct: 78 S-AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQV------GRGLRY 130
Query: 495 LHEDCHPRIIHRDIKSSNILLD-------------------SSFEARVADFGLAKIALEL 535
+H ++H DIK SNI + + ++ D G
Sbjct: 131 IHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT----R 183
Query: 536 DSNTHVSTRVMGTFGYMAPE-------YATSGKLTEKSDVYSFGVVLLELITGRKPVDAS 588
S+ V G ++A E + K+D+++ + ++
Sbjct: 184 ISSPQVEE---GDSRFLANEVLQENYTH------LPKADIFALALTVVCAAGAEPLPRNG 234
Query: 589 QPL 591
Sbjct: 235 DQW 237
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 1e-30
Identities = 62/209 (29%), Positives = 95/209 (45%), Gaps = 14/209 (6%)
Query: 383 FSAHNVLGEGGFGCVYKGVLADGREV-AVKQLK---IGGSQGEREFRAEVEIISRVHHRH 438
F VLG GGFG V+ + ++ A K+L + +G + E +I+++VH R
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 439 LVSLVGYCISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWA-TRVKV-AAGAARGIAYL 495
+VSL Y + L LV + + YH++ + R A G+ +L
Sbjct: 247 IVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHL 305
Query: 496 HEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPE 555
H+ II+RD+K N+LLD R++D GLA + T GT G+MAPE
Sbjct: 306 HQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK--GYA-GTPGFMAPE 359
Query: 556 YATSGKLTEKSDVYSFGVVLLELITGRKP 584
+ D ++ GV L E+I R P
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 1e-30
Identities = 60/249 (24%), Positives = 104/249 (41%), Gaps = 17/249 (6%)
Query: 387 NVLGEGGFGCVYKGVL-ADGREVAVKQLKIGGSQGEREF-RAEVEIISRVHHRHLVSLVG 444
+ LG G G V+K G +A K + + R E++++ + ++V G
Sbjct: 39 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 98
Query: 445 YCISERERLLVYEYVPNDTLHYHLHAEGR---PVMDWATRVKVAAGAARGIAYLHEDCHP 501
S+ E + E++ +L L GR ++ KV+ +G+ YL E
Sbjct: 99 AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL-----GKVSIAVIKGLTYLREKHK- 152
Query: 502 RIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGK 561
I+HRD+K SNIL++S E ++ DFG++ ++ +N+ V GT YM+PE
Sbjct: 153 -IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTRSYMSPERLQGTH 206
Query: 562 LTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRL 621
+ +SD++S G+ L+E+ GR P+ E + A
Sbjct: 207 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNK 266
Query: 622 EKNYVDSEM 630
M
Sbjct: 267 FGMDSRPPM 275
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-30
Identities = 58/240 (24%), Positives = 99/240 (41%), Gaps = 41/240 (17%)
Query: 387 NVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRV-HHRHLVSLVGY 445
+LG G G V GR VAVK++ I E+++++ H +++
Sbjct: 21 KILGYGSSGTVVFQGSFQGRPVAVKRMLI---DFCDIALMEIKLLTESDDHPNVIRYYCS 77
Query: 446 CISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGA-----ARGIAYLHEDCH 500
++R + E N L + ++ + + + + A G+A+LH
Sbjct: 78 ETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL-- 134
Query: 501 PRIIHRDIKSSNILLDSS-------------FEARVADFGLAKIALELDSN--THVSTRV 545
+IIHRD+K NIL+ +S ++DFGL K S+ T+++
Sbjct: 135 -KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPS 193
Query: 546 MGTFGYMAPE-------YATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVE 598
GT G+ APE T +LT D++S G V +++ K P GD+ E
Sbjct: 194 -GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH-----PFGDKYSRE 247
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 119 bits (302), Expect = 4e-30
Identities = 56/210 (26%), Positives = 92/210 (43%), Gaps = 50/210 (23%)
Query: 388 VLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYC 446
VLG G F V+ G+ A+K +K + + E+ ++ ++ H ++V+L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLED-- 73
Query: 447 ISERERLLVYEYVPNDTLHYHLHAEGRPVMDWAT------RV--------KVAAGAAR-- 490
+YE T HY+L VM + R+ K A+ +
Sbjct: 74 --------IYE----STTHYYL------VMQLVSGGELFDRILERGVYTEKDASLVIQQV 115
Query: 491 --GIAYLHEDCHPRIIHRDIKSSNILLDSSFEA---RVADFGLAKIALELDSNTHVSTRV 545
+ YLHE+ I+HRD+K N+L + E + DFGL+K+ + N +ST
Sbjct: 116 LSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM----EQNGIMSTAC 168
Query: 546 MGTFGYMAPEYATSGKLTEKSDVYSFGVVL 575
GT GY+APE ++ D +S GV+
Sbjct: 169 -GTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 7e-30
Identities = 61/250 (24%), Positives = 109/250 (43%), Gaps = 18/250 (7%)
Query: 387 NVLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGERE-FRAEVEIISR-VHHRHLVSLV 443
LG G +G V K + G+ +AVK+++ + E++ +++I R V V+
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFY 72
Query: 444 GYCISERERLLVYEYVP--NDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHP 501
G E + + E + D + + +G+ + K+A + + +LH
Sbjct: 73 GALFREGDVWICMELMDTSLDKFYKQVIDKGQTI-PEDILGKIAVSIVKALEHLHSKLS- 130
Query: 502 RIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPE----YA 557
+IHRD+K SN+L+++ + ++ DFG I+ L + G YMAPE
Sbjct: 131 -VIHRDVKPSNVLINALGQVKMCDFG---ISGYL-VDDVAKDIDAGCKPYMAPERINPEL 185
Query: 558 TSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGD--ESLVEWARPLLAEALEHEDFEA 615
+ KSD++S G+ ++EL R P D+ + +VE P L +F
Sbjct: 186 NQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVD 245
Query: 616 LVDSRLEKNY 625
L+KN
Sbjct: 246 FTSQCLKKNS 255
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 9e-30
Identities = 51/276 (18%), Positives = 92/276 (33%), Gaps = 36/276 (13%)
Query: 388 VLGEGGFGCVYKGV--LADGREVAVKQLKIGGSQGERE-FRAEVEIISRVHHRHLVSL-- 442
+ GG G +Y + +GR V +K L G + AE + ++ V H +V +
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 443 VGYCISERERLLVY---EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDC 499
+ Y EYV +L + + A + ++YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK----LPVAEAIAYLLEILPALSYLHSI- 201
Query: 500 HPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATS 559
+++ D+K NI+L + ++ D G + GT G+ APE
Sbjct: 202 --GLVYNDLKPENIMLTEE-QLKLIDLGAVSRI------NSFGY-LYGTPGFQAPEIVR- 250
Query: 560 GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDS 619
T +D+Y+ G L L + V+ ++ + L+
Sbjct: 251 TGPTVATDIYTVGRTLAALTLDLPTRNG-------RYVDGLPEDDPVLKTYDSYGRLLRR 303
Query: 620 RLEKNYVD-----SEMFWMIEAAAACVRHSATKRPR 650
++ + EM + V T PR
Sbjct: 304 AIDPDPRQRFTTAEEMSAQLTGVLREVVAQDTGVPR 339
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 6e-07
Identities = 12/115 (10%), Positives = 20/115 (17%), Gaps = 3/115 (2%)
Query: 9 AVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQP 68
VL P P T P+ + +
Sbjct: 325 GVLREVVAQDTGVPRPG---LSTIFSPSRSTFGVDLLVAHTDVYLDGQVHAEKLTANEIV 381
Query: 69 SSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVP 123
++ PL P + P Q + +P
Sbjct: 382 TALSVPLVDPTDVAASVLQATVLSQPVQTLDSLRAARHGALDADGVDFSESVELP 436
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 21/120 (17%), Positives = 29/120 (24%), Gaps = 6/120 (5%)
Query: 19 PLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAP 78
+ + P P SP S T + + + A
Sbjct: 329 EVVAQDTGVPRPGLSTIFSPSRSTFGVDLLVAHTDVYLDGQ----VHAEKLTANEIVTAL 384
Query: 79 PPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRT 138
P VDP+ A QA S P + A+ S P VR
Sbjct: 385 SVPLVDPTD--VAASVLQATVLSQPVQTLDSLRAARHGALDADGVDFSESVELPLMEVRA 442
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 7e-05
Identities = 19/158 (12%), Positives = 35/158 (22%), Gaps = 13/158 (8%)
Query: 9 AVLAVPPPSPPLSPPPSTTP---PPTSPPPASPPPS---------PPTSTPPSPPTAPPP 56
V +P P L S P P + + T P
Sbjct: 280 YVDGLPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREVVAQDTGVPR 339
Query: 57 SSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSS 116
+ P + + L A +D + + + P PT ++S
Sbjct: 340 PGLSTIFSPSRSTFGVDLLVAHTDVYLDGQVHAEK-LTANEIVTALSVPLVDPTDVAASV 398
Query: 117 PPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATP 154
+ + A + + P
Sbjct: 399 LQATVLSQPVQTLDSLRAARHGALDADGVDFSESVELP 436
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 9/105 (8%), Positives = 18/105 (17%), Gaps = 3/105 (2%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
P L+ + T + + S P
Sbjct: 332 AQDTGVPRPGLSTIFSPSRSTFGVDLLVAHTDVYLDGQVHAEK---LTANEIVTALSVPL 388
Query: 61 VNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPP 105
V+ S + + P +D +
Sbjct: 389 VDPTDVAASVLQATVLSQPVQTLDSLRAARHGALDADGVDFSESV 433
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 54/205 (26%), Positives = 90/205 (43%), Gaps = 14/205 (6%)
Query: 389 LGEGGFGCVYKGV-LADGREVAVKQL---KIGGSQGEREFRAEVEIISRVHHRHLVSLVG 444
LG+GGF ++ A K + + + E+ I + H+H+V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 445 YCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRII 504
+ +V E +L LH + + + R G YLH + R+I
Sbjct: 109 FFEDNDFVFVVLELCRRRSL-LELHKRRKALTEPEAR-YYLRQIVLGCQYLHRN---RVI 163
Query: 505 HRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVM-GTFGYMAPEYATSGKLT 563
HRD+K N+ L+ E ++ DFGLA +E D +V+ GT Y+APE + +
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATK-VEYDGERK---KVLCGTPNYIAPEVLSKKGHS 219
Query: 564 EKSDVYSFGVVLLELITGRKPVDAS 588
+ DV+S G ++ L+ G+ P + S
Sbjct: 220 FEVDVWSIGCIMYTLLVGKPPFETS 244
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 1e-29
Identities = 65/212 (30%), Positives = 97/212 (45%), Gaps = 22/212 (10%)
Query: 383 FSAHNVLGEGGFGCVYKG-VLADGREVAVKQLK---IGGSQGEREFRAEVEIISRVH--- 435
FS H ++G GGFG VY G+ A+K L I QGE E ++S V
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 436 HRHLVSLVGYCISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKV-AAGAARGIA 493
+V + Y ++L + + + LHYHL G ++ AA G+
Sbjct: 251 CPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA---DMRFYAAEIILGLE 306
Query: 494 YLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMA 553
++H +++RD+K +NILLD R++D GLA + + V GT GYMA
Sbjct: 307 HMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-----GTHGYMA 358
Query: 554 PEYATSGKLTEKS-DVYSFGVVLLELITGRKP 584
PE G + S D +S G +L +L+ G P
Sbjct: 359 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 69/253 (27%), Positives = 114/253 (45%), Gaps = 22/253 (8%)
Query: 388 VLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGERE-FRAEVEIISR-VHHRHLVSLVG 444
+G G +G V K V G+ +AVK+++ + E++ +++++ R ++V G
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 445 YCISERERLLVYEYVP---NDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHP 501
E + + E + + Y + + K+ + + +L E+
Sbjct: 89 ALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILG-KITLATVKALNHLKENLK- 146
Query: 502 RIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPE----YA 557
IIHRDIK SNILLD S ++ DFG I+ +L ++ TR G YMAPE A
Sbjct: 147 -IIHRDIKPSNILLDRSGNIKLCDFG---ISGQL-VDSIAKTRDAGCRPYMAPERIDPSA 201
Query: 558 TSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGD--ESLVEWARPLLAEALEH---ED 612
+ +SDV+S G+ L EL TGR P + D +V+ P L+ + E
Sbjct: 202 SRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPS 261
Query: 613 FEALVDSRLEKNY 625
F V+ L K+
Sbjct: 262 FINFVNLCLTKDE 274
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-29
Identities = 50/269 (18%), Positives = 88/269 (32%), Gaps = 84/269 (31%)
Query: 388 VLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGE-----REFRAEVEI----ISRVHHR 437
+G GGFG V++ D A+K++++ + RE +A ++ I R +
Sbjct: 13 CMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 72
Query: 438 HLVS----------------------------------------------LVGYCISERE 451
L + VG
Sbjct: 73 WLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSP 132
Query: 452 RLLVY---EYVPNDTLH-------YHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHP 501
++ +Y + + L E + ++ A + +LH
Sbjct: 133 KVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQI------AEAVEFLHSK--- 183
Query: 502 RIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVS---------TRVMGTFGYM 552
++HRD+K SNI +V DFGL + + V T +GT YM
Sbjct: 184 GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243
Query: 553 APEYATSGKLTEKSDVYSFGVVLLELITG 581
+PE + K D++S G++L EL+
Sbjct: 244 SPEQIHGNNYSHKVDIFSLGLILFELLYS 272
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 57/250 (22%), Positives = 109/250 (43%), Gaps = 29/250 (11%)
Query: 347 GNGSNSGFSRSPSESGVLGNSRSWFTYDELIQATN---GFSAHNVLGEGGFGCVYKGV-L 402
+G + G +SGV+ + + ++ + ++ +GEG G V
Sbjct: 8 SSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREK 67
Query: 403 ADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPND 462
GR+VAVK + + Q EV I+ H ++V + + E ++ E++
Sbjct: 68 HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFL--- 124
Query: 463 TLHYHLHAEGRPVMDWATRVK--------VAAGAARGIAYLHEDCHPRIIHRDIKSSNIL 514
+G + D ++V+ V + +AYLH +IHRDIKS +IL
Sbjct: 125 --------QGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSIL 173
Query: 515 LDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVV 574
L +++DFG ++ + ++GT +MAPE + + D++S G++
Sbjct: 174 LTLDGRVKLSDFGFCA---QISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIM 230
Query: 575 LLELITGRKP 584
++E++ G P
Sbjct: 231 VIEMVDGEPP 240
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 52/211 (24%), Positives = 96/211 (45%), Gaps = 26/211 (12%)
Query: 383 FSAHNVLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVS 441
++ +G+G G VY + +A G+EVA++Q+ + + E+ ++ + ++V+
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 442 LVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVK--------VAAGAARGIA 493
+ + E +V EY+ G + D T V + +
Sbjct: 82 YLDSYLVGDELWVVMEYL-----------AGGSLTDVVTETCMDEGQIAAVCRECLQALE 130
Query: 494 YLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMA 553
+LH + ++IHRDIKS NILL ++ DFG ++ + ++GT +MA
Sbjct: 131 FLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA---QITPEQSKRSTMVGTPYWMA 184
Query: 554 PEYATSGKLTEKSDVYSFGVVLLELITGRKP 584
PE T K D++S G++ +E+I G P
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 60/245 (24%), Positives = 97/245 (39%), Gaps = 57/245 (23%)
Query: 367 SRSWFTYDELIQATNGFSAHNVLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGERE-F 424
R + I F LG G FG V+ + G E +K + SQ E
Sbjct: 10 GRENLYFQGTIDDL--FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQI 67
Query: 425 RAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWAT---- 480
AE+E++ + H +++ + V+E D + ++ VM+
Sbjct: 68 EAEIEVLKSLDHPNIIKIFE----------VFE----DYHNMYI------VMETCEGGEL 107
Query: 481 --RV------------KVAAGAAR----GIAYLHEDCHPRIIHRDIKSSNILLDSSFEA- 521
R+ A + +AY H ++H+D+K NIL +
Sbjct: 108 LERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHS 164
Query: 522 --RVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELI 579
++ DFGLA++ S+ H + GT YMAPE +T K D++S GVV+ L+
Sbjct: 165 PIKIIDFGLAEL---FKSDEHSTNAA-GTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLL 219
Query: 580 TGRKP 584
TG P
Sbjct: 220 TGCLP 224
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 61/222 (27%), Positives = 96/222 (43%), Gaps = 54/222 (24%)
Query: 388 VLGEGGFGCVYKGV-LADGREVAVKQL---KIGGSQGEREFRAEVEIISRVHHRHLVSLV 443
+LG+G FG V K +E AVK + EVE++ ++ H +++ L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST-ILREVELLKKLDHPNIMKLF 87
Query: 444 GYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWAT------RV--------KVAAGAA 489
+ E D+ +++ V + T + AA
Sbjct: 88 E----------ILE----DSSSFYI------VGELYTGGELFDEIIKRKRFSEHDAARII 127
Query: 490 R----GIAYLHEDCHPRIIHRDIKSSNILLDSSFEA---RVADFGLAKIALELDSNTHVS 542
+ GI Y+H+ I+HRD+K NILL+S + ++ DFGL+ NT +
Sbjct: 128 KQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC---FQQNTKMK 181
Query: 543 TRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKP 584
R+ GT Y+APE G EK DV+S GV+L L++G P
Sbjct: 182 DRI-GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 2e-28
Identities = 26/244 (10%), Positives = 48/244 (19%), Gaps = 45/244 (18%)
Query: 388 VLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGERE---FRAEVEIISRVHHRHLVSLV 443
L G V+ + + A+K +G E +R+
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 444 GYC--------------------------ISERERLLVYEYVPNDTL----HYHLHAEGR 473
+ LL+ D R
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 474 PVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIAL 533
+ A R A L ++H N+ + + D
Sbjct: 189 GDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALW--- 242
Query: 534 ELDSNTHVSTRVMGTFGYMAPEYATSGKL--TEKSDVYSFGVVLLELITGRKPVDASQPL 591
Y E+ + T + + G+ + + P P
Sbjct: 243 ---KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPG 299
Query: 592 GDES 595
S
Sbjct: 300 IKGS 303
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 52/247 (21%), Positives = 86/247 (34%), Gaps = 54/247 (21%)
Query: 388 VLGEGGFGCVYKGV-LADGREVAVK-----QLKIGGSQGEREFRAEVEIISRVHHRHLVS 441
+G+G +G V + A+K +++ + + EV ++ ++HH ++
Sbjct: 33 AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92
Query: 442 LVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRV------------------- 482
L E+ LV E L L+
Sbjct: 93 LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152
Query: 483 ---------------KVAAGAAR----GIAYLHEDCHPRIIHRDIKSSNILLDSSFEARV 523
K+ + R + YLH I HRDIK N L ++ +
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEI 209
Query: 524 --ADFGLAKI--ALELDSNTHVSTRVMGTFGYMAPE--YATSGKLTEKSDVYSFGVVLLE 577
DFGL+K L ++T+ GT ++APE T+ K D +S GV+L
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHL 268
Query: 578 LITGRKP 584
L+ G P
Sbjct: 269 LLMGAVP 275
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 5e-28
Identities = 51/221 (23%), Positives = 86/221 (38%), Gaps = 43/221 (19%)
Query: 388 VLGEGGFGCVYKGV-LADGREVAVKQL---KIGGSQGERE-----FRAEVEIISRVHHRH 438
LG G G V ++VA++ + K E+EI+ +++H
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 439 LVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDW-ATRVKVAAGAAR------- 490
++ + + + +V E + L D ++ +
Sbjct: 202 IIKIKNF-FDAEDYYIVLELMEGGEL-----------FDKVVGNKRLKEATCKLYFYQML 249
Query: 491 -GIAYLHEDCHPRIIHRDIKSSNILLDSSFEA---RVADFGLAKIALELDSNTHVSTRVM 546
+ YLHE+ IIHRD+K N+LL S E ++ DFG +KI L + + T
Sbjct: 250 LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLC- 302
Query: 547 GTFGYMAPE---YATSGKLTEKSDVYSFGVVLLELITGRKP 584
GT Y+APE + D +S GV+L ++G P
Sbjct: 303 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-28
Identities = 52/209 (24%), Positives = 92/209 (44%), Gaps = 19/209 (9%)
Query: 383 FSAHNVLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVS 441
+ LG G FG V++ V A GR K + + + E+ I++++HH L++
Sbjct: 53 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 112
Query: 442 LVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAAR----GIAYLHE 497
L + E +L+ E++ L + AE + + R G+ ++HE
Sbjct: 113 LHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSE-----AEVINYMRQACEGLKHMHE 167
Query: 498 DCHPRIIHRDIKSSNILLDSSFEARV--ADFGLAKIALELDSNTHVSTRVMGTFGYMAPE 555
I+H DIK NI+ ++ + V DFGLA L+ + V T + APE
Sbjct: 168 H---SIVHLDIKPENIMCETKKASSVKIIDFGLATK---LNPDEIVKVTT-ATAEFAAPE 220
Query: 556 YATSGKLTEKSDVYSFGVVLLELITGRKP 584
+ +D+++ GV+ L++G P
Sbjct: 221 IVDREPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 8e-28
Identities = 56/211 (26%), Positives = 100/211 (47%), Gaps = 25/211 (11%)
Query: 383 FSAHNVLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGERE-FRAEVEIISRVHHRHLV 440
F+ +G+G FG V+KG+ + VA+K + + ++ E E + E+ ++S+ ++
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 441 SLVGYCISERERLLVYEYVP----NDTLHYHLHAEGRPVMDWATRVKVAA---GAARGIA 493
G + + + ++ EY+ D L E ++A +G+
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDET----------QIATILREILKGLD 133
Query: 494 YLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMA 553
YLH + + IHRDIK++N+LL E ++ADFG+A +L +GT +MA
Sbjct: 134 YLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAG---QLTDTQIKRNTFVGTPFWMA 187
Query: 554 PEYATSGKLTEKSDVYSFGVVLLELITGRKP 584
PE K+D++S G+ +EL G P
Sbjct: 188 PEVIKQSAYDSKADIWSLGITAIELARGEPP 218
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-27
Identities = 45/212 (21%), Positives = 82/212 (38%), Gaps = 50/212 (23%)
Query: 388 VLGEGGFGCVYKGV-LADGREVAVKQL-KIGGSQGERE-FRAEVEIISRVHHRHLVSLVG 444
LG+G F V + V + G+E A + S + + E I + H ++V L
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77
Query: 445 YCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWAT------RV--------KVAAGAAR 490
+ H++L + D T + A+ +
Sbjct: 78 ----------SIS----EEGHHYL------IFDLVTGGELFEDIVAREYYSEADASHCIQ 117
Query: 491 ----GIAYLHEDCHPRIIHRDIKSSNILLDSSFEA---RVADFGLAKIALELDSNTHVST 543
+ + H+ ++HR++K N+LL S + ++ADFGLA E++
Sbjct: 118 QILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAI---EVEGEQQAWF 171
Query: 544 RVMGTFGYMAPEYATSGKLTEKSDVYSFGVVL 575
GT GY++PE + D+++ GV+L
Sbjct: 172 GFAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 38/297 (12%), Positives = 81/297 (27%), Gaps = 78/297 (26%)
Query: 388 VLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGERE----------------------- 423
VLG+ + G V
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 424 -----FRAEVEIISRVHHRHLVSLVGYC--ISERERLLVYEYVPNDTLHY----HLHAEG 472
F +++ + ++ + + R +Y + ++ + H+
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 473 RPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIA 532
+ R+++ R +A LH H ++H ++ +I+LD + F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256
Query: 533 LELDSNTHVSTRVMGTFGYMAPEY-----------ATSGKLTEKSDVYSFGVVLLELITG 581
+ G+ PE +T D ++ G+V+ +
Sbjct: 257 -------GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309
Query: 582 RKPVDASQPLGD---------------ESLVEW-------ARPLLAEALEHEDFEAL 616
P+ LG +L+E R L +A+E ++E L
Sbjct: 310 DLPITKDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 366
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-27
Identities = 67/262 (25%), Positives = 109/262 (41%), Gaps = 52/262 (19%)
Query: 346 VGNGSNSGFSRSPSESGVLGNSRSWFTYDELIQATNGFSAHNVLGEGGFGCVYKGVLADG 405
+ N +G +P + Q ++ V+G G FG V++ L +
Sbjct: 5 MSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVES 64
Query: 406 REVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERL------LVYEYV 459
EVA+K++ + R E++I+ V H ++V L + S ++ LV EYV
Sbjct: 65 DEVAIKKVLQ---DKRFKNR-ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV 120
Query: 460 PNDTLHYHLHAEGRPVMDWATRVKVAAGAA----------RGIAYLHEDCHPRIIHRDIK 509
P +T++ ++K R +AY+H I HRDIK
Sbjct: 121 P-ETVY--------RASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIK 168
Query: 510 SSNILLDS-SFEARVADFGLAKIALELDSNTH-VSTRVMGTFGYMAPE-------YATSG 560
N+LLD S ++ DFG AKI + + N + +R Y APE Y T+
Sbjct: 169 PQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY-----YRAPELIFGATNYTTN- 222
Query: 561 KLTEKSDVYSFGVVLLELITGR 582
D++S G V+ EL+ G+
Sbjct: 223 -----IDIWSTGCVMAELMQGQ 239
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 58/203 (28%), Positives = 96/203 (47%), Gaps = 10/203 (4%)
Query: 383 FSAHNVLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVS 441
F LGEG +G VYK + G+ VA+KQ+ + +E E+ I+ + H+V
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV--ESDLQEIIKEISIMQQCDSPHVVK 88
Query: 442 LVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHP 501
G + +V EY ++ + + + + + +G+ YLH
Sbjct: 89 YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIAT-ILQSTLKGLEYLHFM--- 144
Query: 502 RIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGK 561
R IHRDIK+ NILL++ A++ADFG+A +L V+GT +MAPE
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVAG---QLTDTMAKRNTVIGTPFWMAPEVIQEIG 201
Query: 562 LTEKSDVYSFGVVLLELITGRKP 584
+D++S G+ +E+ G+ P
Sbjct: 202 YNCVADIWSLGITAIEMAEGKPP 224
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 3e-27
Identities = 40/206 (19%), Positives = 85/206 (41%), Gaps = 20/206 (9%)
Query: 386 HNVLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVG 444
LG G FG V++ V + + K +K+ G+ + E+ I++ HR+++ L
Sbjct: 10 AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV-LVKKEISILNIARHRNILHLHE 68
Query: 445 YCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAAR----GIAYLHEDCH 500
S E ++++E++ + ++ + + + + +LH
Sbjct: 69 SFESMEELVMIFEFISGLDIFERINTSAFELNE-----REIVSYVHQVCEALQFLHSH-- 121
Query: 501 PRIIHRDIKSSNILLDSSFEARV--ADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYAT 558
I H DI+ NI+ + + + +FG A+ L + Y APE
Sbjct: 122 -NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ---LKPGDNFRLLF-TAPEYYAPEVHQ 176
Query: 559 SGKLTEKSDVYSFGVVLLELITGRKP 584
++ +D++S G ++ L++G P
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 64/250 (25%), Positives = 112/250 (44%), Gaps = 21/250 (8%)
Query: 388 VLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGERE-FRAEVEIISR-VHHRHLVSLVG 444
+G G G V+K G +AVKQ++ G++ E + +++++ + ++V G
Sbjct: 32 EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91
Query: 445 YCISERERLLVYEYVPNDT-LHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRI 503
I+ + + E + T P+ + K+ + + YL E +
Sbjct: 92 TFITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILG-KMTVAIVKALYYLKEKHG--V 146
Query: 504 IHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPE-----YAT 558
IHRD+K SNILLD + ++ DFG I+ L + R G YMAPE T
Sbjct: 147 IHRDVKPSNILLDERGQIKLCDFG---ISGRL-VDDKAKDRSAGCAAYMAPERIDPPDPT 202
Query: 559 SGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGD--ESLVEWARPLLAEALEH-EDFEA 615
++DV+S G+ L+EL TG+ P + + +++ PLL + DF++
Sbjct: 203 KPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQS 262
Query: 616 LVDSRLEKNY 625
V L K++
Sbjct: 263 FVKDCLTKDH 272
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 51/219 (23%), Positives = 84/219 (38%), Gaps = 50/219 (22%)
Query: 388 VLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYC 446
+G G +G V V A K++ + F+ E+EI+ + H +++ L
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYE-- 73
Query: 447 ISERERLLVYEYVPNDTLHYHLHAEGRPVMDWAT------RV--------KVAAGAAR-- 490
+E D +L VM+ T RV AA +
Sbjct: 74 --------TFE----DNTDIYL------VMELCTGGELFERVVHKRVFRESDAARIMKDV 115
Query: 491 --GIAYLHEDCHPRIIHRDIKSSNILLDSSFEA---RVADFGLAKIALELDSNTHVSTRV 545
+AY H+ + HRD+K N L + ++ DFGLA + T+V
Sbjct: 116 LSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR---FKPGKMMRTKV 169
Query: 546 MGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKP 584
GT Y++P+ G + D +S GV++ L+ G P
Sbjct: 170 -GTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCGYPP 206
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 55/210 (26%), Positives = 99/210 (47%), Gaps = 17/210 (8%)
Query: 383 FSAHNVLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVS 441
+ LG+G FG VYK G A K ++ + ++ E+EI++ H ++V
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 442 LVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHP 501
L+G + + ++ E+ P + + R + + +V V + +LH
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-VCRQMLEALNFLHSK--- 136
Query: 502 RIIHRDIKSSNILLDSSFEARVADFGL-AKIALELD-SNTHVSTRVMGTFGYMAPEYATS 559
RIIHRD+K+ N+L+ + R+ADFG+ AK L ++ + GT +MAPE
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-----GTPYWMAPEVVMC 191
Query: 560 GKLTE-----KSDVYSFGVVLLELITGRKP 584
+ + K+D++S G+ L+E+ P
Sbjct: 192 ETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-27
Identities = 62/284 (21%), Positives = 115/284 (40%), Gaps = 64/284 (22%)
Query: 325 PYASSQKSDSVFLRPHSPAPLVGNGSNSGFSRSPSESGVLGNSRSWFT--YDELIQATNG 382
++S + L S + + + + S P + G++R + ++
Sbjct: 6 HHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYW-IDGSNRDALSDFFE-------- 56
Query: 383 FSAHNVLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVS 441
+ LG G VY+ + A+K LK + ++ R E+ ++ R+ H +++
Sbjct: 57 --VESELGRGATSIVYRCKQKGTQKPYALKVLKK--TVDKKIVRTEIGVLLRLSHPNIIK 112
Query: 442 LVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWAT------RV--------KVAAG 487
L ++E L V++ T R+ + AA
Sbjct: 113 LKE----------IFE----TPTEISL------VLELVTGGELFDRIVEKGYYSERDAAD 152
Query: 488 AAR----GIAYLHEDCHPRIIHRDIKSSNILLDSSFEA---RVADFGLAKIALELDSNTH 540
A + +AYLHE+ I+HRD+K N+L + ++ADFGL+KI ++
Sbjct: 153 AVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKI---VEHQVL 206
Query: 541 VSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKP 584
+ T GT GY APE + D++S G++ L+ G +P
Sbjct: 207 MKTVC-GTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEP 249
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 4e-27
Identities = 62/218 (28%), Positives = 99/218 (45%), Gaps = 41/218 (18%)
Query: 389 LGEGGFGCVYKGV-LADGREVAVKQL---KIGGSQGEREFRAEVEIISRVHHRHLVSLVG 444
+G+G F V + GREVA+K + ++ + ++ FR EV I+ ++H ++V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKLFE 81
Query: 445 YCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAAR--------GIAYLH 496
+E+ L+ EY + +L A GR + AR + Y H
Sbjct: 82 VIETEKTLYLIMEYASGGEVFDYLVAHGR----------MKEKEARSKFRQIVSAVQYCH 131
Query: 497 EDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTF----GYM 552
+ I+HRD+K+ N+LLD+ ++ADFG SN + F Y
Sbjct: 132 QKR---IVHRDLKAENLLLDADMNIKIADFGF--------SNEFTVGGKLDAFCGAPPYA 180
Query: 553 APEYATSGKLTE--KSDVYSFGVVLLELITGRKPVDAS 588
APE GK + + DV+S GV+L L++G P D
Sbjct: 181 APE-LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ 217
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 5e-27
Identities = 58/246 (23%), Positives = 104/246 (42%), Gaps = 23/246 (9%)
Query: 357 SPSESGVLGNSRSWFTYDELIQATNGFSAHNVLGEGGFGCVYKGV-LADGREVAVK---- 411
SP SG G D+ + + + V+G+G F V + + G++ AVK
Sbjct: 2 SPGISG--GGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDV 59
Query: 412 -QLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPNDTLHYHLHA 470
+ + + E I + H H+V L+ S+ +V+E++ L + +
Sbjct: 60 AKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVK 119
Query: 471 EGRPVMDWATRVKVAAGAAR----GIAYLHEDCHPRIIHRDIKSSNILLDSSFEA---RV 523
++ VA+ R + Y H++ IIHRD+K +LL S + ++
Sbjct: 120 RADAGFVYSEA--VASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKL 174
Query: 524 ADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRK 583
FG+A L + V+ +GT +MAPE + DV+ GV+L L++G
Sbjct: 175 GGFGVAIQ---LGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCL 231
Query: 584 PVDASQ 589
P ++
Sbjct: 232 PFYGTK 237
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-27
Identities = 59/212 (27%), Positives = 92/212 (43%), Gaps = 22/212 (10%)
Query: 383 FSAHNVLGEGGFGCVYKGVLA----DGREVAVKQLK----IGGSQGEREFRAEVEIISRV 434
F +LGEG F V LA RE A+K L+ I ++ E +++SR+
Sbjct: 32 FKFGKILGEGSFSTVV---LARELATSREYAIKILEKRHIIKENKVPY-VTRERDVMSRL 87
Query: 435 HHRHLVSLVGYCISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKV-AAGAARGI 492
H V L + + E+L Y N L ++ G + A +
Sbjct: 88 DHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET---CTRFYTAEIVSAL 143
Query: 493 AYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYM 552
YLH IIHRD+K NILL+ ++ DFG AK+ ++ V GT Y+
Sbjct: 144 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-GTAQYV 199
Query: 553 APEYATSGKLTEKSDVYSFGVVLLELITGRKP 584
+PE T + SD+++ G ++ +L+ G P
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 7e-27
Identities = 54/214 (25%), Positives = 86/214 (40%), Gaps = 28/214 (13%)
Query: 386 HNVLGEGGFGCVYKGV-LADGREVAVK-----QLKIGGSQGERE-FRAEVEIISRVHHRH 438
LG G F V K + G E A K Q + RE EV I+ +V H +
Sbjct: 17 GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 439 LVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAAR----GIAY 494
+++L + + +L+ E V L L + + A + G+ Y
Sbjct: 77 VITLHDVYENRTDVVLILELVSGGELFDFLAQKESL------SEEEATSFIKQILDGVNY 130
Query: 495 LHEDCHPRIIHRDIKSSNILLDSSFEA----RVADFGLAKIALELDSNTHVSTRVMGTFG 550
LH +I H D+K NI+L ++ DFGLA ++ GT
Sbjct: 131 LHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE---IEDGVEFKNIF-GTPE 183
Query: 551 YMAPEYATSGKLTEKSDVYSFGVVLLELITGRKP 584
++APE L ++D++S GV+ L++G P
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 8e-27
Identities = 54/209 (25%), Positives = 97/209 (46%), Gaps = 19/209 (9%)
Query: 383 FSAHNVLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVS 441
S +LG G FG V+K A G ++A K +K G + + E + E+ +++++ H +L+
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 442 LVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAAR----GIAYLHE 497
L S+ + +LV EYV L + E + + + GI ++H+
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELD-----TILFMKQICEGIRHMHQ 205
Query: 498 DCHPRIIHRDIKSSNILLDSSFEARV--ADFGLAKIALELDSNTHVSTRVMGTFGYMAPE 555
I+H D+K NIL + ++ DFGLA+ + GT ++APE
Sbjct: 206 M---YILHLDLKPENILCVNRDAKQIKIIDFGLARR---YKPREKLKVNF-GTPEFLAPE 258
Query: 556 YATSGKLTEKSDVYSFGVVLLELITGRKP 584
++ +D++S GV+ L++G P
Sbjct: 259 VVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 49/213 (23%), Positives = 85/213 (39%), Gaps = 53/213 (24%)
Query: 388 VLGEGGFGCVYKGV-LADGREVAVKQL---KIGGSQGEREFRAEVEIISRVHHRHLVSLV 443
LG+G F V + V G E A K + K+ ++ E I ++ H ++V L
Sbjct: 13 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-LEREARICRKLQHPNIVRLH 71
Query: 444 GYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWAT------RV--------KVAAGAA 489
+ + ++L V D T + A+
Sbjct: 72 D----------SIQ----EESFHYL------VFDLVTGGELFEDIVAREFYSEADASHCI 111
Query: 490 R----GIAYLHEDCHPRIIHRDIKSSNILLDSSFEA---RVADFGLAKIALELDSNTHVS 542
+ IAY H + I+HR++K N+LL S + ++ADFGLA ++ +
Sbjct: 112 QQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE---VNDSEAWH 165
Query: 543 TRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVL 575
GT GY++PE ++ D+++ GV+L
Sbjct: 166 GFA-GTPGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 52/228 (22%), Positives = 84/228 (36%), Gaps = 56/228 (24%)
Query: 386 HNVLGEGGFGCVYKGV-LADGREVAVK-----QLKIGGSQGERE-FRAEVEIISRVHHRH 438
LG G F V K + G + A K + K RE EV I+ + H +
Sbjct: 16 GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 439 LVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWAT------RV--------KV 484
+++L VYE + L +++ + +
Sbjct: 76 VITLHE----------VYE----NKTDVIL------ILELVAGGELFDFLAEKESLTEEE 115
Query: 485 AAGAAR----GIAYLHEDCHPRIIHRDIKSSNILLDSSFEA----RVADFGLAKIALELD 536
A + G+ YLH +I H D+K NI+L ++ DFGLA +D
Sbjct: 116 ATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---ID 169
Query: 537 SNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKP 584
GT ++APE L ++D++S GV+ L++G P
Sbjct: 170 FGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 54/214 (25%), Positives = 87/214 (40%), Gaps = 28/214 (13%)
Query: 386 HNVLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGER------EFRAEVEIISRVHHRH 438
LG G F V K G+E A K +K R E EV I+ + H +
Sbjct: 10 GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPN 69
Query: 439 LVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAAR----GIAY 494
+++L ++ + +L+ E V L L + T A + G+ Y
Sbjct: 70 IITLHDIFENKTDVVLILELVSGGELFDFLAEKESL-----TE-DEATQFLKQILDGVHY 123
Query: 495 LHEDCHPRIIHRDIKSSNILLDSSFEA----RVADFGLAKIALELDSNTHVSTRVMGTFG 550
LH RI H D+K NI+L ++ DFG+A +++ GT
Sbjct: 124 LHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK---IEAGNEFKNIF-GTPE 176
Query: 551 YMAPEYATSGKLTEKSDVYSFGVVLLELITGRKP 584
++APE L ++D++S GV+ L++G P
Sbjct: 177 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 4e-26
Identities = 72/282 (25%), Positives = 101/282 (35%), Gaps = 11/282 (3%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
P + + +P + P + + + A
Sbjct: 1455 PEQKITEIEDGQDGGVTPYSNESGLVNADLDVKDELMFSPLVDSGSNDAMAGGFTAYGGA 1514
Query: 61 VNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPP--PQAVAPSPPPPANVPTTPSSSSPP 118
P P V SP P P + A SP P+ PT+PS S
Sbjct: 1515 DYGEATSPFGAYGEAPTSPGFGVSSPGFSPTSPTYSPTSPAYSPTSPSYSPTSPSYSPTS 1574
Query: 119 PANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSS-SPPPPS 177
P+ PT+PS S P+ T+PS S P+ P +PS S P PT PS S + P S
Sbjct: 1575 PSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYS 1634
Query: 178 SNPPTSTPSPPVLTP-PPHPSQSAPPPVTKSPPASTLSPP-PPSVPSTSSPPAVSPPAPP 235
P+ +P+ P +P P S ++P SP S SP P+ PS S P P
Sbjct: 1635 PTSPSYSPTSPSYSPTSPSYSPTSPAYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSP 1694
Query: 236 --SNSSTRGSPSTPPL-PSVPTEKPTAKSTNGTAVSANASPR 274
S +S SP++P P P P + N + R
Sbjct: 1695 NYSPTSPSYSPTSPGYSPGSPAYSPKQDEQKH---NENENSR 1733
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-25
Identities = 66/274 (24%), Positives = 99/274 (36%), Gaps = 12/274 (4%)
Query: 9 AVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQP 68
+ TP + SP +
Sbjct: 1453 YMPEQKITEIEDGQDGGVTPYSNESGLVNADLDVKDELMFSPLVDSGSNDAMAGGFTAYG 1512
Query: 69 SSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSS 128
+ P +P SP + SP P PT+P+ S P+ PT+PS
Sbjct: 1513 GADYGEA-TSPFGAYGEAPTSPG-FGVSSPGFSPTSPTYSPTSPAYSPTSPSYSPTSPSY 1570
Query: 129 SSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPP 188
S P+ T+PS S P+ P +PS S P PT PS S P PS +P + + SP
Sbjct: 1571 SPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYS-PTSPSYSPTSPSYSPT 1629
Query: 189 VLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTS-----SPPAVSPPAPPSNSSTRGS 243
+ P +P + SP + + SP P+ TS + P+ SP +P + ++
Sbjct: 1630 SPSYSPTSPSYSPTSPSYSPTSPSYSPTSPAYSPTSPSYSPTSPSYSPTSPSYSPTSPSY 1689
Query: 244 PSTPPL--PSVPTEKPTAKSTNGTAVSANASPRN 275
T P P+ P+ PT S + S SP+
Sbjct: 1690 SPTSPNYSPTSPSYSPT--SPGYSPGSPAYSPKQ 1721
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 74.0 bits (181), Expect = 1e-13
Identities = 54/272 (19%), Positives = 77/272 (28%), Gaps = 58/272 (21%)
Query: 18 PPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDA 77
L +P ++ + SP S
Sbjct: 1448 ESLVKYMPEQKITEIEDGQDGGVTPYSNESGLVNADLDVKDELMFSPLVDSGSNDAMAGG 1507
Query: 78 PPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVR 137
+ A P A +P P ++P S P PT+P+ S
Sbjct: 1508 FTAY--GGADYGEATSPFGAYGEAPTSPGFGVSSPGFSPTSPTYSPTSPAYS-------- 1557
Query: 138 TTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPS------------SNPPTSTP 185
P+S S P S ++P S
Sbjct: 1558 ------------------------------PTSPSYSPTSPSYSPTSPSYSPTSPSYSPT 1587
Query: 186 SPPVLTPPPHPSQSAPPPVTKSPPASTLSPP-PPSVPSTSSPPAVSPPAPP--SNSSTRG 242
SP P S ++P SP S SP P+ PS S P P S +S
Sbjct: 1588 SPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSY 1647
Query: 243 SPSTPPL-PSVPTEKPTAKSTNGTAVSANASP 273
SP++P P+ P PT+ S + T S + SP
Sbjct: 1648 SPTSPSYSPTSPAYSPTSPSYSPT--SPSYSP 1677
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 71.3 bits (174), Expect = 9e-13
Identities = 51/207 (24%), Positives = 73/207 (35%), Gaps = 10/207 (4%)
Query: 75 LDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANV-PTTPSSSSPPP 133
+D + P Q +P + P S S+
Sbjct: 1445 IDEESLVKYMPEQKITEIEDGQDGGVTPYSNESGLVNADLDVKDELMFSPLVDSGSNDAM 1504
Query: 134 ANVRTTPSSSSPPPANVPATPSSSSP--PPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLT 191
A T + A P +P P V +P S + P S P +P+ P +
Sbjct: 1505 AGGFTAYGGADYGEATSPFGAYGEAPTSPGFGVSSPGFSPTSPTYSPTSPAYSPTSPSYS 1564
Query: 192 P-PPHPSQSAPPPVTKSPPASTLSPPP-PSVPSTSSPPAVSPPAPPSNSSTRG--SPSTP 247
P P S ++P SP S SP P+ PS S P PS S T SP++P
Sbjct: 1565 PTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSP 1624
Query: 248 PL-PSVPTEKPTAKSTNGTAVSANASP 273
P+ P+ PT+ S + T S + SP
Sbjct: 1625 SYSPTSPSYSPTSPSYSPT--SPSYSP 1649
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 45.1 bits (106), Expect = 9e-05
Identities = 20/145 (13%), Positives = 38/145 (26%), Gaps = 11/145 (7%)
Query: 140 PSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQS 199
+ + TP S+ +P + S +
Sbjct: 1458 KITEIEDGQDGGVTPYSNESGL----VNADLDVKDELMFSPLVDSGSNDAMAGGFTAYGG 1513
Query: 200 APPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPS---TPPLPSVPTEK 256
A S + S + +P S + + SP+ T P S +
Sbjct: 1514 ADY----GEATSPFGAYGEAPTSPGFGVSSPGFSPTSPTYSPTSPAYSPTSPSYSPTSPS 1569
Query: 257 PTAKSTNGTAVSANASPRNAGVLGT 281
+ S + + S + SP + T
Sbjct: 1570 YSPTSPSYSPTSPSYSPTSPSYSPT 1594
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 66/255 (25%), Positives = 100/255 (39%), Gaps = 73/255 (28%)
Query: 389 LGEGGFGCVYKGV-LADGREVAVKQL------KIGGSQGEREFRA--------------- 426
+G+G +G V D A+K L + G R
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 427 -----EVEIISRVHHRHLVSL--VGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWA 479
E+ I+ ++ H ++V L V +E +V+E V PVM+
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELV-----------NQGPVMEVP 129
Query: 480 TRVKVAAGAAR--------GIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKI 531
T ++ AR GI YLH +IIHRDIK SN+L+ ++ADFG++
Sbjct: 130 TLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVS-- 184
Query: 532 ALELDSNTHVSTRVMGTFGYMAPE--------YATSGKLTEKSDVYSFGVVLLELITGRK 583
S+ +S V GT +MAPE + SGK DV++ GV L + G+
Sbjct: 185 NEFKGSDALLSNTV-GTPAFMAPESLSETRKIF--SGK---ALDVWAMGVTLYCFVFGQC 238
Query: 584 PVDASQPLGDESLVE 598
P DE ++
Sbjct: 239 PFM------DERIMC 247
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 52/231 (22%), Positives = 86/231 (37%), Gaps = 63/231 (27%)
Query: 388 VLGEGGFGCVYKGV-LADGREVAVKQL---KIGGSQGERE-----FRAEVEIISRVHHRH 438
LG G G V ++VA+K + K E+EI+ +++H
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 439 LVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWAT------RVKVAAG----- 487
++ + ++ Y++ V++ +V V
Sbjct: 77 IIKIKN----------FFD-----AEDYYI------VLELMEGGELFDKV-VGNKRLKEA 114
Query: 488 -AAR-------GIAYLHEDCHPRIIHRDIKSSNILLDSSFEA---RVADFGLAKIALELD 536
+ YLHE+ IIHRD+K N+LL S E ++ DFG +KI L
Sbjct: 115 TCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LG 168
Query: 537 SNTHVSTRVMGTFGYMAPE---YATSGKLTEKSDVYSFGVVLLELITGRKP 584
+ + T GT Y+APE + D +S GV+L ++G P
Sbjct: 169 ETSLMRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-26
Identities = 54/247 (21%), Positives = 98/247 (39%), Gaps = 57/247 (23%)
Query: 358 PSESGVLGNSRSWFTYDELIQATNGFSAH----NVLGEGGFGCVYKGV-LADGREVAVKQ 412
P + + G + + ++ A+ FS + LG+G F V + V G E A K
Sbjct: 2 PHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKI 61
Query: 413 L---KIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPNDTLHYHLH 469
+ K+ ++ E I ++ H ++V L + + ++L
Sbjct: 62 INTKKLSARDFQK-LEREARICRKLQHPNIVRLHD----------SIQ----EESFHYL- 105
Query: 470 AEGRPVMDWAT------RV--------KVAAGAAR----GIAYLHEDCHPRIIHRDIKSS 511
V D T + A+ + IAY H + I+HR++K
Sbjct: 106 -----VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPE 157
Query: 512 NILLDSSFEA---RVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDV 568
N+LL S + ++ADFGLA ++ + GT GY++PE ++ D+
Sbjct: 158 NLLLASKAKGAAVKLADFGLAIE---VNDSEAWHGFA-GTPGYLSPEVLKKDPYSKPVDI 213
Query: 569 YSFGVVL 575
++ GV+L
Sbjct: 214 WACGVIL 220
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 48/208 (23%), Positives = 88/208 (42%), Gaps = 22/208 (10%)
Query: 388 VLGEGGFGCVYKGV-LADGREVAVKQLKI--GGSQGEREFRAEVEIISRV-HHRHLVSLV 443
LG G F V + + + G+E A K LK G E E+ ++ +++L
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 444 GYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAAR----GIAYLHEDC 499
+ E +L+ EY + E ++ + G+ YLH++
Sbjct: 96 EVYENTSEIILILEYAAGGEIFSLCLPELAEMVS----ENDVIRLIKQILEGVYYLHQN- 150
Query: 500 HPRIIHRDIKSSNILLDSSFEA---RVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEY 556
I+H D+K NILL S + ++ DFG+++ + + + GT Y+APE
Sbjct: 151 --NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK---IGHACELREIM-GTPEYLAPEI 204
Query: 557 ATSGKLTEKSDVYSFGVVLLELITGRKP 584
+T +D+++ G++ L+T P
Sbjct: 205 LNYDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 9e-26
Identities = 55/214 (25%), Positives = 88/214 (41%), Gaps = 28/214 (13%)
Query: 386 HNVLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGER------EFRAEVEIISRVHHRH 438
LG G F V K + G E A K +K S+ R E EV I+ +V H +
Sbjct: 17 GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPN 76
Query: 439 LVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAAR----GIAY 494
+++L + + +L+ E V L L + + A + G+ Y
Sbjct: 77 IITLHDVYENRTDVVLILELVSGGELFDFLAQKESL------SEEEATSFIKQILDGVNY 130
Query: 495 LHEDCHPRIIHRDIKSSNILLDSSFEA----RVADFGLAKIALELDSNTHVSTRVMGTFG 550
LH +I H D+K NI+L ++ DFGLA ++ GT
Sbjct: 131 LHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE---IEDGVEFKNIF-GTPE 183
Query: 551 YMAPEYATSGKLTEKSDVYSFGVVLLELITGRKP 584
++APE L ++D++S GV+ L++G P
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 55/215 (25%), Positives = 102/215 (47%), Gaps = 20/215 (9%)
Query: 383 FSAHNVLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGEREFRAEVEIISRV-HHRHLV 440
F ++G G +G VYKG + G+ A+K + + G E E + E+ ++ + HHR++
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIA 84
Query: 441 S-----LVGYCISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAY 494
+ + ++L LV E+ ++ + + + RG+++
Sbjct: 85 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 144
Query: 495 LHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAP 554
LH+ ++IHRDIK N+LL + E ++ DFG++ +LD +GT +MAP
Sbjct: 145 LHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA---QLDRTVGRRNTFIGTPYWMAP 198
Query: 555 EYATSGKLTE-----KSDVYSFGVVLLELITGRKP 584
E + + KSD++S G+ +E+ G P
Sbjct: 199 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 58/226 (25%), Positives = 93/226 (41%), Gaps = 37/226 (16%)
Query: 378 QATNGFSAHNVLGEGGFGCVYKGVLAD-GREVAVKQLKIGGSQGEREFRAEVEIISRVHH 436
+ + F + G+G FG V G G VA+K++ RE + ++ ++ +HH
Sbjct: 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVLHH 78
Query: 437 RHLVSLVGYCISERER-------LLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAA 489
++V L Y + ER +V EYVP+ LH R +VA
Sbjct: 79 PNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDT-----LHR----CCRNYYRRQVAPPPI 129
Query: 490 ----------RGIAYLHEDCHPRIIHRDIKSSNILLD-SSFEARVADFGLAKIALELDSN 538
R I LH + HRDIK N+L++ + ++ DFG AK + N
Sbjct: 130 LIKVFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN 188
Query: 539 TH-VSTRVMGTFGYMAPEY-ATSGKLTEKSDVYSFGVVLLELITGR 582
+ +R Y APE + T D++S G + E++ G
Sbjct: 189 VAYICSRY-----YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 51/218 (23%), Positives = 91/218 (41%), Gaps = 34/218 (15%)
Query: 388 VLGEGGFGCVYKGV-LADGREVAVK-----QLKIGGSQGEREFRAEVEIISRVHHRHLVS 441
+LGEG +G V + + AVK +L+ + + E++++ R+ H++++
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKK-EIQLLRRLRHKNVIQ 70
Query: 442 L--VGYCISERERLLVYEYVPNDTLHYHLHAEGRPVM-DWATRVKVAAGAAR-------- 490
L V Y +++ +V EY G M D + A
Sbjct: 71 LVDVLYNEEKQKMYMVMEYCVC----------GMQEMLDSVPEKRFPVCQAHGYFCQLID 120
Query: 491 GIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFG 550
G+ YLH I+H+DIK N+LL + +++ G+A+ ++ T G+
Sbjct: 121 GLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT-SQGSPA 176
Query: 551 YMAPEYATSGKLTE--KSDVYSFGVVLLELITGRKPVD 586
+ PE A K D++S GV L + TG P +
Sbjct: 177 FQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 70/266 (26%), Positives = 110/266 (41%), Gaps = 30/266 (11%)
Query: 334 SVFLRPHSPAPLVGNGSNSGFSR--SPSESGVLGNSRSWFTYDELIQATN---GFSAHNV 388
S + H + N F P +G S EL + FS
Sbjct: 2 SYYHHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLRE 61
Query: 389 LGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGEREF---RAEVEIISRVHHRHLVSLVG 444
+G G FG VY + + VA+K++ G Q ++ EV + ++ H + + G
Sbjct: 62 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 445 YCISERERLLVYEYVP---NDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHP 501
+ E LV EY +D L H + + V GA +G+AYLH
Sbjct: 122 CYLREHTAWLVMEYCLGSASDLLEVH-----KKPLQEVEIAAVTHGALQGLAYLHSH--- 173
Query: 502 RIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGK 561
+IHRD+K+ NILL ++ DFG A ++ +N+ +GT +MAPE +
Sbjct: 174 NMIHRDVKAGNILLSEPGLVKLGDFGSA--SIMAPANS-----FVGTPYWMAPEVILAMD 226
Query: 562 LTE---KSDVYSFGVVLLELITGRKP 584
+ K DV+S G+ +EL + P
Sbjct: 227 EGQYDGKVDVWSLGITCIELAERKPP 252
|
| >3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752 | Back alignment and structure |
|---|
Score = 112 bits (280), Expect = 2e-25
Identities = 79/275 (28%), Positives = 111/275 (40%), Gaps = 15/275 (5%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPST-TPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSP 59
P +P + SP + +P + P SP
Sbjct: 1479 PEGAGTPYERSPMVDSGFVGSPDAAAFSPLVQGGSEGREGFGDYGLLGAASPY-KGVQSP 1537
Query: 60 AVNSPPPQPSSP----PPPLDAPPPPEVDPSPP-SPAQPPPQAVAP--SPPPPANVPTTP 112
SP SP P +P P SP P+ P +P SP P+ PT+P
Sbjct: 1538 GYTSPFSSAMSPGYGLTSPSYSPSSPGYSTSPAYMPSSPSYSPTSPSYSPTSPSYSPTSP 1597
Query: 113 SSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSS- 171
S S P+ T+PS S P+ T+PS S P+ P +PS S P PT PS S
Sbjct: 1598 SYSPTSPSYSATSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSP 1657
Query: 172 SPPPPSSNPPTSTPSPPVLTPP-PHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSP--PA 228
+ P S P+ +P+ P +P P S ++P SP S SP + SP P+
Sbjct: 1658 TSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPS 1717
Query: 229 VSPPAP-PSNSSTRGSPSTP-PLPSVPTEKPTAKS 261
SP +P S +S SP++P P+ P+ PT+ S
Sbjct: 1718 YSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPS 1752
|
| >3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 5e-25
Identities = 76/264 (28%), Positives = 104/264 (39%), Gaps = 11/264 (4%)
Query: 16 PSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPL 75
P S SP A P SP
Sbjct: 1490 PMVDSGFVGSPDAAAFSPLVQGGSEGREGFGDYGLLGAASPYKGV-QSPGYTSPFSSAMS 1548
Query: 76 DAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPAN 135
SP SP + A P P+ PT+PS S P+ PT+PS S P+
Sbjct: 1549 PGYGLTSPSYSPSSPGYST--SPAYMPSSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSY 1606
Query: 136 VRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSS-SPPPPSSNPPTSTPSPPVLTP-P 193
T+PS S P+ P +PS S P PT PS S + P S P+ +P+ P +P
Sbjct: 1607 SATSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTS 1666
Query: 194 PHPSQSAPPPVTKSPPASTLSP--PPPSVPSTSSPPAVSPPAPP-SNSSTRGSPSTP-PL 249
P S ++P SP S SP P S + + P+ SP +P S +S SP++P
Sbjct: 1667 PSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYS 1726
Query: 250 PSVPTEKPTAKSTNGTAVSANASP 273
P+ P+ PT+ S + T S + SP
Sbjct: 1727 PTSPSYSPTSPSYSPT--SPSYSP 1748
|
| >3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 1e-23
Identities = 78/277 (28%), Positives = 110/277 (39%), Gaps = 14/277 (5%)
Query: 6 SPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPP 65
+ LA P + TP SP S P + SP S
Sbjct: 1463 TAVPTLAGSGMGTSQLPEGAGTPYERSPMVDSGFVGSPDAAAFSP-LVQGGSEGREGFGD 1521
Query: 66 PQPSSPPPPLDAPPPPEVDPSPPSPAQP--PPQAVAPSPPPPANVPTTPSSSSPPPANVP 123
P P S P + + SP P T+P+ P+ P
Sbjct: 1522 YGLLGAASPYKGVQSPGYTSPFSSAMSPGYGLTSPSYSPSSPGY-STSPAYMPSSPSYSP 1580
Query: 124 TTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNP--P 181
T+PS S P+ T+PS S P+ +PS S P PT PS S P PS +P P
Sbjct: 1581 TSPSYSPTSPSYSPTSPSYSPTSPSYSATSPSYSPTSPSYSPTSPSYS-PTSPSYSPTSP 1639
Query: 182 TSTPSPPVLTP-PPHPSQSAPPPVTKSPPASTLSP--PPPSVPSTSSPPAVSPPAPP-SN 237
+ +P+ P +P P S ++P SP S SP P S + + P+ SP +P S
Sbjct: 1640 SYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSP 1699
Query: 238 SSTRGSPSTPPL-PSVPTEKPTAKSTNGTAVSANASP 273
+S SP++P P+ P+ PT+ S + T S + SP
Sbjct: 1700 TSPSYSPTSPSYSPTSPSYSPTSPSYSPT--SPSYSP 1734
|
| >3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752 | Back alignment and structure |
|---|
Score = 83.6 bits (206), Expect = 1e-16
Identities = 60/265 (22%), Positives = 90/265 (33%), Gaps = 24/265 (9%)
Query: 17 SPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLD 76
S + P + +P +P A SP Q S
Sbjct: 1460 SLGTAVPTLAGSGMGTSQLPEGAGTPYERSPMVDSGFVGSPDAAAFSPLVQGGSEGREGF 1519
Query: 77 APPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANV 136
SP Q P P + +P P+ P++P S
Sbjct: 1520 GDYGLLGAASPYKGVQSP------GYTSPFSSAMSPGYGLTSPSYSPSSPGYS------- 1566
Query: 137 RTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHP 196
T+P+ P+ P +PS S P PT PS S P+S P S SP + P
Sbjct: 1567 -TSPAYMPSSPSYSPTSPSYSPTSPSYSPTSPSYS----PTS-PSYSATSP---SYSPTS 1617
Query: 197 SQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTPPLPSVPTEK 256
+P + SP + + SP PS TS P+ SP +P + ++ T P S +
Sbjct: 1618 PSYSPTSPSYSPTSPSYSPTSPSYSPTS--PSYSPTSPSYSPTSPSYSPTSPSYSPTSPS 1675
Query: 257 PTAKSTNGTAVSANASPRNAGVLGT 281
+ S + + S + SP + T
Sbjct: 1676 YSPTSPSYSPTSPSYSPTSPSYSPT 1700
|
| >3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752 | Back alignment and structure |
|---|
Score = 67.8 bits (165), Expect = 1e-11
Identities = 48/204 (23%), Positives = 68/204 (33%), Gaps = 9/204 (4%)
Query: 75 LDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPA 134
LD P P A P S ++ SP
Sbjct: 1451 LDQDMLMNYSLGTAVPTLAGSGMGTSQLPEGAGTPYERSPMVDSGFVGSPDAAAFSPLVQ 1510
Query: 135 NVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPP 194
A+P P +P SS+ P P+ +PS P + P
Sbjct: 1511 GGSEGREGFGDYGLLGAASPYKGVQSPGY-TSPFSSAMSPGYGLTSPSYSPSSPGYSTSP 1569
Query: 195 HPSQSAPPPVTKSPPASTLSP---PPPSVPSTSSPPAVSPPAP-PSNSSTRGSPSTPPL- 249
S+P SP S SP P S +S P+ S +P S +S SP++P
Sbjct: 1570 AYMPSSPSYSPTSPSYSPTSPSYSPTSPSYSPTS-PSYSATSPSYSPTSPSYSPTSPSYS 1628
Query: 250 PSVPTEKPTAKSTNGTAVSANASP 273
P+ P+ PT+ S + T S + SP
Sbjct: 1629 PTSPSYSPTSPSYSPT--SPSYSP 1650
|
| >3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752 | Back alignment and structure |
|---|
Score = 65.9 bits (160), Expect = 4e-11
Identities = 54/232 (23%), Positives = 81/232 (34%), Gaps = 23/232 (9%)
Query: 66 PQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTT 125
S P A P + P ++ SP
Sbjct: 1457 MNYSLGTAVPTLAGSGMGTSQLPEGAGTPYERSPMVDSGFVGSPD-AAAFSPLVQGGSEG 1515
Query: 126 PSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPP--SSSSP-----PPPSS 178
+P P +P SS+ P T P S SSP P
Sbjct: 1516 REGFGDYGLLGAASPYKGVQSPG--YTSPFSSAMSPGYGLTSPSYSPSSPGYSTSPAYMP 1573
Query: 179 NPPTSTPSPPVLTPP--------PHPSQSAPPPVTKSPPASTLSP-PPPSVPSTS-SPPA 228
+ P+ +P+ P +P P S ++P SP S SP P+ PS S + P+
Sbjct: 1574 SSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSATSPSYSPTSPSYSPTSPSYSPTSPS 1633
Query: 229 VSPPAP-PSNSSTRGSPSTPPL-PSVPTEKPTAKSTNGTAVSAN-ASPRNAG 277
SP +P S +S SP++P P+ P+ PT+ S + T+ S + SP +
Sbjct: 1634 YSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSP 1685
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 61/243 (25%), Positives = 104/243 (42%), Gaps = 25/243 (10%)
Query: 388 VLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGEREFRAEVEIISRV-HHRHLVSLVGY 445
VLGEG V + L +E AVK ++ EVE++ + HR+++ L+ +
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 446 CISERERLLVYEYVPNDTLHYHLHAEGR-PVMDWATRVKVAAGAARGIAYLHEDCHPRII 504
E LV+E + ++ H+H ++ + V+ A A + +LH I
Sbjct: 80 FEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASA---LDFLHN---KGIA 133
Query: 505 HRDIKSSNILLDSSFEA---RVADFGLAKIALELDSNTHVSTRVM----GTFGYMAPE-- 555
HRD+K NIL + + ++ DF L + +ST + G+ YMAPE
Sbjct: 134 HRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVV 193
Query: 556 ---YATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHED 612
+ ++ D++S GV+L L++G P S W R A ++
Sbjct: 194 EAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRC----GSDCGWDRGEACPACQNML 249
Query: 613 FEA 615
FE+
Sbjct: 250 FES 252
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 56/213 (26%), Positives = 86/213 (40%), Gaps = 33/213 (15%)
Query: 389 LGEGGFGCVYKGV-LADGREVAVKQL---KIGGSQGEREFRAEVEIISRVHHRHLVSLVG 444
LGEG +G V V VAVK + + E + E+ I ++H ++V G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP-ENIKK-EICINKMLNHENVVKFYG 72
Query: 445 YCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAAR--------GIAYLH 496
+ + L EY L + + + A+ G+ Y
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDIG----------MPEPDAQRFFHQLMAGVVY-- 120
Query: 497 EDCHPR-IIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPE 555
H I HRDIK N+LLD +++DFGLA + + ++ GT Y+APE
Sbjct: 121 --LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPE 177
Query: 556 YATSGKL--TEKSDVYSFGVVLLELITGRKPVD 586
+ E DV+S G+VL ++ G P D
Sbjct: 178 -LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-25
Identities = 63/211 (29%), Positives = 94/211 (44%), Gaps = 20/211 (9%)
Query: 383 FSAHNVLGEGGFGCVYKGVLADGREV-AVKQLK---IGGSQGEREFRAEVEIISRVHHRH 438
F +G+G FG V D +++ A+K + R E++I+ + H
Sbjct: 17 FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPF 76
Query: 439 LVSLVGYCISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKV-AAGAARGIAYLH 496
LV+L Y + E + +V + + L YHL + VK+ + YL
Sbjct: 77 LVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEE---TVKLFICELVMALDYLQ 132
Query: 497 EDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEY 556
RIIHRD+K NILLD + DF +A L T ++T + GT YMAPE
Sbjct: 133 NQ---RIIHRDMKPDNILLDEHGHVHITDFNIAA---MLPRETQITT-MAGTKPYMAPEM 185
Query: 557 ATSGKLTE--KS-DVYSFGVVLLELITGRKP 584
+S K + D +S GV EL+ GR+P
Sbjct: 186 FSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 54/240 (22%), Positives = 88/240 (36%), Gaps = 54/240 (22%)
Query: 378 QATNGFSAH----NVLGEGGFGCVYKGV-LADGREVAVK---------QLKIGGSQGERE 423
+T+GF + +LG G V + + +E AVK +
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 424 FRAEVEIISRV-HHRHLVSLVGYCISERERLLVYEYVPNDTL--------HYHLHAEGRP 474
EV+I+ +V H +++ L + LV++ + L +E
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTL---SE--- 123
Query: 475 VMDWATRVKVAAGAAR----GIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAK 530
K R I LH+ I+HRD+K NILLD ++ DFG +
Sbjct: 124 --------KETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSC 172
Query: 531 IALELDSNTHVSTRVMGTFGYMAPE------YATSGKLTEKSDVYSFGVVLLELITGRKP 584
LD + GT Y+APE ++ D++S GV++ L+ G P
Sbjct: 173 Q---LDPGEKLREVC-GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 14/213 (6%)
Query: 383 FSAHNVLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGERE-FRAEVEIISRVHHRHLV 440
+ V+G G V +VA+K++ + Q + E++ +S+ HH ++V
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76
Query: 441 SLVGYCISERERLLVYEYVPN---DTLHYHLHAEGRPVMDWATRVKVAA---GAARGIAY 494
S + + E LV + + + H+ A+G +A G+ Y
Sbjct: 77 SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 136
Query: 495 LHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTR--VMGTFGYM 552
LH++ IHRD+K+ NILL ++ADFG++ T R +GT +M
Sbjct: 137 LHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWM 193
Query: 553 APEYATSGKL-TEKSDVYSFGVVLLELITGRKP 584
APE + K+D++SFG+ +EL TG P
Sbjct: 194 APEVMEQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 65/215 (30%), Positives = 104/215 (48%), Gaps = 28/215 (13%)
Query: 383 FSAHNVLGEGGFGCVY---KGVLADGREV-AVKQLK---IGGSQGEREFRAEVEIISRVH 435
F VLG+G FG V+ K +D R++ A+K LK + + + E +I+ V+
Sbjct: 26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLK-VRDRVRTKMERDILVEVN 84
Query: 436 HRHLVSLVGYCISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKV-AAGAARGIA 493
H +V L Y +L L+ +++ L L E + VK A A +
Sbjct: 85 HPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE---DVKFYLAELALALD 140
Query: 494 YLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTF-G-- 550
+LH II+RD+K NILLD ++ DFGL+K +++ + + +F G
Sbjct: 141 HLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY-------SFCGTV 190
Query: 551 -YMAPEYATSGKLTEKSDVYSFGVVLLELITGRKP 584
YMAPE T+ +D +SFGV++ E++TG P
Sbjct: 191 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 107 bits (267), Expect = 6e-25
Identities = 40/291 (13%), Positives = 81/291 (27%), Gaps = 67/291 (23%)
Query: 388 VLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGE---REFRAEVEIISR---------- 433
VLG+ + G V ++ + EV +
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 434 ------------VHHRHLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMD---- 477
V ++ + ER+ ++ + + +L G ++
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 478 -----WATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIA 532
R+++ R +A LH H ++H ++ +I+LD + F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR- 260
Query: 533 LELDSNTHVSTRVMGTFGYMAPE-----YATSGKLTEKSDVYSFGVVLLELITGRKPVDA 587
+ S R A +T D ++ G+ + + P
Sbjct: 261 -DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTD 319
Query: 588 SQPLGD---------------ESLVEW-------ARPLLAEALEHEDFEAL 616
LG +L+E R L +A+E ++E L
Sbjct: 320 DAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 370
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 1e-24
Identities = 36/213 (16%), Positives = 76/213 (35%), Gaps = 14/213 (6%)
Query: 383 FSAHNVLGEG--GFGCVYKGV-LADGREVAVKQLKIGGSQGER--EFRAEVEIISRVHHR 437
+ V+G+G V G V V+++ + E + E+ + +H
Sbjct: 27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86
Query: 438 HLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHE 497
++V I++ E +V ++ + + M+ + G + + Y+H
Sbjct: 87 NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH 146
Query: 498 DCHPRIIHRDIKSSNILLDSSFEARVADFG----LAKIALELDSNTHVSTRVMGTFGYMA 553
+HR +K+S+IL+ + ++ + + +++
Sbjct: 147 M---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLS 203
Query: 554 PEYATSGKL--TEKSDVYSFGVVLLELITGRKP 584
PE KSD+YS G+ EL G P
Sbjct: 204 PEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 64/216 (29%), Positives = 100/216 (46%), Gaps = 28/216 (12%)
Query: 383 FSAHNVLGEGGFGCVY---KGVLADGREV-AVKQLK---IGGSQGEREF-RAEVEIISRV 434
F VLG+GG+G V+ K A+ ++ A+K LK I + + +AE I+ V
Sbjct: 19 FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 435 HHRHLVSLVGYCISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKV-AAGAARGI 492
H +V L+ Y +L L+ EY+ L L EG + D A + +
Sbjct: 79 KHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMED---TACFYLAEISMAL 134
Query: 493 AYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTF-G- 550
+LH+ II+RD+K NI+L+ ++ DFGL K ++ + TH TF G
Sbjct: 135 GHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTH-------TFCGT 184
Query: 551 --YMAPEYATSGKLTEKSDVYSFGVVLLELITGRKP 584
YMAPE D +S G ++ +++TG P
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 48/222 (21%), Positives = 82/222 (36%), Gaps = 54/222 (24%)
Query: 387 NVLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGEREFRAEVEIISR-VHHRHLVSLVG 444
+G G + + + A E AVK + E +EI+ R H ++++L
Sbjct: 28 EDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE----IEILLRYGQHPNIITLKD 83
Query: 445 YCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWAT------RV--------KVAAGAAR 490
VY+ D + ++ V + ++ + A+
Sbjct: 84 ----------VYD----DGKYVYV------VTELMKGGELLDKILRQKFFSEREASAVLF 123
Query: 491 ----GIAYLHEDCHPRIIHRDIKSSNILLDSSFEA----RVADFGLAKIALELDSNTHVS 542
+ YLH ++HRD+K SNIL R+ DFG AK L + +
Sbjct: 124 TITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ---LRAENGLL 177
Query: 543 TRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKP 584
T ++APE D++S GV+L ++TG P
Sbjct: 178 MTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 56/213 (26%), Positives = 86/213 (40%), Gaps = 33/213 (15%)
Query: 389 LGEGGFGCVYKGV-LADGREVAVKQL---KIGGSQGEREFRAEVEIISRVHHRHLVSLVG 444
LGEG +G V V VAVK + + E + E+ I ++H ++V G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP-ENIKK-EICINKMLNHENVVKFYG 72
Query: 445 YCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAAR--------GIAYLH 496
+ + L EY L + + + A+ G+ Y
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDIG----------MPEPDAQRFFHQLMAGVVY-- 120
Query: 497 EDCHPR-IIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPE 555
H I HRDIK N+LLD +++DFGLA + + ++ GT Y+APE
Sbjct: 121 --LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPE 177
Query: 556 YATSGKL--TEKSDVYSFGVVLLELITGRKPVD 586
+ E DV+S G+VL ++ G P D
Sbjct: 178 -LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-24
Identities = 53/218 (24%), Positives = 89/218 (40%), Gaps = 37/218 (16%)
Query: 383 FSAHNVLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVS 441
+ H LG G FG V++ A G A K + + R E++ +S + H LV+
Sbjct: 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 218
Query: 442 LVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRV---------KVAAGAAR-- 490
L + E +++YE++ G + + +V A R
Sbjct: 219 LHDAFEDDNEMVMIYEFM-----------SGGELFE---KVADEHNKMSEDEAVEYMRQV 264
Query: 491 --GIAYLHEDCHPRIIHRDIKSSNILLDSSFEARV--ADFGLAKIALELDSNTHVSTRVM 546
G+ ++HE+ +H D+K NI+ + + DFGL LD V
Sbjct: 265 CKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAH---LDPKQSVKVTT- 317
Query: 547 GTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKP 584
GT + APE A + +D++S GV+ L++G P
Sbjct: 318 GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 51/220 (23%), Positives = 84/220 (38%), Gaps = 52/220 (23%)
Query: 388 VLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGEREFRAEVEIISRV-HHRHLVSLVGY 445
LGEG F K V + AVK I + E+ + H ++V L
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKI--ISKRMEANTQK-EITALKLCEGHPNIVKLHE- 73
Query: 446 CISERERLLVYEYVPNDTLHYHLHAEGRPVMDWAT------RV--------KVAAGAAR- 490
V+ D LH L VM+ R+ A+ R
Sbjct: 74 ---------VFH----DQLHTFL------VMELLNGGELFERIKKKKHFSETEASYIMRK 114
Query: 491 ---GIAYLHEDCHPRIIHRDIKSSNILLDSSFEA---RVADFGLAKIALELDSNTHVSTR 544
++++H+ ++HRD+K N+L + ++ DFG A++ + N + T
Sbjct: 115 LVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARL--KPPDNQPLKTP 169
Query: 545 VMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKP 584
T Y APE E D++S GV+L +++G+ P
Sbjct: 170 C-FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVP 208
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 49/213 (23%), Positives = 97/213 (45%), Gaps = 34/213 (15%)
Query: 387 NVLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGERE------FRAEVEIISRVHHRHL 439
+GEG +G V+K VA+K++++ + E R E+ ++ + H+++
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDD---DDEGVPSSALR-EICLLKELKHKNI 63
Query: 440 VSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDC 499
V L S+++ LV+E+ D L + + +D +G+ + H
Sbjct: 64 VRLHDVLHSDKKLTLVFEFCDQD-LKKYFDSCNGD-LDPEIVKSFLFQLLKGLGFCHSR- 120
Query: 500 HPRIIHRDIKSSNILLDSSFEARVADFGLAKI-ALELDSNTHVSTRVMGTFGYMAPE--- 555
++HRD+K N+L++ + E ++A+FGLA+ + + + V+ T Y P+
Sbjct: 121 --NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA---EVV-TLWYRPPDVLF 174
Query: 556 ----YATSGKLTEKSDVYSFGVVLLELITGRKP 584
Y+TS D++S G + EL +P
Sbjct: 175 GAKLYSTS------IDMWSAGCIFAELANAGRP 201
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-24
Identities = 60/211 (28%), Positives = 89/211 (42%), Gaps = 21/211 (9%)
Query: 383 FSAHNVLGEGGFGCVYKGVLA----DGREVAVKQLKIGGSQGEREF---RAEVEIISRVH 435
F +LG+G FG V L GR A+K LK + E E ++
Sbjct: 150 FEYLKLLGKGTFGKVI---LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR 206
Query: 436 HRHLVSLVGYCISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKV-AAGAARGIA 493
H L +L Y +RL V EY L +HL E D R + A +
Sbjct: 207 HPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED---RARFYGAEIVSALD 262
Query: 494 YLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMA 553
YLH + + +++RD+K N++LD ++ DFGL K ++ + GT Y+A
Sbjct: 263 YLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT---FCGTPEYLA 317
Query: 554 PEYATSGKLTEKSDVYSFGVVLLELITGRKP 584
PE D + GVV+ E++ GR P
Sbjct: 318 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 7e-24
Identities = 67/210 (31%), Positives = 108/210 (51%), Gaps = 33/210 (15%)
Query: 387 NVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGERE------FRAEVEIISRVHHRHLV 440
+GEG +G VYK + GR VA+K++++ E E R E+ ++ +HH ++V
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRIVALKRIRLDA---EDEGIPSTAIR-EISLLKELHHPNIV 82
Query: 441 SLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCH 500
SL+ SER LV+E++ D L L + + RG+A+ H+
Sbjct: 83 SLIDVIHSERCLTLVFEFMEKD-LKKVLDENKTG-LQDSQIKIYLYQLLRGVAHCHQH-- 138
Query: 501 PRIIHRDIKSSNILLDSSFEARVADFGLAKI-ALELDSNTHVSTRVMGTFGYMAPE---- 555
RI+HRD+K N+L++S ++ADFGLA+ + + S TH V+ T Y AP+
Sbjct: 139 -RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH---EVV-TLWYRAPDVLMG 193
Query: 556 ---YATSGKLTEKSDVYSFGVVLLELITGR 582
Y+TS D++S G + E+ITG+
Sbjct: 194 SKKYSTS------VDIWSIGCIFAEMITGK 217
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 9e-24
Identities = 66/219 (30%), Positives = 93/219 (42%), Gaps = 46/219 (21%)
Query: 389 LGEGGFGCVYKGV-LADGREVAVKQL---KIGGSQGEREFRAEVEIISRVHHRHLVSLVG 444
LG G FG V G G +VAVK L KI + + E++ + H H++ L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL-- 76
Query: 445 YCISERER--LLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAAR--------GIAY 494
Y + +V EYV L ++ GR V AR + Y
Sbjct: 77 YQVISTPTDFFMVMEYVSGGELFDYICKHGR----------VEEMEARRLFQQILSAVDY 126
Query: 495 LHEDCHPR-IIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTF---- 549
CH ++HRD+K N+LLD+ A++ADFGL SN + T
Sbjct: 127 ----CHRHMVVHRDLKPENVLLDAHMNAKIADFGL--------SNMMSDGEFLRTSCGSP 174
Query: 550 GYMAPEYATSGKLTE--KSDVYSFGVVLLELITGRKPVD 586
Y APE SG+L + D++S GV+L L+ G P D
Sbjct: 175 NYAAPE-VISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-23
Identities = 55/216 (25%), Positives = 83/216 (38%), Gaps = 23/216 (10%)
Query: 383 FSAHNVLGEGGFGCVYKGVLADGREV-AVKQLK----IGGSQGEREFRAEVEIISRVHHR 437
F V+G G F V + +V A+K + + + FR E +++ R
Sbjct: 63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSC-FREERDVLVNGDRR 121
Query: 438 HLVSLVGYCISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLH 496
+ L + + L LV EY L L G + R A I +H
Sbjct: 122 WITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARF-YLAEIVMAIDSVH 179
Query: 497 EDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVM-GTFGYMAPE 555
+HRDIK NILLD R+ADFG +L ++ V + V GT Y++PE
Sbjct: 180 RL---GYVHRDIKPDNILLDRCGHIRLADFGSCL---KLRADGTVRSLVAVGTPDYLSPE 233
Query: 556 YATSGKLTEKSDVY-------SFGVVLLELITGRKP 584
+ + Y + GV E+ G+ P
Sbjct: 234 ILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-23
Identities = 60/216 (27%), Positives = 87/216 (40%), Gaps = 32/216 (14%)
Query: 383 FSAHNVLGEGGFGCVYKGVLA----DGREVAVKQLK----IGGSQGEREFRAEVEIISRV 434
F +LG+G FG V L GR A+K L+ I + E ++
Sbjct: 7 FDYLKLLGKGTFGKVI---LVREKATGRYYAMKILRKEVIIAKDEVAHT-VTESRVLQNT 62
Query: 435 HHRHLVSLVGYCISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKV-AAGAARGI 492
H L +L Y +RL V EY L +HL E + R + A +
Sbjct: 63 RHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE---RARFYGAEIVSAL 118
Query: 493 AYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTF-G- 550
YLH +++RDIK N++LD ++ DFGL K + + TF G
Sbjct: 119 EYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK-------TFCGT 168
Query: 551 --YMAPEYATSGKLTEKSDVYSFGVVLLELITGRKP 584
Y+APE D + GVV+ E++ GR P
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 57/210 (27%), Positives = 100/210 (47%), Gaps = 33/210 (15%)
Query: 387 NVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGERE------FRAEVEIISRVHHRHLV 440
+GEG +G VYK G A+K++++ E E R E+ I+ + H ++V
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEK---EDEGIPSTTIR-EISILKELKHSNIV 63
Query: 441 SLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCH 500
L +++ +LV+E++ D L L ++ T GIAY H+
Sbjct: 64 KLYDVIHTKKRLVLVFEHLDQD-LKKLLDVCEGG-LESVTAKSFLLQLLNGIAYCHDR-- 119
Query: 501 PRIIHRDIKSSNILLDSSFEARVADFGLAKI-ALELDSNTHVSTRVMGTFGYMAPE---- 555
R++HRD+K N+L++ E ++ADFGLA+ + + TH ++ T Y AP+
Sbjct: 120 -RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH---EIV-TLWYRAPDVLMG 174
Query: 556 ---YATSGKLTEKSDVYSFGVVLLELITGR 582
Y+T+ D++S G + E++ G
Sbjct: 175 SKKYSTT------IDIWSVGCIFAEMVNGT 198
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-23
Identities = 64/220 (29%), Positives = 99/220 (45%), Gaps = 41/220 (18%)
Query: 383 FSAHNVLGEGGFGCVYKGVLAD-GREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVS 441
++ V+G G FG VY+ L D G VA+K++ + R E++I+ ++ H ++V
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFKNR-ELQIMRKLDHCNIVR 111
Query: 442 LVGYCISERERL------LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAA------ 489
L + S E+ LV +YVP ++ V +R K
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPET-----VYR----VARHYSRAKQTLPVIYVKLYM 162
Query: 490 ----RGIAYLHEDCHPRIIHRDIKSSNILLDS-SFEARVADFGLAKIALELDSNTH-VST 543
R +AY+H I HRDIK N+LLD + ++ DFG AK + + N + +
Sbjct: 163 YQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS 219
Query: 544 RVMGTFGYMAPEY-ATSGKLTEKSDVYSFGVVLLELITGR 582
R Y APE + T DV+S G VL EL+ G+
Sbjct: 220 RY-----YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 65/313 (20%), Positives = 109/313 (34%), Gaps = 66/313 (21%)
Query: 302 AVWFAHKRKKKRAGEHIGYTLPSPYASSQKSDSVFLRPHSPAPLVGNGSNSGFSRSPSES 361
V ++++RA I + + S + + + P +
Sbjct: 10 GVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGT 69
Query: 362 -GVLGNSRSWFTYDELIQATNGFSAH----NVLGEGGFGCVYKGV-LADGREVAVKQL-- 413
+ S A F +V+G G V + V A G E AVK +
Sbjct: 70 ENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEV 129
Query: 414 -KIGGSQGERE-----FRAEVEIISRVH-HRHLVSLVGYCISERERLLVYEYVPNDTLHY 466
S + E R E I+ +V H H+++L+ YE +
Sbjct: 130 TAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID----------SYE----SSSFM 175
Query: 467 HLHAEGRPVMDWAT------RV--------KVAAGAAR----GIAYLHEDCHPRIIHRDI 508
L V D + K R +++LH + I+HRD+
Sbjct: 176 FL------VFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDL 226
Query: 509 KSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPE------YATSGKL 562
K NILLD + + R++DFG + L+ + GT GY+APE T
Sbjct: 227 KPENILLDDNMQIRLSDFGFSCH---LEPGEKLRELC-GTPGYLAPEILKCSMDETHPGY 282
Query: 563 TEKSDVYSFGVVL 575
++ D+++ GV+L
Sbjct: 283 GKEVDLWACGVIL 295
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 54/208 (25%), Positives = 90/208 (43%), Gaps = 28/208 (13%)
Query: 387 NVLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGEREFRA--EVEIISRVHHRHLVSLV 443
+GEG +G V+K G+ VA+K+ + A E+ ++ ++ H +LV+L+
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLL 68
Query: 444 GYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRI 503
+R LV+EY + LH L R + + + + + H+ H
Sbjct: 69 EVFRRKRRLHLVFEYCDHTVLHE-LDRYQRG-VPEHLVKSITWQTLQAVNFCHK--H-NC 123
Query: 504 IHRDIKSSNILLDSSFEARVADFGLAK-IALELDSNTH-VSTRVMGTFGYMAPE------ 555
IHRD+K NIL+ ++ DFG A+ + D V+TR Y +PE
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR-----WYRSPELLVGDT 178
Query: 556 -YATSGKLTEKSDVYSFGVVLLELITGR 582
Y DV++ G V EL++G
Sbjct: 179 QYGPP------VDVWAIGCVFAELLSGV 200
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 53/222 (23%), Positives = 85/222 (38%), Gaps = 54/222 (24%)
Query: 388 VLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGEREFRAEVEIISRV-HHRHLVSLVGY 445
VLG G G V + G++ A+K L + R EV+ + H+V ++
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLY-----DSPKARQEVDHHWQASGGPHIVCILD- 89
Query: 446 CISERERLLVYEYVPNDTLHYHLHAEGRPVMDWAT------RV----------KVAAGAA 489
VYE + + + +M+ R+ + AA
Sbjct: 90 ---------VYENMHHGKRCLLI------IMECMEGGELFSRIQERGDQAFTEREAAEIM 134
Query: 490 R----GIAYLHEDCHPRIIHRDIKSSNILLDSSFEA---RVADFGLAKIALELDSNTHVS 542
R I +LH I HRD+K N+L S + ++ DFG AK + +
Sbjct: 135 RDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE----TTQNALQ 187
Query: 543 TRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKP 584
T T Y+APE K + D++S GV++ L+ G P
Sbjct: 188 TPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 1e-22
Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 28/208 (13%)
Query: 387 NVLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGEREFRA--EVEIISRVHHRHLVSLV 443
++GEG +G V K GR VA+K+ + A E++++ ++ H +LV+L+
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLL 90
Query: 444 GYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRI 503
C ++ LV+E+V + L L +D+ K GI + H H I
Sbjct: 91 EVCKKKKRWYLVFEFVDHTILDD-LELFPNG-LDYQVVQKYLFQIINGIGFCHS--H-NI 145
Query: 504 IHRDIKSSNILLDSSFEARVADFGLAK-IALELDSNTH-VSTRVMGTFGYMAPE------ 555
IHRDIK NIL+ S ++ DFG A+ +A + V+TR Y APE
Sbjct: 146 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATR-----WYRAPELLVGDV 200
Query: 556 -YATSGKLTEKSDVYSFGVVLLELITGR 582
Y + DV++ G ++ E+ G
Sbjct: 201 KYGKA------VDVWAIGCLVTEMFMGE 222
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-22
Identities = 58/216 (26%), Positives = 93/216 (43%), Gaps = 25/216 (11%)
Query: 383 FSAHNVLGEGGFGCVYKGVLADGREV-AVKQLK----IGGSQGEREFRAEVEIISRVHHR 437
F V+G G FG V L + +V A+K L + ++ FR E +++ +
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETAC-FREERDVLVNGDSK 134
Query: 438 HLVSLVGYCISERERL-LVYEYVPNDTLHYHLH-AEGRPVMDWATRVKV-AAGAARGIAY 494
+ +L Y + L LV +Y L L E R + A + A I
Sbjct: 135 WITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMA---RFYLAEMVIAIDS 190
Query: 495 LHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVM-GTFGYMA 553
+H+ +HRDIK NIL+D + R+ADFG +L + V + V GT Y++
Sbjct: 191 VHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCL---KLMEDGTVQSSVAVGTPDYIS 244
Query: 554 PEYATSGKLTEKS-----DVYSFGVVLLELITGRKP 584
PE + + + D +S GV + E++ G P
Sbjct: 245 PEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-22
Identities = 57/212 (26%), Positives = 87/212 (41%), Gaps = 34/212 (16%)
Query: 389 LGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCI 447
+G G FG VAVK ++ G + E R E+ + H ++V +
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQR-EIINHRSLRHPNIVRFKEVIL 86
Query: 448 SERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAAR--------GIAYLHEDC 499
+ ++ EY L+ + GR + AR G++Y C
Sbjct: 87 TPTHLAIIMEYASGGELYERICNAGR----------FSEDEARFFFQQLLSGVSY----C 132
Query: 500 HPR-IIHRDIKSSNILLDSSFEAR--VADFGLAKIALELDSNTHVSTRVMGTFGYMAPEY 556
H I HRD+K N LLD S R + DFG +K + L S + V GT Y+APE
Sbjct: 133 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VLHSQPK--STV-GTPAYIAPE- 187
Query: 557 ATSGKLTE--KSDVYSFGVVLLELITGRKPVD 586
+ + +DV+S GV L ++ G P +
Sbjct: 188 VLLRQEYDGKIADVWSCGVTLYVMLVGAYPFE 219
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 3e-22
Identities = 60/217 (27%), Positives = 92/217 (42%), Gaps = 43/217 (19%)
Query: 389 LGEGGFGCVYKGV-LADGREVAVKQL---KIGGSQGEREFRAEVEIISRVHHRHLVSLVG 444
LGEG FG V ++VA+K + + S E+ + + H H++ L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 445 YCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAAR--------GIAYLH 496
+ + ++V EY + L ++ + R + R I Y
Sbjct: 77 VITTPTDIVMVIEYAGGE-LFDYIVEKKR----------MTEDEGRRFFQQIICAIEY-- 123
Query: 497 EDCHPR-IIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTF-G---Y 551
CH I+HRD+K N+LLD + ++ADFGL SN + T G Y
Sbjct: 124 --CHRHKIVHRDLKPENLLLDDNLNVKIADFGL--------SNIMTDGNFLKTSCGSPNY 173
Query: 552 MAPEYATSGKLTE--KSDVYSFGVVLLELITGRKPVD 586
APE +GKL + DV+S G+VL ++ GR P D
Sbjct: 174 AAPE-VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 5e-22
Identities = 65/217 (29%), Positives = 94/217 (43%), Gaps = 42/217 (19%)
Query: 389 LGEGGFGCVYKGV-LADGREVAVKQL---KIGGSQGEREFRAEVEIISRVHHRHLVSLVG 444
LG G FG V G G +VAVK L KI + R E++ + H H++ L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 445 YCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAAR--------GIAYLH 496
+ + +V EYV L ++ GR + +R G+ Y
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYICKNGR----------LDEKESRRLFQQILSGVDY-- 131
Query: 497 EDCHPR-IIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTF----GY 551
CH ++HRD+K N+LLD+ A++ADFGL SN + T Y
Sbjct: 132 --CHRHMVVHRDLKPENVLLDAHMNAKIADFGL--------SNMMSDGEFLRTSCGSPNY 181
Query: 552 MAPEYATSGKLTE--KSDVYSFGVVLLELITGRKPVD 586
APE SG+L + D++S GV+L L+ G P D
Sbjct: 182 AAPE-VISGRLYAGPEVDIWSSGVILYALLCGTLPFD 217
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 6e-22
Identities = 55/219 (25%), Positives = 90/219 (41%), Gaps = 40/219 (18%)
Query: 387 NVLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGEREFRAEV------EI-----ISRV 434
+G G +G VYK G VA+K +++ + E+ +
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSVRVPN---GGGGGGGLPISTVREVALLRRLEAF 71
Query: 435 HHRHLVSL----VGYCISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAA 489
H ++V L ++ LV+E+V D L +L P + T +
Sbjct: 72 EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQD-LRTYLDKAPPPGLPAETIKDLMRQFL 130
Query: 490 RGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTF 549
RG+ +LH + I+HRD+K NIL+ S ++ADFGLA+ ++ V+ T
Sbjct: 131 RGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLAR---IYSYQMALTPVVV-TL 183
Query: 550 GYMAPE------YATSGKLTEKSDVYSFGVVLLELITGR 582
Y APE YAT D++S G + E+ +
Sbjct: 184 WYRAPEVLLQSTYATP------VDMWSVGCIFAEMFRRK 216
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 7e-22
Identities = 66/218 (30%), Positives = 99/218 (45%), Gaps = 28/218 (12%)
Query: 383 FSAHNVLGEGGFGCVY---KGVLADGREV-AVKQLK---IGGSQGEREF-RAEVEIISRV 434
F VLG G +G V+ K D ++ A+K LK I E R E +++ +
Sbjct: 56 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 115
Query: 435 -HHRHLVSLVGYCISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKV-AAGAARG 491
LV+L Y +L L+ +Y+ L HL R V++
Sbjct: 116 RQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEH---EVQIYVGEIVLA 171
Query: 492 IAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVM-GTFG 550
+ +LH+ II+RDIK NILLDS+ + DFGL+K + ++ GT
Sbjct: 172 LEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER---AYDFCGTIE 225
Query: 551 YMAPE---YATSGKLTEKS-DVYSFGVVLLELITGRKP 584
YMAP+ SG +K+ D +S GV++ EL+TG P
Sbjct: 226 YMAPDIVRGGDSGH--DKAVDWWSLGVLMYELLTGASP 261
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 9e-22
Identities = 55/218 (25%), Positives = 85/218 (38%), Gaps = 38/218 (17%)
Query: 389 LGEGGFGCVYKGV-LADGREVAVKQL---KIGGSQGEREFRA-----EVEIISRVHHRHL 439
LG G FG V+ V +EV VK + K+ + + E+ I+SRV H ++
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 440 VSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDW-ATRVKVAAGAAR-------- 490
+ ++ ++ LV E H G + + ++ A
Sbjct: 92 IKVLDIFENQGFFQLVMEK----------HGSGLDLFAFIDRHPRLDEPLASYIFRQLVS 141
Query: 491 GIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFG 550
+ YL IIHRDIK NI++ F ++ DFG A L+ T GT
Sbjct: 142 AVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAY---LERGKLFYTFC-GTIE 194
Query: 551 YMAPEYATSGKLTE--KSDVYSFGVVLLELITGRKPVD 586
Y APE G + +++S GV L L+ P
Sbjct: 195 YCAPE-VLMGNPYRGPELEMWSLGVTLYTLVFEENPFC 231
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 1e-21
Identities = 56/213 (26%), Positives = 104/213 (48%), Gaps = 34/213 (15%)
Query: 387 NVLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGE-----REFRAEVEIISRVHHRHLV 440
LG G + VYKG+ G VA+K++K+ +G RE + ++ + H ++V
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIRE----ISLMKELKHENIV 66
Query: 441 SLVGYCISERERLLVYEYVPND---TLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHE 497
L +E + LV+E++ ND + ++ +G+A+ HE
Sbjct: 67 RLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE 126
Query: 498 DCHPRIIHRDIKSSNILLDSSFEARVADFGLAK-IALELDSNTHVSTRVMGTFGYMAPE- 555
+ +I+HRD+K N+L++ + ++ DFGLA+ + +++ + V+ T Y AP+
Sbjct: 127 N---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS---EVV-TLWYRAPDV 179
Query: 556 ------YATSGKLTEKSDVYSFGVVLLELITGR 582
Y+TS D++S G +L E+ITG+
Sbjct: 180 LMGSRTYSTS------IDIWSCGCILAEMITGK 206
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-21
Identities = 65/220 (29%), Positives = 90/220 (40%), Gaps = 27/220 (12%)
Query: 383 FSAHNVLGEGGFGCVYKGVLA----DGREVAVKQLK----IGGSQGEREFRAEVEIISRV 434
F LG G FG V L G A+K L + Q E E I+ V
Sbjct: 43 FDRIKTLGTGSFGRVM---LVKHKESGNHYAMKILDKQKVVKLKQIEH-TLNEKRILQAV 98
Query: 435 HHRHLVSLVGYCISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKV-AAGAARGI 492
+ LV L + + L +V EYV + HL GR A + AA
Sbjct: 99 NFPFLVKLE-FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA---RFYAAQIVLTF 154
Query: 493 AYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYM 552
YLH +I+RD+K N+L+D +V DFG AK + T T + GT +
Sbjct: 155 EYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGRTW--T-LCGTPEAL 205
Query: 553 APEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLG 592
APE S + D ++ GV++ E+ G P A QP+
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 1e-21
Identities = 56/213 (26%), Positives = 101/213 (47%), Gaps = 35/213 (16%)
Query: 387 NVLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGERE------FRAEVEIISRVHHRHL 439
+ LGEG F VYK + VA+K++K+G ++ R E++++ + H ++
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR-EIKLLQELSHPNI 74
Query: 440 VSLVGYCISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAG-AARGIAYLHE 497
+ L+ + + LV++++ D L + + + +K +G+ YLH+
Sbjct: 75 IGLLD-AFGHKSNISLVFDFMETD-LEVIIKDNSLVLT--PSHIKAYMLMTLQGLEYLHQ 130
Query: 498 DCHPRIIHRDIKSSNILLDSSFEARVADFGLAKI-ALELDSNTHVSTRVMGTFGYMAPE- 555
I+HRD+K +N+LLD + ++ADFGLAK + TH +V+ T Y APE
Sbjct: 131 H---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH---QVV-TRWYRAPEL 183
Query: 556 ------YATSGKLTEKSDVYSFGVVLLELITGR 582
Y D+++ G +L EL+
Sbjct: 184 LFGARMYGVG------VDMWAVGCILAELLLRV 210
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 2e-21
Identities = 59/223 (26%), Positives = 88/223 (39%), Gaps = 30/223 (13%)
Query: 383 FSAHNVLGEGGFGCVY----KGVLADGREVAVKQLK----IGGSQGEREFRAEVEIISRV 434
+ V+G G FG V K + A+K L I S F E +I++
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAF-FWEERDIMAFA 126
Query: 435 HHRHLVSLVGYCISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKV-AAGAARGI 492
+ +V L Y + L +V EY+P L + P WA + A +
Sbjct: 127 NSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVP-EKWA---RFYTAEVVLAL 181
Query: 493 AYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVM-GTFGY 551
+H IHRD+K N+LLD S ++ADFG +++ V GT Y
Sbjct: 182 DAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCM---KMNKEGMVRCDTAVGTPDY 235
Query: 552 MAPE----YATSGKLTEKSDVYSFGVVLLELITGRKPVDASQP 590
++PE G + D +S GV L E++ G P A
Sbjct: 236 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL 278
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 53/214 (24%), Positives = 88/214 (41%), Gaps = 28/214 (13%)
Query: 388 VLGEGGFGCVYKGV-LADGREVAVKQLK-------IGGSQGEREFRAEVEIISRVHHR-- 437
+LG GGFG VY G+ ++D VA+K ++ G R EV ++ +V
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM-EVVLLKKVSSGFS 108
Query: 438 HLVSLVGYCISERERLLVYEYV-PNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLH 496
++ L+ + +L+ E P L + G + + +
Sbjct: 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEAVRH-- 164
Query: 497 EDCHPR-IIHRDIKSSNILLDS-SFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAP 554
CH ++HRDIK NIL+D E ++ DFG AL D+ GT Y P
Sbjct: 165 --CHNCGVLHRDIKDENILIDLNRGELKLIDFGSG--ALLKDTVYTDFD---GTRVYSPP 217
Query: 555 EYATSGKLTE--KSDVYSFGVVLLELITGRKPVD 586
E+ + V+S G++L +++ G P +
Sbjct: 218 EW-IRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 250
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 5e-21
Identities = 66/217 (30%), Positives = 98/217 (45%), Gaps = 33/217 (15%)
Query: 383 FSAHNVLGEGGFGCVYKGVLA----DGREVAVKQLK----IGGSQGEREFRAEVEIISRV 434
F H +LG+G FG V+ LA + A+K LK + E E ++S
Sbjct: 19 FILHKMLGKGSFGKVF---LAEFKKTNQFFAIKALKKDVVLMDDDVEC-TMVEKRVLSLA 74
Query: 435 -HHRHLVSLVGYCISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKV-AAGAARG 491
H L + +E L V EY+ L YH+ + + + R AA G
Sbjct: 75 WEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS---RATFYAAEIILG 130
Query: 492 IAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTF-G 550
+ +LH I++RD+K NILLD ++ADFG+ K + D+ T+ TF G
Sbjct: 131 LQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN-------TFCG 180
Query: 551 ---YMAPEYATSGKLTEKSDVYSFGVVLLELITGRKP 584
Y+APE K D +SFGV+L E++ G+ P
Sbjct: 181 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 5e-21
Identities = 54/216 (25%), Positives = 91/216 (42%), Gaps = 40/216 (18%)
Query: 387 NVLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGERE------FRAEVEIISRVHHRHL 439
LGEG +G VYK + VA+K++++ E E R EV ++ + HR++
Sbjct: 40 TKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH---EEEGVPGTAIR-EVSLLKELQHRNI 95
Query: 440 VSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDC 499
+ L L++EY ND L ++ + P + G+ + H
Sbjct: 96 IELKSVIHHNHRLHLIFEYAEND-LKKYM--DKNPDVSMRVIKSFLYQLINGVNFCH--- 149
Query: 500 HPRIIHRDIKSSNILLDSSFEAR-----VADFGLAKI-ALELDSNTHVSTRVMGTFGYMA 553
R +HRD+K N+LL S + + DFGLA+ + + TH ++ T Y
Sbjct: 150 SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH---EII-TLWYRP 205
Query: 554 PE-------YATSGKLTEKSDVYSFGVVLLELITGR 582
PE Y+TS D++S + E++
Sbjct: 206 PEILLGSRHYSTS------VDIWSIACIWAEMLMKT 235
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 8e-21
Identities = 60/224 (26%), Positives = 96/224 (42%), Gaps = 35/224 (15%)
Query: 383 FSAHNVLGEGGFGCVYKGVLA----DGREVAVKQLK----IGGSQGEREFRAEVEIISRV 434
F LG G FG V+ L +GR A+K LK + Q E E ++S V
Sbjct: 8 FQILRTLGTGSFGRVH---LIRSRHNGRYYAMKVLKKEIVVRLKQVEHT-NDERLMLSIV 63
Query: 435 HHRHLVSLVGYCISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKV-AAGAARGI 492
H ++ + + +++ ++ +Y+ L L R K AA +
Sbjct: 64 THPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP---VAKFYAAEVCLAL 119
Query: 493 AYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTF-G- 550
YLH II+RD+K NILLD + ++ DFG AK + T+ T G
Sbjct: 120 EYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAK---YVPDVTY-------TLCGT 166
Query: 551 --YMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLG 592
Y+APE ++ + D +SFG+++ E++ G P S +
Sbjct: 167 PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK 210
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 8e-21
Identities = 68/216 (31%), Positives = 94/216 (43%), Gaps = 31/216 (14%)
Query: 383 FSAHNVLGEGGFGCVYKGVLA----DGREVAVKQLK----IGGSQGEREFRAEVEIISRV 434
F+ VLG+G FG V L+ AVK LK I E E +++
Sbjct: 22 FNFLMVLGKGSFGKVM---LSERKGTDELYAVKILKKDVVIQDDDVECT-MVEKRVLALP 77
Query: 435 -HHRHLVSLVGYCISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGI 492
L L C +RL V EYV L YH+ GR A V AA A G+
Sbjct: 78 GKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA--VFYAAEIAIGL 134
Query: 493 AYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTF-G- 550
+L II+RD+K N++LDS ++ADFG+ K + T TF G
Sbjct: 135 FFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK-------TFCGT 184
Query: 551 --YMAPEYATSGKLTEKSDVYSFGVVLLELITGRKP 584
Y+APE + D ++FGV+L E++ G+ P
Sbjct: 185 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 8e-21
Identities = 57/210 (27%), Positives = 100/210 (47%), Gaps = 33/210 (15%)
Query: 387 NVLGEGGFGCVYKG-VLADGREVAVKQLKIGGSQGE-----REFRAEVEIISRVHHRHLV 440
+ LGEG + VYKG VA+K++++ +G RE V ++ + H ++V
Sbjct: 8 DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIRE----VSLLKDLKHANIV 63
Query: 441 SLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCH 500
+L +E+ LV+EY+ D L +L G ++ RG+AY H
Sbjct: 64 TLHDIIHTEKSLTLVFEYLDKD-LKQYLDDCGNI-INMHNVKLFLFQLLRGLAYCH---R 118
Query: 501 PRIIHRDIKSSNILLDSSFEARVADFGLAKI-ALELDSNTHVSTRVMGTFGYMAPE---- 555
+++HRD+K N+L++ E ++ADFGLA+ ++ + + V+ T Y P+
Sbjct: 119 QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN---EVV-TLWYRPPDILLG 174
Query: 556 ---YATSGKLTEKSDVYSFGVVLLELITGR 582
Y+T D++ G + E+ TGR
Sbjct: 175 STDYSTQ------IDMWGVGCIFYEMATGR 198
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 8e-21
Identities = 58/217 (26%), Positives = 90/217 (41%), Gaps = 33/217 (15%)
Query: 383 FSAHNVLGEGGFGCVYKGVLA----DGREVAVKQLK----IGGSQGEREFRAEVEIISRV 434
F V+G G + V L R A+K +K + + E + +
Sbjct: 11 FDLLRVIGRGSYAKVL---LVRLKKTDRIYAMKVVKKELVNDDEDIDWV-QTEKHVFEQA 66
Query: 435 -HHRHLVSLVGYCISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKV-AAGAARG 491
+H LV L C RL V EYV L +H+ + + + + +A +
Sbjct: 67 SNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE---HARFYSAEISLA 122
Query: 492 IAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTF-G 550
+ YLHE II+RD+K N+LLDS ++ D+G+ K L T TF G
Sbjct: 123 LNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS-------TFCG 172
Query: 551 ---YMAPEYATSGKLTEKSDVYSFGVVLLELITGRKP 584
Y+APE D ++ GV++ E++ GR P
Sbjct: 173 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 1e-20
Identities = 57/258 (22%), Positives = 103/258 (39%), Gaps = 66/258 (25%)
Query: 389 LGEGGFGCVYKGV---LADGREVAVKQLKIGG--SQGEREFRAEVEIISRVHHRHLVSLV 443
+G G +G VYK D ++ A+KQ++ G RE + ++ + H +++SL
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACRE----IALLRELKHPNVISLQ 84
Query: 444 GYCISERERL--LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAA------------ 489
+S +R L+++Y +D H + + K
Sbjct: 85 KVFLSHADRKVWLLFDYAEHDLWHI---------IKFHRASKANKKPVQLPRGMVKSLLY 135
Query: 490 ---RGIAYLHEDCHPRIIHRDIKSSNILLDSSFEAR----VADFGLAKI-ALELDSNTHV 541
GI YLH + ++HRD+K +NIL+ R +AD G A++ L +
Sbjct: 136 QILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 192
Query: 542 STRVMGTFGYMAPE-------YATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPL--G 592
V+ TF Y APE Y + D+++ G + EL+T P+
Sbjct: 193 DPVVV-TFWYRAPELLLGARHYTKA------IDIWAIGCIFAELLTSE-------PIFHC 238
Query: 593 DESLVEWARPLLAEALEH 610
+ ++ + P + L+
Sbjct: 239 RQEDIKTSNPYHHDQLDR 256
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 66/240 (27%), Positives = 107/240 (44%), Gaps = 50/240 (20%)
Query: 365 GNSRSWFTYDELIQATNGFSAHNVLGEGGFGCVYKG--VLADGREVAVKQLKIGGSQGER 422
G R+ Y+ + +GEG +G V+K + GR VA+K++++ Q
Sbjct: 5 GLCRADQQYECV----------AEIGEGAYGKVFKARDLKNGGRFVALKRVRV---QTGE 51
Query: 423 E------FRAEVEI---ISRVHHRHLVSL----VGYCISERERL-LVYEYVPNDTLHYHL 468
E R EV + + H ++V L +L LV+E+V D L +L
Sbjct: 52 EGMPLSTIR-EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYL 109
Query: 469 HAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGL 528
P + T + RG+ +LH R++HRD+K NIL+ SS + ++ADFGL
Sbjct: 110 DKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL 166
Query: 529 AKIALELDSNTHVSTRVMGTFGYMAPE------YATSGKLTEKSDVYSFGVVLLELITGR 582
A+I +++ V+ T Y APE YAT D++S G + E+ +
Sbjct: 167 ARI---YSFQMALTSVVV-TLWYRAPEVLLQSSYATP------VDLWSVGCIFAEMFRRK 216
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-20
Identities = 50/216 (23%), Positives = 90/216 (41%), Gaps = 34/216 (15%)
Query: 388 VLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGE--------------REFRAEVEIISR 433
+ G +G V GV ++G VA+K ++ + + R R E+ +++
Sbjct: 29 FISSGSYGAVCAGVDSEGIPVAIK--RVFNTVSDGRTVNILSDSFLCKRVLR-EIRLLNH 85
Query: 434 VHHRHLVSLVGYCISERERL-----LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGA 488
HH +++ L + E LV E + D L +H + + + +
Sbjct: 86 FHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTD-LAQVIHDQRIVISPQHIQYFMYH-I 143
Query: 489 ARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNT-HVSTRVMG 547
G+ LHE ++HRD+ NILL + + + DF LA+ + T +V+ R
Sbjct: 144 LLGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRW-- 198
Query: 548 TFGYMAPEY-ATSGKLTEKSDVYSFGVVLLELITGR 582
Y APE T+ D++S G V+ E+ +
Sbjct: 199 ---YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 3e-20
Identities = 55/252 (21%), Positives = 95/252 (37%), Gaps = 73/252 (28%)
Query: 383 FSAHNVLGEGGFGCVYKGVLAD-GREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVS 441
+S LG G FG V + + G+ A+K++ + R E++I+ + H +++
Sbjct: 9 YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ---DPRYKNR-ELDIMKVLDHVNIIK 64
Query: 442 LVGYCISERERL--------------------------------------LVYEYVPNDT 463
LV Y + + ++ EYVP+
Sbjct: 65 LVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDT- 123
Query: 464 LHYHLHAEGRPVMDWATRVKVAAGAA----------RGIAYLHEDCHPRIIHRDIKSSNI 513
LH V+ R + R + ++H I HRDIK N+
Sbjct: 124 ----LHK----VLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNL 172
Query: 514 LLDS-SFEARVADFGLAKIALELDSNTH-VSTRVMGTFGYMAPE-YATSGKLTEKSDVYS 570
L++S ++ DFG AK + + + + +R Y APE + + T D++S
Sbjct: 173 LVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPELMLGATEYTPSIDLWS 227
Query: 571 FGVVLLELITGR 582
G V ELI G+
Sbjct: 228 IGCVFGELILGK 239
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 4e-20
Identities = 66/217 (30%), Positives = 95/217 (43%), Gaps = 33/217 (15%)
Query: 383 FSAHNVLGEGGFGCVYKGVLA----DGREVAVKQLK----IGGSQGEREFRAEVEIISR- 433
F V+G+G FG V LA + AVK L+ + + + +E ++ +
Sbjct: 40 FHFLKVIGKGSFGKVL---LARHKAEEVFYAVKVLQKKAILKKKEEKHI-MSERNVLLKN 95
Query: 434 VHHRHLVSLVGYCISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKV-AAGAARG 491
V H LV L + ++L V +Y+ L YHL E + R + AA A
Sbjct: 96 VKHPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEP---RARFYAAEIASA 151
Query: 492 IAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTF-G 550
+ YLH I++RD+K NILLDS + DFGL K +E +S T TF G
Sbjct: 152 LGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTS-------TFCG 201
Query: 551 ---YMAPEYATSGKLTEKSDVYSFGVVLLELITGRKP 584
Y+APE D + G VL E++ G P
Sbjct: 202 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 4e-20
Identities = 65/298 (21%), Positives = 97/298 (32%), Gaps = 64/298 (21%)
Query: 323 PSPYASSQKSDSVFLRPHSPAPLVGNGSNSGFSRSPSESGVLGNSRSWFTYDELIQATNG 382
P+P Q P + P F Y
Sbjct: 15 PAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIID--DYKVT------ 66
Query: 383 FSAHNVLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGEREFRAEVEIISRV-HHRHLV 440
VLG G G V + + A+K L + R EVE+ R H+V
Sbjct: 67 ---SQVLGLGINGKVLQIFNKRTQEKFALKML----QDCPKARR-EVELHWRASQCPHIV 118
Query: 441 SLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWAT------RV----------KV 484
+V VYE + + VM+ R+ +
Sbjct: 119 RIVD----------VYENLYAGRKCLLI------VMECLDGGELFSRIQDRGDQAFTERE 162
Query: 485 AAGAAR----GIAYLHEDCHPRIIHRDIKSSNILLDSSFEA---RVADFGLAKIALELDS 537
A+ + I YLH I HRD+K N+L S ++ DFG AK E S
Sbjct: 163 ASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTS 216
Query: 538 NTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDES 595
+ ++T T Y+APE K + D++S GV++ L+ G P ++ L
Sbjct: 217 HNSLTTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP 273
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 4e-20
Identities = 66/216 (30%), Positives = 90/216 (41%), Gaps = 31/216 (14%)
Query: 383 FSAHNVLGEGGFGCVYKGVLA----DGREVAVKQLK----IGGSQGEREFRAEVEIISRV 434
F VLG+G FG V LA G AVK LK + E E I+S
Sbjct: 25 FEFIRVLGKGSFGKVM---LARVKETGDLYAVKVLKKDVILQDDDVECT-MTEKRILSLA 80
Query: 435 -HHRHLVSLVGYCISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGI 492
+H L L C +RL V E+V L +H+ R A AA +
Sbjct: 81 RNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARA--RFYAAEIISAL 137
Query: 493 AYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTF-G- 550
+LH+ II+RD+K N+LLD ++ADFG+ K + T TF G
Sbjct: 138 MFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTA-------TFCGT 187
Query: 551 --YMAPEYATSGKLTEKSDVYSFGVVLLELITGRKP 584
Y+APE D ++ GV+L E++ G P
Sbjct: 188 PDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 6e-20
Identities = 56/214 (26%), Positives = 90/214 (42%), Gaps = 27/214 (12%)
Query: 383 FSAHNVLGEGGFGCVYKGVLADGREV-AVKQLK----IGGSQGEREFRAEVEIISRV-HH 436
F V+G G + V L + A++ +K + + E + + +H
Sbjct: 54 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWV-QTEKHVFEQASNH 112
Query: 437 RHLVSLVGYCISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKV-AAGAARGIAY 494
LV L C RL V EYV L +H+ + + + + +A + + Y
Sbjct: 113 PFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE---HARFYSAEISLALNY 168
Query: 495 LHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTF-G--- 550
LHE II+RD+K N+LLDS ++ D+G+ K L T TF G
Sbjct: 169 LHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS-------TFCGTPN 218
Query: 551 YMAPEYATSGKLTEKSDVYSFGVVLLELITGRKP 584
Y+APE D ++ GV++ E++ GR P
Sbjct: 219 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 6e-20
Identities = 57/224 (25%), Positives = 94/224 (41%), Gaps = 46/224 (20%)
Query: 388 VLGEGGFGCVYKGV-LADGREVAVKQLK-------IGGSQGEREFRAEVEIISRVH---- 435
+LG+GGFG V+ G L D +VA+K + S EV ++ +V
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL-EVALLWKVGAGGG 96
Query: 436 HRHLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDW-ATRVKVAAGAAR---- 490
H ++ L+ + ++ +LV E + + D+ + + G +R
Sbjct: 97 HPGVIRLLDWFETQEGFMLVLERPLP----------AQDLFDYITEKGPLGEGPSRCFFG 146
Query: 491 ----GIAYLHEDCHPR-IIHRDIKSSNILLDS-SFEARVADFGLAKIALELDSNTHVSTR 544
I + CH R ++HRDIK NIL+D A++ DFG AL D
Sbjct: 147 QVVAAIQH----CHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG--ALLHDEPYTDFD- 199
Query: 545 VMGTFGYMAPEYATSGKLTE--KSDVYSFGVVLLELITGRKPVD 586
GT Y PE+ S + V+S G++L +++ G P +
Sbjct: 200 --GTRVYSPPEW-ISRHQYHALPATVWSLGILLYDMVCGDIPFE 240
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 90.0 bits (223), Expect = 2e-19
Identities = 60/270 (22%), Positives = 98/270 (36%), Gaps = 72/270 (26%)
Query: 386 HNVLGEGGFGCVYKGVL------ADGREVAVKQLKIGGSQGER-EFRAEVEIISRV-HHR 437
LG G FG V + A R VAVK LK G + E +E++I+ + HH
Sbjct: 27 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 86
Query: 438 HLVSLVGYCISERERLLV-YEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLH 496
++V+L+G C L+V E+ L +L ++ + + T+ + +
Sbjct: 87 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIP 146
Query: 497 EDCHPRI-------------------------------IHRDIKSSNILLDSSFE----- 520
D R+ +++D + L+ SF+
Sbjct: 147 VDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGM 206
Query: 521 --------------AR-----------VADFGLAKIALELDSNTHVSTRVMGTFGYMAPE 555
AR + DFGLA+ + D + +MAPE
Sbjct: 207 EFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK-DPDYVRKGDARLPLKWMAPE 265
Query: 556 YATSGKLTEKSDVYSFGVVLLELIT-GRKP 584
T +SDV+SFGV+L E+ + G P
Sbjct: 266 TIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 5e-19
Identities = 53/219 (24%), Positives = 101/219 (46%), Gaps = 38/219 (17%)
Query: 387 NVLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGERE------FRAEVEIISRVHHRHL 439
+G+G FG V+K G++VA+K++ + + E+E R E++I+ + H ++
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQKVALKKVLM---ENEKEGFPITALR-EIKILQLLKHENV 78
Query: 440 VSLVGYCISERERL--------LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARG 491
V+L+ C ++ LV+++ +D L L + +V G
Sbjct: 79 VNLIEICRTKASPYNRCKGSIYLVFDFCEHD-LAGLLSNVLVK-FTLSEIKRVMQMLLNG 136
Query: 492 IAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLA-KIALELDSNTHVSTRVMGTFG 550
+ Y+H + +I+HRD+K++N+L+ ++ADFGLA +L +S + T + T
Sbjct: 137 LYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 193
Query: 551 YMAPE-------YATSGKLTEKSDVYSFGVVLLELITGR 582
Y PE Y D++ G ++ E+ T
Sbjct: 194 YRPPELLLGERDYGPP------IDLWGAGCIMAEMWTRS 226
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 90.5 bits (224), Expect = 6e-19
Identities = 68/209 (32%), Positives = 94/209 (44%), Gaps = 17/209 (8%)
Query: 383 FSAHNVLGEGGFGCVYKGVLADGREV-AVKQLK----IGGSQGEREFRAEVEIISRV-HH 436
F+ VLG+G FG V E+ AVK LK I E E +++
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECT-MVEKRVLALPGKP 401
Query: 437 RHLVSLVGYCISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYL 495
L L C +RL V EYV L YH+ GR A V AA A G+ +L
Sbjct: 402 PFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA--VFYAAEIAIGLFFL 458
Query: 496 HEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPE 555
II+RD+K N++LDS ++ADFG+ K + T T GT Y+APE
Sbjct: 459 QSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT--KT-FCGTPDYIAPE 512
Query: 556 YATSGKLTEKSDVYSFGVVLLELITGRKP 584
+ D ++FGV+L E++ G+ P
Sbjct: 513 IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 6e-19
Identities = 46/220 (20%), Positives = 90/220 (40%), Gaps = 57/220 (25%)
Query: 389 LGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGEREFRAEVEIISRV-HHRHLVSLVGYC 446
LG G + V++ + + + +V VK LK + ++ R E++I+ + ++++L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKP--VKKKKIKR-EIKILENLRGGPNIITL--AD 98
Query: 447 I----SERERLLVYEYVPNDTLH---------------YHLHAEGRPVMDWATRVKVAAG 487
I R LV+E+V N Y +
Sbjct: 99 IVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEI------------------- 139
Query: 488 AARGIAYLHEDCHPRIIHRDIKSSNILLDSSF-EARVADFGLAKIALELDSNTH-VSTRV 545
+ + Y H I+HRD+K N+++D + R+ D+GLA+ V++R
Sbjct: 140 -LKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY 195
Query: 546 MGTFGYMAPEYATSGKLTEKS-DVYSFGVVLLELITGRKP 584
+ PE ++ + S D++S G +L +I ++P
Sbjct: 196 -----FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 89.9 bits (222), Expect = 1e-18
Identities = 27/199 (13%), Positives = 45/199 (22%)
Query: 29 PPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPP 88
P + +TP P P + PP A P
Sbjct: 4 HKKRVYPQAQLQYGQNATPLQQPAQFMPPQDPAAAGMSYGQMGMPPQGAVPSMGQQQFLT 63
Query: 89 SPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPA 148
+ Q + + ++ P A + P + P ++
Sbjct: 64 PAQEQLHQQIDQATTSMNDMHLHNVPLVDPNAYMQPQVPVQMGTPLQQQQQPMAAPAYGQ 123
Query: 149 NVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSP 208
A + P P + PPP + P PS+ +
Sbjct: 124 PSAAMGQNMRPMNQLYPIDLLTELPPPITDLTLPPPPLVIPPERMLVPSELSNASPDYIR 183
Query: 209 PASTLSPPPPSVPSTSSPP 227
P S+ S P
Sbjct: 184 STLNAVPKNSSLLKKSKLP 202
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 88.7 bits (219), Expect = 3e-18
Identities = 34/229 (14%), Positives = 45/229 (19%), Gaps = 4/229 (1%)
Query: 7 PPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPP 66
V + P P PP PP PS P
Sbjct: 5 KKRVYPQAQLQYGQNATPLQQPAQFMPPQDPAAAGMSYGQMGMPPQGAVPSMGQQQFLTP 64
Query: 67 QPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTP 126
+D D + P A P P A P
Sbjct: 65 AQEQLHQQIDQATTSMNDMHLHNVPLVDPNAYMQPQVPVQMGTPLQQQQQPMAAPAYGQP 124
Query: 127 SSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPS 186
S++ P + PPP + PP P SN
Sbjct: 125 SAAMGQNMRPMNQLYPIDLLTELPPPITDLTLPPP-PLVIPPERMLVPSELSNASPDYIR 183
Query: 187 PPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPP 235
+ P + S + P + P PP
Sbjct: 184 STLNAVPKNSSLLKKSKL---PFGLVIRPYQHLYDDIDPPPLNEDGLIV 229
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 80.3 bits (197), Expect = 1e-15
Identities = 31/200 (15%), Positives = 45/200 (22%), Gaps = 1/200 (0%)
Query: 49 SPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANV 108
P + P P P P PPQ PS +
Sbjct: 3 HHKKRVYPQAQLQYGQNATPLQQPAQFMPPQDPAAAGMSYGQMGMPPQGAVPSMGQQQFL 62
Query: 109 PTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPP 168
T+ + + + P TP P+ P
Sbjct: 63 TPAQEQLHQQIDQATTSMNDMHLHNVPLVDPNAYMQPQVPVQMGTPLQQQQQPMAAPAYG 122
Query: 169 SSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTK-SPPASTLSPPPPSVPSTSSPP 227
S+ + P +LT P P P P + P ++
Sbjct: 123 QPSAAMGQNMRPMNQLYPIDLLTELPPPITDLTLPPPPLVIPPERMLVPSELSNASPDYI 182
Query: 228 AVSPPAPPSNSSTRGSPSTP 247
+ A P NSS P
Sbjct: 183 RSTLNAVPKNSSLLKKSKLP 202
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 69.9 bits (170), Expect = 2e-12
Identities = 26/189 (13%), Positives = 44/189 (23%), Gaps = 10/189 (5%)
Query: 86 SPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSP 145
S P + PA + PP +
Sbjct: 2 SHHKKRVYPQAQLQYGQNATPLQQPAQFMPPQDPAAAGMSYGQMGMPPQ--------GAV 53
Query: 146 PPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVT 205
P + + ++S N P P+ P P Q P
Sbjct: 54 PSMGQQQFLTPAQEQLHQQIDQATTSMNDMHLHNVPLVDPNAY--MQPQVPVQMGTPLQQ 111
Query: 206 KSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTPPLPSVPTEKPTAKSTNGT 265
+ P + + PS + ++ P + P T P +
Sbjct: 112 QQQPMAAPAYGQPSAAMGQNMRPMNQLYPIDLLTELPPPITDLTLPPPPLVIPPERMLVP 171
Query: 266 AVSANASPR 274
+ +NASP
Sbjct: 172 SELSNASPD 180
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 59.8 bits (144), Expect = 2e-09
Identities = 23/146 (15%), Positives = 29/146 (19%), Gaps = 5/146 (3%)
Query: 130 SPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPV 189
S V A P+ PP S P S
Sbjct: 2 SHHKKRVYPQAQLQYGQNATPLQQPAQFMPPQDPAAAGMSYGQMGMPPQGAVPSMGQQQF 61
Query: 190 LTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTPPL 249
LTP T S P A P P T P+
Sbjct: 62 LTPAQEQLHQQIDQATTSMN-----DMHLHNVPLVDPNAYMQPQVPVQMGTPLQQQQQPM 116
Query: 250 PSVPTEKPTAKSTNGTAVSANASPRN 275
+ +P+A P +
Sbjct: 117 AAPAYGQPSAAMGQNMRPMNQLYPID 142
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 47.9 bits (113), Expect = 1e-05
Identities = 14/134 (10%), Positives = 25/134 (18%), Gaps = 6/134 (4%)
Query: 144 SPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPP 203
S V P+ PP + S P Q A P
Sbjct: 2 SHHKKRVYPQAQLQYGQNATPLQQPAQFMPPQDPAAAGMSYG------QMGMPPQGAVPS 55
Query: 204 VTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTPPLPSVPTEKPTAKSTN 263
+ + + ++ + P +P +
Sbjct: 56 MGQQQFLTPAQEQLHQQIDQATTSMNDMHLHNVPLVDPNAYMQPQVPVQMGTPLQQQQQP 115
Query: 264 GTAVSANASPRNAG 277
A + G
Sbjct: 116 MAAPAYGQPSAAMG 129
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 2e-18
Identities = 55/214 (25%), Positives = 91/214 (42%), Gaps = 31/214 (14%)
Query: 383 FSAHNVLGEGGFGCVYKGV-LADGREVAVKQLKIGG-----SQGEREFRAEVEIISRVHH 436
+ +G G G V R VA+K K+ + +R +R E+ ++ V+H
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIK--KLSRPFQNQTHAKRAYR-ELVLMKCVNH 83
Query: 437 RHLVSLVGYCISERERL------LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAA-GAA 489
++++ L+ ++ +V E + + L + E R+
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LCQVIQMELDHE-----RMSYLLYQML 137
Query: 490 RGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNT-HVSTRVMGT 548
GI +LH IIHRD+K SNI++ S ++ DFGLA+ A T +V TR
Sbjct: 138 CGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY--- 191
Query: 549 FGYMAPEYATSGKLTEKSDVYSFGVVLLELITGR 582
Y APE E D++S G ++ E+I G
Sbjct: 192 --YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 6e-18
Identities = 51/233 (21%), Positives = 78/233 (33%), Gaps = 74/233 (31%)
Query: 388 VLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGEREFRAEVEIISRV-HHRHLVSLVGY 445
VLG G G V + + A+K L+ + R EVE+ R H+V +V
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVD- 78
Query: 446 CISERERLLVYEYVPNDTLHYHLHAEGRPVMDWAT------RV----------KVAAGAA 489
VYE + + VM+ R+ + A+
Sbjct: 79 ---------VYENLYAGRKCLLI------VMECLDGGELFSRIQDRGDQAFTEREASEIM 123
Query: 490 R----GIAYLHEDCHPRIIHRDIKSSNILLDSSFEA---RVADFGLAKIALELDSNTHVS 542
+ I YLH I HRD+K N+L S ++ DFG AK
Sbjct: 124 KSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE----------- 169
Query: 543 TRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDES 595
G Y + D++S GV++ L+ G P ++ L
Sbjct: 170 --TTGE-KY-----------DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP 208
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 5e-17
Identities = 31/247 (12%), Positives = 67/247 (27%), Gaps = 47/247 (19%)
Query: 388 VLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGE---REFRAEVEIISRVHHRHLVSLV 443
G ++ + A R+VA+ + G + +E + +SR+ + ++
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 444 GYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRI 503
+ L+V E++ +L + P A R A H +
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGAIRA--MQSLAAAADAAHRA---GV 150
Query: 504 IHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLT 563
S + V+ G +A M
Sbjct: 151 ALSIDHPSRVR--------VSIDGDVVLA---------------YPATMPDA-------N 180
Query: 564 EKSDVYSFGVVLLELITGRKPVDASQPLGDESLV------EWARPLLAEALEHEDFEALV 617
+ D+ G L L+ R P+ + + + P + A+
Sbjct: 181 PQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVA 240
Query: 618 DSRLEKN 624
++ +
Sbjct: 241 ARSVQGD 247
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 2e-16
Identities = 56/213 (26%), Positives = 91/213 (42%), Gaps = 29/213 (13%)
Query: 383 FSAHNVLGEGGFGCVYKGV-LADGREVAVKQLKIGG-----SQGEREFRAEVEIISRVHH 436
+ +G G G V R VA+K K+ + +R +R E+ ++ V+H
Sbjct: 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQNQTHAKRAYR-ELVLMKCVNH 120
Query: 437 RHLVSL--VGYCISERERL----LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAAR 490
++++SL V E LV E + + L + +D +
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LCQVIQMELDHERMSYLLYQMLC 175
Query: 491 GIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNT-HVSTRVMGTF 549
GI +LH IIHRD+K SNI++ S ++ DFGLA+ A T +V TR
Sbjct: 176 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---- 228
Query: 550 GYMAPEYATSGKLTEKSDVYSFGVVLLELITGR 582
Y APE E D++S G ++ E++ +
Sbjct: 229 -YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 5e-16
Identities = 49/229 (21%), Positives = 92/229 (40%), Gaps = 62/229 (27%)
Query: 383 FSAHNVLGEGGFGCVYKGV-LADGREVAVKQLKIGG-----SQGEREFRAEVEIISRVHH 436
+ + +G G +G V + G +VA+K K+ +R +R E+ ++ + H
Sbjct: 26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIK--KLSRPFQSEIFAKRAYR-ELLLLKHMQH 82
Query: 437 RHLVSL--VGYCISERERL----LVYEYVPNDTLH----------------YHLHAEGRP 474
+++ L V S LV ++ D L Y +
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFMQTD-LQKIMGLKFSEEKIQYLVYQM------ 135
Query: 475 VMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALE 534
+G+ Y+H ++HRD+K N+ ++ E ++ DFGLA+ A
Sbjct: 136 --------------LKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 178
Query: 535 LDSNTHVSTRVMGTFGYMAPEYA-TSGKLTEKSDVYSFGVVLLELITGR 582
+ +V TR Y APE + + D++S G ++ E++TG+
Sbjct: 179 -EMTGYVVTRW-----YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 53/228 (23%), Positives = 98/228 (42%), Gaps = 55/228 (24%)
Query: 383 FSAHNVLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGE----REFRAEVEIISRVHHR 437
++ + +GEG +G V + VA+K KI + + R R E++I+ R H
Sbjct: 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIK--KISPFEHQTYCQRTLR-EIKILLRFRHE 85
Query: 438 HLVSLVGYCISERERL-----LVYEYVPNDTLH-----------------YHLHAEGRPV 475
+++ + + +V + + D L+ Y +
Sbjct: 86 NIIGINDIIRAPTIEQMKDVYIVQDLMETD-LYKLLKTQHLSNDHICYFLYQI------- 137
Query: 476 MDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALEL 535
RG+ Y+H ++HRD+K SN+LL+++ + ++ DFGLA++A
Sbjct: 138 -------------LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181
Query: 536 DSNTHVSTRVMGTFGYMAPEYA-TSGKLTEKSDVYSFGVVLLELITGR 582
+T T + T Y APE S T+ D++S G +L E+++ R
Sbjct: 182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3gdb_A Endo-D, putative uncharacterized protein SPR0440; alpha-beta-barrels, cell WALL, peptidoglycan-anchor, secreted, hydrolase; HET: PGE; 1.87A {Streptococcus pneumoniae} PDB: 2xqx_A Length = 937 | Back alignment and structure |
|---|
Score = 78.9 bits (193), Expect = 4e-15
Identities = 15/208 (7%), Positives = 38/208 (18%), Gaps = 2/208 (0%)
Query: 12 AVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSP 71
P + S + A S P+S
Sbjct: 23 ETAVPENSGANTE--LVSGESEHSTNEADKQNEGEHARENKLEKAEGVATASETASPASN 80
Query: 72 PPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSP 131
P A + P + T + + P++ +
Sbjct: 81 EAATTETAEAASAAKPEEKASEVVAETPSAEAKPKSDKETEAKPEATNQGDESKPAAEAN 140
Query: 132 PPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLT 191
+ P +S + P + + ++ L
Sbjct: 141 KTEKEVQPDVPKNTEKTLKPKEIKFNSWEELLKWEPGAREDDAINRGSVVLASRRTGHLV 200
Query: 192 PPPHPSQSAPPPVTKSPPASTLSPPPPS 219
++ ++ + +
Sbjct: 201 NEKASKEAKVQALSNTNSKAKDHASVGG 228
|
| >3gdb_A Endo-D, putative uncharacterized protein SPR0440; alpha-beta-barrels, cell WALL, peptidoglycan-anchor, secreted, hydrolase; HET: PGE; 1.87A {Streptococcus pneumoniae} PDB: 2xqx_A Length = 937 | Back alignment and structure |
|---|
Score = 76.5 bits (187), Expect = 2e-14
Identities = 18/204 (8%), Positives = 33/204 (16%), Gaps = 2/204 (0%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
+ + + + A + + P+ A +
Sbjct: 30 SGANTELVSGESEHSTNEADKQNEGEHARENKLEKAEGVATASETASPASNEAATTETAE 89
Query: 61 VNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPP--PPANVPTTPSSSSPP 118
S + P E P + P+A P A T P
Sbjct: 90 AASAAKPEEKASEVVAETPSAEAKPKSDKETEAKPEATNQGDESKPAAEANKTEKEVQPD 149
Query: 119 PANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSS 178
N P A S + +
Sbjct: 150 VPKNTEKTLKPKEIKFNSWEELLKWEPGAREDDAINRGSVVLASRRTGHLVNEKASKEAK 209
Query: 179 NPPTSTPSPPVLTPPPHPSQSAPP 202
S + +
Sbjct: 210 VQALSNTNSKAKDHASVGGEEFKA 233
|
| >3gdb_A Endo-D, putative uncharacterized protein SPR0440; alpha-beta-barrels, cell WALL, peptidoglycan-anchor, secreted, hydrolase; HET: PGE; 1.87A {Streptococcus pneumoniae} PDB: 2xqx_A Length = 937 | Back alignment and structure |
|---|
Score = 76.2 bits (186), Expect = 2e-14
Identities = 17/204 (8%), Positives = 39/204 (19%), Gaps = 4/204 (1%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
P++S S + A + P+S
Sbjct: 25 AVPENSGANT---ELVSGESEHSTNEADKQNEGEHARENKLEKAEGVATASETASPASNE 81
Query: 61 VNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPA 120
+ ++ + V +P + A+P + P N ++
Sbjct: 82 AATTETAEAASAAKPEEKASEVVAETPSAEAKPKSDKETEAKPEATNQGDESKPAAEANK 141
Query: 121 NVPTTPSSSSPPPANVRTTPSSSSPPPANVPA-TPSSSSPPPVNVPTPPSSSSPPPPSSN 179
+ P + +N + +S N
Sbjct: 142 TEKEVQPDVPKNTEKTLKPKEIKFNSWEELLKWEPGAREDDAINRGSVVLASRRTGHLVN 201
Query: 180 PPTSTPSPPVLTPPPHPSQSAPPP 203
S + +
Sbjct: 202 EKASKEAKVQALSNTNSKAKDHAS 225
|
| >3gdb_A Endo-D, putative uncharacterized protein SPR0440; alpha-beta-barrels, cell WALL, peptidoglycan-anchor, secreted, hydrolase; HET: PGE; 1.87A {Streptococcus pneumoniae} PDB: 2xqx_A Length = 937 | Back alignment and structure |
|---|
Score = 75.4 bits (184), Expect = 3e-14
Identities = 23/214 (10%), Positives = 49/214 (22%), Gaps = 13/214 (6%)
Query: 24 PSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEV 83
T P + + S + + + + P
Sbjct: 21 GEETAVPENSGANTELVSGESEHSTNEA-DKQNEGEHARENKLEKAEGVATASETASPAS 79
Query: 84 DPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSS 143
+ + + A P V TPS+ + P ++ T P ++
Sbjct: 80 NEAATTETAEAASAAKPEEKASEVVAETPSAEAKPKSDKETEA------------KPEAT 127
Query: 144 SPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPP 203
+ + PA ++ + V P ++ P S P +
Sbjct: 128 NQGDESKPAAEANKTEKEVQPDVPKNTEKTLKPKEIKFNSWEELLKWEPGAREDDAINRG 187
Query: 204 VTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSN 237
T + A+S +
Sbjct: 188 SVVLASRRTGHLVNEKASKEAKVQALSNTNSKAK 221
|
| >3gdb_A Endo-D, putative uncharacterized protein SPR0440; alpha-beta-barrels, cell WALL, peptidoglycan-anchor, secreted, hydrolase; HET: PGE; 1.87A {Streptococcus pneumoniae} PDB: 2xqx_A Length = 937 | Back alignment and structure |
|---|
Score = 70.8 bits (172), Expect = 1e-12
Identities = 23/206 (11%), Positives = 48/206 (23%), Gaps = 7/206 (3%)
Query: 45 STPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPP 104
+ P + N+ S +A E + + + + +
Sbjct: 16 NLYFQGEETAVPENSGANTELVSGESEHSTNEADKQNEGEHARENKLEKAE---GVATAS 72
Query: 105 PANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNV 164
P + +++ A + V TPS+ + P ++ + +
Sbjct: 73 ETASPASNEAATTETAEAASAAKPEEKASEVVAETPSAEAKPKSDKETEAKPEATNQGDE 132
Query: 165 PTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTS 224
P + ++ P + L P S + P A S
Sbjct: 133 SKPAAEANKTEKEVQPDVPKNTEKTLKPKEIKFNSWEELLKWEPGAREDDAINRG----S 188
Query: 225 SPPAVSPPAPPSNSSTRGSPSTPPLP 250
A N L
Sbjct: 189 VVLASRRTGHLVNEKASKEAKVQALS 214
|
| >3gdb_A Endo-D, putative uncharacterized protein SPR0440; alpha-beta-barrels, cell WALL, peptidoglycan-anchor, secreted, hydrolase; HET: PGE; 1.87A {Streptococcus pneumoniae} PDB: 2xqx_A Length = 937 | Back alignment and structure |
|---|
Score = 68.5 bits (166), Expect = 5e-12
Identities = 21/210 (10%), Positives = 43/210 (20%), Gaps = 6/210 (2%)
Query: 41 SPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAP 100
T+ P + S + + E + +P
Sbjct: 21 GEETAVPENSGANTELVSG---ESEHSTNEADKQNEGEHARENKLEKAEGVATASETASP 77
Query: 101 SPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPP 160
+ A T ++S+ P + + +P + + P S
Sbjct: 78 ASNEAATTETAEAASAAKPEEKASEVVAETPSAEAKPKSDKETEAKPEATNQGDESKPAA 137
Query: 161 PVNVPTPPSSSSPPPPSSNPPTSTP---SPPVLTPPPHPSQSAPPPVTKSPPASTLSPPP 217
N P + + P + +
Sbjct: 138 EANKTEKEVQPDVPKNTEKTLKPKEIKFNSWEELLKWEPGAREDDAINRGSVVLASRRTG 197
Query: 218 PSVPSTSSPPAVSPPAPPSNSSTRGSPSTP 247
V +S A +NS + S
Sbjct: 198 HLVNEKASKEAKVQALSNTNSKAKDHASVG 227
|
| >3gdb_A Endo-D, putative uncharacterized protein SPR0440; alpha-beta-barrels, cell WALL, peptidoglycan-anchor, secreted, hydrolase; HET: PGE; 1.87A {Streptococcus pneumoniae} PDB: 2xqx_A Length = 937 | Back alignment and structure |
|---|
Score = 64.6 bits (156), Expect = 8e-11
Identities = 19/197 (9%), Positives = 44/197 (22%), Gaps = 1/197 (0%)
Query: 70 SPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSS 129
+ P V + + ++ P + ++
Sbjct: 24 TAVPENSGANTELVSGESEHSTNEADKQNEGEHARENKLEKAEGVATASETASPASNEAA 83
Query: 130 SPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPS-SSSPPPPSSNPPTSTPSPP 188
+ A + V TPS+ + P + T ++ S P
Sbjct: 84 TTETAEAASAAKPEEKASEVVAETPSAEAKPKSDKETEAKPEATNQGDESKPAAEANKTE 143
Query: 189 VLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTPP 248
P P + K ++ P A++ + S G
Sbjct: 144 KEVQPDVPKNTEKTLKPKEIKFNSWEELLKWEPGAREDDAINRGSVVLASRRTGHLVNEK 203
Query: 249 LPSVPTEKPTAKSTNGT 265
+ + + +
Sbjct: 204 ASKEAKVQALSNTNSKA 220
|
| >3gdb_A Endo-D, putative uncharacterized protein SPR0440; alpha-beta-barrels, cell WALL, peptidoglycan-anchor, secreted, hydrolase; HET: PGE; 1.87A {Streptococcus pneumoniae} PDB: 2xqx_A Length = 937 | Back alignment and structure |
|---|
Score = 63.4 bits (153), Expect = 2e-10
Identities = 21/204 (10%), Positives = 44/204 (21%)
Query: 64 PPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVP 123
P ++ + + + + A T S +S A
Sbjct: 27 PENSGANTELVSGESEHSTNEADKQNEGEHARENKLEKAEGVATASETASPASNEAATTE 86
Query: 124 TTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTS 183
T ++S+ P + + +P P + + P S +
Sbjct: 87 TAEAASAAKPEEKASEVVAETPSAEAKPKSDKETEAKPEATNQGDESKPAAEANKTEKEV 146
Query: 184 TPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGS 243
P P T + + + S S +
Sbjct: 147 QPDVPKNTEKTLKPKEIKFNSWEELLKWEPGAREDDAINRGSVVLASRRTGHLVNEKASK 206
Query: 244 PSTPPLPSVPTEKPTAKSTNGTAV 267
+ S K ++ G
Sbjct: 207 EAKVQALSNTNSKAKDHASVGGEE 230
|
| >3gdb_A Endo-D, putative uncharacterized protein SPR0440; alpha-beta-barrels, cell WALL, peptidoglycan-anchor, secreted, hydrolase; HET: PGE; 1.87A {Streptococcus pneumoniae} PDB: 2xqx_A Length = 937 | Back alignment and structure |
|---|
Score = 62.3 bits (150), Expect = 4e-10
Identities = 21/199 (10%), Positives = 44/199 (22%), Gaps = 2/199 (1%)
Query: 81 PEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTP 140
E P + S + ++ +
Sbjct: 21 GEETAVPENSGANTELVSGESEHSTNEADKQNEGEHARENKLEKAEGVATASETASPASN 80
Query: 141 SSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPT--STPSPPVLTPPPHPSQ 198
+++ A + V PS+ + P + + P +
Sbjct: 81 EAATTETAEAASAAKPEEKASEVVAETPSAEAKPKSDKETEAKPEATNQGDESKPAAEAN 140
Query: 199 SAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTPPLPSVPTEKPT 258
V P +T P +S + P + + + L S T
Sbjct: 141 KTEKEVQPDVPKNTEKTLKPKEIKFNSWEELLKWEPGAREDDAINRGSVVLASRRTGHLV 200
Query: 259 AKSTNGTAVSANASPRNAG 277
+ + A S N+
Sbjct: 201 NEKASKEAKVQALSNTNSK 219
|
| >3gdb_A Endo-D, putative uncharacterized protein SPR0440; alpha-beta-barrels, cell WALL, peptidoglycan-anchor, secreted, hydrolase; HET: PGE; 1.87A {Streptococcus pneumoniae} PDB: 2xqx_A Length = 937 | Back alignment and structure |
|---|
Score = 58.0 bits (139), Expect = 8e-09
Identities = 19/190 (10%), Positives = 45/190 (23%), Gaps = 10/190 (5%)
Query: 81 PEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTP 140
E P + A + + + + +
Sbjct: 14 LENLYFQGEETAVPENSGANTELVSGESEHSTNEADKQNEGEHARENKLEKAEG------ 67
Query: 141 SSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSA 200
A+ A+P+S+ S++ P +S TPS +++
Sbjct: 68 ----VATASETASPASNEAATTETAEAASAAKPEEKASEVVAETPSAEAKPKSDKETEAK 123
Query: 201 PPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTPPLPSVPTEKPTAK 260
P + + + + + + + L P +
Sbjct: 124 PEATNQGDESKPAAEANKTEKEVQPDVPKNTEKTLKPKEIKFNSWEELLKWEPGAREDDA 183
Query: 261 STNGTAVSAN 270
G+ V A+
Sbjct: 184 INRGSVVLAS 193
|
| >3gdb_A Endo-D, putative uncharacterized protein SPR0440; alpha-beta-barrels, cell WALL, peptidoglycan-anchor, secreted, hydrolase; HET: PGE; 1.87A {Streptococcus pneumoniae} PDB: 2xqx_A Length = 937 | Back alignment and structure |
|---|
Score = 50.0 bits (118), Expect = 3e-06
Identities = 18/144 (12%), Positives = 37/144 (25%), Gaps = 2/144 (1%)
Query: 134 ANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPP 193
+ + S ++ V+ + S++ +
Sbjct: 9 GHHHQLENLYFQGEETAVPENSGANTELVSGESEHSTNEADKQNEGEHARENKLEKAEGV 68
Query: 194 PHPSQSAPPPVTKSPPASTLSPPPPSVPS--TSSPPAVSPPAPPSNSSTRGSPSTPPLPS 251
S++A P ++ T + P S A +P A S + + + P +
Sbjct: 69 ATASETASPASNEAATTETAEAASAAKPEEKASEVVAETPSAEAKPKSDKETEAKPEATN 128
Query: 252 VPTEKPTAKSTNGTAVSANASPRN 275
E A N T
Sbjct: 129 QGDESKPAAEANKTEKEVQPDVPK 152
|
| >3gdb_A Endo-D, putative uncharacterized protein SPR0440; alpha-beta-barrels, cell WALL, peptidoglycan-anchor, secreted, hydrolase; HET: PGE; 1.87A {Streptococcus pneumoniae} PDB: 2xqx_A Length = 937 | Back alignment and structure |
|---|
Score = 47.3 bits (111), Expect = 2e-05
Identities = 22/236 (9%), Positives = 42/236 (17%), Gaps = 4/236 (1%)
Query: 142 SSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAP 201
+ A P +S S ++ +
Sbjct: 15 ENLYFQGEETAVPENSGANT---ELVSGESEHSTNEADKQNEGEHARENKLEKAEGVATA 71
Query: 202 PPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTPPLPSVPTEKPTAKS 261
+ S + P + S P + E
Sbjct: 72 SETASPASNEAATTETAEAASAAKPEEKASEVVAETPSAEAKPKSDKETEAKPEATNQGD 131
Query: 262 TNGTAVSANASPRNAGVLGTGGAVAIGIAVGFLVLSLLVMAVWFAHKRKKKRAGEHIGYT 321
+ A AN + + S + W ++ A
Sbjct: 132 ESKPAAEANKTEKEVQPDVPKNTEKTLKPKEIKFNSWEELLKW-EPGAREDDAINRGSVV 190
Query: 322 LPSPYASSQKSDSVFLRPHSPAPLVGNGSNSGFSRSPSESGVLGNSRSWFTYDELI 377
L S ++ A N + E W D ++
Sbjct: 191 LASRRTGHLVNEKASKEAKVQALSNTNSKAKDHASVGGEEFKAYAFDYWQYLDSMV 246
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 6e-15
Identities = 58/230 (25%), Positives = 94/230 (40%), Gaps = 62/230 (26%)
Query: 388 VLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQ--GEREFRAEVEIISRVHHRHLVSLVG 444
+LGEG +G V G VA+K+++ R R E++I+ H +++++
Sbjct: 18 LLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKHENIITIFN 76
Query: 445 YCISERERL-----LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAA---------- 489
+ ++ E + D LH +V +
Sbjct: 77 IQRPDSFENFNEVYIIQELMQTD-----LH-------------RVISTQMLSDDHIQYFI 118
Query: 490 ----RGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNT------ 539
R + LH +IHRD+K SN+L++S+ + +V DFGLA+I E ++
Sbjct: 119 YQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQ 175
Query: 540 ------HVSTRVMGTFGYMAPEY-ATSGKLTEKSDVYSFGVVLLELITGR 582
V+TR Y APE TS K + DV+S G +L EL R
Sbjct: 176 QSGMVEFVATR-----WYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 9e-15
Identities = 52/216 (24%), Positives = 95/216 (43%), Gaps = 32/216 (14%)
Query: 388 VLGEGGFGCVYKGV-LADGREVAVKQLKIG---GSQGEREFRAEVEIISRVHHRHLVSLV 443
LG GG G V+ V + VA+K KI + R E++II R+ H ++V +
Sbjct: 18 PLGCGGNGLVFSAVDNDCDKRVAIK--KIVLTDPQSVKHALR-EIKIIRRLDHDNIVKVF 74
Query: 444 GYCISERERL--------------LVYEYVPNDTLHYHLHAEGRPVMDWATRVK-VAAGA 488
+L +V EY+ D L L P+++ +
Sbjct: 75 EILGPSGSQLTDDVGSLTELNSVYIVQEYMETD-LANVLEQ--GPLLE--EHARLFMYQL 129
Query: 489 ARGIAYLHEDCHPRIIHRDIKSSNILLDSSF-EARVADFGLAKIALELDSNTHVSTRVMG 547
RG+ Y+H ++HRD+K +N+ +++ ++ DFGLA+I S+ + +
Sbjct: 130 LRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV 186
Query: 548 TFGYMAPE-YATSGKLTEKSDVYSFGVVLLELITGR 582
T Y +P + T+ D+++ G + E++TG+
Sbjct: 187 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 54/213 (25%), Positives = 97/213 (45%), Gaps = 29/213 (13%)
Query: 383 FSAHNVLGEGGFGCVYKGV-LADGREVAVKQLKIGG-----SQGEREFRAEVEIISRVHH 436
+ +G G +G V V G +VA+K K+ +R +R E+ ++ + H
Sbjct: 27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIK--KLYRPFQSELFAKRAYR-ELRLLKHMRH 83
Query: 437 RHLVSL--VGYCISERERL----LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAAR 490
+++ L V + LV ++ D L + E + + + V +
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFMGTD-LGKLMKHE--KLGEDRIQFLVYQ-MLK 139
Query: 491 GIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFG 550
G+ Y+H IIHRD+K N+ ++ E ++ DFGLA+ A + + +V TR
Sbjct: 140 GLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQA-DSEMTGYVVTRW----- 190
Query: 551 YMAPEYA-TSGKLTEKSDVYSFGVVLLELITGR 582
Y APE + T+ D++S G ++ E+ITG+
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 3e-14
Identities = 54/213 (25%), Positives = 95/213 (44%), Gaps = 29/213 (13%)
Query: 383 FSAHNVLGEGGFGCVYKGV-LADGREVAVKQLKIGG-----SQGEREFRAEVEIISRVHH 436
+ + +G G +G V G VAVK K+ +R +R E+ ++ + H
Sbjct: 31 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYR-ELRLLKHMKH 87
Query: 437 RHLVSLVGYCISERERL------LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAAR 490
+++ L+ R LV + D L+ + + + D + + R
Sbjct: 88 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD-LNNIVKC--QKLTDDHVQFLIYQ-ILR 143
Query: 491 GIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFG 550
G+ Y+H IIHRD+K SN+ ++ E ++ DFGLA+ + + +V+TR
Sbjct: 144 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTG-YVATRW----- 194
Query: 551 YMAPEYA-TSGKLTEKSDVYSFGVVLLELITGR 582
Y APE + D++S G ++ EL+TGR
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 8e-14
Identities = 57/211 (27%), Positives = 88/211 (41%), Gaps = 28/211 (13%)
Query: 389 LGEGGFGCVYKGV-LADGREVAVKQ--LKIGGSQGEREFRAEVEIISRVHHRHLVSLVGY 445
+G G FG +Y G +A G EVA+K +K Q E + I + + + +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESK----IYKMMQGGVGIPTIRW 72
Query: 446 CISERE-RLLVYEYV-PNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRI 503
C +E + ++V E + P+ L + R T + +A I Y+H
Sbjct: 73 CGAEGDYNVMVMELLGPS--LEDLFNFCSR-KFSLKTVLLLADQMISRIEYIHSKN---F 126
Query: 504 IHRDIKSSNILL---DSSFEARVADFGLAKIALELDSNTHVSTR----VMGTFGYMAPEY 556
IHRD+K N L+ + DFGLAK + ++ H+ R + GT Y A
Sbjct: 127 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY-ASIN 185
Query: 557 ATSGKLTEKS---DVYSFGVVLLELITGRKP 584
G E+S D+ S G VL+ G P
Sbjct: 186 THLGI--EQSRRDDLESLGYVLMYFNLGSLP 214
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 49/211 (23%), Positives = 83/211 (39%), Gaps = 26/211 (12%)
Query: 389 LGEGGFGCVYKGV-LADGREVAVKQ--LKIGGSQGEREFRAEVEIISRVHHRHLVSLVGY 445
+GEG FG +++G L + ++VA+K + Q E+R + + V Y
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYR----TYKLLAGCTGIPNVYY 73
Query: 446 CISERE-RLLVYEYV-PNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRI 503
E +LV + + P+ L L GR T A + +HE +
Sbjct: 74 FGQEGLHNVLVIDLLGPS--LEDLLDLCGR-KFSVKTVAMAAKQMLARVQSIHEKS---L 127
Query: 504 IHRDIKSSNILLDSSFEAR-----VADFGLAKIALELDSNTHVSTR----VMGTFGYMAP 554
++RDIK N L+ V DFG+ K + + H+ R + GT Y
Sbjct: 128 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY-MS 186
Query: 555 EYATSGK-LTEKSDVYSFGVVLLELITGRKP 584
G+ + + D+ + G V + + G P
Sbjct: 187 INTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 2e-13
Identities = 65/317 (20%), Positives = 110/317 (34%), Gaps = 83/317 (26%)
Query: 327 ASSQKSDSVFLRPHSPAPLVGNGSNSGFSRSPSESGVLGNSRSWFTYDELIQATNGFSAH 386
A++Q+ +S S + G S P+ S +S + + +
Sbjct: 7 AAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSD--WQIPD------RYEIR 58
Query: 387 NVLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGE-----REFRAEVEIISRVHHRHLV 440
+++G G +G V + + R VA+K KI + R R E+ I++R++H H+V
Sbjct: 59 HLIGTGSYGHVCEAYDKLEKRVVAIK--KILRVFEDLIDCKRILR-EIAILNRLNHDHVV 115
Query: 441 SLVGYCISERERL-----LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAA------ 489
++ I + +V E +D + +
Sbjct: 116 KVLDIVIPKDVEKFDELYVVLEIADSD-FKKLFRT-PVYLTE-----------LHIKTLL 162
Query: 490 ----RGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNT------ 539
G+ Y+H I+HRD+K +N L++ +V DFGLA+ ++
Sbjct: 163 YNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPIS 219
Query: 540 -----------------------HVSTRVMGTFGYMAPEYA-TSGKLTEKSDVYSFGVVL 575
HV TR Y APE TE DV+S G +
Sbjct: 220 PREDDMNLVTFPHTKNLKRQLTGHVVTR-----WYRAPELILLQENYTEAIDVWSIGCIF 274
Query: 576 LELITGRKPVDASQPLG 592
EL+ K A
Sbjct: 275 AELLNMIKENVAYHADR 291
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 3e-13
Identities = 59/295 (20%), Positives = 93/295 (31%), Gaps = 95/295 (32%)
Query: 388 VLGEGGFGCVYKGV-LADGREVAVKQLKIGG-----SQGEREFRAEVEIISRVHHRHLVS 441
++G G +G VY + VA+K K+ +R R E+ I++R+ +++
Sbjct: 33 LIGRGSYGYVYLAYDKNTEKNVAIK--KVNRMFEDLIDCKRILR-EITILNRLKSDYIIR 89
Query: 442 LVGYCISERERL-----LVYEYVPNDTLH------------------YHLHAEGRPVMDW 478
L I + +V E +D L Y+L
Sbjct: 90 LYDLIIPDDLLKFDELYIVLEIADSD-LKKLFKTPIFLTEEHIKTILYNL---------- 138
Query: 479 ATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSN 538
G ++HE IIHRD+K +N LL+ +V DFGLA+
Sbjct: 139 ----------LLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDT 185
Query: 539 T------------------------HVSTRVMGTFGYMAPEYA-TSGKLTEKSDVYSFGV 573
HV TR Y APE T+ D++S G
Sbjct: 186 NIVNDLEENEEPGPHNKNLKKQLTSHVVTR-----WYRAPELILLQENYTKSIDIWSTGC 240
Query: 574 VLLELITGRKPVDASQPLGDESLVEWARPLLA-EALEHEDFEALVDSRLEKNYVD 627
+ EL+ + PL + + EK+ D
Sbjct: 241 IFAELLNMLQSHINDPTNR--------FPLFPGSSCFPLSPDRNSKKVHEKSNRD 287
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 71.3 bits (174), Expect = 3e-13
Identities = 23/122 (18%), Positives = 32/122 (26%), Gaps = 1/122 (0%)
Query: 17 SPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLD 76
S S P S ++ PP + P PPP + P D
Sbjct: 4 SHHHHHHSSGLVPRGSHMVIPSASVTSAASDFLAALHPPVTVPDPAPPPPPAPAAGNPPD 63
Query: 77 APPPPEV-DPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPAN 135
V P P ++AP+ +S+PP A P P
Sbjct: 64 TVTGDSVLQRILRGPTGPGTTSLAPAVRYGRQPGPEAPASAPPAAGRAVPGLYHHPVPEP 123
Query: 136 VR 137
Sbjct: 124 DP 125
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 70.6 bits (172), Expect = 6e-13
Identities = 24/127 (18%), Positives = 35/127 (27%), Gaps = 5/127 (3%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
P + PS ++ S PP P P+PP P PP +
Sbjct: 9 HHSSGLVPRGSHMVIPSASVTSAASDFLAALHPPVTVPDPAPPPPPAP-AAGNPPDTVTG 67
Query: 61 VNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPA 120
+ P P + P+ QP P+A A +PP P
Sbjct: 68 DSVLQRILRGPT----GPGTTSLAPAVRYGRQPGPEAPASAPPAAGRAVPGLYHHPVPEP 123
Query: 121 NVPTTPS 127
+
Sbjct: 124 DPVRVEE 130
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 69.0 bits (168), Expect = 2e-12
Identities = 24/127 (18%), Positives = 31/127 (24%), Gaps = 9/127 (7%)
Query: 21 SPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPP 80
S P S P S + P P P PPP AP
Sbjct: 3 SSHHHHHHSSGLVPRGSHMVIPSASVTSAASDFLAALHP----PVTVPDPAPPPPPAPAA 58
Query: 81 PEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTP 140
+ + P TT + + P + +S PPA R P
Sbjct: 59 GNPPDTVTGDSVLQRI-----LRGPTGPGTTSLAPAVRYGRQPGPEAPASAPPAAGRAVP 113
Query: 141 SSSSPPP 147
P
Sbjct: 114 GLYHHPV 120
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 67.5 bits (164), Expect = 6e-12
Identities = 24/125 (19%), Positives = 33/125 (26%), Gaps = 1/125 (0%)
Query: 45 STPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPP 104
S+ + + P S D + P PA PPP A A PP
Sbjct: 3 SSHHHHHHSSGLVPRGSHMVIPSASVTSAASDFLAALHPPVTVPDPAPPPPPAPAAGNPP 62
Query: 105 PAN-VPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVN 163
+ P TT + + + +S PPA A P P
Sbjct: 63 DTVTGDSVLQRILRGPTGPGTTSLAPAVRYGRQPGPEAPASAPPAAGRAVPGLYHHPVPE 122
Query: 164 VPTPP 168
Sbjct: 123 PDPVR 127
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 62.5 bits (151), Expect = 2e-10
Identities = 24/115 (20%), Positives = 36/115 (31%), Gaps = 6/115 (5%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSP----PTAPPP 56
P + A + PP++ P PPP +P +PP + + PT P
Sbjct: 24 PSASVTSAASDFLAALHPPVTVPDPAPPPPPAPAAGNPPDTVTGDSVLQRILRGPTGPGT 83
Query: 57 SSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTT 111
+S A + P P A PP + P P P +
Sbjct: 84 TSLAPAVRYGR--QPGPEAPASAPPAAGRAVPGLYHHPVPEPDPVRVEEVSRRIK 136
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 60.9 bits (147), Expect = 6e-10
Identities = 24/128 (18%), Positives = 36/128 (28%), Gaps = 7/128 (5%)
Query: 57 SSPAVNSPPPQPSSPPPPLDAPPPPEVDPSP---PSPAQPPPQAVAPSPPPPANVPTTPS 113
SS + P P V + + PP P+PPPP +
Sbjct: 3 SSHH-HHHHSSGLVPRGSHMVIPSASVTSAASDFLAALHPPVTVPDPAPPPPP---APAA 58
Query: 114 SSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSP 173
+ P + P TT + + P + +S PP P
Sbjct: 59 GNPPDTVTGDSVLQRILRGPTGPGTTSLAPAVRYGRQPGPEAPASAPPAAGRAVPGLYHH 118
Query: 174 PPPSSNPP 181
P P +P
Sbjct: 119 PVPEPDPV 126
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 57.8 bits (139), Expect = 6e-09
Identities = 15/125 (12%), Positives = 27/125 (21%), Gaps = 4/125 (3%)
Query: 85 PSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSS 144
+ P+ P + +S A + + P P + +
Sbjct: 6 HHHHHSSGLVPRGSHMVIPSASVTSA----ASDFLAALHPPVTVPDPAPPPPPAPAAGNP 61
Query: 145 PPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPV 204
P + P T + + P + S P P P
Sbjct: 62 PDTVTGDSVLQRILRGPTGPGTTSLAPAVRYGRQPGPEAPASAPPAAGRAVPGLYHHPVP 121
Query: 205 TKSPP 209
P
Sbjct: 122 EPDPV 126
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 56.7 bits (136), Expect = 1e-08
Identities = 20/131 (15%), Positives = 29/131 (22%)
Query: 94 PPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPAT 153
S P S+S A + P P +P N P T
Sbjct: 5 HHHHHHSSGLVPRGSHMVIPSASVTSAASDFLAALHPPVTVPDPAPPPPPAPAAGNPPDT 64
Query: 154 PSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTL 213
+ S + P + + P P P + A P + P
Sbjct: 65 VTGDSVLQRILRGPTGPGTTSLAPAVRYGRQPGPEAPASAPPAAGRAVPGLYHHPVPEPD 124
Query: 214 SPPPPSVPSTS 224
V
Sbjct: 125 PVRVEEVSRRI 135
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 56.3 bits (135), Expect = 2e-08
Identities = 22/125 (17%), Positives = 34/125 (27%), Gaps = 7/125 (5%)
Query: 113 SSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSS 172
SS + P S + T ++S A P PP PP + +
Sbjct: 3 SSHHHHHHSSGLVPRGSHMVIPSASVTSAASDFLAALHPPVTVPDPAPP-----PPPAPA 57
Query: 173 PPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSP--PASTLSPPPPSVPSTSSPPAVS 230
P + +L P P ++ P + P P + P
Sbjct: 58 AGNPPDTVTGDSVLQRILRGPTGPGTTSLAPAVRYGRQPGPEAPASAPPAAGRAVPGLYH 117
Query: 231 PPAPP 235
P P
Sbjct: 118 HPVPE 122
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 54.8 bits (131), Expect = 6e-08
Identities = 17/135 (12%), Positives = 32/135 (23%), Gaps = 1/135 (0%)
Query: 138 TTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPS 197
++ VP P + P P P PP +P
Sbjct: 3 SSHHHHHHSSGLVPRGSHMVIPSASVTSAASDFLAALHPPVTVPDPAPPPPPAPAAGNPP 62
Query: 198 QSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSP-PAPPSNSSTRGSPSTPPLPSVPTEK 256
+ + P + + + P P P+++ + P L P +
Sbjct: 63 DTVTGDSVLQRILRGPTGPGTTSLAPAVRYGRQPGPEAPASAPPAAGRAVPGLYHHPVPE 122
Query: 257 PTAKSTNGTAVSANA 271
P +
Sbjct: 123 PDPVRVEEVSRRIKR 137
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 54.4 bits (130), Expect = 8e-08
Identities = 27/136 (19%), Positives = 39/136 (28%), Gaps = 12/136 (8%)
Query: 68 PSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPS 127
P PS + + + P T P + PPP P+
Sbjct: 5 HHHHHHS-SGLVPRGSHMVIPSASVTSAASDFLAALHPP--VTVPDPAPPPPP----APA 57
Query: 128 SSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSP 187
+ +PP T S P P ++S P P P+S PP + +
Sbjct: 58 AGNPPDT---VTGDSVLQRILRGPTGPGTTSLAP--AVRYGRQPGPEAPASAPPAAGRAV 112
Query: 188 PVLTPPPHPSQSAPPP 203
P L P P
Sbjct: 113 PGLYHHPVPEPDPVRV 128
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 53.6 bits (128), Expect = 1e-07
Identities = 26/131 (19%), Positives = 34/131 (25%), Gaps = 4/131 (3%)
Query: 124 TTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSP--PPVNVPTPPSSSSPPPPSSNPP 181
++ V P + A + PPV VP P P P + NPP
Sbjct: 3 SSHHHHHHSSGLVPRGSHMVIPSASVTSAASDFLAALHPPVTVPDPAPPPPPAPAAGNPP 62
Query: 182 TSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTR 241
+ P T PA P S+PPA P
Sbjct: 63 DTVTGDS--VLQRILRGPTGPGTTSLAPAVRYGRQPGPEAPASAPPAAGRAVPGLYHHPV 120
Query: 242 GSPSTPPLPSV 252
P + V
Sbjct: 121 PEPDPVRVEEV 131
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 47.1 bits (111), Expect = 1e-05
Identities = 13/109 (11%), Positives = 24/109 (22%), Gaps = 3/109 (2%)
Query: 165 PTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTS 224
S P P+++ + + PP P P P +
Sbjct: 8 HHHSSGLVPRGSHMVIPSASVTS---AASDFLAALHPPVTVPDPAPPPPPAPAAGNPPDT 64
Query: 225 SPPAVSPPAPPSNSSTRGSPSTPPLPSVPTEKPTAKSTNGTAVSANASP 273
+ G+ S P + + + A P
Sbjct: 65 VTGDSVLQRILRGPTGPGTTSLAPAVRYGRQPGPEAPASAPPAAGRAVP 113
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 41.7 bits (97), Expect = 7e-04
Identities = 16/99 (16%), Positives = 26/99 (26%), Gaps = 4/99 (4%)
Query: 176 PSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPP 235
+ +S P ++ A+ PP +VP + PP +P A
Sbjct: 5 HHHHHHSSGLVPR--GSHMVIPSASVTSAASDFLAALH--PPVTVPDPAPPPPPAPAAGN 60
Query: 236 SNSSTRGSPSTPPLPSVPTEKPTAKSTNGTAVSANASPR 274
+ G + PT T P
Sbjct: 61 PPDTVTGDSVLQRILRGPTGPGTTSLAPAVRYGRQPGPE 99
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 70.3 bits (171), Expect = 3e-13
Identities = 46/306 (15%), Positives = 85/306 (27%), Gaps = 72/306 (23%)
Query: 379 ATNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGS--------QGEREFRAEVEI 430
T +GEG FG V++ + AD VA+K + I G + E E+ I
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 431 ISRVH---------HRHLVSLVGYCI---------------------SERERL------- 453
+ + L S +R
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 454 --LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSS 511
+V E+ L + AT + +A HRD+
Sbjct: 137 LFIVLEFEFGGID---LEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWG 191
Query: 512 NILLDSSFEARVADFGLAKIA------LELDSNTHVSTRVM--GTFGYMAPEYATS---G 560
N+LL + ++ K + L++ + +R+ G + G
Sbjct: 192 NVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTG 251
Query: 561 KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSR 620
+ D+Y + ++ + S V W L + L+ F+ ++
Sbjct: 252 DGDYQFDIYR--------LMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTP 303
Query: 621 LEKNYV 626
K
Sbjct: 304 AMKQIK 309
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 47/224 (20%), Positives = 86/224 (38%), Gaps = 42/224 (18%)
Query: 380 TNGFSAHNVLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGEREFRA---EVEIISRVH 435
+ + +++G+G FG V K + VA+K +K + EV ++ ++
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIK----NKKAFLNQAQIEVRLLELMN 108
Query: 436 HR------HLVSLVGY-------CIS-ERERLLVYEYV-PNDTLHYHLHAEGRPVMDWAT 480
++V L + C+ E +Y+ + + L+ T
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNL---------T 159
Query: 481 RVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILL--DSSFEARVADFGLAKIALELDSN 538
R K A + +L IIH D+K NILL ++ DFG + +
Sbjct: 160 R-KFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ-RIY 216
Query: 539 THVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGR 582
++ +R F Y +PE D++S G +L+E+ TG
Sbjct: 217 QYIQSR----F-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 65/243 (26%), Positives = 105/243 (43%), Gaps = 76/243 (31%)
Query: 387 NVLGEGGFGCVYKGV-LADGREVAVKQLKIGG-----SQGEREFRAEVEIISRVH-HRHL 439
LG+G +G V+K + G VAVK KI + +R FR E+ I++ + H ++
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVK--KIFDAFQNSTDAQRTFR-EIMILTELSGHENI 71
Query: 440 VSLVGYCISE--RERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAA-------- 489
V+L+ ++ R+ LV++Y+ D LH V
Sbjct: 72 VNLLNVLRADNDRDVYLVFDYMETD-----LH-------------AVIRANILEPVHKQY 113
Query: 490 ------RGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNT---- 539
+ I YLH ++HRD+K SNILL++ +VADFGL++ + + T
Sbjct: 114 VVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIP 170
Query: 540 -------------------HVSTRVMGTFGYMAPEYA-TSGKLTEKSDVYSFGVVLLELI 579
+V+TR Y APE S K T+ D++S G +L E++
Sbjct: 171 LSINENTENFDDDQPILTDYVATR-----WYRAPEILLGSTKYTKGIDMWSLGCILGEIL 225
Query: 580 TGR 582
G+
Sbjct: 226 CGK 228
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 47/211 (22%), Positives = 82/211 (38%), Gaps = 26/211 (12%)
Query: 389 LGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCI 447
+G G FG + G L VA+K + + E ++ + V Y
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPM--KSRAPQLHLEYRFYKQLGSGDGIPQVYYFG 74
Query: 448 SERE-RLLVYEYV-PNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIH 505
+ +V E + P+ L R T + +A + Y+H +I+
Sbjct: 75 PCGKYNAMVLELLGPS--LEDLFDLCDR-TFSLKTVLMIAIQLISRMEYVHSKN---LIY 128
Query: 506 RDIKSSNILL--DSSFEARVA---DFGLAKIALELDSNTHVSTR----VMGTFGYMAPEY 556
RD+K N L+ + +V DF LAK ++ ++ H+ R + GT YM+
Sbjct: 129 RDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSI-N 187
Query: 557 ATSGKLTEKS---DVYSFGVVLLELITGRKP 584
GK E+S D+ + G + + + G P
Sbjct: 188 THLGK--EQSRRDDLEALGHMFMYFLRGSLP 216
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 44/230 (19%), Positives = 80/230 (34%), Gaps = 46/230 (20%)
Query: 389 LGEGGFGCVYKGV------LADGREVAVKQLKIGGSQGEREFR-----AEVEIISRVHHR 437
+G+GGFGC+Y + VK E + A+ E I +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 438 HLVSLVG-----YCISERERLLVYEYV------PNDTLHYHLHAEGRPVMDWATRVKVAA 486
+ +G + Y ++ + L A + T ++++
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSD--LQKIYEANAKR-FSRKTVLQLSL 159
Query: 487 GAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARV--ADFGLAKIALELDSNTHVSTR 544
+ Y+HE +H DIK+SN+LL+ +V D+GLA + +
Sbjct: 160 RILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAAD 216
Query: 545 ----VMGTFGYMAPEYATS-----GK-LTEKSDVYSFGVVLLELITGRKP 584
GT E+ S G + + D+ G +++ +TG P
Sbjct: 217 PKRCHDGT-----IEFT-SIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 5e-12
Identities = 41/231 (17%), Positives = 89/231 (38%), Gaps = 48/231 (20%)
Query: 389 LGEGGFGCVYKGV---------LADGREVAVK------QLKIGGSQGEREFRA-EVEIIS 432
G +Y+ ++ ++K +L + +R + +V
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 433 RVHHRHLV---SLVGYCISERE-RLLVYEYV-PNDTLHYHLHAEGRPVMDWATRVKVAAG 487
+++ L+ + +G+ + + + R LV + + L L + V+ + ++VA
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRS--LQSALDVSPKHVLSERSVLQVACR 167
Query: 488 AARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARV--ADFGLAKIALELDSNTHVSTR- 544
+ +LHE+ +H ++ + NI +D +++V A +G A S HV+
Sbjct: 168 LLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRY--CPSGKHVAYVE 222
Query: 545 -----VMGTFGYMAPEYATS-----GK-LTEKSDVYSFGVVLLELITGRKP 584
G E+ S G + +SD+ S G +L+ + G P
Sbjct: 223 GSRSPHEGD-----LEFI-SMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 48/238 (20%), Positives = 90/238 (37%), Gaps = 74/238 (31%)
Query: 388 VLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGEREFRA---EVEIISRVH-------- 435
LG G F V+ + + VA+K ++ + A E++++ RV+
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVR----GDKVYTEAAEDEIKLLQRVNDADNTKED 81
Query: 436 ---HRHLVSLVGY-----------CISERERLLVYEYVPNDTLHYHLHA-----EGRPVM 476
H++ L+ + + V+E L +L A E R +
Sbjct: 82 SMGANHILKLLDHFNHKGPNGVHVVM-------VFE-----VLGENLLALIKKYEHRGIP 129
Query: 477 DWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSS------FEARVADFGLAK 530
+ +++ G+ Y+H C IIH DIK N+L++ + ++AD G A
Sbjct: 130 LIYVK-QISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA- 185
Query: 531 IALELDSNTHVSTRVMGTFGYMAPE------YATSGKLTEKSDVYSFGVVLLELITGR 582
+ H + + Y +PE + +D++S ++ ELITG
Sbjct: 186 ----CWYDEHYTNSIQTRE-YRSPEVLLGAPWGCG------ADIWSTACLIFELITGD 232
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 5e-11
Identities = 48/230 (20%), Positives = 83/230 (36%), Gaps = 49/230 (21%)
Query: 389 LGEGGFGCVYKGV-LADGREVAVKQLKI---GGSQGEREFR-----AEVEIISRVHHRHL 439
+G GGFG +Y + A +K+ E + A+ + I + R
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 440 VSLVG-----YCISERE-----RLLVYEYV-PNDTLHYHLHAEGRPVMDWATRVKVAAGA 488
+ +G R +V E + + L G +T +++
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERLGID--LQKISGQNGT--FKKSTVLQLGIRM 160
Query: 489 ARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARV--ADFGLAKIALELDSNTHV----- 541
+ Y+HE+ +H DIK++N+LL +V AD+GL+ + H
Sbjct: 161 LDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRY--CPNGNHKQYQEN 215
Query: 542 -STRVMGTFGYMAPEYATS-----GK-LTEKSDVYSFGVVLLELITGRKP 584
GT E+ S G L+ +SDV G +L + G+ P
Sbjct: 216 PRKGHNGT-----IEFT-SLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 5e-11
Identities = 55/220 (25%), Positives = 92/220 (41%), Gaps = 52/220 (23%)
Query: 388 VLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGEREFRA----EVEIISRVHHR----- 437
V+G+G FG V K + VA+K ++ E+ F E+ I+ + +
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVR-----NEKRFHRQAAEEIRILEHLRKQDKDNT 158
Query: 438 -HLVSLVGY-------CIS-ERERLL---VYEYVPNDTLH-YHLHAEGRPVMDWATRVKV 484
+++ ++ C++ E LL +YE + + + L R K
Sbjct: 159 MNVIHMLENFTFRNHICMTFE---LLSMNLYELIKKNKFQGFSLPL---------VR-KF 205
Query: 485 AAGAARGIAYLHEDCHPRIIHRDIKSSNILL--DSSFEARVADFGLAKIALELDSNTHVS 542
A + + LH+ RIIH D+K NILL +V DFG + + T++
Sbjct: 206 AHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVY-TYIQ 261
Query: 543 TRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGR 582
+R F Y APE + D++S G +L EL+TG
Sbjct: 262 SR----F-YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 64.8 bits (156), Expect = 5e-11
Identities = 30/168 (17%), Positives = 38/168 (22%), Gaps = 7/168 (4%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPT-------A 53
P P P LA PSP + + + PP+ P PP
Sbjct: 15 PGPPRIAPPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRLRLSV 74
Query: 54 PPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPS 113
SSP+ P P+ P P PP Q
Sbjct: 75 DEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRARELG 134
Query: 114 SSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPP 161
+ S P A R PA + P
Sbjct: 135 ARVRALKASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALAQPGLP 182
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 61.3 bits (147), Expect = 6e-10
Identities = 37/193 (19%), Positives = 51/193 (26%), Gaps = 5/193 (2%)
Query: 3 PQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVN 62
Q A P PP PP SP + ++ PP +
Sbjct: 2 EQRRVTDFFARRRPGPPRIAPPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQ 61
Query: 63 SPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANV 122
+ PP +D P +P PA P P P A P +S+
Sbjct: 62 ARPPARRRLRLSVDEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQD--- 118
Query: 123 PTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPT 182
T S + R + A+ S +P P P P
Sbjct: 119 --TISELASCLQRARELGARVRALKASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHAL 176
Query: 183 STPSPPVLTPPPH 195
+ P P L P
Sbjct: 177 AQPGLPGLVLPYK 189
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 60.5 bits (145), Expect = 1e-09
Identities = 29/180 (16%), Positives = 43/180 (23%), Gaps = 2/180 (1%)
Query: 23 PPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPE 82
PP PP +P + P A S P++P PP
Sbjct: 11 ARRRPGPPRIAPPKLACRTPSPARPALRAPASATSGS--RKRARPPAAPGRDQARPPARR 68
Query: 83 VDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSS 142
P AP P + S+P P S+ + +
Sbjct: 69 RLRLSVDEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQ 128
Query: 143 SSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPP 202
+ +S+ TP + P P + L P P P
Sbjct: 129 RARELGARVRALKASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALAQPGLPGLVLPY 188
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 59.4 bits (142), Expect = 3e-09
Identities = 27/174 (15%), Positives = 49/174 (28%), Gaps = 5/174 (2%)
Query: 63 SPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANV 122
PP+ + P P P P+ A + A P P P + +V
Sbjct: 15 PGPPRIAPPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRLRLSV 74
Query: 123 PTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPT 182
S S+P + P P + ++ P ++ + + +S
Sbjct: 75 DEVSSPSTPEAP-----DIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQR 129
Query: 183 STPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPS 236
+ + +Q A T P P+ A++ P P
Sbjct: 130 ARELGARVRALKASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALAQPGLPG 183
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 57.8 bits (138), Expect = 8e-09
Identities = 26/179 (14%), Positives = 43/179 (24%)
Query: 45 STPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPP 104
+ P P A +P P + P A PP+
Sbjct: 11 ARRRPGPPRIAPPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRL 70
Query: 105 PANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNV 164
+V S S+P ++P PS + A T S +
Sbjct: 71 RLSVDEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRA 130
Query: 165 PTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPST 223
+ S+ + +P P P P + + P +P
Sbjct: 131 RELGARVRALKASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALAQPGLPGLVLPYK 189
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 56.3 bits (134), Expect = 3e-08
Identities = 28/176 (15%), Positives = 40/176 (22%), Gaps = 4/176 (2%)
Query: 44 TSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPP 103
P PP PP P P+ P A PA P P
Sbjct: 11 ARRRPGPPRIAPPKLACR---TPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPAR 67
Query: 104 PPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVN 163
+ SSP P P+ SP ++TP++ PP + S
Sbjct: 68 RRLRLS-VDEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASC 126
Query: 164 VPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPS 219
+ + P + L+ P
Sbjct: 127 LQRARELGARVRALKASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALAQPGLP 182
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 55.5 bits (132), Expect = 4e-08
Identities = 24/179 (13%), Positives = 41/179 (22%), Gaps = 4/179 (2%)
Query: 78 PPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVR 137
P PP + P + P P P A T S + PP
Sbjct: 15 PGPPRIAPPKLACRTPSP----ARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRL 70
Query: 138 TTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPS 197
P+ A + P P + ++ PP + L +
Sbjct: 71 RLSVDEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRA 130
Query: 198 QSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTPPLPSVPTEK 256
+ V ++ + + + P P+ V K
Sbjct: 131 RELGARVRALKASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALAQPGLPGLVLPYK 189
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 54.7 bits (130), Expect = 8e-08
Identities = 22/171 (12%), Positives = 38/171 (22%)
Query: 86 SPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSP 145
P P + P +A P PA +S+ + P ++
Sbjct: 13 RRPGPPRIAPPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRLRL 72
Query: 146 PPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVT 205
V + + +P P+P P++ P S +
Sbjct: 73 SVDEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRARE 132
Query: 206 KSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTPPLPSVPTEK 256
L + +P A P P L
Sbjct: 133 LGARVRALKASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALAQPGLPG 183
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 52.4 bits (124), Expect = 4e-07
Identities = 26/177 (14%), Positives = 43/177 (24%), Gaps = 2/177 (1%)
Query: 100 PSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSS-- 157
P PP P + +P PA +S+ + R P ++ P
Sbjct: 13 RRPGPPRIAPPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRLRL 72
Query: 158 SPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPP 217
S V+ P+ P + P S S P PPH + + +
Sbjct: 73 SVDEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRARE 132
Query: 218 PSVPSTSSPPAVSPPAPPSNSSTRGSPSTPPLPSVPTEKPTAKSTNGTAVSANASPR 274
+ + G P P P + +
Sbjct: 133 LGARVRALKASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALAQPGLPGLVLPYK 189
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 50.5 bits (119), Expect = 1e-06
Identities = 24/162 (14%), Positives = 40/162 (24%), Gaps = 4/162 (2%)
Query: 108 VPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTP 167
PP TPS + P P+S++ P++ P
Sbjct: 12 RRRPGPPRIAPPKLACRTPSPARPALR----APASATSGSRKRARPPAAPGRDQARPPAR 67
Query: 168 PSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPP 227
S+P T P P P PP T + ++ +S
Sbjct: 68 RRLRLSVDEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCL 127
Query: 228 AVSPPAPPSNSSTRGSPSTPPLPSVPTEKPTAKSTNGTAVSA 269
+ + + S P + + G A
Sbjct: 128 QRARELGARVRALKASAQDAGESCTPEAEGRPEEPCGEKAPA 169
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 47.8 bits (112), Expect = 9e-06
Identities = 22/141 (15%), Positives = 27/141 (19%)
Query: 134 ANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPP 193
A R P +PP + S P + P PP
Sbjct: 11 ARRRPGPPRIAPPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRL 70
Query: 194 PHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTPPLPSVP 253
P T P P P S+P A PP S
Sbjct: 71 RLSVDEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRA 130
Query: 254 TEKPTAKSTNGTAVSANASPR 274
E +
Sbjct: 131 RELGARVRALKASAQDAGESC 151
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 42.4 bits (98), Expect = 4e-04
Identities = 18/122 (14%), Positives = 32/122 (26%)
Query: 155 SSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLS 214
+ P P + P + P P+ + S + +AP PPA
Sbjct: 11 ARRRPGPPRIAPPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRL 70
Query: 215 PPPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTPPLPSVPTEKPTAKSTNGTAVSANASPR 274
S+ S P + + STP P + +++
Sbjct: 71 RLSVDEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRA 130
Query: 275 NA 276
Sbjct: 131 RE 132
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 41.6 bits (96), Expect = 8e-04
Identities = 17/149 (11%), Positives = 34/149 (22%)
Query: 126 PSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTP 185
PP + +P PA +S+ P ++ + P
Sbjct: 11 ARRRPGPPRIAPPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRL 70
Query: 186 SPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPS 245
V + AP P + P+ + S ++ +
Sbjct: 71 RLSVDEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRA 130
Query: 246 TPPLPSVPTEKPTAKSTNGTAVSANASPR 274
V K +A+ +
Sbjct: 131 RELGARVRALKASAQDAGESCTPEAEGRP 159
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 64.4 bits (156), Expect = 5e-11
Identities = 20/130 (15%), Positives = 33/130 (25%)
Query: 5 SSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSP 64
+ + S+ PT + P P+ P S + S
Sbjct: 2 AHHHHHHVDDDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTLSS 61
Query: 65 PPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPT 124
P PP + + P S P+ +P P N ++ PP
Sbjct: 62 PINGMGPPFSVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGLNGV 121
Query: 125 TPSSSSPPPA 134
+ P
Sbjct: 122 LKVPAHPSGN 131
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 64.0 bits (155), Expect = 7e-11
Identities = 26/135 (19%), Positives = 35/135 (25%), Gaps = 3/135 (2%)
Query: 47 PPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPA 106
S VNS P+ P + P SP Q S P
Sbjct: 6 HHHVDDDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTLSSPING 65
Query: 107 NVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPT 166
P SSP P + S + P T S P V ++ P +N
Sbjct: 66 MGPPFSVISSPMG---PHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGLNGVL 122
Query: 167 PPSSSSPPPPSSNPP 181
+ +S
Sbjct: 123 KVPAHPSGNMASFTK 137
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 64.0 bits (155), Expect = 8e-11
Identities = 29/144 (20%), Positives = 40/144 (27%), Gaps = 11/144 (7%)
Query: 22 PPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPP 81
S S SP + P+ P P + SP P+ P
Sbjct: 7 HHVDDDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSP----GQLHSPISTLSSP 62
Query: 82 EVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPS 141
PP P P +VPTTP+ + P S +P ++ P
Sbjct: 63 INGMGPPFSVISSPM-----GPHSMSVPTTPTLGFSTGS--PQLSSPMNPVSSSEDIKPP 115
Query: 142 SSSPPPANVPATPSSSSPPPVNVP 165
VPA PS +
Sbjct: 116 LGLNGVLKVPAHPSGNMASFTKHI 139
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 63.2 bits (153), Expect = 1e-10
Identities = 25/129 (19%), Positives = 37/129 (28%)
Query: 129 SSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPP 188
+ + S +SP A PS + +P SP S+P P
Sbjct: 11 DDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTLSSPINGMGPPF 70
Query: 189 VLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTPP 248
+ P S P T + ST SP S + S P N +
Sbjct: 71 SVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGLNGVLKVPAHPSG 130
Query: 249 LPSVPTEKP 257
+ T+
Sbjct: 131 NMASFTKHI 139
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 61.7 bits (149), Expect = 4e-10
Identities = 24/137 (17%), Positives = 38/137 (27%), Gaps = 3/137 (2%)
Query: 67 QPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTP 126
D +V+ S SP A APS P P + ++P
Sbjct: 4 HHHHHVDDDDKMFSTQVNSSLTSPTGRGSMA-APSLHPSLGPGIGSPGQLHSPISTLSSP 62
Query: 127 SSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPS 186
+ PP S P +VP TP+ + P + PP
Sbjct: 63 INGMGPPF--SVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGLNG 120
Query: 187 PPVLTPPPHPSQSAPPP 203
+ P + ++
Sbjct: 121 VLKVPAHPSGNMASFTK 137
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 61.3 bits (148), Expect = 5e-10
Identities = 22/135 (16%), Positives = 31/135 (22%), Gaps = 4/135 (2%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
S + P+ P P P T P +
Sbjct: 7 HHVDDDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTLSSPIN-G 65
Query: 61 VNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPA 120
+ P SSP P P + PQ +P P ++ P
Sbjct: 66 MGPPFSVISSPMGPHSMSVPT---TPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGLNGVL 122
Query: 121 NVPTTPSSSSPPPAN 135
VP PS +
Sbjct: 123 KVPAHPSGNMASFTK 137
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 60.9 bits (147), Expect = 7e-10
Identities = 24/121 (19%), Positives = 35/121 (28%)
Query: 2 PPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAV 61
+SP ++ PS S P P P S SP P P P
Sbjct: 22 SSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTLSSPINGMGPPFSVISSPMGPHS 81
Query: 62 NSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPAN 121
S P P+ ++P S PP + PA+ +S +
Sbjct: 82 MSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGLNGVLKVPAHPSGNMASFTKHICA 141
Query: 122 V 122
+
Sbjct: 142 I 142
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 60.5 bits (146), Expect = 1e-09
Identities = 22/133 (16%), Positives = 33/133 (24%)
Query: 112 PSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSS 171
T +SS P + + S P P++ + P +
Sbjct: 6 HHHVDDDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTLSSPING 65
Query: 172 SPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSP 231
PP S P + P S P SP S P + P
Sbjct: 66 MGPPFSVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGLNGVLKVP 125
Query: 232 PAPPSNSSTRGSP 244
P N ++
Sbjct: 126 AHPSGNMASFTKH 138
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 60.5 bits (146), Expect = 1e-09
Identities = 22/127 (17%), Positives = 39/127 (30%), Gaps = 1/127 (0%)
Query: 102 PPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPP 161
T +SS P + + S P P + ++P + PP
Sbjct: 10 DDDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTLSSPINGMGPP 69
Query: 162 VNVPTPPSSS-SPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSV 220
+V + P S P++ + P L+ P +P S+ L P
Sbjct: 70 FSVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGLNGVLKVPAHPS 129
Query: 221 PSTSSPP 227
+ +S
Sbjct: 130 GNMASFT 136
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 60.5 bits (146), Expect = 1e-09
Identities = 19/141 (13%), Positives = 30/141 (21%), Gaps = 6/141 (4%)
Query: 31 TSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSP 90
+ + P+ PS P P SP S
Sbjct: 2 AHHHHHHVDDDDKMFSTQVNSSLTSPTGR---GSMAAPSLHPSLGPGIGSPGQLHSPIST 58
Query: 91 AQPPPQAVAPSPP---PPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPP 147
P + P P + ++P +P SSP +
Sbjct: 59 LSSPINGMGPPFSVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGL 118
Query: 148 ANVPATPSSSSPPPVNVPTPP 168
V P+ S +
Sbjct: 119 NGVLKVPAHPSGNMASFTKHI 139
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 23/130 (17%), Positives = 40/130 (30%)
Query: 154 PSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTL 213
+ SS + P + + P + P Q P T S P + +
Sbjct: 7 HHVDDDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTLSSPINGM 66
Query: 214 SPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTPPLPSVPTEKPTAKSTNGTAVSANASP 273
PP + S P ++S P P+ + GSP + + K G
Sbjct: 67 GPPFSVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGLNGVLKVPA 126
Query: 274 RNAGVLGTGG 283
+G + +
Sbjct: 127 HPSGNMASFT 136
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 58.6 bits (141), Expect = 4e-09
Identities = 25/144 (17%), Positives = 41/144 (28%), Gaps = 10/144 (6%)
Query: 84 DPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSS 143
+ V S P + + S P P + ++P +
Sbjct: 6 HHHVDDDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTLSSPING 65
Query: 144 SPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPP 203
PP SSP P S S P P+ T +P P S+ PP
Sbjct: 66 MGPP-----FSVISSPMG-----PHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPP 115
Query: 204 VTKSPPASTLSPPPPSVPSTSSPP 227
+ + + P ++ S +
Sbjct: 116 LGLNGVLKVPAHPSGNMASFTKHI 139
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 58.2 bits (140), Expect = 5e-09
Identities = 24/122 (19%), Positives = 33/122 (27%), Gaps = 1/122 (0%)
Query: 143 SSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPP 202
+ S +SP PS P P S P+ T + PP
Sbjct: 11 DDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHS-PISTLSSPINGMGPP 69
Query: 203 PVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTPPLPSVPTEKPTAKST 262
S P S P+ P+ + P N + PPL K A +
Sbjct: 70 FSVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGLNGVLKVPAHPS 129
Query: 263 NG 264
Sbjct: 130 GN 131
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 55.1 bits (132), Expect = 4e-08
Identities = 28/129 (21%), Positives = 39/129 (30%), Gaps = 5/129 (3%)
Query: 137 RTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHP 196
S+ P S + P ++ P SP S T + + PP
Sbjct: 13 DKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTLSSPINGMGPPFSV 72
Query: 197 SQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTPPLPSVPTEK 256
S P + S P + P ST SP SP P S+S P
Sbjct: 73 ISSPMGPHSMSVPTT-----PTLGFSTGSPQLSSPMNPVSSSEDIKPPLGLNGVLKVPAH 127
Query: 257 PTAKSTNGT 265
P+ + T
Sbjct: 128 PSGNMASFT 136
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 54.7 bits (131), Expect = 6e-08
Identities = 21/152 (13%), Positives = 41/152 (26%), Gaps = 11/152 (7%)
Query: 69 SSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSS 128
+ S P + + P P+ P
Sbjct: 2 AHHHHHHVDDDDKMFSTQVNSSLTSPTGRGSMAAPSLH--PSLGPGIGSP---------G 50
Query: 129 SSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPP 188
P + ++P + PP +V ++P V S+ P S+P S
Sbjct: 51 QLHSPISTLSSPINGMGPPFSVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSE 110
Query: 189 VLTPPPHPSQSAPPPVTKSPPASTLSPPPPSV 220
+ PP + P S ++ + ++
Sbjct: 111 DIKPPLGLNGVLKVPAHPSGNMASFTKHICAI 142
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 52.0 bits (124), Expect = 4e-07
Identities = 16/93 (17%), Positives = 24/93 (25%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
P + + P + PP S P P S P +P P P +P
Sbjct: 47 GSPGQLHSPISTLSSPINGMGPPFSVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPV 106
Query: 61 VNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQP 93
+S +P + P
Sbjct: 107 SSSEDIKPPLGLNGVLKVPAHPSGNMASFTKHI 139
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 51.6 bits (123), Expect = 6e-07
Identities = 18/108 (16%), Positives = 25/108 (23%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
P P ++P PP S SP S PT P
Sbjct: 35 APSLHPSLGPGIGSPGQLHSPISTLSSPINGMGPPFSVISSPMGPHSMSVPTTPTLGFST 94
Query: 61 VNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANV 108
+ P +P + PP P +A +
Sbjct: 95 GSPQLSSPMNPVSSSEDIKPPLGLNGVLKVPAHPSGNMASFTKHICAI 142
|
| >2xag_A Lysine-specific histone demethylase 1; amine oxidase, chromatin regulator, histone inhibitor binding, methylation, nucleosome core, oxidoreductase; HET: FAD TCF; 3.10A {Homo sapiens} PDB: 2xaf_A* 2xah_A* 2xaj_A* 2xaq_A* 2xas_A* 2com_A Length = 852 | Back alignment and structure |
|---|
Score = 62.7 bits (151), Expect = 3e-10
Identities = 30/177 (16%), Positives = 46/177 (25%), Gaps = 8/177 (4%)
Query: 52 TAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVD----PSPPSPAQPPPQAVAPSPPPPAN 107
A + A P S A P + P + + P+ P P
Sbjct: 15 AAAATGTEA--GPGTAGGSENGSEVAAQPAGLSGPAEVGPGAVGERTPRKKEPPRASPPG 72
Query: 108 VPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPV--NVP 165
P S+ P A P S++P + TP +
Sbjct: 73 GLAEPPGSAGPQAGPTVVPGSATPMETGIAETPEGRRTSRRKRAKVEYREMDESLANLSE 132
Query: 166 TPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPS 222
S + P PP PP ++S P + A+ S P +
Sbjct: 133 DEYYSEEERNAKAEKEKKLPPPPPQAPPEEENESEPEEPSGVEGAAFQSRLPHDRMT 189
|
| >2xag_A Lysine-specific histone demethylase 1; amine oxidase, chromatin regulator, histone inhibitor binding, methylation, nucleosome core, oxidoreductase; HET: FAD TCF; 3.10A {Homo sapiens} PDB: 2xaf_A* 2xah_A* 2xaj_A* 2xaq_A* 2xas_A* 2com_A Length = 852 | Back alignment and structure |
|---|
Score = 54.6 bits (130), Expect = 9e-08
Identities = 26/189 (13%), Positives = 38/189 (20%), Gaps = 10/189 (5%)
Query: 2 PPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAV 61
+ T PP A PP A
Sbjct: 17 AATGTEAGPGTAGGSENGSEVAAQPAGLSGPAEVGPGAVGERTPRKKEPPRASPPGGLAE 76
Query: 62 N-------SPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSS 114
+ P P++ + S + AN+
Sbjct: 77 PPGSAGPQAGPTVVPGSATPMETGIAETPEGRRTSRRKRAKVEYREMDESLANLSEDEYY 136
Query: 115 SSPPPANVPTTPSSSSPPPANVRTTPSSSSPP--PANVPATPSSSSPPPVNVPTPPSSSS 172
S PPP + S P P+ V S P + T ++
Sbjct: 137 SEEERNAKAEKEKKLPPPPPQAPPEEENESEPEEPSGVEGAAFQSRLPH-DRMTSQEAAC 195
Query: 173 PPPPSSNPP 181
P S P
Sbjct: 196 FPDIISGPQ 204
|
| >2xag_A Lysine-specific histone demethylase 1; amine oxidase, chromatin regulator, histone inhibitor binding, methylation, nucleosome core, oxidoreductase; HET: FAD TCF; 3.10A {Homo sapiens} PDB: 2xaf_A* 2xah_A* 2xaj_A* 2xaq_A* 2xas_A* 2com_A Length = 852 | Back alignment and structure |
|---|
Score = 51.9 bits (123), Expect = 7e-07
Identities = 31/200 (15%), Positives = 44/200 (22%), Gaps = 6/200 (3%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
++ A A + P + S + PA P P
Sbjct: 7 AAAAAAAAAAAATGTEAGPGTAGGSENGSEVAAQPAGLSGPAEVGPGAVGERTPRKKEPP 66
Query: 61 VNSPPPQPSSPP---PPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSP 117
SPP + PP P P + P
Sbjct: 67 RASPPGGLAEPPGSAGPQAGPTVVP-GSATPMETGIAETPEGRRTSRRKRAKVEYREMDE 125
Query: 118 PPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPP--PVNVPTPPSSSSPPP 175
AN+ S PPP P + S P P V S P
Sbjct: 126 SLANLSEDEYYSEEERNAKAEKEKKLPPPPPQAPPEEENESEPEEPSGVEGAAFQSRLPH 185
Query: 176 PSSNPPTSTPSPPVLTPPPH 195
+ P +++ P
Sbjct: 186 DRMTSQEAACFPDIISGPQQ 205
|
| >2xag_A Lysine-specific histone demethylase 1; amine oxidase, chromatin regulator, histone inhibitor binding, methylation, nucleosome core, oxidoreductase; HET: FAD TCF; 3.10A {Homo sapiens} PDB: 2xaf_A* 2xah_A* 2xaj_A* 2xaq_A* 2xas_A* 2com_A Length = 852 | Back alignment and structure |
|---|
Score = 43.4 bits (101), Expect = 3e-04
Identities = 16/138 (11%), Positives = 32/138 (23%), Gaps = 1/138 (0%)
Query: 138 TTPSSSSPPPANVPATPSSSSPPPVNV-PTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHP 196
++++ + S V P S P P P
Sbjct: 11 AAAAAAAATGTEAGPGTAGGSENGSEVAAQPAGLSGPAEVGPGAVGERTPRKKEPPRASP 70
Query: 197 SQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTPPLPSVPTEK 256
P + P + + P S + A +P ++ R +
Sbjct: 71 PGGLAEPPGSAGPQAGPTVVPGSATPMETGIAETPEGRRTSRRKRAKVEYREMDESLANL 130
Query: 257 PTAKSTNGTAVSANASPR 274
+ + +A A
Sbjct: 131 SEDEYYSEEERNAKAEKE 148
|
| >3pgw_B SM B; protein-RNA complex, U1 snRNA, SM fold, SM core, RRM, splici SNRNPS, splicing factors; HET: DNA; 4.40A {Homo sapiens} PDB: 3cw1_A Length = 231 | Back alignment and structure |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 34/137 (24%), Positives = 42/137 (30%), Gaps = 6/137 (4%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
P A P P P P PS TP T ++ A
Sbjct: 98 AGAAGGPGIGRAAGRGIPAGVPMPQAPAGLAGPVRGVGGPSQQVMTPQGRGTVAAAAAAA 157
Query: 61 VNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPA 120
S P+ PP PPPP +PP PP + P PP +P + P
Sbjct: 158 TASIAGAPTQYPPGRGGPPPPMGRGAPPPGMMGPPPGMRPPMGPPMGIPPGRGTPMGMP- 216
Query: 121 NVPTTPSSSSPPPANVR 137
P PPP +R
Sbjct: 217 -----PPGMRPPPPGMR 228
|
| >3pgw_B SM B; protein-RNA complex, U1 snRNA, SM fold, SM core, RRM, splici SNRNPS, splicing factors; HET: DNA; 4.40A {Homo sapiens} PDB: 3cw1_A Length = 231 | Back alignment and structure |
|---|
Score = 52.7 bits (126), Expect = 8e-08
Identities = 19/133 (14%), Positives = 27/133 (20%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
PP + V P + P P P + +P
Sbjct: 86 PPKDTGIARVPLAGAAGGPGIGRAAGRGIPAGVPMPQAPAGLAGPVRGVGGPSQQVMTPQ 145
Query: 61 VNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPA 120
++ A P + P P P + P P P
Sbjct: 146 GRGTVAAAAAAATASIAGAPTQYPPGRGGPPPPMGRGAPPPGMMGPPPGMRPPMGPPMGI 205
Query: 121 NVPTTPSSSSPPP 133
PPP
Sbjct: 206 PPGRGTPMGMPPP 218
|
| >3pgw_B SM B; protein-RNA complex, U1 snRNA, SM fold, SM core, RRM, splici SNRNPS, splicing factors; HET: DNA; 4.40A {Homo sapiens} PDB: 3cw1_A Length = 231 | Back alignment and structure |
|---|
Score = 50.4 bits (120), Expect = 5e-07
Identities = 28/154 (18%), Positives = 33/154 (21%), Gaps = 5/154 (3%)
Query: 16 PSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPL 75
S + PP P A P P P + P +
Sbjct: 78 VSMTVEGPPPKDTGIARVPLAGAAGGPGIGRAAGRGIPAGVPMPQ---APAGLAGPVRGV 134
Query: 76 DAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPAN 135
P + P A S PPP P PP
Sbjct: 135 GGPSQQVMTPQGRGTVAAAAAAATASIAGAPTQYPPGRGGPPPPMGRGAPPPGMMGPPPG 194
Query: 136 VRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPS 169
+R P P PPP P PP
Sbjct: 195 MR--PPMGPPMGIPPGRGTPMGMPPPGMRPPPPG 226
|
| >3pgw_B SM B; protein-RNA complex, U1 snRNA, SM fold, SM core, RRM, splici SNRNPS, splicing factors; HET: DNA; 4.40A {Homo sapiens} PDB: 3cw1_A Length = 231 | Back alignment and structure |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 27/144 (18%), Positives = 37/144 (25%)
Query: 51 PTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPT 110
PPP + P ++ P + + P P P A +
Sbjct: 82 VEGPPPKDTGIARVPLAGAAGGPGIGRAAGRGIPAGVPMPQAPAGLAGPVRGVGGPSQQV 141
Query: 111 TPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSS 170
A ++S PPP A P PP + P
Sbjct: 142 MTPQGRGTVAAAAAAATASIAGAPTQYPPGRGGPPPPMGRGAPPPGMMGPPPGMRPPMGP 201
Query: 171 SSPPPPSSNPPTSTPSPPVLTPPP 194
PP P P P + PPP
Sbjct: 202 PMGIPPGRGTPMGMPPPGMRPPPP 225
|
| >3pgw_B SM B; protein-RNA complex, U1 snRNA, SM fold, SM core, RRM, splici SNRNPS, splicing factors; HET: DNA; 4.40A {Homo sapiens} PDB: 3cw1_A Length = 231 | Back alignment and structure |
|---|
Score = 47.3 bits (112), Expect = 6e-06
Identities = 29/149 (19%), Positives = 37/149 (24%), Gaps = 2/149 (1%)
Query: 75 LDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPA 134
+ PP D PA + P
Sbjct: 80 MTVEGPPPKDTGIARVPLAGAAGGPGIGRAAGRGIPAGVPMPQAPAGLAGPVRGVGGPSQ 139
Query: 135 NVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPP 194
V T + A AT S + P P P + PP PP + PP
Sbjct: 140 QVMTPQGRGTVAAAAAAATASIAGAPTQYPPGRGGPPPPMGRGAPPPGMMGPPPGMRPPM 199
Query: 195 HPSQSAPPP--VTKSPPASTLSPPPPSVP 221
P PP P + PPPP +
Sbjct: 200 GPPMGIPPGRGTPMGMPPPGMRPPPPGMR 228
|
| >3pgw_B SM B; protein-RNA complex, U1 snRNA, SM fold, SM core, RRM, splici SNRNPS, splicing factors; HET: DNA; 4.40A {Homo sapiens} PDB: 3cw1_A Length = 231 | Back alignment and structure |
|---|
Score = 46.9 bits (111), Expect = 8e-06
Identities = 25/150 (16%), Positives = 37/150 (24%), Gaps = 2/150 (1%)
Query: 108 VPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTP 167
V T P + P + + + P +P P+ + P V P
Sbjct: 78 VSMTVEGPPPKDTGIARVPLAGAAGGPGIGRAAGRGIPAGVPMPQAPAGLAGPVRGVGGP 137
Query: 168 PSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPP 227
P + + PP PP PPP +
Sbjct: 138 SQQVMTPQG--RGTVAAAAAAATASIAGAPTQYPPGRGGPPPPMGRGAPPPGMMGPPPGM 195
Query: 228 AVSPPAPPSNSSTRGSPSTPPLPSVPTEKP 257
P RG+P P P + P
Sbjct: 196 RPPMGPPMGIPPGRGTPMGMPPPGMRPPPP 225
|
| >3pgw_B SM B; protein-RNA complex, U1 snRNA, SM fold, SM core, RRM, splici SNRNPS, splicing factors; HET: DNA; 4.40A {Homo sapiens} PDB: 3cw1_A Length = 231 | Back alignment and structure |
|---|
Score = 45.0 bits (106), Expect = 3e-05
Identities = 24/153 (15%), Positives = 34/153 (22%), Gaps = 10/153 (6%)
Query: 89 SPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPA 148
+ PPP+ + P A P +P P + P
Sbjct: 81 TVEGPPPKDTGIARVPLAGAAGGPGIGRAAGRGIPAGVPMPQAPA-------GLAGPVRG 133
Query: 149 NVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSP 208
+ +P + +S T PP PP P PP
Sbjct: 134 VGGPSQQVMTPQGRGTVAAAA---AAATASIAGAPTQYPPGRGGPPPPMGRGAPPPGMMG 190
Query: 209 PASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTR 241
P + PP PP
Sbjct: 191 PPPGMRPPMGPPMGIPPGRGTPMGMPPPGMRPP 223
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 1e-09
Identities = 12/89 (13%), Positives = 18/89 (20%), Gaps = 1/89 (1%)
Query: 14 PPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPP 73
P P + PA P + P P P +P P ++
Sbjct: 6 TSPGTPGVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDNATVAA 65
Query: 74 PLDAPPPPEVDPSPPSPAQPPPQAVAPSP 102
A + P
Sbjct: 66 G-HATLREHLRDIKAENTDANFYVCPPPT 93
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 58.8 bits (142), Expect = 4e-09
Identities = 19/96 (19%), Positives = 28/96 (29%), Gaps = 2/96 (2%)
Query: 2 PPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAV 61
P + P V + + P+T PP + P P + P PT PP
Sbjct: 2 PAAPTSPGTPGVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPT--PPRPAGD 59
Query: 62 NSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQA 97
N+ + E + PP A
Sbjct: 60 NATVAAGHATLREHLRDIKAENTDANFYVCPPPTGA 95
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 3e-08
Identities = 16/89 (17%), Positives = 24/89 (26%), Gaps = 4/89 (4%)
Query: 16 PSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPL 75
P+ P SP T + P T PP+ AP + P+ +PP P
Sbjct: 2 PAAPTSPGTPGVAAATQ----AANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPA 57
Query: 76 DAPPPPEVDPSPPSPAQPPPQAVAPSPPP 104
+ +A
Sbjct: 58 GDNATVAAGHATLREHLRDIKAENTDANF 86
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 3e-08
Identities = 22/121 (18%), Positives = 36/121 (29%), Gaps = 6/121 (4%)
Query: 122 VPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPP 181
PT+P + A ++P P + A P+ P P + +PP P+ +
Sbjct: 4 APTSPGTPGVAAATQAANGGPATPAPPALGAAPTGDPKPK--KNKKPKNPTPPRPAGDNA 61
Query: 182 TSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTR 241
T L ++ PP + P P P + T
Sbjct: 62 TVAAGHATLREHLRDIKAENTD----ANFYVCPPPTGATVVQFEQPRRCPTRPEGQNYTE 117
Query: 242 G 242
G
Sbjct: 118 G 118
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 5e-08
Identities = 18/97 (18%), Positives = 33/97 (34%), Gaps = 2/97 (2%)
Query: 34 PPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQP 93
P A P P + P++PA + P+ P P +P+PP PA
Sbjct: 2 PAAPTSPGTPGVAAATQAANGGPATPAPPALGAAPTGDPKP--KKNKKPKNPTPPRPAGD 59
Query: 94 PPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSS 130
A ++ + ++ V P+ ++
Sbjct: 60 NATVAAGHATLREHLRDIKAENTDANFYVCPPPTGAT 96
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 54.6 bits (131), Expect = 9e-08
Identities = 17/89 (19%), Positives = 29/89 (32%), Gaps = 2/89 (2%)
Query: 108 VPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANV-PATPSSSSPPPVNVPT 166
PT+P + A ++P P + P+ P N P P+ P N
Sbjct: 4 APTSPGTPGVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDNATV 63
Query: 167 P-PSSSSPPPPSSNPPTSTPSPPVLTPPP 194
++ +T + + PPP
Sbjct: 64 AAGHATLREHLRDIKAENTDANFYVCPPP 92
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 18/92 (19%), Positives = 25/92 (27%), Gaps = 3/92 (3%)
Query: 29 PPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPP 88
P + P + + P T PP+ A + P+P P P PP
Sbjct: 5 PTSPGTPGVAAATQ--AANGGPATPAPPALGAAPTGDPKPKKNKKP-KNPTPPRPAGDNA 61
Query: 89 SPAQPPPQAVAPSPPPPANVPTTPSSSSPPPA 120
+ A A PPP
Sbjct: 62 TVAAGHATLREHLRDIKAENTDANFYVCPPPT 93
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 20/95 (21%), Positives = 35/95 (36%), Gaps = 1/95 (1%)
Query: 65 PPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPT 124
P P+SP P A + P +PA P A P P + + P PA
Sbjct: 2 PAAPTSPGTPGVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDNA 61
Query: 125 TPSSSSPP-PANVRTTPSSSSPPPANVPATPSSSS 158
T ++ ++R + ++ V P+ ++
Sbjct: 62 TVAAGHATLREHLRDIKAENTDANFYVCPPPTGAT 96
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 15/85 (17%), Positives = 26/85 (30%)
Query: 151 PATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPA 210
PA P+S P V T ++ P P+ + P+ ++ PP A
Sbjct: 2 PAAPTSPGTPGVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDNA 61
Query: 211 STLSPPPPSVPSTSSPPAVSPPAPP 235
+ + A + A
Sbjct: 62 TVAAGHATLREHLRDIKAENTDANF 86
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 17/101 (16%), Positives = 27/101 (26%), Gaps = 6/101 (5%)
Query: 84 DPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSS 143
DP+ P+ P VA + P TP+ + A P P+
Sbjct: 1 DPAAPTSPGTP--GVAAATQAANGGPATPAPPALGAA----PTGDPKPKKNKKPKNPTPP 54
Query: 144 SPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTST 184
P N ++ ++ PPT
Sbjct: 55 RPAGDNATVAAGHATLREHLRDIKAENTDANFYVCPPPTGA 95
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 51.9 bits (124), Expect = 6e-07
Identities = 13/95 (13%), Positives = 23/95 (24%), Gaps = 1/95 (1%)
Query: 63 SPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANV 122
+ P P +P +P PA P P P P+ P N
Sbjct: 3 AAPTSPGTPGVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKK-PKNPTPPRPAGDNA 61
Query: 123 PTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSS 157
++ ++ P ++
Sbjct: 62 TVAAGHATLREHLRDIKAENTDANFYVCPPPTGAT 96
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 17/106 (16%), Positives = 32/106 (30%), Gaps = 10/106 (9%)
Query: 67 QPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTP 126
P++P P + P +P PPA P P P
Sbjct: 1 DPAAPTSPGTPGVAAATQAANGGP---------ATPAPPALGAAPTGDPKPKKNKKPKNP 51
Query: 127 SSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSS 172
+ P N T + + ++ + ++ V PP+ ++
Sbjct: 52 TPPRPAGDNA-TVAAGHATLREHLRDIKAENTDANFYVCPPPTGAT 96
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 11/80 (13%), Positives = 20/80 (25%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
+ A P P + P P + P +P P P +
Sbjct: 14 AAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDNATVAAGHATLREH 73
Query: 61 VNSPPPQPSSPPPPLDAPPP 80
+ + + + PP
Sbjct: 74 LRDIKAENTDANFYVCPPPT 93
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 14/87 (16%), Positives = 17/87 (19%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
P A P PP+ PT P P TPP P +
Sbjct: 7 SPGTPGVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDNATVAAG 66
Query: 61 VNSPPPQPSSPPPPLDAPPPPEVDPSP 87
+ P
Sbjct: 67 HATLREHLRDIKAENTDANFYVCPPPT 93
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 49.2 bits (117), Expect = 4e-06
Identities = 21/99 (21%), Positives = 35/99 (35%), Gaps = 7/99 (7%)
Query: 48 PSPPTAP--PPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPP 105
P+ PT+P P + A + P++P PP P P P +P P+PP P
Sbjct: 2 PAAPTSPGTPGVAAATQAANGGPATPAPPALGAAPTGD-PKPKKNKKPK----NPTPPRP 56
Query: 106 ANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSS 144
A T ++ + + P + +
Sbjct: 57 AGDNATVAAGHATLREHLRDIKAENTDANFYVCPPPTGA 95
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 6e-06
Identities = 8/81 (9%), Positives = 19/81 (23%)
Query: 193 PPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTPPLPSV 252
P P T++ +P PP++ + + + T P+
Sbjct: 5 PTSPGTPGVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDNATVA 64
Query: 253 PTEKPTAKSTNGTAVSANASP 273
+ +
Sbjct: 65 AGHATLREHLRDIKAENTDAN 85
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 12/84 (14%), Positives = 21/84 (25%)
Query: 165 PTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTS 224
P P+S P ++ + P PP + P K PP +
Sbjct: 2 PAAPTSPGTPGVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDNA 61
Query: 225 SPPAVSPPAPPSNSSTRGSPSTPP 248
+ A + +
Sbjct: 62 TVAAGHATLREHLRDIKAENTDAN 85
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 7e-05
Identities = 11/78 (14%), Positives = 21/78 (26%), Gaps = 1/78 (1%)
Query: 183 STPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRG 242
++P P + + P P P P +PP P +++T
Sbjct: 6 TSPGTPG-VAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDNATVA 64
Query: 243 SPSTPPLPSVPTEKPTAK 260
+ + K
Sbjct: 65 AGHATLREHLRDIKAENT 82
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 12/81 (14%), Positives = 20/81 (24%), Gaps = 1/81 (1%)
Query: 183 STPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRG 242
+ P+ P TP + A +P L P P P PP +
Sbjct: 3 AAPTSPG-TPGVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDNA 61
Query: 243 SPSTPPLPSVPTEKPTAKSTN 263
+ + +
Sbjct: 62 TVAAGHATLREHLRDIKAENT 82
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 15/79 (18%), Positives = 23/79 (29%), Gaps = 3/79 (3%)
Query: 185 PSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPS-TSSPPAVSPPAPPSNSSTRGS 243
P+ P T P P +A PA+ P + P+ P P P+ G
Sbjct: 2 PAAP--TSPGTPGVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGD 59
Query: 244 PSTPPLPSVPTEKPTAKST 262
+T +
Sbjct: 60 NATVAAGHATLREHLRDIK 78
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 52/247 (21%), Positives = 91/247 (36%), Gaps = 86/247 (34%)
Query: 388 VLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGEREFRA----EVEIISRV-----HHR 437
+G+G FG V + + + AVK ++ +++ E +I+ ++ ++
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVR-----NIKKYTRSAKIEADILKKIQNDDINNN 96
Query: 438 HLVSLVGY-------CIS-ERERLLVYEYV-PNDTLHYHLHAEGRPVMDWATRVKVAAGA 488
++V G C+ E +YE + N+ +H+ +
Sbjct: 97 NIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIED---------IK-LYCIEI 146
Query: 489 ARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEA-------------------------RV 523
+ + YL + + H D+K NILLD + ++
Sbjct: 147 LKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKL 203
Query: 524 ADFGLAKIALELDSNTH---VSTRVMGTFGYMAPE------YATSGKLTEKSDVYSFGVV 574
DFG A S+ H ++TR Y APE + S SD++SFG V
Sbjct: 204 IDFGCA----TFKSDYHGSIINTR----Q-YRAPEVILNLGWDVS------SDMWSFGCV 248
Query: 575 LLELITG 581
L EL TG
Sbjct: 249 LAELYTG 255
|
| >3tx7_B Nuclear receptor subfamily 5 group A member 2; LRH-1, beta-catenin, armadillo repeat, nuclear receptor LIGA binding domain, protein binding; HET: P6L; 2.76A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 23/146 (15%), Positives = 43/146 (29%), Gaps = 7/146 (4%)
Query: 6 SPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPP 65
+ V+ P +S + P + PPT SP P S + PP
Sbjct: 6 AMSQVIQAMPSDLTISSAIQNIHSASKGLPLNHAALPPTDYDRSPFVTSPIS---MTMPP 62
Query: 66 PQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANV--- 122
P + P P P+++ + ++P+S +
Sbjct: 63 HGSLQGYQTYGHFPSRAIKSEYPDPYTSSPESIMGYSYMDSYQTSSPASIPHLILELLKC 122
Query: 123 -PTTPSSSSPPPANVRTTPSSSSPPP 147
P P + A ++ ++ S
Sbjct: 123 EPDEPQVQAKIMAYLQQEQANRSKHE 148
|
| >3tx7_B Nuclear receptor subfamily 5 group A member 2; LRH-1, beta-catenin, armadillo repeat, nuclear receptor LIGA binding domain, protein binding; HET: P6L; 2.76A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 23/112 (20%), Positives = 40/112 (35%), Gaps = 2/112 (1%)
Query: 138 TTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPS 197
P+++ + + + + P + ++ PP + SP +T PPH S
Sbjct: 6 AMSQVIQAMPSDLTISSAIQNIHSASKGLPLNHAALPPTDYDRSPFVTSPISMTMPPHGS 65
Query: 198 QSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTPPL 249
P + S P P TSSP ++ + + T S P L
Sbjct: 66 LQGYQTYGHFPSRAIKSEYPD--PYTSSPESIMGYSYMDSYQTSSPASIPHL 115
|
| >3tx7_B Nuclear receptor subfamily 5 group A member 2; LRH-1, beta-catenin, armadillo repeat, nuclear receptor LIGA binding domain, protein binding; HET: P6L; 2.76A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 57.7 bits (139), Expect = 5e-09
Identities = 20/150 (13%), Positives = 40/150 (26%), Gaps = 3/150 (2%)
Query: 108 VPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTP 167
+ P+++ + + + A+ + ++ PP + +P +SP + +P
Sbjct: 4 LEAMSQVIQAMPSDLTISSAIQNIHSASKGLPLNHAALPPTDYDRSPFVTSPISMTMPPH 63
Query: 168 PSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPP 227
S P + S P P+ S + S P
Sbjct: 64 GSLQGYQTYGHFPSRAIKSE---YPDPYTSSPESIMGYSYMDSYQTSSPASIPHLILELL 120
Query: 228 AVSPPAPPSNSSTRGSPSTPPLPSVPTEKP 257
P P + EK
Sbjct: 121 KCEPDEPQVQAKIMAYLQQEQANRSKHEKL 150
|
| >3tx7_B Nuclear receptor subfamily 5 group A member 2; LRH-1, beta-catenin, armadillo repeat, nuclear receptor LIGA binding domain, protein binding; HET: P6L; 2.76A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 57.3 bits (138), Expect = 7e-09
Identities = 16/144 (11%), Positives = 35/144 (24%), Gaps = 2/144 (1%)
Query: 92 QPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVP 151
+ Q + P ++ + + ++ PP R+ +S P
Sbjct: 5 EAMSQVIQAMPSDLT--ISSAIQNIHSASKGLPLNHAALPPTDYDRSPFVTSPISMTMPP 62
Query: 152 ATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPAS 211
+ P+ S P P ++ P S + S ++ P +
Sbjct: 63 HGSLQGYQTYGHFPSRAIKSEYPDPYTSSPESIMGYSYMDSYQTSSPASIPHLILELLKC 122
Query: 212 TLSPPPPSVPSTSSPPAVSPPAPP 235
P +
Sbjct: 123 EPDEPQVQAKIMAYLQQEQANRSK 146
|
| >3tx7_B Nuclear receptor subfamily 5 group A member 2; LRH-1, beta-catenin, armadillo repeat, nuclear receptor LIGA binding domain, protein binding; HET: P6L; 2.76A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 23/154 (14%), Positives = 39/154 (25%), Gaps = 10/154 (6%)
Query: 40 PSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVD-----PSPPSPAQPP 94
+ P S A+ + P A PP + D SP S PP
Sbjct: 5 EAMSQVIQAMPS--DLTISSAIQNIHSASKGLPLNHAALPPTDYDRSPFVTSPISMTMPP 62
Query: 95 PQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATP 154
++ S P P T+ S + + + +SS ++
Sbjct: 63 HGSLQGYQTYGHFPSRAIKSEYPDP---YTSSPESIMGYSYMDSYQTSSPASIPHLILEL 119
Query: 155 SSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPP 188
P V + ++ S
Sbjct: 120 LKCEPDEPQVQAKIMAYLQQEQANRSKHEKLSTF 153
|
| >3tx7_B Nuclear receptor subfamily 5 group A member 2; LRH-1, beta-catenin, armadillo repeat, nuclear receptor LIGA binding domain, protein binding; HET: P6L; 2.76A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 20/157 (12%), Positives = 38/157 (24%), Gaps = 12/157 (7%)
Query: 21 SPPPSTTPPPTSPPPASPP---PSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDA 77
+ P+ +S S P + PP + + P +
Sbjct: 6 AMSQVIQAMPSDLTISSAIQNIHSASKGLPLNHAALPPT-----DYDRSPFVTSPISMTM 60
Query: 78 PPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVR 137
PP + P + P P + P S + + + +SS ++
Sbjct: 61 PPHGSLQGYQTYGHFPSRAIKSEYPDPYTSSPE----SIMGYSYMDSYQTSSPASIPHLI 116
Query: 138 TTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPP 174
P V A + + S
Sbjct: 117 LELLKCEPDEPQVQAKIMAYLQQEQANRSKHEKLSTF 153
|
| >3tx7_B Nuclear receptor subfamily 5 group A member 2; LRH-1, beta-catenin, armadillo repeat, nuclear receptor LIGA binding domain, protein binding; HET: P6L; 2.76A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 17/138 (12%), Positives = 30/138 (21%)
Query: 87 PPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPP 146
P+ + + + ++ PP + +S
Sbjct: 12 QAMPSDLTISSAIQNIHSASKGLPLNHAALPPTDYDRSPFVTSPISMTMPPHGSLQGYQT 71
Query: 147 PANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTK 206
+ P+ S P +P S S +S S P L + P V
Sbjct: 72 YGHFPSRAIKSEYPDPYTSSPESIMGYSYMDSYQTSSPASIPHLILELLKCEPDEPQVQA 131
Query: 207 SPPASTLSPPPPSVPSTS 224
A
Sbjct: 132 KIMAYLQQEQANRSKHEK 149
|
| >3tx7_B Nuclear receptor subfamily 5 group A member 2; LRH-1, beta-catenin, armadillo repeat, nuclear receptor LIGA binding domain, protein binding; HET: P6L; 2.76A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 21/158 (13%), Positives = 42/158 (26%), Gaps = 9/158 (5%)
Query: 83 VDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSS 142
++ P + + S+S P N P + V + S
Sbjct: 4 LEAMSQVIQAMPSD-----LTISSAIQNIHSASKGLPLNHAALPPTDYDRSPFVTSPISM 58
Query: 143 SSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPP 202
+ PP ++ + P S P P +S+P + + + S P
Sbjct: 59 TMPPHGSLQGYQTYGHFP----SRAIKSEYPDPYTSSPESIMGYSYMDSYQTSSPASIPH 114
Query: 203 PVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSST 240
+ + P + + + ST
Sbjct: 115 LILELLKCEPDEPQVQAKIMAYLQQEQANRSKHEKLST 152
|
| >3tx7_B Nuclear receptor subfamily 5 group A member 2; LRH-1, beta-catenin, armadillo repeat, nuclear receptor LIGA binding domain, protein binding; HET: P6L; 2.76A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 51.2 bits (122), Expect = 6e-07
Identities = 18/151 (11%), Positives = 35/151 (23%), Gaps = 9/151 (5%)
Query: 71 PPPPLDAPPPPEVDPSPPSPAQPPPQ---AVAPSPPPPANVPTTPSSSSPPPANVPTTPS 127
+ P ++ S + + PP + +P +SP +P S
Sbjct: 6 AMSQVIQAMPSDLTISSAIQNIHSASKGLPLNHAALPPTDYDRSPFVTSPISMTMPPHGS 65
Query: 128 SSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPP------SSNPP 181
+ + S P ++P S SS + P P
Sbjct: 66 LQGYQTYGHFPSRAIKSEYPDPYTSSPESIMGYSYMDSYQTSSPASIPHLILELLKCEPD 125
Query: 182 TSTPSPPVLTPPPHPSQSAPPPVTKSPPAST 212
++ + S
Sbjct: 126 EPQVQAKIMAYLQQEQANRSKHEKLSTFGLM 156
|
| >3tx7_B Nuclear receptor subfamily 5 group A member 2; LRH-1, beta-catenin, armadillo repeat, nuclear receptor LIGA binding domain, protein binding; HET: P6L; 2.76A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 50.8 bits (121), Expect = 9e-07
Identities = 21/119 (17%), Positives = 30/119 (25%), Gaps = 2/119 (1%)
Query: 15 PPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPP 74
P + PP P P S P S PS + P +S P
Sbjct: 35 PLNHAALPPTDYDRSPFVTSPISMTMPPHGSLQGYQTYGHFPSRAIKSEYPDPYTSSPES 94
Query: 75 LDAPPPPEV--DPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSP 131
+ + SP S + + P P + AN S+
Sbjct: 95 IMGYSYMDSYQTSSPASIPHLILELLKCEPDEPQVQAKIMAYLQQEQANRSKHEKLSTF 153
|
| >3tx7_B Nuclear receptor subfamily 5 group A member 2; LRH-1, beta-catenin, armadillo repeat, nuclear receptor LIGA binding domain, protein binding; HET: P6L; 2.76A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 48.5 bits (115), Expect = 5e-06
Identities = 21/114 (18%), Positives = 29/114 (25%), Gaps = 2/114 (1%)
Query: 3 PQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVN 62
P + P + +PP T S S P P TS+P S S +
Sbjct: 50 PFVTSPISMTMPPHGSL--QGYQTYGHFPSRAIKSEYPDPYTSSPESIMGYSYMDSYQTS 107
Query: 63 SPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSS 116
SP P L P + QA + +
Sbjct: 108 SPASIPHLILELLKCEPDEPQVQAKIMAYLQQEQANRSKHEKLSTFGLMCKMAD 161
|
| >3tx7_B Nuclear receptor subfamily 5 group A member 2; LRH-1, beta-catenin, armadillo repeat, nuclear receptor LIGA binding domain, protein binding; HET: P6L; 2.76A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 15/109 (13%), Positives = 30/109 (27%), Gaps = 1/109 (0%)
Query: 150 VPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPP 209
+ A P ++ + + S P + + P P ++P +T P
Sbjct: 4 LEAMSQVIQAMPSDLTISSAIQNIHSASKGLPLNHAALPPTDYDRSPFVTSPISMTMPPH 63
Query: 210 ASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTPPLPSVPTEKPT 258
S L S P P ++S + + +
Sbjct: 64 GS-LQGYQTYGHFPSRAIKSEYPDPYTSSPESIMGYSYMDSYQTSSPAS 111
|
| >3tx7_B Nuclear receptor subfamily 5 group A member 2; LRH-1, beta-catenin, armadillo repeat, nuclear receptor LIGA binding domain, protein binding; HET: P6L; 2.76A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 41.1 bits (96), Expect = 9e-04
Identities = 16/110 (14%), Positives = 27/110 (24%), Gaps = 1/110 (0%)
Query: 164 VPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPST 223
+ P ++ + + + +A PP SP ++P
Sbjct: 4 LEAMSQVIQAMPSDLTISSAIQNIHSASKGLPLNHAALPPTDYDRSPFVTSPISMTMPPH 63
Query: 224 SSPPAVSPPAPPSNSSTRGSPSTPPLPSVPTEKPTAKSTNGTAVSANASP 273
S S S P S P + S+ AS
Sbjct: 64 GSLQGYQTY-GHFPSRAIKSEYPDPYTSSPESIMGYSYMDSYQTSSPASI 112
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 3e-09
Identities = 59/243 (24%), Positives = 89/243 (36%), Gaps = 82/243 (33%)
Query: 388 VLGEGGFGCVYKGV--LADGREVAVKQLKIGGSQGEREFRA----EVEIISRVHHR---- 437
LGEG FG V + + A GR VAVK +K + E++++ ++
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVK-----NVDRYCEAARSEIQVLEHLNTTDPNS 75
Query: 438 --HLVSLVGY-------CIS-ERERLLVYEYV-PNDTLHYHLHAEGRPVMDWATRVKVAA 486
V ++ + CI E L Y+++ N L + L R K+A
Sbjct: 76 TFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDH---------IR-KMAY 125
Query: 487 GAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEA-------------------RVADFG 527
+ + +LH ++ H D+K NIL S +V DFG
Sbjct: 126 QICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG 182
Query: 528 LAKIALELDSNTH---VSTRVMGTFGYMAPE------YATSGKLTEKSDVYSFGVVLLEL 578
A D H VSTR Y APE ++ DV+S G +L+E
Sbjct: 183 SA----TYDDEHHSTLVSTRH-----YRAPEVILALGWSQP------CDVWSIGCILIEY 227
Query: 579 ITG 581
G
Sbjct: 228 YLG 230
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 24/209 (11%)
Query: 389 LGEGGFGCVYKGV-LADGREVAVKQ--LKIGGSQGEREFRAEVEIISRVHHRHLVSLVGY 445
+G G FG +Y G + EVA+K +K Q E + I + + V +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESK----IYRILQGGTGIPNVRW 70
Query: 446 CISERE-RLLVYEYV-PNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRI 503
E + +LV + + P+ L + R + T + +A + ++H
Sbjct: 71 FGVEGDYNVLVMDLLGPS--LEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKS---F 124
Query: 504 IHRDIKSSNILLDSSFEAR---VADFGLAKIALELDSNTHVSTR----VMGTFGYMAPEY 556
+HRDIK N L+ A + DFGLAK + ++ H+ R + GT Y A
Sbjct: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY-ASVN 183
Query: 557 ATSGK-LTEKSDVYSFGVVLLELITGRKP 584
G + + D+ S G VL+ + G P
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 54.6 bits (131), Expect = 7e-08
Identities = 27/159 (16%), Positives = 42/159 (26%)
Query: 84 DPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSS 143
S P A + PP + + +PPP T +
Sbjct: 300 IASAPPRAVGHGAGPSGLAPPALQNDRQSGVDEGRTSGWSSMDRRRAPPPIASVGTLAKQ 359
Query: 144 SPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPP 203
P N + N S SS P S+ P + ++P
Sbjct: 360 KAPVGNDASFSKEPVISASNFLGRSSGSSRRPAVSSSRDVMPIDTSEPSRTRATDASPGA 419
Query: 204 VTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRG 242
++ SP + P SS S S+ +G
Sbjct: 420 FRRTSGPQKSSPVNSAEPKHSSSARHSSNVKNYESALKG 458
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 31/168 (18%), Positives = 52/168 (30%), Gaps = 5/168 (2%)
Query: 121 NVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNP 180
+ +S+PP A S PPA S + + PPP ++
Sbjct: 294 KYQQSQIASAPPRAVGHGAGPSGLAPPALQNDRQSGVDEGRTSGWSSMDRRRAPPPIASV 353
Query: 181 PTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSST 240
T + S+ + S+ S P+V S+ + P +T
Sbjct: 354 GTLAKQKAPVGNDASFSKEPVISASNFLGRSSGSSRRPAVSSSRDVMPIDTSEPSRTRAT 413
Query: 241 RGSPS-----TPPLPSVPTEKPTAKSTNGTAVSANASPRNAGVLGTGG 283
SP + P S P K ++ S+N + + G G
Sbjct: 414 DASPGAFRRTSGPQKSSPVNSAEPKHSSSARHSSNVKNYESALKGIEG 461
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 23/150 (15%), Positives = 39/150 (26%), Gaps = 4/150 (2%)
Query: 38 PPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQA 97
+ +PP A + PP + S PPP A
Sbjct: 292 ILKYQQSQIASAPPRAVGHGAGPSGLAPPALQNDRQSGVDEGRTSGWSSMDRRRAPPPIA 351
Query: 98 VAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSS 157
+ P +S + + ++ R SSS +P S
Sbjct: 352 SVGTLAKQ-KAPVGNDASFSKEPVISASNFLGRSSGSSRRPAVSSSRDV---MPIDTSEP 407
Query: 158 SPPPVNVPTPPSSSSPPPPSSNPPTSTPSP 187
S +P + P + P ++ P
Sbjct: 408 SRTRATDASPGAFRRTSGPQKSSPVNSAEP 437
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 55/243 (22%), Positives = 87/243 (35%), Gaps = 82/243 (33%)
Query: 388 VLGEGGFGCVYKGV--LADGREVAVKQLKIGGSQGEREFRA----EVEIISRVHHR---- 437
LGEG FG V + + +VA+K ++ ++R E+ ++ ++ +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIR-----NVGKYREAARLEINVLKKIKEKDKEN 80
Query: 438 --HLVSLVGY-------CIS-ERERLLVYEYV-PNDTLHYHLHAEGRPVMDWATRVKVAA 486
V + + CI+ E +E++ N+ Y L R +A
Sbjct: 81 KFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPH---------VR-HMAY 130
Query: 487 GAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEA-------------------RVADFG 527
+ +LHE ++ H D+K NIL +S RVADFG
Sbjct: 131 QLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG 187
Query: 528 LAKIALELDSNTH---VSTRVMGTFGYMAPE------YATSGKLTEKSDVYSFGVVLLEL 578
A D H V+TR Y PE +A DV+S G +L E
Sbjct: 188 SAT----FDHEHHTTIVATRH-----YRPPEVILELGWAQP------CDVWSIGCILFEY 232
Query: 579 ITG 581
G
Sbjct: 233 YRG 235
|
| >1ej6_B Lambda1; icosahedral, non-equivalence, dsRNA virus, methylase, methyltransferase, guanylyltransferase, zinc finger, icosahedral virus; 3.60A {Reovirus SP} SCOP: i.7.1.1 PDB: 2cse_V Length = 1275 | Back alignment and structure |
|---|
Score = 56.8 bits (136), Expect = 2e-08
Identities = 24/175 (13%), Positives = 35/175 (20%), Gaps = 5/175 (2%)
Query: 2 PPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAV 61
+SS + S P P S P A +
Sbjct: 9 KGKSSGKGNDSTERSDDGSSQLRDKQNNKAGPATTEPGTSNREQYRARPGIASVQRATES 68
Query: 62 NSPPPQPSSPPPPLDAP---PPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPP 118
P + + P + S + T S +
Sbjct: 69 AELPMKNNDEGTPDKKGNTRGDLVNEHSEAKDEADEATQKQAKDTDKSKAQVTYSDTGIN 128
Query: 119 PANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSP 173
AN + S + P S+ A A S PT S
Sbjct: 129 NAN-ELSRSGNVDNEGGSNQKPMSTRIAEAT-SAIVSKHPARVGLPPTASSGHGY 181
|
| >1ej6_B Lambda1; icosahedral, non-equivalence, dsRNA virus, methylase, methyltransferase, guanylyltransferase, zinc finger, icosahedral virus; 3.60A {Reovirus SP} SCOP: i.7.1.1 PDB: 2cse_V Length = 1275 | Back alignment and structure |
|---|
Score = 52.2 bits (124), Expect = 6e-07
Identities = 17/176 (9%), Positives = 30/176 (17%)
Query: 24 PSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEV 83
P T +S + + PA P +
Sbjct: 5 PRKTKGKSSGKGNDSTERSDDGSSQLRDKQNNKAGPATTEPGTSNREQYRARPGIASVQR 64
Query: 84 DPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSS 143
P S T + + S
Sbjct: 65 ATESAELPMKNNDEGTPDKKGNTRGDLVNEHSEAKDEADEATQKQAKDTDKSKAQVTYSD 124
Query: 144 SPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQS 199
+ + S + P S+ +S + P+ L P
Sbjct: 125 TGINNANELSRSGNVDNEGGSNQKPMSTRIAEATSAIVSKHPARVGLPPTASSGHG 180
|
| >1ej6_B Lambda1; icosahedral, non-equivalence, dsRNA virus, methylase, methyltransferase, guanylyltransferase, zinc finger, icosahedral virus; 3.60A {Reovirus SP} SCOP: i.7.1.1 PDB: 2cse_V Length = 1275 | Back alignment and structure |
|---|
Score = 48.7 bits (115), Expect = 7e-06
Identities = 22/180 (12%), Positives = 39/180 (21%), Gaps = 7/180 (3%)
Query: 35 PASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPP--PEVDPSPPSPAQ 92
P + S+ + + Q + P P E + P A
Sbjct: 2 KRIPRKTKGKSSGKGNDSTERSDDGSSQLRDKQNNKAGPATTEPGTSNREQYRARPGIAS 61
Query: 93 PPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPA 152
+ P N TP ++ S + + +
Sbjct: 62 VQRATESAELPMKNNDEGTPDKKGNTRGDLVNEHSEAKDEA----DEATQKQAKDTDKSK 117
Query: 153 TPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPAST 212
+ S +N S S P + S P PP ++
Sbjct: 118 AQVTYSDTGINNANELSRSGNVDNEGGSNQ-KPMSTRIAEATSAIVSKHPARVGLPPTAS 176
|
| >1ej6_B Lambda1; icosahedral, non-equivalence, dsRNA virus, methylase, methyltransferase, guanylyltransferase, zinc finger, icosahedral virus; 3.60A {Reovirus SP} SCOP: i.7.1.1 PDB: 2cse_V Length = 1275 | Back alignment and structure |
|---|
Score = 47.2 bits (111), Expect = 2e-05
Identities = 18/148 (12%), Positives = 28/148 (18%), Gaps = 5/148 (3%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
+ P S P S A+ P P
Sbjct: 32 DKQNNKAGPATTEPGTSNREQYRA--RPGIASVQRATESAELPMKNNDEGT--PDKKGNT 87
Query: 61 VNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPA 120
+ S D + + S AQ + +
Sbjct: 88 RGDLVNEHSEAKDEADEATQKQAKDTDKSKAQVTYSD-TGINNANELSRSGNVDNEGGSN 146
Query: 121 NVPTTPSSSSPPPANVRTTPSSSSPPPA 148
P + + A V P+ PP
Sbjct: 147 QKPMSTRIAEATSAIVSKHPARVGLPPT 174
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 54.9 bits (131), Expect = 6e-08
Identities = 15/114 (13%), Positives = 26/114 (22%)
Query: 24 PSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEV 83
+ P P P PP + SP P ++ + P +P
Sbjct: 15 MANLPNGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSPGSSGG 74
Query: 84 DPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVR 137
S + Q A + + S + P +
Sbjct: 75 GGFFSSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAARVLLVIDEPHTDWA 128
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 52.5 bits (125), Expect = 3e-07
Identities = 15/95 (15%), Positives = 28/95 (29%)
Query: 16 PSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPL 75
P+ ++ PPP P ASP +P ++ + + + +P P S
Sbjct: 19 PNGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSPGSSGGGGFF 78
Query: 76 DAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPT 110
+ + + A Q S
Sbjct: 79 SSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAA 113
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 50.6 bits (120), Expect = 1e-06
Identities = 20/105 (19%), Positives = 33/105 (31%)
Query: 69 SSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSS 128
S + P D P P PPP A +P P + + +S+ P P PS
Sbjct: 10 SDSNFMANLPNGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSP 69
Query: 129 SSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSP 173
S ++ S++ A S + ++
Sbjct: 70 GSSGGGGFFSSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAA 114
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 50.2 bits (119), Expect = 2e-06
Identities = 20/107 (18%), Positives = 29/107 (27%), Gaps = 1/107 (0%)
Query: 42 PPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAV-AP 100
P PPP P+ SP P S + SP +P+
Sbjct: 19 PNGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSPGSSGGGGFF 78
Query: 101 SPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPP 147
S A TT ++++ V + A R P
Sbjct: 79 SSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAARVLLVIDEPHT 125
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 49.5 bits (117), Expect = 3e-06
Identities = 14/92 (15%), Positives = 22/92 (23%)
Query: 13 VPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPP 72
+ P PPP + P S S ++ +P +P SP + SS
Sbjct: 23 MTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSPGSSGGGGFFSSLS 82
Query: 73 PPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPP 104
+ A
Sbjct: 83 NAVKQTTAAAAATFSEQVGGGSGGAGRGGAAA 114
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 48.7 bits (115), Expect = 4e-06
Identities = 12/106 (11%), Positives = 21/106 (19%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
P PP + P + + P + P + P S
Sbjct: 22 YMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSPGSSGGGGFFSSL 81
Query: 61 VNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPA 106
N+ ++ + A V P
Sbjct: 82 SNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAARVLLVIDEPHTDW 127
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 48.3 bits (114), Expect = 6e-06
Identities = 18/99 (18%), Positives = 25/99 (25%), Gaps = 4/99 (4%)
Query: 2 PPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAV 61
P PPP PP + P TP + + P + P AP P S
Sbjct: 19 PNGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAA----PVASPAAPSPGSSGG 74
Query: 62 NSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAP 100
S+ A + + A
Sbjct: 75 GGFFSSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAA 113
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 48.3 bits (114), Expect = 6e-06
Identities = 23/119 (19%), Positives = 37/119 (31%)
Query: 142 SSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAP 201
S S AN+P + P P PPS++SP + S P P+ +P
Sbjct: 10 SDSNFMANLPNGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSP 69
Query: 202 PPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTPPLPSVPTEKPTAK 260
S+LS + ++ S + RG + L +
Sbjct: 70 GSSGGGGFFSSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAARVLLVIDEPHTDWA 128
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 47.1 bits (111), Expect = 1e-05
Identities = 8/106 (7%), Positives = 16/106 (15%)
Query: 14 PPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPP 73
PPP + + + P A P + +S S
Sbjct: 23 MTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSPGSSGGGGFFSSLS 82
Query: 74 PLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPP 119
+ + +
Sbjct: 83 NAVKQTTAAAAATFSEQVGGGSGGAGRGGAAARVLLVIDEPHTDWA 128
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 46.8 bits (110), Expect = 2e-05
Identities = 18/110 (16%), Positives = 28/110 (25%), Gaps = 1/110 (0%)
Query: 52 TAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTT 111
P + P P P P P + A +P+ P P +
Sbjct: 17 NLPNGYMTDLQRPQPPPPPPSAAS-PGATPGSAAASAERASTAAPVASPAAPSPGSSGGG 75
Query: 112 PSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPP 161
SS A TT ++++ V + A P
Sbjct: 76 GFFSSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAARVLLVIDEPHT 125
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 46.8 bits (110), Expect = 2e-05
Identities = 22/129 (17%), Positives = 34/129 (26%), Gaps = 5/129 (3%)
Query: 114 SSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSP 173
S S AN+P + R P P A+ ATP S++ T +SP
Sbjct: 10 SDSNFMANLP-----NGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASP 64
Query: 174 PPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPA 233
PS L+ + +A + + P
Sbjct: 65 AAPSPGSSGGGGFFSSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAARVLLVIDEPH 124
Query: 234 PPSNSSTRG 242
+G
Sbjct: 125 TDWAKYFKG 133
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 46.4 bits (109), Expect = 2e-05
Identities = 12/98 (12%), Positives = 27/98 (27%)
Query: 85 PSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSS 144
P+ PQ P P + T S+++ P +S P+ +
Sbjct: 19 PNGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSPGSSGGGGFF 78
Query: 145 PPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPT 182
+N ++++ + S +
Sbjct: 79 SSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAARV 116
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 46.4 bits (109), Expect = 3e-05
Identities = 15/102 (14%), Positives = 25/102 (24%)
Query: 69 SSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSS 128
+ P P PP P+ P A S A +T + + P A P +
Sbjct: 15 MANLPNGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSPGSSGG 74
Query: 129 SSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSS 170
+ +++ A S
Sbjct: 75 GGFFSSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAARV 116
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 46.0 bits (108), Expect = 3e-05
Identities = 16/110 (14%), Positives = 28/110 (25%)
Query: 56 PSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSS 115
P+ + PQP PPP +P + + VA P
Sbjct: 19 PNGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSPGSSGGGGFF 78
Query: 116 SPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVP 165
S V T ++++ + S + P +
Sbjct: 79 SSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAARVLLVIDEPHTDWA 128
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 46.0 bits (108), Expect = 3e-05
Identities = 20/122 (16%), Positives = 34/122 (27%), Gaps = 3/122 (2%)
Query: 57 SSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSS 116
S + P PPPP P + P + A S + S ++
Sbjct: 10 SDSNFMANLPNGYMTDLQRPQPPPP---PPSAASPGATPGSAAASAERASTAAPVASPAA 66
Query: 117 PPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPP 176
P P + SS A +TT ++++ V + P
Sbjct: 67 PSPGSSGGGGFFSSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAARVLLVIDEPHTD 126
Query: 177 SS 178
+
Sbjct: 127 WA 128
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 45.6 bits (107), Expect = 4e-05
Identities = 15/96 (15%), Positives = 32/96 (33%)
Query: 84 DPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSS 143
+ +P P PS P P + ++S+ + S ++P P + S
Sbjct: 20 NGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSPGSSGGGGFFS 79
Query: 144 SPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSN 179
S A T ++++ V + ++
Sbjct: 80 SLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAAR 115
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 44.5 bits (104), Expect = 9e-05
Identities = 14/98 (14%), Positives = 24/98 (24%)
Query: 87 PPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPP 146
P + P PPP A P S+ A +T + + P A +
Sbjct: 19 PNGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSPGSSGGGGFF 78
Query: 147 PANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTST 184
+ A +++ S
Sbjct: 79 SSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAARV 116
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 44.5 bits (104), Expect = 9e-05
Identities = 15/98 (15%), Positives = 25/98 (25%), Gaps = 3/98 (3%)
Query: 168 PSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPP 227
P+ PP PS P SA ++ A+ ++ P P +S
Sbjct: 19 PNGYMTDLQRPQPPPPPPSAA---SPGATPGSAAASAERASTAAPVASPAAPSPGSSGGG 75
Query: 228 AVSPPAPPSNSSTRGSPSTPPLPSVPTEKPTAKSTNGT 265
+ T + + V A
Sbjct: 76 GFFSSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAA 113
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 44.5 bits (104), Expect = 1e-04
Identities = 10/103 (9%), Positives = 22/103 (21%), Gaps = 3/103 (2%)
Query: 43 PTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSP 102
+ P T P P P + + + P A +P
Sbjct: 15 MANLPNGYMTDLQRPQPPPPPPSAASPGATPG---SAAASAERASTAAPVASPAAPSPGS 71
Query: 103 PPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSP 145
++ S++ S + ++
Sbjct: 72 SGGGGFFSSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAA 114
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 42.9 bits (100), Expect = 3e-04
Identities = 20/117 (17%), Positives = 33/117 (28%), Gaps = 3/117 (2%)
Query: 105 PANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNV 164
AN+P + P P PS++SP S+ A A+P++ SP
Sbjct: 15 MANLPNGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSPGS--- 71
Query: 165 PTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVP 221
S + T+ + S A + + P
Sbjct: 72 SGGGGFFSSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAARVLLVIDEPHTDWA 128
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 42.1 bits (98), Expect = 4e-04
Identities = 11/85 (12%), Positives = 20/85 (23%)
Query: 192 PPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTPPLPS 251
+ PPP S + +P + + + A +P + S
Sbjct: 22 YMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSPGSSGGGGFFSSL 81
Query: 252 VPTEKPTAKSTNGTAVSANASPRNA 276
K T + T
Sbjct: 82 SNAVKQTTAAAAATFSEQVGGGSGG 106
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 42.1 bits (98), Expect = 5e-04
Identities = 14/100 (14%), Positives = 26/100 (26%), Gaps = 1/100 (1%)
Query: 96 QAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPP-PANVPATP 154
A P+ P P A+ TP S++ T +SP P+ +
Sbjct: 15 MANLPNGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSPGSSGG 74
Query: 155 SSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPP 194
N ++++ S +
Sbjct: 75 GGFFSSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAA 114
|
| >3odw_A RHO guanine nucleotide exchange factor 1; regulation of RHOA GTPase, rhogef, DH, PH, signaling PR; 3.20A {Homo sapiens} PDB: 3odx_A Length = 536 | Back alignment and structure |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 31/163 (19%), Positives = 45/163 (27%), Gaps = 7/163 (4%)
Query: 62 NSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPAN 121
+ P LDA +P P +A + P A N
Sbjct: 20 DEPAKTKKGLSSILDAARWNRGEPQVPDF--RHLKAEVDAEKPGATDRKGGVGMPSRDRN 77
Query: 122 VPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPP 181
+ + + + S P A+ P SSP P S S PP S
Sbjct: 78 IGAPGQDTPGVSLHPLSLDSPDREPGADAPLELGDSSP-----QGPMSLESLAPPESTDE 132
Query: 182 TSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTS 224
+ P P +S + PP PP ++ S
Sbjct: 133 GAETESPEPGDEGEPGRSGLELEPEEPPGWRELVPPDTLHSLP 175
|
| >3odw_A RHO guanine nucleotide exchange factor 1; regulation of RHOA GTPase, rhogef, DH, PH, signaling PR; 3.20A {Homo sapiens} PDB: 3odx_A Length = 536 | Back alignment and structure |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 18/156 (11%), Positives = 31/156 (19%), Gaps = 3/156 (1%)
Query: 1 PPPQSSPPAVLAVPP-PSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSP 59
P + + + P P + P +P
Sbjct: 22 PAKTKKGLSSILDAARWNRGEPQVPDFRHLKAEVDAEKPGATDRKGGVGMPSRDRNIGAP 81
Query: 60 AVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPP 119
++P P LD+P +P PQ T + + P
Sbjct: 82 GQDTPGVSLH--PLSLDSPDREPGADAPLELGDSSPQGPMSLESLAPPESTDEGAETESP 139
Query: 120 ANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPS 155
S P P + +
Sbjct: 140 EPGDEGEPGRSGLELEPEEPPGWRELVPPDTLHSLP 175
|
| >3odw_A RHO guanine nucleotide exchange factor 1; regulation of RHOA GTPase, rhogef, DH, PH, signaling PR; 3.20A {Homo sapiens} PDB: 3odx_A Length = 536 | Back alignment and structure |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 27/160 (16%), Positives = 38/160 (23%), Gaps = 11/160 (6%)
Query: 66 PQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTT 125
+ S P +D + + +P P +
Sbjct: 16 NRRSDEPAKTKKGLSSILDAARWNRGEPQ----VPDFRHLKAEVDAEKPGATDRKGGVGM 71
Query: 126 PSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTP 185
PS A + TP S P S SP P P +
Sbjct: 72 PSRDRNIGAPGQDTPGVSLHP-------LSLDSPDREPGADAPLELGDSSPQGPMSLESL 124
Query: 186 SPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSS 225
+PP T ++S P P S L P P
Sbjct: 125 APPESTDEGAETESPEPGDEGEPGRSGLELEPEEPPGWRE 164
|
| >3odw_A RHO guanine nucleotide exchange factor 1; regulation of RHOA GTPase, rhogef, DH, PH, signaling PR; 3.20A {Homo sapiens} PDB: 3odx_A Length = 536 | Back alignment and structure |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 24/157 (15%), Positives = 35/157 (22%), Gaps = 8/157 (5%)
Query: 21 SPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPP 80
P + + A P A + + + P D
Sbjct: 21 EPAKTKKGLSSILDAARWNRGEPQVPDFRHLKAEVDAEKP-GATDRKGGVGMPSRDRNIG 79
Query: 81 PEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTP 140
+P P +P P A+ P SS P P S T
Sbjct: 80 APGQDTPGVSLHPLSLD-SPDREPGADAPLELGDSS------PQGPMSLESLAPPESTDE 132
Query: 141 SSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPS 177
+ + P S + PP PP
Sbjct: 133 GAETESPEPGDEGEPGRSGLELEPEEPPGWRELVPPD 169
|
| >3odw_A RHO guanine nucleotide exchange factor 1; regulation of RHOA GTPase, rhogef, DH, PH, signaling PR; 3.20A {Homo sapiens} PDB: 3odx_A Length = 536 | Back alignment and structure |
|---|
Score = 46.6 bits (110), Expect = 3e-05
Identities = 18/116 (15%), Positives = 25/116 (21%), Gaps = 4/116 (3%)
Query: 140 PSSSSPPPANVPATPSSSSPPPVNVPTPPSSSS----PPPPSSNPPTSTPSPPVLTPPPH 195
S P S N P + P + V P
Sbjct: 16 NRRSDEPAKTKKGLSSILDAARWNRGEPQVPDFRHLKAEVDAEKPGATDRKGGVGMPSRD 75
Query: 196 PSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTPPLPS 251
+ AP T LS P + P + P + S + P
Sbjct: 76 RNIGAPGQDTPGVSLHPLSLDSPDREPGADAPLELGDSSPQGPMSLESLAPPESTD 131
|
| >3odw_A RHO guanine nucleotide exchange factor 1; regulation of RHOA GTPase, rhogef, DH, PH, signaling PR; 3.20A {Homo sapiens} PDB: 3odx_A Length = 536 | Back alignment and structure |
|---|
Score = 46.6 bits (110), Expect = 3e-05
Identities = 29/173 (16%), Positives = 36/173 (20%), Gaps = 14/173 (8%)
Query: 34 PPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQP 93
P + P + + P D PS
Sbjct: 22 PAKTKKGLSSILDAARWNRGEPQVPDFRHLKAEVDAEKPGATD-RKGGVGMPSRDRNIGA 80
Query: 94 PPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPAT 153
P Q P + S P A+ P SSP + S S P
Sbjct: 81 PGQDTPGVSLHP---LSLDSPDREPGADAPLELGDSSP-----QGPMSLESLAPP----- 127
Query: 154 PSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTK 206
S+ P P P P PP S P K
Sbjct: 128 ESTDEGAETESPEPGDEGEPGRSGLELEPEEPPGWRELVPPDTLHSLPKSQVK 180
|
| >3odw_A RHO guanine nucleotide exchange factor 1; regulation of RHOA GTPase, rhogef, DH, PH, signaling PR; 3.20A {Homo sapiens} PDB: 3odx_A Length = 536 | Back alignment and structure |
|---|
Score = 45.1 bits (106), Expect = 6e-05
Identities = 16/140 (11%), Positives = 24/140 (17%), Gaps = 4/140 (2%)
Query: 105 PANVPTTPSSSSPPPA---NVPTTPSSSSPPPANVRTTPSSSSP-PPANVPATPSSSSPP 160
PA SS P P P ++ +P+ + P
Sbjct: 22 PAKTKKGLSSILDAARWNRGEPQVPDFRHLKAEVDAEKPGATDRKGGVGMPSRDRNIGAP 81
Query: 161 PVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSV 220
+ P P + + P S P
Sbjct: 82 GQDTPGVSLHPLSLDSPDREPGADAPLELGDSSPQGPMSLESLAPPESTDEGAETESPEP 141
Query: 221 PSTSSPPAVSPPAPPSNSST 240
P P
Sbjct: 142 GDEGEPGRSGLELEPEEPPG 161
|
| >3iox_A AGI/II, PA; alpha helix, PPII helix, supersandwich fold, surface adhesin WALL, peptidoglycan-anchor, cell adhesion; HET: PMS; 1.80A {Streptococcus mutans} PDB: 3ipk_A* 1jmm_A Length = 497 | Back alignment and structure |
|---|
Score = 53.0 bits (125), Expect = 3e-07
Identities = 21/100 (21%), Positives = 29/100 (29%), Gaps = 3/100 (3%)
Query: 21 SPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSP-AVNSPPPQPSSPPPPLDAPP 79
P T TS P P P+ ++N + P + P
Sbjct: 393 GPNNYVTVGATSATNVMPVSDMPVVPGKDNTDGKKPNIWYSLNGKIRAVNVPKVTKEKPT 452
Query: 80 PPE--VDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSP 117
PP P+ P+ P AP P PT P+
Sbjct: 453 PPVKPTAPTKPTYETEKPLKPAPVAPNYEKEPTPPTRLEH 492
|
| >3iox_A AGI/II, PA; alpha helix, PPII helix, supersandwich fold, surface adhesin WALL, peptidoglycan-anchor, cell adhesion; HET: PMS; 1.80A {Streptococcus mutans} PDB: 3ipk_A* 1jmm_A Length = 497 | Back alignment and structure |
|---|
Score = 49.9 bits (117), Expect = 2e-06
Identities = 22/100 (22%), Positives = 31/100 (31%), Gaps = 2/100 (2%)
Query: 14 PPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPP 73
P + +T P S P P P+ + AVN P P P
Sbjct: 394 PNNYVTVGATSATNVMPVSDMPVVPGKDNTDGKKPNIWYSLNGKIRAVNVPKVTKEKPTP 453
Query: 74 PLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPS 113
P+ P + P+ + P VAP+ PT
Sbjct: 454 PVKPTAPTK--PTYETEKPLKPAPVAPNYEKEPTPPTRLE 491
|
| >3iox_A AGI/II, PA; alpha helix, PPII helix, supersandwich fold, surface adhesin WALL, peptidoglycan-anchor, cell adhesion; HET: PMS; 1.80A {Streptococcus mutans} PDB: 3ipk_A* 1jmm_A Length = 497 | Back alignment and structure |
|---|
Score = 47.6 bits (111), Expect = 1e-05
Identities = 15/90 (16%), Positives = 22/90 (24%)
Query: 42 PPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPS 101
P S P P S + A P+V P+P P P+
Sbjct: 405 ATNVMPVSDMPVVPGKDNTDGKKPNIWYSLNGKIRAVNVPKVTKEKPTPPVKPTAPTKPT 464
Query: 102 PPPPANVPTTPSSSSPPPANVPTTPSSSSP 131
+ P + + P T
Sbjct: 465 YETEKPLKPAPVAPNYEKEPTPPTRLEHHH 494
|
| >3iox_A AGI/II, PA; alpha helix, PPII helix, supersandwich fold, surface adhesin WALL, peptidoglycan-anchor, cell adhesion; HET: PMS; 1.80A {Streptococcus mutans} PDB: 3ipk_A* 1jmm_A Length = 497 | Back alignment and structure |
|---|
Score = 47.6 bits (111), Expect = 1e-05
Identities = 15/94 (15%), Positives = 22/94 (23%)
Query: 13 VPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPP 72
V + + + P P + P + P V P P P
Sbjct: 398 VTVGATSATNVMPVSDMPVVPGKDNTDGKKPNIWYSLNGKIRAVNVPKVTKEKPTPPVKP 457
Query: 73 PPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPA 106
P P P+P P + P
Sbjct: 458 TAPTKPTYETEKPLKPAPVAPNYEKEPTPPTRLE 491
|
| >3iox_A AGI/II, PA; alpha helix, PPII helix, supersandwich fold, surface adhesin WALL, peptidoglycan-anchor, cell adhesion; HET: PMS; 1.80A {Streptococcus mutans} PDB: 3ipk_A* 1jmm_A Length = 497 | Back alignment and structure |
|---|
Score = 45.7 bits (106), Expect = 4e-05
Identities = 18/88 (20%), Positives = 23/88 (26%), Gaps = 5/88 (5%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAP-PPSSP 59
P P + S + PT PP PTAP P+
Sbjct: 409 MPVSDMPVVPGKDNTDGKKPNIWYSLNGKIRAVNVPKVTKEKPT--PPVKPTAPTKPTYE 466
Query: 60 AVNSPPPQPSSPPPPLDAPPP--PEVDP 85
P P +P + PP E
Sbjct: 467 TEKPLKPAPVAPNYEKEPTPPTRLEHHH 494
|
| >3iox_A AGI/II, PA; alpha helix, PPII helix, supersandwich fold, surface adhesin WALL, peptidoglycan-anchor, cell adhesion; HET: PMS; 1.80A {Streptococcus mutans} PDB: 3ipk_A* 1jmm_A Length = 497 | Back alignment and structure |
|---|
Score = 43.0 bits (99), Expect = 3e-04
Identities = 14/99 (14%), Positives = 22/99 (22%), Gaps = 1/99 (1%)
Query: 138 TTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPS 197
+ + P S P S N + P P+
Sbjct: 394 PNNYVTVGATSATNVMPVSDMPVVPGKDNTDGKKPNIWYSLNGKIRAVNVPK-VTKEKPT 452
Query: 198 QSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPS 236
P P T P P+ + + +PP
Sbjct: 453 PPVKPTAPTKPTYETEKPLKPAPVAPNYEKEPTPPTRLE 491
|
| >3iox_A AGI/II, PA; alpha helix, PPII helix, supersandwich fold, surface adhesin WALL, peptidoglycan-anchor, cell adhesion; HET: PMS; 1.80A {Streptococcus mutans} PDB: 3ipk_A* 1jmm_A Length = 497 | Back alignment and structure |
|---|
Score = 42.2 bits (97), Expect = 5e-04
Identities = 17/103 (16%), Positives = 27/103 (26%), Gaps = 1/103 (0%)
Query: 40 PSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVA 99
S P + T+ P + P ++ + P
Sbjct: 391 MSGPNNYVTVGATSATNVMPVSDMPVVPGKDNTDGKKPNIWYSLNGKIRAVNVPKVTKEK 450
Query: 100 PSPPPPANVPTTPSSSSPPPAN-VPTTPSSSSPPPANVRTTPS 141
P+PP PT P+ + P P P+ P R
Sbjct: 451 PTPPVKPTAPTKPTYETEKPLKPAPVAPNYEKEPTPPTRLEHH 493
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 51.3 bits (122), Expect = 3e-07
Identities = 22/145 (15%), Positives = 34/145 (23%)
Query: 11 LAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSS 70
+ P +S P + P + +P PP PP P
Sbjct: 11 SGLVPRGSHMSVHQVIELPAPAQPISVTMVTPADLEPPQAVQPPPEPVVEPEPEPEPIPE 70
Query: 71 PPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSS 130
PP P P P S T+ ++++
Sbjct: 71 PPKEAPVVIEKPKPKPKPKPKPVKKVQEQPKRDVKPVESRPASPFENTAPARLTSSTATA 130
Query: 131 PPPANVRTTPSSSSPPPANVPATPS 155
V + S N P P+
Sbjct: 131 ATSKPVTSVASGPRALSRNQPQYPA 155
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 50.9 bits (121), Expect = 3e-07
Identities = 23/123 (18%), Positives = 35/123 (28%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
P + P + + P+ P PP P P P +P P
Sbjct: 27 ELPAPAQPISVTMVTPADLEPPQAVQPPPEPVVEPEPEPEPIPEPPKEAPVVIEKPKPKP 86
Query: 61 VNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPA 120
P P P P E P+ P P + + + + P T +S P
Sbjct: 87 KPKPKPVKKVQEQPKRDVKPVESRPASPFENTAPARLTSSTATAATSKPVTSVASGPRAL 146
Query: 121 NVP 123
+
Sbjct: 147 SRN 149
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 50.9 bits (121), Expect = 3e-07
Identities = 29/133 (21%), Positives = 40/133 (30%)
Query: 3 PQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVN 62
P+ S +V V P P T P P PP P P P
Sbjct: 15 PRGSHMSVHQVIELPAPAQPISVTMVTPADLEPPQAVQPPPEPVVEPEPEPEPIPEPPKE 74
Query: 63 SPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANV 122
+P P P P P + P P ++ SP SS++ +
Sbjct: 75 APVVIEKPKPKPKPKPKPVKKVQEQPKRDVKPVESRPASPFENTAPARLTSSTATAATSK 134
Query: 123 PTTPSSSSPPPAN 135
P T +S P +
Sbjct: 135 PVTSVASGPRALS 147
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 50.5 bits (120), Expect = 4e-07
Identities = 23/143 (16%), Positives = 35/143 (24%)
Query: 19 PLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAP 78
P + P P+ P S P P P P P P P
Sbjct: 10 SSGLVPRGSHMSVHQVIELPAPAQPISVTMVTPADLEPPQAVQPPPEPVVEPEPEPEPIP 69
Query: 79 PPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRT 138
PP+ P +P P+ P P ++ + ++ T
Sbjct: 70 EPPKEAPVVIEKPKPKPKPKPKPVKKVQEQPKRDVKPVESRPASPFENTAPARLTSSTAT 129
Query: 139 TPSSSSPPPANVPATPSSSSPPP 161
+S S + P
Sbjct: 130 AATSKPVTSVASGPRALSRNQPQ 152
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 48.2 bits (114), Expect = 2e-06
Identities = 22/109 (20%), Positives = 29/109 (26%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
P P AV P P P P P P P P P P P
Sbjct: 42 PADLEPPQAVQPPPEPVVEPEPEPEPIPEPPKEAPVVIEKPKPKPKPKPKPVKKVQEQPK 101
Query: 61 VNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVP 109
+ P + P + P + + P +VA P +
Sbjct: 102 RDVKPVESRPASPFENTAPARLTSSTATAATSKPVTSVASGPRALSRNQ 150
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 47.0 bits (111), Expect = 7e-06
Identities = 25/143 (17%), Positives = 35/143 (24%)
Query: 34 PPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQP 93
P S P +V P PP + PP P V+P P P
Sbjct: 10 SSGLVPRGSHMSVHQVIELPAPAQPISVTMVTPADLEPPQAVQPPPEPVVEPEPEPEPIP 69
Query: 94 PPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPAT 153
P AP P +++ + AT
Sbjct: 70 EPPKEAPVVIEKPKPKPKPKPKPVKKVQEQPKRDVKPVESRPASPFENTAPARLTSSTAT 129
Query: 154 PSSSSPPPVNVPTPPSSSSPPPP 176
++S P P + S P
Sbjct: 130 AATSKPVTSVASGPRALSRNQPQ 152
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 45.9 bits (108), Expect = 1e-05
Identities = 21/105 (20%), Positives = 22/105 (20%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
PP PP V P P P P P P P P
Sbjct: 47 PPQAVQPPPEPVVEPEPEPEPIPEPPKEAPVVIEKPKPKPKPKPKPVKKVQEQPKRDVKP 106
Query: 61 VNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPP 105
V S P P P + A S P
Sbjct: 107 VESRPASPFENTAPARLTSSTATAATSKPVTSVASGPRALSRNQP 151
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 44.7 bits (105), Expect = 4e-05
Identities = 17/120 (14%), Positives = 19/120 (15%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
+ P P P P P PP P P P P
Sbjct: 38 TMVTPADLEPPQAVQPPPEPVVEPEPEPEPIPEPPKEAPVVIEKPKPKPKPKPKPVKKVQ 97
Query: 61 VNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPA 120
P S A S + P A
Sbjct: 98 EQPKRDVKPVESRPASPFENTAPARLTSSTATAATSKPVTSVASGPRALSRNQPQYPARA 157
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 40.9 bits (95), Expect = 7e-04
Identities = 21/143 (14%), Positives = 31/143 (21%)
Query: 132 PPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLT 191
V S +PA S V + PP P P +
Sbjct: 10 SSGLVPRGSHMSVHQVIELPAPAQPISVTMVTPADLEPPQAVQPPPEPVVEPEPEPEPIP 69
Query: 192 PPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTPPLPS 251
PP + P V +T + T +
Sbjct: 70 EPPKEAPVVIEKPKPKPKPKPKPVKKVQEQPKRDVKPVESRPASPFENTAPARLTSSTAT 129
Query: 252 VPTEKPTAKSTNGTAVSANASPR 274
T KP +G + P+
Sbjct: 130 AATSKPVTSVASGPRALSRNQPQ 152
|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 4e-07
Identities = 19/96 (19%), Positives = 27/96 (28%), Gaps = 2/96 (2%)
Query: 140 PSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQS 199
+PA SS + P + + + P PP
Sbjct: 344 TEDDKDAETEIPAGESSDAAPSADAAQMKEMMAMMQKMQQQQAAYPPQGYAPPPQGYPPQ 403
Query: 200 APPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPP 235
PP + P P P +PP +PPA P
Sbjct: 404 GYPP--QGYPPQGYPPQGYPPPPQGAPPQGAPPAAP 437
|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
Score = 51.5 bits (123), Expect = 6e-07
Identities = 18/98 (18%), Positives = 24/98 (24%), Gaps = 2/98 (2%)
Query: 123 PTTPSSSSPPPANVRTTPSSSSPPPANVPA--TPSSSSPPPVNVPTPPSSSSPPPPSSNP 180
+ SS + P A+ + PP
Sbjct: 341 DKETEDDKDAETEIPAGESSDAAPSADAAQMKEMMAMMQKMQQQQAAYPPQGYAPPPQGY 400
Query: 181 PTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPP 218
P P P +P Q PPP +PP PP
Sbjct: 401 PPQGYPPQGYPPQGYPPQGYPPPPQGAPPQGAPPAAPP 438
|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
Score = 51.1 bits (122), Expect = 8e-07
Identities = 24/106 (22%), Positives = 30/106 (28%), Gaps = 7/106 (6%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
+ A +P + P + + P APPP
Sbjct: 342 KETEDDKDAETEIPAGESSDAAPSADAAQMKEMMAMMQKMQQQQAAYPPQGYAPPPQGYP 401
Query: 61 VNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPA 106
PPQ PP PP PP P PPQ P+ PP
Sbjct: 402 PQGYPPQG---YPPQGYPPQGY----PPPPQGAPPQGAPPAAPPQG 440
|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 22/98 (22%), Positives = 27/98 (27%), Gaps = 4/98 (4%)
Query: 109 PTTPSSSSPPPANVPTTPSSSSPPPANVRTTPS----SSSPPPANVPATPSSSSPPPVNV 164
+P SS + P A+ P +PPP
Sbjct: 341 DKETEDDKDAETEIPAGESSDAAPSADAAQMKEMMAMMQKMQQQQAAYPPQGYAPPPQGY 400
Query: 165 PTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPP 202
P PP PP P PP PP +APP
Sbjct: 401 PPQGYPPQGYPPQGYPPQGYPPPPQGAPPQGAPPAAPP 438
|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 21/86 (24%), Positives = 26/86 (30%), Gaps = 2/86 (2%)
Query: 24 PSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEV 83
P+ +P + + P +PPPQ PP P
Sbjct: 355 PAGESSDAAPSADAAQMKEMMAMMQKMQQQQAAYPPQGYAPPPQ--GYPPQGYPPQGYPP 412
Query: 84 DPSPPSPAQPPPQAVAPSPPPPANVP 109
PP PPPQ P PPA P
Sbjct: 413 QGYPPQGYPPPPQGAPPQGAPPAAPP 438
|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
Score = 48.8 bits (116), Expect = 4e-06
Identities = 24/102 (23%), Positives = 31/102 (30%), Gaps = 4/102 (3%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPP--TAPPPSS 58
++ P+ S + + PP APPP
Sbjct: 340 DDKETEDDKDAETEIPAGESSDAAPSADAAQMKEMMAMMQKMQQQQAAYPPQGYAPPPQG 399
Query: 59 PAVNSPPPQPSSPP--PPLDAPPPPEVDPSPPSPAQPPPQAV 98
PPQ P PP PPPP+ P +P PPQ V
Sbjct: 400 YPPQGYPPQGYPPQGYPPQGYPPPPQGAPPQGAPPAAPPQGV 441
|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 22/102 (21%), Positives = 29/102 (28%), Gaps = 3/102 (2%)
Query: 22 PPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPP 81
T P + P + + Q ++ PP APPP
Sbjct: 339 FDDKETEDDKDAETEIPAGESSDAAPSADAAQMKEMMAMMQKMQQQQAAYPPQGYAPPPQ 398
Query: 82 EVDPSPPSPAQPPPQAVAPS---PPPPANVPTTPSSSSPPPA 120
P P PPQ P PPP P ++PP
Sbjct: 399 GYPPQGYPPQGYPPQGYPPQGYPPPPQGAPPQGAPPAAPPQG 440
|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 23/108 (21%), Positives = 28/108 (25%), Gaps = 4/108 (3%)
Query: 29 PPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPP 88
+ A P + A A PP+ P
Sbjct: 338 QFDDKETEDDKDAETEIPAGESSDAAPSADAAQMKEMMAMMQKMQQQQAAYPPQ--GYAP 395
Query: 89 SPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANV 136
P PPQ P PP P P PPP P + + PP V
Sbjct: 396 PPQGYPPQGYPPQGYPPQGYP--PQGYPPPPQGAPPQGAPPAAPPQGV 441
|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 27/118 (22%), Positives = 33/118 (27%), Gaps = 5/118 (4%)
Query: 9 AVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQP 68
A+ P P + PS A A+ Q
Sbjct: 325 AISQTFPWVLTCCQFDDKETEDDKDAETEIPAGESSDAAPSADAAQMKEMMAMMQKMQQQ 384
Query: 69 SSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTP 126
+ PP PPP+ P P PPQ P PP P P +PP P P
Sbjct: 385 QAAYPPQGYAPPPQGYP----PQGYPPQGYPPQGYPPQGYPPPP-QGAPPQGAPPAAP 437
|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 22/108 (20%), Positives = 31/108 (28%), Gaps = 5/108 (4%)
Query: 92 QPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVP 151
Q + +P SS + P A+ + + ++ PP
Sbjct: 338 QFDDKETEDDKDAETEIPAGESSDAAPSADAAQMKEMMAMMQKMQQ--QQAAYPPQ---G 392
Query: 152 ATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQS 199
P PP P PP PP +PP PP P Q
Sbjct: 393 YAPPPQGYPPQGYPPQGYPPQGYPPQGYPPPPQGAPPQGAPPAAPPQG 440
|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
Score = 41.4 bits (97), Expect = 9e-04
Identities = 20/101 (19%), Positives = 28/101 (27%), Gaps = 4/101 (3%)
Query: 151 PATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPA 210
+ P SS PS++ ++ + PP +PP
Sbjct: 339 FDDKETEDDKDAETEIPAGESSDAAPSADAAQMKEMMAMMQKMQQQQAAYPPQGY-APPP 397
Query: 211 STL---SPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTPP 248
PP P PP PP P P+ PP
Sbjct: 398 QGYPPQGYPPQGYPPQGYPPQGYPPPPQGAPPQGAPPAAPP 438
|
| >1w7p_D VPS36P, YLR417W; ESCRT-II complex, endosomal protein sorting, protein transpo; 3.60A {Saccharomyces cerevisiae} SCOP: a.4.5.54 a.4.5.54 Length = 566 | Back alignment and structure |
|---|
Score = 52.0 bits (123), Expect = 5e-07
Identities = 21/241 (8%), Positives = 50/241 (20%), Gaps = 1/241 (0%)
Query: 41 SPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAP 100
SP P++ + + S E P P +
Sbjct: 87 SPRLILFFKDPSSKDELGKSAETASADVVSTWVCPICMVSNETQGEFTKDTLPTPICINC 146
Query: 101 SPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPP 160
P + + + S + N+ + ++ P P
Sbjct: 147 GVPADYELTKSSINCSNAIDPNANPQNQFGVNSENICPACTFANHPQIGNCEICGHRLPN 206
Query: 161 PVNVPTPPSSSSPPPPSSNPPTSTPS-PPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPS 219
V + + + + S + S S+ + +
Sbjct: 207 ASKVRSKLNRLNFHDSRVHIELEKNSLARNKSSHSALSSSSSTGSSTEFVQLSFRKSDGV 266
Query: 220 VPSTSSPPAVSPPAPPSNSSTRGSPSTPPLPSVPTEKPTAKSTNGTAVSANASPRNAGVL 279
+ S ++ A+ N + ++ N G+
Sbjct: 267 LFSQATERALENILTEKNKHIFNQNVVSVNGVDMRKGASSHEYNNEVPFIETKLSRIGIS 326
Query: 280 G 280
Sbjct: 327 S 327
|
| >1w7p_D VPS36P, YLR417W; ESCRT-II complex, endosomal protein sorting, protein transpo; 3.60A {Saccharomyces cerevisiae} SCOP: a.4.5.54 a.4.5.54 Length = 566 | Back alignment and structure |
|---|
Score = 45.8 bits (107), Expect = 4e-05
Identities = 26/245 (10%), Positives = 49/245 (20%), Gaps = 11/245 (4%)
Query: 4 QSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPP----ASPPPSPPTSTPPSPPTAPPPSSP 59
SP +L PS S S T + T P P
Sbjct: 85 TRSPRLILFFKDPSSKDELGKSAETASADVVSTWVCPICMVSNETQGEFTKDTLPTPICI 144
Query: 60 AVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPP 119
P + + +P + + + P+ P +
Sbjct: 145 NCGVPADYELTKSSINCSNAIDPN-ANPQNQFGVNSENICPA----CTFANHPQIGNCEI 199
Query: 120 ANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPP--S 177
+S N S + + S + + SS S
Sbjct: 200 CGHRLPNASKVRSKLNRLNFHDSRVHIELEKNSLARNKSSHSALSSSSSTGSSTEFVQLS 259
Query: 178 SNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSN 237
+ + +++ ++S P +
Sbjct: 260 FRKSDGVLFSQATERALENILTEKNKHIFNQNVVSVNGVDMRKGASSHEYNNEVPFIETK 319
Query: 238 SSTRG 242
S G
Sbjct: 320 LSRIG 324
|
| >1w7p_D VPS36P, YLR417W; ESCRT-II complex, endosomal protein sorting, protein transpo; 3.60A {Saccharomyces cerevisiae} SCOP: a.4.5.54 a.4.5.54 Length = 566 | Back alignment and structure |
|---|
Score = 43.9 bits (102), Expect = 1e-04
Identities = 20/222 (9%), Positives = 37/222 (16%), Gaps = 19/222 (8%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
+ S + P + P+P P S
Sbjct: 100 KDELGKSAETASADVVSTWVCPICMVSNETQGEFTKDTLPTPICINCGVPADYELTKSSI 159
Query: 61 VNSPPPQPSSPPPPLDAPPPPEVDPS-----PPSPAQ----PPPQAVAPSPPPPANVPTT 111
S P++ P + P+ P A N
Sbjct: 160 NCSNAIDPNANPQNQFGVNSENICPACTFANHPQIGNCEICGHRLPNASKVRSKLNRLNF 219
Query: 112 PSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPT----- 166
S + + S A ++ + SS + S
Sbjct: 220 HDSRVHIELEKNSLARNKSSHSALSSSSSTGSSTEFVQLSFRKSDGVLFSQATERALENI 279
Query: 167 -----PPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPP 203
+ + + P
Sbjct: 280 LTEKNKHIFNQNVVSVNGVDMRKGASSHEYNNEVPFIETKLS 321
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 6e-07
Identities = 48/274 (17%), Positives = 84/274 (30%), Gaps = 86/274 (31%)
Query: 389 LGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGEREFRAEVEIISRVH--------HRHL 439
LG G F V+ + + VA+K +K E E+ ++ V +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD-EIRLLKSVRNSDPNDPNREMV 103
Query: 440 VSLVGY-----------CISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGA 488
V L+ C +V+E + + L + + + + + + K+
Sbjct: 104 VQLLDDFKISGVNGTHIC-------MVFEVLGHHLLKWIIKSNYQGLPLPCVK-KIIQQV 155
Query: 489 ARGIAYLHEDCHPRIIHRDIKSSNILLDSS------------------------------ 518
+G+ YLH C IIH DIK NILL +
Sbjct: 156 LQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTA 213
Query: 519 -------------------FEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATS 559
+ ++AD G A + H + + T Y + E
Sbjct: 214 PATAGNFLVNPLEPKNAEKLKVKIADLGNACWV-----HKHFTEDIQ-TRQYRSLEVLIG 267
Query: 560 GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGD 593
+D++S + EL TG +
Sbjct: 268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEY 301
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.0 bits (121), Expect = 1e-06
Identities = 45/312 (14%), Positives = 101/312 (32%), Gaps = 58/312 (18%)
Query: 398 YKGVLADGREVAVKQLKIGGSQG-EREF--RAEVEIISRVHHRHL-VSLVGYCISERERL 453
YK +L+ + V Q + + E++ I + + + ++
Sbjct: 18 YKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEE 77
Query: 454 LVYEYVPNDTLHYHLHAEGRPVMDW-ATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSN 512
+V ++V + L R + + +K + ++ + R+ + D N
Sbjct: 78 MVQKFV-EEVL--------RINYKFLMSPIKTEQRQPSMMTRMYIEQRDRL-YND----N 123
Query: 513 ILLDSSFEARVADFGLAKIAL-ELDSNTHVSTRVMGTFG--YMAPEYATSGKLTEKSDVY 569
+ +R+ + + AL EL +V + G ++A + S K+ K D
Sbjct: 124 QVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMD-- 181
Query: 570 SFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSE 629
F + L L P + L + L+ P +H + +L + + +E
Sbjct: 182 -FKIFWLNLKNCNSPETVLEML--QKLLYQIDPNWTSRSDHSS-----NIKLRIHSIQAE 233
Query: 630 --MFWMIEAAAAC------VRHSATKRPRMSQVVRALD--------TLDGASDLTNGVKP 673
+ C V++ ++ A + T +T+ +
Sbjct: 234 LRRLLKSKPYENCLLVLLNVQN--------AKAWNAFNLSCKILLTTRF--KQVTDFLSA 283
Query: 674 GQSGIFSSAQHS 685
+ S HS
Sbjct: 284 ATTTHISLDHHS 295
|
| >1rh1_A Colicin B; FEPA, cytotoxic bacterial protein, TONB, antibiotic; 2.50A {Escherichia coli} SCOP: b.110.1.1 f.1.1.1 Length = 511 | Back alignment and structure |
|---|
Score = 49.7 bits (117), Expect = 3e-06
Identities = 38/258 (14%), Positives = 62/258 (24%), Gaps = 9/258 (3%)
Query: 13 VPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPP 72
V PS P P +S S PP +P P + +
Sbjct: 20 VVWPSTGRIPGGDVKPGGSSGLAPSMPPGWGDYSPQGIALVQSVLFPGII----RRIILD 75
Query: 73 PPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPP 132
L+ S SP + A + P S P + +S
Sbjct: 76 KELEEGDWSGWSVSVHSPWGNEKVSAARTVLENGLRGGLPEPSRPAAVSFARLEPASGNE 135
Query: 133 PANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTP 192
+R + ++PA+ ++ V V + P+ P
Sbjct: 136 QKIIRLMVTQQLEQVTDIPASQLPAAGNNVPVKYRLTDLMQNGTQYMAIIG--GIPMTVP 193
Query: 193 --PPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSSTRGSPSTPPLP 250
P P T + P P++P SN +
Sbjct: 194 VVDAVPVPDRSRPGTNIKDVYSA-PVSPNLPDLVLSVGQMNTPVRSNPEIQEDGVISETG 252
Query: 251 SVPTEKPTAKSTNGTAVS 268
+ T S N +
Sbjct: 253 NYVEAGYTMSSNNHDVIV 270
|
| >2yew_A Capsid protein, coat protein; alphavirus, molecular dynamics; 5.00A {Barmah forest virus} Length = 253 | Back alignment and structure |
|---|
Score = 46.9 bits (111), Expect = 8e-06
Identities = 12/83 (14%), Positives = 17/83 (20%)
Query: 14 PPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPP 73
P P P PPA P S A + + P
Sbjct: 8 TFYGRRWRPAPVQRYIPQPQPPAPPRRRRGPSQLQQLVAALGALALQPKQKQKRAQKKPK 67
Query: 74 PLDAPPPPEVDPSPPSPAQPPPQ 96
P P + + +
Sbjct: 68 KTPPPKPKKTQKPKKPTQKKKSK 90
|
| >2yew_A Capsid protein, coat protein; alphavirus, molecular dynamics; 5.00A {Barmah forest virus} Length = 253 | Back alignment and structure |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 15/96 (15%), Positives = 20/96 (20%), Gaps = 3/96 (3%)
Query: 15 PPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPP 74
P P P PP P P+ A+ + QP
Sbjct: 5 PTQTFYGRRWRPAPVQRYIPQPQPPAPPR---RRRGPSQLQQLVAALGALALQPKQKQKR 61
Query: 75 LDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPT 110
P P P +P P +
Sbjct: 62 AQKKPKKTPPPKPKKTQKPKKPTQKKKSKPGKRMRN 97
|
| >2yew_A Capsid protein, coat protein; alphavirus, molecular dynamics; 5.00A {Barmah forest virus} Length = 253 | Back alignment and structure |
|---|
Score = 41.5 bits (97), Expect = 5e-04
Identities = 16/92 (17%), Positives = 19/92 (20%), Gaps = 4/92 (4%)
Query: 43 PTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSP 102
PT T P P PQP P PP P ++ + Q
Sbjct: 5 PTQTFYGRRWRPAPVQR----YIPQPQPPAPPRRRRGPSQLQQLVAALGALALQPKQKQK 60
Query: 103 PPPANVPTTPSSSSPPPANVPTTPSSSSPPPA 134
TP P
Sbjct: 61 RAQKKPKKTPPPKPKKTQKPKKPTQKKKSKPG 92
|
| >2uv8_A Fatty acid synthase subunit alpha (FAS2); fatty acid biosynthesis, malonyl/palmitoyl transferase, phosphopantetheine, transferase; HET: GVL FMN; 3.10A {Saccharomyces cerevisiae} PDB: 2vkz_A* 3hmj_A* Length = 1887 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 9e-06
Identities = 10/55 (18%), Positives = 17/55 (30%)
Query: 27 TPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPP 81
P + P TP + AP ++PA + ++ D P
Sbjct: 93 DPSELAAKEEPAKEEAPAPTPAASAPAPAAAAPAPVAAAAPAAAAAEIADEPVKA 147
|
| >2uv8_A Fatty acid synthase subunit alpha (FAS2); fatty acid biosynthesis, malonyl/palmitoyl transferase, phosphopantetheine, transferase; HET: GVL FMN; 3.10A {Saccharomyces cerevisiae} PDB: 2vkz_A* 3hmj_A* Length = 1887 | Back alignment and structure |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 12/48 (25%), Positives = 19/48 (39%)
Query: 12 AVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSP 59
P P+ TP ++P PA+ P+P + P+ A P
Sbjct: 97 LAAKEEPAKEEAPAPTPAASAPAPAAAAPAPVAAAAPAAAAAEIADEP 144
|
| >2uv8_A Fatty acid synthase subunit alpha (FAS2); fatty acid biosynthesis, malonyl/palmitoyl transferase, phosphopantetheine, transferase; HET: GVL FMN; 3.10A {Saccharomyces cerevisiae} PDB: 2vkz_A* 3hmj_A* Length = 1887 | Back alignment and structure |
|---|
Score = 42.3 bits (99), Expect = 7e-04
Identities = 10/60 (16%), Positives = 19/60 (31%), Gaps = 2/60 (3%)
Query: 2 PPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAV 61
P + + P P ++ P P + PA + P + P +S +
Sbjct: 94 PSELAAKE--EPAKEEAPAPTPAASAPAPAAAAPAPVAAAAPAAAAAEIADEPVKASLLL 151
|
| >2uv8_A Fatty acid synthase subunit alpha (FAS2); fatty acid biosynthesis, malonyl/palmitoyl transferase, phosphopantetheine, transferase; HET: GVL FMN; 3.10A {Saccharomyces cerevisiae} PDB: 2vkz_A* 3hmj_A* Length = 1887 | Back alignment and structure |
|---|
Score = 42.3 bits (99), Expect = 7e-04
Identities = 12/55 (21%), Positives = 18/55 (32%)
Query: 15 PPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPS 69
P P+ P P AS P + P AP ++ + P + S
Sbjct: 94 PSELAAKEEPAKEEAPAPTPAASAPAPAAAAPAPVAAAAPAAAAAEIADEPVKAS 148
|
| >3i2d_A E3 SUMO-protein ligase SIZ1; signal transduction, replication, ring E3, PIAS, ubiquitin, UBC9, metal-binding, nucleus; 2.60A {Saccharomyces cerevisiae} Length = 371 | Back alignment and structure |
|---|
Score = 46.1 bits (108), Expect = 2e-05
Identities = 14/100 (14%), Positives = 23/100 (23%), Gaps = 4/100 (4%)
Query: 16 PSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPL 75
+P + + P + SP + T + +S A P SS
Sbjct: 2 LTPLSAITVRSMEGPPTVQQQSPSVIRQSPTQRRKTSTTSSTSRAPPPTNPDASSSSSSF 61
Query: 76 DAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSS 115
P SP + + S
Sbjct: 62 AVPTIHFK----ESPFYKIQRLIPELVMNVEVTGGRGMCS 97
|
| >3i2d_A E3 SUMO-protein ligase SIZ1; signal transduction, replication, ring E3, PIAS, ubiquitin, UBC9, metal-binding, nucleus; 2.60A {Saccharomyces cerevisiae} Length = 371 | Back alignment and structure |
|---|
Score = 44.2 bits (103), Expect = 1e-04
Identities = 18/83 (21%), Positives = 26/83 (31%)
Query: 14 PPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPP 73
+ PP+ S SP TST S APPP++P +S + P
Sbjct: 7 AITVRSMEGPPTVQQQSPSVIRQSPTQRRKTSTTSSTSRAPPPTNPDASSSSSSFAVPTI 66
Query: 74 PLDAPPPPEVDPSPPSPAQPPPQ 96
P ++ P
Sbjct: 67 HFKESPFYKIQRLIPELVMNVEV 89
|
| >3i2d_A E3 SUMO-protein ligase SIZ1; signal transduction, replication, ring E3, PIAS, ubiquitin, UBC9, metal-binding, nucleus; 2.60A {Saccharomyces cerevisiae} Length = 371 | Back alignment and structure |
|---|
Score = 43.4 bits (101), Expect = 2e-04
Identities = 17/94 (18%), Positives = 23/94 (24%)
Query: 147 PANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTK 206
+ A S P V S P+ TST S PPP ++ +
Sbjct: 2 LTPLSAITVRSMEGPPTVQQQSPSVIRQSPTQRRKTSTTSSTSRAPPPTNPDASSSSSSF 61
Query: 207 SPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSST 240
+ P P P V
Sbjct: 62 AVPTIHFKESPFYKIQRLIPELVMNVEVTGGRGM 95
|
| >3i2d_A E3 SUMO-protein ligase SIZ1; signal transduction, replication, ring E3, PIAS, ubiquitin, UBC9, metal-binding, nucleus; 2.60A {Saccharomyces cerevisiae} Length = 371 | Back alignment and structure |
|---|
Score = 42.2 bits (98), Expect = 4e-04
Identities = 20/116 (17%), Positives = 29/116 (25%), Gaps = 2/116 (1%)
Query: 88 PSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPP 147
+P PP + SP +T SS+S P SSSS
Sbjct: 2 LTPLSAITVRSMEGPPTVQQQSPSVIRQSPTQRRKTSTTSSTSRAPPPTNPDASSSSSSF 61
Query: 148 ANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPP 203
A S P + + + L+ + S P
Sbjct: 62 AVPTIHFKES--PFYKIQRLIPELVMNVEVTGGRGMCSAKFKLSKADYNLLSNPNS 115
|
| >3i2d_A E3 SUMO-protein ligase SIZ1; signal transduction, replication, ring E3, PIAS, ubiquitin, UBC9, metal-binding, nucleus; 2.60A {Saccharomyces cerevisiae} Length = 371 | Back alignment and structure |
|---|
Score = 42.2 bits (98), Expect = 5e-04
Identities = 16/76 (21%), Positives = 20/76 (26%), Gaps = 4/76 (5%)
Query: 27 TPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPS 86
+ P S PPT SP + + +S PP P S
Sbjct: 1 SLTPLSAITVRSMEGPPTVQQQSPSVIRQSPTQRRKTSTTSSTSRAPPPTNPDA----SS 56
Query: 87 PPSPAQPPPQAVAPSP 102
S P SP
Sbjct: 57 SSSSFAVPTIHFKESP 72
|
| >3i2d_A E3 SUMO-protein ligase SIZ1; signal transduction, replication, ring E3, PIAS, ubiquitin, UBC9, metal-binding, nucleus; 2.60A {Saccharomyces cerevisiae} Length = 371 | Back alignment and structure |
|---|
Score = 41.8 bits (97), Expect = 5e-04
Identities = 14/91 (15%), Positives = 25/91 (27%)
Query: 2 PPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAV 61
P + + PP SP P ++ + P +P + SS AV
Sbjct: 4 PLSAITVRSMEGPPTVQQQSPSVIRQSPTQRRKTSTTSSTSRAPPPTNPDASSSSSSFAV 63
Query: 62 NSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQ 92
+ + S P ++
Sbjct: 64 PTIHFKESPFYKIQRLIPELVMNVEVTGGRG 94
|
| >2j63_A AP-endonuclease; base excision repair, lyase; 2.48A {Leishmania major} Length = 467 | Back alignment and structure |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 23/132 (17%), Positives = 35/132 (26%), Gaps = 1/132 (0%)
Query: 15 PPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPS-SPAVNSPPPQPSSPPP 73
P +S P+ PPS A + V P +
Sbjct: 15 VPRGSHMASKRCRQCSGDSASSSTSSLSPSELPPSKKAAGGQRVTAEVEVAPITTDATSA 74
Query: 74 PLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPP 133
+ A + + SPA+ A + + T + + A S P
Sbjct: 75 TVTAAGGAKKKATTGSPARRTSSAAKITNGDAGELIRTAEALAALNAKKSEKEIWSDVVP 134
Query: 134 ANVRTTPSSSSP 145
RTT S P
Sbjct: 135 FVRRTTDSDFDP 146
|
| >2uv9_A Fatty acid synthase alpha subunits; fungal, dehydratase, enoyl reductase, ketoacyl synthase, ketoacyl reductase; 3.1A {Thermomyces lanuginosus} PDB: 2uvb_A* Length = 1878 | Back alignment and structure |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 14/56 (25%), Positives = 17/56 (30%)
Query: 26 TTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPP 81
P P P S + P + P AP + A P P DAP
Sbjct: 92 VEPIEDEPEPTPAAASSADAAPAAAPAAPAAPAAAPAPAPASAGPAAPVQDAPVTA 147
|
| >2uv9_A Fatty acid synthase alpha subunits; fungal, dehydratase, enoyl reductase, ketoacyl synthase, ketoacyl reductase; 3.1A {Thermomyces lanuginosus} PDB: 2uvb_A* Length = 1878 | Back alignment and structure |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 13/59 (22%), Positives = 20/59 (33%)
Query: 26 TTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVD 84
P P +P + P+ A P + A +P P + P P+ P D
Sbjct: 91 DVEPIEDEPEPTPAAASSADAAPAAAPAAPAAPAAAPAPAPASAGPAAPVQDAPVTATD 149
|
| >3dva_I Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase...; oxidoreductase, multienzyme complex; HET: TPW; 2.35A {Bacillus stearothermophilus} PDB: 3dv0_I* 3duf_I* 1b5s_A 1lab_A 1lac_A 1w3d_A Length = 428 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 3e-05
Identities = 9/117 (7%), Positives = 19/117 (16%), Gaps = 34/117 (29%)
Query: 5 SSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAV--- 61
+ T + P+ P + + P + P+V
Sbjct: 79 PGYENMTFKGQEQEEAKKEEKTETVSKEEKVDAVAPNAPAAEAEAGPNRRVIAMPSVRKY 138
Query: 62 -------------------------------NSPPPQPSSPPPPLDAPPPPEVDPSP 87
+ P ++ A P
Sbjct: 139 AREKGVDIRLVQGTGKNGRVLKEDIDAFLAGGAKPAPAAAEEKAAPAAAKPATTEGE 195
|
| >3dva_I Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase...; oxidoreductase, multienzyme complex; HET: TPW; 2.35A {Bacillus stearothermophilus} PDB: 3dv0_I* 3duf_I* 1b5s_A 1lab_A 1lac_A 1w3d_A Length = 428 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 2e-04
Identities = 15/117 (12%), Positives = 20/117 (17%), Gaps = 26/117 (22%)
Query: 27 TPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPP------- 79
T T + + P + A P
Sbjct: 81 YENMTFKGQEQEEAKKEEKTETVSKEEKVDAVAPNAPAAEAEAGPNRRVIAMPSVRKYAR 140
Query: 80 -----PPEVDPSPP--------------SPAQPPPQAVAPSPPPPANVPTTPSSSSP 117
V + A+P P A P A P T P
Sbjct: 141 EKGVDIRLVQGTGKNGRVLKEDIDAFLAGGAKPAPAAAEEKAAPAAAKPATTEGEFP 197
|
| >1x9d_A Endoplasmic reticulum mannosyl-oligosaccharide 1, 2-alpha-mannosidase; substrate analogue, glycosyl hydrolase; HET: SMD; 1.41A {Homo sapiens} SCOP: a.102.2.1 PDB: 1fo3_A* 1fo2_A* 1fmi_A Length = 538 | Back alignment and structure |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 16/78 (20%), Positives = 23/78 (29%), Gaps = 3/78 (3%)
Query: 79 PPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRT 138
PP D + + + AP P P P + P + P+
Sbjct: 10 DPPSQDLKDGTQEEATKRQEAPVDPRP---EGDPQRTVISWRGAVIEPEQGTELPSRRAE 66
Query: 139 TPSSSSPPPANVPATPSS 156
P+ PPA TP
Sbjct: 67 VPTKPPLPPARTQGTPVH 84
|
| >1x9d_A Endoplasmic reticulum mannosyl-oligosaccharide 1, 2-alpha-mannosidase; substrate analogue, glycosyl hydrolase; HET: SMD; 1.41A {Homo sapiens} SCOP: a.102.2.1 PDB: 1fo3_A* 1fo2_A* 1fmi_A Length = 538 | Back alignment and structure |
|---|
Score = 42.3 bits (99), Expect = 5e-04
Identities = 14/79 (17%), Positives = 17/79 (21%), Gaps = 2/79 (2%)
Query: 14 PPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPP 73
PP P P P T S A P + P + P
Sbjct: 11 PPSQDLKDGTQEEATKRQEAPVDPRPEGDPQRTVISWRGAVIE--PEQGTELPSRRAEVP 68
Query: 74 PLDAPPPPEVDPSPPSPAQ 92
PP +P
Sbjct: 69 TKPPLPPARTQGTPVHLNY 87
|
| >3ghg_A Fibrinogen alpha chain; triple-stranded coiled coil, beta sheets, alpha helices, AMY amyloidosis, blood coagulation, disease mutation, glycoprot phosphoprotein; HET: NAG NDG BMA MAN GAL SIA; 2.90A {Homo sapiens} PDB: 3h32_A* 2a45_G* Length = 562 | Back alignment and structure |
|---|
Score = 44.9 bits (105), Expect = 9e-05
Identities = 27/180 (15%), Positives = 54/180 (30%), Gaps = 6/180 (3%)
Query: 104 PPANVPTTPSSSSPPPANVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVN 163
P N T S+S + +P + S + + S N ++ + +
Sbjct: 245 PGGNEITRGGSTSYGTGSETESPRNPSSAGSWNSGSSGPGSTGNRNPGSSGTGGTATWKP 304
Query: 164 VPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPST 223
+ P S+ S+ ST + +P P + + P ++ A + +
Sbjct: 305 GSSGPGSTGSWNSGSSGTGSTGNQNPGSPRPGSTGTWNPGSSERGSAGHWTS------ES 358
Query: 224 SSPPAVSPPAPPSNSSTRGSPSTPPLPSVPTEKPTAKSTNGTAVSANASPRNAGVLGTGG 283
S + S S SP + + T + +G + L T
Sbjct: 359 SVSGSTGQWHSESGSFRPDSPGSGNARPNNPDWGTFEEVSGNVSPGTRREYHTEKLVTSK 418
|
| >1pcx_A Protein transport protein SEC24; 2.50A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 PDB: 1pd0_A 1pd1_A Length = 810 | Back alignment and structure |
|---|
Score = 44.2 bits (103), Expect = 1e-04
Identities = 21/63 (33%), Positives = 23/63 (36%), Gaps = 2/63 (3%)
Query: 34 PPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQP--SSPPPPLDAPPPPEVDPSPPSPA 91
PA PS P P PPP + PPPPL PP + PS S A
Sbjct: 2 APAYGQPSAAMGQNMRPMNQLYPIDLLTELPPPITDLTLPPPPLVIPPERMLVPSELSNA 61
Query: 92 QPP 94
P
Sbjct: 62 SPD 64
|
| >1zvo_C Myeloma immunoglobulin D delta; immunoglobulin fold, antibody, immune system; NMR {Homo sapiens} Length = 512 | Back alignment and structure |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 27/178 (15%), Positives = 36/178 (20%), Gaps = 8/178 (4%)
Query: 66 PQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPANVPTT 125
+ P + P SP P + S P
Sbjct: 128 SSAPTKAPDVFPIISGCRHPKDNSPVVLACLITGYHPTSVTVTWYMGTQSQPQRTFPEIQ 187
Query: 126 PSSSSPPPANVRTTPSSSSPPPA---NVPATPSSSSPPPVNVPTPP--SSSSPPPPSSNP 180
S ++ +TP V T S S P P +SS P
Sbjct: 188 RRDSYYMTSSQLSTPLQQWRQGEYKCVVQHTASKSKKEIFRWPESPKAQASSVPTAQPQA 247
Query: 181 PTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSP---PPPSVPSTSSPPAVSPPAPP 235
S + K P PS + P V P
Sbjct: 248 EGSLAKATTAPATTRNTGRGGEEKKKEKEKEEQEERETKTPECPSHTQPLGVYLLTPA 305
|
| >3oun_A Putative uncharacterized protein TB39.8; peptidoglycan, Ser/Thr kinase, pseudokinase, FHA domain, REG phosphorylation; HET: TPO; 2.71A {Mycobacterium tuberculosis} Length = 157 | Back alignment and structure |
|---|
Score = 41.4 bits (97), Expect = 2e-04
Identities = 10/79 (12%), Positives = 16/79 (20%), Gaps = 4/79 (5%)
Query: 36 ASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPP 95
S S+ P + P +P+ P+ P
Sbjct: 2 GSSQHHHHHSSGLVPRGSHMPQGGG----YAEPAGRDYDYGQSGAPDYGQPAPGGYSGYG 57
Query: 96 QAVAPSPPPPANVPTTPSS 114
Q S + S
Sbjct: 58 QGGYGSAGTSVTLQLDDGS 76
|
| >1eys_C Photosynthetic reaction center; membrane protein complex, electron transport; HET: BGL BCL BPH MQ8 HEM CRT LDA PEF; 2.20A {Thermochromatium tepidum} SCOP: a.138.1.2 Length = 382 | Back alignment and structure |
|---|
Score = 43.3 bits (101), Expect = 2e-04
Identities = 15/73 (20%), Positives = 23/73 (31%)
Query: 34 PPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQP 93
P + P S P + + A + P P+ P +A P + +
Sbjct: 306 PGLYKTAVTQEALPGSAPASEAAPAAATEAAPEAPAQEVPAAEAVPAAAEPGAAEAAGSV 365
Query: 94 PPQAVAPSPPPPA 106
P V P PA
Sbjct: 366 EPAPVEEVAPAPA 378
|
| >1eys_C Photosynthetic reaction center; membrane protein complex, electron transport; HET: BGL BCL BPH MQ8 HEM CRT LDA PEF; 2.20A {Thermochromatium tepidum} SCOP: a.138.1.2 Length = 382 | Back alignment and structure |
|---|
Score = 41.4 bits (96), Expect = 8e-04
Identities = 12/73 (16%), Positives = 20/73 (27%)
Query: 19 PLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPPPLDAP 78
P + T + +P +T +P A P +
Sbjct: 306 PGLYKTAVTQEALPGSAPASEAAPAAATEAAPEAPAQEVPAAEAVPAAAEPGAAEAAGSV 365
Query: 79 PPPEVDPSPPSPA 91
P V+ P+PA
Sbjct: 366 EPAPVEEVAPAPA 378
|
| >2vg3_A Undecaprenyl pyrophosphate synthetase; transferase, cell WALL biogenesis/degradation, cell cycle, P transferase; HET: GPP; 1.8A {Mycobacterium tuberculosis} PDB: 2vg2_A* 2vg4_A Length = 284 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 2e-04
Identities = 15/49 (30%), Positives = 22/49 (44%), Gaps = 1/49 (2%)
Query: 159 PPPVNVPTPPSSSSPPPPSSNPPTSTPSPPVLTPPPHPSQSAPPPVTKS 207
P P + PT P +S+ P P + P PP H S++A P +
Sbjct: 6 PAPDDYPTFPDTSTWPVVFPELPAAPYGGPC-RPPQHTSKAAAPRIPAD 53
|
| >1kxf_A Sindbis virus capsid protein; chymotrypsin-like serine proteinase, wild type, viral protein; 2.38A {Sindbis virus} SCOP: b.47.1.3 PDB: 1ld4_A 3j0f_A Length = 264 | Back alignment and structure |
|---|
Score = 41.7 bits (97), Expect = 5e-04
Identities = 14/106 (13%), Positives = 22/106 (20%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
P P + + P+ A +T P P PP
Sbjct: 13 PFPAPTAMWRPRRRRQAAPMPARNGLASQIQQLTTAVSALVIGQATRPQNPRPRPPPRQK 72
Query: 61 VNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPA 106
+P P P + + P Q +
Sbjct: 73 KQAPKQPPKPKKPKPQEKKKKQPAKTKPGKRQRMALKLEADRLFDV 118
|
| >1kxf_A Sindbis virus capsid protein; chymotrypsin-like serine proteinase, wild type, viral protein; 2.38A {Sindbis virus} SCOP: b.47.1.3 PDB: 1ld4_A 3j0f_A Length = 264 | Back alignment and structure |
|---|
Score = 40.9 bits (95), Expect = 8e-04
Identities = 15/107 (14%), Positives = 23/107 (21%), Gaps = 3/107 (2%)
Query: 14 PPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPAVNSPPPQPSSPPP 73
P P+ P +P PA + + +A P P
Sbjct: 15 PAPTAMWRPRR---RRQAAPMPARNGLASQIQQLTTAVSALVIGQATRPQNPRPRPPPRQ 71
Query: 74 PLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPA 120
AP P P + Q P + +
Sbjct: 72 KKQAPKQPPKPKKPKPQEKKKKQPAKTKPGKRQRMALKLEADRLFDV 118
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* Length = 258 | Back alignment and structure |
|---|
Score = 41.2 bits (96), Expect = 7e-04
Identities = 28/169 (16%), Positives = 54/169 (31%), Gaps = 29/169 (17%)
Query: 386 HNVLGEGGFGCVYKGVLA---DGREVAVKQLKIGGS---------QGEREF-------RA 426
V+ G V+ +AVK +I S G+ F +
Sbjct: 52 GGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKE 111
Query: 427 EVEIISRVHHRHLVSLVGYCIS------ERERLLVYEYVPNDTLHYHLHAEGRPVMDWAT 480
+V I + R+L +S + +L+ E++ D L E +
Sbjct: 112 KVFIWTEKEFRNLERAKEAGVSVPQPYTYMKNVLLMEFIGEDELPAPTLVELGRELKELD 171
Query: 481 RVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLA 529
+ + L+++ ++H D+ NI+ + D G A
Sbjct: 172 VEGIFNDVVENVKRLYQEA--ELVHADLSEYNIMYID--KVYFIDMGQA 216
|
| >1mv3_A MYC box dependent interacting protein 1; tumor suppressor, endocytosis/exocytosis complex; NMR {Homo sapiens} SCOP: b.34.2.1 Length = 213 | Back alignment and structure |
|---|
Score = 40.8 bits (94), Expect = 7e-04
Identities = 21/132 (15%), Positives = 29/132 (21%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
PA A P + P SP PP PPP P
Sbjct: 11 RVNHEPEPAGGATPGATLPKSPSQLRKGPPVPPPPKHTPSKEVKQEQILSLFEDTFVPEI 70
Query: 61 VNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPA 120
+ P QP+ P P A + + P T + + +
Sbjct: 71 SVTTPSQPAEASEVAGGTQPAAGAQEPGETAASEAASSSLPAVVVETFPATVNGTVEGGS 130
Query: 121 NVPTTPSSSSPP 132
Sbjct: 131 GAGRLDLPPGFM 142
|
| >1mv3_A MYC box dependent interacting protein 1; tumor suppressor, endocytosis/exocytosis complex; NMR {Homo sapiens} SCOP: b.34.2.1 Length = 213 | Back alignment and structure |
|---|
Score = 40.8 bits (94), Expect = 7e-04
Identities = 25/140 (17%), Positives = 40/140 (28%)
Query: 1 PPPQSSPPAVLAVPPPSPPLSPPPSTTPPPTSPPPASPPPSPPTSTPPSPPTAPPPSSPA 60
P + V P P+ +P + P+ P P PP TP S
Sbjct: 3 SPAATPEIRVNHEPEPAGGATPGATLPKSPSQLRKGPPVPPPPKHTPSKEVKQEQILSLF 62
Query: 61 VNSPPPQPSSPPPPLDAPPPPEVDPSPPSPAQPPPQAVAPSPPPPANVPTTPSSSSPPPA 120
++ P+ S P A + P+ P A S +++P + P
Sbjct: 63 EDTFVPEISVTTPSQPAEASEVAGGTQPAAGAQEPGETAASEAASSSLPAVVVETFPATV 122
Query: 121 NVPTTPSSSSPPPANVRTTP 140
N S +
Sbjct: 123 NGTVEGGSGAGRLDLPPGFM 142
|
| >2qlv_B Protein SIP2, protein SPM2; heterotrimer, ATP-binding, carbohydrate metabolism, kinase, membrane, nucleotide-binding, nucleus; 2.60A {Saccharomyces cerevisiae} SCOP: b.1.18.21 d.353.1.1 Length = 252 | Back alignment and structure |
|---|
Score = 40.8 bits (94), Expect = 8e-04
Identities = 16/131 (12%), Positives = 29/131 (22%)
Query: 121 NVPTTPSSSSPPPANVRTTPSSSSPPPANVPATPSSSSPPPVNVPTPPSSSSPPPPSSNP 180
V + + + S P P P
Sbjct: 84 EVRQPEKNPTNEKIRSKEADSMRPPTSDRSSIALQIGKDPDDFGDGYTRFHEDLSPRPPL 143
Query: 181 PTSTPSPPVLTPPPHPSQSAPPPVTKSPPASTLSPPPPSVPSTSSPPAVSPPAPPSNSST 240
+T P V T P + + T PP +P ++ +
Sbjct: 144 EYTTDIPAVFTDPSVMERYYYTLDRQQSNTDTSWLTPPQLPPQLENVILNKYYATQDQFN 203
Query: 241 RGSPSTPPLPS 251
+ P+P+
Sbjct: 204 ENNSGALPIPN 214
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 727 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.92 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.84 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.76 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.54 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.43 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.36 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.26 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 99.06 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.97 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.94 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.89 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.81 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.78 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.56 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.52 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.47 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.39 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.32 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 98.25 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 98.09 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 98.08 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 98.05 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 98.04 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.97 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.91 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.91 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.77 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.63 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 97.56 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 97.51 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 97.4 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.99 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.29 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 96.09 | |
| 2k9y_A | 41 | Ephrin type-A receptor 2; receptor tyrosine kinase | 95.79 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 95.16 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 94.91 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 92.71 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 92.48 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 91.9 | |
| 2l8s_A | 54 | Integrin alpha-1; transmembrane region, detergent | 91.3 | |
| 2knc_A | 54 | Integrin alpha-IIB; transmembrane signaling, prote | 90.42 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 89.96 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 89.63 | |
| 2x6h_A | 696 | GH13170P, VPS34, phosphotidylinositol 3 kinase 59F | 89.54 | |
| 1cja_A | 342 | Protein (actin-fragmin kinase); transferase; HET: | 89.1 | |
| 1iij_A | 35 | ERBB-2 receptor protein-tyrosine kinase; alpha-hel | 88.01 | |
| 2knc_B | 79 | Integrin beta-3; transmembrane signaling, protein | 87.89 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 85.79 | |
| 3ls8_A | 614 | Phosphatidylinositol 3-kinase catalytic subunit ty | 85.49 | |
| 2k1a_A | 42 | Integrin alpha-IIB; single-PASS transmembrane segm | 83.77 | |
| 2k9j_B | 43 | Integrin beta-3; transmembrane complex, cell adhes | 83.2 | |
| 2l34_A | 33 | TYRO protein tyrosine kinase-binding protein; immu | 81.75 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-55 Score=468.12 Aligned_cols=259 Identities=26% Similarity=0.449 Sum_probs=214.1
Q ss_pred cCccccceeccCCceEEEEEEEc------CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA------DGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLL 454 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 454 (727)
++|.+.++||+|+||.||+|++. +|+.||||+++....+..++|++|+++|++|+|+|||+|+|+|.+++.+||
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 56889999999999999999874 478899999987666667889999999999999999999999999999999
Q ss_pred EEeeccCCccchhcccCC-----------CCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEE
Q 041135 455 VYEYVPNDTLHYHLHAEG-----------RPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARV 523 (727)
Q Consensus 455 V~Ey~~~gsL~~~L~~~~-----------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL 523 (727)
|||||.+|+|.++|+.++ ...++|.++++|+.||++||+|||++ +|||||||++||||++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEE
Confidence 999999999999997642 34689999999999999999999999 9999999999999999999999
Q ss_pred EeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHH
Q 041135 524 ADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARP 602 (727)
Q Consensus 524 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~ 602 (727)
+|||+|+.....+ ........+||.+|||||++.++.|+.++|||||||+||||+| |+.||.+... ..+.
T Consensus 170 ~DFGla~~~~~~~-~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~---~~~~----- 240 (299)
T 4asz_A 170 GDFGMSRDVYSTD-YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---NEVI----- 240 (299)
T ss_dssp CCCSCHHHHTGGG-CEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH---HHHH-----
T ss_pred CCcccceecCCCC-ceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHH-----
Confidence 9999998653322 2222334579999999999999999999999999999999998 9999976431 1111
Q ss_pred HHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 603 LLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 603 ~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
..+.+. ............+.+||.+||+.||++||+|.||++.|+++..
T Consensus 241 -----------~~i~~~-~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 241 -----------ECITQG-RVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp -----------HHHHHT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----------HHHHcC-CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 111111 1112233344568899999999999999999999999998754
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-55 Score=470.95 Aligned_cols=259 Identities=28% Similarity=0.451 Sum_probs=208.6
Q ss_pred cCccccceeccCCceEEEEEEEc------CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA------DGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLL 454 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 454 (727)
++|.+.++||+|+||+||+|+++ +++.||||+++.......++|++|+++|++|+|+|||+|+|+|.+++.+||
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 46788899999999999999874 478899999987666667889999999999999999999999999999999
Q ss_pred EEeeccCCccchhcccCC-------------CCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcE
Q 041135 455 VYEYVPNDTLHYHLHAEG-------------RPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEA 521 (727)
Q Consensus 455 V~Ey~~~gsL~~~L~~~~-------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~v 521 (727)
|||||.+|+|.++|+... ...++|.++++|+.||++||+|||++ +|||||||++||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcE
Confidence 999999999999997643 23489999999999999999999999 99999999999999999999
Q ss_pred EEEeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhh
Q 041135 522 RVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWA 600 (727)
Q Consensus 522 kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~ 600 (727)
||+|||+++.....+ ........+||..|||||++.++.|+.++||||||||||||+| |+.||..... ..+.
T Consensus 198 Ki~DFGla~~~~~~~-~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~---~~~~--- 270 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTD-YYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN---TEAI--- 270 (329)
T ss_dssp EECCCC-----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH---HHHH---
T ss_pred EEcccccceeccCCC-cceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH---HHHH---
Confidence 999999998653222 2223345789999999999999999999999999999999999 8999976431 1111
Q ss_pred HHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 601 RPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 601 ~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
..+.+ ..+..........+.+||++||+.||++||+|.||+++|+.+.+
T Consensus 271 -------------~~i~~-g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 271 -------------DCITQ-GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp -------------HHHHH-TCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -------------HHHHc-CCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 11111 11122233344568899999999999999999999999998854
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-55 Score=465.63 Aligned_cols=257 Identities=26% Similarity=0.459 Sum_probs=211.6
Q ss_pred cCccccceeccCCceEEEEEEEc------CCcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceee
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA------DGREVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYCISERERL 453 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 453 (727)
.+++++++||+|+||+||+|++. +++.||||+++.... ...++|++|+++|++|+|+|||+|+|+|.+++.++
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 34677899999999999999873 467899999975433 33568999999999999999999999999999999
Q ss_pred EEEeeccCCccchhcccCC--------------CCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCC
Q 041135 454 LVYEYVPNDTLHYHLHAEG--------------RPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSF 519 (727)
Q Consensus 454 lV~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~ 519 (727)
||||||.+|+|.++|+.+. ...++|.++++|+.||++||+|||++ +|||||||++||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCC
Confidence 9999999999999996532 23589999999999999999999999 999999999999999999
Q ss_pred cEEEEeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHH
Q 041135 520 EARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVE 598 (727)
Q Consensus 520 ~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~ 598 (727)
.+||+|||+++.....+ ........+||.+|||||++.++.|+.++||||||||||||+| |+.||.+... ..+.
T Consensus 183 ~~Ki~DFGlar~~~~~~-~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~---~~~~- 257 (308)
T 4gt4_A 183 NVKISDLGLFREVYAAD-YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QDVV- 257 (308)
T ss_dssp CEEECCSCCBCGGGGGG-CBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH---HHHH-
T ss_pred CEEECCcccceeccCCC-ceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH---HHHH-
Confidence 99999999998653322 2223445689999999999999999999999999999999998 8999976431 1111
Q ss_pred hhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhc
Q 041135 599 WARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661 (727)
Q Consensus 599 ~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 661 (727)
..+...........+...+.+||.+||+.||++||+|.||+++|+.+
T Consensus 258 ----------------~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 258 ----------------EMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp ----------------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred ----------------HHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11111111223344556688999999999999999999999999875
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-54 Score=458.27 Aligned_cols=261 Identities=29% Similarity=0.490 Sum_probs=203.7
Q ss_pred hcCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCC--chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEe
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGG--SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYE 457 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 457 (727)
.++|++.++||+|+||+||+|+++ ..||||+++... .+..+.|++|+++|++++|+|||+|+|+|.+ +.+|||||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 467889999999999999999875 369999997543 2344679999999999999999999999865 56899999
Q ss_pred eccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCC
Q 041135 458 YVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDS 537 (727)
Q Consensus 458 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 537 (727)
||+||+|.++|+.... .+++.++++|+.||++||+|||++ +|||||||++||||++++.+||+|||+|+......
T Consensus 112 y~~gGsL~~~l~~~~~-~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~- 186 (307)
T 3omv_A 112 WCEGSSLYKHLHVQET-KFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS- 186 (307)
T ss_dssp CCSSCBHHHHHHTSCC-CCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred cCCCCCHHHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCC-
Confidence 9999999999976532 489999999999999999999999 99999999999999999999999999998643222
Q ss_pred CccccccccCCccccccCcccC---CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHH
Q 041135 538 NTHVSTRVMGTFGYMAPEYATS---GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFE 614 (727)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~l~~---~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~ 614 (727)
........+||..|||||++.+ +.|+.++||||||||||||++|+.||.+.... . .....+........
T Consensus 187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~---~---~~~~~~~~~~~~p~-- 258 (307)
T 3omv_A 187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR---D---QIIFMVGRGYASPD-- 258 (307)
T ss_dssp -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH---H---HHHHHHHTTCCCCC--
T ss_pred cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH---H---HHHHHHhcCCCCCC--
Confidence 2223445789999999999964 35899999999999999999999999764321 1 11111110000000
Q ss_pred HHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 615 ALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 615 ~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
+ ..........+.+||.+||+.||++||+|.||++.|+.++.
T Consensus 259 ------~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 259 ------L-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp ------S-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred ------c-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 0 01122334568899999999999999999999999998753
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-54 Score=462.89 Aligned_cols=251 Identities=21% Similarity=0.369 Sum_probs=204.1
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC--chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEe
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG--SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYE 457 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 457 (727)
++|+++++||+|+||+||+|++. +|+.||||+++... ....+.|++|+++|++|+|+|||+++++|.+++.+|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 67999999999999999999975 69999999997543 2334679999999999999999999999999999999999
Q ss_pred eccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCC
Q 041135 458 YVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDS 537 (727)
Q Consensus 458 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 537 (727)
||.||+|.++|+.++...+++.+++.|+.||+.||+|||++ +|||||||++||||++++.+||+|||+|+.+..
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--- 177 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS--- 177 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCH---
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecC---
Confidence 99999999999877666689999999999999999999999 999999999999999999999999999985421
Q ss_pred CccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHH
Q 041135 538 NTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALV 617 (727)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~ 617 (727)
........+||..|||||++.+..|+.++||||||||||||++|+.||.+.. ..+.... ++
T Consensus 178 ~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~------~~~~~~~-------------i~ 238 (350)
T 4b9d_A 178 TVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS------MKNLVLK-------------II 238 (350)
T ss_dssp HHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHH-------------HH
T ss_pred CcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC------HHHHHHH-------------HH
Confidence 1223345689999999999999999999999999999999999999997643 1111111 11
Q ss_pred HHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 618 DSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 618 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
..... .........+.+||++||+.||++||++.||+++
T Consensus 239 ~~~~~-~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 239 SGSFP-PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp HTCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cCCCC-CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11110 1112223457889999999999999999999875
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-53 Score=456.18 Aligned_cols=251 Identities=21% Similarity=0.311 Sum_probs=210.0
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeec
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYV 459 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 459 (727)
+.|+++++||+|+||.||+|+++ +|+.||||+++.......+.+.+|+++|++|+|+|||+|+++|.+++.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56999999999999999999975 69999999998766666678999999999999999999999999999999999999
Q ss_pred cCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCc
Q 041135 460 PNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNT 539 (727)
Q Consensus 460 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 539 (727)
.||+|.++++.. .+++.+++.|+.||+.||+|||++ +|||||||++||||+.++.+||+|||+|+.+.. ..
T Consensus 154 ~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~---~~ 224 (346)
T 4fih_A 154 EGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK---EV 224 (346)
T ss_dssp TTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS---SS
T ss_pred CCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCC---CC
Confidence 999999998754 389999999999999999999999 999999999999999999999999999986422 22
Q ss_pred cccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHH
Q 041135 540 HVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDS 619 (727)
Q Consensus 540 ~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~ 619 (727)
......+||..|||||++.+..|+.++||||||||||||++|+.||.+... .+... .+.+.
T Consensus 225 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~------~~~~~-------------~i~~~ 285 (346)
T 4fih_A 225 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP------LKAMK-------------MIRDN 285 (346)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHH-------------HHHHS
T ss_pred CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHHHH-------------HHHcC
Confidence 334567899999999999999999999999999999999999999975431 11111 01110
Q ss_pred H-hhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 620 R-LEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 620 ~-l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
. ............+.+||.+||+.||++|+++.||+++=+
T Consensus 286 ~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~ 326 (346)
T 4fih_A 286 LPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPF 326 (346)
T ss_dssp SCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGG
T ss_pred CCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHh
Confidence 0 001111222345788999999999999999999988633
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-53 Score=457.82 Aligned_cols=268 Identities=25% Similarity=0.369 Sum_probs=216.9
Q ss_pred cHHHHHHHhcCccccceeccCCceEEEEEEEcC------CcEEEEEEeeeCCch-hHHHHHHHHHHHHHcCC-CCceeEe
Q 041135 372 TYDELIQATNGFSAHNVLGEGGFGCVYKGVLAD------GREVAVKQLKIGGSQ-GEREFRAEVEIISRVHH-RHLVSLV 443 (727)
Q Consensus 372 ~~~el~~~~~~~~~~~~LG~G~fg~Vy~~~~~~------g~~vaVK~l~~~~~~-~~~~~~~Ei~~l~~l~H-pnIv~l~ 443 (727)
..++|+...++|+++++||+|+||+||+|++.+ ++.||||+++..... ..+.|.+|+++|++++| +|||+|+
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 345566667889999999999999999998643 368999999765443 34679999999999965 8999999
Q ss_pred eEeecc-ceeeEEEeeccCCccchhcccCC--------------CCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCC
Q 041135 444 GYCISE-RERLLVYEYVPNDTLHYHLHAEG--------------RPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDI 508 (727)
Q Consensus 444 ~~~~~~-~~~~lV~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDL 508 (727)
|+|.+. +.+|||||||.+|+|.++|+... +..+++.+++.|+.||++||+|||++ +||||||
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDL 211 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL 211 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCcc
Confidence 999764 56899999999999999997532 24589999999999999999999999 9999999
Q ss_pred CCCceEECCCCcEEEEeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCC
Q 041135 509 KSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDA 587 (727)
Q Consensus 509 kp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~ 587 (727)
|++||||++++.+||+|||+|+.+... .........+||..|||||++.++.|+.++|||||||+||||++ |+.||.+
T Consensus 212 K~~NILl~~~~~vKi~DFGlar~~~~~-~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 212 AARNILLSEKNVVKICDFGLARDIYKD-PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTC-TTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CccceeeCCCCCEEECcchhhhhcccC-CCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999865322 22223445689999999999999999999999999999999998 9999976
Q ss_pred CCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhcc
Q 041135 588 SQPLGDESLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLD 662 (727)
Q Consensus 588 ~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 662 (727)
.... .. +...+....+..........+.+||.+||+.||++||+|.||+++|+.+.
T Consensus 291 ~~~~--~~-----------------~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ll 346 (353)
T 4ase_A 291 VKID--EE-----------------FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 346 (353)
T ss_dssp CCCS--HH-----------------HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCHH--HH-----------------HHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 4321 11 11111112222223333456889999999999999999999999998874
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=462.13 Aligned_cols=250 Identities=21% Similarity=0.317 Sum_probs=209.8
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeec
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYV 459 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 459 (727)
+.|+++++||+|+||.||+|+++ +|+.||||+++.......+.+.+|+++|++|+|+|||+|+++|.+++.+|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56999999999999999999975 59999999998776666778999999999999999999999999999999999999
Q ss_pred cCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCc
Q 041135 460 PNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNT 539 (727)
Q Consensus 460 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 539 (727)
.||+|.++++.. .+++.++..|+.||+.||+|||++ +|||||||++||||+.+|.+||+|||+|+.+. ...
T Consensus 231 ~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~---~~~ 301 (423)
T 4fie_A 231 EGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS---KEV 301 (423)
T ss_dssp TTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECC---SSC
T ss_pred CCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECC---CCC
Confidence 999999998754 389999999999999999999999 99999999999999999999999999998642 222
Q ss_pred cccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHH
Q 041135 540 HVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDS 619 (727)
Q Consensus 540 ~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~ 619 (727)
......+||..|||||++.+..|+.++||||||||||||++|+.||.+... .+... .+.+.
T Consensus 302 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~------~~~~~-------------~i~~~ 362 (423)
T 4fie_A 302 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP------LKAMK-------------MIRDN 362 (423)
T ss_dssp CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHH-------------HHHHS
T ss_pred ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHHHH-------------HHHcC
Confidence 334567899999999999999999999999999999999999999975431 11111 01110
Q ss_pred H-hhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 041135 620 R-LEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRAL 658 (727)
Q Consensus 620 ~-l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 658 (727)
. ............+.+||.+||..||++|+++.||+++=
T Consensus 363 ~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp 402 (423)
T 4fie_A 363 LPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHP 402 (423)
T ss_dssp CCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCG
T ss_pred CCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCH
Confidence 0 00011112234578899999999999999999998863
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=450.04 Aligned_cols=254 Identities=21% Similarity=0.218 Sum_probs=205.7
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeec
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYV 459 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 459 (727)
+.|++.++||+|+||.||+|+++ +|+.||||+++... .+.+|+++|++|+|+|||+++++|.+++.+|||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 45888899999999999999975 58999999997532 2357999999999999999999999999999999999
Q ss_pred cCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCC-cEEEEeeccchhhhccCCC
Q 041135 460 PNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSF-EARVADFGLAKIALELDSN 538 (727)
Q Consensus 460 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~-~vkL~DFGla~~~~~~~~~ 538 (727)
.||+|.++|+..+. +++.+++.|+.||+.||+|||++ +|||||||++||||+.++ ++||+|||+|+.+......
T Consensus 133 ~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 133 EGGSLGQLIKQMGC--LPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp TTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred CCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 99999999987654 89999999999999999999999 999999999999999887 6999999999865322211
Q ss_pred c--cccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHH
Q 041135 539 T--HVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEAL 616 (727)
Q Consensus 539 ~--~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l 616 (727)
. .....++||..|||||++.+..|+.++||||||||||||++|+.||.+....... ..+.... ..
T Consensus 208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~------~~i~~~~---~~---- 274 (336)
T 4g3f_A 208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC------LKIASEP---PP---- 274 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCH------HHHHHSC---CG----
T ss_pred cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH------HHHHcCC---CC----
Confidence 1 1223468999999999999999999999999999999999999999865432211 1111100 00
Q ss_pred HHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhcc
Q 041135 617 VDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLD 662 (727)
Q Consensus 617 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 662 (727)
+ ..+.......+.+||.+||++||++|+++.||+++|+.+.
T Consensus 275 ----~-~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l 315 (336)
T 4g3f_A 275 ----I-REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKAL 315 (336)
T ss_dssp ----G-GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----c-hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 0 0112223345788999999999999999999999988764
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-53 Score=445.86 Aligned_cols=250 Identities=24% Similarity=0.339 Sum_probs=207.6
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
++|+++++||+|+||+||+|+++ +|+.||||+++... ....+.+.+|+++|++|+|+|||+++++|.+++.+||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 46999999999999999999975 68999999997432 233467999999999999999999999999999999999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccC
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 536 (727)
|||.||+|.++|++.+. +++.++..|+.||+.||+|||++ +|||||||++||||++++.+||+|||+|+.+.. .
T Consensus 112 Ey~~gG~L~~~i~~~~~--l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~-~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP-E 185 (311)
T ss_dssp CCCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCT-T
T ss_pred ecCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCC-C
Confidence 99999999999987654 89999999999999999999999 999999999999999999999999999986532 2
Q ss_pred CCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHH
Q 041135 537 SNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEAL 616 (727)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l 616 (727)
.........+||..|||||++.+..|+.++||||||||||||++|+.||.+.+. .+... .+
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~------~~~~~-------------~i 246 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE------GLIFA-------------KI 246 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHH-------------HH
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHH-------------HH
Confidence 222334567899999999999999999999999999999999999999975431 11111 11
Q ss_pred HHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 617 VDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 617 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
+...+ .+.......+.+|+++||+.||++|++++|++.+
T Consensus 247 ~~~~~--~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 247 IKLEY--DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp HHTCC--CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred HcCCC--CCCcccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence 11111 1222223457889999999999999999987543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-52 Score=435.99 Aligned_cols=246 Identities=25% Similarity=0.390 Sum_probs=196.7
Q ss_pred ccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC--chhHHHHHHHHHHHHHcCCCCceeEeeEeec----cceeeEE
Q 041135 383 FSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG--SQGEREFRAEVEIISRVHHRHLVSLVGYCIS----ERERLLV 455 (727)
Q Consensus 383 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~----~~~~~lV 455 (727)
|++.++||+|+||.||+|++. +|+.||||++.... ....+.|++|+++|++|+|+|||+++++|.+ +..+|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 356678999999999999975 58899999996432 2334679999999999999999999999875 3568999
Q ss_pred EeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCc--EEeeCCCCCceEEC-CCCcEEEEeeccchhh
Q 041135 456 YEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPR--IIHRDIKSSNILLD-SSFEARVADFGLAKIA 532 (727)
Q Consensus 456 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~--ivHrDLkp~NILl~-~~~~vkL~DFGla~~~ 532 (727)
||||.||+|.++|++... +++..++.|+.||+.||+|||++ + |||||||++||||+ .++.+||+|||+|+..
T Consensus 108 mEy~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EeCCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 999999999999987654 89999999999999999999998 7 99999999999997 4789999999999853
Q ss_pred hccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhh
Q 041135 533 LELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHED 612 (727)
Q Consensus 533 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~ 612 (727)
. .......+||..|||||++.+ .|+.++||||||||||||++|+.||...... .... .. +..+
T Consensus 183 ~-----~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~-----~~~~----~~-i~~~- 245 (290)
T 3fpq_A 183 R-----ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-----AQIY----RR-VTSG- 245 (290)
T ss_dssp C-----TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----HHHH----HH-HTTT-
T ss_pred C-----CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH-----HHHH----HH-HHcC-
Confidence 1 123345789999999999875 6999999999999999999999999753211 1110 00 0000
Q ss_pred HHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 613 FEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 613 ~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
.....+.......+.+||.+||+.||++||++.||+++
T Consensus 246 -------~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 246 -------VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp -------CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -------CCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00001111112347789999999999999999999876
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-53 Score=448.42 Aligned_cols=271 Identities=23% Similarity=0.317 Sum_probs=201.4
Q ss_pred cCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccc----eeeEEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISER----ERLLVY 456 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~----~~~lV~ 456 (727)
++|.+.++||+|+||.||+|++ +|+.||||+++... .....+++|+..+.+++|+|||+|+|+|.+++ .+||||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4588889999999999999998 58999999986432 11223445666667889999999999998754 579999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcC-----CCcEEeeCCCCCceEECCCCcEEEEeeccchh
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDC-----HPRIIHRDIKSSNILLDSSFEARVADFGLAKI 531 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-----~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 531 (727)
|||+||+|.++|+.. .++|..+++|+.||++||+|||+++ ..+|||||||++||||++++++||+|||+|+.
T Consensus 81 Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp ECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred cCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 999999999999765 3899999999999999999999752 34899999999999999999999999999986
Q ss_pred hhccCCC-ccccccccCCccccccCcccCC------CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHH
Q 041135 532 ALELDSN-THVSTRVMGTFGYMAPEYATSG------KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLL 604 (727)
Q Consensus 532 ~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~------~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l 604 (727)
....... .......+||..|||||++.+. .++.++||||||||||||++|+.+|......... +..+.
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p-~~~~~---- 232 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP-YYDLV---- 232 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT-TTTTS----
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccccc-chhcc----
Confidence 5322211 1122346899999999999764 3678999999999999999998877543321110 00000
Q ss_pred HHhhchhhHHHHH----HHHhhcc-----cchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccCC
Q 041135 605 AEALEHEDFEALV----DSRLEKN-----YVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDGA 664 (727)
Q Consensus 605 ~~~~~~~~~~~l~----d~~l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 664 (727)
.....+..+. +..++.. ...+....+.+||++||+.||++||+|.||++.|+++.+.
T Consensus 233 ---~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 233 ---PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp ---CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ---cccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 0000111111 1111111 1234556788999999999999999999999999988653
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-51 Score=426.66 Aligned_cols=248 Identities=22% Similarity=0.339 Sum_probs=192.2
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
++|++++.||+|+||.||+|++. +|+.||||+++... ......+.+|+++|++++|+|||++++++.+++.+||||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999964 69999999996432 233457999999999999999999999999999999999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccC
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 536 (727)
||| +|+|.++|..++. +++.+++.|+.||+.||+|||++ +|+|||||++||||++++.+||+|||+|+...+
T Consensus 93 Ey~-~g~L~~~l~~~~~--l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~-- 164 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRDK--MSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD-- 164 (275)
T ss_dssp ECC-CEEHHHHHHHSCS--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred eCC-CCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC--
Confidence 999 6899998877654 89999999999999999999999 999999999999999999999999999985422
Q ss_pred CCccccccccCCccccccCcccCCCC-CchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHH
Q 041135 537 SNTHVSTRVMGTFGYMAPEYATSGKL-TEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEA 615 (727)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~l~~~~~-~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~ 615 (727)
.......+||..|||||++.+..+ +.++|||||||+||||++|+.||.... ..+..+.
T Consensus 165 --~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~------~~~~~~~------------- 223 (275)
T 3hyh_A 165 --GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES------IPVLFKN------------- 223 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHH-------------
T ss_pred --CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC------HHHHHHH-------------
Confidence 222345789999999999998876 579999999999999999999997532 1111111
Q ss_pred HHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 616 LVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 616 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
+.+... .+.......+.+|+++||+.||++|+++.||+++=+
T Consensus 224 i~~~~~--~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw 265 (275)
T 3hyh_A 224 ISNGVY--TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDW 265 (275)
T ss_dssp HHHTCC--CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHH
T ss_pred HHcCCC--CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCcc
Confidence 111111 111222344778999999999999999999998643
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=437.17 Aligned_cols=248 Identities=25% Similarity=0.330 Sum_probs=197.3
Q ss_pred cCccccceeccCCceEEEEEEEc----CCcEEEEEEeeeCC--chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA----DGREVAVKQLKIGG--SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLL 454 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~----~g~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 454 (727)
++|+++++||+|+||+||+|+.. .++.||||+++... ......+++|+++|++|+|+|||+++++|.+++.+||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 46999999999999999999863 47899999996432 2233468899999999999999999999999999999
Q ss_pred EEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhc
Q 041135 455 VYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALE 534 (727)
Q Consensus 455 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 534 (727)
|||||.||+|.++|++.+. +++.++..|+.||+.||+|||++ +|||||||++||||++++.+||+|||+|+....
T Consensus 104 vmEy~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEVM--FTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EECCCTTCEEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEEcCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 9999999999999987654 89999999999999999999999 999999999999999999999999999985422
Q ss_pred cCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHH
Q 041135 535 LDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFE 614 (727)
Q Consensus 535 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~ 614 (727)
........+||..|||||++.++.|+.++|||||||+||||++|+.||.+.+. .+....
T Consensus 179 ---~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~------~~~~~~------------ 237 (304)
T 3ubd_A 179 ---HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR------KETMTM------------ 237 (304)
T ss_dssp -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHH------------
T ss_pred ---CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH------HHHHHH------------
Confidence 12233457899999999999999999999999999999999999999976431 111111
Q ss_pred HHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCC-----HHHHHHH
Q 041135 615 ALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPR-----MSQVVRA 657 (727)
Q Consensus 615 ~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 657 (727)
++...+ .+.......+.+|+++||+.||++|++ ++||+++
T Consensus 238 -i~~~~~--~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 238 -ILKAKL--GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp -HHHCCC--CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred -HHcCCC--CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 111111 122222345788999999999999998 4566654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=421.27 Aligned_cols=252 Identities=21% Similarity=0.378 Sum_probs=188.4
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCch-hHHHHHHHHHHHHHcCCCCceeEeeEeeccc--------
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQ-GEREFRAEVEIISRVHHRHLVSLVGYCISER-------- 450 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~-------- 450 (727)
++|+++++||+|+||.||+|+++ +|+.||||+++..... ..+.+++|+++|++|+|+|||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 35999999999999999999975 6899999999765543 3467999999999999999999999987544
Q ss_pred ----eeeEEEeeccCCccchhcccCCC-CcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEe
Q 041135 451 ----ERLLVYEYVPNDTLHYHLHAEGR-PVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVAD 525 (727)
Q Consensus 451 ----~~~lV~Ey~~~gsL~~~L~~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~D 525 (727)
.+|||||||.||+|.++++.+.. ....+..++.|+.||++||+|||++ +|||||||++||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEcc
Confidence 36899999999999999986543 2345667889999999999999999 999999999999999999999999
Q ss_pred eccchhhhccCCCc---------cccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhh
Q 041135 526 FGLAKIALELDSNT---------HVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESL 596 (727)
Q Consensus 526 FGla~~~~~~~~~~---------~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l 596 (727)
||+|+.+....... ......+||..|||||++.+..|+.++||||||||||||++ ||... ...
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~-----~~~ 233 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ-----MER 233 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH-----HHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc-----cHH
Confidence 99998653322111 11234689999999999999999999999999999999996 66431 111
Q ss_pred HHhhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 597 VEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 597 ~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
... +.. +....+.... ......+.+|+++||+.||++||++.||+++
T Consensus 234 ~~~----~~~-~~~~~~p~~~---------~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 234 VRT----LTD-VRNLKFPPLF---------TQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HHH----HHH-HHTTCCCHHH---------HHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHH----HHH-HhcCCCCCCC---------cccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 100 000 0011110110 1112235679999999999999999999875
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=428.37 Aligned_cols=266 Identities=20% Similarity=0.300 Sum_probs=202.1
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc--hhHHHHHHHHHHHHHcCCCCceeEeeEeec------cce
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS--QGEREFRAEVEIISRVHHRHLVSLVGYCIS------ERE 451 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~------~~~ 451 (727)
++|+++++||+|+||.||+|+++ +|+.||||+++.... ...+.+.+|+++|++|+|+|||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999975 699999999964332 334578899999999999999999998764 357
Q ss_pred eeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchh
Q 041135 452 RLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKI 531 (727)
Q Consensus 452 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 531 (727)
+|||||||. |+|.++|..++. +++.++..|++||+.||+|||++ +|||||||++||||+.++.+||+|||+|+.
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~~--l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQP--LTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSSC--CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEeCCC-CCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeee
Confidence 899999995 678888877654 99999999999999999999999 999999999999999999999999999986
Q ss_pred hhccC-CCccccccccCCccccccCcccCC-CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhc
Q 041135 532 ALELD-SNTHVSTRVMGTFGYMAPEYATSG-KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALE 609 (727)
Q Consensus 532 ~~~~~-~~~~~~~~~~gt~~y~aPE~l~~~-~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~ 609 (727)
+.... .........+||..|||||++.+. .++.++||||||||||||++|+.||.+.+.. +....++.....
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~------~~l~~I~~~~g~ 281 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV------HQLQLIMMVLGT 281 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH------HHHHHHHHHHCC
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH------HHHHHHHHhcCC
Confidence 53221 122234457899999999998875 5699999999999999999999999865321 111111111000
Q ss_pred ----------hhhHHHHHHHHhhccc-------chhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 610 ----------HEDFEALVDSRLEKNY-------VDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 610 ----------~~~~~~l~d~~l~~~~-------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
...+...+.. +.... .......+.+|+.+||..||++|+++.|++++=+
T Consensus 282 p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~ 347 (398)
T 4b99_A 282 PSPAVIQAVGAERVRAYIQS-LPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPF 347 (398)
T ss_dssp CCGGGTC-----CHHHHHHS-SCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGG
T ss_pred CChHHhhhhhhhhhhhhhhc-CCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHh
Confidence 0000111100 00000 0011234778999999999999999999998733
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=413.35 Aligned_cols=201 Identities=23% Similarity=0.362 Sum_probs=170.9
Q ss_pred HHhcCccccceeccCCceEEEEEEEc----CCcEEEEEEeeeCCchhHHHHHHHHHHHHHc-CCCCceeEeeEeecccee
Q 041135 378 QATNGFSAHNVLGEGGFGCVYKGVLA----DGREVAVKQLKIGGSQGEREFRAEVEIISRV-HHRHLVSLVGYCISERER 452 (727)
Q Consensus 378 ~~~~~~~~~~~LG~G~fg~Vy~~~~~----~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~ 452 (727)
+..++|+++++||+|+||.||+|+.+ .++.||||++... .....+.+|+++|+.+ +|+|||+++++|.+++++
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 45678999999999999999999863 4688999998643 3345788999999998 699999999999999999
Q ss_pred eEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCC-CcEEEEeeccchh
Q 041135 453 LLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSS-FEARVADFGLAKI 531 (727)
Q Consensus 453 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~-~~vkL~DFGla~~ 531 (727)
|||||||.||+|.++++ .+++.++..++.||+.||+|||++ +||||||||+||||+.+ +.+||+|||+|+.
T Consensus 96 ~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp EEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 99999999999999884 288999999999999999999999 99999999999999876 7999999999975
Q ss_pred hhccCC-------------------------CccccccccCCccccccCcccCC-CCCchhHHHHHhHHHHHHHhCCCCC
Q 041135 532 ALELDS-------------------------NTHVSTRVMGTFGYMAPEYATSG-KLTEKSDVYSFGVVLLELITGRKPV 585 (727)
Q Consensus 532 ~~~~~~-------------------------~~~~~~~~~gt~~y~aPE~l~~~-~~~~ksDVwS~Gvil~eLltG~~Pf 585 (727)
..+... ........+||..|||||++.+. .|+.++||||+|||||||++|+.||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 422110 01112345799999999999875 5899999999999999999999999
Q ss_pred CCC
Q 041135 586 DAS 588 (727)
Q Consensus 586 ~~~ 588 (727)
...
T Consensus 248 ~~~ 250 (361)
T 4f9c_A 248 YKA 250 (361)
T ss_dssp SCC
T ss_pred CCC
Confidence 654
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=408.20 Aligned_cols=285 Identities=43% Similarity=0.695 Sum_probs=237.1
Q ss_pred ccHHHHHHHhcCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccc
Q 041135 371 FTYDELIQATNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISER 450 (727)
Q Consensus 371 ~~~~el~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~ 450 (727)
+.+.++....++|++.++||+|+||.||+|++++|+.||||++........+.+.+|+++|++++|+||++++++|.+++
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 34445556778999999999999999999998889999999988776667788999999999999999999999999999
Q ss_pred eeeEEEeeccCCccchhcccCCC--CcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeecc
Q 041135 451 ERLLVYEYVPNDTLHYHLHAEGR--PVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGL 528 (727)
Q Consensus 451 ~~~lV~Ey~~~gsL~~~L~~~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGl 528 (727)
..++||||+.+|+|.+++..... ..+++.++++|+.||++||+|||++ +|+|||||++||||+.++.+||+|||+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccc
Confidence 99999999999999999976542 3489999999999999999999999 999999999999999999999999999
Q ss_pred chhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhh
Q 041135 529 AKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEAL 608 (727)
Q Consensus 529 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~ 608 (727)
++...... .........|+..|+|||++.++.++.++|||||||+||||++|+.||..........+.+|.....
T Consensus 186 ~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~---- 260 (321)
T 2qkw_B 186 SKKGTELD-QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH---- 260 (321)
T ss_dssp CEECSSSS-CCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHH----
T ss_pred cccccccc-ccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcc----
Confidence 97542211 2222344568999999999999999999999999999999999999998776655555555543321
Q ss_pred chhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 609 EHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 609 ~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
..+.+..+++..+...........+.+|+.+||+.||++||++.||+++|+.+..
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 261 NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp TTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 2222333334444445556677789999999999999999999999999998754
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-47 Score=434.66 Aligned_cols=254 Identities=21% Similarity=0.304 Sum_probs=208.6
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEee
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 458 (727)
.++|+++++||+|+||.||+|+++ +|+.||||+++.....+.+.+++|+++|+.|+|+|||+|+++|.++..+||||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 367999999999999999999975 6999999999876666677899999999999999999999999999999999999
Q ss_pred ccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCC--CcEEEEeeccchhhhccC
Q 041135 459 VPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSS--FEARVADFGLAKIALELD 536 (727)
Q Consensus 459 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~--~~vkL~DFGla~~~~~~~ 536 (727)
|.||+|.++|.... ..+++.++..|+.||++||+|||++ +|+|||||++||||+.+ +.+||+|||+|+.+..
T Consensus 236 ~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~-- 309 (573)
T 3uto_A 236 MSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP-- 309 (573)
T ss_dssp CCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT--
T ss_pred cCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccC--
Confidence 99999999886543 2489999999999999999999999 99999999999999854 8999999999986421
Q ss_pred CCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHH
Q 041135 537 SNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEAL 616 (727)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l 616 (727)
.......+||..|||||++.+..|+.++|||||||||||||+|+.||.+... .+....+.....
T Consensus 310 --~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~------~~~~~~i~~~~~-------- 373 (573)
T 3uto_A 310 --KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND------DETLRNVKSCDW-------- 373 (573)
T ss_dssp --TSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHTTCC--------
T ss_pred --CCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHHHHHHHhCCC--------
Confidence 2233456899999999999999999999999999999999999999976431 111111110000
Q ss_pred HHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 041135 617 VDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRAL 658 (727)
Q Consensus 617 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 658 (727)
.+...........+.+||++||+.||++|+++.||+++=
T Consensus 374 ---~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hp 412 (573)
T 3uto_A 374 ---NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHP 412 (573)
T ss_dssp ---CCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHST
T ss_pred ---CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 001111112233477899999999999999999998863
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=406.75 Aligned_cols=288 Identities=49% Similarity=0.829 Sum_probs=237.8
Q ss_pred ccccHHHHHHHhcCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCch-hHHHHHHHHHHHHHcCCCCceeEeeEee
Q 041135 369 SWFTYDELIQATNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQ-GEREFRAEVEIISRVHHRHLVSLVGYCI 447 (727)
Q Consensus 369 ~~~~~~el~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~~~~~ 447 (727)
..|+++++....++|++.++||+|+||.||+|++.+|+.||||+++..... ....+.+|+++|++++|+||++++++|.
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 97 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 97 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence 457889999999999999999999999999999888999999999754332 2347899999999999999999999999
Q ss_pred ccceeeEEEeeccCCccchhcccCCC--CcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEe
Q 041135 448 SERERLLVYEYVPNDTLHYHLHAEGR--PVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVAD 525 (727)
Q Consensus 448 ~~~~~~lV~Ey~~~gsL~~~L~~~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~D 525 (727)
+....+|||||+.+|+|.++++.... ..+++..++.|+.||+.||+|||+++..+|+|||||++||||+.++.+||+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~D 177 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 177 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECC
T ss_pred cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEecc
Confidence 99999999999999999999976543 3489999999999999999999998666899999999999999999999999
Q ss_pred eccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCC--CCCchhhHHhhHHH
Q 041135 526 FGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQ--PLGDESLVEWARPL 603 (727)
Q Consensus 526 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~--~~~~~~l~~~~~~~ 603 (727)
||+++.... ..........|+..|+|||++.+..++.++|||||||+||||++|+.||+... ......+.+|...
T Consensus 178 fg~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~- 254 (326)
T 3uim_A 178 FGLAKLMDY--KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG- 254 (326)
T ss_dssp CSSCEECCS--SSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT-
T ss_pred CccccccCc--ccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH-
Confidence 999985421 22233445669999999999998899999999999999999999999996321 1122233333322
Q ss_pred HHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhcc
Q 041135 604 LAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLD 662 (727)
Q Consensus 604 l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 662 (727)
.+....+..+++..+...+...+...+.+|+.+||+.||++||++.||+++|+...
T Consensus 255 ---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 255 ---LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp ---TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred ---HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 22333344455555666677778888999999999999999999999999999754
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=428.32 Aligned_cols=249 Identities=27% Similarity=0.369 Sum_probs=199.5
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHH---HHHHHHcCCCCceeEeeEeeccceee
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAE---VEIISRVHHRHLVSLVGYCISERERL 453 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~E---i~~l~~l~HpnIv~l~~~~~~~~~~~ 453 (727)
++|+++++||+|+||+||+|+++ +|+.||||+++... ......+++| +.+++.++|+|||+|+++|.+.+.+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 67999999999999999999975 59999999996421 1222334444 55566678999999999999999999
Q ss_pred EEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhh
Q 041135 454 LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIAL 533 (727)
Q Consensus 454 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~ 533 (727)
||||||.||+|.++|...+. +++..+..|+.||+.||+|||++ +|||||||++||||+.+|++||+|||+|+.+.
T Consensus 269 lVmEy~~GGdL~~~l~~~~~--l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp EEECCCCSCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEecCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 99999999999999987665 89999999999999999999999 99999999999999999999999999998542
Q ss_pred ccCCCccccccccCCccccccCcccC-CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhh
Q 041135 534 ELDSNTHVSTRVMGTFGYMAPEYATS-GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHED 612 (727)
Q Consensus 534 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~ 612 (727)
. ......+||..|||||++.+ ..|+.++||||||||||||++|+.||.+....... +..+.
T Consensus 344 ~-----~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~---~i~~~---------- 405 (689)
T 3v5w_A 344 K-----KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---EIDRM---------- 405 (689)
T ss_dssp S-----CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHH---HHHHH----------
T ss_pred C-----CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHh----------
Confidence 2 12345689999999999975 57999999999999999999999999764322111 11110
Q ss_pred HHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCC-----HHHHHHH
Q 041135 613 FEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPR-----MSQVVRA 657 (727)
Q Consensus 613 ~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 657 (727)
++.. ...+.......+.+||.+||+.||++|++ +.||+++
T Consensus 406 ---i~~~--~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 406 ---TLTM--AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp ---HHHC--CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred ---hcCC--CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 1111 11122223345788999999999999998 7888765
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=393.04 Aligned_cols=260 Identities=27% Similarity=0.412 Sum_probs=210.1
Q ss_pred hcCccccceeccCCceEEEEEEEc----CCcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeE
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA----DGREVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLL 454 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~----~g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 454 (727)
.++|++.++||+|+||.||+|++. .+..||||+++.... ...+.|.+|+++|++++|+||++++++|.+++..||
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 356899999999999999999974 355699999975433 344679999999999999999999999999999999
Q ss_pred EEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhc
Q 041135 455 VYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALE 534 (727)
Q Consensus 455 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 534 (727)
||||+.+|+|.++++.... .+++.+++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++....
T Consensus 128 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHDG-QFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp EEECCTTCBHHHHHHTTTT-CSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred EeeCCCCCcHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence 9999999999999965432 489999999999999999999999 999999999999999999999999999986533
Q ss_pred cCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhH
Q 041135 535 LDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDF 613 (727)
Q Consensus 535 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~ 613 (727)
............++..|+|||++.+..++.++|||||||+||||++ |+.||..... .. +
T Consensus 204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~---~~-----------------~ 263 (325)
T 3kul_A 204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN---RD-----------------V 263 (325)
T ss_dssp ---CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH---HH-----------------H
T ss_pred CccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH---HH-----------------H
Confidence 3222333334566889999999999999999999999999999999 9999965321 11 1
Q ss_pred HHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 614 EALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 614 ~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
...+...............+.+|+++||+.||++||++.||++.|+.+..
T Consensus 264 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~ 313 (325)
T 3kul_A 264 ISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313 (325)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 11111111222223334568899999999999999999999999998864
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=396.78 Aligned_cols=260 Identities=27% Similarity=0.416 Sum_probs=211.6
Q ss_pred hcCccccceeccCCceEEEEEEEc--------CCcEEEEEEeeeCCc-hhHHHHHHHHHHHHHc-CCCCceeEeeEeecc
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA--------DGREVAVKQLKIGGS-QGEREFRAEVEIISRV-HHRHLVSLVGYCISE 449 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~--------~g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~ 449 (727)
.++|++++.||+|+||.||+|++. ++..||||+++.... ...+.+.+|+++|+++ +|+||++++++|.++
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 356899999999999999999863 356799999975543 3346799999999999 899999999999999
Q ss_pred ceeeEEEeeccCCccchhcccCCC--------------CcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEE
Q 041135 450 RERLLVYEYVPNDTLHYHLHAEGR--------------PVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILL 515 (727)
Q Consensus 450 ~~~~lV~Ey~~~gsL~~~L~~~~~--------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl 515 (727)
+..||||||+.+|+|.++|+.... ..+++.++++|+.||++||+|||++ +|+|||||++||||
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEE
Confidence 999999999999999999976532 3478999999999999999999999 99999999999999
Q ss_pred CCCCcEEEEeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCch
Q 041135 516 DSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDE 594 (727)
Q Consensus 516 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~ 594 (727)
+.++.+||+|||+++...... .........++..|+|||++.+..++.++|||||||+||||++ |+.||..... .
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~---~ 312 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNID-YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---E 312 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCC-TTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG---G
T ss_pred CCCCCEEEccccCCcccCccc-ceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH---H
Confidence 999999999999998543222 1122334567889999999999999999999999999999999 9999976431 1
Q ss_pred hhHHhhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 595 SLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 595 ~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
.+. ..+...............+.+|+++||+.||++||++.||++.|+.+..
T Consensus 313 ~~~-----------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 313 ELF-----------------KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp GHH-----------------HHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHH-----------------HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 111 1111111122223344568899999999999999999999999998753
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-45 Score=386.44 Aligned_cols=261 Identities=28% Similarity=0.409 Sum_probs=212.8
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeec
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYV 459 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 459 (727)
++|++.++||+|+||.||+|++. +|+.||||++........+.|.+|+++|++++|+||++++++|.+++..+|||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 56899999999999999999975 58999999987666666788999999999999999999999999999999999999
Q ss_pred cCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCc
Q 041135 460 PNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNT 539 (727)
Q Consensus 460 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 539 (727)
.+|+|.++++.... .+++.+++.|+.||++||+|||++ +|+|||||++||||+.++.+||+|||+++.........
T Consensus 90 ~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 90 KGGTLRGIIKSMDS-QYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp TTCBHHHHHHHCCT-TSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred CCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence 99999999976432 489999999999999999999999 99999999999999999999999999997543221111
Q ss_pred -----------cccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhh
Q 041135 540 -----------HVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEAL 608 (727)
Q Consensus 540 -----------~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~ 608 (727)
......+||..|+|||++.+..++.++|||||||+||||++|..+|...........
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~------------ 233 (310)
T 3s95_A 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG------------ 233 (310)
T ss_dssp --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS------------
T ss_pred cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh------------
Confidence 011246799999999999999999999999999999999999999876443221110
Q ss_pred chhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 609 EHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 609 ~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
.......+..+... ....+.+|+++||+.||++||++.||++.|+.+..
T Consensus 234 --~~~~~~~~~~~~~~----~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~ 282 (310)
T 3s95_A 234 --LNVRGFLDRYCPPN----CPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282 (310)
T ss_dssp --BCHHHHHHHTCCTT----CCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --hhhhccccccCCCC----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 01111111111122 22347889999999999999999999999998854
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=382.16 Aligned_cols=253 Identities=23% Similarity=0.377 Sum_probs=209.5
Q ss_pred hcCccccceeccCCceEEEEEEE-cCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEee
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVL-ADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 458 (727)
.++|+++++||+|+||.||+|+. .+|+.||||++........+.+.+|+.+|++++|+||++++++|.+++..+|||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 36799999999999999999986 46899999999876666677899999999999999999999999999999999999
Q ss_pred ccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCC
Q 041135 459 VPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSN 538 (727)
Q Consensus 459 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 538 (727)
+.+|+|.+++... .+++.+++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++.... .
T Consensus 99 ~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~---~ 169 (297)
T 3fxz_A 99 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP---E 169 (297)
T ss_dssp CTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS---T
T ss_pred CCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCC---c
Confidence 9999999999765 388999999999999999999999 999999999999999999999999999875422 2
Q ss_pred ccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHH
Q 041135 539 THVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVD 618 (727)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d 618 (727)
.......+|+..|+|||++.+..++.++|||||||+||||++|+.||...... +....+.. .
T Consensus 170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~~~~------------~ 231 (297)
T 3fxz_A 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIAT------------N 231 (297)
T ss_dssp TCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHH------------H
T ss_pred ccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHh------------C
Confidence 22334567999999999999999999999999999999999999999754310 10000000 0
Q ss_pred HHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 619 SRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 619 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
..............+.+|+.+||+.||++||++.||+++-.
T Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~ 272 (297)
T 3fxz_A 232 GTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQF 272 (297)
T ss_dssp CSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGG
T ss_pred CCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChh
Confidence 00011112223345789999999999999999999998644
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=388.36 Aligned_cols=259 Identities=31% Similarity=0.448 Sum_probs=204.0
Q ss_pred HhcCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCc--hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 379 ATNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGS--QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 379 ~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
..++|++.++||+|+||.||+|++ +|+.||||++..... ...+.+.+|+++|++++|+||++++++|.+....+|||
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 356799999999999999999988 588999999875543 33457899999999999999999999999999999999
Q ss_pred eeccCCccchhcccCCC-CcccHHHHHHHHHHHHHHHHHHHhcCCCc--EEeeCCCCCceEECCCCcEEEEeeccchhhh
Q 041135 457 EYVPNDTLHYHLHAEGR-PVMDWATRVKVAAGAARGIAYLHEDCHPR--IIHRDIKSSNILLDSSFEARVADFGLAKIAL 533 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~--ivHrDLkp~NILl~~~~~vkL~DFGla~~~~ 533 (727)
||+.+|+|.++++.... ..+++..++.|+.||++||+|||++ + |+|||||++||||+.++.+||+|||+++...
T Consensus 114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence 99999999999976542 2488999999999999999999998 8 9999999999999999999999999997532
Q ss_pred ccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhH
Q 041135 534 ELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDF 613 (727)
Q Consensus 534 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~ 613 (727)
. .........|+..|+|||++.+..++.++|||||||+||||++|+.||..... .....
T Consensus 191 ~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~---~~~~~--------------- 249 (309)
T 3p86_A 191 S---TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP---AQVVA--------------- 249 (309)
T ss_dssp --------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH---HHHHH---------------
T ss_pred c---cccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHH---------------
Confidence 1 11223446799999999999999999999999999999999999999975431 11100
Q ss_pred HHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 614 EALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 614 ~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
.+................+.+|+++||+.||++||++.||++.|+.+..
T Consensus 250 -~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 250 -AVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp -HHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred -HHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0000111112222333458899999999999999999999999998854
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-45 Score=398.05 Aligned_cols=259 Identities=27% Similarity=0.432 Sum_probs=200.0
Q ss_pred cCccccceeccCCceEEEEEEEc----CCcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA----DGREVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLV 455 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~----~g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 455 (727)
++|++.++||+|+||.||+|++. ++..||||+++.... ...++|.+|+++|++++|+||++++++|.+....+||
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 56899999999999999999875 577899999976533 3446799999999999999999999999999999999
Q ss_pred EeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhcc
Q 041135 456 YEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALEL 535 (727)
Q Consensus 456 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 535 (727)
|||+.+|+|.++++... ..+++.+++.|+.||++||+|||++ +|+|||||++||||+.++.+||+|||+++.....
T Consensus 125 ~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 125 TEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200 (373)
T ss_dssp EECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence 99999999999997653 3589999999999999999999999 9999999999999999999999999999865332
Q ss_pred CCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHH
Q 041135 536 DSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFE 614 (727)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~ 614 (727)
...........++..|+|||++.++.++.++|||||||+||||++ |+.||..... .. +.
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~---~~-----------------~~ 260 (373)
T 2qol_A 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---QD-----------------VI 260 (373)
T ss_dssp -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH---HH-----------------HH
T ss_pred CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH---HH-----------------HH
Confidence 222222223446788999999999999999999999999999998 9999965321 11 11
Q ss_pred HHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 615 ALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 615 ~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
..++..............+.+|+.+||+.||++||++.||++.|+++..
T Consensus 261 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 309 (373)
T 2qol_A 261 KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309 (373)
T ss_dssp HHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence 1112222222223334568899999999999999999999999998854
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=386.05 Aligned_cols=273 Identities=26% Similarity=0.396 Sum_probs=209.0
Q ss_pred hcCccccceeccCCceEEEEEEE-----cCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeecc--cee
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVL-----ADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISE--RER 452 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~-----~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~--~~~ 452 (727)
.++|+++++||+|+||.||+|++ .+|+.||||+++.......+.+.+|+++|++++|+||++++++|... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 35689999999999999999985 25889999999876666667899999999999999999999998654 458
Q ss_pred eEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhh
Q 041135 453 LLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIA 532 (727)
Q Consensus 453 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~ 532 (727)
+|||||+.+|+|.+++..... .+++..+++|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++..
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~ 164 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVL 164 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGG-GCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred EEEEEeCCCCCHHHHHHhccc-ccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence 999999999999999976532 489999999999999999999999 9999999999999999999999999999865
Q ss_pred hccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhch--
Q 041135 533 LELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEH-- 610 (727)
Q Consensus 533 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~-- 610 (727)
..............++..|+|||++.+..++.++|||||||+||||++|..+|.... .++.+.+.......
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~-------~~~~~~~~~~~~~~~~ 237 (295)
T 3ugc_A 165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPP-------AEFMRMIGNDKQGQMI 237 (295)
T ss_dssp -----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHH-------HHHHHHHCTTCCTHHH
T ss_pred cCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCCh-------HHHHhhhcCccccchh
Confidence 332222223334567888999999999999999999999999999999999886421 01100000000000
Q ss_pred -hhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 611 -EDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 611 -~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
..+...+...............+.+|+++||+.||++||++.||++.|+.+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 238 VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 01111111111222233344568899999999999999999999999998854
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=373.91 Aligned_cols=257 Identities=25% Similarity=0.457 Sum_probs=210.9
Q ss_pred hcCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeec
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYV 459 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 459 (727)
.++|++++.||+|+||.||+|++.+++.||||+++... ...+++.+|+++|++++|+||++++++|.++...++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 35689999999999999999999889999999997543 34567999999999999999999999999999999999999
Q ss_pred cCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCc
Q 041135 460 PNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNT 539 (727)
Q Consensus 460 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 539 (727)
.+++|.++++.... .+++..++.|+.||++||+|||++ +|+|||||++||||+.++.+||+|||+++.... ...
T Consensus 88 ~~~~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~ 161 (269)
T 4hcu_A 88 EHGCLSDYLRTQRG-LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD--DQY 161 (269)
T ss_dssp TTCBHHHHHHTTTT-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC--HHH
T ss_pred CCCcHHHHHHhcCc-ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccc--ccc
Confidence 99999999966433 589999999999999999999999 999999999999999999999999999975421 111
Q ss_pred cccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHH
Q 041135 540 HVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVD 618 (727)
Q Consensus 540 ~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d 618 (727)
.......++..|+|||++.+..++.++|||||||++|||++ |+.||..... ..+ . ..+ .
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~---~~~---~-------------~~~-~ 221 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEV---V-------------EDI-S 221 (269)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHH---H-------------HHH-H
T ss_pred ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH---HHH---H-------------HHH-h
Confidence 12233456788999999999999999999999999999999 9999975321 110 0 001 1
Q ss_pred HHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 619 SRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 619 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
..............+.+|+++||+.||++||++.||+++|+++.+
T Consensus 222 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 222 TGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 111111122223457899999999999999999999999998854
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-44 Score=382.86 Aligned_cols=250 Identities=24% Similarity=0.344 Sum_probs=207.2
Q ss_pred hcCccccceeccCCceEEEEEEE-cCCcEEEEEEeeeCC--chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVL-ADGREVAVKQLKIGG--SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
.++|++++.||+|+||.||+|++ .+|+.||||++.... ....+.+.+|+++|+.++|+||+++++++.+.+..||||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 45799999999999999999997 579999999997542 234467889999999999999999999999999999999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccC
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 536 (727)
||+.+|+|.+++..++. +++.+++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++....
T Consensus 94 e~~~~~~L~~~l~~~~~--l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~-- 166 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHGR--MKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV-- 166 (328)
T ss_dssp CCCTTCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS--
T ss_pred ECCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCC--
Confidence 99999999999977654 89999999999999999999999 999999999999999999999999999975421
Q ss_pred CCccccccccCCccccccCcccCCCCC-chhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHH
Q 041135 537 SNTHVSTRVMGTFGYMAPEYATSGKLT-EKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEA 615 (727)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~l~~~~~~-~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~ 615 (727)
.......+|+..|+|||++.+..+. .++|||||||+||||++|+.||..... .+... .
T Consensus 167 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~-------------~ 225 (328)
T 3fe3_A 167 --GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL------KELRE-------------R 225 (328)
T ss_dssp --SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHH-------------H
T ss_pred --CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH------HHHHH-------------H
Confidence 2234456899999999999988765 899999999999999999999976431 11111 1
Q ss_pred HHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 616 LVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 616 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
+..... .........+.+|+++||..||++||++.||+++-+
T Consensus 226 i~~~~~--~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~ 267 (328)
T 3fe3_A 226 VLRGKY--RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRW 267 (328)
T ss_dssp HHHCCC--CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTT
T ss_pred HHhCCC--CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHh
Confidence 111111 111122334778999999999999999999998744
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=381.28 Aligned_cols=258 Identities=23% Similarity=0.331 Sum_probs=206.6
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCch-hHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEe
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQ-GEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYE 457 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 457 (727)
.++|+++++||+|+||.||+|++. +|+.||||++...... ..+.+++|+.+|+.++|+||++++++|.+++..|||||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 367999999999999999999976 6899999999754332 34678999999999999999999999999999999999
Q ss_pred eccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCC
Q 041135 458 YVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDS 537 (727)
Q Consensus 458 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 537 (727)
|+.+|+|.+++..... +++.+++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++.+.. ..
T Consensus 86 ~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~-~~ 159 (323)
T 3tki_A 86 YCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRY-NN 159 (323)
T ss_dssp CCTTEEGGGGSBTTTB--CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEE-TT
T ss_pred cCCCCcHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceecc-CC
Confidence 9999999999976544 89999999999999999999999 999999999999999999999999999975422 12
Q ss_pred CccccccccCCccccccCcccCCCC-CchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHH
Q 041135 538 NTHVSTRVMGTFGYMAPEYATSGKL-TEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEAL 616 (727)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~l~~~~~-~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l 616 (727)
........+|+..|+|||++.+..+ +.++|||||||+||||++|+.||....... ..+..|
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~~~----------------- 221 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDW----------------- 221 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS-HHHHHH-----------------
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH-HHHHHH-----------------
Confidence 2223345689999999999988775 779999999999999999999997654321 111111
Q ss_pred HHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhc
Q 041135 617 VDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661 (727)
Q Consensus 617 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 661 (727)
................+.+|+++||+.||++||++.||+++-+..
T Consensus 222 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~ 266 (323)
T 3tki_A 222 KEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 266 (323)
T ss_dssp HTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTT
T ss_pred hcccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhc
Confidence 111111111122234577899999999999999999999875543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=371.11 Aligned_cols=257 Identities=26% Similarity=0.408 Sum_probs=210.7
Q ss_pred hcCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeec
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYV 459 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 459 (727)
.++|++++.||+|+||.||+|+++++..||||+++... ...+++.+|+++|++++|+||++++++|.++...++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 46799999999999999999999888899999997543 33567999999999999999999999999999999999999
Q ss_pred cCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCc
Q 041135 460 PNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNT 539 (727)
Q Consensus 460 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 539 (727)
.+++|.+++.... ..+++.+++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++.... ...
T Consensus 86 ~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~--~~~ 159 (268)
T 3sxs_A 86 SNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD--DQY 159 (268)
T ss_dssp TTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCT--TCE
T ss_pred CCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecch--hhh
Confidence 9999999987643 2489999999999999999999999 999999999999999999999999999975422 122
Q ss_pred cccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHH
Q 041135 540 HVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVD 618 (727)
Q Consensus 540 ~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d 618 (727)
.......++..|+|||++.+..++.++|||||||++|||++ |+.||...... +.. ..+ .
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~-------------~~~-~ 219 (268)
T 3sxs_A 160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS------EVV-------------LKV-S 219 (268)
T ss_dssp EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHH-------------HHH-H
T ss_pred hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH------HHH-------------HHH-H
Confidence 22234456778999999998889999999999999999999 99999754310 000 000 0
Q ss_pred HHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 619 SRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 619 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
..............+.+|+++||+.||++||++.||++.|+.+.+
T Consensus 220 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 220 QGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp TTCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred cCCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 011111111123357889999999999999999999999998864
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=373.70 Aligned_cols=282 Identities=38% Similarity=0.667 Sum_probs=225.6
Q ss_pred ccccHHHHHHHhcCcccc------ceeccCCceEEEEEEEcCCcEEEEEEeeeCC----chhHHHHHHHHHHHHHcCCCC
Q 041135 369 SWFTYDELIQATNGFSAH------NVLGEGGFGCVYKGVLADGREVAVKQLKIGG----SQGEREFRAEVEIISRVHHRH 438 (727)
Q Consensus 369 ~~~~~~el~~~~~~~~~~------~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~----~~~~~~~~~Ei~~l~~l~Hpn 438 (727)
..|.++++..++++|... ++||+|+||.||+|++ +++.||||++.... ....+.+.+|+++|++++|+|
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 458899999999888776 8999999999999987 58899999986432 234567999999999999999
Q ss_pred ceeEeeEeeccceeeEEEeeccCCccchhcccCC-CCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECC
Q 041135 439 LVSLVGYCISERERLLVYEYVPNDTLHYHLHAEG-RPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDS 517 (727)
Q Consensus 439 Iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~ 517 (727)
|+++++++.+.+..++||||+.+++|.+++.... ...+++..+++|+.||++||+|||++ +|+|||||++||||++
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~ 168 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDE 168 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECT
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcC
Confidence 9999999999999999999999999999886432 33589999999999999999999999 9999999999999999
Q ss_pred CCcEEEEeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhH
Q 041135 518 SFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLV 597 (727)
Q Consensus 518 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~ 597 (727)
++.+||+|||+++..... ..........|+..|+|||++.+ .++.++|||||||+||||++|+.||....... .+.
T Consensus 169 ~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~ 244 (307)
T 2nru_A 169 AFTAKISDFGLARASEKF-AQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ--LLL 244 (307)
T ss_dssp TCCEEECCCTTCEECCSC-SSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS--BTT
T ss_pred CCcEEEeecccccccccc-cccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH--HHH
Confidence 999999999999754221 12222344679999999998875 58899999999999999999999998654322 111
Q ss_pred HhhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhcc
Q 041135 598 EWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLD 662 (727)
Q Consensus 598 ~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 662 (727)
.+...+. .....+...++..+ ..........+.+|+.+||+.||++||++.||+++|+++.
T Consensus 245 ~~~~~~~---~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 245 DIKEEIE---DEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHHHHHH---TTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHHhh---hhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 2211111 11122333333322 2234455667889999999999999999999999999874
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=404.96 Aligned_cols=262 Identities=24% Similarity=0.405 Sum_probs=213.9
Q ss_pred HHHHHhcCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeE
Q 041135 375 ELIQATNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLL 454 (727)
Q Consensus 375 el~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 454 (727)
++....++|++.++||+|+||.||+|+++++..||||+++... ...+.|.+|+++|++++|+||+++++++. ++..+|
T Consensus 182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~l 259 (454)
T 1qcf_A 182 AWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYI 259 (454)
T ss_dssp CSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred ceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEE
Confidence 3444567799999999999999999999889999999997543 45678999999999999999999999986 567899
Q ss_pred EEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhc
Q 041135 455 VYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALE 534 (727)
Q Consensus 455 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 534 (727)
||||+.+|+|.++|+......+.+..+++|+.||++||+|||++ +|+|||||++||||+.++.+||+|||+++....
T Consensus 260 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 260 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp EECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred EEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 99999999999999865444578899999999999999999999 999999999999999999999999999986421
Q ss_pred cCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhH
Q 041135 535 LDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDF 613 (727)
Q Consensus 535 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~ 613 (727)
. .........++..|+|||++.++.++.++|||||||+||||++ |+.||..... ..+.
T Consensus 337 ~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~---~~~~---------------- 395 (454)
T 1qcf_A 337 N--EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---PEVI---------------- 395 (454)
T ss_dssp H--HHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHH----------------
T ss_pred C--ceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH---HHHH----------------
Confidence 1 1111233456789999999998999999999999999999999 9999975321 1111
Q ss_pred HHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 614 EALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 614 ~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
..+....+..........+.+||++||+.||++||++.+|++.|+.+..
T Consensus 396 -~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 396 -RALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp -HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred -HHHHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 1111111122222334568899999999999999999999999998754
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=407.02 Aligned_cols=260 Identities=25% Similarity=0.400 Sum_probs=216.2
Q ss_pred HHhcCccccceeccCCceEEEEEEEcC-CcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 378 QATNGFSAHNVLGEGGFGCVYKGVLAD-GREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 378 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~-g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
...++|++.++||+|+||.||+|++++ ++.||||+++... ...++|.+|+++|++++|+||++++++|.++...||||
T Consensus 217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 295 (495)
T 1opk_A 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 295 (495)
T ss_dssp CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence 345678999999999999999999875 8899999997543 34678999999999999999999999999999999999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccC
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 536 (727)
||+.+|+|.++|+......+++..++.|+.||++||+|||++ +|+|||||++||||+.++.+||+|||+++....
T Consensus 296 E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~-- 370 (495)
T 1opk_A 296 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTG-- 370 (495)
T ss_dssp ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTT--
T ss_pred EccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccC--
Confidence 999999999999876666789999999999999999999999 999999999999999999999999999986421
Q ss_pred CCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHH
Q 041135 537 SNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFEA 615 (727)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~ 615 (727)
..........++..|+|||++.++.++.++|||||||+||||++ |+.||..... .. +..
T Consensus 371 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~---~~-----------------~~~ 430 (495)
T 1opk_A 371 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQ-----------------VYE 430 (495)
T ss_dssp CCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG---GG-----------------HHH
T ss_pred CceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH---HH-----------------HHH
Confidence 11222234456789999999999999999999999999999999 9999976431 11 111
Q ss_pred HHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 616 LVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 616 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
.+....+..........+.+||++||+.||++||++.||++.|+.+..
T Consensus 431 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 431 LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred HHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 122222222233344568899999999999999999999999998743
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=389.82 Aligned_cols=269 Identities=25% Similarity=0.373 Sum_probs=214.6
Q ss_pred ccHHHHHHHhcCccccceeccCCceEEEEEEEc------CCcEEEEEEeeeCCch-hHHHHHHHHHHHHHc-CCCCceeE
Q 041135 371 FTYDELIQATNGFSAHNVLGEGGFGCVYKGVLA------DGREVAVKQLKIGGSQ-GEREFRAEVEIISRV-HHRHLVSL 442 (727)
Q Consensus 371 ~~~~el~~~~~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vaVK~l~~~~~~-~~~~~~~Ei~~l~~l-~HpnIv~l 442 (727)
+...++....++|+++++||+|+||.||+|++. +++.||||+++..... ..+.+.+|+++|+++ +|+||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 445566666788999999999999999999842 3578999999754433 346799999999999 79999999
Q ss_pred eeEeeccc-eeeEEEeeccCCccchhcccCCC------------------------------------------------
Q 041135 443 VGYCISER-ERLLVYEYVPNDTLHYHLHAEGR------------------------------------------------ 473 (727)
Q Consensus 443 ~~~~~~~~-~~~lV~Ey~~~gsL~~~L~~~~~------------------------------------------------ 473 (727)
+++|.+.+ ..+|||||+.+|+|.++++....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 99998755 48999999999999999876532
Q ss_pred ----------------CcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCC
Q 041135 474 ----------------PVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDS 537 (727)
Q Consensus 474 ----------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 537 (727)
..+++..++.|+.||++||+|||++ +|+|||||++||||+.++.+||+|||+++..... .
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~-~ 247 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKD-P 247 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC-T
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeeccc-c
Confidence 1288999999999999999999999 9999999999999999999999999999854322 1
Q ss_pred CccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHH
Q 041135 538 NTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFEAL 616 (727)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l 616 (727)
.........|+..|+|||++.+..++.++||||||||||||++ |+.||...... ..+ ...
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~-----------------~~~ 308 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEF-----------------CRR 308 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS--HHH-----------------HHH
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh--HHH-----------------HHH
Confidence 2223345678899999999999999999999999999999998 99999764321 111 111
Q ss_pred HHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhcc
Q 041135 617 VDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLD 662 (727)
Q Consensus 617 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 662 (727)
+...............+.+|+.+||+.||++||++.||+++|+.+.
T Consensus 309 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 309 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 1111111222223345888999999999999999999999999875
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=378.56 Aligned_cols=264 Identities=22% Similarity=0.310 Sum_probs=215.6
Q ss_pred cccHHHHHHHhcC----------ccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCC
Q 041135 370 WFTYDELIQATNG----------FSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRH 438 (727)
Q Consensus 370 ~~~~~el~~~~~~----------~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~Hpn 438 (727)
.|+++++..+.+. |+..++||+|+||.||+|++. +|+.||||+++.......+.+.+|+.+|++++|+|
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n 103 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence 3677787776653 777889999999999999986 69999999998766666778999999999999999
Q ss_pred ceeEeeEeeccceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCC
Q 041135 439 LVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSS 518 (727)
Q Consensus 439 Iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~ 518 (727)
|++++++|...+..+|||||+.+++|.+++... .+++..++.|+.||++||+|||++ +|+|||||++||||+.+
T Consensus 104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~ 177 (321)
T 2c30_A 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLD 177 (321)
T ss_dssp BCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT
T ss_pred cceEEEEEEECCEEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCC
Confidence 999999999999999999999999999998653 489999999999999999999999 99999999999999999
Q ss_pred CcEEEEeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHH
Q 041135 519 FEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVE 598 (727)
Q Consensus 519 ~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~ 598 (727)
+.+||+|||+++.... .........|+..|+|||++.+..++.++|||||||+||||++|+.||..... . +
T Consensus 178 ~~~kl~Dfg~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~---~---~ 248 (321)
T 2c30_A 178 GRVKLSDFGFCAQISK---DVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP---V---Q 248 (321)
T ss_dssp CCEEECCCTTCEECCS---SSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---H---H
T ss_pred CcEEEeeeeeeeeccc---CccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---H---H
Confidence 9999999999975422 12223456799999999999999999999999999999999999999975421 1 1
Q ss_pred hhHHHHHHhhchhhHHHHHHHHh-hcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhc
Q 041135 599 WARPLLAEALEHEDFEALVDSRL-EKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661 (727)
Q Consensus 599 ~~~~~l~~~~~~~~~~~l~d~~l-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 661 (727)
... .+.+... ...........+.+|+.+||+.||++||++.||+++....
T Consensus 249 ~~~-------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~ 299 (321)
T 2c30_A 249 AMK-------------RLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLL 299 (321)
T ss_dssp HHH-------------HHHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGG
T ss_pred HHH-------------HHhcCCCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhc
Confidence 110 0101000 0001111233578899999999999999999999875543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=386.03 Aligned_cols=263 Identities=25% Similarity=0.417 Sum_probs=211.9
Q ss_pred HHhcCccccceeccCCceEEEEEEEc------CCcEEEEEEeeeCCch-hHHHHHHHHHHHHHcCCCCceeEeeEeeccc
Q 041135 378 QATNGFSAHNVLGEGGFGCVYKGVLA------DGREVAVKQLKIGGSQ-GEREFRAEVEIISRVHHRHLVSLVGYCISER 450 (727)
Q Consensus 378 ~~~~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vaVK~l~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~ 450 (727)
...++|++++.||+|+||.||+|++. +++.||||+++..... ..+.|.+|+++|++++|+||++++++|.+++
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 123 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 123 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence 34578999999999999999999975 3488999999755433 3467999999999999999999999999999
Q ss_pred eeeEEEeeccCCccchhcccCC----------------------CCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCC
Q 041135 451 ERLLVYEYVPNDTLHYHLHAEG----------------------RPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDI 508 (727)
Q Consensus 451 ~~~lV~Ey~~~gsL~~~L~~~~----------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDL 508 (727)
..+|||||+.+|+|.++++... ...+++.+++.|+.||++||+|||++ +|+||||
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dl 200 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDL 200 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence 9999999999999999987642 14589999999999999999999999 9999999
Q ss_pred CCCceEECCCCcEEEEeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCC
Q 041135 509 KSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDA 587 (727)
Q Consensus 509 kp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~ 587 (727)
|++||||+.++.+||+|||+++...... .........|+..|+|||++.+..++.++|||||||+||||++ |+.||..
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSAD-YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGG-CBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CcceEEECCCCeEEEeecCCCcccccCc-cccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence 9999999999999999999998653221 1122334568899999999999999999999999999999999 9999975
Q ss_pred CCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccCC
Q 041135 588 SQPLGDESLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDGA 664 (727)
Q Consensus 588 ~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 664 (727)
... ..+. ..+.+..+ ..........+.+|+++||+.||++||++.||+++|+++.+.
T Consensus 280 ~~~---~~~~----------------~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 280 MAH---EEVI----------------YYVRDGNI-LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp SCH---HHHH----------------HHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred CCh---HHHH----------------HHHhCCCc-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 321 1110 01111111 112222334588999999999999999999999999998653
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=392.40 Aligned_cols=264 Identities=27% Similarity=0.395 Sum_probs=212.3
Q ss_pred hcCccccceeccCCceEEEEEEEc------CCcEEEEEEeeeCC-chhHHHHHHHHHHHHHcCCCCceeEeeEeecccee
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA------DGREVAVKQLKIGG-SQGEREFRAEVEIISRVHHRHLVSLVGYCISERER 452 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 452 (727)
.++|+++++||+|+||.||+|++. +++.||||+++... ......+.+|+.+|++++|+||++++++|.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 356899999999999999999953 46789999996543 34456799999999999999999999999999999
Q ss_pred eEEEeeccCCccchhcccCCC-----CcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCC---cEEEE
Q 041135 453 LLVYEYVPNDTLHYHLHAEGR-----PVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSF---EARVA 524 (727)
Q Consensus 453 ~lV~Ey~~~gsL~~~L~~~~~-----~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~---~vkL~ 524 (727)
+|||||+.+|+|.++++.... ..+.+.+++.|+.||++||+|||++ +|+|||||++||||+.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEEC
Confidence 999999999999999976432 3589999999999999999999999 999999999999998544 59999
Q ss_pred eeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHH
Q 041135 525 DFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPL 603 (727)
Q Consensus 525 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~ 603 (727)
|||+++...... .........|+..|+|||++.+..++.++|||||||+||||++ |+.||..... ..+
T Consensus 227 DFG~a~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~---~~~------- 295 (367)
T 3l9p_A 227 DFGMARDIYRAG-YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---QEV------- 295 (367)
T ss_dssp CCHHHHHHHHHS-SCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHH-------
T ss_pred CCcccccccccc-ccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHH-------
Confidence 999998653322 1222334568899999999999999999999999999999998 9999975431 111
Q ss_pred HHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccCCCcC
Q 041135 604 LAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDGASDL 667 (727)
Q Consensus 604 l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 667 (727)
...+...............+.+|+++||+.||++||++.||+++|+.+....+.
T Consensus 296 ----------~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~~ 349 (367)
T 3l9p_A 296 ----------LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 349 (367)
T ss_dssp ----------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHH
T ss_pred ----------HHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChhh
Confidence 111111111122223344588999999999999999999999999988654443
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=375.31 Aligned_cols=257 Identities=23% Similarity=0.385 Sum_probs=208.0
Q ss_pred hcCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeec
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYV 459 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 459 (727)
.++|+++++||+|+||.||+|++.++..||||+++... ...+++.+|+++|++++|+||++++++|.+++..+|||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 45799999999999999999999988899999997543 34567999999999999999999999999999999999999
Q ss_pred cCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCc
Q 041135 460 PNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNT 539 (727)
Q Consensus 460 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 539 (727)
.+++|.+++..... .+++.+++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++..... ..
T Consensus 102 ~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~--~~ 175 (283)
T 3gen_A 102 ANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD--EY 175 (283)
T ss_dssp TTCBHHHHHHCGGG-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH--HH
T ss_pred CCCcHHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccc--cc
Confidence 99999999976322 489999999999999999999999 9999999999999999999999999999754211 11
Q ss_pred cccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHH
Q 041135 540 HVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVD 618 (727)
Q Consensus 540 ~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d 618 (727)
.......++..|+|||++.+..++.++|||||||++|||++ |+.||..... . + ....+.
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~---~---~--------------~~~~~~ 235 (283)
T 3gen_A 176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN---S---E--------------TAEHIA 235 (283)
T ss_dssp HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH---H---H--------------HHHHHH
T ss_pred ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh---h---H--------------HHHHHh
Confidence 12233456788999999998899999999999999999998 9999975431 0 0 001111
Q ss_pred HHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 619 SRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 619 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
..+...........+.+|+++||+.||++||++.||+++|+++.+
T Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 236 QGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 111111222223458899999999999999999999999998753
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=383.59 Aligned_cols=271 Identities=28% Similarity=0.386 Sum_probs=210.0
Q ss_pred hcCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccc----eeeEE
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISER----ERLLV 455 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~----~~~lV 455 (727)
.++|+++++||+|+||.||+|++. |+.||||+++... .....+.+|+.+|++++|+||++++++|.+.. .++||
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 467999999999999999999985 8999999986432 33445677999999999999999999998744 46999
Q ss_pred EeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcC-------CCcEEeeCCCCCceEECCCCcEEEEeecc
Q 041135 456 YEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDC-------HPRIIHRDIKSSNILLDSSFEARVADFGL 528 (727)
Q Consensus 456 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-------~~~ivHrDLkp~NILl~~~~~vkL~DFGl 528 (727)
|||+.+|+|.++++.+. +++..+++|+.||++||+|||+++ ..+|+|||||++||||+.++.+||+|||+
T Consensus 101 ~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~ 177 (322)
T 3soc_A 101 TAFHEKGSLSDFLKANV---VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL 177 (322)
T ss_dssp EECCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EecCCCCCHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCc
Confidence 99999999999997643 899999999999999999999751 23799999999999999999999999999
Q ss_pred chhhhccCCCccccccccCCccccccCcccCC-----CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHH
Q 041135 529 AKIALELDSNTHVSTRVMGTFGYMAPEYATSG-----KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPL 603 (727)
Q Consensus 529 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~ 603 (727)
++...... .........|+..|+|||++.+. .++.++|||||||+||||++|+.||..........+...
T Consensus 178 a~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~---- 252 (322)
T 3soc_A 178 ALKFEAGK-SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE---- 252 (322)
T ss_dssp CEEECTTS-CCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH----
T ss_pred cccccccc-CccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh----
Confidence 97543221 12223346799999999999873 456789999999999999999999987554322222111
Q ss_pred HHHhhchhhHHHHHHHHhhccc---------chhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 604 LAEALEHEDFEALVDSRLEKNY---------VDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 604 l~~~~~~~~~~~l~d~~l~~~~---------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
.........+.+....... .......+.+|+++||+.||++||++.||++.|+++.+
T Consensus 253 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 253 ---IGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp ---HCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---hccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0111112222221111110 12344568899999999999999999999999998864
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=388.97 Aligned_cols=260 Identities=27% Similarity=0.406 Sum_probs=212.0
Q ss_pred hcCccccceeccCCceEEEEEEEc--------CCcEEEEEEeeeCCc-hhHHHHHHHHHHHHHc-CCCCceeEeeEeecc
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA--------DGREVAVKQLKIGGS-QGEREFRAEVEIISRV-HHRHLVSLVGYCISE 449 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~--------~g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~ 449 (727)
.++|+++++||+|+||.||+|++. ++..||||+++.... ...+.+.+|+++|+++ +|+||++++++|.++
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 467999999999999999999862 246799999975533 3346799999999999 899999999999999
Q ss_pred ceeeEEEeeccCCccchhcccCC--------------CCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEE
Q 041135 450 RERLLVYEYVPNDTLHYHLHAEG--------------RPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILL 515 (727)
Q Consensus 450 ~~~~lV~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl 515 (727)
+..+|||||+.+|+|.+++.... ...+++.++++|+.||+.||+|||++ +|+|||||++||||
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEE
Confidence 99999999999999999997654 23589999999999999999999999 99999999999999
Q ss_pred CCCCcEEEEeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCch
Q 041135 516 DSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDE 594 (727)
Q Consensus 516 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~ 594 (727)
++++.+||+|||+++...... .........++..|+|||++.+..++.++|||||||+||||++ |+.||..... .
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~---~ 300 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHID-YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---E 300 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCC-TTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---H
T ss_pred cCCCcEEEcccCccccccccc-ccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH---H
Confidence 999999999999998543221 1122334567889999999999999999999999999999999 9999975421 1
Q ss_pred hhHHhhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 595 SLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 595 ~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
. +...+...............+.+|+++||+.||++||++.||++.|+.+..
T Consensus 301 ~-----------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 352 (382)
T 3tt0_A 301 E-----------------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 352 (382)
T ss_dssp H-----------------HHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H-----------------HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1 111111111222223334558899999999999999999999999998854
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=395.02 Aligned_cols=260 Identities=23% Similarity=0.368 Sum_probs=209.7
Q ss_pred HhcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 379 ATNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 379 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
..++|++.++||+|+||.||+|++. +|+.||||+++.... ...+.|.+|+++|++++|+||++++++|.+++..||||
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 3467899999999999999999986 689999999875432 23357899999999999999999999999999999999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccC
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 536 (727)
||+.+|+|.++++..+ ..+++..++.|+.||++||+|||++ +|+|||||++||||+.++.+||+|||+++......
T Consensus 192 e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267 (377)
T ss_dssp ECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred EcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence 9999999999997643 2488999999999999999999999 99999999999999999999999999997532110
Q ss_pred CCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHH
Q 041135 537 SNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFEA 615 (727)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~ 615 (727)
.........++..|+|||++.++.++.++|||||||+||||++ |+.||..... .. ...
T Consensus 268 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~---~~-----------------~~~ 326 (377)
T 3cbl_A 268 -YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN---QQ-----------------TRE 326 (377)
T ss_dssp -EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH---HH-----------------HHH
T ss_pred -eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HH-----------------HHH
Confidence 0011112235778999999999999999999999999999998 9999975431 11 111
Q ss_pred HHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 616 LVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 616 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
.+...............+.+||++||+.||++||++.+|++.|+.+..
T Consensus 327 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 327 FVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 111111112222234468899999999999999999999999998753
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=397.33 Aligned_cols=252 Identities=28% Similarity=0.436 Sum_probs=209.5
Q ss_pred hcCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccc-eeeEEEee
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISER-ERLLVYEY 458 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~-~~~lV~Ey 458 (727)
.++|+++++||+|+||.||+|++. |+.||||+++... ..+.|.+|+++|++++|+||++++++|.+.. ..||||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 467899999999999999999985 7899999997543 4578999999999999999999999987765 78999999
Q ss_pred ccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCC
Q 041135 459 VPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSN 538 (727)
Q Consensus 459 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 538 (727)
+.+|+|.++|+.++...+++..++.|+.||++||+|||++ +|+|||||++||||+.++.+||+|||+++....
T Consensus 269 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~---- 341 (450)
T 1k9a_A 269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS---- 341 (450)
T ss_dssp CTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccc----
Confidence 9999999999877666689999999999999999999999 999999999999999999999999999974311
Q ss_pred ccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHH
Q 041135 539 THVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALV 617 (727)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~ 617 (727)
......++..|+|||++.++.++.++|||||||+||||++ |+.||....... +. ..+
T Consensus 342 --~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~-----------------~~i 399 (450)
T 1k9a_A 342 --TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VV-----------------PRV 399 (450)
T ss_dssp -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---HH-----------------HHH
T ss_pred --cccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH-----------------HHH
Confidence 1122357889999999999999999999999999999998 999997654221 11 111
Q ss_pred HHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 618 DSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 618 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
....+..........+.+||++||+.||++||++.||++.|+.+..
T Consensus 400 ~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 400 EKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 1111222233344568899999999999999999999999998754
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=410.40 Aligned_cols=259 Identities=27% Similarity=0.403 Sum_probs=211.8
Q ss_pred HHhcCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEe
Q 041135 378 QATNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYE 457 (727)
Q Consensus 378 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 457 (727)
...++|++.++||+|+||.||+|+++++..||||+++... ...++|++|+++|++|+|+||++++++|.+ +..|||||
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 3456788999999999999999999888899999997543 345689999999999999999999999876 67899999
Q ss_pred eccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCC
Q 041135 458 YVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDS 537 (727)
Q Consensus 458 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 537 (727)
|+.+|+|.++|+......+++.++++|+.||++||+|||++ +|||||||++||||++++.+||+|||+++.....
T Consensus 342 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-- 416 (535)
T 2h8h_A 342 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN-- 416 (535)
T ss_dssp CCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH--
T ss_pred hhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCC--
Confidence 99999999999865444589999999999999999999999 9999999999999999999999999999854211
Q ss_pred CccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHH
Q 041135 538 NTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFEAL 616 (727)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l 616 (727)
.........++..|+|||++.++.++.++||||||||||||++ |+.||..... ..+ ...
T Consensus 417 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~---~~~-----------------~~~ 476 (535)
T 2h8h_A 417 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REV-----------------LDQ 476 (535)
T ss_dssp HHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH---HHH-----------------HHH
T ss_pred ceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHH-----------------HHH
Confidence 1111233457789999999999999999999999999999999 9999975321 111 111
Q ss_pred HHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 617 VDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 617 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
+....+..........+.+||++||+.||++||++.+|++.|+.+..
T Consensus 477 i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 477 VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred HHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 11111122223334568899999999999999999999999998754
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=381.57 Aligned_cols=250 Identities=23% Similarity=0.313 Sum_probs=206.3
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeC---CchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIG---GSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
++|+++++||+|+||.||+|+.+ +|+.||||+++.. .......+.+|+++|++++|+||++++++|.+.+..||||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 57999999999999999999976 5899999999743 2233457889999999999999999999999999999999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccC
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 536 (727)
||+.||+|..++...+. +++..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++....
T Consensus 85 E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~-- 157 (337)
T 1o6l_A 85 EYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-- 157 (337)
T ss_dssp ECCTTCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred eCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhccc--
Confidence 99999999999876554 89999999999999999999999 999999999999999999999999999975321
Q ss_pred CCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHH
Q 041135 537 SNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEAL 616 (727)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l 616 (727)
........+||..|+|||++.+..++.++|||||||+||||++|+.||..... .+... .+
T Consensus 158 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~-------------~i 217 (337)
T 1o6l_A 158 -DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------ERLFE-------------LI 217 (337)
T ss_dssp -TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHH-------------HH
T ss_pred -CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH------HHHHH-------------HH
Confidence 12223456899999999999999999999999999999999999999975321 11111 11
Q ss_pred HHHHhhcccchhHHHHHHHHHHHHhccCCCCCC-----CHHHHHHHHh
Q 041135 617 VDSRLEKNYVDSEMFWMIEAAAACVRHSATKRP-----RMSQVVRALD 659 (727)
Q Consensus 617 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L~ 659 (727)
+...+ .+.......+.+|+++||+.||++|+ ++.||+++-.
T Consensus 218 ~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~ 263 (337)
T 1o6l_A 218 LMEEI--RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263 (337)
T ss_dssp HHCCC--CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred HcCCC--CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCC
Confidence 11111 12222334578899999999999999 8999988743
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=377.49 Aligned_cols=264 Identities=17% Similarity=0.211 Sum_probs=210.2
Q ss_pred hcCccccceeccCCceEEEEEEE-cCCcEEEEEEeeeCCchhHHHHHHHHHHHHHc-CCCCceeEeeEeeccceeeEEEe
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVL-ADGREVAVKQLKIGGSQGEREFRAEVEIISRV-HHRHLVSLVGYCISERERLLVYE 457 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E 457 (727)
.++|+++++||+|+||.||+|+. .+|+.||||++.... ..+.+.+|+++|++| +|+||+++++++.++...+||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 35799999999999999999996 468999999987543 235689999999999 89999999999999999999999
Q ss_pred eccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCc-----EEEEeeccchhh
Q 041135 458 YVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFE-----ARVADFGLAKIA 532 (727)
Q Consensus 458 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~-----vkL~DFGla~~~ 532 (727)
|+ +++|.+++.... ..+++..++.|+.||+.||+|||++ +|+|||||++||||+.++. +||+|||+++.+
T Consensus 86 ~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 86 LL-GPSLEDLFDLCD-RTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred eC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 99 999999987642 3589999999999999999999999 9999999999999998887 999999999865
Q ss_pred hccCCCcc----ccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhh
Q 041135 533 LELDSNTH----VSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEAL 608 (727)
Q Consensus 533 ~~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~ 608 (727)
........ .....+||..|+|||++.+..++.++||||||||||||++|+.||....... +.+....+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~---~~~~~~~i~~~~~ 237 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADT---LKERYQKIGDTKR 237 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSS---HHHHHHHHHHHHH
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccccc---HHHHHHHHHhhhc
Confidence 33222111 1245689999999999999999999999999999999999999998754322 1111111111000
Q ss_pred chhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccCC
Q 041135 609 EHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDGA 664 (727)
Q Consensus 609 ~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 664 (727)
. ... ..+... .. .+.+|++.||+.||++||++.+|++.|+.+...
T Consensus 238 ~-~~~-----~~~~~~----~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~ 282 (330)
T 2izr_A 238 A-TPI-----EVLCEN----FP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDR 282 (330)
T ss_dssp H-SCH-----HHHTTT----CH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred c-CCH-----HHHhcc----Ch-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHH
Confidence 0 000 001111 11 688999999999999999999999999987543
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=380.15 Aligned_cols=257 Identities=25% Similarity=0.420 Sum_probs=202.2
Q ss_pred cCccccceeccCCceEEEEEEEc-CCc----EEEEEEeeeCC-chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGR----EVAVKQLKIGG-SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLL 454 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~----~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 454 (727)
++|+++++||+|+||.||+|++. +|+ .||||.++... ....+.|.+|+++|++++|+||++++++|.++. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 56899999999999999999964 344 35888875433 244568999999999999999999999998765 789
Q ss_pred EEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhc
Q 041135 455 VYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALE 534 (727)
Q Consensus 455 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 534 (727)
||||+.+|+|.++++.... .+++..++.|+.||++||+|||++ +|+|||||++||||+.++.+||+|||+++....
T Consensus 94 v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEECCTTCBHHHHHHHSTT-SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred EEEecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 9999999999999976543 489999999999999999999999 999999999999999999999999999986532
Q ss_pred cCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhH
Q 041135 535 LDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDF 613 (727)
Q Consensus 535 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~ 613 (727)
.. .........++..|+|||++.+..++.++|||||||+||||++ |+.||...... . +
T Consensus 170 ~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~-----------------~ 228 (327)
T 3poz_A 170 EE-KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---E-----------------I 228 (327)
T ss_dssp TC-C-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---G-----------------H
T ss_pred Cc-ccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH---H-----------------H
Confidence 22 2222334567889999999999999999999999999999999 99999764321 1 1
Q ss_pred HHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 614 EALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 614 ~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
...+...............+.+|+.+||+.||++||++.||+++|+.+..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 229 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp HHHHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred HHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 11222222222233344568899999999999999999999999998754
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-44 Score=372.30 Aligned_cols=262 Identities=26% Similarity=0.416 Sum_probs=211.8
Q ss_pred HHHHHhcCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeE
Q 041135 375 ELIQATNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLL 454 (727)
Q Consensus 375 el~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 454 (727)
++....++|++++.||+|+||.||+|++.+++.||||+++... ...+.+.+|+++|++++|+||+++++++.+ +..++
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 84 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI 84 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEE
Confidence 3444557899999999999999999999888899999987543 345689999999999999999999999874 46899
Q ss_pred EEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhc
Q 041135 455 VYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALE 534 (727)
Q Consensus 455 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 534 (727)
||||+.+++|.+++.......+++.++++|+.||++||+|||++ +|+|||||++||||++++.+||+|||+++....
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 99999999999999765433589999999999999999999999 999999999999999999999999999975422
Q ss_pred cCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhH
Q 041135 535 LDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDF 613 (727)
Q Consensus 535 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~ 613 (727)
..........++..|+|||++.++.++.++|||||||+||||++ |+.||..... ..+.
T Consensus 162 --~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~---------------- 220 (279)
T 1qpc_A 162 --NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN---PEVI---------------- 220 (279)
T ss_dssp --SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHH----------------
T ss_pred --cccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH---HHHH----------------
Confidence 11122234557789999999998899999999999999999999 9999975321 1110
Q ss_pred HHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 614 EALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 614 ~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
..+...............+.+|+++||+.||++||++.+|++.|+.+..
T Consensus 221 -~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 269 (279)
T 1qpc_A 221 -QNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (279)
T ss_dssp -HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHHhcccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 0111111111222233468899999999999999999999999998753
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=375.74 Aligned_cols=260 Identities=28% Similarity=0.423 Sum_probs=211.6
Q ss_pred hcCccccceeccCCceEEEEEEE------cCCcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEeecccee
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVL------ADGREVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYCISERER 452 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~------~~g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 452 (727)
.++|++.+.||+|+||.||+|++ .+++.||||+++.... ...+.+.+|+++|++++|+||++++++|.+++..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 46799999999999999999986 2458899999975433 3346789999999999999999999999999999
Q ss_pred eEEEeeccCCccchhcccCCC----------------------CcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCC
Q 041135 453 LLVYEYVPNDTLHYHLHAEGR----------------------PVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKS 510 (727)
Q Consensus 453 ~lV~Ey~~~gsL~~~L~~~~~----------------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp 510 (727)
++||||+.+++|.+++..... ..+++.++++|+.||++||+|||++ +|+|||||+
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccch
Confidence 999999999999999976532 3488999999999999999999999 999999999
Q ss_pred CceEECCCCcEEEEeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCC
Q 041135 511 SNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQ 589 (727)
Q Consensus 511 ~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~ 589 (727)
+||||++++.+||+|||+++...... .........++..|+|||++.+..++.++|||||||+||||++ |+.||....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEED-SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTS-CEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred heEEEcCCCCEEEccccccccccccc-cceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999997543221 1112234567889999999999899999999999999999999 999997643
Q ss_pred CCCchhhHHhhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 590 PLGDESLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 590 ~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
.. .+. ..+...............+.+|+++||+.||++||++.||+++|+++..
T Consensus 258 ~~---~~~-----------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 258 PE---RLF-----------------NLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp GG---GHH-----------------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HH---HHH-----------------HHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 21 111 1111111112222334458899999999999999999999999998754
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=379.17 Aligned_cols=254 Identities=24% Similarity=0.322 Sum_probs=205.9
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCch------hHHHHHHHHHHHHHcCCCCceeEeeEeecccee
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQ------GEREFRAEVEIISRVHHRHLVSLVGYCISERER 452 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~------~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 452 (727)
.++|+++++||+|+||.||+|+.+ +|+.||||+++..... ..+.+.+|+++|++++|+||++++++|.+....
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 467999999999999999999976 5899999999754332 246799999999999999999999999999999
Q ss_pred eEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCC----cEEEEeecc
Q 041135 453 LLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSF----EARVADFGL 528 (727)
Q Consensus 453 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~----~vkL~DFGl 528 (727)
||||||+.||+|.+++.... .+++.+++.|+.||+.||+|||++ +|+|||||++||||++++ .+||+|||+
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCS--CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred EEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 99999999999999997654 489999999999999999999999 999999999999998776 799999999
Q ss_pred chhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhh
Q 041135 529 AKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEAL 608 (727)
Q Consensus 529 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~ 608 (727)
++.... .......+||..|+|||++.+..++.++||||||||||||++|+.||.+... . +....+....
T Consensus 166 a~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~---~---~~~~~i~~~~- 234 (361)
T 2yab_A 166 AHEIED----GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---Q---ETLANITAVS- 234 (361)
T ss_dssp CEECCT----TCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH---H---HHHHHHHTTC-
T ss_pred ceEcCC----CCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH---H---HHHHHHHhcC-
Confidence 975422 1223456799999999999999999999999999999999999999976431 1 1111110000
Q ss_pred chhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 609 EHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 609 ~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
..+ ...+.......+.+||++||..||++|+++.||+++-+
T Consensus 235 --~~~--------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 275 (361)
T 2yab_A 235 --YDF--------DEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275 (361)
T ss_dssp --CCC--------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred --CCC--------CchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcC
Confidence 000 00001112234778999999999999999999997643
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=373.49 Aligned_cols=260 Identities=26% Similarity=0.404 Sum_probs=216.1
Q ss_pred HHhcCccccceeccCCceEEEEEEEcC-CcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 378 QATNGFSAHNVLGEGGFGCVYKGVLAD-GREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 378 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~-g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
...++|++.++||+|+||.||+|++.+ ++.||||+++.. ....+.+.+|+++|++++|+||++++++|.++...++||
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 88 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 88 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence 345679999999999999999999864 889999998743 344578999999999999999999999999999999999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccC
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 536 (727)
||+.+++|.+++.......+++..++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++....
T Consensus 89 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~-- 163 (288)
T 3kfa_A 89 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-- 163 (288)
T ss_dssp ECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS--
T ss_pred EcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccC--
Confidence 999999999999876666799999999999999999999999 999999999999999999999999999986422
Q ss_pred CCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHH
Q 041135 537 SNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFEA 615 (727)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~ 615 (727)
..........++..|+|||++.+..++.++|||||||++|||++ |+.||...... . +..
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~---~-----------------~~~ 223 (288)
T 3kfa_A 164 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---Q-----------------VYE 223 (288)
T ss_dssp SSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---G-----------------HHH
T ss_pred CccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---H-----------------HHH
Confidence 12222334567889999999999999999999999999999999 99999764311 1 111
Q ss_pred HHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 616 LVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 616 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
.+...............+.+|+++||+.||++||++.||++.|+.+..
T Consensus 224 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~ 271 (288)
T 3kfa_A 224 LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271 (288)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence 111122222223334568899999999999999999999999998743
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=379.49 Aligned_cols=262 Identities=25% Similarity=0.377 Sum_probs=210.5
Q ss_pred HhcCccccceeccCCceEEEEEEEc------CCcEEEEEEeeeCC-chhHHHHHHHHHHHHHc-CCCCceeEeeEeeccc
Q 041135 379 ATNGFSAHNVLGEGGFGCVYKGVLA------DGREVAVKQLKIGG-SQGEREFRAEVEIISRV-HHRHLVSLVGYCISER 450 (727)
Q Consensus 379 ~~~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~ 450 (727)
..++|++.++||+|+||.||+|++. +++.||||+++... ....+.+.+|+++|+++ +|+||++++++|.+.+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 4567999999999999999999962 45689999997543 23446799999999999 8999999999999999
Q ss_pred eeeEEEeeccCCccchhcccCCC---------------------CcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCC
Q 041135 451 ERLLVYEYVPNDTLHYHLHAEGR---------------------PVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIK 509 (727)
Q Consensus 451 ~~~lV~Ey~~~gsL~~~L~~~~~---------------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLk 509 (727)
..+|||||+.+|+|.+++..... ..+++.+++.|+.||+.||+|||++ +|+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCC
Confidence 99999999999999999976543 2378999999999999999999999 99999999
Q ss_pred CCceEECCCCcEEEEeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCC
Q 041135 510 SSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDAS 588 (727)
Q Consensus 510 p~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~ 588 (727)
++||||+.++.+||+|||+++..... ..........|+..|+|||++.++.++.++|||||||+||||++ |+.||...
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSD-SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGC-TTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccC-ccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 99999999999999999999865322 22223344567889999999999999999999999999999998 99999765
Q ss_pred CCCCchhhHHhhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 589 QPLGDESLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 589 ~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
... .. +...+...............+.+|+++||+.||++||++.||+++|+.+..
T Consensus 279 ~~~--~~-----------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 334 (344)
T 1rjb_A 279 PVD--AN-----------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA 334 (344)
T ss_dssp CCS--HH-----------------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred CcH--HH-----------------HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 321 11 111111112222222234558889999999999999999999999998754
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=368.26 Aligned_cols=261 Identities=26% Similarity=0.388 Sum_probs=206.3
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc---hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEE
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS---QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLV 455 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 455 (727)
.++|+++++||+|+||.||+|++. +|+.||||++..... ...+.+.+|++++++++|+||+++++++.+++..|||
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 467999999999999999999965 589999999864332 3346789999999999999999999999999999999
Q ss_pred EeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhcc
Q 041135 456 YEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALEL 535 (727)
Q Consensus 456 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 535 (727)
|||+.+++|.+++...+. +++.+++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++.....
T Consensus 90 ~e~~~g~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHGP--LSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp EECCCSCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred EeCCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 999999999999987654 89999999999999999999999 9999999999999999999999999999864221
Q ss_pred CCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHH
Q 041135 536 DSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEA 615 (727)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~ 615 (727)
........+|+..|+|||++.+..++.++|||||||+||||++|+.||..... .+..... +... ...
T Consensus 165 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~~~~~----~~~~-~~~ 231 (294)
T 4eqm_A 165 --SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA------VSIAIKH----IQDS-VPN 231 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH------HHHHHHH----HSSC-CCC
T ss_pred --cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHH----hhcc-CCC
Confidence 11223346799999999999999999999999999999999999999976431 0110000 0000 000
Q ss_pred HHHHHhhcccchhHHHHHHHHHHHHhccCCCCCC-CHHHHHHHHhhccC
Q 041135 616 LVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRP-RMSQVVRALDTLDG 663 (727)
Q Consensus 616 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~~ 663 (727)
+...........+.+++.+||+.||++|+ ++.++++.|+.+..
T Consensus 232 -----~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 232 -----VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp -----HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred -----cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 00011122234588899999999999999 89999999998754
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=398.31 Aligned_cols=258 Identities=28% Similarity=0.407 Sum_probs=207.3
Q ss_pred HhcCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEee
Q 041135 379 ATNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 379 ~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 458 (727)
..++|++.++||+|+||.||+|+++++..||||+++... ...++|.+|+++|++++|+||++++++|.+ +..+|||||
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 456789999999999999999999888899999997543 345689999999999999999999999876 678999999
Q ss_pred ccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCC
Q 041135 459 VPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSN 538 (727)
Q Consensus 459 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 538 (727)
+.+|+|.++|+......+++.+++.|+.||+.||+|||++ +|+|||||++||||++++.+||+|||+++..... .
T Consensus 260 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~ 334 (452)
T 1fmk_A 260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN--E 334 (452)
T ss_dssp CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred hcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCC--c
Confidence 9999999999765444589999999999999999999999 9999999999999999999999999999864321 1
Q ss_pred ccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHH
Q 041135 539 THVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALV 617 (727)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~ 617 (727)
........++..|+|||++.++.++.++|||||||+||||++ |+.||..... ..+ ...+
T Consensus 335 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~---~~~-----------------~~~i 394 (452)
T 1fmk_A 335 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REV-----------------LDQV 394 (452)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHH-----------------HHHH
T ss_pred eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH---HHH-----------------HHHH
Confidence 112233457889999999999999999999999999999999 9999975321 110 0111
Q ss_pred HHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 618 DSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 618 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
....+..........+.+||++||+.||++||++.+|++.|+.+..
T Consensus 395 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 395 ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp HTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 1111122223334568899999999999999999999999998754
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=373.69 Aligned_cols=261 Identities=26% Similarity=0.384 Sum_probs=212.6
Q ss_pred hcCccccceeccCCceEEEEEEE------cCCcEEEEEEeeeCCc-hhHHHHHHHHHHHHHc-CCCCceeEeeEeeccce
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVL------ADGREVAVKQLKIGGS-QGEREFRAEVEIISRV-HHRHLVSLVGYCISERE 451 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~------~~g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~ 451 (727)
.++|++.+.||+|+||.||+|++ .+++.||||+++.... ...+.+.+|+++|+++ +|+||++++++|.+++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 46799999999999999999985 2468899999975543 3346799999999999 89999999999999999
Q ss_pred eeEEEeeccCCccchhcccCCCC----------------cccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEE
Q 041135 452 RLLVYEYVPNDTLHYHLHAEGRP----------------VMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILL 515 (727)
Q Consensus 452 ~~lV~Ey~~~gsL~~~L~~~~~~----------------~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl 515 (727)
.+|||||+.+|+|.+++...... .+++.++++++.||++||+|||++ +|+|||||++||||
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEE
Confidence 99999999999999998765432 489999999999999999999999 99999999999999
Q ss_pred CCCCcEEEEeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCch
Q 041135 516 DSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDE 594 (727)
Q Consensus 516 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~ 594 (727)
+.++.+||+|||+++...... .........|+..|+|||++.+..++.++|||||||+||||++ |+.||...... .
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~ 255 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDS-NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD--S 255 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCT-TSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS--H
T ss_pred cCCCCEEEccccccccccccc-cceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch--h
Confidence 999999999999998653221 1222334567889999999999999999999999999999999 99999764321 1
Q ss_pred hhHHhhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 595 SLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 595 ~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
. +...+...............+.+|+++||+.||++||++.||+++|+++..
T Consensus 256 ~-----------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 307 (313)
T 1t46_A 256 K-----------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (313)
T ss_dssp H-----------------HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H-----------------HHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 1 111111112222222234458899999999999999999999999998753
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=369.11 Aligned_cols=250 Identities=22% Similarity=0.290 Sum_probs=196.9
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCch--------------------------hHHHHHHHHHHHH
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQ--------------------------GEREFRAEVEIIS 432 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~--------------------------~~~~~~~Ei~~l~ 432 (727)
.++|++.++||+|+||.||+|++. +|+.||||+++..... ..+.+.+|+++|+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 357999999999999999999975 5889999999654311 1256889999999
Q ss_pred HcCCCCceeEeeEeec--cceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCC
Q 041135 433 RVHHRHLVSLVGYCIS--ERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKS 510 (727)
Q Consensus 433 ~l~HpnIv~l~~~~~~--~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp 510 (727)
+++|+||+++++++.+ +...||||||+.+++|.+++... .+++.+++.++.||++||+|||++ +|+|||||+
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp 165 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK---PLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKP 165 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCG
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCH
Confidence 9999999999999986 56889999999999999876543 489999999999999999999999 999999999
Q ss_pred CceEECCCCcEEEEeeccchhhhccCCCccccccccCCccccccCcccCCC---CCchhHHHHHhHHHHHHHhCCCCCCC
Q 041135 511 SNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGK---LTEKSDVYSFGVVLLELITGRKPVDA 587 (727)
Q Consensus 511 ~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~---~~~ksDVwS~Gvil~eLltG~~Pf~~ 587 (727)
+||||+.++.+||+|||+++.... .........|+..|+|||++.+.. ++.++|||||||+||||++|+.||..
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKG---SDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSS---SSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHEEECCCCCEEEecCCCcccccc---ccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 999999999999999999975422 222234567999999999998765 47899999999999999999999975
Q ss_pred CCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 588 SQPLGDESLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 588 ~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
.. ...+.. .+....+...........+.+|+++||+.||++||++.||+++
T Consensus 243 ~~------~~~~~~-------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 243 ER------IMCLHS-------------KIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp SS------HHHHHH-------------HHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred cc------HHHHHH-------------HHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 32 111111 0111111111111223457899999999999999999999875
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=369.95 Aligned_cols=262 Identities=22% Similarity=0.400 Sum_probs=201.6
Q ss_pred hcCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHH--cCCCCceeEeeEeec----cceee
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISR--VHHRHLVSLVGYCIS----ERERL 453 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~--l~HpnIv~l~~~~~~----~~~~~ 453 (727)
.++|+++++||+|+||.||+|++ +|+.||||++.. .....+.+|.+++.. ++|+||+++++++.+ ....+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecc---ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 46799999999999999999998 689999999863 345567778888877 789999999999765 34679
Q ss_pred EEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHH--------hcCCCcEEeeCCCCCceEECCCCcEEEEe
Q 041135 454 LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLH--------EDCHPRIIHRDIKSSNILLDSSFEARVAD 525 (727)
Q Consensus 454 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH--------~~~~~~ivHrDLkp~NILl~~~~~vkL~D 525 (727)
|||||+.+|+|.++++.. .+++..+++|+.||++||+||| ++ +|+|||||++||||+.++.+||+|
T Consensus 83 lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp EEECCCTTCBHHHHHTTC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECC
T ss_pred EehhhccCCCHHHHHhhc---ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEee
Confidence 999999999999999653 4899999999999999999999 77 999999999999999999999999
Q ss_pred eccchhhhccCCCcc-ccccccCCccccccCcccCC------CCCchhHHHHHhHHHHHHHhC----------CCCCCCC
Q 041135 526 FGLAKIALELDSNTH-VSTRVMGTFGYMAPEYATSG------KLTEKSDVYSFGVVLLELITG----------RKPVDAS 588 (727)
Q Consensus 526 FGla~~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~------~~~~ksDVwS~Gvil~eLltG----------~~Pf~~~ 588 (727)
||+++.......... ......||..|+|||++.+. .++.++|||||||+||||++| +.||...
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 999975432211111 12235799999999999876 455799999999999999999 7777554
Q ss_pred CCCCchhhHHhhHHHHHHhhchhhHHHHHHHHh-hcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhc
Q 041135 589 QPLGDESLVEWARPLLAEALEHEDFEALVDSRL-EKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661 (727)
Q Consensus 589 ~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 661 (727)
...... ...+ ..... .... ...+ ...+.......+.+|+++||+.||++||++.||++.|+++
T Consensus 237 ~~~~~~-~~~~-~~~~~---~~~~-----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 237 VPNDPS-FEDM-RKVVC---VDQQ-----RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SCSSCC-HHHH-HHHHT---TSCC-----CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCcc-hhhh-hHHHh---ccCC-----CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 322111 1110 00000 0000 0000 0112234556789999999999999999999999999976
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=380.64 Aligned_cols=270 Identities=17% Similarity=0.206 Sum_probs=208.2
Q ss_pred hcCccccceeccCCceEEEEEEEcC------CcEEEEEEeeeCCchhH-----------HHHHHHHHHHHHcCCCCceeE
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLAD------GREVAVKQLKIGGSQGE-----------REFRAEVEIISRVHHRHLVSL 442 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~~------g~~vaVK~l~~~~~~~~-----------~~~~~Ei~~l~~l~HpnIv~l 442 (727)
.++|+++++||+|+||.||+|++.+ ++.||||++........ ..+.+|+..++.++|+||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4579999999999999999999764 47899999875432111 123345556667789999999
Q ss_pred eeEeecc----ceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEEC--
Q 041135 443 VGYCISE----RERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLD-- 516 (727)
Q Consensus 443 ~~~~~~~----~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~-- 516 (727)
+++|.+. ...||||||+ +++|.+++.... ..+++..++.|+.||+.||+|||++ +|+|||||++||||+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA-KRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYK 188 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESS
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecC
Confidence 9999875 4579999999 999999997653 3589999999999999999999999 999999999999998
Q ss_pred CCCcEEEEeeccchhhhccCCCc----cccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCC
Q 041135 517 SSFEARVADFGLAKIALELDSNT----HVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLG 592 (727)
Q Consensus 517 ~~~~vkL~DFGla~~~~~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~ 592 (727)
.++.+||+|||+++.+....... ......+||..|+|||++.+..++.++|||||||+||||++|+.||.....
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~-- 266 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK-- 266 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT--
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc--
Confidence 88999999999997653222111 111345699999999999999999999999999999999999999985432
Q ss_pred chhhHHhhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccCC
Q 041135 593 DESLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDGA 664 (727)
Q Consensus 593 ~~~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 664 (727)
...+..+.... ....+..+++.++..... ...+.+|+..||+.||++||++.+|++.|+.+...
T Consensus 267 ~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~---~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~ 330 (364)
T 3op5_A 267 DPKYVRDSKIR-----YRENIASLMDKCFPAANA---PGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKA 330 (364)
T ss_dssp CHHHHHHHHHH-----HHHCHHHHHHHHSCTTCC---CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHH-----hhhhHHHHHHHhcccccC---HHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Confidence 12222221111 123455556655532222 23578899999999999999999999999987543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=380.82 Aligned_cols=274 Identities=27% Similarity=0.355 Sum_probs=213.8
Q ss_pred cCccccceeccCCceEEEEEEE-----cCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEee--ccceee
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVL-----ADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCI--SERERL 453 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~-----~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~--~~~~~~ 453 (727)
++|+++++||+|+||.||+|++ .+|+.||||+++.......+.+.+|+++|++++|+||+++++++. +....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5689999999999999999984 358899999998766666678999999999999999999999987 456689
Q ss_pred EEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhh
Q 041135 454 LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIAL 533 (727)
Q Consensus 454 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~ 533 (727)
|||||+.+++|.+++..... .+++..++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++...
T Consensus 103 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRA-RLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred EEEeecCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceecc
Confidence 99999999999999976432 489999999999999999999999 99999999999999999999999999998653
Q ss_pred ccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhH
Q 041135 534 ELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDF 613 (727)
Q Consensus 534 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~ 613 (727)
.............|+..|+|||++.+..++.++|||||||+||||++|+.||..... ....... ..........+
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~----~~~~~~~-~~~~~~~~~~~ 253 (327)
T 3lxl_A 179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSA----EFLRMMG-CERDVPALSRL 253 (327)
T ss_dssp TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH----HHHHHCC-----CCHHHHH
T ss_pred cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccc----hhhhhcc-cccccccHHHH
Confidence 222222233445688899999999999999999999999999999999999864211 0000000 00000000112
Q ss_pred HHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 614 EALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 614 ~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
...+...............+.+|+++||+.||++||++.||+++|+.+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 254 LELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred HHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 22222222222333444568899999999999999999999999998864
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=376.89 Aligned_cols=261 Identities=27% Similarity=0.435 Sum_probs=203.2
Q ss_pred cCccccceeccCCceEEEEEEEcC-----CcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLAD-----GREVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLL 454 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~~-----g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 454 (727)
++|++.++||+|+||.||+|++.. +..||||+++.... .....+.+|+++|++++|+||+++++++.+.+..+|
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 568889999999999999998653 24599999975433 334578999999999999999999999999999999
Q ss_pred EEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhc
Q 041135 455 VYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALE 534 (727)
Q Consensus 455 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 534 (727)
||||+.+++|.+++.... ..+++.+++.|+.||++||+|||++ +|+|||||++||||+.++.+||+|||+++....
T Consensus 124 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 199 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199 (333)
T ss_dssp EEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence 999999999999997643 2589999999999999999999999 999999999999999999999999999986533
Q ss_pred cCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhH
Q 041135 535 LDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDF 613 (727)
Q Consensus 535 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~ 613 (727)
............++..|+|||++.+..++.++|||||||+||||++ |+.||..... ..+
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~---~~~----------------- 259 (333)
T 1mqb_A 200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN---HEV----------------- 259 (333)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHH-----------------
T ss_pred ccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH---HHH-----------------
Confidence 2222222233456789999999999999999999999999999999 9999965321 111
Q ss_pred HHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccCCC
Q 041135 614 EALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDGAS 665 (727)
Q Consensus 614 ~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 665 (727)
...+...............+.+|+++||+.||++||++.||++.|+++....
T Consensus 260 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 260 MKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp HHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred HHHHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 0111111111112223345889999999999999999999999999886533
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=376.09 Aligned_cols=270 Identities=29% Similarity=0.376 Sum_probs=210.8
Q ss_pred ccccceeccCCceEEEEEEEc-----CCcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEeecc--ceeeE
Q 041135 383 FSAHNVLGEGGFGCVYKGVLA-----DGREVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYCISE--RERLL 454 (727)
Q Consensus 383 ~~~~~~LG~G~fg~Vy~~~~~-----~g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~--~~~~l 454 (727)
|+++++||+|+||.||++.++ +|+.||||+++.... ...+.+.+|+++|++++|+||++++++|.+. ...+|
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 588999999999999998753 588999999975543 3356799999999999999999999999874 57899
Q ss_pred EEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhc
Q 041135 455 VYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALE 534 (727)
Q Consensus 455 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 534 (727)
||||+.+|+|.+++.... +++..++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++....
T Consensus 113 v~e~~~~~~L~~~l~~~~---~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp EECCCTTCBHHHHGGGSC---CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred EEecccCCcHHHHHhhCC---CCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 999999999999997653 89999999999999999999999 999999999999999999999999999986533
Q ss_pred cCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHH
Q 041135 535 LDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFE 614 (727)
Q Consensus 535 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~ 614 (727)
............|+..|+|||++.+..++.++|||||||+||||++|+.||...... ...+..+... ......+.
T Consensus 187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~-~~~~~~~~~~----~~~~~~~~ 261 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTK-FLELIGIAQG----QMTVLRLT 261 (318)
T ss_dssp TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH-HHHHHCSCCH----HHHHHHHH
T ss_pred cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchh-hhhhhccccc----chhHHHHH
Confidence 222222334456888999999999989999999999999999999999998642100 0000000000 00111222
Q ss_pred HHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 615 ALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 615 ~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
..++..............+.+|+++||+.||++||++.||++.|+.+.+
T Consensus 262 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 310 (318)
T 3lxp_A 262 ELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310 (318)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 3333333333334445568899999999999999999999999998753
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=366.19 Aligned_cols=252 Identities=24% Similarity=0.354 Sum_probs=207.7
Q ss_pred cCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCC--chhHHHHHHHHHHHHHcCCCCceeEeeEeecc--ceeeEEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGG--SQGEREFRAEVEIISRVHHRHLVSLVGYCISE--RERLLVY 456 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~--~~~~lV~ 456 (727)
++|++.++||+|+||.||+|+++ |+.||||+++... ....+.|.+|+++|++++|+||++++++|.+. ...++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 56899999999999999999985 8999999997653 23346799999999999999999999999887 7789999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCc--EEeeCCCCCceEECCCCcEEEEeeccchhhhc
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPR--IIHRDIKSSNILLDSSFEARVADFGLAKIALE 534 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~--ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 534 (727)
||+.+|+|.++++......+++.+++.|+.||++||+|||++ + |+|||||++||||+.++.+||+|||++...
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~-- 163 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSF-- 163 (271)
T ss_dssp ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT--
T ss_pred cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeee--
Confidence 999999999999887665689999999999999999999998 8 999999999999999999999999987532
Q ss_pred cCCCccccccccCCccccccCcccCCCCCc---hhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchh
Q 041135 535 LDSNTHVSTRVMGTFGYMAPEYATSGKLTE---KSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHE 611 (727)
Q Consensus 535 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~---ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~ 611 (727)
......|+..|+|||++.+..+.. ++|||||||+||||++|+.||..... .+.
T Consensus 164 ------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~------------ 219 (271)
T 3kmu_A 164 ------QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN------MEI------------ 219 (271)
T ss_dssp ------SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH------HHH------------
T ss_pred ------cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh------HHH------------
Confidence 122346899999999998765544 89999999999999999999975431 010
Q ss_pred hHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 612 DFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 612 ~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
...+................+.+|+.+||+.||++||++.||++.|+.+.+
T Consensus 220 -~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 220 -GMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp -HHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred -HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 111111112222223334458899999999999999999999999998753
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=364.98 Aligned_cols=250 Identities=29% Similarity=0.476 Sum_probs=195.5
Q ss_pred cCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCc----hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGS----QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
++|++.++||+|+||.||+|++. |+.||||+++.... ...+.+++|+++++.++|+||++++++|.+++..++||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 57899999999999999999985 89999999875432 22467899999999999999999999999999999999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCc---EEeeCCCCCceEECC--------CCcEEEEe
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPR---IIHRDIKSSNILLDS--------SFEARVAD 525 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~---ivHrDLkp~NILl~~--------~~~vkL~D 525 (727)
||+.+++|.+++... .+++..++.++.||++||+|||++ + |+|||||++||||+. ++.+||+|
T Consensus 86 e~~~~~~L~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~---~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 86 EFARGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLHDE---AIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp ECCTTEEHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHS---SSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred EcCCCCCHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 999999999998643 489999999999999999999998 7 999999999999986 77899999
Q ss_pred eccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHH
Q 041135 526 FGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLA 605 (727)
Q Consensus 526 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~ 605 (727)
||+++..... ......|+..|+|||++.+..++.++|||||||++|||++|+.||..... ...
T Consensus 160 fg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~--------- 222 (271)
T 3dtc_A 160 FGLAREWHRT-----TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG---LAV--------- 222 (271)
T ss_dssp CCC------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH---HHH---------
T ss_pred CCcccccccc-----cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHH---------
Confidence 9999754221 12245689999999999999999999999999999999999999975431 000
Q ss_pred HhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhc
Q 041135 606 EALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661 (727)
Q Consensus 606 ~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 661 (727)
........+...........+.+|+++||+.||++||++.||+++|+.+
T Consensus 223 -------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 223 -------AYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp -------HHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred -------HHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 0111111112222233345688999999999999999999999999864
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=365.13 Aligned_cols=264 Identities=17% Similarity=0.219 Sum_probs=211.0
Q ss_pred hcCccccceeccCCceEEEEEEE-cCCcEEEEEEeeeCCchhHHHHHHHHHHHHHc-CCCCceeEeeEeeccceeeEEEe
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVL-ADGREVAVKQLKIGGSQGEREFRAEVEIISRV-HHRHLVSLVGYCISERERLLVYE 457 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E 457 (727)
.++|++++.||+|+||.||+|+. .+|+.||||++... ...+.+.+|+++++++ +|+||+++++++.++...+||||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC--CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 35799999999999999999996 56899999998643 3345789999999999 79999999999999999999999
Q ss_pred eccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCc-----EEEEeeccchhh
Q 041135 458 YVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFE-----ARVADFGLAKIA 532 (727)
Q Consensus 458 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~-----vkL~DFGla~~~ 532 (727)
|+ +++|.+++...+. .+++.++++|+.||++||+|||++ +|+|||||++||||+.++. +||+|||+++..
T Consensus 87 ~~-~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 87 LL-GPSLEDLLDLCGR-KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp CC-CCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred ec-CCCHHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 99 9999999976532 489999999999999999999999 9999999999999987765 999999999865
Q ss_pred hccCCCc----cccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhh
Q 041135 533 LELDSNT----HVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEAL 608 (727)
Q Consensus 533 ~~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~ 608 (727)
....... .......|+..|+|||++.+..++.++|||||||+||||++|+.||................ ...
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~---~~~- 237 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG---EKK- 237 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH---HHH-
T ss_pred ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHH---hhc-
Confidence 3322211 12345679999999999999999999999999999999999999998755433222211110 000
Q ss_pred chhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 609 EHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 609 ~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
...... .+.. .....+.+|+.+||+.||++||++++|++.|+++..
T Consensus 238 ~~~~~~-----~~~~----~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~ 283 (298)
T 1csn_A 238 QSTPLR-----ELCA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 283 (298)
T ss_dssp HHSCHH-----HHTT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred cCccHH-----HHHh----hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence 000000 0111 123457899999999999999999999999998854
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=379.49 Aligned_cols=256 Identities=21% Similarity=0.351 Sum_probs=202.3
Q ss_pred hcCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCc--hhHHHHHHHHHHHHHcCC--CCceeEeeEeeccceeeEE
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGS--QGEREFRAEVEIISRVHH--RHLVSLVGYCISERERLLV 455 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l~H--pnIv~l~~~~~~~~~~~lV 455 (727)
.++|+++++||+|+||.||+|+..+++.||||+++.... ...+.+.+|+++|++++| +||+++++++.++...|||
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 356999999999999999999998899999999975433 334678999999999986 9999999999999999999
Q ss_pred EeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhcc
Q 041135 456 YEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALEL 535 (727)
Q Consensus 456 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 535 (727)
|| +.+++|.+++..... +++.+++.|+.||+.||+|||++ +|+|||||++||||+ ++.+||+|||+++.....
T Consensus 88 ~e-~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp EC-CCSEEHHHHHHHSCC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred Ee-CCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 99 568899999987654 89999999999999999999999 999999999999997 578999999999854321
Q ss_pred CCCccccccccCCccccccCcccC-----------CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHH
Q 041135 536 DSNTHVSTRVMGTFGYMAPEYATS-----------GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLL 604 (727)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~l~~-----------~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l 604 (727)
.........+|+..|+|||++.+ ..++.++|||||||+||||++|+.||..... ..
T Consensus 161 -~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~-------- 227 (343)
T 3dbq_A 161 -TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN----QI-------- 227 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS----HH--------
T ss_pred -cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh----HH--------
Confidence 12222345679999999999865 6789999999999999999999999975321 00
Q ss_pred HHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhc
Q 041135 605 AEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661 (727)
Q Consensus 605 ~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 661 (727)
..+..+++......+.......+.+|+.+||+.||++||++.||+++.+..
T Consensus 228 ------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~ 278 (343)
T 3dbq_A 228 ------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 278 (343)
T ss_dssp ------HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred ------HHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccc
Confidence 111222222233333333344678999999999999999999999986644
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=374.87 Aligned_cols=270 Identities=23% Similarity=0.337 Sum_probs=207.9
Q ss_pred cCccccceeccCCceEEEEEEE-----cCCcEEEEEEeeeCC-chhHHHHHHHHHHHHHcCCCCceeEeeEeecc--cee
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVL-----ADGREVAVKQLKIGG-SQGEREFRAEVEIISRVHHRHLVSLVGYCISE--RER 452 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~-----~~g~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~--~~~ 452 (727)
++|+++++||+|+||.||+|++ .+|+.||||+++... ....+.+.+|+++|++++|+||++++++|.+. ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4488999999999999999984 358999999997443 23346799999999999999999999999876 568
Q ss_pred eEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhh
Q 041135 453 LLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIA 532 (727)
Q Consensus 453 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~ 532 (727)
++||||+.+++|.+++..... .+++..++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++..
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNKN-KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAI 176 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHTT-TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEEeCCCCcHHHHHHhccc-cCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccccc
Confidence 999999999999999965432 489999999999999999999999 9999999999999999999999999999865
Q ss_pred hccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhh
Q 041135 533 LELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHED 612 (727)
Q Consensus 533 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~ 612 (727)
..............|+..|+|||++.+..++.++|||||||+||||++|+.+|.... .. .............
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~-~~~~~~~~~~~~~ 248 (302)
T 4e5w_A 177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPM-------AL-FLKMIGPTHGQMT 248 (302)
T ss_dssp CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH-------HH-HHHHHCSCCGGGH
T ss_pred cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchh-------hH-HhhccCCcccccC
Confidence 332222233345678889999999999999999999999999999999998864311 00 0000000001111
Q ss_pred HHHH---HHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhcc
Q 041135 613 FEAL---VDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLD 662 (727)
Q Consensus 613 ~~~l---~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 662 (727)
...+ +...............+.+|+++||+.||++||++.||++.|+.+.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 249 VTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 1111 1111122223333456889999999999999999999999998763
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=394.31 Aligned_cols=262 Identities=21% Similarity=0.264 Sum_probs=208.9
Q ss_pred HHHHHHHhcCccccceeccCCceEEEEEEEcC-CcEEEEEEeeeCCc---hhHHHHHHHHHHHHHcCCCCceeEeeEeec
Q 041135 373 YDELIQATNGFSAHNVLGEGGFGCVYKGVLAD-GREVAVKQLKIGGS---QGEREFRAEVEIISRVHHRHLVSLVGYCIS 448 (727)
Q Consensus 373 ~~el~~~~~~~~~~~~LG~G~fg~Vy~~~~~~-g~~vaVK~l~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~ 448 (727)
+.++....++|+++++||+|+||+||+|++++ |+.||||+++.... .....+++|+++|..++|+||++++++|.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 44455556889999999999999999999864 78999999974221 222348999999999999999999999999
Q ss_pred cceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeecc
Q 041135 449 ERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGL 528 (727)
Q Consensus 449 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGl 528 (727)
++.+|||||||.||+|.++|+... ..+++..++.++.||+.||+|||++ +|||||||++||||+.++.+||+|||+
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGl 221 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGS 221 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CCEEEEEEecCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhh
Confidence 999999999999999999997642 2489999999999999999999999 999999999999999999999999999
Q ss_pred chhhhccCCCccccccccCCccccccCccc-----CCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHH
Q 041135 529 AKIALELDSNTHVSTRVMGTFGYMAPEYAT-----SGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPL 603 (727)
Q Consensus 529 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~ 603 (727)
++.... .........+||..|+|||++. ++.++.++||||||||||||++|+.||..... .+.
T Consensus 222 a~~~~~--~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~------~~~---- 289 (437)
T 4aw2_A 222 CLKLME--DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL------VET---- 289 (437)
T ss_dssp CEECCT--TSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHH----
T ss_pred hhhccc--CCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh------hHH----
Confidence 975422 2222334468999999999997 56789999999999999999999999975431 111
Q ss_pred HHHhhchhhHHHHHHHHhhcccc---hhHHHHHHHHHHHHhccCCCC--CCCHHHHHHHHh
Q 041135 604 LAEALEHEDFEALVDSRLEKNYV---DSEMFWMIEAAAACVRHSATK--RPRMSQVVRALD 659 (727)
Q Consensus 604 l~~~~~~~~~~~l~d~~l~~~~~---~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~L~ 659 (727)
+..++.......+. ......+.+||++||..++++ |++++||+++-.
T Consensus 290 ---------~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpf 341 (437)
T 4aw2_A 290 ---------YGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPF 341 (437)
T ss_dssp ---------HHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGG
T ss_pred ---------HHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCc
Confidence 11111111111111 112345778999999888888 999999998744
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=384.11 Aligned_cols=249 Identities=27% Similarity=0.376 Sum_probs=200.7
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHHHHHHc-CCCCceeEeeEeeccceeeE
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVEIISRV-HHRHLVSLVGYCISERERLL 454 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~l 454 (727)
.++|+++++||+|+||.||+|+++ +|+.||||+++... ....+.+.+|+++|+.+ +|+||++++++|.+.+..||
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 467999999999999999999975 58999999997432 22345688999999988 69999999999999999999
Q ss_pred EEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhc
Q 041135 455 VYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALE 534 (727)
Q Consensus 455 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 534 (727)
|||||.||+|.++++..+. +++..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++...
T Consensus 102 v~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~- 175 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSRR--FDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI- 175 (353)
T ss_dssp EEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC-
T ss_pred EEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeecc-
Confidence 9999999999999987654 89999999999999999999999 99999999999999999999999999997431
Q ss_pred cCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHH
Q 041135 535 LDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFE 614 (727)
Q Consensus 535 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~ 614 (727)
.........+||..|+|||++.+..++.++|||||||+||||++|+.||..... .+. +.
T Consensus 176 --~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~-------------~~ 234 (353)
T 3txo_A 176 --CNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE------DDL-------------FE 234 (353)
T ss_dssp --C---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHH-------------HH
T ss_pred --cCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH------HHH-------------HH
Confidence 122233456899999999999998899999999999999999999999975431 111 11
Q ss_pred HHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCH------HHHHHH
Q 041135 615 ALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRM------SQVVRA 657 (727)
Q Consensus 615 ~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~~ 657 (727)
.++...+ .+.......+.+|+++||+.||++|+++ .||+++
T Consensus 235 ~i~~~~~--~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 235 AILNDEV--VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp HHHHCCC--CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred HHHcCCC--CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 1111111 1222233457889999999999999998 777765
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=370.10 Aligned_cols=273 Identities=18% Similarity=0.244 Sum_probs=210.0
Q ss_pred cCccccceeccCCceEEEEEEEcC-CcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEeeccc--eeeEEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLAD-GREVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYCISER--ERLLVY 456 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~~-g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~--~~~lV~ 456 (727)
++|++.++||+|+||.||+|++.. |+.||||+++.... ...+.+.+|+++|++++|+||+++++++.+.. ..+|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 568999999999999999999764 89999999975332 33467889999999999999999999998755 779999
Q ss_pred eeccCCccchhcccCCC-CcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEE----CCCCcEEEEeeccchh
Q 041135 457 EYVPNDTLHYHLHAEGR-PVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILL----DSSFEARVADFGLAKI 531 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl----~~~~~vkL~DFGla~~ 531 (727)
||+.+++|.+++..... ..+++.+++.|+.||++||+|||++ +|+|||||++|||| +.++.+||+|||+++.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 99999999999976533 2389999999999999999999999 99999999999999 7888899999999975
Q ss_pred hhccCCCccccccccCCccccccCccc--------CCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHH
Q 041135 532 ALELDSNTHVSTRVMGTFGYMAPEYAT--------SGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPL 603 (727)
Q Consensus 532 ~~~~~~~~~~~~~~~gt~~y~aPE~l~--------~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~ 603 (727)
... ........|+..|+|||++. +..++.++||||||||||||++|+.||...... ....+....+
T Consensus 166 ~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~~~~~~ 239 (319)
T 4euu_A 166 LED----DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP--RRNKEVMYKI 239 (319)
T ss_dssp CCT----TCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCG--GGCHHHHHHH
T ss_pred cCC----CCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc--chhHHHHHHH
Confidence 422 12223457999999999986 577899999999999999999999999754321 1112222222
Q ss_pred HHHhhch--hhHHHHHHH--------HhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhcc
Q 041135 604 LAEALEH--EDFEALVDS--------RLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLD 662 (727)
Q Consensus 604 l~~~~~~--~~~~~l~d~--------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 662 (727)
+...... ..+...... .....+.......+.+|+++||+.||++|++++|++++.....
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred hcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 1111000 000000000 0011223445566889999999999999999999999988654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=383.73 Aligned_cols=256 Identities=22% Similarity=0.357 Sum_probs=203.6
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHHHHHHc-CCCCceeEeeEeeccceeeE
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVEIISRV-HHRHLVSLVGYCISERERLL 454 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~l 454 (727)
.++|+++++||+|+||+||+|+++ +|+.||||+++... ....+.+.+|+.+|+++ +|+||++++++|.+...+||
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 357999999999999999999976 47899999997542 22334688999999887 89999999999999999999
Q ss_pred EEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhc
Q 041135 455 VYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALE 534 (727)
Q Consensus 455 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 534 (727)
||||+.||+|..++...+. +++..++.++.||+.||+|||++ +|||||||++||||+.++.+||+|||+++....
T Consensus 131 V~E~~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEcCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 9999999999999987654 89999999999999999999999 999999999999999999999999999974321
Q ss_pred cCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchh--hHHhhHHHHHHhhchhh
Q 041135 535 LDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDES--LVEWARPLLAEALEHED 612 (727)
Q Consensus 535 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~--l~~~~~~~l~~~~~~~~ 612 (727)
........+||..|+|||++.+..++.++||||||||||||++|+.||.......... ..++.
T Consensus 206 ---~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~------------ 270 (396)
T 4dc2_A 206 ---PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL------------ 270 (396)
T ss_dssp ---TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHH------------
T ss_pred ---CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHH------------
Confidence 2223445789999999999999999999999999999999999999997543211100 00000
Q ss_pred HHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCH------HHHHHH
Q 041135 613 FEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRM------SQVVRA 657 (727)
Q Consensus 613 ~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~~ 657 (727)
+..+....+ .+.......+.+|+++||+.||++|+++ .||+++
T Consensus 271 ~~~i~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 271 FQVILEKQI--RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp HHHHHHCCC--CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred HHHHhcccc--CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 111111111 1222233457899999999999999985 676665
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=370.21 Aligned_cols=267 Identities=24% Similarity=0.341 Sum_probs=200.8
Q ss_pred hcCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCc--hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEe
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGS--QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYE 457 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 457 (727)
.++|+++++||+|+||.||+|++.+|+.||||+++.... ...+.+.+|+++|++++|+||++++++|.++...+||||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 467999999999999999999998899999999975432 224678899999999999999999999999999999999
Q ss_pred eccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCC
Q 041135 458 YVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDS 537 (727)
Q Consensus 458 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 537 (727)
|+.+ +|.+++.... ..+++..++.|+.||++||+|||++ +|+|||||++||||+.++.+||+|||+++... .
T Consensus 100 ~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~---~ 171 (311)
T 3niz_A 100 FMEK-DLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFG---I 171 (311)
T ss_dssp CCSE-EHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETT---S
T ss_pred CCCC-CHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecC---C
Confidence 9975 6766665543 3489999999999999999999999 99999999999999999999999999997542 1
Q ss_pred CccccccccCCccccccCcccC-CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhh-----chh
Q 041135 538 NTHVSTRVMGTFGYMAPEYATS-GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEAL-----EHE 611 (727)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~-----~~~ 611 (727)
.........|+..|+|||++.+ ..++.++|||||||+||||++|+.||........ +... ...+.... ...
T Consensus 172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~i-~~~~~~~~~~~~~~~~ 248 (311)
T 3niz_A 172 PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ--LPKI-FSILGTPNPREWPQVQ 248 (311)
T ss_dssp CCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH--HHHH-HHHHCCCCTTTSGGGT
T ss_pred CcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH--HHHH-HHHHCCCChHHhhhhh
Confidence 2222344578999999999976 5689999999999999999999999987553321 1111 11000000 000
Q ss_pred hHHHHHHHHhh---c----ccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 612 DFEALVDSRLE---K----NYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 612 ~~~~l~d~~l~---~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
.+..+.+.... . .........+.+|+++||+.||++||++.||+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00000000000 0 0001112347799999999999999999999986
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=364.16 Aligned_cols=257 Identities=25% Similarity=0.441 Sum_probs=210.3
Q ss_pred hcCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeec
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYV 459 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 459 (727)
.++|++.+.||+|+||.||+|++.+++.||||+++.... ..+.+.+|+++|++++|+||++++++|.+++..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 356899999999999999999998899999999975433 3468999999999999999999999999999999999999
Q ss_pred cCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCc
Q 041135 460 PNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNT 539 (727)
Q Consensus 460 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 539 (727)
.+++|.+++.... ..+++..++.++.||++||+|||++ +|+|||||++||||+.++.+||+|||+++.... ...
T Consensus 86 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~--~~~ 159 (267)
T 3t9t_A 86 EHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD--DQY 159 (267)
T ss_dssp TTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCC--HHH
T ss_pred CCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccc--ccc
Confidence 9999999997653 2588999999999999999999999 999999999999999999999999999975421 111
Q ss_pred cccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHH
Q 041135 540 HVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVD 618 (727)
Q Consensus 540 ~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d 618 (727)
.......++..|+|||++.+..++.++|||||||+||||++ |+.||..... . +... .+ .
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~---~~~~-------------~i-~ 219 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---S---EVVE-------------DI-S 219 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---H---HHHH-------------HH-H
T ss_pred cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH---H---HHHH-------------HH-h
Confidence 12233457788999999998899999999999999999999 8999975321 1 1100 01 0
Q ss_pred HHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 619 SRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 619 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
..............+.+|+++||+.||++||++.||+++|+++.+
T Consensus 220 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 220 TGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 011111112223457889999999999999999999999998854
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=369.94 Aligned_cols=253 Identities=22% Similarity=0.307 Sum_probs=205.1
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCch------hHHHHHHHHHHHHHcCCCCceeEeeEeeccceee
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQ------GEREFRAEVEIISRVHHRHLVSLVGYCISERERL 453 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~------~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 453 (727)
++|++.+.||+|+||.||+|++. +|+.||||+++..... ..+.+.+|+++|++++|+||++++++|.+....+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 45999999999999999999975 5899999999754322 3567999999999999999999999999999999
Q ss_pred EEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCC----cEEEEeeccc
Q 041135 454 LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSF----EARVADFGLA 529 (727)
Q Consensus 454 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~----~vkL~DFGla 529 (727)
|||||+.+++|.+++.... .+++.+++.|+.||+.||+|||++ +|+|||||++||||+.++ .+||+|||++
T Consensus 91 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp EEEECCCSCBHHHHHTTSS--CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEcCCCCCHHHHHHhcC--CcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 9999999999999997654 489999999999999999999999 999999999999998877 8999999999
Q ss_pred hhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhc
Q 041135 530 KIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALE 609 (727)
Q Consensus 530 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~ 609 (727)
+.... .......+|+..|+|||++.+..++.++||||||||||||++|+.||..... .+....+....
T Consensus 166 ~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~~~~~~-- 233 (326)
T 2y0a_A 166 HKIDF----GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------QETLANVSAVN-- 233 (326)
T ss_dssp EECCT----TSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHHTC--
T ss_pred eECCC----CCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH------HHHHHHHHhcC--
Confidence 75421 1123346799999999999999999999999999999999999999975321 11111110000
Q ss_pred hhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 610 HEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 610 ~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
..+ ...+.......+.+|+++||+.||++||++.||+++-.
T Consensus 234 -~~~--------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 274 (326)
T 2y0a_A 234 -YEF--------EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274 (326)
T ss_dssp -CCC--------CHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTT
T ss_pred -CCc--------CccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 000 00001112234778999999999999999999998744
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=377.35 Aligned_cols=261 Identities=26% Similarity=0.381 Sum_probs=210.4
Q ss_pred HhcCccccceeccCCceEEEEEEEcC------CcEEEEEEeeeCCc-hhHHHHHHHHHHHHHc-CCCCceeEeeEeeccc
Q 041135 379 ATNGFSAHNVLGEGGFGCVYKGVLAD------GREVAVKQLKIGGS-QGEREFRAEVEIISRV-HHRHLVSLVGYCISER 450 (727)
Q Consensus 379 ~~~~~~~~~~LG~G~fg~Vy~~~~~~------g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~ 450 (727)
..++|++.+.||+|+||.||+|++.. +..||||+++.... ...+.+.+|+++|+++ +|+||++++++|.+++
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 35679999999999999999999743 24799999975443 3346799999999999 8999999999999999
Q ss_pred eeeEEEeeccCCccchhcccCC------------CCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCC
Q 041135 451 ERLLVYEYVPNDTLHYHLHAEG------------RPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSS 518 (727)
Q Consensus 451 ~~~lV~Ey~~~gsL~~~L~~~~------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~ 518 (727)
..+|||||+.+|+|.+++.... ...+++..++.|+.||+.||+|||++ +|+|||||++||||+.+
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNG 200 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGG
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCC
Confidence 9999999999999999986532 23478999999999999999999999 99999999999999999
Q ss_pred CcEEEEeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhH
Q 041135 519 FEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLV 597 (727)
Q Consensus 519 ~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~ 597 (727)
+.+||+|||+++...... .........|+..|+|||++.+..++.++|||||||+||||++ |+.||...... ..
T Consensus 201 ~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~~-- 275 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDS-NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN--SK-- 275 (333)
T ss_dssp GEEEBCCCGGGCCGGGCT-TSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS--HH--
T ss_pred CeEEECcccccccccccc-ceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh--HH--
Confidence 999999999998553221 2222334567889999999999999999999999999999998 99999764321 11
Q ss_pred HhhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhcc
Q 041135 598 EWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLD 662 (727)
Q Consensus 598 ~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 662 (727)
+..++...............+.+|+.+||+.||++||++.||++.|+.+.
T Consensus 276 ---------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 276 ---------------FYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp ---------------HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---------------HHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 11111211212122222345788999999999999999999999999874
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=367.17 Aligned_cols=259 Identities=24% Similarity=0.375 Sum_probs=208.2
Q ss_pred cCccccc-eeccCCceEEEEEEEc---CCcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEE
Q 041135 381 NGFSAHN-VLGEGGFGCVYKGVLA---DGREVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLV 455 (727)
Q Consensus 381 ~~~~~~~-~LG~G~fg~Vy~~~~~---~g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 455 (727)
++|.+.+ +||+|+||.||+|++. +++.||||+++.... ...+.+.+|+++|++++|+||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4566666 9999999999999864 578899999976533 3456799999999999999999999999 45668999
Q ss_pred EeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhcc
Q 041135 456 YEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALEL 535 (727)
Q Consensus 456 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 535 (727)
|||+.+++|.+++.... ..+++..+++++.||++||+|||++ +|+|||||++||||+.++.+||+|||+++.....
T Consensus 88 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 163 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163 (287)
T ss_dssp EECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEeCCCCCHHHHHHhCC-ccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence 99999999999986543 3589999999999999999999999 9999999999999999999999999999865322
Q ss_pred CCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHH
Q 041135 536 DSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFE 614 (727)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~ 614 (727)
...........|+..|+|||++.+..++.++|||||||+||||++ |+.||..... ..+..
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~---------------- 224 (287)
T 1u59_A 164 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVMA---------------- 224 (287)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT---HHHHH----------------
T ss_pred cceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH---HHHHH----------------
Confidence 222222233457889999999998899999999999999999998 9999976432 11111
Q ss_pred HHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccCC
Q 041135 615 ALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDGA 664 (727)
Q Consensus 615 ~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 664 (727)
.+.......+.......+.+|+++||+.||++||++.||+++|+.+...
T Consensus 225 -~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 273 (287)
T 1u59_A 225 -FIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 273 (287)
T ss_dssp -HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 1111111122233345688999999999999999999999999988543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=370.02 Aligned_cols=256 Identities=17% Similarity=0.274 Sum_probs=207.3
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEee
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 458 (727)
.++|++++.||+|+||.||+|++. +|+.||+|+++.. ......+.+|+++|+.++|+||++++++|.+.+..+|||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 467999999999999999999976 5889999998744 34456789999999999999999999999999999999999
Q ss_pred ccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECC--CCcEEEEeeccchhhhccC
Q 041135 459 VPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDS--SFEARVADFGLAKIALELD 536 (727)
Q Consensus 459 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~--~~~vkL~DFGla~~~~~~~ 536 (727)
|.||+|.+++.... ..+++.+++.++.||+.||+|||++ +|+|||||++||||+. ++.+||+|||+++....
T Consensus 83 ~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~-- 156 (321)
T 1tki_A 83 ISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP-- 156 (321)
T ss_dssp CCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT--
T ss_pred CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC--
Confidence 99999999987643 2489999999999999999999999 9999999999999987 78999999999975421
Q ss_pred CCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHH
Q 041135 537 SNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEAL 616 (727)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l 616 (727)
........|+..|+|||++.+..++.++|||||||+||||++|+.||..... . +....+...... +.
T Consensus 157 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~---~~~~~i~~~~~~---~~-- 223 (321)
T 1tki_A 157 --GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN---Q---QIIENIMNAEYT---FD-- 223 (321)
T ss_dssp --TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH---H---HHHHHHHHTCCC---CC--
T ss_pred --CCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH---H---HHHHHHHcCCCC---CC--
Confidence 1223446789999999999998899999999999999999999999975431 1 111111110000 00
Q ss_pred HHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhc
Q 041135 617 VDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661 (727)
Q Consensus 617 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 661 (727)
..........+.+|+++||..||++||++.|++++-+-.
T Consensus 224 ------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~ 262 (321)
T 1tki_A 224 ------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLK 262 (321)
T ss_dssp ------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred ------hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhc
Confidence 000011223478999999999999999999999986643
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=376.89 Aligned_cols=257 Identities=25% Similarity=0.392 Sum_probs=202.7
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcE----EEEEEeeeCC-chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGRE----VAVKQLKIGG-SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLL 454 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~----vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 454 (727)
++|+++++||+|+||.||+|++. +|+. ||+|++.... ....+.+.+|+.++++++|+||++++++|. +...++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 56899999999999999999975 3443 7888775433 233457889999999999999999999986 456899
Q ss_pred EEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhc
Q 041135 455 VYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALE 534 (727)
Q Consensus 455 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 534 (727)
||||+.+|+|.+++.... ..+++..++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++....
T Consensus 92 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp EEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred EEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 999999999999987652 3588999999999999999999999 999999999999999999999999999986532
Q ss_pred cCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhH
Q 041135 535 LDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDF 613 (727)
Q Consensus 535 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~ 613 (727)
. ..........|+..|+|||++.++.++.++|||||||+||||++ |+.||....... +
T Consensus 168 ~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~----------------- 226 (325)
T 3kex_A 168 D-DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE---V----------------- 226 (325)
T ss_dssp C-TTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH---H-----------------
T ss_pred c-cccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH---H-----------------
Confidence 2 22223345678889999999999999999999999999999999 999998654211 1
Q ss_pred HHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 614 EALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 614 ~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
...+...............+.+|+.+||+.||++||++.||+++|+.+..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 227 PDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp HHHHHTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred HHHHHcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 11111111111111222347789999999999999999999999998754
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=375.12 Aligned_cols=251 Identities=25% Similarity=0.363 Sum_probs=197.1
Q ss_pred hcCccccceeccCCceEEEEEEE----cCCcEEEEEEeeeCC----chhHHHHHHHHHHHHHcCCCCceeEeeEeeccce
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVL----ADGREVAVKQLKIGG----SQGEREFRAEVEIISRVHHRHLVSLVGYCISERE 451 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~----~~g~~vaVK~l~~~~----~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~ 451 (727)
.++|+++++||+|+||.||+|+. .+|+.||||+++... ......+.+|+++|++++|+||++++++|.+++.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 35699999999999999999997 468999999997542 2334568899999999999999999999999999
Q ss_pred eeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchh
Q 041135 452 RLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKI 531 (727)
Q Consensus 452 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 531 (727)
.||||||+.+++|.+++...+. +.+..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++.
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREGI--FMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 9999999999999999976554 88999999999999999999999 999999999999999999999999999975
Q ss_pred hhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchh
Q 041135 532 ALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHE 611 (727)
Q Consensus 532 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~ 611 (727)
... ........+|+..|+|||++.+..++.++|||||||+||||++|+.||..... .+..
T Consensus 171 ~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~----------- 230 (327)
T 3a62_A 171 SIH---DGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR------KKTI----------- 230 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHH-----------
T ss_pred ccc---CCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH------HHHH-----------
Confidence 321 11223456799999999999999999999999999999999999999975431 1111
Q ss_pred hHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCC-----CHHHHHHHHh
Q 041135 612 DFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRP-----RMSQVVRALD 659 (727)
Q Consensus 612 ~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L~ 659 (727)
..++...+ .+.......+.+|+++||+.||++|+ ++.||+++-.
T Consensus 231 --~~i~~~~~--~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~ 279 (327)
T 3a62_A 231 --DKILKCKL--NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPF 279 (327)
T ss_dssp --HHHHHTCC--CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGG
T ss_pred --HHHHhCCC--CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCc
Confidence 11111111 12222234578999999999999999 7888887644
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=364.63 Aligned_cols=252 Identities=34% Similarity=0.578 Sum_probs=203.0
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhH-------HHHHHHHHHHHHcCCCCceeEeeEeecccee
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGE-------REFRAEVEIISRVHHRHLVSLVGYCISERER 452 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~-------~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 452 (727)
++|++.++||+|+||.||+|++. +++.||||++........ +.+.+|+++|++++|+||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 56899999999999999999974 689999999865433221 57899999999999999999999997665
Q ss_pred eEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCc--EEeeCCCCCceEECCCCc-----EEEEe
Q 041135 453 LLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPR--IIHRDIKSSNILLDSSFE-----ARVAD 525 (727)
Q Consensus 453 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~--ivHrDLkp~NILl~~~~~-----vkL~D 525 (727)
+|||||+.+|+|.+++.... ..+++..++.++.||+.||+|||++ + |+|||||++||||+.++. +||+|
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 69999999999988886543 3589999999999999999999998 8 999999999999987776 99999
Q ss_pred eccchhhhccCCCccccccccCCccccccCccc--CCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHH
Q 041135 526 FGLAKIALELDSNTHVSTRVMGTFGYMAPEYAT--SGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPL 603 (727)
Q Consensus 526 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~ 603 (727)
||+++... .......|+..|+|||++. ...++.++|||||||+||||++|+.||....... ..+
T Consensus 173 fg~~~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~~~---- 238 (287)
T 4f0f_A 173 FGLSQQSV------HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK----IKF---- 238 (287)
T ss_dssp CTTCBCCS------SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH----HHH----
T ss_pred CCcccccc------ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH----HHH----
Confidence 99997421 1234467899999999994 4567899999999999999999999997644221 000
Q ss_pred HHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhc
Q 041135 604 LAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661 (727)
Q Consensus 604 l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 661 (727)
...+....+...........+.+|+++||+.||++||++.||++.|+++
T Consensus 239 ---------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 239 ---------INMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp ---------HHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ---------HHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 0111111222223333345688999999999999999999999999864
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=374.56 Aligned_cols=260 Identities=27% Similarity=0.419 Sum_probs=209.5
Q ss_pred hcCccccceeccCCceEEEEEEEc--------CCcEEEEEEeeeCCc-hhHHHHHHHHHHHHHc-CCCCceeEeeEeecc
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA--------DGREVAVKQLKIGGS-QGEREFRAEVEIISRV-HHRHLVSLVGYCISE 449 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~--------~g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~ 449 (727)
.++|++++.||+|+||.||+|++. +++.||||+++.... ...+.+.+|+++|+++ +|+||++++++|.++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 467999999999999999999863 467899999975433 3346799999999999 899999999999999
Q ss_pred ceeeEEEeeccCCccchhcccCCC--------------CcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEE
Q 041135 450 RERLLVYEYVPNDTLHYHLHAEGR--------------PVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILL 515 (727)
Q Consensus 450 ~~~~lV~Ey~~~gsL~~~L~~~~~--------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl 515 (727)
+..+|||||+.+|+|.+++..... ..+++.++++|+.||++||+|||++ +|+|||||++||||
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEE
Confidence 999999999999999999976542 2488999999999999999999999 99999999999999
Q ss_pred CCCCcEEEEeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCch
Q 041135 516 DSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDE 594 (727)
Q Consensus 516 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~ 594 (727)
+.++.+||+|||+++...... .........++..|+|||++.+..++.++|||||||+||||++ |+.||..... .
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~ 266 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNID-YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---E 266 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTS-SEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH---H
T ss_pred cCCCCEEEccccccccccccc-cccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH---H
Confidence 999999999999997543211 1122234567889999999998899999999999999999999 9999975321 1
Q ss_pred hhHHhhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 595 SLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 595 ~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
.+. ..+...............+.+|+++||+.||++||++.||++.|+.+..
T Consensus 267 ~~~-----------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 267 ELF-----------------KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp HHH-----------------HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHH-----------------HHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 110 1111111112222334458899999999999999999999999998853
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=380.52 Aligned_cols=253 Identities=23% Similarity=0.313 Sum_probs=205.8
Q ss_pred HhcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc--hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEE
Q 041135 379 ATNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS--QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLV 455 (727)
Q Consensus 379 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 455 (727)
..++|+++++||+|+||.||+|+++ +|+.||||+++.... ...+.+.+|+++|++++|+||++++++|.+++..|||
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3567999999999999999999975 589999999975432 3346789999999999999999999999999999999
Q ss_pred EeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCC---CcEEEEeeccchhh
Q 041135 456 YEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSS---FEARVADFGLAKIA 532 (727)
Q Consensus 456 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~---~~vkL~DFGla~~~ 532 (727)
|||+.+|+|.+++..+. .+++.+++.++.||++||+|||++ +|+|||||++||||+.+ +.+||+|||+++..
T Consensus 107 ~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 107 FDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp ECCCCSCBHHHHHTTCS--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred EecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 99999999999887654 489999999999999999999999 99999999999999764 45999999999754
Q ss_pred hccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhh
Q 041135 533 LELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHED 612 (727)
Q Consensus 533 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~ 612 (727)
.. .......+|+..|+|||++.+..++.++||||||||||||++|+.||..... .+....
T Consensus 182 ~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~------~~~~~~---------- 241 (362)
T 2bdw_A 182 ND----SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ------HRLYAQ---------- 241 (362)
T ss_dssp TT----CCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHH----------
T ss_pred cC----CcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHH----------
Confidence 22 1223346799999999999999999999999999999999999999975321 111111
Q ss_pred HHHHHHHHhh--cccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 613 FEALVDSRLE--KNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 613 ~~~l~d~~l~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
+....+. ..........+.+|+.+||+.||++|+++.|++++-+
T Consensus 242 ---i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 287 (362)
T 2bdw_A 242 ---IKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPW 287 (362)
T ss_dssp ---HHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHH
T ss_pred ---HHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence 1111110 0011122345788999999999999999999998754
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=389.06 Aligned_cols=260 Identities=22% Similarity=0.261 Sum_probs=208.5
Q ss_pred HHHHHHhcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHHHHHHcCCCCceeEeeEeecc
Q 041135 374 DELIQATNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVEIISRVHHRHLVSLVGYCISE 449 (727)
Q Consensus 374 ~el~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~ 449 (727)
.++....++|+++++||+|+||.||+|+++ +|+.||||+++... ....+.+.+|+++|+.++|+||++++++|.++
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 344445678999999999999999999986 48899999986421 12234588999999999999999999999999
Q ss_pred ceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccc
Q 041135 450 RERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLA 529 (727)
Q Consensus 450 ~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla 529 (727)
..+|||||||.||+|.++++.. .+.+..++.++.||+.||+|||++ +|||||||++||||+.++.+||+|||++
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a 215 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTC 215 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEecccee
Confidence 9999999999999999998754 378999999999999999999999 9999999999999999999999999999
Q ss_pred hhhhccCCCccccccccCCccccccCcccCCC----CCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHH
Q 041135 530 KIALELDSNTHVSTRVMGTFGYMAPEYATSGK----LTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLA 605 (727)
Q Consensus 530 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~----~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~ 605 (727)
+.... .........+||..|+|||++.+.. ++.++||||||||||||++|+.||..... .+.
T Consensus 216 ~~~~~--~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~------ 281 (410)
T 3v8s_A 216 MKMNK--EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGT------ 281 (410)
T ss_dssp EECCT--TSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH------HHH------
T ss_pred Eeecc--CCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh------hhH------
Confidence 75421 1122234578999999999998765 78999999999999999999999975431 111
Q ss_pred HhhchhhHHHHHHHHhhcccc--hhHHHHHHHHHHHHhccCCCC--CCCHHHHHHHHhh
Q 041135 606 EALEHEDFEALVDSRLEKNYV--DSEMFWMIEAAAACVRHSATK--RPRMSQVVRALDT 660 (727)
Q Consensus 606 ~~~~~~~~~~l~d~~l~~~~~--~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~L~~ 660 (727)
+..++.......+. ......+.+||++||..++++ |+++.||+++-..
T Consensus 282 -------~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f 333 (410)
T 3v8s_A 282 -------YSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFF 333 (410)
T ss_dssp -------HHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGG
T ss_pred -------HHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccc
Confidence 11122211111111 122345788999999999988 9999999998554
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=375.82 Aligned_cols=254 Identities=21% Similarity=0.320 Sum_probs=203.2
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC-----chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceee
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG-----SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERL 453 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~-----~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 453 (727)
.++|++.++||+|+||.||+|+++ +|+.||||+++... ....+.+.+|+++|++++|+||++++++|.+++..|
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 356999999999999999999975 58999999986421 123567999999999999999999999999999999
Q ss_pred EEEeeccCCccchhcccC--CCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCc---EEEEeecc
Q 041135 454 LVYEYVPNDTLHYHLHAE--GRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFE---ARVADFGL 528 (727)
Q Consensus 454 lV~Ey~~~gsL~~~L~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~---vkL~DFGl 528 (727)
||||||.+++|.+++... ....+++..++.|+.||++||+|||++ +|+|||||++||||+.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999998877543 233589999999999999999999999 9999999999999976554 99999999
Q ss_pred chhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhh
Q 041135 529 AKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEAL 608 (727)
Q Consensus 529 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~ 608 (727)
++.... ........+||..|+|||++.+..++.++||||||||||||++|+.||.... .. ....
T Consensus 180 a~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~---~~~~------ 243 (351)
T 3c0i_A 180 AIQLGE---SGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----ER---LFEG------ 243 (351)
T ss_dssp CEECCT---TSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----HH---HHHH------
T ss_pred eeEecC---CCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----HH---HHHH------
Confidence 975422 2222345679999999999999999999999999999999999999997531 11 1111
Q ss_pred chhhHHHHHHHHhhcc--cchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 609 EHEDFEALVDSRLEKN--YVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 609 ~~~~~~~l~d~~l~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
++...+... ........+.+|+++||+.||++||++.||+++-+
T Consensus 244 -------i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~ 289 (351)
T 3c0i_A 244 -------IIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPW 289 (351)
T ss_dssp -------HHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred -------HHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChh
Confidence 111100000 00111235788999999999999999999998644
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=366.62 Aligned_cols=256 Identities=24% Similarity=0.368 Sum_probs=196.5
Q ss_pred hcCccccceeccCCceEEEEEEEcC----CcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeE
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLAD----GREVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLL 454 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~~----g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 454 (727)
.++|++.++||+|+||.||+|++.. +..||||+++.... ...+.+.+|+.+|++++|+||+++++++. ++..||
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 4679999999999999999998743 45799999875433 33467999999999999999999999985 456899
Q ss_pred EEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhc
Q 041135 455 VYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALE 534 (727)
Q Consensus 455 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 534 (727)
||||+.+++|.+++.... ..+++..++.++.||++||+|||++ +|+|||||++||||+.++.+||+|||+++....
T Consensus 93 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168 (281)
T ss_dssp EEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccCc
Confidence 999999999999997653 3589999999999999999999999 999999999999999999999999999986532
Q ss_pred cCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhH
Q 041135 535 LDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDF 613 (727)
Q Consensus 535 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~ 613 (727)
. .........++..|+|||++.+..++.++|||||||+||||++ |+.||...... .+..
T Consensus 169 ~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~---~~~~--------------- 228 (281)
T 1mp8_A 169 S--TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIG--------------- 228 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHH---------------
T ss_pred c--cccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH---HHHH---------------
Confidence 1 1112233456789999999998899999999999999999996 99999764321 1111
Q ss_pred HHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhcc
Q 041135 614 EALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLD 662 (727)
Q Consensus 614 ~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 662 (727)
.+ ...............+.+|+++||+.||++||++.||++.|+.+.
T Consensus 229 -~i-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 229 -RI-ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp -HH-HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HH-HcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00 001111122233445789999999999999999999999999874
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=377.62 Aligned_cols=262 Identities=26% Similarity=0.375 Sum_probs=196.2
Q ss_pred HhcCccccceeccCCceEEEEEEEcCC----cEEEEEEeeeC--CchhHHHHHHHHHHHHHcCCCCceeEeeEeecccee
Q 041135 379 ATNGFSAHNVLGEGGFGCVYKGVLADG----REVAVKQLKIG--GSQGEREFRAEVEIISRVHHRHLVSLVGYCISERER 452 (727)
Q Consensus 379 ~~~~~~~~~~LG~G~fg~Vy~~~~~~g----~~vaVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 452 (727)
..++|+++++||+|+||.||+|++..+ ..||||+++.. .....+.+.+|+++|++++|+||+++++++.+....
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 456799999999999999999986543 27999999754 344557899999999999999999999999877655
Q ss_pred ------eEEEeeccCCccchhcccCC----CCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEE
Q 041135 453 ------LLVYEYVPNDTLHYHLHAEG----RPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEAR 522 (727)
Q Consensus 453 ------~lV~Ey~~~gsL~~~L~~~~----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vk 522 (727)
++||||+.+|+|.+++.... ...+++.++++|+.||++||+|||++ +|+|||||++||||++++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEE
Confidence 99999999999999886432 22489999999999999999999999 999999999999999999999
Q ss_pred EEeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhH
Q 041135 523 VADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWAR 601 (727)
Q Consensus 523 L~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~ 601 (727)
|+|||+++...... .........++..|+|||++.+..++.++|||||||+||||++ |+.||...... .+.
T Consensus 178 l~Dfg~a~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~---- 249 (323)
T 3qup_A 178 VADFGLSRKIYSGD-YYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA---EIY---- 249 (323)
T ss_dssp ECCCCC------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHH----
T ss_pred Eeeccccccccccc-cccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH---HHH----
Confidence 99999998643221 1122233456788999999999999999999999999999999 99999764321 111
Q ss_pred HHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccCC
Q 041135 602 PLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDGA 664 (727)
Q Consensus 602 ~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 664 (727)
..+ ...............+.+|+++||+.||++||++.||++.|+++...
T Consensus 250 ------------~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 250 ------------NYL-IGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp ------------HHH-HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ------------HHH-hcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 001 11111112223334588999999999999999999999999988643
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=382.78 Aligned_cols=272 Identities=16% Similarity=0.251 Sum_probs=205.9
Q ss_pred cCccccceeccC--CceEEEEEEEc-CCcEEEEEEeeeCC--chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEE
Q 041135 381 NGFSAHNVLGEG--GFGCVYKGVLA-DGREVAVKQLKIGG--SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLV 455 (727)
Q Consensus 381 ~~~~~~~~LG~G--~fg~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 455 (727)
++|+++++||+| +||.||+|++. +|+.||||+++... ....+.+++|+++|++++|+|||+++++|.+++..|||
T Consensus 25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 104 (389)
T 3gni_B 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV 104 (389)
T ss_dssp GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEE
Confidence 469999999999 99999999986 68999999997543 23346788999999999999999999999999999999
Q ss_pred EeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhcc
Q 041135 456 YEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALEL 535 (727)
Q Consensus 456 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 535 (727)
||||.+|+|.+++.......+++..++.|+.||++||+|||++ +|+|||||++||||+.++.+||+|||++......
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~ 181 (389)
T 3gni_B 105 TSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISH 181 (389)
T ss_dssp EECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEET
T ss_pred EEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeeccc
Confidence 9999999999999876555699999999999999999999999 9999999999999999999999999998643221
Q ss_pred CCC----ccccccccCCccccccCcccC--CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhc
Q 041135 536 DSN----THVSTRVMGTFGYMAPEYATS--GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALE 609 (727)
Q Consensus 536 ~~~----~~~~~~~~gt~~y~aPE~l~~--~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~ 609 (727)
... .......+|+..|+|||++.+ ..++.++||||||||||||++|+.||....... .+.+.....+...+.
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~ 259 (389)
T 3gni_B 182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKLNGTVPCLLD 259 (389)
T ss_dssp TEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTT--HHHHC----------
T ss_pred cccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHhcCCCCcccc
Confidence 111 111223478999999999987 579999999999999999999999997654322 111111111000000
Q ss_pred hh------------------hHHHHHHH---------HhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 610 HE------------------DFEALVDS---------RLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 610 ~~------------------~~~~l~d~---------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
.. .+...+.. .....+.......+.+|+++||+.||++||++.||+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 00 00000000 00000111122347889999999999999999999977
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=372.54 Aligned_cols=247 Identities=25% Similarity=0.352 Sum_probs=205.1
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
++|+++++||+|+||.||+|+.+ +|+.||||+++... ....+.+.+|+.+|+.++|+||++++++|.+....||||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 56999999999999999999975 68999999997432 223456889999999999999999999999999999999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccC
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 536 (727)
||+.||+|.+++..... +++..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++....
T Consensus 86 e~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~-- 158 (318)
T 1fot_A 86 DYIEGGELFSLLRKSQR--FPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-- 158 (318)
T ss_dssp CCCCSCBHHHHHHHTSS--CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS--
T ss_pred eCCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCC--
Confidence 99999999999987654 89999999999999999999999 999999999999999999999999999975321
Q ss_pred CCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHH
Q 041135 537 SNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEAL 616 (727)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l 616 (727)
.....+||..|+|||++.+..++.++|||||||+||||++|+.||..... .+. +..+
T Consensus 159 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~-------------~~~i 215 (318)
T 1fot_A 159 ----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------MKT-------------YEKI 215 (318)
T ss_dssp ----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHH-------------HHHH
T ss_pred ----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH------HHH-------------HHHH
Confidence 22346799999999999999999999999999999999999999975321 111 1111
Q ss_pred HHHHhhcccchhHHHHHHHHHHHHhccCCCCCC-----CHHHHHHHHh
Q 041135 617 VDSRLEKNYVDSEMFWMIEAAAACVRHSATKRP-----RMSQVVRALD 659 (727)
Q Consensus 617 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L~ 659 (727)
+...+ .+.......+.+|+++||..||++|+ ++.||+++-.
T Consensus 216 ~~~~~--~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~ 261 (318)
T 1fot_A 216 LNAEL--RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW 261 (318)
T ss_dssp HHCCC--CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred HhCCC--CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCcc
Confidence 11111 12222234578899999999999999 8899887643
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-43 Score=371.09 Aligned_cols=269 Identities=26% Similarity=0.376 Sum_probs=213.7
Q ss_pred cHHHHHHHhcCccccceeccCCceEEEEEEE------cCCcEEEEEEeeeCCch-hHHHHHHHHHHHHHc-CCCCceeEe
Q 041135 372 TYDELIQATNGFSAHNVLGEGGFGCVYKGVL------ADGREVAVKQLKIGGSQ-GEREFRAEVEIISRV-HHRHLVSLV 443 (727)
Q Consensus 372 ~~~el~~~~~~~~~~~~LG~G~fg~Vy~~~~------~~g~~vaVK~l~~~~~~-~~~~~~~Ei~~l~~l-~HpnIv~l~ 443 (727)
...++....++|++.+.||+|+||.||+|++ .+++.||||+++..... ..+.+.+|+++|+++ +|+||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 3445555568899999999999999999985 24688999999754433 345799999999999 699999999
Q ss_pred eEeeccc-eeeEEEeeccCCccchhcccCCCC--------------cccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCC
Q 041135 444 GYCISER-ERLLVYEYVPNDTLHYHLHAEGRP--------------VMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDI 508 (727)
Q Consensus 444 ~~~~~~~-~~~lV~Ey~~~gsL~~~L~~~~~~--------------~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDL 508 (727)
++|.+.+ ..++||||+.+++|.+++...... .+++..++.++.||++||+|||++ +|+||||
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~di 174 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL 174 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccC
Confidence 9988754 589999999999999999765432 288999999999999999999999 9999999
Q ss_pred CCCceEECCCCcEEEEeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCC
Q 041135 509 KSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDA 587 (727)
Q Consensus 509 kp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~ 587 (727)
|++||||+.++.+||+|||+++..... ..........|+..|+|||++.+..++.++|||||||+||||++ |+.||..
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARDIYKD-PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTC-TTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred ccceEEECCCCCEEECCCccccccccC-ccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999854322 12222334567889999999999999999999999999999998 9999976
Q ss_pred CCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 588 SQPLGDESLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 588 ~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
.... ..+. ..+...............+.+++.+||+.||++||++.||+++|+.+.+
T Consensus 254 ~~~~--~~~~-----------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 254 VKID--EEFC-----------------RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp CCCS--HHHH-----------------HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cchh--HHHH-----------------HHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 4321 1110 1111111111122223457889999999999999999999999998753
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=371.49 Aligned_cols=253 Identities=20% Similarity=0.349 Sum_probs=196.1
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEeeccc-------
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYCISER------- 450 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~------- 450 (727)
.++|+++++||+|+||.||+|++. +|+.||||+++.... ...+.+.+|+++|++++|+||++++++|.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 356999999999999999999986 799999999975443 34567999999999999999999999986543
Q ss_pred --------------------------------------------------eeeEEEeeccCCccchhcccCCC-CcccHH
Q 041135 451 --------------------------------------------------ERLLVYEYVPNDTLHYHLHAEGR-PVMDWA 479 (727)
Q Consensus 451 --------------------------------------------------~~~lV~Ey~~~gsL~~~L~~~~~-~~l~~~ 479 (727)
..+||||||.+++|.+++..... ....+.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 37999999999999999976543 234566
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCC---------ccccccccCCcc
Q 041135 480 TRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSN---------THVSTRVMGTFG 550 (727)
Q Consensus 480 ~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~---------~~~~~~~~gt~~ 550 (727)
.+++|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++........ .......+|+..
T Consensus 165 ~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 7899999999999999999 9999999999999999999999999999864322111 112234579999
Q ss_pred ccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHhhcccchhHH
Q 041135 551 YMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEM 630 (727)
Q Consensus 551 y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~ 630 (727)
|+|||++.+..++.++|||||||+||||++|..++.. .... +.. .....+... .....
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--------~~~~----~~~-~~~~~~~~~---------~~~~~ 299 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--------RVRI----ITD-VRNLKFPLL---------FTQKY 299 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--------HHHH----HHH-HHTTCCCHH---------HHHHC
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--------HHHH----HHH-hhccCCCcc---------cccCC
Confidence 9999999999999999999999999999998665321 0000 000 000000000 11122
Q ss_pred HHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 631 FWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 631 ~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
..+.+|+++||+.||++||++.||+++
T Consensus 300 ~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 300 PQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred hhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 346789999999999999999999976
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=372.57 Aligned_cols=260 Identities=28% Similarity=0.400 Sum_probs=195.8
Q ss_pred hcCccccceeccCCceEEEEEEE-cCCcEEEEEEeeeCCch---hHHHHHHHHHHHHHcCCCCceeEeeEeeccce----
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVL-ADGREVAVKQLKIGGSQ---GEREFRAEVEIISRVHHRHLVSLVGYCISERE---- 451 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vaVK~l~~~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~---- 451 (727)
.++|+++++||+|+||.||+|++ .+|+.||||+++..... ....+.+|++++++++|+||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46799999999999999999996 56899999999754322 23578899999999999999999999876543
Q ss_pred eeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchh
Q 041135 452 RLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKI 531 (727)
Q Consensus 452 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 531 (727)
.||||||+.+++|.++++..+. +++.+++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++.
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred cEEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 4999999999999999987654 89999999999999999999999 999999999999999999999999999986
Q ss_pred hhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchh
Q 041135 532 ALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHE 611 (727)
Q Consensus 532 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~ 611 (727)
..............+|+..|+|||++.+..++.++|||||||+||||++|+.||..... .+.....+.. ..
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~~~~~~~~---~~ 236 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVRE---DP 236 (311)
T ss_dssp ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHC---CC
T ss_pred ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhcC---CC
Confidence 54332222333446799999999999999999999999999999999999999975431 1111111100 00
Q ss_pred hHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH-Hhhc
Q 041135 612 DFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA-LDTL 661 (727)
Q Consensus 612 ~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~-L~~~ 661 (727)
.... .. .......+.+|+.+||+.||++|+++.+++++ |..+
T Consensus 237 ~~~~----~~----~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 237 IPPS----AR----HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp CCHH----HH----STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CCcc----cc----cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 0000 00 01122347889999999999999976665544 5444
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=377.98 Aligned_cols=256 Identities=20% Similarity=0.255 Sum_probs=196.6
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEee
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 458 (727)
.++|+++++||+|+||.||+++.. +|+.||||++.... ...+.+++|+.++++++|+||++++++|.+....+|||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 356999999999999999999976 68999999997543 3346789999999999999999999999999999999999
Q ss_pred ccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCc--EEEEeeccchhhhccC
Q 041135 459 VPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFE--ARVADFGLAKIALELD 536 (727)
Q Consensus 459 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~--vkL~DFGla~~~~~~~ 536 (727)
+.+|+|.+++...+. +++..++.|+.||++||+|||++ +|+|||||++||||+.++. +||+|||+++....
T Consensus 98 ~~~~~L~~~l~~~~~--~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~-- 170 (361)
T 3uc3_A 98 ASGGELYERICNAGR--FSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-- 170 (361)
T ss_dssp CCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred CCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccc--
Confidence 999999999876554 89999999999999999999999 9999999999999987765 99999999974321
Q ss_pred CCccccccccCCccccccCcccCCCCCch-hHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHH
Q 041135 537 SNTHVSTRVMGTFGYMAPEYATSGKLTEK-SDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEA 615 (727)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k-sDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~ 615 (727)
.......+|+..|+|||++.+..+..+ +|||||||+||||++|+.||........ +.... ..
T Consensus 171 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~~~-------------~~ 233 (361)
T 3uc3_A 171 --HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--YRKTI-------------QR 233 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC--HHHHH-------------HH
T ss_pred --cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH--HHHHH-------------HH
Confidence 122234579999999999988887665 8999999999999999999976443211 11111 11
Q ss_pred HHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhh
Q 041135 616 LVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDT 660 (727)
Q Consensus 616 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 660 (727)
++...............+.+|+++||+.||++||++.||+++-+.
T Consensus 234 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f 278 (361)
T 3uc3_A 234 ILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWF 278 (361)
T ss_dssp HHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHH
T ss_pred HhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcch
Confidence 111111111111123457899999999999999999999988554
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=368.72 Aligned_cols=257 Identities=25% Similarity=0.374 Sum_probs=204.5
Q ss_pred hcCccccc-eeccCCceEEEEEEEc---CCcEEEEEEeeeCC--chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceee
Q 041135 380 TNGFSAHN-VLGEGGFGCVYKGVLA---DGREVAVKQLKIGG--SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERL 453 (727)
Q Consensus 380 ~~~~~~~~-~LG~G~fg~Vy~~~~~---~g~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 453 (727)
.++|++.+ +||+|+||.||+|++. +++.||||+++... ....+.+.+|+++|++++|+||+++++++ +.+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 45688888 9999999999999653 46889999997543 23356799999999999999999999999 566789
Q ss_pred EEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhh
Q 041135 454 LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIAL 533 (727)
Q Consensus 454 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~ 533 (727)
+||||+.+++|.+++..+.. +++..++.|+.||++||+|||++ +|+|||||++||||+.++.+||+|||+++...
T Consensus 94 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALR 168 (291)
T ss_dssp EEEECCTTEEHHHHHHHCTT--CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEeCCCCCHHHHHHhCcC--CCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence 99999999999999987644 89999999999999999999999 99999999999999999999999999997543
Q ss_pred ccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhh
Q 041135 534 ELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHED 612 (727)
Q Consensus 534 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~ 612 (727)
.............++..|+|||++.+..++.++|||||||+||||++ |+.||..... ..+
T Consensus 169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~---------------- 229 (291)
T 1xbb_A 169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEV---------------- 229 (291)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHH----------------
T ss_pred cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH---HHH----------------
Confidence 22221222233456789999999998889999999999999999999 9999975431 111
Q ss_pred HHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhcc
Q 041135 613 FEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLD 662 (727)
Q Consensus 613 ~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 662 (727)
...+...............+.+|+++||+.||++||++.||++.|+++.
T Consensus 230 -~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 278 (291)
T 1xbb_A 230 -TAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278 (291)
T ss_dssp -HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1111111111222233456889999999999999999999999999874
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=381.62 Aligned_cols=254 Identities=22% Similarity=0.255 Sum_probs=194.7
Q ss_pred cCcccc-ceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHH-cCCCCceeEeeEeec----cceee
Q 041135 381 NGFSAH-NVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISR-VHHRHLVSLVGYCIS----ERERL 453 (727)
Q Consensus 381 ~~~~~~-~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~-l~HpnIv~l~~~~~~----~~~~~ 453 (727)
++|.+. ++||+|+||.||+|++. +|+.||||+++. ...+.+|++++.+ ++|+||++++++|.. ...+|
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 346665 78999999999999975 588999999863 3467889998855 589999999999875 56789
Q ss_pred EEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECC---CCcEEEEeeccch
Q 041135 454 LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDS---SFEARVADFGLAK 530 (727)
Q Consensus 454 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~---~~~vkL~DFGla~ 530 (727)
||||||.||+|.++|.......+++.+++.|+.||+.||+|||++ +|||||||++||||+. ++.+||+|||+++
T Consensus 136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 999999999999999877656699999999999999999999999 9999999999999987 7899999999998
Q ss_pred hhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhch
Q 041135 531 IALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEH 610 (727)
Q Consensus 531 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~ 610 (727)
.... .......+||..|+|||++.+..++.++||||||||||||++|+.||........... .
T Consensus 213 ~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~--~----------- 275 (400)
T 1nxk_A 213 ETTS----HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG--M----------- 275 (400)
T ss_dssp ECC---------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCS--H-----------
T ss_pred ccCC----CCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHH--H-----------
Confidence 5321 1223456789999999999999999999999999999999999999976543221100 0
Q ss_pred hhHHHHHHHHhhc--ccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhc
Q 041135 611 EDFEALVDSRLEK--NYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661 (727)
Q Consensus 611 ~~~~~l~d~~l~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 661 (727)
...+....+.. .........+.+||++||+.||++||++.||+++-+..
T Consensus 276 --~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~ 326 (400)
T 1nxk_A 276 --KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 326 (400)
T ss_dssp --HHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred --HHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccc
Confidence 00011111100 00112234578899999999999999999999986654
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=373.18 Aligned_cols=257 Identities=23% Similarity=0.342 Sum_probs=203.6
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHHHHHHc-CCCCceeEeeEeeccceeeEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVEIISRV-HHRHLVSLVGYCISERERLLV 455 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lV 455 (727)
++|+++++||+|+||.||+|+++ +|+.||||+++... ....+.+.+|+++|+++ +|+||++++++|.+....|||
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 56999999999999999999976 58899999997542 23345688999999988 899999999999999999999
Q ss_pred EeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhcc
Q 041135 456 YEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALEL 535 (727)
Q Consensus 456 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 535 (727)
|||+.+|+|.+++...+. +++..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++....
T Consensus 89 ~e~~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~- 162 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQRK--LPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR- 162 (345)
T ss_dssp ECCCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC-
T ss_pred EeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccC-
Confidence 999999999999976554 89999999999999999999999 999999999999999999999999999975321
Q ss_pred CCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHH
Q 041135 536 DSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEA 615 (727)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~ 615 (727)
........+||..|+|||++.+..++.++||||||||||||++|+.||............ ... ..+..
T Consensus 163 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~--~~~--------~~~~~ 230 (345)
T 3a8x_A 163 --PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN--TED--------YLFQV 230 (345)
T ss_dssp --TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC---------CHH--------HHHHH
T ss_pred --CCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccc--cHH--------HHHHH
Confidence 122334568999999999999999999999999999999999999999753321110000 000 00111
Q ss_pred HHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCH------HHHHHH
Q 041135 616 LVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRM------SQVVRA 657 (727)
Q Consensus 616 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~~ 657 (727)
+....+ .+.......+.+|+++||+.||++|+++ .||+++
T Consensus 231 i~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 231 ILEKQI--RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp HHHCCC--CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred HHcCCC--CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 111111 1222233457889999999999999995 666665
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=363.29 Aligned_cols=265 Identities=18% Similarity=0.288 Sum_probs=200.2
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc--hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEe
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS--QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYE 457 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 457 (727)
++|+++++||+|+||.||+|++. +|+.||||+++.... ...+.+.+|+++|++++|+||++++++|.+++..+||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999975 589999999975433 234678899999999999999999999999999999999
Q ss_pred eccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCC
Q 041135 458 YVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDS 537 (727)
Q Consensus 458 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 537 (727)
|+.++.+..+...++ .+++..++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++... .
T Consensus 82 ~~~~~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~---~ 153 (292)
T 3o0g_A 82 FCDQDLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFG---I 153 (292)
T ss_dssp CCSEEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC---S
T ss_pred cCCCCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecC---C
Confidence 997655544444333 489999999999999999999999 99999999999999999999999999997542 1
Q ss_pred CccccccccCCccccccCcccCCC-CCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhc--hhhHH
Q 041135 538 NTHVSTRVMGTFGYMAPEYATSGK-LTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALE--HEDFE 614 (727)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~l~~~~-~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~--~~~~~ 614 (727)
.........|+..|+|||++.+.. ++.++|||||||+||||++|..||..... ..+....++..... ...+.
T Consensus 154 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~-----~~~~~~~i~~~~~~~~~~~~~ 228 (292)
T 3o0g_A 154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND-----VDDQLKRIFRLLGTPTEEQWP 228 (292)
T ss_dssp CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS-----HHHHHHHHHHHHCCCCTTTCT
T ss_pred ccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC-----HHHHHHHHHHHhCCCChhhhh
Confidence 222334567899999999998766 89999999999999999999888643321 11111111111000 00000
Q ss_pred HHHH---H---------HhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 041135 615 ALVD---S---------RLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRAL 658 (727)
Q Consensus 615 ~l~d---~---------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 658 (727)
.+.+ . .............+.+|+++||+.||++||+++||+++-
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 284 (292)
T 3o0g_A 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHP 284 (292)
T ss_dssp TGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred hhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCc
Confidence 0000 0 000001112234577999999999999999999998863
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=405.09 Aligned_cols=257 Identities=25% Similarity=0.380 Sum_probs=202.8
Q ss_pred cCccccc-eeccCCceEEEEEEEc---CCcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEE
Q 041135 381 NGFSAHN-VLGEGGFGCVYKGVLA---DGREVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLV 455 (727)
Q Consensus 381 ~~~~~~~-~LG~G~fg~Vy~~~~~---~g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 455 (727)
+++.+.+ +||+|+||.||+|+++ ++..||||+++.... ...++|.+|+++|++++|+|||+++++|.+ +..+||
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 3445555 7999999999999874 466799999976533 345789999999999999999999999976 568999
Q ss_pred EeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhcc
Q 041135 456 YEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALEL 535 (727)
Q Consensus 456 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 535 (727)
||||.+|+|.++|..+. ..+++..++.|+.||++||+|||++ +|||||||++||||++++.+||+|||+++.....
T Consensus 414 ~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~ 489 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489 (613)
T ss_dssp EECCTTCBHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred EEeCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence 99999999999997543 3589999999999999999999999 9999999999999999999999999999865322
Q ss_pred CCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHH
Q 041135 536 DSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFE 614 (727)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~ 614 (727)
...........++..|+|||++.++.++.++||||||||||||++ |+.||..... ..+.
T Consensus 490 ~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~---~~~~----------------- 549 (613)
T 2ozo_A 490 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVM----------------- 549 (613)
T ss_dssp ------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS---HHHH-----------------
T ss_pred CceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH---HHHH-----------------
Confidence 221222223446789999999999999999999999999999998 9999976432 1111
Q ss_pred HHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhcc
Q 041135 615 ALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLD 662 (727)
Q Consensus 615 ~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 662 (727)
..+....+..........+.+||++||+.||++||++.+|++.|+.+.
T Consensus 550 ~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 597 (613)
T 2ozo_A 550 AFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 597 (613)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 111111122223334456889999999999999999999999999874
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=370.15 Aligned_cols=246 Identities=23% Similarity=0.241 Sum_probs=193.1
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc--hhHHHHHHHHHHHHHc-CCCCceeEeeEeeccceeeEEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS--QGEREFRAEVEIISRV-HHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
++|+++++||+|+||.||+|++. +|+.||||++..... .....+.+|+..+.++ +|+||++++++|.+++..+|||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 56999999999999999999986 699999999864332 3334556666666665 8999999999999999999999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccC
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 536 (727)
||+ +++|.+++.... ..+++..++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++....
T Consensus 137 e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~-- 209 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT-- 209 (311)
T ss_dssp ECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred ecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeeccc--
Confidence 999 678888776543 2589999999999999999999999 999999999999999999999999999875421
Q ss_pred CCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHH
Q 041135 537 SNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEAL 616 (727)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l 616 (727)
........||..|+|||++.+ .++.++|||||||+||||++|..+|... ..... +...
T Consensus 210 --~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~-----~~~~~---------~~~~----- 267 (311)
T 3p1a_A 210 --AGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG-----EGWQQ---------LRQG----- 267 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH-----HHHHH---------HTTT-----
T ss_pred --CCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc-----cHHHH---------Hhcc-----
Confidence 222344569999999999886 7899999999999999999997766431 11000 0011
Q ss_pred HHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 041135 617 VDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRAL 658 (727)
Q Consensus 617 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 658 (727)
.+...+.......+.+|+++||+.||++||++.||+++-
T Consensus 268 ---~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp 306 (311)
T 3p1a_A 268 ---YLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALP 306 (311)
T ss_dssp ---CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred ---CCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCc
Confidence 111111112234588999999999999999999999753
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=362.22 Aligned_cols=249 Identities=24% Similarity=0.390 Sum_probs=205.2
Q ss_pred HhcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeec---------
Q 041135 379 ATNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCIS--------- 448 (727)
Q Consensus 379 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~--------- 448 (727)
..++|+++++||+|+||.||+|++. +|+.||||+++... +.+.+|+++|++++|+||++++++|..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 3456999999999999999999986 68999999997542 467899999999999999999998864
Q ss_pred -------cceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcE
Q 041135 449 -------ERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEA 521 (727)
Q Consensus 449 -------~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~v 521 (727)
....+|||||+.+++|.+++.......+++..++.|+.||+.||+|||++ +|+|||||++||||++++.+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCE
Confidence 44579999999999999999766545689999999999999999999999 99999999999999999999
Q ss_pred EEEeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhH
Q 041135 522 RVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWAR 601 (727)
Q Consensus 522 kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~ 601 (727)
||+|||+++..... .......|+..|+|||++.+..++.++|||||||+||||++|+.+|... ..
T Consensus 162 kl~Dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--------~~--- 226 (284)
T 2a19_B 162 KIGDFGLVTSLKND----GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--------SK--- 226 (284)
T ss_dssp EECCCTTCEESSCC----SCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--------HH---
T ss_pred EECcchhheecccc----ccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--------HH---
Confidence 99999999754221 1223456899999999999999999999999999999999998876310 00
Q ss_pred HHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 602 PLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 602 ~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
.+..+.+..+... ....+.+|+++||+.||++||++.||+++|+.+..
T Consensus 227 ----------~~~~~~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 227 ----------FFTDLRDGIISDI----FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp ----------HHHHHHTTCCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred ----------HHHHhhccccccc----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 0111111112111 22347789999999999999999999999998864
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=372.99 Aligned_cols=263 Identities=21% Similarity=0.273 Sum_probs=203.9
Q ss_pred HHHHHhcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeC-----CchhHHHHHHHHHHHHHcCCCCceeEeeEeec
Q 041135 375 ELIQATNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIG-----GSQGEREFRAEVEIISRVHHRHLVSLVGYCIS 448 (727)
Q Consensus 375 el~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~-----~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~ 448 (727)
++....++|+++++||+|+||.||+|+.. +++.||||+++.. .....+.+.+|+++|++++|+||++++++|.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 35667788999999999999999999974 5889999998643 23445679999999999999999999999999
Q ss_pred cceeeEEEeeccCCccchhcccC--------------------------------------CCCcccHHHHHHHHHHHHH
Q 041135 449 ERERLLVYEYVPNDTLHYHLHAE--------------------------------------GRPVMDWATRVKVAAGAAR 490 (727)
Q Consensus 449 ~~~~~lV~Ey~~~gsL~~~L~~~--------------------------------------~~~~l~~~~~~~i~~qia~ 490 (727)
.+..+|||||+.+|+|.+++... ....+++..++.|+.||++
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 99999999999999999988521 0123467788999999999
Q ss_pred HHHHHHhcCCCcEEeeCCCCCceEECCCC--cEEEEeeccchhhhccCCCc-cccccccCCccccccCcccC--CCCCch
Q 041135 491 GIAYLHEDCHPRIIHRDIKSSNILLDSSF--EARVADFGLAKIALELDSNT-HVSTRVMGTFGYMAPEYATS--GKLTEK 565 (727)
Q Consensus 491 gL~yLH~~~~~~ivHrDLkp~NILl~~~~--~vkL~DFGla~~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~--~~~~~k 565 (727)
||+|||++ +|+|||||++||||+.++ .+||+|||+++.+....... .......|+..|+|||++.+ ..++.+
T Consensus 180 ~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 99999999 999999999999998766 89999999998653322221 12345679999999999975 678899
Q ss_pred hHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHhh--cccchhHHHHHHHHHHHHhcc
Q 041135 566 SDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRLE--KNYVDSEMFWMIEAAAACVRH 643 (727)
Q Consensus 566 sDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l~--~~~~~~~~~~l~~li~~cl~~ 643 (727)
+|||||||+||||++|+.||..... .+... .+++..+. ..........+.+|+++||+.
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~------~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 317 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVND------ADTIS-------------QVLNKKLCFENPNYNVLSPLARDLLSNLLNR 317 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSH------HHHHH-------------HHHHCCCCTTSGGGGGSCHHHHHHHHHHSCS
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCCh------HHHHH-------------HHHhcccccCCcccccCCHHHHHHHHHHcCC
Confidence 9999999999999999999975431 11111 11111110 001111234578899999999
Q ss_pred CCCCCCCHHHHHHHHh
Q 041135 644 SATKRPRMSQVVRALD 659 (727)
Q Consensus 644 dP~~RPs~~evl~~L~ 659 (727)
||++||++.||+++-.
T Consensus 318 ~p~~Rps~~~~l~hp~ 333 (345)
T 3hko_A 318 NVDERFDAMRALQHPW 333 (345)
T ss_dssp CTTTSCCHHHHHHSHH
T ss_pred ChhHCCCHHHHhcChh
Confidence 9999999999998644
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=385.72 Aligned_cols=253 Identities=20% Similarity=0.281 Sum_probs=204.7
Q ss_pred HhcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc--hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEE
Q 041135 379 ATNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS--QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLV 455 (727)
Q Consensus 379 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 455 (727)
..++|+++++||+|+||.||+|+.. +|+.||+|+++.... ...+.+.+|+++|++++|+||++++++|.+++..|||
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 4567999999999999999999864 689999999975443 3345789999999999999999999999999999999
Q ss_pred EeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEEC---CCCcEEEEeeccchhh
Q 041135 456 YEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLD---SSFEARVADFGLAKIA 532 (727)
Q Consensus 456 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~---~~~~vkL~DFGla~~~ 532 (727)
||||.||+|.+++..+.. +++.++..++.||+.||+|||++ +|+|||||++||||+ +++.+||+|||+++..
T Consensus 89 ~E~~~gg~L~~~i~~~~~--~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 89 FDLVTGGELFEDIVAREY--YSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp ECCCBCCBHHHHHHHCSC--CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EEeCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 999999999999877654 89999999999999999999999 999999999999998 5678999999999754
Q ss_pred hccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhh
Q 041135 533 LELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHED 612 (727)
Q Consensus 533 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~ 612 (727)
.. ........+|+..|+|||++.+..++.++||||||||||||++|+.||..... . +..
T Consensus 164 ~~---~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~---~---~~~------------ 222 (444)
T 3soa_A 164 EG---EQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ---H---RLY------------ 222 (444)
T ss_dssp CT---TCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH---H---HHH------------
T ss_pred cC---CCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH---H---HHH------------
Confidence 21 22223456899999999999999999999999999999999999999975321 1 111
Q ss_pred HHHHHHHHhh--cccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 041135 613 FEALVDSRLE--KNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRAL 658 (727)
Q Consensus 613 ~~~l~d~~l~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 658 (727)
..+....+. ..........+.+|+++||+.||++||++.|++++-
T Consensus 223 -~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp 269 (444)
T 3soa_A 223 -QQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHP 269 (444)
T ss_dssp -HHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSC
T ss_pred -HHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCc
Confidence 111111110 001112234578999999999999999999999863
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=378.89 Aligned_cols=250 Identities=25% Similarity=0.338 Sum_probs=203.8
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
++|+++++||+|+||.||+|++. +|+.||||+++... ....+.+.+|+++|+.++|+|||+++++|.+....||||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 56999999999999999999975 48899999986432 233467889999999999999999999999999999999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccC
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 536 (727)
||+.||+|.+++..... +++..++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++...
T Consensus 95 e~~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~--- 166 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQNVH--FKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLP--- 166 (384)
T ss_dssp CCCTTEEHHHHHHTTCC--CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred ecCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeecc---
Confidence 99999999999987654 89999999999999999999999 99999999999999999999999999997542
Q ss_pred CCccccccccCCccccccCcccC---CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhH
Q 041135 537 SNTHVSTRVMGTFGYMAPEYATS---GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDF 613 (727)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~l~~---~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~ 613 (727)
........+||..|+|||++.+ ..++.++||||||||||||++|+.||..........+...
T Consensus 167 -~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~-------------- 231 (384)
T 4fr4_A 167 -RETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT-------------- 231 (384)
T ss_dssp -TTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHH--------------
T ss_pred -CCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHH--------------
Confidence 1223345689999999999974 4589999999999999999999999976443221111110
Q ss_pred HHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCC-HHHHHHH
Q 041135 614 EALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPR-MSQVVRA 657 (727)
Q Consensus 614 ~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~ 657 (727)
+.. ....+.......+.+|+++||+.||++|++ +.+|+++
T Consensus 232 --~~~--~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~h 272 (384)
T 4fr4_A 232 --FET--TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNF 272 (384)
T ss_dssp --HHH--CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred --Hhh--cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence 000 111122233345889999999999999998 7777653
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=381.89 Aligned_cols=255 Identities=21% Similarity=0.346 Sum_probs=201.7
Q ss_pred cCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCC--chhHHHHHHHHHHHHHcC--CCCceeEeeEeeccceeeEEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGG--SQGEREFRAEVEIISRVH--HRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~--HpnIv~l~~~~~~~~~~~lV~ 456 (727)
++|+++++||+|+||.||+|++.+|+.||||+++... ....+.+++|+++|++++ |+||+++++++..++.+||||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 4599999999999999999998889999999997543 234467999999999996 599999999999999999999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccC
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 536 (727)
| +.+++|.+++.... .+++.+++.|+.||+.||+|||++ +|+|||||++||||+ ++.+||+|||+++.+...
T Consensus 136 E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~- 207 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD- 207 (390)
T ss_dssp E-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred e-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCC-
Confidence 9 56889999998765 488889999999999999999999 999999999999995 579999999999854321
Q ss_pred CCccccccccCCccccccCcccC-----------CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHH
Q 041135 537 SNTHVSTRVMGTFGYMAPEYATS-----------GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLA 605 (727)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~l~~-----------~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~ 605 (727)
.........+||..|+|||++.+ ..++.++||||||||||||++|+.||..... ...
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-----~~~------- 275 (390)
T 2zmd_A 208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QIS------- 275 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----HHH-------
T ss_pred CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-----HHH-------
Confidence 11222345679999999999875 3689999999999999999999999975321 000
Q ss_pred HhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhc
Q 041135 606 EALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661 (727)
Q Consensus 606 ~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 661 (727)
.+..+++......+.......+.+|+++||+.||++||++.||+++.+..
T Consensus 276 ------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~ 325 (390)
T 2zmd_A 276 ------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325 (390)
T ss_dssp ------HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred ------HHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcc
Confidence 11222222222222222234578999999999999999999999886543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=380.65 Aligned_cols=208 Identities=24% Similarity=0.338 Sum_probs=181.1
Q ss_pred ccHHHHHHHhcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcC-----CCCceeEee
Q 041135 371 FTYDELIQATNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRVH-----HRHLVSLVG 444 (727)
Q Consensus 371 ~~~~el~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~-----HpnIv~l~~ 444 (727)
|.+++.....++|+++++||+|+||.||+|++. +|+.||||+++. .....+.+.+|+++|++++ |+||+++++
T Consensus 25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence 333444445678999999999999999999974 688999999863 2344567888999999996 999999999
Q ss_pred EeeccceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECC-------
Q 041135 445 YCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDS------- 517 (727)
Q Consensus 445 ~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~------- 517 (727)
+|...+..+|||||+ +++|.+++.......+++.+++.|+.||+.||+|||++ +|+|||||++||||+.
T Consensus 104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~ 179 (360)
T 3llt_A 104 KFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSL 179 (360)
T ss_dssp EEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEE
T ss_pred eeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccc
Confidence 999999999999999 99999999877666689999999999999999999999 9999999999999975
Q ss_pred ------------------CCcEEEEeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHH
Q 041135 518 ------------------SFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELI 579 (727)
Q Consensus 518 ------------------~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLl 579 (727)
++.+||+|||+++.... ......|+..|+|||++.+..++.++|||||||+||||+
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 253 (360)
T 3llt_A 180 ITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD------YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELY 253 (360)
T ss_dssp EEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS------CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred cchhcccccccccccccCCCCEEEEeccCceecCC------CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHH
Confidence 78999999999975321 223457899999999999999999999999999999999
Q ss_pred hCCCCCCCCC
Q 041135 580 TGRKPVDASQ 589 (727)
Q Consensus 580 tG~~Pf~~~~ 589 (727)
+|+.||....
T Consensus 254 ~g~~pf~~~~ 263 (360)
T 3llt_A 254 TGSLLFRTHE 263 (360)
T ss_dssp HSSCSCCCSS
T ss_pred HCCCCCCCCc
Confidence 9999997643
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=374.58 Aligned_cols=266 Identities=26% Similarity=0.430 Sum_probs=212.4
Q ss_pred HHHHHHhcCccccceeccCCceEEEEEEEc------CCcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEe
Q 041135 374 DELIQATNGFSAHNVLGEGGFGCVYKGVLA------DGREVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYC 446 (727)
Q Consensus 374 ~el~~~~~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~ 446 (727)
+++....++|++.++||+|+||.||+|++. +++.||||+++.... .....+.+|+++|++++|+||+++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 344455678999999999999999999864 367899999875433 3345789999999999999999999999
Q ss_pred eccceeeEEEeeccCCccchhcccCC--------CCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCC
Q 041135 447 ISERERLLVYEYVPNDTLHYHLHAEG--------RPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSS 518 (727)
Q Consensus 447 ~~~~~~~lV~Ey~~~gsL~~~L~~~~--------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~ 518 (727)
.+.+..+|||||+.+|+|.++++... ...+++..+++|+.||+.||+|||++ +|+|||||++||||+.+
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~ 174 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 174 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTT
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCC
Confidence 99999999999999999999986532 13468899999999999999999999 99999999999999999
Q ss_pred CcEEEEeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhH
Q 041135 519 FEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLV 597 (727)
Q Consensus 519 ~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~ 597 (727)
+.+||+|||+++...... .........|+..|+|||++.+..++.++|||||||+||||++ |+.||..... ..+.
T Consensus 175 ~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~ 250 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETD-YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN---EQVL 250 (322)
T ss_dssp CCEEECCTTCCCGGGGGG-CEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH---HHHH
T ss_pred CeEEECcCcccccccccc-ccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH---HHHH
Confidence 999999999998653221 1122234567889999999999999999999999999999999 8999875421 1110
Q ss_pred HhhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 598 EWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 598 ~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
. .+....+ ..........+.+|+++||+.||++||++.||+++|+++..
T Consensus 251 ---~-------------~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 251 ---R-------------FVMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp ---H-------------HHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ---H-------------HHHcCCc-CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 0 0111111 11122233458899999999999999999999999998743
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=363.81 Aligned_cols=264 Identities=21% Similarity=0.331 Sum_probs=199.4
Q ss_pred cCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCch--hHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEee
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQ--GEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~--~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 458 (727)
++|+++++||+|+||.||+|+..+|+.||||+++..... ..+.+.+|+++|++++|+||+++++++.+++..+|||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 579999999999999999999988999999999754332 236788999999999999999999999999999999999
Q ss_pred ccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCC
Q 041135 459 VPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSN 538 (727)
Q Consensus 459 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 538 (727)
+.+ +|.+++.... ..+++..++.++.||++||+|||++ +|+|||||++||||+.++.+||+|||+++.... .
T Consensus 82 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~---~ 153 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGI---P 153 (288)
T ss_dssp CSE-EHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred cCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCc---c
Confidence 975 8888776543 2488999999999999999999999 999999999999999999999999999986421 1
Q ss_pred ccccccccCCccccccCcccCC-CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhc--hhhHHH
Q 041135 539 THVSTRVMGTFGYMAPEYATSG-KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALE--HEDFEA 615 (727)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~l~~~-~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~--~~~~~~ 615 (727)
........|+..|+|||++.+. .++.++|||||||+||||++|+.||..... ... ...++..... ...+..
T Consensus 154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~---~~~~~~~~~~~~~~~~~~ 227 (288)
T 1ob3_A 154 VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE---ADQ---LMRIFRILGTPNSKNWPN 227 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHH---HHHHHHHHCCCCTTTSTT
T ss_pred ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHH---HHHHHHHHCCCChhhchh
Confidence 1223345789999999999764 589999999999999999999999976431 111 1111110000 000000
Q ss_pred HH-----HHHhh-------cccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 041135 616 LV-----DSRLE-------KNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRAL 658 (727)
Q Consensus 616 l~-----d~~l~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 658 (727)
+. +..+. ..+.......+.+|+++||+.||++||++.||+++-
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 282 (288)
T 1ob3_A 228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHA 282 (288)
T ss_dssp GGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred hhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence 00 00000 001112234578999999999999999999998764
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-43 Score=377.66 Aligned_cols=251 Identities=25% Similarity=0.364 Sum_probs=204.4
Q ss_pred HHhcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHHHHHHc-CCCCceeEeeEeecccee
Q 041135 378 QATNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVEIISRV-HHRHLVSLVGYCISERER 452 (727)
Q Consensus 378 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~ 452 (727)
...++|+++++||+|+||.||+|+++ +|+.||||+++... ....+.+.+|+++|+.+ +|+||++++++|.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34578999999999999999999986 58999999997432 23345688899999987 899999999999999999
Q ss_pred eEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhh
Q 041135 453 LLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIA 532 (727)
Q Consensus 453 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~ 532 (727)
||||||+.||+|.+++...+. +++..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++..
T Consensus 94 ~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 999999999999999987554 89999999999999999999999 9999999999999999999999999999743
Q ss_pred hccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhh
Q 041135 533 LELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHED 612 (727)
Q Consensus 533 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~ 612 (727)
.. ........+||..|+|||++.+..++.++|||||||+||||++|+.||..... . +..
T Consensus 169 ~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~---~~~------------ 227 (345)
T 1xjd_A 169 ML---GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE---E---ELF------------ 227 (345)
T ss_dssp CC---TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---H---HHH------------
T ss_pred cc---CCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH---H---HHH------------
Confidence 21 12223457899999999999999999999999999999999999999975431 1 111
Q ss_pred HHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHH-HHHHH
Q 041135 613 FEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMS-QVVRA 657 (727)
Q Consensus 613 ~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~~ 657 (727)
..+.... ..+.......+.+|+++||..||++|+++. ||+++
T Consensus 228 -~~i~~~~--~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 228 -HSIRMDN--PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp -HHHHHCC--CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred -HHHHhCC--CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence 1111110 112222234578899999999999999997 77654
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=387.16 Aligned_cols=262 Identities=23% Similarity=0.218 Sum_probs=206.8
Q ss_pred cHHHHHHHhcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHHHHHHcCCCCceeEeeEee
Q 041135 372 TYDELIQATNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVEIISRVHHRHLVSLVGYCI 447 (727)
Q Consensus 372 ~~~el~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~ 447 (727)
.++++....++|+++++||+|+||.||+|+++ +|+.||||+++... ....+.+++|+++|.+++|+||++++++|.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 34455555688999999999999999999985 68999999997432 122345889999999999999999999999
Q ss_pred ccceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeec
Q 041135 448 SERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFG 527 (727)
Q Consensus 448 ~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFG 527 (727)
+++.+||||||+.||+|.++|.+.+. .+++..++.++.||+.||+|||++ +|||||||++||||+.++++||+|||
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFG 207 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKFGE-RIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFG 207 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHSS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeech
Confidence 99999999999999999999976432 489999999999999999999999 99999999999999999999999999
Q ss_pred cchhhhccCCCccccccccCCccccccCccc-------CCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhh
Q 041135 528 LAKIALELDSNTHVSTRVMGTFGYMAPEYAT-------SGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWA 600 (727)
Q Consensus 528 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-------~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~ 600 (727)
+++.... .........+||..|+|||++. ++.++.++||||||||||||++|+.||..... .+..
T Consensus 208 la~~~~~--~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~ 279 (412)
T 2vd5_A 208 SCLKLRA--DGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST------AETY 279 (412)
T ss_dssp TCEECCT--TSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHH
T ss_pred hheeccC--CCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH------HHHH
Confidence 9975422 1122233468999999999997 45689999999999999999999999976431 1111
Q ss_pred HHHHHHhhchhhHHHHHHHHhhccc---chhHHHHHHHHHHHHhccCCCCC---CCHHHHHHHHh
Q 041135 601 RPLLAEALEHEDFEALVDSRLEKNY---VDSEMFWMIEAAAACVRHSATKR---PRMSQVVRALD 659 (727)
Q Consensus 601 ~~~l~~~~~~~~~~~l~d~~l~~~~---~~~~~~~l~~li~~cl~~dP~~R---Ps~~evl~~L~ 659 (727)
. .++.......+ .......+.+||++||. ++++| ++++||+++-.
T Consensus 280 ~-------------~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpf 330 (412)
T 2vd5_A 280 G-------------KIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPF 330 (412)
T ss_dssp H-------------HHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGG
T ss_pred H-------------HHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCC
Confidence 1 11111000000 11123357889999999 99998 58999987743
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=373.06 Aligned_cols=267 Identities=18% Similarity=0.221 Sum_probs=201.0
Q ss_pred cCccccceeccCCceEEEEEEEc----CCcEEEEEEeeeCCchh-----------HHHHHHHHHHHHHcCCCCceeEeeE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA----DGREVAVKQLKIGGSQG-----------EREFRAEVEIISRVHHRHLVSLVGY 445 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~----~g~~vaVK~l~~~~~~~-----------~~~~~~Ei~~l~~l~HpnIv~l~~~ 445 (727)
++|+++++||+|+||.||+|++. ++..||||++....... ...+.+|+.+++.++|+||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 56999999999999999999985 57889999987543321 1346678889999999999999999
Q ss_pred eec----cceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCC--
Q 041135 446 CIS----ERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSF-- 519 (727)
Q Consensus 446 ~~~----~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~-- 519 (727)
+.+ ....||||||+ +++|.+++...+ .+++.++++|+.||+.||+|||++ +|+|||||++||||+.++
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSSTT
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCCC
Confidence 988 67889999999 999999998765 589999999999999999999999 999999999999998877
Q ss_pred cEEEEeeccchhhhccCCC----ccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchh
Q 041135 520 EARVADFGLAKIALELDSN----THVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDES 595 (727)
Q Consensus 520 ~vkL~DFGla~~~~~~~~~----~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~ 595 (727)
.+||+|||+++.+...... ........|+..|+|||++.+..++.++|||||||+||||++|+.||...... ..
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~--~~ 268 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD--PV 268 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC--HH
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccc--cH
Confidence 9999999999765322111 11124467999999999999999999999999999999999999999643211 11
Q ss_pred hHHhhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 596 LVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 596 l~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
........+. ..+...+...+.. ......+.+|+++||+.||++||++.+|++.|+++..
T Consensus 269 ~~~~~~~~~~-----~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 269 AVQTAKTNLL-----DELPQSVLKWAPS---GSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHHHHHHH-----HTTTHHHHHHSCT---TSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHHHHHHhhc-----ccccHHHHhhccc---cccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 1111111110 1111111111111 0122358899999999999999999999999998743
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=376.99 Aligned_cols=251 Identities=26% Similarity=0.357 Sum_probs=204.7
Q ss_pred HhcCccccceeccCCceEEEEEEEcC-CcEEEEEEeeeCC---chhHHHHHHHHHHHHHc-CCCCceeEeeEeeccceee
Q 041135 379 ATNGFSAHNVLGEGGFGCVYKGVLAD-GREVAVKQLKIGG---SQGEREFRAEVEIISRV-HHRHLVSLVGYCISERERL 453 (727)
Q Consensus 379 ~~~~~~~~~~LG~G~fg~Vy~~~~~~-g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~ 453 (727)
..++|+++++||+|+||.||+|+++. |+.||||+++... ....+.+.+|+++|..+ +|+||+++++++.+.+..|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 34679999999999999999999864 7899999997432 23345688999999987 7999999999999999999
Q ss_pred EEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhh
Q 041135 454 LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIAL 533 (727)
Q Consensus 454 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~ 533 (727)
|||||+.||+|.+++...+. +++..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++...
T Consensus 98 lv~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVGR--FKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEeCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 99999999999999987554 89999999999999999999999 99999999999999999999999999997431
Q ss_pred ccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhH
Q 041135 534 ELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDF 613 (727)
Q Consensus 534 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~ 613 (727)
.........+||..|+|||++.+..++.++|||||||+||||++|+.||..... .+. +
T Consensus 173 ---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~-------------~ 230 (353)
T 2i0e_A 173 ---WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DEL-------------F 230 (353)
T ss_dssp ---CTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHH-------------H
T ss_pred ---cCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH------HHH-------------H
Confidence 112233456899999999999999999999999999999999999999975321 111 1
Q ss_pred HHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCC-----HHHHHHHH
Q 041135 614 EALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPR-----MSQVVRAL 658 (727)
Q Consensus 614 ~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~L 658 (727)
..++...+ .+.......+.+|+++||+.||++|++ ++||+++-
T Consensus 231 ~~i~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~ 278 (353)
T 2i0e_A 231 QSIMEHNV--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHA 278 (353)
T ss_dssp HHHHHCCC--CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSG
T ss_pred HHHHhCCC--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCc
Confidence 11111111 122223345789999999999999995 57777653
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=377.38 Aligned_cols=255 Identities=21% Similarity=0.301 Sum_probs=207.4
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEee
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 458 (727)
.++|+++++||+|+||.||+|+.. +|+.||+|++..........+.+|+++|++++|+||++++++|.++...+|||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 357999999999999999999975 5889999999866555667899999999999999999999999999999999999
Q ss_pred ccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECC--CCcEEEEeeccchhhhccC
Q 041135 459 VPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDS--SFEARVADFGLAKIALELD 536 (727)
Q Consensus 459 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~--~~~vkL~DFGla~~~~~~~ 536 (727)
+.+|+|.+++.... ..+++.+++.|+.||+.||+|||++ +|+|||||++||||+. ++.+||+|||+++....
T Consensus 130 ~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~-- 203 (387)
T 1kob_A 130 LSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP-- 203 (387)
T ss_dssp CCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT--
T ss_pred CCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCC--
Confidence 99999999987653 2489999999999999999999999 9999999999999974 57899999999985421
Q ss_pred CCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHH
Q 041135 537 SNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEAL 616 (727)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l 616 (727)
.......+||..|+|||++.+..++.++||||||||||||++|+.||..... .+....+....+
T Consensus 204 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~------~~~~~~i~~~~~-------- 267 (387)
T 1kob_A 204 --DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD------LETLQNVKRCDW-------- 267 (387)
T ss_dssp --TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHHCCC--------
T ss_pred --CcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCC--------
Confidence 1223345799999999999999999999999999999999999999976421 111111100000
Q ss_pred HHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 617 VDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 617 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
.+...........+.+|+++||+.||++||++.||+++-.
T Consensus 268 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 307 (387)
T 1kob_A 268 ---EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPW 307 (387)
T ss_dssp ---CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTT
T ss_pred ---CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCcc
Confidence 0011111122345789999999999999999999998754
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=368.07 Aligned_cols=263 Identities=23% Similarity=0.332 Sum_probs=206.3
Q ss_pred hcCccccceeccCCceEEEEEEE-cCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEee----ccceeeE
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVL-ADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCI----SERERLL 454 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~----~~~~~~l 454 (727)
.++|+++++||+|+||.||+++. .+|+.||||++........+.+.+|++++++++|+||++++++|. .....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 46799999999999999999997 568999999998766666778999999999999999999999997 3447899
Q ss_pred EEeeccCCccchhcccC--CCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhh
Q 041135 455 VYEYVPNDTLHYHLHAE--GRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIA 532 (727)
Q Consensus 455 V~Ey~~~gsL~~~L~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~ 532 (727)
||||+.+|+|.+++... ....+++.+++.|+.||++||+|||++ +|+|||||++||||+.++.+||+|||+++..
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 99999999999988752 234589999999999999999999999 9999999999999999999999999998753
Q ss_pred hccCCCc------cccccccCCccccccCcccCCC---CCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHH
Q 041135 533 LELDSNT------HVSTRVMGTFGYMAPEYATSGK---LTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPL 603 (727)
Q Consensus 533 ~~~~~~~------~~~~~~~gt~~y~aPE~l~~~~---~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~ 603 (727)
....... .......|+..|+|||++.+.. ++.++|||||||+||||++|+.||.......
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----------- 253 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG----------- 253 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT-----------
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc-----------
Confidence 2111100 0112345799999999997654 6889999999999999999999995311100
Q ss_pred HHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 604 LAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 604 l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
..+...+...+...........+.+|+.+||+.||++||++.||+++|+.+..
T Consensus 254 -------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 254 -------DSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp -------SCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred -------chhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 01111111111111112233458899999999999999999999999998854
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=366.79 Aligned_cols=252 Identities=23% Similarity=0.383 Sum_probs=203.3
Q ss_pred hcCccccceeccCCceEEEEEEEcC-C-------cEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccce
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLAD-G-------REVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERE 451 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~~-g-------~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~ 451 (727)
.++|++.+.||+|+||.||+|++.. + ..||||+++.......+.+.+|+++|++++|+||++++++|.+++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 3568999999999999999998653 3 5799999976666667789999999999999999999999999999
Q ss_pred eeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCc--------EEE
Q 041135 452 RLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFE--------ARV 523 (727)
Q Consensus 452 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~--------vkL 523 (727)
.+|||||+.+++|.+++.... ..+++..++.|+.||++||+|||++ +|+|||||++||||+.++. +||
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred CEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeee
Confidence 999999999999999997653 2488999999999999999999999 9999999999999988876 999
Q ss_pred EeeccchhhhccCCCccccccccCCccccccCcccC-CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHH
Q 041135 524 ADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATS-GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARP 602 (727)
Q Consensus 524 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~ 602 (727)
+|||+++.... .....|+..|+|||++.+ ..++.++|||||||+||||++|..++..... ....
T Consensus 163 ~Dfg~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~--~~~~------ 227 (289)
T 4fvq_A 163 SDPGISITVLP-------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD--SQRK------ 227 (289)
T ss_dssp CCCCSCTTTSC-------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC--HHHH------
T ss_pred ccCcccccccC-------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc--hHHH------
Confidence 99999974311 123457889999999987 6799999999999999999996554432211 0000
Q ss_pred HHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 603 LLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 603 ~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
...... ...........+.+|+++||+.||++||++.||++.|+.+..
T Consensus 228 -----------~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 228 -----------LQFYED--RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp -----------HHHHHT--TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred -----------HHHhhc--cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 000000 111111122347889999999999999999999999998854
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=372.06 Aligned_cols=258 Identities=24% Similarity=0.422 Sum_probs=201.0
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcE----EEEEEeeeC-CchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceee
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGRE----VAVKQLKIG-GSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERL 453 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~----vaVK~l~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 453 (727)
.++|+++++||+|+||.||+|++. +|+. |++|.++.. .....+.+.+|+++|++++|+||++++++|..+. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 357999999999999999999964 3443 577777533 2344578999999999999999999999998765 78
Q ss_pred EEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhh
Q 041135 454 LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIAL 533 (727)
Q Consensus 454 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~ 533 (727)
+||||+.+|+|.+++..... .+++..++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++...
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred EEEEecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 99999999999999876533 489999999999999999999999 99999999999999999999999999998653
Q ss_pred ccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhh
Q 041135 534 ELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHED 612 (727)
Q Consensus 534 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~ 612 (727)
... .........++..|+|||++.+..++.++|||||||+||||++ |+.||...... .
T Consensus 169 ~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~----------------- 227 (327)
T 3lzb_A 169 AEE-KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---E----------------- 227 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---G-----------------
T ss_pred Ccc-ccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH---H-----------------
Confidence 221 2222334557889999999999999999999999999999999 99999764321 1
Q ss_pred HHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 613 FEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 613 ~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
+...+...............+.+|+++||+.||++||++.||++.|+++..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 228 ISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp HHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 111111111122222334458899999999999999999999999998854
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=366.08 Aligned_cols=254 Identities=30% Similarity=0.470 Sum_probs=198.8
Q ss_pred cCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeecc
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVP 460 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 460 (727)
++|++.++||+|+||.||+|++. ++.||||+++. ....+.|.+|+++|++++|+||++++++|.+ ..+|||||+.
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence 56889999999999999999985 78999999863 3445679999999999999999999999874 4789999999
Q ss_pred CCccchhcccCCC-CcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCc-EEEEeeccchhhhccCCC
Q 041135 461 NDTLHYHLHAEGR-PVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFE-ARVADFGLAKIALELDSN 538 (727)
Q Consensus 461 ~gsL~~~L~~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~-vkL~DFGla~~~~~~~~~ 538 (727)
+|+|.++++.... ..+++..+++++.||++||+|||+.+..+|+|||||++||||+.++. +||+|||+++....
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~---- 158 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT---- 158 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc----
Confidence 9999999976543 24788899999999999999999932228999999999999988876 79999999975421
Q ss_pred ccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHH
Q 041135 539 THVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVD 618 (727)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d 618 (727)
......|+..|+|||++.+..++.++|||||||+||||++|+.||...... .....| .+.
T Consensus 159 --~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~----------------~~~ 218 (307)
T 2eva_A 159 --HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP--AFRIMW----------------AVH 218 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS--HHHHHH----------------HHH
T ss_pred --ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc--HHHHHH----------------HHh
Confidence 122346899999999999999999999999999999999999999754321 100000 000
Q ss_pred HHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 619 SRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 619 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
..............+.+|+.+||+.||++||++.||++.|+.+..
T Consensus 219 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 219 NGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp TTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred cCCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 011111222233457899999999999999999999999998754
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=366.17 Aligned_cols=268 Identities=25% Similarity=0.392 Sum_probs=203.1
Q ss_pred HHHhcCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHc--CCCCceeEeeEeecc----c
Q 041135 377 IQATNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRV--HHRHLVSLVGYCISE----R 450 (727)
Q Consensus 377 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l--~HpnIv~l~~~~~~~----~ 450 (727)
....++|+++++||+|+||.||+|++. |+.||||++... ....+.+|.+++..+ +|+||+++++++.+. .
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 344578999999999999999999985 899999998632 334556666666654 899999999999877 6
Q ss_pred eeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcC-----CCcEEeeCCCCCceEECCCCcEEEEe
Q 041135 451 ERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDC-----HPRIIHRDIKSSNILLDSSFEARVAD 525 (727)
Q Consensus 451 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-----~~~ivHrDLkp~NILl~~~~~vkL~D 525 (727)
..+|||||+.+|+|.++++.. .+++..+++|+.||+.||+|||+++ ..+|+|||||++||||+.++.+||+|
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~D 185 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD 185 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred ceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEe
Confidence 889999999999999999764 3899999999999999999999752 23799999999999999999999999
Q ss_pred eccchhhhccCCCcc-ccccccCCccccccCcccCCCCCch------hHHHHHhHHHHHHHhC----------CCCCCCC
Q 041135 526 FGLAKIALELDSNTH-VSTRVMGTFGYMAPEYATSGKLTEK------SDVYSFGVVLLELITG----------RKPVDAS 588 (727)
Q Consensus 526 FGla~~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k------sDVwS~Gvil~eLltG----------~~Pf~~~ 588 (727)
||+++.+........ .....+|+..|+|||++.+..+..+ +|||||||+||||++| +.||...
T Consensus 186 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~ 265 (337)
T 3mdy_A 186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265 (337)
T ss_dssp CTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence 999975432221111 1224579999999999988766554 9999999999999999 5555443
Q ss_pred CCCCchhhHHhhHHHHHHhhchhhHHHHH-HHHhhccc-----chhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhcc
Q 041135 589 QPLGDESLVEWARPLLAEALEHEDFEALV-DSRLEKNY-----VDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLD 662 (727)
Q Consensus 589 ~~~~~~~l~~~~~~~l~~~~~~~~~~~l~-d~~l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 662 (727)
...... ... +...+ ...+...+ .......+.+|+++||+.||++||++.||+++|+++.
T Consensus 266 ~~~~~~-~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 330 (337)
T 3mdy_A 266 VPSDPS-YED--------------MREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS 330 (337)
T ss_dssp SCSSCC-HHH--------------HHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCCCc-hhh--------------hHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHH
Confidence 221110 000 00000 01111111 1245667899999999999999999999999999987
Q ss_pred CCCc
Q 041135 663 GASD 666 (727)
Q Consensus 663 ~~~~ 666 (727)
+..+
T Consensus 331 ~~~~ 334 (337)
T 3mdy_A 331 ESQD 334 (337)
T ss_dssp HTTT
T ss_pred hhcc
Confidence 6443
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=374.87 Aligned_cols=247 Identities=26% Similarity=0.308 Sum_probs=205.3
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
++|+++++||+|+||.||+|++. +|+.||||+++... ....+.+.+|+++|+.++|+||++++++|.+....||||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 56999999999999999999975 58999999996432 223457889999999999999999999999999999999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccC
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 536 (727)
||+.||+|.+++...+. +++..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++....
T Consensus 121 e~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~-- 193 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-- 193 (350)
T ss_dssp ECCTTCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS--
T ss_pred cCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccC--
Confidence 99999999999987654 89999999999999999999999 999999999999999999999999999985421
Q ss_pred CCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHH
Q 041135 537 SNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEAL 616 (727)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l 616 (727)
.....+||..|+|||++.+..++.++|||||||+||||++|+.||..... .+. +..+
T Consensus 194 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~-------------~~~i 250 (350)
T 1rdq_E 194 ----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP------IQI-------------YEKI 250 (350)
T ss_dssp ----CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHH-------------HHHH
T ss_pred ----CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH------HHH-------------HHHH
Confidence 12346799999999999999999999999999999999999999975421 111 1111
Q ss_pred HHHHhhcccchhHHHHHHHHHHHHhccCCCCCCC-----HHHHHHHHh
Q 041135 617 VDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPR-----MSQVVRALD 659 (727)
Q Consensus 617 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~L~ 659 (727)
....+ .+.......+.+|+++||+.||++|++ +.||+++-.
T Consensus 251 ~~~~~--~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~ 296 (350)
T 1rdq_E 251 VSGKV--RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296 (350)
T ss_dssp HHCCC--CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred HcCCC--CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcC
Confidence 11111 122222345789999999999999998 888877643
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=375.28 Aligned_cols=271 Identities=26% Similarity=0.397 Sum_probs=210.8
Q ss_pred hcCccccceeccCCceEEEEEEE-----cCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccc--ee
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVL-----ADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISER--ER 452 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~-----~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~--~~ 452 (727)
.++|+++++||+|+||.||+|++ .+|+.||||+++.......+.+.+|+++|++++|+||++++++|...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 35689999999999999999984 358999999998766666778999999999999999999999987654 67
Q ss_pred eEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhh
Q 041135 453 LLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIA 532 (727)
Q Consensus 453 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~ 532 (727)
+|||||+.+++|.+++..... .+++..+++++.||++||+|||++ +|+|||||++||||+.++.+||+|||+++..
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp EEEECCCTTCBHHHHHHHSTT-SSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEECCCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 999999999999999976532 489999999999999999999999 9999999999999999999999999999864
Q ss_pred hccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhc---
Q 041135 533 LELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALE--- 609 (727)
Q Consensus 533 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~--- 609 (727)
..............++..|+|||++.+..++.++|||||||+||||++|+.+|.... .++.+. +.....
T Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~-------~~~~~~-~~~~~~~~~ 267 (326)
T 2w1i_A 196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPP-------AEFMRM-IGNDKQGQM 267 (326)
T ss_dssp CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHH-------HHHHHH-HCTTCCTHH
T ss_pred cccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCH-------HHHHHh-hccccchhh
Confidence 322211122233567788999999998889999999999999999999998875321 000000 000000
Q ss_pred -hhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhcc
Q 041135 610 -HEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLD 662 (727)
Q Consensus 610 -~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 662 (727)
...+.+.+...............+.+|+++||+.||++||++.||++.|+++.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 268 IVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 00111122211111222333456889999999999999999999999999875
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=362.14 Aligned_cols=266 Identities=20% Similarity=0.307 Sum_probs=199.2
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCch--hHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQ--GEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~--~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
.++|+++++||+|+||.||+|++. +|+.||||++...... ..+.+.+|+++|++++|+||++++++|.+.+..+|||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 367999999999999999999986 4899999998654332 2456889999999999999999999999999999999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccC
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 536 (727)
||+.+++|.++++.... +++..++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++....
T Consensus 82 e~~~~~~l~~~~~~~~~--~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-- 154 (311)
T 4agu_A 82 EYCDHTVLHELDRYQRG--VPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTG-- 154 (311)
T ss_dssp ECCSEEHHHHHHHTSSC--CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EeCCCchHHHHHhhhcC--CCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccC--
Confidence 99999999988876544 89999999999999999999999 999999999999999999999999999975421
Q ss_pred CCccccccccCCccccccCcccC-CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHH
Q 041135 537 SNTHVSTRVMGTFGYMAPEYATS-GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEA 615 (727)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~ 615 (727)
.........|+..|+|||++.+ ..++.++|||||||+||||++|+.||...... .........+.... .....
T Consensus 155 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~--~~~~~ 228 (311)
T 4agu_A 155 -PSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDV---DQLYLIRKTLGDLI--PRHQQ 228 (311)
T ss_dssp ------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCSCC--HHHHH
T ss_pred -cccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhcccc--ccccc
Confidence 1222344578999999999986 56899999999999999999999999764321 11111111100000 00000
Q ss_pred HHH-HHhhcc--------------cchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 041135 616 LVD-SRLEKN--------------YVDSEMFWMIEAAAACVRHSATKRPRMSQVVRAL 658 (727)
Q Consensus 616 l~d-~~l~~~--------------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 658 (727)
.+. ...... ........+.+|+++||+.||++||+++||+++-
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 286 (311)
T 4agu_A 229 VFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHP 286 (311)
T ss_dssp HHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSG
T ss_pred ccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcCh
Confidence 000 000000 0011223478899999999999999999999873
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=356.24 Aligned_cols=256 Identities=23% Similarity=0.333 Sum_probs=206.4
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC-chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEe
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG-SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYE 457 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 457 (727)
.++|++++.||+|+||.||+|++. +|+.||||+++... ....+.+.+|+++++.++|+||+++++++.+++..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 456999999999999999999976 68999999997543 2345679999999999999999999999999999999999
Q ss_pred eccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCC
Q 041135 458 YVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDS 537 (727)
Q Consensus 458 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 537 (727)
|+.+++|.+++.... .+++..++.++.||++||+|||++ +|+|||||++||||+.++.+||+|||++...... .
T Consensus 86 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~-~ 159 (276)
T 2yex_A 86 YCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN-N 159 (276)
T ss_dssp CCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET-T
T ss_pred ecCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCC-c
Confidence 999999999997654 489999999999999999999999 9999999999999999999999999999754221 1
Q ss_pred CccccccccCCccccccCcccCCCC-CchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHH
Q 041135 538 NTHVSTRVMGTFGYMAPEYATSGKL-TEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEAL 616 (727)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~l~~~~~-~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l 616 (727)
.........|+..|+|||++.+..+ +.++|||||||+||||++|+.||....... ..+..|.
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~---------------- 222 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWK---------------- 222 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS-HHHHHHH----------------
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH-HHHHHhh----------------
Confidence 1222345678999999999988765 779999999999999999999997654321 1111110
Q ss_pred HHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 617 VDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 617 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
...............+.+|+++||+.||++||++.||+++-.
T Consensus 223 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 264 (276)
T 2yex_A 223 -EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRW 264 (276)
T ss_dssp -TTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred -hcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCcc
Confidence 000000011122334778999999999999999999988643
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=360.53 Aligned_cols=256 Identities=25% Similarity=0.372 Sum_probs=203.0
Q ss_pred hcCccccceeccCCceEEEEEEEcC----CcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeE
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLAD----GREVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLL 454 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~~----g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 454 (727)
.++|++.++||+|+||.||+|++.+ +..||||+++.... ...+.+.+|+++|++++|+||+++++++.++ ..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence 3568999999999999999998643 34699999875432 3456799999999999999999999998754 5689
Q ss_pred EEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhc
Q 041135 455 VYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALE 534 (727)
Q Consensus 455 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 534 (727)
||||+.+++|.+++.... ..+++..++.++.||++||+|||++ +|+|||||++||||+.++.+||+|||+++....
T Consensus 90 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIED 165 (281)
T ss_dssp EEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred EEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence 999999999999997643 2488999999999999999999999 999999999999999999999999999985422
Q ss_pred cCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhH
Q 041135 535 LDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDF 613 (727)
Q Consensus 535 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~ 613 (727)
. .........++..|+|||++.+..++.++|||||||+||||++ |+.||...... .+..
T Consensus 166 ~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~---~~~~--------------- 225 (281)
T 3cc6_A 166 E--DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK---DVIG--------------- 225 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG---GHHH---------------
T ss_pred c--cccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH---HHHH---------------
Confidence 1 1112234567889999999998899999999999999999998 99999754321 1111
Q ss_pred HHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhcc
Q 041135 614 EALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLD 662 (727)
Q Consensus 614 ~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 662 (727)
.+...............+.+|+++||+.||++||++.||++.|+.+.
T Consensus 226 --~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 226 --VLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp --HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --HHhcCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 11111111111222345889999999999999999999999999874
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=373.26 Aligned_cols=252 Identities=23% Similarity=0.335 Sum_probs=191.1
Q ss_pred HhcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEe
Q 041135 379 ATNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYE 457 (727)
Q Consensus 379 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 457 (727)
..++|++.++||+|+||.||+|++. +++.||||+++.. ...+.+++|+++|++++|+||++++++|.+....+||||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc--hhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 4567999999999999999999986 4789999998743 234678899999999999999999999999999999999
Q ss_pred eccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECC---CCcEEEEeeccchhhhc
Q 041135 458 YVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDS---SFEARVADFGLAKIALE 534 (727)
Q Consensus 458 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~---~~~vkL~DFGla~~~~~ 534 (727)
|+.+++|.+++...+. +++.+++.++.||++||+|||++ +|+|||||++||||+. ++.+||+|||+++....
T Consensus 129 ~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 129 LVTGGELFDRIVEKGY--YSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp CCCSCBHHHHHTTCSS--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred eCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 9999999999876544 89999999999999999999999 9999999999999975 88999999999985421
Q ss_pred cCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHH
Q 041135 535 LDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFE 614 (727)
Q Consensus 535 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~ 614 (727)
.......+|+..|+|||++.+..++.++|||||||+||||++|+.||...... ..+ + .
T Consensus 204 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~-------~---------~ 261 (349)
T 2w4o_A 204 ----QVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD--QFM-------F---------R 261 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH--HHH-------H---------H
T ss_pred ----ccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc--HHH-------H---------H
Confidence 12233467899999999999999999999999999999999999999654311 100 0 0
Q ss_pred HHHHHHh--hcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 615 ALVDSRL--EKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 615 ~l~d~~l--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
.+..... ...+.......+.+|+++||+.||++||++.||+++-.
T Consensus 262 ~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 308 (349)
T 2w4o_A 262 RILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPW 308 (349)
T ss_dssp HHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred HHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 1111100 00111222345789999999999999999999998644
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=364.84 Aligned_cols=260 Identities=21% Similarity=0.341 Sum_probs=197.9
Q ss_pred cCccccceeccCCceEEEEEEE-cCCcEEEEEEeeeCC---chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVL-ADGREVAVKQLKIGG---SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
++|++.++||+|+||.||+|+. .+|+.||||+++... ......+.+|+++|++++|+||++++++|.+++..+|||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 4699999999999999999997 468999999997532 334467899999999999999999999999999999999
Q ss_pred eeccCCccchhcccC--CCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhc
Q 041135 457 EYVPNDTLHYHLHAE--GRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALE 534 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 534 (727)
||+.+++|.+++... ....+++..++.++.||++||+|||++ +|+|||||++||||+.++.+||+|||+++....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 999999999988642 234589999999999999999999999 999999999999999999999999999975422
Q ss_pred cCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHH
Q 041135 535 LDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFE 614 (727)
Q Consensus 535 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~ 614 (727)
.........|+..|+|||++.+..++.++|||||||+||||++|+.||...... ...+...
T Consensus 189 ---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~------------ 249 (310)
T 2wqm_A 189 ---KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKK------------ 249 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----HHHHHHH------------
T ss_pred ---CCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----HHHHHHH------------
Confidence 112223457899999999999999999999999999999999999999753211 1111110
Q ss_pred HHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 615 ALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 615 ~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
+....+...........+.+|+++||+.||++||++.||++.|+++..
T Consensus 250 -~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~ 297 (310)
T 2wqm_A 250 -IEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA 297 (310)
T ss_dssp -HHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -hhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 000011100111223457889999999999999999999999998864
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=385.51 Aligned_cols=196 Identities=24% Similarity=0.374 Sum_probs=153.9
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeC--CchhHHHHHHHHHHHHHcCCCCceeEeeEeec-----cce
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIG--GSQGEREFRAEVEIISRVHHRHLVSLVGYCIS-----ERE 451 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~-----~~~ 451 (727)
.++|+++++||+|+||.||+|++. +|+.||||++... .....+.+.+|+++|++++|+|||+++++|.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 367999999999999999999865 6899999998643 22344678999999999999999999999954 357
Q ss_pred eeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchh
Q 041135 452 RLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKI 531 (727)
Q Consensus 452 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 531 (727)
+||||||+ +++|.++++.... +++..++.|+.||++||+|||++ +|||||||++||||+.++.+||+|||+++.
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~~--l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTPVY--LTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSSCC--CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEecc-ccchhhhcccCCC--CCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchh
Confidence 89999998 5788888876543 89999999999999999999999 999999999999999999999999999986
Q ss_pred hhccCCC------------------------ccccccccCCccccccCcc-cCCCCCchhHHHHHhHHHHHHHhC
Q 041135 532 ALELDSN------------------------THVSTRVMGTFGYMAPEYA-TSGKLTEKSDVYSFGVVLLELITG 581 (727)
Q Consensus 532 ~~~~~~~------------------------~~~~~~~~gt~~y~aPE~l-~~~~~~~ksDVwS~Gvil~eLltG 581 (727)
....... .......+||..|+|||++ .+..++.++||||||||||||++|
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 5321110 0123446789999999986 456799999999999999999993
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=403.36 Aligned_cols=250 Identities=26% Similarity=0.380 Sum_probs=199.5
Q ss_pred ceeccCCceEEEEEEEc---CCcEEEEEEeeeCCc--hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeeccC
Q 041135 387 NVLGEGGFGCVYKGVLA---DGREVAVKQLKIGGS--QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPN 461 (727)
Q Consensus 387 ~~LG~G~fg~Vy~~~~~---~g~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 461 (727)
++||+|+||.||+|.+. .++.||||+++.... ...++|.+|+++|++++|+|||+++++|.+ +..+||||||.+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 57999999999999753 467899999975432 335789999999999999999999999965 457899999999
Q ss_pred CccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCccc
Q 041135 462 DTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHV 541 (727)
Q Consensus 462 gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 541 (727)
|+|.++|+.+.. +++..++.|+.||+.||+|||++ +|||||||++||||++++.+||+|||+++.+.........
T Consensus 454 g~L~~~l~~~~~--l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 528 (635)
T 4fl3_A 454 GPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 528 (635)
T ss_dssp EEHHHHHHHCTT--CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred CCHHHHHhhCCC--CCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence 999999976544 89999999999999999999999 9999999999999999999999999999865433322223
Q ss_pred cccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHH
Q 041135 542 STRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSR 620 (727)
Q Consensus 542 ~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~ 620 (727)
.....++..|+|||++.+..++.++||||||||||||++ |+.||..... .. +...+...
T Consensus 529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~---~~-----------------~~~~i~~~ 588 (635)
T 4fl3_A 529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SE-----------------VTAMLEKG 588 (635)
T ss_dssp ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HH-----------------HHHHHHTT
T ss_pred ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH---HH-----------------HHHHHHcC
Confidence 334567889999999999999999999999999999998 9999976431 11 11111222
Q ss_pred hhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhcc
Q 041135 621 LEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLD 662 (727)
Q Consensus 621 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 662 (727)
............+.+||++||+.||++||++.+|+++|+++.
T Consensus 589 ~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 630 (635)
T 4fl3_A 589 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 630 (635)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 222233334456889999999999999999999999999764
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=377.08 Aligned_cols=249 Identities=24% Similarity=0.312 Sum_probs=198.4
Q ss_pred cccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeeccCC
Q 041135 384 SAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPND 462 (727)
Q Consensus 384 ~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 462 (727)
...++||+|+||.||+|++. +|+.||||+++.......+.+++|+++|++++|+||++++++|.+.+..+|||||+.++
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 33678999999999999974 68999999998766666778999999999999999999999999999999999999999
Q ss_pred ccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEE--CCCCcEEEEeeccchhhhccCCCcc
Q 041135 463 TLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILL--DSSFEARVADFGLAKIALELDSNTH 540 (727)
Q Consensus 463 sL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl--~~~~~vkL~DFGla~~~~~~~~~~~ 540 (727)
+|.+++.... ..+++.+++.|+.||++||+|||++ +|+|||||++|||| ++++.+||+|||+++.... ..
T Consensus 172 ~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~----~~ 243 (373)
T 2x4f_A 172 ELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP----RE 243 (373)
T ss_dssp EEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCT----TC
T ss_pred cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCC----cc
Confidence 9998886543 2488999999999999999999999 99999999999999 6778999999999985422 11
Q ss_pred ccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHH
Q 041135 541 VSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSR 620 (727)
Q Consensus 541 ~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~ 620 (727)
.....+|+..|+|||++.+..++.++||||||||||||++|+.||..... .+.... ++...
T Consensus 244 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~------~~~~~~-------------i~~~~ 304 (373)
T 2x4f_A 244 KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND------AETLNN-------------ILACR 304 (373)
T ss_dssp BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHH-------------HHHTC
T ss_pred ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHH-------------HHhcc
Confidence 22345799999999999999999999999999999999999999976431 111111 11111
Q ss_pred h--hcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 621 L--EKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 621 l--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
+ ...........+.+|+.+||+.||++||++.||+++-.
T Consensus 305 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~ 345 (373)
T 2x4f_A 305 WDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPW 345 (373)
T ss_dssp CCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred CCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcC
Confidence 1 00011122345789999999999999999999998643
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=367.57 Aligned_cols=263 Identities=21% Similarity=0.332 Sum_probs=190.5
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCch-hHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEe
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQ-GEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYE 457 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 457 (727)
.++|+++++||+|+||.||+|++. +|+.||||+++..... ..+.+.+|+++|++++|+||+++++++.+++..+||||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 357899999999999999999865 5899999999755432 34678899999999999999999999999999999999
Q ss_pred eccCCccchhcccCC----CCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhh
Q 041135 458 YVPNDTLHYHLHAEG----RPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIAL 533 (727)
Q Consensus 458 y~~~gsL~~~L~~~~----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~ 533 (727)
|+. |+|.+++.... ...+++..++.++.||++||+|||++ +|+|||||++||||+.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 997 58888775432 23588999999999999999999999 99999999999999999999999999997542
Q ss_pred ccCCCccccccccCCccccccCcccCC-CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhc---
Q 041135 534 ELDSNTHVSTRVMGTFGYMAPEYATSG-KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALE--- 609 (727)
Q Consensus 534 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~--- 609 (727)
. .........|+..|+|||++.+. .++.++|||||||+||||++|+.||..... ..... .++.....
T Consensus 160 ~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~---~i~~~~~~~~~ 230 (317)
T 2pmi_A 160 I---PVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND---EEQLK---LIFDIMGTPNE 230 (317)
T ss_dssp S---CCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHH---HHHHHHCSCCT
T ss_pred C---CcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh---HHHHH---HHHHHhCCCCh
Confidence 1 11223345789999999999864 689999999999999999999999976432 11111 11110000
Q ss_pred --------------------hhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 610 --------------------HEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 610 --------------------~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
...+...+...... .....+.+|+++||+.||++||++.||+++-.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~ 296 (317)
T 2pmi_A 231 SLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKE----PLDGNLMDFLHGLLQLNPDMRLSAKQALHHPW 296 (317)
T ss_dssp TTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSS----CCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred hHhhhhhhhhhcccccccccchhHHHhhcccccc----cCCHHHHHHHHHHCCCCcccCCCHHHHhCChh
Confidence 00111111111111 12235889999999999999999999988633
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=369.97 Aligned_cols=262 Identities=26% Similarity=0.397 Sum_probs=206.3
Q ss_pred hcCccccceeccCCceEEEEEEE------cCCcEEEEEEeeeCC-chhHHHHHHHHHHHHHcCCCCceeEeeEeecccee
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVL------ADGREVAVKQLKIGG-SQGEREFRAEVEIISRVHHRHLVSLVGYCISERER 452 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~------~~g~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 452 (727)
.++|++++.||+|+||.||+|++ .+++.||||++.... ......+.+|+.+|++++|+||+++++++.+....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 45799999999999999999984 247789999996443 34456799999999999999999999999999999
Q ss_pred eEEEeeccCCccchhcccCCC-----CcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECC---CCcEEEE
Q 041135 453 LLVYEYVPNDTLHYHLHAEGR-----PVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDS---SFEARVA 524 (727)
Q Consensus 453 ~lV~Ey~~~gsL~~~L~~~~~-----~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~---~~~vkL~ 524 (727)
||||||+.+++|.+++..... ..+++.+++.++.||++||.|||++ +|+|||||++||||+. ++.+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999976542 3488999999999999999999999 9999999999999984 4569999
Q ss_pred eeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHH
Q 041135 525 DFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPL 603 (727)
Q Consensus 525 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~ 603 (727)
|||+++...... .........|+..|+|||++.+..++.++|||||||+||||++ |+.||..... ..+.
T Consensus 186 Dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~------ 255 (327)
T 2yfx_A 186 DFGMARDIYRAS-YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---QEVL------ 255 (327)
T ss_dssp CCHHHHHHHC-------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHH------
T ss_pred cccccccccccc-ccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH---HHHH------
Confidence 999998653222 1122334567899999999999999999999999999999998 9999975321 1111
Q ss_pred HHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccCCC
Q 041135 604 LAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDGAS 665 (727)
Q Consensus 604 l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 665 (727)
..+...............+.+|+++||+.||++||++.||+++|+.+....
T Consensus 256 -----------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 256 -----------EFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp -----------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred -----------HHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 111111111122223345889999999999999999999999999886543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=361.39 Aligned_cols=260 Identities=30% Similarity=0.531 Sum_probs=194.8
Q ss_pred hcCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCc--hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEe
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGS--QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYE 457 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 457 (727)
.++|++.++||+|+||.||+|++. ..||||+++.... ...+.|.+|+++|++++|+||+++++++ .....++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 356899999999999999999874 3699999975433 3346799999999999999999999976 4556899999
Q ss_pred eccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCC
Q 041135 458 YVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDS 537 (727)
Q Consensus 458 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 537 (727)
|+.+++|.+++.... ..+++..+++|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++......
T Consensus 100 ~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 174 (289)
T 3og7_A 100 WCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS- 174 (289)
T ss_dssp CCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred ecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccccccc-
Confidence 999999999986543 3589999999999999999999999 99999999999999999999999999997543211
Q ss_pred CccccccccCCccccccCccc---CCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHH
Q 041135 538 NTHVSTRVMGTFGYMAPEYAT---SGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFE 614 (727)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~l~---~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~ 614 (727)
.........|+..|+|||++. +..++.++|||||||+||||++|+.||...... ..+.+ .+........
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~----~~~~~~~~~~-- 246 (289)
T 3og7_A 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--DQIIE----MVGRGSLSPD-- 246 (289)
T ss_dssp ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH--HHHHH----HHHHTSCCCC--
T ss_pred ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH--HHHHH----HhcccccCcc--
Confidence 122234467899999999987 567889999999999999999999999764321 11111 0100000000
Q ss_pred HHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhcc
Q 041135 615 ALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLD 662 (727)
Q Consensus 615 ~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 662 (727)
+ ..........+.+|+++||+.||++||++.||++.|+++.
T Consensus 247 ------~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 247 ------L-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp ------T-TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ------h-hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 0 0111223356889999999999999999999999999874
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=357.32 Aligned_cols=266 Identities=21% Similarity=0.288 Sum_probs=203.7
Q ss_pred HHhcCccccceeccCCceEEEEEEE-cCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEe-eccceeeEE
Q 041135 378 QATNGFSAHNVLGEGGFGCVYKGVL-ADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYC-ISERERLLV 455 (727)
Q Consensus 378 ~~~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~-~~~~~~~lV 455 (727)
...++|+++++||+|+||.||+|++ .+|+.||||++.... ....+.+|+++++.++|.|++..+++| .++...+||
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 3457899999999999999999996 568999999876432 334688999999999988877766665 566778999
Q ss_pred EeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEE---CCCCcEEEEeeccchhh
Q 041135 456 YEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILL---DSSFEARVADFGLAKIA 532 (727)
Q Consensus 456 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl---~~~~~vkL~DFGla~~~ 532 (727)
|||+ +++|.+++..... .+++.+++.|+.||+.||+|||++ +|+|||||++|||| ++++.+||+|||+++..
T Consensus 84 ~e~~-~~~L~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCSR-KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EECC-CCBHHHHHHHTTS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EEcc-CCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 9999 9999999875432 489999999999999999999999 99999999999999 78899999999999865
Q ss_pred hccCCCc----cccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhh
Q 041135 533 LELDSNT----HVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEAL 608 (727)
Q Consensus 533 ~~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~ 608 (727)
....... .......|+..|+|||++.+..++.++|||||||+||||++|+.||................ ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~---~~~~ 235 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS---EKKM 235 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHH---HHHH
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhh---cccc
Confidence 3322211 12235679999999999999999999999999999999999999998755433222211110 0000
Q ss_pred chhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 609 EHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 609 ~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
. ... ..+...+ ...+.+|+++||+.||++||++.+|++.|+++..
T Consensus 236 ~-~~~-----~~~~~~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~ 280 (296)
T 4hgt_A 236 S-TPI-----EVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp H-SCH-----HHHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred c-chh-----hhhhccC----CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence 0 000 0011111 2358899999999999999999999999998754
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=355.30 Aligned_cols=253 Identities=19% Similarity=0.238 Sum_probs=204.5
Q ss_pred hcCccccceeccCCceEEEEEEEcC-CcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEee
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLAD-GREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~~-g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 458 (727)
.++|++.++||+|+||.||+|++.+ ++.||||++........+.+.+|+++|++++|+||++++++|.++...++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 4569999999999999999999764 778999999866556677899999999999999999999999999999999999
Q ss_pred ccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEE---CCCCcEEEEeeccchhhhcc
Q 041135 459 VPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILL---DSSFEARVADFGLAKIALEL 535 (727)
Q Consensus 459 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl---~~~~~vkL~DFGla~~~~~~ 535 (727)
+.+++|.+++..+.. +++.++++|+.||+.||+|||++ +|+|||||++|||| +.++.+||+|||++.....
T Consensus 88 ~~~~~L~~~~~~~~~--~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~- 161 (277)
T 3f3z_A 88 CTGGELFERVVHKRV--FRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP- 161 (277)
T ss_dssp CCSCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT-
T ss_pred cCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccC-
Confidence 999999998876654 89999999999999999999999 99999999999999 7889999999999975421
Q ss_pred CCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHH
Q 041135 536 DSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEA 615 (727)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~ 615 (727)
........|+..|+|||++.+. ++.++|||||||+||||++|+.||..... . +....+..... .+
T Consensus 162 ---~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~---~~~~~~~~~~~---~~-- 226 (277)
T 3f3z_A 162 ---GKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTD---S---EVMLKIREGTF---TF-- 226 (277)
T ss_dssp ---TSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSH---H---HHHHHHHHCCC---CC--
T ss_pred ---ccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCH---H---HHHHHHHhCCC---CC--
Confidence 1223445789999999998764 89999999999999999999999975431 1 11110000000 00
Q ss_pred HHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 616 LVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 616 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
...........+.+|+++||+.||++||++.|++++-.
T Consensus 227 ------~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~ 264 (277)
T 3f3z_A 227 ------PEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEW 264 (277)
T ss_dssp ------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred ------CchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHH
Confidence 00000012235788999999999999999999987633
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=360.58 Aligned_cols=258 Identities=23% Similarity=0.356 Sum_probs=205.7
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC--chhHHHHHHHHHHHHHcCCCCceeEeeEeec--cceeeE
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG--SQGEREFRAEVEIISRVHHRHLVSLVGYCIS--ERERLL 454 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~--~~~~~l 454 (727)
.++|++++.||+|+||.||+|+.. +|+.||||+++... ....+.+.+|+++|++++|+||++++++|.+ +...+|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 357999999999999999999975 68999999997543 2334679999999999999999999998854 568899
Q ss_pred EEeeccCCccchhcccCC--CCcccHHHHHHHHHHHHHHHHHHHhcCCCc-----EEeeCCCCCceEECCCCcEEEEeec
Q 041135 455 VYEYVPNDTLHYHLHAEG--RPVMDWATRVKVAAGAARGIAYLHEDCHPR-----IIHRDIKSSNILLDSSFEARVADFG 527 (727)
Q Consensus 455 V~Ey~~~gsL~~~L~~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~-----ivHrDLkp~NILl~~~~~vkL~DFG 527 (727)
||||+.+++|.+++.... ...+++..+++|+.||+.||+|||++ + |+|||||++||||+.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 999999999999987532 33489999999999999999999998 7 9999999999999999999999999
Q ss_pred cchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHh
Q 041135 528 LAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEA 607 (727)
Q Consensus 528 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~ 607 (727)
+++.... .........|+..|+|||++.+..++.++|||||||+||||++|+.||..... ..+ .
T Consensus 162 ~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~---~------- 225 (279)
T 2w5a_A 162 LARILNH---DTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KEL---A------- 225 (279)
T ss_dssp HHHHC------CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHH---H-------
T ss_pred hheeecc---ccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH---HHH---H-------
Confidence 9976421 11222345789999999999999999999999999999999999999976431 111 0
Q ss_pred hchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 608 LEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 608 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
..+.+... ..........+.+|+.+||+.||++||++.||+++++....
T Consensus 226 ------~~i~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 226 ------GKIREGKF-RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp ------HHHHHTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred ------HHHhhccc-ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 01111111 11112223458899999999999999999999998876543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=361.61 Aligned_cols=266 Identities=24% Similarity=0.311 Sum_probs=201.6
Q ss_pred hcCccccceeccCCceEEEEEEE-cCCcEEEEEEeeeCCc-----hhHHHHHHHHHHHHHcC---CCCceeEeeEeeccc
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVL-ADGREVAVKQLKIGGS-----QGEREFRAEVEIISRVH---HRHLVSLVGYCISER 450 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vaVK~l~~~~~-----~~~~~~~~Ei~~l~~l~---HpnIv~l~~~~~~~~ 450 (727)
.++|+++++||+|+||.||+|++ .+|+.||||+++.... .....+.+|++++++++ |+||++++++|....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 56899999999999999999996 4689999999975332 12346778888887775 999999999998754
Q ss_pred -----eeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEe
Q 041135 451 -----ERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVAD 525 (727)
Q Consensus 451 -----~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~D 525 (727)
..++||||+. ++|.+++.......+++.+++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~D 163 (308)
T 3g33_A 88 TDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLAD 163 (308)
T ss_dssp SSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEECS
T ss_pred CCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEee
Confidence 5799999996 5999999877666699999999999999999999999 999999999999999999999999
Q ss_pred eccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHH
Q 041135 526 FGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLA 605 (727)
Q Consensus 526 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~ 605 (727)
||+++.... ........||..|+|||++.+..++.++|||||||+||||++|+.||..... .. ....++.
T Consensus 164 fg~a~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~---~~~~i~~ 233 (308)
T 3g33_A 164 FGLARIYSY----QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE---AD---QLGKIFD 233 (308)
T ss_dssp CSCTTTSTT----CCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSH---HH---HHHHHHH
T ss_pred CccccccCC----CcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCH---HH---HHHHHHH
Confidence 999985421 2223456789999999999999999999999999999999999999976431 11 1111111
Q ss_pred Hhhch--hhHHH---HHHHHhh-------cccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 606 EALEH--EDFEA---LVDSRLE-------KNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 606 ~~~~~--~~~~~---l~d~~l~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
..... ..+.. +....+. ..........+.+|+++||+.||++|+++.|++++-+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~ 299 (308)
T 3g33_A 234 LIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY 299 (308)
T ss_dssp HHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTT
T ss_pred HhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCcc
Confidence 00000 00000 0000000 0001112345788999999999999999999988643
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=378.69 Aligned_cols=246 Identities=26% Similarity=0.356 Sum_probs=193.0
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc---hhHHHHHHHHHH-HHHcCCCCceeEeeEeeccceeeEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS---QGEREFRAEVEI-ISRVHHRHLVSLVGYCISERERLLV 455 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~---~~~~~~~~Ei~~-l~~l~HpnIv~l~~~~~~~~~~~lV 455 (727)
++|+++++||+|+||.||+|+++ +++.||||+++.... .....+.+|..+ ++.++|+||++++++|.+.+.+|||
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 56999999999999999999976 488999999975432 233456677776 4678999999999999999999999
Q ss_pred EeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhcc
Q 041135 456 YEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALEL 535 (727)
Q Consensus 456 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 535 (727)
|||+.||+|.++++..+. +.+..++.++.||+.||+|||++ +|+|||||++||||+.++++||+|||+++....
T Consensus 118 ~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~- 191 (373)
T 2r5t_A 118 LDYINGGELFYHLQRERC--FLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIE- 191 (373)
T ss_dssp EECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC-
T ss_pred EeCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCcccccccc-
Confidence 999999999999977554 88899999999999999999999 999999999999999999999999999985322
Q ss_pred CCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHH
Q 041135 536 DSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEA 615 (727)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~ 615 (727)
........+||..|+|||++.+..++.++||||||||||||++|+.||..... .+. +..
T Consensus 192 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~-------------~~~ 250 (373)
T 2r5t_A 192 --HNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT------AEM-------------YDN 250 (373)
T ss_dssp --CCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH------HHH-------------HHH
T ss_pred --CCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHH-------------HHH
Confidence 12233457899999999999999999999999999999999999999975321 111 111
Q ss_pred HHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHH
Q 041135 616 LVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVV 655 (727)
Q Consensus 616 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 655 (727)
++...+ .+.......+.+|+++||+.||++|+++.+.+
T Consensus 251 i~~~~~--~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~ 288 (373)
T 2r5t_A 251 ILNKPL--QLKPNITNSARHLLEGLLQKDRTKRLGAKDDF 288 (373)
T ss_dssp HHHSCC--CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred HHhccc--CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence 111111 12222334578899999999999999985433
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=373.55 Aligned_cols=250 Identities=23% Similarity=0.296 Sum_probs=203.9
Q ss_pred cCccccceeccCCceEEEEEEE-cCCcEEEEEEeeeCC---chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVL-ADGREVAVKQLKIGG---SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
++|++++.||+|+||.||+|++ .+|+.||||++.... ......+.+|+++|+.++|+||++++++|.+....+|||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5799999999999999999997 468999999986432 222357899999999999999999999999999999999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccC
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 536 (727)
||+ +|+|.+++...+. +++.+++.|+.||+.||+|||++ +|+|||||++||||++++.+||+|||+++....
T Consensus 89 E~~-~g~l~~~l~~~~~--l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~-- 160 (336)
T 3h4j_B 89 EYA-GGELFDYIVEKKR--MTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD-- 160 (336)
T ss_dssp CCC-CEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT--
T ss_pred ECC-CCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccC--
Confidence 999 7888888876554 89999999999999999999999 999999999999999999999999999975422
Q ss_pred CCccccccccCCccccccCcccCCCC-CchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHH
Q 041135 537 SNTHVSTRVMGTFGYMAPEYATSGKL-TEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEA 615 (727)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~l~~~~~-~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~ 615 (727)
.......+|+..|+|||++.+..+ +.++|||||||+||||++|+.||+..........+ ....
T Consensus 161 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i-----------~~~~--- 224 (336)
T 3h4j_B 161 --GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV-----------NSCV--- 224 (336)
T ss_dssp --SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC-----------CSSC---
T ss_pred --CcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH-----------HcCC---
Confidence 222345679999999999998776 78999999999999999999999764322111000 0000
Q ss_pred HHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhc
Q 041135 616 LVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661 (727)
Q Consensus 616 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 661 (727)
..........+.+|+++||+.||++||++.||+++-+..
T Consensus 225 -------~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~ 263 (336)
T 3h4j_B 225 -------YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFN 263 (336)
T ss_dssp -------CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHH
T ss_pred -------CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhc
Confidence 001111223467899999999999999999999886644
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=365.16 Aligned_cols=265 Identities=25% Similarity=0.366 Sum_probs=208.4
Q ss_pred HHHHhcCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHH--cCCCCceeEeeEeeccc---
Q 041135 376 LIQATNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISR--VHHRHLVSLVGYCISER--- 450 (727)
Q Consensus 376 l~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~--l~HpnIv~l~~~~~~~~--- 450 (727)
.....++|++.++||+|+||.||+|++ +|+.||||+++. .....+.+|++++.. ++|+||+++++++.+..
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 37 QRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred cccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 344567899999999999999999998 589999999863 345678889999988 78999999999998876
Q ss_pred -eeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHH--------hcCCCcEEeeCCCCCceEECCCCcE
Q 041135 451 -ERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLH--------EDCHPRIIHRDIKSSNILLDSSFEA 521 (727)
Q Consensus 451 -~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH--------~~~~~~ivHrDLkp~NILl~~~~~v 521 (727)
..+|||||+.+|+|.+++... .+++.++++++.||+.||+||| ++ +|+|||||++||||+.++.+
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~~~ 186 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNGTC 186 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTSCE
T ss_pred ceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCCCE
Confidence 789999999999999999764 3899999999999999999999 77 99999999999999999999
Q ss_pred EEEeeccchhhhccCCCc-cccccccCCccccccCcccCCC------CCchhHHHHHhHHHHHHHhC----------CCC
Q 041135 522 RVADFGLAKIALELDSNT-HVSTRVMGTFGYMAPEYATSGK------LTEKSDVYSFGVVLLELITG----------RKP 584 (727)
Q Consensus 522 kL~DFGla~~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~------~~~ksDVwS~Gvil~eLltG----------~~P 584 (727)
||+|||+++......... .......|+..|+|||++.+.. ++.++|||||||+||||++| +.|
T Consensus 187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p 266 (342)
T 1b6c_B 187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266 (342)
T ss_dssp EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence 999999997543221111 1223457999999999998762 33789999999999999999 677
Q ss_pred CCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHhhccc-----chhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 585 VDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRLEKNY-----VDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 585 f~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
|....... .....+... +....+.... .......+.+|+++||+.||++||++.||+++|+
T Consensus 267 ~~~~~~~~-~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~ 332 (342)
T 1b6c_B 267 YYDLVPSD-PSVEEMRKV-------------VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332 (342)
T ss_dssp TTTTSCSS-CCHHHHHHH-------------HTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHH
T ss_pred ccccCcCc-ccHHHHHHH-------------HHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence 76543221 111111110 0111111111 2245567889999999999999999999999999
Q ss_pred hccCC
Q 041135 660 TLDGA 664 (727)
Q Consensus 660 ~~~~~ 664 (727)
++.+.
T Consensus 333 ~i~~~ 337 (342)
T 1b6c_B 333 QLSQQ 337 (342)
T ss_dssp HHHHT
T ss_pred HHHHH
Confidence 98653
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=383.55 Aligned_cols=264 Identities=20% Similarity=0.281 Sum_probs=207.8
Q ss_pred hcCccccceeccCCceEEEEEEE-cCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCC-CCceeEeeEeeccceeeEEEe
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVL-ADGREVAVKQLKIGGSQGEREFRAEVEIISRVHH-RHLVSLVGYCISERERLLVYE 457 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H-pnIv~l~~~~~~~~~~~lV~E 457 (727)
.++|+++++||+|+||.||+|++ .+|+.||||+++.... ...+.+|+++|+.|+| .+|..+..++.+....+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 46799999999999999999996 4689999998865432 3468899999999986 566666677777888899999
Q ss_pred eccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEE---CCCCcEEEEeeccchhhhc
Q 041135 458 YVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILL---DSSFEARVADFGLAKIALE 534 (727)
Q Consensus 458 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl---~~~~~vkL~DFGla~~~~~ 534 (727)
|+ +++|.+++..... .+++.+++.|+.||+.||+|||++ +|||||||++|||| ++++.+||+|||+++.+..
T Consensus 84 ~~-g~sL~~ll~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp CC-CCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred CC-CCCHHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 99 9999999875432 489999999999999999999999 99999999999999 5889999999999986533
Q ss_pred cCCCc----cccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhch
Q 041135 535 LDSNT----HVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEH 610 (727)
Q Consensus 535 ~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~ 610 (727)
..... ......+|+..|+|||++.+..++.++||||||||||||++|+.||............+.. ....+ .
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i---~~~~~-~ 234 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI---SEKKV-A 234 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHH---HHHHH-H
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHH---hhccc-c
Confidence 22211 1223568999999999999999999999999999999999999999876543322222111 11100 0
Q ss_pred hhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 611 EDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 611 ~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
..+..+ ...+ ...+.+|+++||+.||++||++.+|++.|+++..
T Consensus 235 ~~~~~l-----~~~~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~ 278 (483)
T 3sv0_A 235 TSIEAL-----CRGY----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI 278 (483)
T ss_dssp SCHHHH-----HTTS----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred ccHHHH-----hcCC----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 111111 1112 2358899999999999999999999999998744
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=374.72 Aligned_cols=266 Identities=24% Similarity=0.390 Sum_probs=193.1
Q ss_pred HHhcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeC--CchhHHHHHHHHHHHHHcC-CCCceeEeeEeeccc--e
Q 041135 378 QATNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIG--GSQGEREFRAEVEIISRVH-HRHLVSLVGYCISER--E 451 (727)
Q Consensus 378 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~--~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~--~ 451 (727)
...++|+++++||+|+||.||+|++. +|+.||||++... .....+.+.+|+.+|+++. |+||++++++|..++ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 34578999999999999999999974 6899999998533 3344567889999999997 999999999997544 6
Q ss_pred eeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchh
Q 041135 452 RLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKI 531 (727)
Q Consensus 452 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 531 (727)
+|||||||. ++|..+++.+ .+++..+..|+.||++||+|||++ +|+|||||++||||+.++.+||+|||+++.
T Consensus 86 ~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 899999997 5888888764 488999999999999999999999 999999999999999999999999999975
Q ss_pred hhccC------------------CCccccccccCCccccccCcccC-CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCC
Q 041135 532 ALELD------------------SNTHVSTRVMGTFGYMAPEYATS-GKLTEKSDVYSFGVVLLELITGRKPVDASQPLG 592 (727)
Q Consensus 532 ~~~~~------------------~~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~ 592 (727)
+.... .........+||..|+|||++.+ ..++.++||||||||||||++|+.||.+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~- 237 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM- 237 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH-
Confidence 42211 11122344689999999999987 67899999999999999999999999765321
Q ss_pred chhhHHhhHHHHHHhhch-----------hhHHHHHHH----------------------HhhcccchhHHHHHHHHHHH
Q 041135 593 DESLVEWARPLLAEALEH-----------EDFEALVDS----------------------RLEKNYVDSEMFWMIEAAAA 639 (727)
Q Consensus 593 ~~~l~~~~~~~l~~~~~~-----------~~~~~l~d~----------------------~l~~~~~~~~~~~l~~li~~ 639 (727)
+....++. .+.. .....+++. .............+.+|+++
T Consensus 238 -----~~~~~i~~-~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~ 311 (388)
T 3oz6_A 238 -----NQLERIIG-VIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDK 311 (388)
T ss_dssp -----HHHHHHHH-HHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHH
T ss_pred -----HHHHHHHH-hcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHH
Confidence 11111110 0000 000000000 00000001123357899999
Q ss_pred HhccCCCCCCCHHHHHHH
Q 041135 640 CVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 640 cl~~dP~~RPs~~evl~~ 657 (727)
||+.||++|+++.|++++
T Consensus 312 ~L~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 312 LLQFNPNKRISANDALKH 329 (388)
T ss_dssp HCCSSGGGSCCHHHHTTS
T ss_pred hhccCcccCCCHHHHhCC
Confidence 999999999999999988
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=367.78 Aligned_cols=263 Identities=27% Similarity=0.388 Sum_probs=199.3
Q ss_pred HHHhcCccccceeccCCceEEEEEEEc----CCcEEEEEEeeeCCc--hhHHHHHHHHHHHHHcCCCCceeEeeEeeccc
Q 041135 377 IQATNGFSAHNVLGEGGFGCVYKGVLA----DGREVAVKQLKIGGS--QGEREFRAEVEIISRVHHRHLVSLVGYCISER 450 (727)
Q Consensus 377 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~----~g~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~ 450 (727)
....++|++.++||+|+||.||+|++. .++.||||+++.... ...+.+.+|+++|++++|+||++++++|.+..
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 109 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS 109 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence 334567999999999999999999864 245899999875432 33467999999999999999999999998755
Q ss_pred -----eeeEEEeeccCCccchhcccC----CCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcE
Q 041135 451 -----ERLLVYEYVPNDTLHYHLHAE----GRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEA 521 (727)
Q Consensus 451 -----~~~lV~Ey~~~gsL~~~L~~~----~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~v 521 (727)
..++||||+.+++|.+++... ....+++..+++|+.||++||.|||++ +|+|||||++||||+.++.+
T Consensus 110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~ 186 (313)
T 3brb_A 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTV 186 (313)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCE
T ss_pred ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcE
Confidence 349999999999999988432 234589999999999999999999999 99999999999999999999
Q ss_pred EEEeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhh
Q 041135 522 RVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWA 600 (727)
Q Consensus 522 kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~ 600 (727)
||+|||+++...... .........++..|+|||++.+..++.++|||||||+||||++ |+.||...... .+..
T Consensus 187 kl~Dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~-- 260 (313)
T 3brb_A 187 CVADFGLSKKIYSGD-YYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH---EMYD-- 260 (313)
T ss_dssp EECSCSCC-----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHH--
T ss_pred EEeecCcceeccccc-ccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH---HHHH--
Confidence 999999997643221 1122233567889999999999999999999999999999999 88998754321 1110
Q ss_pred HHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 601 RPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 601 ~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
.+...............+.+|+.+||+.||++||++.+|+++|+.+..
T Consensus 261 ---------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~ 308 (313)
T 3brb_A 261 ---------------YLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308 (313)
T ss_dssp ---------------HHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------------HHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 011111112222333458899999999999999999999999998753
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=372.72 Aligned_cols=258 Identities=25% Similarity=0.360 Sum_probs=189.0
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcC-CCCceeEeeEee--------cc
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRVH-HRHLVSLVGYCI--------SE 449 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~--------~~ 449 (727)
..+|++.++||+|+||.||+|++. +|+.||||++........+.+.+|+.+|+++. |+||+++++++. ..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 457999999999999999999975 68999999997776666778999999999996 999999999984 34
Q ss_pred ceeeEEEeeccCCccchhccc-CCCCcccHHHHHHHHHHHHHHHHHHHhcCCCc--EEeeCCCCCceEECCCCcEEEEee
Q 041135 450 RERLLVYEYVPNDTLHYHLHA-EGRPVMDWATRVKVAAGAARGIAYLHEDCHPR--IIHRDIKSSNILLDSSFEARVADF 526 (727)
Q Consensus 450 ~~~~lV~Ey~~~gsL~~~L~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~--ivHrDLkp~NILl~~~~~vkL~DF 526 (727)
...+|||||+. |+|.+++.. .....+++.++++|+.||+.||+|||++ + |+|||||++||||+.++.+||+||
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecC
Confidence 46799999995 788887754 2233589999999999999999999998 8 999999999999999999999999
Q ss_pred ccchhhhccCCCc---------cccccccCCccccccCcc---cCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCch
Q 041135 527 GLAKIALELDSNT---------HVSTRVMGTFGYMAPEYA---TSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDE 594 (727)
Q Consensus 527 Gla~~~~~~~~~~---------~~~~~~~gt~~y~aPE~l---~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~ 594 (727)
|+++......... .......|+..|+|||++ .+..++.++|||||||+||||++|+.||.......
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-- 260 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR-- 260 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH--
Confidence 9997643221110 011135689999999998 56678999999999999999999999996532110
Q ss_pred hhHHhhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccCC
Q 041135 595 SLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDGA 664 (727)
Q Consensus 595 ~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 664 (727)
+++..+...........+.+|+++||+.||++||++.||+++|+.+...
T Consensus 261 ---------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~ 309 (337)
T 3ll6_A 261 ---------------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA 309 (337)
T ss_dssp --------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---------------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 0111111111111122367899999999999999999999999988653
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=357.73 Aligned_cols=254 Identities=23% Similarity=0.396 Sum_probs=208.0
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEe
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYE 457 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 457 (727)
.+.|+++++||+|+||.||+|+.. +|+.||||+++.... ...+.+.+|+++|++++|+||++++++|.++...+||||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 356899999999999999999864 589999999975543 345789999999999999999999999999999999999
Q ss_pred eccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCC
Q 041135 458 YVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDS 537 (727)
Q Consensus 458 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 537 (727)
|+.+++|.+++... .+++..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++....
T Consensus 101 ~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~--- 171 (303)
T 3a7i_A 101 YLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD--- 171 (303)
T ss_dssp CCTTEEHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBT---
T ss_pred eCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCc---
Confidence 99999999998653 489999999999999999999999 999999999999999999999999999975422
Q ss_pred CccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHH
Q 041135 538 NTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALV 617 (727)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~ 617 (727)
.........|+..|+|||++.+..++.++|||||||+||||++|+.||..... .... . .+
T Consensus 172 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~---~--------------~~ 231 (303)
T 3a7i_A 172 TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP---MKVL---F--------------LI 231 (303)
T ss_dssp TBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHH---H--------------HH
T ss_pred cccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH---HHHH---H--------------Hh
Confidence 11223345789999999999999999999999999999999999999975321 1000 0 00
Q ss_pred HHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhcc
Q 041135 618 DSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLD 662 (727)
Q Consensus 618 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 662 (727)
...............+.+|+.+||+.||++||++.||+++.....
T Consensus 232 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 276 (303)
T 3a7i_A 232 PKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILR 276 (303)
T ss_dssp HHSCCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHH
T ss_pred hcCCCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhc
Confidence 001111111222345789999999999999999999999866543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=361.84 Aligned_cols=252 Identities=28% Similarity=0.434 Sum_probs=200.6
Q ss_pred hcCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeecc-ceeeEEEee
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISE-RERLLVYEY 458 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~-~~~~lV~Ey 458 (727)
.++|++.+.||+|+||.||+|++. |+.||||+++.. ...+.+.+|+++|++++|+||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 467999999999999999999884 899999998743 3456799999999999999999999997654 478999999
Q ss_pred ccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCC
Q 041135 459 VPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSN 538 (727)
Q Consensus 459 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 538 (727)
+.+++|.+++.......+++..+++++.||++||+|||++ +|+|||||++||||+.++.+||+|||+++.....
T Consensus 97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--- 170 (278)
T 1byg_A 97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 170 (278)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccccc---
Confidence 9999999999766544478899999999999999999999 9999999999999999999999999999754211
Q ss_pred ccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHH
Q 041135 539 THVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALV 617 (727)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~ 617 (727)
.....++..|+|||++.+..++.++|||||||+||||++ |+.||..... ..+. ..+
T Consensus 171 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~---~~~~-----------------~~~ 227 (278)
T 1byg_A 171 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVV-----------------PRV 227 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG---GGHH-----------------HHH
T ss_pred ---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH---HHHH-----------------HHH
Confidence 123357889999999999999999999999999999998 9999975431 1111 011
Q ss_pred HHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 618 DSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 618 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
...............+.+|+++||+.||++||++.||++.|+++..
T Consensus 228 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 228 EKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273 (278)
T ss_dssp TTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence 1111112222334458899999999999999999999999998853
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=386.79 Aligned_cols=251 Identities=22% Similarity=0.307 Sum_probs=196.6
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeC---CchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEE
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIG---GSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLV 455 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 455 (727)
.++|+++++||+|+||.||+|+.. +|+.||||+++.. .......+.+|+++|++++|+||++++++|.+.+.+|||
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 367999999999999999999975 5899999999743 233345678899999999999999999999999999999
Q ss_pred EeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHh-cCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhc
Q 041135 456 YEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHE-DCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALE 534 (727)
Q Consensus 456 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 534 (727)
|||+.+|+|.+++..... +++..++.|+.||+.||+|||+ + +|||||||++||||+.++.+||+|||+++....
T Consensus 227 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 227 MEYANGGELFFHLSRERV--FSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp ECCCSSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EeeCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 999999999999976654 8999999999999999999998 7 899999999999999999999999999975321
Q ss_pred cCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHH
Q 041135 535 LDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFE 614 (727)
Q Consensus 535 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~ 614 (727)
........+||..|+|||++.+..++.++||||||||||||++|+.||..... . +...
T Consensus 302 ---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~---~~~~------------- 359 (446)
T 4ejn_A 302 ---DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---E---KLFE------------- 359 (446)
T ss_dssp --------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---H---HHHH-------------
T ss_pred ---CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH---H---HHHH-------------
Confidence 12223457899999999999999999999999999999999999999975321 1 1111
Q ss_pred HHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCC-----CHHHHHHHHh
Q 041135 615 ALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRP-----RMSQVVRALD 659 (727)
Q Consensus 615 ~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L~ 659 (727)
.+.... ..+.......+.+|+.+||+.||++|+ ++.||+++-.
T Consensus 360 ~i~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~ 407 (446)
T 4ejn_A 360 LILMEE--IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRF 407 (446)
T ss_dssp HHHHCC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred HHHhCC--CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCcc
Confidence 111111 112222334578999999999999999 9999988643
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=353.41 Aligned_cols=253 Identities=23% Similarity=0.317 Sum_probs=204.8
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC--chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG--SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
.++|++.++||+|+||.||+|++. +|+.||||++.... ....+.+.+|++++++++|+||++++++|.++...++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 467999999999999999999975 58999999997543 233467889999999999999999999999999999999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCc---EEEEeeccchhhh
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFE---ARVADFGLAKIAL 533 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~---vkL~DFGla~~~~ 533 (727)
||+.+++|.+++..... +++.+++.++.||+.||+|||++ +|+|||||++||||+.++. +||+|||++....
T Consensus 85 e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 85 DLVTGGELFEDIVAREF--YSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp CCCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 99999999988876643 89999999999999999999999 9999999999999976654 9999999997542
Q ss_pred ccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhH
Q 041135 534 ELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDF 613 (727)
Q Consensus 534 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~ 613 (727)
. ........|+..|+|||++.+..++.++|||||||+||||++|+.||..... . +...
T Consensus 160 ~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---~---~~~~------------ 217 (284)
T 3kk8_A 160 D----SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---H---RLYA------------ 217 (284)
T ss_dssp S----SCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---H---HHHH------------
T ss_pred c----CccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch---h---HHHH------------
Confidence 1 1222346789999999999999999999999999999999999999965321 1 1111
Q ss_pred HHHHHHHhhc--ccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhh
Q 041135 614 EALVDSRLEK--NYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDT 660 (727)
Q Consensus 614 ~~l~d~~l~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 660 (727)
.+....+.. .........+.+|+++||+.||++||++.||+++-.-
T Consensus 218 -~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~ 265 (284)
T 3kk8_A 218 -QIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 265 (284)
T ss_dssp -HHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHH
T ss_pred -HHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccc
Confidence 011111100 0001223457899999999999999999999997543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=366.59 Aligned_cols=268 Identities=23% Similarity=0.324 Sum_probs=200.4
Q ss_pred cCcccc-ceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHc-CCCCceeEeeEeeccceeeEEEe
Q 041135 381 NGFSAH-NVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRV-HHRHLVSLVGYCISERERLLVYE 457 (727)
Q Consensus 381 ~~~~~~-~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E 457 (727)
++|++. ++||+|+||.||+|+.. +|+.||||+++.......+.+.+|+++|.++ +|+||+++++++.+++..|||||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 457774 78999999999999964 6899999999866656667899999999985 79999999999999999999999
Q ss_pred eccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCc---EEEEeeccchhhhc
Q 041135 458 YVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFE---ARVADFGLAKIALE 534 (727)
Q Consensus 458 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~---vkL~DFGla~~~~~ 534 (727)
|+.+++|.+++..... +++.+++.|+.||++||+|||++ +|+|||||++||||+.++. +||+|||+++....
T Consensus 92 ~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 92 KMRGGSILSHIHKRRH--FNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp CCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred cCCCCcHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 9999999999977643 89999999999999999999999 9999999999999988765 99999999975422
Q ss_pred cCCC----ccccccccCCccccccCcccC-----CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHH
Q 041135 535 LDSN----THVSTRVMGTFGYMAPEYATS-----GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLA 605 (727)
Q Consensus 535 ~~~~----~~~~~~~~gt~~y~aPE~l~~-----~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~ 605 (727)
.... .......+|+..|+|||++.+ ..++.++|||||||+||||++|+.||......... |......
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~----~~~~~~~ 242 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCG----WDRGEAC 242 (316)
T ss_dssp ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSC----C----CC
T ss_pred CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccc----ccccccc
Confidence 1111 111223569999999999975 45889999999999999999999999875432211 1000000
Q ss_pred HhhchhhHHHHHHHHhhcccc----hhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 606 EALEHEDFEALVDSRLEKNYV----DSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 606 ~~~~~~~~~~l~d~~l~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
.......+..+....+ .+. ......+.+|+++||+.||++||++.||+++-.
T Consensus 243 ~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 298 (316)
T 2ac3_A 243 PACQNMLFESIQEGKY--EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPW 298 (316)
T ss_dssp HHHHHHHHHHHHHCCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTT
T ss_pred hhHHHHHHHHHhccCc--ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChh
Confidence 0000000111111111 011 112235789999999999999999999998644
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=377.27 Aligned_cols=274 Identities=18% Similarity=0.244 Sum_probs=209.6
Q ss_pred cCccccceeccCCceEEEEEEEcC-CcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEeeccc--eeeEEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLAD-GREVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYCISER--ERLLVY 456 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~~-g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~--~~~lV~ 456 (727)
++|++.++||+|+||.||+|++.. |+.||||+++.... ...+.+.+|+++|++++|+||+++++++.+.. ..+|||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 568999999999999999999864 89999999974332 33467889999999999999999999998755 779999
Q ss_pred eeccCCccchhcccCCC-CcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEE----CCCCcEEEEeeccchh
Q 041135 457 EYVPNDTLHYHLHAEGR-PVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILL----DSSFEARVADFGLAKI 531 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl----~~~~~vkL~DFGla~~ 531 (727)
||+.+|+|.++++.... ..+++..++.|+.||+.||+|||++ +|+|||||++|||| +.++.+||+|||+++.
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 99999999999976532 2389999999999999999999999 99999999999999 7788899999999975
Q ss_pred hhccCCCccccccccCCccccccCcccC--------CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHH
Q 041135 532 ALELDSNTHVSTRVMGTFGYMAPEYATS--------GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPL 603 (727)
Q Consensus 532 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~ 603 (727)
... .......+|+..|+|||++.+ ..++.++|||||||+||||++|+.||......... .+....+
T Consensus 166 ~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~--~~~~~~~ 239 (396)
T 4eut_A 166 LED----DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYKI 239 (396)
T ss_dssp CCC----GGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC--HHHHHHH
T ss_pred ccC----CCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch--HHHHHHH
Confidence 422 122334679999999999865 56788999999999999999999999764432111 1111111
Q ss_pred HHHhhch--hhHHHHHHH--------HhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 604 LAEALEH--EDFEALVDS--------RLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 604 l~~~~~~--~~~~~l~d~--------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
+...... ..+....+. .............+.+|+++||+.||++|++++|+++.|+.+..
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 1100000 000000000 00011224455668899999999999999999999999988754
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=360.63 Aligned_cols=254 Identities=23% Similarity=0.324 Sum_probs=205.2
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCch------hHHHHHHHHHHHHHcCCCCceeEeeEeecccee
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQ------GEREFRAEVEIISRVHHRHLVSLVGYCISERER 452 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~------~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 452 (727)
.++|++++.||+|+||.||+|++. +|+.||||+++..... ..+.+.+|+++|++++|+||++++++|.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 356999999999999999999976 5899999999754322 356799999999999999999999999999999
Q ss_pred eEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCC----cEEEEeecc
Q 041135 453 LLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSF----EARVADFGL 528 (727)
Q Consensus 453 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~----~vkL~DFGl 528 (727)
+|||||+.+++|.+++.... .+++..++.|+.||+.||+|||++ +|+|||||++||||+.++ .+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCS--CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred EEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 99999999999999997654 489999999999999999999999 999999999999999887 799999999
Q ss_pred chhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhh
Q 041135 529 AKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEAL 608 (727)
Q Consensus 529 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~ 608 (727)
++.... ........|+..|+|||++.+..++.++|||||||+||||++|+.||..... . +....+....
T Consensus 166 ~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~---~~~~~i~~~~- 234 (321)
T 2a2a_A 166 AHEIED----GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---Q---ETLANITSVS- 234 (321)
T ss_dssp CEECCT----TCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH---H---HHHHHHHTTC-
T ss_pred ceecCc----cccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH---H---HHHHHHHhcc-
Confidence 975422 1122345789999999999999999999999999999999999999975421 1 1111000000
Q ss_pred chhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 609 EHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 609 ~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
..+. ..+.......+.+|+++||+.||++||++.||+++-.
T Consensus 235 --~~~~--------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~ 275 (321)
T 2a2a_A 235 --YDFD--------EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275 (321)
T ss_dssp --CCCC--------HHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTT
T ss_pred --cccC--------hhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence 0000 0000111234788999999999999999999998643
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=355.56 Aligned_cols=265 Identities=20% Similarity=0.266 Sum_probs=206.7
Q ss_pred hcCccccceeccCCceEEEEEEE-cCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEe-eccceeeEEEe
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVL-ADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYC-ISERERLLVYE 457 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~-~~~~~~~lV~E 457 (727)
.++|++.++||+|+||.||+|++ .+|+.||||++.... ..+.+.+|+++++.++|.+++..++++ .++...+||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 46799999999999999999996 578999999987543 235689999999999988877666655 55677899999
Q ss_pred eccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEE---CCCCcEEEEeeccchhhhc
Q 041135 458 YVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILL---DSSFEARVADFGLAKIALE 534 (727)
Q Consensus 458 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl---~~~~~vkL~DFGla~~~~~ 534 (727)
|+ +++|.+++.... ..+++.+++.|+.||+.||+|||++ +|+|||||++|||| ++++.+||+|||+++....
T Consensus 86 ~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred ec-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 99 999999987433 2489999999999999999999999 99999999999999 4888999999999986432
Q ss_pred cCCCc----cccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhch
Q 041135 535 LDSNT----HVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEH 610 (727)
Q Consensus 535 ~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~ 610 (727)
..... .......|+..|+|||++.+..++.++|||||||+||||++|+.||................ .....
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~---~~~~~- 236 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS---EKKMS- 236 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHH---HHHHH-
T ss_pred cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhc---ccccC-
Confidence 22111 11245679999999999999999999999999999999999999998754332222211110 00000
Q ss_pred hhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccCC
Q 041135 611 EDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDGA 664 (727)
Q Consensus 611 ~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 664 (727)
... ..+... ....+.+|+++||+.||++||++.+|++.|+++...
T Consensus 237 ~~~-----~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 281 (296)
T 3uzp_A 237 TPI-----EVLCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp SCH-----HHHTTT----SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred Cch-----HHHHhh----CCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHh
Confidence 000 011111 123478899999999999999999999999988543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=372.18 Aligned_cols=254 Identities=22% Similarity=0.294 Sum_probs=202.5
Q ss_pred HhcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHc-CCCCceeEeeEeeccceeeEEE
Q 041135 379 ATNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRV-HHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 379 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
..++|++++.||+|+||.||+|+++ +|+.||||+++... ..+.+|+++|.++ +|+||++++++|.++...||||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK----RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT----CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc----CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 3467999999999999999999976 58899999997432 2456788899888 7999999999999999999999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCC----CcEEEEeeccchhh
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSS----FEARVADFGLAKIA 532 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~----~~vkL~DFGla~~~ 532 (727)
|||.||+|.+++...+. +++.+++.++.||+.||+|||++ +|+|||||++||||.++ +.+||+|||+++..
T Consensus 96 E~~~gg~L~~~i~~~~~--~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 96 ELMKGGELLDKILRQKF--FSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCCCSCBHHHHHHTCTT--CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred eCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 99999999999876654 89999999999999999999999 99999999999998433 35999999999854
Q ss_pred hccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhh
Q 041135 533 LELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHED 612 (727)
Q Consensus 533 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~ 612 (727)
.. ........+|+..|+|||++.+..++.++|||||||+||||++|+.||......... ++...
T Consensus 171 ~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~---~~~~~---------- 234 (342)
T 2qr7_A 171 RA---ENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPE---EILAR---------- 234 (342)
T ss_dssp BC---TTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHH---HHHHH----------
T ss_pred cC---CCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHH---HHHHH----------
Confidence 22 122234567899999999999888999999999999999999999999754321111 11111
Q ss_pred HHHHHHHHh--hcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhh
Q 041135 613 FEALVDSRL--EKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDT 660 (727)
Q Consensus 613 ~~~l~d~~l--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 660 (727)
+....+ ...+.......+.+|+++||+.||++|+++.||+++-+.
T Consensus 235 ---i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~ 281 (342)
T 2qr7_A 235 ---IGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281 (342)
T ss_dssp ---HHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHH
T ss_pred ---HccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCee
Confidence 111111 111112233457889999999999999999999987554
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=368.20 Aligned_cols=251 Identities=21% Similarity=0.301 Sum_probs=205.7
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEE
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLV 455 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 455 (727)
.++|.++++||+|+||.||++++. +++.||+|++.... ....+.+.+|+++|++++|+||++++++|.+++..|||
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 356899999999999999999976 47899999986432 23456789999999999999999999999999999999
Q ss_pred EeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhcc
Q 041135 456 YEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALEL 535 (727)
Q Consensus 456 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 535 (727)
|||+.+++|.+++..+. .+++.+++.|+.||++||+|||++ +|+|||||++||||+.++.+||+|||+++....
T Consensus 120 ~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~- 193 (335)
T 2owb_A 120 LELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY- 193 (335)
T ss_dssp ECCCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCS-
T ss_pred EecCCCCCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceeccc-
Confidence 99999999999887654 389999999999999999999999 999999999999999999999999999975421
Q ss_pred CCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHH
Q 041135 536 DSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEA 615 (727)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~ 615 (727)
.........|+..|+|||++.+..++.++|||||||+||||++|+.||..... .+... .
T Consensus 194 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~-------------~ 252 (335)
T 2owb_A 194 --DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL------KETYL-------------R 252 (335)
T ss_dssp --TTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHH-------------H
T ss_pred --CcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH------HHHHH-------------H
Confidence 11223446789999999999999999999999999999999999999975321 11110 1
Q ss_pred HHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 616 LVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 616 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
+....+ .+.......+.+|+++||+.||++||++.||+++-.
T Consensus 253 ~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~ 294 (335)
T 2owb_A 253 IKKNEY--SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEF 294 (335)
T ss_dssp HHHTCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred HhcCCC--CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 111111 111122335778999999999999999999998644
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=376.33 Aligned_cols=258 Identities=29% Similarity=0.453 Sum_probs=195.2
Q ss_pred CccccceeccCCceEEEEEEEcC--C--cEEEEEEeeeCC-chhHHHHHHHHHHHHHcCCCCceeEeeEeec-cceeeEE
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLAD--G--REVAVKQLKIGG-SQGEREFRAEVEIISRVHHRHLVSLVGYCIS-ERERLLV 455 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~~--g--~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~-~~~~~lV 455 (727)
.|++.++||+|+||.||+|++.+ + ..||||+++... ....+.|.+|+++|++++|+||++++++|.+ ++..+||
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 46778999999999999998642 2 468999986433 3445789999999999999999999998764 4578999
Q ss_pred EeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhcc
Q 041135 456 YEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALEL 535 (727)
Q Consensus 456 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 535 (727)
|||+.+|+|.++++.... .+++.+++.|+.||++||+|||++ +|+|||||++||||++++.+||+|||+++.....
T Consensus 170 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EECCTTCBHHHHHHCTTC-CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EECCCCCCHHHHHhhccc-CCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccccc
Confidence 999999999999976433 578999999999999999999999 9999999999999999999999999999864322
Q ss_pred CCC-ccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhH
Q 041135 536 DSN-THVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDF 613 (727)
Q Consensus 536 ~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~ 613 (727)
... ........++..|+|||++.+..++.++|||||||+||||++ |..||....... +...
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~~~-------------- 308 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVY-------------- 308 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HHHH--------------
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HHHH--------------
Confidence 111 112234567889999999999999999999999999999999 677776544321 1110
Q ss_pred HHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 614 EALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 614 ~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
+.. .............+.+|+++||+.||++||++.||++.|+.+..
T Consensus 309 --~~~-~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~ 355 (373)
T 3c1x_A 309 --LLQ-GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 355 (373)
T ss_dssp --HHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --HHc-CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 000 00111112223458899999999999999999999999998854
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=367.40 Aligned_cols=257 Identities=28% Similarity=0.435 Sum_probs=203.9
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcE--EEEEEeeeCC-chhHHHHHHHHHHHHHc-CCCCceeEeeEeeccceeeEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGRE--VAVKQLKIGG-SQGEREFRAEVEIISRV-HHRHLVSLVGYCISERERLLV 455 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~--vaVK~l~~~~-~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lV 455 (727)
++|++.++||+|+||.||+|++. +|.. |+||+++... ....+.+.+|+++|+++ +|+||++++++|.+.+..|||
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 56899999999999999999965 4554 4999887432 33446799999999999 899999999999999999999
Q ss_pred EeeccCCccchhcccCC--------------CCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcE
Q 041135 456 YEYVPNDTLHYHLHAEG--------------RPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEA 521 (727)
Q Consensus 456 ~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~v 521 (727)
|||+.+++|.+++.... ...+++.+++.|+.||++||+|||++ +|+|||||++||||+.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence 99999999999987653 23589999999999999999999999 99999999999999999999
Q ss_pred EEEeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhh
Q 041135 522 RVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWA 600 (727)
Q Consensus 522 kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~ 600 (727)
||+|||+++.... ........++..|+|||++.+..++.++|||||||+||||++ |+.||..... ..+
T Consensus 182 kL~Dfg~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~---~~~---- 250 (327)
T 1fvr_A 182 KIADFGLSRGQEV----YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AEL---- 250 (327)
T ss_dssp EECCTTCEESSCE----ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHH----
T ss_pred EEcccCcCccccc----cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH---HHH----
Confidence 9999999974211 112233456889999999998889999999999999999998 9999975431 110
Q ss_pred HHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccCC
Q 041135 601 RPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDGA 664 (727)
Q Consensus 601 ~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 664 (727)
.. .+...............+.+|+++||+.||++||++.||++.|+.+...
T Consensus 251 ---~~----------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 301 (327)
T 1fvr_A 251 ---YE----------KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 301 (327)
T ss_dssp ---HH----------HGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ---HH----------HhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 00 0011111112222334588999999999999999999999999987543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=367.08 Aligned_cols=248 Identities=19% Similarity=0.283 Sum_probs=180.8
Q ss_pred cceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcC-CCCceeEeeEeeccceeeEEEeeccCCc
Q 041135 386 HNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRVH-HRHLVSLVGYCISERERLLVYEYVPNDT 463 (727)
Q Consensus 386 ~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~lV~Ey~~~gs 463 (727)
.++||+|+||.||+|++. +|+.||||++.. .....+.+|+++|+++. |+||++++++|.++...||||||+.+|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 478999999999999975 589999999863 34567889999999997 9999999999999999999999999999
Q ss_pred cchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCC---cEEEEeeccchhhhccCCCcc
Q 041135 464 LHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSF---EARVADFGLAKIALELDSNTH 540 (727)
Q Consensus 464 L~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~---~vkL~DFGla~~~~~~~~~~~ 540 (727)
|.+++..+.. +++.+++.|+.||+.||+|||++ +|+|||||++||||+.++ .+||+|||+++... ....
T Consensus 93 L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~---~~~~ 164 (325)
T 3kn6_A 93 LFERIKKKKH--FSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP---PDNQ 164 (325)
T ss_dssp HHHHHHHCSC--CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECC---C---
T ss_pred HHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecC---CCCC
Confidence 9999987654 89999999999999999999999 999999999999997655 89999999997532 1222
Q ss_pred ccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHH
Q 041135 541 VSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSR 620 (727)
Q Consensus 541 ~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~ 620 (727)
.....+|+..|+|||++.+..++.++|||||||+||||++|+.||......... ....++++..
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~----------------~~~~~~~~~i 228 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTC----------------TSAVEIMKKI 228 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------C----------------CCHHHHHHHH
T ss_pred cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccccc----------------ccHHHHHHHH
Confidence 234457899999999999999999999999999999999999999764421110 0011111111
Q ss_pred hhcccc------hhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhh
Q 041135 621 LEKNYV------DSEMFWMIEAAAACVRHSATKRPRMSQVVRALDT 660 (727)
Q Consensus 621 l~~~~~------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 660 (727)
....+. ......+.+|+++||+.||++||++.||+++-+.
T Consensus 229 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~ 274 (325)
T 3kn6_A 229 KKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWL 274 (325)
T ss_dssp TTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGG
T ss_pred HcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhh
Confidence 111110 1123457899999999999999999999877543
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=363.30 Aligned_cols=260 Identities=25% Similarity=0.366 Sum_probs=197.5
Q ss_pred hcCccccceeccCCceEEEEEEEc--CCc--EEEEEEeeeC---CchhHHHHHHHHHHHHHcCCCCceeEeeEeecccee
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA--DGR--EVAVKQLKIG---GSQGEREFRAEVEIISRVHHRHLVSLVGYCISERER 452 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~--~g~--~vaVK~l~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 452 (727)
.++|+++++||+|+||.||+|++. +++ .||||+++.. .....+.+.+|+++|++++|+||+++++++.++. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 356999999999999999999863 233 6899998754 2344568999999999999999999999998765 8
Q ss_pred eEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhh
Q 041135 453 LLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIA 532 (727)
Q Consensus 453 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~ 532 (727)
++||||+.+++|.+++.... ..+++..+++++.||++||+|||++ +|+|||||++||||+.++.+||+|||+++..
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccccc
Confidence 89999999999999987643 2488999999999999999999999 9999999999999999999999999999765
Q ss_pred hccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchh
Q 041135 533 LELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHE 611 (727)
Q Consensus 533 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~ 611 (727)
..............++..|+|||++.+..++.++|||||||+||||++ |+.||..... .. ..
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~---~~----------- 234 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG---SQ---IL----------- 234 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HH---HH-----------
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH---HH---HH-----------
Confidence 332222222334567889999999998889999999999999999999 9999975431 11 10
Q ss_pred hHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 612 DFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 612 ~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
..+................+.+|+++||+.||++||++.+|++.|+++..
T Consensus 235 --~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 235 --HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp --HHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred --HHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 01111111111122233458899999999999999999999999998754
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=357.23 Aligned_cols=251 Identities=29% Similarity=0.419 Sum_probs=203.4
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc---hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEE
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS---QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLV 455 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 455 (727)
.++|++++.||+|+||.||+|++. +++.||||++..... .....+++|++++++++|+||++++++|.+....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 356999999999999999999875 477899999864321 2245688999999999999999999999999999999
Q ss_pred EeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhcc
Q 041135 456 YEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALEL 535 (727)
Q Consensus 456 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 535 (727)
|||+.+++|.+++..... +++..++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||++.....
T Consensus 88 ~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~- 161 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS- 161 (279)
T ss_dssp ECCCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EecCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCc-
Confidence 999999999999876644 89999999999999999999998 999999999999999999999999999864321
Q ss_pred CCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHH
Q 041135 536 DSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEA 615 (727)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~ 615 (727)
.......|+..|+|||++.+..++.++|||||||+||||++|+.||..... .+.. ..
T Consensus 162 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~-------------~~ 218 (279)
T 3fdn_A 162 ----SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY------QETY-------------KR 218 (279)
T ss_dssp ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHH-------------HH
T ss_pred ----ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH------HHHH-------------HH
Confidence 122345789999999999999999999999999999999999999975321 1110 00
Q ss_pred HHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhc
Q 041135 616 LVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661 (727)
Q Consensus 616 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 661 (727)
+. .....+.......+.+|+++||+.||++||++.||+++-+-.
T Consensus 219 ~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~ 262 (279)
T 3fdn_A 219 IS--RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 262 (279)
T ss_dssp HH--HTCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHH
T ss_pred HH--hCCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCcccc
Confidence 10 111122222334577899999999999999999999986543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=358.74 Aligned_cols=259 Identities=24% Similarity=0.353 Sum_probs=203.7
Q ss_pred CccccceeccCCceEEEEEEEcC----CcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEeecccee-eEE
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLAD----GREVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYCISERER-LLV 455 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~~----g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~-~lV 455 (727)
.|++.++||+|+||.||+|++.+ +..||||+++.... ...+.+.+|+++|++++|+||++++++|.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 36667999999999999998643 23799999875433 3446789999999999999999999999876655 999
Q ss_pred EeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhcc
Q 041135 456 YEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALEL 535 (727)
Q Consensus 456 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 535 (727)
|||+.+|+|.+++.... ..+++..++.|+.||+.||+|||++ +|+|||||++||||++++.+||+|||+++.....
T Consensus 102 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp ECCCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred EecccCCCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 99999999999997643 3579999999999999999999999 9999999999999999999999999999754322
Q ss_pred CC-CccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHH
Q 041135 536 DS-NTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFE 614 (727)
Q Consensus 536 ~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~ 614 (727)
.. .........++..|+|||.+.+..++.++|||||||++|||++|..+|..... ...+ .
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~--~~~~-----------------~ 238 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID--PFDL-----------------T 238 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC--GGGH-----------------H
T ss_pred cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC--HHHH-----------------H
Confidence 11 11222345678899999999999999999999999999999996666543221 1111 1
Q ss_pred HHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 615 ALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 615 ~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
..+...............+.+|+++||+.||++||++.||++.|+++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 287 (298)
T 3pls_A 239 HFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVS 287 (298)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 1111111111222233458899999999999999999999999998854
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=373.11 Aligned_cols=265 Identities=15% Similarity=0.220 Sum_probs=204.9
Q ss_pred cCccccceeccCCceEEEEEEEcC---------CcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCcee----------
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLAD---------GREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVS---------- 441 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~~---------g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~---------- 441 (727)
++|++.++||+|+||.||+|++.. ++.||||+++.. +.+.+|+++|++++|+||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 569999999999999999999764 789999998743 46889999999999999987
Q ss_pred -----EeeEeec-cceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEE
Q 041135 442 -----LVGYCIS-ERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILL 515 (727)
Q Consensus 442 -----l~~~~~~-~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl 515 (727)
+++++.. +...||||||+ +++|.+++.......+++.++++|+.||+.||+|||++ +|+|||||++||||
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFV 192 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEE
Confidence 6677765 67889999999 99999999876445699999999999999999999999 99999999999999
Q ss_pred CCCC--cEEEEeeccchhhhccCCC----ccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCC
Q 041135 516 DSSF--EARVADFGLAKIALELDSN----THVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQ 589 (727)
Q Consensus 516 ~~~~--~vkL~DFGla~~~~~~~~~----~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~ 589 (727)
+.++ .+||+|||+++.+...... ........|+..|+|||++.+..++.++|||||||+||||++|+.||....
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 9998 9999999999765322211 111234579999999999999999999999999999999999999997643
Q ss_pred CCCchhhHHhhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccCC
Q 041135 590 PLGDESLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDGA 664 (727)
Q Consensus 590 ~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 664 (727)
.. ...+..+...+.. . ...+.+... ........+.+|+++||+.||++||++.||++.|+++...
T Consensus 273 ~~-~~~~~~~~~~~~~-~-----~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 337 (352)
T 2jii_A 273 PN-TEDIMKQKQKFVD-K-----PGPFVGPCG---HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQD 337 (352)
T ss_dssp TC-HHHHHHHHHHHHH-S-----CCCEECTTS---CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred cC-HHHHHHHHHhccC-C-----hhhhhhhcc---ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHh
Confidence 21 1111111100000 0 000000000 0011234588999999999999999999999999988643
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=383.20 Aligned_cols=249 Identities=25% Similarity=0.381 Sum_probs=204.9
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc---hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS---QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
++|.+++.||+|+||.||+|++. +|+.||||+++.... .....+.+|+++|+.++|+||+++++++.+....||||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 56999999999999999999976 699999999974321 23457899999999999999999999999999999999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccC
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 536 (727)
||+.+|+|.+++..++. +++.+++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++....
T Consensus 96 E~~~gg~L~~~l~~~~~--l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~-- 168 (476)
T 2y94_A 96 EYVSGGELFDYICKNGR--LDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD-- 168 (476)
T ss_dssp ECCSSEEHHHHTTSSSS--CCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCT--
T ss_pred eCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccc--
Confidence 99999999999976654 89999999999999999999999 999999999999999999999999999985421
Q ss_pred CCccccccccCCccccccCcccCCCC-CchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHH
Q 041135 537 SNTHVSTRVMGTFGYMAPEYATSGKL-TEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEA 615 (727)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~l~~~~~-~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~ 615 (727)
.......+|+..|+|||++.+..+ +.++||||||||||||++|+.||+.... . .. +..
T Consensus 169 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~---~---~~-------------~~~ 227 (476)
T 2y94_A 169 --GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV---P---TL-------------FKK 227 (476)
T ss_dssp --TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS---H---HH-------------HHH
T ss_pred --cccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH---H---HH-------------HHH
Confidence 122345679999999999998765 6899999999999999999999975431 1 11 111
Q ss_pred HHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 616 LVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 616 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
+.+.... ........+.+|+++||+.||++||++.||+++-+
T Consensus 228 i~~~~~~--~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~ 269 (476)
T 2y94_A 228 ICDGIFY--TPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEW 269 (476)
T ss_dssp HHTTCCC--CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHH
T ss_pred HhcCCcC--CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHH
Confidence 1111111 11112234788999999999999999999998643
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=366.27 Aligned_cols=255 Identities=22% Similarity=0.350 Sum_probs=204.3
Q ss_pred HHHHHhcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc--------hhHHHHHHHHHHHHHc-CCCCceeEee
Q 041135 375 ELIQATNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS--------QGEREFRAEVEIISRV-HHRHLVSLVG 444 (727)
Q Consensus 375 el~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~--------~~~~~~~~Ei~~l~~l-~HpnIv~l~~ 444 (727)
......++|++.+.||+|+||.||+|++. +|+.||||+++.... ...+.+.+|+++|+++ +|+||+++++
T Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 167 (365)
T 2y7j_A 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID 167 (365)
T ss_dssp HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 33455678999999999999999999985 699999999875432 1134678999999999 7999999999
Q ss_pred EeeccceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEE
Q 041135 445 YCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVA 524 (727)
Q Consensus 445 ~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~ 524 (727)
+|......||||||+.+++|.+++..... +++..++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+
T Consensus 168 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~~--l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~ 242 (365)
T 2y7j_A 168 SYESSSFMFLVFDLMRKGELFDYLTEKVA--LSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLS 242 (365)
T ss_dssp EEEBSSEEEEEECCCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred EEeeCCEEEEEEEeCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEE
Confidence 99999999999999999999999976543 89999999999999999999999 99999999999999999999999
Q ss_pred eeccchhhhccCCCccccccccCCccccccCcccC------CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHH
Q 041135 525 DFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATS------GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVE 598 (727)
Q Consensus 525 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~------~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~ 598 (727)
|||++..... .......+|+..|+|||++.+ ..++.++||||||||||||++|+.||..... . .
T Consensus 243 DfG~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~---~---~ 312 (365)
T 2y7j_A 243 DFGFSCHLEP----GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ---I---L 312 (365)
T ss_dssp CCTTCEECCT----TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---H---H
T ss_pred ecCcccccCC----CcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH---H---H
Confidence 9999975422 122344679999999999863 3588899999999999999999999975321 1 1
Q ss_pred hhHHHHHHhhchhhHHHHHHHHhhcc--cchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 599 WARPLLAEALEHEDFEALVDSRLEKN--YVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 599 ~~~~~l~~~~~~~~~~~l~d~~l~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
....+. ....... ........+.+|+++||+.||++||++.||+++
T Consensus 313 ~~~~i~-------------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 313 MLRMIM-------------EGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HHHHHH-------------HTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHH-------------hCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111110 0000000 000112347889999999999999999999986
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=359.99 Aligned_cols=251 Identities=23% Similarity=0.345 Sum_probs=203.7
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEee
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 458 (727)
.++|++.++||+|+||.||+|+.. +|+.||||+++.......+.+.+|+++|++++|+||++++++|.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 456999999999999999999975 6899999999865555556799999999999999999999999999999999999
Q ss_pred ccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEE---CCCCcEEEEeeccchhhhcc
Q 041135 459 VPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILL---DSSFEARVADFGLAKIALEL 535 (727)
Q Consensus 459 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl---~~~~~vkL~DFGla~~~~~~ 535 (727)
+.+++|.+++...+. +++..++.++.||+.||+|||++ +|+|||||++|||| ++++.+||+|||+++...
T Consensus 88 ~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~-- 160 (304)
T 2jam_A 88 VSGGELFDRILERGV--YTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ-- 160 (304)
T ss_dssp CCSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC--
T ss_pred CCCccHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecC--
Confidence 999999998876543 89999999999999999999999 99999999999999 788999999999987431
Q ss_pred CCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHH
Q 041135 536 DSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEA 615 (727)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~ 615 (727)
........|+..|+|||++.+..++.++|||||||+||||++|+.||..... ..+ . ..
T Consensus 161 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~---~-------------~~ 218 (304)
T 2jam_A 161 ---NGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE---SKL---F-------------EK 218 (304)
T ss_dssp ---CBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH---HHH---H-------------HH
T ss_pred ---CCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHH---H-------------HH
Confidence 1122345689999999999999999999999999999999999999975321 111 0 11
Q ss_pred HHHHHh--hcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 616 LVDSRL--EKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 616 l~d~~l--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
+..... ...+.......+.+|+.+||+.||++||++.||+++-.
T Consensus 219 i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~ 264 (304)
T 2jam_A 219 IKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPW 264 (304)
T ss_dssp HHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred HHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcc
Confidence 111110 11111222345889999999999999999999998754
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=372.84 Aligned_cols=256 Identities=27% Similarity=0.351 Sum_probs=205.1
Q ss_pred cCccccceeccCCceEEEEEEE----cCCcEEEEEEeeeCC----chhHHHHHHHHHHHHHc-CCCCceeEeeEeeccce
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVL----ADGREVAVKQLKIGG----SQGEREFRAEVEIISRV-HHRHLVSLVGYCISERE 451 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~----~~g~~vaVK~l~~~~----~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~ 451 (727)
++|+++++||+|+||.||+|+. .+|+.||||+++... ....+.+.+|+++|+++ +|+||++++++|.++..
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 5699999999999999999997 368999999986432 23345688899999999 69999999999999999
Q ss_pred eeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchh
Q 041135 452 RLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKI 531 (727)
Q Consensus 452 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 531 (727)
.+|||||+.+++|.+++..... +++..++.++.||++||+|||++ +|+|||||++||||+.++.+||+|||+++.
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred EEEEeecCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 9999999999999999987654 89999999999999999999999 999999999999999999999999999975
Q ss_pred hhccCCCccccccccCCccccccCcccCC--CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhc
Q 041135 532 ALELDSNTHVSTRVMGTFGYMAPEYATSG--KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALE 609 (727)
Q Consensus 532 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~ 609 (727)
+.. .........+||..|+|||++.++ .++.++||||||||||||++|+.||........ ..++.+.++
T Consensus 209 ~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~----- 279 (355)
T 1vzo_A 209 FVA--DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QAEISRRIL----- 279 (355)
T ss_dssp CCG--GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--HHHHHHHHH-----
T ss_pred ccc--CCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch--HHHHHHHHh-----
Confidence 422 112223446799999999999863 478999999999999999999999976433211 111111111
Q ss_pred hhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCC-----CHHHHHHHHhh
Q 041135 610 HEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRP-----RMSQVVRALDT 660 (727)
Q Consensus 610 ~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L~~ 660 (727)
. ....+.......+.+|+++||..||++|+ ++.||+++...
T Consensus 280 --------~--~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f 325 (355)
T 1vzo_A 280 --------K--SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 325 (355)
T ss_dssp --------H--CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred --------c--cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcch
Confidence 0 01112223334578899999999999999 99999988654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=389.33 Aligned_cols=255 Identities=29% Similarity=0.391 Sum_probs=209.3
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEE
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLV 455 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 455 (727)
.++|+++++||+|+||.||+|+++ +|+.||||+++... ......+.+|+++|++++|+||++++++|.+.+.+|||
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 367999999999999999999975 68999999996432 23345688999999999999999999999999999999
Q ss_pred EeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhcc
Q 041135 456 YEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALEL 535 (727)
Q Consensus 456 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 535 (727)
|||+.||+|.+++...+...+++..++.++.||+.||+|||++ +|||||||++||||+.++.+||+|||+++....
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~- 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE- 338 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT-
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceeccc-
Confidence 9999999999999876665699999999999999999999999 999999999999999999999999999975421
Q ss_pred CCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHH
Q 041135 536 DSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEA 615 (727)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~ 615 (727)
.......+||..|+|||++.+..++.++||||||||||||++|+.||.......... +. ..
T Consensus 339 ---~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~--~i--------------~~ 399 (576)
T 2acx_A 339 ---GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE--EV--------------ER 399 (576)
T ss_dssp ---TCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHH--HH--------------HH
T ss_pred ---CccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHH--HH--------------HH
Confidence 112334589999999999999999999999999999999999999998654321111 10 01
Q ss_pred HHHHHhhcccchhHHHHHHHHHHHHhccCCCCCC-----CHHHHHHHH
Q 041135 616 LVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRP-----RMSQVVRAL 658 (727)
Q Consensus 616 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L 658 (727)
.+. .....+.......+.+||++||+.||++|+ ++.||+++-
T Consensus 400 ~i~-~~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~Hp 446 (576)
T 2acx_A 400 LVK-EVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHP 446 (576)
T ss_dssp HHH-HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSG
T ss_pred Hhh-cccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhCh
Confidence 111 011122223334578999999999999999 788988763
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=361.39 Aligned_cols=259 Identities=20% Similarity=0.256 Sum_probs=199.3
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc---hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEE
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS---QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLV 455 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 455 (727)
.++|++.++||+|+||.||+|++. +|+.||||+++.... ...+.+.+|+++|++++|+||++++++|.+++..|||
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 478999999999999999999975 688999999875422 2236789999999999999999999999999999999
Q ss_pred EeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhcc
Q 041135 456 YEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALEL 535 (727)
Q Consensus 456 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 535 (727)
|||+.+++|.+++..... +++.+++.|+.||++||+|||++ +|+|||||++||||+.++.+||+|||+++.....
T Consensus 113 ~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQGP--LAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EECCCCEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EEecCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 999999999999987643 89999999999999999999999 9999999999999999999999999999754321
Q ss_pred CCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHH
Q 041135 536 DSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEA 615 (727)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~ 615 (727)
.........|+..|+|||++.+..++.++|||||||+||||++|+.||..... ......+.....
T Consensus 188 --~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~~~~~~~------ 252 (309)
T 2h34_A 188 --KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL-------SVMGAHINQAIP------ 252 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH-------HHHHHHHHSCCC------
T ss_pred --ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH-------HHHHHHhccCCC------
Confidence 11223345789999999999999999999999999999999999999975321 011100100000
Q ss_pred HHHHHhhcccchhHHHHHHHHHHHHhccCCCCCC-CHHHHHHHHhhccC
Q 041135 616 LVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRP-RMSQVVRALDTLDG 663 (727)
Q Consensus 616 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~~ 663 (727)
............+.+|+.+||+.||++|| ++++|++.|+++..
T Consensus 253 -----~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~ 296 (309)
T 2h34_A 253 -----RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA 296 (309)
T ss_dssp -----CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred -----CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence 00011112233478899999999999999 99999999998754
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=369.55 Aligned_cols=250 Identities=26% Similarity=0.390 Sum_probs=200.6
Q ss_pred cCccccceeccCCceEEEEEEE-cCCcEEEEEEeeeCCch---hHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVL-ADGREVAVKQLKIGGSQ---GEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vaVK~l~~~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
+.|++++.||+|+||.||+|+. .+|+.||||++...... ..+.+.+|+++|++++|+||++++++|.+++..+|||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4589999999999999999996 46899999999754332 2357889999999999999999999999999999999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccC
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 536 (727)
||+. |+|.+++.... ..+++.+++.|+.||++||+|||++ +|+|||||++||||+.++.+||+|||+++....
T Consensus 134 e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~-- 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 206 (348)
T ss_dssp ECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred ecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC--
Confidence 9997 56777665432 2489999999999999999999999 999999999999999999999999999975421
Q ss_pred CCccccccccCCccccccCccc---CCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhH
Q 041135 537 SNTHVSTRVMGTFGYMAPEYAT---SGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDF 613 (727)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~l~---~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~ 613 (727)
.....|+..|+|||++. ++.++.++||||||||||||++|+.||..... .+...
T Consensus 207 -----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~------~~~~~------------ 263 (348)
T 1u5q_A 207 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALY------------ 263 (348)
T ss_dssp -----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHH------------
T ss_pred -----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh------HHHHH------------
Confidence 23457899999999985 56789999999999999999999999965421 11111
Q ss_pred HHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhc
Q 041135 614 EALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661 (727)
Q Consensus 614 ~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 661 (727)
.+................+.+|+.+||+.||++||++.||+++....
T Consensus 264 -~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~ 310 (348)
T 1u5q_A 264 -HIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 310 (348)
T ss_dssp -HHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHH
T ss_pred -HHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhh
Confidence 11111100011112233477899999999999999999999887654
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=358.42 Aligned_cols=259 Identities=29% Similarity=0.428 Sum_probs=201.2
Q ss_pred cCccccceeccCCceEEEEEEEcC----CcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEee-ccceeeE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLAD----GREVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYCI-SERERLL 454 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~~----g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~-~~~~~~l 454 (727)
.+|++.++||+|+||.||+|++.+ +..||||+++.... ...+.+.+|+++|++++|+||++++++|. .++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 458889999999999999998643 23589998875433 33467999999999999999999999865 4567899
Q ss_pred EEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhc
Q 041135 455 VYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALE 534 (727)
Q Consensus 455 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 534 (727)
||||+.+|+|.++++... ..+++.+++.|+.||++||+|||++ +|+|||||++||||++++.+||+|||+++....
T Consensus 105 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred EEeCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccccc
Confidence 999999999999997643 3578999999999999999999999 999999999999999999999999999975432
Q ss_pred cCC-CccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhh
Q 041135 535 LDS-NTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHED 612 (727)
Q Consensus 535 ~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~ 612 (727)
... .........|+..|+|||++.+..++.++|||||||++|||++ |..+|....... +..
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~~~-------------- 243 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITV-------------- 243 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT---HHH--------------
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH---HHH--------------
Confidence 211 1122334567889999999999999999999999999999999 555565433211 100
Q ss_pred HHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 613 FEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 613 ~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
.+...............+.+|+++||+.||++||++.||++.|+.+..
T Consensus 244 ---~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 244 ---YLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp ---HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HHhcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 000001111111223458899999999999999999999999998854
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=371.65 Aligned_cols=268 Identities=23% Similarity=0.340 Sum_probs=208.1
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEee
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 458 (727)
++|+++++||+|+||.||+|++. +|+.||||+++.... ...+.+.+|+++|++++|+||++++++|.+++..+|||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 57999999999999999999976 689999999976533 3346799999999999999999999999999999999999
Q ss_pred ccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCC
Q 041135 459 VPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSN 538 (727)
Q Consensus 459 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 538 (727)
+.+++|.++++.... +++..++.|+.||+.||+|||+.+ +|+|||||++||||+.++.+||+|||+++.....
T Consensus 113 ~~~~~L~~~l~~~~~--~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 185 (360)
T 3eqc_A 113 MDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 185 (360)
T ss_dssp CTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---
T ss_pred CCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc---
Confidence 999999999987654 889999999999999999999832 7999999999999999999999999999755322
Q ss_pred ccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHH----------------
Q 041135 539 THVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARP---------------- 602 (727)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~---------------- 602 (727)
......|+..|+|||++.+..++.++|||||||+||||++|+.||..... ..+......
T Consensus 186 --~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (360)
T 3eqc_A 186 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA---KELELMFGCQVEGDAAETPPRPRTP 260 (360)
T ss_dssp --C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCH---HHHHHHHC-----------------
T ss_pred --cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHhcccccccCCCCCCCcccC
Confidence 22345789999999999999999999999999999999999999976431 111100000
Q ss_pred ------HHHHhhchhhHHHHHHHHhhccc----chhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhh
Q 041135 603 ------LLAEALEHEDFEALVDSRLEKNY----VDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDT 660 (727)
Q Consensus 603 ------~l~~~~~~~~~~~l~d~~l~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 660 (727)
+.........+..+++....... .......+.+|+++||+.||++||++.||+++-+.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 328 (360)
T 3eqc_A 261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 328 (360)
T ss_dssp -------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHH
T ss_pred CCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHh
Confidence 00000001111222222222211 11123458899999999999999999999987553
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=381.21 Aligned_cols=262 Identities=21% Similarity=0.281 Sum_probs=196.2
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeC--CchhHHHHHHHHHHHHHcCCCCceeEeeEeecc------c
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIG--GSQGEREFRAEVEIISRVHHRHLVSLVGYCISE------R 450 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~------~ 450 (727)
.++|+++++||+|+||.||+|++. +|+.||||++... .....+.+.+|+++|+.++|+||++++++|... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 478999999999999999999865 5899999999743 334456788999999999999999999999654 4
Q ss_pred eeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccch
Q 041135 451 ERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAK 530 (727)
Q Consensus 451 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~ 530 (727)
..||||||+.++ |.+++.. .+++..++.|+.||++||+|||++ +|+|||||++||||+.++.+||+|||+++
T Consensus 141 ~~~lv~E~~~~~-l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~ 212 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 212 (464)
T ss_dssp EEEEEEECCSEE-HHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred eEEEEEeCCCCC-HHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence 579999999765 5555543 288999999999999999999999 99999999999999999999999999998
Q ss_pred hhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHh---
Q 041135 531 IALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEA--- 607 (727)
Q Consensus 531 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~--- 607 (727)
.... .......+||..|+|||++.+..++.++||||||||||||++|+.||.+.+.. +....++...
T Consensus 213 ~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~------~~~~~i~~~lg~p 282 (464)
T 3ttj_A 213 TAGT----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI------DQWNKVIEQLGTP 282 (464)
T ss_dssp --------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHHHCSC
T ss_pred ecCC----CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHhcCCC
Confidence 5422 22334568999999999999999999999999999999999999999764421 1111111100
Q ss_pred ----hc--hhhHHHHHHHH---------------hhc---ccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 608 ----LE--HEDFEALVDSR---------------LEK---NYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 608 ----~~--~~~~~~l~d~~---------------l~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
+. ...+...++.. +.. .........+.+|+++||+.||++|++++|++++-+
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~ 358 (464)
T 3ttj_A 283 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 358 (464)
T ss_dssp CHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred CHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChh
Confidence 00 00011111100 000 000111345889999999999999999999998744
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=363.87 Aligned_cols=259 Identities=21% Similarity=0.300 Sum_probs=205.8
Q ss_pred HHHHHhcCcccc-ceeccCCceEEEEEEEc-CCcEEEEEEeeeCC--chhHHHHHHHHHHHHHcC-CCCceeEeeEeecc
Q 041135 375 ELIQATNGFSAH-NVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG--SQGEREFRAEVEIISRVH-HRHLVSLVGYCISE 449 (727)
Q Consensus 375 el~~~~~~~~~~-~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~ 449 (727)
......++|.+. ++||+|+||.||+|+.. +|+.||||+++... ......+.+|+.+|++++ |+||++++++|.+.
T Consensus 22 ~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~ 101 (327)
T 3lm5_A 22 SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT 101 (327)
T ss_dssp CHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred HHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC
Confidence 344556668877 89999999999999976 58999999987432 233568999999999995 69999999999999
Q ss_pred ceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECC---CCcEEEEee
Q 041135 450 RERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDS---SFEARVADF 526 (727)
Q Consensus 450 ~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~---~~~vkL~DF 526 (727)
...+|||||+.+|+|.+++.......+++.+++.|+.||+.||+|||++ +|+|||||++||||+. ++.+||+||
T Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Df 178 (327)
T 3lm5_A 102 SEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDF 178 (327)
T ss_dssp SEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred CeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEeeC
Confidence 9999999999999999999776556799999999999999999999999 9999999999999987 789999999
Q ss_pred ccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHH
Q 041135 527 GLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAE 606 (727)
Q Consensus 527 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~ 606 (727)
|+++.... .......+|+..|+|||++.+..++.++|||||||+||||++|+.||..... . +...
T Consensus 179 g~a~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~---~~~~----- 243 (327)
T 3lm5_A 179 GMSRKIGH----ACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN---Q---ETYL----- 243 (327)
T ss_dssp GGCEEC-------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---H---HHHH-----
T ss_pred ccccccCC----ccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---h---HHHH-----
Confidence 99985421 1122346799999999999999999999999999999999999999976431 0 0000
Q ss_pred hhchhhHHHHHHHH--hhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 607 ALEHEDFEALVDSR--LEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 607 ~~~~~~~~~l~d~~--l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
.+.... ............+.+|+++||+.||++||++.||+++-.
T Consensus 244 --------~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~ 290 (327)
T 3lm5_A 244 --------NISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSW 290 (327)
T ss_dssp --------HHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGG
T ss_pred --------HHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHh
Confidence 000000 011111223345788999999999999999999988744
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=356.89 Aligned_cols=252 Identities=21% Similarity=0.292 Sum_probs=206.0
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEE
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLV 455 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 455 (727)
.++|.+.++||+|+||.||+|++. +|+.||+|++.... ....+.+.+|++++++++|+||++++++|.+++..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 356899999999999999999986 47899999986442 23446789999999999999999999999999999999
Q ss_pred EeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhcc
Q 041135 456 YEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALEL 535 (727)
Q Consensus 456 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 535 (727)
|||+.+++|.+++..... +++.+++.|+.||++||+|||++ +|+|||||++||||+.++.+||+|||+++....
T Consensus 94 ~e~~~~~~L~~~~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~- 167 (294)
T 2rku_A 94 LELCRRRSLLELHKRRKA--LTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY- 167 (294)
T ss_dssp EECCTTCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCS-
T ss_pred EecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceeccc-
Confidence 999999999998876543 89999999999999999999999 999999999999999999999999999975421
Q ss_pred CCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHH
Q 041135 536 DSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEA 615 (727)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~ 615 (727)
.........|+..|+|||++.+..++.++|||||||+||||++|+.||..... .+.. ..
T Consensus 168 --~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~-------------~~ 226 (294)
T 2rku_A 168 --DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL------KETY-------------LR 226 (294)
T ss_dssp --TTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHH-------------HH
T ss_pred --CccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHH-------------HH
Confidence 11223346789999999999998999999999999999999999999975431 1100 01
Q ss_pred HHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhh
Q 041135 616 LVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDT 660 (727)
Q Consensus 616 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 660 (727)
+.... ..........+.+|+++||+.||++||++.||+++-..
T Consensus 227 ~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~ 269 (294)
T 2rku_A 227 IKKNE--YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFF 269 (294)
T ss_dssp HHTTC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred Hhhcc--CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChhe
Confidence 11110 01112223457889999999999999999999987553
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=364.87 Aligned_cols=271 Identities=20% Similarity=0.275 Sum_probs=200.7
Q ss_pred cHHHHHHHhcCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCch-----------hHHHHHHHHHHHHHcCCCCce
Q 041135 372 TYDELIQATNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQ-----------GEREFRAEVEIISRVHHRHLV 440 (727)
Q Consensus 372 ~~~el~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~-----------~~~~~~~Ei~~l~~l~HpnIv 440 (727)
.++++....++|+++++||+|+||.||+|+..+|+.||||++...... ..+.+.+|+++|++++|+||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 456778888999999999999999999999888999999998643221 126799999999999999999
Q ss_pred eEeeEeec-----cceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEE
Q 041135 441 SLVGYCIS-----ERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILL 515 (727)
Q Consensus 441 ~l~~~~~~-----~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl 515 (727)
+++++|.. ....||||||+. |+|.+++.... ..+++..++.|+.||+.||+|||++ +|+|||||++||||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR-IVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILL 167 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEE
Confidence 99999853 346799999997 57777665443 3589999999999999999999999 99999999999999
Q ss_pred CCCCcEEEEeeccchhhhccCCCccccccccCCccccccCcccC-CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCch
Q 041135 516 DSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATS-GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDE 594 (727)
Q Consensus 516 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~ 594 (727)
+.++.+||+|||+++.... ........|+..|+|||++.+ ..++.++|||||||+||||++|+.||.....
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---- 239 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTA----DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF---- 239 (362)
T ss_dssp CTTCCEEECCTTC-------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----
T ss_pred cCCCCEEEEecCccccccc----ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH----
Confidence 9999999999999974321 222334578999999999987 6789999999999999999999999976431
Q ss_pred hhHHhhHHHHHHhhchhhH-----------HHHHHHHhhcc-------cchhHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 041135 595 SLVEWARPLLAEALEHEDF-----------EALVDSRLEKN-------YVDSEMFWMIEAAAACVRHSATKRPRMSQVVR 656 (727)
Q Consensus 595 ~l~~~~~~~l~~~~~~~~~-----------~~l~d~~l~~~-------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 656 (727)
.+....++.. ...... ...+...+... ........+.+|+++||+.||++||++.||++
T Consensus 240 --~~~~~~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 240 --YNQLNKIVEV-VGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp --HHHHHHHHHH-HCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --HHHHHHHHHH-cCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 1111111110 111111 11111110000 01111234789999999999999999999998
Q ss_pred HH
Q 041135 657 AL 658 (727)
Q Consensus 657 ~L 658 (727)
+-
T Consensus 317 hp 318 (362)
T 3pg1_A 317 HP 318 (362)
T ss_dssp SG
T ss_pred Cc
Confidence 73
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=365.61 Aligned_cols=272 Identities=25% Similarity=0.425 Sum_probs=198.1
Q ss_pred hcCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHH--HHHcCCCCceeEeeEeec-----ccee
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEI--ISRVHHRHLVSLVGYCIS-----ERER 452 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~--l~~l~HpnIv~l~~~~~~-----~~~~ 452 (727)
.++|+++++||+|+||.||+|++ +|+.||||+++.. ....+..|.++ +..++|+||+++++++.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 35799999999999999999987 6899999998743 23344445554 445899999999986542 3367
Q ss_pred eEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcC------CCcEEeeCCCCCceEECCCCcEEEEee
Q 041135 453 LLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDC------HPRIIHRDIKSSNILLDSSFEARVADF 526 (727)
Q Consensus 453 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~------~~~ivHrDLkp~NILl~~~~~vkL~DF 526 (727)
+|||||+.+|+|.+++.... +++..+++|+.||++||+|||+++ ..+|+|||||++||||+.++.+||+||
T Consensus 88 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DF 164 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDF 164 (336)
T ss_dssp EEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCC
T ss_pred EEEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeec
Confidence 89999999999999997653 588899999999999999999862 237999999999999999999999999
Q ss_pred ccchhhhccC-----CCccccccccCCccccccCcccC-------CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCch
Q 041135 527 GLAKIALELD-----SNTHVSTRVMGTFGYMAPEYATS-------GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDE 594 (727)
Q Consensus 527 Gla~~~~~~~-----~~~~~~~~~~gt~~y~aPE~l~~-------~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~ 594 (727)
|+++...... .........+||..|+|||++.+ ..++.++|||||||+||||++|+.+|.........
T Consensus 165 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~ 244 (336)
T 3g2f_A 165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY 244 (336)
T ss_dssp TTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCC
T ss_pred cceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHH
Confidence 9997543211 11122234579999999999987 35667999999999999999998877544332211
Q ss_pred hhHHhhHHHHHHhhchhhHHHHHHH----Hhhccc------chhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 595 SLVEWARPLLAEALEHEDFEALVDS----RLEKNY------VDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 595 ~l~~~~~~~l~~~~~~~~~~~l~d~----~l~~~~------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
... + .........+..+... ..+..+ .......+.+||.+||+.||++||++.||++.|+++..
T Consensus 245 ~~~-~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 245 QMA-F----QTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp CCT-T----HHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHh-h----hcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 100 0 0001111111111111 111111 11244568999999999999999999999999999864
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=350.71 Aligned_cols=251 Identities=23% Similarity=0.353 Sum_probs=200.9
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCch------hHHHHHHHHHHHHHcCCCCceeEeeEeeccceee
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQ------GEREFRAEVEIISRVHHRHLVSLVGYCISERERL 453 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~------~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 453 (727)
++|++++.||+|+||.||+|++. +|+.||||+++..... ..+.+.+|+++|++++|+||++++++|.+....+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 56999999999999999999986 5899999999754321 3567999999999999999999999999999999
Q ss_pred EEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCC----cEEEEeeccc
Q 041135 454 LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSF----EARVADFGLA 529 (727)
Q Consensus 454 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~----~vkL~DFGla 529 (727)
+||||+.+++|.+++..+. .+++.+++.++.||++||+|||++ +|+|||||++||||+.++ .+||+|||++
T Consensus 85 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 9999999999999997654 389999999999999999999999 999999999999998877 8999999999
Q ss_pred hhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhc
Q 041135 530 KIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALE 609 (727)
Q Consensus 530 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~ 609 (727)
+.... ........|+..|+|||++.+..++.++|||||||+||||++|+.||..... . +....+.. .
T Consensus 160 ~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~---~~~~~~~~-~-- 226 (283)
T 3bhy_A 160 HKIEA----GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK---Q---ETLTNISA-V-- 226 (283)
T ss_dssp EECC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH---H---HHHHHHHT-T--
T ss_pred eeccC----CCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch---H---HHHHHhHh-c--
Confidence 75422 1122345689999999999999999999999999999999999999976431 1 11000000 0
Q ss_pred hhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 610 HEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 610 ~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
...+ ...........+.+|+++||+.||++||++.||+++
T Consensus 227 ~~~~--------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 227 NYDF--------DEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp CCCC--------CHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred ccCC--------cchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 0000 000001122347889999999999999999999985
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=366.59 Aligned_cols=258 Identities=18% Similarity=0.274 Sum_probs=194.2
Q ss_pred HhcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchh--HHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEE
Q 041135 379 ATNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQG--EREFRAEVEIISRVHHRHLVSLVGYCISERERLLV 455 (727)
Q Consensus 379 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~--~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 455 (727)
..++|+++++||+|+||.||+|++. +|+.||||+++...... .+.+.+|+++|++++|+||+++++++.++...+||
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 3567999999999999999999865 68999999997543322 35678999999999999999999999999999999
Q ss_pred EeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEE-----CCCCcEEEEeeccch
Q 041135 456 YEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILL-----DSSFEARVADFGLAK 530 (727)
Q Consensus 456 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl-----~~~~~vkL~DFGla~ 530 (727)
|||+. |+|.+++..... +++..++.|+.||+.||+|||++ +|+|||||++|||| ++++.+||+|||+++
T Consensus 112 ~e~~~-~~L~~~~~~~~~--~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~ 185 (329)
T 3gbz_A 112 FEYAE-NDLKKYMDKNPD--VSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185 (329)
T ss_dssp EECCS-EEHHHHHHHCTT--CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred EecCC-CCHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence 99997 589888877654 89999999999999999999999 99999999999999 455669999999998
Q ss_pred hhhccCCCccccccccCCccccccCcccCC-CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhh-
Q 041135 531 IALELDSNTHVSTRVMGTFGYMAPEYATSG-KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEAL- 608 (727)
Q Consensus 531 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~- 608 (727)
.... ........+|+..|+|||++.+. .++.++||||||||||||++|+.+|...... +....++....
T Consensus 186 ~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~~~~~~~~ 256 (329)
T 3gbz_A 186 AFGI---PIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI------DQLFKIFEVLGL 256 (329)
T ss_dssp HHC--------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHHHCC
T ss_pred ccCC---cccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH------HHHHHHHHHhCC
Confidence 6521 12223445789999999999875 4899999999999999999999999764311 11111111100
Q ss_pred ----------------------chhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 609 ----------------------EHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 609 ----------------------~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
....+...+. ......+.+|+++||+.||++||++.||+++-.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 321 (329)
T 3gbz_A 257 PDDTTWPGVTALPDWKQSFPKFRGKTLKRVLG--------ALLDDEGLDLLTAMLEMDPVKRISAKNALEHPY 321 (329)
T ss_dssp CCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHG--------GGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred CchhhhhhhhhhhhhhhhhhhhccccHhhhcc--------cccCHHHHHHHHHHccCChhhCCCHHHHhCCcc
Confidence 0000111110 011234789999999999999999999998643
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=353.84 Aligned_cols=248 Identities=26% Similarity=0.381 Sum_probs=204.5
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++|+||+++++++.+++..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 56999999999999999999976 57889999986432 222467899999999999999999999999999999999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccC
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 536 (727)
||+.+++|.+++...+. +++..++.++.||++||+|||++ +|+|||||++||||+.++.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~-- 166 (284)
T 2vgo_A 94 EFAPRGELYKELQKHGR--FDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS-- 166 (284)
T ss_dssp CCCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSS--
T ss_pred EeCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcc--
Confidence 99999999999977654 89999999999999999999999 999999999999999999999999999864321
Q ss_pred CCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHH
Q 041135 537 SNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEAL 616 (727)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l 616 (727)
.......|+..|+|||++.+..++.++|||||||++|||++|+.||..... .+.. ..+
T Consensus 167 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~-------------~~~ 224 (284)
T 2vgo_A 167 ---LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH------TETH-------------RRI 224 (284)
T ss_dssp ---SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHH-------------HHH
T ss_pred ---cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH------hHHH-------------HHH
Confidence 122345789999999999999999999999999999999999999975321 1111 011
Q ss_pred HHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 617 VDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 617 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
... ...+.......+.+|+++||+.||++||++.||+++-.
T Consensus 225 ~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~ 265 (284)
T 2vgo_A 225 VNV--DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPW 265 (284)
T ss_dssp HTT--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHH
T ss_pred hcc--ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHH
Confidence 111 11122222345788999999999999999999998644
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=363.35 Aligned_cols=259 Identities=23% Similarity=0.385 Sum_probs=200.5
Q ss_pred HHHHHhcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHc-CCCCceeEeeEeec----
Q 041135 375 ELIQATNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRV-HHRHLVSLVGYCIS---- 448 (727)
Q Consensus 375 el~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~---- 448 (727)
++....++|+++++||+|+||.||+|++. +|+.||||++.... .....+.+|+++|+++ +|+||++++++|..
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 34445678999999999999999999974 68999999997543 3456899999999999 79999999999987
Q ss_pred --cceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEee
Q 041135 449 --ERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADF 526 (727)
Q Consensus 449 --~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DF 526 (727)
....+|||||+.+++|.+++.......+++..++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Df 173 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDF 173 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCC
T ss_pred cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeC
Confidence 46789999999999999999876545689999999999999999999999 9999999999999999999999999
Q ss_pred ccchhhhccCCCccccccccCCccccccCccc-----CCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhH
Q 041135 527 GLAKIALELDSNTHVSTRVMGTFGYMAPEYAT-----SGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWAR 601 (727)
Q Consensus 527 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~ 601 (727)
|++..... .........|+..|+|||++. +..++.++|||||||+||||++|+.||..... . +..
T Consensus 174 g~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~---~~~- 243 (326)
T 2x7f_A 174 GVSAQLDR---TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP---M---RAL- 243 (326)
T ss_dssp TTTC----------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH---H---HHH-
T ss_pred cCceecCc---CccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH---H---HHH-
Confidence 99975421 111223457899999999997 56788999999999999999999999965321 0 000
Q ss_pred HHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 602 PLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 602 ~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
..+................+.+|+++||..||++||++.||+++-.
T Consensus 244 ------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~ 289 (326)
T 2x7f_A 244 ------------FLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPF 289 (326)
T ss_dssp ------------HHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHH
T ss_pred ------------HHhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChH
Confidence 0000100000011112345788999999999999999999998644
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=367.74 Aligned_cols=267 Identities=20% Similarity=0.241 Sum_probs=203.3
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcC--------CCCceeEeeEee---
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRVH--------HRHLVSLVGYCI--- 447 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~--------HpnIv~l~~~~~--- 447 (727)
.++|+++++||+|+||.||+|+.. +|+.||||+++.. ....+.+.+|+++|++++ |+||++++++|.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 367999999999999999999864 5889999998632 344567899999999996 788999999998
Q ss_pred -ccceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCC-------
Q 041135 448 -SERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSF------- 519 (727)
Q Consensus 448 -~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~------- 519 (727)
+....+|||||+ +++|.+++.......+++..++.|+.||++||+|||+++ +|+|||||++||||+.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhhh
Confidence 566889999999 555555555544446899999999999999999999964 799999999999998775
Q ss_pred ------------------------------------------cEEEEeeccchhhhccCCCccccccccCCccccccCcc
Q 041135 520 ------------------------------------------EARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYA 557 (727)
Q Consensus 520 ------------------------------------------~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l 557 (727)
.+||+|||+++.... .....+||..|+|||++
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~------~~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK------HFTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB------CSCSCCSCGGGCCHHHH
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc------cCccCCCCCcccCChhh
Confidence 899999999975421 12345789999999999
Q ss_pred cCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHh----------------
Q 041135 558 TSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRL---------------- 621 (727)
Q Consensus 558 ~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l---------------- 621 (727)
.+..++.++||||||||||||++|+.||............+....+.. .+.......+.....
T Consensus 266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIE-LLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHH-HHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHH-hcCCCChHHhhcccccccccCCccccccccc
Confidence 999999999999999999999999999987554332211111111111 111000000000000
Q ss_pred ------------hcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 622 ------------EKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 622 ------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
...+.......+.+|+++||+.||++||++.||+++
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 012234455678899999999999999999999976
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=356.47 Aligned_cols=251 Identities=23% Similarity=0.325 Sum_probs=196.4
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEee
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 458 (727)
++|.+.++||+|+||.||+|+.. +|+.||||++..... ...+.+.+|+++|++++|+||++++++|.+....++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 46899999999999999999975 588999999875432 3457899999999999999999999999999999999999
Q ss_pred ccCCccchhcccC--CCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEE---CCCCcEEEEeeccchhhh
Q 041135 459 VPNDTLHYHLHAE--GRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILL---DSSFEARVADFGLAKIAL 533 (727)
Q Consensus 459 ~~~gsL~~~L~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl---~~~~~vkL~DFGla~~~~ 533 (727)
+.+|+|.+++... ....+++..++.|+.||++||+|||++ +|+|||||++|||| +.++.+||+|||+++...
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999988543 223589999999999999999999999 99999999999999 456789999999997542
Q ss_pred ccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhH
Q 041135 534 ELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDF 613 (727)
Q Consensus 534 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~ 613 (727)
. ........|+..|+|||++. +.++.++|||||||+||||++|+.||..... . +...... ....
T Consensus 179 ~----~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~---~---~~~~~~~---~~~~-- 242 (285)
T 3is5_A 179 S----DEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL---E---EVQQKAT---YKEP-- 242 (285)
T ss_dssp ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---H---HHHHHHH---HCCC--
T ss_pred C----cccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH---H---HHHhhhc---cCCc--
Confidence 2 12234467899999999986 5689999999999999999999999976431 1 1000000 0000
Q ss_pred HHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 614 EALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 614 ~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
.... ........+.+|+++||+.||++||++.||+++
T Consensus 243 ------~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 243 ------NYAV-ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp ------CCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred ------cccc-ccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 000112357789999999999999999999875
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=364.29 Aligned_cols=270 Identities=21% Similarity=0.288 Sum_probs=198.4
Q ss_pred HHhcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchh-----HHHHHHHHHHHHHcCCCCceeEeeEeeccce
Q 041135 378 QATNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQG-----EREFRAEVEIISRVHHRHLVSLVGYCISERE 451 (727)
Q Consensus 378 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~-----~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~ 451 (727)
...++|+++++||+|+||.||+|++. +|+.||||+++...... .+.+.+|+++|++++|+||++++++|.+...
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999975 58999999997533221 2468899999999999999999999999999
Q ss_pred eeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchh
Q 041135 452 RLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKI 531 (727)
Q Consensus 452 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 531 (727)
.+|||||+.+ +|.+++..+. ..+++.+++.++.||++||+|||++ +|+|||||++||||+.++.+||+|||+++.
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred eEEEEEcCCC-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 9999999976 7777776543 3588899999999999999999999 999999999999999999999999999986
Q ss_pred hhccCCCccccccccCCccccccCcccCC-CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhch
Q 041135 532 ALELDSNTHVSTRVMGTFGYMAPEYATSG-KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEH 610 (727)
Q Consensus 532 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~ 610 (727)
... ........+|+..|+|||++.+. .++.++||||||||||||++|+.+|.+... .+....++......
T Consensus 162 ~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~------~~~~~~i~~~~~~~ 232 (346)
T 1ua2_A 162 FGS---PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD------LDQLTRIFETLGTP 232 (346)
T ss_dssp TTS---CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHHHCCC
T ss_pred ccC---CcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHHHcCCC
Confidence 422 22223456789999999999764 489999999999999999999999876431 11111111110000
Q ss_pred --hhHHHH---HHHHhhcc--------cchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhc
Q 041135 611 --EDFEAL---VDSRLEKN--------YVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661 (727)
Q Consensus 611 --~~~~~l---~d~~l~~~--------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 661 (727)
..+..+ .+...... ........+.+|+++||+.||++||++.||+++-...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~ 296 (346)
T 1ua2_A 233 TEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 296 (346)
T ss_dssp CTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGT
T ss_pred ChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhh
Confidence 000000 00000000 0011224588999999999999999999999986543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=354.19 Aligned_cols=249 Identities=25% Similarity=0.380 Sum_probs=198.1
Q ss_pred CccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC--chhHHHHHHHHHHHHHcCCCCceeEeeEeec----cceeeE
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG--SQGEREFRAEVEIISRVHHRHLVSLVGYCIS----ERERLL 454 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~----~~~~~l 454 (727)
.|++.++||+|+||.||+|++. ++..||||+++... ....+.+.+|+++|++++|+||++++++|.. +...+|
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 3788899999999999999975 57899999987542 3344678999999999999999999999875 456899
Q ss_pred EEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCc--EEeeCCCCCceEEC-CCCcEEEEeeccchh
Q 041135 455 VYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPR--IIHRDIKSSNILLD-SSFEARVADFGLAKI 531 (727)
Q Consensus 455 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~--ivHrDLkp~NILl~-~~~~vkL~DFGla~~ 531 (727)
||||+.+++|.+++..... +++..++.|+.||+.||+|||++ + |+|||||++||||+ +++.+||+|||+++.
T Consensus 107 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEecCCCCHHHHHHHccC--CCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 9999999999999977543 88999999999999999999998 8 99999999999997 789999999999974
Q ss_pred hhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchh
Q 041135 532 ALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHE 611 (727)
Q Consensus 532 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~ 611 (727)
.. ........|+..|+|||++.+ .++.++|||||||+||||++|+.||...... ..+.. .
T Consensus 182 ~~-----~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~~~~~----~----- 241 (290)
T 1t4h_A 182 KR-----ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-----AQIYR----R----- 241 (290)
T ss_dssp CC-----TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----HHHHH----H-----
T ss_pred cc-----ccccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcH-----HHHHH----H-----
Confidence 32 122334578999999998874 5899999999999999999999999753311 11100 0
Q ss_pred hHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 612 DFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 612 ~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
+........+.......+.+|+++||+.||++||++.||+++-.
T Consensus 242 ----~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~ 285 (290)
T 1t4h_A 242 ----VTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF 285 (290)
T ss_dssp ----HTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred ----HhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcc
Confidence 00000011111112235789999999999999999999998643
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=352.92 Aligned_cols=247 Identities=21% Similarity=0.286 Sum_probs=199.7
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeC--CchhHHHHHHHHHHHHHc-CCCCceeEeeEeeccceeeEE
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIG--GSQGEREFRAEVEIISRV-HHRHLVSLVGYCISERERLLV 455 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~--~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lV 455 (727)
.++|+++++||+|+||.||+|++. +|+.||||+++.. ......++.+|+.++.++ +|+||++++++|.+++..+||
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 456999999999999999999986 6999999999753 334456788999999999 899999999999999999999
Q ss_pred EeeccCCccchhcccCC--CCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECC----------------
Q 041135 456 YEYVPNDTLHYHLHAEG--RPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDS---------------- 517 (727)
Q Consensus 456 ~Ey~~~gsL~~~L~~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~---------------- 517 (727)
|||+.+++|.+++.... ...+++.+++.|+.||++||+|||++ +|+|||||++||||+.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 99999999999997642 13489999999999999999999999 9999999999999984
Q ss_pred ---CCcEEEEeeccchhhhccCCCccccccccCCccccccCcccCC-CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCc
Q 041135 518 ---SFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSG-KLTEKSDVYSFGVVLLELITGRKPVDASQPLGD 593 (727)
Q Consensus 518 ---~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~ 593 (727)
+..+||+|||+++.... .....|+..|+|||++.+. .++.++|||||||+||||++|+.++...
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----- 234 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISS-------PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG----- 234 (289)
T ss_dssp ---CCCEEECCCTTCEETTC-------SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS-----
T ss_pred cCCceEEEEcccccccccCC-------ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch-----
Confidence 44799999999975422 1223589999999999876 5668999999999999999998766421
Q ss_pred hhhHHhhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 594 ESLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 594 ~~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
.. +..+....+ ..........+.+|+++||+.||++||++.||+++-.
T Consensus 235 ~~-----------------~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~ 282 (289)
T 1x8b_A 235 DQ-----------------WHEIRQGRL-PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSV 282 (289)
T ss_dssp HH-----------------HHHHHTTCC-CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTT
T ss_pred hH-----------------HHHHHcCCC-CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChH
Confidence 11 011111111 1112222345789999999999999999999988744
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=366.31 Aligned_cols=245 Identities=22% Similarity=0.307 Sum_probs=202.9
Q ss_pred HhcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCch--------hHHHHHHHHHHHHHcCCCCceeEeeEeecc
Q 041135 379 ATNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQ--------GEREFRAEVEIISRVHHRHLVSLVGYCISE 449 (727)
Q Consensus 379 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~--------~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~ 449 (727)
..++|+++++||+|+||.||+|++. +|+.||||+++..... ....+.+|+++|++++|+||++++++|.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 3567999999999999999999964 6889999999754321 234688899999999999999999999999
Q ss_pred ceeeEEEeeccCC-ccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeecc
Q 041135 450 RERLLVYEYVPND-TLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGL 528 (727)
Q Consensus 450 ~~~~lV~Ey~~~g-sL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGl 528 (727)
+..+|||||+.+| +|.+++..... +++..++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~~--l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHPR--LDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGS 176 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCCC--CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEEeCCCCccHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeeccc
Confidence 9999999999777 99999877654 89999999999999999999999 999999999999999999999999999
Q ss_pred chhhhccCCCccccccccCCccccccCcccCCCC-CchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHh
Q 041135 529 AKIALELDSNTHVSTRVMGTFGYMAPEYATSGKL-TEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEA 607 (727)
Q Consensus 529 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~ 607 (727)
++.... .......+|+..|+|||++.+..+ +.++|||||||+||||++|+.||.......
T Consensus 177 a~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--------------- 237 (335)
T 3dls_A 177 AAYLER----GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV--------------- 237 (335)
T ss_dssp CEECCT----TCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT---------------
T ss_pred ceECCC----CCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH---------------
Confidence 975422 122334679999999999998876 789999999999999999999996522100
Q ss_pred hchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 608 LEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 608 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
...+. ........+.+|+++||+.||++||++.||+++-+
T Consensus 238 ----------~~~~~--~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~ 277 (335)
T 3dls_A 238 ----------EAAIH--PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPW 277 (335)
T ss_dssp ----------TTCCC--CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTT
T ss_pred ----------hhccC--CCcccCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 00000 01111234778999999999999999999999754
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=362.17 Aligned_cols=267 Identities=24% Similarity=0.348 Sum_probs=201.3
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCch--hHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQ--GEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~--~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
.++|+++++||+|+||.||+|++. +|+.||||++...... ..+.+.+|+++|++++|+||++++++|.+.+..+|||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 357999999999999999999976 4899999998654332 2456889999999999999999999999999999999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccC
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 536 (727)
||+.+++|.+++..... +++..++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++....
T Consensus 104 e~~~~~~l~~~~~~~~~--~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-- 176 (331)
T 4aaa_A 104 EFVDHTILDDLELFPNG--LDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA-- 176 (331)
T ss_dssp ECCSEEHHHHHHHSTTC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred ecCCcchHHHHHhhccC--CCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecC--
Confidence 99999999988765544 89999999999999999999999 999999999999999999999999999975422
Q ss_pred CCccccccccCCccccccCcccCC-CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHH
Q 041135 537 SNTHVSTRVMGTFGYMAPEYATSG-KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEA 615 (727)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~l~~~-~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~ 615 (727)
.........|+..|+|||++.+. .++.++|||||||+||||++|+.||...... ..+..... .+. ........
T Consensus 177 -~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~-~~~--~~~~~~~~ 250 (331)
T 4aaa_A 177 -PGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDI--DQLYHIMM-CLG--NLIPRHQE 250 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHH-HHC--SCCHHHHH
T ss_pred -CccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHH-HhC--CCChhhhh
Confidence 12223345789999999999875 7899999999999999999999999764321 11111100 000 00000001
Q ss_pred HHHH-Hhhc--------------ccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 616 LVDS-RLEK--------------NYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 616 l~d~-~l~~--------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
.+.. .... .........+.+|+++||+.||++||++.||+++-.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~ 309 (331)
T 4aaa_A 251 LFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF 309 (331)
T ss_dssp HHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred HhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCch
Confidence 1100 0000 000112345889999999999999999999998744
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=353.97 Aligned_cols=253 Identities=23% Similarity=0.336 Sum_probs=199.8
Q ss_pred CccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeecc
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVP 460 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 460 (727)
+|....+||+|+||.||+|++. +++.||||+++.......+.+.+|++++++++|+||++++++|.+.+..+|||||+.
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 3555568999999999999964 588999999987666667789999999999999999999999999999999999999
Q ss_pred CCccchhcccCC-CCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECC-CCcEEEEeeccchhhhccCCC
Q 041135 461 NDTLHYHLHAEG-RPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDS-SFEARVADFGLAKIALELDSN 538 (727)
Q Consensus 461 ~gsL~~~L~~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~-~~~vkL~DFGla~~~~~~~~~ 538 (727)
+++|.+++.... ...+++..++.++.||+.||+|||++ +|+|||||++||||+. ++.+||+|||+++.....
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~--- 176 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI--- 176 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCC---
Confidence 999999987653 33467889999999999999999999 9999999999999987 899999999999754221
Q ss_pred ccccccccCCccccccCcccCCC--CCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHH
Q 041135 539 THVSTRVMGTFGYMAPEYATSGK--LTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEAL 616 (727)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~l~~~~--~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l 616 (727)
........|+..|+|||++.++. ++.++|||||||+||||++|+.||..... ..... ...
T Consensus 177 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~---------------~~~ 238 (295)
T 2clq_A 177 NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE---PQAAM---------------FKV 238 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSS---HHHHH---------------HHH
T ss_pred CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCc---hhHHH---------------Hhh
Confidence 12233457899999999997643 88999999999999999999999964321 00000 000
Q ss_pred HHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 041135 617 VDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRAL 658 (727)
Q Consensus 617 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 658 (727)
................+.+|+.+||+.||++||++.||+++-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~ 280 (295)
T 2clq_A 239 GMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDE 280 (295)
T ss_dssp HHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSG
T ss_pred ccccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 001111122223344578899999999999999999998763
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=354.41 Aligned_cols=252 Identities=25% Similarity=0.349 Sum_probs=184.1
Q ss_pred hcCccccceeccCCceEEEEEEE-cCCcEEEEEEeeeCCc---hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEE
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVL-ADGREVAVKQLKIGGS---QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLV 455 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vaVK~l~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 455 (727)
.++|++.++||+|+||.||+|+. .+|+.||||++..... ...+.+.+|++++++++|+||+++++++.+.+..+||
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 35799999999999999999997 4689999999964321 2236789999999999999999999999999999999
Q ss_pred EeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhcc
Q 041135 456 YEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALEL 535 (727)
Q Consensus 456 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 535 (727)
|||+.+++|.+++.... ..+++.+++.++.||++||+|||++ +|+|||||++||||+.++.+||+|||+++.....
T Consensus 90 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp EECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 99999999999987643 3589999999999999999999999 9999999999999999999999999999754211
Q ss_pred CCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHH
Q 041135 536 DSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEA 615 (727)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~ 615 (727)
........|+..|+|||++.+..++.++|||||||+||||++|+.||......... .... ...
T Consensus 166 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----------~~~~-~~~--- 228 (278)
T 3cok_A 166 ---HEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL----------NKVV-LAD--- 228 (278)
T ss_dssp -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------CC-SSC---
T ss_pred ---CCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH----------HHHh-hcc---
Confidence 11223457899999999999988999999999999999999999999764422100 0000 000
Q ss_pred HHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 616 LVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 616 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
..........+.+|+.+||+.||++||++.||+++-.
T Consensus 229 -------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~ 265 (278)
T 3cok_A 229 -------YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPF 265 (278)
T ss_dssp -------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTT
T ss_pred -------cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCcc
Confidence 0011112234778999999999999999999988643
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=349.30 Aligned_cols=250 Identities=22% Similarity=0.334 Sum_probs=196.4
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEE
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLV 455 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 455 (727)
.++|++++.||+|+||.||+|++. +|+.||||+++... ....+.+.+|+++|++++|+||+++++++.+.+..+||
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 357999999999999999999986 68999999986432 22345789999999999999999999999999999999
Q ss_pred EeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhcc
Q 041135 456 YEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALEL 535 (727)
Q Consensus 456 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 535 (727)
|||+.+++|.+++..... +++..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++....
T Consensus 90 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~- 163 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHGR--VEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD- 163 (276)
T ss_dssp EECCCSCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred EeccCCCcHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCC-
Confidence 999999999999976654 88999999999999999999999 999999999999999999999999999975422
Q ss_pred CCCccccccccCCccccccCcccCCCC-CchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHH
Q 041135 536 DSNTHVSTRVMGTFGYMAPEYATSGKL-TEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFE 614 (727)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~ 614 (727)
........|+..|+|||++.+..+ +.++||||||++||||++|+.||..... .+...
T Consensus 164 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~------------- 221 (276)
T 2h6d_A 164 ---GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV------PTLFK------------- 221 (276)
T ss_dssp ----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHH-------------
T ss_pred ---CcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH------HHHHH-------------
Confidence 112234568999999999988765 6899999999999999999999975321 11100
Q ss_pred HHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 615 ALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 615 ~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
.+.... ..........+.+|+.+||+.||++||++.||+++-.
T Consensus 222 ~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~ 264 (276)
T 2h6d_A 222 KIRGGV--FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEW 264 (276)
T ss_dssp HHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHH
T ss_pred HhhcCc--ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChh
Confidence 010000 0111122345788999999999999999999998744
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=363.98 Aligned_cols=268 Identities=22% Similarity=0.342 Sum_probs=195.9
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchh-HHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEee
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQG-EREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~-~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 458 (727)
++|+++++||+|+||.||+|++. +|+.||||+++...... ...+.+|+++|++++|+||++++++|.+++..+|||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999976 68999999997543322 22466899999999999999999999999999999999
Q ss_pred ccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCC
Q 041135 459 VPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSN 538 (727)
Q Consensus 459 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 538 (727)
+. |+|.+++...+. .+++..++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++.... .
T Consensus 82 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~---~ 153 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGN-IINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSI---P 153 (324)
T ss_dssp CS-EEHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred cc-cCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccC---C
Confidence 97 588887765433 589999999999999999999999 999999999999999999999999999975321 1
Q ss_pred ccccccccCCccccccCcccC-CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhH----
Q 041135 539 THVSTRVMGTFGYMAPEYATS-GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDF---- 613 (727)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~---- 613 (727)
........|+..|+|||++.+ ..++.++|||||||+||||++|+.||..... ..........+... ....+
T Consensus 154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~~~~-~~~~~~~~~ 229 (324)
T 3mtl_A 154 TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV---EEQLHFIFRILGTP-TEETWPGIL 229 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCC-CTTTSTTGG
T ss_pred ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCC-ChHhchhhh
Confidence 222334578999999999987 5689999999999999999999999976432 11111111110000 00000
Q ss_pred --HHHHHHHhhcc-------cchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhh
Q 041135 614 --EALVDSRLEKN-------YVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDT 660 (727)
Q Consensus 614 --~~l~d~~l~~~-------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 660 (727)
..+........ ........+.+|+++||+.||++||++.||+++-+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f 285 (324)
T 3mtl_A 230 SNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFF 285 (324)
T ss_dssp GCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGG
T ss_pred cchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhh
Confidence 00000000000 001112347799999999999999999999987443
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=372.30 Aligned_cols=256 Identities=21% Similarity=0.305 Sum_probs=193.5
Q ss_pred HHhcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC--------chhHHHHHHHHHHHHHcCCCCceeEeeEeec
Q 041135 378 QATNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG--------SQGEREFRAEVEIISRVHHRHLVSLVGYCIS 448 (727)
Q Consensus 378 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~--------~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~ 448 (727)
...++|.+.++||+|+||.||+|++. +++.||||++.... ......+.+|+++|++++|+||++++++|..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 45678999999999999999999875 58999999987432 1122358899999999999999999999854
Q ss_pred cceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCC---CcEEEEe
Q 041135 449 ERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSS---FEARVAD 525 (727)
Q Consensus 449 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~---~~vkL~D 525 (727)
+..||||||+.+|+|.+++..+.. +++.+++.|+.||++||+|||++ +|+|||||++||||+.+ +.+||+|
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~D 285 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGNKR--LKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD 285 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSSCC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred -CceEEEEEcCCCCcHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEee
Confidence 557999999999999999877654 89999999999999999999999 99999999999999654 4599999
Q ss_pred eccchhhhccCCCccccccccCCccccccCcccC---CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHH
Q 041135 526 FGLAKIALELDSNTHVSTRVMGTFGYMAPEYATS---GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARP 602 (727)
Q Consensus 526 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~ 602 (727)
||+++... ........+|+..|+|||++.+ ..++.++|||||||+||||++|+.||....... .+.+.
T Consensus 286 FG~a~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~~--- 356 (419)
T 3i6u_A 286 FGHSKILG----ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQ--- 356 (419)
T ss_dssp SSTTTSCC---------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CHHHH---
T ss_pred cccceecC----CCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HHHHH---
Confidence 99998542 1223345679999999999864 568889999999999999999999997643221 11110
Q ss_pred HHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 603 LLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 603 ~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
+... ........ .......+.+|+++||+.||++||++.|++++-+
T Consensus 357 -i~~~-~~~~~~~~---------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 402 (419)
T 3i6u_A 357 -ITSG-KYNFIPEV---------WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPW 402 (419)
T ss_dssp -HHTT-CCCCCHHH---------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred -HhcC-CCCCCchh---------hcccCHHHHHHHHHHccCChhHCcCHHHHhCCcc
Confidence 0000 00000000 0112234789999999999999999999998744
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=382.52 Aligned_cols=254 Identities=26% Similarity=0.367 Sum_probs=206.0
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
++|+++++||+|+||.||+|+++ +|+.||||+++... ....+.+.+|+++|++++|+||++++++|.+...+||||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 67999999999999999999985 59999999996432 223457889999999999999999999999999999999
Q ss_pred eeccCCccchhcccCC--CCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhc
Q 041135 457 EYVPNDTLHYHLHAEG--RPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALE 534 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 534 (727)
||+.||+|.++|.... ...+++..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++....
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 9999999999987643 34589999999999999999999999 999999999999999999999999999985422
Q ss_pred cCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHH
Q 041135 535 LDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFE 614 (727)
Q Consensus 535 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~ 614 (727)
........+||..|+|||++.+..++.++||||||||||||++|+.||........ ..++...
T Consensus 342 ---~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~--~~~~~~~------------ 404 (543)
T 3c4z_A 342 ---GQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQR------------ 404 (543)
T ss_dssp ---TCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC--HHHHHHH------------
T ss_pred ---CCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh--HHHHHHH------------
Confidence 12223346899999999999999999999999999999999999999986532211 1111111
Q ss_pred HHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCH-----HHHHHH
Q 041135 615 ALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRM-----SQVVRA 657 (727)
Q Consensus 615 ~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~ 657 (727)
++... ..+.......+.+|+++||+.||++|+++ .+|+++
T Consensus 405 -i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 405 -VLEQA--VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp -HHHCC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred -Hhhcc--cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 11111 11222334567889999999999999975 667654
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=372.34 Aligned_cols=201 Identities=23% Similarity=0.342 Sum_probs=167.2
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeC--CchhHHHHHHHHHHHHHcCCCCceeEeeEeecc-----ce
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIG--GSQGEREFRAEVEIISRVHHRHLVSLVGYCISE-----RE 451 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~-----~~ 451 (727)
.++|+++++||+|+||.||+|++. +|+.||||+++.. .....+.+.+|+++|++++|+||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 467999999999999999999975 5889999999643 223446789999999999999999999999876 57
Q ss_pred eeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchh
Q 041135 452 RLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKI 531 (727)
Q Consensus 452 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 531 (727)
.||||||+. ++|.++++.... +++..++.|+.||++||+|||++ +|+|||||++||||+.++.+||+|||+++.
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~~--l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPIF--LTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSCC--CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEecCC-cCHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 899999985 699998876543 89999999999999999999999 999999999999999999999999999986
Q ss_pred hhccCCCc-------------------cccccccCCccccccCcc-cCCCCCchhHHHHHhHHHHHHHhCCCCCC
Q 041135 532 ALELDSNT-------------------HVSTRVMGTFGYMAPEYA-TSGKLTEKSDVYSFGVVLLELITGRKPVD 586 (727)
Q Consensus 532 ~~~~~~~~-------------------~~~~~~~gt~~y~aPE~l-~~~~~~~ksDVwS~Gvil~eLltG~~Pf~ 586 (727)
........ ......+||..|+|||++ .+..++.++||||||||||||++|..+|.
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 43221110 123456899999999986 45669999999999999999998655554
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=363.44 Aligned_cols=270 Identities=21% Similarity=0.294 Sum_probs=202.9
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCch-hHHHHHHHHHHHHHcCCCCceeEeeEeecc-----cee
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQ-GEREFRAEVEIISRVHHRHLVSLVGYCISE-----RER 452 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~-----~~~ 452 (727)
.++|+++++||+|+||.||+|+.. +|+.||||++...... ..+.+.+|+++|++++|+||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 457999999999999999999975 6889999999754333 346789999999999999999999999754 367
Q ss_pred eEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhh
Q 041135 453 LLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIA 532 (727)
Q Consensus 453 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~ 532 (727)
||||||+. |+|.+++... .+++..++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++..
T Consensus 106 ~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVA 178 (364)
T ss_dssp EEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence 99999996 5888888654 389999999999999999999999 9999999999999999999999999999865
Q ss_pred hccCCCccccccccCCccccccCcccC-CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHH------
Q 041135 533 LELDSNTHVSTRVMGTFGYMAPEYATS-GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLA------ 605 (727)
Q Consensus 533 ~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~------ 605 (727)
.............+|+..|+|||++.+ ..++.++|||||||+||||++|+.||....... ........+.
T Consensus 179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~ 255 (364)
T 3qyz_A 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD---QLNHILGILGSPSQED 255 (364)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG---HHHHHHHHHCSCCHHH
T ss_pred CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH---HHHHHHHHhCCCCHHH
Confidence 332222223345689999999998765 458999999999999999999999997654321 1111110000
Q ss_pred -HhhchhhHHHHHHHHhhcc------cchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 606 -EALEHEDFEALVDSRLEKN------YVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 606 -~~~~~~~~~~l~d~~l~~~------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
..+................ ........+.+|+++||+.||++|+++.||+++-.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 316 (364)
T 3qyz_A 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 316 (364)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcc
Confidence 0000000000000000000 00112235789999999999999999999998744
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=360.84 Aligned_cols=271 Identities=19% Similarity=0.282 Sum_probs=199.2
Q ss_pred cCccccceeccCCceEEEEEEE-cCCcEEEEEEeeeCCc--hhHHHHHHHHHHHHHcCCCCceeEeeEeec--------c
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVL-ADGREVAVKQLKIGGS--QGEREFRAEVEIISRVHHRHLVSLVGYCIS--------E 449 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~--------~ 449 (727)
++|+++++||+|+||.||+|++ .+|+.||||++..... .....+.+|+++|++++|+||++++++|.+ .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 5699999999999999999997 4689999999865433 224578899999999999999999999987 4
Q ss_pred ceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccc
Q 041135 450 RERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLA 529 (727)
Q Consensus 450 ~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla 529 (727)
+..+|||||+.+ +|..++.... ..+++.+++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||++
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred ceEEEEEeccCC-CHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 468999999976 5655554432 2489999999999999999999999 9999999999999999999999999999
Q ss_pred hhhhccCC-CccccccccCCccccccCcccC-CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHh
Q 041135 530 KIALELDS-NTHVSTRVMGTFGYMAPEYATS-GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEA 607 (727)
Q Consensus 530 ~~~~~~~~-~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~ 607 (727)
+.+..... .........|+..|+|||++.+ ..++.++||||||||||||++|+.+|.+... .............
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~~- 247 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE---QHQLALISQLCGS- 247 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCC-
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCC-
Confidence 75432211 2222345678999999999976 4589999999999999999999999986432 1111111100000
Q ss_pred hchhhHHHHHHHHhhc---------ccchh------HHHHHHHHHHHHhccCCCCCCCHHHHHHHHhh
Q 041135 608 LEHEDFEALVDSRLEK---------NYVDS------EMFWMIEAAAACVRHSATKRPRMSQVVRALDT 660 (727)
Q Consensus 608 ~~~~~~~~l~d~~l~~---------~~~~~------~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 660 (727)
.....+..+.+..+.. ..... ....+.+|+++||+.||++|+++.||+++-..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f 315 (351)
T 3mi9_A 248 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 315 (351)
T ss_dssp CCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred CChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCc
Confidence 0000000000000000 00000 01237789999999999999999999987543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=355.23 Aligned_cols=258 Identities=19% Similarity=0.271 Sum_probs=200.8
Q ss_pred cCccccceeccCCceEEEEEEE-cCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcC-CCCceeEeeEeec--cceeeEEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVL-ADGREVAVKQLKIGGSQGEREFRAEVEIISRVH-HRHLVSLVGYCIS--ERERLLVY 456 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~--~~~~~lV~ 456 (727)
++|+++++||+|+||.||+|++ .+|+.||||+++. ...+.+.+|+++|++++ |+||+++++++.+ ....+|||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 6799999999999999999986 4689999999863 33567999999999997 9999999999987 66789999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCC-cEEEEeeccchhhhcc
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSF-EARVADFGLAKIALEL 535 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~-~vkL~DFGla~~~~~~ 535 (727)
||+.+++|.++++. +++.+++.|+.||+.||+|||++ +|+|||||++||||+.++ .+||+|||+++.....
T Consensus 113 e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 113 EHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp ECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred eccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 99999999988853 78899999999999999999999 999999999999999766 8999999999754221
Q ss_pred CCCccccccccCCccccccCcccC-CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHH
Q 041135 536 DSNTHVSTRVMGTFGYMAPEYATS-GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFE 614 (727)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~ 614 (727)
.......|+..|+|||++.+ ..++.++|||||||+||||++|+.||...... ...+.... ..+....+.
T Consensus 185 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~-~~~l~~~~-----~~~~~~~~~ 254 (330)
T 3nsz_A 185 ----QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-YDQLVRIA-----KVLGTEDLY 254 (330)
T ss_dssp ----CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH-HHHHHHHH-----HHHCHHHHH
T ss_pred ----CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCch-HHHHHHHH-----HhcCCchhh
Confidence 12234578999999999987 67899999999999999999999999643321 11111111 111111121
Q ss_pred HHHHHHh-----------------------hcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 615 ALVDSRL-----------------------EKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 615 ~l~d~~l-----------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
..++... ...........+.+|+++||+.||++||++.||+++-.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~ 322 (330)
T 3nsz_A 255 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 322 (330)
T ss_dssp HHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGG
T ss_pred hHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCcc
Confidence 1111100 00001112345889999999999999999999998643
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=380.59 Aligned_cols=252 Identities=22% Similarity=0.330 Sum_probs=205.3
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEE
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLV 455 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 455 (727)
.++|++.++||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+++|++++|+||++++++|.+.+..|||
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 356999999999999999999976 68999999986432 33456799999999999999999999999999999999
Q ss_pred EeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEE---CCCCcEEEEeeccchhh
Q 041135 456 YEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILL---DSSFEARVADFGLAKIA 532 (727)
Q Consensus 456 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl---~~~~~vkL~DFGla~~~ 532 (727)
||||.+|+|.+++..... +++..++.|+.||+.||+|||++ +|+|||||++|||| +.++.+||+|||+++.+
T Consensus 105 ~e~~~~~~L~~~~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRKR--FSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp ECCCCSCBHHHHHHTCSC--CBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 999999999998876654 89999999999999999999999 99999999999999 56789999999999864
Q ss_pred hccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhh
Q 041135 533 LELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHED 612 (727)
Q Consensus 533 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~ 612 (727)
.. .......+|+..|+|||++.+ .++.++||||||||||||++|+.||..... . +...
T Consensus 180 ~~----~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~---~~~~----------- 237 (484)
T 3nyv_A 180 EA----SKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE---Y---DILK----------- 237 (484)
T ss_dssp CC----CCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---H---HHHH-----------
T ss_pred cc----ccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH---H---HHHH-----------
Confidence 22 122344579999999999976 689999999999999999999999976431 1 1111
Q ss_pred HHHHHHHHhhc--ccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhh
Q 041135 613 FEALVDSRLEK--NYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDT 660 (727)
Q Consensus 613 ~~~l~d~~l~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 660 (727)
.+....+.. .........+.+|+++||+.||++||++.|++++-+.
T Consensus 238 --~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~ 285 (484)
T 3nyv_A 238 --KVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWI 285 (484)
T ss_dssp --HHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHH
T ss_pred --HHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhh
Confidence 111111100 0111223457899999999999999999999987553
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=356.11 Aligned_cols=254 Identities=22% Similarity=0.345 Sum_probs=199.5
Q ss_pred HhcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEe
Q 041135 379 ATNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYE 457 (727)
Q Consensus 379 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 457 (727)
..++|++++.||+|+||.||+|++. +|+.||||++........+.+.+|+++|++++|+||++++++|.+++..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 3467999999999999999999986 489999999976666667789999999999999999999999999999999999
Q ss_pred eccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCC
Q 041135 458 YVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDS 537 (727)
Q Consensus 458 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 537 (727)
|+.+++|.+++..... .+++..++.++.||+.||.|||++ +|+|||||++||||+.++.+||+|||++......
T Consensus 97 ~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 170 (302)
T 2j7t_A 97 FCPGGAVDAIMLELDR-GLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-- 170 (302)
T ss_dssp CCTTEEHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH--
T ss_pred eCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccc--
Confidence 9999999998865332 489999999999999999999999 9999999999999999999999999998643211
Q ss_pred CccccccccCCccccccCcc-----cCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhh
Q 041135 538 NTHVSTRVMGTFGYMAPEYA-----TSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHED 612 (727)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~l-----~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~ 612 (727)
........|+..|+|||++ .+..++.++|||||||+||||++|+.||..... .+....
T Consensus 171 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~---------- 233 (302)
T 2j7t_A 171 -LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLK---------- 233 (302)
T ss_dssp -HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHH----------
T ss_pred -ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH------HHHHHH----------
Confidence 1112335689999999998 366789999999999999999999999975431 011000
Q ss_pred HHHHHHHHhh-cccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 041135 613 FEALVDSRLE-KNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRAL 658 (727)
Q Consensus 613 ~~~l~d~~l~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 658 (727)
+...... ..........+.+|+++||+.||++||++.||+++-
T Consensus 234 ---~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~ 277 (302)
T 2j7t_A 234 ---IAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHP 277 (302)
T ss_dssp ---HHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTST
T ss_pred ---HhccCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence 0000000 001112234578899999999999999999998763
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=351.89 Aligned_cols=256 Identities=20% Similarity=0.286 Sum_probs=200.2
Q ss_pred HhcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC----chhHHHHHHHHHHHHHcCCCCceeEeeEee--ccce
Q 041135 379 ATNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG----SQGEREFRAEVEIISRVHHRHLVSLVGYCI--SERE 451 (727)
Q Consensus 379 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~----~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~--~~~~ 451 (727)
..++|+++++||+|+||.||+|++. +|+.||||+++... ....+.+.+|+++|++++|+||+++++++. +...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 3468999999999999999999974 58899999997432 234567999999999999999999999984 4557
Q ss_pred eeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchh
Q 041135 452 RLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKI 531 (727)
Q Consensus 452 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 531 (727)
.+|||||+.++ |.+++.......+++..++.|+.||++||+|||++ +|+|||||++||||+.++.+||+|||+++.
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccc
Confidence 89999999877 66666655555689999999999999999999999 999999999999999999999999999975
Q ss_pred hhccCCCccccccccCCccccccCcccCCC--CCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhc
Q 041135 532 ALELDSNTHVSTRVMGTFGYMAPEYATSGK--LTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALE 609 (727)
Q Consensus 532 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~ 609 (727)
..... .........|+..|+|||++.+.. ++.++|||||||+||||++|+.||.... ..+...
T Consensus 159 ~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~-------- 223 (305)
T 2wtk_C 159 LHPFA-ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN------IYKLFE-------- 223 (305)
T ss_dssp CCTTC-SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHH--------
T ss_pred cCccc-cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch------HHHHHH--------
Confidence 42211 122233456899999999998654 4789999999999999999999997532 111111
Q ss_pred hhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhh
Q 041135 610 HEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDT 660 (727)
Q Consensus 610 ~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 660 (727)
.+..... .+.......+.+|+++||+.||++||++.||+++-..
T Consensus 224 -----~i~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 267 (305)
T 2wtk_C 224 -----NIGKGSY--AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWF 267 (305)
T ss_dssp -----HHHHCCC--CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHH
T ss_pred -----HHhcCCC--CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCccc
Confidence 1111111 1122233457889999999999999999999987553
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=354.24 Aligned_cols=254 Identities=24% Similarity=0.372 Sum_probs=199.9
Q ss_pred HhcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEe
Q 041135 379 ATNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYE 457 (727)
Q Consensus 379 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 457 (727)
..++|++++.||+|+||.||+|++. +|+.||||++.... ..+.+.+|+++|++++|+||+++++++.+.+..+||||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4567999999999999999999976 48999999987532 34678999999999999999999999999999999999
Q ss_pred eccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCC
Q 041135 458 YVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDS 537 (727)
Q Consensus 458 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 537 (727)
|+.+++|.+++.... ..+++..++.++.||+.||.|||++ +|+|||||++||||+.++.+||+|||+++....
T Consensus 105 ~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~--- 177 (314)
T 3com_A 105 YCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD--- 177 (314)
T ss_dssp CCTTEEHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBT---
T ss_pred cCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhh---
Confidence 999999999986432 2489999999999999999999999 999999999999999999999999999975422
Q ss_pred CccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHH
Q 041135 538 NTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALV 617 (727)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~ 617 (727)
.........|+..|+|||++.+..++.++|||||||+||||++|+.||...... +.... +...
T Consensus 178 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~-~~~~---------- 240 (314)
T 3com_A 178 TMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM------RAIFM-IPTN---------- 240 (314)
T ss_dssp TBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHH-HHHS----------
T ss_pred hccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH------HHHHH-HhcC----------
Confidence 112233457899999999999999999999999999999999999999753210 00000 0000
Q ss_pred HHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 618 DSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 618 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
..............+.+|+.+||+.||++||++.||+++-.
T Consensus 241 -~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~ 281 (314)
T 3com_A 241 -PPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPF 281 (314)
T ss_dssp -CCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHH
T ss_pred -CCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHH
Confidence 00000011112345789999999999999999999998644
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=368.59 Aligned_cols=251 Identities=17% Similarity=0.185 Sum_probs=202.6
Q ss_pred hcCccccceeccCCceEEEEEE------EcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcC---CCCceeEeeEeeccc
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGV------LADGREVAVKQLKIGGSQGEREFRAEVEIISRVH---HRHLVSLVGYCISER 450 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~------~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~---HpnIv~l~~~~~~~~ 450 (727)
.++|++.++||+|+||.||+|+ ..+++.||||+++.. ...++.+|++++++++ |+||++++++|..++
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~ 140 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN 140 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence 4679999999999999999994 446889999998643 3457888888888887 999999999999999
Q ss_pred eeeEEEeeccCCccchhcccC---CCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECC----------
Q 041135 451 ERLLVYEYVPNDTLHYHLHAE---GRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDS---------- 517 (727)
Q Consensus 451 ~~~lV~Ey~~~gsL~~~L~~~---~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~---------- 517 (727)
..|||||||.+|+|.++++.. ....+++..++.|+.||++||+|||++ +|||||||++||||+.
T Consensus 141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~ 217 (365)
T 3e7e_A 141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDD 217 (365)
T ss_dssp CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC-----
T ss_pred CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcccccc
Confidence 999999999999999999742 234589999999999999999999998 9999999999999988
Q ss_pred -CCcEEEEeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhh
Q 041135 518 -SFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESL 596 (727)
Q Consensus 518 -~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l 596 (727)
++.+||+|||+++..... .........+||..|+|||++.+..++.++||||||||||||++|+.||....... ..+
T Consensus 218 ~~~~~kl~DFG~a~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~ 295 (365)
T 3e7e_A 218 LSAGLALIDLGQSIDMKLF-PKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE-CKP 295 (365)
T ss_dssp -CTTEEECCCTTCEEGGGS-CTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-EEE
T ss_pred ccCCEEEeeCchhhhhhcc-CCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc-eee
Confidence 899999999999754322 22233455789999999999999999999999999999999999999996433210 000
Q ss_pred HHhhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCC-CCHHHHHHHHhhcc
Q 041135 597 VEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKR-PRMSQVVRALDTLD 662 (727)
Q Consensus 597 ~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R-Ps~~evl~~L~~~~ 662 (727)
. . .+.. +. ....+.+++..||+.++.+| +++.+|.+.|+++.
T Consensus 296 ~-------------~--------~~~~-~~--~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l 338 (365)
T 3e7e_A 296 E-------------G--------LFRR-LP--HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF 338 (365)
T ss_dssp C-------------S--------CCTT-CS--SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred c-------------h--------hccc-cC--cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHH
Confidence 0 0 0000 01 12235678889999999998 57888888888764
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=369.70 Aligned_cols=199 Identities=23% Similarity=0.308 Sum_probs=173.9
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHc------CCCCceeEeeEeecccee
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRV------HHRHLVSLVGYCISERER 452 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l------~HpnIv~l~~~~~~~~~~ 452 (727)
..+|+++++||+|+||.||+|++. +|+.||||+++.. ....+.+.+|+++|+.+ +|+||++++++|......
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 457999999999999999999875 4899999998642 33456788899999888 467999999999999999
Q ss_pred eEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCc--EEEEeeccch
Q 041135 453 LLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFE--ARVADFGLAK 530 (727)
Q Consensus 453 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~--vkL~DFGla~ 530 (727)
+|||||+. ++|.+++.......+++..+++|+.||+.||+|||++ +|||||||++||||+.++. +||+|||+++
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 99999995 6888888776656689999999999999999999999 9999999999999999887 9999999997
Q ss_pred hhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCC
Q 041135 531 IALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQ 589 (727)
Q Consensus 531 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~ 589 (727)
.... .....+|+..|+|||++.+..++.++||||||||||||++|+.||....
T Consensus 251 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 251 YEHQ------RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp ETTC------CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ecCC------cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 4321 1234578999999999999999999999999999999999999997653
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=357.40 Aligned_cols=266 Identities=26% Similarity=0.346 Sum_probs=203.3
Q ss_pred HHhcCccccceeccCCceEEEEEEE--cCCcEEEEEEeeeCCc--hhHHHHHHHHHHHHHc---CCCCceeEeeEee---
Q 041135 378 QATNGFSAHNVLGEGGFGCVYKGVL--ADGREVAVKQLKIGGS--QGEREFRAEVEIISRV---HHRHLVSLVGYCI--- 447 (727)
Q Consensus 378 ~~~~~~~~~~~LG~G~fg~Vy~~~~--~~g~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l---~HpnIv~l~~~~~--- 447 (727)
...++|++++.||+|+||.||+|++ .+|+.||||+++.... .....+.+|+++++.+ +|+||++++++|.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 3457899999999999999999997 3688999999975432 2234677888888777 7999999999997
Q ss_pred --ccceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEe
Q 041135 448 --SERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVAD 525 (727)
Q Consensus 448 --~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~D 525 (727)
.....+|||||+. |+|.+++.......+++..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEec
Confidence 5667899999997 6999998876655689999999999999999999999 999999999999999999999999
Q ss_pred eccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHH
Q 041135 526 FGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLA 605 (727)
Q Consensus 526 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~ 605 (727)
||+++.... ........|+..|+|||++.+..++.++|||||||+||||++|+.||..... .. ....++.
T Consensus 164 fg~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~---~~~~i~~ 233 (326)
T 1blx_A 164 FGLARIYSF----QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD---VD---QLGKILD 233 (326)
T ss_dssp CCSCCCCCG----GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HH---HHHHHHH
T ss_pred CcccccccC----CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH---HH---HHHHHHH
Confidence 999975421 1223446789999999999999999999999999999999999999976431 11 1111111
Q ss_pred Hhhc--hhhHHHHH---HHHh-------hcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 606 EALE--HEDFEALV---DSRL-------EKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 606 ~~~~--~~~~~~l~---d~~l-------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
.... ...+.... ...+ ...+.......+.+|+++||+.||++||++.||+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 234 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp HHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000 00000000 0000 001112233457899999999999999999999975
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=376.50 Aligned_cols=242 Identities=14% Similarity=0.170 Sum_probs=188.9
Q ss_pred hcCccccceeccCCceEEEEEEE-cCCcEEEEEEeeeC---CchhHHHHHHHHH---HHHHcCCCCceeEe-------eE
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVL-ADGREVAVKQLKIG---GSQGEREFRAEVE---IISRVHHRHLVSLV-------GY 445 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vaVK~l~~~---~~~~~~~~~~Ei~---~l~~l~HpnIv~l~-------~~ 445 (727)
.++|++.++||+|+||.||+|++ .+|+.||||+++.. .....+.|++|++ +|++++|+|||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 35688999999999999999996 46999999999743 3344578999995 55556799999998 55
Q ss_pred eeccc-----------------eeeEEEeeccCCccchhcccCCC-----CcccHHHHHHHHHHHHHHHHHHHhcCCCcE
Q 041135 446 CISER-----------------ERLLVYEYVPNDTLHYHLHAEGR-----PVMDWATRVKVAAGAARGIAYLHEDCHPRI 503 (727)
Q Consensus 446 ~~~~~-----------------~~~lV~Ey~~~gsL~~~L~~~~~-----~~l~~~~~~~i~~qia~gL~yLH~~~~~~i 503 (727)
+.+.+ ..||||||+ +|+|.+++...+. ..+.+..+++|+.||++||+|||++ +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 55443 278999999 6899999875422 2244588889999999999999999 99
Q ss_pred EeeCCCCCceEECCCCcEEEEeeccchhhhccCCCccccccccCCccccccCcccCC-----------CCCchhHHHHHh
Q 041135 504 IHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSG-----------KLTEKSDVYSFG 572 (727)
Q Consensus 504 vHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----------~~~~ksDVwS~G 572 (727)
+|||||++||||+.++.+||+|||+++... ......+| ..|+|||++.+. .++.++||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~------~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG 300 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG------ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALG 300 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETT------CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecC------CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHH
Confidence 999999999999999999999999998421 12344567 999999999887 899999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHH
Q 041135 573 VVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMS 652 (727)
Q Consensus 573 vil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 652 (727)
|+||||++|+.||...........+ +. ........+.+|+++||+.||++||++.
T Consensus 301 ~il~elltg~~Pf~~~~~~~~~~~~-----------------------~~--~~~~~~~~~~~li~~~L~~dp~~Rpt~~ 355 (377)
T 3byv_A 301 LVIYWIWCADLPITKDAALGGSEWI-----------------------FR--SCKNIPQPVRALLEGFLRYPKEDRLLPL 355 (377)
T ss_dssp HHHHHHHHSSCCC------CCSGGG-----------------------GS--SCCCCCHHHHHHHHHHTCSSGGGCCCHH
T ss_pred HHHHHHHHCCCCCcccccccchhhh-----------------------hh--hccCCCHHHHHHHHHHcCCCchhCCCHH
Confidence 9999999999999764432111000 00 0011123477899999999999999999
Q ss_pred HHHHH
Q 041135 653 QVVRA 657 (727)
Q Consensus 653 evl~~ 657 (727)
||+++
T Consensus 356 e~l~h 360 (377)
T 3byv_A 356 QAMET 360 (377)
T ss_dssp HHHTS
T ss_pred HHhhC
Confidence 99975
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=362.41 Aligned_cols=265 Identities=19% Similarity=0.289 Sum_probs=204.5
Q ss_pred hcCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchh-----------------HHHHHHHHHHHHHcCCCCceeE
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQG-----------------EREFRAEVEIISRVHHRHLVSL 442 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~-----------------~~~~~~Ei~~l~~l~HpnIv~l 442 (727)
.++|+++++||+|+||.||+|++ +|+.||||++....... .+.+.+|+++|++++|+||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 36799999999999999999999 89999999996432111 1789999999999999999999
Q ss_pred eeEeeccceeeEEEeeccCCccchh------cccCCCCcccHHHHHHHHHHHHHHHHHHHh-cCCCcEEeeCCCCCceEE
Q 041135 443 VGYCISERERLLVYEYVPNDTLHYH------LHAEGRPVMDWATRVKVAAGAARGIAYLHE-DCHPRIIHRDIKSSNILL 515 (727)
Q Consensus 443 ~~~~~~~~~~~lV~Ey~~~gsL~~~------L~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivHrDLkp~NILl 515 (727)
+++|.+.+..+|||||+.+++|.++ +.......+++..++.|+.||+.||+|||+ + +|+|||||++||||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEE
Confidence 9999999999999999999999998 665445569999999999999999999999 8 99999999999999
Q ss_pred CCCCcEEEEeeccchhhhccCCCccccccccCCccccccCcccCC-CCCc-hhHHHHHhHHHHHHHhCCCCCCCCCCCCc
Q 041135 516 DSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSG-KLTE-KSDVYSFGVVLLELITGRKPVDASQPLGD 593 (727)
Q Consensus 516 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~-ksDVwS~Gvil~eLltG~~Pf~~~~~~~~ 593 (727)
+.++.+||+|||+++.... .......|+..|+|||++.+. .++. ++|||||||+||||++|+.||......
T Consensus 186 ~~~~~~kl~dfg~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-- 258 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVD-----KKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL-- 258 (348)
T ss_dssp CTTSCEEECCCTTCEECBT-----TEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--
T ss_pred cCCCcEEEecccccccccc-----ccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--
Confidence 9999999999999975421 133456789999999999887 6666 999999999999999999999865421
Q ss_pred hhhHHhhHHHHHHhhchhh-HHHHHHHHh---hcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 041135 594 ESLVEWARPLLAEALEHED-FEALVDSRL---EKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRAL 658 (727)
Q Consensus 594 ~~l~~~~~~~l~~~~~~~~-~~~l~d~~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 658 (727)
..+.+. +......... ...+..... ...........+.+|+++||+.||++||++.||+++-
T Consensus 259 ~~~~~~---i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp 324 (348)
T 2pml_X 259 VELFNN---IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHE 324 (348)
T ss_dssp HHHHHH---HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred HHHHHH---HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence 111110 0000000000 000000000 0000011234578999999999999999999999863
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=355.17 Aligned_cols=253 Identities=22% Similarity=0.305 Sum_probs=196.1
Q ss_pred HhcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc--------hhHHHHHHHHHHHHHcCCCCceeEeeEeecc
Q 041135 379 ATNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS--------QGEREFRAEVEIISRVHHRHLVSLVGYCISE 449 (727)
Q Consensus 379 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~--------~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~ 449 (727)
..++|++++.||+|+||.||+|++. +|+.||||+++.... .....+.+|+++|++++|+||+++++++..+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3467999999999999999999975 588999999864321 1234588999999999999999999998765
Q ss_pred ceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCC---cEEEEee
Q 041135 450 RERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSF---EARVADF 526 (727)
Q Consensus 450 ~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~---~vkL~DF 526 (727)
. .|+||||+.+++|.+++..+.. +++..++.++.||+.||+|||++ +|+|||||++||||+.++ .+||+||
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGNKR--LKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTTCC--CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred c-eEEEEecCCCCcHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccC
Confidence 5 8999999999999998876544 89999999999999999999999 999999999999998665 4999999
Q ss_pred ccchhhhccCCCccccccccCCccccccCccc---CCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHH
Q 041135 527 GLAKIALELDSNTHVSTRVMGTFGYMAPEYAT---SGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPL 603 (727)
Q Consensus 527 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~ 603 (727)
|+++... .........|+..|+|||++. +..++.++|||||||+||||++|+.||....... .+.+.
T Consensus 162 g~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~---- 231 (322)
T 2ycf_A 162 GHSKILG----ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQ---- 231 (322)
T ss_dssp TTCEECC----CCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHHH----
T ss_pred ccceecc----cccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHHH----
Confidence 9997542 122233457899999999974 4678899999999999999999999997654321 11110
Q ss_pred HHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 604 LAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 604 l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
+.... ....... .......+.+|+++||+.||++||++.||+++
T Consensus 232 ~~~~~-~~~~~~~---------~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 232 ITSGK-YNFIPEV---------WAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp HHHTC-CCCCHHH---------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHhCc-cccCchh---------hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 00000 0000000 01122357899999999999999999999875
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=349.57 Aligned_cols=252 Identities=21% Similarity=0.290 Sum_probs=203.1
Q ss_pred HhcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc---------hhHHHHHHHHHHHHHcC-CCCceeEeeEee
Q 041135 379 ATNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS---------QGEREFRAEVEIISRVH-HRHLVSLVGYCI 447 (727)
Q Consensus 379 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~---------~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~ 447 (727)
..++|++.++||+|+||.||+|++. +|+.||||+++.... ...+.+.+|+++|+++. |+||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3467999999999999999999985 589999999975431 22356889999999996 999999999999
Q ss_pred ccceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeec
Q 041135 448 SERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFG 527 (727)
Q Consensus 448 ~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFG 527 (727)
++...+|||||+.+++|.+++..+. .+++..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred cCCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEeccc
Confidence 9999999999999999999997654 389999999999999999999999 99999999999999999999999999
Q ss_pred cchhhhccCCCccccccccCCccccccCccc------CCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhH
Q 041135 528 LAKIALELDSNTHVSTRVMGTFGYMAPEYAT------SGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWAR 601 (727)
Q Consensus 528 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~------~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~ 601 (727)
+++.... ........|+..|+|||++. ...++.++|||||||+||||++|+.||..... .+...
T Consensus 170 ~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~ 239 (298)
T 1phk_A 170 FSCQLDP----GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ------MLMLR 239 (298)
T ss_dssp TCEECCT----TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHH
T ss_pred chhhcCC----CcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH------HHHHH
Confidence 9975421 11233457899999999985 45688999999999999999999999965321 11111
Q ss_pred HHHHHhhchhhHHHHHHHHhhc--ccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 041135 602 PLLAEALEHEDFEALVDSRLEK--NYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRAL 658 (727)
Q Consensus 602 ~~l~~~~~~~~~~~l~d~~l~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 658 (727)
. +....... .........+.+|+++||+.||++||++.||+++-
T Consensus 240 ~-------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~ 285 (298)
T 1phk_A 240 M-------------IMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHP 285 (298)
T ss_dssp H-------------HHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSG
T ss_pred H-------------HhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhCh
Confidence 1 11111100 00112234588999999999999999999998753
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=393.46 Aligned_cols=250 Identities=26% Similarity=0.359 Sum_probs=205.3
Q ss_pred HhcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeC---CchhHHHHHHHHHHHHHc-CCCCceeEeeEeeccceee
Q 041135 379 ATNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIG---GSQGEREFRAEVEIISRV-HHRHLVSLVGYCISERERL 453 (727)
Q Consensus 379 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~---~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~ 453 (727)
..++|+++++||+|+||.||+|+++ +|+.||||+++.. .....+.+.+|+++|..+ +|+||++|++++.+.+.+|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 3468999999999999999999975 5788999999743 223345688899999987 6999999999999999999
Q ss_pred EEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhh
Q 041135 454 LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIAL 533 (727)
Q Consensus 454 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~ 533 (727)
|||||+.||+|.++|+..+. +++..++.|+.||+.||+|||++ +|||||||++||||+.++.+||+|||+++...
T Consensus 419 lV~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVGR--FKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEEeCcCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 99999999999999987654 89999999999999999999999 99999999999999999999999999997432
Q ss_pred ccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhH
Q 041135 534 ELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDF 613 (727)
Q Consensus 534 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~ 613 (727)
. ........+||..|+|||++.+..++.++||||||||||||++|+.||...+. .+. +
T Consensus 494 ~---~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~------~~~-------------~ 551 (674)
T 3pfq_A 494 W---DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DEL-------------F 551 (674)
T ss_dssp C---TTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHH-------------H
T ss_pred c---CCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH------HHH-------------H
Confidence 1 12234457899999999999999999999999999999999999999976431 111 1
Q ss_pred HHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCH-----HHHHHH
Q 041135 614 EALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRM-----SQVVRA 657 (727)
Q Consensus 614 ~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~ 657 (727)
..++... ..+.......+.+||++||+.||++|+++ +||+++
T Consensus 552 ~~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 552 QSIMEHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp HHHHSSC--CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred HHHHhCC--CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 1111111 12223334458899999999999999997 677664
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=368.01 Aligned_cols=260 Identities=21% Similarity=0.330 Sum_probs=196.2
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC--chhHHHHHHHHHHHHHcCCCCceeEeeEeeccc------
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG--SQGEREFRAEVEIISRVHHRHLVSLVGYCISER------ 450 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~------ 450 (727)
.++|++++.||+|+||.||+|++. +|+.||||++.... ....+.+.+|+++|++++|+||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 467999999999999999999974 68999999985432 233467889999999999999999999998653
Q ss_pred eeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccch
Q 041135 451 ERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAK 530 (727)
Q Consensus 451 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~ 530 (727)
..||||||+ +++|.++++.. .+++..++.++.||++||+|||++ +|+|||||++||||+.++.+||+|||+++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR 176 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence 459999999 88999988763 388999999999999999999999 99999999999999999999999999998
Q ss_pred hhhccCCCccccccccCCccccccCcccC-CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHH----
Q 041135 531 IALELDSNTHVSTRVMGTFGYMAPEYATS-GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLA---- 605 (727)
Q Consensus 531 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~---- 605 (727)
.... .....+||..|+|||++.+ ..++.++||||||||||||++|+.+|.+.+.. +....++.
T Consensus 177 ~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~l~~i~~~~g~ 244 (367)
T 1cm8_A 177 QADS------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL------DQLKEIMKVTGT 244 (367)
T ss_dssp ECCS------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHHHCC
T ss_pred cccc------ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHhcCC
Confidence 5321 1334578999999999987 67999999999999999999999999764321 11111111
Q ss_pred ------HhhchhhHHHHHHHHhh---c---ccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 041135 606 ------EALEHEDFEALVDSRLE---K---NYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRAL 658 (727)
Q Consensus 606 ------~~~~~~~~~~l~d~~l~---~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 658 (727)
..+.......++...-. . .........+.+|+++||..||++|+++.|++++-
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp 309 (367)
T 1cm8_A 245 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHP 309 (367)
T ss_dssp CCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred CCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcCh
Confidence 01111111111111000 0 01112234578999999999999999999999963
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=352.94 Aligned_cols=264 Identities=21% Similarity=0.311 Sum_probs=204.3
Q ss_pred hcCccccceeccCCceEEEEEEE--cCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCC------CceeEeeEeeccce
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVL--ADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHR------HLVSLVGYCISERE 451 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~--~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~Hp------nIv~l~~~~~~~~~ 451 (727)
.++|+++++||+|+||.||+|+. .+|+.||||+++.. ....+.+.+|+++|+.++|. +|++++++|.+.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 35799999999999999999987 35889999998643 34456789999999999765 49999999999999
Q ss_pred eeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECC--------------
Q 041135 452 RLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDS-------------- 517 (727)
Q Consensus 452 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~-------------- 517 (727)
.+|||||+ +++|.+++.......+++..++.|+.||++||+|||++ +|+|||||++||||+.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccccc
Confidence 99999999 88999999877655689999999999999999999999 9999999999999987
Q ss_pred -----CCcEEEEeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCC
Q 041135 518 -----SFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLG 592 (727)
Q Consensus 518 -----~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~ 592 (727)
++.+||+|||+++.... ......|+..|+|||++.+..++.++|||||||+||||++|+.||.....
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-- 239 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDE------HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS-- 239 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTS------CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH--
T ss_pred cccccCCCceEeeCcccccCcc------ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh--
Confidence 67899999999975321 12345789999999999999999999999999999999999999976432
Q ss_pred chhhHHhhHHHHH--------Hhhc-------------hhhHHHHHHHHh---h--cccchhHHHHHHHHHHHHhccCCC
Q 041135 593 DESLVEWARPLLA--------EALE-------------HEDFEALVDSRL---E--KNYVDSEMFWMIEAAAACVRHSAT 646 (727)
Q Consensus 593 ~~~l~~~~~~~l~--------~~~~-------------~~~~~~l~d~~l---~--~~~~~~~~~~l~~li~~cl~~dP~ 646 (727)
..........+. .... .......+.... . ..........+.+|+++||+.||+
T Consensus 240 -~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 318 (339)
T 1z57_A 240 -KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPA 318 (339)
T ss_dssp -HHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred -HHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcc
Confidence 111111111100 0000 000000000000 0 011223456688999999999999
Q ss_pred CCCCHHHHHHH
Q 041135 647 KRPRMSQVVRA 657 (727)
Q Consensus 647 ~RPs~~evl~~ 657 (727)
+||++.||+++
T Consensus 319 ~Rpt~~ell~h 329 (339)
T 1z57_A 319 KRITLREALKH 329 (339)
T ss_dssp TSCCHHHHTTS
T ss_pred cccCHHHHhcC
Confidence 99999999876
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=358.69 Aligned_cols=260 Identities=21% Similarity=0.339 Sum_probs=202.2
Q ss_pred HHHHhcCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCC--chhHHHHHHHHHHHHHcC--CCCceeEeeEeeccce
Q 041135 376 LIQATNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGG--SQGEREFRAEVEIISRVH--HRHLVSLVGYCISERE 451 (727)
Q Consensus 376 l~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~--HpnIv~l~~~~~~~~~ 451 (727)
+....++|+++++||+|+||.||+|++.+|+.||||+++... ....+.+++|+++|++++ |+||+++++++.++..
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 102 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 102 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence 334456799999999999999999999889999999997543 234467999999999997 5999999999999999
Q ss_pred eeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchh
Q 041135 452 RLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKI 531 (727)
Q Consensus 452 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 531 (727)
.+|||| +.+++|.+++.... .+++.+++.|+.||++||+|||++ +|+|||||++||||++ +.+||+|||+++.
T Consensus 103 ~~lv~e-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~ 175 (313)
T 3cek_A 103 IYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQ 175 (313)
T ss_dssp EEEEEC-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC
T ss_pred EEEEEe-cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeecccccc
Confidence 999999 56889999997754 488999999999999999999999 9999999999999964 7999999999975
Q ss_pred hhccCCCccccccccCCccccccCcccC-----------CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhh
Q 041135 532 ALELDSNTHVSTRVMGTFGYMAPEYATS-----------GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWA 600 (727)
Q Consensus 532 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----------~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~ 600 (727)
..... .........|+..|+|||++.+ ..++.++|||||||+||||++|+.||..... .. .
T Consensus 176 ~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~----~~-~-- 247 (313)
T 3cek_A 176 MQPDT-TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN----QI-S-- 247 (313)
T ss_dssp ---------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS----HH-H--
T ss_pred ccCcc-ccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH----HH-H--
Confidence 43211 1122234578999999999876 4688899999999999999999999965321 00 0
Q ss_pred HHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhc
Q 041135 601 RPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661 (727)
Q Consensus 601 ~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 661 (727)
.+..+++......+.......+.+|+++||+.||++||++.||+++-...
T Consensus 248 -----------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~ 297 (313)
T 3cek_A 248 -----------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 297 (313)
T ss_dssp -----------HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred -----------HHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCcccc
Confidence 11122222222222222334588999999999999999999999876543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=374.98 Aligned_cols=251 Identities=22% Similarity=0.317 Sum_probs=202.0
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeC--CchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIG--GSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
.++|+++++||+|+||.||+|++. +|+.||||+++.. .......+.+|+++|++++|+||++++++|.+....||||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 456999999999999999999975 6899999998632 2234567899999999999999999999999999999999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEEC---CCCcEEEEeeccchhhh
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLD---SSFEARVADFGLAKIAL 533 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~---~~~~vkL~DFGla~~~~ 533 (727)
|||.+|+|.+++..... +++..++.|+.||+.||.|||++ +|+|||||++||||+ .++.+||+|||+++...
T Consensus 101 e~~~~~~L~~~~~~~~~--~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp CCCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EcCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 99999999998876654 89999999999999999999999 999999999999995 56689999999997542
Q ss_pred ccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhH
Q 041135 534 ELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDF 613 (727)
Q Consensus 534 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~ 613 (727)
. .......+|+..|+|||++.+ .++.++||||||||||||++|+.||..... .+...
T Consensus 176 ~----~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~------------ 232 (486)
T 3mwu_A 176 Q----NTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE------YDILK------------ 232 (486)
T ss_dssp C----C----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHH------------
T ss_pred C----CCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHH------------
Confidence 2 122344679999999999986 599999999999999999999999975431 11111
Q ss_pred HHHHHHHhhc--ccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 614 EALVDSRLEK--NYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 614 ~~l~d~~l~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
.+....+.. .........+.+|+++||+.||++||++.|++++-+
T Consensus 233 -~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~ 279 (486)
T 3mwu_A 233 -RVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPW 279 (486)
T ss_dssp -HHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHH
T ss_pred -HHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHh
Confidence 111111100 011122345789999999999999999999998744
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=372.99 Aligned_cols=260 Identities=26% Similarity=0.318 Sum_probs=193.0
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeecc------ceee
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISE------RERL 453 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~------~~~~ 453 (727)
.+|+++++||+|+||.||+|++. +|+.||||++... ...+.+|+++|++|+|+|||+++++|... ..++
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC----TTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc----chhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 35889999999999999999985 5899999998643 23345799999999999999999998542 2467
Q ss_pred EEEeeccCCccchhccc--CCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCC-CcEEEEeeccch
Q 041135 454 LVYEYVPNDTLHYHLHA--EGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSS-FEARVADFGLAK 530 (727)
Q Consensus 454 lV~Ey~~~gsL~~~L~~--~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~-~~vkL~DFGla~ 530 (727)
|||||+.+ +|.+++.. .....+.+..++.|+.||++||+|||++ +|+|||||++||||+.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999976 45444432 2234589999999999999999999998 99999999999999955 678999999998
Q ss_pred hhhccCCCccccccccCCccccccCcccCC-CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhc
Q 041135 531 IALELDSNTHVSTRVMGTFGYMAPEYATSG-KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALE 609 (727)
Q Consensus 531 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~ 609 (727)
.+... ......+|+..|+|||++.+. .++.++||||||||||||++|+.||.+... .+.+.++.+ .+.
T Consensus 206 ~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~--~~~l~~i~~-----~lg 274 (420)
T 1j1b_A 206 QLVRG----EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG--VDQLVEIIK-----VLG 274 (420)
T ss_dssp ECCTT----CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHH-----HHC
T ss_pred hcccC----CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHH-----HhC
Confidence 54221 122345789999999999765 799999999999999999999999976431 112222111 111
Q ss_pred hhhHHHHHH--HH-------------hhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 610 HEDFEALVD--SR-------------LEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 610 ~~~~~~l~d--~~-------------l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
....+.+.. .. +...+.......+.+|+++||..||++|+++.|++++-.
T Consensus 275 ~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~ 339 (420)
T 1j1b_A 275 TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339 (420)
T ss_dssp SCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred CCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHh
Confidence 111111110 00 000011122345889999999999999999999998644
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=353.83 Aligned_cols=267 Identities=21% Similarity=0.309 Sum_probs=196.5
Q ss_pred hcCccccceeccCCceEEEEEEEcC-CcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEee-----------
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLAD-GREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCI----------- 447 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~~-g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~----------- 447 (727)
.++|+++++||+|+||.||+|++.+ |+.||||++........+.+.+|+++|++++|+||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 4679999999999999999999864 8999999998766666678999999999999999999999874
Q ss_pred ---ccceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEEC-CCCcEEE
Q 041135 448 ---SERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLD-SSFEARV 523 (727)
Q Consensus 448 ---~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~-~~~~vkL 523 (727)
+....+|||||+. |+|.+++... .+.+..++.++.||++||+|||++ +|+|||||++||||+ +++.+||
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQG---PLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhcC---CccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEE
Confidence 3467899999997 6899888653 388999999999999999999999 999999999999997 5779999
Q ss_pred EeeccchhhhccCCCccccccccCCccccccCcccC-CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHH
Q 041135 524 ADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATS-GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARP 602 (727)
Q Consensus 524 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~ 602 (727)
+|||+++................++..|+|||++.+ ..++.++|||||||+||||++|+.||...... +....
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~------~~~~~ 236 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL------EQMQL 236 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHH
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH------HHHHH
Confidence 999999864322222222334567899999998876 67899999999999999999999999864321 11111
Q ss_pred HHHHhh--chhhHHH-------HHHHHhhcc------cchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 603 LLAEAL--EHEDFEA-------LVDSRLEKN------YVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 603 ~l~~~~--~~~~~~~-------l~d~~l~~~------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
++.... ......+ .+...+... ........+.+|+++||+.||++||++.||+++-.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 308 (320)
T 2i6l_A 237 ILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPY 308 (320)
T ss_dssp HHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHH
T ss_pred HHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcc
Confidence 111100 0000000 011111000 01112345889999999999999999999998643
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=371.70 Aligned_cols=275 Identities=20% Similarity=0.260 Sum_probs=186.0
Q ss_pred cCccc-cceeccCCceEEEEEEEc---CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeec--cceeeE
Q 041135 381 NGFSA-HNVLGEGGFGCVYKGVLA---DGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCIS--ERERLL 454 (727)
Q Consensus 381 ~~~~~-~~~LG~G~fg~Vy~~~~~---~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~--~~~~~l 454 (727)
+.|++ .++||+|+||.||+|+++ +++.||||+++.. .....+.+|+++|++|+|+||++++++|.. +...||
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 34666 458999999999999975 4789999998643 233578899999999999999999999954 678899
Q ss_pred EEeeccCCccchhcccC-------CCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEE----CCCCcEEE
Q 041135 455 VYEYVPNDTLHYHLHAE-------GRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILL----DSSFEARV 523 (727)
Q Consensus 455 V~Ey~~~gsL~~~L~~~-------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl----~~~~~vkL 523 (727)
||||+.+ +|.+++... ....+++..++.|+.||+.||+|||++ +|+|||||++|||| +.++.+||
T Consensus 98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 9999965 666665421 122489999999999999999999999 99999999999999 67889999
Q ss_pred EeeccchhhhccCCCccccccccCCccccccCcccCC-CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCc---hhhHHh
Q 041135 524 ADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSG-KLTEKSDVYSFGVVLLELITGRKPVDASQPLGD---ESLVEW 599 (727)
Q Consensus 524 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~---~~l~~~ 599 (727)
+|||+++.+.............+||..|+|||++.+. .++.++||||||||||||++|+.||........ ....+.
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 253 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 253 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence 9999998653322222333456899999999999874 589999999999999999999999976543110 000011
Q ss_pred hHHHHHHh-----------hchhhHHHHHHHHhhccc------------chhHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 041135 600 ARPLLAEA-----------LEHEDFEALVDSRLEKNY------------VDSEMFWMIEAAAACVRHSATKRPRMSQVVR 656 (727)
Q Consensus 600 ~~~~l~~~-----------~~~~~~~~l~d~~l~~~~------------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 656 (727)
+..++... ........++.......+ .......+.+|+++||+.||++|+++.||++
T Consensus 254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11111100 000001111111100000 0011234779999999999999999999999
Q ss_pred HHhhc
Q 041135 657 ALDTL 661 (727)
Q Consensus 657 ~L~~~ 661 (727)
+-+..
T Consensus 334 hp~f~ 338 (405)
T 3rgf_A 334 DPYFL 338 (405)
T ss_dssp SGGGT
T ss_pred Chhhc
Confidence 86654
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=375.90 Aligned_cols=249 Identities=22% Similarity=0.350 Sum_probs=197.7
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC--chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG--SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
.++|+++++||+|+||.||+|++. +++.||||+++... ......+.+|+++|+.++|+||++++++|.+....||||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 446999999999999999999976 68899999997543 233567899999999999999999999999999999999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECC---CCcEEEEeeccchhhh
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDS---SFEARVADFGLAKIAL 533 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~---~~~vkL~DFGla~~~~ 533 (727)
|||.+|+|.+++..... +++..++.|+.||+.||+|||++ +|+|||||++||||+. ++.+||+|||+++...
T Consensus 116 e~~~~g~L~~~~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 116 ECYKGGELFDEIIHRMK--FNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp ECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred ecCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 99999999988876544 89999999999999999999999 9999999999999975 4569999999997542
Q ss_pred ccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhH
Q 041135 534 ELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDF 613 (727)
Q Consensus 534 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~ 613 (727)
. .......+|+..|+|||++. +.++.++||||||||||||++|+.||..... . +....
T Consensus 191 ~----~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~---~~~~~----------- 248 (494)
T 3lij_A 191 N----QKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD---Q---EILRK----------- 248 (494)
T ss_dssp T----TBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---H---HHHHH-----------
T ss_pred C----CccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH---H---HHHHH-----------
Confidence 1 12234567999999999987 4699999999999999999999999976431 1 11111
Q ss_pred HHHHHHHhh--cccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 614 EALVDSRLE--KNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 614 ~~l~d~~l~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
+....+. ..........+.+|+++||+.||++||++.|++++
T Consensus 249 --i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 249 --VEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp --HHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred --HHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 1111110 00011223457889999999999999999999876
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=372.98 Aligned_cols=253 Identities=23% Similarity=0.306 Sum_probs=201.2
Q ss_pred HhcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc-------------hhHHHHHHHHHHHHHcCCCCceeEee
Q 041135 379 ATNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS-------------QGEREFRAEVEIISRVHHRHLVSLVG 444 (727)
Q Consensus 379 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~-------------~~~~~~~~Ei~~l~~l~HpnIv~l~~ 444 (727)
..++|+++++||+|+||.||+|++. +++.||||+++.... ...+.+.+|+++|++++|+||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3567999999999999999999975 578999999875321 23467899999999999999999999
Q ss_pred EeeccceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCC---cE
Q 041135 445 YCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSF---EA 521 (727)
Q Consensus 445 ~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~---~v 521 (727)
+|.+....|||||||.+|+|.+++..... +++..++.|+.||+.||+|||++ +|+|||||++||||+.++ .+
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRHK--FDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSE
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccE
Confidence 99999999999999999999998876654 89999999999999999999999 999999999999998765 69
Q ss_pred EEEeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhH
Q 041135 522 RVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWAR 601 (727)
Q Consensus 522 kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~ 601 (727)
||+|||+++.... .......+|+..|+|||++. +.++.++||||||||||||++|+.||..... . +...
T Consensus 189 kl~Dfg~a~~~~~----~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~---~~~~ 257 (504)
T 3q5i_A 189 KIVDFGLSSFFSK----DYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND---Q---DIIK 257 (504)
T ss_dssp EECCCTTCEECCT----TSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---H---HHHH
T ss_pred EEEECCCCEEcCC----CCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH---H---HHHH
Confidence 9999999975421 22234567999999999987 4689999999999999999999999976431 1 1111
Q ss_pred HHHHHhhchhhHHHHHHHHhhcc--cchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhh
Q 041135 602 PLLAEALEHEDFEALVDSRLEKN--YVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDT 660 (727)
Q Consensus 602 ~~l~~~~~~~~~~~l~d~~l~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 660 (727)
.+. ...+... ........+.+|+++||+.||.+||++.||+++-+-
T Consensus 258 ~i~-------------~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 305 (504)
T 3q5i_A 258 KVE-------------KGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWI 305 (504)
T ss_dssp HHH-------------HCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred HHH-------------cCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhh
Confidence 111 1000000 001112347899999999999999999999987543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=356.21 Aligned_cols=271 Identities=20% Similarity=0.229 Sum_probs=190.6
Q ss_pred HHHHHHhcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccce-
Q 041135 374 DELIQATNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERE- 451 (727)
Q Consensus 374 ~el~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~- 451 (727)
.+.....++|+++++||+|+||.||+|++. +|+.||||++... ......+.+|++.|+.++|+||++++++|.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 345667789999999999999999999975 5899999998643 2334467788899999999999999999975433
Q ss_pred ------eeEEEeeccCCccchhcc-cCCCCcccHHHHHHHHHHHHHHHHHHH--hcCCCcEEeeCCCCCceEECC-CCcE
Q 041135 452 ------RLLVYEYVPNDTLHYHLH-AEGRPVMDWATRVKVAAGAARGIAYLH--EDCHPRIIHRDIKSSNILLDS-SFEA 521 (727)
Q Consensus 452 ------~~lV~Ey~~~gsL~~~L~-~~~~~~l~~~~~~~i~~qia~gL~yLH--~~~~~~ivHrDLkp~NILl~~-~~~v 521 (727)
.+|||||+.++.+..+.. ......+.+..++.|+.||+.||.||| ++ +|+|||||++||||+. ++.+
T Consensus 95 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp CTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEE
T ss_pred cccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcE
Confidence 789999998754433221 122335889999999999999999999 77 9999999999999986 8999
Q ss_pred EEEeeccchhhhccCCCccccccccCCccccccCcccCCC-CCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhh
Q 041135 522 RVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGK-LTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWA 600 (727)
Q Consensus 522 kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~ 600 (727)
||+|||+++.... ........|+..|+|||++.+.. ++.++|||||||+||||++|+.||...... ..+..
T Consensus 172 kl~Dfg~a~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~--~~~~~-- 243 (360)
T 3e3p_A 172 KLCDFGSAKKLSP----SEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA--GQLHE-- 243 (360)
T ss_dssp EECCCTTCBCCCT----TSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHH--
T ss_pred EEeeCCCceecCC----CCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH--HHHHH--
Confidence 9999999985422 12223457899999999997654 899999999999999999999999764311 11111
Q ss_pred HHHHHHhhchhh--HHHHHHH----------------HhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 601 RPLLAEALEHED--FEALVDS----------------RLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 601 ~~~l~~~~~~~~--~~~l~d~----------------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
++.. +.... +...++. .+...........+.+|+.+||+.||++||++.||+++-+
T Consensus 244 --~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 317 (360)
T 3e3p_A 244 --IVRV-LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPY 317 (360)
T ss_dssp --HHHH-HCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGG
T ss_pred --HHHH-cCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcc
Confidence 1110 00000 0000000 0000111123456889999999999999999999998744
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=360.08 Aligned_cols=262 Identities=22% Similarity=0.297 Sum_probs=193.0
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC--chhHHHHHHHHHHHHHcCCCCceeEeeEeeccc------
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG--SQGEREFRAEVEIISRVHHRHLVSLVGYCISER------ 450 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~------ 450 (727)
.++|++++.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+++|+.++|+||++++++|....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 467999999999999999999875 58899999997532 233467889999999999999999999997654
Q ss_pred eeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccch
Q 041135 451 ERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAK 530 (727)
Q Consensus 451 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~ 530 (727)
..||||||+.+ +|.+++.. .+++..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 175 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred ceEEEEEcCCC-CHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeeccc
Confidence 78999999975 67777753 388999999999999999999999 99999999999999999999999999998
Q ss_pred hhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHH----
Q 041135 531 IALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAE---- 606 (727)
Q Consensus 531 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~---- 606 (727)
.... .......+|+..|+|||++.+..++.++||||||||||||++|+.||.+.+.. ..+ ..++..
T Consensus 176 ~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~~-~~i~~~~~~~ 245 (371)
T 2xrw_A 176 TAGT----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI-----DQW-NKVIEQLGTP 245 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHH-HHHHC-CCCC
T ss_pred cccc----ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH-----HHH-HHHHHHhCCC
Confidence 5421 12233467899999999999999999999999999999999999999764321 111 111000
Q ss_pred ---hhc--hhhHHHHHH---------------HHhhc---ccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 607 ---ALE--HEDFEALVD---------------SRLEK---NYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 607 ---~~~--~~~~~~l~d---------------~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
.+. ...+...+. ..+.. .........+.+|+++||..||++|++++||+++-.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 321 (371)
T 2xrw_A 246 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 321 (371)
T ss_dssp CHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred CHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcc
Confidence 000 000001110 00000 001112456889999999999999999999998754
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=359.81 Aligned_cols=262 Identities=22% Similarity=0.344 Sum_probs=201.0
Q ss_pred HHHHhcCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCc--hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceee
Q 041135 376 LIQATNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGS--QGEREFRAEVEIISRVHHRHLVSLVGYCISERERL 453 (727)
Q Consensus 376 l~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 453 (727)
+....++|++.++||+|+||.||+|++++ .||||+++.... ...+.+.+|+++|++++|+||+++++++.+....+
T Consensus 28 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 105 (319)
T 2y4i_B 28 WDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLA 105 (319)
T ss_dssp SSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEE
T ss_pred ccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceE
Confidence 33445779999999999999999999853 499999875432 23356889999999999999999999999999999
Q ss_pred EEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhh
Q 041135 454 LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIAL 533 (727)
Q Consensus 454 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~ 533 (727)
+||||+.+++|.+++.... ..+++.+++.|+.||++||+|||++ +|+|||||++||||+ ++.+||+|||+++...
T Consensus 106 iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 106 IITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISG 180 (319)
T ss_dssp EECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred EEeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence 9999999999999997654 3589999999999999999999999 999999999999998 6799999999987542
Q ss_pred ccCC--CccccccccCCccccccCcccC---------CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHH
Q 041135 534 ELDS--NTHVSTRVMGTFGYMAPEYATS---------GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARP 602 (727)
Q Consensus 534 ~~~~--~~~~~~~~~gt~~y~aPE~l~~---------~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~ 602 (727)
.... .........|+..|+|||++.+ ..++.++|||||||+||||++|+.||..... ..+ ..
T Consensus 181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~---~~- 253 (319)
T 2y4i_B 181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA---EAI---IW- 253 (319)
T ss_dssp -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH---HHH---HH-
T ss_pred cccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHH---HH-
Confidence 2111 1122233568999999999875 3578999999999999999999999975331 110 00
Q ss_pred HHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 603 LLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 603 ~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
.+................+.+|+.+||+.||++||++.||++.|+.+..
T Consensus 254 ------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~ 302 (319)
T 2y4i_B 254 ------------QMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPK 302 (319)
T ss_dssp ------------HHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred ------------HhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 0000000000001122347889999999999999999999999998854
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=366.51 Aligned_cols=262 Identities=24% Similarity=0.341 Sum_probs=194.2
Q ss_pred HHHhcCccccceeccCCceEEEEEEE-cCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeec-------
Q 041135 377 IQATNGFSAHNVLGEGGFGCVYKGVL-ADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCIS------- 448 (727)
Q Consensus 377 ~~~~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~------- 448 (727)
....++|+++++||+|+||.||+|++ .+|+.||||++.... ..+.+|+++|+.++|+||++++++|..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 34567899999999999999999987 468999999986432 234579999999999999999999854
Q ss_pred -------------------------------cceeeEEEeeccCCccchhccc--CCCCcccHHHHHHHHHHHHHHHHHH
Q 041135 449 -------------------------------ERERLLVYEYVPNDTLHYHLHA--EGRPVMDWATRVKVAAGAARGIAYL 495 (727)
Q Consensus 449 -------------------------------~~~~~lV~Ey~~~gsL~~~L~~--~~~~~l~~~~~~~i~~qia~gL~yL 495 (727)
+...+|||||+. |+|.+++.. .....+.+..++.|+.||++||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 334789999997 476666543 2233589999999999999999999
Q ss_pred HhcCCCcEEeeCCCCCceEEC-CCCcEEEEeeccchhhhccCCCccccccccCCccccccCcccCC-CCCchhHHHHHhH
Q 041135 496 HEDCHPRIIHRDIKSSNILLD-SSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSG-KLTEKSDVYSFGV 573 (727)
Q Consensus 496 H~~~~~~ivHrDLkp~NILl~-~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~ksDVwS~Gv 573 (727)
|++ +|+|||||++||||+ .++.+||+|||+++..... .......|+..|+|||++.+. .++.++|||||||
T Consensus 158 H~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 230 (383)
T 3eb0_A 158 HSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS----EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGC 230 (383)
T ss_dssp HTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT----SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred HHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC----CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHH
Confidence 998 999999999999997 6889999999999854221 123345789999999998875 4899999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHH---------------HhhcccchhHHHHHHHHHH
Q 041135 574 VLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDS---------------RLEKNYVDSEMFWMIEAAA 638 (727)
Q Consensus 574 il~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~---------------~l~~~~~~~~~~~l~~li~ 638 (727)
+||||++|+.||.+.... +.+.. ++. .+.....+.+... .+...+.......+.+|+.
T Consensus 231 il~ell~g~~pf~~~~~~--~~~~~----i~~-~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 303 (383)
T 3eb0_A 231 VFGELILGKPLFSGETSI--DQLVR----IIQ-IMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLE 303 (383)
T ss_dssp HHHHHHHSSCSSCCSSHH--HHHHH----HHH-HHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHH
T ss_pred HHHHHHhCCCCCCCCChH--HHHHH----HHH-HhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHH
Confidence 999999999999764321 11111 111 1111111111100 0001111122345789999
Q ss_pred HHhccCCCCCCCHHHHHHH
Q 041135 639 ACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 639 ~cl~~dP~~RPs~~evl~~ 657 (727)
+||+.||++|+++.||+++
T Consensus 304 ~~L~~dP~~R~t~~e~l~h 322 (383)
T 3eb0_A 304 QILRYEPDLRINPYEAMAH 322 (383)
T ss_dssp HHCCSSGGGSCCHHHHHTS
T ss_pred HHccCChhhCCCHHHHhcC
Confidence 9999999999999999875
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=349.64 Aligned_cols=255 Identities=21% Similarity=0.317 Sum_probs=186.6
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchh-H-HHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQG-E-REFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~-~-~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
.++|+++++||+|+||.||+|++. +|+.||||+++...... . +.+.++..+++.++|+||++++++|.+++..+|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 467999999999999999999974 68999999997543322 2 33445555677889999999999999999999999
Q ss_pred eeccCCccchhccc--CCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhc
Q 041135 457 EYVPNDTLHYHLHA--EGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALE 534 (727)
Q Consensus 457 Ey~~~gsL~~~L~~--~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 534 (727)
||+. |+|.+++.. .....+++..++.|+.||+.||+|||+++ +|+|||||++||||+.++.+||+|||+++....
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 9997 477776643 12335899999999999999999999853 799999999999999999999999999975422
Q ss_pred cCCCccccccccCCccccccCcc----cCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhch
Q 041135 535 LDSNTHVSTRVMGTFGYMAPEYA----TSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEH 610 (727)
Q Consensus 535 ~~~~~~~~~~~~gt~~y~aPE~l----~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~ 610 (727)
. .......|+..|+|||++ .+..++.++|||||||+||||++|+.||..... ...
T Consensus 163 ~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~------------- 221 (290)
T 3fme_A 163 D----VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT----PFQ------------- 221 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC----HHH-------------
T ss_pred c----ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc----hHH-------------
Confidence 1 122334689999999996 556789999999999999999999999975321 000
Q ss_pred hhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 611 EDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 611 ~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
.+...+...............+.+|+.+||+.||++||++.||+++-.
T Consensus 222 -~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~ 269 (290)
T 3fme_A 222 -QLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPF 269 (290)
T ss_dssp -HHHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHH
T ss_pred -HHHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcc
Confidence 011111111111111222345789999999999999999999998533
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=361.36 Aligned_cols=261 Identities=19% Similarity=0.289 Sum_probs=198.5
Q ss_pred HhcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc--hhHHHHHHHHHHHHHcCCCCceeEeeEeecccee---
Q 041135 379 ATNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS--QGEREFRAEVEIISRVHHRHLVSLVGYCISERER--- 452 (727)
Q Consensus 379 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~--- 452 (727)
..++|.+.++||+|+||.||+|++. +|+.||||+++.... ...+.+.+|+++|++++|+||++++++|......
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 3468999999999999999999975 589999999975432 2346788999999999999999999999877654
Q ss_pred ---eEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccc
Q 041135 453 ---LLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLA 529 (727)
Q Consensus 453 ---~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla 529 (727)
||||||+. ++|.+++... +++..++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||++
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~~~----~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMGME----FSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTTSC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred eeEEEEEcccc-ccHHHHhhcC----CCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 99999996 6777777432 89999999999999999999999 9999999999999999999999999999
Q ss_pred hhhhccCCCccccccccCCccccccCcccC-CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHH--
Q 041135 530 KIALELDSNTHVSTRVMGTFGYMAPEYATS-GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAE-- 606 (727)
Q Consensus 530 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~-- 606 (727)
+.... ......|+..|+|||++.+ ..++.++|||||||+||||++|+.||..... .+....++..
T Consensus 192 ~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~~~~~ 259 (371)
T 4exu_A 192 RHADA------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY------LDQLTQILKVTG 259 (371)
T ss_dssp --------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHHHC
T ss_pred ccccc------CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHHHhC
Confidence 75421 2234578999999999987 6789999999999999999999999976431 1111111110
Q ss_pred --------hhchhhHHHHHHHHhhcc------cchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 607 --------ALEHEDFEALVDSRLEKN------YVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 607 --------~~~~~~~~~l~d~~l~~~------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
.+........+....... ........+.+|+++||+.||++||++.||+++-.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 326 (371)
T 4exu_A 260 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF 326 (371)
T ss_dssp CCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred CCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcc
Confidence 001111111111100000 01112345889999999999999999999998744
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=367.89 Aligned_cols=255 Identities=11% Similarity=0.043 Sum_probs=182.5
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc---hhHHHHHHHHHHHHHc--CCCCceeEe-------eEee
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS---QGEREFRAEVEIISRV--HHRHLVSLV-------GYCI 447 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~---~~~~~~~~Ei~~l~~l--~HpnIv~l~-------~~~~ 447 (727)
.+|+++++||+|+||.||+|++. +|+.||||+++.... ...+.+++|+++++.| +|+||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 34889999999999999999975 689999999986543 2345678886666665 599988755 3443
Q ss_pred cc-----------------ceeeEEEeeccCCccchhcccCCCCcccHHHH------HHHHHHHHHHHHHHHhcCCCcEE
Q 041135 448 SE-----------------RERLLVYEYVPNDTLHYHLHAEGRPVMDWATR------VKVAAGAARGIAYLHEDCHPRII 504 (727)
Q Consensus 448 ~~-----------------~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~------~~i~~qia~gL~yLH~~~~~~iv 504 (727)
.. ...||||||+. |+|.+++...+. .+.+..+ +.|+.||++||+|||++ +||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~iv 216 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAANLQSK---GLV 216 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCc
Confidence 22 34799999998 899999976432 2455556 78889999999999999 999
Q ss_pred eeCCCCCceEECCCCcEEEEeeccchhhhccCCCccccccccCCccccccCcccC--CCCCchhHHHHHhHHHHHHHhCC
Q 041135 505 HRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATS--GKLTEKSDVYSFGVVLLELITGR 582 (727)
Q Consensus 505 HrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~ksDVwS~Gvil~eLltG~ 582 (727)
|||||++||||+.++.+||+|||+++.... ......++..|+|||++.+ ..++.++|||||||+||||++|+
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGT------RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTC------EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCC------CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 999999999999999999999999985421 1113456799999999987 67999999999999999999999
Q ss_pred CCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 041135 583 KPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRAL 658 (727)
Q Consensus 583 ~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 658 (727)
.||..........+... .+.......+...........+.+|+.+||+.||++||++.||+++-
T Consensus 291 ~Pf~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 354 (371)
T 3q60_A 291 LPFGLVTPGIKGSWKRP------------SLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETP 354 (371)
T ss_dssp CSTTBCCTTCTTCCCBC------------CTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSH
T ss_pred CCCCCcCcccccchhhh------------hhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCH
Confidence 99987643211110000 00000000000011112234578899999999999999999998753
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=358.28 Aligned_cols=267 Identities=19% Similarity=0.259 Sum_probs=202.2
Q ss_pred cCccccceeccCCceEEEEEEE-cCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcC-----------CCCceeEeeEeec
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVL-ADGREVAVKQLKIGGSQGEREFRAEVEIISRVH-----------HRHLVSLVGYCIS 448 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~-----------HpnIv~l~~~~~~ 448 (727)
++|+++++||+|+||.||+|++ .+|+.||||+++. .....+.+.+|+++|++++ |+||+++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 5799999999999999999997 4689999999863 2334567889999999886 7899999999986
Q ss_pred cc----eeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEEC------CC
Q 041135 449 ER----ERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLD------SS 518 (727)
Q Consensus 449 ~~----~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~------~~ 518 (727)
.+ ..+|||||+ +++|.+++.......+++..++.|+.||+.||+|||+++ +|+|||||++||||+ .+
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~~~ 174 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENL 174 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTE
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCcCc
Confidence 54 789999999 999999998765556899999999999999999999953 799999999999994 44
Q ss_pred CcEEEEeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHH
Q 041135 519 FEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVE 598 (727)
Q Consensus 519 ~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~ 598 (727)
+.+||+|||+++.... ......|+..|+|||++.+..++.++|||||||+||||++|+.||............+
T Consensus 175 ~~~kl~Dfg~a~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 248 (373)
T 1q8y_A 175 IQIKIADLGNACWYDE------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 248 (373)
T ss_dssp EEEEECCCTTCEETTB------CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred ceEEEcccccccccCC------CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence 5899999999975422 1234578999999999999999999999999999999999999998654321111111
Q ss_pred hhHHHHHHhhc-------hh----------------------hHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCC
Q 041135 599 WARPLLAEALE-------HE----------------------DFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRP 649 (727)
Q Consensus 599 ~~~~~l~~~~~-------~~----------------------~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP 649 (727)
....++...-. .. .+..++.. ...+.......+.+|+++||+.||++||
T Consensus 249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTE--KYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHH--TTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhh--cccCCcchHHHHHHHHHHHhccCccccC
Confidence 11111110000 00 00111111 1123345566788999999999999999
Q ss_pred CHHHHHHHHh
Q 041135 650 RMSQVVRALD 659 (727)
Q Consensus 650 s~~evl~~L~ 659 (727)
++.||+++-.
T Consensus 327 t~~ell~hp~ 336 (373)
T 1q8y_A 327 DAGGLVNHPW 336 (373)
T ss_dssp CHHHHHTCGG
T ss_pred CHHHHhhChh
Confidence 9999998644
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=365.23 Aligned_cols=264 Identities=20% Similarity=0.304 Sum_probs=185.3
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC--chhHHHHHHHHHHHHHcCCCCceeEeeEeecc------c
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG--SQGEREFRAEVEIISRVHHRHLVSLVGYCISE------R 450 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~------~ 450 (727)
.++|++++.||+|+||.||+|++. +|+.||||++.... ....+.+.+|+++|+.++|+||++++++|... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 478999999999999999999864 68999999986432 23446788999999999999999999998754 5
Q ss_pred eeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccch
Q 041135 451 ERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAK 530 (727)
Q Consensus 451 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~ 530 (727)
..||||||+ +++|.++++.. .+++..++.|+.||++||+|||++ +|+|||||++||||+.++.+||+|||+++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp CCEEEEECC-CEECC-----C---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred eEEEEeccc-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence 679999999 78999888653 489999999999999999999999 99999999999999999999999999998
Q ss_pred hhhccCCCccccccccCCccccccCcccC-CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHH-----
Q 041135 531 IALELDSNTHVSTRVMGTFGYMAPEYATS-GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLL----- 604 (727)
Q Consensus 531 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l----- 604 (727)
.... ......||..|+|||++.+ ..++.++||||||||||||++|+.||.+.+.. .........+
T Consensus 181 ~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~l~~i~~~~g~p~~ 251 (367)
T 2fst_X 181 HTAD------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI---DQLKLILRLVGTPGA 251 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCSCCH
T ss_pred cccc------cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCH
Confidence 5421 1234578999999999987 67899999999999999999999999764321 1111110000
Q ss_pred --HHhhchhhHHHHHHHHhhcc-c-----chhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 605 --AEALEHEDFEALVDSRLEKN-Y-----VDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 605 --~~~~~~~~~~~l~d~~l~~~-~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
...+.......++....... . .......+.+|+++||..||++|+++.|++++-.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~ 314 (367)
T 2fst_X 252 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 314 (367)
T ss_dssp HHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred HHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChh
Confidence 00011111111111100000 0 0111234789999999999999999999998744
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=357.90 Aligned_cols=265 Identities=24% Similarity=0.402 Sum_probs=186.4
Q ss_pred HhcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC-chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 379 ATNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG-SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 379 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
..++|++.++||+|+||.||+|++. +|+.||||++.... ....+++.+|+++|++++|+||++++++|...+..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 4578999999999999999999864 68999999986543 233467889999999999999999999999999999999
Q ss_pred eeccCCccchhcccC------CCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccch
Q 041135 457 EYVPNDTLHYHLHAE------GRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAK 530 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~ 530 (727)
||+.+++|.+++... ....+++..++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 999999999988631 233589999999999999999999999 99999999999999999999999999997
Q ss_pred hhhccCC--CccccccccCCccccccCcccC-CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHh
Q 041135 531 IALELDS--NTHVSTRVMGTFGYMAPEYATS-GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEA 607 (727)
Q Consensus 531 ~~~~~~~--~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~ 607 (727)
....... .........|+..|+|||++.+ ..++.++|||||||+||||++|+.||....... .. ...+..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~---~~~~~~- 242 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK---VL---MLTLQN- 242 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---HH---HHHHTS-
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh---HH---HHHhcc-
Confidence 5432111 1112234578999999999876 568999999999999999999999997653211 00 000000
Q ss_pred hchhhHH-HHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 041135 608 LEHEDFE-ALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRAL 658 (727)
Q Consensus 608 ~~~~~~~-~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 658 (727)
....+. ...+..+ .......+.+|+.+||+.||++||++.||+++-
T Consensus 243 -~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~ 289 (303)
T 2vwi_A 243 -DPPSLETGVQDKEM----LKKYGKSFRKMISLCLQKDPEKRPTAAELLRHK 289 (303)
T ss_dssp -SCCCTTC-----CC----CCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTST
T ss_pred -CCCccccccccchh----hhhhhHHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence 000000 0001111 111223578899999999999999999998863
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=363.88 Aligned_cols=260 Identities=27% Similarity=0.343 Sum_probs=194.6
Q ss_pred cCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccc------eeeE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISER------ERLL 454 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~------~~~l 454 (727)
.+|+++++||+|+||.||+|++.++..||||++.... ....+|+++|+.++|+||++++++|.... ..+|
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK----RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCc----chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 4689999999999999999999887889999886432 23347999999999999999999996543 3789
Q ss_pred EEeeccCCccchhccc-CCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEEC-CCCcEEEEeeccchhh
Q 041135 455 VYEYVPNDTLHYHLHA-EGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLD-SSFEARVADFGLAKIA 532 (727)
Q Consensus 455 V~Ey~~~gsL~~~L~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~-~~~~vkL~DFGla~~~ 532 (727)
||||+.++.+..+.+. .....+.+..++.|+.||++||+|||++ +|+|||||++||||+ .++.+||+|||+++..
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 9999987655544321 1233589999999999999999999999 999999999999998 7999999999999854
Q ss_pred hccCCCccccccccCCccccccCcccCC-CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchh
Q 041135 533 LELDSNTHVSTRVMGTFGYMAPEYATSG-KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHE 611 (727)
Q Consensus 533 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~ 611 (727)
... .......|+..|+|||++.+. .++.++||||||||||||++|+.||.+.... +.+.+.. . .+...
T Consensus 193 ~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~--~~l~~i~----~-~~g~p 261 (394)
T 4e7w_A 193 IAG----EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI--DQLVEII----K-VLGTP 261 (394)
T ss_dssp CTT----CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHH----H-HHCCC
T ss_pred cCC----CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHH----H-HhCCC
Confidence 221 122345789999999999765 5899999999999999999999999864321 1111111 1 11111
Q ss_pred hHHHHH--HHHh-h------------cccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 041135 612 DFEALV--DSRL-E------------KNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRAL 658 (727)
Q Consensus 612 ~~~~l~--d~~l-~------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 658 (727)
..+.+. +... . ..+.......+.+|+++||+.||++|+++.|++++-
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 323 (394)
T 4e7w_A 262 SREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHP 323 (394)
T ss_dssp CHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred CHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcCh
Confidence 111110 0000 0 001111234588999999999999999999999873
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=352.43 Aligned_cols=247 Identities=22% Similarity=0.352 Sum_probs=193.5
Q ss_pred HHHhcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCch------hHHHHHHHHHHHHHc----CCCCceeEeeE
Q 041135 377 IQATNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQ------GEREFRAEVEIISRV----HHRHLVSLVGY 445 (727)
Q Consensus 377 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~------~~~~~~~Ei~~l~~l----~HpnIv~l~~~ 445 (727)
....++|+++++||+|+||.||+|++. +|+.||||+++..... ....+.+|+++++++ +|+||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 445678999999999999999999864 6889999999754321 234567899999999 89999999999
Q ss_pred eeccceeeEEEee-ccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEEC-CCCcEEE
Q 041135 446 CISERERLLVYEY-VPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLD-SSFEARV 523 (727)
Q Consensus 446 ~~~~~~~~lV~Ey-~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~-~~~~vkL 523 (727)
|.+.+..++|||| +.+++|.+++..+.. +++..+++|+.||++||+|||++ +|+|||||++||||+ +++.+||
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKGP--LGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEEE
Confidence 9999999999999 789999999987554 89999999999999999999999 999999999999998 8899999
Q ss_pred EeeccchhhhccCCCccccccccCCccccccCcccCCCCC-chhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHH
Q 041135 524 ADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLT-EKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARP 602 (727)
Q Consensus 524 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~ 602 (727)
+|||+++.... .......|+..|+|||++.+..+. .++|||||||+||||++|+.||.... .
T Consensus 182 ~dfg~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~------- 244 (312)
T 2iwi_A 182 IDFGSGALLHD-----EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-----E------- 244 (312)
T ss_dssp CCCSSCEECCS-----SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----H-------
T ss_pred EEcchhhhccc-----CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----H-------
Confidence 99999975422 122345689999999999876664 59999999999999999999996421 0
Q ss_pred HHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhh
Q 041135 603 LLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDT 660 (727)
Q Consensus 603 ~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 660 (727)
+.+.. ..+.......+.+|+++||+.||++||++.||+++-..
T Consensus 245 -------------~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~ 287 (312)
T 2iwi_A 245 -------------ILEAE--LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWM 287 (312)
T ss_dssp -------------HHHTC--CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTT
T ss_pred -------------Hhhhc--cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence 00000 11112223457889999999999999999999987543
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=384.75 Aligned_cols=257 Identities=24% Similarity=0.373 Sum_probs=203.8
Q ss_pred HhcCccccceeccCCceEEEEEEEcC----CcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceee
Q 041135 379 ATNGFSAHNVLGEGGFGCVYKGVLAD----GREVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYCISERERL 453 (727)
Q Consensus 379 ~~~~~~~~~~LG~G~fg~Vy~~~~~~----g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 453 (727)
..++|++.++||+|+||.||+|++.. +..||||+++.... ...+.|.+|+.+|++++|+||++++++|.+ +..|
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceE
Confidence 34679999999999999999999743 56799999875433 334679999999999999999999999854 5689
Q ss_pred EEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhh
Q 041135 454 LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIAL 533 (727)
Q Consensus 454 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~ 533 (727)
|||||+.+|+|.++++.+. ..+++..++.|+.||++||+|||++ +|+|||||++||||+.++.+||+|||+++...
T Consensus 467 lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542 (656)
T ss_dssp EEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred EEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence 9999999999999997653 3489999999999999999999999 99999999999999999999999999998642
Q ss_pred ccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhh
Q 041135 534 ELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHED 612 (727)
Q Consensus 534 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~ 612 (727)
. ..........++..|+|||++.+..++.++|||||||+||||++ |+.||..... ..+.
T Consensus 543 ~--~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~---~~~~--------------- 602 (656)
T 2j0j_A 543 D--STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---NDVI--------------- 602 (656)
T ss_dssp C------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHH---------------
T ss_pred C--CcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH---HHHH---------------
Confidence 2 11222234567789999999999999999999999999999997 9999975431 1111
Q ss_pred HHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhcc
Q 041135 613 FEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLD 662 (727)
Q Consensus 613 ~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 662 (727)
..+ ...............+.+|+.+||+.||++||++.||++.|+.+.
T Consensus 603 -~~i-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 603 -GRI-ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp -HHH-HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HHH-HcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 001 111111122233456889999999999999999999999999874
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=350.23 Aligned_cols=266 Identities=19% Similarity=0.259 Sum_probs=201.1
Q ss_pred hcCccccceeccCCceEEEEEEEc-CC-cEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCC------ceeEeeEeeccce
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DG-REVAVKQLKIGGSQGEREFRAEVEIISRVHHRH------LVSLVGYCISERE 451 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g-~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~Hpn------Iv~l~~~~~~~~~ 451 (727)
.++|+++++||+|+||.||+|+.. ++ +.||||+++.. ....+.+.+|+++|++++|.| |+.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 467999999999999999999974 34 68999998632 344567889999999997665 8999999999999
Q ss_pred eeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEE----------------
Q 041135 452 RLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILL---------------- 515 (727)
Q Consensus 452 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl---------------- 515 (727)
.+|||||+ +++|.+++.......+++.+++.|+.||+.||+|||++ +|+|||||++||||
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccccccc
Confidence 99999999 66666666665545689999999999999999999999 99999999999999
Q ss_pred ---CCCCcEEEEeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCC
Q 041135 516 ---DSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLG 592 (727)
Q Consensus 516 ---~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~ 592 (727)
+.++.+||+|||+++.... ......|+..|+|||++.+..++.++|||||||+||||++|+.||.....
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-- 244 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHE------HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN-- 244 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTS------CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--
T ss_pred ccccCCCcEEEeecCccccccc------cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--
Confidence 5678999999999975321 12345789999999999999999999999999999999999999976432
Q ss_pred chhhHHhhHHHHHH-------hhch--------------hhHHHHHHHHh---h--cccchhHHHHHHHHHHHHhccCCC
Q 041135 593 DESLVEWARPLLAE-------ALEH--------------EDFEALVDSRL---E--KNYVDSEMFWMIEAAAACVRHSAT 646 (727)
Q Consensus 593 ~~~l~~~~~~~l~~-------~~~~--------------~~~~~l~d~~l---~--~~~~~~~~~~l~~li~~cl~~dP~ 646 (727)
..........+.. .... ......+.... . ......+...+.+|+++||+.||+
T Consensus 245 -~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 323 (355)
T 2eu9_A 245 -REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPA 323 (355)
T ss_dssp -HHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred -HHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChh
Confidence 1111111111000 0000 00000000000 0 011123345688999999999999
Q ss_pred CCCCHHHHHHHHh
Q 041135 647 KRPRMSQVVRALD 659 (727)
Q Consensus 647 ~RPs~~evl~~L~ 659 (727)
+||++.||+++-.
T Consensus 324 ~Rpt~~e~l~hp~ 336 (355)
T 2eu9_A 324 QRITLAEALLHPF 336 (355)
T ss_dssp TSCCHHHHTTSGG
T ss_pred hCcCHHHHhcChh
Confidence 9999999987633
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=356.84 Aligned_cols=270 Identities=21% Similarity=0.284 Sum_probs=199.8
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEeecc-----cee
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYCISE-----RER 452 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~-----~~~ 452 (727)
.++|++.++||+|+||.||+|++. +|+.||||+++.... .....+.+|+++|++++|+||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 467999999999999999999976 589999999965433 3345788999999999999999999998764 678
Q ss_pred eEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhh
Q 041135 453 LLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIA 532 (727)
Q Consensus 453 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~ 532 (727)
++||||+. ++|.+++... .+++..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++..
T Consensus 90 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 99999996 6888888653 489999999999999999999999 9999999999999999999999999999754
Q ss_pred hccCCCcc-------ccccccCCccccccCcccC-CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHH
Q 041135 533 LELDSNTH-------VSTRVMGTFGYMAPEYATS-GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLL 604 (727)
Q Consensus 533 ~~~~~~~~-------~~~~~~gt~~y~aPE~l~~-~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l 604 (727)
........ .....+|+..|+|||++.+ ..++.++|||||||+||||++|+.||...... .........+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~ 239 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYR---HQLLLIFGII 239 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHH
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHHHh
Confidence 32111110 1223578999999998765 67899999999999999999999999764311 1110000000
Q ss_pred HH--------hhchhhHHHHHHHHhhc------ccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 605 AE--------ALEHEDFEALVDSRLEK------NYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 605 ~~--------~~~~~~~~~l~d~~l~~------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
.. ..........+...... .........+.+|+++||+.||++||++.||+++-.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 308 (353)
T 2b9h_A 240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPY 308 (353)
T ss_dssp CCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred CCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcc
Confidence 00 00000111111100000 000122345789999999999999999999998644
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=343.48 Aligned_cols=252 Identities=23% Similarity=0.321 Sum_probs=201.9
Q ss_pred HHhcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC--chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeE
Q 041135 378 QATNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG--SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLL 454 (727)
Q Consensus 378 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 454 (727)
...++|+++++||+|+||.||+|+.. +|+.||||+++... ....+.+.+|+++|++++|+||+++++++.+....++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34567999999999999999999976 68999999986432 2345679999999999999999999999999999999
Q ss_pred EEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCC---CcEEEEeeccchh
Q 041135 455 VYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSS---FEARVADFGLAKI 531 (727)
Q Consensus 455 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~---~~vkL~DFGla~~ 531 (727)
||||+.+++|.+++..... +++.+++.|+.||+.||+|||++ +|+|||||++||||+.+ +.+||+|||+++.
T Consensus 99 v~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~ 173 (287)
T 2wei_A 99 VGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (287)
T ss_dssp EECCCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred EEEccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCccee
Confidence 9999999999988876543 89999999999999999999999 99999999999999654 4799999999975
Q ss_pred hhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchh
Q 041135 532 ALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHE 611 (727)
Q Consensus 532 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~ 611 (727)
.... .......|+..|+|||++.+ .++.++|||||||+||||++|+.||..... . +....
T Consensus 174 ~~~~----~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~---~~~~~--------- 233 (287)
T 2wei_A 174 FQQN----TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE---Y---DILKR--------- 233 (287)
T ss_dssp BCCC----SSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---H---HHHHH---------
T ss_pred ecCC----CccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH---H---HHHHH---------
Confidence 4221 11233458889999999876 489999999999999999999999975421 1 11111
Q ss_pred hHHHHHHHHhhcc--cchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 041135 612 DFEALVDSRLEKN--YVDSEMFWMIEAAAACVRHSATKRPRMSQVVRAL 658 (727)
Q Consensus 612 ~~~~l~d~~l~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 658 (727)
+........ ........+.+|+++||+.||++||++.||+++-
T Consensus 234 ----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp 278 (287)
T 2wei_A 234 ----VETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHP 278 (287)
T ss_dssp ----HHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSH
T ss_pred ----HHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCH
Confidence 111111000 0011234578899999999999999999999853
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=358.28 Aligned_cols=202 Identities=22% Similarity=0.265 Sum_probs=172.3
Q ss_pred HhcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcC-CC-----CceeEeeEeeccce
Q 041135 379 ATNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRVH-HR-----HLVSLVGYCISERE 451 (727)
Q Consensus 379 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~-Hp-----nIv~l~~~~~~~~~ 451 (727)
..++|+++++||+|+||.||+|++. +|+.||||+++.. ......+.+|+++|+.++ |. +|++++++|...+.
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 3468999999999999999999975 5889999998732 333567888999999885 55 49999999999999
Q ss_pred eeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEEC--CCCcEEEEeeccc
Q 041135 452 RLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLD--SSFEARVADFGLA 529 (727)
Q Consensus 452 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~--~~~~vkL~DFGla 529 (727)
.+|||||+. ++|.+++.......+++..++.|+.||+.||.|||.+ +.+|||||||++||||+ .++.+||+|||++
T Consensus 131 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a 208 (382)
T 2vx3_A 131 LCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208 (382)
T ss_dssp EEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred eEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence 999999995 5999988876655689999999999999999999952 12899999999999994 5788999999999
Q ss_pred hhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCC
Q 041135 530 KIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQ 589 (727)
Q Consensus 530 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~ 589 (727)
+.... .....+|+..|+|||++.+..++.++||||||||||||++|+.||....
T Consensus 209 ~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 209 CQLGQ------RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp EETTC------CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eeccc------ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 75421 1234578999999999999999999999999999999999999998643
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=353.74 Aligned_cols=255 Identities=20% Similarity=0.234 Sum_probs=176.4
Q ss_pred HhcCccccc-eeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeec----ccee
Q 041135 379 ATNGFSAHN-VLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCIS----ERER 452 (727)
Q Consensus 379 ~~~~~~~~~-~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~----~~~~ 452 (727)
..++|.+.+ +||+|+||.||+|++. +|+.||||++... .....+....++.++|+||++++++|.. +...
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 346788855 6999999999999986 6899999998642 2222233334567789999999999976 4568
Q ss_pred eEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECC---CCcEEEEeeccc
Q 041135 453 LLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDS---SFEARVADFGLA 529 (727)
Q Consensus 453 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~---~~~vkL~DFGla 529 (727)
+|||||+.+|+|.+++.......+++.+++.|+.||+.||+|||++ +|+|||||++||||+. ++.+||+|||++
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 9999999999999999877666799999999999999999999999 9999999999999976 456999999999
Q ss_pred hhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhc
Q 041135 530 KIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALE 609 (727)
Q Consensus 530 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~ 609 (727)
+.... ......+|+..|+|||++.+..++.++|||||||+||||++|+.||.......... ..
T Consensus 179 ~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~~---------- 241 (336)
T 3fhr_A 179 KETTQ-----NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP--GM---------- 241 (336)
T ss_dssp EEC---------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------
T ss_pred eeccc-----cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh--hH----------
Confidence 75321 12234578999999999998899999999999999999999999997543211000 00
Q ss_pred hhhHHHHHHH--HhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhh
Q 041135 610 HEDFEALVDS--RLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDT 660 (727)
Q Consensus 610 ~~~~~~l~d~--~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 660 (727)
...+... .+...........+.+|+++||+.||++||++.||+++-+.
T Consensus 242 ---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 291 (336)
T 3fhr_A 242 ---KRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWI 291 (336)
T ss_dssp ------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHH
T ss_pred ---HHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccc
Confidence 0000000 00111111223457899999999999999999999997553
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=344.94 Aligned_cols=255 Identities=26% Similarity=0.380 Sum_probs=194.3
Q ss_pred HhcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeec---------
Q 041135 379 ATNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCIS--------- 448 (727)
Q Consensus 379 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~--------- 448 (727)
..++|+++++||+|+||.||+|+.. +|+.||||+++.. ....+.+.+|+++|++++|+||++++++|.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 3457999999999999999999974 6899999999643 3345678999999999999999999998865
Q ss_pred ----cceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEE
Q 041135 449 ----ERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVA 524 (727)
Q Consensus 449 ----~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~ 524 (727)
....||||||+.+++|.++++... ..+++..++.|+.||++||+|||++ +|+|||||++||||+.++.+||+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEEC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEe
Confidence 456799999999999999997643 3578889999999999999999999 99999999999999999999999
Q ss_pred eeccchhhhccCC-----------CccccccccCCccccccCcccCC-CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCC
Q 041135 525 DFGLAKIALELDS-----------NTHVSTRVMGTFGYMAPEYATSG-KLTEKSDVYSFGVVLLELITGRKPVDASQPLG 592 (727)
Q Consensus 525 DFGla~~~~~~~~-----------~~~~~~~~~gt~~y~aPE~l~~~-~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~ 592 (727)
|||+++....... .........|+..|+|||++.+. .++.++|||||||+||||++ +|...
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~---- 231 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG---- 231 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH----
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc----
Confidence 9999975422110 01122345789999999999865 68999999999999999998 44321
Q ss_pred chhhHHhhHHHHHHhhchhhHHHHHH--HHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 593 DESLVEWARPLLAEALEHEDFEALVD--SRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 593 ~~~l~~~~~~~l~~~~~~~~~~~l~d--~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
....+.. ..+.. ..+...+.......+.+|+++||+.||++||++.||+++-+
T Consensus 232 -~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~ 286 (303)
T 1zy4_A 232 -MERVNIL-------------KKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGW 286 (303)
T ss_dssp -HHHHHHH-------------HHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSC
T ss_pred -hhHHHHH-------------HhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCC
Confidence 1111110 01111 11122233334456789999999999999999999998643
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=353.51 Aligned_cols=260 Identities=19% Similarity=0.287 Sum_probs=197.8
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc--hhHHHHHHHHHHHHHcCCCCceeEeeEeeccce-----
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS--QGEREFRAEVEIISRVHHRHLVSLVGYCISERE----- 451 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~----- 451 (727)
.++|.+.+.||+|+||.||+|++. +|+.||||++..... ...+.+.+|+.+|++++|+||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 467999999999999999999975 589999999865332 234678899999999999999999999987653
Q ss_pred -eeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccch
Q 041135 452 -RLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAK 530 (727)
Q Consensus 452 -~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~ 530 (727)
.|+||||+. ++|.+++.. .+++..++.|+.||++||+|||++ +|+|||||++||||+.++.+||+|||+++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred eEEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccccc
Confidence 499999996 688877753 389999999999999999999999 99999999999999999999999999997
Q ss_pred hhhccCCCccccccccCCccccccCcccC-CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHH---
Q 041135 531 IALELDSNTHVSTRVMGTFGYMAPEYATS-GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAE--- 606 (727)
Q Consensus 531 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~--- 606 (727)
.... ......|+..|+|||++.+ ..++.++|||||||+||||++|+.||..... .+....++..
T Consensus 175 ~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~~~i~~~~~~ 242 (353)
T 3coi_A 175 HADA------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY------LDQLTQILKVTGV 242 (353)
T ss_dssp C--------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH------HHHHHHHHHHHCB
T ss_pred CCCC------CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHHHhCC
Confidence 5321 1234578999999999987 6789999999999999999999999976432 1111111110
Q ss_pred -------hhchhhHHHHHHHHh---hc---ccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 607 -------ALEHEDFEALVDSRL---EK---NYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 607 -------~~~~~~~~~l~d~~l---~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
.+........+.... .. .........+.+|+++||+.||++||++.||+++-.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 308 (353)
T 3coi_A 243 PGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF 308 (353)
T ss_dssp CCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred CCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence 001111111111100 00 011123446889999999999999999999998743
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=350.89 Aligned_cols=247 Identities=21% Similarity=0.345 Sum_probs=200.4
Q ss_pred HHHHhcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCch------hHHHHHHHHHHHHHcC--CCCceeEeeEe
Q 041135 376 LIQATNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQ------GEREFRAEVEIISRVH--HRHLVSLVGYC 446 (727)
Q Consensus 376 l~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~------~~~~~~~Ei~~l~~l~--HpnIv~l~~~~ 446 (727)
.....++|+++++||+|+||.||+|++. +|+.||||+++..... ..+.+.+|+++|++++ |+||+++++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 3345678999999999999999999864 6889999999754322 2356788999999996 59999999999
Q ss_pred eccceeeEEEeeccC-CccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEEC-CCCcEEEE
Q 041135 447 ISERERLLVYEYVPN-DTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLD-SSFEARVA 524 (727)
Q Consensus 447 ~~~~~~~lV~Ey~~~-gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~-~~~~vkL~ 524 (727)
.+.+..++||||+.+ ++|.+++..+.. +++..++.|+.||++||+|||++ +|+|||||++||||+ +++.+||+
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l~~~~~--l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEEC
T ss_pred ecCCcEEEEEEcCCCCccHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEe
Confidence 999999999999986 899999876543 89999999999999999999999 999999999999998 78899999
Q ss_pred eeccchhhhccCCCccccccccCCccccccCcccCCCC-CchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHH
Q 041135 525 DFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKL-TEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPL 603 (727)
Q Consensus 525 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~ 603 (727)
|||+++.... .......|+..|+|||++.+..+ +.++|||||||+||||++|+.||.... .
T Consensus 193 Dfg~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----~-------- 254 (320)
T 3a99_A 193 DFGSGALLKD-----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----E-------- 254 (320)
T ss_dssp CCTTCEECCS-----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----H--------
T ss_pred eCcccccccc-----ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-----h--------
Confidence 9999975421 12234578999999999987665 688999999999999999999996421 0
Q ss_pred HHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 604 LAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 604 l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
++...+ .+.......+.+|+++||+.||++||++.||+++-.
T Consensus 255 ------------~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~ 296 (320)
T 3a99_A 255 ------------IIRGQV--FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 296 (320)
T ss_dssp ------------HHHCCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred ------------hhcccc--cccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHh
Confidence 000000 011122335788999999999999999999988643
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=341.72 Aligned_cols=253 Identities=23% Similarity=0.313 Sum_probs=180.0
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchh-H-HHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQG-E-REFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~-~-~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
.++|+++++||+|+||.||+|++. +|+.||||+++...... . +.+.++..+++.++|+||++++++|.+++..+|||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 456999999999999999999985 68999999997554322 2 33445556778889999999999999999999999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHh-cCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhcc
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHE-DCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALEL 535 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 535 (727)
||+ ++.+..++... ...+++..++.|+.||++||+|||+ + +|+|||||++||||+.++.+||+|||+++.....
T Consensus 104 e~~-~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp CCC-SEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecc-CCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 999 55555544432 2358999999999999999999998 5 8999999999999999999999999999754221
Q ss_pred CCCccccccccCCccccccCccc-----CCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhch
Q 041135 536 DSNTHVSTRVMGTFGYMAPEYAT-----SGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEH 610 (727)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~ 610 (727)
.......|+..|+|||++. +..++.++|||||||+||||++|+.||...... .+...
T Consensus 179 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~--------- 240 (318)
T 2dyl_A 179 ----KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-----FEVLT--------- 240 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHH---------
T ss_pred ----ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-----HHHHH---------
Confidence 1223456899999999995 456889999999999999999999999753210 01111
Q ss_pred hhHHHHHHHHhh-cccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 611 EDFEALVDSRLE-KNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 611 ~~~~~l~d~~l~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
.++..... ..........+.+|+++||+.||++||++.||+++-.
T Consensus 241 ----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~ 286 (318)
T 2dyl_A 241 ----KVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSF 286 (318)
T ss_dssp ----HHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHH
T ss_pred ----HHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHH
Confidence 11110000 0000112345788999999999999999999988643
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=348.29 Aligned_cols=258 Identities=24% Similarity=0.360 Sum_probs=178.6
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc-hhHHHHHHHHH-HHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS-QGEREFRAEVE-IISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~-~~~~~~~~Ei~-~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
.++|++++.||+|+||.||+|++. +|+.||||+++.... ....++.+|+. +++.++|+||+++++++.+++..+|||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 367899999999999999999985 689999999976533 23345666666 667789999999999999999999999
Q ss_pred eeccCCccchhccc---CCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhh
Q 041135 457 EYVPNDTLHYHLHA---EGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIAL 533 (727)
Q Consensus 457 Ey~~~gsL~~~L~~---~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~ 533 (727)
||+.+ +|.+++.. .....+.+..+++|+.||++||.|||++. +|+|||||++||||+.++.+||+|||+++...
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 99975 66666542 22345899999999999999999999853 79999999999999999999999999997542
Q ss_pred ccCCCccccccccCCccccccCcc----cCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhc
Q 041135 534 ELDSNTHVSTRVMGTFGYMAPEYA----TSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALE 609 (727)
Q Consensus 534 ~~~~~~~~~~~~~gt~~y~aPE~l----~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~ 609 (727)
.. .......|+..|+|||++ .+..++.++|||||||+||||++|+.||....... +.. .....
T Consensus 178 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~----~~~~~ 244 (327)
T 3aln_A 178 DS----IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-----DQL----TQVVK 244 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------------CCCCC
T ss_pred cc----cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-----HHH----HHHhc
Confidence 21 122334689999999999 45678999999999999999999999997532110 000 00000
Q ss_pred hhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 610 HEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 610 ~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
+.. ..+...........+.+|+++||+.||++||++.||+++-.
T Consensus 245 -~~~-----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~ 288 (327)
T 3aln_A 245 -GDP-----PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPF 288 (327)
T ss_dssp -SCC-----CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHH
T ss_pred -CCC-----CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChH
Confidence 000 00111111122345889999999999999999999988644
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=356.09 Aligned_cols=254 Identities=24% Similarity=0.321 Sum_probs=186.2
Q ss_pred cCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHc-CCCCceeEeeEeeccceeeEEEeec
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRV-HHRHLVSLVGYCISERERLLVYEYV 459 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~ 459 (727)
+.|.+.++||+|+||+||++...+|+.||||++... ..+.+.+|+++|+++ +|+||+++++++.++...|||||||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 345667899999999998777778999999998642 345678999999987 8999999999999999999999999
Q ss_pred cCCccchhcccCCCC-----cccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECC-------------CCcE
Q 041135 460 PNDTLHYHLHAEGRP-----VMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDS-------------SFEA 521 (727)
Q Consensus 460 ~~gsL~~~L~~~~~~-----~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~-------------~~~v 521 (727)
. |+|.+++...... ...+..++.|+.||+.||+|||++ +|+|||||++||||+. ++.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEE
Confidence 5 6999998765431 123445678999999999999999 9999999999999965 3589
Q ss_pred EEEeeccchhhhccCCC-ccccccccCCccccccCcccC-------CCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCC
Q 041135 522 RVADFGLAKIALELDSN-THVSTRVMGTFGYMAPEYATS-------GKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLG 592 (727)
Q Consensus 522 kL~DFGla~~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~-------~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~ 592 (727)
||+|||+++........ ........||..|+|||++.+ ..++.++|||||||+||||++ |+.||......
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~- 246 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR- 246 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH-
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh-
Confidence 99999999864321111 111234579999999999976 578999999999999999999 99999653210
Q ss_pred chhhHHhhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 593 DESLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 593 ~~~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
. ..++........ +...........+.+|+++||+.||++||++.||+++
T Consensus 247 -~------~~i~~~~~~~~~--------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 247 -E------SNIIRGIFSLDE--------MKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp -H------HHHHHTCCCCCC--------CTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -H------HHHhcCCCCccc--------ccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 0 001110000000 0000112234568899999999999999999999874
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=357.47 Aligned_cols=252 Identities=23% Similarity=0.289 Sum_probs=186.8
Q ss_pred hcCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHc-CCCCceeEeeEeeccceeeEEEee
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRV-HHRHLVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey 458 (727)
..+|++.++||+|+||.||.....+|+.||||++.... ...+.+|+++|+++ +|+|||++++++.+....||||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 34688999999999999665556679999999986432 23467899999999 799999999999999999999999
Q ss_pred ccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECC-----CCcEEEEeeccchhhh
Q 041135 459 VPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDS-----SFEARVADFGLAKIAL 533 (727)
Q Consensus 459 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~-----~~~vkL~DFGla~~~~ 533 (727)
|. |+|.+++..... .+.+.+++.|+.||++||+|||++ +|+|||||++||||+. +.++||+|||+++...
T Consensus 100 ~~-g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 100 CA-ATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp CS-EEHHHHHHSSSC-CCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred CC-CCHHHHHHhcCC-CccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 95 689888876543 244556789999999999999999 9999999999999943 3468899999998653
Q ss_pred ccCCCccccccccCCccccccCccc---CCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhc
Q 041135 534 ELDSNTHVSTRVMGTFGYMAPEYAT---SGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALE 609 (727)
Q Consensus 534 ~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~ 609 (727)
............+||..|+|||++. +..++.++||||||||||||++ |+.||...... .. . ....
T Consensus 175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~---~~----~----~~~~ 243 (432)
T 3p23_A 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR---QA----N----ILLG 243 (432)
T ss_dssp -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH---HH----H----HHTT
T ss_pred CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH---HH----H----HHhc
Confidence 2222222334567999999999998 4567889999999999999999 99999543210 00 0 0000
Q ss_pred hhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 610 HEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 610 ~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
..... . ..........+.+|+++||+.||++||++.||+++
T Consensus 244 ~~~~~-----~--~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 244 ACSLD-----C--LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp CCCCT-----T--SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cCCcc-----c--cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 00000 0 00112233447789999999999999999999954
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=330.72 Aligned_cols=231 Identities=13% Similarity=0.092 Sum_probs=183.6
Q ss_pred cCccccceeccCCceEEEEEEEcC-CcEEEEEEeeeCCc---hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLAD-GREVAVKQLKIGGS---QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~~-g~~vaVK~l~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
++|+++++||+|+||.||+|++.. |+.||||+++.... ...+.|.+|++++++++|+||+++++++.+++..||||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 569999999999999999999864 89999999975433 22367999999999999999999999999999999999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccC
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 536 (727)
||+.|++|.++++.. ....++++|+.||++||+|||++ +|+|||||++||||++++.+||+++|.
T Consensus 111 e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~~-------- 175 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPAT-------- 175 (286)
T ss_dssp ECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCCC--------
T ss_pred EecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEeccc--------
Confidence 999999999998543 35557889999999999999999 999999999999999999999985542
Q ss_pred CCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchh-hHHhhHHHHHHhhchhhHHH
Q 041135 537 SNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDES-LVEWARPLLAEALEHEDFEA 615 (727)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~-l~~~~~~~l~~~~~~~~~~~ 615 (727)
++ .++.++|||||||+||||++|+.||.......... ..... .+....
T Consensus 176 ---------------~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~---------~~~~~~ 224 (286)
T 3uqc_A 176 ---------------MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDT---------AGQPIE 224 (286)
T ss_dssp ---------------CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCT---------TSCBCC
T ss_pred ---------------cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHh---------ccCCCC
Confidence 22 36889999999999999999999998755322110 00000 000000
Q ss_pred HHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccCC
Q 041135 616 LVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDGA 664 (727)
Q Consensus 616 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 664 (727)
. ..+. ......+.+|+.+||+.||++| ++.||++.|+++...
T Consensus 225 ~--~~~~----~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 225 P--ADID----RDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp H--HHHC----TTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred h--hhcc----cCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 0 0011 1122347889999999999999 999999999988653
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=366.44 Aligned_cols=239 Identities=21% Similarity=0.304 Sum_probs=191.3
Q ss_pred hcCccccceeccCCceEEEEEEEc--CCcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEeeccce-----
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA--DGREVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYCISERE----- 451 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~--~g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~----- 451 (727)
.++|+++++||+|+||.||+|++. +|+.||||++..... .....+.+|+++|++++|+||++++++|.+.+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 367999999999999999999975 589999999865433 344578999999999999999999999987665
Q ss_pred eeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchh
Q 041135 452 RLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKI 531 (727)
Q Consensus 452 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 531 (727)
.||||||+.|++|.+++.. .+++.+++.|+.||++||+|||++ +|||||||++||||+.+ .+||+|||+++.
T Consensus 159 ~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred eEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchh
Confidence 6999999999999988755 489999999999999999999999 99999999999999886 899999999985
Q ss_pred hhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchh
Q 041135 532 ALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHE 611 (727)
Q Consensus 532 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~ 611 (727)
... ....+||..|+|||++.++ ++.++||||||||||||++|..+|......... . ..
T Consensus 231 ~~~-------~~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~---~-----------~~ 288 (681)
T 2pzi_A 231 INS-------FGYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLP---E-----------DD 288 (681)
T ss_dssp TTC-------CSCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSCC---T-----------TC
T ss_pred ccc-------CCccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccccc---c-----------cc
Confidence 422 1345799999999999765 489999999999999999998888653211100 0 00
Q ss_pred hHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCC-HHHHHHHHhhc
Q 041135 612 DFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPR-MSQVVRALDTL 661 (727)
Q Consensus 612 ~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~L~~~ 661 (727)
. .......+.+|+.+||+.||++|++ ++++.+.|..+
T Consensus 289 ~-------------~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 289 P-------------VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp H-------------HHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred c-------------ccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 0 0001124678999999999999995 66666666544
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=366.21 Aligned_cols=271 Identities=25% Similarity=0.340 Sum_probs=200.6
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC-chhHHHHHHHHHHHHHcCCCCceeEeeEeec------ccee
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG-SQGEREFRAEVEIISRVHHRHLVSLVGYCIS------ERER 452 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~------~~~~ 452 (727)
++|++.++||+|+||.||+|++. +|+.||||+++... ....+.+.+|+++|++++|+||+++++++.. ++..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 67999999999999999999874 58999999987543 3345679999999999999999999999765 6677
Q ss_pred eEEEeeccCCccchhcccCC-CCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCc---EEEEeecc
Q 041135 453 LLVYEYVPNDTLHYHLHAEG-RPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFE---ARVADFGL 528 (727)
Q Consensus 453 ~lV~Ey~~~gsL~~~L~~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~---vkL~DFGl 528 (727)
+|||||+.||+|.+++.... ...+++..++.|+.||+.||+|||++ +|+|||||++||||+.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 99999999999999997643 23588999999999999999999999 9999999999999986654 99999999
Q ss_pred chhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhh
Q 041135 529 AKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEAL 608 (727)
Q Consensus 529 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~ 608 (727)
++.... ........|+..|+|||++.+..++.++|||||||+||||++|+.||.... ....|...+.....
T Consensus 171 a~~~~~----~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~-----~~~~~~~~i~~~~~ 241 (676)
T 3qa8_A 171 AKELDQ----GELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW-----QPVQWHGKVREKSN 241 (676)
T ss_dssp CCBTTS----CCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSC-----HHHHSSTTCC----
T ss_pred cccccc----ccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCccc-----chhhhhhhhhcccc
Confidence 985422 122344679999999999999999999999999999999999999997532 11222111100000
Q ss_pred chhhHHHHHHHH--------hhcccchhHHHHHHHHHHHHhccCCCCCCCHHH-----HHHHHhhccC
Q 041135 609 EHEDFEALVDSR--------LEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQ-----VVRALDTLDG 663 (727)
Q Consensus 609 ~~~~~~~l~d~~--------l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e-----vl~~L~~~~~ 663 (727)
............ ............+.+|+++||..||++||++.| +.+.|+.+..
T Consensus 242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 000000000000 001122334566889999999999999999988 4455555543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=328.12 Aligned_cols=234 Identities=22% Similarity=0.290 Sum_probs=180.9
Q ss_pred cCcccc-ceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHH-HHcCCCCceeEeeEeec----cceee
Q 041135 381 NGFSAH-NVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEII-SRVHHRHLVSLVGYCIS----ERERL 453 (727)
Q Consensus 381 ~~~~~~-~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l-~~l~HpnIv~l~~~~~~----~~~~~ 453 (727)
++|.+. ++||+|+||.||+|+.. +|+.||||+++. ...+.+|++++ +.++|+||++++++|.+ +...+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 457776 78999999999999974 689999999863 35678899988 55689999999999987 67789
Q ss_pred EEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECC---CCcEEEEeeccch
Q 041135 454 LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDS---SFEARVADFGLAK 530 (727)
Q Consensus 454 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~---~~~vkL~DFGla~ 530 (727)
|||||+.+|+|.+++.......+++..++.|+.||+.||+|||++ +|+|||||++||||+. ++.+||+|||+++
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 168 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence 999999999999999887656799999999999999999999999 9999999999999987 7899999999986
Q ss_pred hhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhch
Q 041135 531 IALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEH 610 (727)
Q Consensus 531 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~ 610 (727)
.. .+..++.++|||||||+||||++|+.||............ . ..+..
T Consensus 169 ~~-------------------------~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~--~-----~~~~~ 216 (299)
T 3m2w_A 169 ET-------------------------TGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM--K-----TRIRM 216 (299)
T ss_dssp EC-------------------------TTCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCS--C-----CSSCT
T ss_pred cc-------------------------ccccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHH--H-----HHHhh
Confidence 32 1245778999999999999999999999754321100000 0 00000
Q ss_pred hhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhh
Q 041135 611 EDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDT 660 (727)
Q Consensus 611 ~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 660 (727)
..+. +...........+.+|+.+||+.||++||++.||+++-..
T Consensus 217 ~~~~------~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~ 260 (299)
T 3m2w_A 217 GQYE------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 260 (299)
T ss_dssp TCCS------SCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred cccc------CCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhh
Confidence 0000 0000001122347889999999999999999999987553
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=335.72 Aligned_cols=244 Identities=18% Similarity=0.228 Sum_probs=183.0
Q ss_pred hcCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCc--------hhHHHHHHHHHHHHHcC---------CCCceeE
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGS--------QGEREFRAEVEIISRVH---------HRHLVSL 442 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~--------~~~~~~~~Ei~~l~~l~---------HpnIv~l 442 (727)
.++|+++++||+|+||.||+|++ +|+.||||+++.... ...+.+.+|+++|++++ |+|||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 35688999999999999999998 689999999986532 22367899999999886 7777766
Q ss_pred eeEe-----------------ec-------------cceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHH
Q 041135 443 VGYC-----------------IS-------------ERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGI 492 (727)
Q Consensus 443 ~~~~-----------------~~-------------~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL 492 (727)
++++ .+ +...|||||||.+|+|.+.+.+ ..+++..++.|+.||+.||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHH
Confidence 6654 32 6788999999999977766644 2479999999999999999
Q ss_pred HHHH-hcCCCcEEeeCCCCCceEECCCC--------------------cEEEEeeccchhhhccCCCccccccccCCccc
Q 041135 493 AYLH-EDCHPRIIHRDIKSSNILLDSSF--------------------EARVADFGLAKIALELDSNTHVSTRVMGTFGY 551 (727)
Q Consensus 493 ~yLH-~~~~~~ivHrDLkp~NILl~~~~--------------------~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y 551 (727)
+||| ++ +|||||||++||||+.++ .+||+|||+|+.... ...+||..|
T Consensus 175 ~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~--------~~~~gt~~y 243 (336)
T 2vuw_A 175 AVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD--------GIVVFCDVS 243 (336)
T ss_dssp HHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET--------TEEECCCCT
T ss_pred HHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC--------CcEEEeecc
Confidence 9999 88 999999999999999886 899999999985421 234799999
Q ss_pred cccCcccCCCCCchhHHHHHhHH-HHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHhhcccchhHH
Q 041135 552 MAPEYATSGKLTEKSDVYSFGVV-LLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEM 630 (727)
Q Consensus 552 ~aPE~l~~~~~~~ksDVwS~Gvi-l~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~ 630 (727)
+|||++.+.. +.++||||||++ +++++.|..||.. ..|...+....+....+. ............
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~---------~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~s 309 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN---------VLWLHYLTDKMLKQMTFK----TKCNTPAMKQIK 309 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH---------HHHHHHHHHHHHHTCCCS----SCCCSHHHHHHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc---------hhhhhHHHHhhhhhhccC----cccchhhhhhcC
Confidence 9999998766 899999998776 7778889888742 122221111111000000 000000112344
Q ss_pred HHHHHHHHHHhccCCCCCCCHHHHH-HH
Q 041135 631 FWMIEAAAACVRHSATKRPRMSQVV-RA 657 (727)
Q Consensus 631 ~~l~~li~~cl~~dP~~RPs~~evl-~~ 657 (727)
..+.+|+++||+.| ++.|++ ++
T Consensus 310 ~~~~dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 310 RKIQEFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp HHHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred HHHHHHHHHHhccC-----CHHHHHhcC
Confidence 56889999999987 899988 54
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=345.53 Aligned_cols=241 Identities=15% Similarity=0.176 Sum_probs=180.0
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCch---hHHHHHHHHHHHHHcCC-CCceeE---------e---
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQ---GEREFRAEVEIISRVHH-RHLVSL---------V--- 443 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~---~~~~~~~Ei~~l~~l~H-pnIv~l---------~--- 443 (727)
..|++.++||+|+||.||+|++. +|+.||||+++..... ..+.|++|+.+++.++| .|+..+ +
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 44778899999999999999964 6999999998744332 24679999999999987 322111 1
Q ss_pred ---------eEeec-----cceeeEEEeeccCCccchhcc-----cCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEE
Q 041135 444 ---------GYCIS-----ERERLLVYEYVPNDTLHYHLH-----AEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRII 504 (727)
Q Consensus 444 ---------~~~~~-----~~~~~lV~Ey~~~gsL~~~L~-----~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iv 504 (727)
.++.. ....+++|+++ +++|.++++ ......+++..++.|+.||++||+|||++ +||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 11111 12346667665 788988874 22334588899999999999999999999 999
Q ss_pred eeCCCCCceEECCCCcEEEEeeccchhhhccCCCccccccccCCccccccCcc----------cCCCCCchhHHHHHhHH
Q 041135 505 HRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYA----------TSGKLTEKSDVYSFGVV 574 (727)
Q Consensus 505 HrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l----------~~~~~~~ksDVwS~Gvi 574 (727)
|||||++||||+.++.+||+|||+++.... .....+| ..|+|||++ .+..++.++|||||||+
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA------SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTE------EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCC------ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 999999999999999999999999875422 1344567 999999999 55668899999999999
Q ss_pred HHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHH
Q 041135 575 LLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQV 654 (727)
Q Consensus 575 l~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 654 (727)
||||++|+.||......... +. .+... ......+.+||++||+.||++||++.|+
T Consensus 307 l~elltg~~Pf~~~~~~~~~---~~--------------------~~~~~--~~~~~~~~~li~~~l~~dP~~Rpt~~~~ 361 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALGGS---EW--------------------IFRSC--KNIPQPVRALLEGFLRYPKEDRLLPLQA 361 (413)
T ss_dssp HHHHHHSSCCCCTTGGGSCS---GG--------------------GGSSC--CCCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHCCCCCCCcchhhhH---HH--------------------HHhhc--ccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 99999999999764321100 00 00000 0112447889999999999999998888
Q ss_pred HHH
Q 041135 655 VRA 657 (727)
Q Consensus 655 l~~ 657 (727)
+++
T Consensus 362 l~~ 364 (413)
T 3dzo_A 362 MET 364 (413)
T ss_dssp TTS
T ss_pred HhC
Confidence 664
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.2e-31 Score=305.24 Aligned_cols=185 Identities=18% Similarity=0.163 Sum_probs=130.6
Q ss_pred ceeccCCceEEEEEE-EcCCcEEEEEEeeeCC----------chhHHHHHHHHHHHHHc-CCCCceeEeeEeeccceeeE
Q 041135 387 NVLGEGGFGCVYKGV-LADGREVAVKQLKIGG----------SQGEREFRAEVEIISRV-HHRHLVSLVGYCISERERLL 454 (727)
Q Consensus 387 ~~LG~G~fg~Vy~~~-~~~g~~vaVK~l~~~~----------~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~l 454 (727)
..++.|++|.+..++ +..|+.|+||++.... ....++|++|+++|+++ +|+||++|++++++++..||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 345667776666544 2348899999996432 12335799999999999 69999999999999999999
Q ss_pred EEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhc
Q 041135 455 VYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALE 534 (727)
Q Consensus 455 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 534 (727)
|||||+|++|.++|..++. ++.. +|+.||+.||+|||++ |||||||||+||||++++++||+|||+|+....
T Consensus 320 VMEyv~G~~L~d~i~~~~~--l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAGEE--IDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EEECCCSEEHHHHHHTTCC--CCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EEecCCCCcHHHHHHhCCC--CCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 9999999999999987654 5543 5889999999999999 999999999999999999999999999985422
Q ss_pred cCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCC
Q 041135 535 LDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRK 583 (727)
Q Consensus 535 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~ 583 (727)
........+||..|||||++.+ .+..++|+|++|+++++|++|..
T Consensus 392 ---~~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 392 ---DCSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp -----CCSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred ---CCccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccc
Confidence 2223345789999999999976 46778999999999988876543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.4e-28 Score=276.76 Aligned_cols=186 Identities=16% Similarity=0.214 Sum_probs=145.1
Q ss_pred cccceeccCCceEEEEEEEcCCcEEEEEEeeeCCch--------hHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEE
Q 041135 384 SAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQ--------GEREFRAEVEIISRVHHRHLVSLVGYCISERERLLV 455 (727)
Q Consensus 384 ~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~--------~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 455 (727)
...++||+|+||.||+|++ .++.+++|++...... ..+.+++|+++|++++|+||+++..++.+.+..|||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3457899999999999955 5788999987543211 124589999999999999999776666677788999
Q ss_pred EeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhcc
Q 041135 456 YEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALEL 535 (727)
Q Consensus 456 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 535 (727)
|||+.|++|.++++. +++|+.||++||+|||++ +|+|||||++||||++ .+||+|||+++.....
T Consensus 418 mE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 418 MSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp EECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred EECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 999999999999876 458999999999999999 9999999999999998 9999999999864221
Q ss_pred CCCc----cccccccCCccccccCcccC--CCCCchhHHHHHhHHHHHHHhCCCCC
Q 041135 536 DSNT----HVSTRVMGTFGYMAPEYATS--GKLTEKSDVYSFGVVLLELITGRKPV 585 (727)
Q Consensus 536 ~~~~----~~~~~~~gt~~y~aPE~l~~--~~~~~ksDVwS~Gvil~eLltG~~Pf 585 (727)
.... ......+||..|||||++.+ ..|+...|+|+.++-.++.+.++..|
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 1100 01235689999999999987 56788899999999998888877665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-25 Score=235.59 Aligned_cols=153 Identities=16% Similarity=0.155 Sum_probs=123.9
Q ss_pred HHHHHHHhcCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCc------------------hhHHHHHHHHHHHHHc
Q 041135 373 YDELIQATNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGS------------------QGEREFRAEVEIISRV 434 (727)
Q Consensus 373 ~~el~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~------------------~~~~~~~~Ei~~l~~l 434 (727)
+..+......|++.+.||+|+||.||+|++.+|+.||||+++.... .....+.+|+++|+++
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 3444555677888899999999999999997799999999964321 1245689999999999
Q ss_pred CCCCceeEeeEeeccceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceE
Q 041135 435 HHRHLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNIL 514 (727)
Q Consensus 435 ~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIL 514 (727)
+ | +++++++.. +..||||||+.|++|.+ +.. .+...|+.||++||+|||++ +|+|||||++|||
T Consensus 162 ~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NIL 225 (282)
T 1zar_A 162 Q--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVL 225 (282)
T ss_dssp T--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEE
T ss_pred c--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEE
Confidence 9 5 777776543 55699999999999988 422 23457999999999999999 9999999999999
Q ss_pred ECCCCcEEEEeeccchhhhccCCCccccccccCCccccccCccc
Q 041135 515 LDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYAT 558 (727)
Q Consensus 515 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~ 558 (727)
|+ ++.+||+|||+++. +..|+|+|++.
T Consensus 226 l~-~~~vkl~DFG~a~~----------------~~~~~a~e~l~ 252 (282)
T 1zar_A 226 VS-EEGIWIIDFPQSVE----------------VGEEGWREILE 252 (282)
T ss_dssp EE-TTEEEECCCTTCEE----------------TTSTTHHHHHH
T ss_pred EE-CCcEEEEECCCCeE----------------CCCCCHHHHHH
Confidence 99 99999999999973 23477888764
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=3.4e-21 Score=199.59 Aligned_cols=144 Identities=19% Similarity=0.172 Sum_probs=109.7
Q ss_pred HHHHHHhcCccccceeccCCceEEEEEEE-cCCcE--EEEEEeeeCCch------------------------hHHHHHH
Q 041135 374 DELIQATNGFSAHNVLGEGGFGCVYKGVL-ADGRE--VAVKQLKIGGSQ------------------------GEREFRA 426 (727)
Q Consensus 374 ~el~~~~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~--vaVK~l~~~~~~------------------------~~~~~~~ 426 (727)
..+......|++.+.||+|+||.||+|++ .+|+. ||||+++..... ....+.+
T Consensus 40 ~~~~~~~~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 119 (258)
T 1zth_A 40 YKLSAKGYITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEK 119 (258)
T ss_dssp HHHHHTTSEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHH
T ss_pred HHHHhCCCchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHH
Confidence 33433344477889999999999999998 67989 999987543111 1135789
Q ss_pred HHHHHHHcCCCCc--eeEeeEeeccceeeEEEeeccC-C----ccchhcccCCCCcccHHHHHHHHHHHHHHHHHHH-hc
Q 041135 427 EVEIISRVHHRHL--VSLVGYCISERERLLVYEYVPN-D----TLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLH-ED 498 (727)
Q Consensus 427 Ei~~l~~l~HpnI--v~l~~~~~~~~~~~lV~Ey~~~-g----sL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH-~~ 498 (727)
|+++|++++|.+| ..++++ ...+|||||+.+ | .|.+++.. +.+.++..++.||+.||.||| ++
T Consensus 120 E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~ 190 (258)
T 1zth_A 120 EFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEA 190 (258)
T ss_dssp HHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTS
T ss_pred HHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHC
Confidence 9999999988754 444442 356899999943 4 44443322 235577899999999999999 87
Q ss_pred CCCcEEeeCCCCCceEECCCCcEEEEeeccchh
Q 041135 499 CHPRIIHRDIKSSNILLDSSFEARVADFGLAKI 531 (727)
Q Consensus 499 ~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 531 (727)
+|||||||++||||++ .++|+|||+|..
T Consensus 191 ---givHrDlkp~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 191 ---ELVHADLSEYNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp ---CEECSSCSTTSEEESS--SEEECCCTTCEE
T ss_pred ---CEEeCCCCHHHEEEcC--cEEEEECccccc
Confidence 9999999999999988 999999999974
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.76 E-value=5.7e-19 Score=191.39 Aligned_cols=139 Identities=14% Similarity=0.147 Sum_probs=101.4
Q ss_pred HHHhcCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCc--------------hhHHHH--------HHHHHHHHHc
Q 041135 377 IQATNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGS--------------QGEREF--------RAEVEIISRV 434 (727)
Q Consensus 377 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~--------------~~~~~~--------~~Ei~~l~~l 434 (727)
.....-|++.+.||.|+||.||+|+..+|+.||||+++.... .....+ .+|...|.+|
T Consensus 91 ~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL 170 (397)
T 4gyi_A 91 AARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKAL 170 (397)
T ss_dssp HHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH
Confidence 333445999999999999999999998999999999753210 011122 2455566666
Q ss_pred CCCCce--eEeeEeeccceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCc
Q 041135 435 HHRHLV--SLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSN 512 (727)
Q Consensus 435 ~HpnIv--~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~N 512 (727)
.+.++. ..+++ ...+|||||+.|+.|..++.. .+...++.||+.+|.|||++ ||||||||+.|
T Consensus 171 ~~~gv~vp~p~~~----~~~~LVME~i~G~~L~~l~~~--------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~N 235 (397)
T 4gyi_A 171 YEEGFPVPEPIAQ----SRHTIVMSLVDALPMRQVSSV--------PDPASLYADLIALILRLAKH---GLIHGDFNEFN 235 (397)
T ss_dssp HHTTCSCCCEEEE----ETTEEEEECCSCEEGGGCCCC--------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTS
T ss_pred HhcCCCCCeeeec----cCceEEEEecCCccHhhhccc--------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHH
Confidence 433322 22222 123799999999888765432 23457889999999999998 99999999999
Q ss_pred eEECCCC----------cEEEEeeccch
Q 041135 513 ILLDSSF----------EARVADFGLAK 530 (727)
Q Consensus 513 ILl~~~~----------~vkL~DFGla~ 530 (727)
|||++++ .+.|+||+-+.
T Consensus 236 ILl~~dgd~~d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 236 ILIREEKDAEDPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp EEEEEEECSSCTTSEEEEEEECCCTTCE
T ss_pred EEEeCCCCcccccccccceEEEEeCCcc
Confidence 9998776 38999999775
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=3e-14 Score=147.06 Aligned_cols=148 Identities=14% Similarity=0.052 Sum_probs=118.0
Q ss_pred HHHHHhcCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcC-CCCceeEeeEeeccceee
Q 041135 375 ELIQATNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVH-HRHLVSLVGYCISERERL 453 (727)
Q Consensus 375 el~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~ 453 (727)
.+.....+|++...++.|+++.||++... |+.++||+...........+.+|+++|+.|. |.++.++++++.+.+..|
T Consensus 8 ~l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~ 86 (263)
T 3tm0_A 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence 34455577999999999999999999764 7899999986432233456999999999995 677889999999888999
Q ss_pred EEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcC----------------------------------
Q 041135 454 LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDC---------------------------------- 499 (727)
Q Consensus 454 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~---------------------------------- 499 (727)
+||||++|.+|.+.+.. ......++.+++++|..||+..
T Consensus 87 lv~e~i~G~~l~~~~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T 3tm0_A 87 LLMSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEECCSSEEHHHHCCT-------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred EEEEecCCeehhhccCC-------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence 99999999998776421 2234578889999999999810
Q ss_pred ----------------------CCcEEeeCCCCCceEECCCCcEEEEeeccch
Q 041135 500 ----------------------HPRIIHRDIKSSNILLDSSFEARVADFGLAK 530 (727)
Q Consensus 500 ----------------------~~~ivHrDLkp~NILl~~~~~vkL~DFGla~ 530 (727)
...++|+||++.|||++++..+.|+||+.+.
T Consensus 160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 0369999999999999876667799999875
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.43 E-value=2e-13 Score=139.98 Aligned_cols=137 Identities=15% Similarity=0.103 Sum_probs=102.9
Q ss_pred cCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCC--ceeEeeEeeccceeeEEEee
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRH--LVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~Hpn--Iv~l~~~~~~~~~~~lV~Ey 458 (727)
.++.+..+.+.|.++.||++...+|+.++||+.... ....+.+|+++|+.+++.+ +.++++++.+++..++||||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 445554444566679999998777888999987543 2356889999999997545 55788988887888999999
Q ss_pred ccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 041135 459 VPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDC--------------------------------------- 499 (727)
Q Consensus 459 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--------------------------------------- 499 (727)
++|..|. +.. . ....++.++++.|..||+..
T Consensus 97 i~G~~l~--~~~-----~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (264)
T 1nd4_A 97 VPGQDLL--SSH-----L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA 166 (264)
T ss_dssp CSSEETT--TSC-----C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred cCCcccC--cCc-----C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence 9998884 211 1 12356777778888888641
Q ss_pred ----------------CCcEEeeCCCCCceEECCCCcEEEEeeccch
Q 041135 500 ----------------HPRIIHRDIKSSNILLDSSFEARVADFGLAK 530 (727)
Q Consensus 500 ----------------~~~ivHrDLkp~NILl~~~~~vkL~DFGla~ 530 (727)
...++||||++.|||+++++.++|+|||.+.
T Consensus 167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1139999999999999887667799999975
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.36 E-value=3.3e-12 Score=138.15 Aligned_cols=143 Identities=17% Similarity=0.227 Sum_probs=108.5
Q ss_pred cccceeccCCceEEEEEEEcCCcEEEEEEee--eCCc-hhHHHHHHHHHHHHHcC--CCCceeEeeEeecc---ceeeEE
Q 041135 384 SAHNVLGEGGFGCVYKGVLADGREVAVKQLK--IGGS-QGEREFRAEVEIISRVH--HRHLVSLVGYCISE---RERLLV 455 (727)
Q Consensus 384 ~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~--~~~~-~~~~~~~~Ei~~l~~l~--HpnIv~l~~~~~~~---~~~~lV 455 (727)
..++.|+.|.++.||+.... +..++||+.. .... .....+.+|+++|+.|. +..+.++++++.+. +..|+|
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred ceEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 34678999999999998875 4678888775 3221 23457889999999997 45678999998776 457999
Q ss_pred EeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 041135 456 YEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDC------------------------------------ 499 (727)
Q Consensus 456 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~------------------------------------ 499 (727)
|||+.|..|.+.... .++..++..++.++++.|..||+..
T Consensus 120 me~v~G~~l~~~~~~----~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 120 MEFVSGRVLWDQSLP----GMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EECCCCBCCCCTTCT----TCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEecCCeecCCCccc----cCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999999888542221 2677888899999999999999731
Q ss_pred -------------------CCcEEeeCCCCCceEECCCCc--EEEEeeccchh
Q 041135 500 -------------------HPRIIHRDIKSSNILLDSSFE--ARVADFGLAKI 531 (727)
Q Consensus 500 -------------------~~~ivHrDLkp~NILl~~~~~--vkL~DFGla~~ 531 (727)
...+||||+++.|||++.++. +.|+||+++..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 247999999999999987653 68999999864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.26 E-value=3.1e-12 Score=135.18 Aligned_cols=185 Identities=22% Similarity=0.274 Sum_probs=121.8
Q ss_pred cceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcC-CCC--ceeEeeEeeccc---eeeEEEeec
Q 041135 386 HNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVH-HRH--LVSLVGYCISER---ERLLVYEYV 459 (727)
Q Consensus 386 ~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~-Hpn--Iv~l~~~~~~~~---~~~lV~Ey~ 459 (727)
++.|+.|.+..||+. ++.++||+... ......+.+|+++|+.+. +.. +.++++++.... ..|+||||+
T Consensus 25 i~~~~~G~~n~v~~v----~~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEI----NRDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEES----TTSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEE----CCEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 466899999999986 35689998642 234567999999999984 333 445665554433 348999999
Q ss_pred cCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhc-----------------------------------------
Q 041135 460 PNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHED----------------------------------------- 498 (727)
Q Consensus 460 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~----------------------------------------- 498 (727)
+|..|...... .++..++..++.++++.|..||+.
T Consensus 99 ~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 99 KGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred CCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 99988754322 256677778888888888888861
Q ss_pred --------------CCCcEEeeCCCCCceEECC--CCcEEEEeeccchhhhccCCCccccc--------------cccCC
Q 041135 499 --------------CHPRIIHRDIKSSNILLDS--SFEARVADFGLAKIALELDSNTHVST--------------RVMGT 548 (727)
Q Consensus 499 --------------~~~~ivHrDLkp~NILl~~--~~~vkL~DFGla~~~~~~~~~~~~~~--------------~~~gt 548 (727)
....++|+||++.|||+++ +..+.|+||+.+..... ...... .+...
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~---~~Dl~~~~~~~~~~~~~~~~~~l~~ 251 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDP---DNDFISLMEDDEEYGMEFVSKILNH 251 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECT---THHHHTTCCTTTSCCHHHHHHHHHH
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCCh---HHHHHHHHhhccccCHHHHHHHHHH
Confidence 0135899999999999988 55688999998864210 000000 00000
Q ss_pred ccccc-cCcccCCCCCchhHHHHHhHHHHHHHhCCCCC
Q 041135 549 FGYMA-PEYATSGKLTEKSDVYSFGVVLLELITGRKPV 585 (727)
Q Consensus 549 ~~y~a-PE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf 585 (727)
+++.. ++.+. +.....+.|++|+++|++.+|+.+|
T Consensus 252 Y~~~~~~~~~~--r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 252 YKHKDIPTVLE--KYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HTCSCHHHHHH--HHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred cCCCCcHHHHH--HHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 11111 12111 1123468999999999999987644
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.94 E-value=3e-09 Score=112.42 Aligned_cols=136 Identities=21% Similarity=0.218 Sum_probs=94.0
Q ss_pred cceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCC---CceeEeeEee-ccceeeEEEeeccC
Q 041135 386 HNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHR---HLVSLVGYCI-SERERLLVYEYVPN 461 (727)
Q Consensus 386 ~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~Hp---nIv~l~~~~~-~~~~~~lV~Ey~~~ 461 (727)
++.|+.|....||+. |+.++||+.. .......+.+|+++|+.|.+. .|.+++.++. ..+..|+||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 456889999999987 5778888853 223456789999999999753 3557777764 44567899999999
Q ss_pred CccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhc-------------------------------------------
Q 041135 462 DTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHED------------------------------------------- 498 (727)
Q Consensus 462 gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~------------------------------------------- 498 (727)
..|....... ++..++..++.++++.|..||+.
T Consensus 98 ~~l~~~~~~~----l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 98 QILGEDGMAV----LPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp EECHHHHHTT----SCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred eECchhhhhh----CCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 8886532111 23334444444444444444432
Q ss_pred --------------CCCcEEeeCCCCCceEECC---CCc-EEEEeeccchh
Q 041135 499 --------------CHPRIIHRDIKSSNILLDS---SFE-ARVADFGLAKI 531 (727)
Q Consensus 499 --------------~~~~ivHrDLkp~NILl~~---~~~-vkL~DFGla~~ 531 (727)
....++|+|+++.|||++. ++. +.|+||+.+..
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2235799999999999987 455 58999998864
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.81 E-value=4.1e-08 Score=101.15 Aligned_cols=140 Identities=16% Similarity=0.142 Sum_probs=100.2
Q ss_pred cCccccceeccCCce-EEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcC-CCCceeEeeEeeccceeeEEEe
Q 041135 381 NGFSAHNVLGEGGFG-CVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRVH-HRHLVSLVGYCISERERLLVYE 457 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg-~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E 457 (727)
.+|+. +.+..|..| .||+.... ++..++||+-.. ....++.+|..+|+.|. +--|-++++++.+.+..|||||
T Consensus 25 ~g~~~-~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme 100 (272)
T 4gkh_A 25 YGYRW-ARDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTT 100 (272)
T ss_dssp TTCEE-EEEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred cCCeE-EEccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEE
Confidence 34443 344555555 69987764 467899998652 23557899999999885 4446788999999899999999
Q ss_pred eccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 041135 458 YVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDC-------------------------------------- 499 (727)
Q Consensus 458 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-------------------------------------- 499 (727)
+++|..+.+..... ......++.++++.|..||...
T Consensus 101 ~l~G~~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (272)
T 4gkh_A 101 AIPGKTAFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGW 174 (272)
T ss_dssp CCCSEEHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTC
T ss_pred eeCCccccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccch
Confidence 99998876654321 2233455666666666666321
Q ss_pred -----------------CCcEEeeCCCCCceEECCCCcEEEEeeccch
Q 041135 500 -----------------HPRIIHRDIKSSNILLDSSFEARVADFGLAK 530 (727)
Q Consensus 500 -----------------~~~ivHrDLkp~NILl~~~~~vkL~DFGla~ 530 (727)
...++|+|+++.|||+++++.+-|+||+.+.
T Consensus 175 ~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 175 PVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp CHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1238999999999999988777899999886
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.78 E-value=1.3e-08 Score=109.50 Aligned_cols=81 Identities=7% Similarity=-0.035 Sum_probs=58.7
Q ss_pred ccee-ccCCceEEEEEEEc-------CCcEEEEEEeeeCC---chhHHHHHHHHHHHHHcCC---CCceeEeeEeecc--
Q 041135 386 HNVL-GEGGFGCVYKGVLA-------DGREVAVKQLKIGG---SQGEREFRAEVEIISRVHH---RHLVSLVGYCISE-- 449 (727)
Q Consensus 386 ~~~L-G~G~fg~Vy~~~~~-------~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H---pnIv~l~~~~~~~-- 449 (727)
.+.| +.|..+.+|+.... +|+.+++|+..... ......+.+|+++|+.|.. -.+.++++++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4667 88989999998764 26789999765322 1112568899999998853 3567888887665
Q ss_pred -ceeeEEEeeccCCccch
Q 041135 450 -RERLLVYEYVPNDTLHY 466 (727)
Q Consensus 450 -~~~~lV~Ey~~~gsL~~ 466 (727)
+..|+||||++|..|.+
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 35689999999877654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.56 E-value=4.1e-07 Score=96.67 Aligned_cols=139 Identities=16% Similarity=0.248 Sum_probs=82.5
Q ss_pred ceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCC--CCceeEee------EeeccceeeEEEee
Q 041135 387 NVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHH--RHLVSLVG------YCISERERLLVYEY 458 (727)
Q Consensus 387 ~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H--pnIv~l~~------~~~~~~~~~lV~Ey 458 (727)
+.|+.|.++.||+....+| .++||+... ...++..|+++++.|.. -.+.+++. +....+..++||||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~----~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHR----PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECS----CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCC----CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677899999988654 589998864 22445566777776642 23445553 12345677899999
Q ss_pred ccCCccc--------------hhcccCC-----C-------CcccHHHH-------------------------------
Q 041135 459 VPNDTLH--------------YHLHAEG-----R-------PVMDWATR------------------------------- 481 (727)
Q Consensus 459 ~~~gsL~--------------~~L~~~~-----~-------~~l~~~~~------------------------------- 481 (727)
++|..+. ..||... . ....|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986553 0112110 0 01122111
Q ss_pred HHHHHHHHHHHHHHHh----------cCCCcEEeeCCCCCceEECCCCcEEEEeeccch
Q 041135 482 VKVAAGAARGIAYLHE----------DCHPRIIHRDIKSSNILLDSSFEARVADFGLAK 530 (727)
Q Consensus 482 ~~i~~qia~gL~yLH~----------~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~ 530 (727)
..++..+.+++++|+. .....+||||+++.|||++.++.+.|+||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 1111223446666663 023489999999999999888899999999875
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.52 E-value=1.4e-07 Score=103.05 Aligned_cols=75 Identities=15% Similarity=0.094 Sum_probs=50.6
Q ss_pred cceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc-------hhHHHHHHHHHHHHHcCC--C-CceeEeeEeeccceeeE
Q 041135 386 HNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS-------QGEREFRAEVEIISRVHH--R-HLVSLVGYCISERERLL 454 (727)
Q Consensus 386 ~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~-------~~~~~~~~Ei~~l~~l~H--p-nIv~l~~~~~~~~~~~l 454 (727)
.+.||.|.++.||++++. +++.|+||....... .....+.+|+++|+.+.. + .+.+++.+ +.+..+|
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 568999999999999754 468899998643211 123457889999998853 3 34466654 3345689
Q ss_pred EEeeccCC
Q 041135 455 VYEYVPND 462 (727)
Q Consensus 455 V~Ey~~~g 462 (727)
||||+.+.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999774
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.47 E-value=5.1e-07 Score=99.53 Aligned_cols=74 Identities=18% Similarity=0.206 Sum_probs=47.0
Q ss_pred ccceeccCCceEEEEEEEcCCcEEEEEEeeeC-----Cc----hhHHHHHHHHHHHHH-cCCCCceeEeeEeeccceeeE
Q 041135 385 AHNVLGEGGFGCVYKGVLADGREVAVKQLKIG-----GS----QGEREFRAEVEIISR-VHHRHLVSLVGYCISERERLL 454 (727)
Q Consensus 385 ~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~-----~~----~~~~~~~~Ei~~l~~-l~HpnIv~l~~~~~~~~~~~l 454 (727)
.++.||.|..+.||++.. +++.++||..... .. .....++.|+..+.. .....+.+++++. .+..++
T Consensus 38 ~i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l 114 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI 114 (420)
T ss_dssp EEEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred EEEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence 356799999999999965 5778999943211 10 122334444443332 2335667777765 456789
Q ss_pred EEeec-cC
Q 041135 455 VYEYV-PN 461 (727)
Q Consensus 455 V~Ey~-~~ 461 (727)
||||+ .+
T Consensus 115 v~e~l~~g 122 (420)
T 2pyw_A 115 GMRYLEPP 122 (420)
T ss_dssp EECCCCTT
T ss_pred EEeecCCc
Confidence 99999 76
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.39 E-value=1.3e-06 Score=91.07 Aligned_cols=80 Identities=24% Similarity=0.249 Sum_probs=60.3
Q ss_pred cCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCC---CCceeEeeEeeccceeeEEEe
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHH---RHLVSLVGYCISERERLLVYE 457 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H---pnIv~l~~~~~~~~~~~lV~E 457 (727)
..+.-++.+|.|..+.||+.++.||+.|+||+...........|.+|++.|+.|.. --+.+++++. ..++|||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e 90 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAME 90 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEE
Confidence 34666788999999999999999999999998764444444568999999999852 2345566543 2378999
Q ss_pred eccCCcc
Q 041135 458 YVPNDTL 464 (727)
Q Consensus 458 y~~~gsL 464 (727)
|+.++..
T Consensus 91 ~l~~~~~ 97 (288)
T 3f7w_A 91 WVDERPP 97 (288)
T ss_dssp CCCCCCC
T ss_pred eecccCC
Confidence 9987654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.32 E-value=3.8e-06 Score=88.70 Aligned_cols=139 Identities=17% Similarity=0.137 Sum_probs=93.5
Q ss_pred cccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcC---CCCceeEeeEeeccceeeEEEeecc
Q 041135 384 SAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVH---HRHLVSLVGYCISERERLLVYEYVP 460 (727)
Q Consensus 384 ~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~---HpnIv~l~~~~~~~~~~~lV~Ey~~ 460 (727)
.-.+.|+.|.+..+|+... +++.++||+.... ....+.+|++.|+.|. .-.+.++++++...+..++||||++
T Consensus 39 ~~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp CEEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eeeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 3456799999999999876 4778999987532 3567899999999885 3568899999888888999999999
Q ss_pred CCccch-----------hcccCCC-C-------------------cccHHHHH---HHHH----------------HHHH
Q 041135 461 NDTLHY-----------HLHAEGR-P-------------------VMDWATRV---KVAA----------------GAAR 490 (727)
Q Consensus 461 ~gsL~~-----------~L~~~~~-~-------------------~l~~~~~~---~i~~----------------qia~ 490 (727)
|..+.. .||.... . .-+|.+.+ ++.. .++.
T Consensus 115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~ 194 (312)
T 3jr1_A 115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ 194 (312)
T ss_dssp CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence 876521 2232211 0 11343221 1111 1111
Q ss_pred H-HHHHHh-cCCCcEEeeCCCCCceEECCCCcEEEEeec
Q 041135 491 G-IAYLHE-DCHPRIIHRDIKSSNILLDSSFEARVADFG 527 (727)
Q Consensus 491 g-L~yLH~-~~~~~ivHrDLkp~NILl~~~~~vkL~DFG 527 (727)
. ...|.. ...+.+||+|+...|||++.++ +.|+||+
T Consensus 195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1 123321 1245899999999999999887 8899984
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.25 E-value=4.3e-06 Score=88.24 Aligned_cols=157 Identities=13% Similarity=0.109 Sum_probs=91.9
Q ss_pred ccHHHHHHHhcCccc-----cceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCC--ceeEe
Q 041135 371 FTYDELIQATNGFSA-----HNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRH--LVSLV 443 (727)
Q Consensus 371 ~~~~el~~~~~~~~~-----~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~Hpn--Iv~l~ 443 (727)
++.+++......|.+ ++.|+.|....+|+....+| .+++|+.... ....++..|+++++.|...+ +.+++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 445666666555654 34567788899999987655 6889987642 22346778888888875322 33444
Q ss_pred eE------eeccceeeEEEeeccCCccch--------------hcccC----CC------CcccHHHHHH----------
Q 041135 444 GY------CISERERLLVYEYVPNDTLHY--------------HLHAE----GR------PVMDWATRVK---------- 483 (727)
Q Consensus 444 ~~------~~~~~~~~lV~Ey~~~gsL~~--------------~L~~~----~~------~~l~~~~~~~---------- 483 (727)
.. ....+..++||+|++|..+.. .||.. .. ....|...+.
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 22 122356689999999865421 11211 00 0012222110
Q ss_pred --HHHHHHHHHHHHHhcC----CCcEEeeCCCCCceEECCCCcEEEEeeccch
Q 041135 484 --VAAGAARGIAYLHEDC----HPRIIHRDIKSSNILLDSSFEARVADFGLAK 530 (727)
Q Consensus 484 --i~~qia~gL~yLH~~~----~~~ivHrDLkp~NILl~~~~~vkL~DFGla~ 530 (727)
+...+.+.+++|+... ..++||+|+++.|||++++..+.|+||+.+.
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 0112445566665421 3479999999999999887666899999875
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.09 E-value=1.6e-05 Score=84.05 Aligned_cols=141 Identities=17% Similarity=0.143 Sum_probs=84.6
Q ss_pred ceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCC--CceeEeeE-----eeccceeeEEEeec
Q 041135 387 NVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHR--HLVSLVGY-----CISERERLLVYEYV 459 (727)
Q Consensus 387 ~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~Hp--nIv~l~~~-----~~~~~~~~lV~Ey~ 459 (727)
..|+ |....||+....+|+.++||+.+... .....+..|+.+++.|... .+.+++.. ...++..++||||+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4566 88889999887778789999986321 2345678899999888522 24555543 12244567899999
Q ss_pred cCCccch--------------hcccC-------CCCcccHHHH----HHH---------------HHHHHHHHHHHHhc-
Q 041135 460 PNDTLHY--------------HLHAE-------GRPVMDWATR----VKV---------------AAGAARGIAYLHED- 498 (727)
Q Consensus 460 ~~gsL~~--------------~L~~~-------~~~~l~~~~~----~~i---------------~~qia~gL~yLH~~- 498 (727)
+|..+.. .||.. .+..+++... ..+ ...+.+.++.|...
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 8865431 01110 0111222111 001 11111223333322
Q ss_pred ---CCCcEEeeCCCCCceEECCCCcEEEEeeccchh
Q 041135 499 ---CHPRIIHRDIKSSNILLDSSFEARVADFGLAKI 531 (727)
Q Consensus 499 ---~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 531 (727)
....+||||+++.|||++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 233689999999999999 4 899999998763
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=98.08 E-value=6e-06 Score=87.76 Aligned_cols=140 Identities=14% Similarity=0.085 Sum_probs=74.9
Q ss_pred ceeccCCceE-EEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCC--CCceeEeeEeeccceeeEEEeeccCCc
Q 041135 387 NVLGEGGFGC-VYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHH--RHLVSLVGYCISERERLLVYEYVPNDT 463 (727)
Q Consensus 387 ~~LG~G~fg~-Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H--pnIv~l~~~~~~~~~~~lV~Ey~~~gs 463 (727)
+.|+.|.... +|+....+|+.+++|...... ..++..|+++++.|.. -.+.+++.+..+.+ ++|||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence 4565565554 667765447778887643221 1456678888887752 33567777654443 78999997655
Q ss_pred cchhcc---------------------cCC---CCcccHHHHH-------H-------------HHHHHHHHHHHHHh--
Q 041135 464 LHYHLH---------------------AEG---RPVMDWATRV-------K-------------VAAGAARGIAYLHE-- 497 (727)
Q Consensus 464 L~~~L~---------------------~~~---~~~l~~~~~~-------~-------------i~~qia~gL~yLH~-- 497 (727)
+.+++. ... ...++..... . ....+.+.++.|..
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 543221 110 0011111100 0 00111222333311
Q ss_pred -cCCCcEEeeCCCCCceEECCC----CcEEEEeeccchh
Q 041135 498 -DCHPRIIHRDIKSSNILLDSS----FEARVADFGLAKI 531 (727)
Q Consensus 498 -~~~~~ivHrDLkp~NILl~~~----~~vkL~DFGla~~ 531 (727)
.....+||||+.+.|||++.+ +.+.|+||+.+..
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 113479999999999999874 6899999998864
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=98.05 E-value=1.1e-05 Score=89.10 Aligned_cols=73 Identities=22% Similarity=0.258 Sum_probs=51.7
Q ss_pred cceeccCCceEEEEEEEcC--------CcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCc-eeEeeEeeccceeeEEE
Q 041135 386 HNVLGEGGFGCVYKGVLAD--------GREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHL-VSLVGYCISERERLLVY 456 (727)
Q Consensus 386 ~~~LG~G~fg~Vy~~~~~~--------g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnI-v~l~~~~~~~~~~~lV~ 456 (727)
++.|+.|....||++...+ ++.|+||+.... .....+.+|+.+|+.|...+| .++++++.+ .+||
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4568888889999998753 578999987421 112456689999998863333 577776643 3899
Q ss_pred eeccCCcc
Q 041135 457 EYVPNDTL 464 (727)
Q Consensus 457 Ey~~~gsL 464 (727)
||++|..|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99987554
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=98.04 E-value=1.2e-05 Score=84.28 Aligned_cols=137 Identities=13% Similarity=0.088 Sum_probs=78.0
Q ss_pred ccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCc-eeEeeEeeccceeeEEEeec-cCC
Q 041135 385 AHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHL-VSLVGYCISERERLLVYEYV-PND 462 (727)
Q Consensus 385 ~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnI-v~l~~~~~~~~~~~lV~Ey~-~~g 462 (727)
-++.|+.|....+|+. +.++||+..... ....+..+|+.+++.+...+| .++++++. +.-++|+||+ .|.
T Consensus 22 ~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~-~~~~~r~~E~~~l~~l~~~g~~P~~~~~~~--~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 22 GPLERLGGLTNLVFRA-----GDLCLRIPGKGT-EEYINRANEAVAAREAAKAGVSPEVLHVDP--ATGVMVTRYIAGAQ 93 (301)
T ss_dssp SCEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEECT--TTCCEEEECCTTCE
T ss_pred ceeEcCCcccccccee-----eeEEEECCCCCc-cceeCHHHHHHHHHHHHHcCCCCceEEEEC--CCCEEEEeecCCCc
Confidence 3678999999999998 568888875431 112234678888888853333 46666543 3347899999 665
Q ss_pred ccch------------------hcccCCC---CcccH-HHHHHHHH--------------HHHHHHHHHH----h-cCCC
Q 041135 463 TLHY------------------HLHAEGR---PVMDW-ATRVKVAA--------------GAARGIAYLH----E-DCHP 501 (727)
Q Consensus 463 sL~~------------------~L~~~~~---~~l~~-~~~~~i~~--------------qia~gL~yLH----~-~~~~ 501 (727)
.|.. .||.... ..++. ..+..+.. .+.+.+..|. . ....
T Consensus 94 ~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~ 173 (301)
T 3dxq_A 94 TMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPL 173 (301)
T ss_dssp ECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCC
T ss_pred cCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCc
Confidence 5532 0111110 00011 11111100 1111111111 1 1133
Q ss_pred cEEeeCCCCCceEECCCCcEEEEeeccch
Q 041135 502 RIIHRDIKSSNILLDSSFEARVADFGLAK 530 (727)
Q Consensus 502 ~ivHrDLkp~NILl~~~~~vkL~DFGla~ 530 (727)
.++|+|+.+.||| ..++.+.|+||+.+.
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~ 201 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSG 201 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEeccccc
Confidence 5999999999999 556678999999875
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.97 E-value=3.9e-05 Score=85.32 Aligned_cols=75 Identities=8% Similarity=0.028 Sum_probs=50.2
Q ss_pred cceeccCCceEEEEEEEcC-CcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCc-eeEeeEeeccceeeEEEeeccCCc
Q 041135 386 HNVLGEGGFGCVYKGVLAD-GREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHL-VSLVGYCISERERLLVYEYVPNDT 463 (727)
Q Consensus 386 ~~~LG~G~fg~Vy~~~~~~-g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnI-v~l~~~~~~~~~~~lV~Ey~~~gs 463 (727)
++.|+.|-...+|+....+ +..|+||+..... ....+..+|+.+|+.|...+| .++++++.+ .+||||++|..
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCcc
Confidence 3567888889999998865 4788899874321 111233689999999975555 577777632 35999999865
Q ss_pred cc
Q 041135 464 LH 465 (727)
Q Consensus 464 L~ 465 (727)
|.
T Consensus 188 l~ 189 (458)
T 2qg7_A 188 LS 189 (458)
T ss_dssp CC
T ss_pred CC
Confidence 53
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.91 E-value=3e-05 Score=84.02 Aligned_cols=139 Identities=19% Similarity=0.170 Sum_probs=83.7
Q ss_pred ceeccCCceEEEEEEEc--------CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcC-CCCceeEeeEeeccceeeEEEe
Q 041135 387 NVLGEGGFGCVYKGVLA--------DGREVAVKQLKIGGSQGEREFRAEVEIISRVH-HRHLVSLVGYCISERERLLVYE 457 (727)
Q Consensus 387 ~~LG~G~fg~Vy~~~~~--------~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E 457 (727)
+.|..|-...+|++... +++.|+||+.... ......+.+|+++|+.|. +.-..++++++.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 45667778889998864 2478999986321 223456779999999885 3334577777654 29999
Q ss_pred eccCCccchh-----------------cccCCC---Ccc--cHHHHHHHHHHHH-------------------HHHHHHH
Q 041135 458 YVPNDTLHYH-----------------LHAEGR---PVM--DWATRVKVAAGAA-------------------RGIAYLH 496 (727)
Q Consensus 458 y~~~gsL~~~-----------------L~~~~~---~~l--~~~~~~~i~~qia-------------------~gL~yLH 496 (727)
|++|..|... ||.... ... -+.++.+++.++. +.+++|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998666421 122110 111 1334444443331 2233333
Q ss_pred hc-----CCCcEEeeCCCCCceEECCC----CcEEEEeeccch
Q 041135 497 ED-----CHPRIIHRDIKSSNILLDSS----FEARVADFGLAK 530 (727)
Q Consensus 497 ~~-----~~~~ivHrDLkp~NILl~~~----~~vkL~DFGla~ 530 (727)
+. ....++|+|+...|||++.+ +.++|+||.++.
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 21 12369999999999999876 789999999885
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.91 E-value=2.5e-05 Score=84.22 Aligned_cols=74 Identities=12% Similarity=0.028 Sum_probs=46.7
Q ss_pred cceeccCCceEEEEEEEcC---------CcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCC-ceeEeeEeeccceeeEE
Q 041135 386 HNVLGEGGFGCVYKGVLAD---------GREVAVKQLKIGGSQGEREFRAEVEIISRVHHRH-LVSLVGYCISERERLLV 455 (727)
Q Consensus 386 ~~~LG~G~fg~Vy~~~~~~---------g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~Hpn-Iv~l~~~~~~~~~~~lV 455 (727)
++.|+.|....+|+....+ ++.+++|+..... ....+..+|+++|+.|...+ +.++++.+. -++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEecC----CcEE
Confidence 4567888888999998754 2688888765321 11223578999999886334 447776542 2689
Q ss_pred EeeccCCcc
Q 041135 456 YEYVPNDTL 464 (727)
Q Consensus 456 ~Ey~~~gsL 464 (727)
|||++|..|
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999988654
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.77 E-value=7.9e-05 Score=79.52 Aligned_cols=67 Identities=9% Similarity=0.088 Sum_probs=44.6
Q ss_pred cCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCC---CCceeEeeE------eeccceeeEEEeeccC
Q 041135 391 EGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHH---RHLVSLVGY------CISERERLLVYEYVPN 461 (727)
Q Consensus 391 ~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H---pnIv~l~~~------~~~~~~~~lV~Ey~~~ 461 (727)
.|....||+....+| .+++|+...... .+|+.+|+.|.. ++|.+.+.. +...+..++||+|++|
T Consensus 33 ~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G 105 (339)
T 3i1a_A 33 ADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHA 105 (339)
T ss_dssp SCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCC
T ss_pred CccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCC
Confidence 333689999987767 899998764331 456677766632 225555543 2334677899999998
Q ss_pred Ccc
Q 041135 462 DTL 464 (727)
Q Consensus 462 gsL 464 (727)
..+
T Consensus 106 ~~~ 108 (339)
T 3i1a_A 106 PNG 108 (339)
T ss_dssp CBT
T ss_pred CcC
Confidence 765
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.56 E-value=5.6e-05 Score=54.23 Aligned_cols=35 Identities=14% Similarity=0.240 Sum_probs=25.1
Q ss_pred ccCCceeehHHHHHHHHHHHHHHHHHhhhcccccc
Q 041135 280 GTGGAVAIGIAVGFLVLSLLVMAVWFAHKRKKKRA 314 (727)
Q Consensus 280 ~~~~~i~i~v~v~~~~l~lli~~~~~~~~rrk~~~ 314 (727)
++...|+.|+++++++++++++++||++|||++++
T Consensus 8 s~~~~IA~gVVgGv~~~~ii~~~~~~~~RRr~~~~ 42 (44)
T 2ks1_B 8 PKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVR 42 (44)
T ss_dssp SCSSSSTHHHHHHHHHHHHHHHHHHHHHHTTTCCS
T ss_pred CCcceEEeehhHHHHHHHHHHHHHHHHhhhhHhhc
Confidence 34455788888888888777777777777666544
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.51 E-value=6.4e-05 Score=53.78 Aligned_cols=35 Identities=17% Similarity=0.301 Sum_probs=24.7
Q ss_pred ccCCceeehHHHHHHHHHHHHHHHHHhhhcccccc
Q 041135 280 GTGGAVAIGIAVGFLVLSLLVMAVWFAHKRKKKRA 314 (727)
Q Consensus 280 ~~~~~i~i~v~v~~~~l~lli~~~~~~~~rrk~~~ 314 (727)
++...|+.|++.++++++++++++||++|||++++
T Consensus 7 s~~~aIA~gVVgGv~~v~ii~~~~~~~~RRRr~~~ 41 (44)
T 2l2t_A 7 ARTPLIAAGVIGGLFILVIVGLTFAVYVRRKSIKK 41 (44)
T ss_dssp CSSHHHHHHHHHHHHHHHHHHHHHHHHHHTTCSSC
T ss_pred CCcceEEEeehHHHHHHHHHHHHHHHHhhhhhhhh
Confidence 34455788888888887777777777776666554
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=97.40 E-value=0.0006 Score=74.85 Aligned_cols=74 Identities=5% Similarity=0.026 Sum_probs=50.7
Q ss_pred cceeccCCceEEEEEEEcC--------CcEEEEEEeeeCCchhHHHHHHHHHHHHHcC-CCCceeEeeEeeccceeeEEE
Q 041135 386 HNVLGEGGFGCVYKGVLAD--------GREVAVKQLKIGGSQGEREFRAEVEIISRVH-HRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 386 ~~~LG~G~fg~Vy~~~~~~--------g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~lV~ 456 (727)
++.|..|-...+|+....+ ++.|+||+..... ....+..+|+++|+.|. +.-..++++.+. -++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence 4567778888999998753 5789999864322 22234578999999885 333456665442 27899
Q ss_pred eeccCCcc
Q 041135 457 EYVPNDTL 464 (727)
Q Consensus 457 Ey~~~gsL 464 (727)
||++|..|
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99998765
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=96.99 E-value=0.0023 Score=69.77 Aligned_cols=29 Identities=28% Similarity=0.407 Sum_probs=25.1
Q ss_pred cEEeeCCCCCceEE------CCCCcEEEEeeccch
Q 041135 502 RIIHRDIKSSNILL------DSSFEARVADFGLAK 530 (727)
Q Consensus 502 ~ivHrDLkp~NILl------~~~~~vkL~DFGla~ 530 (727)
.++|+|+...|||+ +++..++|+||.+|.
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 47899999999999 456789999999885
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.29 E-value=0.015 Score=57.26 Aligned_cols=100 Identities=12% Similarity=0.043 Sum_probs=64.5
Q ss_pred CccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCccc
Q 041135 462 DTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHV 541 (727)
Q Consensus 462 gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 541 (727)
-+|.++|+..+. .++++++|.++.|.+++|.-+-... .-..+=+.+..|+|..+|.|.+.+ +.+.
T Consensus 33 vSL~eIL~~~~~-PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQ-PINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred ccHHHHHHHcCC-CcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc-----------
Confidence 367788876554 6899999999999999987763211 111333445899999999887653 1111
Q ss_pred cccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhC
Q 041135 542 STRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITG 581 (727)
Q Consensus 542 ~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG 581 (727)
.....+.+||.+. ...+.+.=||+||++||.-+--
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDy 132 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDY 132 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHTT
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhc
Confidence 0112356787764 3567899999999999999863
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=96.09 E-value=0.0035 Score=44.77 Aligned_cols=27 Identities=26% Similarity=0.396 Sum_probs=12.6
Q ss_pred eehHHHHHHHHHHHHHHHHHhhhcccc
Q 041135 286 AIGIAVGFLVLSLLVMAVWFAHKRKKK 312 (727)
Q Consensus 286 ~i~v~v~~~~l~lli~~~~~~~~rrk~ 312 (727)
+++.++++++++++++++++|+|||+.
T Consensus 14 Ia~~vVGvll~vi~~l~~~~~~RRR~~ 40 (44)
T 2jwa_A 14 IISAVVGILLVVVLGVVFGILIKRRQQ 40 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHCS
T ss_pred hHHHHHHHHHHHHHHHHHHhheehhhh
Confidence 344455544444444444444444443
|
| >2k9y_A Ephrin type-A receptor 2; receptor tyrosine kinase, membrane protein, dimeric transmembrane domain, ephrin receptor, ATP-binding, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.79 E-value=0.0035 Score=44.60 Aligned_cols=29 Identities=38% Similarity=0.567 Sum_probs=16.2
Q ss_pred CCceeehHHHHHHHHHHHHHHHHHhhhcc
Q 041135 282 GGAVAIGIAVGFLVLSLLVMAVWFAHKRK 310 (727)
Q Consensus 282 ~~~i~i~v~v~~~~l~lli~~~~~~~~rr 310 (727)
...|++++++++++++++++++|++||||
T Consensus 12 ~~~I~~~vv~Gv~ll~~iv~~~~~~~rRr 40 (41)
T 2k9y_A 12 NLAVIGGVAVGVVLLLVLAGVGFFIHRRR 40 (41)
T ss_dssp STHHHHHHHHHHHHHHHHHHHHHSSSSSC
T ss_pred eEEEEeehhHHHHHHHHHHHHheeEeeec
Confidence 34466666666666553455555555544
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=95.16 E-value=0.013 Score=40.68 Aligned_cols=24 Identities=21% Similarity=0.409 Sum_probs=11.0
Q ss_pred eehHHHHHHHHHHHH-HHHHHhhhc
Q 041135 286 AIGIAVGFLVLSLLV-MAVWFAHKR 309 (727)
Q Consensus 286 ~i~v~v~~~~l~lli-~~~~~~~~r 309 (727)
+.|++++.++.++++ +++||+|||
T Consensus 13 IAGiVvG~v~gv~li~~l~~~~~rr 37 (38)
T 2k1k_A 13 IVAVIFGLLLGAALLLGILVFRSRR 37 (38)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred eeeeehHHHHHHHHHHHHHHHHeec
Confidence 355555555433333 334444444
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=94.91 E-value=0.053 Score=53.24 Aligned_cols=116 Identities=8% Similarity=0.082 Sum_probs=79.2
Q ss_pred CCCCceeEeeEeeccceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceE
Q 041135 435 HHRHLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNIL 514 (727)
Q Consensus 435 ~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIL 514 (727)
.|++++.. .+-.+++.+.|.|+.-.++.=...++ .++..++++++..|+....+++.. +|--|+|+||+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik-----~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~NL~ 111 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK-----SFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDELF 111 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG-----GSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGGEE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH-----hcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecceEE
Confidence 57888866 45555566566565543222222232 367889999999999888776654 78899999999
Q ss_pred ECCCCcEEEEeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCC
Q 041135 515 LDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVD 586 (727)
Q Consensus 515 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~ 586 (727)
++.++.++|.-.|+-.. +.|. .++...=+-.+=+++..+++++..|+
T Consensus 112 f~~~~~p~i~~RGik~~--------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 112 FTRDGLPIAKTRGLQNV--------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp ECTTSCEEESCCEETTT--------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EcCCCCEEEEEccCccC--------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999987776432 1121 23334445567788899999887764
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.71 E-value=0.078 Score=37.97 Aligned_cols=32 Identities=19% Similarity=0.117 Sum_probs=25.0
Q ss_pred CCceeehHHHHHHHHHHHHHHHHHhhhccccc
Q 041135 282 GGAVAIGIAVGFLVLSLLVMAVWFAHKRKKKR 313 (727)
Q Consensus 282 ~~~i~i~v~v~~~~l~lli~~~~~~~~rrk~~ 313 (727)
.+..+||-+++++++++++++++..+++++||
T Consensus 13 IA~gVVgGv~~~~ii~~~~~~~~RRr~~~~kR 44 (44)
T 2ks1_B 13 IATGMVGALLLLLVVALGIGLFMRRRHIVRKR 44 (44)
T ss_dssp STHHHHHHHHHHHHHHHHHHHHHHTTTCCSCC
T ss_pred EEeehhHHHHHHHHHHHHHHHHhhhhHhhccC
Confidence 44456777777777779999999999988875
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=92.48 E-value=0.41 Score=47.03 Aligned_cols=115 Identities=12% Similarity=0.144 Sum_probs=76.5
Q ss_pred CCCCceeEeeEeeccceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHH-HHHhcCCCcEEeeCCCCCce
Q 041135 435 HHRHLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIA-YLHEDCHPRIIHRDIKSSNI 513 (727)
Q Consensus 435 ~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~-yLH~~~~~~ivHrDLkp~NI 513 (727)
.|+++ -..+-.+++.+.|.|+.-.++.=...++ .++..++++++..|+.... +++. -+|--|+|+||
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-----~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL 115 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-----KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENL 115 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-----TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-----hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceE
Confidence 47777 2233355666666666543433333332 2688899999999988777 6654 48888999999
Q ss_pred EECCCCcEEEEeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCC
Q 041135 514 LLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVD 586 (727)
Q Consensus 514 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~ 586 (727)
+++.++.++|.-.|+-.. +.|. .++...=+-.+=+++..++.++.-|+
T Consensus 116 ~f~~~~~p~i~hRGi~~~--------------------lpP~-----e~~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 116 MFNRALEPFFLHVGVKES--------------------LPPD-----EWDDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp EECTTCCEEESCCEETTT--------------------BSSC-----SCCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred EEeCCCcEEEEEcCCccc--------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999988776431 2222 22333334567788888988887664
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=91.90 E-value=0.062 Score=38.40 Aligned_cols=33 Identities=27% Similarity=0.148 Sum_probs=25.4
Q ss_pred CCceeehHHHHHHHHHHHHHHHHHhhhcccccc
Q 041135 282 GGAVAIGIAVGFLVLSLLVMAVWFAHKRKKKRA 314 (727)
Q Consensus 282 ~~~i~i~v~v~~~~l~lli~~~~~~~~rrk~~~ 314 (727)
.+..+||-++++++++++++++|..+|+++||.
T Consensus 12 IA~gVVgGv~~v~ii~~~~~~~~RRRr~~~kra 44 (44)
T 2l2t_A 12 IAAGVIGGLFILVIVGLTFAVYVRRKSIKKKRA 44 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHTTCSSCCCC
T ss_pred EEEeehHHHHHHHHHHHHHHHHhhhhhhhhccC
Confidence 444567767777777799999999998888873
|
| >2l8s_A Integrin alpha-1; transmembrane region, detergent micelle, CE adhesion; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=91.30 E-value=0.15 Score=38.04 Aligned_cols=23 Identities=30% Similarity=0.687 Sum_probs=13.9
Q ss_pred ceeehHHHHHHHHHHHHHHHHHh
Q 041135 284 AVAIGIAVGFLVLSLLVMAVWFA 306 (727)
Q Consensus 284 ~i~i~v~v~~~~l~lli~~~~~~ 306 (727)
.|++++++|+++++++++++|.+
T Consensus 11 iIi~svl~GLLLL~Lii~~LwK~ 33 (54)
T 2l8s_A 11 VILLSAFAGLLLLMLLILALWKI 33 (54)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHHc
Confidence 34555566666666666666644
|
| >2knc_A Integrin alpha-IIB; transmembrane signaling, protein structure, cell A cleavage on PAIR of basic residues, disease mutation, disul bond, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=90.42 E-value=0.26 Score=36.86 Aligned_cols=23 Identities=39% Similarity=0.794 Sum_probs=13.8
Q ss_pred ceeehHHHHHHHHHHHHHHHHHh
Q 041135 284 AVAIGIAVGFLVLSLLVMAVWFA 306 (727)
Q Consensus 284 ~i~i~v~v~~~~l~lli~~~~~~ 306 (727)
.|++++++|+++++++++++|.+
T Consensus 14 iIi~svl~GLllL~li~~~LwK~ 36 (54)
T 2knc_A 14 WVLVGVLGGLLLLTILVLAMWKV 36 (54)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHHc
Confidence 34555556666666666666644
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=89.96 E-value=0.081 Score=36.68 Aligned_cols=28 Identities=21% Similarity=0.134 Sum_probs=23.5
Q ss_pred ccCCceeehHHHHHHHHHHHHHHHHHhh
Q 041135 280 GTGGAVAIGIAVGFLVLSLLVMAVWFAH 307 (727)
Q Consensus 280 ~~~~~i~i~v~v~~~~l~lli~~~~~~~ 307 (727)
+..+.|+||+++++++++++++++|+++
T Consensus 11 GaIAGiVvG~v~gv~li~~l~~~~~rrr 38 (38)
T 2k1k_A 11 GEIVAVIFGLLLGAALLLGILVFRSRRA 38 (38)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHCCC
T ss_pred CceeeeehHHHHHHHHHHHHHHHHeecC
Confidence 4557899999999999999999998764
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=89.63 E-value=0.11 Score=37.08 Aligned_cols=31 Identities=13% Similarity=0.151 Sum_probs=24.7
Q ss_pred CCceeehHHHHHHHHHHHHHHHHHhhhccccc
Q 041135 282 GGAVAIGIAVGFLVLSLLVMAVWFAHKRKKKR 313 (727)
Q Consensus 282 ~~~i~i~v~v~~~~l~lli~~~~~~~~rrk~~ 313 (727)
.+.+++| ++.++++++++++++..+|.++|+
T Consensus 14 Ia~~vVG-vll~vi~~l~~~~~~RRR~~~~kK 44 (44)
T 2jwa_A 14 IISAVVG-ILLVVVLGVVFGILIKRRQQKIRK 44 (44)
T ss_dssp HHHHHHH-HHHHHHHHHHHHHHHHHHCSCCCC
T ss_pred hHHHHHH-HHHHHHHHHHHHhheehhhhhccC
Confidence 4556788 668888888889999999888774
|
| >2x6h_A GH13170P, VPS34, phosphotidylinositol 3 kinase 59F; transferase; 2.90A {Drosophila melanogaster} PDB: 2x6f_A 2x6i_A* 2x6j_A* 2x6k_A* | Back alignment and structure |
|---|
Probab=89.54 E-value=16 Score=42.06 Aligned_cols=45 Identities=24% Similarity=0.175 Sum_probs=33.5
Q ss_pred HHHHHHHHHHH--HHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccch
Q 041135 479 ATRVKVAAGAA--RGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAK 530 (727)
Q Consensus 479 ~~~~~i~~qia--~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~ 530 (727)
..+..+++.+| ..+.|+=.. +|-..+||||+.+|++.=+|||++.
T Consensus 529 ~ar~nF~~SlA~~Svv~YILGl-------GDRH~~NILid~tG~v~HIDFG~~f 575 (696)
T 2x6h_A 529 EVMDTYIKSCAGYCVITYLLGV-------GDRHLDNLLLTTNGKLFHIDFGYIL 575 (696)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTC-------CCCCTTTEEECTTSCEEECCCCSCT
T ss_pred HHHHHHHHHHHHHHHHHHHccC-------CCCCCcceEEeCCCCEEEEeehhhh
Confidence 34455555554 455565543 7889999999999999999999874
|
| >1cja_A Protein (actin-fragmin kinase); transferase; HET: AMP; 2.90A {Physarum polycephalum} SCOP: d.144.1.3 | Back alignment and structure |
|---|
Probab=89.10 E-value=1.2 Score=46.56 Aligned_cols=139 Identities=14% Similarity=0.117 Sum_probs=73.0
Q ss_pred ccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEe------------------
Q 041135 385 AHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYC------------------ 446 (727)
Q Consensus 385 ~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~------------------ 446 (727)
.++.+-.| .+.||.+.. ++..|+||-. .....+-|..++...-.+.-+++ +++.+.
T Consensus 73 ~I~~s~~G-stgvff~~t-d~~~~VVK~s---~~l~~E~l~s~LA~~LGlpiP~~-Riv~~~~~E~~e~~~~L~~~~~~~ 146 (342)
T 1cja_A 73 GIERSEKG-TEGLFFVET-ESGVFIVKRS---TNIESETFCSLLCMRLGLHAPKV-RVVSSNSEEGTNMLECLAAIDKSF 146 (342)
T ss_dssp EEEECCST-TSCEEEEEE-SSCEEEEECC---TTHHHHHHHHHHHHHHTCCCCCE-EEEESSSHHHHHHHHHHHHHCSSS
T ss_pred EEEeccCC-CCCeEEEEe-CCCEEEEeCc---HHHHHHHHHHHHHHHhCCCCCCe-eEEeeCcHHHHHHHHHHHHhhhhh
Confidence 33444455 456666666 5788999954 22222334444444444444442 222211
Q ss_pred -----eccceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCc-EEe-eCCCCCceEECCCC
Q 041135 447 -----ISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPR-IIH-RDIKSSNILLDSSF 519 (727)
Q Consensus 447 -----~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~-ivH-rDLkp~NILl~~~~ 519 (727)
...+..+++|||+.|..|.+.-+......+..+.... .+-+-+++++..+.+.- +++ .--.+.|||+++++
T Consensus 147 ~~l~~l~~~~~~l~meyv~G~~L~e~~~~~~~~~f~~~~~k~--LG~Ii~FDi~InN~DR~Pl~W~n~GN~~NIL~~~~n 224 (342)
T 1cja_A 147 RVITTLANQANILLMELVRGITLNKLTTTSAPEVLTKSTMQQ--LGSLMALDVIVNNSDRLPIAWTNEGNLDNIMLSERG 224 (342)
T ss_dssp CHHHHHTTCSEEEEEECCCEEESTTCCSSSHHHHSCHHHHHH--HHHHHHHHHHHTCCSSSCSSSCSCCCGGGEEEESBT
T ss_pred HHHHHhhcccceehhhhcCCCccccchhhhhhhhcCHHHHHh--hchhheehhhhcCCccCcccccCCCChhheEEeCCC
Confidence 0122456999999977776543321111122222221 12244677777665422 111 12467899997654
Q ss_pred -cEEEEeeccchh
Q 041135 520 -EARVADFGLAKI 531 (727)
Q Consensus 520 -~vkL~DFGla~~ 531 (727)
.+.++|.+++..
T Consensus 225 ~~~~~IDhn~af~ 237 (342)
T 1cja_A 225 ATVVPIDSKIIPL 237 (342)
T ss_dssp TCEEECSCCCCCC
T ss_pred CeEEEEcCCcccc
Confidence 599999999863
|
| >1iij_A ERBB-2 receptor protein-tyrosine kinase; alpha-helix-PI-bulge-alpha-helix, signaling protein; NMR {Synthetic} SCOP: j.35.1.1 | Back alignment and structure |
|---|
Probab=88.01 E-value=0.077 Score=35.81 Aligned_cols=25 Identities=24% Similarity=0.343 Sum_probs=10.4
Q ss_pred eeehHHHHHHHHHHHHHHHHHhhhcc
Q 041135 285 VAIGIAVGFLVLSLLVMAVWFAHKRK 310 (727)
Q Consensus 285 i~i~v~v~~~~l~lli~~~~~~~~rr 310 (727)
|+.|++. +++++++.+.+.+++|||
T Consensus 10 IaagVvg-lll~vii~l~~~~~iRRr 34 (35)
T 1iij_A 10 IIATVVG-VLLFLILVVVVGILIKRR 34 (35)
T ss_dssp HHHHHHH-HHHHHHHTTTTTHHHHHC
T ss_pred eHHHHHH-HHHHHHHHHHhheEEeec
Confidence 3444444 443334434344444444
|
| >2knc_B Integrin beta-3; transmembrane signaling, protein structure, cell A cleavage on PAIR of basic residues, disease mutation, disul bond, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.89 E-value=0.12 Score=42.17 Aligned_cols=24 Identities=17% Similarity=0.390 Sum_probs=15.9
Q ss_pred CceeehHHHHHHHHHHHHHHHHHh
Q 041135 283 GAVAIGIAVGFLVLSLLVMAVWFA 306 (727)
Q Consensus 283 ~~i~i~v~v~~~~l~lli~~~~~~ 306 (727)
..|++|++++++++.|+++++|.+
T Consensus 11 ~~Iv~gvi~gilliGllllliwk~ 34 (79)
T 2knc_B 11 LVVLLSVMGAILLIGLAALLIWKL 34 (79)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhHHHHHHHHHHHHHHHHHHHHH
Confidence 446667777777777776666654
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=85.79 E-value=0.08 Score=58.63 Aligned_cols=61 Identities=5% Similarity=0.037 Sum_probs=18.3
Q ss_pred cccceeccCCceEEEEEEEcC-CcEEEE------EEeeeCC--chhHHHHHHHHHHHHHcCCCCceeEeeEee
Q 041135 384 SAHNVLGEGGFGCVYKGVLAD-GREVAV------KQLKIGG--SQGEREFRAEVEIISRVHHRHLVSLVGYCI 447 (727)
Q Consensus 384 ~~~~~LG~G~fg~Vy~~~~~~-g~~vaV------K~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~ 447 (727)
.+.+.|| ||.||+|.+.. ...||| |.++... .+....|.+|..+++.++|+|+++.++|..
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 3456676 99999999864 367888 7665422 222346888999999999999999988764
|
| >3ls8_A Phosphatidylinositol 3-kinase catalytic subunit type 3; alpha/beta protein, PIK3C3, compound 15E, structural genomics, SGC stockholm; HET: AJZ; 2.25A {Homo sapiens} PDB: 3ihy_A | Back alignment and structure |
|---|
Probab=85.49 E-value=12 Score=42.34 Aligned_cols=46 Identities=22% Similarity=0.137 Sum_probs=34.5
Q ss_pred HHHHHHHHHHHH--HHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccch
Q 041135 478 WATRVKVAAGAA--RGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAK 530 (727)
Q Consensus 478 ~~~~~~i~~qia--~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~ 530 (727)
+..+..+++.+| ..+.|+=.. +|=..+||||+.+|++.=+|||++.
T Consensus 454 ~~a~~nF~~S~A~ySvv~YILGi-------gDRH~~NILld~tG~v~HIDFG~~f 501 (614)
T 3ls8_A 454 AEVMDTYVKSCAGYCVITYILGV-------GDRHLDNLLLTKTGKLFHIDFGYIL 501 (614)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTC-------CCCCTTSEEECTTSCEEECCCSSCT
T ss_pred HHHHHHHHHHHHHHhHhheeeec-------cCCCCcceeEcCCCCEeeeehHHhh
Confidence 445556666554 456666544 6788999999999999999999874
|
| >2k1a_A Integrin alpha-IIB; single-PASS transmembrane segment, alternative splicing, calcium, cell adhesion, cleavage on PAIR of basic residues; NMR {Homo sapiens} PDB: 2k9j_A | Back alignment and structure |
|---|
Probab=83.77 E-value=0.62 Score=32.94 Aligned_cols=23 Identities=39% Similarity=0.794 Sum_probs=13.2
Q ss_pred ceeehHHHHHHHHHHHHHHHHHh
Q 041135 284 AVAIGIAVGFLVLSLLVMAVWFA 306 (727)
Q Consensus 284 ~i~i~v~v~~~~l~lli~~~~~~ 306 (727)
.|++++++|+++++++++++|.+
T Consensus 12 iIi~s~l~GLllL~li~~~LwK~ 34 (42)
T 2k1a_A 12 WVLVGVLGGLLLLTILVLAMWKV 34 (42)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHHHHHc
Confidence 34455555666666666666644
|
| >2k9j_B Integrin beta-3; transmembrane complex, cell adhesion, cleavage on basic residues, disease mutation, glycoprotein, pyrrolidone carboxylic acid; NMR {Homo sapiens} PDB: 2rmz_A 2rn0_A 2l91_A | Back alignment and structure |
|---|
Probab=83.20 E-value=0.42 Score=34.06 Aligned_cols=30 Identities=13% Similarity=0.255 Sum_probs=18.5
Q ss_pred CceeehHHHHHHHHHHHHHHHHHhhhcccc
Q 041135 283 GAVAIGIAVGFLVLSLLVMAVWFAHKRKKK 312 (727)
Q Consensus 283 ~~i~i~v~v~~~~l~lli~~~~~~~~rrk~ 312 (727)
..|+.|++++++++.++++++|.++..-+.
T Consensus 10 ~~Iv~gvi~~ivliGl~lLliwk~~~~i~D 39 (43)
T 2k9j_B 10 LVVLLSVMGAILLIGLAALLIWKLLITIHD 39 (43)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred eehHHHHHHHHHHHHHHHHHHHHHHHheeh
Confidence 345567777777777777777765544433
|
| >2l34_A TYRO protein tyrosine kinase-binding protein; immunoreceptor, transmembrane assembly, DAP12, protein bindi; NMR {Homo sapiens} PDB: 2l35_B | Back alignment and structure |
|---|
Probab=81.75 E-value=0.93 Score=30.26 Aligned_cols=25 Identities=40% Similarity=0.527 Sum_probs=14.6
Q ss_pred eeehHHHHHHHHHHHHHHHHHhhhc
Q 041135 285 VAIGIAVGFLVLSLLVMAVWFAHKR 309 (727)
Q Consensus 285 i~i~v~v~~~~l~lli~~~~~~~~r 309 (727)
.+.|++++-+++.+++++++|++.|
T Consensus 8 aIaGIVvgdi~~t~~i~~~vy~~~r 32 (33)
T 2l34_A 8 VLAGIVVGDLVLTVLIALAVYFLGR 32 (33)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred eEEeEeHHHHHHHHHHHHHHhheec
Confidence 4567777776665555555544443
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 727 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 8e-79 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-74 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-73 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-73 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 6e-72 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-71 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-71 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-70 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-69 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-68 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-68 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-67 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-66 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-66 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 8e-66 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-65 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 9e-65 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-64 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-64 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-64 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-63 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-63 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-63 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 8e-63 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-62 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-61 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-60 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-58 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-58 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-55 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-54 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-54 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-53 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-53 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-53 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-53 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-53 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-52 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-51 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-51 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-51 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-51 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-50 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-49 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-48 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-47 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-47 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-46 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 7e-45 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 7e-45 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-44 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-43 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-43 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-43 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-42 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-40 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-39 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-38 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-37 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-36 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-32 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-30 | |
| d1pq1a_ | 196 | f.1.4.1 (A:) Apoptosis regulator Bcl-xL {Mouse (Mu | 0.004 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 251 bits (642), Expect = 8e-79
Identities = 74/280 (26%), Positives = 131/280 (46%), Gaps = 28/280 (10%)
Query: 387 NVLGEGGFGCVYKGVLADGREVAVKQLKIGG--SQGEREFRAEVEIISRVHHRHLVSLVG 444
+G G FG VYKG +VAVK L + Q + F+ EV ++ + H +++ +G
Sbjct: 14 QRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 445 YCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRII 504
Y + + +V ++ +L++HLH + + +A A+G+ YLH II
Sbjct: 72 YS-TAPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLH---AKSII 126
Query: 505 HRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYAT---SGK 561
HRD+KS+NI L ++ DFGLA + S +H ++ G+ +MAPE
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATV-KSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 562 LTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRL 621
+ +SDVY+FG+VL EL+TG+ P + + + ++ D + +
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQLPYS------NINNRDQIIFMVGRGYLSPDLSKVRSNCP 239
Query: 622 EKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661
+ M A C++ +RP Q++ +++ L
Sbjct: 240 KA---------MKRLMAECLKKKRDERPLFPQILASIELL 270
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 241 bits (615), Expect = 1e-74
Identities = 68/299 (22%), Positives = 120/299 (40%), Gaps = 34/299 (11%)
Query: 386 HNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEI--ISRVHHRHLVSLV 443
+G+G FG V++G G EVAVK S+ ER + E EI + H +++ +
Sbjct: 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFI 63
Query: 444 GYCISER----ERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDC 499
+ + LV +Y + +L +L+ R + +K+A A G+A+LH +
Sbjct: 64 AADNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 500 -----HPRIIHRDIKSSNILLDSSFEARVADFGL-AKIALELDSNTHVSTRVMGTFGYMA 553
P I HRD+KS NIL+ + +AD GL + D+ +GT YMA
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180
Query: 554 PEYATS------GKLTEKSDVYSFGVVLLELITGRKP----VDASQPLGDESLVEWARPL 603
PE + +++D+Y+ G+V E+ D P D + +
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240
Query: 604 LAEALEHEDFEALVDSRLEKNYVDSEMFW-MIEAAAACVRHSATKRPRMSQVVRALDTL 661
+ + + + + + E M + C + R ++ + L L
Sbjct: 241 MRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 237 bits (605), Expect = 2e-73
Identities = 71/286 (24%), Positives = 118/286 (41%), Gaps = 30/286 (10%)
Query: 383 FSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSL 442
LG G FG V+ G +VAVK LK G S F AE ++ ++ H+ LV L
Sbjct: 15 LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRL 73
Query: 443 VGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPR 502
E ++ EY+ N +L L + + +AA A G+A++ E
Sbjct: 74 YAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--- 129
Query: 503 IIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKL 562
IHRD++++NIL+ + ++ADFGLA++ D+ + APE G
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIE--DNEYTAREGAKFPIKWTAPEAINYGTF 187
Query: 563 TEKSDVYSFGVVLLELITGRKPVDASQPLGD--ESLVEWARPLLAEALEHEDFEALVDSR 620
T KSDV+SFG++L E++T + + ++L R + + E
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEE--------- 238
Query: 621 LEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDGASD 666
+ + C + RP + L+ A++
Sbjct: 239 ------------LYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 238 bits (608), Expect = 3e-73
Identities = 58/212 (27%), Positives = 102/212 (48%), Gaps = 11/212 (5%)
Query: 379 ATNGFSAHNVLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGERE-FRAEVEIISRVHH 436
+ F + LG G G V+K G +A K + + R E++++ +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 437 RHLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLH 496
++V G S+ E + E++ +L L GR + KV+ +G+ YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLR 121
Query: 497 EDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEY 556
E +I+HRD+K SNIL++S E ++ DFG++ ++ +N+ V GT YM+PE
Sbjct: 122 EKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTRSYMSPER 174
Query: 557 ATSGKLTEKSDVYSFGVVLLELITGRKPVDAS 588
+ +SD++S G+ L+E+ GR P+
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 206
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (594), Expect = 6e-72
Identities = 68/276 (24%), Positives = 121/276 (43%), Gaps = 32/276 (11%)
Query: 387 NVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYC 446
+G+G FG V G G +VAVK +K + F AE +++++ H +LV L+G
Sbjct: 13 QTIGKGEFGDVMLGDY-RGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVI 69
Query: 447 ISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIH 505
+ E+ L +V EY+ +L +L + GR V+ +K + + YL +H
Sbjct: 70 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 126
Query: 506 RDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEK 565
RD+ + N+L+ A+V+DFGL K A + + APE K + K
Sbjct: 127 RDLAARNVLVSEDNVAKVSDFGLTKEA------SSTQDTGKLPVKWTAPEALREKKFSTK 180
Query: 566 SDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRLEKNY 625
SDV+SFG++L E+ + + P L + ++ + +A +
Sbjct: 181 SDVWSFGILLWEIYSFGRV-----PYPRIPLKD----VVPRVEKGYKMDAP-------DG 224
Query: 626 VDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661
++ +++ C A RP Q+ L+ +
Sbjct: 225 CPPAVYEVMK---NCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 233 bits (595), Expect = 1e-71
Identities = 72/307 (23%), Positives = 128/307 (41%), Gaps = 39/307 (12%)
Query: 371 FTYDELIQATNGFSA---------HNVLGEGGFGCVYKGVLA----DGREVAVKQLKIGG 417
FT+++ +A F+ V+G G FG V G L VA+K LK G
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 418 S-QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVM 476
+ + R+F +E I+ + H +++ L G +++ E++ N +L L
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQ-F 125
Query: 477 DWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536
V + G A G+ YL +HRD+ + NIL++S+ +V+DFGL++ +
Sbjct: 126 TVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182
Query: 537 SNTHVSTRV--MGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDE 594
S+ ++ + + APE K T SDV+S+G+V+ E+++ + P D
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER-----PYWDM 237
Query: 595 SLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQV 654
+ + + D RL + C + RP+ Q+
Sbjct: 238 TNQDVINAIEQ------------DYRLPPPMDCPSALHQL--MLDCWQKDRNHRPKFGQI 283
Query: 655 VRALDTL 661
V LD +
Sbjct: 284 VNTLDKM 290
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (590), Expect = 2e-71
Identities = 68/275 (24%), Positives = 121/275 (44%), Gaps = 26/275 (9%)
Query: 387 NVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYC 446
+G G FG V+ G + +VA+K ++ G + E +F E E++ ++ H LV L G C
Sbjct: 11 QEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 447 ISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHR 506
+ + LV+E++ + L +L + R + T + + G + +IHR
Sbjct: 70 LEQAPICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEG---MAYLEEACVIHR 125
Query: 507 DIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKS 566
D+ + N L+ + +V+DFG+ + L D ST + +PE + + + KS
Sbjct: 126 DLAARNCLVGENQVIKVSDFGMTRFVL--DDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 183
Query: 567 DVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRLEKNYV 626
DV+SFGV++ E+ + K P + S E + RL K +
Sbjct: 184 DVWSFGVLMWEVFSEGKI-----PYENRSNSEVVEDIST------------GFRLYKPRL 226
Query: 627 DSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661
S + I C + RP S+++R L +
Sbjct: 227 ASTHVYQI--MNHCWKERPEDRPAFSRLLRQLAEI 259
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (579), Expect = 7e-70
Identities = 67/276 (24%), Positives = 114/276 (41%), Gaps = 26/276 (9%)
Query: 383 FSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSL 442
+ LG G FG V G +VA+K +K G S E EF E +++ + H LV L
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQL 64
Query: 443 VGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPR 502
G C +R ++ EY+ N L +L +++ + YL +
Sbjct: 65 YGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLE---SKQ 120
Query: 503 IIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKL 562
+HRD+ + N L++ +V+DFGL++ LD S + PE K
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYV--LDDEYTSSVGSKFPVRWSPPEVLMYSKF 178
Query: 563 TEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRLE 622
+ KSD+++FGV++ E+ + K P + E A + RL
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKM-----PYERFTNSETAEHIAQ------------GLRLY 221
Query: 623 KNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRAL 658
+ ++ SE + I +C A +RP ++ +
Sbjct: 222 RPHLASEKVYTI--MYSCWHEKADERPTFKILLSNI 255
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (581), Expect = 2e-69
Identities = 81/283 (28%), Positives = 122/283 (43%), Gaps = 30/283 (10%)
Query: 386 HNVLGEGGFGCVYKGVLAD----GREVAVKQLKIGGSQGE-REFRAEVEIISRVHHRHLV 440
+ V+G G FGCVY G L D AVK L GE +F E I+ H +++
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 441 SLVGYCI-SERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDC 499
SL+G C+ SE L+V Y+ + L + E + A+G +
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQVAKG---MKFLA 147
Query: 500 HPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNT-HVSTRVMGTFGYMAPEYAT 558
+ +HRD+ + N +LD F +VADFGLA+ + + ++ H T +MA E
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207
Query: 559 SGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVD 618
+ K T KSDV+SFGV+L EL+T P P D + + LL
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQ------------G 250
Query: 619 SRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661
RL + + + E C A RP S++V + +
Sbjct: 251 RRLLQPEYCPD--PLYEVMLKCWHPKAEMRPSFSELVSRISAI 291
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (569), Expect = 4e-68
Identities = 68/285 (23%), Positives = 123/285 (43%), Gaps = 29/285 (10%)
Query: 383 FSAHNVLGEGGFGCVYKGVLADG-----REVAVKQLKIGGSQGER-EFRAEVEIISRVHH 436
+ V+G G FG VYKG+L VA+K LK G ++ +R +F E I+ + H
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 437 RHLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLH 496
+++ L G + +++ EY+ N E V + G A G+ YL
Sbjct: 69 HNIIRLEGVISKYKPMMIITEYMENGA-LDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA 127
Query: 497 EDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEY 556
+ +HRD+ + NIL++S+ +V+DFGL+++ + T+ ++ + APE
Sbjct: 128 ---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184
Query: 557 ATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEAL 616
+ K T SDV+SFG+V+ E++T + L + +
Sbjct: 185 ISYRKFTSASDVWSFGIVMWEVMTYGERPY-------------------WELSNHEVMKA 225
Query: 617 VDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661
++ + + C + +RP+ + +V LD L
Sbjct: 226 INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (568), Expect = 5e-68
Identities = 66/278 (23%), Positives = 115/278 (41%), Gaps = 32/278 (11%)
Query: 387 NVLGEGGFGCVYKGVLAD---GREVAVKQLKIGGSQGE--REFRAEVEIISRVHHRHLVS 441
LG G FG V KG + VAVK LK + E AE ++ ++ + ++V
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 442 LVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHP 501
++G C +E +LV E L+ +L + +++ + G+ YL
Sbjct: 73 MIGICEAE-SWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLE---ES 126
Query: 502 RIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGK 561
+HRD+ + N+LL + A+++DFGL+K ++ T + APE K
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186
Query: 562 LTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSR 620
+ KSDV+SFGV++ E + G+KP + +++E + A + L++
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNL- 245
Query: 621 LEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRAL 658
C + RP + V L
Sbjct: 246 -------------------CWTYDVENRPGFAAVELRL 264
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (565), Expect = 1e-67
Identities = 64/289 (22%), Positives = 117/289 (40%), Gaps = 29/289 (10%)
Query: 375 ELIQATNGFSAHNV-LGEGGFGCVYKGVLA---DGREVAVKQLKIGGSQGERE-FRAEVE 429
+L + ++ LG G FG V +GV +VA+K LK G + + E E +
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61
Query: 430 IISRVHHRHLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAA 489
I+ ++ + ++V L+G C +LV E LH L + + + ++ +
Sbjct: 62 IMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVS 119
Query: 490 RGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTF 549
G+ YL +HRD+ + N+LL + A+++DFGL+K DS +
Sbjct: 120 MGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176
Query: 550 GYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALE 609
+ APE K + +SDV+S+GV + E ++ + P E + +E
Sbjct: 177 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK-----PYKKMKGPE-----VMAFIE 226
Query: 610 HEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRAL 658
E++ ++ C + RP V + +
Sbjct: 227 QGKRMECPPE------CPPELYALMS---DCWIYKWEDRPDFLTVEQRM 266
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 219 bits (559), Expect = 1e-66
Identities = 69/298 (23%), Positives = 123/298 (41%), Gaps = 26/298 (8%)
Query: 373 YDELIQATNGFSAHNVLGEGGFGCVYKGVLAD-GREVAVKQLKIGGSQGEREFRAEVEII 431
YD+ + + LG G +G VY+GV VAVK LK + E EF E ++
Sbjct: 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVM 67
Query: 432 SRVHHRHLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARG 491
+ H +LV L+G C E ++ E++ L +L R + + +A +
Sbjct: 68 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 127
Query: 492 IAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGY 551
+ YL + IHRD+ + N L+ + +VADFGL+++ +
Sbjct: 128 MEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAGAKFPIKW 182
Query: 552 MAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHE 611
APE K + KSDV++FGV+L E+ T ++
Sbjct: 183 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY-------------------PGIDLS 223
Query: 612 DFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDGASDLTN 669
L++ + + E AC + + + RP +++ +A +T+ S +++
Sbjct: 224 QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 281
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (556), Expect = 6e-66
Identities = 72/301 (23%), Positives = 115/301 (38%), Gaps = 46/301 (15%)
Query: 383 FSAHNVLGEGGFGCVYKGVLA------DGREVAVKQLKIGGSQGERE-FRAEVEIISRV- 434
S LG G FG V + VAVK LK ERE +E++++S +
Sbjct: 25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG 84
Query: 435 HHRHLVSLVGYCISERERLLVYEYVPNDTLHYHLH----------------AEGRPVMDW 478
+H ++V+L+G C L++ EY L L + +D
Sbjct: 85 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 479 ATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSN 538
+ + A+G+A+L IHRD+ + NILL ++ DFGLA+ ++ DSN
Sbjct: 145 EDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARD-IKNDSN 200
Query: 539 THVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVE 598
V +MAPE + T +SDV+S+G+ L EL + P
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP-------- 252
Query: 599 WARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRAL 658
F ++ + M + C KRP Q+V+ +
Sbjct: 253 ----------VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302
Query: 659 D 659
+
Sbjct: 303 E 303
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (552), Expect = 8e-66
Identities = 63/279 (22%), Positives = 107/279 (38%), Gaps = 32/279 (11%)
Query: 387 NVLGEGGFGCVYKGV-LADGREVAVKQLKIG--GSQGEREFRAEVEIISRVHHRHLVSLV 443
+G G +G K +DG+ + K+L G ++ +EV ++ + H ++V
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69
Query: 444 GYCISERERLL--VYEYVPNDTLHYHLHAEG--RPVMDWATRVKVAAGAARGIAYLHE-- 497
I L V EY L + R +D ++V + H
Sbjct: 70 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129
Query: 498 DCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYA 557
D ++HRD+K +N+ LD ++ DFGLA+I L+ +T + +GT YM+PE
Sbjct: 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI---LNHDTSFAKAFVGTPYYMSPEQM 186
Query: 558 TSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALV 617
EKSD++S G +L EL P A LA + F +
Sbjct: 187 NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-----------LAGKIREGKFRRIP 235
Query: 618 DSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVR 656
E+ +I + RP + +++
Sbjct: 236 YR------YSDELNEIIT---RMLNLKDYHRPSVEEILE 265
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 2e-65
Identities = 63/280 (22%), Positives = 111/280 (39%), Gaps = 39/280 (13%)
Query: 387 NVLGEGGFGCVYKGVLAD-GREVAVKQLKIGG--SQGEREFRAEVEIISRVHHRHLVSLV 443
+G G F VYKG+ + EVA +L+ + F+ E E++ + H ++V
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 444 GYCISERER----LLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDC 499
S + +LV E + + TL +L M +G+ +LH
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHT-R 131
Query: 500 HPRIIHRDIKSSNILLDS-SFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYAT 558
P IIHRD+K NI + + ++ D GLA + + V+GT +MAPE
Sbjct: 132 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL-----KRASFAKAVIGTPEFMAPEMY- 185
Query: 559 SGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGD--ESLVEWARPLLAEALEHEDFEAL 616
K E DVY+FG+ +LE+ T P Q + +P + + + + +
Sbjct: 186 EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEI 245
Query: 617 VDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVR 656
++ C+R + +R + ++
Sbjct: 246 IEG--------------------CIRQNKDERYSIKDLLN 265
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (546), Expect = 9e-65
Identities = 71/277 (25%), Positives = 113/277 (40%), Gaps = 26/277 (9%)
Query: 383 FSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSL 442
LG+G FG V+ G VA+K LK G + F E +++ ++ H LV L
Sbjct: 19 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQL 77
Query: 443 VGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPR 502
SE +V EY+ +L L E + V +AA A G+AY+
Sbjct: 78 YAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMN 133
Query: 503 IIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKL 562
+HRD++++NIL+ + +VADFGLA++ D+ + APE A G+
Sbjct: 134 YVHRDLRAANILVGENLVCKVADFGLARLIE--DNEYTARQGAKFPIKWTAPEAALYGRF 191
Query: 563 TEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRLE 622
T KSDV+SFG++L EL T + + + + V+
Sbjct: 192 TIKSDVWSFGILLTELTTKGRVPY-------------------PGMVNREVLDQVERGYR 232
Query: 623 KNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659
+ + C R +RP + L+
Sbjct: 233 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (544), Expect = 1e-64
Identities = 71/278 (25%), Positives = 114/278 (41%), Gaps = 35/278 (12%)
Query: 383 FSAHNVLGEGGFGCVYKGVL-ADGREVAVKQLK---IGGSQGEREFRAEVEIISRVHHRH 438
F LG+G FG VY +A+K L + + E + R EVEI S + H +
Sbjct: 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67
Query: 439 LVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHED 498
++ L GY L+ EY P T++ L + D A ++Y H
Sbjct: 68 ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCHS- 124
Query: 499 CHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYAT 558
R+IHRDIK N+LL S+ E ++ADFG + + + T + GT Y+ PE
Sbjct: 125 --KRVIHRDIKPENLLLGSAGELKIADFGWSV-----HAPSSRRTTLCGTLDYLPPEMIE 177
Query: 559 SGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVD 618
EK D++S GV+ E + G+ P +A+ + + + E L+
Sbjct: 178 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT-EGARDLIS 236
Query: 619 SRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVR 656
L+ N ++RP + +V+
Sbjct: 237 RLLKHN--------------------PSQRPMLREVLE 254
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 214 bits (546), Expect = 1e-64
Identities = 63/310 (20%), Positives = 114/310 (36%), Gaps = 52/310 (16%)
Query: 381 NGFSAHNVLGEGGFGCVYKGVL------ADGREVAVKQLKIGGSQGER-EFRAEVEIISR 433
N +GEG FG V++ VAVK LK S + +F+ E +++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 434 VHHRHLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGR-------------------- 473
+ ++V L+G C + L++EY+ L+ L +
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 474 --PVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKI 531
P + A ++ +A A G+AYL + +HRD+ + N L+ + ++ADFGL++
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 532 ALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPL 591
+ +M PE + T +SDV+++GVVL E+ + P
Sbjct: 190 -IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ-----PY 243
Query: 592 GDESLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRM 651
+ E + D + ++ + C RP
Sbjct: 244 YGMAHEEV-------------IYYVRDGNILA-CPENCPLELYNLMRLCWSKLPADRPSF 289
Query: 652 SQVVRALDTL 661
+ R L +
Sbjct: 290 CSIHRILQRM 299
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 4e-64
Identities = 73/335 (21%), Positives = 125/335 (37%), Gaps = 60/335 (17%)
Query: 363 VLGNSRSWFTYDELIQAT---------NGFSAHNVLGEGGFGCVYKGVL------ADGRE 407
V G+S + + Y + + VLG G FG V +
Sbjct: 10 VTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQ 69
Query: 408 VAVKQLKIGGSQGERE-FRAEVEIISRV-HHRHLVSLVGYCISERERLLVYEYVPNDTLH 465
VAVK LK ERE +E+++++++ H ++V+L+G C L++EY L
Sbjct: 70 VAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLL 129
Query: 466 YHLH---------------------AEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRII 504
+L E V+ + + A A+G+ +L +
Sbjct: 130 NYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCV 186
Query: 505 HRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTE 564
HRD+ + N+L+ ++ DFGLA+ + DSN V +MAPE G T
Sbjct: 187 HRDLAARNVLVTHGKVVKICDFGLARDIMS-DSNYVVRGNARLPVKWMAPESLFEGIYTI 245
Query: 565 KSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRLEKN 624
KSDV+S+G++L E+ + P +F L+ + + +
Sbjct: 246 KSDVWSYGILLWEIFSLGVN-----PYPGIP-------------VDANFYKLIQNGFKMD 287
Query: 625 YVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659
+ +C + KRP + L
Sbjct: 288 QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 4e-63
Identities = 65/279 (23%), Positives = 119/279 (42%), Gaps = 31/279 (11%)
Query: 388 VLGEGGFGCVYKGVLAD----GREVAVKQLKIGGSQGERE-FRAEVEIISRVHHRHLVSL 442
+GEG FG V++G+ VA+K K S RE F E + + H H+V L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 443 VGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPR 502
+G +E ++ E L L +D A+ + A + +AYL R
Sbjct: 74 IGVI-TENPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYLES---KR 128
Query: 503 IIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKL 562
+HRDI + N+L+ S+ ++ DFGL++ DS + +++ +MAPE +
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMAPESINFRRF 186
Query: 563 TEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRLE 622
T SDV+ FGV + E++ P + + +E+ + + +
Sbjct: 187 TSASDVWMFGVCMWEILMHGVK-----PFQGVKNND-----VIGRIENGERLPMPPN--- 233
Query: 623 KNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661
++ ++ C + ++RPR +++ L T+
Sbjct: 234 ---CPPTLYSLMT---KCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 5e-63
Identities = 63/279 (22%), Positives = 104/279 (37%), Gaps = 31/279 (11%)
Query: 383 FSAHNVLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGERE-FRAEVEIISRVHHRHLV 440
+ LGEG +G V V VAVK + + + E + E+ I ++H ++V
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66
Query: 441 SLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCH 500
G+ + L EY L + + M + G+ YLH
Sbjct: 67 KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLH---G 121
Query: 501 PRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSG 560
I HRDIK N+LLD +++DFGLA + ++ + ++ GT Y+APE
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATV-FRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 561 KL-TEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEH--EDFEALV 617
+ E DV+S G+VL ++ G P D E + + AL+
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 240
Query: 618 DSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVR 656
L +N + R + + +
Sbjct: 241 HKILVEN--------------------PSARITIPDIKK 259
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 210 bits (536), Expect = 5e-63
Identities = 70/282 (24%), Positives = 110/282 (39%), Gaps = 40/282 (14%)
Query: 383 FSAHNVLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGE---REFRAEVEIISRVHHRH 438
FS +G G FG VY + + VA+K++ G Q ++ EV + ++ H +
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 439 LVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHED 498
+ G + E LV EY + + V GA +G+AYLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP--LQEVEIAAVTHGALQGLAYLHS- 133
Query: 499 CHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYAT 558
+IHRD+K+ NILL ++ DFG A I + +GT +MAPE
Sbjct: 134 --HNMIHRDVKAGNILLSEPGLVKLGDFGSASI-------MAPANSFVGTPYWMAPEVIL 184
Query: 559 S---GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGD-ESLVEWARPLLAEALEHEDFE 614
+ G+ K DV+S G+ +EL + P+ + + + P L E F
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFR 244
Query: 615 ALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVR 656
VDS L+K RP +++
Sbjct: 245 NFVDSCLQKI--------------------PQDRPTSEVLLK 266
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 8e-63
Identities = 65/279 (23%), Positives = 102/279 (36%), Gaps = 30/279 (10%)
Query: 387 NVLGEGGFGCVYKGVL----ADGREVAVKQLK---IGGSQGEREFRAEVEIISRVHHRHL 439
LG+G FG V +G VAVK LK + + +F EV + + HR+L
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 440 VSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDC 499
+ L G ++ ++ V E P +L L T + A A G+ YL
Sbjct: 74 IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVAEGMGYLES-- 129
Query: 500 HPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATS 559
R IHRD+ + N+LL + ++ DFGL + + D + + F + APE +
Sbjct: 130 -KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 560 GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDS 619
+ SD + FGV L E+ T + P + + + E E
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQE-----PWIGLNGSQILHKIDKEGERLPRPEDCPQD 243
Query: 620 RLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRAL 658
+ C H RP + L
Sbjct: 244 -------------IYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 5e-62
Identities = 57/246 (23%), Positives = 99/246 (40%), Gaps = 15/246 (6%)
Query: 387 NVLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGY 445
LG+G FG VYK A K + + ++ E++I++ H ++V L+
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 446 CISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIH 505
E ++ E+ + + RP + + V + YLH+ +IIH
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLELERP-LTESQIQVVCKQTLDALNYLHD---NKIIH 133
Query: 506 RDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYA-----TSG 560
RD+K+ NIL + ++ADFG++ +GT +MAPE
Sbjct: 134 RDLKAGNILFTLDGDIKLADFGVSAK---NTRTIQRRDSFIGTPYWMAPEVVMCETSKDR 190
Query: 561 KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEH--EDFEALVD 618
K+DV+S G+ L+E+ P P+ + + P +F+ +
Sbjct: 191 PYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLK 250
Query: 619 SRLEKN 624
LEKN
Sbjct: 251 KCLEKN 256
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 1e-61
Identities = 74/300 (24%), Positives = 125/300 (41%), Gaps = 45/300 (15%)
Query: 381 NGFSAHNVLGEGGFGCVYKGVLADG---REVAVKQLKIGGS-QGEREFRAEVEIISRV-H 435
N +V+GEG FG V K + + A+K++K S R+F E+E++ ++ H
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 436 HRHLVSLVGYCISERERLLVYEYVPNDTLHYHLH--------------AEGRPVMDWATR 481
H ++++L+G C L EY P+ L L +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 482 VKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHV 541
+ AA ARG+ YL + + IHRD+ + NIL+ ++ A++ADFGL++
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK 182
Query: 542 STRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWAR 601
T +MA E T SDV+S+GV+L E+++ P + E
Sbjct: 183 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-----PYCGMTCAELYE 237
Query: 602 PLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661
L RLEK + + + C R +RP +Q++ +L+ +
Sbjct: 238 KLPQ------------GYRLEKPLNCDDE--VYDLMRQCWREKPYERPSFAQILVSLNRM 283
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 2e-60
Identities = 70/285 (24%), Positives = 124/285 (43%), Gaps = 31/285 (10%)
Query: 383 FSAHNVLGEGGFGCVYKGV-LADGRE----VAVKQLKIGGS-QGEREFRAEVEIISRVHH 436
F VLG G FG VYKG+ + +G + VA+K+L+ S + +E E +++ V +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 437 RHLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLH 496
H+ L+G C++ +L+ L Y E + + + A+G+ YL
Sbjct: 71 PHVCRLLGICLTSTVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYL- 127
Query: 497 EDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEY 556
R++HRD+ + N+L+ + ++ DFGLAK+ L + + + +MA E
Sbjct: 128 --EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL-LGAEEKEYHAEGGKVPIKWMALES 184
Query: 557 ATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEAL 616
T +SDV+S+GV + EL+T P E ++ LE
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGSK-----PYDGIPASE-----ISSILEK------ 228
Query: 617 VDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661
RL + + + +MI C A RP+ +++ +
Sbjct: 229 -GERLPQPPICTIDVYMI--MVKCWMIDADSRPKFRELIIEFSKM 270
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 2e-58
Identities = 72/298 (24%), Positives = 116/298 (38%), Gaps = 45/298 (15%)
Query: 387 NVLGEGGFGCVYKGV------LADGREVAVKQLKIGGSQGE-REFRAEVEIISR-VHHRH 438
LG G FG V + A R VAVK LK G + E R +E++I+ HH +
Sbjct: 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78
Query: 439 LVSLVGYCISERERL-LVYEYVPNDTLHYHLHAEG--------------RPVMDWATRVK 483
+V+L+G C L ++ E+ L +L ++ + + +
Sbjct: 79 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138
Query: 484 VAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVST 543
+ A+G+ +L + IHRD+ + NILL ++ DFGLA+ + D +
Sbjct: 139 YSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK-DPDYVRKG 194
Query: 544 RVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPL 603
+MAPE T +SDV+SFGV+L E+ + P + E
Sbjct: 195 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDEEFCRR 249
Query: 604 LAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661
L E + M + C ++RP S++V L L
Sbjct: 250 LKEGTRMRAPDYTTPE-------------MYQTMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 5e-58
Identities = 58/241 (24%), Positives = 107/241 (44%), Gaps = 12/241 (4%)
Query: 387 NVLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGY 445
+G+G G VY + +A G+EVA++Q+ + + E+ ++ + ++V+ +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 446 CISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIH 505
+ E +V EY+ +L + MD V + + +LH + ++IH
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFLHSN---QVIH 139
Query: 506 RDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEK 565
RDIKS NILL ++ DFG ++ + ++GT +MAPE T K
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCA---QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 196
Query: 566 SDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEH--EDFEALVDSRLEK 623
D++S G++ +E+I G P PL L+ + E F ++ L+
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDM 256
Query: 624 N 624
+
Sbjct: 257 D 257
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 190 bits (484), Expect = 6e-55
Identities = 69/254 (27%), Positives = 110/254 (43%), Gaps = 20/254 (7%)
Query: 381 NGFSAHNVLGEGGFGCVYKGVLAD-GREVAVKQLK---IGGSQGEREFRAEVEIISRVH- 435
N FS H ++G GGFG VY AD G+ A+K L I QGE E ++S V
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 436 --HRHLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIA 493
+V + + + + + + LHYHL G A AA G+
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLE 121
Query: 494 YLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMA 553
++H +++RD+K +NILLD R++D GLA D + +GT GYMA
Sbjct: 122 HMHN---RFVVYRDLKPANILLDEHGHVRISDLGLAC-----DFSKKKPHASVGTHGYMA 173
Query: 554 PEYATSGK-LTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEH-- 610
PE G +D +S G +L +L+ G P + + + E +
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFS 233
Query: 611 EDFEALVDSRLEKN 624
+ +L++ L+++
Sbjct: 234 PELRSLLEGLLQRD 247
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 1e-54
Identities = 70/299 (23%), Positives = 117/299 (39%), Gaps = 47/299 (15%)
Query: 387 NVLGEGGFGCVYKGVL--------ADGREVAVKQLKIGGSQGE-REFRAEVEIISRV-HH 436
LGEG FG V +VAVK LK ++ + + +E+E++ + H
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 437 RHLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRP--------------VMDWATRV 482
+++++L+G C + ++ EY L +L A P + V
Sbjct: 79 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138
Query: 483 KVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVS 542
A ARG+ YL + IHRD+ + N+L+ ++ADFGLA+ + +
Sbjct: 139 SCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARD-IHHIDYYKKT 194
Query: 543 TRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARP 602
T +MAPE T +SDV+SFGV+L E+ T P + E +
Sbjct: 195 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS-----PYPGVPVEELFK- 248
Query: 603 LLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661
L+ + + + C ++RP Q+V LD +
Sbjct: 249 -------------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 186 bits (473), Expect = 2e-54
Identities = 73/256 (28%), Positives = 122/256 (47%), Gaps = 16/256 (6%)
Query: 380 TNGFSAHNVLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGE---REFRAEVEIISRVH 435
++ + +LG GG V+ L R+VAVK L+ ++ FR E + + ++
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 436 HRHLVSLVGYCISERERL----LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARG 491
H +V++ +E +V EYV TL +H EG M ++V A A +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQA 123
Query: 492 IAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGY 551
+ + H+ IIHRD+K +NI++ ++ +V DFG+A+ + ++ + V+GT Y
Sbjct: 124 LNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 180
Query: 552 MAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEH- 610
++PE A + +SDVYS G VL E++TG P P+ P+ A
Sbjct: 181 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG 240
Query: 611 --EDFEALVDSRLEKN 624
D +A+V L KN
Sbjct: 241 LSADLDAVVLKALAKN 256
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 3e-53
Identities = 65/291 (22%), Positives = 117/291 (40%), Gaps = 38/291 (13%)
Query: 383 FSAHNVLGEGGFGCVYKGVL------ADGREVAVKQLKIGGSQGER-EFRAEVEIISRVH 435
+ LG+G FG VY+GV VA+K + S ER EF E ++ +
Sbjct: 22 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 81
Query: 436 HRHLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGR--------PVMDWATRVKVAAG 487
H+V L+G + L++ E + L +L + + +++A
Sbjct: 82 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 141
Query: 488 AARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMG 547
A G+AYL + +HRD+ + N ++ F ++ DFG+ + E + +
Sbjct: 142 IADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE-TDYYRKGGKGLL 197
Query: 548 TFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEA 607
+M+PE G T SDV+SFGVVL E+ T + P S
Sbjct: 198 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ-----PYQGLS------------ 240
Query: 608 LEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRAL 658
+ +++ L D+ + E C +++ RP +++ ++
Sbjct: 241 -NEQVLRFVMEGGLLD-KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 289
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 4e-53
Identities = 63/246 (25%), Positives = 96/246 (39%), Gaps = 11/246 (4%)
Query: 383 FSAHNVLGEGGFGCVYKGV-LADGREVAVKQLK---IGGSQGEREFRAEVEIISRVHHRH 438
F +LGEG F V LA RE A+K L+ I E +++SR+ H
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 439 LVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHED 498
V L + + Y N L ++ G D A + YLH
Sbjct: 70 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHG- 126
Query: 499 CHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYAT 558
IIHRD+K NILL+ ++ DFG AK+ +S + +GT Y++PE T
Sbjct: 127 --KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANSFVGTAQYVSPELLT 183
Query: 559 SGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVD 618
+ SD+++ G ++ +L+ G P A + E LV+
Sbjct: 184 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKF-FPKARDLVE 242
Query: 619 SRLEKN 624
L +
Sbjct: 243 KLLVLD 248
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 183 bits (465), Expect = 4e-53
Identities = 49/284 (17%), Positives = 93/284 (32%), Gaps = 29/284 (10%)
Query: 388 VLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYC 446
+GEG FG +++G L + ++VA+K + R E + + V Y
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 447 ISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHR 506
E ++ + +L L GR T A + +HE +++R
Sbjct: 70 GQEGLHNVLVIDLLGPSLEDLLDLCGRK-FSVKTVAMAAKQMLARVQSIHE---KSLVYR 125
Query: 507 DIKSSNILLDSSFE-----ARVADFGLAKIALELDSNTHV----STRVMGTFGYMAPEYA 557
DIK N L+ V DFG+ K + + H+ + GT YM+
Sbjct: 126 DIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTH 185
Query: 558 TSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALV 617
+ + + D+ + G V + + G P + ++ E + E + L
Sbjct: 186 LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER----IGEKKQSTPLRELC 241
Query: 618 DSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661
E + + + P + +
Sbjct: 242 AG------FPEEFYKYMH---YARNLAFDATPDYDYLQGLFSKV 276
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 185 bits (470), Expect = 5e-53
Identities = 57/243 (23%), Positives = 101/243 (41%), Gaps = 14/243 (5%)
Query: 388 VLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYC 446
LG G FG V++ V A GR K + + + E+ I++++HH L++L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 447 ISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHR 506
+ E +L+ E++ L + AE M A + A G+ ++HE I+H
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHMHE---HSIVHL 151
Query: 507 DIKSSNILLDSSFEARV--ADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTE 564
DIK NI+ ++ + V DFGLA + + T + APE +
Sbjct: 152 DIKPENIMCETKKASSVKIIDFGLATKL----NPDEIVKVTTATAEFAAPEIVDREPVGF 207
Query: 565 KSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEH---EDFEALVDSRL 621
+D+++ GV+ L++G P L V+ E + + + + L
Sbjct: 208 YTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLL 267
Query: 622 EKN 624
+K
Sbjct: 268 QKE 270
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 183 bits (464), Expect = 6e-53
Identities = 58/283 (20%), Positives = 97/283 (34%), Gaps = 29/283 (10%)
Query: 388 VLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYC 446
+G G FG +Y G +A G EVA+K + + E +I + + + +C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 447 ISERERL-LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIH 505
+E + +V E + + T + +A I Y+H IH
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIHS---KNFIH 126
Query: 506 RDIKSSNIL---LDSSFEARVADFGLAKIALELDSNTHV----STRVMGTFGYMAPEYAT 558
RD+K N L + DFGLAK + ++ H+ + + GT Y +
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186
Query: 559 SGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVD 618
+ + + D+ S G VL+ G P + E E +
Sbjct: 187 GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER---------ISEKKMSTPI 237
Query: 619 SRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661
L K Y SE + C +P S + + L
Sbjct: 238 EVLCKGY-PSEFATYLN---FCRSLRFDDKPDYSYLRQLFRNL 276
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 179 bits (455), Expect = 6e-52
Identities = 53/262 (20%), Positives = 97/262 (37%), Gaps = 29/262 (11%)
Query: 383 FSAHNVLGEGGFGCVYKGV-LADGREVAVKQLKIGGS---------QGEREFRAEVEIIS 432
+ +LG G V + + +E AVK + + G + EV+I+
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 433 RVH-HRHLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARG 491
+V H +++ L + LV++ + L +L + + K+
Sbjct: 65 KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALLEV 122
Query: 492 IAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGY 551
I LH+ I+HRD+K NILLD ++ DFG + V GT Y
Sbjct: 123 ICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQL----DPGEKLREVCGTPSY 175
Query: 552 MAPEYATSG------KLTEKSDVYSFGVVLLELITGRKPVDASQPLGD-ESLVEWARPLL 604
+APE ++ D++S GV++ L+ G P + + ++
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG 235
Query: 605 AEALEH--EDFEALVDSRLEKN 624
+ + + + LV L
Sbjct: 236 SPEWDDYSDTVKDLVSRFLVVQ 257
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 2e-51
Identities = 62/285 (21%), Positives = 104/285 (36%), Gaps = 24/285 (8%)
Query: 387 NVLGEGGFGCVYKG--VLADGREVAVKQLKIGGSQGEREFRAEVEI-----ISRVHHRHL 439
+GEG +G V+K + GR VA+K++++ + E+ + H ++
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 440 VSLVGYCISERERLLVYEYVPNDTLH----YHLHAEGRPVMDWATRVKVAAGAARGIAYL 495
V L C R + + + +L P + T + RG+ +L
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 496 HEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPE 555
H ++HRD+K NIL+ SS + ++ADFGLA+I S T V+ T Y APE
Sbjct: 133 HSHR---VVHRDLKPQNILVTSSGQIKLADFGLARI----YSFQMALTSVVVTLWYRAPE 185
Query: 556 YATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEA 615
D++S G + E+ + S + + L E D
Sbjct: 186 VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 245
Query: 616 LVDSRLEKNYVDSEMFWMIEAAAA------CVRHSATKRPRMSQV 654
+ K+ E F C+ + KR
Sbjct: 246 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 180 bits (457), Expect = 3e-51
Identities = 53/243 (21%), Positives = 95/243 (39%), Gaps = 14/243 (5%)
Query: 388 VLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYC 446
LG G FG V++ A G A K + + R E++ +S + H LV+L
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 447 ISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHR 506
+ E +++YE++ L + E M V+ +G+ ++HE+ +H
Sbjct: 93 EDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMHENN---YVHL 148
Query: 507 DIKSSNILLDSSFEARV--ADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTE 564
D+K NI+ + + DFGL GT + APE A +
Sbjct: 149 DLKPENIMFTTKRSNELKLIDFGLTAHL----DPKQSVKVTTGTAEFAAPEVAEGKPVGY 204
Query: 565 KSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEH---EDFEALVDSRL 621
+D++S GV+ L++G P V+ + ++ ED + + L
Sbjct: 205 YTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLL 264
Query: 622 EKN 624
+
Sbjct: 265 LAD 267
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 3e-51
Identities = 48/243 (19%), Positives = 98/243 (40%), Gaps = 15/243 (6%)
Query: 388 VLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYC 446
LG G FG V++ V + + K +K+ G+ + + E+ I++ HR+++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70
Query: 447 ISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHR 506
S E ++++E++ + ++ ++ V + +LH I H
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEALQFLHS---HNIGHF 126
Query: 507 DIKSSNILLDSSFEARV--ADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTE 564
DI+ NI+ + + + +FG A+ + Y APE ++
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQL----KPGDNFRLLFTAPEYYAPEVHQHDVVST 182
Query: 565 KSDVYSFGVVLLELITGRKPVDASQPLGD-ESLVEWARPLLAEALEH--EDFEALVDSRL 621
+D++S G ++ L++G P A E+++ EA + + VD L
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLL 242
Query: 622 EKN 624
K
Sbjct: 243 VKE 245
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 178 bits (453), Expect = 3e-51
Identities = 57/263 (21%), Positives = 109/263 (41%), Gaps = 20/263 (7%)
Query: 370 WFTYDELIQATNGFSAHNVLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGERE-FRAE 427
W +++ + + +VLG G F V + VA+K + +G+ E
Sbjct: 1 WKQAEDI---RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENE 57
Query: 428 VEIISRVHHRHLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAG 487
+ ++ ++ H ++V+L S L+ + V L + +G ++
Sbjct: 58 IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF--YTERDASRLIFQ 115
Query: 488 AARGIAYLHEDCHPRIIHRDIKSSNILLDSSFE---ARVADFGLAKIALELDSNTHVSTR 544
+ YLH+ I+HRD+K N+L S E ++DFGL+K+ D + +ST
Sbjct: 116 VLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTA 169
Query: 545 VMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGD-ESLVEWARPL 603
GT GY+APE ++ D +S GV+ L+ G P E +++
Sbjct: 170 C-GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEF 228
Query: 604 LAEALEH--EDFEALVDSRLEKN 624
+ + + + + +EK+
Sbjct: 229 DSPYWDDISDSAKDFIRHLMEKD 251
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 174 bits (442), Expect = 6e-50
Identities = 56/282 (19%), Positives = 114/282 (40%), Gaps = 21/282 (7%)
Query: 387 NVLGEGGFGCVYKGVLADGREVAVKQLKIGGS--QGEREFRAEVEIISRVHHRHLVSLVG 444
+GEG +G VYK G A+K++++ E+ I+ + H ++V L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 445 YCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRII 504
+++ +LV+E++ D EG ++ T GIAY H+ R++
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCEGG--LESVTAKSFLLQLLNGIAYCHD---RRVL 122
Query: 505 HRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTE 564
HRD+K N+L++ E ++ADFGLA+ + ++ + S K +
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARA--FGIPVRKYTHEIVTLWYRAPDVLMGSKKYST 180
Query: 565 KSDVYSFGVVLLELITGRKPVDASQP----------LGDESLVEWARPLLAEALEHEDFE 614
D++S G + E++ G LG + W P + E +++
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNW--PNVTELPKYDPNF 238
Query: 615 ALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVR 656
+ + ++++ I+ + ++ +R Q +
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 2e-49
Identities = 63/247 (25%), Positives = 100/247 (40%), Gaps = 14/247 (5%)
Query: 383 FSAHNVLGEGGFGCVYKGV-LADGREVAVKQLK---IGGSQGEREFRAEVEIISRV-HHR 437
F H +LG+G FG V+ + A+K LK + E ++S H
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 438 HLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHE 497
L + ++ V EY+ L YH+ + + D + AA G+ +LH
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFLHS 121
Query: 498 DCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYA 557
I++RD+K NILLD ++ADFG+ K E + GT Y+APE
Sbjct: 122 ---KGIVYRDLKLDNILLDKDGHIKIADFGMCK---ENMLGDAKTNTFCGTPDYIAPEIL 175
Query: 558 TSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALV 617
K D +SFGV+L E++ G+ P + P LE ++ + L+
Sbjct: 176 LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLE-KEAKDLL 234
Query: 618 DSRLEKN 624
+
Sbjct: 235 VKLFVRE 241
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 171 bits (435), Expect = 1e-48
Identities = 60/246 (24%), Positives = 101/246 (41%), Gaps = 16/246 (6%)
Query: 383 FSAHNVLGEGGFGCVYKGV-LADGREVAVKQLK---IGGSQGEREFRAEVEIISRVHHRH 438
F LG G FG V+ +GR A+K LK + + E ++S V H
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 439 LVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHED 498
++ + G ++ ++ +Y+ L L R A AA L
Sbjct: 66 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFY-----AAEVCLALEYL 120
Query: 499 CHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYAT 558
II+RD+K NILLD + ++ DFG AK V+ + GT Y+APE +
Sbjct: 121 HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV------PDVTYTLCGTPDYIAPEVVS 174
Query: 559 SGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVD 618
+ + D +SFG+++ E++ G P S + + A +ED + L+
Sbjct: 175 TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFF-NEDVKDLLS 233
Query: 619 SRLEKN 624
+ ++
Sbjct: 234 RLITRD 239
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 2e-47
Identities = 62/297 (20%), Positives = 120/297 (40%), Gaps = 29/297 (9%)
Query: 380 TNGFSAHNVLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGERE-FRAEVEIISRVHHR 437
++ + +GEG +G V + VA+K++ Q + E++I+ R H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 438 HLVSLVGYCISERERLLVYEYVPN---DTLHYHLHAEGRPVMDWATRVKVAAGAARGIAY 494
+++ + + + Y+ Y L + RG+ Y
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH--LSNDHICYFLYQILRGLKY 124
Query: 495 LHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAP 554
+H ++HRD+K SN+LL+++ + ++ DFGLA++A +T T + T Y AP
Sbjct: 125 IHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 181
Query: 555 EYATSGKL-TEKSDVYSFGVVLLELITGRKPVDASQP----------LGDESLVEWARPL 603
E + K T+ D++S G +L E+++ R LG S + +
Sbjct: 182 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 241
Query: 604 LAEA----LEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVR 656
+A L + +RL N DS+ +++ + + KR + Q +
Sbjct: 242 NLKARNYLLSLPHKNKVPWNRLFPN-ADSKALDLLD---KMLTFNPHKRIEVEQALA 294
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 4e-47
Identities = 60/275 (21%), Positives = 102/275 (37%), Gaps = 28/275 (10%)
Query: 388 VLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGEREFRAEVEIISRV-HHRHLVSLVGY 445
VLG G G V + + A+K L+ + R EVE+ R H+V +V
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDV 73
Query: 446 C----ISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHP 501
+ L+V E + L + G ++ I YLH
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---I 130
Query: 502 RIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGK 561
I HRD+K N+L S + A E S+ ++T T Y+APE K
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT-PCYTPYYVAPEVLGPEK 189
Query: 562 LTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRL 621
+ D++S GV++ L+ G P ++ L P + + +E
Sbjct: 190 YDKSCDMWSLGVIMYILLCGYPPFYSNHGL-------AISPGMKTRIRMGQYE---FPNP 239
Query: 622 EKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVR 656
E + V E+ +I ++ T+R +++ +
Sbjct: 240 EWSEVSEEVKMLIR---NLLKTEPTQRMTITEFMN 271
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 1e-46
Identities = 48/214 (22%), Positives = 87/214 (40%), Gaps = 20/214 (9%)
Query: 388 VLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGER------EFRAEVEIISRVHHRHLV 440
LG G F V K + G + A K +K ++ R + EV I+ + H +++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 441 SLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCH 500
+L ++ + +L+ E V L L + + AT + + ++
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF-----LKQILNGVYYLHS 131
Query: 501 PRIIHRDIKSSNILLDSSFEAR----VADFGLAKIALELDSNTHVSTRVMGTFGYMAPEY 556
+I H D+K NI+L + + DFGLA + + GT ++APE
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI----DFGNEFKNIFGTPEFVAPEI 187
Query: 557 ATSGKLTEKSDVYSFGVVLLELITGRKPVDASQP 590
L ++D++S GV+ L++G P
Sbjct: 188 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 221
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 7e-45
Identities = 53/292 (18%), Positives = 114/292 (39%), Gaps = 29/292 (9%)
Query: 387 NVLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQG--EREFRAEVEIISRVHHRHLVSLV 443
+G+G FG V+K G++VA+K++ + + E++I+ + H ++V+L+
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 444 GYCISERER--------LLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYL 495
C ++ LV+++ +D + + + RV + L
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRV-----MQMLLNGL 130
Query: 496 HEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAK-IALELDSNTHVSTRVMGTFGYMAP 554
+ +I+HRD+K++N+L+ ++ADFGLA+ +L +S + T + T Y P
Sbjct: 131 YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPP 190
Query: 555 EYATSGKL-TEKSDVYSFGVVLLELITGRKPVDASQPLG-----DESLVEWARPLLAEAL 608
E + D++ G ++ E+ T + + + +
Sbjct: 191 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD 250
Query: 609 EHEDFEALVDSRLEKNYVDSEMFWMIEAAAA------CVRHSATKRPRMSQV 654
+E +E L + +K V + + A + +R
Sbjct: 251 NYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 7e-45
Identities = 50/213 (23%), Positives = 93/213 (43%), Gaps = 11/213 (5%)
Query: 383 FSAHNVLGEGGFGCVYKGV-LADGREVAVKQLKIGGS--QGEREFRAEVEIISRVHHRHL 439
F +GEG +G VYK G VA+K++++ E+ ++ ++H ++
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 440 VSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDC 499
V L+ +E + LV+E++ D L + A + +G+A+ H
Sbjct: 64 VKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 500 HPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPE-YAT 558
++HRD+K N+L+++ ++ADFGLA+ T + T Y APE
Sbjct: 123 ---VLHRDLKPQNLLINTEGAIKLADFGLARA---FGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 559 SGKLTEKSDVYSFGVVLLELITGRKPVDASQPL 591
+ D++S G + E++T R +
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 209
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 3e-44
Identities = 59/287 (20%), Positives = 112/287 (39%), Gaps = 28/287 (9%)
Query: 387 NVLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQG-----EREFRAEVEIISRVHHRHLV 440
+ LGEG F VYK + VA+K++K+G R E++++ + H +++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 441 SLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCH 500
L+ + LV++++ D V+ + +G+ YLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW- 120
Query: 501 PRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSG 560
I+HRD+K +N+LLD + ++ADFGLAK S T + T Y APE
Sbjct: 121 --ILHRDLKPNNLLLDENGVLKLADFGLAK---SFGSPNRAYTHQVVTRWYRAPELLFGA 175
Query: 561 KL-TEKSDVYSFGVVLLELITGRKPVDASQP----------LGDESLVEWARPLLAEALE 609
++ D+++ G +L EL+ + LG + +W
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235
Query: 610 HEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVR 656
+ + ++ +I+ + R +Q ++
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQ---GLFLFNPCARITATQALK 279
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 1e-43
Identities = 62/248 (25%), Positives = 94/248 (37%), Gaps = 13/248 (5%)
Query: 381 NGFSAHNVLGEGGFGCVYKGV-LADGREVAVKQLK---IGGSQGEREFRAEVEIISRVHH 436
N F +LG+G FG V A GR A+K L+ I E ++ H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 437 RHLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLH 496
L +L + V EY L +HL E + A A ++ L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY-----GAEIVSALE 119
Query: 497 EDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEY 556
+++RDIK N++LD ++ DFGL K E S+ GT Y+APE
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPEV 176
Query: 557 ATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEAL 616
D + GVV+ E++ GR P L+ L + ++L
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTL-SPEAKSL 235
Query: 617 VDSRLEKN 624
+ L+K+
Sbjct: 236 LAGLLKKD 243
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 2e-43
Identities = 54/258 (20%), Positives = 96/258 (37%), Gaps = 40/258 (15%)
Query: 388 VLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGERE------FRAEVEIISRVHHRH-- 438
+LG GGFG VY G+ ++D VA+K ++ E EV ++ +V
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 439 LVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHED 498
++ L+ + +L+ E + E + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHN- 128
Query: 499 CHPRIIHRDIKSSNILLDSS-FEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYA 557
++HRDIK NIL+D + E ++ DFG + V T GT Y PE+
Sbjct: 129 --CGVLHRDIKDENILIDLNRGELKLIDFGSGAL-----LKDTVYTDFDGTRVYSPPEWI 181
Query: 558 TSGKL-TEKSDVYSFGVVLLELITGRKPVDASQPLGD-------------ESLVEW---- 599
+ + V+S G++L +++ G P + + + + L+ W
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLAL 241
Query: 600 ---ARPLLAEALEHEDFE 614
RP E H +
Sbjct: 242 RPSDRPTFEEIQNHPWMQ 259
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 2e-43
Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 383 FSAHNVLGEGGFGCVYKGVLAD-GREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVS 441
++ V+G G FG VY+ L D G VA+K++ Q +R E++I+ ++ H ++V
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 77
Query: 442 LVGYCISERER------LLVYEYVPNDTLHYHLH-AEGRPVMDWATRVKVAAGAARGIAY 494
L + S E+ LV +YVP H + + + R +AY
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 495 LHEDCHPRIIHRDIKSSNILLDS-SFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMA 553
+H I HRDIK N+LLD + ++ DFG AK +L + + +
Sbjct: 138 IHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK---QLVRGEPNVSYICSRYYRAP 191
Query: 554 PEYATSGKLTEKSDVYSFGVVLLELITGRKP 584
+ T DV+S G VL EL+ G+
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPI 222
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 2e-42
Identities = 47/282 (16%), Positives = 108/282 (38%), Gaps = 19/282 (6%)
Query: 387 NVLGEGGFGCVYKGV-LADGREVAVKQLKIGGS--QGEREFRAEVEIISRVHHRHLVSLV 443
+GEG +G V+K VA+K++++ E+ ++ + H+++V L
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 444 GYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRI 503
S+++ LV+E+ D Y G + + + L +
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSF-----LFQLLKGLGFCHSRNV 122
Query: 504 IHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLT 563
+HRD+K N+L++ + E ++A+FGLA+ S V+ + + +
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAF--GIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180
Query: 564 EKSDVYSFGVVLLELITGRKPVDASQPLGDE---------SLVEWARPLLAEALEHEDFE 614
D++S G + EL +P+ + D+ + E P + + +++ +
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240
Query: 615 ALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVR 656
+ N V + ++ + +R + ++
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 149 bits (377), Expect = 2e-40
Identities = 60/241 (24%), Positives = 90/241 (37%), Gaps = 16/241 (6%)
Query: 388 VLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGERE---FRAEVEIISRVHHRHLVSLV 443
LG G FG V G A+K L ++ E I+ V+ LV L
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 444 GYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRI 503
+V EYV + HL GR AA YLH +
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHS---LDL 162
Query: 504 IHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLT 563
I+RD+K N+L+D +V DFG AK + + GT +APE S
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAK------RVKGRTWTLCGTPEALAPEIILSKGYN 216
Query: 564 EKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRLEK 623
+ D ++ GV++ E+ G P A QP+ + + D + L+ + L+
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF-SSDLKDLLRNLLQV 275
Query: 624 N 624
+
Sbjct: 276 D 276
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 4e-39
Identities = 48/237 (20%), Positives = 95/237 (40%), Gaps = 25/237 (10%)
Query: 368 RSWFTYDELIQATNGFSAH----NVLGEGGFGCVYKGV-LADGREVAVKQLKIGGS--QG 420
RS F E+ + A +G G +G V V G +VA+K+L
Sbjct: 1 RSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELF 60
Query: 421 EREFRAEVEIISRVHHRHLVSLVGYCISER------ERLLVYEYVPNDTLHYHLHAEGRP 474
+ E+ ++ + H +++ L+ + + LV ++ T L +
Sbjct: 61 AKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEK- 117
Query: 475 VMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALE 534
+ + +G+ Y+H HRD+K N+ ++ E ++ DFGLA+ A
Sbjct: 118 -LGEDRIQFLVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQA-- 171
Query: 535 LDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPL 591
++ ++ V+ + + T+ D++S G ++ E+ITG+ S L
Sbjct: 172 ---DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL 225
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 4e-38
Identities = 65/254 (25%), Positives = 101/254 (39%), Gaps = 25/254 (9%)
Query: 387 NVLGEGGFGCVYKGVLA----DGREVAVKQLK----IGGSQGEREFRAEVEIISRV-HHR 437
VLG G +G V+ G+ A+K LK + ++ R E +++ +
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 438 HLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHE 497
LV+L +E + L+ +Y+ L HL R + L
Sbjct: 90 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY-----VGEIVLALEH 144
Query: 498 DCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYA 557
II+RDIK NILLDS+ + DFGL+K + T + GT YMAP+
Sbjct: 145 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF--VADETERAYDFCGTIEYMAPDIV 202
Query: 558 TSGK--LTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEH----- 610
G + D +S GV++ EL+TG P S E +R +L +
Sbjct: 203 RGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE--KNSQAEISRRILKSEPPYPQEMS 260
Query: 611 EDFEALVDSRLEKN 624
+ L+ L K+
Sbjct: 261 ALAKDLIQRLLMKD 274
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 7e-37
Identities = 47/212 (22%), Positives = 84/212 (39%), Gaps = 21/212 (9%)
Query: 388 VLGEGGFGCVYKGV-LADGREVAVKQLK--IGGSQGEREFRAEVEIISRVHHRHLVSLVG 444
+G G G V R VA+K+L + E+ ++ V+H++++SL+
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 445 YCISER------ERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHED 498
++ + LV E + + +D + GI +LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQME-----LDHERMSYLLYQMLCGIKHLHSA 138
Query: 499 CHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYAT 558
IHRD+K SNI++ S ++ DFGLA+ + + T + T Y APE
Sbjct: 139 GI---IHRDLKPSNIVVKSDCTLKILDFGLART----AGTSFMMTPYVVTRYYRAPEVIL 191
Query: 559 SGKLTEKSDVYSFGVVLLELITGRKPVDASQP 590
E D++S G ++ E++ +
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 223
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 138 bits (348), Expect = 1e-36
Identities = 53/315 (16%), Positives = 114/315 (36%), Gaps = 41/315 (13%)
Query: 366 NSRSWFTYDELIQATNG---FSAHNVLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGE 421
R ++ Y+ + + LG G + V++ + + + +V VK LK +
Sbjct: 17 RPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK---PVKK 73
Query: 422 REFRAEVEIISRV-HHRHLVSLVGYCISERERL--LVYEYVPNDTLHYHLHAEGRPVMDW 478
++ + E++I+ + ++++L R LV+E+V N +
Sbjct: 74 KKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTD 128
Query: 479 ATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSF-EARVADFGLAKIALELDS 537
+ + Y H I+HRD+K N+++D + R+ D+GLA+
Sbjct: 129 YDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 185
Query: 538 NTHVSTRVMGTFGYMAPEYATSGKL-TEKSDVYSFGVVLLELITGRKPVDAS-------- 588
+ + + PE ++ D++S G +L +I ++P
Sbjct: 186 YNVR----VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 241
Query: 589 ---QPLGDESLVEWARPL-LAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAA-----A 639
+ LG E L ++ + D + + +V SE ++ A
Sbjct: 242 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 301
Query: 640 CVRHSATKRPRMSQV 654
+R+ R +
Sbjct: 302 LLRYDHQSRLTAREA 316
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 125 bits (314), Expect = 6e-32
Identities = 45/261 (17%), Positives = 92/261 (35%), Gaps = 21/261 (8%)
Query: 388 VLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYC 446
LG G F V+ + + VA+K ++ G E++++ RV+
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 447 ISERERLL-VYEYVPNDTLHYHLHAE-------------GRPVMDWATRVKVAAGAARGI 492
+ +LL + + + +H + E + +++ G+
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 493 AYLHEDCHPRIIHRDIKSSNILLDSS-FEARVADFGLAKIALELDSNTHVSTRVMGTFGY 551
Y+H IIH DIK N+L++ + +A + + H T + T Y
Sbjct: 139 DYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY-TNSIQTREY 195
Query: 552 MAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHE 611
+PE +D++S ++ ELITG + + + + E L
Sbjct: 196 RSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH-IAQIIELLGEL 254
Query: 612 DFEALVDSRLEKNYVDSEMFW 632
L + + + + +S
Sbjct: 255 PSYLLRNGKYTRTFFNSRGLL 275
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 119 bits (300), Expect = 1e-31
Identities = 37/201 (18%), Positives = 65/201 (32%), Gaps = 25/201 (12%)
Query: 387 NVLGEGGFGCVYKGVLADGREVAVKQLKIGGS----------QGEREFRAEVEIISRVHH 436
++GEG V+ E VK K+G + G+ F +R
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 437 RHLVSLVGYCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLH 496
R L L G + + Y + N L + A+ + +V +A +
Sbjct: 66 RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120
Query: 497 EDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEY 556
I+H D+ N+L+ + DF + E + V Y + Y
Sbjct: 121 HRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSRTY 176
Query: 557 ATSGKLTEKSDVYSFGVVLLE 577
T + D+ S +L+
Sbjct: 177 RT------EKDINSAIDRILQ 191
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 2e-30
Identities = 39/206 (18%), Positives = 82/206 (39%), Gaps = 19/206 (9%)
Query: 387 NVLGEGGFGCVYKGV-LADGREVAVKQLKIGGSQGE--REFRAEVEIISRVHHRHLVSLV 443
+ +G G +G V G VAVK+L + E+ ++ + H +++ L+
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 444 GYC-----ISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHED 498
+ E + + ++ ++ + + + RG+ Y+H
Sbjct: 84 DVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSA 140
Query: 499 CHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYAT 558
HRD+K SN+ ++ E ++ DFGLA+ ++ ++ V +
Sbjct: 141 DII---HRDLKPSNLAVNEDCELKILDFGLARH-----TDDEMTGYVATRWYRAPEIMLN 192
Query: 559 SGKLTEKSDVYSFGVVLLELITGRKP 584
+ D++S G ++ EL+TGR
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTL 218
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 727 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 99.04 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.63 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.48 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 98.06 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.86 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.82 | |
| d1cjaa_ | 342 | Actin-fragmin kinase, catalytic domain {Physarum p | 90.06 | |
| d1e7ua4 | 369 | Phoshoinositide 3-kinase (PI3K), catalytic domain | 85.14 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-53 Score=437.51 Aligned_cols=256 Identities=25% Similarity=0.426 Sum_probs=201.5
Q ss_pred cCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeecc
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVP 460 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 460 (727)
++|+++++||+|+||.||+|++.+++.||||+++.. ....++|.+|+++|++++|+|||+++|+|.+++..+||||||.
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 468999999999999999999988999999999753 3445789999999999999999999999999999999999999
Q ss_pred CCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCcc
Q 041135 461 NDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTH 540 (727)
Q Consensus 461 ~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 540 (727)
+|+|.++++... ..+.+..+++|+.||++||+|||++ +|+|||||++||||++++.+||+|||+++..... ...
T Consensus 84 ~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~--~~~ 157 (263)
T d1sm2a_ 84 HGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD--QYT 157 (263)
T ss_dssp TCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred CCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCC--Cce
Confidence 999999987653 3588999999999999999999999 9999999999999999999999999999865322 222
Q ss_pred ccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHH
Q 041135 541 VSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSR 620 (727)
Q Consensus 541 ~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~ 620 (727)
......||..|||||++.++.++.++|||||||+||||++|..+|..... ...+. ..+...
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~--~~~~~-----------------~~i~~~ 218 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--NSEVV-----------------EDISTG 218 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC--HHHHH-----------------HHHHHT
T ss_pred eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC--HHHHH-----------------HHHHhc
Confidence 23346789999999999999999999999999999999996554432211 11111 111111
Q ss_pred hhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhcc
Q 041135 621 LEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLD 662 (727)
Q Consensus 621 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 662 (727)
.+..........+.+|+.+||+.||++||+|+||+++|+++.
T Consensus 219 ~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 219 FRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 122222233456889999999999999999999999999875
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.5e-53 Score=445.10 Aligned_cols=260 Identities=25% Similarity=0.373 Sum_probs=216.3
Q ss_pred HhcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEe
Q 041135 379 ATNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYE 457 (727)
Q Consensus 379 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 457 (727)
..++|++.++||+|+||.||+|+++ +|+.||||+++.. ....++|++|+++|++++|+|||+++|+|.+++..|||||
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 93 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence 3467999999999999999999986 4889999998744 3445689999999999999999999999999999999999
Q ss_pred eccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCC
Q 041135 458 YVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDS 537 (727)
Q Consensus 458 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 537 (727)
||.+|+|.++|.......+++..+++|+.||++||+|||++ +|||||||++||||++++.+||+|||+|+.... .
T Consensus 94 ~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~--~ 168 (287)
T d1opja_ 94 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--D 168 (287)
T ss_dssp CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS--S
T ss_pred cccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCC--C
Confidence 99999999999877666799999999999999999999999 999999999999999999999999999986422 2
Q ss_pred CccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHH
Q 041135 538 NTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALV 617 (727)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~ 617 (727)
.........|+..|+|||++.++.++.++|||||||+||||++|..||..... .. .+.+++
T Consensus 169 ~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~--~~-----------------~~~~~i 229 (287)
T d1opja_ 169 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LS-----------------QVYELL 229 (287)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC--HH-----------------HHHHHH
T ss_pred CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch--HH-----------------HHHHHH
Confidence 22333445688999999999999999999999999999999998777643221 11 111222
Q ss_pred HHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 618 DSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 618 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
.......+.......+.+|+++||+.||++||+|.||++.|+.+.+
T Consensus 230 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 230 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred hcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 2222223333344568899999999999999999999999988754
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-53 Score=439.61 Aligned_cols=258 Identities=26% Similarity=0.407 Sum_probs=210.0
Q ss_pred HhcCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEee
Q 041135 379 ATNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 379 ~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 458 (727)
..++|+++++||+|+||.||+|++++++.||||+++.. ....+.|.+|+++|++++|+|||+++|+|.+ +..||||||
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey 88 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence 34679999999999999999999988899999999753 3445689999999999999999999998865 567999999
Q ss_pred ccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCC
Q 041135 459 VPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSN 538 (727)
Q Consensus 459 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 538 (727)
|.+|+|.++++......+++.++++|+.||++||+|||++ +|+|||||++||||++++.+||+|||+|+... ...
T Consensus 89 ~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~--~~~ 163 (272)
T d1qpca_ 89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIE--DNE 163 (272)
T ss_dssp CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECS--SSC
T ss_pred CCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEcc--CCc
Confidence 9999999988766555689999999999999999999999 99999999999999999999999999998652 222
Q ss_pred ccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHH
Q 041135 539 THVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVD 618 (727)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d 618 (727)
........|+..|||||++.++.++.++|||||||+||||++|..+|..... ...+. ..+.
T Consensus 164 ~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~--~~~~~-----------------~~i~ 224 (272)
T d1qpca_ 164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--NPEVI-----------------QNLE 224 (272)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHH-----------------HHHH
T ss_pred cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC--HHHHH-----------------HHHH
Confidence 2334456789999999999999999999999999999999997666543221 11111 1111
Q ss_pred HHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhcc
Q 041135 619 SRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLD 662 (727)
Q Consensus 619 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 662 (727)
...+..........+.+|+++||+.||++||+|+||++.|+.+.
T Consensus 225 ~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 225 RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 11111122223345889999999999999999999999998763
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-52 Score=437.30 Aligned_cols=261 Identities=29% Similarity=0.493 Sum_probs=203.4
Q ss_pred hcCccccceeccCCceEEEEEEEcCCcEEEEEEeeeC--CchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEe
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIG--GSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYE 457 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 457 (727)
.++|+++++||+|+||.||+|+++ ..||||+++.. ..+..+.|++|+++|++++|+|||+++|++.+ ..++||||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 467999999999999999999874 36999999754 33445789999999999999999999998865 56899999
Q ss_pred eccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCC
Q 041135 458 YVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDS 537 (727)
Q Consensus 458 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 537 (727)
||.+|+|.++|+.... .+++.++++|+.||++||+|||++ +|||||||++||||++++.+||+|||+|+..... .
T Consensus 84 y~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~-~ 158 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW-S 158 (276)
T ss_dssp CCCEEEHHHHHHTSCC-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred cCCCCCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeecccc-C
Confidence 9999999999976433 489999999999999999999999 9999999999999999999999999999764322 2
Q ss_pred CccccccccCCccccccCcccCC---CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHH
Q 041135 538 NTHVSTRVMGTFGYMAPEYATSG---KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFE 614 (727)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~l~~~---~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~ 614 (727)
.........||..|||||++.+. .|+.++|||||||+||||++|+.||.+.... . .....+........
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~---~---~~~~~~~~~~~~p~-- 230 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR---D---QIIFMVGRGYLSPD-- 230 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH---H---HHHHHHHHTSCCCC--
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH---H---HHHHHHhcCCCCCc--
Confidence 22334556899999999999753 4899999999999999999999999764321 0 01111111100000
Q ss_pred HHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 615 ALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 615 ~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
+ ..........+.+||.+||+.||++||+|+||+++|+.+..
T Consensus 231 ------~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 231 ------L-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp ------G-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------c-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 0 01122233468899999999999999999999999998753
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.1e-52 Score=438.75 Aligned_cols=259 Identities=25% Similarity=0.417 Sum_probs=200.0
Q ss_pred cCccccceeccCCceEEEEEEEcC-C---cEEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLAD-G---REVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLV 455 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~~-g---~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 455 (727)
++|++.++||+|+||+||+|+++. | ..||||++..... ...++|.+|+++|++++|+|||+++|+|.+++..+||
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 457788999999999999999753 2 3588998865433 3446799999999999999999999999999999999
Q ss_pred EeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhcc
Q 041135 456 YEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALEL 535 (727)
Q Consensus 456 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 535 (727)
||||.+|+|.+++..... .+++.++++|+.||++||+|||++ +|||||||++||||+.++++||+|||+++.....
T Consensus 106 ~Ey~~~g~L~~~~~~~~~-~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQNDG-QFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp EECCTTEEHHHHHHTTTT-CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEecCCCcceeeeccccC-CCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEccCC
Confidence 999999999998876443 489999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCCcc--ccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhh
Q 041135 536 DSNTH--VSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHED 612 (727)
Q Consensus 536 ~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~ 612 (727)
..... ......|+..|||||++.++.++.++|||||||+||||++ |+.||..... ..+.
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~---~~~~--------------- 243 (299)
T d1jpaa_ 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN---QDVI--------------- 243 (299)
T ss_dssp --------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHH---------------
T ss_pred CCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH---HHHH---------------
Confidence 22111 1223568999999999999999999999999999999998 8999975431 1111
Q ss_pred HHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 613 FEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 613 ~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
..+....+..........+.+|+.+||+.||++||+|.||++.|+++.+
T Consensus 244 --~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 244 --NAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp --HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred --HHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 1111112222333345568899999999999999999999999988743
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-52 Score=430.86 Aligned_cols=253 Identities=23% Similarity=0.328 Sum_probs=203.7
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEee
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 458 (727)
++|+++++||+|+||+||+|+++ +|+.||||+++.... +..+.+++|+++|++++|+|||++++++.+++..||||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 56999999999999999999975 689999999975443 3345799999999999999999999999999999999999
Q ss_pred ccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCC
Q 041135 459 VPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSN 538 (727)
Q Consensus 459 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 538 (727)
|.||+|.++|+.+. .+++.+++.|+.||++||+|||++ +|||||||++||||++++.+||+|||+|+..... ..
T Consensus 85 ~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~-~~ 158 (271)
T d1nvra_ 85 CSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN-NR 158 (271)
T ss_dssp CTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEET-TE
T ss_pred cCCCcHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccC-Cc
Confidence 99999999997654 489999999999999999999999 9999999999999999999999999999865322 22
Q ss_pred ccccccccCCccccccCcccCCCC-CchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHH
Q 041135 539 THVSTRVMGTFGYMAPEYATSGKL-TEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALV 617 (727)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~l~~~~~-~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~ 617 (727)
.......+||..|||||++.+..+ +.++||||||||||||++|+.||....... ..+.. +.
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~-~~~~~-----------------~~ 220 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSD-----------------WK 220 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS-HHHHH-----------------HH
T ss_pred cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH-HHHHH-----------------Hh
Confidence 233455789999999999988776 578999999999999999999997644221 11100 00
Q ss_pred HHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 618 DSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 618 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
...............+.+|+.+||+.||++||+++||+++
T Consensus 221 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 221 EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp TTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0000011111122346789999999999999999999775
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-51 Score=426.09 Aligned_cols=254 Identities=23% Similarity=0.389 Sum_probs=212.0
Q ss_pred cCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeecc
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVP 460 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 460 (727)
++|+++++||+|+||.||+|++++++.||||+++... ...++|++|+++|++++|+|||+++|+|.+++.+++||||+.
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 5789999999999999999999888999999998543 345789999999999999999999999999999999999999
Q ss_pred CCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCcc
Q 041135 461 NDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTH 540 (727)
Q Consensus 461 ~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 540 (727)
+|+|.+++..... .+.+..+++|+.||++||+|||++ +|+|||||++||||++++.+||+|||+++..... ...
T Consensus 83 ~g~l~~~~~~~~~-~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~--~~~ 156 (258)
T d1k2pa_ 83 NGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD--EYT 156 (258)
T ss_dssp TEEHHHHHHSGGG-CCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS--SCC
T ss_pred CCcHHHhhhcccc-CCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCC--Cce
Confidence 9999988765432 478999999999999999999999 9999999999999999999999999999864322 222
Q ss_pred ccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHH
Q 041135 541 VSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDS 619 (727)
Q Consensus 541 ~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~ 619 (727)
......|+..|+|||++.++.++.++|||||||++|||++ |+.||..... ..+ ...+..
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~---~~~-----------------~~~i~~ 216 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN---SET-----------------AEHIAQ 216 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH---HHH-----------------HHHHHT
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH---HHH-----------------HHHHHh
Confidence 3344678999999999999999999999999999999998 8999976431 111 111111
Q ss_pred HhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhc
Q 041135 620 RLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661 (727)
Q Consensus 620 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 661 (727)
..+..........+.+||.+||+.||++||++.||+++|.++
T Consensus 217 ~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 217 GLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred CCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 122222333345688999999999999999999999998653
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-51 Score=431.86 Aligned_cols=250 Identities=22% Similarity=0.382 Sum_probs=208.0
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeec
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYV 459 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 459 (727)
++|+++++||+|+||+||+|++. +|+.||||+++.......+.+.+|+++|++++|+|||+++++|.+++..|||||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 46999999999999999999964 69999999998766666678999999999999999999999999999999999999
Q ss_pred cCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCc
Q 041135 460 PNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNT 539 (727)
Q Consensus 460 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 539 (727)
.||+|.+++..+ .+++.+++.|+.||+.||+|||++ +|||||||++||||+.++++||+|||+|+.+. ...
T Consensus 100 ~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~---~~~ 170 (293)
T d1yhwa1 100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT---PEQ 170 (293)
T ss_dssp TTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECC---STT
T ss_pred CCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeec---ccc
Confidence 999999987654 389999999999999999999999 99999999999999999999999999998642 222
Q ss_pred cccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHH
Q 041135 540 HVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDS 619 (727)
Q Consensus 540 ~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~ 619 (727)
......+||..|||||++.++.++.++|||||||+||||++|+.||.+... .+....+... .
T Consensus 171 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~~~~~~------------~ 232 (293)
T d1yhwa1 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP------LRALYLIATN------------G 232 (293)
T ss_dssp CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHH------------C
T ss_pred ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH------HHHHHHHHhC------------C
Confidence 334556899999999999999999999999999999999999999975431 1111111100 0
Q ss_pred HhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 620 RLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 620 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
.............+.+|+++||+.||++|+++.||+++
T Consensus 233 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 233 TPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp SCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred CCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00111122223457889999999999999999999875
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-51 Score=430.64 Aligned_cols=260 Identities=26% Similarity=0.407 Sum_probs=203.8
Q ss_pred cCccccceeccCCceEEEEEEEcCC-----cEEEEEEeeeCCch-hHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLADG-----REVAVKQLKIGGSQ-GEREFRAEVEIISRVHHRHLVSLVGYCISERERLL 454 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~~g-----~~vaVK~l~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 454 (727)
..|++.++||+|+||.||+|+++++ ..||||+++..... ...+|++|+++|++++|+|||+++|+|.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4588899999999999999997642 36999999754433 34579999999999999999999999999999999
Q ss_pred EEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhc
Q 041135 455 VYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALE 534 (727)
Q Consensus 455 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 534 (727)
|||||.+++|.+++.... ..+++.++++|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++....
T Consensus 87 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp EEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccC
Confidence 999999999998876543 2589999999999999999999999 999999999999999999999999999986543
Q ss_pred cCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHH
Q 041135 535 LDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFE 614 (727)
Q Consensus 535 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~ 614 (727)
............||..|||||++.++.++.++|||||||+||||++|..+|..... ... +.
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~--~~~-----------------~~ 223 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS--NHE-----------------VM 223 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHH-----------------HH
T ss_pred CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC--HHH-----------------HH
Confidence 33333334456789999999999999999999999999999999997766643221 111 11
Q ss_pred HHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 615 ALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 615 ~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
+.+....+..........+.+|+.+||+.||++||+|.||++.|+++.+
T Consensus 224 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 224 KAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp HHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 1222223333334445668899999999999999999999999998754
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-51 Score=429.92 Aligned_cols=257 Identities=25% Similarity=0.392 Sum_probs=208.5
Q ss_pred cCccccce-eccCCceEEEEEEEc---CCcEEEEEEeeeCCch-hHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEE
Q 041135 381 NGFSAHNV-LGEGGFGCVYKGVLA---DGREVAVKQLKIGGSQ-GEREFRAEVEIISRVHHRHLVSLVGYCISERERLLV 455 (727)
Q Consensus 381 ~~~~~~~~-LG~G~fg~Vy~~~~~---~g~~vaVK~l~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 455 (727)
++|.+.++ ||+|+||.||+|+++ ++..||||+++..... ..++|++|+++|++++|+|||+++|+|.+ +..|||
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 45777774 999999999999864 3557999999755433 34679999999999999999999999975 467999
Q ss_pred EeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhcc
Q 041135 456 YEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALEL 535 (727)
Q Consensus 456 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 535 (727)
||||++|+|.+++.... ..+++.++++|+.||++||+|||++ +|||||||++||||+.++.+||+|||+++.....
T Consensus 87 mE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp EECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccccc
Confidence 99999999999876543 2589999999999999999999999 9999999999999999999999999999865433
Q ss_pred CCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHH
Q 041135 536 DSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFE 614 (727)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~ 614 (727)
...........||..|||||++.++.++.++|||||||+||||++ |+.||..... ..+.
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~---~~~~----------------- 222 (285)
T d1u59a_ 163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVM----------------- 222 (285)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT---HHHH-----------------
T ss_pred ccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH---HHHH-----------------
Confidence 333333445678999999999999999999999999999999998 9999976431 1111
Q ss_pred HHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhcc
Q 041135 615 ALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLD 662 (727)
Q Consensus 615 ~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 662 (727)
..+....+..........+.+||.+||+.||++||+|.+|++.|+.+.
T Consensus 223 ~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~ 270 (285)
T d1u59a_ 223 AFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270 (285)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 111111112222333456889999999999999999999999998764
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-51 Score=422.74 Aligned_cols=246 Identities=29% Similarity=0.433 Sum_probs=205.2
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
++|++++.||+|+||.||+|+++ +|+.||||+++... ....+.+++|+++|++++|+|||+++++|.+++..||||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 45999999999999999999985 58899999986422 233467899999999999999999999999999999999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccC
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 536 (727)
|||.+|+|.++|..... +++.+++.|+.||++||+|||++ +|||||||++||||+.++.+||+|||+|+....
T Consensus 86 Ey~~~g~L~~~l~~~~~--l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~-- 158 (263)
T d2j4za1 86 EYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-- 158 (263)
T ss_dssp ECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC--
T ss_pred eecCCCcHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC--
Confidence 99999999999987654 89999999999999999999999 999999999999999999999999999975321
Q ss_pred CCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHH
Q 041135 537 SNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEAL 616 (727)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l 616 (727)
......+||..|||||++.+..++.++|||||||+||||++|+.||..... .+... .+
T Consensus 159 ---~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~-------------~i 216 (263)
T d2j4za1 159 ---SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY------QETYK-------------RI 216 (263)
T ss_dssp ---CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHH-------------HH
T ss_pred ---CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH------HHHHH-------------HH
Confidence 123446799999999999999999999999999999999999999975431 11111 11
Q ss_pred HHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 617 VDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 617 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
.... ..+.......+.+|+.+||+.||++||+++||+++
T Consensus 217 ~~~~--~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 217 SRVE--FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp HTTC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred HcCC--CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 1111 11222223457889999999999999999999875
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-51 Score=426.30 Aligned_cols=249 Identities=26% Similarity=0.387 Sum_probs=200.1
Q ss_pred ceeccCCceEEEEEEEcC---CcEEEEEEeeeCC--chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeeccC
Q 041135 387 NVLGEGGFGCVYKGVLAD---GREVAVKQLKIGG--SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYVPN 461 (727)
Q Consensus 387 ~~LG~G~fg~Vy~~~~~~---g~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 461 (727)
++||+|+||.||+|++++ ++.||||+++... ....++|.+|+++|++++|+|||+++|+|.+ +..+||||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999998653 4689999996432 2334679999999999999999999999965 457899999999
Q ss_pred CccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCccc
Q 041135 462 DTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNTHV 541 (727)
Q Consensus 462 gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 541 (727)
|+|.++++.... +++.++++|+.||++||+|||++ +|||||||++||||+.++.+||+|||+++.+.........
T Consensus 92 g~L~~~l~~~~~--l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 92 GPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp EEHHHHHHHCTT--CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred CcHHHHHhhccC--CCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence 999999987654 89999999999999999999999 9999999999999999999999999999865333333333
Q ss_pred cccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHH
Q 041135 542 STRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDSR 620 (727)
Q Consensus 542 ~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~ 620 (727)
.....||..|||||++.++.++.++|||||||+||||++ |+.||.+... ..+ ...+...
T Consensus 167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~---~~~-----------------~~~i~~~ 226 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEV-----------------TAMLEKG 226 (277)
T ss_dssp ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHH-----------------HHHHHTT
T ss_pred ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH---HHH-----------------HHHHHcC
Confidence 345678999999999999999999999999999999998 8999975431 111 1111111
Q ss_pred hhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhc
Q 041135 621 LEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661 (727)
Q Consensus 621 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 661 (727)
.+..........+.+||.+||+.||++||+|.||+++|+..
T Consensus 227 ~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 227 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 11222333345688999999999999999999999998865
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-50 Score=432.47 Aligned_cols=257 Identities=25% Similarity=0.392 Sum_probs=208.0
Q ss_pred hcCccccceeccCCceEEEEEEEcC------CcEEEEEEeeeCC-chhHHHHHHHHHHHHHc-CCCCceeEeeEeeccce
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLAD------GREVAVKQLKIGG-SQGEREFRAEVEIISRV-HHRHLVSLVGYCISERE 451 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~~------g~~vaVK~l~~~~-~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~ 451 (727)
.++|+++++||+|+||+||+|++.. +..||||++.... ......+.+|+.+|+++ +|+|||+++|+|.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 4679999999999999999998653 2369999986433 33446799999999998 89999999999999999
Q ss_pred eeEEEeeccCCccchhcccCCC---------------------CcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCC
Q 041135 452 RLLVYEYVPNDTLHYHLHAEGR---------------------PVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKS 510 (727)
Q Consensus 452 ~~lV~Ey~~~gsL~~~L~~~~~---------------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp 510 (727)
.|||||||++|+|.++|+.+.. ..+++.+++.|+.||++||+|||++ +|||||||+
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCch
Confidence 9999999999999999976532 2478999999999999999999999 999999999
Q ss_pred CceEECCCCcEEEEeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCC
Q 041135 511 SNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQ 589 (727)
Q Consensus 511 ~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~ 589 (727)
+||||+.++.+||+|||+|+...... .........||..|||||++.++.++.++|||||||+||||++ |+.||.+..
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDS-NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCT-TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hccccccCCeEEEeeccccccccCCC-ceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999998653322 2223345678999999999999999999999999999999998 899997643
Q ss_pred CCCchhhHHhhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 590 PLGDESLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 590 ~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
.. .. +.+++....+..........+.+||.+||+.||++||+|+||+++|.
T Consensus 272 ~~--~~-----------------~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 272 VD--AN-----------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CS--HH-----------------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HH--HH-----------------HHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 21 11 11122222222233333456889999999999999999999999996
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-51 Score=423.37 Aligned_cols=254 Identities=23% Similarity=0.352 Sum_probs=193.2
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc--hhHHHHHHHHHHHHHcCCCCceeEeeEeec--cceeeEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS--QGEREFRAEVEIISRVHHRHLVSLVGYCIS--ERERLLV 455 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~--~~~~~lV 455 (727)
++|++++.||+|+||.||+|+++ +|+.||||+++.... ...+.+.+|+++|++++|+|||+++++|.+ ++.+|||
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57999999999999999999975 689999999975532 334568999999999999999999999975 4567999
Q ss_pred EeeccCCccchhcccC--CCCcccHHHHHHHHHHHHHHHHHHHhcC--CCcEEeeCCCCCceEECCCCcEEEEeeccchh
Q 041135 456 YEYVPNDTLHYHLHAE--GRPVMDWATRVKVAAGAARGIAYLHEDC--HPRIIHRDIKSSNILLDSSFEARVADFGLAKI 531 (727)
Q Consensus 456 ~Ey~~~gsL~~~L~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~--~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 531 (727)
||||.||+|.+++... ....+++.+++.|+.||+.||+|||++. ..+|||||||++||||+.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998643 2345899999999999999999999871 11399999999999999999999999999986
Q ss_pred hhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchh
Q 041135 532 ALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHE 611 (727)
Q Consensus 532 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~ 611 (727)
+.. ........+||..|||||++.+..++.++|||||||+||||++|+.||..... . +..
T Consensus 164 ~~~---~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~---~---~~~----------- 223 (269)
T d2java1 164 LNH---DTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---K---ELA----------- 223 (269)
T ss_dssp C--------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---H---HHH-----------
T ss_pred ccc---CCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH---H---HHH-----------
Confidence 532 22233457899999999999999999999999999999999999999975421 1 111
Q ss_pred hHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 612 DFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 612 ~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
..+.+..+. .........+.+|+.+||+.||++||++.||+++
T Consensus 224 --~~i~~~~~~-~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 224 --GKIREGKFR-RIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp --HHHHHTCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --HHHHcCCCC-CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 111111111 1112223457889999999999999999999864
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-51 Score=425.65 Aligned_cols=258 Identities=26% Similarity=0.392 Sum_probs=206.7
Q ss_pred hcCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeec
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYV 459 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 459 (727)
.++|++++.||+|+||.||+|++++++.||||+++.. ....+.|.+|+.+|++++|+|||+++|+|.+ +..+||||||
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence 3579999999999999999999998889999999744 4456789999999999999999999999865 5679999999
Q ss_pred cCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCc
Q 041135 460 PNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNT 539 (727)
Q Consensus 460 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 539 (727)
.+|+|..++.......++|.++++|+.||++||+|||++ +|+|||||++||||++++.+||+|||+++.... ...
T Consensus 94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~--~~~ 168 (285)
T d1fmka3 94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED--NEY 168 (285)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccC--CCc
Confidence 999999988766545699999999999999999999999 999999999999999999999999999986532 222
Q ss_pred cccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHH
Q 041135 540 HVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVDS 619 (727)
Q Consensus 540 ~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~ 619 (727)
.......|+..|+|||++.++.++.++|||||||+||||++|..+|..... ...+ ...+..
T Consensus 169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~--~~~~-----------------~~~i~~ 229 (285)
T d1fmka3 169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--NREV-----------------LDQVER 229 (285)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHH-----------------HHHHHT
T ss_pred eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC--HHHH-----------------HHHHHh
Confidence 233446789999999999999999999999999999999997777654321 1111 111111
Q ss_pred HhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 620 RLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 620 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
..+..........+.+||.+||+.||++||+|++|+++|+....
T Consensus 230 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 230 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred cCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 22222333344568899999999999999999999999987643
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=425.16 Aligned_cols=251 Identities=22% Similarity=0.330 Sum_probs=206.2
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeec
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYV 459 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 459 (727)
+.|++++.||+|+||.||+|++. +|+.||||+++.......+.+++|+++|++++|+|||+++++|.+++..|||||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46899999999999999999975 68999999998776677788999999999999999999999999999999999999
Q ss_pred cCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCc
Q 041135 460 PNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNT 539 (727)
Q Consensus 460 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 539 (727)
.+|+|.+++.+..+ .+++.++..|+.||++||+|||++ +|||||||++||||+.++.+||+|||+|+..... .
T Consensus 92 ~~g~L~~~~~~~~~-~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~---~ 164 (288)
T d2jfla1 92 AGGAVDAVMLELER-PLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT---I 164 (288)
T ss_dssp TTEEHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHH---H
T ss_pred CCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCC---c
Confidence 99999998765432 489999999999999999999999 9999999999999999999999999999753221 1
Q ss_pred cccccccCCccccccCccc-----CCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHH
Q 041135 540 HVSTRVMGTFGYMAPEYAT-----SGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFE 614 (727)
Q Consensus 540 ~~~~~~~gt~~y~aPE~l~-----~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~ 614 (727)
......+||..|||||++. +..|+.++|||||||+||||++|+.||...... . ...
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~---~---~~~------------- 225 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM---R---VLL------------- 225 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG---G---HHH-------------
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH---H---HHH-------------
Confidence 2234568999999999984 456889999999999999999999999764321 1 111
Q ss_pred HHHHHHh-hcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 615 ALVDSRL-EKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 615 ~l~d~~l-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
.+..... ...........+.+|+++||+.||++|+++.||+++
T Consensus 226 ~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 226 KIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp HHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHHcCCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111100 001112223457889999999999999999999875
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-51 Score=434.92 Aligned_cols=266 Identities=23% Similarity=0.366 Sum_probs=207.5
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEe
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYE 457 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 457 (727)
.++|+++++||+|+||.||+|++. +|+.||||+++.... ...+.+.+|+++|++++|+|||+++++|.+++++|||||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 467999999999999999999975 689999999976533 334679999999999999999999999999999999999
Q ss_pred eccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHh-cCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccC
Q 041135 458 YVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHE-DCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536 (727)
Q Consensus 458 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 536 (727)
||.||+|.+++++++. +++..++.++.||++||+|||+ + +|+|||||++||||++++++||+|||+|+...+.
T Consensus 85 y~~gg~L~~~l~~~~~--l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~- 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 158 (322)
T ss_dssp CCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred cCCCCcHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccCCC-
Confidence 9999999999987654 8999999999999999999996 5 7999999999999999999999999999865332
Q ss_pred CCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHH-----------
Q 041135 537 SNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLA----------- 605 (727)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~----------- 605 (727)
.....+||..|||||++.+..|+.++||||||||||||++|+.||...+... ..+. +......
T Consensus 159 ----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~ 232 (322)
T d1s9ja_ 159 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE-LELM-FGCQVEGDAAETPPRPRT 232 (322)
T ss_dssp ----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTH-HHHH-C-----------------
T ss_pred ----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHH-HHHHhcCCcccCCccccc
Confidence 2234689999999999999999999999999999999999999997654221 1000 0000000
Q ss_pred ----------HhhchhhHHHHHHHHhhccc----chhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 606 ----------EALEHEDFEALVDSRLEKNY----VDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 606 ----------~~~~~~~~~~l~d~~l~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
.........+.++....... .......+.+|+++||+.||++|++++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp -------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 00000111112221111110 01112347889999999999999999999985
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-50 Score=416.53 Aligned_cols=246 Identities=26% Similarity=0.397 Sum_probs=196.0
Q ss_pred ccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC--chhHHHHHHHHHHHHHcCCCCceeEeeEeec----cceeeEE
Q 041135 383 FSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG--SQGEREFRAEVEIISRVHHRHLVSLVGYCIS----ERERLLV 455 (727)
Q Consensus 383 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~----~~~~~lV 455 (727)
|++.++||+|+||+||+|++. +|+.||||+++... ....+.|.+|+++|++++|+|||+++++|.+ +..+|||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 356678999999999999975 58899999987543 2334679999999999999999999999875 3567999
Q ss_pred EeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCc--EEeeCCCCCceEEC-CCCcEEEEeeccchhh
Q 041135 456 YEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPR--IIHRDIKSSNILLD-SSFEARVADFGLAKIA 532 (727)
Q Consensus 456 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~--ivHrDLkp~NILl~-~~~~vkL~DFGla~~~ 532 (727)
||||.+|+|.+++++... +++.+++.|+.||++||+|||++ + |||||||++||||+ +++.+||+|||+|+..
T Consensus 91 mE~~~~g~L~~~l~~~~~--~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp EECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EeCCCCCcHHHHHhcccc--ccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 999999999999987654 89999999999999999999998 7 99999999999996 5789999999999753
Q ss_pred hccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhh
Q 041135 533 LELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHED 612 (727)
Q Consensus 533 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~ 612 (727)
. .......+||..|||||++.+ .++.++|||||||+||||++|+.||...... . +..+ . +..+
T Consensus 166 ~-----~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~--~---~~~~----~-i~~~- 228 (270)
T d1t4ha_ 166 R-----ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA--A---QIYR----R-VTSG- 228 (270)
T ss_dssp C-----TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--H---HHHH----H-HTTT-
T ss_pred c-----CCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH--H---HHHH----H-HHcC-
Confidence 1 122345689999999999875 5999999999999999999999999753211 1 1000 0 0000
Q ss_pred HHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 613 FEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 613 ~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
.....+.......+.+|+.+||+.||++||++.||+++
T Consensus 229 -------~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 229 -------VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp -------CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -------CCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 00011111122347789999999999999999999874
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-50 Score=423.38 Aligned_cols=250 Identities=24% Similarity=0.340 Sum_probs=203.5
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
++|+++++||+|+||+||+|++. +|+.||||+++... ....+.+.+|+++|++++|+|||+++++|.+++..||||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 56999999999999999999975 68999999986432 233457899999999999999999999999999999999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccC
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 536 (727)
|||.||+|.+++...+. +++.+++.++.||+.||+|||++ +|||||||++||||++++.+||+|||+|+.+.. .
T Consensus 88 Ey~~gg~L~~~~~~~~~--l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~-~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP-E 161 (288)
T ss_dssp CCCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EccCCCCHHHhhhccCC--CCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc-C
Confidence 99999999999887654 89999999999999999999999 999999999999999999999999999986422 1
Q ss_pred CCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHH
Q 041135 537 SNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEAL 616 (727)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l 616 (727)
.........+||..|||||++.+..++.++|||||||+||||++|+.||...+. . +.. ..+
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---~---~~~-------------~~i 222 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---Y---LIF-------------QKI 222 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---H---HHH-------------HHH
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH---H---HHH-------------HHH
Confidence 122233456899999999999999999999999999999999999999975421 1 111 111
Q ss_pred HHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 617 VDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 617 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
+... ..+.......+.+||.+||+.||++|++++|+++.
T Consensus 223 ~~~~--~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 223 IKLE--YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp HTTC--CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred HcCC--CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 1111 11222233457889999999999999999998654
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-50 Score=427.95 Aligned_cols=256 Identities=25% Similarity=0.425 Sum_probs=202.1
Q ss_pred cCccccceeccCCceEEEEEEEc-CCc----EEEEEEeeeC-CchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGR----EVAVKQLKIG-GSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLL 454 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~----~vaVK~l~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 454 (727)
++|+++++||+|+||.||+|++. +|+ .||||+++.. ..+..++|++|+++|++++|+|||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46999999999999999999875 343 5889988643 334567899999999999999999999999865 5678
Q ss_pred EEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhc
Q 041135 455 VYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALE 534 (727)
Q Consensus 455 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 534 (727)
||||+.+|+|.+++..+. ..+++..+++|+.||++||+|||++ +|||||||++||||+.++.+||+|||+++....
T Consensus 88 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EEEeccCCcccccccccc-cCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 889999999988876653 3589999999999999999999999 999999999999999999999999999986532
Q ss_pred cCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhH
Q 041135 535 LDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDF 613 (727)
Q Consensus 535 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~ 613 (727)
.. .........||..|||||++.++.++.++|||||||+||||++ |+.||++.... . +
T Consensus 164 ~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~---~-----------------~ 222 (317)
T d1xkka_ 164 EE-KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---E-----------------I 222 (317)
T ss_dssp TC-C--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG---G-----------------H
T ss_pred cc-ccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH---H-----------------H
Confidence 22 2222344578999999999999999999999999999999998 88888764321 1 1
Q ss_pred HHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhcc
Q 041135 614 EALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLD 662 (727)
Q Consensus 614 ~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 662 (727)
...+....+..........+.+|+++||+.||++||++.||+++|+++.
T Consensus 223 ~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 223 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp HHHHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence 1112222222222333456889999999999999999999999998874
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.6e-49 Score=426.65 Aligned_cols=252 Identities=22% Similarity=0.314 Sum_probs=207.3
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeec
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYV 459 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 459 (727)
++|+++++||+|+||.||+|++. +|+.||||++........+.+++|+++|++|+|+|||+++++|.+++.+|||||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 57999999999999999999975 68999999998766666678999999999999999999999999999999999999
Q ss_pred cCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEEC--CCCcEEEEeeccchhhhccCC
Q 041135 460 PNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLD--SSFEARVADFGLAKIALELDS 537 (727)
Q Consensus 460 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~--~~~~vkL~DFGla~~~~~~~~ 537 (727)
.||+|.++|..... .+++.+++.|+.||+.||+|||++ +|||||||++||||+ .++.+||+|||+++.+..
T Consensus 106 ~gg~L~~~l~~~~~-~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~--- 178 (350)
T d1koaa2 106 SGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP--- 178 (350)
T ss_dssp CSCBHHHHHTCTTS-CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT---
T ss_pred CCCCHHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccc---
Confidence 99999998865432 489999999999999999999999 999999999999995 467899999999985421
Q ss_pred CccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHH
Q 041135 538 NTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALV 617 (727)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~ 617 (727)
.......+||..|||||++.+..++.++|||||||+||||++|+.||.+... .+....+.....
T Consensus 179 -~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~~~--------- 242 (350)
T d1koaa2 179 -KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND------DETLRNVKSCDW--------- 242 (350)
T ss_dssp -TSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCC---------
T ss_pred -ccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCC---------
Confidence 2233456899999999999999999999999999999999999999975421 111111111000
Q ss_pred HHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 618 DSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 618 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
.+...........+.+|+++||..||++||++.||+++
T Consensus 243 --~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 243 --NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp --CSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred --CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00011111223357889999999999999999999986
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-49 Score=421.75 Aligned_cols=245 Identities=25% Similarity=0.397 Sum_probs=200.3
Q ss_pred CccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCch---hHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEe
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQ---GEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYE 457 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 457 (727)
.|++++.||+|+||.||+|++. +|+.||||+++..... ..+.+.+|+++|++++|+|||+++++|.+++..|||||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 4899999999999999999964 6889999999765432 23568899999999999999999999999999999999
Q ss_pred eccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCC
Q 041135 458 YVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDS 537 (727)
Q Consensus 458 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 537 (727)
||.+|+|..++..+. .+++.+++.|+.||+.||+|||++ +|||||||++||||++++.+||+|||+|+....
T Consensus 96 ~~~~g~l~~~~~~~~--~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~--- 167 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--- 167 (309)
T ss_dssp CCSEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---
T ss_pred ecCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC---
Confidence 999999987765554 489999999999999999999999 999999999999999999999999999975321
Q ss_pred CccccccccCCccccccCcccC---CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHH
Q 041135 538 NTHVSTRVMGTFGYMAPEYATS---GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFE 614 (727)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~l~~---~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~ 614 (727)
....+||..|||||++.+ +.|+.++|||||||+||||++|+.||.+... .+. +.
T Consensus 168 ----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~------~~~-------------~~ 224 (309)
T d1u5ra_ 168 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSA-------------LY 224 (309)
T ss_dssp ----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHH-------------HH
T ss_pred ----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH------HHH-------------HH
Confidence 234579999999999864 4589999999999999999999999975321 010 11
Q ss_pred HHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 615 ALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 615 ~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
.++...............+.+|+.+||+.||++||++.||+++
T Consensus 225 ~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 225 HIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp HHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred HHHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 1111111111111123457889999999999999999999885
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.3e-49 Score=419.75 Aligned_cols=251 Identities=23% Similarity=0.335 Sum_probs=191.2
Q ss_pred HhcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 379 ATNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 379 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
..+.|+++++||+|+||+||+|+++ +|+.||||++..... .....+.+|+++|++++|+|||+++++|.+++.+||||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3467999999999999999999975 589999999975433 23356889999999999999999999999999999999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEEC---CCCcEEEEeeccchhhh
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLD---SSFEARVADFGLAKIAL 533 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~---~~~~vkL~DFGla~~~~ 533 (727)
|||.||+|.++|..++. +++.++..|+.||+.||+|||++ +|||||||++||||. +++.+||+|||+++...
T Consensus 87 E~~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKGF--YTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCCSCBHHHHHHTCSC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred eccCCCcHHHhhhcccC--CCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 99999999999977554 89999999999999999999999 999999999999994 57899999999998542
Q ss_pred ccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhH
Q 041135 534 ELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDF 613 (727)
Q Consensus 534 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~ 613 (727)
. .......+||..|||||++.++.++.++|||||||+||||++|+.||..... ..+ +
T Consensus 162 ~----~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---~~~----------------~ 218 (307)
T d1a06a_ 162 P----GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND---AKL----------------F 218 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHH----------------H
T ss_pred C----CCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH---HHH----------------H
Confidence 2 1223456799999999999999999999999999999999999999975321 111 0
Q ss_pred HHHHHHHhh--cccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 614 EALVDSRLE--KNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 614 ~~l~d~~l~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
..++..... ..........+.+|+.+||+.||++|+++.||+++
T Consensus 219 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 219 EQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp HHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 111111110 11112223457899999999999999999999886
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.4e-49 Score=418.82 Aligned_cols=264 Identities=25% Similarity=0.396 Sum_probs=211.0
Q ss_pred HHHHHhcCccccceeccCCceEEEEEEEc------CCcEEEEEEeeeCCchh-HHHHHHHHHHHHHcCCCCceeEeeEee
Q 041135 375 ELIQATNGFSAHNVLGEGGFGCVYKGVLA------DGREVAVKQLKIGGSQG-EREFRAEVEIISRVHHRHLVSLVGYCI 447 (727)
Q Consensus 375 el~~~~~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vaVK~l~~~~~~~-~~~~~~Ei~~l~~l~HpnIv~l~~~~~ 447 (727)
+|+.-.++|++++.||+|+||.||+|+++ +++.||||+++...... .++|.+|+++|++++|+||++++++|.
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 34444678999999999999999999864 35789999997554433 467999999999999999999999999
Q ss_pred ccceeeEEEeeccCCccchhcccCC----------------------CCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEe
Q 041135 448 SERERLLVYEYVPNDTLHYHLHAEG----------------------RPVMDWATRVKVAAGAARGIAYLHEDCHPRIIH 505 (727)
Q Consensus 448 ~~~~~~lV~Ey~~~gsL~~~L~~~~----------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH 505 (727)
+.+..++||||+.+|+|.++|+... ...+.+.++++|+.||+.||+|||++ +|||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivH 163 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVH 163 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEe
Confidence 9999999999999999999886432 23478899999999999999999999 9999
Q ss_pred eCCCCCceEECCCCcEEEEeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCC-CC
Q 041135 506 RDIKSSNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGR-KP 584 (727)
Q Consensus 506 rDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~-~P 584 (727)
||||++||||+.++.+||+|||+++..... ..........|+..|+|||++.+..++.++|||||||+||||++|. .|
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSA-DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGG-GCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred eEEcccceEECCCCcEEEccchhheeccCC-ccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence 999999999999999999999999865332 2222334567899999999999999999999999999999999986 46
Q ss_pred CCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhcc
Q 041135 585 VDASQPLGDESLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLD 662 (727)
Q Consensus 585 f~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 662 (727)
|..... ..+. ..+.+. ............+.+|+.+||+.||++||+|.||+++|+++.
T Consensus 243 ~~~~~~---~e~~----------------~~v~~~-~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 243 YYGMAH---EEVI----------------YYVRDG-NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTTSCH---HHHH----------------HHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCH---HHHH----------------HHHHcC-CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 654321 1111 111111 111122233446889999999999999999999999999873
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.6e-48 Score=420.65 Aligned_cols=250 Identities=22% Similarity=0.324 Sum_probs=207.6
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEeec
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEYV 459 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 459 (727)
++|+++++||+|+||.||+|+.. +|+.||||+++.....+.+.+++|+++|++|+|+|||+++++|.+++.+|||||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 46999999999999999999974 69999999998766566678899999999999999999999999999999999999
Q ss_pred cCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEEC--CCCcEEEEeeccchhhhccCC
Q 041135 460 PNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLD--SSFEARVADFGLAKIALELDS 537 (727)
Q Consensus 460 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~--~~~~vkL~DFGla~~~~~~~~ 537 (727)
.||+|.+++.... ..+++.+++.|+.||+.||+|||++ +|||||||++||||+ .++.+||+|||+|+.+..
T Consensus 109 ~gg~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~--- 181 (352)
T d1koba_ 109 SGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP--- 181 (352)
T ss_dssp CCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT---
T ss_pred CCChHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCC---
Confidence 9999988776543 2489999999999999999999999 999999999999997 678999999999986422
Q ss_pred CccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHH
Q 041135 538 NTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALV 617 (727)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~ 617 (727)
.......+|+..|||||++.+..++.++|||||||+||||++|+.||.+... .+.. ..+.
T Consensus 182 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~-------------~~i~ 241 (352)
T d1koba_ 182 -DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD------LETL-------------QNVK 241 (352)
T ss_dssp -TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHH-------------HHHH
T ss_pred -CCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH------HHHH-------------HHHH
Confidence 2234456799999999999999999999999999999999999999975431 1111 1111
Q ss_pred HHH--hhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 618 DSR--LEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 618 d~~--l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
... +...........+.+||.+||+.||++|+++.||+++
T Consensus 242 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 242 RCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp HCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111 1111112233457899999999999999999999876
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=410.82 Aligned_cols=252 Identities=22% Similarity=0.321 Sum_probs=204.8
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc------hhHHHHHHHHHHHHHcCCCCceeEeeEeecccee
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS------QGEREFRAEVEIISRVHHRHLVSLVGYCISERER 452 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~------~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 452 (727)
.++|++++.||+|+||+||+|+++ +|+.||||+++.... ...+.|++|+++|++++|+|||+++++|.+++.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 467999999999999999999974 689999999964322 2246799999999999999999999999999999
Q ss_pred eEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCC----cEEEEeecc
Q 041135 453 LLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSF----EARVADFGL 528 (727)
Q Consensus 453 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~----~vkL~DFGl 528 (727)
|||||||.||+|.++|..++. +++.+++.|+.||+.||+|||++ +|||||||++||||+.++ .+||+|||+
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~~--l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEcCCCccccchhccccc--cchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhh
Confidence 999999999999999977654 89999999999999999999999 999999999999998776 599999999
Q ss_pred chhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhh
Q 041135 529 AKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEAL 608 (727)
Q Consensus 529 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~ 608 (727)
++.... ........|+..|+|||++.++.++.++|||||||+||||++|+.||.+... . +....+...
T Consensus 164 a~~~~~----~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---~---~~~~~i~~~-- 231 (293)
T d1jksa_ 164 AHKIDF----GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---Q---ETLANVSAV-- 231 (293)
T ss_dssp CEECTT----SCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---H---HHHHHHHTT--
T ss_pred hhhcCC----CccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH---H---HHHHHHHhc--
Confidence 975421 2223456789999999999999999999999999999999999999976431 1 111111000
Q ss_pred chhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 609 EHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 609 ~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
...+. ..........+.+|+++||+.||++||++.||+++
T Consensus 232 -~~~~~--------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 232 -NYEFE--------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp -CCCCC--------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -CCCCC--------chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000 00011122347789999999999999999999875
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=411.94 Aligned_cols=250 Identities=28% Similarity=0.437 Sum_probs=200.8
Q ss_pred cCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeec-cceeeEEEeec
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCIS-ERERLLVYEYV 459 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~-~~~~~lV~Ey~ 459 (727)
++|+++++||+|+||.||+|+++ |+.||||+++.. ...+.|++|+++|++++|+|||+++|+|.+ .+.+||||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 56889999999999999999995 789999998643 345779999999999999999999999865 45689999999
Q ss_pred cCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCCc
Q 041135 460 PNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSNT 539 (727)
Q Consensus 460 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 539 (727)
.+|+|.++|+.+....+++..+++|+.||+.||+|||++ +|+|||||++|||++.++.+||+|||+++....
T Consensus 84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~----- 155 (262)
T d1byga_ 84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS----- 155 (262)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCC-----
Confidence 999999999776555689999999999999999999999 999999999999999999999999999985421
Q ss_pred cccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHH
Q 041135 540 HVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVD 618 (727)
Q Consensus 540 ~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d 618 (727)
......++..|+|||++.++.++.++|||||||+||||++ |+.||..... ..+.. .+.
T Consensus 156 -~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~---~~~~~-----------------~i~ 214 (262)
T d1byga_ 156 -TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVP-----------------RVE 214 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG---GGHHH-----------------HHT
T ss_pred -CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH---HHHHH-----------------HHH
Confidence 1233467899999999999999999999999999999998 6777765321 11111 111
Q ss_pred HHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhcc
Q 041135 619 SRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLD 662 (727)
Q Consensus 619 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 662 (727)
...+..+.......+.+|+++||+.||++||+|.||+++|+++.
T Consensus 215 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 215 KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 11222333333456889999999999999999999999999875
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=414.79 Aligned_cols=257 Identities=25% Similarity=0.365 Sum_probs=197.6
Q ss_pred cCccccceeccCCceEEEEEEEcC----CcEEEEEEeeeC---CchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceee
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLAD----GREVAVKQLKIG---GSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERL 453 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~~----g~~vaVK~l~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 453 (727)
++|++++.||+|+||.||+|+++. +..||||+++.. ..+..++|.+|+++|++++|+|||+++|+|.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 569999999999999999998642 247899998643 23344679999999999999999999999976 4678
Q ss_pred EEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhh
Q 041135 454 LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIAL 533 (727)
Q Consensus 454 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~ 533 (727)
||||||.+|+|.+++..+.. .+++..+++++.||++||+|||++ +|+|||||++||||+.++.+||+|||+++...
T Consensus 87 lv~e~~~~~~l~~~~~~~~~-~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGG-GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeeeecCcchhhhhhcccC-CCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 99999999999988765433 489999999999999999999999 99999999999999999999999999998654
Q ss_pred ccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhh
Q 041135 534 ELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHED 612 (727)
Q Consensus 534 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~ 612 (727)
.............|+..|+|||++.+..++.++|||||||+||||++ |+.||.+... ...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~---~~~---------------- 223 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG---SQI---------------- 223 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHH----------------
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH---HHH----------------
Confidence 33333333445678899999999999999999999999999999998 8999975431 111
Q ss_pred HHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhc
Q 041135 613 FEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTL 661 (727)
Q Consensus 613 ~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 661 (727)
+..+.....+..........+.+|+.+||+.||++||+|.||++.|+++
T Consensus 224 ~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 224 LHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp HHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1111111111122222334588999999999999999999999999875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-49 Score=410.45 Aligned_cols=256 Identities=25% Similarity=0.374 Sum_probs=197.0
Q ss_pred hcCccccceeccCCceEEEEEEEcC----CcEEEEEEeeeCCchh-HHHHHHHHHHHHHcCCCCceeEeeEeeccceeeE
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLAD----GREVAVKQLKIGGSQG-EREFRAEVEIISRVHHRHLVSLVGYCISERERLL 454 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~~----g~~vaVK~l~~~~~~~-~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 454 (727)
.++|+++++||+|+||.||+|++.. +..||||+++...... .+.|.+|+++|++++|+|||+++|+|. ++..||
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 3579999999999999999998753 3568899886544333 457999999999999999999999996 467899
Q ss_pred EEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhc
Q 041135 455 VYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALE 534 (727)
Q Consensus 455 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 534 (727)
||||+.+|+|.+++.... ..+++..++.++.||++||+|||++ +|||||||++||||++++.+||+|||+++.+..
T Consensus 85 v~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp EEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccC
Confidence 999999999999876543 3589999999999999999999999 999999999999999999999999999986432
Q ss_pred cCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCchhhHHhhHHHHHHhhchhhH
Q 041135 535 LDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLAEALEHEDF 613 (727)
Q Consensus 535 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~ 613 (727)
..........||..|+|||++.++.++.++|||||||+||||++ |+.||...... .+..
T Consensus 161 --~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~---~~~~--------------- 220 (273)
T d1mp8a_ 161 --STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIG--------------- 220 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHH---------------
T ss_pred --CcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH---HHHH---------------
Confidence 12223345678999999999999999999999999999999998 89999764321 1111
Q ss_pred HHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhcc
Q 041135 614 EALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLD 662 (727)
Q Consensus 614 ~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 662 (727)
.+. ..............+.+||.+||+.||++||++.||+++|+.+.
T Consensus 221 -~i~-~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 221 -RIE-NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp -HHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HHH-cCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 111 11111222333456889999999999999999999999998874
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-49 Score=415.72 Aligned_cols=266 Identities=26% Similarity=0.366 Sum_probs=201.4
Q ss_pred HHHHHHhcCccccceeccCCceEEEEEEEc------CCcEEEEEEeeeCCc-hhHHHHHHHHHHHHHc-CCCCceeEeeE
Q 041135 374 DELIQATNGFSAHNVLGEGGFGCVYKGVLA------DGREVAVKQLKIGGS-QGEREFRAEVEIISRV-HHRHLVSLVGY 445 (727)
Q Consensus 374 ~el~~~~~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l-~HpnIv~l~~~ 445 (727)
++|+...++|+++++||+|+||.||+|++. +++.||||+++.... ...+.+.+|+.++.++ +|+|||+++++
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 444444578999999999999999999864 246899999975443 3345788888888887 68999999999
Q ss_pred eecc-ceeeEEEeeccCCccchhcccCC--------------CCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCC
Q 041135 446 CISE-RERLLVYEYVPNDTLHYHLHAEG--------------RPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKS 510 (727)
Q Consensus 446 ~~~~-~~~~lV~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp 510 (727)
+.+. ..+++|||||.+|+|.++|+.+. ...+++.+++.|+.||++||+|||++ +|||||||+
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp 162 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 162 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCG
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCc
Confidence 8764 46899999999999999986542 23488999999999999999999999 999999999
Q ss_pred CceEECCCCcEEEEeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCC-CCCCCCC
Q 041135 511 SNILLDSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGR-KPVDASQ 589 (727)
Q Consensus 511 ~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~-~Pf~~~~ 589 (727)
+||||++++.+||+|||+|+...... .........||..|||||++.++.++.++|||||||+||||++|. .||....
T Consensus 163 ~NILl~~~~~~Kl~DFGla~~~~~~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~ 241 (299)
T d1ywna1 163 RNILLSEKNVVKICDFGLARDIYKDP-DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 241 (299)
T ss_dssp GGEEECGGGCEEECC------CCSCT-TSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceeECCCCcEEEccCcchhhccccc-cccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999998643222 222334567999999999999999999999999999999999965 5676433
Q ss_pred CCCchhhHHhhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhcc
Q 041135 590 PLGDESLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLD 662 (727)
Q Consensus 590 ~~~~~~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 662 (727)
.. .. +...+...............+.+||++||+.||++||++.||+++|+++.
T Consensus 242 ~~--~~-----------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 242 ID--EE-----------------FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp CS--HH-----------------HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH--HH-----------------HHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 21 11 11111111122222233345889999999999999999999999999874
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4e-48 Score=404.45 Aligned_cols=261 Identities=26% Similarity=0.374 Sum_probs=201.7
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc---hhHHHHHHHHHHHHHcCCCCceeEeeEeeccc----e
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS---QGEREFRAEVEIISRVHHRHLVSLVGYCISER----E 451 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~----~ 451 (727)
.++|++++.||+|+||.||+|++. +|+.||||+++.... ...+.|.+|+++|++++|+|||++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 467999999999999999999974 699999999975433 23457899999999999999999999998654 4
Q ss_pred eeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchh
Q 041135 452 RLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKI 531 (727)
Q Consensus 452 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 531 (727)
.|||||||.|++|.+++...+. +++.+++.|+.||++||+|||++ +|||||||++||||+.++.++|+|||+++.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~--l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred EEEEEECCCCCEehhhhcccCC--CCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhh
Confidence 7899999999999998877654 89999999999999999999999 999999999999999999999999999875
Q ss_pred hhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchh
Q 041135 532 ALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHE 611 (727)
Q Consensus 532 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~ 611 (727)
..............+||..|||||++.+..++.++|||||||+||||++|+.||..... .+.....+. ..
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~~~~----~~ 230 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVR----ED 230 (277)
T ss_dssp CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHH----CC
T ss_pred hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH------HHHHHHHHh----cC
Confidence 43333333344557899999999999999999999999999999999999999975431 111111111 00
Q ss_pred hHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCC-CHHHHHHHHhhcc
Q 041135 612 DFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRP-RMSQVVRALDTLD 662 (727)
Q Consensus 612 ~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~ 662 (727)
. .............+.+|+++||+.||++|| ++++|++.|.++.
T Consensus 231 ~-------~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 231 P-------IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp C-------CCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred C-------CCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 0 000011112234578899999999999999 8999999988764
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-48 Score=414.73 Aligned_cols=248 Identities=23% Similarity=0.324 Sum_probs=206.4
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeC---CchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIG---GSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
++|+++++||+|+||.||+|+.+ +|+.||||+++.. .....+.+.+|+++|++++|+|||+++++|.+++.+||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 56999999999999999999974 6999999999743 2233467889999999999999999999999999999999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccC
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 536 (727)
|||.||+|.+++..++. +++..++.++.||+.||+|||++ +|||||||++||||+.+|.+||+|||+|+....
T Consensus 85 ey~~gg~L~~~~~~~~~--~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~-- 157 (337)
T d1o6la_ 85 EYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-- 157 (337)
T ss_dssp ECCTTCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred eccCCCchhhhhhcccC--CcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeeccccccccc--
Confidence 99999999999987665 88999999999999999999999 999999999999999999999999999985421
Q ss_pred CCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHH
Q 041135 537 SNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEAL 616 (727)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l 616 (727)
........+||..|||||++.+..|+.++|||||||+||||++|+.||.+.+. . +... .+
T Consensus 158 -~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~---~---~~~~-------------~i 217 (337)
T d1o6la_ 158 -DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---E---RLFE-------------LI 217 (337)
T ss_dssp -TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---H---HHHH-------------HH
T ss_pred -CCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH---H---HHHH-------------HH
Confidence 22234457899999999999999999999999999999999999999976431 1 1111 11
Q ss_pred HHHHhhcccchhHHHHHHHHHHHHhccCCCCCCC-----HHHHHHH
Q 041135 617 VDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPR-----MSQVVRA 657 (727)
Q Consensus 617 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 657 (727)
.... ..+.......+.+||++||+.||++|++ +.||+++
T Consensus 218 ~~~~--~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 218 LMEE--IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHCC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred hcCC--CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 1111 1122223345788999999999999995 8888875
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.3e-48 Score=411.51 Aligned_cols=245 Identities=25% Similarity=0.360 Sum_probs=204.3
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeC---CchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIG---GSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
++|+++++||+|+||+||+|+++ +|+.||||+++.. .....+.+++|+++|++++|+|||++++++.+++.+|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 46999999999999999999975 5899999999643 2233467899999999999999999999999999999999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccC
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 536 (727)
|||.||+|..++..... +.+..++.++.||+.||+|||++ +|||||||++||||+.++.+||+|||+|+....
T Consensus 84 E~~~gg~l~~~~~~~~~--~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~-- 156 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQR--FPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-- 156 (316)
T ss_dssp CCCCSCBHHHHHHHTSS--CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS--
T ss_pred eecCCcccccccccccc--ccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc--
Confidence 99999999998877655 78888899999999999999999 999999999999999999999999999986421
Q ss_pred CCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHH
Q 041135 537 SNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEAL 616 (727)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l 616 (727)
.....+||..|||||++.++.++.++|||||||+||||++|+.||.+... .+.. ..+
T Consensus 157 ----~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~-------------~~i 213 (316)
T d1fota_ 157 ----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------MKTY-------------EKI 213 (316)
T ss_dssp ----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHH-------------HHH
T ss_pred ----ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH------HHHH-------------HHH
Confidence 22356899999999999999999999999999999999999999975431 1111 111
Q ss_pred HHHHhhcccchhHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 041135 617 VDSRLEKNYVDSEMFWMIEAAAACVRHSATKRP-----RMSQVVRA 657 (727)
Q Consensus 617 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 657 (727)
+.... .+.......+.+++.+||..||++|+ +++||+++
T Consensus 214 ~~~~~--~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 214 LNAEL--RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp HHCCC--CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HcCCC--CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 11111 12222234478899999999999996 89999876
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-48 Score=409.82 Aligned_cols=261 Identities=26% Similarity=0.372 Sum_probs=212.4
Q ss_pred hcCccccceeccCCceEEEEEEEc------CCcEEEEEEeeeCCch-hHHHHHHHHHHHHHc-CCCCceeEeeEeeccce
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA------DGREVAVKQLKIGGSQ-GEREFRAEVEIISRV-HHRHLVSLVGYCISERE 451 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vaVK~l~~~~~~-~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~ 451 (727)
.++|+++++||+|+||.||+|++. +++.||||+++..... ...+|.+|+.+++++ +|+|||+++|+|.+...
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 467999999999999999999863 3578999999765443 345799999999999 69999999999999999
Q ss_pred eeEEEeeccCCccchhcccCC----------------CCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEE
Q 041135 452 RLLVYEYVPNDTLHYHLHAEG----------------RPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILL 515 (727)
Q Consensus 452 ~~lV~Ey~~~gsL~~~L~~~~----------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl 515 (727)
.+||||||.+|+|.++|+... ...+++.++++|+.||++||+|||++ +|||||||++||||
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccccc
Confidence 999999999999999987543 23588999999999999999999999 99999999999999
Q ss_pred CCCCcEEEEeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchh
Q 041135 516 DSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDES 595 (727)
Q Consensus 516 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~ 595 (727)
+.++.+||+|||+++..... .........+|+..|+|||++.++.++.++|||||||+||||+++..+|.......
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~--- 254 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKND-SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD--- 254 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSC-TTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS---
T ss_pred cccCcccccccchheeccCC-CcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH---
Confidence 99999999999999865322 22334455789999999999999999999999999999999999555543322211
Q ss_pred hHHhhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhcc
Q 041135 596 LVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLD 662 (727)
Q Consensus 596 l~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 662 (727)
..+.++++..++..........+.+||.+||+.||++||+|.||+++|+++.
T Consensus 255 ---------------~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 255 ---------------SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp ---------------HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---------------HHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence 1122233333333333334456889999999999999999999999998753
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-48 Score=410.82 Aligned_cols=256 Identities=27% Similarity=0.424 Sum_probs=202.8
Q ss_pred cCccccceeccCCceEEEEEEEcC-Cc--EEEEEEeeeC-CchhHHHHHHHHHHHHHc-CCCCceeEeeEeeccceeeEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLAD-GR--EVAVKQLKIG-GSQGEREFRAEVEIISRV-HHRHLVSLVGYCISERERLLV 455 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~~-g~--~vaVK~l~~~-~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lV 455 (727)
++|++.++||+|+||.||+|++++ |. .||||+++.. ..+..++|.+|+++|+++ +|+|||+++|+|.+++.++||
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 568899999999999999999754 44 4778887543 333456799999999998 799999999999999999999
Q ss_pred EeeccCCccchhcccC--------------CCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcE
Q 041135 456 YEYVPNDTLHYHLHAE--------------GRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEA 521 (727)
Q Consensus 456 ~Ey~~~gsL~~~L~~~--------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~v 521 (727)
|||+.+|+|.++|+.+ ....+++..+++++.||++||.|||++ +|||||||++|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence 9999999999998754 234689999999999999999999999 99999999999999999999
Q ss_pred EEEeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCC-CCCCCCCCCchhhHHhh
Q 041135 522 RVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRK-PVDASQPLGDESLVEWA 600 (727)
Q Consensus 522 kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~-Pf~~~~~~~~~~l~~~~ 600 (727)
||+|||+++..... .......||..|+|||.+.++.++.++|||||||+||||++|.. ||.... ...+.+
T Consensus 167 kl~DfG~a~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~---~~~~~~-- 237 (309)
T d1fvra_ 167 KIADFGLSRGQEVY----VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT---CAELYE-- 237 (309)
T ss_dssp EECCTTCEESSCEE----CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHH--
T ss_pred EEcccccccccccc----ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC---HHHHHH--
Confidence 99999999754221 12234568999999999999999999999999999999999765 565432 111111
Q ss_pred HHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 601 RPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 601 ~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
.+....+..........+.+||.+||+.||++||+|+||+++|+++.+
T Consensus 238 ---------------~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 238 ---------------KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp ---------------HGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------------HHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 011111112222334468899999999999999999999999998754
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=407.26 Aligned_cols=255 Identities=29% Similarity=0.432 Sum_probs=202.3
Q ss_pred cceeccCCceEEEEEEEcCC----cEEEEEEeeeC-CchhHHHHHHHHHHHHHcCCCCceeEeeEeec-cceeeEEEeec
Q 041135 386 HNVLGEGGFGCVYKGVLADG----REVAVKQLKIG-GSQGEREFRAEVEIISRVHHRHLVSLVGYCIS-ERERLLVYEYV 459 (727)
Q Consensus 386 ~~~LG~G~fg~Vy~~~~~~g----~~vaVK~l~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~-~~~~~lV~Ey~ 459 (727)
.++||+|+||+||+|++.++ ..||||+++.. +....++|.+|+++|++++|+|||+++|+|.+ +...++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 57899999999999997542 35899998743 33445789999999999999999999999875 56889999999
Q ss_pred cCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCC-
Q 041135 460 PNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSN- 538 (727)
Q Consensus 460 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~- 538 (727)
.+|+|.++++.... .+.+..+++|+.||++||.|||+. +|+|||||++||||++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~~-~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 112 KHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp TTCBHHHHHHCTTC-CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred ecCchhhhhccccc-cchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 99999998876543 578889999999999999999999 9999999999999999999999999999865432222
Q ss_pred ccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHHHH
Q 041135 539 THVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEALVD 618 (727)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l~d 618 (727)
........|+..|+|||++.++.++.++|||||||+||||++|+.||...... .++...+ ..
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~-----~~~~~~i-------------~~ 249 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-----FDITVYL-------------LQ 249 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-----------CHHHH-------------HT
T ss_pred ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH-----HHHHHHH-------------Hc
Confidence 22233467899999999999999999999999999999999988888653211 1111111 11
Q ss_pred HHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 619 SRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 619 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
. .+..........+.+||.+||+.||++||+|.||+++|+++..
T Consensus 250 g-~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 250 G-RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp T-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C-CCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 0 1111112223458899999999999999999999999998854
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-48 Score=407.74 Aligned_cols=259 Identities=28% Similarity=0.409 Sum_probs=206.7
Q ss_pred hcCccccceeccCCceEEEEEEEcC--------CcEEEEEEeeeCCc-hhHHHHHHHHHHHHHc-CCCCceeEeeEeecc
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLAD--------GREVAVKQLKIGGS-QGEREFRAEVEIISRV-HHRHLVSLVGYCISE 449 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~~--------g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~ 449 (727)
.++|+++++||+|+||.||+|++.. +..||||+++.... ....++.+|+..+.++ +|+|||+++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 3578999999999999999998632 34799999976544 3346889999999988 799999999999999
Q ss_pred ceeeEEEeeccCCccchhcccCCC--------------CcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEE
Q 041135 450 RERLLVYEYVPNDTLHYHLHAEGR--------------PVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILL 515 (727)
Q Consensus 450 ~~~~lV~Ey~~~gsL~~~L~~~~~--------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl 515 (727)
+..++|||||.+|+|.++|+.+.. ..+++.++++++.||+.||+|||++ +|||||||++||||
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceee
Confidence 999999999999999999975532 3489999999999999999999999 99999999999999
Q ss_pred CCCCcEEEEeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHh-CCCCCCCCCCCCch
Q 041135 516 DSSFEARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELIT-GRKPVDASQPLGDE 594 (727)
Q Consensus 516 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~ 594 (727)
+.++.+||+|||+++...... .........|+..|+|||++.++.|+.++|||||||+||||++ |+.||..... .
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~---~ 244 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHID-YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---E 244 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCC-TTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---H
T ss_pred cCCCCeEeccchhhccccccc-cccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH---H
Confidence 999999999999998654322 2233455678999999999999999999999999999999998 6888865331 1
Q ss_pred hhHHhhHHHHHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhcc
Q 041135 595 SLVEWARPLLAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLD 662 (727)
Q Consensus 595 ~l~~~~~~~l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 662 (727)
.+ ...+...............+.+||.+||+.||++||++.||++.|+++.
T Consensus 245 ~~-----------------~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 245 EL-----------------FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp HH-----------------HHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH-----------------HHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 11 1111222222222333445889999999999999999999999998874
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-49 Score=415.54 Aligned_cols=268 Identities=23% Similarity=0.322 Sum_probs=200.6
Q ss_pred cCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHH--HHHHHHHHcCCCCceeEeeEeeccc----eeeE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFR--AEVEIISRVHHRHLVSLVGYCISER----ERLL 454 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~--~Ei~~l~~l~HpnIv~l~~~~~~~~----~~~l 454 (727)
++|.+.++||+|+||.||+|++ +|+.||||+++.. ..+++. +|+..+.+++|+|||+++|+|.+++ .+||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 4578889999999999999998 5899999998643 233444 4555556789999999999998654 5799
Q ss_pred EEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcC-----CCcEEeeCCCCCceEECCCCcEEEEeeccc
Q 041135 455 VYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDC-----HPRIIHRDIKSSNILLDSSFEARVADFGLA 529 (727)
Q Consensus 455 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-----~~~ivHrDLkp~NILl~~~~~vkL~DFGla 529 (727)
|||||.+|+|.++|+++ .++|..+++++.|++.||+|||+.. +.+|||||||++||||++++.+||+|||++
T Consensus 79 v~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 99999999999999865 3899999999999999999999731 238999999999999999999999999999
Q ss_pred hhhhccCCCc-cccccccCCccccccCcccCCC------CCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhh----HH
Q 041135 530 KIALELDSNT-HVSTRVMGTFGYMAPEYATSGK------LTEKSDVYSFGVVLLELITGRKPVDASQPLGDESL----VE 598 (727)
Q Consensus 530 ~~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~------~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l----~~ 598 (727)
+......... ......+||.+|||||++.+.. ++.++|||||||+||||++|..+|........... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 8653322221 1234568999999999987643 56799999999999999999988754332111000 00
Q ss_pred hhHHHHHHhhchhhHHHHHHHHhhc----c-cchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 599 WARPLLAEALEHEDFEALVDSRLEK----N-YVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 599 ~~~~~l~~~~~~~~~~~l~d~~l~~----~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
+....+. ..+.+..++. . ........+.+|+++||+.||++||+|.||+++|+++.+
T Consensus 236 ~~~~~~~--------~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 297 (303)
T d1vjya_ 236 PSVEEMR--------KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp CCHHHHH--------HHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred chHHHHH--------HHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 0000000 0111111111 1 123445668899999999999999999999999998864
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-47 Score=404.49 Aligned_cols=253 Identities=18% Similarity=0.288 Sum_probs=204.8
Q ss_pred HhcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEe
Q 041135 379 ATNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYE 457 (727)
Q Consensus 379 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 457 (727)
..++|++++.||+|+||.||+|+++ +|+.||||+++... .+...+++|+++|+.++|+|||+++++|.+++.+|||||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 3578999999999999999999975 58899999997543 344578899999999999999999999999999999999
Q ss_pred eccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECC--CCcEEEEeeccchhhhcc
Q 041135 458 YVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDS--SFEARVADFGLAKIALEL 535 (727)
Q Consensus 458 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~--~~~vkL~DFGla~~~~~~ 535 (727)
||.||+|.++|+.++. .+++.+++.|+.||++||+|||++ +|+|||||++||||+. ++.+||+|||+++...
T Consensus 82 ~~~gg~L~~~i~~~~~-~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~-- 155 (321)
T d1tkia_ 82 FISGLDIFERINTSAF-ELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK-- 155 (321)
T ss_dssp CCCCCBHHHHHTSSSC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECC--
T ss_pred cCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccc--
Confidence 9999999999976542 489999999999999999999999 9999999999999974 4589999999997532
Q ss_pred CCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHH
Q 041135 536 DSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEA 615 (727)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~ 615 (727)
........+|+..|+|||.+.+..++.++||||||||||||++|+.||..... .+....+..... .+..
T Consensus 156 --~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~------~~~~~~i~~~~~---~~~~ 224 (321)
T d1tkia_ 156 --PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN------QQIIENIMNAEY---TFDE 224 (321)
T ss_dssp --TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHTCC---CCCH
T ss_pred --cCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCC---CCCh
Confidence 12233446789999999999999999999999999999999999999976431 111111111000 0000
Q ss_pred HHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 616 LVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 616 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
. ........+.+|+++||..||++|+++.||+++
T Consensus 225 ~--------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 225 E--------AFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp H--------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred h--------hccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 000112347789999999999999999999985
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-47 Score=412.02 Aligned_cols=245 Identities=25% Similarity=0.306 Sum_probs=204.2
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 456 (727)
++|+++++||+|+||.||+|+++ +|+.||||+++... ....+.+.+|+++|+.++|+|||+++++|.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 46999999999999999999975 69999999986422 233457889999999999999999999999999999999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccC
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELD 536 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 536 (727)
||+.+|+|..++..++. +++.+++.|+.||+.||+|||++ +|||||||++||||+.++.+||+|||+|+....
T Consensus 121 e~~~~g~l~~~l~~~~~--l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~-- 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-- 193 (350)
T ss_dssp ECCTTCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS--
T ss_pred ccccccchhhhHhhcCC--CCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc--
Confidence 99999999999977654 89999999999999999999999 999999999999999999999999999986421
Q ss_pred CCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHHH
Q 041135 537 SNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEAL 616 (727)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~l 616 (727)
.....+||..|||||++.+..++.++|||||||+||||++|+.||.+... ..... .+
T Consensus 194 ----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~-------------~i 250 (350)
T d1rdqe_ 194 ----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP------IQIYE-------------KI 250 (350)
T ss_dssp ----CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHH-------------HH
T ss_pred ----ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH------HHHHH-------------HH
Confidence 22346799999999999999999999999999999999999999975321 11111 11
Q ss_pred HHHHhhcccchhHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 041135 617 VDSRLEKNYVDSEMFWMIEAAAACVRHSATKRP-----RMSQVVRA 657 (727)
Q Consensus 617 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 657 (727)
....+ .+.......+.+|+++||+.||++|+ ++.||+++
T Consensus 251 ~~~~~--~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 251 VSGKV--RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp HHCCC--CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred hcCCC--CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 11111 11222234578999999999999995 89998875
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-48 Score=410.90 Aligned_cols=259 Identities=24% Similarity=0.403 Sum_probs=209.2
Q ss_pred hcCccccceeccCCceEEEEEEEc------CCcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEeecccee
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA------DGREVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYCISERER 452 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 452 (727)
.++|+++++||+|+||.||+|++. +++.||||+++.... +....|.+|+++|++++|+|||+++|+|..++..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 467899999999999999999864 257899999975433 3335689999999999999999999999999999
Q ss_pred eEEEeeccCCccchhcccCC--------CCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEE
Q 041135 453 LLVYEYVPNDTLHYHLHAEG--------RPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVA 524 (727)
Q Consensus 453 ~lV~Ey~~~gsL~~~L~~~~--------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~ 524 (727)
+||||||.+|+|.++++... ...+++..+++|+.||++||.|||++ +|||||||++||||++++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEe
Confidence 99999999999999886431 23468899999999999999999999 99999999999999999999999
Q ss_pred eeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCC-CCCCCCCCCCchhhHHhhHHH
Q 041135 525 DFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGR-KPVDASQPLGDESLVEWARPL 603 (727)
Q Consensus 525 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~-~Pf~~~~~~~~~~l~~~~~~~ 603 (727)
|||+++...... .........|+..|+|||.+.++.++.++|||||||+||||++|+ .||..... .++
T Consensus 176 DFGla~~~~~~~-~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~------~~~---- 244 (308)
T d1p4oa_ 176 DFGMTRDIYETD-YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN------EQV---- 244 (308)
T ss_dssp CTTCCCGGGGGG-CEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH------HHH----
T ss_pred ecccceeccCCc-ceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH------HHH----
Confidence 999998654322 223344567899999999999999999999999999999999985 66654321 111
Q ss_pred HHHhhchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhcc
Q 041135 604 LAEALEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLD 662 (727)
Q Consensus 604 l~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 662 (727)
+..+.+.. ...........+.+||.+||+.||++||+|.||+++|++..
T Consensus 245 ---------~~~i~~~~-~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 245 ---------LRFVMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp ---------HHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred ---------HHHHHhCC-CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 11111111 11112223346889999999999999999999999998764
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.9e-47 Score=396.63 Aligned_cols=250 Identities=22% Similarity=0.299 Sum_probs=203.7
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCch---------hHHHHHHHHHHHHHcC-CCCceeEeeEeec
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQ---------GEREFRAEVEIISRVH-HRHLVSLVGYCIS 448 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~---------~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~ 448 (727)
.++|+++++||+|+||+||+|+.. +|+.||||+++..... ..+.+.+|+++|++++ |+|||+++++|.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 367999999999999999999974 6899999999754321 1235889999999997 9999999999999
Q ss_pred cceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeecc
Q 041135 449 ERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGL 528 (727)
Q Consensus 449 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGl 528 (727)
++..|||||||.+|+|.++|+.++. +++.+++.++.||++||+|||++ +|||||||++||||+.++.+||+|||+
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~--l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred CcceEEEEEcCCCchHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchh
Confidence 9999999999999999999987654 89999999999999999999999 999999999999999999999999999
Q ss_pred chhhhccCCCccccccccCCccccccCcccC------CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHH
Q 041135 529 AKIALELDSNTHVSTRVMGTFGYMAPEYATS------GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARP 602 (727)
Q Consensus 529 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~------~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~ 602 (727)
++.+.. .......+||..|++||++.+ ..++.++|||||||+||||++|+.||.+... .+..+
T Consensus 157 a~~~~~----~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~------~~~~~- 225 (277)
T d1phka_ 157 SCQLDP----GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ------MLMLR- 225 (277)
T ss_dssp CEECCT----TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHH-
T ss_pred eeEccC----CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH------HHHHH-
Confidence 986422 223345679999999999863 3478899999999999999999999976431 01111
Q ss_pred HHHHhhchhhHHHHHHHHh--hcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 603 LLAEALEHEDFEALVDSRL--EKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 603 ~l~~~~~~~~~~~l~d~~l--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
.++.... ...........+.+|+++||+.||++|+++.||+++
T Consensus 226 ------------~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 226 ------------MIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp ------------HHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred ------------HHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1111111 111111223457899999999999999999999875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-47 Score=406.68 Aligned_cols=252 Identities=23% Similarity=0.292 Sum_probs=198.3
Q ss_pred cCccccc-eeccCCceEEEEEEE-cCCcEEEEEEeeeCCchhHHHHHHHHHHHHHc-CCCCceeEeeEeec----cceee
Q 041135 381 NGFSAHN-VLGEGGFGCVYKGVL-ADGREVAVKQLKIGGSQGEREFRAEVEIISRV-HHRHLVSLVGYCIS----ERERL 453 (727)
Q Consensus 381 ~~~~~~~-~LG~G~fg~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~----~~~~~ 453 (727)
++|++++ +||+|+||.||+|++ .+|+.||||+++. ...+++|++++.++ +|+|||+++++|.+ +..+|
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 5688775 699999999999997 4689999999863 35678899987655 89999999999875 46789
Q ss_pred EEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECC---CCcEEEEeeccch
Q 041135 454 LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDS---SFEARVADFGLAK 530 (727)
Q Consensus 454 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~---~~~vkL~DFGla~ 530 (727)
||||||.||+|.++|..++...+++.+++.|+.||+.||+|||++ +|+|||||++||||++ ++.+||+|||+|+
T Consensus 86 ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccceee
Confidence 999999999999999876656799999999999999999999999 9999999999999975 5679999999998
Q ss_pred hhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhch
Q 041135 531 IALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEH 610 (727)
Q Consensus 531 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~ 610 (727)
.... .......+||..|||||++.+..|+.++||||||||||||++|+.||.+........ . +...+..
T Consensus 163 ~~~~----~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~---~----~~~~i~~ 231 (335)
T d2ozaa1 163 ETTS----HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---G----MKTRIRM 231 (335)
T ss_dssp ECCC----CCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------------CCCS
T ss_pred eccC----CCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH---H----HHHHHhc
Confidence 5432 122345689999999999999999999999999999999999999997654321100 0 0000000
Q ss_pred hhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 611 EDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 611 ~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
..+. +...........+.+|+++||+.||++|+++.||+++
T Consensus 232 ~~~~------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 232 GQYE------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp CSSS------CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCC------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 0000 0000001112347889999999999999999999986
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.7e-47 Score=411.15 Aligned_cols=247 Identities=27% Similarity=0.371 Sum_probs=198.1
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHH---HHHHHHcCCCCceeEeeEeeccceee
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAE---VEIISRVHHRHLVSLVGYCISERERL 453 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~E---i~~l~~l~HpnIv~l~~~~~~~~~~~ 453 (727)
++|+++++||+|+||.||+|++. +|+.||||++.... ......+.+| +++|+.++|+|||+++++|.+++.+|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57999999999999999999975 58999999986322 1222334444 55666678999999999999999999
Q ss_pred EEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhh
Q 041135 454 LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIAL 533 (727)
Q Consensus 454 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~ 533 (727)
||||||.||+|.++|..+.. +.+.+++.|+.||+.||+|||++ +|||||||++||||+.++.+||+|||+|+.+.
T Consensus 84 ivmE~~~gg~L~~~l~~~~~--~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEECCCCSCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEecCCCcHHHHHHhccc--ccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 99999999999999987654 78999999999999999999999 99999999999999999999999999998542
Q ss_pred ccCCCccccccccCCccccccCcccC-CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhh
Q 041135 534 ELDSNTHVSTRVMGTFGYMAPEYATS-GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHED 612 (727)
Q Consensus 534 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~ 612 (727)
. ......+||..|||||++.+ ..++.++|||||||+||||++|+.||..........
T Consensus 159 ~-----~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~----------------- 216 (364)
T d1omwa3 159 K-----KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----------------- 216 (364)
T ss_dssp S-----SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH-----------------
T ss_pred C-----CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH-----------------
Confidence 2 12344679999999999975 468999999999999999999999998654322111
Q ss_pred HHHHHHHHhh--cccchhHHHHHHHHHHHHhccCCCCCCC-----HHHHHHH
Q 041135 613 FEALVDSRLE--KNYVDSEMFWMIEAAAACVRHSATKRPR-----MSQVVRA 657 (727)
Q Consensus 613 ~~~l~d~~l~--~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 657 (727)
+....+. ..+.......+.+||.+||+.||++|++ ++||+++
T Consensus 217 ---~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 217 ---IDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp ---HHHHSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred ---HHHhcccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 0111110 1111222345789999999999999999 6888875
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-47 Score=405.46 Aligned_cols=248 Identities=25% Similarity=0.373 Sum_probs=202.0
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC---chhHHHHHHHHHHHH-HcCCCCceeEeeEeeccceeeEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG---SQGEREFRAEVEIIS-RVHHRHLVSLVGYCISERERLLV 455 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~~~Ei~~l~-~l~HpnIv~l~~~~~~~~~~~lV 455 (727)
++|+++++||+|+||+||+|++. +|+.||||+++... ....+.+.+|+.+|. .++|+|||++++++.+++.+|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999975 58999999997432 223345677777765 68999999999999999999999
Q ss_pred EeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhcc
Q 041135 456 YEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALEL 535 (727)
Q Consensus 456 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 535 (727)
||||.+|+|.++++.+.. +++.+++.++.||+.||+|||++ +|+|||||++|||+++++.+||+|||+++...
T Consensus 82 mEy~~~g~L~~~i~~~~~--~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~-- 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM-- 154 (320)
T ss_dssp EECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC--
T ss_pred EeecCCCcHHHHhhccCC--CCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcc--
Confidence 999999999999987665 88899999999999999999999 99999999999999999999999999997532
Q ss_pred CCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHHH
Q 041135 536 DSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFEA 615 (727)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~ 615 (727)
.........+||..|+|||++.++.++.++|||||||+||||++|+.||.+... ..+ .. .
T Consensus 155 -~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~---~~~---~~-------------~ 214 (320)
T d1xjda_ 155 -LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE---EEL---FH-------------S 214 (320)
T ss_dssp -CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHH---HH-------------H
T ss_pred -cccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH---HHH---HH-------------H
Confidence 222334456899999999999999999999999999999999999999976431 111 00 0
Q ss_pred HHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHH-HHHHH
Q 041135 616 LVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMS-QVVRA 657 (727)
Q Consensus 616 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~~ 657 (727)
+.... ..+.......+.+|+.+||+.||++|+++. ||+++
T Consensus 215 i~~~~--~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 215 IRMDN--PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp HHHCC--CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred HHcCC--CCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence 11100 111122234578999999999999999995 77653
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-47 Score=398.84 Aligned_cols=259 Identities=22% Similarity=0.285 Sum_probs=194.5
Q ss_pred ccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchh-----HHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEee
Q 041135 385 AHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQG-----EREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 385 ~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~-----~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 458 (727)
.+++||+|+||+||+|+++ +|+.||||+++...... .+.+.+|+++|++++|+|||+++++|.+++..||||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3588999999999999975 58999999986443221 24688999999999999999999999999999999999
Q ss_pred ccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCC
Q 041135 459 VPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSN 538 (727)
Q Consensus 459 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 538 (727)
+.++++..++..+. .+++.++..|++||+.||+|||++ +|+|||||++|||++.++.+||+|||+++.... .
T Consensus 82 ~~~~~~~~~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~---~ 153 (299)
T d1ua2a_ 82 METDLEVIIKDNSL--VLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGS---P 153 (299)
T ss_dssp CSEEHHHHHTTCCS--SCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS---C
T ss_pred hcchHHhhhhhccc--CCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCC---C
Confidence 99988877765443 488999999999999999999999 999999999999999999999999999976432 2
Q ss_pred ccccccccCCccccccCcccCC-CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhc--hhhHHH
Q 041135 539 THVSTRVMGTFGYMAPEYATSG-KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALE--HEDFEA 615 (727)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~l~~~-~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~--~~~~~~ 615 (727)
.......+||..|+|||++.+. .++.++|||||||+||||++|+.+|.+... ... ...++..... ...+..
T Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~---~~~---l~~i~~~~~~~~~~~~~~ 227 (299)
T d1ua2a_ 154 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD---LDQ---LTRIFETLGTPTEEQWPD 227 (299)
T ss_dssp CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHH---HHHHHHHHCCCCTTTSSS
T ss_pred cccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCH---HHH---HHHHHHhcCCCChhhccc
Confidence 2223346799999999998754 579999999999999999999999976431 111 1111110000 000000
Q ss_pred HH---HHHhhc--------ccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 616 LV---DSRLEK--------NYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 616 l~---d~~l~~--------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
.. ...... .........+.+|+++||+.||++|+++.|++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 228 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 00 000000 0001112347899999999999999999999875
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-46 Score=392.25 Aligned_cols=264 Identities=20% Similarity=0.300 Sum_probs=198.9
Q ss_pred cCccccceeccCCceEEEEEEE-cCCcEEEEEEeeeCCc--hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEe
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVL-ADGREVAVKQLKIGGS--QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYE 457 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 457 (727)
++|+++++||+|+||.||+|++ .+|+.||||+++.... ...+.+.+|+++|++++|+|||+++++|.++..+|||||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5799999999999999999997 4689999999965432 234678999999999999999999999999999999999
Q ss_pred eccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCC
Q 041135 458 YVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDS 537 (727)
Q Consensus 458 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 537 (727)
|+.++.+. ++.......+++.+++.|+.||+.||+|||++ +|||||||++|||++.++.+||+|||+|+....
T Consensus 82 ~~~~~~~~-~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~--- 154 (298)
T d1gz8a_ 82 FLHQDLKK-FMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--- 154 (298)
T ss_dssp CCSEEHHH-HHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC---
T ss_pred ecCCchhh-hhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccC---
Confidence 99765444 44443444689999999999999999999999 999999999999999999999999999986532
Q ss_pred CccccccccCCccccccCcccCCC-CCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhc--hhhHH
Q 041135 538 NTHVSTRVMGTFGYMAPEYATSGK-LTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALE--HEDFE 614 (727)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~l~~~~-~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~--~~~~~ 614 (727)
.........|+..|+|||++.... ++.++|||||||+||||++|+.||.+.+.. . ....++..... ...+.
T Consensus 155 ~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~---~---~~~~i~~~~~~~~~~~~~ 228 (298)
T d1gz8a_ 155 PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI---D---QLFRIFRTLGTPDEVVWP 228 (298)
T ss_dssp CSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---H---HHHHHHHHHCCCCTTTST
T ss_pred CcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH---H---HHHHHHHhcCCCchhhcc
Confidence 223344567999999999887765 578999999999999999999999764311 1 11111110000 00000
Q ss_pred HHHH-HHhhcc-----------cchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 615 ALVD-SRLEKN-----------YVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 615 ~l~d-~~l~~~-----------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
.... ...... ........+.+|+++||+.||++|+++.||+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 229 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0000 000000 001112347889999999999999999999986
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=6.4e-46 Score=389.31 Aligned_cols=263 Identities=21% Similarity=0.345 Sum_probs=200.7
Q ss_pred cCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCch--hHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEee
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQ--GEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~--~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 458 (727)
++|+++++||+|+||+||+|++++|+.||||+++..... ..+.+.+|+++|++++|+|||+++++|.+++..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 579999999999999999999999999999999754332 246799999999999999999999999999999999999
Q ss_pred ccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCCC
Q 041135 459 VPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDSN 538 (727)
Q Consensus 459 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 538 (727)
+.++++..+++.++. +++..++.|+.||+.||+|||++ +|||||||++||||+.++.+||+|||++..... .
T Consensus 82 ~~~~~~~~~~~~~~~--l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~---~ 153 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEGG--LESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGI---P 153 (286)
T ss_dssp CSEEHHHHHHTSTTC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred ehhhhHHHHHhhcCC--cchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceeccc---C
Confidence 988888777765544 99999999999999999999999 999999999999999999999999999986532 1
Q ss_pred ccccccccCCccccccCcccCC-CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhc--hhhHHH
Q 041135 539 THVSTRVMGTFGYMAPEYATSG-KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALE--HEDFEA 615 (727)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~l~~~-~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~--~~~~~~ 615 (727)
........|+..|++||.+.+. .++.++|||||||+||||++|+.||..... ... ...++..... ...+..
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~---~~~---~~~i~~~~~~~~~~~~~~ 227 (286)
T d1ob3a_ 154 VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE---ADQ---LMRIFRILGTPNSKNWPN 227 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHH---HHHHHHHHCCCCTTTSTT
T ss_pred ccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCH---HHH---HHHHHHhhCCCChhhccc
Confidence 2223345688999999999765 568999999999999999999999976431 111 1111110000 000000
Q ss_pred HHH-HHhh-----------cccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 616 LVD-SRLE-----------KNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 616 l~d-~~l~-----------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
... .... ..+.......+.+|+++||+.||++|++++||+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp GGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 0000 00111122357799999999999999999999864
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=391.66 Aligned_cols=241 Identities=21% Similarity=0.364 Sum_probs=195.7
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc------hhHHHHHHHHHHHHHcC--CCCceeEeeEeeccc
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS------QGEREFRAEVEIISRVH--HRHLVSLVGYCISER 450 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~------~~~~~~~~Ei~~l~~l~--HpnIv~l~~~~~~~~ 450 (727)
.++|+++++||+|+||.||+|++. +|+.||||+++.... .....+.+|+++|++++ |+|||+++++|.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 357999999999999999999975 689999999864321 12234778999999997 899999999999999
Q ss_pred eeeEEEeeccC-CccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECC-CCcEEEEeecc
Q 041135 451 ERLLVYEYVPN-DTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDS-SFEARVADFGL 528 (727)
Q Consensus 451 ~~~lV~Ey~~~-gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~-~~~vkL~DFGl 528 (727)
..|+||||+.+ ++|.+++..+.. +++.+++.++.||++||+|||++ +|||||||++||||+. ++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~--l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred eEEEEEEeccCcchHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcccc
Confidence 99999999976 577777766544 89999999999999999999999 9999999999999985 57999999999
Q ss_pred chhhhccCCCccccccccCCccccccCcccCCCC-CchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHh
Q 041135 529 AKIALELDSNTHVSTRVMGTFGYMAPEYATSGKL-TEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEA 607 (727)
Q Consensus 529 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~ 607 (727)
|+... ........||..|+|||++.+..+ +.++|||||||+||||++|+.||...+ .+ .
T Consensus 158 a~~~~-----~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~i-------~--- 217 (273)
T d1xwsa_ 158 GALLK-----DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EI-------I--- 217 (273)
T ss_dssp CEECC-----SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HH-------H---
T ss_pred ceecc-----cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----HH-------h---
Confidence 97532 122345679999999999987665 577999999999999999999996421 00 0
Q ss_pred hchhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 608 LEHEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 608 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
...+ .+.......+.+|+++||+.||++||+++||+++
T Consensus 218 ----------~~~~--~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 218 ----------RGQV--FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp ----------HCCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----------hccc--CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 0000 1111122347889999999999999999999875
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-45 Score=388.24 Aligned_cols=264 Identities=25% Similarity=0.339 Sum_probs=197.8
Q ss_pred hcCccccceeccCCceEEEEEEEc-C-CcEEEEEEeeeCCc--hhHHHHHHHHHHHHHc---CCCCceeEeeEeec----
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-D-GREVAVKQLKIGGS--QGEREFRAEVEIISRV---HHRHLVSLVGYCIS---- 448 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~-g~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l---~HpnIv~l~~~~~~---- 448 (727)
.++|+++++||+|+||+||+|++. + ++.||||+++.... .....+.+|+++|+.| +|+||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999999974 3 66799999975432 2234577888888776 79999999999853
Q ss_pred -cceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeec
Q 041135 449 -ERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFG 527 (727)
Q Consensus 449 -~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFG 527 (727)
+...+++|||+.++.+...... ....+++..++.|+.||+.||+|||++ +|||||||++|||+++++.+||+|||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred cCceEEEEEEeccCCchhhhhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchh
Confidence 3467999999988877654433 334589999999999999999999999 99999999999999999999999999
Q ss_pred cchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHh
Q 041135 528 LAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEA 607 (727)
Q Consensus 528 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~ 607 (727)
+++... ........+||..|||||++.+..|+.++|||||||+||||++|+.||.+... .. ....++...
T Consensus 162 ~~~~~~----~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~---~~---~~~~i~~~~ 231 (305)
T d1blxa_ 162 LARIYS----FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD---VD---QLGKILDVI 231 (305)
T ss_dssp SCCCCC----GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HH---HHHHHHHHH
T ss_pred hhhhhc----ccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH---HH---HHHHHHHhh
Confidence 987432 22334557899999999999999999999999999999999999999976431 11 111111100
Q ss_pred hch--hhHHHH---HHHHh-------hcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 608 LEH--EDFEAL---VDSRL-------EKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 608 ~~~--~~~~~l---~d~~l-------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
... ..+... ..... ...+.......+.+|+.+||+.||++|+++.||+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 232 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp CCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000 000000 00000 001111223357789999999999999999999886
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-45 Score=393.74 Aligned_cols=269 Identities=20% Similarity=0.270 Sum_probs=198.4
Q ss_pred hcCccccceeccCCceEEEEEEE-cCCcEEEEEEeeeCCc-hhHHHHHHHHHHHHHcCCCCceeEeeEeeccc----eee
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVL-ADGREVAVKQLKIGGS-QGEREFRAEVEIISRVHHRHLVSLVGYCISER----ERL 453 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vaVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~----~~~ 453 (727)
..+|+++++||+|+||+||+|+. .+|+.||||+++.... ...+.+++|+++|++|+|+||++++++|.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 45699999999999999999986 4799999999975433 33467899999999999999999999997643 335
Q ss_pred EEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhh
Q 041135 454 LVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIAL 533 (727)
Q Consensus 454 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~ 533 (727)
++++|+.+|+|.+++..+ .+++.+++.|+.||++||+|||++ +|||||||++||||++++.+||+|||+++...
T Consensus 87 ~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 566677799999999754 389999999999999999999999 99999999999999999999999999998654
Q ss_pred ccCCCccccccccCCccccccCcccC-CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHH----hh
Q 041135 534 ELDSNTHVSTRVMGTFGYMAPEYATS-GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAE----AL 608 (727)
Q Consensus 534 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~----~~ 608 (727)
............+|+..|+|||++.. ..++.++|||||||++|||++|+.||...... .........+.. ..
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~ 237 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL---DQLNHILGILGSPSQEDL 237 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCSCCHHHH
T ss_pred CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHH---HHHHHHhhhccCCChhhh
Confidence 43333334456789999999999855 46789999999999999999999999764321 111100000000 00
Q ss_pred chhhHHHHHHHHh--hccc-------chhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 609 EHEDFEALVDSRL--EKNY-------VDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 609 ~~~~~~~l~d~~l--~~~~-------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
.........+... .... .......+.+|+.+||+.||++|+++.||+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000000000000 0000 00111347899999999999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.6e-44 Score=377.37 Aligned_cols=263 Identities=17% Similarity=0.231 Sum_probs=207.8
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCC-CCceeEeeEeeccceeeEEEee
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRVHH-RHLVSLVGYCISERERLLVYEY 458 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H-pnIv~l~~~~~~~~~~~lV~Ey 458 (727)
++|+++++||+|+||.||+|++. +|+.||||++... .....+++|+++++.|+| +||+.+++++.++...++||||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccc--cCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 57999999999999999999975 6899999988643 234568899999999975 8999999999999999999999
Q ss_pred ccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECC-----CCcEEEEeeccchhhh
Q 041135 459 VPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDS-----SFEARVADFGLAKIAL 533 (727)
Q Consensus 459 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~-----~~~vkL~DFGla~~~~ 533 (727)
+ +++|.++++..+. .+.+.++++|+.|++.||+|||++ +|||||||++||||+. ++.+||+|||+|+.+.
T Consensus 83 ~-~~~l~~~~~~~~~-~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 83 L-GPSLEDLLDLCGR-KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp C-CCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred c-CCCHHHHHHhhcc-chhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 9 7888888865543 589999999999999999999999 9999999999999964 5789999999998654
Q ss_pred ccCCCc----cccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhc
Q 041135 534 ELDSNT----HVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALE 609 (727)
Q Consensus 534 ~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~ 609 (727)
+..... ......+||..|||||++.+..++.++|||||||++|||++|+.||.+..........+. +.... .
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~---i~~~~-~ 233 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER---IGEKK-Q 233 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH---HHHHH-H
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHH---HHhcc-C
Confidence 322221 123346899999999999999999999999999999999999999987554332221111 11000 0
Q ss_pred hhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhccC
Q 041135 610 HEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLDG 663 (727)
Q Consensus 610 ~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 663 (727)
..... .+...+ ...+.+|+..|+..++++||+++.|.+.|+++.+
T Consensus 234 ~~~~~-----~l~~~~----p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~ 278 (293)
T d1csna_ 234 STPLR-----ELCAGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278 (293)
T ss_dssp HSCHH-----HHTTTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred CCChH-----HhcCCC----CHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHH
Confidence 00111 111112 2347889999999999999999999999887643
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.3e-44 Score=378.70 Aligned_cols=262 Identities=20% Similarity=0.244 Sum_probs=196.2
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCce-eEeeEeeccceeeEEEee
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLV-SLVGYCISERERLLVYEY 458 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv-~l~~~~~~~~~~~lV~Ey 458 (727)
++|++++.||+|+||.||+|++. +|+.||||+++... ...++.+|+++++.++|.|++ .+.+++.++...++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 56999999999999999999974 58999999987543 335688999999999876655 455556677788999999
Q ss_pred ccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEEC---CCCcEEEEeeccchhhhcc
Q 041135 459 VPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLD---SSFEARVADFGLAKIALEL 535 (727)
Q Consensus 459 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~---~~~~vkL~DFGla~~~~~~ 535 (727)
+. ++|.+++.... ..+++..++.++.||+.||+|||++ +|||||||++||||+ .+..+||+|||+|+.+.+.
T Consensus 85 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 85 LG-PSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp CC-CBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred cC-Cchhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 95 45555444332 2489999999999999999999999 999999999999985 4567999999999865432
Q ss_pred CCCc----cccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchh
Q 041135 536 DSNT----HVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHE 611 (727)
Q Consensus 536 ~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~ 611 (727)
.... .......||..|||||++.+..++.++|||||||+||||++|+.||............... ..... ..
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~---~~~~~-~~ 235 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI---SEKKM-ST 235 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHH---HHHHH-HS
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHh---hcccC-CC
Confidence 2221 1234568999999999999999999999999999999999999999765432211111100 00000 00
Q ss_pred hHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhhcc
Q 041135 612 DFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRALDTLD 662 (727)
Q Consensus 612 ~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 662 (727)
. ...+...+ ...+.+|+..||+.+|++||++.+|.+.|+++.
T Consensus 236 ~-----~~~~~~~~----p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~ 277 (299)
T d1ckia_ 236 P-----IEVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277 (299)
T ss_dssp C-----HHHHTTTS----CHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred C-----hhHhccCC----CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 0 01111111 234788999999999999999999999888764
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-45 Score=388.92 Aligned_cols=271 Identities=17% Similarity=0.267 Sum_probs=196.3
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc--hhHHHHHHHHHHHHHcCCCCceeEeeEeec--------c
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS--QGEREFRAEVEIISRVHHRHLVSLVGYCIS--------E 449 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~--------~ 449 (727)
++|+++++||+|+||+||+|++. +|+.||||+++.... ...+.+.+|+++|++++|+||++++++|.. +
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 67999999999999999999974 699999999864432 334678999999999999999999999865 3
Q ss_pred ceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccc
Q 041135 450 RERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLA 529 (727)
Q Consensus 450 ~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla 529 (727)
..+|+||||+.++++..+..... .+....++.|+.||++||+|||++ +|||||||++||||+.++.+||+|||++
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~~~--~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNVLV--KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCTTC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred ceEEEEEeccCCCccchhhhccc--ccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeeccee
Confidence 46799999998888776655444 388899999999999999999999 9999999999999999999999999999
Q ss_pred hhhhccCC-CccccccccCCccccccCcccCC-CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHh
Q 041135 530 KIALELDS-NTHVSTRVMGTFGYMAPEYATSG-KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEA 607 (727)
Q Consensus 530 ~~~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~-~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~ 607 (727)
+.+..... ........+||..|+|||++.+. .++.++|||||||+||||++|+.||.+... ..........+...
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~---~~~~~~i~~~~~~~ 241 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE---QHQLALISQLCGSI 241 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCC
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCH---HHHHHHHHHhcCCC
Confidence 75432221 12223346799999999999865 689999999999999999999999975431 11111111000000
Q ss_pred -------hchhhHHHHHHHHhhcccchh-------HHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 041135 608 -------LEHEDFEALVDSRLEKNYVDS-------EMFWMIEAAAACVRHSATKRPRMSQVVRALD 659 (727)
Q Consensus 608 -------~~~~~~~~l~d~~l~~~~~~~-------~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 659 (727)
.........+........... ....+++|+.+||+.||++|++++||+++=.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpf 307 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 307 (318)
T ss_dssp CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChh
Confidence 000000000000000000000 0123678999999999999999999998743
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-44 Score=388.49 Aligned_cols=266 Identities=21% Similarity=0.326 Sum_probs=194.9
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc--hhHHHHHHHHHHHHHcCCCCceeEeeEeeccc------
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS--QGEREFRAEVEIISRVHHRHLVSLVGYCISER------ 450 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~------ 450 (727)
.++|+++++||+|+||+||+|++. +|+.||||+++.... ...+.+.+|+++|++++|+|||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 467999999999999999999975 599999999974322 33457889999999999999999999997654
Q ss_pred eeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccch
Q 041135 451 ERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAK 530 (727)
Q Consensus 451 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~ 530 (727)
.+||||||| +++|..+++.. .+++..++.|+.||+.||+|||++ +|||||||++|||++.++.+||+|||+|+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR 169 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecc-cccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhccccccccccccccee
Confidence 569999999 66777766543 389999999999999999999999 99999999999999999999999999998
Q ss_pred hhhccCCCccccccccCCccccccCcccCC-CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHH------
Q 041135 531 IALELDSNTHVSTRVMGTFGYMAPEYATSG-KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPL------ 603 (727)
Q Consensus 531 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~------ 603 (727)
... .......|+..|+|||++.+. .++.++|||||||+||||++|+.||...+... .+.......
T Consensus 170 ~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~~ 241 (346)
T d1cm8a_ 170 QAD------SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD--QLKEIMKVTGTPPAE 241 (346)
T ss_dssp ECC------SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCHH
T ss_pred ccC------CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHH--HHHHHHhccCCCcHH
Confidence 542 123456799999999998764 57899999999999999999999997653211 111100000
Q ss_pred HHHhhchhhHHHHHHHHhhcc-------cchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH--Hhhc
Q 041135 604 LAEALEHEDFEALVDSRLEKN-------YVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA--LDTL 661 (727)
Q Consensus 604 l~~~~~~~~~~~l~d~~l~~~-------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~ 661 (727)
+............ ...+... ........+.+|+.+||..||++|+++.||+++ |+.+
T Consensus 242 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 242 FVQRLQSDEAKNY-MKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHHTCSCHHHHHH-HHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHhhhcchhhhhh-hccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 0000000001111 1111000 011112346789999999999999999999987 5544
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-45 Score=393.73 Aligned_cols=257 Identities=26% Similarity=0.334 Sum_probs=192.5
Q ss_pred CccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeecc------ceeeE
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCISE------RERLL 454 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~------~~~~l 454 (727)
+|+.+++||+|+||+||+|++. +|+.||||+++... ..+.+|+++|++++|+||++++++|... .++||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc----hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 4888899999999999999985 58999999997532 2345799999999999999999998542 35789
Q ss_pred EEeeccCCccchhccc-CCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCC-cEEEEeeccchhh
Q 041135 455 VYEYVPNDTLHYHLHA-EGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSF-EARVADFGLAKIA 532 (727)
Q Consensus 455 V~Ey~~~gsL~~~L~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~-~vkL~DFGla~~~ 532 (727)
|||||.++.+..+++. .....+++.+++.|++||++||+|||++ +|||||||++||||+.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987755444332 2334589999999999999999999998 999999999999999775 8999999999754
Q ss_pred hccCCCccccccccCCccccccCcccC-CCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchh
Q 041135 533 LELDSNTHVSTRVMGTFGYMAPEYATS-GKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHE 611 (727)
Q Consensus 533 ~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~ 611 (727)
.. .......+|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...... +.+.. ++.. +...
T Consensus 174 ~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~--~~l~~----i~~~-~g~~ 242 (350)
T d1q5ka_ 174 VR----GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV--DQLVE----IIKV-LGTP 242 (350)
T ss_dssp CT----TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH--HHHHH----HHHH-HCCC
T ss_pred cC----CcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH--HHHHH----HHHH-hCCC
Confidence 22 122334679999999998875 46899999999999999999999999764321 11111 1110 0000
Q ss_pred hHHHHHHHHh----hc------------ccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 612 DFEALVDSRL----EK------------NYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 612 ~~~~l~d~~l----~~------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
. .+.+.... .. .........+.+|+.+||+.||++|+++.||+++
T Consensus 243 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 243 T-REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp C-HHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred h-HHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 01111000 00 0111123347889999999999999999999975
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5.5e-43 Score=374.13 Aligned_cols=256 Identities=19% Similarity=0.285 Sum_probs=195.8
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcC-CCCceeEeeEeec--cceeeEEE
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRVH-HRHLVSLVGYCIS--ERERLLVY 456 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~--~~~~~lV~ 456 (727)
++|+++++||+|+||+||+|++. +|+.||||+++.. ..+.+++|+++|++++ |+||++++++|.. ...+++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 57999999999999999999974 6899999998643 3467899999999995 9999999999874 45689999
Q ss_pred eeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCC-cEEEEeeccchhhhcc
Q 041135 457 EYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSF-EARVADFGLAKIALEL 535 (727)
Q Consensus 457 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~-~vkL~DFGla~~~~~~ 535 (727)
|||.+++|..+++ .+++.+++.|+.||++||+|||++ +|||||||++||||+.++ .+||+|||+|+....
T Consensus 112 e~~~~~~L~~~~~-----~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~- 182 (328)
T d3bqca1 112 EHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP- 182 (328)
T ss_dssp ECCCSCBGGGTTT-----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCT-
T ss_pred eecCCCcHHHHhc-----CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccC-
Confidence 9999999987653 389999999999999999999999 999999999999998654 699999999985422
Q ss_pred CCCccccccccCCccccccCcccCC-CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhchhhHH
Q 041135 536 DSNTHVSTRVMGTFGYMAPEYATSG-KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEHEDFE 614 (727)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~~~~~ 614 (727)
.......+||..|+|||.+.+. .++.++|||||||++|||++|+.||....... ..... +...+......
T Consensus 183 ---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~-~~~~~-----i~~~~g~~~~~ 253 (328)
T d3bqca1 183 ---GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY-DQLVR-----IAKVLGTEDLY 253 (328)
T ss_dssp ---TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH-HHHHH-----HHHHHCHHHHH
T ss_pred ---CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhH-HHHHH-----HHHHHCCchhh
Confidence 1223456789999999998875 47999999999999999999999997643211 01111 11111111111
Q ss_pred HHHHHH-----------------------hhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 615 ALVDSR-----------------------LEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 615 ~l~d~~-----------------------l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
...... ............+.+||++||..||++|++++||+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 254 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp HHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111100 0000011122347889999999999999999999875
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-44 Score=380.44 Aligned_cols=253 Identities=26% Similarity=0.362 Sum_probs=200.9
Q ss_pred cCccccceeccCCceEEEEEEEc----CCcEEEEEEeeeCC----chhHHHHHHHHHHHHHcCC-CCceeEeeEeeccce
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA----DGREVAVKQLKIGG----SQGEREFRAEVEIISRVHH-RHLVSLVGYCISERE 451 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~----~g~~vaVK~l~~~~----~~~~~~~~~Ei~~l~~l~H-pnIv~l~~~~~~~~~ 451 (727)
++|+++++||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+++|++++| +||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 55999999999999999999852 47899999985432 2334678899999999976 799999999999999
Q ss_pred eeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchh
Q 041135 452 RLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKI 531 (727)
Q Consensus 452 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 531 (727)
.++||||+.+|+|.+++...+. +.+..++.++.||+.||+|||++ +|||||||++||||+.++.+||+|||+++.
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~--~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eeeeeecccccHHHHHHHhccc--ccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhh
Confidence 9999999999999999987765 67888999999999999999999 999999999999999999999999999975
Q ss_pred hhccCCCccccccccCCccccccCcccCC--CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhc
Q 041135 532 ALELDSNTHVSTRVMGTFGYMAPEYATSG--KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALE 609 (727)
Q Consensus 532 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~ 609 (727)
+... .........|+..|++||.+.+. .++.++|||||||+||||++|+.||.......... ...+.
T Consensus 179 ~~~~--~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~--~i~~~------- 247 (322)
T d1vzoa_ 179 FVAD--ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA--EISRR------- 247 (322)
T ss_dssp CCGG--GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH--HHHHH-------
T ss_pred hccc--ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHh-------
Confidence 4221 22223446799999999999765 46789999999999999999999998764332111 11000
Q ss_pred hhhHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 041135 610 HEDFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRP-----RMSQVVRA 657 (727)
Q Consensus 610 ~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 657 (727)
.... ...+.......+.+|+++||+.||++|+ +++||+++
T Consensus 248 ------~~~~--~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 248 ------ILKS--EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp ------HHHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred ------cccC--CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 0010 1111223344588899999999999999 47888764
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=372.65 Aligned_cols=264 Identities=19% Similarity=0.299 Sum_probs=203.1
Q ss_pred cCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc--hhHHHHHHHHHHHHHcCCCCceeEeeEeeccceeeEEEe
Q 041135 381 NGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS--QGEREFRAEVEIISRVHHRHLVSLVGYCISERERLLVYE 457 (727)
Q Consensus 381 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 457 (727)
++|+++++||+|+||+||+|++. +|+.||||+++.... .....+++|+.+|++++|+||++++++|.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57999999999999999999974 689999999975433 335678999999999999999999999999999999999
Q ss_pred eccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchhhhccCC
Q 041135 458 YVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKIALELDS 537 (727)
Q Consensus 458 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 537 (727)
|+.+++|..+++..+. +.+..++.++.|+++||+|||++ +|||||||++||||+.++.+||+|||+++....
T Consensus 82 ~~~~~~l~~~~~~~~~--~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~--- 153 (292)
T d1unla_ 82 FCDQDLKKYFDSCNGD--LDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGI--- 153 (292)
T ss_dssp CCSEEHHHHHHHTTTC--CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS---
T ss_pred eccccccccccccccc--cchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccC---
Confidence 9999999888876654 78999999999999999999999 999999999999999999999999999986422
Q ss_pred CccccccccCCccccccCcccCCC-CCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhch--hhHH
Q 041135 538 NTHVSTRVMGTFGYMAPEYATSGK-LTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALEH--EDFE 614 (727)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~l~~~~-~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~~--~~~~ 614 (727)
.........++..|++||++.+.. ++.++|||||||++|||++|+.||..... .. +....+....... ..+.
T Consensus 154 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~--~~---~~~~~~~~~~~~~~~~~~~ 228 (292)
T d1unla_ 154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VD---DQLKRIFRLLGTPTEEQWP 228 (292)
T ss_dssp CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS--HH---HHHHHHHHHHCCCCTTTCT
T ss_pred CCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCC--HH---HHHHHHHhhcCCCChhhhh
Confidence 222233456788999999988765 68999999999999999999999754321 11 1111111110000 0000
Q ss_pred HHH---HH---------HhhcccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 615 ALV---DS---------RLEKNYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 615 ~l~---d~---------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
... +. .............+.+|+++||+.||++|++++||+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 00 00000111222357789999999999999999999875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=375.79 Aligned_cols=260 Identities=21% Similarity=0.243 Sum_probs=190.4
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCC--chhHHHHHHHHHHHHHcCCCCceeEeeEeec------cc
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGG--SQGEREFRAEVEIISRVHHRHLVSLVGYCIS------ER 450 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~------~~ 450 (727)
.++|+++++||+|+||+||+|++. +|+.||||+++... ....+.+.+|+.+|++++|+|||+++++|.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 367999999999999999999975 59999999997443 2334578999999999999999999999964 36
Q ss_pred eeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccch
Q 041135 451 ERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAK 530 (727)
Q Consensus 451 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~ 530 (727)
++|||||||.+++|..+ .. .+++..++.++.||+.||+|||++ ||+|||||++|||++.++.+||+|||+++
T Consensus 96 ~~~iv~Ey~~~~l~~~~-~~----~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 96 DVYLVMELMDANLCQVI-QM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEEECCSEEHHHHH-TS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eeEEEEeccchHHHHhh-hc----CCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhh
Confidence 78999999977665544 32 378999999999999999999999 99999999999999999999999999988
Q ss_pred hhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhh--
Q 041135 531 IALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEAL-- 608 (727)
Q Consensus 531 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~-- 608 (727)
... ........+||..|+|||++.+..++.++||||+||++|||++|+.||.+... . .....++....
T Consensus 168 ~~~----~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~---~---~~~~~i~~~~~~~ 237 (355)
T d2b1pa1 168 TAG----TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY---I---DQWNKVIEQLGTP 237 (355)
T ss_dssp -----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---H---HHHHHHHHHHCCC
T ss_pred ccc----cccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCH---H---HHHHHHHHhccCC
Confidence 542 22334456799999999999999999999999999999999999999975431 1 11111111000
Q ss_pred -------chhhHHHHHHHHhhc------------------ccchhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 609 -------EHEDFEALVDSRLEK------------------NYVDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 609 -------~~~~~~~l~d~~l~~------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
....+..++...... .........+.+|+++||..||++|++++||+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp CHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 001111111111000 0011223457899999999999999999999987
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-43 Score=375.58 Aligned_cols=259 Identities=20% Similarity=0.291 Sum_probs=195.0
Q ss_pred hcCccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCc--hhHHHHHHHHHHHHHcCCCCceeEeeEeec-----cce
Q 041135 380 TNGFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGS--QGEREFRAEVEIISRVHHRHLVSLVGYCIS-----ERE 451 (727)
Q Consensus 380 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~-----~~~ 451 (727)
.++|+++++||+|+||+||+|++. +|+.||||+++.... ...+.+.+|+++|++++|+|||++++++.. +..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 567999999999999999999964 699999999975432 334578899999999999999999999864 334
Q ss_pred eeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEEeeccchh
Q 041135 452 RLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVADFGLAKI 531 (727)
Q Consensus 452 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 531 (727)
.++||+|+.+|+|.++++.+ .+++.+++.|+.||+.||+|||++ +|+|||||++|||++.++.+||+|||++..
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred eEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcc
Confidence 57778888999999998654 389999999999999999999999 999999999999999999999999999974
Q ss_pred hhccCCCccccccccCCccccccCcccCC-CCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhhHHHHHHhhc-
Q 041135 532 ALELDSNTHVSTRVMGTFGYMAPEYATSG-KLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLAEALE- 609 (727)
Q Consensus 532 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~l~~~~~- 609 (727)
.. .......|+..|+|||++.+. .++.++|||||||+||||++|+.||.+.+.. .. ...++.....
T Consensus 171 ~~------~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~---~~---~~~i~~~~~~~ 238 (348)
T d2gfsa1 171 TD------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI---DQ---LKLILRLVGTP 238 (348)
T ss_dssp CT------GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH---HH---HHHHHHHHCCC
T ss_pred cC------cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHH---HH---HHHHHHhcCCC
Confidence 32 223446789999999987765 4688999999999999999999999764321 11 1111111000
Q ss_pred ---------hhhHHHHHHHHhhccc-------chhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 041135 610 ---------HEDFEALVDSRLEKNY-------VDSEMFWMIEAAAACVRHSATKRPRMSQVVRA 657 (727)
Q Consensus 610 ---------~~~~~~l~d~~l~~~~-------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 657 (727)
......... .+.... .......+.+||++||+.||++|+++.||+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 239 GAELLKKISSESARNYIQ-SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp CHHHHTTCCCHHHHHHHT-TSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ChHHhhhccchhhhhhhh-hcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 000000000 000000 01112347789999999999999999999985
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.5e-38 Score=343.64 Aligned_cols=264 Identities=19% Similarity=0.227 Sum_probs=190.3
Q ss_pred CccccceeccCCceEEEEEEEc-CCcEEEEEEeeeCCchhHHHHHHHHHHHHHcC-----------CCCceeEeeEeecc
Q 041135 382 GFSAHNVLGEGGFGCVYKGVLA-DGREVAVKQLKIGGSQGEREFRAEVEIISRVH-----------HRHLVSLVGYCISE 449 (727)
Q Consensus 382 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~-----------HpnIv~l~~~~~~~ 449 (727)
+|+++++||+|+||+||+|+.. +|+.||||+++.. ....+.+.+|+++|+.++ |+||+++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 4999999999999999999974 6999999998743 233457888999998875 57899999988653
Q ss_pred --ceeeEEEeeccCCccc-hhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCC------c
Q 041135 450 --RERLLVYEYVPNDTLH-YHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSF------E 520 (727)
Q Consensus 450 --~~~~lV~Ey~~~gsL~-~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~------~ 520 (727)
...+++|+++.++.+. ..........+.+..++.++.||++||+|||+.. +|+|||||++||||+.++ .
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~--~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTEEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc--CcccccCChhHeeeeccCcccccce
Confidence 4556677766555433 3333444456889999999999999999999832 899999999999997654 4
Q ss_pred EEEEeeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHHHHHhCCCCCCCCCCCCchhhHHhh
Q 041135 521 ARVADFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWA 600 (727)
Q Consensus 521 vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~ 600 (727)
+||+|||+++.... .....+|+..|+|||++.+..++.++|||||||+|+||++|+.||............+..
T Consensus 171 ~kl~dfg~s~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 171 IKIADLGNACWYDE------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEECCCTTCEETTB------CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred eeEeeccccccccc------ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 99999999975421 223467999999999999999999999999999999999999999765432211111111
Q ss_pred HHHHHHhhchh------------------------------hHHHHHHHHhhcccchhHHHHHHHHHHHHhccCCCCCCC
Q 041135 601 RPLLAEALEHE------------------------------DFEALVDSRLEKNYVDSEMFWMIEAAAACVRHSATKRPR 650 (727)
Q Consensus 601 ~~~l~~~~~~~------------------------------~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs 650 (727)
...+. .+... .+..... ....+.......+.+|+.+||+.||++||+
T Consensus 245 ~~~~~-~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt 321 (362)
T d1q8ya_ 245 AQIIE-LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLT--EKYKFSKDEAKEISDFLSPMLQLDPRKRAD 321 (362)
T ss_dssp HHHHH-HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHH--HTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHH-HhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcc--cccccCcccCHHHHHHHHHHCCCChhHCcC
Confidence 11110 00000 0000010 111233455667899999999999999999
Q ss_pred HHHHHHH
Q 041135 651 MSQVVRA 657 (727)
Q Consensus 651 ~~evl~~ 657 (727)
++||+++
T Consensus 322 a~e~L~H 328 (362)
T d1q8ya_ 322 AGGLVNH 328 (362)
T ss_dssp HHHHHTC
T ss_pred HHHHhcC
Confidence 9999886
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=1.1e-25 Score=220.39 Aligned_cols=171 Identities=18% Similarity=0.156 Sum_probs=121.7
Q ss_pred ccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCc------------------hhHHHHHHHHHHHHHcCCCCceeEee
Q 041135 383 FSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGS------------------QGEREFRAEVEIISRVHHRHLVSLVG 444 (727)
Q Consensus 383 ~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~------------------~~~~~~~~Ei~~l~~l~HpnIv~l~~ 444 (727)
+.+.++||+|+||.||+|++.+|+.||||+++.... .....+.+|+..|.++.|.+++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 356799999999999999998999999998753211 01123557889999999999999887
Q ss_pred EeeccceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcCCCcEEeeCCCCCceEECCCCcEEEE
Q 041135 445 YCISERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDSSFEARVA 524 (727)
Q Consensus 445 ~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~ 524 (727)
+.. .+|||||+.++.+.. +......+++.||+++|+|||++ +|+|||||++||||+++ .++|+
T Consensus 82 ~~~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 82 WEG----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp EET----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEEC
T ss_pred ecC----CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEE
Confidence 642 379999998876543 33345578999999999999999 99999999999999865 58999
Q ss_pred eeccchhhhccCCCccccccccCCccccccCcccCCCCCchhHHHHHhHHHH
Q 041135 525 DFGLAKIALELDSNTHVSTRVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLL 576 (727)
Q Consensus 525 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDVwS~Gvil~ 576 (727)
|||+|+.......... ..+.+. .+ -|.+ .+.|..++||||+.--++
T Consensus 145 DFG~a~~~~~~~~~~~-l~rd~~---~~-~~~f-~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 145 DFPQSVEVGEEGWREI-LERDVR---NI-ITYF-SRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp CCTTCEETTSTTHHHH-HHHHHH---HH-HHHH-HHHHCCCCCHHHHHHHHH
T ss_pred ECCCcccCCCCCcHHH-HHHHHH---HH-HHHH-cCCCCCcccHHHHHHHHh
Confidence 9999975321111000 000000 00 0111 356788999999765443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=99.04 E-value=4.9e-10 Score=112.65 Aligned_cols=149 Identities=14% Similarity=0.074 Sum_probs=107.5
Q ss_pred HHHHHHhcCccccceeccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcC-CCCceeEeeEeecccee
Q 041135 374 DELIQATNGFSAHNVLGEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVH-HRHLVSLVGYCISERER 452 (727)
Q Consensus 374 ~el~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~ 452 (727)
.|+....+.|++.+..+-+..+.||+... +++.++||+...........+.+|..+|+.|. +--+.++++++.+++..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 46777778888877766566679999865 56778889876544444556889999999885 44567888888888899
Q ss_pred eEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHHHHHhcC---------------------------------
Q 041135 453 LLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIAYLHEDC--------------------------------- 499 (727)
Q Consensus 453 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--------------------------------- 499 (727)
++||++++|..+...+... .....++.++++.|..||+..
T Consensus 86 ~lv~~~l~G~~~~~~~~~~-------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE-------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC-------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEEeccccccccccccc-------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 9999999998876543221 122334455555555555321
Q ss_pred -----------------------CCcEEeeCCCCCceEECCCCcEEEEeeccch
Q 041135 500 -----------------------HPRIIHRDIKSSNILLDSSFEARVADFGLAK 530 (727)
Q Consensus 500 -----------------------~~~ivHrDLkp~NILl~~~~~vkL~DFGla~ 530 (727)
...++|+|+.+.|||+++++.+.|+||+.+.
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1248999999999999987667799999886
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.63 E-value=3.5e-08 Score=98.22 Aligned_cols=130 Identities=16% Similarity=0.076 Sum_probs=87.6
Q ss_pred eeccCC-ceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCC--CCceeEeeEeeccceeeEEEeeccCCcc
Q 041135 388 VLGEGG-FGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHH--RHLVSLVGYCISERERLLVYEYVPNDTL 464 (727)
Q Consensus 388 ~LG~G~-fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~H--pnIv~l~~~~~~~~~~~lV~Ey~~~gsL 464 (727)
.+..|. .+.||+...++|..++||..... ...++.+|+++|+.|.. -.+.++++++.+++..++||+|++|..+
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCcc---CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 344454 36899998888888999976533 23467889999988853 3356788888888888999999988776
Q ss_pred chhcccCCCCcccHHHHHHHHHHHHH---------------------------------------------------HHH
Q 041135 465 HYHLHAEGRPVMDWATRVKVAAGAAR---------------------------------------------------GIA 493 (727)
Q Consensus 465 ~~~L~~~~~~~l~~~~~~~i~~qia~---------------------------------------------------gL~ 493 (727)
..... .. ..++.++.+ .+.
T Consensus 94 ~~~~~-------~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (255)
T d1nd4a_ 94 LSSHL-------AP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 163 (255)
T ss_dssp TTSCC-------CH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred ccccc-------cH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHH
Confidence 43210 00 011112222 223
Q ss_pred HHHhcC----CCcEEeeCCCCCceEECCCCcEEEEeeccch
Q 041135 494 YLHEDC----HPRIIHRDIKSSNILLDSSFEARVADFGLAK 530 (727)
Q Consensus 494 yLH~~~----~~~ivHrDLkp~NILl~~~~~vkL~DFGla~ 530 (727)
.|.... ...+||+|+.+.|||++++..+.|+||+.+.
T Consensus 164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 164 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 332221 2248999999999999987777899999875
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.48 E-value=3.3e-07 Score=97.60 Aligned_cols=77 Identities=17% Similarity=0.160 Sum_probs=50.1
Q ss_pred cceeccCCceEEEEEEEcC-CcEEEEEEeee----CC---chhHHHHHHHHHHHHHcC-C--CCceeEeeEeeccceeeE
Q 041135 386 HNVLGEGGFGCVYKGVLAD-GREVAVKQLKI----GG---SQGEREFRAEVEIISRVH-H--RHLVSLVGYCISERERLL 454 (727)
Q Consensus 386 ~~~LG~G~fg~Vy~~~~~~-g~~vaVK~l~~----~~---~~~~~~~~~Ei~~l~~l~-H--pnIv~l~~~~~~~~~~~l 454 (727)
.+.||.|....||+....+ |+.|+||.-.. .. ........+|.++|+.+. + ..+.+++++. ....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEE
Confidence 4579999999999998654 67899997532 11 112234567888888774 3 3456666553 445579
Q ss_pred EEeeccCCcc
Q 041135 455 VYEYVPNDTL 464 (727)
Q Consensus 455 V~Ey~~~gsL 464 (727)
||||+.+..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=98.06 E-value=3.9e-05 Score=78.21 Aligned_cols=157 Identities=11% Similarity=0.025 Sum_probs=87.5
Q ss_pred ccHHHHHHHhcCcccccee-----ccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCce--eEe
Q 041135 371 FTYDELIQATNGFSAHNVL-----GEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLV--SLV 443 (727)
Q Consensus 371 ~~~~el~~~~~~~~~~~~L-----G~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv--~l~ 443 (727)
++.+|+.....+|.+.+++ ..|---..|+.+..+| .+++|++... ....++..|+++|..|...++. ..+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~--~~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCC--CCHHHHHHHHHHHHhhhhccccccccc
Confidence 4567888888888775543 3555578899988765 4899987532 2345677788888887533221 111
Q ss_pred e------EeeccceeeEEEeeccCCccchh--------------ccc----CC-----CC----------------cccH
Q 041135 444 G------YCISERERLLVYEYVPNDTLHYH--------------LHA----EG-----RP----------------VMDW 478 (727)
Q Consensus 444 ~------~~~~~~~~~lV~Ey~~~gsL~~~--------------L~~----~~-----~~----------------~l~~ 478 (727)
. +.......+.++.++.+...... ++. .. .. ....
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 1 11123445667777766443211 000 00 00 0001
Q ss_pred HHHHHHHHHHHHHHHHHHh-cCCCcEEeeCCCCCceEECCCCcEEEEeeccch
Q 041135 479 ATRVKVAAGAARGIAYLHE-DCHPRIIHRDIKSSNILLDSSFEARVADFGLAK 530 (727)
Q Consensus 479 ~~~~~i~~qia~gL~yLH~-~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~ 530 (727)
..+...+..+...+..++. ....+|||+|+...|||++++...-|+||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 1112222222222222221 124589999999999999988777899999885
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.86 E-value=3.3e-05 Score=81.67 Aligned_cols=74 Identities=18% Similarity=0.178 Sum_probs=52.0
Q ss_pred cceeccCCceEEEEEEEcCC--------cEEEEEEeeeCCchhHHHHHHHHHHHHHcC-CCCceeEeeEeeccceeeEEE
Q 041135 386 HNVLGEGGFGCVYKGVLADG--------REVAVKQLKIGGSQGEREFRAEVEIISRVH-HRHLVSLVGYCISERERLLVY 456 (727)
Q Consensus 386 ~~~LG~G~fg~Vy~~~~~~g--------~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~lV~ 456 (727)
++.|+.|---.+|++...++ +.|++++.- . .....+..+|.++++.+. +.-..+++++|.+ ++||
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 46788888889999987543 456666654 2 233456778999999886 4334588887753 5899
Q ss_pred eeccCCccc
Q 041135 457 EYVPNDTLH 465 (727)
Q Consensus 457 Ey~~~gsL~ 465 (727)
||+.|..|.
T Consensus 121 efi~g~~l~ 129 (395)
T d1nw1a_ 121 EYIPSRPLS 129 (395)
T ss_dssp CCCCEEECC
T ss_pred EEeccccCC
Confidence 999886553
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.82 E-value=1.8e-05 Score=81.47 Aligned_cols=137 Identities=16% Similarity=0.142 Sum_probs=81.4
Q ss_pred CCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCc--eeEee-----EeeccceeeEEEeeccCCcc
Q 041135 392 GGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHL--VSLVG-----YCISERERLLVYEYVPNDTL 464 (727)
Q Consensus 392 G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnI--v~l~~-----~~~~~~~~~lV~Ey~~~gsL 464 (727)
+.-..||+++..+|+.|++|+.+.+ ....+++..|+++|..|...+| +..+. .+..++..+.|++|+.|..+
T Consensus 33 s~EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~ 111 (325)
T d1zyla1 33 SYENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF 111 (325)
T ss_dssp CSSSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred cccceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence 3346899999999999999998643 2345678889999998863332 22211 12335567889999987543
Q ss_pred chh--------------ccc----C---CCCcccH-------------------HHHHHHHHHHHHHHHHHHhc----CC
Q 041135 465 HYH--------------LHA----E---GRPVMDW-------------------ATRVKVAAGAARGIAYLHED----CH 500 (727)
Q Consensus 465 ~~~--------------L~~----~---~~~~l~~-------------------~~~~~i~~qia~gL~yLH~~----~~ 500 (727)
... +|. . .+..+++ ..+..+...+.+.++.+... ..
T Consensus 112 ~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p 191 (325)
T d1zyla1 112 EADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT 191 (325)
T ss_dssp CSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred CCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCC
Confidence 210 110 0 0111111 11112222223333333322 23
Q ss_pred CcEEeeCCCCCceEECCCCcEEEEeeccchh
Q 041135 501 PRIIHRDIKSSNILLDSSFEARVADFGLAKI 531 (727)
Q Consensus 501 ~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 531 (727)
.++||+|+.+.|||++++ ..|+||+.+..
T Consensus 192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 479999999999999754 45899998863
|
| >d1cjaa_ d.144.1.3 (A:) Actin-fragmin kinase, catalytic domain {Physarum polycephalum [TaxId: 5791]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Actin-fragmin kinase, catalytic domain domain: Actin-fragmin kinase, catalytic domain species: Physarum polycephalum [TaxId: 5791]
Probab=90.06 E-value=0.43 Score=46.61 Aligned_cols=133 Identities=15% Similarity=0.114 Sum_probs=73.5
Q ss_pred ccCCceEEEEEEEcCCcEEEEEEeeeCCchhHHHHHHHHHHHHHcCCCCceeEeeEeec---------------------
Q 041135 390 GEGGFGCVYKGVLADGREVAVKQLKIGGSQGEREFRAEVEIISRVHHRHLVSLVGYCIS--------------------- 448 (727)
Q Consensus 390 G~G~fg~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~--------------------- 448 (727)
.++|.+-|+.+..+ +..++||.- .....+.|..|+...-.+.-+... ++..|..
T Consensus 77 s~~Gs~Gv~FV~~e-~gaiVlK~s---~tta~E~y~~eLAr~LGvpvPqmR-vI~~~~~E~~~~~~~~l~~~e~d~~I~s 151 (342)
T d1cjaa_ 77 SEKGTEGLFFVETE-SGVFIVKRS---TNIESETFCSLLCMRLGLHAPKVR-VVSSNSEEGTNMLECLAAIDKSFRVITT 151 (342)
T ss_dssp CCSTTSCEEEEEES-SCEEEEECC---TTHHHHHHHHHHHHHHTCCCCCEE-EEESSSHHHHHHHHHHHHHCSSSCHHHH
T ss_pred eecCCceEEEEEcC-CceEEEecC---CchHHHHHHHHHHHHhCCCCCceE-EecCCCHHHHHHHHHHhcCCChhHHHHH
Confidence 34444445555554 556778852 334445667777766667777643 3332211
Q ss_pred --cceeeEEEeeccCCccchhcccCCCCcccHHHHHHHHHHHHHHHH-HHHhcCCCcEEeeCC-CCCceEECCCC-cEEE
Q 041135 449 --ERERLLVYEYVPNDTLHYHLHAEGRPVMDWATRVKVAAGAARGIA-YLHEDCHPRIIHRDI-KSSNILLDSSF-EARV 523 (727)
Q Consensus 449 --~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~-yLH~~~~~~ivHrDL-kp~NILl~~~~-~vkL 523 (727)
....+++|||+.|..|.+.-.......+..+....+ +-+-+++ ++|......+++|+- .+.||++++++ .+..
T Consensus 152 el~~A~~liMeYvpG~~l~e~~~~~a~~~fs~~~l~~L--GkIiaFDifInN~DR~PL~Wrn~GN~~Niml~~n~~~~~~ 229 (342)
T d1cjaa_ 152 LANQANILLMELVRGITLNKLTTTSAPEVLTKSTMQQL--GSLMALDVIVNNSDRLPIAWTNEGNLDNIMLSERGATVVP 229 (342)
T ss_dssp HTTCSEEEEEECCCEEESTTCCSSSHHHHSCHHHHHHH--HHHHHHHHHHTCCSSSCSSSCSCCCGGGEEEESBTTCEEE
T ss_pred HHhcccceeeeccCCccccccccccchhhhcHHHHHHh--hhHHHHHHHHcCCccccccccCCCCccceEEecCCcEEEE
Confidence 234579999998888766543221111222222211 1122333 455544445666642 67899998776 7788
Q ss_pred Eeeccc
Q 041135 524 ADFGLA 529 (727)
Q Consensus 524 ~DFGla 529 (727)
+|=|..
T Consensus 230 IDs~i~ 235 (342)
T d1cjaa_ 230 IDSKII 235 (342)
T ss_dssp CSCCCC
T ss_pred ecCCcc
Confidence 886655
|